data_2kud_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kud _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 108.425 -0.954 . . . . 73.239999999999995 108.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 22.7 m -131.27 158.48 43.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 123.102 0.561 . . . . 74.319999999999993 109.53 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.71 137.25 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.726 -0.842 . . . . 74.239999999999995 108.726 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.36 124.52 36.97 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-O 120.828 0.347 . . . . 70.340000000000003 110.519 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.01 142.64 96.85 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.16 2.573 . . . . 74.040000000000006 113.304 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.71 149.96 34.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.742 -1.117 . . . . 71.109999999999999 110.167 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.83 31.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.987 1.375 . . . . 65.010000000000005 108.006 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -64.44 133.97 53.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.057 -1.429 . . . . 74.319999999999993 110.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.18 -0.13 47.49 Favored Glycine 0 C--N 1.317 -0.495 0 C-N-CA 121.407 -0.425 . . . . 71.239999999999995 112.326 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.23 -176.88 3.94 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.615 -0.883 . . . . 72.430000000000007 108.615 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 91.6 p -81.3 168.41 18.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 118.407 0.548 . . . . 73.299999999999997 110.266 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.432 ' O ' HG13 ' A' ' 374' ' ' ILE . 1.8 p -63.15 -34.83 78.46 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 110.637 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.91 -39.25 93.98 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.731 0.412 . . . . 74.230000000000004 110.548 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -59.57 -42.83 93.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.106 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.89 81.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.745 . . . . 73.310000000000002 110.343 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 370' ' ' SER . 80.9 mt -58.4 -46.34 89.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.654 -0.703 . . . . 74.209999999999994 110.546 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -46.98 78.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.317 -0.401 . . . . 73.040000000000006 111.705 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 74.0 m -60.9 -47.53 85.98 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.727 0.298 . . . . 71.230000000000004 111.291 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.57 -39.51 93.88 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.045 -0.262 . . . . 75.239999999999995 110.998 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.07 -42.92 99.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.459 0.703 . . . . 71.540000000000006 109.727 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -33.71 76.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.778 -0.646 . . . . 75.409999999999997 111.323 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -83.84 -10.2 58.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.057 -0.52 . . . . 75.540000000000006 111.743 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.98 0.28 56.19 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.249 -0.977 . . . . 74.340000000000003 112.497 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 53.6 m-85 -78.07 151.11 33.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.675 -0.491 . . . . 73.420000000000002 109.675 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 383' ' ' LYS . 3.0 mptp? -102.06 147.19 26.89 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.867 -1.531 . . . . 74.120000000000005 106.867 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.69 141.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-O 121.378 0.609 . . . . 72.109999999999999 111.623 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -118.65 127.97 54.08 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.334 -1.358 . . . . 73.040000000000006 107.334 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.4 m -99.71 123.95 44.48 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 109.277 -0.638 . . . . 73.510000000000005 109.277 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.63 119.57 39.14 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.302 -1.74 . . . . 73.040000000000006 106.302 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -119.18 141.29 48.99 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 110.155 -0.313 . . . . 75.510000000000005 110.155 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.404 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 11.0 ptpt -139.4 134.89 16.69 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 116.057 -0.52 . . . . 73.549999999999997 111.109 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 6.1 Cg_exo -82.7 134.24 7.33 Favored 'Trans proline' 0 C--O 1.246 0.893 0 N-CA-C 106.737 -2.063 . . . . 71.409999999999997 106.737 165.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.404 ' HB2' ' HD3' ' A' ' 389' ' ' LYS . 5.0 t70 -154.38 -176.73 6.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.182 -1.407 . . . . 73.519999999999996 112.239 -171.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.9 t -92.44 -41.09 10.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.017 -1.845 . . . . 71.420000000000002 106.017 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -101.83 74.52 1.49 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.92 -1.511 . . . . 75.510000000000005 106.92 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.1 pp -88.64 121.02 70.31 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 115.435 1.643 . . . . 73.140000000000001 115.435 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.578 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 16.5 Cg_exo -75.48 157.37 40.8 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.78 2.32 . . . . 62.420000000000002 109.519 164.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.64 160.91 47.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.33 2.02 . . . . 74.109999999999999 111.864 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.59 -6.91 5.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.041 0.756 . . . . 72.030000000000001 113.041 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -90.59 166.74 13.03 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.409 -0.814 . . . . 74.120000000000005 108.938 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.07 117.76 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.076 -0.713 . . . . 71.540000000000006 109.076 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -106.43 -28.63 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.346 -0.613 . . . . 75.030000000000001 109.346 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 168.16 28.09 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.957 -1.657 . . . . 70.209999999999994 108.957 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 p -132.58 -177.76 4.62 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-O 120.96 0.41 . . . . 71.129999999999995 110.698 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -100.94 138.78 20.11 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.947 -1.131 . . . . 65.030000000000001 107.947 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.9 -29.54 3.76 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 124.573 3.515 . . . . 75.140000000000001 114.703 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.58 -28.39 54.79 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.236 0.614 . . . . 62.200000000000003 112.0 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.66 54.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.944 0.402 . . . . 71.340000000000003 111.203 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -6.76 59.25 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.557 0.577 . . . . 71.329999999999998 112.557 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.5 m -86.02 147.69 26.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.649 -1.612 . . . . 71.530000000000001 106.649 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.0 m -74.45 112.83 11.01 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.417 -0.957 . . . . 65.120000000000005 108.417 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.67 165.06 29.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.047 -0.723 . . . . 72.319999999999993 109.047 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 50.3 m -69.23 134.13 48.81 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 120.6 -0.44 . . . . 72.340000000000003 110.242 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.89 112.01 2.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 72.230000000000004 110.218 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.53 24.21 5.1 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.537 -1.025 . . . . 74.239999999999995 110.537 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.99 -169.12 2.43 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.409 -1.33 . . . . 72.109999999999999 107.409 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.1 125.05 53.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.814 -0.554 . . . . 75.530000000000001 110.209 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -111.42 125.65 68.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.926 -0.579 . . . . 73.400000000000006 109.442 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.2 t -89.59 130.74 35.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.086 -0.709 . . . . 72.450000000000003 109.086 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 65.9 t -108.67 118.78 56.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.083 -1.08 . . . . 74.439999999999998 108.083 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.4 121.65 34.09 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.164 -0.68 . . . . 72.340000000000003 109.164 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 13.8 p -133.96 152.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.432 -1.321 . . . . 64.450000000000003 107.432 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.578 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 43.7 m -126.74 130.82 51.09 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 121.574 -0.703 . . . . 72.25 110.224 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -118.05 106.66 13.13 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.522 0.677 . . . . 72.340000000000003 110.995 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 79.33 141.24 2.19 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.205 -0.907 . . . . 54.100000000000001 114.204 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 24.0 Cg_endo -74.28 147.56 37.49 Favored 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 121.09 1.193 . . . . 74.099999999999994 109.465 172.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -72.77 164.91 25.83 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 109.628 -177.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -125.48 154.23 42.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.934 -1.136 . . . . 75.540000000000006 107.934 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 427' ' ' ARG . 0.2 OUTLIER -141.9 153.48 44.44 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.318 -0.993 . . . . 71.219999999999999 108.318 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -83.06 138.86 33.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.962 -1.866 . . . . 73.120000000000005 105.962 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 69.2 mt -80.3 115.55 55.52 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 120.587 -0.445 . . . . 73.310000000000002 110.332 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.16 141.08 38.81 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.31 1.34 . . . . 70.430000000000007 109.969 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.6 78.77 9.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.619 1.2 . . . . 62.32 110.393 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.47 -10.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.531 -1.668 . . . . 73.299999999999997 107.588 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 4.6 m -59.9 -50.02 75.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.224 -1.353 . . . . 74.109999999999999 110.486 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 21.4 m -57.95 -13.56 4.76 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 125.598 1.559 . . . . 72.439999999999998 113.063 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.23 -47.08 11.18 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.731 -0.606 . . . . 74.230000000000004 110.681 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.407 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 26.6 m -160.82 145.68 14.14 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.652 -0.87 . . . . 75.140000000000001 108.652 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.57 -44.36 89.72 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 122.995 0.518 . . . . 63.210000000000001 111.085 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.76 84.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.815 -0.63 . . . . 73.549999999999997 110.748 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.407 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.5 mm-40 -61.89 -43.46 98.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.47 -0.786 . . . . 75.430000000000007 111.262 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.61 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 123.543 0.527 . . . . 63.439999999999998 110.729 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.76 -51.05 49.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.06 -0.518 . . . . 73.120000000000005 112.057 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -69.28 -44.94 70.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 114.04 1.126 . . . . 75.430000000000007 114.04 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.33 -38.39 84.82 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.978 -0.289 . . . . 73.329999999999998 111.312 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.15 -32.62 73.01 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.213 -0.595 . . . . 71.310000000000002 111.499 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.7 m -64.24 -40.38 95.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.999 -0.741 . . . . 75.219999999999999 108.999 174.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.65 66.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.711 -0.677 . . . . 75.200000000000003 110.798 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -12.4 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.164 0.507 . . . . 64.420000000000002 110.303 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . 0.491 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 124.15 -27.57 5.56 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.886 -0.673 . . . . 73.150000000000006 113.713 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 445' ' ' THR . 88.8 m-85 -62.09 142.14 57.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.236 0.518 . . . . 71.439999999999998 111.392 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.89 13.71 4.42 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.59 -1.291 . . . . 53.210000000000001 113.278 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -128.35 113.82 16.08 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.321 -0.517 . . . . 74.420000000000002 110.049 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.1 152.36 47.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.199 0.523 . . . . 72.420000000000002 111.515 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -143.17 123.81 14.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.74 -1.578 . . . . 74.010000000000005 106.74 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -94.72 134.71 37.02 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.73 159.69 41.28 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.741 -1.207 . . . . 75.239999999999995 107.741 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.656 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.1 m-80 -128.32 140.64 51.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.535 -0.913 . . . . 74.109999999999999 108.535 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.0 m -125.17 137.58 30.02 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 109.164 -0.68 . . . . 73.010000000000005 109.164 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 490' ' ' SER . 15.9 Cg_endo -61.55 121.39 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.414 2.076 . . . . 72.019999999999996 111.265 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.7 m -133.44 171.41 14.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.288 -0.634 . . . . 62.039999999999999 109.288 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.4 m -58.67 143.28 82.28 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 123.823 0.849 . . . . 73.049999999999997 108.867 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.473 ' O ' HG11 ' A' ' 464' ' ' VAL . 6.1 Cg_endo -50.6 -25.91 15.76 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.553 2.835 . . . . 63.25 113.027 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.41 -18.71 65.51 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.215 0.45 . . . . 71.140000000000001 112.215 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.22 5.17 18.26 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.281 -0.262 . . . . 74.340000000000003 111.126 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 461' ' ' PRO . 7.6 p -60.25 127.3 19.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.006 0.432 . . . . 74.109999999999999 110.895 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.03 82.06 Favored Glycine 0 C--N 1.308 -0.978 0 C-N-CA 120.469 -0.872 . . . . 75.329999999999998 112.453 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -111.28 153.41 25.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.568 -0.901 . . . . 75.049999999999997 108.568 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 434' ' ' THR . 86.5 t -84.03 135.55 24.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.814 -1.55 . . . . 72.519999999999996 106.814 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.75 -5.15 9.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 118.804 -1.158 . . . . 75.540000000000006 111.527 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 145.23 -153.67 25.42 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 111.066 -0.814 . . . . 63.119999999999997 111.066 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.1 p -116.79 160.38 20.9 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.489 -0.93 . . . . 60.210000000000001 108.489 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.4 t30 -74.08 -51.4 4.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 119.491 -0.884 . . . . 73.340000000000003 110.188 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.1 Cg_exo -71.03 152.39 62.71 Favored 'Trans proline' 0 C--N 1.381 2.288 0 N-CA-C 108.122 -1.53 . . . . 64.239999999999995 108.122 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.28 127.04 19.93 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.908 1.738 . . . . 75.25 111.775 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.79 -23.26 61.54 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.822 0.82 . . . . 63.439999999999998 110.753 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.54 0.18 47.64 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.592 -0.731 . . . . 74.120000000000005 110.422 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.46 150.57 20.46 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 109.182 -0.673 . . . . 73.420000000000002 109.182 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -88.23 106.95 18.54 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -106.51 148.27 28.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.618 -0.265 . . . . 54.310000000000002 110.921 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.14 157.83 36.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.395 0.517 . . . . 72.25 112.395 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 425' ' ' GLU . 40.5 mm -60.15 -35.61 62.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.684 0.754 . . . . 75.319999999999993 110.79 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.6 p -91.62 5.19 50.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.141 -0.936 . . . . 73.329999999999998 112.278 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -83.22 141.27 32.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.44 113.44 22.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.048 0.451 . . . . 71.030000000000001 110.618 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.06 119.81 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 108.898 -0.778 . . . . 74.519999999999996 108.898 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 60.6 mt -92.9 113.36 27.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.663 -1.236 . . . . 75.340000000000003 107.663 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.52 123.3 48.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 107.953 -1.128 . . . . 73.230000000000004 107.953 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 17.6 pt -107.24 122.77 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.713 0.768 . . . . 73.340000000000003 111.798 -176.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.656 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 60.2 t -98.67 139.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.164 -0.925 . . . . 70.420000000000002 108.988 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.87 118.47 4.69 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.744 -0.942 . . . . 72.310000000000002 110.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.719 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 52.9 m -141.09 129.78 22.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.59 -0.359 . . . . 72.109999999999999 110.216 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 106.411 -2.676 . . . . 71.329999999999998 106.411 177.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 107.653 -1.239 . . . . 73.329999999999998 107.653 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.81 155.14 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 116.476 -0.329 . . . . 74.319999999999993 110.486 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.2 136.97 34.89 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.556 -1.646 . . . . 74.230000000000004 106.556 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.62 138.27 19.59 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 116.265 -0.425 . . . . 73.439999999999998 110.27 -172.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.12 126.69 17.76 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.961 2.441 . . . . 65.109999999999999 112.814 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.41 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 9.9 t70 -70.21 153.77 42.7 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 114.482 -1.235 . . . . 75.340000000000003 110.457 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.441 ' HA ' ' NE2' ' A' ' 368' ' ' GLN . 17.1 m -109.75 3.59 9.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 114.239 1.2 . . . . 75.430000000000007 114.239 -174.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.41 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 39.6 ptt180 -62.94 130.29 44.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.077 0.465 . . . . 74.329999999999998 110.229 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.05 -2.9 47.8 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.815 -0.707 . . . . 75.120000000000005 111.723 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 365' ' ' VAL . 48.7 mt-30 -115.5 167.92 10.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.868 -0.79 . . . . 73.420000000000002 108.868 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.6 p -78.1 164.53 24.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.416 -0.587 . . . . 73.329999999999998 109.416 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 30.1 p -58.18 -45.53 87.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.155 0.503 . . . . 63.039999999999999 110.21 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.75 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.47 -0.787 . . . . 63.210000000000001 111.77 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.22 -34.74 76.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.465 0.65 . . . . 61.439999999999998 109.56 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.21 69.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 61.219999999999999 110.158 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.2 mt -58.75 -45.45 91.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.941 -0.572 . . . . 74.120000000000005 110.07 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.1 92.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.623 -0.717 . . . . 74.019999999999996 111.721 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 78.5 m -63.29 -48.66 77.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.243 -0.435 . . . . 75.25 111.816 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.86 -41.53 91.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.653 -0.249 . . . . 71.049999999999997 111.532 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -59.68 -41.59 91.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.905 0.753 . . . . 75.430000000000007 110.09 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -69.34 -31.34 69.71 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.249 -0.432 . . . . 70.219999999999999 111.184 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -79.13 -14.79 58.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.375 -0.375 . . . . 74.040000000000006 110.799 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.4 15.24 51.53 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.651 -0.785 . . . . 73.319999999999993 111.827 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -93.52 160.32 14.84 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.928 -0.397 . . . . 74.450000000000003 109.928 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.9 mmtp -104.66 135.35 46.22 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.025 -0.731 . . . . 74.430000000000007 109.025 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.38 138.59 49.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-O 121.256 0.55 . . . . 75.450000000000003 111.584 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -110.88 128.55 55.84 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.539 -1.282 . . . . 74.219999999999999 107.539 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.8 m -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 108.028 -1.101 . . . . 72.010000000000005 108.028 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 125.3 53.79 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 103.636 -2.727 . . . . 74.219999999999999 103.636 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -125.75 142.78 51.35 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 120.001 -0.68 . . . . 62.350000000000001 110.594 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -134.01 131.84 21.08 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 120.724 -0.39 . . . . 74.129999999999995 110.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.35 134.74 6.87 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.97 1.78 . . . . 73.5 109.2 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 -171.95 -176.04 1.62 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.467 -1.679 . . . . 71.109999999999999 106.467 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 68.3 m -129.53 -8.49 4.62 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.422 0.629 . . . . 65.510000000000005 111.084 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -94.29 3.45 55.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.815 -1.18 . . . . 64.340000000000003 107.815 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.2 pp -88.52 151.05 47.65 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.513 -1.222 . . . . 72.340000000000003 113.4 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.65 172.03 11.58 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 122.538 2.159 . . . . 74.439999999999998 110.13 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.69 161.57 9.83 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.149 2.566 . . . . 63.399999999999999 112.255 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.401 ' HB2' HG11 ' A' ' 420' ' ' VAL . 3.7 p-10 -57.14 -9.05 0.8 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 124.711 1.204 . . . . 64.549999999999997 113.04 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -67.66 136.74 54.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.745 -1.576 . . . . 73.340000000000003 106.745 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.63 118.31 11.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.766 -0.374 . . . . 75.239999999999995 110.541 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.2 tp -93.16 -41.18 12.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.038 -0.727 . . . . 73.120000000000005 109.038 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.39 157.61 27.44 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.08 -1.208 . . . . 72.400000000000006 110.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -124.34 -178.49 4.12 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.964 0.906 . . . . 74.140000000000001 109.716 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 155.14 36.77 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 107.458 -1.312 . . . . 74.150000000000006 107.458 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.66 -15.06 5.95 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.977 3.118 . . . . 64.450000000000003 115.805 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.12 -21.91 64.17 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 112.741 0.645 . . . . 74.230000000000004 112.741 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.79 -50.84 31.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.607 . . . . 61.229999999999997 111.076 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -85.05 -7.9 58.91 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.613 0.597 . . . . 75.420000000000002 112.613 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 56.5 m -91.51 139.34 30.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.48 -1.304 . . . . 73.420000000000002 107.48 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 40.1 m -75.0 113.54 12.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.211 0.529 . . . . 73.140000000000001 109.954 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.75 169.48 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 107.271 -1.381 . . . . 74.439999999999998 107.271 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -68.27 148.52 50.67 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.104 0.478 . . . . 72.209999999999994 111.409 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.36 111.03 3.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.941 -0.572 . . . . 64.430000000000007 110.338 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.16 20.39 8.35 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.656 -0.783 . . . . 71.120000000000005 112.338 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -89.49 -170.73 2.95 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.628 -0.879 . . . . 62.219999999999999 108.628 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.5 pt-20 -112.45 124.54 52.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.118 1.155 . . . . 73.340000000000003 114.118 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.02 138.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.269 -1.382 . . . . 74.409999999999997 107.269 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -103.01 121.43 42.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.324 -0.95 . . . . 72.010000000000005 111.578 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.62 119.95 46.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.085 -1.08 . . . . 71.140000000000001 108.085 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 419' ' ' ASN . 0.8 OUTLIER -93.89 118.01 30.88 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.587 -0.523 . . . . 71.209999999999994 109.587 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.4 t -122.06 140.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.593 -0.73 . . . . 73.420000000000002 109.859 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.7 m -94.66 121.68 36.48 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.769 -1.197 . . . . 70.430000000000007 107.769 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.3 p -119.15 106.29 12.22 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.905 -0.318 . . . . 74.319999999999993 111.647 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.81 147.34 2.39 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 115.069 0.788 . . . . 63.119999999999997 115.069 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.7 Cg_endo -81.04 147.4 16.56 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.011 1.807 . . . . 73.099999999999994 111.161 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.58 149.19 26.05 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.788 -0.449 . . . . 65.310000000000002 109.788 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 44.8 mt-30 -129.1 155.67 45.08 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.935 -0.765 . . . . 73.400000000000006 108.935 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -146.76 164.24 33.4 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.448 -1.315 . . . . 74.040000000000006 107.448 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 138.86 31.52 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 110.441 -0.207 . . . . 75.329999999999998 110.441 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -83.07 119.26 73.89 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.729 -0.841 . . . . 75.019999999999996 108.729 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.43 141.27 89.8 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.584 2.189 . . . . 74.239999999999995 112.331 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -79.78 -7.04 58.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.904 -0.589 . . . . 73.129999999999995 111.499 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.58 -16.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.685 0.794 . . . . 72.219999999999999 110.74 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 23.6 m -49.89 -47.04 52.25 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.475 1.11 . . . . 73.310000000000002 113.155 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 m -59.04 -22.04 60.06 Favored 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 124.553 1.141 . . . . 74.299999999999997 112.467 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.408 ' C ' ' HG1' ' A' ' 436' ' ' THR . 75.8 mt -78.1 -44.16 26.97 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 112.529 0.566 . . . . 70.420000000000002 112.529 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 435' ' ' LEU . 60.3 m -160.63 136.2 8.09 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.245 -0.65 . . . . 74.129999999999995 109.245 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -60.78 -45.42 94.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.238 0.458 . . . . 74.530000000000001 112.238 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.15 80.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.49 0.662 . . . . 74.109999999999999 110.749 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.47 -43.72 69.21 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.953 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.16 -51.72 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.431 -0.804 . . . . 60.539999999999999 111.453 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.4 -41.19 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.886 -0.597 . . . . 64.430000000000007 111.369 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.407 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -67.69 -47.03 70.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.783 -0.367 . . . . 65.109999999999999 111.847 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.18 -38.55 88.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.971 0.36 . . . . 74.540000000000006 111.971 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.854 -0.338 . . . . 74.230000000000004 111.576 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 98.6 m -65.78 -38.77 89.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.363 0.125 . . . . 72.25 111.243 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.36 70.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.17 0.509 . . . . 72.450000000000003 110.467 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.17 -13.79 58.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.947 -0.569 . . . . 74.109999999999999 111.027 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.81 8.82 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.038 -1.077 . . . . 72.230000000000004 114.113 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 445' ' ' THR . 93.2 m-85 -78.89 111.52 15.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 117.91 0.855 . . . . 72.439999999999998 110.189 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -112.14 -21.64 6.2 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.426 -0.892 . . . . 74.310000000000002 112.495 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -95.15 111.47 23.3 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.491 -0.559 . . . . 72.239999999999995 109.491 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.03 159.03 25.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.444 0.64 . . . . 72.109999999999999 110.885 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 26.1 tptp -137.93 123.19 19.35 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 103.813 -2.662 . . . . 74.439999999999998 103.813 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -101.28 125.93 47.96 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.459 -0.496 . . . . 72.120000000000005 110.845 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.84 35.1 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.168 -0.679 . . . . 72.319999999999993 109.168 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.01 139.49 47.25 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.736 -0.468 . . . . 71.209999999999994 109.736 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 p -117.86 136.16 23.64 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 109.49 -0.559 . . . . 71.019999999999996 109.49 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.5 Cg_exo -61.43 120.53 8.24 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.428 2.085 . . . . 65.109999999999999 109.977 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.6 m -133.11 167.55 20.12 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.108 -0.496 . . . . 74.329999999999998 111.149 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 464' ' ' VAL . 4.6 p -76.89 156.24 82.56 Favored Pre-proline 0 N--CA 1.432 -1.369 0 C-N-CA 123.66 0.784 . . . . 73.430000000000007 109.377 174.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -49.71 -27.75 15.87 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 124.225 3.283 . . . . 74.129999999999995 114.157 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.37 -18.33 59.99 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.139 -0.482 . . . . 73.129999999999995 112.05 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.93 -18.29 13.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.642 0.258 . . . . 74.420000000000002 110.563 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 91.3 t -59.5 127.0 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.976 -0.557 . . . . 72.420000000000002 111.366 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.52 -4.46 58.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.033 -0.603 . . . . 51.299999999999997 111.813 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -122.87 161.05 24.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.103 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.95 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.909 -0.775 . . . . 71.239999999999995 108.909 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.61 -25.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.559 -0.857 . . . . 72.049999999999997 111.31 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 174.21 38.18 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.208 -0.757 . . . . 64.230000000000004 111.208 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -126.3 154.84 42.88 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.967 -0.753 . . . . 74.319999999999993 108.967 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.9 t30 -65.08 -53.28 42.41 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.248 -0.581 . . . . 62.32 110.982 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.8 Cg_exo -71.95 123.44 9.31 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 107.744 -1.675 . . . . 75.540000000000006 107.744 170.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 33.7 Cg_endo -62.7 137.45 63.72 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 122.885 2.39 . . . . 75.219999999999999 114.4 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.42 7.92 8.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.145 -0.934 . . . . 71.25 110.613 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -108.37 -4.66 17.21 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.302 -0.863 . . . . 60.119999999999997 109.548 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.403 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 28.9 mt-30 -137.24 175.67 9.4 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.268 1.032 . . . . 65.099999999999994 113.401 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 426' ' ' GLN . 29.5 m -94.3 130.5 40.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.157 -1.838 . . . . 72.230000000000004 109.449 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.1 m -131.49 149.59 52.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.144 -0.687 . . . . 64.409999999999997 109.144 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -63.05 154.76 29.75 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.96 0.726 . . . . 71.340000000000003 112.96 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.08 -15.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.208 1.004 . . . . 72.310000000000002 108.37 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.64 -5.29 59.17 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.039 -0.982 . . . . 65.430000000000007 108.899 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -87.7 128.84 35.3 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.122 -1.436 . . . . 72.450000000000003 107.122 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.36 124.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.195 -1.039 . . . . 73.219999999999999 108.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.33 118.69 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 C-N-CA 120.194 -0.602 . . . . 75.329999999999998 109.65 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.0 mp -92.16 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 105.034 -2.21 . . . . 74.420000000000002 105.034 174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 121.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 107.588 -1.264 . . . . 70.219999999999999 107.588 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.78 119.11 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 121.322 0.582 . . . . 73.040000000000006 110.455 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.14 134.92 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.508 -0.923 . . . . 73.329999999999998 108.508 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.06 115.24 4.16 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.222 -1.151 . . . . 64.400000000000006 110.222 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 39.8 p -142.39 145.93 34.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.986 0.393 . . . . 73.549999999999997 110.39 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.912 0 N-CA-C 108.004 -2.038 . . . . 61.420000000000002 108.004 177.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 CA--C 1.485 -1.542 0 N-CA-C 107.417 -1.327 . . . . 74.409999999999997 107.417 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.24 142.25 32.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.153 0.501 . . . . 73.439999999999998 111.242 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.25 136.05 36.07 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.51 -1.663 . . . . 72.129999999999995 106.51 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.9 p -97.17 135.4 21.93 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 119.742 -0.783 . . . . 71.329999999999998 110.611 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.0 129.85 32.39 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.767 2.311 . . . . 75.019999999999996 111.282 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.63 147.83 52.18 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.041 . . . . 72.310000000000002 109.519 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.8 m -109.19 5.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 116.424 -0.353 . . . . 75.430000000000007 111.413 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -52.74 135.32 35.57 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.788 0.835 . . . . 74.230000000000004 111.758 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.48 1.56 59.06 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.469 -0.872 . . . . 64.010000000000005 112.946 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -121.21 179.8 4.29 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.185 -0.597 . . . . 74.340000000000003 110.639 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.2 p -73.25 149.65 42.62 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.962 -0.755 . . . . 72.299999999999997 108.962 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.0 p -63.43 -33.34 75.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.082 0.468 . . . . 75.209999999999994 110.39 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.62 86.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.412 -0.813 . . . . 70.230000000000004 111.594 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.98 -38.36 85.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.854 0.359 . . . . 72.129999999999995 110.167 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.92 78.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.968 -1.015 . . . . 74.310000000000002 110.174 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 85.0 mt -69.05 -46.21 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.804 -0.635 . . . . 73.140000000000001 110.644 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.07 -47.07 88.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.641 0.608 . . . . 72.129999999999995 112.641 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.5 m -65.49 -44.25 87.64 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 75.150000000000006 109.878 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.438 HD22 ' HB ' ' A' ' 416' ' ' ILE . 13.3 tp -64.78 -37.75 88.65 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.924 -1.035 . . . . 73.439999999999998 110.351 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -60.51 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.984 1.313 . . . . 75.239999999999995 110.369 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -67.37 -22.64 65.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.994 -0.548 . . . . 72.219999999999999 110.805 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -85.36 -8.67 58.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.885 -0.598 . . . . 73.310000000000002 111.72 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 86.24 9.89 75.54 Favored Glycine 0 C--O 1.253 1.315 0 C-N-CA 120.912 -0.661 . . . . 54.439999999999998 113.915 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.401 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 54.8 m-85 -77.85 151.8 33.71 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.102 0.477 . . . . 73.319999999999993 110.217 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -88.26 132.74 34.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.199 -1.778 . . . . 74.540000000000006 106.199 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 134.98 59.18 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.804 0 CA-C-O 121.759 0.79 . . . . 71.200000000000003 110.956 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -110.36 126.51 54.33 Favored 'General case' 0 C--N 1.268 -2.961 0 N-CA-C 104.743 -2.318 . . . . 75.409999999999997 104.743 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.5 m -112.73 118.86 36.16 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 108.242 -1.021 . . . . 74.230000000000004 108.242 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.52 118.89 36.98 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.45 -1.315 . . . . 73.310000000000002 107.45 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.84 124.72 53.23 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.992 -1.114 . . . . 74.340000000000003 107.992 176.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -125.45 137.07 29.16 Favored Pre-proline 0 C--N 1.284 -2.24 0 C-N-CA 119.577 -0.849 . . . . 74.219999999999999 111.131 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -88.54 128.34 2.09 Favored 'Trans proline' 0 N--CA 1.426 -2.454 0 N-CA-C 107.972 -1.588 . . . . 75.219999999999999 107.972 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 48.4 t0 -174.47 170.42 3.55 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.364 -1.347 . . . . 62.399999999999999 107.364 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.438 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 24.0 m -106.61 -18.69 13.89 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.536 0.684 . . . . 75.230000000000004 109.219 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.7 m -90.61 36.91 0.9 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 123.191 1.472 . . . . 74.319999999999993 107.71 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 391' ' ' ASP . 28.1 pt -88.8 141.69 30.05 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 114.285 -1.325 . . . . 73.409999999999997 110.72 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -73.66 173.86 13.2 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.129 1.886 . . . . 74.239999999999995 108.39 166.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.72 161.59 35.21 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.958 1.772 . . . . 71.140000000000001 111.772 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.89 -13.28 2.5 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 124.071 0.948 . . . . 62.210000000000001 111.969 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -99.61 122.55 42.82 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.696 -2.335 . . . . 71.239999999999995 104.696 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.0 117.88 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.88 0.847 . . . . 73.109999999999999 109.808 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.7 tp -90.97 -29.28 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.38 -0.827 . . . . 74.400000000000006 110.294 -174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.46 157.82 27.8 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 120.516 -0.849 . . . . 62.109999999999999 111.408 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 65.1 p -125.58 -176.91 3.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.165 -1.05 . . . . 73.209999999999994 108.165 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -101.71 139.92 20.77 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.649 -0.871 . . . . 62.130000000000003 108.649 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -48.64 -14.46 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 124.396 3.397 . . . . 74.109999999999999 115.414 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.15 64.79 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.244 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.3 -27.68 63.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.534 0.683 . . . . 73.200000000000003 110.678 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -90.32 -3.72 57.58 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.609 -0.723 . . . . 74.349999999999994 109.554 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 41.4 m -91.32 156.94 17.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.634 -1.247 . . . . 63.109999999999999 107.634 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 p -74.37 112.57 10.66 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.698 0.761 . . . . 65.019999999999996 111.056 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.48 170.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.037 -0.983 . . . . 72.030000000000001 108.903 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 75.4 p -75.8 158.73 31.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.813 -0.755 . . . . 73.420000000000002 110.835 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.54 109.94 2.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.375 -0.972 . . . . 74.319999999999993 108.375 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 92.23 29.2 11.63 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.279 -0.728 . . . . 75.0 111.279 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.3 t70 -76.79 -174.51 3.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.964 0.505 . . . . 74.299999999999997 109.655 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.53 126.97 42.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.161 0.505 . . . . 73.420000000000002 112.178 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.438 ' HB ' HD22 ' A' ' 377' ' ' LEU . 51.0 mm -121.16 127.22 75.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.472 -0.936 . . . . 75.049999999999997 108.472 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -94.38 119.13 32.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.134 0.969 . . . . 73.329999999999998 110.813 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.06 131.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.991 -1.114 . . . . 70.109999999999999 107.991 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -101.57 128.7 47.72 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.818 -0.438 . . . . 75.530000000000001 109.818 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 38.9 t -132.07 131.74 61.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.205 -1.035 . . . . 73.129999999999995 108.205 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 19.0 m -91.89 122.28 34.27 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.408 -0.59 . . . . 72.040000000000006 109.408 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.4 m -120.6 106.04 11.38 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.995 -0.372 . . . . 72.409999999999997 109.995 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 73.72 118.12 0.08 OUTLIER Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.88 0.712 . . . . 52.140000000000001 114.88 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.8 Cg_exo -71.34 138.25 32.56 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 121.919 1.746 . . . . 74.400000000000006 109.391 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 2.8 mm-40 -78.44 142.8 37.27 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 114.597 1.332 . . . . 75.439999999999998 114.597 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.82 133.56 55.31 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 113.435 -1.711 . . . . 70.319999999999993 108.674 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.14 157.8 35.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.203 -1.777 . . . . 75.519999999999996 106.203 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.81 137.41 33.72 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.609 -0.436 . . . . 75.540000000000006 110.409 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.16 128.66 56.83 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.056 -1.461 . . . . 75.420000000000002 107.056 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.409 ' HB2' HG13 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.36 141.4 38.83 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.503 1.469 . . . . 62.229999999999997 112.683 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.147 0.499 . . . . 73.439999999999998 111.171 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 430' ' ' PRO . 8.9 p -65.9 -14.84 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.841 0.829 . . . . 73.519999999999996 109.851 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.7 m -52.75 -41.53 64.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.751 1.22 . . . . 71.510000000000005 111.953 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.8 m -64.15 -13.62 49.51 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.024 0.93 . . . . 73.140000000000001 112.083 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.73 -45.44 14.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.3 0.482 . . . . 61.149999999999999 112.3 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 86.9 m -156.05 135.68 12.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.65 -0.5 . . . . 74.010000000000005 109.65 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 441' ' ' VAL . 62.7 t80 -57.43 -53.57 56.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.153 0.797 . . . . 74.519999999999996 113.153 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.04 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.004 0.43 . . . . 75.409999999999997 111.248 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -62.02 -43.21 99.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.013 -0.994 . . . . 71.340000000000003 108.862 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.88 79.85 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.364 -0.834 . . . . 72.239999999999995 110.619 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.9 t -58.93 -47.07 90.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.794 -0.639 . . . . 71.120000000000005 111.275 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.6 mmpt? -64.95 -46.51 81.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.704 -0.226 . . . . 74.030000000000001 111.213 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.69 -38.77 92.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.396 -0.365 . . . . 71.450000000000003 111.472 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 452' ' ' PHE . 30.5 tp -67.29 -39.94 86.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.267 -0.424 . . . . 72.519999999999996 109.871 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.8 m -65.76 -38.86 90.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.261 -0.644 . . . . 72.109999999999999 109.261 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.59 73.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.55 -0.75 . . . . 74.439999999999998 111.138 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.24 31.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.795 -0.639 . . . . 74.409999999999997 110.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.7 -17.61 49.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.341 -0.457 . . . . 55.030000000000001 112.575 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -83.11 83.83 7.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.381 0.61 . . . . 73.120000000000005 110.558 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -98.04 17.02 59.35 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.769 -0.932 . . . . 75.329999999999998 110.769 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -103.86 110.56 22.73 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.814 -1.551 . . . . 74.540000000000006 106.814 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . 0.523 ' CE2' HD22 ' A' ' 444' ' ' LEU . 93.4 m-85 -119.41 152.45 36.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.522 0.677 . . . . 73.439999999999998 112.073 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 0.1 OUTLIER -147.1 121.0 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.231 -2.137 . . . . 75.310000000000002 105.231 170.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -91.0 130.37 36.92 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.601 0.715 . . . . 74.409999999999997 111.584 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.19 152.84 46.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.4 -1.333 . . . . 75.310000000000002 107.4 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.12 149.8 52.31 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.151 0.501 . . . . 72.439999999999998 110.726 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.5 m -132.78 131.72 22.19 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 115.603 -0.726 . . . . 73.540000000000006 109.204 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 490' ' ' SER . 31.6 Cg_exo -61.51 120.01 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.004 1.802 . . . . 74.530000000000001 108.274 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.547 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 17.0 m -130.0 177.24 7.43 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.992 -0.549 . . . . 71.340000000000003 109.762 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 43.1 m -67.15 139.27 95.07 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.637 -1.246 . . . . 74.140000000000001 107.637 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.469 ' O ' HG11 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.72 -23.62 8.56 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.806 3.004 . . . . 74.219999999999999 114.168 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -61.4 -32.29 72.22 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.347 0.659 . . . . 55.329999999999998 111.155 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.07 0.73 56.08 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.386 0.513 . . . . 75.420000000000002 112.386 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 461' ' ' PRO . 10.4 p -59.89 126.95 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.247 0.546 . . . . 74.120000000000005 111.114 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.47 78.31 Favored Glycine 0 C--O 1.244 0.767 0 C-N-CA 120.686 -0.769 . . . . 70.510000000000005 112.191 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.79 148.3 33.85 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.986 -0.746 . . . . 72.140000000000001 108.986 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.14 132.74 30.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.061 -1.088 . . . . 74.049999999999997 108.061 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.68 -26.81 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.422 -0.911 . . . . 71.200000000000003 111.134 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.75 169.65 40.34 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.626 -0.797 . . . . 65.219999999999999 111.39 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.2 p -127.46 149.07 50.27 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.507 -0.924 . . . . 72.409999999999997 108.507 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.466 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.7 t30 -62.35 -52.78 63.7 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 119.327 -0.368 . . . . 73.129999999999995 110.725 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.1 Cg_exo -73.7 142.73 32.71 Favored 'Trans proline' 0 C--N 1.374 1.871 0 N-CA-C 108.178 -1.508 . . . . 75.120000000000005 108.178 171.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 126.79 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.262 1.975 . . . . 71.150000000000006 112.786 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.64 26.99 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.169 0.985 . . . . 53.420000000000002 110.253 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -111.66 4.24 18.45 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.842 -1.072 . . . . 65.239999999999995 110.922 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.08 164.81 27.54 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.067 0.937 . . . . 75.519999999999996 111.939 -172.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.84 125.54 29.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.299 -1.773 . . . . 71.430000000000007 108.94 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -130.82 148.32 52.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.186 -0.672 . . . . 74.549999999999997 109.186 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -69.97 140.93 53.06 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.292 0.091 . . . . 72.230000000000004 111.039 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.438 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 1.9 mp -60.76 -18.81 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.954 1.302 . . . . 75.219999999999999 111.931 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.23 5.11 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 75.319999999999993 112.063 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.97 132.29 33.84 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.672 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.3 t -79.89 114.77 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.936 -1.876 . . . . 75.340000000000003 105.936 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.04 120.54 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-O 121.255 0.55 . . . . 75.349999999999994 109.829 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 68.4 mt -91.23 112.25 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.287 -1.746 . . . . 74.310000000000002 106.287 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.39 119.39 51.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 114.658 -1.156 . . . . 74.109999999999999 108.064 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 25.7 mt -99.83 115.97 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-O 121.508 0.671 . . . . 73.530000000000001 109.559 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.65 140.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.353 -0.98 . . . . 74.319999999999993 108.353 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 121.95 5.59 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 109.062 -1.615 . . . . 75.540000000000006 109.062 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.8 m -140.08 125.2 18.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 122.035 -0.685 . . . . 74.140000000000001 110.212 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.413 -2.837 0 N-CA-C 107.818 -2.113 . . . . 75.310000000000002 107.818 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.169 -1.049 . . . . 74.420000000000002 108.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.11 145.05 29.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.885 -0.413 . . . . 73.340000000000003 109.885 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.71 137.39 34.84 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.172 -1.047 . . . . 73.519999999999996 108.172 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.09 136.08 21.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 C-N-CA 120.57 -0.452 . . . . 73.030000000000001 109.991 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 154.6 12.18 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.711 2.941 . . . . 72.439999999999998 115.165 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.59 101.64 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 74.549999999999997 110.308 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.85 -3.65 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.25 0.548 . . . . 74.329999999999998 111.712 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.486 -0.779 . . . . 74.010000000000005 109.903 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.2 58.97 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.655 -0.978 . . . . 64.510000000000005 110.655 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -124.44 170.17 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.587 -1.264 . . . . 71.310000000000002 107.587 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.8 p -74.98 157.1 35.51 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.684 -0.487 . . . . 73.5 109.684 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.4 p -62.17 -37.86 86.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.016 0.436 . . . . 54.119999999999997 110.461 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.28 94.74 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.872 -0.604 . . . . 74.209999999999994 110.897 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.65 -37.46 76.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.505 -0.316 . . . . 73.25 110.952 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.33 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.040000000000006 110.66 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -42.62 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.258 0.348 . . . . 75.340000000000003 111.173 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.61 88.22 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.388 -0.369 . . . . 75.030000000000001 111.09 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.1 m -63.58 -46.63 84.98 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.599 -0.273 . . . . 74.340000000000003 110.743 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.18 -41.86 96.92 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.986 -0.375 . . . . 74.540000000000006 109.986 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -59.82 -46.6 88.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 73.310000000000002 110.439 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.37 -33.91 76.93 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 112.657 0.614 . . . . 74.319999999999993 112.657 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -84.83 -4.23 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.09 -0.505 . . . . 75.150000000000006 112.159 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.46 7.85 64.74 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 119.88 -1.152 . . . . 53.530000000000001 113.146 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -83.76 167.65 16.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.516 -0.55 . . . . 74.420000000000002 109.516 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -105.79 161.58 14.3 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.293 -1.373 . . . . 70.420000000000002 107.293 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 151.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-O 121.881 0.848 . . . . 74.129999999999995 112.576 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 417' ' ' THR . 29.5 ttm-85 -137.05 141.07 42.43 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.567 -2.012 . . . . 71.239999999999995 105.567 172.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -135.24 133.08 38.6 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.331 -0.618 . . . . 73.409999999999997 109.331 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.71 119.94 36.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.335 -0.987 . . . . 75.409999999999997 108.335 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -95.58 122.43 38.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.099 -1.075 . . . . 74.040000000000006 108.099 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 0.1 OUTLIER -128.55 122.71 21.87 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 113.067 0.766 . . . . 74.340000000000003 113.067 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.52 129.07 4.19 Favored 'Trans proline' 0 C--O 1.247 0.933 0 N-CA-C 106.719 -2.07 . . . . 73.439999999999998 106.719 165.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.4 t70 -163.68 -176.03 4.44 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 72.010000000000005 109.042 -171.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 p -100.77 -23.72 14.55 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.34 -0.985 . . . . 64.299999999999997 108.34 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.2 m -89.3 35.45 0.81 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.279 -1.328 . . . . 73.439999999999998 108.983 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 45.8 pt -88.18 123.5 68.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 114.37 1.248 . . . . 73.230000000000004 114.37 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 2.5 Cg_endo -85.15 174.89 6.86 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.861 2.374 . . . . 75.329999999999998 108.126 165.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.16 160.94 35.93 Favored 'Trans proline' 0 C--O 1.212 -0.817 0 C-N-CA 122.475 2.117 . . . . 71.209999999999994 111.261 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.22 -7.47 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.906 0.706 . . . . 74.519999999999996 112.906 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.87 147.77 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.033 -1.839 . . . . 74.450000000000003 106.033 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.37 116.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.186 -1.413 . . . . 73.25 107.186 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.5 mm -90.54 -39.77 12.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.299 -0.63 . . . . 74.109999999999999 109.299 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 157.67 27.48 Favored Glycine 0 N--CA 1.411 -3.013 0 CA-C-N 115.214 -0.903 . . . . 64.510000000000005 111.01 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -122.32 -179.68 4.26 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.49 -0.929 . . . . 62.299999999999997 108.49 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.33 139.92 20.67 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 108.948 -0.76 . . . . 71.450000000000003 108.948 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.37 -24.47 1.03 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 124.618 3.546 . . . . 75.439999999999998 114.84 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.5 63.37 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 123.133 0.573 . . . . 72.200000000000003 111.456 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.97 94.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.64 0.734 . . . . 74.109999999999999 110.464 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -4.75 57.62 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.531 -0.759 . . . . 75.409999999999997 111.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.9 m -88.83 152.85 21.51 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.938 -1.505 . . . . 74.030000000000001 106.938 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.5 m -74.12 113.53 11.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.953 0.882 . . . . 53.0 110.688 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.6 170.71 5.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.342 -1.299 . . . . 73.409999999999997 110.061 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 136.36 57.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.765 -0.652 . . . . 71.219999999999999 111.61 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.45 119.95 13.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.508 -0.553 . . . . 73.299999999999997 109.508 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 87.3 32.12 14.81 Favored Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 121.1 -0.572 . . . . 70.150000000000006 112.133 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.53 174.99 6.84 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.939 -0.763 . . . . 74.200000000000003 108.939 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -100.35 121.22 41.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.831 0.824 . . . . 71.329999999999998 112.782 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.76 124.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.667 -1.235 . . . . 74.540000000000006 107.667 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 13.4 t -91.85 130.29 37.65 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.532 0.682 . . . . 61.030000000000001 109.891 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 130.74 64.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.021 -0.991 . . . . 74.239999999999995 108.422 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -97.53 127.9 43.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.406 -0.961 . . . . 65.540000000000006 108.406 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.02 135.11 62.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.609 -0.886 . . . . 74.400000000000006 108.609 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 47.0 m -106.51 123.94 48.85 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.833 -0.542 . . . . 75.319999999999993 111.7 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.5 p -118.2 105.54 11.9 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.737 -0.665 . . . . 74.349999999999994 110.69 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.09 146.03 2.19 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.059 0.784 . . . . 73.209999999999994 115.059 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 76.7 Cg_endo -81.74 149.65 16.25 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.344 2.029 . . . . 75.340000000000003 111.753 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.05 144.76 40.6 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.52 -0.764 . . . . 72.310000000000002 110.849 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.44 ' HB3' HG23 ' A' ' 477' ' ' THR . 45.5 mt-30 -118.85 156.88 28.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.675 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -153.51 154.66 34.76 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.848 -1.538 . . . . 70.319999999999993 106.848 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.8 140.17 29.98 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.02 -0.733 . . . . 74.450000000000003 109.02 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.8 mp -78.98 126.47 82.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.851 -1.166 . . . . 74.099999999999994 107.851 -175.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.97 140.32 79.53 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.203 1.936 . . . . 70.430000000000007 112.176 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.77 12.9 28.37 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.789 0.804 . . . . 73.019999999999996 110.08 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.2 -12.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.919 -1.037 . . . . 73.010000000000005 108.965 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 18.0 m -52.76 -40.51 63.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.503 -1.226 . . . . 74.040000000000006 112.624 -174.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -63.01 -17.91 62.73 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.365 1.246 . . . . 73.420000000000002 114.365 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.36 -44.91 15.56 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.086 0.47 . . . . 63.340000000000003 111.689 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 65.6 m -150.2 133.22 16.16 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.896 -0.503 . . . . 74.430000000000007 109.969 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -58.37 -45.31 88.47 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.467 0.479 . . . . 75.010000000000005 111.163 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.16 -42.37 80.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.042 -0.526 . . . . 60.509999999999998 110.694 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.75 -39.39 94.15 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 116.064 -0.516 . . . . 74.019999999999996 111.398 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.53 73.18 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.526 0.516 . . . . 53.450000000000003 109.768 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.03 -45.9 95.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.102 -0.499 . . . . 71.200000000000003 110.673 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.47 -47.72 75.13 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.813 0.301 . . . . 74.549999999999997 111.813 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -66.32 -40.24 89.81 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.109999999999999 111.688 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.0 -38.43 85.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.619 -0.432 . . . . 74.129999999999995 111.608 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 68.9 m -64.81 -38.8 92.19 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.478 -0.564 . . . . 71.439999999999998 109.478 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.85 65.24 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.395 0.616 . . . . 74.409999999999997 110.455 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.44 -13.22 59.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.482 0.658 . . . . 73.450000000000003 110.296 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.22 -13.32 26.14 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.691 -0.766 . . . . 51.119999999999997 113.651 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -71.62 114.96 10.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.525 -0.546 . . . . 73.329999999999998 109.525 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.97 17.38 8.67 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.45 -0.881 . . . . 71.439999999999998 111.58 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -120.58 111.25 17.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.478 -1.675 . . . . 75.209999999999994 106.478 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.3 155.01 39.42 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.772 0.796 . . . . 74.409999999999997 112.882 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 4.5 tppp? -145.17 125.08 13.47 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.598 -1.63 . . . . 74.319999999999993 106.598 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . 0.449 HE21 HG23 ' A' ' 488' ' ' VAL . 65.0 tt0 -100.44 126.08 46.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.169 0.509 . . . . 71.549999999999997 110.888 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.64 156.43 37.51 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.431 -0.952 . . . . 70.310000000000002 108.431 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.302 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.4 m -133.94 144.57 52.21 Favored Pre-proline 0 C--N 1.286 -2.183 0 N-CA-C 109.171 -0.677 . . . . 72.310000000000002 109.171 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_endo -62.54 122.82 11.35 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 123.257 2.638 . . . . 72.430000000000007 113.21 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.7 m -132.87 170.73 14.9 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.537 -0.912 . . . . 71.209999999999994 108.537 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.7 m -69.72 145.61 94.95 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 107.678 -1.23 . . . . 74.219999999999999 107.678 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.8 Cg_endo -49.36 -23.76 7.67 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 124.129 3.219 . . . . 75.299999999999997 114.255 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.84 -30.11 71.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.368 0.604 . . . . 74.230000000000004 110.43 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.35 1.35 35.42 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.821 -0.627 . . . . 74.420000000000002 112.581 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.6 p -60.18 126.29 17.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 119.415 -0.914 . . . . 73.0 110.72 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.92 -5.94 72.83 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.598 -0.81 . . . . 65.409999999999997 112.169 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.88 155.61 17.85 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.927 -0.768 . . . . 75.549999999999997 108.927 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 433' ' ' SER . 66.3 t -84.67 131.59 33.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.923 -0.769 . . . . 72.340000000000003 108.923 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.13 -14.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.838 -0.745 . . . . 75.450000000000003 110.903 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.53 -177.65 41.87 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 115.567 -0.742 . . . . 74.230000000000004 111.441 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.9 p -130.44 150.03 51.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.682 -1.229 . . . . 72.420000000000002 107.682 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.9 t30 -63.87 -51.36 64.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 120.262 -0.575 . . . . 65.120000000000005 110.307 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.3 Cg_exo -75.41 130.48 12.91 Favored 'Trans proline' 0 C--N 1.375 1.955 0 N-CA-C 108.376 -1.432 . . . . 71.450000000000003 108.376 170.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.94 136.53 57.46 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.697 2.264 . . . . 73.239999999999995 113.399 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.62 6.84 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.066 0.936 . . . . 72.340000000000003 109.845 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.488 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -104.61 2.59 30.81 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.857 -1.065 . . . . 75.409999999999997 109.664 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -145.97 173.71 11.91 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.975 -0.69 . . . . 75.409999999999997 110.923 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 426' ' ' GLN . 18.2 m -102.26 140.62 36.3 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 124.308 1.043 . . . . 74.340000000000003 110.948 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 77.8 p -137.84 150.38 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.373 -0.602 . . . . 74.510000000000005 109.373 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.5 146.68 51.7 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.885 -0.326 . . . . 73.340000000000003 110.38 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.76 -11.13 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 124.052 0.941 . . . . 64.129999999999995 111.629 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 5.5 p -87.04 5.79 35.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.412 0.625 . . . . 72.349999999999994 111.065 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -93.01 142.12 27.64 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.656 -0.702 . . . . 63.439999999999998 110.362 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 52.4 t -85.79 115.18 26.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.946 -1.501 . . . . 74.329999999999998 106.946 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 81.9 t -86.58 119.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-O 121.467 0.651 . . . . 62.43 109.998 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 49.0 mt -92.36 112.9 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 107.302 -1.37 . . . . 72.400000000000006 107.302 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.38 127.13 49.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.451 -1.315 . . . . 73.430000000000007 107.451 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 15.6 mm -102.27 113.13 37.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.132 0.491 . . . . 72.109999999999999 109.943 -173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.449 HG23 HE21 ' A' ' 454' ' ' GLN . 32.9 t -98.3 141.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.673 -0.862 . . . . 72.129999999999995 108.673 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -90.52 121.12 6.1 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 111.035 -0.826 . . . . 72.209999999999994 111.035 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.5 m -141.39 143.76 34.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.582 -0.896 . . . . 64.230000000000004 108.582 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.562 0 CA-C-O 118.229 -1.317 . . . . 74.200000000000003 110.538 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 74.140000000000001 108.419 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.41 151.77 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.362 -0.607 . . . . 64.219999999999999 109.362 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -95.15 136.99 34.8 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.289 -1.374 . . . . 72.319999999999993 107.289 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.0 p -100.04 121.8 52.72 Favored Pre-proline 0 C--N 1.287 -2.122 0 N-CA-C 108.914 -0.772 . . . . 74.400000000000006 108.914 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.94 136.8 63.53 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.602 2.201 . . . . 74.519999999999996 113.046 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.539 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 7.5 p-10 -72.61 137.23 46.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.254 -0.885 . . . . 73.099999999999994 110.004 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.82 45.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 122.585 1.183 . . . . 74.010000000000005 110.482 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.539 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.8 ptm85 -65.51 136.29 56.23 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.418 -1.265 . . . . 72.329999999999998 110.921 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.48 0.55 62.79 Favored Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.79 -0.719 . . . . 51.329999999999998 113.024 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -125.95 172.12 10.19 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 122.586 -0.361 . . . . 72.230000000000004 110.13 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.1 p -77.14 167.14 22.27 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.626 0.251 . . . . 74.549999999999997 110.604 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.7 p -63.04 -33.96 76.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.078 0.465 . . . . 72.200000000000003 110.03 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.5 97.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.719 -0.673 . . . . 70.319999999999993 110.258 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.83 -41.43 95.75 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.539 -0.541 . . . . 73.430000000000007 109.539 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.74 80.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.108 -0.497 . . . . 71.219999999999999 110.784 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.15 -46.02 88.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.701 -0.681 . . . . 72.219999999999999 110.079 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.42 86.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.819 -0.628 . . . . 53.109999999999999 111.61 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.2 m -60.58 -47.11 87.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.326 0.25 . . . . 72.230000000000004 111.552 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.55 -42.02 95.97 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.533 -0.467 . . . . 73.25 110.593 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -41.56 91.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 109.806 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -29.27 67.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.384 -0.825 . . . . 73.450000000000003 111.12 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -82.68 -14.4 54.72 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.458 -0.571 . . . . 73.510000000000005 109.458 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.555 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.45 -2.63 56.19 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.822 -0.626 . . . . 63.240000000000002 111.692 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 46.5 m-85 -81.5 156.71 25.15 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.937 0.398 . . . . 74.510000000000005 110.075 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -105.16 147.78 27.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.371 -1.344 . . . . 73.420000000000002 107.371 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.75 142.73 30.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 121.957 0.884 . . . . 73.530000000000001 112.748 -175.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 417' ' ' THR . 58.2 ttt180 -119.06 133.39 55.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.014 -1.847 . . . . 74.329999999999998 106.014 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.9 m -104.94 125.66 51.18 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.499 -0.88 . . . . 74.299999999999997 111.36 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.2 tm? -111.51 119.33 38.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.234 -2.135 . . . . 74.400000000000006 105.234 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.543 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -112.85 122.63 48.23 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 109.292 -0.633 . . . . 74.430000000000007 109.292 -178.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -115.78 127.38 26.83 Favored Pre-proline 0 C--N 1.289 -2.034 0 C-N-CA 119.939 -0.705 . . . . 75.230000000000004 111.287 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -87.39 128.9 2.64 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 N-CA-C 107.234 -1.871 . . . . 73.010000000000005 107.234 167.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -142.66 -179.4 6.29 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.639 -1.225 . . . . 70.409999999999997 110.199 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.4 m -98.15 -33.47 11.12 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.365 -1.346 . . . . 60.530000000000001 107.365 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 34.5 m -101.57 71.13 1.31 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.178 -1.415 . . . . 74.409999999999997 107.178 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 18.8 pt -100.85 125.32 38.92 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.867 -1.06 . . . . 74.430000000000007 111.97 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.57 175.86 3.68 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 N-CA-C 107.66 -1.708 . . . . 72.400000000000006 107.66 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 398' ' ' HIS . 52.0 Cg_exo -59.9 162.45 16.07 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.083 1.855 . . . . 74.450000000000003 109.992 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -56.81 -8.42 0.6 Allowed 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.254 1.022 . . . . 64.450000000000003 113.034 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 396' ' ' PRO . 36.9 m80 -62.7 131.74 49.95 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.075 -0.713 . . . . 75.0 109.075 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.61 118.43 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 CA-C-N 115.645 -0.707 . . . . 73.099999999999994 109.159 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 401' ' ' GLY . 2.2 pp -91.13 -28.03 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.105 -0.952 . . . . 72.349999999999994 110.359 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.424 ' N ' HD13 ' A' ' 400' ' ' ILE . . . -169.42 157.31 29.04 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.515 -1.434 . . . . 72.400000000000006 109.515 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 403' ' ' ASP . 8.9 m -114.42 -177.18 3.07 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 106.332 -1.729 . . . . 63.109999999999999 106.332 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 402' ' ' THR . 10.5 t70 -97.96 138.72 20.99 Favored Pre-proline 0 C--N 1.267 -2.996 0 N-CA-C 109.092 -0.707 . . . . 73.209999999999994 109.092 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.48 -25.7 0.88 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 125.098 3.865 . . . . 72.340000000000003 115.463 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.73 68.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.954 0.407 . . . . 72.329999999999998 110.72 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.8 -38.57 62.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.775 0.798 . . . . 71.030000000000001 109.79 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.26 -5.08 48.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.903 -1.044 . . . . 71.310000000000002 110.704 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.4 m -86.8 147.87 25.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.044 -1.095 . . . . 73.219999999999999 108.044 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.9 p -74.52 112.97 11.24 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.329 -0.619 . . . . 75.109999999999999 109.329 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.28 169.22 22.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.349 -0.982 . . . . 74.219999999999999 108.349 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.1 p -80.14 137.75 36.78 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.003 -1.079 . . . . 65.530000000000001 110.432 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -60.36 138.61 57.94 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.218 -0.446 . . . . 55.25 110.655 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 100.92 15.63 28.13 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.192 -1.004 . . . . 70.349999999999994 110.779 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.51 -174.32 4.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.952 -1.499 . . . . 74.450000000000003 106.952 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 126.49 55.33 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.431 0.634 . . . . 70.519999999999996 110.926 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.01 119.44 61.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 4.9 t -85.13 118.93 24.99 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.899 0.857 . . . . 73.120000000000005 109.728 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.84 122.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.01 -0.995 . . . . 72.230000000000004 108.387 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 9.6 p30 -90.66 128.71 36.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.448 0.642 . . . . 74.439999999999998 110.461 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.0 143.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.333 -1.358 . . . . 70.099999999999994 107.333 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 2.1 p -88.04 120.02 28.98 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 119.143 -1.023 . . . . 73.340000000000003 108.898 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.0 m -120.2 105.31 10.84 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.962 -0.755 . . . . 74.349999999999994 108.962 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 75.73 166.13 19.57 Favored Glycine 0 C--O 1.259 1.677 0 CA-C-O 122.118 0.843 . . . . 64.25 114.293 177.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -96.0 157.32 1.42 Allowed 'Trans proline' 0 N--CA 1.429 -2.265 0 C-N-CA 122.998 2.466 . . . . 75.109999999999999 112.866 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.59 20.22 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.524 -2.028 . . . . 74.209999999999994 105.524 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -120.1 152.73 37.17 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.746 -0.465 . . . . 75.540000000000006 109.746 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.449 ' HG2' ' HB3' ' A' ' 447' ' ' ALA . 0.0 OUTLIER -146.84 156.68 43.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.067 -1.086 . . . . 75.450000000000003 108.067 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -83.93 140.15 32.13 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.348 -0.982 . . . . 73.120000000000005 108.348 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.59 119.24 76.2 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 106.634 -1.617 . . . . 71.530000000000001 106.634 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.49 140.36 94.34 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 121.675 1.584 . . . . 73.230000000000004 111.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.44 -0.68 56.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.441 0.638 . . . . 75.420000000000002 110.88 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.29 -6.54 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.887 0.851 . . . . 75.230000000000004 109.562 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 10.6 p -63.72 -28.17 69.71 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.148 -0.933 . . . . 63.329999999999998 112.105 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.6 p -65.32 -13.92 59.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 113.453 0.909 . . . . 64.209999999999994 113.453 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.7 -48.55 68.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.694 0.257 . . . . 63.409999999999997 111.694 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 12.3 t -174.32 165.49 4.01 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 121.234 -0.186 . . . . 75.219999999999999 110.545 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.47 -52.54 65.2 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.319 1.048 . . . . 74.010000000000005 112.666 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.83 84.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.396 -0.366 . . . . 63.439999999999998 111.593 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.67 -45.96 90.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 65.109999999999999 109.956 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.22 78.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 55.350000000000001 111.129 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.62 -46.81 95.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 116.275 -0.42 . . . . 75.129999999999995 110.907 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.48 -47.69 82.88 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.079 0.4 . . . . 75.439999999999998 112.079 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.08 -46.3 84.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.202 0.445 . . . . 74.349999999999994 112.202 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.91 -36.72 80.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.562 0.578 . . . . 73.319999999999993 112.562 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.1 m -64.44 -40.85 96.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.044 0.449 . . . . 70.420000000000002 110.075 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.59 63.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.461 0.648 . . . . 65.230000000000004 110.42 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.449 ' HB3' ' HG2' ' A' ' 427' ' ' ARG . . . -79.32 -12.89 59.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.628 -0.714 . . . . 72.439999999999998 110.049 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.84 -19.66 10.23 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.639 -0.709 . . . . 64.120000000000005 113.173 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.28 102.93 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.071 0.463 . . . . 75.530000000000001 110.489 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.22 19.85 33.93 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.744 -0.741 . . . . 64.219999999999999 111.914 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -123.63 111.48 16.27 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.411 -0.588 . . . . 72.129999999999995 109.411 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.14 158.28 39.42 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.437 0.636 . . . . 74.109999999999999 111.656 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.65 126.85 16.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.476 -1.676 . . . . 75.099999999999994 106.476 170.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -87.52 132.54 34.0 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.037 -0.357 . . . . 71.519999999999996 110.037 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.72 161.5 37.4 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.285 -1.006 . . . . 51.240000000000002 108.285 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 23.5 m-80 -133.93 149.84 51.29 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 122.537 0.335 . . . . 71.340000000000003 110.305 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 31.1 t -128.52 131.46 23.78 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 107.246 -1.39 . . . . 72.510000000000005 107.246 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.7 Cg_endo -61.8 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.764 1.642 . . . . 72.519999999999996 109.209 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 19.4 m -126.97 175.46 8.06 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 109.98 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.6 m -63.92 133.17 95.49 Favored Pre-proline 0 N--CA 1.424 -1.746 0 N-CA-C 106.289 -1.745 . . . . 72.409999999999997 106.289 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.54 -23.91 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.367 2.712 . . . . 73.5 114.027 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -67.04 -21.36 65.92 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.185 0.439 . . . . 74.019999999999996 112.185 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.2 7.84 40.74 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 121.904 -0.497 . . . . 64.319999999999993 111.622 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.2 p -59.25 127.36 18.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 CA-C-O 121.321 0.581 . . . . 73.329999999999998 110.843 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.76 -6.72 70.33 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 115.543 -0.753 . . . . 71.540000000000006 112.104 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -100.64 151.12 22.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.875 -0.787 . . . . 75.450000000000003 108.875 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.19 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.773 -0.825 . . . . 75.420000000000002 108.773 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.49 -16.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 120.168 -0.613 . . . . 74.299999999999997 112.38 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.19 160.23 12.34 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.019 -0.832 . . . . 70.019999999999996 111.019 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 7.9 p -119.32 149.65 41.45 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.631 -1.248 . . . . 65.420000000000002 107.631 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.6 t30 -59.28 -49.7 91.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 119.797 -0.761 . . . . 62.229999999999997 110.731 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -76.07 117.6 4.72 Favored 'Trans proline' 0 C--N 1.372 1.812 0 N-CA-C 107.642 -1.715 . . . . 75.019999999999996 107.642 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.2 Cg_endo -62.9 142.95 90.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.888 2.392 . . . . 71.230000000000004 114.744 -173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.27 0.12 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.814 -1.084 . . . . 71.510000000000005 113.24 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -109.14 0.12 19.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.29 -0.881 . . . . 73.420000000000002 109.517 175.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.473 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 6.5 tp-100 -117.74 162.11 18.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.725 0.774 . . . . 71.109999999999999 111.926 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.3 m -97.34 132.22 43.27 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.255 -1.338 . . . . 75.239999999999995 108.6 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.1 m -136.47 149.0 47.98 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.985 -0.376 . . . . 63.25 109.985 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.3 141.85 52.31 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 75.319999999999993 109.942 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.9 -17.0 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 114.454 1.279 . . . . 75.340000000000003 114.454 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.0 p -88.9 5.29 44.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.676 -0.64 . . . . 71.140000000000001 112.022 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -90.3 147.63 23.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.311 -0.625 . . . . 74.299999999999997 109.311 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.4 t -83.25 119.55 32.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.629 -0.878 . . . . 73.219999999999999 108.629 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.93 119.18 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 108.507 -0.923 . . . . 73.299999999999997 108.507 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.5 112.73 26.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.182 -1.784 . . . . 73.209999999999994 106.182 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.69 113.37 36.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.478 -1.304 . . . . 73.299999999999997 107.478 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 22.4 mt -101.95 121.13 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.693 -0.685 . . . . 73.329999999999998 109.84 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.406 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 38.2 t -97.36 143.68 12.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.41 -0.959 . . . . 72.349999999999994 108.41 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -89.82 118.09 5.16 Favored Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 110.177 -1.169 . . . . 64.439999999999998 110.177 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 50.9 m -134.93 136.85 42.6 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.68 -0.859 . . . . 74.25 108.68 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.42 -2.373 0 N-CA-C 109.065 -1.614 . . . . 73.129999999999995 109.065 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 109.327 -0.62 . . . . 75.219999999999999 109.327 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.34 157.71 29.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.373 -0.376 . . . . 75.010000000000005 110.104 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.98 136.88 34.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.108 -1.442 . . . . 71.409999999999997 107.108 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.9 137.47 20.93 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 120.194 -0.602 . . . . 61.409999999999997 110.644 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -43.63 124.21 4.2 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 124.068 3.178 . . . . 73.530000000000001 114.67 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.29 138.07 40.3 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.244 -1.391 . . . . 74.219999999999999 107.244 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 399' ' ' VAL . 31.0 m -102.16 23.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 113.545 0.943 . . . . 75.510000000000005 113.545 -170.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -62.73 135.04 57.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.314 0.578 . . . . 72.450000000000003 111.82 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.88 -3.78 77.9 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.139 -0.784 . . . . 72.230000000000004 111.139 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -114.96 160.19 19.85 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.624 -0.51 . . . . 72.120000000000005 109.624 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 67.9 p -75.65 158.34 32.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 110.37 -0.233 . . . . 65.409999999999997 110.37 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.477 ' O ' HD12 ' A' ' 374' ' ' ILE . 17.9 p -63.13 -37.13 86.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 120.771 0.32 . . . . 74.230000000000004 110.449 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.08 90.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.249 -0.432 . . . . 64.420000000000002 110.584 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.89 -34.94 79.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.125 0.488 . . . . 61.409999999999997 110.487 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.526 -0.761 . . . . 75.349999999999994 110.371 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 370' ' ' SER . 1.4 mp -58.55 -44.37 89.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.748 -0.66 . . . . 74.150000000000006 110.213 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.79 84.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.219 -0.446 . . . . 65.430000000000007 112.133 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 85.5 m -60.83 -47.17 87.58 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.647 0.24 . . . . 72.409999999999997 111.647 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.51 -39.02 93.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.779 0.323 . . . . 74.140000000000001 110.921 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.12 -46.0 89.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.345 -0.843 . . . . 71.120000000000005 109.601 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -70.57 -24.43 62.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 112.238 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -81.14 -15.3 56.26 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.144 -0.622 . . . . 75.450000000000003 111.584 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 98.98 14.84 35.24 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.679 -1.248 . . . . 73.409999999999997 111.888 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.406 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 48.6 m-85 -97.26 168.86 10.16 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.548 -0.908 . . . . 74.430000000000007 108.548 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.5 mmtp -113.49 157.25 22.23 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.514 -1.291 . . . . 72.010000000000005 107.514 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.451 HG13 HG13 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -135.0 142.37 40.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 121.293 0.568 . . . . 74.400000000000006 111.802 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -112.18 128.02 56.11 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.6 m -100.44 123.68 44.98 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 119.329 -0.948 . . . . 64.409999999999997 108.522 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.98 119.41 38.97 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 105.421 -2.066 . . . . 72.430000000000007 105.421 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.516 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -107.99 122.05 46.05 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.529 -0.915 . . . . 73.120000000000005 108.529 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 137.82 31.09 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.566 -0.454 . . . . 74.120000000000005 111.143 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -93.1 148.88 2.52 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.735 2.29 . . . . 71.409999999999997 111.487 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 4.9 t70 170.06 174.75 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.758 -1.571 . . . . 74.209999999999994 106.758 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.674 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 22.0 m -99.3 -33.97 10.51 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.823 -0.806 . . . . 73.239999999999995 108.823 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.8 p -94.71 63.19 2.81 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 122.538 1.161 . . . . 73.409999999999997 108.255 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.442 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -95.6 151.57 38.6 Favored Pre-proline 0 N--CA 1.424 -1.742 0 CA-C-N 113.644 -1.617 . . . . 74.349999999999994 112.51 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.42 143.73 58.88 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 N-CA-C 107.24 -1.869 . . . . 73.030000000000001 107.24 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 398' ' ' HIS . 15.5 Cg_endo -56.92 148.67 66.05 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.242 1.962 . . . . 74.209999999999994 111.461 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.91 -9.68 10.68 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.019 0.914 . . . . 64.099999999999994 110.734 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.423 ' H ' ' C ' ' A' ' 396' ' ' PRO . 38.0 m80 -96.52 125.99 41.39 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 103.708 -2.701 . . . . 74.519999999999996 103.708 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.445 HG12 HG23 ' A' ' 365' ' ' VAL . 31.2 t -62.37 119.25 5.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.576 0.703 . . . . 75.200000000000003 111.969 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.6 tp -84.97 -29.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.369 -0.832 . . . . 73.230000000000004 109.367 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.07 160.32 33.18 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 403' ' ' ASP . 0.7 OUTLIER -113.14 -175.66 2.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 105.825 -1.917 . . . . 72.239999999999995 105.825 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 402' ' ' THR . 17.3 t70 -99.38 136.58 20.38 Favored Pre-proline 0 C--N 1.265 -3.089 0 N-CA-C 109.71 -0.478 . . . . 74.239999999999995 109.71 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -33.73 -31.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 1 C-N-CA 126.069 4.513 . . . . 74.439999999999998 115.88 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.56 -31.92 66.6 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 122.652 0.381 . . . . 73.510000000000005 111.0 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -35.3 64.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.364 0.602 . . . . 75.209999999999994 110.58 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.93 -15.08 59.29 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.01 -0.541 . . . . 74.340000000000003 110.183 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 70.8 m -86.35 147.09 26.2 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.241 -1.022 . . . . 75.319999999999993 108.241 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.7 m -74.81 112.9 11.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.008 -1.108 . . . . 71.310000000000002 108.008 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.05 170.22 18.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.663 -0.699 . . . . 74.040000000000006 110.845 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.1 p -65.91 131.52 46.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.403 -0.817 . . . . 60.039999999999999 110.628 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.46 4.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.077 0.465 . . . . 73.329999999999998 110.114 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 123.29 -2.07 9.66 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.393 -0.908 . . . . 75.239999999999995 112.342 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.78 158.87 32.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.057 -0.349 . . . . 75.329999999999998 110.057 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.9 pt-20 -87.29 121.4 29.68 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.371 0.605 . . . . 64.420000000000002 111.273 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.82 131.15 45.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.851 -1.166 . . . . 71.109999999999999 107.851 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -91.55 130.0 37.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.506 0.67 . . . . 75.420000000000002 110.301 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.8 t -117.57 125.46 74.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.591 -1.263 . . . . 73.540000000000006 107.591 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.9 129.2 43.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.008 -0.367 . . . . 75.239999999999995 110.008 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.5 p -125.58 147.95 30.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.98 -1.119 . . . . 74.400000000000006 107.98 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.8 p -96.51 123.34 40.14 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.056 0.455 . . . . 65.230000000000004 112.197 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 t -117.61 106.08 12.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.168 -0.613 . . . . 75.150000000000006 111.393 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 74.48 130.19 0.21 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.517 0.967 . . . . 73.420000000000002 115.517 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 22.8 Cg_exo -68.43 145.99 66.95 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.943 1.762 . . . . 52.020000000000003 109.294 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.31 147.24 31.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.084 0.772 . . . . 65.549999999999997 113.084 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.4 mt-30 -123.21 137.43 54.88 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.409999999999997 107.732 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -137.15 164.4 28.54 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.451 -0.574 . . . . 75.409999999999997 109.451 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -82.49 137.8 34.53 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.277 -1.008 . . . . 74.040000000000006 108.277 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.4 mt -80.85 114.35 47.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.543 -0.91 . . . . 64.030000000000001 108.543 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 140.74 37.27 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.343 1.362 . . . . 65.239999999999995 110.296 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.76 96.57 5.55 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.133 1.161 . . . . 73.400000000000006 114.133 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.3 6.76 3.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.112 -2.921 . . . . 72.430000000000007 103.112 165.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 4.6 m -71.05 -46.37 62.13 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 112.176 -2.284 . . . . 73.129999999999995 110.86 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 466' ' ' LYS . 21.6 m -57.01 -31.77 65.46 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.529 0.681 . . . . 75.120000000000005 110.031 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.82 -48.19 8.42 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.728 -0.669 . . . . 74.209999999999994 111.723 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 57.7 m -132.38 122.95 25.81 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 121.991 -0.443 . . . . 62.009999999999998 112.145 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -60.91 -40.57 93.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.98 0.912 . . . . 74.340000000000003 111.531 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.14 93.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 65.319999999999993 110.302 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -65.39 -35.62 81.5 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.446 -0.797 . . . . 60.450000000000003 111.384 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.22 94.1 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.632 0.583 . . . . 62.340000000000003 109.487 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.23 -49.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.769 -0.651 . . . . 74.349999999999994 110.691 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -65.09 -49.23 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.434 0.531 . . . . 72.510000000000005 112.434 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -68.02 -38.66 82.84 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.912 0.708 . . . . 74.329999999999998 112.912 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.44 -37.1 79.92 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.291 -0.564 . . . . 72.450000000000003 111.462 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.7 m -64.41 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.274 -0.639 . . . . 73.540000000000006 109.274 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.31 77.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.763 -0.653 . . . . 74.310000000000002 111.03 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -14.66 58.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.092 0.472 . . . . 73.519999999999996 110.225 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.41 -23.46 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-O 119.531 -0.594 . . . . 63.240000000000002 113.86 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -55.66 122.97 12.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.003 0.521 . . . . 75.129999999999995 111.962 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.01 8.66 5.73 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.48 -0.782 . . . . 74.420000000000002 111.62 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -110.23 110.62 21.52 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.735 -1.58 . . . . 75.340000000000003 106.735 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.37 150.29 52.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.918 0.866 . . . . 75.319999999999993 112.418 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 27.6 tptp -139.07 122.93 17.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.272 -1.751 . . . . 64.510000000000005 106.272 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -93.32 135.75 34.25 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 110.053 -0.351 . . . . 75.120000000000005 110.053 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.09 152.22 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.556 -0.535 . . . . 71.329999999999998 109.556 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.66 129.4 55.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.585 -0.895 . . . . 63.100000000000001 108.585 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.9 t -126.6 137.88 31.31 Favored Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.788 -1.19 . . . . 64.040000000000006 107.788 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.82 135.16 46.96 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.679 2.253 . . . . 70.540000000000006 110.427 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -148.18 169.86 19.11 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.465 -0.939 . . . . 73.140000000000001 108.465 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.6 m -65.46 144.12 98.87 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.785 0.834 . . . . 74.319999999999993 109.214 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.601 ' O ' HG12 ' A' ' 464' ' ' VAL . 93.3 Cg_exo -49.29 -23.47 7.04 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.915 3.076 . . . . 74.219999999999999 114.745 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -68.86 -31.98 71.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 71.209999999999994 111.142 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.39 -12.24 21.62 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 111.305 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.3 p -60.19 126.95 18.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-O 121.464 0.65 . . . . 73.420000000000002 110.448 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 98.6 -13.35 62.7 Favored Glycine 0 C--N 1.301 -1.383 0 N-CA-C 111.284 -0.726 . . . . 61.240000000000002 111.284 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 434' ' ' THR . 11.7 mptt -103.02 163.47 12.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.775 -0.824 . . . . 73.120000000000005 108.775 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.2 135.71 24.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.07 -1.085 . . . . 72.129999999999995 108.07 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.02 -12.06 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.399 -0.92 . . . . 73.319999999999993 110.546 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 151.93 176.46 24.66 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 115.198 -0.91 . . . . 73.409999999999997 112.082 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.4 p -116.41 149.46 39.38 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.607 -1.257 . . . . 74.200000000000003 107.607 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -64.68 -49.38 70.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 120.201 -0.599 . . . . 75.209999999999994 111.489 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.6 146.18 66.5 Favored 'Trans proline' 0 C--N 1.372 1.8 0 N-CA-C 108.724 -1.298 . . . . 74.230000000000004 108.724 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.69 126.52 18.41 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.522 2.148 . . . . 73.450000000000003 112.886 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.48 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.86 2.06 36.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.654 0.74 . . . . 70.109999999999999 111.608 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -109.9 -1.56 17.7 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.069 -0.514 . . . . 75.439999999999998 110.903 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.429 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -131.94 159.01 39.94 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.704 0.764 . . . . 72.430000000000007 111.39 -173.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -67.19 106.93 2.16 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.656 -1.611 . . . . 74.319999999999993 109.874 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.6 m -108.52 150.03 28.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.83 -0.804 . . . . 75.310000000000002 108.83 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.72 144.66 47.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.183 -0.673 . . . . 73.209999999999994 109.183 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.674 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 50.2 mm -70.7 -13.78 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.185 0.993 . . . . 70.530000000000001 109.16 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -87.8 -11.02 49.22 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.703 -1.135 . . . . 63.450000000000003 109.78 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.34 138.56 47.39 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.456 -0.942 . . . . 72.510000000000005 108.456 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.52 113.86 19.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.374 -1.343 . . . . 64.049999999999997 107.374 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.54 118.37 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 C-N-CA 119.526 -0.87 . . . . 74.219999999999999 108.825 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.1 mp -92.35 112.14 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 105.783 -1.932 . . . . 71.340000000000003 105.783 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 114.3 33.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.545 -1.65 . . . . 74.140000000000001 106.545 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 18.9 mt -104.27 116.93 48.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.633 -0.712 . . . . 74.140000000000001 110.216 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.74 137.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.243 -1.021 . . . . 74.230000000000004 108.243 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.62 99.33 1.0 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 109.633 -1.387 . . . . 74.329999999999998 109.633 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.2 m -142.79 105.73 4.54 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 122.742 0.417 . . . . 74.030000000000001 109.971 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.165 0 N-CA-C 109.398 -1.481 . . . . 62.329999999999998 109.398 178.153 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 107.695 -1.224 . . . . 63.210000000000001 107.695 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 19.9 m -136.09 156.6 37.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.511 -0.552 . . . . 64.450000000000003 109.511 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -94.7 136.25 35.23 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.803 -1.925 . . . . 74.519999999999996 105.803 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.5 m -97.71 141.11 22.49 Favored Pre-proline 0 C--N 1.282 -2.341 0 C-N-CA 119.128 -1.029 . . . . 74.430000000000007 110.948 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.95 133.19 56.55 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.124 2.549 . . . . 73.120000000000005 113.146 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.16 126.2 28.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.032 -0.985 . . . . 73.209999999999994 110.39 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.6 m -91.79 10.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 73.519999999999996 112.109 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.94 141.37 58.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 72.420000000000002 109.838 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.65 -0.14 45.94 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.489 -0.644 . . . . 74.510000000000005 111.489 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 -179.22 3.93 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.315 -0.624 . . . . 73.530000000000001 109.315 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.7 p -86.04 169.96 12.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.727 -0.789 . . . . 71.109999999999999 109.342 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.3 p -61.81 -38.98 90.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.739 0.304 . . . . 73.219999999999999 111.118 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.14 87.57 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.247 -0.433 . . . . 65.109999999999999 110.93 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -60.94 -43.66 98.35 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.199 -0.297 . . . . 74.420000000000002 110.199 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.91 75.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.524 -0.762 . . . . 63.210000000000001 110.198 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -58.28 -46.14 88.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.745 -0.661 . . . . 75.010000000000005 110.651 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.13 89.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.064 -0.517 . . . . 73.329999999999998 111.448 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 94.3 m -64.77 -48.25 75.2 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 120.575 0.226 . . . . 74.219999999999999 111.275 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.21 -38.71 91.29 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.436 -0.506 . . . . 73.450000000000003 110.892 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.02 -46.71 88.62 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.654 0.596 . . . . 61.409999999999997 109.908 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.4 -36.88 85.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.907 -0.588 . . . . 75.219999999999999 111.833 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -79.5 -14.45 58.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.540000000000006 111.652 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.3 16.35 32.57 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.387 -0.911 . . . . 72.340000000000003 113.523 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.19 166.96 12.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.912 0.387 . . . . 62.119999999999997 110.432 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 29.0 mmmt -99.93 153.14 19.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.193 -1.41 . . . . 74.439999999999998 107.193 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.409 HG13 HG22 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -130.19 138.47 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.432 0.634 . . . . 71.340000000000003 112.593 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.466 ' HB3' HG22 ' A' ' 417' ' ' THR . 14.0 ttm180 -115.46 135.93 53.6 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.05 -1.463 . . . . 74.310000000000002 107.05 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.6 m -99.6 128.11 45.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 119.351 -0.94 . . . . 72.109999999999999 110.525 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.77 119.54 38.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.928 -1.879 . . . . 73.400000000000006 105.928 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.51 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.02 128.4 56.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 120.883 0.373 . . . . 64.409999999999997 110.142 -178.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.436 ' HZ3' ' HB3' ' A' ' 389' ' ' LYS . 0.6 OUTLIER -121.53 115.7 30.97 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 112.11 0.411 . . . . 75.319999999999993 112.11 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -87.94 134.4 3.15 Favored 'Trans proline' 0 C--O 1.256 1.386 0 C-N-CA 123.306 2.67 . . . . 72.409999999999997 111.825 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t70 172.2 -169.32 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 106.374 -1.713 . . . . 71.200000000000003 106.374 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.523 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 21.3 m -120.52 -12.86 8.87 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.010000000000005 109.399 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -90.84 14.41 13.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.567 1.175 . . . . 74.319999999999993 108.291 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.4 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.54 151.08 47.65 Favored Pre-proline 0 N--CA 1.424 -1.763 0 CA-C-N 114.739 -1.119 . . . . 74.140000000000001 110.931 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.73 171.29 18.28 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.104 1.87 . . . . 73.200000000000003 111.35 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 398' ' ' HIS . 74.0 Cg_exo -56.53 163.03 7.34 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.504 2.803 . . . . 72.129999999999995 111.752 172.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.68 -7.26 0.64 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.214 1.006 . . . . 71.329999999999998 112.973 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 42.5 m170 -83.38 142.15 31.23 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.826 -0.805 . . . . 74.409999999999997 108.826 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.47 117.92 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-O 121.864 0.84 . . . . 73.120000000000005 109.544 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.76 -27.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.933 -1.03 . . . . 74.310000000000002 110.471 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.87 161.15 28.08 Favored Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 109.515 -1.434 . . . . 71.519999999999996 109.515 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.2 p -113.58 -178.48 3.39 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 121.035 0.445 . . . . 71.349999999999994 111.328 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.55 132.09 22.2 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.026 -1.472 . . . . 63.420000000000002 107.026 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.55 -30.04 11.42 Favored 'Trans proline' 0 N--CA 1.481 0.769 0 C-N-CA 124.137 3.225 . . . . 74.420000000000002 114.92 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.9 67.12 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 111.57 0.211 . . . . 71.349999999999994 111.57 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.68 -33.45 60.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.451 0.643 . . . . 73.5 110.28 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -86.17 -10.36 54.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.6 -0.727 . . . . 74.239999999999995 110.474 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 46.3 m -83.48 153.19 24.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.131 -1.433 . . . . 72.409999999999997 107.131 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.4 m -74.39 113.24 11.39 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.686 -0.806 . . . . 74.200000000000003 109.858 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.89 169.4 15.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 123.947 0.899 . . . . 75.409999999999997 109.075 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.3 t -78.96 146.96 33.14 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.913 -0.773 . . . . 74.25 108.913 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -70.87 113.22 7.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.061 -0.718 . . . . 75.109999999999999 109.061 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.71 9.1 11.45 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.384 -0.826 . . . . 54.350000000000001 111.722 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.0 -173.53 4.77 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.297 -1.371 . . . . 73.340000000000003 107.297 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 9.4 pt-20 -106.36 141.36 37.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.741 -0.784 . . . . 75.200000000000003 111.632 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -118.89 137.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.897 -1.149 . . . . 75.540000000000006 107.897 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 385' ' ' ARG . 68.4 p -92.64 130.53 38.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 120.988 0.423 . . . . 71.25 110.264 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.6 128.14 55.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.195 -1.039 . . . . 75.409999999999997 108.195 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.67 128.87 45.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.973 -0.38 . . . . 74.140000000000001 109.973 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 10.1 p -137.53 142.43 36.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.085 -0.709 . . . . 73.400000000000006 109.085 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.4 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 14.6 m -88.1 122.26 31.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.53 -0.544 . . . . 74.25 109.53 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 41.2 p -119.62 107.45 13.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.628 -0.26 . . . . 63.43 111.435 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 86.35 131.41 2.92 Favored Glycine 0 C--N 1.299 -1.522 0 C-N-CA 120.437 -0.887 . . . . 71.239999999999995 114.004 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 97.1 Cg_endo -82.3 157.83 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.635 2.223 . . . . 74.439999999999998 111.378 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 2.9 mm-40 -85.67 124.19 31.92 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.568 -0.53 . . . . 73.209999999999994 109.568 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -120.51 130.91 54.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.039 -1.097 . . . . 75.420000000000002 108.039 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -131.18 152.06 50.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 74.510000000000005 108.51 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -89.81 138.49 31.44 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 109.821 -0.437 . . . . 73.310000000000002 109.821 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -80.3 119.38 76.26 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.085 -0.709 . . . . 71.129999999999995 109.085 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.51 141.4 97.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.765 2.31 . . . . 75.319999999999993 111.864 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.58 8.98 25.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.33 0.492 . . . . 73.510000000000005 112.33 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.43 -7.86 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.998 0.904 . . . . 74.340000000000003 108.767 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 p -59.2 -42.85 91.91 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.982 -1.008 . . . . 72.140000000000001 111.845 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.5 p -69.4 -16.72 63.57 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.543 0.737 . . . . 74.25 112.367 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.25 -32.82 19.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.383 -0.371 . . . . 73.519999999999996 111.94 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.4 m -151.72 123.99 8.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.448 -0.575 . . . . 73.209999999999994 109.448 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.86 -45.42 92.66 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.275 0.472 . . . . 73.129999999999995 112.275 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.25 -43.89 95.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 75.299999999999997 110.135 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.11 -37.65 88.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.138 -0.937 . . . . 74.230000000000004 109.949 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.093 -0.503 . . . . 73.420000000000002 110.51 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.27 -43.42 98.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.697 -0.683 . . . . 73.340000000000003 110.033 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 30.8 mmmt -64.67 -47.43 78.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.398 -0.364 . . . . 74.530000000000001 111.368 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -63.83 -38.85 92.63 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 111.982 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.0 -39.41 90.27 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.01 -0.737 . . . . 72.340000000000003 109.01 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.7 m -66.75 -45.91 77.07 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.335 -0.848 . . . . 73.349999999999994 110.163 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.83 -22.93 65.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.862 0.865 . . . . 64.109999999999999 112.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.68 -11.04 59.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.413 0.625 . . . . 64.510000000000005 110.628 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.38 -15.89 19.96 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.679 -0.772 . . . . 63.119999999999997 112.986 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.54 124.7 23.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.928 0.394 . . . . 73.340000000000003 111.182 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.78 13.17 9.28 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.028 -0.829 . . . . 73.230000000000004 111.028 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -111.95 111.26 22.06 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 70.400000000000006 107.458 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -126.0 146.41 49.89 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 121.097 -0.241 . . . . 74.329999999999998 110.921 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 25.3 ttmm -153.17 122.66 6.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.353 -1.351 . . . . 75.409999999999997 107.353 171.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.46 135.3 43.19 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.247 0.546 . . . . 64.340000000000003 111.825 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.73 158.04 28.36 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.044 -1.095 . . . . 71.319999999999993 108.044 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.41 134.48 51.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.844 -0.799 . . . . 64.430000000000007 108.844 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.2 t -138.79 131.16 15.73 Favored Pre-proline 0 C--N 1.287 -2.137 0 N-CA-C 108.655 -0.868 . . . . 71.0 108.655 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 128.56 21.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.994 1.796 . . . . 65.439999999999998 109.151 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.7 t -137.13 -178.75 5.34 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.541 -0.911 . . . . 72.140000000000001 108.541 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 12.0 m -51.1 131.06 31.27 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.925 1.29 . . . . 74.430000000000007 109.484 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.79 -33.05 31.3 Favored 'Trans proline' 0 C--N 1.364 1.371 0 C-N-CA 123.815 3.01 . . . . 63.109999999999999 114.065 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -67.44 -32.24 72.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 72.109999999999999 111.668 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.33 -9.7 40.94 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.165 -0.334 . . . . 72.299999999999997 111.51 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 42.1 t -59.17 129.97 22.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 CA-C-N 115.749 -0.66 . . . . 71.510000000000005 111.861 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.34 1.28 56.8 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.841 -1.072 . . . . 52.210000000000001 110.937 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -131.22 166.33 21.41 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 109.128 -0.693 . . . . 73.230000000000004 109.128 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.95 136.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.927 -0.768 . . . . 71.430000000000007 108.927 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.29 -16.54 7.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.13 -0.628 . . . . 74.409999999999997 111.564 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.61 163.79 22.14 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.26 -0.882 . . . . 72.200000000000003 110.999 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.5 p -122.37 157.57 31.54 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.006 -1.479 . . . . 75.150000000000006 107.006 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -62.23 -54.51 48.85 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 119.058 -1.057 . . . . 74.420000000000002 111.298 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -74.83 112.82 3.65 Favored 'Trans proline' 0 C--N 1.371 1.757 0 N-CA-C 107.801 -1.654 . . . . 75.430000000000007 107.801 169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.36 162.07 43.36 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.391 2.061 . . . . 74.200000000000003 114.523 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.9 -4.01 32.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.864 -1.062 . . . . 63.439999999999998 111.553 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -108.23 12.24 26.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.098 -0.501 . . . . 71.010000000000005 109.814 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.63 151.77 46.06 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.461 0.648 . . . . 72.439999999999998 110.675 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.7 m -104.44 101.95 11.62 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.053 -1.462 . . . . 73.129999999999995 107.053 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.7 m -106.73 145.34 32.16 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.503 -0.317 . . . . 75.340000000000003 111.272 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.74 145.99 54.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.066 -0.516 . . . . 74.530000000000001 110.665 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 48.3 mm -67.25 -9.1 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 124.375 1.07 . . . . 75.040000000000006 111.42 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.8 p -86.88 -2.91 58.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.665 0.745 . . . . 74.120000000000005 110.71 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -95.82 133.93 39.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.544 -0.753 . . . . 74.109999999999999 109.382 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.28 119.37 28.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.932 -1.136 . . . . 74.200000000000003 107.932 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.18 119.15 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.628 -0.879 . . . . 64.310000000000002 108.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.3 mt -93.85 112.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.133 -1.432 . . . . 74.329999999999998 107.133 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.98 117.19 46.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.659 -1.155 . . . . 70.200000000000003 108.823 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 35.0 mt -99.93 119.8 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.374 0.606 . . . . 73.540000000000006 110.09 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.43 124.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 75.049999999999997 108.851 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.7 96.38 1.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.45 -1.86 . . . . 75.150000000000006 108.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.435 ' HA ' HG11 ' A' ' 464' ' ' VAL . 5.1 p -142.79 131.51 22.66 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 110.071 -0.344 . . . . 72.25 110.071 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.0 0 N-CA-C 106.851 -2.499 . . . . 64.129999999999995 106.851 176.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 CA--C 1.499 -0.999 0 N-CA-C 108.28 -1.008 . . . . 62.439999999999998 108.28 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.46 153.65 39.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.514 -0.55 . . . . 73.319999999999993 109.514 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.43 138.59 32.91 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.04 -1.096 . . . . 64.219999999999999 108.04 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.59 126.62 42.65 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.335 -0.617 . . . . 74.219999999999999 109.335 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.1 141.75 89.76 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.413 2.742 . . . . 74.239999999999995 114.995 -174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.15 138.28 31.63 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.683 -1.228 . . . . 74.430000000000007 107.683 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.05 27.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-O 121.936 0.874 . . . . 64.319999999999993 109.073 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -55.45 144.23 26.44 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.823 -1.535 . . . . 71.099999999999994 111.694 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.92 44.65 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.961 -0.856 . . . . 50.229999999999997 110.961 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -127.18 -173.3 2.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.963 -0.384 . . . . 73.219999999999999 109.963 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.9 p -70.82 151.37 44.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.755 0.312 . . . . 74.010000000000005 111.385 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 p -63.43 -36.46 83.81 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.346 -0.388 . . . . 63.039999999999999 111.411 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.76 88.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.192 -0.458 . . . . 74.209999999999994 110.546 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.41 -36.52 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 110.637 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.16 70.93 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.122 -0.49 . . . . 74.150000000000006 110.99 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.34 -43.58 98.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.831 -0.622 . . . . 74.549999999999997 110.774 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.33 94.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.448 -0.342 . . . . 74.040000000000006 111.829 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.2 m -63.93 -47.07 81.95 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.961 0.41 . . . . 73.239999999999995 110.105 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.49 -38.1 89.84 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -59.89 -45.24 93.14 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.174 0.989 . . . . 75.439999999999998 109.846 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -70.17 -16.55 63.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 74.219999999999999 111.991 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -86.86 -14.14 42.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.639 -0.874 . . . . 74.519999999999996 108.639 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.86 5.2 62.91 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.53 -0.843 . . . . 73.340000000000003 111.668 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 35.6 m-85 -86.15 149.72 24.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.212 0.529 . . . . 74.430000000000007 110.291 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 13.9 mmmm -91.41 153.22 20.02 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.216 -1.401 . . . . 65.430000000000007 107.216 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.03 147.46 25.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 C-N-CA 120.3 -0.56 . . . . 74.209999999999994 111.421 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -111.07 132.22 54.43 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.012 -1.848 . . . . 73.129999999999995 106.012 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.5 m -115.72 118.2 32.37 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.372 -0.973 . . . . 71.150000000000006 108.372 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.59 119.02 36.71 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.817 -1.179 . . . . 72.530000000000001 107.817 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -104.36 131.79 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.23 0.538 . . . . 73.409999999999997 110.187 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -136.76 130.61 17.82 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.707 -0.678 . . . . 74.530000000000001 110.836 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.36 135.55 4.46 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.494 2.129 . . . . 73.150000000000006 111.616 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 34.4 t70 168.56 166.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.168 1.387 . . . . 52.219999999999999 107.305 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.604 ' O ' ' HB ' ' A' ' 481' ' ' THR . 9.4 p -123.25 8.19 9.12 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 113.096 0.776 . . . . 75.450000000000003 113.096 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -82.34 -24.51 34.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.132 -1.803 . . . . 63.420000000000002 106.132 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 6.7 pt -88.91 148.65 41.76 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.721 -2.036 . . . . 73.129999999999995 109.718 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.63 173.01 14.01 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.098 2.532 . . . . 75.040000000000006 112.268 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.14 162.78 6.98 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 123.558 2.838 . . . . 71.319999999999993 112.69 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.46 -8.21 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.631 1.172 . . . . 74.409999999999997 113.993 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -75.47 115.69 15.4 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.396 -1.705 . . . . 75.219999999999999 106.396 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.48 117.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.018 0.437 . . . . 75.099999999999994 110.456 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.57 -27.21 3.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.641 -0.709 . . . . 73.140000000000001 110.137 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.29 157.02 27.04 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.072 -1.211 . . . . 62.039999999999999 110.072 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.9 p -128.12 -176.52 3.82 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 124.493 1.117 . . . . 75.129999999999995 111.076 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.83 132.92 22.15 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.524 -1.287 . . . . 74.099999999999994 107.524 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.59 -20.34 12.05 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.786 2.991 . . . . 74.530000000000001 114.175 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.63 61.29 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 122.453 0.301 . . . . 72.109999999999999 110.922 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.67 -41.15 84.19 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.44 0.638 . . . . 72.239999999999995 110.337 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.16 -3.87 59.09 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 120.261 -0.575 . . . . 72.439999999999998 111.534 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.4 m -80.13 131.54 35.76 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.671 -1.603 . . . . 73.120000000000005 106.671 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.8 m -74.61 113.3 11.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.032 -0.667 . . . . 75.299999999999997 110.086 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.25 167.73 24.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.246 -0.888 . . . . 63.210000000000001 109.335 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.17 50.35 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 109.459 -0.571 . . . . 75.510000000000005 109.459 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -62.51 130.8 46.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.369 0.668 . . . . 64.420000000000002 111.981 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 109.35 16.48 11.08 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.604 -0.808 . . . . 54.509999999999998 113.809 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.18 175.57 7.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.346 -1.353 . . . . 74.549999999999997 107.346 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 10.7 pt-20 -109.4 140.2 43.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 112.026 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.0 133.24 65.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -89.78 118.67 29.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.93 0.871 . . . . 62.439999999999998 110.038 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.3 133.58 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.91 -1.041 . . . . 72.400000000000006 109.176 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -96.97 128.74 44.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.813 -0.63 . . . . 74.209999999999994 110.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.3 p -130.25 131.9 65.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.304 -0.628 . . . . 72.400000000000006 109.304 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -91.9 122.55 34.53 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.326 -0.62 . . . . 64.120000000000005 109.326 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 16.5 p -118.92 106.66 12.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.756 0.312 . . . . 55.340000000000003 111.7 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.48 104.95 0.69 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.581 -0.819 . . . . 74.099999999999994 113.042 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 18.8 Cg_exo -66.99 128.93 19.59 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.53 2.154 . . . . 74.0 110.478 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.44 143.48 32.07 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.826 -0.35 . . . . 74.140000000000001 111.703 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -131.97 157.12 44.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.307 -0.997 . . . . 74.400000000000006 108.307 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -142.59 154.82 44.77 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.557 -0.534 . . . . 74.310000000000002 109.557 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.68 139.64 30.36 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.849 -0.426 . . . . 72.299999999999997 109.849 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.6 mp -78.7 116.15 57.4 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.844 -0.799 . . . . 64.099999999999994 108.844 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.55 140.91 40.77 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.868 1.712 . . . . 73.239999999999995 110.156 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -107.19 87.4 2.5 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.453 -1.299 . . . . 72.439999999999998 113.671 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.0 0.69 7.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 104.261 -2.496 . . . . 70.409999999999997 104.261 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 8.9 m -68.78 -50.11 53.02 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.972 -1.922 . . . . 73.129999999999995 110.236 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 m -64.88 -16.45 63.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 121.791 0.805 . . . . 74.519999999999996 109.908 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -48.42 7.01 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.482 -0.781 . . . . 74.010000000000005 110.241 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 66.0 m -147.71 123.91 10.84 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.085 0.469 . . . . 74.340000000000003 111.19 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -42.42 97.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.996 0.739 . . . . 72.409999999999997 112.996 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.22 -40.26 81.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 65.140000000000001 110.573 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -67.03 -35.3 79.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.485 -0.779 . . . . 74.530000000000001 111.815 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -59.67 -48.39 81.84 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.964 0.412 . . . . 65.349999999999994 110.26 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.57 -47.93 90.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.645 -0.707 . . . . 74.150000000000006 110.501 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -66.6 -45.7 78.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.02 -0.536 . . . . 73.310000000000002 112.119 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -66.28 -47.12 74.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 111.813 0.301 . . . . 71.010000000000005 111.813 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.11 -39.07 89.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.517 0.562 . . . . 73.0 112.517 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.0 m -61.81 -42.21 98.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.715 0.293 . . . . 74.439999999999998 110.483 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.66 66.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 73.230000000000004 111.06 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.08 59.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.958 -0.565 . . . . 73.420000000000002 111.038 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 116.52 -7.43 18.03 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.339 -0.934 . . . . 64.349999999999994 113.594 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.09 105.2 8.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.48 0.64 . . . . 73.530000000000001 109.717 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -111.74 5.16 27.67 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.723 -0.671 . . . . 72.439999999999998 111.629 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 23.1 mmt180 -113.8 111.45 21.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 73.400000000000006 108.343 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.61 156.54 43.21 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.297 0.57 . . . . 75.420000000000002 111.655 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -135.79 123.21 21.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.314 -2.106 . . . . 75.109999999999999 105.314 170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.97 122.36 36.38 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.9 155.19 35.96 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.063 -0.717 . . . . 61.200000000000003 109.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -128.08 138.45 52.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.847 0.356 . . . . 74.510000000000005 110.674 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.8 t -123.19 131.22 24.34 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.151 -1.425 . . . . 72.340000000000003 107.151 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.01 124.48 14.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.524 2.15 . . . . 74.239999999999995 110.139 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 24.8 m -134.98 160.85 36.99 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.64 -0.504 . . . . 64.510000000000005 109.64 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.81 146.22 87.09 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.482 -1.303 . . . . 74.310000000000002 107.482 175.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 464' ' ' VAL . 79.1 Cg_exo -52.26 -24.02 19.66 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 123.372 2.715 . . . . 75.230000000000004 114.306 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.51 -31.86 73.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.116 0.484 . . . . 74.430000000000007 110.857 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.37 5.08 44.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.02 0.378 . . . . 73.420000000000002 112.02 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.1 p -60.43 128.85 22.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 C-N-CA 120.087 -0.645 . . . . 75.319999999999993 110.779 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.1 83.14 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.888 -0.596 . . . . 55.420000000000002 112.584 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -116.38 148.22 40.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.165 -1.421 . . . . 75.230000000000004 107.165 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 433' ' ' SER . 62.0 t -84.05 136.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.038 -0.727 . . . . 71.400000000000006 109.038 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 -14.62 10.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.781 -0.768 . . . . 75.340000000000003 111.233 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.12 173.56 41.01 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.948 -0.861 . . . . 73.420000000000002 110.948 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.2 p -137.22 158.87 43.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.276 -1.009 . . . . 72.5 108.276 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.9 t-20 -69.54 -54.62 10.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 119.809 -0.756 . . . . 75.230000000000004 109.863 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.55 118.07 4.76 Favored 'Trans proline' 0 C--N 1.376 2.024 0 N-CA-C 107.574 -1.741 . . . . 74.430000000000007 107.574 172.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 475' ' ' ASN . 43.0 Cg_endo -69.17 139.71 42.97 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.732 1.621 . . . . 75.430000000000007 112.277 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.17 24.74 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.424 1.09 . . . . 62.5 112.466 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 473' ' ' PRO . 38.6 m-80 -108.32 -22.28 12.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.385 1.074 . . . . 75.299999999999997 109.822 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -131.67 160.09 36.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 C-N-CA 119.292 -0.963 . . . . 75.239999999999995 111.498 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.69 141.9 49.86 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 126.12 1.768 . . . . 64.420000000000002 110.54 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 56.3 m -133.76 149.7 51.46 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.12 -1.067 . . . . 74.530000000000001 108.12 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -76.61 157.95 31.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-O 120.803 0.335 . . . . 72.209999999999994 110.338 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.438 HG21 ' O ' ' A' ' 448' ' ' GLY . 50.8 mm -66.83 -16.34 20.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.112 0.958 . . . . 63.549999999999997 110.004 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 392' ' ' SER . 12.4 t -99.35 2.59 45.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.37 -0.832 . . . . 74.439999999999998 110.009 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 10.1 m120 -83.32 146.07 28.71 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.515 -0.55 . . . . 75.239999999999995 109.515 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.47 114.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 74.519999999999996 107.271 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.49 119.47 35.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.109 -0.7 . . . . 75.209999999999994 109.109 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.4 mp -92.06 112.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 106.608 -1.627 . . . . 60.210000000000001 106.608 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.33 121.93 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.664 -1.236 . . . . 73.019999999999996 107.664 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.41 111.58 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 121.418 0.627 . . . . 71.329999999999998 110.015 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.2 140.83 17.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.361 -0.977 . . . . 74.530000000000001 108.361 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.93 100.37 1.22 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.504 -1.038 . . . . 53.149999999999999 110.504 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 50.2 m -141.97 130.07 22.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.595 -0.52 . . . . 61.229999999999997 109.595 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.224 0 N-CA-C 107.871 -2.092 . . . . 73.319999999999993 107.871 -178.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 . . . . . 0 CA--C 1.492 -1.262 0 N-CA-C 108.751 -0.833 . . . . 65.409999999999997 108.751 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 150.68 31.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.274 -0.639 . . . . 72.340000000000003 109.274 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.31 136.6 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.659 -1.978 . . . . 74.209999999999994 105.659 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.5 p -97.46 128.48 34.52 Favored Pre-proline 0 C--N 1.282 -2.331 0 C-N-CA 119.117 -1.033 . . . . 75.109999999999999 109.627 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.97 128.07 23.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.841 2.361 . . . . 75.409999999999997 112.425 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -68.81 119.62 13.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.75 -1.113 . . . . 74.040000000000006 110.765 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 30.5 m -82.95 25.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.983 -1.008 . . . . 71.519999999999996 112.817 -174.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 400' ' ' ILE . 11.2 ptt-85 -67.85 144.04 55.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 122.044 -0.41 . . . . 74.0 111.941 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.83 0.5 45.61 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.875 -0.679 . . . . 53.530000000000001 113.647 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 0.9 OUTLIER -126.45 -172.85 2.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.336 0.568 . . . . 74.329999999999998 110.338 -177.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.8 p -79.44 164.2 24.16 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 118.266 0.484 . . . . 65.319999999999993 110.513 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 61.4 p -63.67 -33.66 76.13 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.368 -0.604 . . . . 74.340000000000003 109.368 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.14 90.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.143 -0.935 . . . . 63.329999999999998 110.339 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -60.14 -42.82 95.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.648 -0.251 . . . . 73.010000000000005 110.984 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -51.51 69.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.691 0.62 . . . . 64.310000000000002 110.438 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.73 -46.19 96.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.644 -0.707 . . . . 74.329999999999998 110.517 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.11 98.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.69 -0.686 . . . . 74.310000000000002 112.177 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.9 m -60.77 -47.69 85.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.844 0.354 . . . . 72.439999999999998 110.835 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.05 -38.82 92.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.779 0.323 . . . . 75.319999999999993 111.295 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.85 -47.62 85.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.557 -0.747 . . . . 65.230000000000004 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -68.9 -27.96 66.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.968 -0.56 . . . . 73.219999999999999 111.559 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -81.61 -13.63 57.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 111.977 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.14 14.55 48.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.561 -0.828 . . . . 63.310000000000002 112.895 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -88.61 170.57 10.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.636 -0.505 . . . . 61.530000000000001 109.636 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 14.2 mmmm -100.47 159.25 15.3 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.501 -1.296 . . . . 75.5 107.501 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.36 146.38 34.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.406 0.622 . . . . 73.310000000000002 110.996 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -123.59 147.43 47.33 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 105.495 -2.039 . . . . 73.129999999999995 105.495 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.4 m -116.5 129.19 56.06 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 109.072 -0.714 . . . . 74.140000000000001 109.072 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.32 118.8 36.85 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.19 -2.152 . . . . 65.040000000000006 105.19 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.441 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -115.92 129.5 56.43 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.45 -0.574 . . . . 74.239999999999995 109.45 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -138.45 134.54 17.54 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 116.351 -0.386 . . . . 70.040000000000006 110.614 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -93.38 132.68 0.88 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.92 2.413 . . . . 74.129999999999995 110.85 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.0 t70 -175.22 171.39 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.124 -1.436 . . . . 73.340000000000003 107.124 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.8 m -114.39 -5.48 12.9 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.356 0.598 . . . . 74.420000000000002 110.323 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -87.9 -12.82 43.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.104 0.954 . . . . 63.109999999999999 108.94 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 12.5 pt -88.58 144.12 33.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.001 -1.0 . . . . 74.439999999999998 110.861 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.4 177.22 8.79 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.343 2.695 . . . . 75.239999999999995 110.76 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.53 160.75 10.85 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.002 2.468 . . . . 74.040000000000006 112.357 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.407 ' HB2' HG21 ' A' ' 420' ' ' VAL . 2.5 p-10 -57.74 -9.5 1.25 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 124.987 1.315 . . . . 74.219999999999999 113.631 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.89 114.46 11.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.839 -1.911 . . . . 70.540000000000006 105.839 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.52 118.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.171 0.986 . . . . 74.439999999999998 111.408 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 366' ' ' ARG . 7.8 tp -90.53 -32.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.895 -1.048 . . . . 75.519999999999996 109.86 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -157.87 157.38 28.17 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 109.592 -1.403 . . . . 73.329999999999998 109.592 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.0 p -116.47 -179.75 3.77 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.063 -0.717 . . . . 73.049999999999997 109.063 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.64 147.55 34.0 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 120.174 -0.611 . . . . 75.230000000000004 109.416 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.65 -7.38 2.15 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.373 3.382 . . . . 71.549999999999997 115.501 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.28 72.8 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.058 -0.349 . . . . 72.420000000000002 110.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.73 68.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.695 0.759 . . . . 75.219999999999999 110.107 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.7 -10.83 59.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.278 -0.874 . . . . 74.219999999999999 111.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 83.0 m -81.01 151.81 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.794 -1.187 . . . . 73.530000000000001 107.794 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.5 m -74.06 112.86 10.6 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.303 0.573 . . . . 72.530000000000001 109.7 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.42 159.69 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.081 -0.963 . . . . 63.219999999999999 109.47 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 36.6 m -74.16 146.82 43.17 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.202 -0.666 . . . . 51.420000000000002 109.202 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.3 35.5 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.874 0.369 . . . . 73.209999999999994 110.423 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.46 25.86 24.7 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.724 -0.671 . . . . 70.540000000000006 112.006 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 411' ' ' SER . 4.4 t70 -85.89 -175.68 5.68 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.792 -1.188 . . . . 72.439999999999998 107.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.7 pt-20 -114.06 133.76 55.32 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.672 -0.811 . . . . 62.43 111.357 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.37 129.74 62.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 109.315 -0.624 . . . . 72.230000000000004 109.315 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.9 t -88.18 123.17 32.55 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 122.085 0.945 . . . . 72.430000000000007 109.994 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.81 114.61 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 107.506 -1.294 . . . . 73.25 107.506 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.08 -1.082 . . . . 73.310000000000002 108.08 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 397' ' ' ASP . 14.8 p -121.41 135.96 59.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.253 0.549 . . . . 75.450000000000003 110.558 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 19.9 m -84.63 121.11 27.18 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.663 -0.866 . . . . 73.129999999999995 108.663 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -119.87 104.9 10.59 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.657 -0.247 . . . . 75.019999999999996 111.449 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.02 145.72 0.12 Allowed Glycine 0 CA--C 1.542 1.729 0 N-CA-C 115.962 1.145 . . . . 65.230000000000004 115.962 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 57.9 Cg_endo -82.07 128.47 5.74 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.565 1.51 . . . . 74.099999999999994 109.964 172.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 0.1 OUTLIER -73.55 156.9 37.65 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.608 -0.516 . . . . 62.130000000000003 109.608 -177.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.4 mt-30 -121.71 157.48 30.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.032 0.444 . . . . 74.349999999999994 110.779 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -145.59 145.02 30.82 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.857 -0.794 . . . . 73.540000000000006 108.857 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.29 138.93 32.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.668 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -84.09 124.76 73.96 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.859 -0.61 . . . . 74.530000000000001 110.18 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 74.7 Cg_exo -61.85 141.6 90.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.435 2.09 . . . . 62.009999999999998 111.032 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.81 20.41 2.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.334 0.494 . . . . 64.129999999999995 112.334 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.18 -6.37 10.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.34 -0.391 . . . . 64.310000000000002 111.902 -175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.0 m -51.44 -51.09 57.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.909 0.883 . . . . 72.129999999999995 112.435 -177.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.3 m -61.12 -27.18 68.2 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.765 0.826 . . . . 74.409999999999997 111.716 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.15 -48.32 8.69 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.687 0.279 . . . . 73.109999999999999 111.702 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.0 m -146.47 115.84 7.08 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.814 -0.354 . . . . 72.349999999999994 111.083 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -59.23 -44.01 92.34 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.682 -0.69 . . . . 73.0 110.937 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.65 -46.6 83.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 75.219999999999999 111.258 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.02 -35.46 78.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.498 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.98 -43.58 95.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.314 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.84 -42.65 95.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.956 -0.565 . . . . 65.340000000000003 110.179 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.6 mmtt -66.22 -43.23 87.27 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.159 0.504 . . . . 74.219999999999999 110.352 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.473 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 39.3 mmtm -62.93 -47.74 81.92 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.521 -0.763 . . . . 74.450000000000003 111.246 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.97 -32.7 73.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.597 0.592 . . . . 73.420000000000002 112.597 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 52.3 m -67.54 -41.21 84.67 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.611 -0.514 . . . . 75.230000000000004 109.611 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.17 -22.83 61.99 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.83 0.824 . . . . 75.340000000000003 110.587 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.89 59.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.326 -0.852 . . . . 70.5 110.423 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.13 -20.41 45.37 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.992 -0.549 . . . . 72.0 113.178 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -57.84 127.42 31.99 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.117 0.484 . . . . 75.329999999999998 111.874 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -129.12 12.92 6.05 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.389 -0.823 . . . . 60.310000000000002 111.208 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -115.75 111.04 19.96 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.332 -0.988 . . . . 75.430000000000007 108.332 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -132.93 148.59 52.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.106 0.479 . . . . 75.310000000000002 110.756 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -140.53 122.24 15.31 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 105.578 -2.008 . . . . 73.140000000000001 105.578 170.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.89 128.83 45.18 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.566 -0.531 . . . . 72.25 109.566 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.0 161.41 26.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.037 -0.727 . . . . 74.519999999999996 109.037 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -129.31 129.17 44.51 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.594 -0.891 . . . . 72.099999999999994 108.594 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -123.42 137.64 28.81 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 109.555 -0.535 . . . . 64.140000000000001 109.555 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.5 Cg_exo -61.87 134.01 47.77 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.303 2.002 . . . . 63.130000000000003 110.594 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.1 m -148.15 161.83 40.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.48 -0.563 . . . . 73.129999999999995 109.48 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 20.8 m -57.75 142.99 77.43 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 124.335 1.022 . . . . 55.149999999999999 108.261 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.13 -23.27 6.28 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.673 2.916 . . . . 71.200000000000003 114.579 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.34 -33.11 74.06 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.709 -0.62 . . . . 74.530000000000001 110.305 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.44 -9.86 28.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 112.482 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 461' ' ' PRO . 8.9 p -60.22 127.25 19.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 119.836 -0.746 . . . . 74.340000000000003 110.21 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.99 71.82 Favored Glycine 0 C--N 1.307 -1.043 0 C-N-CA 120.629 -0.796 . . . . 51.439999999999998 112.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -107.97 161.74 14.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.658 -0.867 . . . . 75.049999999999997 108.658 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.98 129.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.591 -0.892 . . . . 75.519999999999996 108.591 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.08 -13.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.964 -0.695 . . . . 75.140000000000001 111.471 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 160.3 12.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.661 -0.699 . . . . 63.109999999999999 111.637 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.8 p -119.34 149.39 41.89 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.696 -1.224 . . . . 71.030000000000001 107.696 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.91 -51.46 79.19 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.34 -0.544 . . . . 72.219999999999999 110.707 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.2 Cg_exo -82.44 115.81 2.58 Favored 'Trans proline' 0 C--N 1.368 1.595 0 N-CA-C 107.841 -1.638 . . . . 74.430000000000007 107.841 169.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.56 159.51 52.2 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.326 2.017 . . . . 73.519999999999996 113.657 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.63 -4.14 35.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.145 0.974 . . . . 50.409999999999997 111.706 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -105.34 11.12 33.17 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 109.072 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -127.75 156.4 42.5 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.669 0.747 . . . . 60.020000000000003 110.7 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 14.8 m -102.76 115.7 31.12 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.403 -1.271 . . . . 73.519999999999996 107.625 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.4 m -117.68 148.32 42.09 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 110.237 -0.283 . . . . 74.019999999999996 110.237 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.51 156.95 38.08 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.386 -0.228 . . . . 74.0 110.386 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.3 -22.78 19.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.57 0.7 . . . . 72.530000000000001 110.215 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -87.4 1.98 51.79 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.893 0.854 . . . . 73.219999999999999 109.861 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.46 130.17 34.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.478 -1.675 . . . . 70.209999999999994 106.478 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.19 113.99 19.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.602 -0.518 . . . . 75.439999999999998 109.602 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.37 118.7 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 N-CA-C 108.68 -0.859 . . . . 71.439999999999998 108.68 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 77.0 mt -94.45 112.89 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 107.176 -1.416 . . . . 73.230000000000004 107.176 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.61 115.44 46.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 N-CA-C 107.49 -1.3 . . . . 73.439999999999998 107.49 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.6 mt -103.61 119.82 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 115.982 -0.554 . . . . 74.099999999999994 110.148 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.16 136.24 29.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.566 -0.902 . . . . 73.329999999999998 108.566 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -71.88 113.34 4.51 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.129 -1.188 . . . . 73.25 110.129 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.2 m -131.73 104.89 7.16 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.453 -0.573 . . . . 74.239999999999995 109.453 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.096 0 N-CA-C 108.812 -1.715 . . . . 55.229999999999997 108.812 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.75 -1.204 . . . . 71.140000000000001 107.75 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.54 162.34 38.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.009 0.433 . . . . 74.340000000000003 111.664 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.23 137.33 37.9 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.233 -1.025 . . . . 73.5 108.233 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.98 133.68 20.22 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 109.343 -0.614 . . . . 73.040000000000006 109.343 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 147.03 87.54 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.89 2.394 . . . . 73.310000000000002 113.666 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.06 145.4 31.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.653 -0.703 . . . . 72.439999999999998 109.175 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.1 t -107.43 31.63 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.602 -1.629 . . . . 73.420000000000002 106.602 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.36 134.12 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.388 -1.733 . . . . 75.430000000000007 111.149 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.88 -5.19 57.96 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 111.373 -0.691 . . . . 60.420000000000002 111.373 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -119.25 -176.94 3.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 120.705 0.288 . . . . 75.340000000000003 110.225 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.6 p -72.02 158.7 35.5 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 111.531 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.5 t -63.1 -33.8 76.23 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.372 -0.603 . . . . 74.329999999999998 109.372 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.23 90.36 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.535 0.522 . . . . 72.219999999999999 110.356 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 116.332 -0.394 . . . . 73.019999999999996 110.648 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.424 ' O ' HD22 ' A' ' 377' ' ' LEU . . . -60.65 -51.4 69.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.577 -0.738 . . . . 60.200000000000003 111.035 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.95 -43.18 97.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.433 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.64 98.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 70.439999999999998 112.349 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 58.7 m -64.03 -47.34 80.6 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.355 0.598 . . . . 73.230000000000004 110.264 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 373' ' ' ALA . 4.4 mm? -64.34 -38.45 91.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 73.409999999999997 110.768 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.2 -45.95 91.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.653 -0.703 . . . . 73.340000000000003 110.072 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -66.22 -30.71 71.21 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.389 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.7 mmt-85 -78.95 -13.83 59.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.479 . . . . 75.209999999999994 111.012 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.9 13.5 56.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.889 -0.672 . . . . 74.299999999999997 113.228 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 59.4 m-85 -85.33 166.24 16.62 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.487 0.66 . . . . 75.299999999999997 111.755 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 55.8 mtmt -109.02 132.61 53.94 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.605 -1.257 . . . . 74.109999999999999 107.605 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.76 146.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.462 0.649 . . . . 75.430000000000007 112.651 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -109.5 127.73 54.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.887 -1.894 . . . . 72.430000000000007 105.887 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.4 m -107.34 117.65 34.64 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 106.663 -1.606 . . . . 73.329999999999998 106.663 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.23 118.52 36.15 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.116 -1.809 . . . . 75.310000000000002 106.116 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.43 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -113.03 128.0 56.38 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 109.164 -0.68 . . . . 75.329999999999998 109.164 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.21 138.71 33.48 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.938 -0.574 . . . . 73.0 110.364 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -82.63 146.04 13.27 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.92 1.746 . . . . 72.219999999999999 108.716 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.8 t0 -179.62 -175.0 0.32 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.349 -1.722 . . . . 75.239999999999995 106.349 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 51.4 m -135.11 0.26 2.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.158 0.504 . . . . 72.519999999999996 110.441 174.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 -14.95 49.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.221 -1.399 . . . . 61.219999999999999 107.221 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.418 HD11 ' CB ' ' A' ' 421' ' ' SER . 14.2 pt -91.86 145.47 31.1 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.086 -1.416 . . . . 74.299999999999997 111.189 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.41 -172.88 1.47 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 123.18 2.587 . . . . 72.230000000000004 108.838 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.58 161.7 7.36 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.35 2.033 . . . . 74.340000000000003 112.608 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -57.03 -8.12 0.6 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 125.228 1.411 . . . . 73.329999999999998 114.463 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -71.66 122.36 20.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.577 -1.268 . . . . 75.540000000000006 107.577 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.04 118.42 7.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 123.589 0.756 . . . . 73.420000000000002 111.645 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 400' ' ' ILE . 0.2 OUTLIER -96.4 -28.83 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.857 -0.61 . . . . 75.310000000000002 111.031 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.47 157.73 27.48 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 110.76 -0.936 . . . . 72.0 110.76 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.3 p -126.98 -177.88 4.2 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 123.283 0.633 . . . . 74.219999999999999 110.268 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.69 136.15 19.63 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.537 -1.653 . . . . 75.030000000000001 106.537 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.72 -16.67 2.48 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.406 3.404 . . . . 75.510000000000005 115.282 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.83 32.93 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 123.622 0.769 . . . . 74.200000000000003 111.854 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.44 -44.49 82.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.125 0.488 . . . . 71.430000000000007 111.034 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -86.09 -2.32 58.21 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.19 0.519 . . . . 73.040000000000006 111.662 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 67.1 m -81.55 146.79 29.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.846 -1.538 . . . . 72.420000000000002 106.846 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.2 m -74.66 112.74 11.17 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.168 -1.049 . . . . 72.540000000000006 108.168 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.23 166.81 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.519 -0.764 . . . . 74.340000000000003 111.064 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.2 t -74.51 144.66 44.01 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.108 -1.071 . . . . 63.009999999999998 108.108 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.43 114.67 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 71.310000000000002 110.521 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.34 40.68 4.16 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.668 -0.777 . . . . 71.120000000000005 111.767 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -93.2 -177.38 4.44 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.607 -1.257 . . . . 74.409999999999997 107.607 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 41.2 mt-10 -107.19 119.9 40.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.207 0.527 . . . . 65.150000000000006 111.957 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.21 130.59 61.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.538 -0.912 . . . . 75.120000000000005 108.538 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.4 t -95.05 130.76 41.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.355 0.598 . . . . 75.299999999999997 110.015 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.39 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.711 -0.848 . . . . 73.329999999999998 108.711 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -91.33 128.82 37.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.489 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.16 138.59 53.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.229 -0.896 . . . . 71.510000000000005 109.428 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.418 ' CB ' HD11 ' A' ' 394' ' ' ILE . 16.0 m -89.08 121.47 31.44 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.449 -0.575 . . . . 71.439999999999998 109.449 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.2 t -120.83 104.82 10.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 119.144 -1.022 . . . . 71.5 111.005 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 64.19 172.23 2.61 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.907 0.723 . . . . 70.129999999999995 114.907 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 72.9 Cg_endo -97.18 155.09 1.06 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 122.73 2.287 . . . . 72.349999999999994 113.322 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.452 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 4.5 mm-40 -84.87 141.37 30.48 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.78 -0.645 . . . . 74.319999999999993 110.247 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -117.26 147.37 42.6 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.458 -0.942 . . . . 73.310000000000002 108.458 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.29 155.39 39.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.561 -1.274 . . . . 75.209999999999994 107.561 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -88.81 138.16 31.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.79 -0.448 . . . . 74.25 109.79 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.8 mp -83.09 129.14 62.34 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.385 -0.968 . . . . 75.25 108.385 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.55 140.51 89.83 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.362 2.041 . . . . 74.219999999999999 112.356 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.03 -5.73 56.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.558 0.694 . . . . 73.239999999999995 110.18 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.36 -7.57 10.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.986 -1.006 . . . . 61.439999999999998 110.936 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.424 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 20.7 m -56.48 -41.76 77.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.304 -0.862 . . . . 64.450000000000003 111.228 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -61.74 -23.13 65.95 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.23 1.012 . . . . 75.219999999999999 111.77 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.12 -35.79 15.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.512 . . . . 74.230000000000004 111.888 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.4 m -148.68 119.48 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.08 -0.387 . . . . 64.450000000000003 110.849 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -58.13 -51.17 70.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 111.77 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.98 -43.6 98.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 75.209999999999994 111.605 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.67 -35.28 80.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.666 -0.697 . . . . 73.430000000000007 110.166 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.03 -51.39 69.83 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 123.775 0.672 . . . . 65.510000000000005 109.627 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.0 t -58.89 -44.12 90.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 72.409999999999997 110.48 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 73.5 mmtt -66.21 -46.64 76.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 75.230000000000004 111.762 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.0 -37.95 87.23 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.876 0.324 . . . . 64.239999999999995 111.876 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 440' ' ' ALA . 10.4 mp -65.21 -40.48 94.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.932 0.145 . . . . 74.439999999999998 111.286 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.2 m -61.25 -47.06 87.8 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.33 -0.619 . . . . 73.030000000000001 109.33 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.12 -24.96 65.98 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.851 -0.613 . . . . 70.299999999999997 111.696 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.2 -8.86 59.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 65.209999999999994 111.354 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.28 48.7 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.639 -0.791 . . . . 72.230000000000004 113.187 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.25 99.34 6.23 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.266 -0.549 . . . . 75.310000000000002 109.687 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.43 23.1 27.45 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.238 -0.745 . . . . 74.340000000000003 111.238 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -118.58 111.72 18.95 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.671 -1.233 . . . . 72.140000000000001 107.671 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -131.31 144.1 51.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.012 0.91 . . . . 72.510000000000005 113.06 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 18.4 tptm -140.3 123.4 16.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.548 -1.66 . . . . 75.439999999999998 106.525 170.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -95.99 135.16 38.13 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.555 -0.535 . . . . 74.510000000000005 109.555 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.0 153.02 51.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.025 -0.732 . . . . 73.450000000000003 109.025 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -121.8 129.37 52.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.886 0.374 . . . . 74.010000000000005 110.481 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.2 t -117.2 142.46 30.14 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 107.869 -1.16 . . . . 72.209999999999994 107.869 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.98 126.96 19.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.266 1.977 . . . . 74.019999999999996 109.968 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.6 t -137.96 -178.21 5.16 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.749 -0.834 . . . . 71.219999999999999 108.749 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.422 ' HB ' HD13 ' A' ' 463' ' ' LEU . 21.0 m -63.94 138.02 97.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.41 -1.33 . . . . 75.340000000000003 107.41 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.81 -29.31 33.82 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.629 2.886 . . . . 71.420000000000002 113.965 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -76.23 -19.06 58.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.921 0.711 . . . . 75.540000000000006 112.921 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.422 HD13 ' HB ' ' A' ' 460' ' ' THR . 10.4 mp -95.17 4.62 53.4 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.808 0.299 . . . . 73.5 111.808 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -60.15 126.35 17.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-O 121.335 0.588 . . . . 73.109999999999999 110.54 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.11 -0.16 66.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.748 -0.66 . . . . 54.310000000000002 112.09 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.57 152.29 24.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.985 -1.117 . . . . 73.349999999999994 107.985 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 56.4 t -84.07 141.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.06 -0.718 . . . . 72.120000000000005 109.06 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.22 -14.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.127 -0.629 . . . . 70.030000000000001 111.456 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.08 168.28 20.91 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.733 -0.947 . . . . 73.439999999999998 110.733 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.0 p -116.95 159.3 22.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.427 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -63.52 -54.69 41.27 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 119.96 -0.696 . . . . 65.310000000000002 111.132 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 18.3 Cg_exo -72.87 112.98 3.64 Favored 'Trans proline' 0 C--N 1.373 1.834 0 N-CA-C 107.465 -1.783 . . . . 73.549999999999997 107.465 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 49.5 Cg_endo -65.65 149.03 87.62 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.917 2.412 . . . . 75.109999999999999 114.938 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.8 -0.88 28.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.299999999999997 110.03 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -104.41 7.33 35.52 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.439 -1.255 . . . . 75.430000000000007 110.252 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.465 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 34.9 tt0 -159.01 165.48 33.92 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.906 -0.717 . . . . 65.530000000000001 109.593 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.2 m -92.52 126.4 37.59 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.633 -0.877 . . . . 71.430000000000007 108.633 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.9 m -125.96 148.85 49.15 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.939 -0.393 . . . . 75.319999999999993 109.939 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.9 148.19 50.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.632 0.253 . . . . 75.519999999999996 111.636 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.4 mm -66.41 -12.58 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.442 0 C-N-CA 124.388 1.075 . . . . 73.310000000000002 110.818 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.3 t -87.91 5.0 42.64 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.868 0.842 . . . . 75.409999999999997 110.328 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -90.96 135.43 33.74 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.382 -0.599 . . . . 73.319999999999993 109.382 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.69 122.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.964 -1.495 . . . . 71.530000000000001 106.964 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.23 118.59 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 C-N-CA 119.618 -0.833 . . . . 72.329999999999998 108.882 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 63.8 mt -92.93 112.24 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 105.935 -1.876 . . . . 75.319999999999993 105.935 174.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.4 109.13 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 106.688 -1.597 . . . . 73.340000000000003 106.688 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.0 mt -97.2 116.9 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 115.513 -0.767 . . . . 71.040000000000006 109.867 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 t -97.52 141.04 16.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.961 -1.125 . . . . 74.319999999999993 107.961 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -91.31 127.11 8.72 Favored Glycine 0 N--CA 1.407 -3.276 0 N-CA-C 109.849 -1.3 . . . . 71.430000000000007 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.7 m -136.39 128.83 30.28 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.348 -0.612 . . . . 72.409999999999997 109.348 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.287 0 N-CA-C 108.569 -1.812 . . . . 64.409999999999997 108.569 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 CA--C 1.492 -1.272 0 N-CA-C 107.706 -1.22 . . . . 73.299999999999997 107.706 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.14 149.72 20.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.803 -0.443 . . . . 72.030000000000001 109.803 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.298 -1.371 . . . . 65.120000000000005 107.298 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.415 HG13 ' HB1' ' A' ' 406' ' ' ALA . 3.6 p -97.82 118.66 63.71 Favored Pre-proline 0 C--N 1.282 -2.351 0 N-CA-C 108.637 -0.875 . . . . 72.329999999999998 108.637 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.7 160.68 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.77 2.313 . . . . 75.319999999999993 113.823 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.505 ' OD2' ' HD3' ' A' ' 366' ' ' ARG . 14.6 p-10 -72.33 119.58 16.74 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.243 -0.89 . . . . 52.299999999999997 109.976 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.64 35.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 125.564 1.546 . . . . 73.420000000000002 110.728 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.505 ' HD3' ' OD2' ' A' ' 364' ' ' ASP . 15.0 ptt180 -63.87 144.55 56.98 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.622 -1.627 . . . . 75.400000000000006 112.859 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.56 0.74 59.2 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.724 -0.75 . . . . 64.400000000000006 114.685 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.49 171.69 12.73 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.375 1.088 . . . . 73.340000000000003 110.995 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -71.59 156.77 39.02 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.261 -0.427 . . . . 75.349999999999994 110.547 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.404 ' O ' HD12 ' A' ' 374' ' ' ILE . 8.4 p -59.78 -37.12 78.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.945 0.403 . . . . 72.400000000000006 110.574 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.0 91.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.993 -0.548 . . . . 72.420000000000002 111.335 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.67 -41.88 74.92 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.487 -0.485 . . . . 74.329999999999998 110.406 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.99 -51.32 69.7 Favored 'General case' 0 C--O 1.239 0.532 0 O-C-N 123.809 0.693 . . . . 72.409999999999997 111.94 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 370' ' ' SER . 1.7 mp -60.64 -46.07 96.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.281 -0.418 . . . . 73.200000000000003 110.951 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.36 87.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.035 0.383 . . . . 73.209999999999994 112.035 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 79.1 m -60.83 -45.56 93.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.742 0.306 . . . . 73.239999999999995 111.197 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.62 -38.13 89.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.363 -0.38 . . . . 72.400000000000006 110.688 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.13 -46.15 90.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.125 0.97 . . . . 74.519999999999996 110.485 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -70.36 -18.66 63.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.757 -0.656 . . . . 73.120000000000005 111.263 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -88.49 -8.26 55.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.972 -0.558 . . . . 74.239999999999995 111.13 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.2 56.15 Favored Glycine 0 CA--C 1.504 -0.655 0 C-N-CA 120.986 -0.626 . . . . 61.350000000000001 113.353 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -80.83 150.27 29.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.226 0.536 . . . . 71.310000000000002 110.41 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -100.06 144.74 28.74 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.066 -1.457 . . . . 74.340000000000003 107.066 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 139.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.498 -174.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -116.19 127.75 55.04 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 74.329999999999998 107.246 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.7 m -104.7 123.75 48.17 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.265 -0.574 . . . . 70.150000000000006 110.086 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.53 119.71 39.67 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.55 -0.907 . . . . 71.140000000000001 108.55 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.41 127.52 52.11 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.913 -0.585 . . . . 73.209999999999994 109.635 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -134.97 139.59 32.55 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 111.773 0.286 . . . . 65.129999999999995 111.773 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 60.3 Cg_endo -89.19 145.23 5.13 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.424 2.082 . . . . 74.319999999999993 110.215 170.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.9 t70 -171.09 -176.64 1.99 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.502 -0.925 . . . . 73.109999999999999 108.502 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 3.5 m -98.65 -39.61 8.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.743 -1.577 . . . . 74.549999999999997 106.743 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -101.86 73.47 1.41 Allowed 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.406 -1.331 . . . . 72.010000000000005 107.406 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.443 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 14.5 pt -93.83 127.45 45.47 Favored Pre-proline 0 N--CA 1.419 -1.978 0 CA-C-N 113.016 -1.902 . . . . 75.420000000000002 111.593 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -69.86 124.33 10.93 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 N-CA-C 106.105 -2.306 . . . . 75.420000000000002 106.105 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 398' ' ' HIS . 14.9 Cg_endo -56.23 159.98 11.69 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.049 2.499 . . . . 75.109999999999999 113.749 -173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.9 -8.81 3.4 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.375 1.07 . . . . 74.329999999999998 111.696 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 396' ' ' PRO . 16.1 m170 -103.82 106.86 17.49 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.073 -2.195 . . . . 72.319999999999993 105.073 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.0 m -62.63 119.72 7.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 O-C-N 124.585 1.178 . . . . 71.329999999999998 113.378 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.59 -28.22 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 113.865 -1.516 . . . . 63.420000000000002 109.89 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.47 170.4 32.88 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 110.598 -1.001 . . . . 54.520000000000003 110.598 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 5.9 m -120.02 -178.21 3.6 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.389 -2.078 . . . . 70.430000000000007 105.389 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -100.02 141.14 22.21 Favored Pre-proline 0 C--N 1.266 -3.024 0 N-CA-C 108.995 -0.742 . . . . 75.230000000000004 108.995 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -41.98 -26.32 0.47 Allowed 'Trans proline' 0 C--N 1.371 1.731 1 C-N-CA 125.555 4.17 . . . . 75.109999999999999 115.248 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.55 62.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.981 0.512 . . . . 74.409999999999997 110.683 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . 0.415 ' HB1' HG13 ' A' ' 362' ' ' VAL . . . -77.06 -44.47 30.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.678 -0.692 . . . . 71.319999999999993 110.856 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -7.62 54.54 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.69 -0.686 . . . . 72.230000000000004 111.936 -174.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.3 m -85.17 146.02 27.32 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.421 -0.955 . . . . 73.540000000000006 108.421 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.4 p -73.49 113.87 11.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 109.795 -0.446 . . . . 73.510000000000005 109.795 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 168.84 20.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.8 m -72.84 133.25 44.37 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.369 -0.974 . . . . 73.209999999999994 108.369 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -55.86 135.78 51.81 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 112.442 0.534 . . . . 75.5 112.442 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.86 47.04 4.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.082 -0.963 . . . . 74.420000000000002 111.094 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -108.68 178.88 4.35 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.981 -1.118 . . . . 75.409999999999997 107.981 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.79 122.13 40.53 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.801 0.44 . . . . 52.119999999999997 111.388 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -111.18 128.88 67.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.723 -0.843 . . . . 72.140000000000001 108.723 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -87.39 128.0 35.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.138 -0.69 . . . . 64.530000000000001 109.138 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.21 128.85 73.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.532 -0.914 . . . . 75.109999999999999 108.532 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -100.96 128.34 47.03 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.395 -0.366 . . . . 72.329999999999998 110.694 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.28 146.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.558 -1.275 . . . . 73.540000000000006 107.558 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.443 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 8.8 p -98.93 123.29 43.11 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.059 -0.657 . . . . 54.210000000000001 112.531 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -118.28 105.32 11.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.888 -0.596 . . . . 75.349999999999994 110.145 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 72.94 161.2 6.01 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 121.898 0.721 . . . . 24.239999999999998 114.497 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.0 Cg_endo -92.33 157.62 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.496 2.13 . . . . 75.010000000000005 110.871 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.8 131.63 42.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 120.092 -0.643 . . . . 61.149999999999999 110.219 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -121.08 138.96 53.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.681 -0.69 . . . . 74.510000000000005 109.611 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.429 ' HG2' ' HB2' ' A' ' 447' ' ' ALA . 0.1 OUTLIER -131.8 150.19 52.23 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 108.566 -0.902 . . . . 74.349999999999994 108.566 -175.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.98 131.65 34.23 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.064 -1.087 . . . . 72.230000000000004 108.064 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.08 125.23 82.11 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.372 -0.603 . . . . 72.140000000000001 109.372 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.37 141.25 73.86 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.255 1.97 . . . . 62.450000000000003 110.951 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.5 -5.26 59.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.466 0.651 . . . . 71.109999999999999 110.199 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.47 -1.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 74.420000000000002 111.165 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 7.2 p -65.6 -41.53 92.66 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.921 0.867 . . . . 75.230000000000004 109.708 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.4 m -65.84 -13.24 59.18 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 125.271 1.429 . . . . 71.319999999999993 111.213 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.18 -35.75 17.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.0 m -157.94 125.21 5.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.909 -0.494 . . . . 50.149999999999999 110.522 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -57.58 -48.79 78.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.437 0.532 . . . . 73.019999999999996 112.437 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.0 76.71 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.439 -0.346 . . . . 52.450000000000003 111.888 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.88 -34.7 71.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.962 -0.563 . . . . 73.430000000000007 111.176 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.01 86.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.477 -0.329 . . . . 75.200000000000003 110.459 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.28 -42.33 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.822 -0.627 . . . . 74.019999999999996 109.935 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -61.62 -47.59 84.75 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 111.922 0.342 . . . . 73.209999999999994 111.922 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.55 -45.54 92.46 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.55 0.34 . . . . 75.439999999999998 111.54 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.28 -40.79 81.7 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.469 -0.492 . . . . 74.329999999999998 112.175 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.2 m -63.82 -39.33 93.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.956 0.407 . . . . 74.209999999999994 110.402 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.65 -25.96 65.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 75.409999999999997 110.946 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 427' ' ' ARG . . . -86.88 -8.59 57.14 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.857 -0.61 . . . . 74.219999999999999 110.938 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.3 -15.98 13.01 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.558 -0.829 . . . . 72.439999999999998 114.08 176.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.36 113.15 3.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.995 0.898 . . . . 74.540000000000006 111.54 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.86 -12.57 11.17 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.823 -0.703 . . . . 72.109999999999999 111.422 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -91.06 111.19 22.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.1 -0.704 . . . . 75.230000000000004 109.1 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -136.07 154.49 51.01 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.54 0.685 . . . . 64.409999999999997 111.864 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -137.03 122.3 19.3 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 104.841 -2.281 . . . . 74.140000000000001 104.841 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -113.57 127.89 56.24 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.023 0.439 . . . . 74.239999999999995 110.625 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.06 165.29 27.96 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.701 -0.682 . . . . 73.150000000000006 110.034 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.96 141.15 47.12 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.771 -1.196 . . . . 74.319999999999993 107.771 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.6 t -116.93 129.57 25.22 Favored Pre-proline 0 N--CA 1.407 -2.607 0 N-CA-C 107.008 -1.479 . . . . 74.409999999999997 107.008 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.55 119.97 7.15 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 122.227 1.952 . . . . 73.340000000000003 109.791 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 2.9 p -148.24 -178.35 6.26 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 115.045 -0.98 . . . . 74.109999999999999 108.84 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.3 m -61.32 128.72 90.14 Favored Pre-proline 0 C--N 1.291 -1.941 0 N-CA-C 108.48 -0.933 . . . . 75.109999999999999 108.48 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.68 -22.94 10.29 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.646 2.898 . . . . 72.430000000000007 112.899 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.11 -30.17 69.09 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.34 0.656 . . . . 72.099999999999994 110.918 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.63 5.16 44.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.362 -0.381 . . . . 73.439999999999998 111.427 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.5 p -59.58 132.26 24.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 CA-C-O 121.15 0.5 . . . . 73.430000000000007 111.247 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.81 -10.79 73.82 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.689 -0.767 . . . . 70.010000000000005 112.748 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.67 147.01 30.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.38 -0.6 . . . . 74.439999999999998 109.38 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.86 135.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.125 -1.065 . . . . 75.019999999999996 108.125 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.97 -16.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.516 -0.874 . . . . 71.239999999999995 111.542 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.37 167.28 32.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.641 -0.79 . . . . 74.400000000000006 111.693 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.2 p -131.78 145.62 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.309 -0.996 . . . . 74.430000000000007 108.309 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -58.97 -53.8 62.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 120.337 -0.545 . . . . 75.530000000000001 110.532 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -70.84 118.39 5.67 Favored 'Trans proline' 0 C--N 1.376 2.011 0 N-CA-C 107.338 -1.831 . . . . 74.430000000000007 107.338 169.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.12 151.93 30.8 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.028 1.819 . . . . 75.150000000000006 113.685 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.74 -0.93 5.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.005 -0.998 . . . . 73.209999999999994 112.244 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -107.81 -3.02 19.43 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.497 -0.32 . . . . 75.140000000000001 110.69 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -118.19 157.0 27.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.442 0.639 . . . . 75.230000000000004 110.601 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 10.3 m -102.69 97.75 7.88 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 74.109999999999999 107.404 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 40.4 m -100.88 147.99 25.48 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.986 -0.552 . . . . 73.209999999999994 110.082 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.77 148.22 51.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.107 -0.497 . . . . 74.010000000000005 110.861 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.554 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 33.0 mm -69.81 -5.04 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 122.464 1.126 . . . . 74.340000000000003 109.996 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.4 p -87.49 0.9 54.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.598 0.714 . . . . 75.239999999999995 109.736 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 482' ' ' ASN . 0.8 OUTLIER -93.07 139.42 30.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.425 -0.807 . . . . 74.219999999999999 109.08 -179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.93 123.42 36.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.911 -1.144 . . . . 75.209999999999994 107.911 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.36 118.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 108.679 -0.86 . . . . 73.510000000000005 108.679 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.41 HD13 HD21 ' A' ' 471' ' ' ASN . 2.6 mp -92.4 113.65 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.204 -1.776 . . . . 73.200000000000003 106.204 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 114.64 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 N-CA-C 108.297 -1.001 . . . . 72.239999999999995 108.297 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -106.9 123.07 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.358 -0.837 . . . . 65.400000000000006 111.214 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.36 144.0 11.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.75 -1.114 . . . . 74.340000000000003 108.486 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.58 113.42 4.61 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 108.904 -1.678 . . . . 73.209999999999994 108.904 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.9 m -139.63 113.11 8.4 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 109.178 -0.675 . . . . 71.329999999999998 109.178 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.417 -2.633 0 N-CA-C 108.499 -1.84 . . . . 62.0 108.499 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 106.594 -1.632 . . . . 72.400000000000006 106.594 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.51 154.25 23.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 110.177 -0.305 . . . . 75.140000000000001 110.177 -175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -98.97 132.12 44.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.805 -1.183 . . . . 65.319999999999993 107.805 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.1 118.33 61.67 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.832 -0.747 . . . . 74.25 111.461 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.89 143.08 71.78 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.439 2.093 . . . . 71.540000000000006 112.189 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.614 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 4.0 p30 -82.68 177.9 8.46 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.225 -0.898 . . . . 73.209999999999994 111.239 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 17.1 m -138.67 29.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.478 -1.237 . . . . 74.420000000000002 108.537 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.614 ' HG3' ' OD1' ' A' ' 364' ' ' ASP 0.264 0.1 OUTLIER -64.15 146.74 53.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.438 0.903 . . . . 73.450000000000003 113.438 -174.049 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.2 0.2 41.04 Favored Glycine 0 C--N 1.308 -0.989 0 N-CA-C 110.368 -1.093 . . . . 71.200000000000003 110.368 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.52 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 46.7 mt-30 -116.44 -170.68 1.86 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.899 -0.778 . . . . 75.439999999999998 108.899 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.0 p -69.91 150.99 46.17 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.471 0.309 . . . . 74.230000000000004 111.132 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 374' ' ' ILE . 38.1 t -57.98 -36.15 72.19 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.443 -0.947 . . . . 65.209999999999994 108.443 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.3 94.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.308 -0.86 . . . . 75.010000000000005 112.237 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.88 -40.24 91.43 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.75 0.309 . . . . 75.310000000000002 110.199 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.18 88.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 72.319999999999993 110.637 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 370' ' ' SER . 76.5 mt -62.59 -46.39 96.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.68 -0.691 . . . . 74.140000000000001 110.202 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.34 79.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.997 -0.547 . . . . 73.0 112.087 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 85.5 m -60.73 -47.83 84.54 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.659 -0.246 . . . . 70.519999999999996 111.128 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.52 -38.04 89.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.71 0.263 . . . . 74.030000000000001 111.71 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -41.98 97.8 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 109.414 -0.587 . . . . 72.0 109.414 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -69.82 -22.93 63.26 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.473 -0.785 . . . . 74.140000000000001 112.107 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.2 mmt180 -84.96 -14.27 48.1 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.504 -0.554 . . . . 73.109999999999999 109.504 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.84 56.68 Favored Glycine 0 C--O 1.239 0.421 0 C-N-CA 120.895 -0.669 . . . . 53.520000000000003 112.201 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.33 149.26 25.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.966 -0.383 . . . . 74.530000000000001 109.966 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -100.18 132.35 45.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.782 -0.822 . . . . 75.319999999999993 108.782 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -121.88 137.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 113.232 0.827 . . . . 63.020000000000003 113.232 -174.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -110.56 127.87 55.4 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 107.309 -1.367 . . . . 71.219999999999999 107.309 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.0 m -99.33 121.82 41.62 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.136 -1.061 . . . . 70.219999999999999 108.136 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -111.49 119.5 38.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.251 -1.388 . . . . 73.150000000000006 107.251 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.46 128.69 55.34 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 109.431 -0.581 . . . . 72.329999999999998 109.431 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -133.04 146.25 60.42 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.904 -0.406 . . . . 74.400000000000006 109.904 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -93.08 128.87 0.74 Allowed 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.221 1.947 . . . . 74.450000000000003 109.81 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.0 t70 -173.14 -175.12 1.14 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.732 -1.21 . . . . 70.040000000000006 107.732 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.8 m -130.63 -0.68 4.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.753 0.787 . . . . 75.239999999999995 109.975 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -91.11 -0.63 57.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.881 1.324 . . . . 71.409999999999997 107.473 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.475 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.63 151.75 48.33 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.076 -1.42 . . . . 70.310000000000002 112.641 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.16 178.32 6.44 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.425 2.084 . . . . 73.450000000000003 109.698 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.96 158.13 18.24 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 121.923 1.749 . . . . 74.109999999999999 111.786 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.81 -7.21 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.842 0.829 . . . . 70.409999999999997 113.119 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -86.83 122.66 31.01 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.216 -2.513 . . . . 74.439999999999998 104.216 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 118.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.626 0.727 . . . . 75.209999999999994 111.811 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.8 mm -97.87 -28.37 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.533 -0.758 . . . . 72.519999999999996 111.004 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.94 157.99 27.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.039 -1.077 . . . . 62.240000000000002 111.794 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.8 p -114.16 -177.53 3.15 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 123.577 0.751 . . . . 75.109999999999999 111.123 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.06 143.73 27.04 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.109999999999999 107.705 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -40.25 -32.63 0.72 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 124.807 3.672 . . . . 74.099999999999994 114.715 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.09 -30.01 61.41 Favored 'General case' 0 C--O 1.208 -1.103 0 O-C-N 123.437 0.46 . . . . 72.420000000000002 111.608 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.72 -35.56 75.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.109 0.48 . . . . 73.040000000000006 111.021 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -95.66 -0.85 51.2 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.944 0.402 . . . . 72.530000000000001 111.939 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -98.29 155.94 16.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.322 -1.362 . . . . 71.150000000000006 107.322 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 11.3 p -74.31 112.7 10.73 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.723 -0.843 . . . . 73.329999999999998 108.723 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.51 169.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.439 -0.578 . . . . 74.209999999999994 109.439 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 20.3 m -69.65 146.9 51.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.298 -0.631 . . . . 64.519999999999996 109.298 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.81 108.17 2.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.821 -1.177 . . . . 73.299999999999997 107.821 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.61 59.68 1.26 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.444 -1.462 . . . . 74.340000000000003 109.444 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.3 t0 -109.94 -173.51 2.27 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.039 -1.097 . . . . 74.230000000000004 108.039 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -93.62 121.96 35.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.815 0.846 . . . . 74.230000000000004 110.079 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.8 mm -124.23 137.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.112 -1.44 . . . . 72.209999999999994 107.112 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.1 t -113.2 131.25 55.95 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 75.019999999999996 110.833 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 76.4 t -102.18 128.28 54.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.112 -0.949 . . . . 71.230000000000004 108.748 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -99.0 129.83 45.3 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.131 -0.486 . . . . 44.310000000000002 110.044 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 9.0 p -136.16 136.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.271 0.558 . . . . 73.230000000000004 109.705 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.475 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 8.2 m -89.59 123.75 33.94 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.942 -0.572 . . . . 73.209999999999994 110.982 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -119.18 105.83 11.76 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.193 -0.603 . . . . 72.340000000000003 110.015 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.08 129.32 0.5 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 120.649 -0.786 . . . . 71.430000000000007 114.792 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 17.0 Cg_exo -70.75 157.92 57.11 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.685 2.257 . . . . 75.430000000000007 110.582 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.01 155.52 19.78 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.361 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.7 mt-30 -127.84 138.78 52.82 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.827 -0.805 . . . . 72.25 108.827 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -135.52 157.68 46.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.093 -0.706 . . . . 74.209999999999994 109.093 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.64 139.35 32.86 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.653 -0.499 . . . . 75.530000000000001 109.653 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -80.47 127.34 76.21 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 108.66 -0.866 . . . . 74.450000000000003 108.66 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.53 141.57 62.3 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.842 2.361 . . . . 74.510000000000005 111.805 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.76 -15.5 48.28 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.511 0.672 . . . . 63.130000000000003 111.785 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.3 -10.55 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 121.399 0.619 . . . . 72.510000000000005 110.824 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.1 m -55.73 -45.4 77.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.583 0.753 . . . . 65.150000000000006 112.533 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 3.5 p -69.84 -15.67 63.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.345 0.593 . . . . 73.120000000000005 112.562 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.01 -37.99 13.92 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 111.003 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.9 m -146.98 122.22 10.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.062 0.458 . . . . 61.25 111.043 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -60.59 -42.27 96.38 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.789 0.835 . . . . 72.099999999999994 112.276 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.94 78.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.489 . . . . 73.420000000000002 110.822 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.75 -39.8 73.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.06 -0.518 . . . . 75.310000000000002 110.96 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.61 68.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.854 -0.612 . . . . 64.430000000000007 111.031 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.52 -43.83 90.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.785 0.661 . . . . 73.340000000000003 112.785 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.34 -48.53 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.801 -0.36 . . . . 73.439999999999998 111.774 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.84 -40.18 87.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 113.897 1.073 . . . . 74.549999999999997 113.897 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.39 -43.17 77.87 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.977 -0.689 . . . . 72.319999999999993 112.215 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.7 m -61.6 -43.98 97.85 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.024 0.44 . . . . 72.400000000000006 110.364 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.09 -25.1 62.47 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.795 -0.639 . . . . 72.430000000000007 111.765 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -12.69 59.77 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.172 0.51 . . . . 61.530000000000001 110.631 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.62 -19.01 8.58 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.337 -0.935 . . . . 71.340000000000003 112.791 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.2 103.82 1.67 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.68 11.59 18.48 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 111.029 -0.829 . . . . 75.340000000000003 111.029 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -108.87 111.05 22.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 106.68 -1.6 . . . . 73.010000000000005 106.68 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.98 155.82 49.68 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.268 0.556 . . . . 62.310000000000002 111.425 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 122.3 20.33 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 102.843 -3.021 . . . . 72.430000000000007 102.843 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -93.91 135.14 35.55 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.867 -0.42 . . . . 74.400000000000006 109.867 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 141.09 37.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.161 0.505 . . . . 72.510000000000005 110.741 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -118.96 129.36 55.12 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.058 -1.46 . . . . 75.230000000000004 107.058 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -125.36 145.35 50.62 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.448 -0.575 . . . . 75.030000000000001 109.448 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.422 ' HA ' ' HA2' ' A' ' 491' ' ' GLY . 13.4 Cg_exo -68.54 126.77 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.773 1.649 . . . . 63.039999999999999 110.378 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.6 m -135.71 172.92 12.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.984 -0.747 . . . . 75.150000000000006 108.984 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 25.6 m -62.81 140.09 97.26 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.402 -0.962 . . . . 74.519999999999996 108.402 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -49.32 -31.24 22.19 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.792 2.995 . . . . 75.140000000000001 113.782 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.69 -21.88 64.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.236 0.541 . . . . 71.329999999999998 111.434 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.72 -8.52 17.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.218 -0.446 . . . . 73.439999999999998 110.937 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 76.3 t -60.09 127.21 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 120.977 0.417 . . . . 61.049999999999997 110.641 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.54 59.08 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.881 -0.888 . . . . 71.329999999999998 110.881 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.22 162.42 13.21 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.663 -0.865 . . . . 74.420000000000002 108.663 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.83 128.59 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.773 -1.566 . . . . 75.329999999999998 106.773 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.42 -16.87 7.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.381 -0.928 . . . . 74.340000000000003 111.526 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.11 159.0 16.13 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 111.113 -0.795 . . . . 64.439999999999998 111.113 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.4 p -119.94 154.29 34.68 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.425 -1.694 . . . . 74.420000000000002 106.425 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -64.19 -49.94 70.72 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 119.43 -0.908 . . . . 74.340000000000003 110.349 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.4 Cg_exo -78.2 115.9 3.81 Favored 'Trans proline' 0 C--N 1.371 1.731 0 N-CA-C 108.051 -1.557 . . . . 72.25 108.051 168.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.54 149.93 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.077 1.852 . . . . 74.420000000000002 112.488 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.442 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.04 4.24 4.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.445 0.641 . . . . 63.25 112.596 -176.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -108.35 2.15 22.32 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 110.67 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -117.65 155.42 29.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.752 0.787 . . . . 75.129999999999995 111.556 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 426' ' ' GLN . 17.4 m -95.62 111.83 23.68 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.987 -1.486 . . . . 64.319999999999993 106.987 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.6 m -115.14 149.25 37.92 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.731 -0.47 . . . . 72.430000000000007 109.731 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -62.29 150.84 38.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.156 0.503 . . . . 74.040000000000006 111.226 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.26 -26.51 27.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.035 0.921 . . . . 74.329999999999998 109.353 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 m -89.87 5.14 47.57 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.967 -1.015 . . . . 72.150000000000006 110.117 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -83.62 135.3 34.66 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 107.609 -1.256 . . . . 64.310000000000002 107.609 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 58.8 t -79.01 114.5 19.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.249 -0.649 . . . . 75.140000000000001 109.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.77 119.52 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.082 -0.71 . . . . 74.340000000000003 109.082 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 3.0 mp -92.23 114.25 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.357 -1.72 . . . . 75.310000000000002 106.357 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.29 118.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.676 -1.231 . . . . 74.510000000000005 107.676 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.1 mt -110.32 117.33 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.587 0.708 . . . . 75.310000000000002 110.27 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.23 138.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.581 -0.736 . . . . 73.340000000000003 109.122 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.09 107.76 3.2 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.975 -0.85 . . . . 74.409999999999997 110.975 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.414 ' HA ' HG11 ' A' ' 464' ' ' VAL . 36.6 m -143.37 113.94 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.105 -0.702 . . . . 74.140000000000001 109.105 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 458' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.311 0 N-CA-C 110.183 -1.167 . . . . 74.109999999999999 110.183 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 105.486 -2.042 . . . . 73.010000000000005 105.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.86 164.2 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 120.88 0.372 . . . . 74.040000000000006 111.13 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -94.29 137.14 33.8 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.8 -1.926 . . . . 75.319999999999993 105.8 173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.57 139.72 21.55 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 108.294 -1.002 . . . . 75.329999999999998 108.294 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -37.99 135.79 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.8 3.0 . . . . 63.409999999999997 113.835 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.78 88.96 1.33 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.791 -1.188 . . . . 71.400000000000006 107.791 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.42 -0.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 116.888 2.181 . . . . 73.340000000000003 116.888 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 145.25 56.5 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.032 -0.667 . . . . 74.239999999999995 112.231 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 0.48 45.29 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.802 -0.919 . . . . 74.120000000000005 110.802 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -117.3 172.51 7.26 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.608 -1.627 . . . . 71.209999999999994 106.608 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 91.0 p -81.3 153.67 26.95 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 118.482 -1.287 . . . . 62.310000000000002 107.865 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.5 m -56.65 -40.47 75.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.535 0.207 . . . . 74.140000000000001 110.897 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.67 -36.99 79.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.015 0.436 . . . . 71.310000000000002 111.395 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -67.5 -36.69 81.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.537 0.684 . . . . 73.409999999999997 109.508 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.44 90.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.495 -0.775 . . . . 73.319999999999993 110.134 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 370' ' ' SER . 70.5 mt -57.72 -46.42 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.696 0.398 . . . . 74.310000000000002 110.134 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.69 91.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.932 -0.576 . . . . 75.299999999999997 110.684 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.7 m -64.73 -47.59 77.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.412 -0.358 . . . . 72.409999999999997 111.095 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.29 -38.79 91.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 111.655 0.243 . . . . 73.25 111.655 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.11 -48.88 79.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.254 -0.647 . . . . 75.430000000000007 109.254 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -72.07 -16.47 62.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.2 -0.909 . . . . 72.5 111.935 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.91 -15.07 49.37 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.034 -1.098 . . . . 70.430000000000007 108.034 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.4 5.6 61.78 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.59 -0.732 . . . . 33.350000000000001 111.786 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -91.83 158.95 16.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.198 0.523 . . . . 73.239999999999995 111.745 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 75.1 mmtt -95.62 146.31 24.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.052 -1.092 . . . . 73.439999999999998 108.052 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.1 OUTLIER -126.72 144.04 38.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 121.209 0.528 . . . . 74.209999999999994 111.56 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -110.46 139.92 45.22 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.019 -2.215 . . . . 75.219999999999999 105.019 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -112.68 121.0 43.47 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 119.174 -1.01 . . . . 70.450000000000003 110.015 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.64 119.27 38.11 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.572 -1.64 . . . . 73.530000000000001 106.572 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -107.04 122.37 46.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.927 -0.768 . . . . 75.349999999999994 108.927 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.443 ' HE3' ' OD1' ' A' ' 419' ' ' ASN . 17.6 ptpt -121.15 116.97 30.87 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 113.12 0.785 . . . . 74.439999999999998 113.12 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.53 140.24 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.445 2.097 . . . . 74.230000000000004 109.205 168.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 175.18 -166.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.136 -2.542 . . . . 55.009999999999998 104.136 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.415 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 15.1 m -132.67 -4.03 3.28 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 118.907 0.776 . . . . 73.299999999999997 109.982 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.1 m -106.49 38.03 2.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.204 -2.147 . . . . 71.439999999999998 105.204 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 391' ' ' ASP . 16.3 pt -87.1 151.16 51.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 113.176 -1.829 . . . . 74.129999999999995 113.078 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.07 137.33 34.31 Favored 'Trans proline' 0 N--CA 1.429 -2.306 0 N-CA-C 105.974 -2.356 . . . . 74.040000000000006 105.974 165.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 398' ' ' HIS . 49.9 Cg_exo -56.66 160.69 11.27 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.332 2.021 . . . . 73.209999999999994 111.787 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.67 -8.52 2.06 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.947 0.879 . . . . 75.120000000000005 111.722 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.0 m170 -103.45 111.05 23.31 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.778 -2.675 . . . . 74.430000000000007 103.778 171.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.52 119.34 6.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.962 0.887 . . . . 74.540000000000006 112.426 -166.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.4 -27.84 4.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.958 0 CA-C-N 114.528 -1.215 . . . . 75.239999999999995 112.14 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.48 27.31 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.65 -0.98 . . . . 72.049999999999997 110.65 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.5 p -114.69 -178.0 3.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.639 0.733 . . . . 65.319999999999993 112.375 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -104.18 136.48 19.18 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 107.437 -1.32 . . . . 73.530000000000001 107.437 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -48.91 -25.37 8.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.155 3.236 . . . . 73.310000000000002 115.327 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.96 -36.04 69.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.471 0.309 . . . . 75.209999999999994 110.976 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.94 83.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 74.109999999999999 110.769 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.45 -11.4 58.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.296 -0.865 . . . . 74.109999999999999 110.953 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.1 m -93.62 155.25 17.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.143 -1.058 . . . . 74.340000000000003 108.143 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 9.7 p -74.5 114.51 12.98 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 121.543 0.687 . . . . 74.019999999999996 110.154 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.1 m -123.87 169.23 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.333 -0.849 . . . . 72.420000000000002 109.574 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 65.6 m -62.41 149.34 42.79 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.978 0.418 . . . . 74.400000000000006 111.499 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.68 112.04 3.98 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.156 -1.053 . . . . 71.209999999999994 108.156 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.45 25.54 13.65 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.346 -0.931 . . . . 35.420000000000002 112.091 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.73 -173.88 4.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.0 pt-20 -108.72 132.87 53.52 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.472 0.653 . . . . 72.140000000000001 112.435 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 47.7 mm -119.86 131.48 72.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.221 -1.029 . . . . 74.400000000000006 108.221 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.3 t -89.45 131.35 35.55 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.379 0.609 . . . . 71.120000000000005 109.999 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.15 134.67 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 109.268 -0.641 . . . . 74.129999999999995 109.268 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.443 ' OD1' ' HE3' ' A' ' 389' ' ' LYS . 41.6 m-80 -103.6 129.8 50.93 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 111.655 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.8 p -134.29 142.09 41.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.13 -1.063 . . . . 75.430000000000007 108.13 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 12.9 p -101.72 123.12 45.18 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.338 -0.545 . . . . 63.420000000000002 111.761 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -120.14 107.01 12.51 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.423 -0.511 . . . . 73.430000000000007 111.546 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.89 142.61 6.59 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.714 -0.755 . . . . 72.120000000000005 114.342 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.5 Cg_endo -87.92 133.47 3.0 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.295 1.997 . . . . 75.299999999999997 111.625 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.474 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 8.7 mm-40 -72.83 134.05 44.72 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 122.211 -0.305 . . . . 72.109999999999999 110.537 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -123.27 134.01 54.12 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.776 -0.824 . . . . 75.319999999999993 108.776 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -131.99 150.94 52.02 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.893 -1.151 . . . . 74.120000000000005 107.893 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -82.33 138.95 34.38 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.403 -0.962 . . . . 75.120000000000005 108.403 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.9 mt -82.35 117.24 67.73 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.7 -0.852 . . . . 73.120000000000005 108.7 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.55 140.24 39.26 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.303 1.335 . . . . 73.319999999999993 110.884 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.46 84.37 5.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.333 1.063 . . . . 64.420000000000002 112.282 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.65 -5.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 113.645 -1.616 . . . . 74.530000000000001 106.726 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.449 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 7.7 m -62.74 -43.14 99.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.727 -1.579 . . . . 71.25 111.498 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.3 m -58.55 -21.31 52.19 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 122.957 0.503 . . . . 74.319999999999993 111.733 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.68 -48.08 64.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 122.289 -0.257 . . . . 74.299999999999997 110.59 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.1 t 178.45 161.85 0.66 Allowed 'General case' 0 C--O 1.249 1.054 0 N-CA-C 108.748 -0.834 . . . . 71.409999999999997 108.748 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -57.75 -42.65 84.39 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.987 0.915 . . . . 75.200000000000003 111.998 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.25 81.41 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.885 0.328 . . . . 63.109999999999999 111.885 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.78 -38.88 92.76 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.246 -0.434 . . . . 63.409999999999997 110.645 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -51.09 71.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.301 -0.863 . . . . 73.299999999999997 110.238 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.27 -43.12 98.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.536 -0.756 . . . . 74.040000000000006 111.364 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.491 ' HZ1' ' HB3' ' A' ' 442' ' ' LYS . 9.2 mtpm? -63.25 -49.37 74.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.247 0.462 . . . . 75.230000000000004 112.247 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -68.03 -41.3 82.35 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 113.099 0.777 . . . . 73.430000000000007 113.099 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 -41.04 90.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.678 -0.409 . . . . 71.049999999999997 112.044 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -66.39 -38.8 88.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.932 -0.396 . . . . 74.150000000000006 109.932 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.26 73.79 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.253 -0.43 . . . . 74.519999999999996 110.879 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.92 58.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.368 -0.378 . . . . 72.219999999999999 110.892 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.31 -20.34 9.67 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.865 -0.683 . . . . 70.099999999999994 113.97 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 105.68 1.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.37 . . . . 74.099999999999994 110.315 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.53 22.22 15.5 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 120.563 -0.827 . . . . 71.040000000000006 111.13 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.55 111.07 18.13 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.163 -1.051 . . . . 75.530000000000001 108.163 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.4 147.1 52.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.281 0.562 . . . . 75.420000000000002 111.26 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 8.1 tmtm? -138.67 123.45 18.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.768 -1.938 . . . . 72.450000000000003 105.768 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -98.53 135.47 40.02 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.612 -0.435 . . . . 62.130000000000003 111.072 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.01 148.48 50.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.506 -1.294 . . . . 75.519999999999996 107.506 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.25 130.34 46.12 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.788 -0.819 . . . . 73.420000000000002 108.788 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.9 p -130.93 143.93 51.42 Favored Pre-proline 0 C--N 1.291 -1.964 0 C-N-CA 120.463 -0.495 . . . . 64.400000000000006 110.888 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_exo -63.71 122.87 11.12 Favored 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.622 2.215 . . . . 73.239999999999995 110.281 175.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.8 m -130.06 162.63 28.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.495 -0.321 . . . . 73.420000000000002 111.203 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.4 m -60.26 142.65 89.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.638 1.175 . . . . 75.400000000000006 108.782 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 464' ' ' VAL . 90.9 Cg_exo -49.25 -24.06 7.72 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.108 3.205 . . . . 75.349999999999994 114.498 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.19 -19.21 64.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 111.886 0.328 . . . . 75.420000000000002 111.886 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.33 -11.45 12.55 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.841 0.682 . . . . 75.310000000000002 112.841 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 461' ' ' PRO . 22.4 m -59.93 134.71 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 112.672 0.619 . . . . 72.239999999999995 112.672 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.12 74.44 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.348 -0.842 . . . . 74.219999999999999 111.189 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -119.9 165.19 14.95 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-O 121.252 0.549 . . . . 74.120000000000005 109.646 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 92.6 t -84.02 134.96 25.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.767 -1.198 . . . . 74.340000000000003 107.767 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.71 -12.0 8.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 119.863 -0.735 . . . . 75.230000000000004 110.952 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.25 169.96 20.3 Favored Glycine 0 N--CA 1.414 -2.805 0 CA-C-N 115.346 -0.843 . . . . 71.430000000000007 111.263 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -116.62 150.63 37.77 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.136 -1.061 . . . . 75.25 108.136 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.427 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.3 t30 -64.12 -47.4 79.37 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.537 -0.465 . . . . 52.25 109.924 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 10.4 Cg_exo -76.23 117.29 4.59 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 107.6 -1.731 . . . . 74.400000000000006 107.6 167.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.74 144.18 88.43 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.082 1.855 . . . . 70.420000000000002 113.037 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.41 12.94 3.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.166 0.984 . . . . 71.230000000000004 110.394 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -109.18 1.58 20.4 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.967 -1.015 . . . . 62.299999999999997 108.619 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -125.17 159.39 31.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.174 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.4 m -93.6 115.77 28.26 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.358 -1.292 . . . . 74.25 108.822 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.1 m -116.02 148.54 40.05 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.965 -0.383 . . . . 72.510000000000005 109.965 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.51 152.24 46.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.449 0.3 . . . . 73.420000000000002 111.203 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.83 -26.21 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 121.315 0.578 . . . . 73.030000000000001 111.961 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 13.0 t -96.28 5.03 51.86 Favored 'General case' 0 C--O 1.241 0.658 0 O-C-N 122.01 -0.431 . . . . 75.340000000000003 110.467 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -74.2 129.73 38.39 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.996 -1.113 . . . . 71.140000000000001 107.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 113.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.765 -0.828 . . . . 73.109999999999999 108.765 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.33 120.02 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.567 -0.742 . . . . 72.329999999999998 109.855 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 66.8 mt -91.54 112.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.895 -1.52 . . . . 64.420000000000002 106.895 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 120.4 53.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 107.937 -1.134 . . . . 75.120000000000005 107.937 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 24.0 mt -105.2 118.82 53.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.088 0.47 . . . . 75.310000000000002 110.111 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.08 134.92 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 115.79 -0.641 . . . . 73.430000000000007 109.339 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.64 106.23 3.09 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.516 -1.034 . . . . 64.540000000000006 110.516 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -122.07 119.11 30.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.925 -0.769 . . . . 72.450000000000003 108.925 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 CA-C-O 118.009 -1.44 . . . . 75.25 109.764 -177.282 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.431 -1.399 0 N-CA-C 108.203 -1.036 . . . . 64.439999999999998 108.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.2 154.75 37.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 120.985 0.421 . . . . 75.219999999999999 110.875 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.25 139.03 32.15 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.857 -2.275 . . . . 74.230000000000004 104.857 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.2 130.86 32.82 Favored Pre-proline 0 C--N 1.283 -2.325 0 C-N-CA 119.072 -1.051 . . . . 62.420000000000002 109.367 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -41.03 125.65 2.36 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.847 3.031 . . . . 73.349999999999994 112.069 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.86 157.16 38.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.26 -1.336 . . . . 74.409999999999997 109.471 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.82 -0.24 9.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.612 -0.435 . . . . 75.120000000000005 110.973 -173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.4 ptp180 -54.91 131.05 43.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.547 0.689 . . . . 75.420000000000002 112.612 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 101.74 -1.29 52.39 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.359 -0.837 . . . . 65.319999999999993 111.146 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -118.42 -178.06 3.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.502 -0.555 . . . . 73.140000000000001 109.502 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 82.9 p -87.87 171.23 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.619 0.6 . . . . 61.520000000000003 112.619 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 8.7 p -63.89 -39.09 93.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.03 -0.532 . . . . 74.349999999999994 109.989 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.38 87.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.593 -0.73 . . . . 74.420000000000002 110.033 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.83 -44.07 90.83 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 123.209 0.318 . . . . 53.149999999999999 111.533 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.98 -51.18 67.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.866 0.365 . . . . 73.040000000000006 111.099 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 378' ' ' GLN . 1.8 mp -68.32 -46.28 81.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 111.71 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.42 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.622 0.601 . . . . 61.450000000000003 112.622 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.531 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 22.9 m -66.94 -48.29 69.05 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.629 -0.429 . . . . 74.420000000000002 110.44 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.98 -37.47 87.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.091 -0.504 . . . . 73.329999999999998 112.209 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . 0.496 ' NE2' HD12 ' A' ' 384' ' ' ILE . 5.7 tp-100 -59.21 -47.65 84.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.446 -0.946 . . . . 74.409999999999997 108.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.01 -28.13 67.15 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.161 -0.927 . . . . 74.230000000000004 112.486 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 376' ' ' THR . 10.6 mpt_? -84.47 -8.81 58.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 111.051 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 88.81 16.78 57.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.212 -0.994 . . . . 73.129999999999995 113.232 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -80.2 156.12 27.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.108 0.48 . . . . 75.519999999999996 110.323 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 31.5 mmmt -90.32 132.9 35.31 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.614 -1.625 . . . . 74.019999999999996 106.614 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.496 HD12 ' NE2' ' A' ' 378' ' ' GLN . 0.2 OUTLIER -129.53 134.73 63.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 121.541 0.686 . . . . 73.400000000000006 112.086 -177.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -112.35 127.9 56.14 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.3 m -117.67 121.16 40.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.328 -0.619 . . . . 73.230000000000004 109.328 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.21 119.25 37.71 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.399 -1.704 . . . . 74.140000000000001 106.399 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -101.54 131.22 47.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.621 -0.881 . . . . 74.230000000000004 108.621 179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.9 122.06 15.11 Favored Pre-proline 0 C--N 1.287 -2.132 0 CA-C-N 116.277 -0.419 . . . . 62.43 111.775 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 425' ' ' GLU . 6.0 Cg_exo -81.41 132.4 7.99 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.959 1.772 . . . . 74.409999999999997 107.78 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 15.1 t70 -159.46 -162.26 1.02 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.548 -1.278 . . . . 64.409999999999997 107.548 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 67.3 m -145.14 1.58 0.97 Allowed 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 119.392 0.996 . . . . 64.109999999999999 112.789 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -131.12 22.12 4.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 122.609 1.195 . . . . 75.430000000000007 108.206 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.468 ' CG1' ' HB3' ' A' ' 391' ' ' ASP . 1.9 pp -88.91 152.47 48.59 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 113.625 -1.625 . . . . 62.109999999999999 112.996 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.51 157.18 53.27 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.791 1.661 . . . . 73.549999999999997 109.236 170.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.11 160.54 41.34 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 122.294 1.996 . . . . 72.340000000000003 111.104 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.425 ' HB2' HG11 ' A' ' 420' ' ' VAL . 3.6 p30 -60.4 -9.69 3.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.517 0.675 . . . . 75.140000000000001 111.943 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -84.53 111.06 19.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.456 -2.424 . . . . 62.310000000000002 104.456 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.18 118.52 4.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 122.07 0.938 . . . . 75.0 112.704 -167.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.3 tp -98.1 -31.1 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 75.540000000000006 109.386 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.98 156.77 27.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 108.894 -1.682 . . . . 70.430000000000007 108.894 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 22.2 p -114.5 -175.72 2.75 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 123.307 0.643 . . . . 74.420000000000002 111.306 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -99.58 137.84 20.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 106.464 -1.68 . . . . 74.209999999999994 106.464 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -42.97 -30.75 1.98 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.418 3.412 . . . . 60.219999999999999 114.64 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -38.3 64.62 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.931 0.492 . . . . 75.010000000000005 111.432 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.99 -27.87 62.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.729 0.776 . . . . 74.5 111.153 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.23 -8.06 49.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 110.665 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.6 m -92.54 156.53 17.07 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.947 -0.761 . . . . 73.340000000000003 108.947 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.1 m -74.15 112.79 10.64 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.606 -1.257 . . . . 74.329999999999998 107.606 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.28 170.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.932 -0.576 . . . . 73.120000000000005 109.749 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -83.96 140.07 32.15 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.404 -1.332 . . . . 61.43 107.404 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.1 2.14 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.135 0.493 . . . . 75.030000000000001 110.184 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.29 21.38 6.61 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.596 -0.812 . . . . 63.25 111.751 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -85.94 -171.33 3.53 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.474 -1.306 . . . . 70.340000000000003 107.474 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.9 pt-20 -107.91 138.87 43.4 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 118.831 0.741 . . . . 72.439999999999998 111.895 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.6 122.68 67.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.743 -1.206 . . . . 65.519999999999996 107.743 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -96.19 119.39 34.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.039 0.923 . . . . 73.530000000000001 110.249 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.72 126.66 68.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.053 -0.976 . . . . 71.420000000000002 109.33 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.7 128.87 44.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.437 -0.949 . . . . 74.209999999999994 108.437 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 78.0 t -121.73 130.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.382 -0.969 . . . . 73.030000000000001 108.382 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 122.91 37.99 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.776 -0.453 . . . . 75.129999999999995 109.776 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.5 t -117.16 105.28 12.08 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.84 0.829 . . . . 73.319999999999993 110.981 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 60.99 178.69 2.39 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.983 -1.008 . . . . 74.239999999999995 115.136 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 10.1 Cg_endo -90.82 131.93 1.58 Allowed 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.038 2.492 . . . . 73.230000000000004 111.757 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.4 tp10 -72.87 151.59 41.89 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.754 -0.462 . . . . 74.120000000000005 109.754 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.5 mt-30 -123.78 150.88 43.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.477 -0.783 . . . . 72.420000000000002 110.359 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -150.33 153.95 36.98 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.403 -1.332 . . . . 74.230000000000004 107.403 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 9.5 pt-20 -82.55 138.88 34.13 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.348 -0.982 . . . . 74.439999999999998 108.348 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 71.4 mt -80.43 124.32 82.37 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.608 -0.886 . . . . 74.439999999999998 108.608 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.86 140.06 59.55 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.069 1.179 . . . . 72.349999999999994 110.697 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.72 82.12 2.76 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 122.232 1.015 . . . . 65.319999999999993 111.94 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.86 1.43 6.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.197 -1.779 . . . . 75.150000000000006 106.197 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.457 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 5.0 m -67.8 -53.49 26.61 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 113.094 -1.866 . . . . 73.420000000000002 110.301 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 24.5 p -64.73 -19.12 65.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.431 0.9 . . . . 73.319999999999993 113.431 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.95 -38.21 13.01 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.711 1.004 . . . . 64.109999999999999 113.711 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 90.4 m -157.32 135.08 10.75 Favored 'General case' 0 CA--C 1.554 1.11 0 O-C-N 121.911 -0.493 . . . . 72.439999999999998 110.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -65.09 -47.28 77.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.543 0.737 . . . . 75.450000000000003 112.671 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.51 87.47 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.515 0.674 . . . . 74.219999999999999 110.865 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.54 -40.6 95.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.75 -1.114 . . . . 63.32 108.813 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.83 -51.67 68.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.784 -1.098 . . . . 73.120000000000005 111.705 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.72 -38.55 82.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.515 0.931 . . . . 75.430000000000007 113.515 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -66.53 -50.71 62.29 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 119.113 -1.035 . . . . 72.209999999999994 110.144 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.313 85.4 mttt -68.62 -39.73 80.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 115.58 1.696 . . . . 72.230000000000004 115.58 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.64 -43.38 89.65 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.745 -0.382 . . . . 74.510000000000005 111.795 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.1 m -69.24 -38.28 78.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.824 -0.35 . . . . 71.329999999999998 111.853 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.1 71.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.698 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.08 59.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 72.439999999999998 111.034 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . 0.424 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 124.39 -19.98 7.07 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.688 -0.767 . . . . 64.230000000000004 113.442 176.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -78.86 101.26 7.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.364 0.602 . . . . 74.120000000000005 111.0 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -119.99 17.47 9.96 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.013 -0.835 . . . . 73.430000000000007 111.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -107.57 111.16 23.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.791 -1.559 . . . . 74.510000000000005 106.791 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.39 160.25 34.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.145 0.794 . . . . 75.519999999999996 113.145 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 23.6 ttmm -151.91 127.39 10.02 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.715 -1.957 . . . . 73.329999999999998 105.715 170.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.72 134.92 39.38 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 120.67 0.271 . . . . 74.340000000000003 110.304 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.02 156.28 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.717 -0.475 . . . . 65.200000000000003 109.717 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.16 132.35 54.03 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.253 -0.647 . . . . 70.109999999999999 109.253 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.0 t -119.25 137.12 24.93 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.749 -0.834 . . . . 71.230000000000004 108.749 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.4 Cg_exo -61.56 119.78 7.08 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.061 1.841 . . . . 75.510000000000005 109.102 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.8 m -138.74 -178.46 5.32 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.066 -0.716 . . . . 71.150000000000006 109.066 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.8 m -58.95 131.44 86.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.361 -0.977 . . . . 75.150000000000006 108.361 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.9 -34.1 35.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.832 3.021 . . . . 73.310000000000002 114.538 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.71 -14.71 61.19 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 122.687 0.395 . . . . 72.319999999999993 112.006 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.39 7.58 45.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.769 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -59.49 125.93 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.781 0.8 . . . . 70.420000000000002 111.645 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.65 -5.01 79.86 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.882 -0.599 . . . . 70.409999999999997 112.427 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -102.77 145.59 29.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.093 -1.077 . . . . 74.340000000000003 108.093 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 433' ' ' SER . 54.4 t -83.89 129.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.721 -0.474 . . . . 75.010000000000005 109.721 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.94 -19.68 5.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.582 -0.447 . . . . 74.299999999999997 111.449 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.6 174.23 41.16 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.634 -0.986 . . . . 62.539999999999999 110.634 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -130.93 155.07 47.39 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.696 -0.853 . . . . 72.140000000000001 108.696 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -61.2 -53.43 63.22 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 120.795 -0.362 . . . . 65.040000000000006 110.854 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.1 Cg_exo -82.6 119.34 2.97 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 107.38 -1.815 . . . . 74.530000000000001 107.38 168.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.94 147.77 94.22 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.532 2.154 . . . . 72.519999999999996 113.848 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.65 2.92 20.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.473 -0.785 . . . . 74.329999999999998 112.524 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.7 -3.09 17.02 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.813 -0.554 . . . . 74.209999999999994 109.614 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -108.46 151.73 25.66 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.191 0.996 . . . . 73.310000000000002 112.201 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.431 HG22 ' HB3' ' A' ' 426' ' ' GLN . 26.6 m -84.24 114.01 21.52 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.625 -1.625 . . . . 71.129999999999995 108.668 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.2 m -120.42 150.13 41.28 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.506 0.722 . . . . 74.329999999999998 109.424 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.07 147.22 45.2 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.4 -0.592 . . . . 73.099999999999994 109.4 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.424 HG21 ' O ' ' A' ' 448' ' ' GLY . 1.9 mp -66.27 -11.68 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 122.246 1.022 . . . . 71.430000000000007 110.317 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 6.4 t -98.45 -0.66 43.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.279 -0.873 . . . . 73.150000000000006 109.379 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -78.61 142.19 37.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.63 -0.507 . . . . 72.140000000000001 109.63 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.05 113.52 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.263 -1.014 . . . . 73.040000000000006 108.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.0 t -87.81 118.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 108.606 -0.887 . . . . 72.510000000000005 108.606 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.4 mt -92.7 112.54 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 106.791 -1.559 . . . . 73.140000000000001 106.791 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.61 107.62 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 107.374 -1.343 . . . . 74.430000000000007 107.374 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.4 113.99 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 115.11 -0.95 . . . . 73.420000000000002 110.123 -174.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.32 138.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 114.959 -1.018 . . . . 65.120000000000005 108.335 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.09 130.64 11.06 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 110.254 -1.139 . . . . 71.340000000000003 110.254 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 26.6 m -140.78 120.07 13.0 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.293 -0.632 . . . . 74.430000000000007 109.293 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 107.807 -2.117 . . . . 72.219999999999999 107.807 178.68 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 106.515 -1.661 . . . . 73.519999999999996 106.515 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.64 159.73 37.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 120.794 0.33 . . . . 74.329999999999998 111.132 -174.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -94.88 137.35 34.07 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.053 -1.091 . . . . 72.540000000000006 108.053 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.35 141.3 22.82 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.277 -0.638 . . . . 74.409999999999997 109.277 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.59 123.83 4.96 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 123.456 2.771 . . . . 73.140000000000001 113.699 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.526 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 21.5 t70 -74.59 134.84 42.08 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.218 -1.355 . . . . 70.510000000000005 108.838 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 35.0 m -91.41 29.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.732 1.012 . . . . 74.140000000000001 113.732 -169.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.526 ' NH1' ' HB3' ' A' ' 364' ' ' ASP . 35.2 ptt-85 -65.73 127.05 30.38 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.916 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.58 57.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.276 -0.964 . . . . 70.519999999999996 114.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 2.0 pt20 -120.97 169.66 10.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 117.491 0.646 . . . . 75.299999999999997 110.724 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 98.8 p -80.46 173.96 12.08 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.713 -0.395 . . . . 54.439999999999998 111.475 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.4 p -63.0 -33.87 76.35 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.275 -0.42 . . . . 61.030000000000001 110.617 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.547 -0.297 . . . . 54.119999999999997 110.505 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -62.03 -41.65 98.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.382 -0.372 . . . . 64.329999999999998 110.832 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -58.62 -51.54 69.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 71.109999999999999 110.602 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.43 -42.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 110.898 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.05 -46.06 92.22 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 112.036 0.384 . . . . 74.420000000000002 112.036 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.7 m -61.92 -47.92 82.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.297 . . . . 74.420000000000002 110.916 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.3 mm? -65.42 -38.38 89.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.379 -0.373 . . . . 73.030000000000001 111.66 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.88 -48.49 81.56 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.57 0.748 . . . . 73.209999999999994 109.442 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.43 -25.31 63.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 74.530000000000001 111.203 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -78.53 -15.29 58.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.97 -0.752 . . . . 75.409999999999997 108.97 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.17 56.88 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.357 -0.925 . . . . 73.319999999999993 111.829 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 22.6 m-85 -89.7 160.66 16.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.979 0.419 . . . . 75.239999999999995 110.613 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 53.8 mtmt -105.02 132.76 50.85 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.678 -1.23 . . . . 73.140000000000001 107.678 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 141.33 43.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.328 0.585 . . . . 72.150000000000006 112.373 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -118.49 136.64 53.7 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.046 -1.464 . . . . 74.109999999999999 107.046 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 m -99.64 125.33 45.46 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.752 -0.833 . . . . 71.310000000000002 108.752 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.82 120.33 41.61 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.584 -1.265 . . . . 73.319999999999993 107.584 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.13 121.88 31.89 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.288 -0.414 . . . . 65.439999999999998 109.911 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -123.77 125.23 25.98 Favored Pre-proline 0 C--N 1.312 -1.028 0 C-N-CA 119.564 -0.854 . . . . 73.430000000000007 110.208 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -89.11 147.11 5.46 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.735 2.29 . . . . 73.510000000000005 111.306 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.4 t70 177.13 -168.37 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.233 -1.766 . . . . 63.25 106.233 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 50.2 m -143.25 -1.29 1.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.585 0.63 . . . . 74.040000000000006 111.429 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.0 m -82.93 -10.65 58.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.099 -1.445 . . . . 74.340000000000003 107.099 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 421' ' ' SER . 11.2 pt -104.74 151.61 39.35 Favored Pre-proline 0 N--CA 1.427 -1.624 0 CA-C-N 114.042 -1.435 . . . . 73.030000000000001 109.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -86.25 -176.51 2.12 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.708 2.272 . . . . 72.25 111.521 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.65 163.32 3.95 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.515 2.81 . . . . 74.340000000000003 112.737 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.415 ' HB2' ' CG2' ' A' ' 420' ' ' VAL . 4.4 p-10 -55.87 -7.93 0.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.374 1.47 . . . . 70.400000000000006 114.33 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -63.51 115.4 4.63 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.087 -1.819 . . . . 74.430000000000007 106.087 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.88 118.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.778 0.799 . . . . 61.420000000000002 110.499 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.69 -29.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.041 -0.981 . . . . 74.439999999999998 109.91 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -171.57 160.58 32.6 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.43 -1.068 . . . . 51.310000000000002 110.43 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 -174.54 2.48 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.695 -1.224 . . . . 74.209999999999994 107.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.36 144.3 27.85 Favored Pre-proline 0 C--N 1.279 -2.474 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.98 -29.05 1.41 Allowed 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 124.676 3.584 . . . . 61.509999999999998 114.413 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.09 68.58 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.543 0.337 . . . . 63.039999999999999 111.162 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.66 58.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 65.109999999999999 110.96 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.29 0.14 53.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.472 0.654 . . . . 75.140000000000001 110.943 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.1 m -92.79 157.3 16.49 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.66 -1.608 . . . . 61.329999999999998 106.66 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.26 112.39 10.37 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.054 -1.091 . . . . 72.099999999999994 108.054 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.51 169.4 18.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.202 -0.908 . . . . 71.530000000000001 109.334 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 18.0 m -74.33 133.79 42.54 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.661 -0.496 . . . . 75.120000000000005 109.661 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.69 134.89 54.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.309 -0.405 . . . . 71.030000000000001 110.405 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.29 24.22 32.11 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.879 -0.677 . . . . 63.43 112.499 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.56 179.76 4.74 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.867 -0.79 . . . . 65.25 108.867 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.4 mt-10 -94.21 123.7 37.77 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 111.996 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.07 126.27 74.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.643 -1.244 . . . . 74.200000000000003 107.643 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -90.49 118.77 30.22 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.477 -0.934 . . . . 71.239999999999995 108.477 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.53 113.18 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.189 -1.041 . . . . 75.010000000000005 108.189 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -88.51 129.85 35.36 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.49 -0.929 . . . . 74.349999999999994 108.49 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 397' ' ' ASP . 12.4 p -123.5 146.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.163 -1.051 . . . . 74.420000000000002 108.163 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 394' ' ' ILE . 3.5 p -84.59 119.71 25.52 Favored 'General case' 0 N--CA 1.411 -2.418 0 C-N-CA 119.372 -0.931 . . . . 71.099999999999994 108.79 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.8 m -121.8 106.69 11.52 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.968 -0.56 . . . . 71.209999999999994 110.916 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 84.99 129.35 2.01 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.649 -0.786 . . . . 64.329999999999998 114.183 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 52.3 Cg_endo -76.37 133.04 14.18 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 121.735 1.623 . . . . 63.340000000000003 109.536 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.31 137.15 46.47 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.475 0.655 . . . . 62.210000000000001 112.35 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 38.4 mt-30 -120.37 140.85 50.7 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.872 -1.058 . . . . 75.230000000000004 108.48 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.41 145.41 51.2 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.59 -1.263 . . . . 72.430000000000007 107.59 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 14.8 pt-20 -83.7 138.99 33.04 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.905 -0.718 . . . . 73.5 109.082 177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 80.8 mt -80.3 124.29 82.62 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.017 -1.105 . . . . 64.019999999999996 108.017 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.89 141.94 41.8 Favored 'Trans proline' 0 C--O 1.252 1.193 0 C-N-CA 122.164 1.909 . . . . 62.439999999999998 112.677 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -78.22 77.08 4.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.217 1.008 . . . . 73.420000000000002 109.414 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.25 -7.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.131 -1.395 . . . . 73.409999999999997 110.281 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 3.3 p -68.94 -31.93 71.16 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.854 -0.612 . . . . 73.120000000000005 111.116 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -62.26 -24.59 67.35 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 125.285 1.434 . . . . 74.400000000000006 113.18 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.64 -47.75 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 75.129999999999995 112.037 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.0 t -177.21 153.04 0.92 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.827 -0.805 . . . . 74.230000000000004 108.827 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -58.37 -38.66 77.73 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.823 0.849 . . . . 72.310000000000002 111.276 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.46 -47.99 78.02 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.554 0.534 . . . . 73.230000000000004 111.115 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 34.6 mm-40 -70.33 -38.31 74.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 111.178 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.27 -46.35 88.76 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.613 0.571 . . . . 65.230000000000004 110.763 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.46 -47.6 80.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.633 -0.427 . . . . 74.150000000000006 110.699 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 31.9 mmmt -63.46 -47.1 83.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.163 0.431 . . . . 74.200000000000003 112.163 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.9 mmtt -63.6 -45.51 90.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 72.129999999999995 110.578 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.14 -32.48 72.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.61 0.596 . . . . 74.140000000000001 112.61 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.7 m -66.25 -38.74 88.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.558 -0.534 . . . . 75.0 109.558 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.64 67.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.953 -0.567 . . . . 74.109999999999999 110.628 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.29 -13.55 59.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 71.230000000000004 110.63 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.62 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 120.227 -0.987 . . . . 53.109999999999999 113.743 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.44 132.97 47.18 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 117.705 0.753 . . . . 63.350000000000001 110.917 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.98 16.04 4.76 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.592 -0.813 . . . . 71.430000000000007 112.395 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 32.3 mmt180 -125.43 111.96 15.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.513 -1.292 . . . . 72.420000000000002 107.513 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.91 152.21 49.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.085 0.469 . . . . 75.140000000000001 111.118 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -146.05 123.26 11.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.989 -1.486 . . . . 73.319999999999993 106.989 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -91.27 134.81 34.27 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.241 -0.584 . . . . 72.299999999999997 110.31 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -129.78 145.67 51.55 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.217 -1.031 . . . . 73.219999999999999 108.217 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -118.7 139.08 52.11 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.088 -0.708 . . . . 71.319999999999993 109.088 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.7 m -132.39 136.21 27.62 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.717 -0.475 . . . . 72.120000000000005 109.717 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.61 120.99 8.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.875 2.383 . . . . 72.439999999999998 112.184 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 43.9 m -124.85 172.51 9.29 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.71 -0.677 . . . . 74.329999999999998 110.098 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.8 p -67.29 151.09 97.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 O-C-N 123.794 0.684 . . . . 53.439999999999998 109.972 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.538 ' O ' HG12 ' A' ' 464' ' ' VAL . 71.8 Cg_exo -53.51 -27.18 39.53 Favored 'Trans proline' 0 CA--C 1.55 1.281 0 C-N-CA 122.839 2.36 . . . . 74.230000000000004 113.422 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.18 -23.89 54.73 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.73 -0.606 . . . . 74.530000000000001 112.226 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 37.4 tp -107.41 -9.39 16.01 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.069 0.461 . . . . 72.439999999999998 110.505 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.3 p -59.44 133.57 24.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.793 -0.639 . . . . 73.140000000000001 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.52 -14.09 59.41 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.613 -0.803 . . . . 64.030000000000001 112.168 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.75 158.04 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.382 0.61 . . . . 73.219999999999999 110.563 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 87.7 t -84.28 137.5 20.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.71 -1.589 . . . . 73.040000000000006 106.71 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.74 -13.79 8.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.342 -0.943 . . . . 74.319999999999993 110.563 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.88 -173.6 29.57 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 109.952 -1.259 . . . . 64.25 109.952 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.2 p -116.3 151.37 35.99 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.39 -1.337 . . . . 74.150000000000006 107.39 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -59.37 -51.46 81.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.732 -0.47 . . . . 75.310000000000002 109.732 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.01 133.94 22.47 Favored 'Trans proline' 0 C--N 1.378 2.086 0 N-CA-C 108.59 -1.35 . . . . 74.230000000000004 108.59 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.48 150.54 86.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.752 2.301 . . . . 75.150000000000006 114.534 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.31 8.49 38.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.311 1.053 . . . . 61.109999999999999 110.948 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -109.04 3.4 22.04 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.307 -0.871 . . . . 53.549999999999997 109.975 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -141.77 159.54 42.01 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-O 121.807 0.813 . . . . 73.099999999999994 111.591 -172.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -76.68 133.97 39.38 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.608 -1.633 . . . . 65.239999999999995 111.411 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 38.4 m -131.52 149.31 52.57 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.653 -1.24 . . . . 72.25 107.653 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -78.61 153.33 31.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.927 0.785 . . . . 73.140000000000001 111.683 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 47.4 mm -69.28 -8.23 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 122.163 0.982 . . . . 71.340000000000003 110.624 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -105.44 1.25 27.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.712 -0.676 . . . . 71.010000000000005 109.692 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 9.1 m120 -87.05 147.49 25.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.816 -0.809 . . . . 74.230000000000004 108.816 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.54 121.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.244 -1.021 . . . . 72.129999999999995 108.244 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.4 t -91.89 118.97 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.903 -0.777 . . . . 73.109999999999999 108.903 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.99 113.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.183 -1.414 . . . . 70.109999999999999 107.183 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.52 119.92 48.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.949 -1.13 . . . . 73.319999999999993 107.949 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 48.2 mt -103.23 114.96 44.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.434 0.635 . . . . 74.040000000000006 110.86 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.32 131.23 45.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.909 -0.775 . . . . 74.510000000000005 108.909 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.0 100.4 1.87 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.279 -1.129 . . . . 74.400000000000006 110.279 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.406 ' HA ' HG23 ' A' ' 464' ' ' VAL . 30.7 t -136.71 103.98 5.38 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.765 -0.828 . . . . 74.310000000000002 108.765 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.533 0 N-CA-C 108.471 -1.851 . . . . 72.040000000000006 108.471 176.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 121.23 0.538 . . . . 71.420000000000002 110.637 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.07 139.91 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.17 -0.923 . . . . 75.150000000000006 108.955 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.56 137.16 36.91 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.468 -1.679 . . . . 73.430000000000007 106.468 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -96.99 124.26 50.42 Favored Pre-proline 0 C--N 1.294 -1.838 0 C-N-CA 119.757 -0.777 . . . . 71.010000000000005 111.446 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.87 146.31 2.46 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.814 3.676 . . . . 74.299999999999997 115.681 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -71.16 144.96 50.02 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.929 -1.032 . . . . 62.130000000000003 110.138 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -108.08 29.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.218 -1.401 . . . . 63.340000000000003 107.218 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -58.85 135.41 57.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.176 -1.375 . . . . 73.219999999999999 111.398 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 94.84 -15.35 63.57 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.97 -0.559 . . . . 65.230000000000004 112.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -107.19 175.26 5.56 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.588 -0.36 . . . . 73.319999999999993 110.724 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.6 p -75.57 158.12 32.93 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.825 0.345 . . . . 73.409999999999997 111.771 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.415 ' O ' HG13 ' A' ' 374' ' ' ILE . 44.6 t -63.25 -36.12 82.59 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.812 -0.81 . . . . 63.32 108.812 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.66 94.01 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 115.638 -0.71 . . . . 70.209999999999994 111.209 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.35 -41.38 98.55 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.127 -0.488 . . . . 73.510000000000005 109.89 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.43 83.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.461 -0.791 . . . . 63.399999999999999 110.934 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.36 -47.02 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.375 . . . . 71.299999999999997 110.301 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.95 79.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.969 -0.56 . . . . 43.229999999999997 111.855 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.7 m -62.72 -46.33 88.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.427 -0.352 . . . . 74.530000000000001 111.912 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -38.43 91.0 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.173 -0.211 . . . . 73.120000000000005 111.184 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.43 -47.2 86.38 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.922 0.889 . . . . 71.510000000000005 109.138 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.41 -20.16 62.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.129 -0.941 . . . . 73.310000000000002 111.706 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -86.79 -15.44 39.28 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.268 -0.641 . . . . 75.219999999999999 109.268 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.49 5.0 57.06 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.487 -0.863 . . . . 74.239999999999995 111.446 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -90.47 158.59 16.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.158 0.504 . . . . 74.319999999999993 110.479 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 22.6 mmtp -106.05 138.55 42.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.757 -1.571 . . . . 75.400000000000006 106.757 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.87 147.45 21.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 119.676 -0.81 . . . . 73.430000000000007 112.964 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.442 ' HB3' HG22 ' A' ' 417' ' ' THR . 21.6 ttt180 -116.95 130.09 56.47 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.842 -1.54 . . . . 75.400000000000006 106.842 174.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.7 p -98.6 117.73 33.7 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 119.978 -0.689 . . . . 75.230000000000004 109.415 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -114.74 119.78 37.84 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.341 -1.355 . . . . 75.239999999999995 107.341 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.81 126.14 55.11 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.722 -0.844 . . . . 75.209999999999994 108.722 176.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -122.42 133.65 24.5 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 120.257 -0.577 . . . . 75.340000000000003 111.033 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.19 140.32 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.091 2.527 . . . . 71.439999999999998 110.708 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.4 t70 179.75 -166.48 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.575 -1.269 . . . . 73.299999999999997 107.575 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.452 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 70.9 m -119.66 -11.15 9.46 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.422 0.63 . . . . 71.519999999999996 109.592 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -95.25 27.03 3.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.425 1.107 . . . . 73.450000000000003 108.234 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.4 pp -97.4 141.03 22.4 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 115.254 -0.884 . . . . 62.409999999999997 113.375 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.91 -179.99 4.4 Favored 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 123.239 2.626 . . . . 74.340000000000003 110.794 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 398' ' ' HIS . 77.7 Cg_exo -57.65 163.08 9.44 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.522 2.815 . . . . 72.019999999999996 112.563 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.14 -8.79 0.75 Allowed 'General case' 0 N--CA 1.522 3.149 0 C-N-CA 124.441 1.096 . . . . 71.530000000000001 112.25 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 396' ' ' PRO . 32.3 m170 -83.75 157.12 22.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.657 -0.868 . . . . 74.150000000000006 108.657 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.26 116.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 N-CA-C 105.414 -2.069 . . . . 72.430000000000007 105.414 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.8 tt -89.99 -29.22 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 122.342 1.068 . . . . 74.310000000000002 109.036 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.57 170.59 38.18 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 104.623 -3.391 . . . . 54.210000000000001 104.623 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -176.26 2.87 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 107.249 -1.389 . . . . 74.519999999999996 107.249 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.78 145.7 30.59 Favored Pre-proline 0 C--N 1.253 -3.623 0 N-CA-C 107.93 -1.137 . . . . 74.420000000000002 107.93 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.04 -36.03 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.879 3.719 . . . . 63.229999999999997 114.047 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.63 -37.07 65.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.127 0.571 . . . . 74.209999999999994 111.701 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.64 -28.98 30.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 110.496 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -83.73 -8.02 59.35 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.203 -0.908 . . . . 73.430000000000007 110.754 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 59.1 m -91.58 140.59 29.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.571 -1.27 . . . . 73.349999999999994 107.571 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 36.4 m -76.73 112.49 13.36 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.359 -0.978 . . . . 74.519999999999996 108.359 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.25 169.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.138 -0.937 . . . . 75.540000000000006 109.828 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 m -65.65 152.96 42.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.458 -0.942 . . . . 73.109999999999999 108.458 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.02 109.16 0.89 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.141 0.496 . . . . 75.129999999999995 111.293 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.16 1.27 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 115.596 -0.729 . . . . 74.519999999999996 111.78 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -134.96 -169.53 2.38 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.352 -1.721 . . . . 73.430000000000007 106.352 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 12.4 pt-20 -95.04 132.9 39.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.989 0.813 . . . . 74.329999999999998 111.617 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.97 119.4 61.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.576 -1.268 . . . . 73.530000000000001 107.576 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 385' ' ' ARG . 40.2 p -87.31 119.19 27.31 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.333 0.587 . . . . 73.230000000000004 109.849 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.99 121.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.161 -1.422 . . . . 75.340000000000003 107.161 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 7.9 p30 -107.95 125.78 51.91 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.446 0.641 . . . . 62.43 111.891 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 11.3 p -120.28 151.47 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.908 -1.042 . . . . 64.409999999999997 108.41 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.2 p -91.55 123.49 35.0 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 111.862 0.319 . . . . 74.030000000000001 111.862 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.9 t -119.04 106.13 12.11 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.806 -0.758 . . . . 75.530000000000001 111.667 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 66.29 161.23 0.98 Allowed Glycine 0 CA--C 1.552 2.401 0 N-CA-C 115.912 1.125 . . . . 71.420000000000002 115.912 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.2 Cg_endo -94.36 139.71 1.24 Allowed 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 122.708 2.272 . . . . 73.549999999999997 112.311 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.61 142.26 37.4 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.094 0.473 . . . . 73.129999999999995 111.735 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.6 mt-30 -122.54 147.14 46.73 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.243 -0.89 . . . . 73.230000000000004 108.636 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.44 163.73 29.39 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.523 -0.917 . . . . 73.439999999999998 108.523 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.63 135.7 33.86 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.856 -0.338 . . . . 74.230000000000004 110.592 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -80.83 119.29 75.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.068 -0.716 . . . . 73.420000000000002 109.068 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 444' ' ' LEU . 70.6 Cg_exo -56.05 141.17 87.12 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.94 2.427 . . . . 72.049999999999997 112.16 176.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -88.01 10.77 17.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 62.130000000000003 111.526 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.21 -5.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.275 0.559 . . . . 74.349999999999994 110.279 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -58.86 -40.71 85.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.01 -0.996 . . . . 75.409999999999997 110.932 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 0.6 OUTLIER -68.58 -16.95 64.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.812 0.845 . . . . 73.120000000000005 112.381 -179.003 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.26 -34.91 14.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.801 -0.636 . . . . 73.340000000000003 111.75 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 83.9 m -153.85 133.2 12.73 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.953 -0.467 . . . . 70.549999999999997 110.645 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.99 -41.63 97.44 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.074 0.55 . . . . 64.200000000000003 110.365 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 65.129999999999995 110.626 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 443' ' ' LYS . 21.2 mm-40 -63.66 -40.83 97.82 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.948 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -60.67 -51.15 70.61 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 123.56 0.538 . . . . 73.420000000000002 110.217 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.33 -50.36 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.481 -0.488 . . . . 55.32 112.033 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.94 -47.97 67.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.625 0.602 . . . . 73.140000000000001 112.625 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 439' ' ' GLU . 47.5 mmtm -67.14 -38.49 85.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.011 0.374 . . . . 74.510000000000005 112.011 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 440' ' ' ALA . 11.2 mp -67.89 -36.15 79.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.599 -0.44 . . . . 74.409999999999997 111.271 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.0 m -64.91 -39.2 93.16 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.309 -0.626 . . . . 73.540000000000006 109.309 176.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.57 71.07 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.97 -0.559 . . . . 72.299999999999997 110.788 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.47 -13.18 59.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 74.010000000000005 110.666 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.48 -20.63 8.29 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.425 -0.893 . . . . 55.350000000000001 113.561 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 445' ' ' THR . 98.1 m-85 -66.86 135.32 53.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 117.485 0.642 . . . . 73.010000000000005 111.369 -175.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.55 12.22 4.59 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 110.926 -0.87 . . . . 64.120000000000005 110.926 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -114.48 111.45 21.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.453 -1.314 . . . . 74.430000000000007 107.453 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.7 152.12 50.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.659 0.266 . . . . 74.209999999999994 110.72 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.45 124.22 14.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.151 -1.055 . . . . 70.209999999999994 108.151 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.93 127.11 33.63 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 110.188 -0.301 . . . . 72.129999999999995 110.188 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.61 158.12 44.02 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.612 -0.884 . . . . 70.010000000000005 108.612 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -125.14 150.31 47.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.794 0.331 . . . . 74.310000000000002 110.593 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 30.6 t -137.48 133.19 17.97 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 107.88 -1.156 . . . . 72.319999999999993 107.88 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.04 127.6 21.75 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.514 2.143 . . . . 71.120000000000005 109.599 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.6 m -148.26 174.74 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 122.118 -0.364 . . . . 71.129999999999995 111.277 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.3 m -56.31 132.36 75.89 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.703 0.801 . . . . 62.210000000000001 110.102 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -48.79 -31.73 20.33 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.056 3.171 . . . . 73.120000000000005 114.861 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -18.55 65.41 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.24 0.543 . . . . 74.400000000000006 111.264 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 6.6 mp -106.93 6.04 28.85 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.074 -0.512 . . . . 75.319999999999993 111.508 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.6 p -60.41 126.98 19.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.258 0.552 . . . . 74.239999999999995 110.989 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.81 0.36 83.79 Favored Glycine 0 C--N 1.309 -0.94 0 CA-C-N 115.83 -0.623 . . . . 73.540000000000006 111.934 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 89.0 mttt -112.52 159.14 19.1 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.921 -1.14 . . . . 73.409999999999997 107.921 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 57.3 t -83.99 132.71 30.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.564 -0.532 . . . . 74.329999999999998 109.564 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -98.59 -16.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.222 -0.591 . . . . 70.319999999999993 111.402 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.81 174.08 37.79 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.653 -0.703 . . . . 60.299999999999997 111.704 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.7 p -124.06 149.69 45.83 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.444 -0.947 . . . . 54.119999999999997 108.444 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.438 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.6 t-20 -62.48 -51.96 69.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 120.561 -0.456 . . . . 74.019999999999996 110.921 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 11.2 Cg_exo -73.62 133.84 19.42 Favored 'Trans proline' 0 C--N 1.377 2.059 0 N-CA-C 108.304 -1.46 . . . . 73.319999999999993 108.304 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 475' ' ' ASN . 40.4 Cg_endo -65.35 130.73 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.377 2.052 . . . . 75.329999999999998 113.216 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.58 17.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.531 1.157 . . . . 44.310000000000002 109.714 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 473' ' ' PRO . 11.4 m120 -108.6 -10.11 15.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.383 -1.281 . . . . 73.439999999999998 108.462 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -140.82 164.83 29.18 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-O 121.734 0.778 . . . . 65.519999999999996 111.368 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.7 m -84.45 124.89 31.84 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.182 -1.372 . . . . 72.519999999999996 109.431 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.2 m -125.62 149.46 48.38 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.373 -0.603 . . . . 75.310000000000002 109.373 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.66 146.74 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.537 0.208 . . . . 71.329999999999998 111.156 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.58 -22.09 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 121.755 0.788 . . . . 74.409999999999997 110.9 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 11.1 t -87.71 0.89 55.1 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.509 -0.768 . . . . 74.409999999999997 110.294 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.01 131.11 34.51 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.389 -0.967 . . . . 64.540000000000006 108.389 177.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.46 119.06 28.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.66 -0.867 . . . . 75.209999999999994 108.66 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.15 118.22 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.49 0 N-CA-C 108.115 -1.069 . . . . 73.340000000000003 108.115 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.83 112.75 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 106.341 -1.725 . . . . 75.420000000000002 106.341 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.89 119.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 108.54 -0.911 . . . . 74.25 108.54 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 23.2 mt -101.18 109.3 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 108.94 -0.763 . . . . 73.439999999999998 108.94 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 36.3 t -97.92 137.77 24.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.462 -0.79 . . . . 73.450000000000003 109.958 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -74.84 95.76 0.92 Allowed Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.488 -0.778 . . . . 75.319999999999993 111.212 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 38.1 m -142.88 112.84 7.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.775 -0.824 . . . . 75.439999999999998 108.775 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.012 0 N-CA-C 110.75 -0.94 . . . . 64.329999999999998 110.75 179.254 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.596 0.712 . . . . 75.530000000000001 111.963 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.02 144.01 35.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.844 -1.071 . . . . 73.430000000000007 108.9 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.42 137.43 35.5 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.402 -1.703 . . . . 65.219999999999999 106.402 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.7 p -98.14 127.31 37.09 Favored Pre-proline 0 C--N 1.29 -1.989 0 C-N-CA 119.097 -1.041 . . . . 74.319999999999993 110.004 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.68 143.53 79.36 Favored 'Trans proline' 0 C--O 1.244 0.789 0 C-N-CA 123.031 2.487 . . . . 73.0 112.7 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -68.95 127.01 31.62 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.599 -0.728 . . . . 73.400000000000006 110.0 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 26.7 m -81.83 5.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.911 -0.586 . . . . 70.040000000000006 112.11 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -61.1 142.97 56.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.912 -0.585 . . . . 75.340000000000003 111.761 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.31 -9.78 53.92 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.884 -0.598 . . . . 63.119999999999997 111.868 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -119.38 -173.69 2.57 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.354 -0.61 . . . . 75.439999999999998 109.354 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 94.7 p -86.98 162.16 17.81 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 119.637 -0.825 . . . . 73.230000000000004 109.317 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 374' ' ' ILE . 74.1 p -61.93 -33.23 73.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.986 0.422 . . . . 72.420000000000002 110.065 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.67 97.45 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.878 -0.601 . . . . 73.310000000000002 110.862 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -62.31 -42.7 99.58 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 109.817 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.42 77.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.89 -1.05 . . . . 73.400000000000006 110.734 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.6 -47.26 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 75.329999999999998 110.477 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.44 78.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.271 -0.422 . . . . 73.319999999999993 111.937 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.7 m -61.55 -48.59 80.31 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.137 0.494 . . . . 72.209999999999994 110.635 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 74.6 mt -65.74 -38.19 88.46 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 75.230000000000004 111.739 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -61.05 -43.53 98.74 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.565 -0.531 . . . . 75.219999999999999 109.565 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.67 77.75 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.031 0.443 . . . . 62.310000000000002 111.017 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -78.27 -15.12 59.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.126 -0.488 . . . . 75.239999999999995 111.233 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.99 16.47 41.27 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.595 -1.288 . . . . 62.409999999999997 112.269 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.12 152.2 18.93 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.237 -0.653 . . . . 74.310000000000002 109.237 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 35.0 mmtp -94.31 141.2 28.84 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.529 -0.915 . . . . 73.120000000000005 108.529 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 133.96 67.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.331 0.586 . . . . 63.149999999999999 111.607 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -110.51 130.85 55.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.79 -1.189 . . . . 75.25 107.79 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 p -98.9 119.29 37.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 120.429 -0.509 . . . . 73.239999999999995 109.884 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.6 tt -111.43 119.13 37.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.459 -1.682 . . . . 74.140000000000001 106.459 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.536 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -106.36 122.57 46.52 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.325 0.583 . . . . 75.519999999999996 110.324 -177.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.03 131.31 24.44 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.326 -0.852 . . . . 65.109999999999999 111.119 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -91.12 130.73 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.916 2.411 . . . . 73.150000000000006 111.34 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 174.95 -170.36 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.733 -1.58 . . . . 74.310000000000002 106.733 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.1 m -113.36 -27.94 7.76 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.439 -1.319 . . . . 75.530000000000001 107.439 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 m -91.72 58.82 3.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.982 -1.488 . . . . 74.549999999999997 106.982 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 391' ' ' ASP . 1.5 pp -115.9 151.58 46.58 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 114.009 -1.45 . . . . 64.219999999999999 113.005 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.9 119.53 5.71 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.217 1.945 . . . . 71.409999999999997 108.267 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.55 161.88 16.49 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 C-N-CA 123.386 2.724 . . . . 75.25 113.165 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.64 -8.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.947 0.899 . . . . 74.530000000000001 112.119 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 45.1 m170 -106.18 109.49 21.44 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 104.202 -2.518 . . . . 73.430000000000007 104.202 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.76 118.0 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 122.045 0.926 . . . . 61.399999999999999 111.986 -170.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -96.29 -27.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.776 -1.102 . . . . 74.450000000000003 112.105 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.437 ' N ' HD11 ' A' ' 400' ' ' ILE . . . -146.65 156.96 27.24 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 110.257 -1.137 . . . . 75.420000000000002 110.257 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.4 p -125.37 -178.58 4.27 Favored 'General case' 0 C--N 1.275 -2.645 0 C-N-CA 122.989 0.516 . . . . 73.109999999999999 109.799 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.95 133.57 20.96 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.509 -1.293 . . . . 63.229999999999997 107.509 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.15 -17.94 9.19 Favored 'Trans proline' 0 C--O 1.26 1.585 0 C-N-CA 123.875 3.05 . . . . 72.129999999999995 115.194 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.84 64.27 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 122.115 -0.365 . . . . 71.420000000000002 110.744 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.71 65.36 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 121.038 0.447 . . . . 53.399999999999999 110.836 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -13.39 60.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.082 0.468 . . . . 75.239999999999995 110.957 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 61.2 m -73.33 138.06 45.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.94 113.3 12.09 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.417 0.627 . . . . 65.019999999999996 110.066 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.36 170.08 8.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.169 -0.923 . . . . 74.540000000000006 109.56 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 27.6 m -70.12 132.35 45.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.021 -0.733 . . . . 61.539999999999999 109.021 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -51.91 113.99 1.17 Allowed 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.862 0.726 . . . . 63.43 112.301 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.04 57.87 1.28 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 112.675 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -114.31 -166.79 1.13 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.868 -1.531 . . . . 73.25 106.868 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.8 pt-20 -113.08 134.59 54.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 119.327 0.967 . . . . 75.209999999999994 112.596 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.95 135.9 54.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.29 -1.004 . . . . 73.329999999999998 108.29 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -94.73 125.96 39.72 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.401 0.62 . . . . 60.210000000000001 109.615 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.36 116.33 47.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.82 -1.178 . . . . 73.349999999999994 107.82 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.86 128.0 35.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.097 -0.705 . . . . 73.430000000000007 109.097 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.48 145.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.295 -0.411 . . . . 71.010000000000005 110.054 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 24.1 p -84.9 123.72 30.81 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.066 0.547 . . . . 72.140000000000001 112.117 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.8 t -118.38 106.58 12.88 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 120.022 -0.671 . . . . 74.450000000000003 109.352 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.0 109.5 0.05 OUTLIER Glycine 0 C--O 1.262 1.893 0 N-CA-C 115.028 0.771 . . . . 44.329999999999998 115.028 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 30.1 Cg_exo -64.75 127.69 19.31 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.3 1.333 . . . . 73.109999999999999 109.53 172.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 6.9 mm-40 -73.38 131.55 42.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 113.255 0.835 . . . . 74.420000000000002 113.255 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.5 mt-30 -123.22 133.72 54.19 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 106.891 -1.522 . . . . 72.319999999999993 106.891 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.676 -0.861 . . . . 74.439999999999998 108.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -83.43 138.21 33.57 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.782 -0.645 . . . . 74.329999999999998 109.311 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.3 mt -89.9 125.11 61.84 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.886 -0.413 . . . . 62.229999999999997 109.886 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.7 141.79 46.41 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.355 2.037 . . . . 72.120000000000005 112.745 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.22 6.87 30.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.104 -0.498 . . . . 73.150000000000006 111.676 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.3 p -76.89 -14.3 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.679 0.752 . . . . 74.030000000000001 109.673 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.9 m -53.21 -37.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.785 1.234 . . . . 64.409999999999997 112.754 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 4.3 p -69.54 -14.16 62.71 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 113.84 1.052 . . . . 73.409999999999997 113.84 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.75 -38.26 17.09 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 122.136 -0.352 . . . . 71.010000000000005 111.877 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 73.8 m -153.83 131.72 11.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.769 -0.456 . . . . 63.25 109.769 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -62.09 -43.52 98.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.094 0.557 . . . . 73.129999999999995 112.048 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.2 83.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.212 0.53 . . . . 74.329999999999998 110.374 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.26 -44.38 95.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.888 -1.051 . . . . 73.400000000000006 109.51 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.18 66.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 74.239999999999995 111.524 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.24 -38.86 81.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.668 0.618 . . . . 75.109999999999999 112.668 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -67.54 -46.71 72.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.508 -0.477 . . . . 74.340000000000003 111.071 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -64.83 -40.72 95.64 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.5 mp -65.85 -41.4 91.74 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.583 -0.447 . . . . 74.420000000000002 111.498 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.7 m -62.09 -43.36 98.99 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.801 -0.444 . . . . 74.329999999999998 109.801 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.15 -16.87 62.56 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 111.757 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -89.73 -7.19 55.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.106 0.479 . . . . 75.409999999999997 110.363 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . 0.41 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 110.9 -8.73 29.6 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.1 -0.571 . . . . 55.420000000000002 112.851 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -85.01 92.7 8.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.262 0.553 . . . . 73.530000000000001 110.151 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -100.16 -2.03 55.85 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.462 -1.055 . . . . 72.25 110.462 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -94.97 110.78 22.64 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.48 -0.933 . . . . 75.329999999999998 108.48 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -123.46 157.69 32.92 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.623 0.725 . . . . 74.140000000000001 111.477 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -149.54 131.41 15.14 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 103.934 -2.617 . . . . 72.219999999999999 103.934 173.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -111.0 135.07 52.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.961 -0.695 . . . . 74.319999999999993 111.394 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.36 135.69 37.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.802 -0.814 . . . . 75.540000000000006 108.802 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.9 129.21 56.66 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.399 -1.334 . . . . 75.340000000000003 107.399 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 45.3 p -121.11 150.32 53.31 Favored Pre-proline 0 C--N 1.284 -2.267 0 C-N-CA 120.597 -0.441 . . . . 71.209999999999994 110.503 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.9 Cg_exo -61.58 120.61 8.34 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.207 1.938 . . . . 60.240000000000002 110.431 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.9 t -127.38 -178.53 4.49 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.472 -1.677 . . . . 74.209999999999994 106.472 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 m -74.05 142.54 79.44 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 107.844 -1.169 . . . . 74.310000000000002 107.844 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.469 ' O ' HG12 ' A' ' 464' ' ' VAL . 99.1 Cg_exo -49.67 -23.29 7.89 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.593 2.862 . . . . 62.32 113.931 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.92 -11.82 60.04 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.227 0.536 . . . . 65.109999999999999 112.118 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.4 3.12 15.7 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.923 -0.486 . . . . 74.209999999999994 111.641 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.9 p -59.92 127.45 19.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.326 0.584 . . . . 71.340000000000003 111.662 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.88 -15.6 63.04 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 120.769 -0.729 . . . . 72.200000000000003 112.176 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -100.66 149.59 23.62 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.112 -0.699 . . . . 74.349999999999994 109.112 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 91.5 t -76.93 130.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.708 -1.219 . . . . 62.109999999999999 107.708 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.04 -22.6 4.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.939 -0.704 . . . . 72.450000000000003 111.949 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.49 -177.58 45.79 Favored Glycine 0 N--CA 1.423 -2.177 0 C-N-CA 120.778 -0.725 . . . . 51.240000000000002 111.373 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.7 p -136.01 154.88 50.93 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.449 -0.945 . . . . 72.420000000000002 108.449 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.5 t-20 -56.97 -51.85 78.54 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-O 119.151 -0.452 . . . . 75.120000000000005 111.435 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.6 Cg_endo -86.34 119.01 1.68 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 N-CA-C 107.15 -1.904 . . . . 74.120000000000005 107.15 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.47 162.21 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.197 1.932 . . . . 75.25 113.704 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.39 4.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.135 0.969 . . . . 74.019999999999996 111.104 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.86 -0.55 19.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.103 -0.953 . . . . 75.510000000000005 109.3 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -108.07 153.4 23.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.905 0.859 . . . . 73.219999999999999 112.031 -174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.1 m -112.09 93.66 4.56 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.655 -1.611 . . . . 74.109999999999999 107.358 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -100.91 148.58 24.83 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.23 -0.441 . . . . 73.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.484 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -63.16 152.83 36.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.995 0.426 . . . . 74.129999999999995 111.48 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.41 HG21 ' O ' ' A' ' 448' ' ' GLY . 1.7 mp -63.83 -21.41 28.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.641 0.734 . . . . 72.349999999999994 111.429 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.82 1.2 56.44 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 111.808 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.99 140.24 30.48 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.819 -0.438 . . . . 71.420000000000002 109.819 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 36.6 t -85.21 123.19 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.73 -0.668 . . . . 71.430000000000007 109.415 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.85 119.81 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 108.526 -0.916 . . . . 73.329999999999998 108.526 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.495 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 1.7 mp -91.89 112.76 26.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.652 -1.981 . . . . 72.409999999999997 105.652 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.75 119.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.591 -1.263 . . . . 65.299999999999997 107.591 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 38.8 mt -106.1 116.32 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.702 0.763 . . . . 72.239999999999995 110.57 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.13 142.85 13.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.502 -0.772 . . . . 70.230000000000004 108.959 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.63 117.53 4.59 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 111.183 -0.767 . . . . 62.509999999999998 111.183 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.4 m -116.34 106.99 14.26 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.163 -0.68 . . . . 75.450000000000003 109.163 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.086 0 N-CA-C 109.981 -1.248 . . . . 70.420000000000002 109.981 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.432 -1.337 0 CA-C-O 120.928 0.394 . . . . 74.129999999999995 110.4 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.71 152.11 13.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 123.917 0.887 . . . . 73.230000000000004 108.987 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.92 136.32 36.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.873 -1.899 . . . . 75.400000000000006 105.873 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.5 127.01 32.53 Favored Pre-proline 0 C--N 1.284 -2.272 0 C-N-CA 119.89 -0.724 . . . . 72.329999999999998 111.122 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.36 133.71 57.51 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.986 2.457 . . . . 71.510000000000005 112.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -59.44 134.49 57.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.012 -0.995 . . . . 75.329999999999998 111.168 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 5.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.377 -0.829 . . . . 75.329999999999998 112.476 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.5 ptt-85 -65.69 137.72 57.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.657 -0.868 . . . . 74.209999999999994 108.657 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.37 0.37 50.39 Favored Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.687 -0.965 . . . . 54.420000000000002 110.687 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -130.15 176.76 7.83 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.483 -0.932 . . . . 74.340000000000003 108.483 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 88.4 p -87.94 167.8 13.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.736 -0.839 . . . . 75.030000000000001 108.736 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -61.29 -34.22 74.86 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.993 0.425 . . . . 73.420000000000002 110.346 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.06 -44.84 87.68 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.704 -0.68 . . . . 74.019999999999996 110.407 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -60.03 -44.98 94.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.528 -0.545 . . . . 64.409999999999997 109.528 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.08 67.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.226 -0.897 . . . . 73.219999999999999 111.018 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.5 -44.33 92.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.888 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.08 77.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 111.645 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 36.7 m -64.08 -47.52 79.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.547 -0.297 . . . . 73.299999999999997 111.199 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.13 -39.46 93.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.768 0.285 . . . . 72.430000000000007 111.768 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -60.04 -45.35 93.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.1 -0.704 . . . . 75.219999999999999 109.1 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -69.58 -27.65 65.29 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.169 -0.923 . . . . 75.329999999999998 112.025 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.589 ' HD3' ' O ' ' A' ' 376' ' ' THR . 8.5 mpt_? -85.62 -8.22 58.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.678 0.275 . . . . 72.140000000000001 110.999 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.27 14.35 54.21 Favored Glycine 0 CA--C 1.505 -0.594 0 C-N-CA 120.287 -0.959 . . . . 72.010000000000005 112.753 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -94.14 154.06 17.78 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.048 -0.723 . . . . 72.129999999999995 109.048 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.0 mmtp -104.79 133.6 49.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.263 -1.014 . . . . 71.120000000000005 108.263 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -117.82 144.86 24.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-O 121.524 0.678 . . . . 74.530000000000001 111.905 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -110.9 127.75 55.56 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 107.093 -1.447 . . . . 72.349999999999994 107.093 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.4 m -99.58 120.0 38.97 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.505 -1.665 . . . . 75.409999999999997 106.505 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.93 118.72 34.26 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.426 -1.324 . . . . 74.200000000000003 107.426 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.44 121.57 36.12 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.278 -1.378 . . . . 74.0 107.278 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.36 127.73 25.75 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 111.856 0.317 . . . . 75.310000000000002 111.856 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -87.99 131.59 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.522 2.148 . . . . 71.030000000000001 110.731 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.4 t70 174.06 -164.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.716 -1.587 . . . . 70.420000000000002 106.716 -178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 50.1 m -142.34 -0.53 1.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.343 0.657 . . . . 74.340000000000003 110.481 173.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -105.7 25.19 11.11 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 106.571 -1.64 . . . . 74.329999999999998 106.571 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 15.8 pt -115.13 151.41 45.66 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 113.708 -1.587 . . . . 74.299999999999997 110.212 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.45 147.58 36.72 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.035 1.823 . . . . 75.409999999999997 111.465 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.47 163.9 6.17 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.408 3.406 . . . . 73.109999999999999 112.288 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -56.28 -8.56 0.52 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 123.315 0.646 . . . . 73.140000000000001 112.006 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.1 m170 -91.63 113.37 25.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.213 -2.514 . . . . 74.530000000000001 104.213 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.18 118.32 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.358 0.599 . . . . 65.030000000000001 111.047 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.78 -29.49 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.206 -0.907 . . . . 74.430000000000007 109.049 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.18 157.12 27.28 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 110.432 -1.067 . . . . 71.140000000000001 110.432 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -126.03 -179.44 4.71 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 123.545 0.738 . . . . 52.409999999999997 110.418 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.33 140.29 21.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 72.340000000000003 108.639 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.39 -26.02 0.89 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 124.948 3.766 . . . . 62.43 115.53 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.34 -24.9 61.13 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 112.045 0.387 . . . . 74.450000000000003 112.045 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.74 69.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.475 0.655 . . . . 74.319999999999993 110.357 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -78.26 -11.99 59.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.59 -0.732 . . . . 63.219999999999999 111.65 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -78.82 137.46 37.71 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.063 -1.458 . . . . 72.230000000000004 107.063 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 m -82.54 112.27 19.3 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 72.329999999999998 107.712 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.6 167.42 18.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.566 -1.272 . . . . 74.329999999999998 107.566 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.2 p -61.01 147.66 42.83 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 123.46 0.704 . . . . 75.439999999999998 111.345 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.8 116.66 3.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.002 -0.544 . . . . 72.439999999999998 111.513 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.95 51.48 2.26 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.793 -0.64 . . . . 73.439999999999998 113.053 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.71 -170.14 1.69 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.803 -1.184 . . . . 74.329999999999998 107.803 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -99.05 135.27 40.7 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.494 0.664 . . . . 73.209999999999994 112.577 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.9 mm -125.17 138.76 53.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 124.796 1.239 . . . . 73.430000000000007 108.159 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 12.3 t -99.82 131.89 45.51 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.77 0.795 . . . . 65.099999999999994 111.701 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.3 t -108.15 120.71 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.459 -1.312 . . . . 74.430000000000007 107.459 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.74 129.04 41.83 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.341 -0.39 . . . . 74.5 111.458 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.75 131.3 73.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.835 -1.172 . . . . 75.409999999999997 107.835 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 49.6 p -85.96 121.85 29.18 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.099 -0.704 . . . . 72.409999999999997 109.099 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -119.45 106.7 12.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.197 -0.601 . . . . 75.430000000000007 111.1 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 71.03 125.89 0.06 OUTLIER Glycine 0 CA--C 1.544 1.874 0 N-CA-C 114.801 0.681 . . . . 74.310000000000002 114.801 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.1 Cg_exo -70.52 128.2 15.01 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.255 1.303 . . . . 71.349999999999994 109.44 173.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 15.2 mm-40 -72.3 144.78 48.21 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 112.463 0.542 . . . . 63.340000000000003 112.463 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.4 mt-30 -116.01 149.01 39.54 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.811 -1.086 . . . . 73.310000000000002 108.562 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -136.78 144.87 43.98 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.523 -0.917 . . . . 74.519999999999996 108.523 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 37.1 tt0 -81.74 119.25 23.62 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.122 -1.807 . . . . 71.040000000000006 106.122 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 62.1 mt -80.88 127.83 73.52 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.471 -0.937 . . . . 75.510000000000005 108.471 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 141.79 38.89 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.928 1.752 . . . . 62.009999999999998 110.627 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.84 73.89 10.28 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.373 1.083 . . . . 75.409999999999997 108.269 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.19 -4.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 113.668 -1.605 . . . . 74.129999999999995 107.34 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 8.7 m -67.13 -38.88 86.32 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 113.583 -1.644 . . . . 51.539999999999999 111.767 -176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 16.3 p -69.84 -16.75 63.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 112.86 0.689 . . . . 74.519999999999996 112.86 -169.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.28 -48.99 11.29 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.545 -0.752 . . . . 72.450000000000003 111.656 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.2 m -157.59 130.19 7.39 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.03 -0.419 . . . . 72.239999999999995 110.116 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -55.88 -47.07 78.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.477 0.711 . . . . 72.409999999999997 112.218 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.76 84.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 71.099999999999994 111.306 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 35.4 mm-40 -67.5 -38.95 85.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 111.214 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 433' ' ' SER . . . -59.4 -50.85 72.37 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.614 0.572 . . . . 62.119999999999997 111.043 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.3 -45.34 98.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.516 -0.765 . . . . 75.209999999999994 110.624 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.11 -40.67 86.91 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 112.952 0.723 . . . . 75.239999999999995 112.952 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.8 mmtt -66.21 -47.18 74.7 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 110.084 -0.339 . . . . 72.530000000000001 110.084 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.647 0.61 . . . . 72.120000000000005 112.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.9 m -63.98 -39.04 93.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.907 -0.405 . . . . 74.239999999999995 109.907 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -27.02 63.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.551 . . . . 72.420000000000002 110.832 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 -13.65 59.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.336 -0.393 . . . . 65.439999999999998 111.249 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 129.96 -26.18 4.27 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.196 -1.002 . . . . 61.420000000000002 113.26 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -80.84 91.57 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.312 . . . . 72.519999999999996 110.17 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.48 26.86 16.93 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 120.512 -0.851 . . . . 71.239999999999995 111.71 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -124.77 111.84 16.01 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.587 -1.264 . . . . 73.109999999999999 107.587 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 158.97 37.2 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.777 0.799 . . . . 74.140000000000001 111.982 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.52 123.25 21.15 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.872 -1.899 . . . . 74.129999999999995 105.872 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.62 126.96 35.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.145 0.278 . . . . 74.420000000000002 110.49 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.409 ' C ' HD21 ' A' ' 456' ' ' ASN . . . -136.39 150.72 48.93 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -129.74 148.84 51.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.505 -0.554 . . . . 75.25 109.505 178.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 66.4 m -135.86 133.3 19.85 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 116.488 -0.324 . . . . 73.219999999999999 110.969 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.3 Cg_endo -61.79 121.57 9.73 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.715 2.277 . . . . 73.109999999999999 110.028 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.8 p -146.39 -178.36 6.11 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.878 -1.156 . . . . 64.340000000000003 107.878 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.476 ' HB ' HD21 ' A' ' 463' ' ' LEU . 9.3 m -52.2 122.98 26.11 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.17 -0.678 . . . . 73.219999999999999 109.17 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.02 -23.63 9.51 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.314 3.342 . . . . 73.540000000000006 115.197 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -75.4 -6.43 49.98 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.81 -0.556 . . . . 72.329999999999998 111.966 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.476 HD21 ' HB ' ' A' ' 460' ' ' THR . 4.4 mm? -98.69 5.02 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.099 -0.375 . . . . 73.209999999999994 110.955 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -59.67 126.7 17.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 CA-C-O 121.545 0.688 . . . . 74.219999999999999 111.489 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.84 -1.14 85.05 Favored Glycine 0 C--O 1.243 0.657 0 CA-C-N 115.748 -0.66 . . . . 50.119999999999997 111.772 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -111.1 144.42 40.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.148 -1.427 . . . . 74.030000000000001 107.148 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 434' ' ' THR . 61.8 t -83.82 134.9 25.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 109.496 -0.557 . . . . 73.430000000000007 109.496 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.37 -14.88 7.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.404 -0.518 . . . . 74.040000000000006 110.803 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.98 167.75 23.87 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 115.719 -0.673 . . . . 52.420000000000002 111.811 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.7 p -124.28 146.17 48.94 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.417 -1.327 . . . . 73.099999999999994 107.417 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.5 t-20 -56.54 -50.72 86.14 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 64.549999999999997 110.497 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.9 Cg_exo -81.4 104.95 1.54 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 105.41 -2.573 . . . . 73.209999999999994 105.41 163.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.0 Cg_endo -63.04 149.82 90.44 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.395 2.063 . . . . 74.409999999999997 114.248 -169.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.434 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.8 16.51 0.86 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.264 1.03 . . . . 74.340000000000003 110.106 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 473' ' ' PRO . 0.8 OUTLIER -111.3 -3.64 15.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 124.918 1.287 . . . . 73.230000000000004 108.718 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -120.9 163.32 18.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.921 -1.036 . . . . 72.230000000000004 112.162 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 10.6 m -101.48 104.88 15.82 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.728 -1.582 . . . . 71.420000000000002 106.728 175.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.8 t -116.89 148.84 40.96 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.583 -0.525 . . . . 75.439999999999998 109.583 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.14 140.71 58.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.236 -0.438 . . . . 54.509999999999998 110.622 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.9 mm -60.58 -16.46 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 125.159 1.384 . . . . 63.130000000000003 111.776 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 10.4 t -87.93 3.62 47.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.264 -0.426 . . . . 75.049999999999997 111.185 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 46.5 m-80 -91.12 140.61 29.65 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.751 0.31 . . . . 64.120000000000005 110.634 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.64 122.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.851 -1.166 . . . . 65.040000000000006 107.851 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.05 119.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 N-CA-C 108.605 -0.887 . . . . 72.040000000000006 108.605 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 47.0 mt -91.82 112.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 104.799 -2.297 . . . . 73.109999999999999 104.799 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.412 HD13 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.84 120.45 52.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 108.685 -0.857 . . . . 74.329999999999998 108.685 -173.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.78 118.73 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 121.559 0.695 . . . . 75.409999999999997 109.333 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.45 139.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.351 -0.981 . . . . 75.019999999999996 108.351 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.27 121.66 6.22 Favored Glycine 0 N--CA 1.42 -2.43 0 N-CA-C 108.471 -1.852 . . . . 75.329999999999998 108.471 175.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 7.1 t -140.45 103.88 4.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.15 -0.685 . . . . 71.0 109.15 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.609 0 N-CA-C 109.478 -1.449 . . . . 74.530000000000001 109.478 178.18 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 107.242 -1.392 . . . . 74.120000000000005 107.242 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.82 156.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-O 120.972 0.415 . . . . 73.209999999999994 110.506 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.41 136.85 37.96 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.604 -1.628 . . . . 75.329999999999998 106.604 174.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.45 129.03 27.71 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 119.437 -0.905 . . . . 73.400000000000006 109.889 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 139.79 70.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.33 2.686 . . . . 74.310000000000002 113.21 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.66 137.49 55.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.839 -1.073 . . . . 72.540000000000006 109.107 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.0 m -103.43 14.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.986 0.422 . . . . 73.140000000000001 111.96 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 0.9 OUTLIER -65.29 138.82 58.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.23 -0.441 . . . . 75.150000000000006 111.558 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 -2.08 76.35 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 115.603 -0.726 . . . . 71.129999999999995 111.449 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -116.67 162.67 17.29 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.473 -0.566 . . . . 72.239999999999995 109.473 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 79.3 p -74.75 163.16 28.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 122.764 0.426 . . . . 74.329999999999998 111.774 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 21.5 p -60.91 -45.4 94.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.165 -0.47 . . . . 73.340000000000003 110.874 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.37 95.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.992 -0.549 . . . . 62.340000000000003 111.55 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.91 -39.73 83.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.056 -0.657 . . . . 74.540000000000006 109.905 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . 0.404 ' O ' HD22 ' A' ' 377' ' ' LEU . . . -60.99 -51.84 67.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.056 -0.52 . . . . 74.420000000000002 110.099 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.517 . . . . 62.509999999999998 110.7 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.39 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.462 -0.336 . . . . 74.319999999999993 111.673 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 98.3 m -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.689 -0.232 . . . . 74.420000000000002 111.18 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 373' ' ' ALA . 4.5 mm? -64.87 -42.44 94.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.811 0.339 . . . . 75.439999999999998 111.002 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.81 -48.43 80.64 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.854 0.861 . . . . 74.25 109.721 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -70.5 -25.35 63.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.506 -0.77 . . . . 70.219999999999999 111.584 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.4 -15.83 57.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.453 -0.573 . . . . 74.219999999999999 109.453 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.431 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.4 6.09 53.57 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 119.807 -1.187 . . . . 51.409999999999997 111.683 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.4 169.08 11.7 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.233 0.54 . . . . 74.510000000000005 109.88 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.9 mmtt -113.73 157.9 21.62 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.508 -1.293 . . . . 73.129999999999995 107.508 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.42 142.68 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 111.126 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -116.81 138.63 51.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.552 -1.647 . . . . 75.239999999999995 106.552 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 3.3 p -101.81 127.06 48.78 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.386 -0.525 . . . . 74.540000000000006 110.151 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.45 119.54 39.15 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.04 -1.467 . . . . 75.299999999999997 107.04 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.535 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 0.0 OUTLIER -114.85 134.12 55.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.416 -0.514 . . . . 75.030000000000001 111.252 -175.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -137.02 141.77 35.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.853 -0.612 . . . . 75.430000000000007 110.192 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.5 Cg_endo -97.04 143.57 0.76 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.155 2.57 . . . . 75.120000000000005 113.234 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.7 t70 163.55 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.996 -1.853 . . . . 73.319999999999993 105.996 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 m -122.18 -12.7 8.25 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.996 -0.742 . . . . 64.219999999999999 108.996 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.3 m -98.03 14.65 26.69 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 122.457 1.123 . . . . 74.340000000000003 108.769 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 391' ' ' ASP . 9.9 pt -88.64 151.83 48.41 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 115.068 -0.969 . . . . 64.409999999999997 111.601 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.06 126.78 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.921 1.747 . . . . 73.230000000000004 110.78 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.85 161.99 9.52 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.718 2.945 . . . . 74.420000000000002 112.265 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 370' ' ' SER . 4.4 p-10 -57.03 -9.93 0.99 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.477 0.711 . . . . 75.040000000000006 112.399 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -91.89 113.84 26.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.536 -2.024 . . . . 55.409999999999997 105.536 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.88 119.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 124.362 1.039 . . . . 75.340000000000003 112.29 -167.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.8 mt -95.41 -31.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 72.299999999999997 109.928 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.57 157.96 27.56 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.518 -0.849 . . . . 74.310000000000002 111.472 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.9 p -129.04 -179.1 4.92 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.588 0.755 . . . . 73.400000000000006 109.599 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -101.74 142.35 24.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.02 -1.104 . . . . 73.540000000000006 108.02 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.65 -26.45 9.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.848 3.032 . . . . 74.400000000000006 114.075 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.69 46.41 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.366 0.666 . . . . 75.439999999999998 111.168 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.42 95.28 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.723 -0.671 . . . . 61.109999999999999 111.434 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.54 -5.95 58.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.413 0.523 . . . . 64.299999999999997 112.413 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 37.0 m -85.95 153.01 22.48 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.96 -1.496 . . . . 75.310000000000002 106.96 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.69 112.76 11.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.761 -0.776 . . . . 61.520000000000003 110.142 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.6 m -117.94 153.04 19.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 62.340000000000003 109.542 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -67.62 141.73 56.66 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.565 -0.531 . . . . 71.519999999999996 109.565 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.26 134.6 44.9 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.529 0.732 . . . . 74.319999999999993 112.594 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 84.09 37.48 11.27 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.455 -0.793 . . . . 64.409999999999997 113.991 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -95.91 176.22 6.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.192 -1.04 . . . . 74.25 108.192 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.2 pt-20 -111.07 120.0 40.89 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.189 0.811 . . . . 74.540000000000006 113.189 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.79 137.85 25.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 114.951 -1.022 . . . . 72.530000000000001 108.535 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.4 t -96.02 128.67 43.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.816 0.817 . . . . 74.329999999999998 110.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.48 129.03 59.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.538 -0.912 . . . . 65.510000000000005 108.538 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -85.01 127.99 34.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.385 -0.598 . . . . 65.420000000000002 109.385 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.95 135.09 64.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.502 -0.925 . . . . 73.010000000000005 108.502 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.8 p -84.24 122.08 28.38 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.246 -0.649 . . . . 55.409999999999997 109.246 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 39.9 m -120.3 104.96 10.47 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 120.049 -0.66 . . . . 62.299999999999997 112.443 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 70.62 131.07 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 N-CA-C 115.766 1.066 . . . . 73.329999999999998 115.766 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.4 Cg_exo -75.06 134.65 17.96 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.943 1.762 . . . . 73.430000000000007 109.491 173.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.2 mm-40 -72.84 148.8 44.12 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.249 0.547 . . . . 73.349999999999994 112.266 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.8 mt-30 -124.08 139.03 54.34 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.682 -1.144 . . . . 73.549999999999997 108.015 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 14.9 mmt-85 -130.45 154.64 47.53 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 116.163 -0.471 . . . . 72.349999999999994 109.771 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.64 138.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.579 -0.897 . . . . 74.299999999999997 108.579 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -94.28 109.64 43.74 Favored Pre-proline 0 C--O 1.203 -1.352 0 N-CA-C 109.005 -0.739 . . . . 75.109999999999999 109.005 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.01 140.56 34.94 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 121.549 1.5 . . . . 73.140000000000001 111.716 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -92.5 95.17 9.48 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 118.465 -1.294 . . . . 75.120000000000005 112.172 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.63 9.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 104.502 -2.407 . . . . 64.230000000000004 104.502 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 22.6 t -78.89 -48.11 15.24 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.058 -1.883 . . . . 74.230000000000004 109.188 -172.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 40.3 p -63.85 -19.97 65.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.631 0.729 . . . . 71.439999999999998 110.829 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.29 -49.27 6.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.05 -0.977 . . . . 74.120000000000005 110.083 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 4.7 p -151.03 125.59 9.56 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.105 0.479 . . . . 75.400000000000006 112.117 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -61.64 -47.12 86.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 73.019999999999996 110.927 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.26 -47.84 80.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.824 . . . . 74.319999999999993 112.134 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.97 -34.75 73.79 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.995 -0.548 . . . . 72.530000000000001 112.059 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.82 -44.75 96.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.571 -0.286 . . . . 74.340000000000003 110.357 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.29 -39.84 82.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.594 0.559 . . . . 74.150000000000006 110.157 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -60.82 -48.14 83.14 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.878 -0.601 . . . . 74.430000000000007 110.504 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.8 -47.53 71.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 111.068 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.94 -43.07 84.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.046 -0.979 . . . . 75.209999999999994 111.384 -173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.3 m -69.17 -39.57 78.66 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.967 0.413 . . . . 73.329999999999998 110.224 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -16.14 62.55 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.374 -0.375 . . . . 73.219999999999999 111.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.78 -13.79 59.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.215 0.531 . . . . 72.140000000000001 109.969 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.46 -25.26 7.39 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.737 -0.744 . . . . 70.019999999999996 112.14 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -57.43 127.1 30.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.972 0.415 . . . . 71.319999999999993 111.504 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -133.55 27.72 3.35 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 109.673 -1.371 . . . . 62.219999999999999 109.673 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -128.04 111.4 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.824 -1.547 . . . . 73.439999999999998 106.824 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -135.88 154.18 51.23 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.977 0.418 . . . . 64.239999999999995 110.782 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -146.13 123.25 11.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.624 -1.25 . . . . 73.299999999999997 107.624 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -108.84 132.19 54.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.942 -0.303 . . . . 70.230000000000004 110.697 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -147.68 166.3 27.87 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.898 -0.592 . . . . 65.230000000000004 109.518 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.8 m120 -112.74 143.65 43.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.303 -0.629 . . . . 74.409999999999997 109.303 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.6 t -127.17 141.48 40.86 Favored Pre-proline 0 C--N 1.288 -2.107 0 N-CA-C 107.739 -1.208 . . . . 74.209999999999994 107.739 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_endo -63.37 135.18 48.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.862 2.375 . . . . 75.530000000000001 112.427 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.3 p -148.13 -178.88 6.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 105.648 -1.982 . . . . 63.229999999999997 105.648 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.6 m -63.69 128.2 92.45 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.076 -1.453 . . . . 70.129999999999995 107.076 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.33 -28.24 14.97 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.272 3.315 . . . . 74.430000000000007 114.576 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.31 -9.88 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 111.911 0.337 . . . . 71.209999999999994 111.911 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.6 mp -103.3 11.97 36.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.458 -0.201 . . . . 75.019999999999996 110.458 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 13.0 p -59.0 127.32 18.03 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-O 121.611 0.719 . . . . 64.439999999999998 110.969 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.57 57.81 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.408 -0.815 . . . . 62.149999999999999 111.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.16 144.8 29.6 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.271 -1.011 . . . . 74.430000000000007 108.271 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 433' ' ' SER . 65.6 t -83.43 138.24 19.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 75.340000000000003 108.503 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -98.08 -11.37 8.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.22 -0.592 . . . . 75.239999999999995 111.615 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.68 -177.71 28.56 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 111.121 -0.792 . . . . 70.349999999999994 111.121 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 5.4 p -116.75 161.38 19.34 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.69 -0.856 . . . . 75.120000000000005 108.69 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.15 -55.37 44.75 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.259 -0.4 . . . . 75.019999999999996 111.323 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 133.67 18.69 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 N-CA-C 108.226 -1.49 . . . . 75.319999999999993 108.226 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.5 Cg_endo -62.89 134.56 47.18 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.013 1.809 . . . . 75.219999999999999 111.598 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.92 19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.852 0.861 . . . . 73.230000000000004 113.045 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.549 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -110.54 -8.23 14.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.428 -0.953 . . . . 70.519999999999996 108.428 174.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -99.52 156.75 16.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.068 -0.969 . . . . 74.510000000000005 113.178 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 m -106.6 110.23 22.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.422 -1.717 . . . . 72.140000000000001 106.877 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -117.61 148.46 41.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.464 -0.198 . . . . 73.129999999999995 110.464 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.12 149.41 50.57 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.269 0.356 . . . . 74.140000000000001 111.018 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.95 -14.43 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 125.083 1.353 . . . . 72.420000000000002 111.837 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.17 4.01 44.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.7 0.8 . . . . 65.040000000000006 111.701 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -97.73 134.74 40.49 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.003 -0.544 . . . . 75.319999999999993 110.607 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.99 114.93 24.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.677 -0.86 . . . . 73.299999999999997 108.677 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.44 119.85 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.378 0.609 . . . . 72.150000000000006 109.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.72 120.24 41.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.43 -1.322 . . . . 74.430000000000007 107.43 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.29 118.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 107.836 -1.172 . . . . 75.219999999999999 107.836 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -111.46 122.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.173 0.987 . . . . 74.319999999999993 112.361 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 35.5 t -97.53 141.2 16.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.713 -1.13 . . . . 64.129999999999995 108.053 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.43 121.75 5.92 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 111.657 -0.577 . . . . 63.130000000000003 111.657 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.6 m -142.06 120.89 12.72 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.153 -0.684 . . . . 60.409999999999997 109.153 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.578 0 N-CA-C 109.665 -1.374 . . . . 74.439999999999998 109.665 178.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 106.606 -1.627 . . . . 64.409999999999997 106.606 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.65 154.14 37.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 122.528 0.331 . . . . 74.329999999999998 110.176 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -95.0 136.65 35.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.489 -0.93 . . . . 74.25 108.489 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.96 142.04 23.94 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 116.148 -0.478 . . . . 72.400000000000006 111.814 -170.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.14 142.77 20.19 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 124.015 3.143 . . . . 74.099999999999994 113.414 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.21 125.69 29.73 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.471 -0.786 . . . . 75.010000000000005 109.651 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.28 27.05 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.569 1.176 . . . . 73.140000000000001 110.669 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 145.66 55.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.09 -0.959 . . . . 74.209999999999994 111.498 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 1.0 45.49 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.998 -0.62 . . . . 72.549999999999997 114.36 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -134.6 162.5 32.11 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 117.293 0.546 . . . . 60.530000000000001 110.883 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.4 p -66.93 159.89 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.227 0.329 . . . . 61.210000000000001 110.298 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 21.2 p -56.76 -40.5 75.92 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.586 0.231 . . . . 71.019999999999996 111.62 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.36 77.85 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 111.563 0.209 . . . . 74.450000000000003 111.563 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.71 -36.76 76.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.51 -0.552 . . . . 72.420000000000002 109.51 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.7 68.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.019 -0.537 . . . . 70.120000000000005 110.812 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.46 -38.0 76.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.764 -0.653 . . . . 74.239999999999995 110.607 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.07 99.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.964 -0.562 . . . . 74.209999999999994 110.338 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 50.6 m -61.21 -47.2 87.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.353 -0.385 . . . . 71.299999999999997 110.755 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.8 -38.64 91.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.433 0.158 . . . . 74.140000000000001 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.16 -46.78 89.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.366 -0.605 . . . . 73.129999999999995 109.366 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.27 -28.0 68.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.805 -0.634 . . . . 73.120000000000005 111.507 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -80.98 -14.57 57.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.365 -0.38 . . . . 74.200000000000003 111.42 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.09 48.11 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.858 -0.686 . . . . 65.230000000000004 113.667 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.91 161.97 14.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.491 0.646 . . . . 75.099999999999994 111.353 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -97.01 140.13 31.99 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.221 -1.77 . . . . 71.209999999999994 106.221 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.3 152.31 21.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.296 0.57 . . . . 75.540000000000006 112.316 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -136.16 128.99 31.04 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.934 -1.136 . . . . 72.120000000000005 107.934 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -100.58 132.83 45.77 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.187 -0.671 . . . . 73.040000000000006 109.187 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.55 119.14 35.79 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.666 -1.976 . . . . 71.310000000000002 105.666 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.37 122.19 46.49 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.974 -0.75 . . . . 62.210000000000001 108.974 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.509 ' HZ1' ' HB2' ' A' ' 389' ' ' LYS . 0.1 OUTLIER -134.54 133.3 21.33 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.023 -0.535 . . . . 74.040000000000006 111.9 -176.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -81.63 129.56 6.5 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.073 1.849 . . . . 75.530000000000001 108.288 169.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.4 -170.29 3.19 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.905 -1.518 . . . . 74.510000000000005 112.145 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.7 t -104.66 -40.63 5.94 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.318 -1.734 . . . . 53.549999999999997 106.318 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 395' ' ' PRO . 32.2 m -93.0 71.51 4.65 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.543 -1.651 . . . . 52.420000000000002 106.543 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 16.6 pt -89.58 112.96 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 113.241 -1.8 . . . . 73.239999999999995 113.587 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 393' ' ' THR . 6.3 Cg_exo -79.1 119.61 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 105.81 -2.419 . . . . 73.340000000000003 105.81 167.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 398' ' ' HIS . 52.5 Cg_exo -55.12 150.48 39.16 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 C-N-CA 122.631 2.221 . . . . 64.120000000000005 114.24 -170.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.481 ' HA ' ' CG1' ' A' ' 420' ' ' VAL . 29.8 t70 -60.06 -9.65 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.626 1.203 . . . . 51.100000000000001 111.722 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.413 ' H ' ' C ' ' A' ' 396' ' ' PRO . 19.6 m170 -109.51 115.51 30.06 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 103.292 -2.855 . . . . 74.200000000000003 103.292 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.17 117.98 4.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 123.695 0.622 . . . . 72.109999999999999 109.53 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.57 -29.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.987 -1.116 . . . . 72.200000000000003 107.987 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.37 168.47 27.81 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 109.387 -1.485 . . . . 62.229999999999997 109.387 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 81.2 p -113.93 -176.36 2.88 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.827 0.823 . . . . 73.099999999999994 111.365 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.31 142.89 25.48 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 105.654 -1.98 . . . . 70.230000000000004 105.654 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.62 -31.67 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.286 3.324 . . . . 74.049999999999997 114.441 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.08 67.42 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 112.381 0.512 . . . . 75.230000000000004 112.381 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.25 81.95 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 121.5 0.667 . . . . 74.310000000000002 110.125 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.83 -0.39 57.7 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.842 0.83 . . . . 73.120000000000005 110.604 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 93.8 m -85.55 143.99 28.17 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.008 -1.479 . . . . 75.019999999999996 107.008 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.0 m -74.84 114.61 13.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.867 -0.733 . . . . 71.420000000000002 109.381 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.96 170.17 8.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 124.823 1.249 . . . . 52.340000000000003 108.921 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 23.2 t -69.67 156.98 38.13 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.535 -0.543 . . . . 75.319999999999993 109.535 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -73.38 109.6 7.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.124 -1.065 . . . . 73.200000000000003 108.124 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.53 26.51 11.87 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.673 -0.971 . . . . 52.350000000000001 110.673 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.8 t0 -76.99 -171.57 2.03 Favored 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.807 -0.812 . . . . 71.109999999999999 108.807 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.68 127.46 53.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.463 0.649 . . . . 70.209999999999994 111.129 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.63 120.1 61.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.202 -1.036 . . . . 74.230000000000004 108.202 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -97.88 128.23 44.34 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.642 -0.873 . . . . 65.510000000000005 108.642 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.57 119.58 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.717 -0.475 . . . . 71.120000000000005 109.717 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.7 121.88 33.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.459 -0.941 . . . . 74.439999999999998 108.459 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 397' ' ' ASP . 23.6 t -128.83 144.72 37.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.426 -0.953 . . . . 75.319999999999993 108.426 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 71.9 p -98.03 128.92 44.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.306 -0.958 . . . . 75.209999999999994 110.9 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 60.6 m -118.73 105.56 11.69 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.069 -1.456 . . . . 74.319999999999993 107.069 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 80.53 145.1 3.97 Favored Glycine 0 CA--C 1.546 2.011 0 C-N-CA 120.973 -0.632 . . . . 52.539999999999999 113.445 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -87.95 153.2 7.16 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 121.903 1.735 . . . . 63.229999999999997 110.38 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 146.17 47.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.177 -0.675 . . . . 73.439999999999998 109.177 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 42.0 mt-30 -128.74 124.13 34.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.632 -0.877 . . . . 73.450000000000003 108.632 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.14 159.51 34.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.469 -1.308 . . . . 73.25 107.469 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.65 139.87 30.12 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 110.209 -0.293 . . . . 75.329999999999998 110.209 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.61 131.89 63.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.631 -0.877 . . . . 74.400000000000006 108.631 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.4 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.24 151.07 60.25 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.466 2.111 . . . . 72.310000000000002 111.905 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.19 -6.55 44.49 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.485 -0.325 . . . . 71.209999999999994 110.702 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.4 HG12 ' HB2' ' A' ' 430' ' ' PRO . 11.9 p -65.84 -15.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 122.123 0.964 . . . . 75.109999999999999 109.69 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 14.0 m -52.73 -32.95 45.77 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.889 1.676 . . . . 74.230000000000004 112.084 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 85.5 m -59.8 -34.33 72.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.53 0.732 . . . . 74.430000000000007 112.585 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.45 -37.69 83.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.307 0.854 . . . . 71.340000000000003 113.307 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.8 m -158.3 133.53 8.66 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.723 -0.473 . . . . 72.319999999999993 109.723 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.61 -49.35 75.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.559 . . . . 74.319999999999993 111.724 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.44 85.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.943 -0.571 . . . . 72.299999999999997 110.449 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.25 -41.96 99.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.933 -1.03 . . . . 64.299999999999997 109.834 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.47 69.23 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.355 -0.839 . . . . 74.510000000000005 110.582 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.34 -40.0 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.584 -0.735 . . . . 74.519999999999996 110.405 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -60.8 -46.34 90.88 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.607 -0.27 . . . . 74.319999999999993 111.064 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -47.6 83.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.268 0.355 . . . . 73.430000000000007 111.86 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.36 -40.55 85.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.946 0.721 . . . . 74.439999999999998 112.946 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.2 m -61.8 -43.44 98.83 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.065 0.46 . . . . 73.409999999999997 110.158 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.53 -22.33 61.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.696 -0.684 . . . . 75.450000000000003 111.553 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.21 -13.09 57.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.005 0.431 . . . . 73.219999999999999 111.061 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -19.12 8.91 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.443 -0.884 . . . . 61.439999999999998 112.715 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.27 110.86 6.17 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.017 -0.734 . . . . 73.319999999999993 109.017 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -120.08 17.08 9.97 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.457 -0.878 . . . . 72.420000000000002 111.602 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -119.4 111.4 18.1 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.872 -1.159 . . . . 65.120000000000005 107.872 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.25 152.37 50.58 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.082 0.468 . . . . 74.439999999999998 111.892 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -138.69 126.22 21.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.756 -1.572 . . . . 74.409999999999997 106.756 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -93.4 126.25 38.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 121.229 -0.189 . . . . 72.310000000000002 111.001 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.82 161.16 38.22 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.114 0.483 . . . . 70.439999999999998 110.111 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.06 133.29 53.67 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.059 0.457 . . . . 71.129999999999995 110.179 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.1 p -116.97 133.43 23.1 Favored Pre-proline 0 N--CA 1.413 -2.28 0 CA-C-N 115.583 -0.735 . . . . 71.439999999999998 109.482 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.8 123.66 13.06 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.435 2.09 . . . . 71.439999999999998 110.609 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 8.7 t -148.16 -177.99 6.05 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.557 -1.275 . . . . 65.299999999999997 107.557 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 463' ' ' LEU . 20.5 m -51.65 116.45 7.92 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.139 0.976 . . . . 73.200000000000003 110.492 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.92 -28.75 19.21 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 124.329 3.353 . . . . 74.140000000000001 116.065 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.19 -25.93 58.63 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.746 -0.596 . . . . 74.430000000000007 112.366 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 460' ' ' THR . 3.2 pp -92.8 12.04 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.695 -0.402 . . . . 71.209999999999994 112.038 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.6 p -53.29 130.85 15.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.428 0.632 . . . . 72.140000000000001 111.228 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.84 -13.32 59.21 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.819 -0.912 . . . . 61.32 110.819 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.01 147.25 26.41 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.305 0.574 . . . . 74.420000000000002 109.773 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 434' ' ' THR . 52.7 t -83.68 129.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.478 -0.783 . . . . 72.400000000000006 110.004 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -15.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 118.571 -1.251 . . . . 71.200000000000003 110.724 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.51 37.95 Favored Glycine 0 N--CA 1.418 -2.516 0 CA-C-N 115.331 -0.849 . . . . 62.43 111.146 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.9 p -136.15 161.87 34.53 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 7.7 t30 -62.97 -49.76 80.12 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 120.75 -0.38 . . . . 71.219999999999999 110.87 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.44 141.71 47.3 Favored 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 106.586 -2.121 . . . . 64.209999999999994 106.586 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.48 127.24 21.24 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.771 1.648 . . . . 63.539999999999999 112.699 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 -1.69 21.07 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.885 0.874 . . . . 73.109999999999999 113.162 -174.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -110.02 -4.27 15.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.028 -0.42 . . . . 72.420000000000002 110.136 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.3 176.51 5.6 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 114.626 1.343 . . . . 75.400000000000006 114.626 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 2.3 m -80.48 132.65 35.73 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.708 -1.587 . . . . 65.319999999999993 110.334 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.7 p -137.26 149.54 47.2 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.605 -0.887 . . . . 73.209999999999994 108.605 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.23 148.55 45.41 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 120.206 -0.598 . . . . 64.109999999999999 111.262 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.76 -28.24 44.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.865 0.84 . . . . 75.510000000000005 110.878 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 p -88.0 5.48 40.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.954 -1.021 . . . . 63.450000000000003 111.434 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.0 135.83 33.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.111 -1.44 . . . . 71.109999999999999 107.111 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 53.0 t -79.83 112.91 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.351 -1.351 . . . . 64.549999999999997 107.351 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.25 118.81 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 60.8 mt -92.6 113.39 27.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 106.469 -1.678 . . . . 74.329999999999998 106.469 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.18 116.46 39.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 108.545 -0.909 . . . . 74.140000000000001 108.545 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 12.3 pt -102.9 117.06 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.491 1.139 . . . . 71.430000000000007 111.571 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.67 132.88 40.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.557 -1.275 . . . . 73.340000000000003 107.557 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -68.92 113.58 5.31 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.773 -1.331 . . . . 74.310000000000002 109.773 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 8.7 m -135.01 103.72 5.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.759 -0.46 . . . . 72.019999999999996 109.759 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 108.399 -1.88 . . . . 65.310000000000002 108.399 178.837 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.492 -1.274 0 N-CA-C 104.679 -2.341 . . . . 73.200000000000003 104.679 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.74 152.92 19.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 119.522 -0.871 . . . . 74.299999999999997 113.149 -167.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.28 137.07 34.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.417 -1.697 . . . . 74.409999999999997 106.417 172.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.93 131.56 27.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 C-N-CA 119.27 -0.972 . . . . 73.219999999999999 109.711 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.65 150.74 51.04 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.7 2.933 . . . . 70.209999999999994 114.026 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -72.76 -30.13 63.88 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 110.459 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 42.5 t 66.77 27.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 124.193 1.949 . . . . 73.319999999999993 107.097 -174.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 28.0 ptt180 -58.17 125.08 21.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 112.464 -2.153 . . . . 70.140000000000001 113.362 -176.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.52 -16.78 54.63 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.863 -1.062 . . . . 54.32 111.719 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.89 170.23 8.04 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.796 0.439 . . . . 72.5 110.006 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.9 p -71.75 160.86 31.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.185 0.517 . . . . 71.549999999999997 111.998 -175.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 374' ' ' ILE . 11.3 p -62.05 -33.85 75.17 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.637 -0.711 . . . . 74.209999999999994 110.245 174.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.5 98.58 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.011 -0.54 . . . . 71.439999999999998 110.688 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.91 -39.83 79.44 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.847 -0.341 . . . . 72.519999999999996 110.249 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.3 72.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.187 -0.46 . . . . 43.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 370' ' ' SER . 1.7 mp -58.77 -45.26 91.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.661 178.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.55 83.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.169 -0.469 . . . . 72.549999999999997 111.769 -179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.3 m -61.62 -47.44 85.39 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.585 0.354 . . . . 73.420000000000002 111.229 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.84 -38.67 91.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.619 0.229 . . . . 74.129999999999995 111.619 178.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -46.16 90.12 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.501 0.72 . . . . 74.310000000000002 109.496 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -70.9 -16.62 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.32 -0.854 . . . . 64.120000000000005 112.484 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -87.31 -14.09 41.81 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.583 -0.895 . . . . 72.519999999999996 108.583 176.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.616 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.75 -2.67 55.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-N 115.089 -0.96 . . . . 74.120000000000005 111.976 178.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.72 150.6 34.42 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.162 0.506 . . . . 72.040000000000006 111.271 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 145.03 25.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.26 -1.756 . . . . 75.140000000000001 106.26 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.61 135.72 60.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.887 1.069 . . . . 73.530000000000001 113.887 -174.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -111.03 132.07 54.54 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.647 -1.983 . . . . 61.520000000000003 105.647 172.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.1 m -119.52 122.73 42.31 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.236 -0.586 . . . . 71.450000000000003 110.378 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.23 127.45 55.61 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.872 -1.159 . . . . 72.140000000000001 107.872 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.508 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -108.82 122.48 47.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.084 -0.71 . . . . 63.130000000000003 109.084 -179.257 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.2 OUTLIER -122.0 132.77 24.18 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.283 -0.417 . . . . 65.540000000000006 110.76 -177.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -97.56 137.6 0.44 Allowed 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 122.3 2.0 . . . . 74.510000000000005 113.152 176.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 13.8 t70 164.85 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 126.645 1.978 . . . . 74.209999999999994 106.277 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 25.9 m -138.27 -8.48 1.52 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 118.901 0.773 . . . . 64.439999999999998 111.909 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.79 -3.32 57.5 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 122.156 0.979 . . . . 74.430000000000007 109.601 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 7.4 pt -99.69 151.7 37.55 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 113.982 -1.463 . . . . 74.299999999999997 110.368 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.43 131.91 48.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.302 2.668 . . . . 64.230000000000004 113.932 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -55.3 164.54 3.78 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 124.913 3.742 . . . . 73.129999999999995 113.511 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.419 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 17.1 t70 -55.25 -9.9 0.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.493 1.517 . . . . 73.340000000000003 113.457 -174.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -87.58 124.31 33.37 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.921 -1.14 . . . . 74.519999999999996 107.921 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 44.8 t -63.16 119.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.607 -0.724 . . . . 75.329999999999998 109.845 -173.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.6 tp -90.5 -32.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.587 -0.733 . . . . 74.120000000000005 109.48 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -174.88 169.11 41.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.842 -0.903 . . . . 53.100000000000001 110.842 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.8 p -114.48 -176.69 2.96 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.066 0.947 . . . . 75.129999999999995 108.696 176.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.49 143.49 26.52 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 108.563 -0.903 . . . . 71.340000000000003 108.563 -176.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -37.23 -30.7 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.8 1 C-N-CA 125.394 4.063 . . . . 75.409999999999997 115.593 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.76 -32.15 70.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.126 0.489 . . . . 75.409999999999997 110.972 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.52 25.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.619 -0.718 . . . . 73.349999999999994 110.373 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -88.57 -7.09 57.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.393 -0.822 . . . . 74.0 111.661 -173.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.3 m -95.39 162.22 13.75 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.144 -1.428 . . . . 71.25 107.144 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 28.8 m -74.26 113.34 11.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 120.059 -0.656 . . . . 74.430000000000007 110.16 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.48 165.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.304 -0.862 . . . . 75.409999999999997 109.761 178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.8 m -75.51 141.64 42.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.96 129.93 42.01 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.294 0.569 . . . . 74.319999999999993 110.226 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 103.01 11.14 35.14 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.524 -0.846 . . . . 65.420000000000002 111.896 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.17 173.74 10.97 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.68 -1.23 . . . . 75.420000000000002 107.68 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -110.63 122.62 48.23 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.644 0.735 . . . . 74.409999999999997 111.366 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.8 mm -113.05 133.42 58.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.181 -0.918 . . . . 74.409999999999997 109.779 -175.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -102.69 124.87 49.02 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.479 -0.934 . . . . 72.0 108.479 177.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.48 134.39 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.596 -0.52 . . . . 72.400000000000006 109.596 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -110.05 129.23 55.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.186 -0.672 . . . . 73.310000000000002 109.186 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -128.59 141.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.838 -1.074 . . . . 74.310000000000002 108.211 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 10.6 m -95.9 122.62 38.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.546 -0.862 . . . . 72.510000000000005 110.102 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 59.8 p -117.82 107.48 14.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.758 -0.655 . . . . 75.120000000000005 110.985 -177.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.32 136.62 2.02 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.809 -0.632 . . . . 70.310000000000002 113.486 177.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 71.1 Cg_endo -75.67 155.02 39.82 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.33 2.02 . . . . 73.230000000000004 111.634 178.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.21 143.86 30.17 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 74.519999999999996 108.918 174.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.7 mt-30 -127.51 135.53 50.49 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.719 -1.215 . . . . 74.209999999999994 107.719 175.056 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -131.99 157.1 44.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.873 -0.788 . . . . 74.230000000000004 108.873 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.13 138.94 31.0 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.206 -1.405 . . . . 73.209999999999994 107.206 174.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -80.21 113.67 40.67 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.332 -0.618 . . . . 74.019999999999996 109.332 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.65 140.61 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.792 1.661 . . . . 61.130000000000003 109.878 176.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -107.47 97.58 7.3 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.375 1.083 . . . . 72.239999999999995 113.603 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.27 5.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 105.349 -2.093 . . . . 75.140000000000001 105.349 169.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 12.8 m -72.07 -46.42 56.95 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 113.447 -1.706 . . . . 71.540000000000006 110.393 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 23.1 p -65.37 -23.29 66.94 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.208 -0.906 . . . . 63.009999999999998 110.962 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.42 -48.07 7.34 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.461 -0.79 . . . . 73.439999999999998 111.326 -179.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.3 m -143.79 113.41 7.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.251 -178.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -55.48 -51.83 65.64 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.371 1.068 . . . . 74.310000000000002 112.608 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.46 -43.65 96.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.401 . . . . 74.329999999999998 111.212 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.66 -35.06 79.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.822 -0.627 . . . . 73.219999999999999 110.47 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.72 -48.52 81.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 116.012 -0.54 . . . . 63.5 110.666 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.43 -43.3 90.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-N 115.17 -0.923 . . . . 71.129999999999995 109.834 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 71.5 mmtt -66.43 -47.53 72.9 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 110.524 -177.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.57 -41.46 88.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 112.123 -177.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.31 -32.98 73.5 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.574 0.583 . . . . 75.420000000000002 112.574 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.4 m -66.96 -43.26 83.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.842 -0.799 . . . . 75.219999999999999 108.842 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.16 62.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.976 -0.556 . . . . 70.230000000000004 111.042 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.81 -13.11 59.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.413 0.625 . . . . 75.450000000000003 110.005 177.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.36 -6.31 45.79 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-O 119.223 -0.765 . . . . 53.109999999999999 114.016 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.17 130.71 44.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.118 0.959 . . . . 75.439999999999998 110.562 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.6 2.82 10.22 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.061 -1.066 . . . . 73.530000000000001 113.478 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.44 114.29 19.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.895 -0.779 . . . . 73.420000000000002 108.895 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -131.96 161.95 31.88 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.11 0.481 . . . . 75.530000000000001 110.731 -176.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' A' ' 453' ' ' LYS . 1.4 tpmt? -149.23 122.94 9.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 74.239999999999995 105.53 172.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -107.74 134.87 50.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.042 0.449 . . . . 72.129999999999995 111.193 -176.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.4 145.35 47.22 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.369 -0.832 . . . . 75.109999999999999 109.12 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 31.2 m-80 -117.65 129.51 55.79 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.372 -1.344 . . . . 63.420000000000002 107.372 175.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.8 t -130.23 147.37 65.46 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.853 -0.795 . . . . 65.230000000000004 108.853 -176.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -61.51 130.99 33.8 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 122.632 2.222 . . . . 74.519999999999996 111.489 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 55.1 p -136.23 -177.93 4.93 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.782 -1.192 . . . . 73.439999999999998 107.782 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.1 m -66.12 136.73 95.49 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 106.17 -1.789 . . . . 75.450000000000003 106.17 172.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.15 -28.16 19.06 Favored 'Trans proline' 0 C--O 1.207 -1.058 0 C-N-CA 123.583 2.855 . . . . 71.310000000000002 113.334 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -62.24 -16.76 55.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.496 0.554 . . . . 74.400000000000006 112.496 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.59 6.0 27.49 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.108 -0.37 . . . . 71.030000000000001 110.866 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.76 127.44 19.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.446 0.641 . . . . 64.319999999999993 111.807 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.56 -3.37 85.14 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.495 -0.775 . . . . 71.150000000000006 112.692 175.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -112.1 160.79 17.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.499 -0.926 . . . . 72.030000000000001 108.499 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.49 131.34 34.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.588 -0.893 . . . . 73.430000000000007 108.588 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.48 -20.75 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.239 0.543 . . . . 74.120000000000005 111.437 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.35 166.73 30.59 Favored Glycine 0 N--CA 1.418 -2.559 0 C-N-CA 120.46 -0.876 . . . . 64.420000000000002 111.891 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.0 p -125.01 144.2 50.51 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.194 -1.41 . . . . 75.239999999999995 107.194 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.7 t-20 -57.41 -48.19 97.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 120.604 -0.438 . . . . 63.119999999999997 110.899 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -78.25 121.04 5.12 Favored 'Trans proline' 0 C--N 1.37 1.66 0 N-CA-C 107.952 -1.595 . . . . 74.030000000000001 107.952 168.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.13 140.79 80.11 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.377 2.052 . . . . 74.340000000000003 112.401 -176.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.423 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.17 11.59 0.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.675 0.79 . . . . 62.119999999999997 112.754 -176.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -109.81 -0.16 18.52 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.882 -0.414 . . . . 73.219999999999999 109.882 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.431 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.1 OUTLIER -124.65 160.99 27.24 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.645 0.735 . . . . 74.239999999999995 111.473 -173.279 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -91.16 132.69 35.91 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.961 -1.472 . . . . 63.539999999999999 109.732 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.2 m -132.11 148.4 52.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.949 -0.76 . . . . 63.340000000000003 108.949 177.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.75 159.67 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.261 0.553 . . . . 44.100000000000001 111.848 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.0 -27.2 31.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.545 0.688 . . . . 74.439999999999998 109.835 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.1 t -88.11 5.12 42.73 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.255 -0.884 . . . . 64.140000000000001 109.905 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.76 136.83 35.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.989 -1.486 . . . . 72.530000000000001 106.989 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 65.0 t -82.57 116.36 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.942 0.401 . . . . 72.340000000000003 109.99 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.81 118.57 33.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.355 -0.98 . . . . 74.329999999999998 108.355 177.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.2 mp -92.78 112.95 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.017 -1.475 . . . . 73.439999999999998 107.017 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.65 118.3 49.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.164 -1.051 . . . . 73.540000000000006 108.164 -177.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 28.8 mt -107.45 119.5 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 121.472 0.654 . . . . 74.439999999999998 109.986 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.439 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 22.1 t -97.99 139.26 20.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.446 -0.946 . . . . 74.040000000000006 108.446 -178.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.87 124.5 7.01 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.193 -0.763 . . . . 61.409999999999997 111.193 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 20.1 t -131.87 103.64 6.43 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.821 -1.177 . . . . 75.25 107.821 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.249 0 N-CA-C 109.756 -1.338 . . . . 71.329999999999998 109.756 179.222 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.32 -0.993 . . . . 75.239999999999995 108.32 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.41 161.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 116.54 -0.3 . . . . 72.109999999999999 110.832 -173.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 137.08 37.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.388 -0.967 . . . . 75.109999999999999 108.388 175.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.0 135.14 21.54 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.695 -0.483 . . . . 70.519999999999996 109.695 -176.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.6 150.92 86.13 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.256 1.97 . . . . 71.310000000000002 112.012 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.576 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 3.2 p30 -79.09 179.75 7.17 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.384 -0.825 . . . . 74.349999999999994 110.674 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.67 26.4 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 N-CA-C 107.433 -1.321 . . . . 73.439999999999998 107.433 176.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.576 ' HG3' ' OD1' ' A' ' 364' ' ' ASP . 0.9 OUTLIER -66.25 139.47 58.08 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.563 0.579 . . . . 74.230000000000004 112.563 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.65 0.24 59.28 Favored Glycine 0 C--N 1.307 -1.081 0 N-CA-C 111.577 -0.609 . . . . 53.200000000000003 111.577 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -122.57 -168.12 1.68 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.907 0.483 . . . . 70.099999999999994 109.718 -178.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -89.1 158.18 18.04 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.757 0.313 . . . . 75.019999999999996 110.548 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 31.1 t -63.37 -33.73 76.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.831 -0.803 . . . . 70.310000000000002 108.831 173.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.1 88.56 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.556 -0.747 . . . . 75.140000000000001 110.83 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.73 -43.92 87.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.491 -0.559 . . . . 72.439999999999998 109.491 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.5 -45.85 80.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.563 -0.744 . . . . 75.230000000000004 111.788 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.17 -48.06 89.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 123.382 0.426 . . . . 73.430000000000007 110.853 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.51 70.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.374 0.509 . . . . 71.439999999999998 112.374 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.616 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.0 m -61.35 -48.07 82.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.252 -0.431 . . . . 71.530000000000001 111.492 -177.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.92 -37.84 88.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.703 0.287 . . . . 73.129999999999995 111.398 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -60.59 -44.62 96.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.402 0.681 . . . . 73.25 109.879 177.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.08 -22.64 64.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.729 -0.668 . . . . 74.340000000000003 111.284 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.2 mmt180 -84.13 -14.27 50.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.088 0.47 . . . . 74.349999999999994 109.843 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.425 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 99.54 4.68 55.95 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.707 -0.679 . . . . 72.349999999999994 112.554 176.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.88 160.54 17.16 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 120.84 0.353 . . . . 74.200000000000003 110.487 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.37 142.82 32.21 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.69 -1.596 . . . . 74.219999999999999 106.69 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.09 132.61 67.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.996 -0.681 . . . . 75.049999999999997 111.384 -178.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -109.11 126.51 53.27 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 105.751 -1.944 . . . . 72.25 105.751 176.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 m -116.05 118.19 32.2 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 120.305 -0.558 . . . . 73.519999999999996 110.302 -173.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.06 119.18 34.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.097 -1.446 . . . . 74.140000000000001 107.097 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -118.1 133.53 55.82 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.956 -0.757 . . . . 75.409999999999997 108.956 178.177 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -139.47 148.85 58.01 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 109.432 -0.581 . . . . 74.010000000000005 109.432 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.07 136.61 16.51 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 108.158 -1.516 . . . . 74.409999999999997 108.158 167.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t0 -173.15 164.73 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.032 -2.21 . . . . 63.020000000000003 105.032 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.452 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.3 t -115.96 -9.39 11.78 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 118.89 0.768 . . . . 75.129999999999995 110.664 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.8 m -79.5 -18.01 52.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.925 0.869 . . . . 75.319999999999993 109.386 -176.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.7 pt -103.48 150.87 38.47 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 72.049999999999997 110.333 -178.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 46.8 Cg_endo -78.74 -166.74 0.43 Allowed 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 124.425 3.416 . . . . 73.319999999999993 113.123 -174.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 9.3 Cg_endo -55.74 163.91 5.03 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.292 2.661 . . . . 71.239999999999995 112.011 168.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.44 -7.89 0.46 Allowed 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.886 1.674 . . . . 51.200000000000003 113.631 -174.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -73.28 116.63 14.05 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.309 -0.997 . . . . 63.539999999999999 108.309 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.87 119.2 11.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.384 -0.825 . . . . 75.329999999999998 110.817 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.93 -27.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.695 -0.684 . . . . 73.230000000000004 111.682 -177.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.08 158.33 27.65 Favored Glycine 0 N--CA 1.423 -2.19 0 C-N-CA 120.021 -1.085 . . . . 73.329999999999998 110.652 -178.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -113.22 -178.21 3.32 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.758 -0.46 . . . . 75.519999999999996 109.758 -178.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.93 131.99 22.65 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 108.338 -0.986 . . . . 65.519999999999996 108.338 -177.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -44.32 -32.52 5.29 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 124.521 3.481 . . . . 73.219999999999999 115.158 -176.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.89 68.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.371 -0.377 . . . . 61.200000000000003 111.581 -177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.54 79.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.44 0.638 . . . . 71.319999999999993 110.579 178.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -88.81 1.07 55.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.202 -0.599 . . . . 70.140000000000001 111.118 -178.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.7 m -86.35 150.04 24.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.715 -1.217 . . . . 73.420000000000002 107.715 172.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.58 112.43 10.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.53 169.98 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.859 -0.609 . . . . 75.219999999999999 110.77 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -63.19 142.99 58.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.754 -0.657 . . . . 63.130000000000003 109.967 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.96 109.74 2.65 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.562 -0.533 . . . . 74.420000000000002 109.562 177.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 106.01 33.56 3.46 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.578 -0.82 . . . . 74.430000000000007 112.079 -178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -90.4 177.26 6.44 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.084 -1.08 . . . . 63.450000000000003 108.084 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.04 120.17 36.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.22 0.533 . . . . 72.510000000000005 111.158 -177.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.84 126.03 59.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.126 -1.435 . . . . 75.209999999999994 107.126 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.1 t -93.62 125.21 38.1 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.275 1.036 . . . . 72.030000000000001 111.556 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.02 120.01 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 73.239999999999995 107.655 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.82 119.11 32.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.813 -0.63 . . . . 53.420000000000002 109.301 178.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 21.5 t -117.22 142.12 32.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.617 -0.72 . . . . 75.439999999999998 109.809 -175.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 1.9 p -102.27 121.55 42.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 116.071 -0.513 . . . . 63.020000000000003 110.309 177.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.1 p -119.75 105.46 11.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.236 -0.585 . . . . 74.129999999999995 110.861 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.93 120.74 0.18 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 121.143 -0.551 . . . . 72.340000000000003 113.639 178.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 55.7 Cg_endo -75.22 128.95 11.71 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.239 1.959 . . . . 74.319999999999993 111.654 176.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -73.33 135.1 44.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.351 0.871 . . . . 75.099999999999994 113.351 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.5 mt-30 -128.04 142.44 51.22 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.28 -1.378 . . . . 63.119999999999997 107.28 172.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -129.56 151.78 49.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.642 -0.873 . . . . 74.310000000000002 108.642 -178.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 39.9 mt-10 -83.45 133.91 34.89 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.886 -0.413 . . . . 74.510000000000005 109.886 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 61.2 mt -81.96 128.53 68.06 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.507 -1.294 . . . . 63.229999999999997 107.507 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.87 140.37 35.03 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 121.141 1.228 . . . . 72.219999999999999 111.122 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.29 72.62 5.33 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.057 0.932 . . . . 73.129999999999995 110.813 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.1 16.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.953 -1.476 . . . . 74.109999999999999 108.454 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -81.26 -24.85 37.04 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.991 -1.004 . . . . 71.040000000000006 110.586 -175.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 3.1 p -69.26 -13.73 62.56 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 113.103 0.779 . . . . 72.209999999999994 113.103 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.61 -47.63 72.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.642 0.608 . . . . 72.439999999999998 112.642 -177.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.1 m -162.37 137.94 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.394 -0.965 . . . . 75.129999999999995 108.394 -178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -53.77 -50.12 66.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.8 0.44 . . . . 72.439999999999998 111.826 178.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.98 90.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.361 0.413 . . . . 72.120000000000005 111.076 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 72.9 mm-40 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 71.319999999999993 111.17 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.09 92.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.82 0.7 . . . . 74.439999999999998 110.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.84 -42.51 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 64.510000000000005 109.975 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -67.08 -44.99 78.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.288 -0.414 . . . . 74.530000000000001 111.036 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 32.9 mmmt -61.97 -46.28 89.95 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.009 0.193 . . . . 75.040000000000006 110.887 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.18 81.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.486 0.551 . . . . 72.519999999999996 112.486 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 64.0 m -62.44 -40.85 97.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.807 -0.442 . . . . 65.530000000000001 109.807 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.45 -29.75 68.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.040000000000006 111.206 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -6.75 57.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 73.420000000000002 111.198 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.2 -2.82 33.14 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.06 -0.59 . . . . 73.310000000000002 113.412 175.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -93.63 96.0 9.56 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.665 -0.495 . . . . 74.109999999999999 109.665 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -104.38 -3.91 43.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.115 -0.794 . . . . 63.119999999999997 111.115 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -93.92 112.08 23.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.514 -0.921 . . . . 72.120000000000005 108.514 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.67 150.99 48.68 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.469 0.652 . . . . 72.340000000000003 112.011 -175.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -134.28 122.41 22.67 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 105.067 -2.197 . . . . 73.340000000000003 105.067 172.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -97.9 129.81 44.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.07 -0.652 . . . . 53.140000000000001 112.435 -174.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.69 150.97 50.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.142 -1.429 . . . . 72.409999999999997 107.142 175.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.551 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 35.9 m-80 -129.44 149.5 51.19 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.634 -0.506 . . . . 73.129999999999995 109.634 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.2 t -128.97 133.61 25.4 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 107.438 -1.319 . . . . 73.230000000000004 107.438 177.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.5 Cg_exo -61.9 118.73 5.63 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.493 1.462 . . . . 72.150000000000006 108.622 176.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.9 m -128.07 168.27 15.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.188 0.518 . . . . 74.430000000000007 111.852 -172.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 21.0 p -69.55 151.89 96.49 Favored Pre-proline 0 N--CA 1.417 -2.095 0 CA-C-N 114.705 -1.134 . . . . 72.25 110.452 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.513 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.2 Cg_endo -52.13 -24.48 20.26 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.827 3.018 . . . . 65.519999999999996 114.937 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.44 -30.56 57.42 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.721 -0.612 . . . . 74.120000000000005 112.282 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.71 -3.26 49.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.178 0.436 . . . . 64.109999999999999 112.178 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.2 p -60.2 127.16 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.116 0.484 . . . . 71.530000000000001 110.636 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.57 82.58 Favored Glycine 0 C--O 1.248 1.009 0 CA-C-N 115.773 -0.649 . . . . 53.100000000000001 111.746 177.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -110.66 154.37 23.92 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.019 -0.734 . . . . 73.200000000000003 109.019 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 434' ' ' THR . 57.5 t -84.61 135.06 25.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 N-CA-C 106.644 -1.613 . . . . 54.030000000000001 106.644 175.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.43 -27.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.042 -1.463 . . . . 75.120000000000005 110.687 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.01 163.7 34.0 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.797 -0.921 . . . . 74.109999999999999 110.797 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.6 p -119.02 154.49 33.01 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.941 -1.133 . . . . 73.0 107.941 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.439 ' HB3' ' HB ' ' A' ' 485' ' ' ILE . 24.4 t-20 -69.38 -51.26 17.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 119.619 -0.833 . . . . 65.129999999999995 110.627 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.5 Cg_exo -68.35 141.32 51.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 107.443 -1.791 . . . . 64.420000000000002 107.443 168.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.19 126.85 19.56 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 122.168 1.912 . . . . 71.409999999999997 112.984 -175.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.19 4.47 26.57 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.144 -0.934 . . . . 72.010000000000005 111.785 -175.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.6 OUTLIER -109.67 -11.62 14.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.351 175.537 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -114.08 -179.73 3.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.606 1.706 . . . . 72.030000000000001 115.606 -168.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.8 m -88.2 116.18 26.22 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.866 -1.97 . . . . 72.340000000000003 110.676 -174.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.8 m -121.36 148.18 44.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.19 -0.67 . . . . 73.510000000000005 109.19 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.9 149.18 50.06 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 122.392 0.277 . . . . 72.099999999999994 111.122 -177.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 43.2 mm -68.9 -26.02 31.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.195 0.521 . . . . 75.120000000000005 111.019 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -88.83 -0.5 57.41 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.501 -0.75 . . . . 52.009999999999998 110.049 177.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -70.42 130.94 43.24 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.473 -0.566 . . . . 74.310000000000002 109.473 -176.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.87 113.18 18.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.564 -1.273 . . . . 74.209999999999994 107.564 177.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.16 120.06 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-O 121.321 0.581 . . . . 74.540000000000006 109.871 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 45.4 mt -91.2 112.28 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.605 -1.998 . . . . 73.439999999999998 105.605 177.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 121.45 60.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.667 0 CA-C-N 115.016 -0.993 . . . . 72.329999999999998 108.404 -174.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 2.4 mp -99.22 117.87 44.97 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.767 0.794 . . . . 75.040000000000006 109.049 -177.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.551 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 26.7 t -97.66 141.36 16.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.809 -1.087 . . . . 64.549999999999997 108.54 -176.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -89.4 116.81 4.79 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.49 -1.444 . . . . 72.140000000000001 109.49 175.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.0 t -136.6 138.93 41.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.006 -1.109 . . . . 75.530000000000001 108.006 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.562 0 N-CA-C 108.555 -1.818 . . . . 55.420000000000002 108.555 179.675 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 411' ' ' SER . 28.1 m-20 . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 106.491 -1.67 . . . . 71.310000000000002 106.491 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.97 165.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 114.682 1.364 . . . . 71.439999999999998 114.682 -166.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -93.11 137.03 32.83 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.507 -1.664 . . . . 74.099999999999994 106.507 174.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.66 141.61 23.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.109 -0.636 . . . . 74.200000000000003 111.078 -171.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.63 129.92 16.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.569 1.513 . . . . 72.319999999999993 111.435 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 8.1 p-10 -80.12 133.78 36.11 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.355 -0.839 . . . . 63.009999999999998 110.372 -179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.9 t -87.74 47.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.443 1.116 . . . . 73.140000000000001 110.513 -172.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.3 ptm180 -66.88 139.97 57.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.134 -0.939 . . . . 75.25 111.544 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.05 0.18 60.15 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 116.117 -0.492 . . . . 73.129999999999995 112.906 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -120.35 175.35 6.01 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 122.509 -0.406 . . . . 74.150000000000006 110.154 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.3 p -72.98 157.24 37.8 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.218 -0.29 . . . . 54.100000000000001 110.218 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.2 p -59.78 -39.05 83.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.848 -0.427 . . . . 72.109999999999999 109.848 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.77 93.25 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.412 -0.813 . . . . 70.439999999999998 111.993 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -67.13 -41.99 85.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 -178.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.3 78.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.421 -0.809 . . . . 64.209999999999994 111.189 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 370' ' ' SER . 98.7 mt -58.63 -44.83 90.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.577 -0.527 . . . . 75.450000000000003 109.577 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.66 74.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.25 -0.886 . . . . 62.109999999999999 112.063 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 29.1 m -66.12 -48.66 70.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.415 0.626 . . . . 74.120000000000005 109.872 -179.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.89 -39.83 91.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.782 -0.645 . . . . 74.439999999999998 110.581 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.6 -44.9 96.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 74.140000000000001 110.668 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -70.08 -21.31 63.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.153 0.501 . . . . 64.549999999999997 111.261 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -86.98 -14.65 41.08 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.158 -0.474 . . . . 72.299999999999997 111.458 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.26 8.05 66.89 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.261 -0.971 . . . . 75.0 112.657 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -75.36 163.75 27.12 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.158 -0.682 . . . . 73.5 109.158 178.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.8 mmtm -103.29 132.85 49.22 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.349 -0.982 . . . . 74.5 108.349 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.17 153.87 39.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 121.742 0.782 . . . . 74.109999999999999 112.823 -175.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -123.33 128.23 49.64 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.529 -1.669 . . . . 64.329999999999998 106.78 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.6 m -106.25 117.75 34.85 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.114 -1.069 . . . . 74.420000000000002 108.114 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.4 tm? -111.66 118.93 37.0 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 107.741 -1.207 . . . . 74.049999999999997 107.741 -176.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.41 122.2 46.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.32 -0.993 . . . . 75.0 108.32 174.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -125.87 136.29 28.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 C-N-CA 120.446 -0.502 . . . . 72.340000000000003 111.706 -176.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.416 ' C ' ' HG3' ' A' ' 425' ' ' GLU . 2.4 Cg_endo -85.51 131.43 4.04 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 122.197 1.932 . . . . 72.519999999999996 108.163 167.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -175.3 -173.67 0.67 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.431 -2.063 . . . . 73.5 105.431 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 49.7 m -117.36 -6.6 11.24 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.943 0.877 . . . . 63.329999999999998 109.116 175.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.9 m -98.36 35.45 1.78 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.717 -1.586 . . . . 75.340000000000003 106.717 175.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.4 pp -88.33 146.43 37.86 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.893 -1.049 . . . . 73.230000000000004 112.131 -176.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.09 178.44 5.89 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.148 1.899 . . . . 70.310000000000002 109.399 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 398' ' ' HIS . 16.5 Cg_exo -71.28 161.37 45.95 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 121.609 1.539 . . . . 75.049999999999997 110.648 172.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -9.0 3.52 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.418 1.104 . . . . 75.239999999999995 111.095 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 396' ' ' PRO . 34.0 m80 -110.42 137.07 48.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 105.379 -2.082 . . . . 74.400000000000006 105.379 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.54 118.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 123.453 0.471 . . . . 63.109999999999999 109.748 -173.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.424 ' O ' HD11 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.31 -29.32 4.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.769 -1.567 . . . . 72.209999999999994 106.769 178.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.66 168.6 41.67 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 108.995 -1.642 . . . . 61.25 108.995 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 402' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 364' ' ' ASP . 10.9 m -114.33 -177.07 3.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.583 -1.636 . . . . 72.400000000000006 106.583 178.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -97.53 140.06 21.77 Favored Pre-proline 0 C--N 1.26 -3.307 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 -175.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -33.81 -30.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 1 C-N-CA 126.209 4.606 . . . . 75.510000000000005 115.53 -177.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.82 47.16 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 123.611 0.765 . . . . 74.230000000000004 112.014 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.87 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 74.349999999999994 111.612 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -81.56 -0.6 42.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.837 0.68 . . . . 74.420000000000002 112.837 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 58.8 m -88.37 155.68 19.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.12 -1.437 . . . . 74.299999999999997 107.12 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.7 m -73.12 114.02 10.82 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.492 0.663 . . . . 74.310000000000002 109.273 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.74 170.29 5.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.305 -0.861 . . . . 72.25 109.537 -178.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 411' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 8.5 t -71.01 149.14 46.92 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 109.219 -0.66 . . . . 74.439999999999998 109.219 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.22 109.66 2.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.442 -0.948 . . . . 73.219999999999999 108.442 177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.36 32.62 9.36 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.923 -0.871 . . . . 50.310000000000002 110.923 -176.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.6 t0 -87.05 -174.9 5.13 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 107.831 -1.174 . . . . 63.109999999999999 107.831 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 7.9 pt-20 -97.45 138.11 35.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.51 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -125.01 124.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.933 -1.136 . . . . 73.209999999999994 107.933 175.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -90.86 125.95 35.89 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.846 0.831 . . . . 71.349999999999994 110.533 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.99 117.71 56.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.15 -1.055 . . . . 70.299999999999997 108.15 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 5.3 p30 -106.33 129.44 54.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.308 0.575 . . . . 74.239999999999995 112.468 -177.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.8 152.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.763 -1.108 . . . . 73.420000000000002 108.588 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 31.1 p -88.56 123.29 32.91 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.672 0.619 . . . . 71.120000000000005 112.672 -174.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 p -119.87 103.46 9.36 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.13 -1.028 . . . . 73.430000000000007 110.067 169.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.13 0.12 Allowed Glycine 0 CA--C 1.553 2.428 0 N-CA-C 115.473 0.949 . . . . 74.209999999999994 115.473 177.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.8 Cg_endo -85.47 133.65 4.61 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.202 1.935 . . . . 71.209999999999994 110.652 173.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.416 ' HG3' ' C ' ' A' ' 390' ' ' PRO . 10.0 mt-10 -76.44 145.19 39.45 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 113.167 0.803 . . . . 75.329999999999998 113.167 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.9 mt-30 -120.66 157.23 30.04 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.183 -1.371 . . . . 74.420000000000002 108.748 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -143.17 156.62 44.81 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.413 -1.329 . . . . 73.439999999999998 107.413 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.8 138.86 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.132 -1.062 . . . . 72.420000000000002 108.132 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.52 132.14 62.84 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 75.349999999999994 108.687 -177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -53.19 141.53 58.64 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.607 2.205 . . . . 74.140000000000001 113.224 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.13 -17.72 48.91 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.505 -1.225 . . . . 73.010000000000005 112.19 -175.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.5 m -75.47 5.41 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.448 0.907 . . . . 64.230000000000004 113.448 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 48.3 m -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.264 0.839 . . . . 72.319999999999993 113.264 -175.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 52.5 m -68.92 -13.91 62.72 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.973 0.509 . . . . 74.140000000000001 112.365 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.16 -45.51 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.61 0.596 . . . . 73.040000000000006 112.61 -175.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.1 m -162.73 145.22 10.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.525 -1.287 . . . . 72.319999999999993 107.525 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -56.84 -42.93 80.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.329 . . . . 74.010000000000005 111.102 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -62.62 -36.76 83.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 71.019999999999996 111.048 179.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.8 -44.77 76.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.07 -0.715 . . . . 64.340000000000003 109.07 -178.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.18 70.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.545 -1.207 . . . . 72.230000000000004 110.773 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.43 -38.29 80.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 -177.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.8 mmtt -65.3 -49.02 71.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.9 -0.72 . . . . 74.319999999999993 110.166 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.01 -42.57 84.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.116 0.784 . . . . 74.299999999999997 113.116 -177.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.37 -43.69 76.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.231 0.456 . . . . 71.5 112.231 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -63.31 -41.86 98.97 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.951 0.405 . . . . 72.299999999999997 110.628 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.0 -24.64 62.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.96 -0.564 . . . . 63.149999999999999 111.602 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.56 -5.83 59.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 70.209999999999994 111.453 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.59 -17.73 25.47 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.473 -0.87 . . . . 63.030000000000001 112.204 178.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.04 67.89 7.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.201 0.524 . . . . 74.129999999999995 109.921 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -96.2 32.49 6.38 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.67 -0.972 . . . . 75.420000000000002 110.67 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -118.7 110.42 17.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.023 -1.843 . . . . 65.120000000000005 106.023 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.89 154.15 47.6 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.339 1.066 . . . . 74.299999999999997 113.084 -176.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.58 123.11 12.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 104.998 -2.223 . . . . 74.430000000000007 104.998 168.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -98.11 135.34 39.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.207 0.527 . . . . 74.329999999999998 111.469 -172.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.416 ' C ' HD21 ' A' ' 456' ' ' ASN . . . -127.09 148.01 50.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.425 -1.324 . . . . 65.420000000000002 107.425 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.416 HD21 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -124.44 141.42 52.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.088 -1.078 . . . . 63.520000000000003 108.088 178.253 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.2 m -140.36 147.14 48.51 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 108.862 -0.792 . . . . 74.439999999999998 108.862 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 490' ' ' SER . 33.8 Cg_exo -61.45 129.66 28.95 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.708 2.272 . . . . 75.299999999999997 111.678 -176.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -145.83 164.68 31.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 111.035 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -61.37 144.6 91.75 Favored Pre-proline 0 N--CA 1.442 -0.864 0 O-C-N 124.27 0.981 . . . . 74.120000000000005 110.463 178.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.37 -34.28 31.93 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.996 3.131 . . . . 74.219999999999999 113.832 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.77 -15.3 62.66 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.381 0.511 . . . . 75.530000000000001 112.381 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 -8.52 14.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.504 -0.316 . . . . 75.450000000000003 111.775 176.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 81.3 t -60.35 126.94 19.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 120.953 0.406 . . . . 74.319999999999993 110.546 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.87 -3.16 70.36 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 110.962 -0.855 . . . . 75.099999999999994 110.962 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -116.38 155.44 28.48 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.086 -1.079 . . . . 75.310000000000002 108.086 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 486' ' ' ILE . 45.5 t -84.57 127.36 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.511 -0.551 . . . . 62.420000000000002 109.511 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.85 -18.14 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.929 -0.708 . . . . 74.120000000000005 111.405 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.19 161.7 28.04 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.574 -0.822 . . . . 73.140000000000001 111.708 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 15.9 p -132.92 155.47 49.01 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.366 -1.346 . . . . 73.439999999999998 107.366 177.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -59.53 -57.85 23.87 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 120.516 -0.474 . . . . 73.329999999999998 110.103 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.19 125.21 5.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 109.09 -1.158 . . . . 74.519999999999996 109.09 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -62.36 144.17 94.7 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.057 1.838 . . . . 72.109999999999999 112.044 -177.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.29 5.98 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.159 0.984 . . . . 65.319999999999993 112.674 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -109.0 -14.51 14.54 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 110.029 176.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.97 150.64 20.18 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.156 0.979 . . . . 74.239999999999995 111.717 -172.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 19.4 m -85.23 111.42 19.82 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 113.588 -1.642 . . . . 71.219999999999999 107.769 178.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.0 m -118.19 148.56 42.25 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.917 -0.583 . . . . 73.120000000000005 110.036 -175.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.58 146.72 52.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 122.587 0.355 . . . . 70.430000000000007 110.781 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 48.3 mm -67.21 -14.68 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 CA-C-O 122.171 0.986 . . . . 74.510000000000005 110.306 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.0 t -92.16 5.52 50.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.603 -0.726 . . . . 71.310000000000002 110.358 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.459 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -89.66 133.76 34.49 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 110.062 -0.347 . . . . 72.329999999999998 110.062 178.399 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 122.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.855 -1.165 . . . . 71.209999999999994 107.855 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.77 119.79 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 120.19 -0.604 . . . . 75.319999999999993 109.49 -178.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.35 112.51 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.596 -2.372 . . . . 75.510000000000005 104.596 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.73 118.93 56.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 114.959 -1.018 . . . . 74.120000000000005 108.754 -173.528 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 41.2 mt -100.16 116.49 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.994 -0.743 . . . . 74.129999999999995 108.994 -177.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.6 138.14 23.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.692 -1.225 . . . . 73.519999999999996 107.692 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.48 114.69 3.93 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.285 -1.526 . . . . 64.340000000000003 109.285 177.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.7 m -142.9 143.93 32.23 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 122.009 -0.7 . . . . 74.140000000000001 109.667 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.364 0 N-CA-C 108.693 -1.763 . . . . 53.130000000000003 108.693 178.252 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.502 -0.897 0 N-CA-C 106.675 -1.602 . . . . 72.030000000000001 106.675 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.94 149.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.585 0.231 . . . . 74.420000000000002 110.45 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.8 136.48 36.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.637 -0.875 . . . . 74.109999999999999 108.637 177.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.86 127.49 37.04 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 120.329 -0.548 . . . . 75.109999999999999 110.389 -175.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -56.05 148.83 56.34 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.086 2.524 . . . . 60.0 113.388 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 146.3 53.03 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.392 -0.822 . . . . 74.230000000000004 111.493 -178.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.531 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 24.2 m -96.37 25.31 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 122.337 1.065 . . . . 72.040000000000006 109.659 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -65.32 137.17 57.35 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.778 -1.101 . . . . 75.439999999999998 111.995 -177.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.43 0.91 47.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.451 -0.88 . . . . 73.450000000000003 114.001 176.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 1.8 pt20 -125.83 -172.16 2.54 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.193 -0.669 . . . . 55.219999999999999 109.193 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.3 p -90.11 164.48 14.45 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.81 -0.756 . . . . 74.310000000000002 109.701 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 374' ' ' ILE . 3.8 p -62.09 -33.61 74.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.798 0.332 . . . . 74.239999999999995 110.305 175.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.66 98.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.794 -0.639 . . . . 73.420000000000002 109.962 176.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.321 -0.4 . . . . 72.25 110.108 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.29 70.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.763 0.665 . . . . 72.219999999999999 110.47 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 370' ' ' SER . 91.0 mt -60.25 -46.51 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.646 -0.706 . . . . 74.0 110.046 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.29 -46.99 84.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.105 -0.498 . . . . 74.200000000000003 111.905 -178.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.83 -47.84 76.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.516 -0.311 . . . . 74.230000000000004 110.431 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.17 -38.01 89.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.561 -0.29 . . . . 73.120000000000005 111.695 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -59.77 -46.92 87.67 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.601 0.76 . . . . 74.010000000000005 109.11 177.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -67.97 -30.73 70.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.558 -0.746 . . . . 72.349999999999994 111.193 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -80.09 -11.29 59.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.839 -0.619 . . . . 64.140000000000001 111.917 178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.72 12.46 58.04 Favored Glycine 0 CA--C 1.497 -1.034 0 C-N-CA 120.284 -0.96 . . . . 62.539999999999999 112.953 174.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.21 146.46 24.74 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.972 0.415 . . . . 74.049999999999997 109.954 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 34.0 mmtp -88.3 132.82 34.25 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.832 -1.914 . . . . 74.530000000000001 105.832 -178.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 141.45 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 119.899 -0.72 . . . . 73.310000000000002 111.674 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -115.99 127.98 55.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.175 -1.417 . . . . 75.310000000000002 107.175 177.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.6 m -101.06 119.27 38.5 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.597 -0.841 . . . . 73.140000000000001 109.709 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -111.73 119.65 39.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.64 -1.244 . . . . 74.430000000000007 107.64 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -96.27 122.6 39.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.648 -0.706 . . . . 72.209999999999994 109.25 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -123.79 115.89 27.87 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 115.737 -0.665 . . . . 73.439999999999998 111.883 -177.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.59 134.7 6.62 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.18 1.92 . . . . 64.530000000000001 110.569 174.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.5 t70 175.71 -168.42 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 105.396 -2.076 . . . . 74.040000000000006 105.396 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.6 m -132.43 -11.0 3.2 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 118.38 0.537 . . . . 74.319999999999993 111.42 176.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 44.9 p -99.13 14.35 29.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.357 1.075 . . . . 63.100000000000001 109.5 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.5 pp -88.59 152.6 49.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 CA-C-N 113.877 -1.511 . . . . 74.010000000000005 112.583 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.66 138.65 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.152 1.901 . . . . 73.140000000000001 109.921 174.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.25 154.5 40.05 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.796 2.33 . . . . 64.120000000000005 111.893 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.32 -8.48 3.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.506 0.67 . . . . 74.530000000000001 111.866 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -95.66 109.19 21.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.143 -2.169 . . . . 74.209999999999994 105.143 172.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.8 119.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.232 1.015 . . . . 72.030000000000001 112.85 -169.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.46 -29.02 3.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.063 -1.426 . . . . 73.5 110.504 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.54 28.88 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.029 -1.228 . . . . 71.430000000000007 110.029 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 -175.23 2.63 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.874 -0.787 . . . . 73.349999999999994 108.874 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.31 140.93 21.83 Favored Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 115.777 -0.647 . . . . 75.319999999999993 109.795 -172.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.27 -24.77 6.24 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 125.077 3.852 . . . . 64.120000000000005 115.059 -177.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.01 -29.34 69.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.591 0.234 . . . . 53.420000000000002 110.981 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.33 57.96 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 121.673 0.749 . . . . 73.25 110.13 178.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.4 -9.68 59.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.359 -0.837 . . . . 75.310000000000002 110.733 -178.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.2 m -87.53 151.08 23.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.613 -0.884 . . . . 73.430000000000007 108.613 177.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 66.3 m -74.17 116.81 15.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.412 0.625 . . . . 72.109999999999999 109.636 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.09 169.97 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.444 -0.798 . . . . 73.150000000000006 109.501 -177.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.0 t -79.02 155.4 28.85 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.746 -1.205 . . . . 74.030000000000001 107.746 176.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.3 110.74 4.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.244 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.07 37.7 1.63 Allowed Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.585 -0.734 . . . . 75.329999999999998 111.707 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.31 178.57 5.93 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.722 -1.214 . . . . 71.140000000000001 107.722 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.0 mt-10 -100.19 108.97 21.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 111.525 -176.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.01 126.78 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.377 -1.342 . . . . 75.0 107.377 177.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 72.5 p -90.71 123.49 34.34 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.296 -0.562 . . . . 54.100000000000001 109.763 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.34 121.07 47.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.18 -1.045 . . . . 75.299999999999997 108.18 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -92.24 124.6 36.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.313 -0.625 . . . . 71.510000000000005 109.313 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.7 p -126.26 131.03 71.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.89 -1.152 . . . . 72.150000000000006 107.89 175.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 39.9 m -94.4 122.13 36.65 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.413 -0.915 . . . . 74.040000000000006 108.945 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 19.8 m -119.36 107.07 12.92 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.527 -0.761 . . . . 74.540000000000006 110.623 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 80.02 147.5 4.65 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 121.244 -0.503 . . . . 54.409999999999997 113.482 177.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.4 Cg_endo -85.01 154.48 11.22 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.186 1.924 . . . . 74.340000000000003 110.762 174.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 4.5 mm-40 -83.43 126.64 32.96 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 119.97 -0.692 . . . . 74.010000000000005 111.347 176.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 48.3 mt-30 -100.7 127.69 47.01 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.616 -1.253 . . . . 73.540000000000006 107.616 175.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 449' ' ' PHE . 10.1 tpt180 -122.2 149.41 43.7 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.941 -1.133 . . . . 71.439999999999998 107.941 -173.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -83.11 138.61 33.61 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 122.83 0.452 . . . . 75.319999999999993 111.423 -176.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.6 131.38 40.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 109.849 -0.426 . . . . 75.209999999999994 109.849 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -70.36 141.73 43.54 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.152 2.568 . . . . 71.209999999999994 113.443 176.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.01 -22.25 31.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.913 0.885 . . . . 72.329999999999998 110.061 -178.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.21 -3.55 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 121.877 0.846 . . . . 62.109999999999999 111.223 -175.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 8.7 p -61.03 -31.87 71.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.222 1.009 . . . . 74.319999999999993 111.409 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.4 m -67.38 -26.58 66.53 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.707 0.803 . . . . 73.120000000000005 112.537 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.34 -41.67 47.56 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.583 0.586 . . . . 72.439999999999998 112.583 -172.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.5 m -148.01 139.72 23.84 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.135 -0.691 . . . . 75.109999999999999 109.135 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -61.19 -38.86 88.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.669 -0.493 . . . . 74.510000000000005 109.669 176.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.13 -47.74 84.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.773 -0.649 . . . . 74.420000000000002 110.336 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -36.61 84.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.192 0.307 . . . . 64.239999999999995 111.649 177.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.403 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.43 -51.35 69.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.086 -0.338 . . . . 71.129999999999995 110.086 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.85 -45.76 90.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.278 -0.419 . . . . 75.530000000000001 110.657 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -63.45 -47.41 81.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.477 0.547 . . . . 74.319999999999993 112.477 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -66.28 -40.87 90.35 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.837 0.31 . . . . 72.409999999999997 111.837 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.62 -43.44 89.57 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.552 -0.459 . . . . 74.420000000000002 110.908 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 75.5 m -62.68 -40.49 97.28 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 110.015 -0.365 . . . . 72.420000000000002 110.015 178.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.2 -26.52 64.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.265 -0.425 . . . . 62.340000000000003 111.965 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.96 -13.65 50.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.749 -0.205 . . . . 73.239999999999995 111.25 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.48 -0.03 26.33 Favored Glycine 0 C--N 1.319 -0.409 0 C-N-CA 120.267 -0.968 . . . . 63.420000000000002 113.023 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 81.5 m-85 -83.62 106.91 15.72 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 122.527 -0.396 . . . . 75.219999999999999 110.016 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.4 19.3 13.08 Favored Glycine 0 C--N 1.297 -1.606 0 N-CA-C 110.009 -1.236 . . . . 53.119999999999997 110.009 176.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -113.12 111.02 21.4 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.172 -1.788 . . . . 63.100000000000001 106.172 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -131.46 148.66 52.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 72.450000000000003 111.63 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -142.16 123.04 14.41 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.935 -1.505 . . . . 73.420000000000002 106.935 172.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -104.1 135.76 45.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.916 0.339 . . . . 74.099999999999994 111.916 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.66 156.15 47.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.71 -0.478 . . . . 65.329999999999998 109.71 175.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.78 137.96 54.26 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.799 -0.815 . . . . 74.439999999999998 108.799 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 47.6 m -141.55 147.66 46.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 120.482 -0.487 . . . . 71.409999999999997 111.14 178.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_endo -65.98 125.49 14.26 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.973 2.449 . . . . 65.310000000000002 111.328 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 16.5 t -138.88 -176.49 4.51 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.318 -1.364 . . . . 61.43 107.318 -176.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.6 m -56.64 129.79 76.81 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.898 -0.778 . . . . 74.319999999999993 108.898 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.01 -25.64 12.93 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 124.023 3.149 . . . . 65.329999999999998 114.262 -178.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.41 -24.36 57.12 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.801 0.334 . . . . 73.540000000000006 111.683 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.64 12.18 34.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.639 -0.255 . . . . 71.129999999999995 111.51 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.55 126.39 17.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.849 0.833 . . . . 73.409999999999997 110.787 177.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.17 -6.86 72.51 Favored Glycine 0 C--N 1.306 -1.106 0 CA-C-N 115.194 -0.912 . . . . 72.030000000000001 111.74 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -100.88 152.21 20.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.627 -0.508 . . . . 73.299999999999997 109.627 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.6 136.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.828 -0.805 . . . . 75.439999999999998 108.828 -179.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.04 -16.59 7.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.179 -1.008 . . . . 75.5 110.734 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.91 -179.27 26.81 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.38 -0.827 . . . . 74.319999999999993 111.714 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.9 p -116.82 161.87 18.6 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.286 -1.376 . . . . 75.109999999999999 107.286 178.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.17 -54.58 32.12 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.801 -1.16 . . . . 74.030000000000001 110.602 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.43 120.39 6.92 Favored 'Trans proline' 0 C--N 1.372 1.811 0 N-CA-C 105.963 -2.36 . . . . 73.120000000000005 105.963 166.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.7 Cg_endo -62.68 158.76 40.26 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 122.173 1.915 . . . . 64.549999999999997 113.798 -171.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.6 11.82 0.44 Allowed 'General case' 0 C--O 1.21 -0.975 0 CA-C-O 122.377 1.084 . . . . 72.349999999999994 111.6 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -109.13 -8.09 15.21 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.725 -1.213 . . . . 71.010000000000005 107.725 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -100.39 159.66 14.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.072 -0.967 . . . . 71.010000000000005 111.99 -171.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.1 m -114.66 108.12 16.39 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.428 -1.693 . . . . 74.099999999999994 106.428 177.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.8 p -112.24 143.19 43.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 122.128 -0.358 . . . . 71.450000000000003 111.954 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -63.99 144.37 57.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 72.420000000000002 110.34 176.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.17 -4.57 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.424 1.089 . . . . 74.439999999999998 111.758 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.7 p -87.17 -5.88 58.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.321 -0.862 . . . . 75.109999999999999 110.377 178.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -92.46 139.05 30.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.795 -0.639 . . . . 75.239999999999995 109.405 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.42 122.2 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.496 -1.668 . . . . 75.140000000000001 106.496 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.52 120.35 36.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.875 -0.787 . . . . 74.430000000000007 108.875 -175.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 121.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 108.056 -1.09 . . . . 72.25 108.056 -177.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.25 118.04 56.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.171 -0.922 . . . . 75.129999999999995 108.78 -177.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.29 119.24 48.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-N 115.414 -0.812 . . . . 71.319999999999993 109.482 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.6 t -97.63 133.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.246 -1.39 . . . . 74.109999999999999 107.246 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.02 125.25 7.11 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 111.425 -0.67 . . . . 72.530000000000001 111.425 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -129.52 107.01 9.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.553 -1.647 . . . . 71.450000000000003 106.553 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.416 -2.638 0 CA-C-O 118.478 -1.179 . . . . 74.150000000000006 111.45 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 106.374 -1.713 . . . . 53.219999999999999 106.374 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.5 162.24 15.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 120.893 0.378 . . . . 72.230000000000004 110.992 -172.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -95.01 136.31 35.48 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.856 -1.164 . . . . 74.200000000000003 107.856 178.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 130.9 27.84 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.077 -0.712 . . . . 64.109999999999999 109.077 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -62.39 117.61 4.48 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.335 1.356 . . . . 75.239999999999995 109.023 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.28 166.81 22.26 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.454 -0.794 . . . . 75.299999999999997 109.965 -176.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.72 40.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 122.954 1.359 . . . . 70.140000000000001 111.859 -168.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -66.3 145.81 55.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.929 -1.032 . . . . 74.239999999999995 110.449 172.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.71 0.51 39.68 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 114.33 0.492 . . . . 74.109999999999999 114.33 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . 0.285 0.5 OUTLIER -145.71 172.1 13.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.68 0.74 . . . . 74.400000000000006 112.804 175.592 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.3 p -54.12 154.7 4.09 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.811 1.244 . . . . 74.319999999999993 113.261 -175.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 9.1 p -57.69 -38.86 75.91 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.439 -0.8 . . . . 73.299999999999997 111.267 177.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.75 84.38 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 45.310000000000002 111.052 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.43 -37.03 77.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.103 0.478 . . . . 71.519999999999996 109.74 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.89 67.92 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.446 -0.797 . . . . 63.009999999999998 111.48 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.24 -43.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.79 -0.641 . . . . 74.430000000000007 111.367 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.38 -36.27 83.16 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.917 0.339 . . . . 71.120000000000005 111.917 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.9 m -65.89 -47.61 74.24 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.011 0.434 . . . . 75.129999999999995 110.629 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.98 -38.51 91.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.011 -0.541 . . . . 72.150000000000006 110.802 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -59.35 -42.73 92.22 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.138 0.975 . . . . 71.010000000000005 109.601 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.02 -30.68 69.97 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.965 -0.561 . . . . 73.430000000000007 112.29 178.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -80.97 -9.81 59.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.833 0.349 . . . . 70.540000000000006 111.397 176.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.15 12.64 54.6 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.864 -0.607 . . . . 73.340000000000003 113.526 173.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -91.29 149.18 21.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.12 0.486 . . . . 75.329999999999998 110.514 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 24.4 mmtp -90.5 137.06 32.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.167 -1.79 . . . . 73.239999999999995 106.167 -176.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.21 139.56 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 C-N-CA 118.969 -1.092 . . . . 75.319999999999993 113.526 -175.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -111.31 144.76 39.98 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.638 -1.616 . . . . 74.209999999999994 106.638 172.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.2 m -132.43 124.65 29.03 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.412 -0.958 . . . . 73.439999999999998 108.412 178.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -115.1 119.81 37.67 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.106 -1.442 . . . . 74.310000000000002 107.106 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.513 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -111.36 135.5 51.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.343 -0.614 . . . . 74.549999999999997 109.343 -178.971 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -139.81 132.93 15.25 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.237 -0.585 . . . . 74.200000000000003 111.797 176.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -78.64 140.15 16.47 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.371 2.047 . . . . 74.150000000000006 109.018 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -170.42 -174.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.716 -1.587 . . . . 74.140000000000001 106.716 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 t -108.53 -34.84 6.63 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.714 -1.217 . . . . 74.239999999999995 107.714 177.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.1 p -87.62 40.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.911 0.862 . . . . 71.129999999999995 110.033 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.442 HG23 ' HB3' ' A' ' 391' ' ' ASP . 23.2 pt -88.23 141.89 31.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.139 -0.937 . . . . 74.25 111.85 -176.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 172.79 15.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 106.983 -1.968 . . . . 71.329999999999998 106.983 167.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 398' ' ' HIS . 18.7 Cg_exo -69.15 147.42 66.73 Favored 'Trans proline' 0 C--O 1.209 -0.941 0 C-N-CA 121.373 1.382 . . . . 73.340000000000003 110.778 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.0 -7.16 10.58 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.158 0.98 . . . . 61.409999999999997 111.816 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 396' ' ' PRO . 37.0 m80 -84.28 121.22 27.19 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.691 -2.707 . . . . 74.530000000000001 103.691 173.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.61 117.1 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.512 0.672 . . . . 73.530000000000001 110.372 -170.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.35 -28.18 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 114.893 -1.049 . . . . 74.319999999999993 109.39 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.68 157.82 27.48 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.374 -1.49 . . . . 54.299999999999997 109.374 -178.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -128.11 -174.8 3.31 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 123.679 0.792 . . . . 75.040000000000006 110.663 -173.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.65 129.13 29.51 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.648 -1.241 . . . . 64.340000000000003 107.648 -176.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -50.62 -27.75 20.33 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.202 3.268 . . . . 65.209999999999994 115.193 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.07 -26.0 67.34 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 111.926 0.343 . . . . 74.430000000000007 111.926 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.73 -36.03 81.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.756 0.788 . . . . 72.200000000000003 109.925 176.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -90.26 -2.25 58.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.543 -0.753 . . . . 73.340000000000003 111.216 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -91.31 165.14 13.59 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.061 -1.459 . . . . 71.140000000000001 107.061 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 56.9 p -74.36 113.63 11.81 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.177 0.513 . . . . 74.450000000000003 111.297 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.84 163.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.73 -0.668 . . . . 72.120000000000005 109.466 177.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.7 m -77.7 157.99 29.86 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.514 -0.55 . . . . 41.219999999999999 109.514 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.27 109.74 3.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.385 -0.598 . . . . 74.420000000000002 109.385 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 97.29 25.49 11.03 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.804 -0.712 . . . . 64.510000000000005 112.492 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.6 -172.16 3.7 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.261 -1.015 . . . . 74.209999999999994 108.261 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.0 pt-20 -107.77 139.41 42.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 118.665 0.666 . . . . 74.140000000000001 112.169 -176.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.06 136.52 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.753 -1.203 . . . . 72.319999999999993 107.753 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 10.8 t -108.37 130.93 55.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.611 0.719 . . . . 71.450000000000003 110.675 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 67.5 t -113.79 127.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.182 -0.917 . . . . 73.409999999999997 108.555 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -97.6 127.9 43.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.337 -0.616 . . . . 73.109999999999999 109.337 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 64.0 t -120.96 143.74 32.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.275 -1.009 . . . . 74.409999999999997 108.275 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.6 p -100.79 122.6 43.67 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.176 -0.675 . . . . 63.200000000000003 109.176 178.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 21.1 p -118.64 105.12 11.27 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.662 -0.815 . . . . 73.439999999999998 111.522 -178.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.65 152.22 1.66 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.936 0.735 . . . . 74.430000000000007 114.936 177.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.2 Cg_exo -80.76 148.32 17.66 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.296 1.998 . . . . 71.25 110.506 173.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.65 150.61 42.84 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.861 -0.609 . . . . 75.510000000000005 111.934 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.436 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.9 mt-30 -125.78 145.59 50.14 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.439 -0.949 . . . . 72.129999999999995 108.439 174.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -148.15 156.92 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.013 -1.106 . . . . 74.319999999999993 108.013 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 44.5 tt0 -83.45 136.56 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.923 -0.399 . . . . 74.200000000000003 109.923 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.06 131.08 52.28 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 106.762 -1.57 . . . . 75.099999999999994 106.762 176.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . 0.441 ' CG ' ' HB3' ' A' ' 443' ' ' LYS . 32.1 Cg_endo -70.11 141.3 43.45 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.119 1.212 . . . . 65.430000000000007 110.656 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.36 -5.63 56.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.219 0.533 . . . . 75.040000000000006 111.743 -175.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 430' ' ' PRO . 34.2 m -76.7 -3.83 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 111.019 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.9 m -59.98 -27.58 66.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 63.109999999999999 110.786 178.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 37.6 p -69.15 -12.54 61.76 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.516 -0.766 . . . . 75.019999999999996 112.324 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.99 -47.66 17.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.795 0.665 . . . . 74.439999999999998 112.795 -177.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 27.0 m -153.77 141.06 19.6 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.662 -0.649 . . . . 63.210000000000001 109.921 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -56.18 -50.78 70.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.995 0.518 . . . . 72.219999999999999 112.208 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.32 -45.21 76.35 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.247 0.546 . . . . 63.100000000000001 111.22 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.38 -38.51 78.06 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.001 -0.999 . . . . 74.349999999999994 110.337 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -47.26 86.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.382 0.426 . . . . 64.340000000000003 110.328 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.47 -45.73 93.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.102 -0.499 . . . . 65.530000000000001 110.585 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.59 -41.63 88.2 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.753 0.279 . . . . 73.200000000000003 111.753 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.441 ' HB3' ' CG ' ' A' ' 430' ' ' PRO . 72.1 mmtt -62.77 -42.1 99.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.767 0.318 . . . . 71.530000000000001 111.616 178.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.31 -39.53 82.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.275 -0.421 . . . . 71.219999999999999 111.248 176.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 63.5 m -62.54 -39.58 94.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.573 -0.528 . . . . 74.400000000000006 109.573 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.63 65.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.628 . . . . 65.349999999999994 111.076 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -13.48 56.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.954 0.407 . . . . 63.509999999999998 110.154 177.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.32 -17.09 14.59 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.082 -0.58 . . . . 54.140000000000001 113.225 176.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.59 117.59 13.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.976 0.388 . . . . 71.129999999999995 111.062 -175.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.41 10.74 16.81 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 110.552 -1.019 . . . . 72.5 110.552 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -105.89 111.72 24.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.416 -1.327 . . . . 73.510000000000005 107.416 -177.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -132.77 146.87 52.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.375 0.607 . . . . 62.340000000000003 112.21 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 43.7 tptt -143.01 122.96 13.52 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.771 -1.566 . . . . 74.120000000000005 106.771 172.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -99.59 134.93 41.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.785 0.326 . . . . 65.420000000000002 110.581 -176.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -134.18 150.79 51.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.217 -1.031 . . . . 75.530000000000001 108.217 176.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.43 140.47 51.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.781 -0.452 . . . . 72.549999999999997 109.781 178.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.5 t -127.03 137.37 30.47 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.424 -1.324 . . . . 72.299999999999997 107.424 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.9 Cg_exo -61.23 119.5 6.68 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.338 2.025 . . . . 75.439999999999998 111.189 -177.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.2 m -131.34 -179.84 5.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.527 -0.76 . . . . 63.140000000000001 109.174 -176.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.431 ' HB ' HD11 ' A' ' 463' ' ' LEU . 62.7 m -68.45 136.78 90.9 Favored Pre-proline 0 N--CA 1.428 -1.568 0 N-CA-C 107.848 -1.168 . . . . 75.219999999999999 107.848 174.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.8 -22.88 7.69 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.846 3.697 . . . . 73.230000000000004 114.707 -176.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.58 -17.56 60.0 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.002 0.43 . . . . 74.140000000000001 111.356 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 460' ' ' THR . 7.3 mp -99.67 11.49 39.07 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.959 0.355 . . . . 74.430000000000007 111.959 -178.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 31.0 m -59.61 127.72 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.217 0.532 . . . . 74.140000000000001 111.629 176.092 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.49 -1.42 88.36 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 115.539 -0.755 . . . . 71.209999999999994 111.839 178.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 463' ' ' LEU . 62.8 tttp -101.54 138.94 37.87 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.122 -1.066 . . . . 73.319999999999993 108.122 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 486' ' ' ILE . 60.0 t -84.11 128.08 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.987 0.423 . . . . 71.430000000000007 110.38 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.98 -16.9 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 112.165 0.432 . . . . 73.239999999999995 112.165 -177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.43 166.01 33.5 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.795 -0.717 . . . . 74.420000000000002 111.769 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.8 p -135.77 155.55 50.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.45 -0.945 . . . . 75.0 108.45 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.88 -55.62 42.92 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.421 -0.323 . . . . 74.340000000000003 111.847 176.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.6 Cg_exo -76.8 142.71 22.85 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 108.162 -1.514 . . . . 74.420000000000002 108.162 172.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 30.8 Cg_endo -61.92 127.46 21.46 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.287 1.992 . . . . 72.519999999999996 111.761 -177.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.83 2.58 22.6 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.065 -0.971 . . . . 65.239999999999995 112.013 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -111.32 3.48 18.33 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.328 -0.396 . . . . 75.329999999999998 110.668 177.32 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 8.7 tp-100 -129.57 166.07 20.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.493 0.663 . . . . 64.319999999999993 111.539 -170.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 62.6 m -81.85 124.18 29.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.644 -1.162 . . . . 73.430000000000007 109.799 176.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -127.37 149.47 50.05 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.761 0.424 . . . . 74.409999999999997 110.008 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -72.16 135.71 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.629 0.252 . . . . 73.140000000000001 110.63 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.94 -14.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.88 1.272 . . . . 72.519999999999996 112.282 -174.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -87.51 -2.55 58.69 Favored 'General case' 0 C--N 1.313 -1.003 0 O-C-N 121.6 -0.688 . . . . 75.140000000000001 110.635 -177.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 44.4 m-80 -84.61 136.98 33.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.473 -0.565 . . . . 74.540000000000006 109.473 178.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.85 124.45 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.278 -1.008 . . . . 75.25 108.278 176.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.96 119.09 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 C-N-CA 119.239 -0.984 . . . . 74.450000000000003 109.005 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 2.9 mp -91.7 112.66 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 N-CA-C 104.557 -2.386 . . . . 75.310000000000002 104.557 173.199 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.417 HD12 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.03 118.55 52.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.09 -1.078 . . . . 73.340000000000003 108.09 -175.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.1 mp -99.63 118.35 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.578 0.704 . . . . 73.439999999999998 109.356 -176.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.81 141.3 16.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 107.798 -1.186 . . . . 72.540000000000006 107.798 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.9 124.29 6.52 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.002 -1.239 . . . . 64.25 110.002 177.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.1 t -141.52 136.49 31.22 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.613 -0.884 . . . . 74.340000000000003 108.613 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.665 0 N-CA-C 109.395 -1.482 . . . . 74.439999999999998 109.395 -179.577 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 105.817 -1.92 . . . . 74.230000000000004 105.817 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.88 149.34 21.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 C-N-CA 120.146 -0.622 . . . . 73.430000000000007 110.822 -175.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -94.28 137.22 33.7 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 105.756 -1.942 . . . . 74.420000000000002 105.756 173.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.09 124.79 52.91 Favored Pre-proline 0 C--N 1.279 -2.487 0 C-N-CA 118.342 -1.343 . . . . 72.239999999999995 110.536 -169.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -51.06 129.25 27.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.57 2.847 . . . . 61.329999999999998 113.006 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.3 140.4 43.09 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.492 -1.231 . . . . 71.310000000000002 111.285 -175.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.41 20.28 5.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.635 -1.246 . . . . 75.420000000000002 107.635 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -64.64 133.38 52.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.961 -1.018 . . . . 72.409999999999997 111.457 -178.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 0.19 46.58 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.071 -0.968 . . . . 54.229999999999997 110.905 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -125.22 -179.81 4.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.991 -0.744 . . . . 73.019999999999996 108.991 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 93.9 p -72.48 143.04 48.55 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.485 0.584 . . . . 64.209999999999994 111.389 -176.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 374' ' ' ILE . 27.9 m -62.34 -33.65 75.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.971 178.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.67 94.44 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-N 116.299 -0.409 . . . . 73.030000000000001 111.062 178.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.99 -35.07 76.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 109.889 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.69 92.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.84 -0.618 . . . . 74.420000000000002 110.516 176.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.469 HG22 HG13 ' A' ' 384' ' ' ILE . 82.6 mt -57.79 -46.91 87.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 122.644 0.377 . . . . 75.400000000000006 110.078 178.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.6 94.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.972 -0.558 . . . . 74.299999999999997 111.288 179.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 57.0 m -61.66 -47.64 84.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.894 -0.594 . . . . 72.209999999999994 110.952 -179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.3 -38.45 91.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.388 -0.369 . . . . 75.040000000000006 111.465 178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.87 -42.89 94.71 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.65 0.594 . . . . 74.439999999999998 109.6 178.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.356 0.873 . . . . 53.130000000000003 113.356 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.96 -14.71 53.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.127 0.489 . . . . 72.150000000000006 110.022 173.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.43 53.51 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.941 -0.572 . . . . 63.100000000000001 112.874 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.458 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 43.3 m-85 -84.19 152.96 23.93 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.427 0.632 . . . . 73.120000000000005 111.938 -177.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.64 134.54 34.6 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.008 -1.479 . . . . 75.400000000000006 107.008 177.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.469 HG13 HG22 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -117.47 136.64 53.97 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 C-N-CA 119.197 -1.001 . . . . 73.030000000000001 111.874 -179.14 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -111.69 128.38 56.05 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.003 -1.908 . . . . 74.510000000000005 105.976 178.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.0 m -111.41 136.65 50.26 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 119.403 -0.919 . . . . 64.329999999999998 109.444 -178.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -120.18 117.89 29.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.513 -1.662 . . . . 74.109999999999999 106.513 176.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 122.05 46.11 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.484 -1.673 . . . . 74.140000000000001 106.484 177.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -139.61 148.38 55.75 Favored Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 118.893 -1.123 . . . . 75.409999999999997 110.746 178.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 85.1 Cg_endo -85.48 163.74 10.96 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.274 1.983 . . . . 63.549999999999997 109.584 170.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.2 t70 165.22 -173.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.754 -2.313 . . . . 71.109999999999999 104.754 176.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.427 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 8.4 t -115.84 -25.39 7.77 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.566 -1.642 . . . . 72.510000000000005 106.566 174.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 9.9 m -98.47 69.2 1.9 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.621 -2.363 . . . . 75.439999999999998 104.621 171.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 4.4 pt -95.97 138.56 21.66 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 113.673 -1.603 . . . . 72.019999999999996 112.921 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 421' ' ' SER . 16.7 Cg_exo -70.4 114.35 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 106.224 -2.26 . . . . 74.0 106.224 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 398' ' ' HIS . 24.0 Cg_endo -57.11 160.34 13.12 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.514 2.809 . . . . 72.540000000000006 115.54 -169.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.06 -6.86 2.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.107 0.963 . . . . 74.319999999999993 112.003 176.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 396' ' ' PRO . 63.9 m170 -107.47 120.15 41.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 103.662 -2.718 . . . . 72.099999999999994 103.662 171.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.97 117.97 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.088 0.947 . . . . 75.230000000000004 109.822 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.91 -28.87 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.947 -1.024 . . . . 74.340000000000003 110.441 -174.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.44 157.98 27.56 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.973 -1.251 . . . . 73.25 109.973 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.7 p -118.28 -178.76 3.59 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 123.194 0.598 . . . . 73.439999999999998 109.97 -177.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -102.08 155.2 36.74 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.374 -0.602 . . . . 64.109999999999999 109.374 -176.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.4 -30.66 64.44 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.085 2.523 . . . . 75.540000000000006 113.902 -176.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.15 -30.7 65.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.895 0.378 . . . . 65.329999999999998 110.244 -175.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.54 65.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.594 0.711 . . . . 52.109999999999999 110.05 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 407' ' ' ASN . 0.9 OUTLIER -95.8 -4.64 43.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 111.876 -177.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.1 m -100.16 155.39 17.77 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.244 -1.391 . . . . 63.109999999999999 107.244 176.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 55.2 p -74.77 113.17 11.74 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.191 -0.604 . . . . 75.019999999999996 109.584 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.09 169.93 15.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 116.043 -0.526 . . . . 74.349999999999994 110.772 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.0 p -62.36 133.13 54.64 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.702 -0.681 . . . . 73.109999999999999 109.396 175.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.46 109.33 4.73 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.956 -0.387 . . . . 73.230000000000004 109.956 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.91 10.08 5.43 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 120.137 -1.03 . . . . 45.530000000000001 112.339 -178.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.1 -174.02 4.49 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.785 -0.82 . . . . 74.409999999999997 108.785 -177.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.01 132.16 34.12 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 118.955 0.798 . . . . 72.140000000000001 112.589 -175.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.67 135.24 59.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 106.474 -1.676 . . . . 74.040000000000006 106.474 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.9 t -96.84 130.94 44.04 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 122.086 0.946 . . . . 71.409999999999997 111.764 -177.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.33 122.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 114.577 -1.192 . . . . 74.319999999999993 108.453 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -95.89 129.01 43.27 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.745 -0.661 . . . . 73.420000000000002 111.447 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.83 130.81 52.93 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 108.14 -1.059 . . . . 75.340000000000003 108.14 177.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 395' ' ' PRO . 36.6 p -88.09 121.45 30.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.491 -0.559 . . . . 74.329999999999998 109.491 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 m -120.89 104.82 10.14 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 119.767 -0.773 . . . . 74.340000000000003 110.645 177.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.69 125.39 1.59 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 120.546 -0.835 . . . . 71.540000000000006 113.93 176.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 56.2 Cg_endo -86.49 130.31 3.28 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.33 2.02 . . . . 75.219999999999999 112.562 176.17 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 391' ' ' ASP . 47.6 mt-10 -89.4 137.5 32.27 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.465 0.65 . . . . 75.329999999999998 112.12 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.47 150.45 48.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.546 -1.65 . . . . 74.219999999999999 106.546 173.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpt180 -136.27 148.46 48.02 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.307 -0.998 . . . . 75.109999999999999 108.307 -174.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.9 136.5 34.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.513 -0.921 . . . . 65.329999999999998 108.513 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.8 mt -81.8 131.54 57.11 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.834 -0.802 . . . . 71.409999999999997 108.834 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.65 140.6 87.36 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.583 1.522 . . . . 72.319999999999993 111.876 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.32 0.77 55.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 111.191 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -76.12 -7.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.446 0.641 . . . . 71.230000000000004 109.464 176.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 4.9 p -54.96 -49.68 70.78 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.361 -0.836 . . . . 63.450000000000003 111.687 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 2.1 m -63.79 -22.28 66.83 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.361 1.065 . . . . 71.530000000000001 111.761 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.27 -42.47 13.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.263 0.468 . . . . 74.230000000000004 112.263 -173.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.4 m -145.21 124.12 12.71 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.542 -0.724 . . . . 73.109999999999999 110.905 -178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.24 -53.52 55.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.724 0.639 . . . . 75.420000000000002 112.724 -178.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.43 94.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.737 0.303 . . . . 73.019999999999996 111.495 -176.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.53 -37.68 88.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.652 -0.704 . . . . 73.109999999999999 109.407 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 433' ' ' SER . . . -60.32 -47.18 87.15 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.922 -0.581 . . . . 73.129999999999995 110.76 -179.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.35 -45.71 93.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 75.109999999999999 110.414 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 9.9 mmpt? -64.46 -47.27 79.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 65.5 110.967 -178.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.14 -38.88 89.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.329 -0.396 . . . . 73.349999999999994 111.476 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.2 -43.41 86.83 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.338 0.399 . . . . 73.0 110.366 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 24.3 m -66.84 -46.01 76.45 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.404 0.621 . . . . 75.019999999999996 109.785 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.31 -15.97 63.45 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.374 -0.83 . . . . 73.099999999999994 112.053 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.56 59.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.464 . . . . 64.120000000000005 109.985 178.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.08 -16.4 11.97 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.748 -0.739 . . . . 60.130000000000003 112.036 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 93.6 m-85 -77.49 108.66 10.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.782 0.325 . . . . 75.310000000000002 110.503 -179.053 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.37 20.64 15.83 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.554 -1.019 . . . . 74.209999999999994 110.554 176.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -114.17 111.91 22.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 106.507 -1.664 . . . . 75.140000000000001 106.507 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.49 153.22 45.42 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.438 0.532 . . . . 75.450000000000003 112.438 -170.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 56.4 tptt -150.9 123.41 8.46 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 105.451 -2.055 . . . . 73.510000000000005 105.451 172.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -121.96 134.82 54.83 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.315 -0.554 . . . . 73.140000000000001 111.584 -173.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -142.38 165.02 28.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.514 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.447 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.7 m120 -116.44 142.07 47.35 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.719 -0.845 . . . . 74.140000000000001 108.719 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 19.1 t -131.04 138.55 33.22 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 108.749 -0.834 . . . . 73.010000000000005 108.749 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_exo -61.56 121.1 9.07 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.303 2.002 . . . . 72.329999999999998 110.558 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.3 m -134.26 -178.55 5.09 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 63.130000000000003 107.62 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 16.5 p -68.24 150.24 97.8 Favored Pre-proline 0 N--CA 1.427 -1.586 0 C-N-CA 120.563 -0.455 . . . . 73.530000000000001 109.822 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . 0.477 ' O ' HG11 ' A' ' 464' ' ' VAL . 15.0 Cg_endo -55.69 -23.59 41.71 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.488 2.792 . . . . 73.109999999999999 113.137 -177.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -75.36 -18.45 59.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.869 0.366 . . . . 72.230000000000004 111.871 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.72 -4.45 40.7 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.992 -0.443 . . . . 73.349999999999994 112.102 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.8 p -59.51 136.58 22.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-O 120.717 0.294 . . . . 74.530000000000001 110.935 -178.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.32 84.04 Favored Glycine 0 C--N 1.311 -0.831 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.389 177.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -124.19 158.87 31.38 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 109.668 -0.493 . . . . 72.519999999999996 109.668 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 434' ' ' THR . 58.1 t -83.93 137.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.8 -1.556 . . . . 70.409999999999997 106.8 178.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.54 -10.66 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.013 -1.475 . . . . 72.109999999999999 110.267 178.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 146.56 174.54 18.76 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 115.424 -0.807 . . . . 74.120000000000005 111.524 175.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.0 p -116.58 152.22 34.61 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.97 -1.122 . . . . 74.209999999999994 107.97 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -66.79 -46.06 55.53 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 118.74 -1.184 . . . . 65.239999999999995 111.874 178.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.39 110.15 3.0 Favored 'Trans proline' 0 C--N 1.362 1.261 0 N-CA-C 106.887 -2.005 . . . . 75.319999999999993 106.887 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.02 162.31 32.04 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.292 1.995 . . . . 75.239999999999995 114.286 -171.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -72.73 -5.15 35.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.348 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.49 6.05 49.99 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.421 -1.263 . . . . 71.519999999999996 109.616 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -135.62 162.48 32.59 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.109 -0.701 . . . . 74.109999999999999 109.109 -177.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.7 m -104.47 111.73 24.51 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.235 -1.765 . . . . 73.319999999999993 106.235 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 14.9 t -106.55 148.3 28.4 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.332 -0.547 . . . . 74.540000000000006 109.874 -175.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.25 141.03 58.92 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.283 -0.417 . . . . 53.100000000000001 110.41 178.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 28.9 mm -60.92 -22.61 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.467 0.707 . . . . 72.400000000000006 112.876 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.0 t -91.55 4.43 52.62 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.692 0.758 . . . . 73.540000000000006 110.123 -178.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.67 138.55 34.1 Favored 'General case' 0 CA--C 1.481 -1.687 0 O-C-N 122.015 -0.428 . . . . 74.0 110.47 177.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.54 116.32 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 108.887 -0.783 . . . . 73.519999999999996 108.887 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.08 120.22 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 108.189 -1.041 . . . . 73.340000000000003 108.189 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 0.2 OUTLIER -92.73 117.07 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 106.93 -1.507 . . . . 70.439999999999998 106.93 -178.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 112.4 39.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.948 -1.024 . . . . 64.349999999999994 108.347 -177.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.75 124.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.588 -0.733 . . . . 75.530000000000001 109.275 -177.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.447 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 28.0 t -97.59 134.45 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.248 -1.39 . . . . 73.010000000000005 107.248 178.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -84.07 131.85 10.68 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 110.992 -0.843 . . . . 50.109999999999999 110.992 -178.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.3 t -141.04 132.39 26.71 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.82 -0.808 . . . . 61.130000000000003 108.82 178.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.07 0 N-CA-C 109.244 -1.542 . . . . 65.510000000000005 109.244 174.575 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 107.972 -1.122 . . . . 64.140000000000001 107.972 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.2 150.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 112.398 0.518 . . . . 72.109999999999999 112.398 -170.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -96.4 136.55 36.75 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.538 -1.282 . . . . 63.439999999999998 107.538 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.68 131.3 27.22 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.916 -0.713 . . . . 52.149999999999999 110.079 -175.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.14 142.13 78.46 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.392 2.728 . . . . 70.400000000000006 113.946 -178.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.44 139.39 36.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.698 -1.137 . . . . 73.329999999999998 109.985 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.6 t -113.24 30.98 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 122.51 1.147 . . . . 73.140000000000001 109.794 -175.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.421 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.7 ppt_? -65.39 144.58 56.99 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.582 -0.736 . . . . 75.420000000000002 112.525 178.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 93.4 -5.81 74.61 Favored Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.94 -0.573 . . . . 75.329999999999998 111.699 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -117.34 176.01 5.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.294 -0.632 . . . . 74.409999999999997 109.294 -175.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.8 p -73.92 154.11 39.53 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.742 0.306 . . . . 74.150000000000006 111.139 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.2 -36.1 82.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.752 0.311 . . . . 64.030000000000001 110.619 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.97 93.62 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.104 -0.498 . . . . 74.439999999999998 111.033 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.77 -43.55 92.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.747 -0.464 . . . . 73.209999999999994 109.747 177.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.53 69.6 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.964 -0.562 . . . . 73.549999999999997 111.084 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.62 -42.47 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.347 -0.388 . . . . 73.409999999999997 111.157 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.39 93.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.433 -0.348 . . . . 74.310000000000002 110.993 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 376' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 61.9 m -61.88 -47.24 85.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.551 -0.295 . . . . 71.400000000000006 110.882 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.89 -38.81 92.46 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.621 -0.263 . . . . 73.109999999999999 110.941 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -59.88 -46.92 87.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.908 0.755 . . . . 73.400000000000006 109.647 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -66.43 -27.41 67.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.78 -0.646 . . . . 62.009999999999998 111.774 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 376' ' ' THR . 11.8 mmt180 -81.21 -14.94 57.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.402 -0.363 . . . . 74.239999999999995 110.797 178.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.73 53.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.439 -0.886 . . . . 73.219999999999999 112.029 178.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.16 158.65 15.37 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.385 -0.598 . . . . 74.140000000000001 109.385 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.53 161.43 13.64 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.232 -1.025 . . . . 74.040000000000006 108.232 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 154.98 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.872 0.844 . . . . 72.239999999999995 112.79 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.455 ' HB3' HG21 ' A' ' 417' ' ' THR . 6.7 ttp180 -141.99 129.74 21.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.885 -1.154 . . . . 72.0 107.885 175.445 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.3 m -100.51 130.38 46.58 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.7 -0.481 . . . . 75.340000000000003 109.7 -177.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.94 119.11 36.79 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.708 -1.59 . . . . 74.140000000000001 106.708 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 123.84 39.41 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 72.230000000000004 108.724 177.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -114.57 118.13 41.73 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.747 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 3.0 Cg_endo -88.31 128.43 2.2 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 N-CA-C 107.456 -1.786 . . . . 74.120000000000005 107.456 167.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 -163.88 -178.09 5.47 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.665 -1.214 . . . . 73.140000000000001 110.731 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.2 m -88.87 -42.18 12.01 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.195 -1.78 . . . . 72.150000000000006 106.195 175.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.4 m -88.69 63.43 6.91 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.458 -1.246 . . . . 61.109999999999999 108.636 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 394' ' ' ILE . 2.3 pp -98.77 112.97 63.93 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 114.156 1.169 . . . . 73.299999999999997 114.156 179.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . 0.445 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 73.8 Cg_endo -80.44 170.37 16.04 Favored 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.09 1.86 . . . . 73.219999999999999 110.369 171.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.72 162.65 17.8 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.391 2.727 . . . . 70.019999999999996 112.691 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.66 -8.7 0.95 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 124.218 1.007 . . . . 64.099999999999994 113.135 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -79.78 159.72 26.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.783 -1.192 . . . . 75.530000000000001 107.783 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.56 117.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 105.942 -1.873 . . . . 73.200000000000003 105.942 175.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 401' ' ' GLY . 2.6 pp -92.91 -28.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.408 0.623 . . . . 74.319999999999993 111.79 -178.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.443 ' N ' HD11 ' A' ' 400' ' ' ILE . . . -160.99 158.1 29.67 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.717 -1.753 . . . . 75.310000000000002 108.717 178.702 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -114.43 -179.85 3.75 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 109.189 -0.671 . . . . 75.530000000000001 109.189 179.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.12 140.94 21.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.225 -1.028 . . . . 72.519999999999996 108.225 178.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.69 -29.46 2.34 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.0 3.134 . . . . 74.450000000000003 114.536 177.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.63 60.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.209 0.603 . . . . 64.420000000000002 111.98 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.16 65.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 72.420000000000002 109.857 177.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 4.7 52.32 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.328 -0.851 . . . . 72.549999999999997 110.735 -174.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -92.64 146.39 23.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 105.118 -2.178 . . . . 73.099999999999994 105.118 171.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.5 m -74.37 123.44 24.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 118.797 0.726 . . . . 74.310000000000002 110.171 -178.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.8 169.67 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.772 -1.196 . . . . 72.230000000000004 107.772 -177.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.8 m -66.7 138.86 57.71 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.266 -1.013 . . . . 70.310000000000002 108.266 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.18 111.36 3.89 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.079 -0.341 . . . . 75.510000000000005 110.079 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.63 43.33 0.97 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.752 -0.737 . . . . 65.030000000000001 112.162 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.65 -179.36 3.79 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.354 -1.721 . . . . 73.510000000000005 106.354 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -102.65 135.29 44.55 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.505 0.669 . . . . 75.109999999999999 111.725 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.7 mm -110.28 128.47 66.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.372 -1.344 . . . . 74.140000000000001 107.372 176.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.455 HG21 ' HB3' ' A' ' 385' ' ' ARG . 69.4 p -100.42 130.71 46.55 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.577 -0.527 . . . . 70.420000000000002 109.577 -177.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.48 122.63 69.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.013 -0.54 . . . . 74.319999999999993 110.177 -176.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -91.17 129.46 37.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.141 0.496 . . . . 74.530000000000001 110.998 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.44 146.95 30.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.286 -1.376 . . . . 64.310000000000002 107.286 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.445 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 13.5 m -90.57 122.65 33.56 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.822 -0.751 . . . . 72.430000000000007 111.815 -176.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 32.8 m -120.37 106.16 11.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 109.539 -0.541 . . . . 75.109999999999999 109.539 174.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 77.32 130.57 0.47 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 120.889 -0.672 . . . . 64.430000000000007 114.772 176.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.4 Cg_exo -78.6 144.18 19.63 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.702 1.601 . . . . 65.319999999999993 109.425 171.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 146.06 47.96 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 116.292 -0.413 . . . . 71.450000000000003 109.906 -178.261 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.5 mt-30 -121.52 141.29 51.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.168 -0.924 . . . . 74.400000000000006 108.65 -176.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -143.45 158.68 43.45 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.954 -1.498 . . . . 73.519999999999996 106.954 -177.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.6 OUTLIER -90.1 139.62 30.45 Favored 'General case' 0 C--N 1.28 -2.419 0 O-C-N 123.088 0.242 . . . . 71.540000000000006 110.854 179.512 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -80.03 119.86 77.95 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.788 -1.56 . . . . 72.25 106.788 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.82 140.74 67.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.702 2.268 . . . . 75.219999999999999 113.589 -178.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.61 -22.58 62.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.771 -1.104 . . . . 73.310000000000002 112.364 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.18 2.98 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.679 -0.692 . . . . 74.349999999999994 111.748 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.9 t -62.75 -27.14 69.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.309 0.644 . . . . 74.439999999999998 110.597 179.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 434' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 28.0 p -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 112.851 0.685 . . . . 72.219999999999999 112.851 -177.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 82.6 mt -67.26 -49.01 66.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.912 1.079 . . . . 74.030000000000001 113.912 -171.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.6 m -160.43 148.8 16.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.592 -0.892 . . . . 74.019999999999996 108.592 -175.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.51 -49.83 75.98 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.873 0.694 . . . . 74.140000000000001 112.873 -177.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.01 89.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.714 0.293 . . . . 74.409999999999997 110.942 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.22 -46.32 90.9 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.639 -0.874 . . . . 73.209999999999994 108.639 177.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.66 76.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.948 -1.024 . . . . 63.310000000000002 110.409 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.82 -48.08 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.362 -0.381 . . . . 72.439999999999998 111.089 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.868 0.322 . . . . 73.439999999999998 111.868 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -66.33 -42.12 88.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 111.902 0.334 . . . . 72.049999999999997 111.902 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.43 -38.63 81.38 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.975 -0.29 . . . . 75.340000000000003 111.741 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 86.4 m -62.31 -40.46 96.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.736 -0.468 . . . . 74.209999999999994 109.736 177.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.46 -26.61 66.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.916 -0.584 . . . . 73.310000000000002 111.042 178.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 -13.01 56.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.211 0.529 . . . . 70.519999999999996 110.47 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.55 29.74 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.944 -0.646 . . . . 73.030000000000001 113.267 178.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -78.29 102.65 7.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 117.362 0.581 . . . . 74.519999999999996 109.597 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.73 15.83 34.24 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.694 -0.765 . . . . 65.239999999999995 111.301 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -118.21 110.63 17.8 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.733 -1.21 . . . . 75.129999999999995 107.733 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.35 150.26 45.7 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.589 -176.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 453' ' ' LYS . 0.4 OUTLIER -141.88 122.87 14.55 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.454 -2.054 . . . . 73.219999999999999 105.454 171.239 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.57 134.62 39.56 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.008 -0.677 . . . . 75.549999999999997 109.61 -178.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.19 141.47 49.09 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.938 -1.134 . . . . 74.299999999999997 107.938 176.287 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . 0.528 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.5 m-80 -116.57 140.12 49.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.598 -1.26 . . . . 74.209999999999994 107.598 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -138.62 150.35 65.66 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 109.846 -0.427 . . . . 75.340000000000003 109.846 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_endo -60.71 120.22 7.83 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.496 2.131 . . . . 73.219999999999999 112.184 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -127.27 -178.45 4.45 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.027 -1.471 . . . . 63.140000000000001 107.027 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.0 t -68.88 137.95 90.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.968 -0.752 . . . . 70.430000000000007 108.968 176.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.15 -23.74 23.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.741 2.961 . . . . 74.0 113.98 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.7 -23.95 58.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.797 0.332 . . . . 75.319999999999993 111.677 -177.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.33 12.57 31.54 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.334 0.494 . . . . 72.420000000000002 112.334 -177.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.31 126.74 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.388 0.613 . . . . 74.319999999999993 111.143 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.55 0.07 61.11 Favored Glycine 0 C--N 1.309 -0.968 0 CA-C-N 115.987 -0.551 . . . . 64.120000000000005 112.266 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.63 144.84 30.51 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.668 -1.234 . . . . 75.349999999999994 107.668 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 84.3 t -82.28 126.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.86 -1.163 . . . . 73.239999999999995 107.86 177.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.46 -15.13 7.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.34 -0.544 . . . . 74.349999999999994 112.01 -175.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.02 177.24 33.95 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 120.451 -0.88 . . . . 74.140000000000001 111.576 178.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 8.7 p -125.23 158.81 33.12 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.226 -1.027 . . . . 72.010000000000005 108.226 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -54.35 46.47 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 120.338 -0.545 . . . . 73.099999999999994 110.52 176.103 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.14 108.6 2.53 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 106.037 -2.332 . . . . 64.129999999999995 106.037 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 149.87 89.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.601 2.201 . . . . 74.219999999999999 114.798 -169.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.46 7.65 2.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.742 1.217 . . . . 70.420000000000002 111.987 -177.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.1 -3.05 16.63 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.474 -0.784 . . . . 74.230000000000004 110.605 177.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -129.06 169.65 14.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.036 0.446 . . . . 73.129999999999995 111.335 -171.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 477' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 15.7 m -102.43 135.54 43.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.265 1.026 . . . . 74.519999999999996 108.789 -179.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.8 t -137.46 148.07 45.81 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.425 -0.583 . . . . 72.420000000000002 109.425 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.91 145.6 53.53 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.964 -0.384 . . . . 75.420000000000002 109.964 175.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.9 mm -70.17 -3.33 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.125 0.964 . . . . 74.030000000000001 111.396 -177.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -86.81 5.37 36.91 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.762 0.792 . . . . 74.299999999999997 110.325 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -110.45 138.09 47.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.358 -0.837 . . . . 74.219999999999999 109.473 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.86 124.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.281 -1.007 . . . . 75.400000000000006 108.281 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.0 t -87.36 118.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 C-N-CA 119.074 -1.051 . . . . 74.329999999999998 108.486 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 56.2 mt -93.95 112.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.081 -1.451 . . . . 72.200000000000003 107.081 176.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.62 122.28 50.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.33 -0.989 . . . . 73.299999999999997 108.33 -176.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 26.9 mt -100.87 119.92 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.318 0.58 . . . . 74.319999999999993 110.499 -174.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.528 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 88.9 t -97.99 128.77 49.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.959 -1.126 . . . . 63.229999999999997 107.959 178.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.31 115.42 6.03 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.184 -0.766 . . . . 75.129999999999995 111.184 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 37.5 m -120.35 109.88 15.88 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.334 -0.617 . . . . 63.140000000000001 109.334 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.356 0 N-CA-C 109.478 -1.449 . . . . 75.420000000000002 109.478 -179.211 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 409' ' ' SER . 4.3 p-10 . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 109.1 -0.704 . . . . 72.25 109.1 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.6 m -134.32 153.89 36.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.722 -0.473 . . . . 74.239999999999995 109.722 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -100.86 137.07 39.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.851 -1.166 . . . . 72.25 107.851 175.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.87 124.5 47.68 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 119.556 -0.858 . . . . 73.209999999999994 110.804 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.1 145.05 98.99 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.89 2.393 . . . . 75.329999999999998 112.355 177.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.98 166.1 16.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.872 -0.603 . . . . 74.200000000000003 110.451 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.47 41.68 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.495 1.14 . . . . 74.530000000000001 108.488 -175.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -52.57 128.66 26.78 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.344 -1.298 . . . . 75.510000000000005 113.79 -175.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.76 -18.65 57.02 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 115.503 -0.771 . . . . 72.319999999999993 113.228 173.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -97.73 166.7 11.36 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.613 0.245 . . . . 64.530000000000001 111.198 -176.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 81.2 p -63.3 145.04 56.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.511 . . . . 64.409999999999997 110.684 -175.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.9 p -63.66 -34.08 77.05 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.951 -0.3 . . . . 64.239999999999995 110.275 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.32 88.73 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.193 -0.458 . . . . 61.310000000000002 110.358 176.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -35.08 79.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 110.23 178.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -50.44 71.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 72.209999999999994 110.797 178.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.27 -43.96 87.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 123.416 0.448 . . . . 74.409999999999997 110.407 178.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.36 90.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 110.74 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -46.94 86.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.736 -0.211 . . . . 73.430000000000007 110.831 178.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.98 -39.3 93.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.198 -0.201 . . . . 65.420000000000002 110.753 177.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.2 -44.34 97.45 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.223 0.609 . . . . 64.329999999999998 110.272 179.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.43 -26.27 64.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.779 -0.646 . . . . 65.140000000000001 111.805 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -81.56 -13.5 57.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 110.96 175.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.505 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 94.59 16.58 42.13 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.272 -0.965 . . . . 71.120000000000005 112.368 177.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.56 159.79 14.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.034 -0.728 . . . . 72.109999999999999 109.034 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . 0.415 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 33.5 mmtp -104.9 157.51 17.17 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.263 -1.384 . . . . 74.230000000000004 107.263 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.401 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -136.9 157.48 35.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.451 0.643 . . . . 74.209999999999994 112.04 -175.598 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.417 ' HB3' HG21 ' A' ' 417' ' ' THR . 37.8 ttm105 -127.41 133.11 50.01 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.612 -1.996 . . . . 71.120000000000005 105.612 171.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.7 m -122.32 121.28 36.36 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.204 -0.665 . . . . 70.439999999999998 109.204 -175.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.35 119.2 35.49 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.59 -1.263 . . . . 74.430000000000007 107.59 178.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -113.5 124.1 51.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.642 -0.503 . . . . 74.349999999999994 109.642 178.283 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -132.76 144.28 52.22 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 120.604 -0.439 . . . . 72.450000000000003 110.777 -177.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.82 144.15 13.6 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 N-CA-C 107.662 -1.707 . . . . 75.549999999999997 107.662 166.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.2 t70 -153.42 172.69 16.71 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 118.62 -1.232 . . . . 75.209999999999994 110.227 -176.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.8 m -87.38 -34.72 18.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.731 -1.581 . . . . 74.409999999999997 106.731 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.0 p -108.02 70.24 0.76 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 113.905 -1.498 . . . . 72.019999999999996 109.426 177.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.0 pp -90.0 121.74 68.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.35 1.241 . . . . 73.0 114.35 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.42 172.88 10.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.557 2.171 . . . . 74.420000000000002 108.516 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.73 153.54 61.59 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 122.157 1.905 . . . . 74.129999999999995 111.594 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -6.87 11.62 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.623 0.725 . . . . 65.439999999999998 111.935 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -82.26 143.53 31.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.917 -1.038 . . . . 75.019999999999996 108.858 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.92 118.01 22.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.938 -1.105 . . . . 64.299999999999997 108.889 -178.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.47 -47.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.014 -1.106 . . . . 75.340000000000003 108.014 -178.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.55 170.48 35.8 Favored Glycine 0 N--CA 1.403 -3.543 0 N-CA-C 109.6 -1.4 . . . . 54.240000000000002 109.6 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -119.05 -178.7 3.62 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 108.482 -0.933 . . . . 75.299999999999997 108.482 179.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.74 154.71 37.01 Favored Pre-proline 0 C--N 1.282 -2.342 0 N-CA-C 108.326 -0.99 . . . . 75.200000000000003 108.326 176.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -31.9 -32.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.856 1 C-N-CA 125.861 4.374 . . . . 73.319999999999993 116.159 -176.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -47.26 -35.0 7.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.321 1.048 . . . . 71.239999999999995 112.925 -178.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.27 -49.76 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.068 0.461 . . . . 64.510000000000005 112.023 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.68 -0.4 56.19 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.806 0.669 . . . . 73.200000000000003 112.806 -176.012 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.9 m -87.73 164.24 16.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.439999999999998 107.723 175.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 409' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 359' ' ' ASP . 2.5 p -74.23 113.57 11.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.87 0.843 . . . . 64.400000000000006 112.336 -176.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.62 170.13 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.951 -1.022 . . . . 73.219999999999999 108.856 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.3 t -90.26 151.73 21.38 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.792 -1.188 . . . . 74.510000000000005 107.792 176.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.12 130.92 45.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.328 -0.619 . . . . 71.109999999999999 109.328 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 91.28 25.78 22.95 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.575 -0.822 . . . . 72.200000000000003 112.399 -179.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.01 -175.63 3.93 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.833 -0.803 . . . . 62.310000000000002 108.833 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 29.3 mt-10 -105.43 126.78 52.51 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 118.517 0.598 . . . . 73.329999999999998 111.448 -175.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.59 124.97 60.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.031 -0.729 . . . . 72.219999999999999 109.031 175.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 385' ' ' ARG . 24.8 p -92.25 127.81 37.87 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 109.871 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 82.4 t -124.22 130.85 73.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.427 -176.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -96.87 128.59 43.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.717 -0.674 . . . . 75.25 109.414 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 42.5 t -124.57 140.36 48.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.737 -0.838 . . . . 75.010000000000005 108.737 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.2 p -103.3 122.76 45.46 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.995 0.426 . . . . 72.439999999999998 110.921 179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 25.7 p -118.61 104.93 11.1 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.619 -0.264 . . . . 73.25 110.468 177.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.01 156.11 0.74 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 114.823 0.689 . . . . 61.329999999999998 114.823 177.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 2.4 Cg_endo -84.27 149.4 11.86 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.249 1.966 . . . . 51.130000000000003 110.795 173.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.72 149.41 31.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.776 -0.647 . . . . 72.299999999999997 112.678 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.6 mt-30 -107.01 151.88 24.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.579 -1.267 . . . . 75.049999999999997 107.579 176.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.88 164.38 30.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.325 -0.991 . . . . 74.319999999999993 108.325 -179.116 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.01 138.3 33.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.56 -0.533 . . . . 70.299999999999997 109.56 -178.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.2 mt -83.79 123.66 75.81 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 105.932 -1.877 . . . . 74.030000000000001 105.932 174.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.4 141.23 82.31 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.687 2.258 . . . . 72.310000000000002 113.306 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.46 -22.26 25.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.395 -0.821 . . . . 74.230000000000004 110.539 -177.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.49 -12.59 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.695 0.759 . . . . 75.329999999999998 110.507 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 17.6 m -53.9 -36.7 62.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.287 1.035 . . . . 71.209999999999994 112.012 -179.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 8.9 p -69.48 -12.99 62.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.463 0.912 . . . . 75.349999999999994 113.463 -178.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . 0.475 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.4 mt -89.97 -41.07 11.96 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.753 0.649 . . . . 62.039999999999999 112.753 -178.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 91.6 m -149.24 125.82 11.0 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.979 -0.378 . . . . 74.430000000000007 109.979 -176.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.75 -48.17 80.4 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.735 . . . . 75.540000000000006 112.983 -178.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.23 90.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 110.95 -178.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 13.8 mm-40 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.953 -0.567 . . . . 71.450000000000003 109.923 179.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.87 -51.08 71.25 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.766 -0.652 . . . . 71.109999999999999 109.736 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.76 -43.8 96.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.743 -0.662 . . . . 74.329999999999998 110.742 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.46 -48.57 74.74 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.167 0.432 . . . . 75.430000000000007 112.167 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 74.4 mmtt -67.62 -39.71 84.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.831 0.348 . . . . 74.409999999999997 111.415 -178.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.05 -39.77 93.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.562 -0.532 . . . . 74.439999999999998 109.562 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 94.3 m -67.45 -41.25 85.02 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.864 -0.607 . . . . 64.299999999999997 110.2 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.24 -16.78 63.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.199 -0.455 . . . . 72.5 111.774 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.9 -3.37 59.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.305 -0.407 . . . . 74.299999999999997 110.807 177.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.11 33.84 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.968 -0.634 . . . . 63.140000000000001 113.178 176.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -67.43 139.21 57.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.694 0.283 . . . . 74.040000000000006 110.828 -177.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -142.3 1.08 1.6 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.779 -0.725 . . . . 70.140000000000001 112.615 -179.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -104.0 111.3 23.8 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.535 -1.283 . . . . 73.340000000000003 107.535 178.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -127.28 144.67 51.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.309 -0.405 . . . . 74.230000000000004 110.29 -174.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -134.8 123.49 23.63 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.64 -1.985 . . . . 72.420000000000002 105.64 171.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -107.63 132.11 53.66 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 118.099 0.409 . . . . 75.450000000000003 111.139 -174.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.0 163.22 30.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.1 -0.5 . . . . 74.349999999999994 109.719 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -121.58 131.81 54.33 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.34 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -123.27 144.56 44.02 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 106.799 -1.556 . . . . 73.019999999999996 106.799 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.67 133.5 24.03 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 121.866 1.711 . . . . 73.329999999999998 111.057 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.1 m -143.75 174.97 10.34 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.583 -0.895 . . . . 71.340000000000003 108.583 -178.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 27.2 p -65.35 149.63 96.81 Favored Pre-proline 0 C--N 1.311 -1.09 0 O-C-N 123.463 0.477 . . . . 75.540000000000006 109.842 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.47 -36.26 38.83 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 72.420000000000002 112.365 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -69.26 -22.02 63.86 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.976 0.732 . . . . 72.530000000000001 112.976 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.34 -9.77 21.94 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.778 -0.369 . . . . 74.010000000000005 111.637 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -59.9 126.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 CA-C-O 121.089 0.471 . . . . 74.010000000000005 110.372 177.014 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.24 -7.19 58.32 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.1 -0.8 . . . . 73.239999999999995 111.1 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.8 mptp? -107.34 156.27 19.08 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.792 -0.818 . . . . 74.049999999999997 108.792 177.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.15 127.58 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.654 -1.239 . . . . 71.400000000000006 107.654 175.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.9 -19.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.138 0.792 . . . . 73.319999999999993 113.138 -175.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.36 167.96 31.51 Favored Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.422 -0.894 . . . . 73.519999999999996 111.325 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.6 p -136.96 154.18 50.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.043 -1.465 . . . . 72.310000000000002 107.043 179.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -69.31 -48.68 25.46 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 118.984 -1.086 . . . . 74.219999999999999 109.369 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.85 106.72 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 N-CA-C 106.937 -1.986 . . . . 75.439999999999998 106.937 165.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.1 Cg_endo -65.06 151.62 85.1 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.879 2.386 . . . . 70.140000000000001 115.084 -169.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.0 12.68 0.81 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.76 1.224 . . . . 74.400000000000006 111.35 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 473' ' ' PRO . 44.8 m-80 -110.3 -15.59 13.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.577 -0.738 . . . . 74.519999999999996 110.493 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.08 154.68 22.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.848 0.832 . . . . 74.319999999999993 111.499 -171.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -87.74 110.61 20.58 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.014 -1.476 . . . . 65.349999999999994 107.014 178.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.5 m -112.83 148.52 34.68 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.772 -0.194 . . . . 74.200000000000003 111.134 -174.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.18 142.44 58.41 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.175 0.59 . . . . 73.319999999999993 110.66 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.0 mm -64.7 -21.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.495 0.664 . . . . 71.140000000000001 111.147 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.6 p -87.14 1.83 51.79 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 116.006 -0.543 . . . . 74.239999999999995 111.412 -177.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -89.75 145.45 25.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 116.191 -0.459 . . . . 75.450000000000003 111.107 178.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.34 122.75 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.719 -0.845 . . . . 74.150000000000006 108.719 176.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.08 120.74 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 108.66 -0.867 . . . . 71.340000000000003 108.66 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -92.21 112.74 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.711 -1.218 . . . . 73.150000000000006 107.711 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.56 105.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.693 -1.225 . . . . 71.099999999999994 107.693 -177.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.43 118.29 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.034 -0.985 . . . . 73.439999999999998 109.338 -176.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.7 t -97.32 138.54 21.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.568 -1.271 . . . . 75.019999999999996 107.568 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -81.55 108.48 2.88 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 109.424 -1.471 . . . . 74.319999999999993 109.424 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 13.3 t -142.67 118.02 10.23 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 62.109999999999999 108.566 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.316 0 N-CA-C 108.834 -1.706 . . . . 75.420000000000002 108.834 179.34 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 107.623 -1.251 . . . . 75.209999999999994 107.623 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.62 161.5 32.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.033 0.444 . . . . 62.43 111.208 -173.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -100.69 136.32 40.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.644 -1.243 . . . . 74.099999999999994 107.644 173.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -98.49 133.2 22.92 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.149 -1.056 . . . . 64.319999999999993 108.149 -177.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.83 164.27 36.22 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 121.966 1.777 . . . . 70.209999999999994 113.67 -176.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 366' ' ' ARG . 4.1 m-20 -67.51 120.89 14.69 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.844 -1.071 . . . . 54.530000000000001 108.244 176.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.83 30.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.582 0 CA-C-O 123.067 1.413 . . . . 75.340000000000003 110.146 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 364' ' ' ASP . 15.1 ptt85 -62.49 144.09 56.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.716 -1.584 . . . . 73.430000000000007 113.041 -177.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.01 0.47 48.29 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.303 -0.862 . . . . 61.210000000000001 114.164 173.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -132.77 175.88 8.95 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.824 0.812 . . . . 74.430000000000007 111.569 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 97.3 p -74.77 171.45 13.94 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.636 0.374 . . . . 75.540000000000006 111.028 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 14.6 m -61.85 -45.66 92.84 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.99 0.424 . . . . 75.209999999999994 110.09 178.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.83 80.4 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.106 -0.497 . . . . 74.25 111.195 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.47 -42.23 79.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.23 -0.441 . . . . 75.450000000000003 110.701 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.77 81.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 75.010000000000005 110.287 178.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.6 mt -58.71 -42.58 85.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 75.400000000000006 110.715 178.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.23 -47.17 77.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.295 -0.412 . . . . 64.239999999999995 110.985 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 43.7 m -60.77 -45.57 93.81 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 116.511 -0.313 . . . . 75.340000000000003 111.401 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.64 -38.93 92.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.737 0.303 . . . . 72.540000000000006 111.01 176.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.24 -43.3 99.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.704 -0.68 . . . . 74.209999999999994 109.839 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -29.03 70.11 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.885 -0.598 . . . . 74.340000000000003 110.691 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -83.85 -12.12 56.0 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.872 -0.604 . . . . 73.049999999999997 109.709 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 96.92 0.85 60.04 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.997 -0.62 . . . . 71.310000000000002 112.416 177.256 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 43.9 m-85 -79.18 157.15 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.034 0.445 . . . . 74.5 111.851 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.8 137.83 40.5 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 106.711 -1.589 . . . . 71.230000000000004 106.711 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.63 140.26 46.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 113.96 1.096 . . . . 73.120000000000005 113.96 -177.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -110.69 130.89 55.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.03 -1.841 . . . . 75.319999999999993 106.03 173.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.9 m -112.64 118.09 34.08 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.782 -0.822 . . . . 54.340000000000003 108.782 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.44 118.33 32.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.943 -1.502 . . . . 75.510000000000005 106.943 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.67 122.44 47.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.072 -0.714 . . . . 72.5 109.072 177.536 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 0.1 OUTLIER -127.38 133.45 25.09 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.009 -0.541 . . . . 74.319999999999993 110.068 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.416 ' N ' ' HB ' ' A' ' 422' ' ' THR . 57.8 Cg_endo -76.19 139.67 21.55 Favored 'Trans proline' 0 C--O 1.257 1.431 0 C-N-CA 122.371 2.047 . . . . 74.400000000000006 109.326 172.092 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 172.78 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.491 -1.299 . . . . 62.520000000000003 107.491 -176.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.444 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 57.4 m -141.68 -14.38 0.84 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.876 -0.515 . . . . 71.400000000000006 111.928 176.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.5 p -91.37 19.35 6.13 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.364 1.078 . . . . 63.43 109.847 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.8 pt -104.57 150.95 39.11 Favored Pre-proline 0 C--N 1.296 -1.735 0 CA-C-N 114.571 -1.195 . . . . 74.239999999999995 111.839 -173.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 145.23 38.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.494 2.129 . . . . 72.439999999999998 111.291 177.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.48 162.84 7.51 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.26 3.307 . . . . 73.030000000000001 113.362 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.91 -11.78 1.15 Allowed 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 124.257 1.023 . . . . 72.200000000000003 112.451 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -101.97 109.15 20.81 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.082 -2.192 . . . . 73.400000000000006 105.082 176.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.3 p -62.14 120.64 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.079 0.942 . . . . 65.230000000000004 112.302 -170.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.03 -27.9 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.546 -1.206 . . . . 75.530000000000001 110.318 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.62 158.09 27.56 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 119.817 -1.182 . . . . 73.239999999999995 111.97 -177.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.1 p -114.6 -175.58 2.71 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.253 0.621 . . . . 73.109999999999999 110.249 -177.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -100.05 134.77 20.66 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.805 -1.554 . . . . 73.099999999999994 106.805 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.72 -27.94 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 1 C-N-CA 125.395 4.063 . . . . 74.310000000000002 115.939 -175.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.85 -24.16 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.76 0.314 . . . . 51.520000000000003 111.055 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.87 40.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.018 -0.537 . . . . 71.530000000000001 110.816 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -79.26 -2.32 40.66 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.291 0.567 . . . . 74.519999999999996 112.249 -179.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 84.2 m -84.86 146.84 27.1 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.391 -1.337 . . . . 73.030000000000001 107.391 172.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -75.43 119.6 19.73 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.903 -0.719 . . . . 74.329999999999998 110.001 -179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.02 169.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 123.898 0.879 . . . . 71.5 109.225 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.0 t -75.61 142.05 42.73 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.439 -0.949 . . . . 73.310000000000002 108.439 178.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -64.27 109.76 2.0 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.215 -0.661 . . . . 74.120000000000005 109.215 178.092 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 122.96 25.88 1.8 Allowed Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.765 -0.934 . . . . 73.209999999999994 110.765 -175.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.02 -178.29 4.02 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.047 -1.094 . . . . 52.340000000000003 108.047 -178.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.33 120.92 35.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.903 0.859 . . . . 75.519999999999996 112.918 -176.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.1 mm -110.96 121.35 63.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.501 -0.926 . . . . 73.400000000000006 108.501 176.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.9 t -93.81 121.39 35.2 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.549 0.69 . . . . 70.030000000000001 110.037 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.3 t -107.05 126.85 63.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.387 -0.968 . . . . 61.439999999999998 108.387 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -99.75 120.19 39.33 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.244 -0.65 . . . . 64.329999999999998 109.244 -179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.0 t -113.07 142.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.764 -0.828 . . . . 75.439999999999998 108.764 -178.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.0 p -84.87 127.38 34.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.898 1.332 . . . . 74.329999999999998 113.792 -178.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.416 ' HB ' ' N ' ' A' ' 390' ' ' PRO . 8.8 m -101.46 156.84 17.23 Favored 'General case' 1 N--CA 1.376 -4.156 0 N-CA-C 104.092 -2.558 . . . . 74.230000000000004 104.092 170.238 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -34.84 150.64 0.01 OUTLIER Glycine 0 C--N 1.284 -2.357 0 N-CA-C 117.435 1.734 . . . . 74.150000000000006 117.435 -176.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 50.9 Cg_exo -54.71 132.2 50.27 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.128 2.552 . . . . 74.150000000000006 112.918 179.007 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -72.25 140.6 48.73 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.142 -0.935 . . . . 73.299999999999997 109.933 176.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.2 mt-30 -120.3 148.11 44.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.251 -1.018 . . . . 61.43 108.251 176.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -144.56 164.64 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.615 -1.254 . . . . 75.120000000000005 107.615 -176.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.39 138.84 34.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.993 -1.114 . . . . 74.299999999999997 107.993 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.5 mt -80.8 120.47 79.05 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.168 -1.049 . . . . 73.140000000000001 108.168 178.298 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.46 141.55 51.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.96 2.44 . . . . 64.409999999999997 113.69 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.44 -15.65 56.27 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.733 -1.121 . . . . 75.150000000000006 111.253 -176.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.31 -14.62 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.396 -0.82 . . . . 75.329999999999998 110.838 -178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.0 m -53.74 -40.04 65.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.922 0.889 . . . . 73.310000000000002 112.388 -178.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.8 p -69.08 -12.84 62.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 113.384 0.883 . . . . 75.299999999999997 113.384 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -82.7 -48.35 10.97 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.362 -0.535 . . . . 72.530000000000001 110.716 -178.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 75.1 m -157.29 141.74 16.49 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 110.285 -0.265 . . . . 72.510000000000005 110.285 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -56.7 -44.19 81.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.695 1.198 . . . . 74.530000000000001 111.486 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.61 78.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.915 0.388 . . . . 74.109999999999999 110.482 177.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.11 -42.0 94.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.836 -0.62 . . . . 65.519999999999996 110.935 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -60.79 -51.69 68.27 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.599 0.562 . . . . 73.409999999999997 110.662 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.57 -49.18 81.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.948 -0.301 . . . . 74.200000000000003 111.515 -177.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.06 -47.58 70.86 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.569 0.581 . . . . 72.040000000000006 112.569 -178.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -67.05 -38.03 85.12 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.255 0.835 . . . . 71.209999999999994 113.255 -178.566 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.42 -36.46 84.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.269 -0.572 . . . . 73.420000000000002 111.115 174.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 44.9 m -67.35 -39.95 85.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 177.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.95 68.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.157 0.503 . . . . 74.239999999999995 110.605 177.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.64 59.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.302 -0.408 . . . . 55.100000000000001 110.34 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.92 -21.3 8.99 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 119.163 -0.799 . . . . 43.340000000000003 114.697 174.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -55.88 128.33 34.56 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.408 0.892 . . . . 74.450000000000003 113.408 -172.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.46 -1.18 23.31 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.251 -0.886 . . . . 71.340000000000003 114.293 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 10.7 mmm180 -124.12 111.66 16.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 117.699 0.749 . . . . 73.030000000000001 110.549 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -119.07 150.99 39.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.271 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -145.56 136.1 24.21 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.399 -1.704 . . . . 74.209999999999994 106.399 172.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -106.64 134.12 50.28 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.809 0.338 . . . . 73.150000000000006 110.148 -176.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.93 159.14 42.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.231 -0.655 . . . . 62.030000000000001 109.231 177.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -129.35 134.54 47.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.43 -0.952 . . . . 64.409999999999997 108.43 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 t -125.14 146.13 52.82 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 108.997 -0.742 . . . . 74.109999999999999 108.997 -177.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 40.4 Cg_exo -61.57 123.6 13.04 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.332 2.021 . . . . 75.319999999999993 109.244 173.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.5 m -139.26 -179.78 6.07 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 110.211 -0.292 . . . . 72.510000000000005 110.211 -176.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.6 m -56.18 133.5 75.11 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 108.384 -0.969 . . . . 74.420000000000002 108.384 175.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.01 -31.16 33.58 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.828 3.018 . . . . 72.209999999999994 114.173 -175.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.73 -11.23 59.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 111.962 0.356 . . . . 75.430000000000007 111.962 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.69 2.29 38.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.498 -0.319 . . . . 74.420000000000002 111.16 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.7 p -59.62 126.96 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 120.277 -0.569 . . . . 74.340000000000003 110.689 178.032 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.79 78.24 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.161 -1.019 . . . . 72.439999999999998 111.963 178.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -125.42 147.21 49.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.584 -0.895 . . . . 75.439999999999998 108.584 177.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.65 128.64 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.193 -0.669 . . . . 75.409999999999997 109.193 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.66 -5.39 9.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.126 -1.03 . . . . 75.219999999999999 111.226 -178.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.73 29.39 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.534 -0.841 . . . . 74.010000000000005 111.805 176.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.2 p -116.34 153.34 32.17 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.896 -1.15 . . . . 74.25 107.896 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 28.4 t-20 -60.75 -50.35 85.56 Favored Pre-proline 0 C--N 1.317 -0.838 0 O-C-N 123.35 0.406 . . . . 75.329999999999998 111.285 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_exo -77.98 131.28 10.92 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 N-CA-C 107.413 -1.803 . . . . 64.540000000000006 107.413 168.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . 0.4 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.5 Cg_endo -62.46 142.14 89.34 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.373 2.049 . . . . 75.530000000000001 113.552 -175.773 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.99 4.18 15.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.976 0.893 . . . . 72.310000000000002 110.827 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -108.56 3.24 22.79 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.763 -1.108 . . . . 71.109999999999999 108.652 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . 0.4 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 36.1 tt0 -121.83 165.21 16.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.106 -1.072 . . . . 74.530000000000001 108.106 -178.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 2.8 m -98.77 129.64 45.2 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.029 -1.1 . . . . 75.319999999999993 108.029 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 47.5 m -124.42 148.59 47.5 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 -178.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.25 153.75 40.49 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.388 0.514 . . . . 75.519999999999996 112.388 -178.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.26 -29.46 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.359 0.6 . . . . 73.409999999999997 110.694 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 481' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 14.6 t -90.18 2.82 54.94 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.541 0.686 . . . . 72.310000000000002 109.949 177.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 46.1 t30 -86.08 141.55 29.35 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.037 -1.097 . . . . 73.329999999999998 108.037 -178.055 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.47 112.71 17.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 120.051 -0.66 . . . . 72.400000000000006 109.22 -178.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.1 119.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 N-CA-C 107.514 -1.291 . . . . 72.530000000000001 107.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 41.0 mt -98.22 121.03 48.33 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.451 -1.314 . . . . 75.310000000000002 107.451 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.93 120.22 51.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.809 -1.182 . . . . 63.549999999999997 107.809 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.59 123.63 60.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-O 121.527 0.679 . . . . 72.319999999999993 110.048 -176.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.98 137.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.946 -1.131 . . . . 70.299999999999997 107.946 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.57 127.98 8.97 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.424 -1.07 . . . . 65.150000000000006 110.424 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.3 t -133.94 103.89 6.02 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.179 -1.045 . . . . 73.409999999999997 108.179 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.193 0 N-CA-C 108.877 -1.689 . . . . 71.409999999999997 108.877 -178.007 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-O 121.314 0.578 . . . . 75.450000000000003 109.892 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.98 152.23 20.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 110.931 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.54 136.7 43.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.151 -0.477 . . . . 71.109999999999999 109.941 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.95 133.77 20.18 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 109.301 -0.629 . . . . 75.219999999999999 109.301 -176.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.65 159.51 53.21 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.604 2.202 . . . . 71.140000000000001 114.635 -175.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.37 142.96 50.36 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.28 -0.873 . . . . 72.319999999999993 109.166 176.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 6.7 t -107.08 21.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.044 -1.095 . . . . 72.109999999999999 108.044 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 6.0 ptp180 -58.57 145.37 39.61 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.08 -0.964 . . . . 75.450000000000003 112.379 -177.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.4 1.06 43.92 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 113.317 178.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 368' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 7.6 pt20 -138.58 -175.45 4.13 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.263 -1.014 . . . . 73.310000000000002 108.263 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 96.1 p -76.48 163.82 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 119.609 1.095 . . . . 74.239999999999995 112.316 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.7 p -61.85 -34.09 75.34 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.758 -0.655 . . . . 71.030000000000001 109.335 173.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.77 91.73 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.143 -0.935 . . . . 72.239999999999995 109.781 176.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.06 -42.11 89.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.58 -0.736 . . . . 75.329999999999998 110.619 177.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.39 85.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.722 -0.672 . . . . 64.239999999999995 111.224 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.45 -46.12 89.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.087 -0.506 . . . . 75.010000000000005 110.013 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.15 93.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.63 . . . . 54.149999999999999 111.477 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 64.9 m -66.24 -48.25 71.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.145 -0.48 . . . . 64.340000000000003 111.088 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.27 -38.7 91.1 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.325 -0.234 . . . . 74.209999999999994 111.225 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.71 -48.17 82.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.823 -0.806 . . . . 63.119999999999997 108.823 178.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -70.33 -17.31 63.07 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.684 1.364 . . . . 74.239999999999995 114.684 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -89.61 -14.19 35.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.353 -0.539 . . . . 73.340000000000003 111.113 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.11 16.25 30.79 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.345 -0.931 . . . . 63.329999999999998 113.25 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -96.72 154.67 17.15 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.857 -0.423 . . . . 74.230000000000004 109.857 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.61 143.44 26.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.091 -1.448 . . . . 74.140000000000001 107.091 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 384' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -132.75 148.21 31.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.363 0.601 . . . . 65.010000000000005 112.398 -178.802 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 385' ' ' ARG . . . . . 0.432 ' HB3' HG23 ' A' ' 417' ' ' THR . 19.5 ttm-85 -118.28 144.88 45.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.705 -1.591 . . . . 74.219999999999999 106.705 174.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.3 m -98.46 121.58 40.58 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.008 -1.478 . . . . 73.340000000000003 107.008 176.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.34 119.47 38.96 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.872 -1.899 . . . . 74.439999999999998 105.872 -179.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.503 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -110.91 122.06 46.93 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 110.892 -174.619 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 389' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.3 OUTLIER -116.15 119.32 36.88 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 115.402 -0.817 . . . . 73.230000000000004 111.48 -177.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 5.8 Cg_endo -93.25 145.53 2.26 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.031 2.487 . . . . 65.209999999999994 111.662 173.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 391' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 12.0 t70 160.82 -164.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 104.861 -2.274 . . . . 64.230000000000004 104.861 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 392' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 394' ' ' ILE . 14.8 m -132.8 1.68 3.65 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 119.533 1.06 . . . . 72.239999999999995 110.316 175.031 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -97.32 24.39 6.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 106.385 -1.709 . . . . 74.519999999999996 106.385 174.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 394' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 392' ' ' SER . 19.8 pt -89.64 151.57 45.97 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 112.527 -2.124 . . . . 73.319999999999993 110.304 -178.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.55 173.01 15.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 121.837 1.691 . . . . 73.420000000000002 108.652 170.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 396' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 398' ' ' HIS . 50.8 Cg_exo -58.01 160.92 14.28 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.161 1.907 . . . . 73.040000000000006 112.598 174.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.01 -8.07 0.94 Allowed 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.923 1.689 . . . . 70.019999999999996 112.781 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 368' ' ' GLN . 42.9 m80 -82.42 175.47 10.2 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.452 1.101 . . . . 70.439999999999998 108.467 179.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.6 p -91.8 117.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 118.457 -1.297 . . . . 73.319999999999993 109.592 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.81 -28.76 2.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.672 -1.149 . . . . 71.439999999999998 109.808 177.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.34 160.8 27.92 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 119.79 -1.195 . . . . 70.420000000000002 112.192 -173.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 52.4 p -122.43 -174.46 2.91 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.282 1.033 . . . . 71.219999999999999 111.225 -172.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -98.17 142.07 23.98 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 105.896 -1.89 . . . . 71.019999999999996 105.896 -175.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.31 -36.14 6.08 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.795 2.996 . . . . 74.120000000000005 113.647 178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -68.54 -8.21 39.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.962 -0.563 . . . . 61.310000000000002 112.496 -178.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -81.75 -51.45 8.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.548 -0.461 . . . . 72.140000000000001 110.64 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.35 -5.12 59.24 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 120.646 -0.421 . . . . 74.230000000000004 112.043 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.5 m -97.06 142.25 29.23 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 72.420000000000002 106.624 174.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.7 p -74.24 113.74 11.8 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.763 0.792 . . . . 72.430000000000007 111.771 -177.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.25 170.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.887 -1.051 . . . . 74.340000000000003 109.462 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 48.1 m -67.02 138.56 57.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.561 -0.903 . . . . 73.109999999999999 108.561 175.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.81 109.92 0.81 Allowed 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.007 0.523 . . . . 73.239999999999995 111.483 -177.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.93 43.64 1.62 Allowed Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.582 -0.735 . . . . 65.129999999999995 111.997 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -94.39 -167.62 1.7 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.406 -1.331 . . . . 63.310000000000002 107.406 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.36 124.4 52.17 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.695 0.759 . . . . 73.299999999999997 111.612 -179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 416' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 43.7 mm -114.44 135.53 53.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.012 -0.994 . . . . 65.420000000000002 108.554 -176.063 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 417' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 385' ' ' ARG . 71.1 p -94.32 127.07 39.96 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.34 -0.944 . . . . 73.140000000000001 109.689 175.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.28 130.13 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.242 -1.021 . . . . 75.219999999999999 108.242 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -96.69 128.81 43.99 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.595 -175.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 12.6 p -134.33 141.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.391 -0.966 . . . . 75.129999999999995 108.391 176.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 421' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 73.2 p -94.1 122.53 36.71 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.474 -0.565 . . . . 53.32 109.474 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 422' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 388' ' ' GLN . 12.2 t -120.14 107.5 13.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.857 -0.737 . . . . 74.230000000000004 111.992 177.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.04 120.65 1.59 Allowed Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.839 -1.172 . . . . 70.209999999999994 114.431 174.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 424' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.2 Cg_exo -75.94 128.56 10.84 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.898 1.732 . . . . 72.219999999999999 110.207 173.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 480' ' ' ILE . 6.4 mm-40 -74.99 125.75 29.57 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.687 -0.486 . . . . 75.420000000000002 109.687 177.275 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 49.1 mt-30 -110.29 139.08 45.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.083 -0.71 . . . . 73.129999999999995 109.083 177.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 427' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 1.1 tpt180 -132.64 165.45 24.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.995 0.426 . . . . 73.430000000000007 111.579 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.76 139.24 34.96 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.158 0.983 . . . . 75.340000000000003 111.2 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.67 119.82 76.36 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.278 -1.749 . . . . 64.140000000000001 106.278 172.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.25 141.35 81.87 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.651 2.234 . . . . 74.329999999999998 113.368 -178.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 -20.96 23.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.069 -0.969 . . . . 54.32 110.426 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.39 -11.73 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.407 0.623 . . . . 72.030000000000001 110.624 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.2 m -53.0 -41.03 64.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.486 1.114 . . . . 62.420000000000002 112.485 -178.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 3.1 p -68.2 -13.63 62.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.557 0.947 . . . . 74.450000000000003 113.557 -176.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 76.3 mt -86.86 -36.92 18.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.651 0.263 . . . . 64.109999999999999 111.306 -178.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.9 m -158.37 134.15 9.0 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 122.222 -0.299 . . . . 73.310000000000002 110.415 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.05 -46.42 89.21 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.703 0.631 . . . . 74.25 112.703 -178.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.14 -41.23 87.82 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.704 0.287 . . . . 74.230000000000004 110.468 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -63.71 -39.45 94.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.725 -0.671 . . . . 61.539999999999999 110.41 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.87 -50.92 71.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.47 0.481 . . . . 43.119999999999997 109.837 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.44 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 75.120000000000005 110.467 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 442' ' ' LYS . 6.3 mmpt? -61.04 -46.05 92.26 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.996 -0.547 . . . . 73.150000000000006 111.267 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.43 -41.98 96.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.246 0.462 . . . . 74.239999999999995 112.246 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -43.43 96.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.936 0.398 . . . . 72.310000000000002 111.024 176.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.9 m -68.08 -39.63 82.88 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.787 -0.642 . . . . 74.420000000000002 110.333 -178.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.3 62.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 63.020000000000003 111.184 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.76 -12.84 59.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.156 0.503 . . . . 65.239999999999995 109.728 176.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.53 0.7 40.26 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-O 119.168 -0.795 . . . . 74.409999999999997 114.469 174.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.96 137.38 57.1 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.099 0.95 . . . . 74.140000000000001 112.106 -178.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -125.08 13.57 7.53 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.204 -0.759 . . . . 73.299999999999997 111.204 178.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.23 111.37 13.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.504 -0.924 . . . . 71.310000000000002 108.504 -178.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.08 152.74 47.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.89 -0.595 . . . . 74.450000000000003 109.94 -175.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -150.09 122.71 8.58 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.927 -1.138 . . . . 70.299999999999997 107.927 172.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.73 131.98 45.36 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.796 -0.446 . . . . 72.409999999999997 109.796 -177.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -123.57 141.17 52.27 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.315 -1.365 . . . . 73.409999999999997 107.315 175.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -119.28 129.59 54.98 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.219 0.533 . . . . 72.109999999999999 110.288 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.2 t -119.94 130.84 24.64 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 108.506 -0.924 . . . . 74.209999999999994 108.506 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.73 121.81 10.09 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.45 2.1 . . . . 72.420000000000002 109.699 177.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.4 m -133.95 160.28 38.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.916 -0.314 . . . . 72.519999999999996 110.417 -176.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 460' ' ' THR . . . . . 0.529 ' HB ' ' OE1' ' A' ' 462' ' ' GLU . 14.2 p -64.65 159.06 64.47 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 124.856 1.262 . . . . 75.140000000000001 111.81 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.77 -31.13 24.89 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.789 2.992 . . . . 73.129999999999995 113.285 177.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 462' ' ' GLU . . . . . 0.529 ' OE1' ' HB ' ' A' ' 460' ' ' THR . 1.5 pm0 -75.36 -24.54 57.31 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.193 0.812 . . . . 73.409999999999997 113.193 178.115 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.17 -18.67 14.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.211 0.448 . . . . 72.510000000000005 112.211 -179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.5 130.44 23.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.413 0.625 . . . . 72.310000000000002 111.29 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -4.61 64.01 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.743 -0.662 . . . . 65.019999999999996 111.971 178.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 157.05 28.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.227 0.537 . . . . 74.109999999999999 109.95 177.295 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.79 136.51 22.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.496 -1.298 . . . . 65.129999999999995 107.496 176.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.31 -16.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.543 -0.863 . . . . 73.219999999999999 111.301 -177.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.1 175.62 32.32 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.561 -0.745 . . . . 43.520000000000003 111.629 178.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.0 p -122.01 158.99 27.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.385 -0.969 . . . . 75.030000000000001 108.385 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 471' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -64.97 -57.0 17.19 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 119.086 -0.483 . . . . 74.120000000000005 110.666 175.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 472' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.0 Cg_endo -79.63 121.14 4.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 N-CA-C 107.951 -1.596 . . . . 72.430000000000007 107.951 170.176 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 161.29 46.5 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.537 2.158 . . . . 75.129999999999995 113.969 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -69.6 6.59 1.06 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.887 1.275 . . . . 73.319999999999993 113.283 -177.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -108.15 -4.49 17.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.158 -0.682 . . . . 75.010000000000005 109.158 179.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -99.92 161.44 13.61 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.604 -0.726 . . . . 74.409999999999997 109.936 -177.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.0 m -128.92 101.03 5.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.996 -1.483 . . . . 55.299999999999997 106.996 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.9 p -104.41 149.05 25.75 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.139 -0.482 . . . . 71.25 111.576 -174.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 479' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.8 153.53 24.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 74.319999999999993 111.015 177.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 480' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -61.0 -15.1 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 C-N-CA 123.924 0.89 . . . . 65.530000000000001 112.074 -179.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.0 t -94.99 -4.09 47.26 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.8 -0.563 . . . . 72.439999999999998 110.238 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 130.89 37.83 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.98 -0.748 . . . . 70.310000000000002 108.98 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.31 113.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.68 -0.859 . . . . 75.540000000000006 108.68 -179.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.45 120.04 36.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 109.081 -0.711 . . . . 64.219999999999999 109.081 179.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.8 mp -92.34 113.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 73.530000000000001 107.122 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.92 121.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.124 -1.065 . . . . 74.239999999999995 108.124 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 39.7 mt -101.16 116.32 44.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.566 0.698 . . . . 71.219999999999999 110.474 -175.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.5 t -98.1 132.72 42.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.245 -0.889 . . . . 73.239999999999995 109.045 -176.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.7 98.68 1.93 Allowed Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 109.207 -1.557 . . . . 63.420000000000002 109.207 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 18.0 t -140.85 111.89 7.17 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.902 -0.777 . . . . 70.439999999999998 108.902 -176.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.92 0 N-CA-C 109.636 -1.386 . . . . 73.040000000000006 109.636 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 110.691 -0.964 . . . . 73.299999999999997 110.691 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.68 153.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 117.174 0.487 . . . . 64.530000000000001 110.478 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.8 t -123.62 -173.38 2.73 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 107.338 -1.356 . . . . 75.349999999999994 107.338 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -92.82 100.64 13.08 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.986 -0.686 . . . . 75.420000000000002 109.715 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -115.67 127.79 55.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.425 -0.954 . . . . 73.239999999999995 108.425 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 22.7 m -131.27 158.48 43.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 123.102 0.561 . . . . 74.319999999999993 109.53 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.71 137.25 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.726 -0.842 . . . . 74.239999999999995 108.726 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.36 124.52 36.97 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-O 120.828 0.347 . . . . 70.340000000000003 110.519 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.01 142.64 96.85 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.16 2.573 . . . . 74.040000000000006 113.304 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.71 149.96 34.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.742 -1.117 . . . . 71.109999999999999 110.167 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.83 31.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.987 1.375 . . . . 65.010000000000005 108.006 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -64.44 133.97 53.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.057 -1.429 . . . . 74.319999999999993 110.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.18 -0.13 47.49 Favored Glycine 0 C--N 1.317 -0.495 0 C-N-CA 121.407 -0.425 . . . . 71.239999999999995 112.326 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.23 -176.88 3.94 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.615 -0.883 . . . . 72.430000000000007 108.615 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 91.6 p -81.3 168.41 18.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 118.407 0.548 . . . . 73.299999999999997 110.266 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.432 ' O ' HG13 ' A' ' 374' ' ' ILE . 1.8 p -63.15 -34.83 78.46 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 110.637 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.91 -39.25 93.98 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.731 0.412 . . . . 74.230000000000004 110.548 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -59.57 -42.83 93.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.106 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.89 81.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.745 . . . . 73.310000000000002 110.343 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 370' ' ' SER . 80.9 mt -58.4 -46.34 89.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.654 -0.703 . . . . 74.209999999999994 110.546 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -46.98 78.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.317 -0.401 . . . . 73.040000000000006 111.705 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 74.0 m -60.9 -47.53 85.98 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.727 0.298 . . . . 71.230000000000004 111.291 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.57 -39.51 93.88 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.045 -0.262 . . . . 75.239999999999995 110.998 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.07 -42.92 99.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.459 0.703 . . . . 71.540000000000006 109.727 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -33.71 76.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.778 -0.646 . . . . 75.409999999999997 111.323 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -83.84 -10.2 58.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.057 -0.52 . . . . 75.540000000000006 111.743 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.98 0.28 56.19 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.249 -0.977 . . . . 74.340000000000003 112.497 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 53.6 m-85 -78.07 151.11 33.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.675 -0.491 . . . . 73.420000000000002 109.675 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 383' ' ' LYS . 3.0 mptp? -102.06 147.19 26.89 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.867 -1.531 . . . . 74.120000000000005 106.867 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.69 141.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-O 121.378 0.609 . . . . 72.109999999999999 111.623 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -118.65 127.97 54.08 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.334 -1.358 . . . . 73.040000000000006 107.334 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.4 m -99.71 123.95 44.48 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 109.277 -0.638 . . . . 73.510000000000005 109.277 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.63 119.57 39.14 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.302 -1.74 . . . . 73.040000000000006 106.302 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.636 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -119.18 141.29 48.99 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 110.155 -0.313 . . . . 75.510000000000005 110.155 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.404 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 11.0 ptpt -139.4 134.89 16.69 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 116.057 -0.52 . . . . 73.549999999999997 111.109 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 6.1 Cg_exo -82.7 134.24 7.33 Favored 'Trans proline' 0 C--O 1.246 0.893 0 N-CA-C 106.737 -2.063 . . . . 71.409999999999997 106.737 165.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.404 ' HB2' ' HD3' ' A' ' 389' ' ' LYS . 5.0 t70 -154.38 -176.73 6.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.182 -1.407 . . . . 73.519999999999996 112.239 -171.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.9 t -92.44 -41.09 10.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.017 -1.845 . . . . 71.420000000000002 106.017 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -101.83 74.52 1.49 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.92 -1.511 . . . . 75.510000000000005 106.92 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.1 pp -88.64 121.02 70.31 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 115.435 1.643 . . . . 73.140000000000001 115.435 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.578 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 16.5 Cg_exo -75.48 157.37 40.8 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.78 2.32 . . . . 62.420000000000002 109.519 164.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.64 160.91 47.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.33 2.02 . . . . 74.109999999999999 111.864 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.59 -6.91 5.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.041 0.756 . . . . 72.030000000000001 113.041 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -90.59 166.74 13.03 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.409 -0.814 . . . . 74.120000000000005 108.938 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.07 117.76 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.076 -0.713 . . . . 71.540000000000006 109.076 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -106.43 -28.63 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.346 -0.613 . . . . 75.030000000000001 109.346 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 168.16 28.09 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.957 -1.657 . . . . 70.209999999999994 108.957 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 p -132.58 -177.76 4.62 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-O 120.96 0.41 . . . . 71.129999999999995 110.698 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -100.94 138.78 20.11 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.947 -1.131 . . . . 65.030000000000001 107.947 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.9 -29.54 3.76 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 124.573 3.515 . . . . 75.140000000000001 114.703 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.58 -28.39 54.79 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.236 0.614 . . . . 62.200000000000003 112.0 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.66 54.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.944 0.402 . . . . 71.340000000000003 111.203 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -6.76 59.25 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.557 0.577 . . . . 71.329999999999998 112.557 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.5 m -86.02 147.69 26.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.649 -1.612 . . . . 71.530000000000001 106.649 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.0 m -74.45 112.83 11.01 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.417 -0.957 . . . . 65.120000000000005 108.417 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.67 165.06 29.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.047 -0.723 . . . . 72.319999999999993 109.047 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 50.3 m -69.23 134.13 48.81 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 120.6 -0.44 . . . . 72.340000000000003 110.242 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.89 112.01 2.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 72.230000000000004 110.218 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.53 24.21 5.1 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.537 -1.025 . . . . 74.239999999999995 110.537 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.99 -169.12 2.43 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.409 -1.33 . . . . 72.109999999999999 107.409 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.1 125.05 53.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.814 -0.554 . . . . 75.530000000000001 110.209 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -111.42 125.65 68.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.926 -0.579 . . . . 73.400000000000006 109.442 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.2 t -89.59 130.74 35.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.086 -0.709 . . . . 72.450000000000003 109.086 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 65.9 t -108.67 118.78 56.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.083 -1.08 . . . . 74.439999999999998 108.083 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.4 121.65 34.09 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.164 -0.68 . . . . 72.340000000000003 109.164 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 13.8 p -133.96 152.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.432 -1.321 . . . . 64.450000000000003 107.432 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.578 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 43.7 m -126.74 130.82 51.09 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 121.574 -0.703 . . . . 72.25 110.224 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -118.05 106.66 13.13 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.522 0.677 . . . . 72.340000000000003 110.995 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 79.33 141.24 2.19 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.205 -0.907 . . . . 54.100000000000001 114.204 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 24.0 Cg_endo -74.28 147.56 37.49 Favored 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 121.09 1.193 . . . . 74.099999999999994 109.465 172.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -72.77 164.91 25.83 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 109.628 -177.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -125.48 154.23 42.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.934 -1.136 . . . . 75.540000000000006 107.934 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 427' ' ' ARG . 0.2 OUTLIER -141.9 153.48 44.44 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.318 -0.993 . . . . 71.219999999999999 108.318 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -83.06 138.86 33.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.962 -1.866 . . . . 73.120000000000005 105.962 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 69.2 mt -80.3 115.55 55.52 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 120.587 -0.445 . . . . 73.310000000000002 110.332 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.16 141.08 38.81 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.31 1.34 . . . . 70.430000000000007 109.969 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.6 78.77 9.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.619 1.2 . . . . 62.32 110.393 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.47 -10.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.531 -1.668 . . . . 73.299999999999997 107.588 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 4.6 m -59.9 -50.02 75.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.224 -1.353 . . . . 74.109999999999999 110.486 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 21.4 m -57.95 -13.56 4.76 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 125.598 1.559 . . . . 72.439999999999998 113.063 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.23 -47.08 11.18 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.731 -0.606 . . . . 74.230000000000004 110.681 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.407 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 26.6 m -160.82 145.68 14.14 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.652 -0.87 . . . . 75.140000000000001 108.652 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.57 -44.36 89.72 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 122.995 0.518 . . . . 63.210000000000001 111.085 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.76 84.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.815 -0.63 . . . . 73.549999999999997 110.748 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.407 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.5 mm-40 -61.89 -43.46 98.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.47 -0.786 . . . . 75.430000000000007 111.262 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.15 66.61 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 123.543 0.527 . . . . 63.439999999999998 110.729 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.76 -51.05 49.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.06 -0.518 . . . . 73.120000000000005 112.057 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -69.28 -44.94 70.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 114.04 1.126 . . . . 75.430000000000007 114.04 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.33 -38.39 84.82 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.978 -0.289 . . . . 73.329999999999998 111.312 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.15 -32.62 73.01 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.213 -0.595 . . . . 71.310000000000002 111.499 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.7 m -64.24 -40.38 95.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.999 -0.741 . . . . 75.219999999999999 108.999 174.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.65 66.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.711 -0.677 . . . . 75.200000000000003 110.798 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -12.4 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.164 0.507 . . . . 64.420000000000002 110.303 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . 0.491 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 124.15 -27.57 5.56 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.886 -0.673 . . . . 73.150000000000006 113.713 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 445' ' ' THR . 88.8 m-85 -62.09 142.14 57.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.236 0.518 . . . . 71.439999999999998 111.392 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.89 13.71 4.42 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.59 -1.291 . . . . 53.210000000000001 113.278 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -128.35 113.82 16.08 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.321 -0.517 . . . . 74.420000000000002 110.049 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.1 152.36 47.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.199 0.523 . . . . 72.420000000000002 111.515 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -143.17 123.81 14.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.74 -1.578 . . . . 74.010000000000005 106.74 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -94.72 134.71 37.02 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.73 159.69 41.28 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.741 -1.207 . . . . 75.239999999999995 107.741 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.656 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.1 m-80 -128.32 140.64 51.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.535 -0.913 . . . . 74.109999999999999 108.535 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.0 m -125.17 137.58 30.02 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 109.164 -0.68 . . . . 73.010000000000005 109.164 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 490' ' ' SER . 15.9 Cg_endo -61.55 121.39 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.414 2.076 . . . . 72.019999999999996 111.265 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.7 m -133.44 171.41 14.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.288 -0.634 . . . . 62.039999999999999 109.288 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.4 m -58.67 143.28 82.28 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 123.823 0.849 . . . . 73.049999999999997 108.867 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.473 ' O ' HG11 ' A' ' 464' ' ' VAL . 6.1 Cg_endo -50.6 -25.91 15.76 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.553 2.835 . . . . 63.25 113.027 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.41 -18.71 65.51 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.215 0.45 . . . . 71.140000000000001 112.215 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.22 5.17 18.26 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.281 -0.262 . . . . 74.340000000000003 111.126 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.473 HG11 ' O ' ' A' ' 461' ' ' PRO . 7.6 p -60.25 127.3 19.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.006 0.432 . . . . 74.109999999999999 110.895 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.03 82.06 Favored Glycine 0 C--N 1.308 -0.978 0 C-N-CA 120.469 -0.872 . . . . 75.329999999999998 112.453 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -111.28 153.41 25.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.568 -0.901 . . . . 75.049999999999997 108.568 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 434' ' ' THR . 86.5 t -84.03 135.55 24.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.814 -1.55 . . . . 72.519999999999996 106.814 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.75 -5.15 9.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 118.804 -1.158 . . . . 75.540000000000006 111.527 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 145.23 -153.67 25.42 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 111.066 -0.814 . . . . 63.119999999999997 111.066 176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.1 p -116.79 160.38 20.9 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.489 -0.93 . . . . 60.210000000000001 108.489 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.4 t30 -74.08 -51.4 4.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 119.491 -0.884 . . . . 73.340000000000003 110.188 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.1 Cg_exo -71.03 152.39 62.71 Favored 'Trans proline' 0 C--N 1.381 2.288 0 N-CA-C 108.122 -1.53 . . . . 64.239999999999995 108.122 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.28 127.04 19.93 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.908 1.738 . . . . 75.25 111.775 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.79 -23.26 61.54 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.822 0.82 . . . . 63.439999999999998 110.753 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.54 0.18 47.64 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.592 -0.731 . . . . 74.120000000000005 110.422 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.46 150.57 20.46 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 109.182 -0.673 . . . . 73.420000000000002 109.182 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -88.23 106.95 18.54 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -106.51 148.27 28.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.618 -0.265 . . . . 54.310000000000002 110.921 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.14 157.83 36.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.395 0.517 . . . . 72.25 112.395 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 425' ' ' GLU . 40.5 mm -60.15 -35.61 62.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.684 0.754 . . . . 75.319999999999993 110.79 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.6 p -91.62 5.19 50.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.141 -0.936 . . . . 73.329999999999998 112.278 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -83.22 141.27 32.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.44 113.44 22.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.048 0.451 . . . . 71.030000000000001 110.618 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.06 119.81 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 108.898 -0.778 . . . . 74.519999999999996 108.898 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 60.6 mt -92.9 113.36 27.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.663 -1.236 . . . . 75.340000000000003 107.663 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.52 123.3 48.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 107.953 -1.128 . . . . 73.230000000000004 107.953 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 17.6 pt -107.24 122.77 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.713 0.768 . . . . 73.340000000000003 111.798 -176.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.656 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 60.2 t -98.67 139.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.164 -0.925 . . . . 70.420000000000002 108.988 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.87 118.47 4.69 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.744 -0.942 . . . . 72.310000000000002 110.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.719 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 52.9 m -141.09 129.78 22.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.59 -0.359 . . . . 72.109999999999999 110.216 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 106.411 -2.676 . . . . 71.329999999999998 106.411 177.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.3 0 N-CA-C 109.935 -1.266 . . . . 62.130000000000003 109.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.13 142.65 23.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.388 0.614 . . . . 75.219999999999999 112.603 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.5 m -96.88 142.4 28.91 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.972 -1.492 . . . . 73.540000000000006 106.972 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -122.57 127.63 49.7 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.658 -1.238 . . . . 74.519999999999996 107.658 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -101.67 126.7 48.56 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 107.653 -1.239 . . . . 73.329999999999998 107.653 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.81 155.14 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 116.476 -0.329 . . . . 74.319999999999993 110.486 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.2 136.97 34.89 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.556 -1.646 . . . . 74.230000000000004 106.556 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.62 138.27 19.59 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 116.265 -0.425 . . . . 73.439999999999998 110.27 -172.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.12 126.69 17.76 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.961 2.441 . . . . 65.109999999999999 112.814 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.41 ' OD1' ' HG2' ' A' ' 366' ' ' ARG . 9.9 t70 -70.21 153.77 42.7 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 114.482 -1.235 . . . . 75.340000000000003 110.457 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.441 ' HA ' ' NE2' ' A' ' 368' ' ' GLN . 17.1 m -109.75 3.59 9.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 114.239 1.2 . . . . 75.430000000000007 114.239 -174.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.41 ' HG2' ' OD1' ' A' ' 364' ' ' ASP . 39.6 ptt180 -62.94 130.29 44.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.077 0.465 . . . . 74.329999999999998 110.229 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.05 -2.9 47.8 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.815 -0.707 . . . . 75.120000000000005 111.723 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 365' ' ' VAL . 48.7 mt-30 -115.5 167.92 10.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.868 -0.79 . . . . 73.420000000000002 108.868 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.6 p -78.1 164.53 24.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.416 -0.587 . . . . 73.329999999999998 109.416 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 30.1 p -58.18 -45.53 87.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.155 0.503 . . . . 63.039999999999999 110.21 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.75 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.47 -0.787 . . . . 63.210000000000001 111.77 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.22 -34.74 76.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.465 0.65 . . . . 61.439999999999998 109.56 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.21 69.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 61.219999999999999 110.158 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.2 mt -58.75 -45.45 91.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.941 -0.572 . . . . 74.120000000000005 110.07 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.1 92.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.623 -0.717 . . . . 74.019999999999996 111.721 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 78.5 m -63.29 -48.66 77.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.243 -0.435 . . . . 75.25 111.816 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.86 -41.53 91.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.653 -0.249 . . . . 71.049999999999997 111.532 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -59.68 -41.59 91.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.905 0.753 . . . . 75.430000000000007 110.09 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -69.34 -31.34 69.71 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.249 -0.432 . . . . 70.219999999999999 111.184 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -79.13 -14.79 58.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.375 -0.375 . . . . 74.040000000000006 110.799 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.4 15.24 51.53 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.651 -0.785 . . . . 73.319999999999993 111.827 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -93.52 160.32 14.84 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.928 -0.397 . . . . 74.450000000000003 109.928 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.9 mmtp -104.66 135.35 46.22 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.025 -0.731 . . . . 74.430000000000007 109.025 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.38 138.59 49.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-O 121.256 0.55 . . . . 75.450000000000003 111.584 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -110.88 128.55 55.84 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.539 -1.282 . . . . 74.219999999999999 107.539 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.8 m -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 108.028 -1.101 . . . . 72.010000000000005 108.028 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 125.3 53.79 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 103.636 -2.727 . . . . 74.219999999999999 103.636 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -125.75 142.78 51.35 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 120.001 -0.68 . . . . 62.350000000000001 110.594 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -134.01 131.84 21.08 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 120.724 -0.39 . . . . 74.129999999999995 110.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.35 134.74 6.87 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.97 1.78 . . . . 73.5 109.2 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 -171.95 -176.04 1.62 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.467 -1.679 . . . . 71.109999999999999 106.467 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 68.3 m -129.53 -8.49 4.62 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.422 0.629 . . . . 65.510000000000005 111.084 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -94.29 3.45 55.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.815 -1.18 . . . . 64.340000000000003 107.815 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.2 pp -88.52 151.05 47.65 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.513 -1.222 . . . . 72.340000000000003 113.4 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.65 172.03 11.58 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 122.538 2.159 . . . . 74.439999999999998 110.13 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.69 161.57 9.83 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.149 2.566 . . . . 63.399999999999999 112.255 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.401 ' HB2' HG11 ' A' ' 420' ' ' VAL . 3.7 p-10 -57.14 -9.05 0.8 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 124.711 1.204 . . . . 64.549999999999997 113.04 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -67.66 136.74 54.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.745 -1.576 . . . . 73.340000000000003 106.745 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.63 118.31 11.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.766 -0.374 . . . . 75.239999999999995 110.541 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.2 tp -93.16 -41.18 12.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.038 -0.727 . . . . 73.120000000000005 109.038 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.39 157.61 27.44 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.08 -1.208 . . . . 72.400000000000006 110.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -124.34 -178.49 4.12 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.964 0.906 . . . . 74.140000000000001 109.716 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 155.14 36.77 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 107.458 -1.312 . . . . 74.150000000000006 107.458 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.66 -15.06 5.95 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.977 3.118 . . . . 64.450000000000003 115.805 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.12 -21.91 64.17 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 112.741 0.645 . . . . 74.230000000000004 112.741 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.79 -50.84 31.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.607 . . . . 61.229999999999997 111.076 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -85.05 -7.9 58.91 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.613 0.597 . . . . 75.420000000000002 112.613 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 56.5 m -91.51 139.34 30.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.48 -1.304 . . . . 73.420000000000002 107.48 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 40.1 m -75.0 113.54 12.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.211 0.529 . . . . 73.140000000000001 109.954 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.75 169.48 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 107.271 -1.381 . . . . 74.439999999999998 107.271 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -68.27 148.52 50.67 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.104 0.478 . . . . 72.209999999999994 111.409 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.36 111.03 3.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.941 -0.572 . . . . 64.430000000000007 110.338 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.16 20.39 8.35 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.656 -0.783 . . . . 71.120000000000005 112.338 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -89.49 -170.73 2.95 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.628 -0.879 . . . . 62.219999999999999 108.628 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.5 pt-20 -112.45 124.54 52.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.118 1.155 . . . . 73.340000000000003 114.118 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.02 138.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.269 -1.382 . . . . 74.409999999999997 107.269 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -103.01 121.43 42.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.324 -0.95 . . . . 72.010000000000005 111.578 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.62 119.95 46.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.085 -1.08 . . . . 71.140000000000001 108.085 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 419' ' ' ASN . 0.8 OUTLIER -93.89 118.01 30.88 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.587 -0.523 . . . . 71.209999999999994 109.587 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.4 t -122.06 140.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.593 -0.73 . . . . 73.420000000000002 109.859 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.7 m -94.66 121.68 36.48 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.769 -1.197 . . . . 70.430000000000007 107.769 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.3 p -119.15 106.29 12.22 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.905 -0.318 . . . . 74.319999999999993 111.647 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.81 147.34 2.39 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 115.069 0.788 . . . . 63.119999999999997 115.069 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.7 Cg_endo -81.04 147.4 16.56 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.011 1.807 . . . . 73.099999999999994 111.161 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.58 149.19 26.05 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.788 -0.449 . . . . 65.310000000000002 109.788 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 44.8 mt-30 -129.1 155.67 45.08 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.935 -0.765 . . . . 73.400000000000006 108.935 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -146.76 164.24 33.4 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.448 -1.315 . . . . 74.040000000000006 107.448 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 138.86 31.52 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 110.441 -0.207 . . . . 75.329999999999998 110.441 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.495 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -83.07 119.26 73.89 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.729 -0.841 . . . . 75.019999999999996 108.729 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.43 141.27 89.8 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.584 2.189 . . . . 74.239999999999995 112.331 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -79.78 -7.04 58.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.904 -0.589 . . . . 73.129999999999995 111.499 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.58 -16.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.685 0.794 . . . . 72.219999999999999 110.74 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 23.6 m -49.89 -47.04 52.25 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.475 1.11 . . . . 73.310000000000002 113.155 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 m -59.04 -22.04 60.06 Favored 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 124.553 1.141 . . . . 74.299999999999997 112.467 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.408 ' C ' ' HG1' ' A' ' 436' ' ' THR . 75.8 mt -78.1 -44.16 26.97 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 112.529 0.566 . . . . 70.420000000000002 112.529 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 435' ' ' LEU . 60.3 m -160.63 136.2 8.09 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.245 -0.65 . . . . 74.129999999999995 109.245 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -60.78 -45.42 94.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.238 0.458 . . . . 74.530000000000001 112.238 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.15 80.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.49 0.662 . . . . 74.109999999999999 110.749 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.47 -43.72 69.21 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.953 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.16 -51.72 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.431 -0.804 . . . . 60.539999999999999 111.453 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.4 -41.19 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.886 -0.597 . . . . 64.430000000000007 111.369 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.407 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -67.69 -47.03 70.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.783 -0.367 . . . . 65.109999999999999 111.847 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.18 -38.55 88.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.971 0.36 . . . . 74.540000000000006 111.971 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.854 -0.338 . . . . 74.230000000000004 111.576 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 98.6 m -65.78 -38.77 89.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.363 0.125 . . . . 72.25 111.243 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.36 70.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.17 0.509 . . . . 72.450000000000003 110.467 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.17 -13.79 58.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.947 -0.569 . . . . 74.109999999999999 111.027 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.81 8.82 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.038 -1.077 . . . . 72.230000000000004 114.113 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 445' ' ' THR . 93.2 m-85 -78.89 111.52 15.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 117.91 0.855 . . . . 72.439999999999998 110.189 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -112.14 -21.64 6.2 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.426 -0.892 . . . . 74.310000000000002 112.495 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -95.15 111.47 23.3 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.491 -0.559 . . . . 72.239999999999995 109.491 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.03 159.03 25.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.444 0.64 . . . . 72.109999999999999 110.885 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 26.1 tptp -137.93 123.19 19.35 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 103.813 -2.662 . . . . 74.439999999999998 103.813 172.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -101.28 125.93 47.96 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.459 -0.496 . . . . 72.120000000000005 110.845 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.84 35.1 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.168 -0.679 . . . . 72.319999999999993 109.168 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.01 139.49 47.25 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.736 -0.468 . . . . 71.209999999999994 109.736 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 p -117.86 136.16 23.64 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 109.49 -0.559 . . . . 71.019999999999996 109.49 177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.5 Cg_exo -61.43 120.53 8.24 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.428 2.085 . . . . 65.109999999999999 109.977 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.6 m -133.11 167.55 20.12 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.108 -0.496 . . . . 74.329999999999998 111.149 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.453 ' O ' HG22 ' A' ' 464' ' ' VAL . 4.6 p -76.89 156.24 82.56 Favored Pre-proline 0 N--CA 1.432 -1.369 0 C-N-CA 123.66 0.784 . . . . 73.430000000000007 109.377 174.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -49.71 -27.75 15.87 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 124.225 3.283 . . . . 74.129999999999995 114.157 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.37 -18.33 59.99 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.139 -0.482 . . . . 73.129999999999995 112.05 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.93 -18.29 13.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.642 0.258 . . . . 74.420000000000002 110.563 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 91.3 t -59.5 127.0 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.976 -0.557 . . . . 72.420000000000002 111.366 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.52 -4.46 58.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.033 -0.603 . . . . 51.299999999999997 111.813 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -122.87 161.05 24.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.103 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.95 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.909 -0.775 . . . . 71.239999999999995 108.909 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.61 -25.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.559 -0.857 . . . . 72.049999999999997 111.31 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 174.21 38.18 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.208 -0.757 . . . . 64.230000000000004 111.208 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -126.3 154.84 42.88 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.967 -0.753 . . . . 74.319999999999993 108.967 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.416 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.9 t30 -65.08 -53.28 42.41 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.248 -0.581 . . . . 62.32 110.982 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.8 Cg_exo -71.95 123.44 9.31 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 107.744 -1.675 . . . . 75.540000000000006 107.744 170.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 33.7 Cg_endo -62.7 137.45 63.72 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 122.885 2.39 . . . . 75.219999999999999 114.4 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.495 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.42 7.92 8.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.145 -0.934 . . . . 71.25 110.613 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -108.37 -4.66 17.21 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.302 -0.863 . . . . 60.119999999999997 109.548 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.403 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 28.9 mt-30 -137.24 175.67 9.4 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.268 1.032 . . . . 65.099999999999994 113.401 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 426' ' ' GLN . 29.5 m -94.3 130.5 40.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.157 -1.838 . . . . 72.230000000000004 109.449 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.1 m -131.49 149.59 52.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.144 -0.687 . . . . 64.409999999999997 109.144 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -63.05 154.76 29.75 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.96 0.726 . . . . 71.340000000000003 112.96 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.08 -15.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.208 1.004 . . . . 72.310000000000002 108.37 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.64 -5.29 59.17 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.039 -0.982 . . . . 65.430000000000007 108.899 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -87.7 128.84 35.3 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.122 -1.436 . . . . 72.450000000000003 107.122 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.36 124.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.195 -1.039 . . . . 73.219999999999999 108.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.33 118.69 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 C-N-CA 120.194 -0.602 . . . . 75.329999999999998 109.65 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.0 mp -92.16 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 105.034 -2.21 . . . . 74.420000000000002 105.034 174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 121.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 107.588 -1.264 . . . . 70.219999999999999 107.588 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.78 119.11 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 121.322 0.582 . . . . 73.040000000000006 110.455 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.14 134.92 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.508 -0.923 . . . . 73.329999999999998 108.508 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.06 115.24 4.16 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.222 -1.151 . . . . 64.400000000000006 110.222 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 39.8 p -142.39 145.93 34.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.986 0.393 . . . . 73.549999999999997 110.39 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.912 0 N-CA-C 108.004 -2.038 . . . . 61.420000000000002 108.004 177.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.667 0 N-CA-C 111.224 -0.75 . . . . 43.049999999999997 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.8 pp -75.77 133.22 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 121.547 0.689 . . . . 74.230000000000004 110.942 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.2 t -136.96 157.49 46.62 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 55.539999999999999 109.769 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -107.35 84.8 2.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.756 0.788 . . . . 72.450000000000003 109.879 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -115.36 144.22 44.11 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.417 -1.327 . . . . 74.409999999999997 107.417 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.24 142.25 32.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.153 0.501 . . . . 73.439999999999998 111.242 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.25 136.05 36.07 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.51 -1.663 . . . . 72.129999999999995 106.51 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.9 p -97.17 135.4 21.93 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 119.742 -0.783 . . . . 71.329999999999998 110.611 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.0 129.85 32.39 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.767 2.311 . . . . 75.019999999999996 111.282 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.63 147.83 52.18 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.041 . . . . 72.310000000000002 109.519 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.8 m -109.19 5.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 116.424 -0.353 . . . . 75.430000000000007 111.413 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -52.74 135.32 35.57 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.788 0.835 . . . . 74.230000000000004 111.758 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.48 1.56 59.06 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.469 -0.872 . . . . 64.010000000000005 112.946 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -121.21 179.8 4.29 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.185 -0.597 . . . . 74.340000000000003 110.639 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.2 p -73.25 149.65 42.62 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.962 -0.755 . . . . 72.299999999999997 108.962 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.0 p -63.43 -33.34 75.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.082 0.468 . . . . 75.209999999999994 110.39 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.62 86.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.412 -0.813 . . . . 70.230000000000004 111.594 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.98 -38.36 85.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.854 0.359 . . . . 72.129999999999995 110.167 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.92 78.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.968 -1.015 . . . . 74.310000000000002 110.174 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 85.0 mt -69.05 -46.21 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.804 -0.635 . . . . 73.140000000000001 110.644 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.07 -47.07 88.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.641 0.608 . . . . 72.129999999999995 112.641 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.5 m -65.49 -44.25 87.64 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 75.150000000000006 109.878 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.438 HD22 ' HB ' ' A' ' 416' ' ' ILE . 13.3 tp -64.78 -37.75 88.65 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.924 -1.035 . . . . 73.439999999999998 110.351 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -60.51 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.984 1.313 . . . . 75.239999999999995 110.369 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -67.37 -22.64 65.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.994 -0.548 . . . . 72.219999999999999 110.805 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -85.36 -8.67 58.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.885 -0.598 . . . . 73.310000000000002 111.72 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 86.24 9.89 75.54 Favored Glycine 0 C--O 1.253 1.315 0 C-N-CA 120.912 -0.661 . . . . 54.439999999999998 113.915 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.401 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 54.8 m-85 -77.85 151.8 33.71 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.102 0.477 . . . . 73.319999999999993 110.217 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -88.26 132.74 34.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.199 -1.778 . . . . 74.540000000000006 106.199 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.29 134.98 59.18 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.804 0 CA-C-O 121.759 0.79 . . . . 71.200000000000003 110.956 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -110.36 126.51 54.33 Favored 'General case' 0 C--N 1.268 -2.961 0 N-CA-C 104.743 -2.318 . . . . 75.409999999999997 104.743 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.5 m -112.73 118.86 36.16 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 108.242 -1.021 . . . . 74.230000000000004 108.242 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.52 118.89 36.98 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.45 -1.315 . . . . 73.310000000000002 107.45 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.84 124.72 53.23 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.992 -1.114 . . . . 74.340000000000003 107.992 176.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -125.45 137.07 29.16 Favored Pre-proline 0 C--N 1.284 -2.24 0 C-N-CA 119.577 -0.849 . . . . 74.219999999999999 111.131 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -88.54 128.34 2.09 Favored 'Trans proline' 0 N--CA 1.426 -2.454 0 N-CA-C 107.972 -1.588 . . . . 75.219999999999999 107.972 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 48.4 t0 -174.47 170.42 3.55 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.364 -1.347 . . . . 62.399999999999999 107.364 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.438 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 24.0 m -106.61 -18.69 13.89 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.536 0.684 . . . . 75.230000000000004 109.219 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.7 m -90.61 36.91 0.9 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 123.191 1.472 . . . . 74.319999999999993 107.71 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 391' ' ' ASP . 28.1 pt -88.8 141.69 30.05 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 114.285 -1.325 . . . . 73.409999999999997 110.72 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -73.66 173.86 13.2 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.129 1.886 . . . . 74.239999999999995 108.39 166.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.72 161.59 35.21 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.958 1.772 . . . . 71.140000000000001 111.772 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.89 -13.28 2.5 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 124.071 0.948 . . . . 62.210000000000001 111.969 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -99.61 122.55 42.82 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.696 -2.335 . . . . 71.239999999999995 104.696 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.0 117.88 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.88 0.847 . . . . 73.109999999999999 109.808 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.7 tp -90.97 -29.28 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.38 -0.827 . . . . 74.400000000000006 110.294 -174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.46 157.82 27.8 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 120.516 -0.849 . . . . 62.109999999999999 111.408 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 65.1 p -125.58 -176.91 3.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.165 -1.05 . . . . 73.209999999999994 108.165 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -101.71 139.92 20.77 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.649 -0.871 . . . . 62.130000000000003 108.649 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -48.64 -14.46 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 124.396 3.397 . . . . 74.109999999999999 115.414 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.15 64.79 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.244 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.3 -27.68 63.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.534 0.683 . . . . 73.200000000000003 110.678 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -90.32 -3.72 57.58 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.609 -0.723 . . . . 74.349999999999994 109.554 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 41.4 m -91.32 156.94 17.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.634 -1.247 . . . . 63.109999999999999 107.634 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 p -74.37 112.57 10.66 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.698 0.761 . . . . 65.019999999999996 111.056 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.48 170.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.037 -0.983 . . . . 72.030000000000001 108.903 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 75.4 p -75.8 158.73 31.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.813 -0.755 . . . . 73.420000000000002 110.835 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.54 109.94 2.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.375 -0.972 . . . . 74.319999999999993 108.375 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 92.23 29.2 11.63 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.279 -0.728 . . . . 75.0 111.279 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.3 t70 -76.79 -174.51 3.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.964 0.505 . . . . 74.299999999999997 109.655 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.53 126.97 42.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.161 0.505 . . . . 73.420000000000002 112.178 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.438 ' HB ' HD22 ' A' ' 377' ' ' LEU . 51.0 mm -121.16 127.22 75.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.472 -0.936 . . . . 75.049999999999997 108.472 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -94.38 119.13 32.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.134 0.969 . . . . 73.329999999999998 110.813 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.06 131.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.991 -1.114 . . . . 70.109999999999999 107.991 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -101.57 128.7 47.72 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.818 -0.438 . . . . 75.530000000000001 109.818 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 38.9 t -132.07 131.74 61.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.205 -1.035 . . . . 73.129999999999995 108.205 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 19.0 m -91.89 122.28 34.27 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.408 -0.59 . . . . 72.040000000000006 109.408 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.4 m -120.6 106.04 11.38 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.995 -0.372 . . . . 72.409999999999997 109.995 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 73.72 118.12 0.08 OUTLIER Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.88 0.712 . . . . 52.140000000000001 114.88 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.8 Cg_exo -71.34 138.25 32.56 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 121.919 1.746 . . . . 74.400000000000006 109.391 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 2.8 mm-40 -78.44 142.8 37.27 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 114.597 1.332 . . . . 75.439999999999998 114.597 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.82 133.56 55.31 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 113.435 -1.711 . . . . 70.319999999999993 108.674 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.14 157.8 35.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.203 -1.777 . . . . 75.519999999999996 106.203 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.81 137.41 33.72 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.609 -0.436 . . . . 75.540000000000006 110.409 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.16 128.66 56.83 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.056 -1.461 . . . . 75.420000000000002 107.056 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.409 ' HB2' HG13 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.36 141.4 38.83 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.503 1.469 . . . . 62.229999999999997 112.683 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.147 0.499 . . . . 73.439999999999998 111.171 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 430' ' ' PRO . 8.9 p -65.9 -14.84 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.841 0.829 . . . . 73.519999999999996 109.851 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.7 m -52.75 -41.53 64.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.751 1.22 . . . . 71.510000000000005 111.953 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.8 m -64.15 -13.62 49.51 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.024 0.93 . . . . 73.140000000000001 112.083 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.73 -45.44 14.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.3 0.482 . . . . 61.149999999999999 112.3 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 86.9 m -156.05 135.68 12.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.65 -0.5 . . . . 74.010000000000005 109.65 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 441' ' ' VAL . 62.7 t80 -57.43 -53.57 56.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.153 0.797 . . . . 74.519999999999996 113.153 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.04 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.004 0.43 . . . . 75.409999999999997 111.248 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -62.02 -43.21 99.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.013 -0.994 . . . . 71.340000000000003 108.862 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.26 -48.88 79.85 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.364 -0.834 . . . . 72.239999999999995 110.619 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.9 t -58.93 -47.07 90.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.794 -0.639 . . . . 71.120000000000005 111.275 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.6 mmpt? -64.95 -46.51 81.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.704 -0.226 . . . . 74.030000000000001 111.213 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.69 -38.77 92.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.396 -0.365 . . . . 71.450000000000003 111.472 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 452' ' ' PHE . 30.5 tp -67.29 -39.94 86.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.267 -0.424 . . . . 72.519999999999996 109.871 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.8 m -65.76 -38.86 90.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.261 -0.644 . . . . 72.109999999999999 109.261 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.59 73.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.55 -0.75 . . . . 74.439999999999998 111.138 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.24 31.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.795 -0.639 . . . . 74.409999999999997 110.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.7 -17.61 49.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.341 -0.457 . . . . 55.030000000000001 112.575 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -83.11 83.83 7.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.381 0.61 . . . . 73.120000000000005 110.558 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -98.04 17.02 59.35 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.769 -0.932 . . . . 75.329999999999998 110.769 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -103.86 110.56 22.73 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.814 -1.551 . . . . 74.540000000000006 106.814 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . 0.523 ' CE2' HD22 ' A' ' 444' ' ' LEU . 93.4 m-85 -119.41 152.45 36.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.522 0.677 . . . . 73.439999999999998 112.073 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 0.1 OUTLIER -147.1 121.0 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.231 -2.137 . . . . 75.310000000000002 105.231 170.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -91.0 130.37 36.92 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.601 0.715 . . . . 74.409999999999997 111.584 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.19 152.84 46.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.4 -1.333 . . . . 75.310000000000002 107.4 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.12 149.8 52.31 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.151 0.501 . . . . 72.439999999999998 110.726 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.5 m -132.78 131.72 22.19 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 115.603 -0.726 . . . . 73.540000000000006 109.204 173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 490' ' ' SER . 31.6 Cg_exo -61.51 120.01 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.004 1.802 . . . . 74.530000000000001 108.274 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.547 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 17.0 m -130.0 177.24 7.43 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.992 -0.549 . . . . 71.340000000000003 109.762 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 43.1 m -67.15 139.27 95.07 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.637 -1.246 . . . . 74.140000000000001 107.637 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.469 ' O ' HG11 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.72 -23.62 8.56 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.806 3.004 . . . . 74.219999999999999 114.168 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -61.4 -32.29 72.22 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.347 0.659 . . . . 55.329999999999998 111.155 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.07 0.73 56.08 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.386 0.513 . . . . 75.420000000000002 112.386 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 461' ' ' PRO . 10.4 p -59.89 126.95 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.247 0.546 . . . . 74.120000000000005 111.114 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.47 78.31 Favored Glycine 0 C--O 1.244 0.767 0 C-N-CA 120.686 -0.769 . . . . 70.510000000000005 112.191 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.79 148.3 33.85 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.986 -0.746 . . . . 72.140000000000001 108.986 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.14 132.74 30.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.061 -1.088 . . . . 74.049999999999997 108.061 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.68 -26.81 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.422 -0.911 . . . . 71.200000000000003 111.134 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.75 169.65 40.34 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.626 -0.797 . . . . 65.219999999999999 111.39 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.2 p -127.46 149.07 50.27 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.507 -0.924 . . . . 72.409999999999997 108.507 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.466 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.7 t30 -62.35 -52.78 63.7 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 119.327 -0.368 . . . . 73.129999999999995 110.725 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.1 Cg_exo -73.7 142.73 32.71 Favored 'Trans proline' 0 C--N 1.374 1.871 0 N-CA-C 108.178 -1.508 . . . . 75.120000000000005 108.178 171.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 126.79 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.262 1.975 . . . . 71.150000000000006 112.786 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.64 26.99 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.169 0.985 . . . . 53.420000000000002 110.253 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -111.66 4.24 18.45 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.842 -1.072 . . . . 65.239999999999995 110.922 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.08 164.81 27.54 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.067 0.937 . . . . 75.519999999999996 111.939 -172.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.84 125.54 29.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.299 -1.773 . . . . 71.430000000000007 108.94 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -130.82 148.32 52.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.186 -0.672 . . . . 74.549999999999997 109.186 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -69.97 140.93 53.06 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.292 0.091 . . . . 72.230000000000004 111.039 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.438 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 1.9 mp -60.76 -18.81 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.954 1.302 . . . . 75.219999999999999 111.931 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.23 5.11 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 75.319999999999993 112.063 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.97 132.29 33.84 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.672 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.3 t -79.89 114.77 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.936 -1.876 . . . . 75.340000000000003 105.936 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.04 120.54 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-O 121.255 0.55 . . . . 75.349999999999994 109.829 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 68.4 mt -91.23 112.25 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.287 -1.746 . . . . 74.310000000000002 106.287 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.39 119.39 51.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 114.658 -1.156 . . . . 74.109999999999999 108.064 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 25.7 mt -99.83 115.97 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-O 121.508 0.671 . . . . 73.530000000000001 109.559 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.65 140.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.353 -0.98 . . . . 74.319999999999993 108.353 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 121.95 5.59 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 109.062 -1.615 . . . . 75.540000000000006 109.062 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.8 m -140.08 125.2 18.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 122.035 -0.685 . . . . 74.140000000000001 110.212 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.413 -2.837 0 N-CA-C 107.818 -2.113 . . . . 75.310000000000002 107.818 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.949 0 N-CA-C 111.142 -0.783 . . . . 71.129999999999995 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.426 ' O ' HD11 ' A' ' 356' ' ' ILE . 2.6 pp -121.22 132.72 69.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.777 0.799 . . . . 74.540000000000006 112.466 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 11.3 m -103.84 128.78 51.28 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.545 -1.65 . . . . 74.099999999999994 106.545 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -90.59 87.01 6.56 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.711 0.767 . . . . 73.420000000000002 111.486 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.41 146.1 34.75 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.396 -1.274 . . . . 74.420000000000002 108.169 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.11 145.05 29.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.885 -0.413 . . . . 73.340000000000003 109.885 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.71 137.39 34.84 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.172 -1.047 . . . . 73.519999999999996 108.172 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.09 136.08 21.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 C-N-CA 120.57 -0.452 . . . . 73.030000000000001 109.991 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 154.6 12.18 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.711 2.941 . . . . 72.439999999999998 115.165 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.59 101.64 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 74.549999999999997 110.308 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.85 -3.65 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.25 0.548 . . . . 74.329999999999998 111.712 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.486 -0.779 . . . . 74.010000000000005 109.903 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.2 58.97 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.655 -0.978 . . . . 64.510000000000005 110.655 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -124.44 170.17 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.587 -1.264 . . . . 71.310000000000002 107.587 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.8 p -74.98 157.1 35.51 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.684 -0.487 . . . . 73.5 109.684 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.4 p -62.17 -37.86 86.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.016 0.436 . . . . 54.119999999999997 110.461 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.28 94.74 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.872 -0.604 . . . . 74.209999999999994 110.897 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.65 -37.46 76.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.505 -0.316 . . . . 73.25 110.952 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.33 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.040000000000006 110.66 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -42.62 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.258 0.348 . . . . 75.340000000000003 111.173 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.61 88.22 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.388 -0.369 . . . . 75.030000000000001 111.09 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.1 m -63.58 -46.63 84.98 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.599 -0.273 . . . . 74.340000000000003 110.743 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.18 -41.86 96.92 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.986 -0.375 . . . . 74.540000000000006 109.986 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -59.82 -46.6 88.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 73.310000000000002 110.439 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.37 -33.91 76.93 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 112.657 0.614 . . . . 74.319999999999993 112.657 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -84.83 -4.23 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.09 -0.505 . . . . 75.150000000000006 112.159 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.46 7.85 64.74 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 119.88 -1.152 . . . . 53.530000000000001 113.146 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -83.76 167.65 16.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.516 -0.55 . . . . 74.420000000000002 109.516 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -105.79 161.58 14.3 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.293 -1.373 . . . . 70.420000000000002 107.293 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 151.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-O 121.881 0.848 . . . . 74.129999999999995 112.576 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 417' ' ' THR . 29.5 ttm-85 -137.05 141.07 42.43 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.567 -2.012 . . . . 71.239999999999995 105.567 172.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -135.24 133.08 38.6 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.331 -0.618 . . . . 73.409999999999997 109.331 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.71 119.94 36.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.335 -0.987 . . . . 75.409999999999997 108.335 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -95.58 122.43 38.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.099 -1.075 . . . . 74.040000000000006 108.099 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 0.1 OUTLIER -128.55 122.71 21.87 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 113.067 0.766 . . . . 74.340000000000003 113.067 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.52 129.07 4.19 Favored 'Trans proline' 0 C--O 1.247 0.933 0 N-CA-C 106.719 -2.07 . . . . 73.439999999999998 106.719 165.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.4 t70 -163.68 -176.03 4.44 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 72.010000000000005 109.042 -171.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 p -100.77 -23.72 14.55 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.34 -0.985 . . . . 64.299999999999997 108.34 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.2 m -89.3 35.45 0.81 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.279 -1.328 . . . . 73.439999999999998 108.983 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 45.8 pt -88.18 123.5 68.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 114.37 1.248 . . . . 73.230000000000004 114.37 -171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 2.5 Cg_endo -85.15 174.89 6.86 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.861 2.374 . . . . 75.329999999999998 108.126 165.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.16 160.94 35.93 Favored 'Trans proline' 0 C--O 1.212 -0.817 0 C-N-CA 122.475 2.117 . . . . 71.209999999999994 111.261 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.22 -7.47 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.906 0.706 . . . . 74.519999999999996 112.906 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.87 147.77 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.033 -1.839 . . . . 74.450000000000003 106.033 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.37 116.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.186 -1.413 . . . . 73.25 107.186 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.5 mm -90.54 -39.77 12.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.299 -0.63 . . . . 74.109999999999999 109.299 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 157.67 27.48 Favored Glycine 0 N--CA 1.411 -3.013 0 CA-C-N 115.214 -0.903 . . . . 64.510000000000005 111.01 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -122.32 -179.68 4.26 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.49 -0.929 . . . . 62.299999999999997 108.49 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.33 139.92 20.67 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 108.948 -0.76 . . . . 71.450000000000003 108.948 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.37 -24.47 1.03 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 124.618 3.546 . . . . 75.439999999999998 114.84 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.5 63.37 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 123.133 0.573 . . . . 72.200000000000003 111.456 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.97 94.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.64 0.734 . . . . 74.109999999999999 110.464 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -4.75 57.62 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.531 -0.759 . . . . 75.409999999999997 111.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.9 m -88.83 152.85 21.51 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.938 -1.505 . . . . 74.030000000000001 106.938 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.5 m -74.12 113.53 11.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.953 0.882 . . . . 53.0 110.688 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.6 170.71 5.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.342 -1.299 . . . . 73.409999999999997 110.061 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 136.36 57.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.765 -0.652 . . . . 71.219999999999999 111.61 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.45 119.95 13.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.508 -0.553 . . . . 73.299999999999997 109.508 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 87.3 32.12 14.81 Favored Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 121.1 -0.572 . . . . 70.150000000000006 112.133 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.53 174.99 6.84 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.939 -0.763 . . . . 74.200000000000003 108.939 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -100.35 121.22 41.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.831 0.824 . . . . 71.329999999999998 112.782 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.76 124.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.667 -1.235 . . . . 74.540000000000006 107.667 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 13.4 t -91.85 130.29 37.65 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.532 0.682 . . . . 61.030000000000001 109.891 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 130.74 64.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.021 -0.991 . . . . 74.239999999999995 108.422 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -97.53 127.9 43.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.406 -0.961 . . . . 65.540000000000006 108.406 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.02 135.11 62.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.609 -0.886 . . . . 74.400000000000006 108.609 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 47.0 m -106.51 123.94 48.85 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.833 -0.542 . . . . 75.319999999999993 111.7 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.5 p -118.2 105.54 11.9 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.737 -0.665 . . . . 74.349999999999994 110.69 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.09 146.03 2.19 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.059 0.784 . . . . 73.209999999999994 115.059 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 76.7 Cg_endo -81.74 149.65 16.25 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.344 2.029 . . . . 75.340000000000003 111.753 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.05 144.76 40.6 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.52 -0.764 . . . . 72.310000000000002 110.849 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.44 ' HB3' HG23 ' A' ' 477' ' ' THR . 45.5 mt-30 -118.85 156.88 28.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.675 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -153.51 154.66 34.76 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.848 -1.538 . . . . 70.319999999999993 106.848 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.8 140.17 29.98 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.02 -0.733 . . . . 74.450000000000003 109.02 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.8 mp -78.98 126.47 82.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.851 -1.166 . . . . 74.099999999999994 107.851 -175.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.97 140.32 79.53 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.203 1.936 . . . . 70.430000000000007 112.176 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.77 12.9 28.37 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.789 0.804 . . . . 73.019999999999996 110.08 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.2 -12.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.919 -1.037 . . . . 73.010000000000005 108.965 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 18.0 m -52.76 -40.51 63.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.503 -1.226 . . . . 74.040000000000006 112.624 -174.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -63.01 -17.91 62.73 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.365 1.246 . . . . 73.420000000000002 114.365 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.36 -44.91 15.56 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.086 0.47 . . . . 63.340000000000003 111.689 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 65.6 m -150.2 133.22 16.16 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.896 -0.503 . . . . 74.430000000000007 109.969 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -58.37 -45.31 88.47 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.467 0.479 . . . . 75.010000000000005 111.163 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.16 -42.37 80.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.042 -0.526 . . . . 60.509999999999998 110.694 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.75 -39.39 94.15 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 116.064 -0.516 . . . . 74.019999999999996 111.398 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.49 -50.53 73.18 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.526 0.516 . . . . 53.450000000000003 109.768 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.03 -45.9 95.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.102 -0.499 . . . . 71.200000000000003 110.673 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.47 -47.72 75.13 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.813 0.301 . . . . 74.549999999999997 111.813 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -66.32 -40.24 89.81 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.109999999999999 111.688 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.0 -38.43 85.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.619 -0.432 . . . . 74.129999999999995 111.608 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 68.9 m -64.81 -38.8 92.19 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.478 -0.564 . . . . 71.439999999999998 109.478 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.85 65.24 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.395 0.616 . . . . 74.409999999999997 110.455 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.44 -13.22 59.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.482 0.658 . . . . 73.450000000000003 110.296 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.22 -13.32 26.14 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.691 -0.766 . . . . 51.119999999999997 113.651 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -71.62 114.96 10.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.525 -0.546 . . . . 73.329999999999998 109.525 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.97 17.38 8.67 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.45 -0.881 . . . . 71.439999999999998 111.58 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -120.58 111.25 17.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.478 -1.675 . . . . 75.209999999999994 106.478 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.3 155.01 39.42 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.772 0.796 . . . . 74.409999999999997 112.882 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 4.5 tppp? -145.17 125.08 13.47 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.598 -1.63 . . . . 74.319999999999993 106.598 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . 0.449 HE21 HG23 ' A' ' 488' ' ' VAL . 65.0 tt0 -100.44 126.08 46.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.169 0.509 . . . . 71.549999999999997 110.888 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.64 156.43 37.51 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.431 -0.952 . . . . 70.310000000000002 108.431 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.302 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.4 m -133.94 144.57 52.21 Favored Pre-proline 0 C--N 1.286 -2.183 0 N-CA-C 109.171 -0.677 . . . . 72.310000000000002 109.171 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_endo -62.54 122.82 11.35 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 123.257 2.638 . . . . 72.430000000000007 113.21 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.7 m -132.87 170.73 14.9 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.537 -0.912 . . . . 71.209999999999994 108.537 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.7 m -69.72 145.61 94.95 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 107.678 -1.23 . . . . 74.219999999999999 107.678 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.8 Cg_endo -49.36 -23.76 7.67 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 124.129 3.219 . . . . 75.299999999999997 114.255 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.84 -30.11 71.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.368 0.604 . . . . 74.230000000000004 110.43 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.35 1.35 35.42 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.821 -0.627 . . . . 74.420000000000002 112.581 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.6 p -60.18 126.29 17.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 119.415 -0.914 . . . . 73.0 110.72 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.92 -5.94 72.83 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.598 -0.81 . . . . 65.409999999999997 112.169 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.88 155.61 17.85 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.927 -0.768 . . . . 75.549999999999997 108.927 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 433' ' ' SER . 66.3 t -84.67 131.59 33.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.923 -0.769 . . . . 72.340000000000003 108.923 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.13 -14.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.838 -0.745 . . . . 75.450000000000003 110.903 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.53 -177.65 41.87 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 115.567 -0.742 . . . . 74.230000000000004 111.441 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.9 p -130.44 150.03 51.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.682 -1.229 . . . . 72.420000000000002 107.682 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.9 t30 -63.87 -51.36 64.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 120.262 -0.575 . . . . 65.120000000000005 110.307 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.3 Cg_exo -75.41 130.48 12.91 Favored 'Trans proline' 0 C--N 1.375 1.955 0 N-CA-C 108.376 -1.432 . . . . 71.450000000000003 108.376 170.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.94 136.53 57.46 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.697 2.264 . . . . 73.239999999999995 113.399 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.62 6.84 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.066 0.936 . . . . 72.340000000000003 109.845 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.488 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -104.61 2.59 30.81 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.857 -1.065 . . . . 75.409999999999997 109.664 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -145.97 173.71 11.91 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.975 -0.69 . . . . 75.409999999999997 110.923 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 426' ' ' GLN . 18.2 m -102.26 140.62 36.3 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 124.308 1.043 . . . . 74.340000000000003 110.948 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 77.8 p -137.84 150.38 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.373 -0.602 . . . . 74.510000000000005 109.373 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.5 146.68 51.7 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.885 -0.326 . . . . 73.340000000000003 110.38 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.76 -11.13 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 124.052 0.941 . . . . 64.129999999999995 111.629 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 5.5 p -87.04 5.79 35.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.412 0.625 . . . . 72.349999999999994 111.065 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -93.01 142.12 27.64 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.656 -0.702 . . . . 63.439999999999998 110.362 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 52.4 t -85.79 115.18 26.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.946 -1.501 . . . . 74.329999999999998 106.946 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 81.9 t -86.58 119.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-O 121.467 0.651 . . . . 62.43 109.998 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 49.0 mt -92.36 112.9 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 107.302 -1.37 . . . . 72.400000000000006 107.302 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.38 127.13 49.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.451 -1.315 . . . . 73.430000000000007 107.451 -177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 15.6 mm -102.27 113.13 37.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.132 0.491 . . . . 72.109999999999999 109.943 -173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.449 HG23 HE21 ' A' ' 454' ' ' GLN . 32.9 t -98.3 141.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.673 -0.862 . . . . 72.129999999999995 108.673 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -90.52 121.12 6.1 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 111.035 -0.826 . . . . 72.209999999999994 111.035 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.5 m -141.39 143.76 34.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.582 -0.896 . . . . 64.230000000000004 108.582 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.562 0 CA-C-O 118.229 -1.317 . . . . 74.200000000000003 110.538 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.568 0 N-CA-C 109.484 -1.446 . . . . 43.049999999999997 109.484 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.01 144.73 29.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 118.017 0.908 . . . . 74.439999999999998 113.037 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.17 174.28 9.24 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.451 -1.314 . . . . 75.329999999999998 107.451 171.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -87.62 78.43 8.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.115 -1.034 . . . . 75.430000000000007 109.794 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.05 117.2 25.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.636 -1.166 . . . . 74.140000000000001 108.419 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.41 151.77 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.362 -0.607 . . . . 64.219999999999999 109.362 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -95.15 136.99 34.8 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.289 -1.374 . . . . 72.319999999999993 107.289 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.0 p -100.04 121.8 52.72 Favored Pre-proline 0 C--N 1.287 -2.122 0 N-CA-C 108.914 -0.772 . . . . 74.400000000000006 108.914 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.94 136.8 63.53 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.602 2.201 . . . . 74.519999999999996 113.046 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.539 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 7.5 p-10 -72.61 137.23 46.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.254 -0.885 . . . . 73.099999999999994 110.004 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.8 t -89.82 45.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 122.585 1.183 . . . . 74.010000000000005 110.482 -170.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.539 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.8 ptm85 -65.51 136.29 56.23 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.418 -1.265 . . . . 72.329999999999998 110.921 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.48 0.55 62.79 Favored Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.79 -0.719 . . . . 51.329999999999998 113.024 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -125.95 172.12 10.19 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 122.586 -0.361 . . . . 72.230000000000004 110.13 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.1 p -77.14 167.14 22.27 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.626 0.251 . . . . 74.549999999999997 110.604 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.7 p -63.04 -33.96 76.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.078 0.465 . . . . 72.200000000000003 110.03 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.5 97.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.719 -0.673 . . . . 70.319999999999993 110.258 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.83 -41.43 95.75 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.539 -0.541 . . . . 73.430000000000007 109.539 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.74 80.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.108 -0.497 . . . . 71.219999999999999 110.784 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.15 -46.02 88.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.701 -0.681 . . . . 72.219999999999999 110.079 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.42 86.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.819 -0.628 . . . . 53.109999999999999 111.61 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.2 m -60.58 -47.11 87.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.326 0.25 . . . . 72.230000000000004 111.552 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.55 -42.02 95.97 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.533 -0.467 . . . . 73.25 110.593 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -41.56 91.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 109.806 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -29.27 67.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.384 -0.825 . . . . 73.450000000000003 111.12 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -82.68 -14.4 54.72 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.458 -0.571 . . . . 73.510000000000005 109.458 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.555 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.45 -2.63 56.19 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.822 -0.626 . . . . 63.240000000000002 111.692 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 46.5 m-85 -81.5 156.71 25.15 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.937 0.398 . . . . 74.510000000000005 110.075 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -105.16 147.78 27.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.371 -1.344 . . . . 73.420000000000002 107.371 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.75 142.73 30.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 121.957 0.884 . . . . 73.530000000000001 112.748 -175.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 417' ' ' THR . 58.2 ttt180 -119.06 133.39 55.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.014 -1.847 . . . . 74.329999999999998 106.014 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.9 m -104.94 125.66 51.18 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.499 -0.88 . . . . 74.299999999999997 111.36 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.2 tm? -111.51 119.33 38.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.234 -2.135 . . . . 74.400000000000006 105.234 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.543 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -112.85 122.63 48.23 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 109.292 -0.633 . . . . 74.430000000000007 109.292 -178.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -115.78 127.38 26.83 Favored Pre-proline 0 C--N 1.289 -2.034 0 C-N-CA 119.939 -0.705 . . . . 75.230000000000004 111.287 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -87.39 128.9 2.64 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 N-CA-C 107.234 -1.871 . . . . 73.010000000000005 107.234 167.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -142.66 -179.4 6.29 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.639 -1.225 . . . . 70.409999999999997 110.199 -173.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.4 m -98.15 -33.47 11.12 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.365 -1.346 . . . . 60.530000000000001 107.365 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 34.5 m -101.57 71.13 1.31 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.178 -1.415 . . . . 74.409999999999997 107.178 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 18.8 pt -100.85 125.32 38.92 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.867 -1.06 . . . . 74.430000000000007 111.97 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.57 175.86 3.68 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 N-CA-C 107.66 -1.708 . . . . 72.400000000000006 107.66 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 398' ' ' HIS . 52.0 Cg_exo -59.9 162.45 16.07 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.083 1.855 . . . . 74.450000000000003 109.992 171.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -56.81 -8.42 0.6 Allowed 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.254 1.022 . . . . 64.450000000000003 113.034 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.407 ' H ' ' C ' ' A' ' 396' ' ' PRO . 36.9 m80 -62.7 131.74 49.95 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.075 -0.713 . . . . 75.0 109.075 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.61 118.43 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 CA-C-N 115.645 -0.707 . . . . 73.099999999999994 109.159 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 401' ' ' GLY . 2.2 pp -91.13 -28.03 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.105 -0.952 . . . . 72.349999999999994 110.359 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.424 ' N ' HD13 ' A' ' 400' ' ' ILE . . . -169.42 157.31 29.04 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.515 -1.434 . . . . 72.400000000000006 109.515 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 403' ' ' ASP . 8.9 m -114.42 -177.18 3.07 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 106.332 -1.729 . . . . 63.109999999999999 106.332 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 402' ' ' THR . 10.5 t70 -97.96 138.72 20.99 Favored Pre-proline 0 C--N 1.267 -2.996 0 N-CA-C 109.092 -0.707 . . . . 73.209999999999994 109.092 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.48 -25.7 0.88 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 125.098 3.865 . . . . 72.340000000000003 115.463 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.73 68.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.954 0.407 . . . . 72.329999999999998 110.72 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.8 -38.57 62.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.775 0.798 . . . . 71.030000000000001 109.79 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.26 -5.08 48.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.903 -1.044 . . . . 71.310000000000002 110.704 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.4 m -86.8 147.87 25.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.044 -1.095 . . . . 73.219999999999999 108.044 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.9 p -74.52 112.97 11.24 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.329 -0.619 . . . . 75.109999999999999 109.329 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.28 169.22 22.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.349 -0.982 . . . . 74.219999999999999 108.349 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.1 p -80.14 137.75 36.78 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.003 -1.079 . . . . 65.530000000000001 110.432 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -60.36 138.61 57.94 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.218 -0.446 . . . . 55.25 110.655 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 100.92 15.63 28.13 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.192 -1.004 . . . . 70.349999999999994 110.779 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.51 -174.32 4.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.952 -1.499 . . . . 74.450000000000003 106.952 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 126.49 55.33 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.431 0.634 . . . . 70.519999999999996 110.926 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.01 119.44 61.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 4.9 t -85.13 118.93 24.99 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.899 0.857 . . . . 73.120000000000005 109.728 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.84 122.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.01 -0.995 . . . . 72.230000000000004 108.387 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 9.6 p30 -90.66 128.71 36.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.448 0.642 . . . . 74.439999999999998 110.461 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.0 143.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.333 -1.358 . . . . 70.099999999999994 107.333 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 2.1 p -88.04 120.02 28.98 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 119.143 -1.023 . . . . 73.340000000000003 108.898 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.0 m -120.2 105.31 10.84 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.962 -0.755 . . . . 74.349999999999994 108.962 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 75.73 166.13 19.57 Favored Glycine 0 C--O 1.259 1.677 0 CA-C-O 122.118 0.843 . . . . 64.25 114.293 177.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -96.0 157.32 1.42 Allowed 'Trans proline' 0 N--CA 1.429 -2.265 0 C-N-CA 122.998 2.466 . . . . 75.109999999999999 112.866 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.59 20.22 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.524 -2.028 . . . . 74.209999999999994 105.524 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -120.1 152.73 37.17 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.746 -0.465 . . . . 75.540000000000006 109.746 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.449 ' HG2' ' HB3' ' A' ' 447' ' ' ALA . 0.0 OUTLIER -146.84 156.68 43.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.067 -1.086 . . . . 75.450000000000003 108.067 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -83.93 140.15 32.13 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.348 -0.982 . . . . 73.120000000000005 108.348 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.59 119.24 76.2 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 106.634 -1.617 . . . . 71.530000000000001 106.634 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.49 140.36 94.34 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 121.675 1.584 . . . . 73.230000000000004 111.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.44 -0.68 56.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.441 0.638 . . . . 75.420000000000002 110.88 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.29 -6.54 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.887 0.851 . . . . 75.230000000000004 109.562 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 10.6 p -63.72 -28.17 69.71 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.148 -0.933 . . . . 63.329999999999998 112.105 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.6 p -65.32 -13.92 59.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 113.453 0.909 . . . . 64.209999999999994 113.453 -176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.7 -48.55 68.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.694 0.257 . . . . 63.409999999999997 111.694 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 12.3 t -174.32 165.49 4.01 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 121.234 -0.186 . . . . 75.219999999999999 110.545 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.47 -52.54 65.2 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.319 1.048 . . . . 74.010000000000005 112.666 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.83 84.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.396 -0.366 . . . . 63.439999999999998 111.593 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.67 -45.96 90.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 65.109999999999999 109.956 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.22 78.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 55.350000000000001 111.129 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.62 -46.81 95.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 116.275 -0.42 . . . . 75.129999999999995 110.907 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.48 -47.69 82.88 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.079 0.4 . . . . 75.439999999999998 112.079 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.08 -46.3 84.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.202 0.445 . . . . 74.349999999999994 112.202 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.91 -36.72 80.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.562 0.578 . . . . 73.319999999999993 112.562 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.1 m -64.44 -40.85 96.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.044 0.449 . . . . 70.420000000000002 110.075 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.59 63.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.461 0.648 . . . . 65.230000000000004 110.42 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.449 ' HB3' ' HG2' ' A' ' 427' ' ' ARG . . . -79.32 -12.89 59.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.628 -0.714 . . . . 72.439999999999998 110.049 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.84 -19.66 10.23 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.639 -0.709 . . . . 64.120000000000005 113.173 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.28 102.93 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.071 0.463 . . . . 75.530000000000001 110.489 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.22 19.85 33.93 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.744 -0.741 . . . . 64.219999999999999 111.914 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -123.63 111.48 16.27 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.411 -0.588 . . . . 72.129999999999995 109.411 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.14 158.28 39.42 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.437 0.636 . . . . 74.109999999999999 111.656 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.65 126.85 16.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.476 -1.676 . . . . 75.099999999999994 106.476 170.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -87.52 132.54 34.0 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.037 -0.357 . . . . 71.519999999999996 110.037 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.72 161.5 37.4 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.285 -1.006 . . . . 51.240000000000002 108.285 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.406 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 23.5 m-80 -133.93 149.84 51.29 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 122.537 0.335 . . . . 71.340000000000003 110.305 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 31.1 t -128.52 131.46 23.78 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 107.246 -1.39 . . . . 72.510000000000005 107.246 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.7 Cg_endo -61.8 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.764 1.642 . . . . 72.519999999999996 109.209 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.445 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 19.4 m -126.97 175.46 8.06 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 109.98 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.6 m -63.92 133.17 95.49 Favored Pre-proline 0 N--CA 1.424 -1.746 0 N-CA-C 106.289 -1.745 . . . . 72.409999999999997 106.289 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.54 -23.91 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.367 2.712 . . . . 73.5 114.027 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -67.04 -21.36 65.92 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.185 0.439 . . . . 74.019999999999996 112.185 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.2 7.84 40.74 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 121.904 -0.497 . . . . 64.319999999999993 111.622 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.2 p -59.25 127.36 18.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 CA-C-O 121.321 0.581 . . . . 73.329999999999998 110.843 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.76 -6.72 70.33 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 115.543 -0.753 . . . . 71.540000000000006 112.104 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -100.64 151.12 22.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.875 -0.787 . . . . 75.450000000000003 108.875 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.19 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.773 -0.825 . . . . 75.420000000000002 108.773 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.49 -16.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 120.168 -0.613 . . . . 74.299999999999997 112.38 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.19 160.23 12.34 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.019 -0.832 . . . . 70.019999999999996 111.019 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 7.9 p -119.32 149.65 41.45 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.631 -1.248 . . . . 65.420000000000002 107.631 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.412 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.6 t30 -59.28 -49.7 91.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 119.797 -0.761 . . . . 62.229999999999997 110.731 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -76.07 117.6 4.72 Favored 'Trans proline' 0 C--N 1.372 1.812 0 N-CA-C 107.642 -1.715 . . . . 75.019999999999996 107.642 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.473 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.2 Cg_endo -62.9 142.95 90.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.888 2.392 . . . . 71.230000000000004 114.744 -173.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.27 0.12 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.814 -1.084 . . . . 71.510000000000005 113.24 -176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -109.14 0.12 19.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.29 -0.881 . . . . 73.420000000000002 109.517 175.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.473 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 6.5 tp-100 -117.74 162.11 18.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.725 0.774 . . . . 71.109999999999999 111.926 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.3 m -97.34 132.22 43.27 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.255 -1.338 . . . . 75.239999999999995 108.6 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.1 m -136.47 149.0 47.98 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.985 -0.376 . . . . 63.25 109.985 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.3 141.85 52.31 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 75.319999999999993 109.942 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.9 -17.0 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 114.454 1.279 . . . . 75.340000000000003 114.454 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.0 p -88.9 5.29 44.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.676 -0.64 . . . . 71.140000000000001 112.022 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -90.3 147.63 23.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.311 -0.625 . . . . 74.299999999999997 109.311 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.4 t -83.25 119.55 32.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.629 -0.878 . . . . 73.219999999999999 108.629 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.93 119.18 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 108.507 -0.923 . . . . 73.299999999999997 108.507 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.5 112.73 26.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.182 -1.784 . . . . 73.209999999999994 106.182 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.69 113.37 36.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.478 -1.304 . . . . 73.299999999999997 107.478 -177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 22.4 mt -101.95 121.13 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.693 -0.685 . . . . 73.329999999999998 109.84 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.406 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 38.2 t -97.36 143.68 12.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.41 -0.959 . . . . 72.349999999999994 108.41 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -89.82 118.09 5.16 Favored Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 110.177 -1.169 . . . . 64.439999999999998 110.177 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 50.9 m -134.93 136.85 42.6 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.68 -0.859 . . . . 74.25 108.68 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.42 -2.373 0 N-CA-C 109.065 -1.614 . . . . 73.129999999999995 109.065 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.43 0 N-CA-C 109.216 -1.554 . . . . 71.150000000000006 109.216 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.69 140.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 117.911 0.855 . . . . 74.010000000000005 112.437 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.2 t -107.5 137.9 44.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.331 -0.849 . . . . 74.310000000000002 109.495 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -99.73 73.76 1.81 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.559 -0.904 . . . . 74.329999999999998 108.559 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -89.17 144.35 26.18 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.992 -1.004 . . . . 75.219999999999999 109.327 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.34 157.71 29.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.373 -0.376 . . . . 75.010000000000005 110.104 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.98 136.88 34.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.108 -1.442 . . . . 71.409999999999997 107.108 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.9 137.47 20.93 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 120.194 -0.602 . . . . 61.409999999999997 110.644 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -43.63 124.21 4.2 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 124.068 3.178 . . . . 73.530000000000001 114.67 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.29 138.07 40.3 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.244 -1.391 . . . . 74.219999999999999 107.244 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 399' ' ' VAL . 31.0 m -102.16 23.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 113.545 0.943 . . . . 75.510000000000005 113.545 -170.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -62.73 135.04 57.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.314 0.578 . . . . 72.450000000000003 111.82 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.88 -3.78 77.9 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.139 -0.784 . . . . 72.230000000000004 111.139 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -114.96 160.19 19.85 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.624 -0.51 . . . . 72.120000000000005 109.624 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 67.9 p -75.65 158.34 32.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 110.37 -0.233 . . . . 65.409999999999997 110.37 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.477 ' O ' HD12 ' A' ' 374' ' ' ILE . 17.9 p -63.13 -37.13 86.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 120.771 0.32 . . . . 74.230000000000004 110.449 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.08 90.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.249 -0.432 . . . . 64.420000000000002 110.584 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.89 -34.94 79.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.125 0.488 . . . . 61.409999999999997 110.487 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.526 -0.761 . . . . 75.349999999999994 110.371 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 370' ' ' SER . 1.4 mp -58.55 -44.37 89.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.748 -0.66 . . . . 74.150000000000006 110.213 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.79 84.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.219 -0.446 . . . . 65.430000000000007 112.133 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 85.5 m -60.83 -47.17 87.58 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.647 0.24 . . . . 72.409999999999997 111.647 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.51 -39.02 93.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.779 0.323 . . . . 74.140000000000001 110.921 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.12 -46.0 89.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.345 -0.843 . . . . 71.120000000000005 109.601 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -70.57 -24.43 62.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 112.238 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -81.14 -15.3 56.26 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.144 -0.622 . . . . 75.450000000000003 111.584 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 98.98 14.84 35.24 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.679 -1.248 . . . . 73.409999999999997 111.888 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.406 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 48.6 m-85 -97.26 168.86 10.16 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.548 -0.908 . . . . 74.430000000000007 108.548 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.5 mmtp -113.49 157.25 22.23 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.514 -1.291 . . . . 72.010000000000005 107.514 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.451 HG13 HG13 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -135.0 142.37 40.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 121.293 0.568 . . . . 74.400000000000006 111.802 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -112.18 128.02 56.11 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.6 m -100.44 123.68 44.98 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 119.329 -0.948 . . . . 64.409999999999997 108.522 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.98 119.41 38.97 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 105.421 -2.066 . . . . 72.430000000000007 105.421 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.516 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -107.99 122.05 46.05 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.529 -0.915 . . . . 73.120000000000005 108.529 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 137.82 31.09 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.566 -0.454 . . . . 74.120000000000005 111.143 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -93.1 148.88 2.52 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.735 2.29 . . . . 71.409999999999997 111.487 175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 4.9 t70 170.06 174.75 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.758 -1.571 . . . . 74.209999999999994 106.758 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.674 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 22.0 m -99.3 -33.97 10.51 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.823 -0.806 . . . . 73.239999999999995 108.823 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.8 p -94.71 63.19 2.81 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 122.538 1.161 . . . . 73.409999999999997 108.255 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.442 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -95.6 151.57 38.6 Favored Pre-proline 0 N--CA 1.424 -1.742 0 CA-C-N 113.644 -1.617 . . . . 74.349999999999994 112.51 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.42 143.73 58.88 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 N-CA-C 107.24 -1.869 . . . . 73.030000000000001 107.24 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 398' ' ' HIS . 15.5 Cg_endo -56.92 148.67 66.05 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.242 1.962 . . . . 74.209999999999994 111.461 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.91 -9.68 10.68 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.019 0.914 . . . . 64.099999999999994 110.734 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.423 ' H ' ' C ' ' A' ' 396' ' ' PRO . 38.0 m80 -96.52 125.99 41.39 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 103.708 -2.701 . . . . 74.519999999999996 103.708 174.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.445 HG12 HG23 ' A' ' 365' ' ' VAL . 31.2 t -62.37 119.25 5.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.576 0.703 . . . . 75.200000000000003 111.969 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.6 tp -84.97 -29.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.369 -0.832 . . . . 73.230000000000004 109.367 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.07 160.32 33.18 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 403' ' ' ASP . 0.7 OUTLIER -113.14 -175.66 2.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 105.825 -1.917 . . . . 72.239999999999995 105.825 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 402' ' ' THR . 17.3 t70 -99.38 136.58 20.38 Favored Pre-proline 0 C--N 1.265 -3.089 0 N-CA-C 109.71 -0.478 . . . . 74.239999999999995 109.71 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -33.73 -31.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 1 C-N-CA 126.069 4.513 . . . . 74.439999999999998 115.88 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.56 -31.92 66.6 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 122.652 0.381 . . . . 73.510000000000005 111.0 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -35.3 64.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.364 0.602 . . . . 75.209999999999994 110.58 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.93 -15.08 59.29 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.01 -0.541 . . . . 74.340000000000003 110.183 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 70.8 m -86.35 147.09 26.2 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.241 -1.022 . . . . 75.319999999999993 108.241 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.7 m -74.81 112.9 11.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.008 -1.108 . . . . 71.310000000000002 108.008 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.05 170.22 18.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.663 -0.699 . . . . 74.040000000000006 110.845 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.1 p -65.91 131.52 46.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.403 -0.817 . . . . 60.039999999999999 110.628 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.46 4.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.077 0.465 . . . . 73.329999999999998 110.114 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 123.29 -2.07 9.66 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.393 -0.908 . . . . 75.239999999999995 112.342 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.78 158.87 32.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.057 -0.349 . . . . 75.329999999999998 110.057 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.9 pt-20 -87.29 121.4 29.68 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.371 0.605 . . . . 64.420000000000002 111.273 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.82 131.15 45.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.851 -1.166 . . . . 71.109999999999999 107.851 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -91.55 130.0 37.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.506 0.67 . . . . 75.420000000000002 110.301 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.8 t -117.57 125.46 74.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.591 -1.263 . . . . 73.540000000000006 107.591 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.9 129.2 43.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.008 -0.367 . . . . 75.239999999999995 110.008 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.5 p -125.58 147.95 30.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.98 -1.119 . . . . 74.400000000000006 107.98 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.8 p -96.51 123.34 40.14 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.056 0.455 . . . . 65.230000000000004 112.197 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 t -117.61 106.08 12.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.168 -0.613 . . . . 75.150000000000006 111.393 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 74.48 130.19 0.21 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.517 0.967 . . . . 73.420000000000002 115.517 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 22.8 Cg_exo -68.43 145.99 66.95 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.943 1.762 . . . . 52.020000000000003 109.294 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.31 147.24 31.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.084 0.772 . . . . 65.549999999999997 113.084 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.4 mt-30 -123.21 137.43 54.88 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.409999999999997 107.732 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -137.15 164.4 28.54 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.451 -0.574 . . . . 75.409999999999997 109.451 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -82.49 137.8 34.53 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.277 -1.008 . . . . 74.040000000000006 108.277 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.4 mt -80.85 114.35 47.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.543 -0.91 . . . . 64.030000000000001 108.543 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 140.74 37.27 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.343 1.362 . . . . 65.239999999999995 110.296 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.76 96.57 5.55 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.133 1.161 . . . . 73.400000000000006 114.133 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.3 6.76 3.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.112 -2.921 . . . . 72.430000000000007 103.112 165.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 4.6 m -71.05 -46.37 62.13 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 112.176 -2.284 . . . . 73.129999999999995 110.86 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 466' ' ' LYS . 21.6 m -57.01 -31.77 65.46 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.529 0.681 . . . . 75.120000000000005 110.031 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.82 -48.19 8.42 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.728 -0.669 . . . . 74.209999999999994 111.723 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 57.7 m -132.38 122.95 25.81 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 121.991 -0.443 . . . . 62.009999999999998 112.145 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -60.91 -40.57 93.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.98 0.912 . . . . 74.340000000000003 111.531 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.14 93.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 65.319999999999993 110.302 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -65.39 -35.62 81.5 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.446 -0.797 . . . . 60.450000000000003 111.384 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.22 94.1 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.632 0.583 . . . . 62.340000000000003 109.487 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.23 -49.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.769 -0.651 . . . . 74.349999999999994 110.691 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -65.09 -49.23 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.434 0.531 . . . . 72.510000000000005 112.434 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -68.02 -38.66 82.84 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.912 0.708 . . . . 74.329999999999998 112.912 -174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.44 -37.1 79.92 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.291 -0.564 . . . . 72.450000000000003 111.462 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.7 m -64.41 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.274 -0.639 . . . . 73.540000000000006 109.274 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.31 77.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.763 -0.653 . . . . 74.310000000000002 111.03 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -14.66 58.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.092 0.472 . . . . 73.519999999999996 110.225 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.41 -23.46 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-O 119.531 -0.594 . . . . 63.240000000000002 113.86 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -55.66 122.97 12.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.003 0.521 . . . . 75.129999999999995 111.962 -174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.01 8.66 5.73 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.48 -0.782 . . . . 74.420000000000002 111.62 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -110.23 110.62 21.52 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.735 -1.58 . . . . 75.340000000000003 106.735 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.37 150.29 52.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.918 0.866 . . . . 75.319999999999993 112.418 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 27.6 tptp -139.07 122.93 17.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.272 -1.751 . . . . 64.510000000000005 106.272 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -93.32 135.75 34.25 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 110.053 -0.351 . . . . 75.120000000000005 110.053 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.09 152.22 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.556 -0.535 . . . . 71.329999999999998 109.556 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.66 129.4 55.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.585 -0.895 . . . . 63.100000000000001 108.585 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.9 t -126.6 137.88 31.31 Favored Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.788 -1.19 . . . . 64.040000000000006 107.788 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.82 135.16 46.96 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.679 2.253 . . . . 70.540000000000006 110.427 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -148.18 169.86 19.11 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.465 -0.939 . . . . 73.140000000000001 108.465 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.6 m -65.46 144.12 98.87 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.785 0.834 . . . . 74.319999999999993 109.214 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.601 ' O ' HG12 ' A' ' 464' ' ' VAL . 93.3 Cg_exo -49.29 -23.47 7.04 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.915 3.076 . . . . 74.219999999999999 114.745 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -68.86 -31.98 71.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 71.209999999999994 111.142 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.39 -12.24 21.62 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 111.305 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.3 p -60.19 126.95 18.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-O 121.464 0.65 . . . . 73.420000000000002 110.448 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 98.6 -13.35 62.7 Favored Glycine 0 C--N 1.301 -1.383 0 N-CA-C 111.284 -0.726 . . . . 61.240000000000002 111.284 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 434' ' ' THR . 11.7 mptt -103.02 163.47 12.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.775 -0.824 . . . . 73.120000000000005 108.775 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.2 135.71 24.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.07 -1.085 . . . . 72.129999999999995 108.07 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.02 -12.06 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.399 -0.92 . . . . 73.319999999999993 110.546 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 151.93 176.46 24.66 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 115.198 -0.91 . . . . 73.409999999999997 112.082 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.4 p -116.41 149.46 39.38 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.607 -1.257 . . . . 74.200000000000003 107.607 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -64.68 -49.38 70.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 120.201 -0.599 . . . . 75.209999999999994 111.489 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -68.6 146.18 66.5 Favored 'Trans proline' 0 C--N 1.372 1.8 0 N-CA-C 108.724 -1.298 . . . . 74.230000000000004 108.724 170.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.69 126.52 18.41 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.522 2.148 . . . . 73.450000000000003 112.886 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.48 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.86 2.06 36.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.654 0.74 . . . . 70.109999999999999 111.608 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -109.9 -1.56 17.7 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.069 -0.514 . . . . 75.439999999999998 110.903 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.429 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -131.94 159.01 39.94 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.704 0.764 . . . . 72.430000000000007 111.39 -173.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -67.19 106.93 2.16 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.656 -1.611 . . . . 74.319999999999993 109.874 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.6 m -108.52 150.03 28.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.83 -0.804 . . . . 75.310000000000002 108.83 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.72 144.66 47.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.183 -0.673 . . . . 73.209999999999994 109.183 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.674 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 50.2 mm -70.7 -13.78 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.185 0.993 . . . . 70.530000000000001 109.16 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -87.8 -11.02 49.22 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.703 -1.135 . . . . 63.450000000000003 109.78 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.34 138.56 47.39 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.456 -0.942 . . . . 72.510000000000005 108.456 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.52 113.86 19.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.374 -1.343 . . . . 64.049999999999997 107.374 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.54 118.37 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 C-N-CA 119.526 -0.87 . . . . 74.219999999999999 108.825 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.1 mp -92.35 112.14 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 105.783 -1.932 . . . . 71.340000000000003 105.783 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 114.3 33.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.545 -1.65 . . . . 74.140000000000001 106.545 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 18.9 mt -104.27 116.93 48.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.633 -0.712 . . . . 74.140000000000001 110.216 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.74 137.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.243 -1.021 . . . . 74.230000000000004 108.243 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.62 99.33 1.0 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 109.633 -1.387 . . . . 74.329999999999998 109.633 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.2 m -142.79 105.73 4.54 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 122.742 0.417 . . . . 74.030000000000001 109.971 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.165 0 N-CA-C 109.398 -1.481 . . . . 62.329999999999998 109.398 178.153 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.329 0 N-CA-C 109.418 -1.473 . . . . 73.439999999999998 109.418 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.435 HD11 ' O ' ' A' ' 356' ' ' ILE . 2.6 pp -92.11 132.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 117.768 0.784 . . . . 75.209999999999994 111.707 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.8 m -150.05 149.91 31.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.045 -1.835 . . . . 74.549999999999997 106.045 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.73 90.41 3.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 119.505 -0.878 . . . . 73.349999999999994 111.41 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -113.9 138.98 49.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.695 -1.224 . . . . 63.210000000000001 107.695 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 19.9 m -136.09 156.6 37.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.511 -0.552 . . . . 64.450000000000003 109.511 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -94.7 136.25 35.23 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.803 -1.925 . . . . 74.519999999999996 105.803 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.5 m -97.71 141.11 22.49 Favored Pre-proline 0 C--N 1.282 -2.341 0 C-N-CA 119.128 -1.029 . . . . 74.430000000000007 110.948 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.95 133.19 56.55 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.124 2.549 . . . . 73.120000000000005 113.146 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.16 126.2 28.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.032 -0.985 . . . . 73.209999999999994 110.39 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.6 m -91.79 10.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 73.519999999999996 112.109 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.94 141.37 58.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 72.420000000000002 109.838 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.65 -0.14 45.94 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.489 -0.644 . . . . 74.510000000000005 111.489 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 -179.22 3.93 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.315 -0.624 . . . . 73.530000000000001 109.315 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.7 p -86.04 169.96 12.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.727 -0.789 . . . . 71.109999999999999 109.342 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.3 p -61.81 -38.98 90.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.739 0.304 . . . . 73.219999999999999 111.118 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.14 87.57 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.247 -0.433 . . . . 65.109999999999999 110.93 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -60.94 -43.66 98.35 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.199 -0.297 . . . . 74.420000000000002 110.199 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.91 75.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.524 -0.762 . . . . 63.210000000000001 110.198 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -58.28 -46.14 88.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.745 -0.661 . . . . 75.010000000000005 110.651 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.13 89.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.064 -0.517 . . . . 73.329999999999998 111.448 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 94.3 m -64.77 -48.25 75.2 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 120.575 0.226 . . . . 74.219999999999999 111.275 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.21 -38.71 91.29 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.436 -0.506 . . . . 73.450000000000003 110.892 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.02 -46.71 88.62 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.654 0.596 . . . . 61.409999999999997 109.908 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.4 -36.88 85.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.907 -0.588 . . . . 75.219999999999999 111.833 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -79.5 -14.45 58.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.540000000000006 111.652 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.3 16.35 32.57 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.387 -0.911 . . . . 72.340000000000003 113.523 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.19 166.96 12.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.912 0.387 . . . . 62.119999999999997 110.432 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 29.0 mmmt -99.93 153.14 19.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.193 -1.41 . . . . 74.439999999999998 107.193 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.409 HG13 HG22 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -130.19 138.47 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.432 0.634 . . . . 71.340000000000003 112.593 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.466 ' HB3' HG22 ' A' ' 417' ' ' THR . 14.0 ttm180 -115.46 135.93 53.6 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.05 -1.463 . . . . 74.310000000000002 107.05 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.6 m -99.6 128.11 45.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 119.351 -0.94 . . . . 72.109999999999999 110.525 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.77 119.54 38.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.928 -1.879 . . . . 73.400000000000006 105.928 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.51 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.02 128.4 56.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 120.883 0.373 . . . . 64.409999999999997 110.142 -178.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.436 ' HB3' ' HZ3' ' A' ' 389' ' ' LYS . 0.6 OUTLIER -121.53 115.7 30.97 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 112.11 0.411 . . . . 75.319999999999993 112.11 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -87.94 134.4 3.15 Favored 'Trans proline' 0 C--O 1.256 1.386 0 C-N-CA 123.306 2.67 . . . . 72.409999999999997 111.825 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t70 172.2 -169.32 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 106.374 -1.713 . . . . 71.200000000000003 106.374 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.523 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 21.3 m -120.52 -12.86 8.87 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.473 0.654 . . . . 74.010000000000005 109.399 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -90.84 14.41 13.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.567 1.175 . . . . 74.319999999999993 108.291 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.4 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.54 151.08 47.65 Favored Pre-proline 0 N--CA 1.424 -1.763 0 CA-C-N 114.739 -1.119 . . . . 74.140000000000001 110.931 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.73 171.29 18.28 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.104 1.87 . . . . 73.200000000000003 111.35 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 398' ' ' HIS . 74.0 Cg_exo -56.53 163.03 7.34 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.504 2.803 . . . . 72.129999999999995 111.752 172.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.68 -7.26 0.64 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.214 1.006 . . . . 71.329999999999998 112.973 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 42.5 m170 -83.38 142.15 31.23 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.826 -0.805 . . . . 74.409999999999997 108.826 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.47 117.92 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-O 121.864 0.84 . . . . 73.120000000000005 109.544 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.76 -27.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.933 -1.03 . . . . 74.310000000000002 110.471 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.87 161.15 28.08 Favored Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 109.515 -1.434 . . . . 71.519999999999996 109.515 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.2 p -113.58 -178.48 3.39 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 121.035 0.445 . . . . 71.349999999999994 111.328 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.55 132.09 22.2 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.026 -1.472 . . . . 63.420000000000002 107.026 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.55 -30.04 11.42 Favored 'Trans proline' 0 N--CA 1.481 0.769 0 C-N-CA 124.137 3.225 . . . . 74.420000000000002 114.92 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.9 67.12 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 111.57 0.211 . . . . 71.349999999999994 111.57 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.68 -33.45 60.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.451 0.643 . . . . 73.5 110.28 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -86.17 -10.36 54.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.6 -0.727 . . . . 74.239999999999995 110.474 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 46.3 m -83.48 153.19 24.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.131 -1.433 . . . . 72.409999999999997 107.131 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.4 m -74.39 113.24 11.39 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.686 -0.806 . . . . 74.200000000000003 109.858 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.89 169.4 15.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 123.947 0.899 . . . . 75.409999999999997 109.075 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.3 t -78.96 146.96 33.14 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.913 -0.773 . . . . 74.25 108.913 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -70.87 113.22 7.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.061 -0.718 . . . . 75.109999999999999 109.061 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.71 9.1 11.45 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.384 -0.826 . . . . 54.350000000000001 111.722 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.0 -173.53 4.77 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.297 -1.371 . . . . 73.340000000000003 107.297 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 9.4 pt-20 -106.36 141.36 37.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.741 -0.784 . . . . 75.200000000000003 111.632 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -118.89 137.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.897 -1.149 . . . . 75.540000000000006 107.897 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 385' ' ' ARG . 68.4 p -92.64 130.53 38.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 120.988 0.423 . . . . 71.25 110.264 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.6 128.14 55.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.195 -1.039 . . . . 75.409999999999997 108.195 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.67 128.87 45.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.973 -0.38 . . . . 74.140000000000001 109.973 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 10.1 p -137.53 142.43 36.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.085 -0.709 . . . . 73.400000000000006 109.085 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.4 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 14.6 m -88.1 122.26 31.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.53 -0.544 . . . . 74.25 109.53 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 41.2 p -119.62 107.45 13.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.628 -0.26 . . . . 63.43 111.435 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 86.35 131.41 2.92 Favored Glycine 0 C--N 1.299 -1.522 0 C-N-CA 120.437 -0.887 . . . . 71.239999999999995 114.004 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 97.1 Cg_endo -82.3 157.83 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.635 2.223 . . . . 74.439999999999998 111.378 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 2.9 mm-40 -85.67 124.19 31.92 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.568 -0.53 . . . . 73.209999999999994 109.568 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -120.51 130.91 54.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.039 -1.097 . . . . 75.420000000000002 108.039 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -131.18 152.06 50.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 74.510000000000005 108.51 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -89.81 138.49 31.44 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 109.821 -0.437 . . . . 73.310000000000002 109.821 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -80.3 119.38 76.26 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.085 -0.709 . . . . 71.129999999999995 109.085 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.51 141.4 97.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.765 2.31 . . . . 75.319999999999993 111.864 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.58 8.98 25.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.33 0.492 . . . . 73.510000000000005 112.33 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.43 -7.86 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.998 0.904 . . . . 74.340000000000003 108.767 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 p -59.2 -42.85 91.91 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.982 -1.008 . . . . 72.140000000000001 111.845 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 6.5 p -69.4 -16.72 63.57 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.543 0.737 . . . . 74.25 112.367 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.25 -32.82 19.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.383 -0.371 . . . . 73.519999999999996 111.94 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.4 m -151.72 123.99 8.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.448 -0.575 . . . . 73.209999999999994 109.448 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.86 -45.42 92.66 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.275 0.472 . . . . 73.129999999999995 112.275 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.25 -43.89 95.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 75.299999999999997 110.135 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.11 -37.65 88.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.138 -0.937 . . . . 74.230000000000004 109.949 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.093 -0.503 . . . . 73.420000000000002 110.51 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.27 -43.42 98.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.697 -0.683 . . . . 73.340000000000003 110.033 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 30.8 mmmt -64.67 -47.43 78.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.398 -0.364 . . . . 74.530000000000001 111.368 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -63.83 -38.85 92.63 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 111.982 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.0 -39.41 90.27 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.01 -0.737 . . . . 72.340000000000003 109.01 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.7 m -66.75 -45.91 77.07 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.335 -0.848 . . . . 73.349999999999994 110.163 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.83 -22.93 65.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.862 0.865 . . . . 64.109999999999999 112.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.68 -11.04 59.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.413 0.625 . . . . 64.510000000000005 110.628 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.38 -15.89 19.96 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.679 -0.772 . . . . 63.119999999999997 112.986 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.54 124.7 23.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.928 0.394 . . . . 73.340000000000003 111.182 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.78 13.17 9.28 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.028 -0.829 . . . . 73.230000000000004 111.028 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -111.95 111.26 22.06 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 70.400000000000006 107.458 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -126.0 146.41 49.89 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 121.097 -0.241 . . . . 74.329999999999998 110.921 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 25.3 ttmm -153.17 122.66 6.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.353 -1.351 . . . . 75.409999999999997 107.353 171.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.46 135.3 43.19 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.247 0.546 . . . . 64.340000000000003 111.825 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.73 158.04 28.36 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.044 -1.095 . . . . 71.319999999999993 108.044 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.41 134.48 51.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.844 -0.799 . . . . 64.430000000000007 108.844 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.2 t -138.79 131.16 15.73 Favored Pre-proline 0 C--N 1.287 -2.137 0 N-CA-C 108.655 -0.868 . . . . 71.0 108.655 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 128.56 21.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.994 1.796 . . . . 65.439999999999998 109.151 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.7 t -137.13 -178.75 5.34 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.541 -0.911 . . . . 72.140000000000001 108.541 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 12.0 m -51.1 131.06 31.27 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.925 1.29 . . . . 74.430000000000007 109.484 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.79 -33.05 31.3 Favored 'Trans proline' 0 C--N 1.364 1.371 0 C-N-CA 123.815 3.01 . . . . 63.109999999999999 114.065 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -67.44 -32.24 72.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 72.109999999999999 111.668 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.33 -9.7 40.94 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.165 -0.334 . . . . 72.299999999999997 111.51 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.692 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 42.1 t -59.17 129.97 22.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 CA-C-N 115.749 -0.66 . . . . 71.510000000000005 111.861 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.34 1.28 56.8 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.841 -1.072 . . . . 52.210000000000001 110.937 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -131.22 166.33 21.41 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 109.128 -0.693 . . . . 73.230000000000004 109.128 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 49.3 t -80.95 136.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.927 -0.768 . . . . 71.430000000000007 108.927 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.29 -16.54 7.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.13 -0.628 . . . . 74.409999999999997 111.564 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.61 163.79 22.14 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.26 -0.882 . . . . 72.200000000000003 110.999 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.5 p -122.37 157.57 31.54 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.006 -1.479 . . . . 75.150000000000006 107.006 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -62.23 -54.51 48.85 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 119.058 -1.057 . . . . 74.420000000000002 111.298 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -74.83 112.82 3.65 Favored 'Trans proline' 0 C--N 1.371 1.757 0 N-CA-C 107.801 -1.654 . . . . 75.430000000000007 107.801 169.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.36 162.07 43.36 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.391 2.061 . . . . 74.200000000000003 114.523 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.406 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.9 -4.01 32.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.864 -1.062 . . . . 63.439999999999998 111.553 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -108.23 12.24 26.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.098 -0.501 . . . . 71.010000000000005 109.814 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.63 151.77 46.06 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.461 0.648 . . . . 72.439999999999998 110.675 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.7 m -104.44 101.95 11.62 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.053 -1.462 . . . . 73.129999999999995 107.053 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.7 m -106.73 145.34 32.16 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.503 -0.317 . . . . 75.340000000000003 111.272 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.74 145.99 54.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.066 -0.516 . . . . 74.530000000000001 110.665 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.523 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 48.3 mm -67.25 -9.1 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 124.375 1.07 . . . . 75.040000000000006 111.42 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.8 p -86.88 -2.91 58.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.665 0.745 . . . . 74.120000000000005 110.71 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -95.82 133.93 39.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.544 -0.753 . . . . 74.109999999999999 109.382 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.28 119.37 28.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.932 -1.136 . . . . 74.200000000000003 107.932 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.18 119.15 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.628 -0.879 . . . . 64.310000000000002 108.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.3 mt -93.85 112.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.133 -1.432 . . . . 74.329999999999998 107.133 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.98 117.19 46.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.659 -1.155 . . . . 70.200000000000003 108.823 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 35.0 mt -99.93 119.8 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.374 0.606 . . . . 73.540000000000006 110.09 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.43 124.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 75.049999999999997 108.851 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.7 96.38 1.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.45 -1.86 . . . . 75.150000000000006 108.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.435 ' HA ' HG11 ' A' ' 464' ' ' VAL . 5.1 p -142.79 131.51 22.66 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 110.071 -0.344 . . . . 72.25 110.071 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.0 0 N-CA-C 106.851 -2.499 . . . . 64.129999999999995 106.851 176.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 110.379 -1.088 . . . . 73.340000000000003 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 356' ' ' ILE . 2.7 pp -82.4 127.15 39.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.16 0.505 . . . . 74.019999999999996 110.535 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 11.8 m -104.07 148.26 26.45 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.331 -0.988 . . . . 73.040000000000006 108.331 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.5 83.42 6.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.256 0.551 . . . . 75.219999999999999 109.749 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.33 129.51 35.86 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.28 -1.008 . . . . 62.439999999999998 108.28 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.46 153.65 39.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.514 -0.55 . . . . 73.319999999999993 109.514 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.43 138.59 32.91 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.04 -1.096 . . . . 64.219999999999999 108.04 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.59 126.62 42.65 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.335 -0.617 . . . . 74.219999999999999 109.335 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.1 141.75 89.76 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.413 2.742 . . . . 74.239999999999995 114.995 -174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.15 138.28 31.63 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.683 -1.228 . . . . 74.430000000000007 107.683 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.05 27.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-O 121.936 0.874 . . . . 64.319999999999993 109.073 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -55.45 144.23 26.44 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.823 -1.535 . . . . 71.099999999999994 111.694 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.92 44.65 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.961 -0.856 . . . . 50.229999999999997 110.961 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -127.18 -173.3 2.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.963 -0.384 . . . . 73.219999999999999 109.963 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.9 p -70.82 151.37 44.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.755 0.312 . . . . 74.010000000000005 111.385 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 p -63.43 -36.46 83.81 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.346 -0.388 . . . . 63.039999999999999 111.411 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.76 88.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.192 -0.458 . . . . 74.209999999999994 110.546 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.41 -36.52 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 110.637 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.78 -51.16 70.93 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.122 -0.49 . . . . 74.150000000000006 110.99 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.34 -43.58 98.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.831 -0.622 . . . . 74.549999999999997 110.774 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.33 94.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.448 -0.342 . . . . 74.040000000000006 111.829 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.2 m -63.93 -47.07 81.95 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.961 0.41 . . . . 73.239999999999995 110.105 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.49 -38.1 89.84 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -59.89 -45.24 93.14 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.174 0.989 . . . . 75.439999999999998 109.846 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -70.17 -16.55 63.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 74.219999999999999 111.991 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -86.86 -14.14 42.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.639 -0.874 . . . . 74.519999999999996 108.639 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.86 5.2 62.91 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.53 -0.843 . . . . 73.340000000000003 111.668 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 35.6 m-85 -86.15 149.72 24.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.212 0.529 . . . . 74.430000000000007 110.291 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 13.9 mmmm -91.41 153.22 20.02 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.216 -1.401 . . . . 65.430000000000007 107.216 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.03 147.46 25.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 C-N-CA 120.3 -0.56 . . . . 74.209999999999994 111.421 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -111.07 132.22 54.43 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.012 -1.848 . . . . 73.129999999999995 106.012 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.5 m -115.72 118.2 32.37 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.372 -0.973 . . . . 71.150000000000006 108.372 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.59 119.02 36.71 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.817 -1.179 . . . . 72.530000000000001 107.817 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -104.36 131.79 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.23 0.538 . . . . 73.409999999999997 110.187 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -136.76 130.61 17.82 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.707 -0.678 . . . . 74.530000000000001 110.836 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.36 135.55 4.46 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.494 2.129 . . . . 73.150000000000006 111.616 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 34.4 t70 168.56 166.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.168 1.387 . . . . 52.219999999999999 107.305 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.604 ' O ' ' HB ' ' A' ' 481' ' ' THR . 9.4 p -123.25 8.19 9.12 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 113.096 0.776 . . . . 75.450000000000003 113.096 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -82.34 -24.51 34.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.132 -1.803 . . . . 63.420000000000002 106.132 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 6.7 pt -88.91 148.65 41.76 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.721 -2.036 . . . . 73.129999999999995 109.718 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.63 173.01 14.01 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.098 2.532 . . . . 75.040000000000006 112.268 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.14 162.78 6.98 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 123.558 2.838 . . . . 71.319999999999993 112.69 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.46 -8.21 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.631 1.172 . . . . 74.409999999999997 113.993 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -75.47 115.69 15.4 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.396 -1.705 . . . . 75.219999999999999 106.396 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.48 117.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.018 0.437 . . . . 75.099999999999994 110.456 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.57 -27.21 3.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.641 -0.709 . . . . 73.140000000000001 110.137 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.29 157.02 27.04 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.072 -1.211 . . . . 62.039999999999999 110.072 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.9 p -128.12 -176.52 3.82 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 124.493 1.117 . . . . 75.129999999999995 111.076 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.83 132.92 22.15 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.524 -1.287 . . . . 74.099999999999994 107.524 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.59 -20.34 12.05 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.786 2.991 . . . . 74.530000000000001 114.175 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.63 61.29 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 122.453 0.301 . . . . 72.109999999999999 110.922 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.67 -41.15 84.19 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.44 0.638 . . . . 72.239999999999995 110.337 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.16 -3.87 59.09 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 120.261 -0.575 . . . . 72.439999999999998 111.534 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.4 m -80.13 131.54 35.76 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.671 -1.603 . . . . 73.120000000000005 106.671 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.8 m -74.61 113.3 11.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.032 -0.667 . . . . 75.299999999999997 110.086 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.25 167.73 24.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.246 -0.888 . . . . 63.210000000000001 109.335 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.17 50.35 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 109.459 -0.571 . . . . 75.510000000000005 109.459 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -62.51 130.8 46.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.369 0.668 . . . . 64.420000000000002 111.981 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 109.35 16.48 11.08 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.604 -0.808 . . . . 54.509999999999998 113.809 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.18 175.57 7.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.346 -1.353 . . . . 74.549999999999997 107.346 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 10.7 pt-20 -109.4 140.2 43.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 112.026 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.0 133.24 65.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -89.78 118.67 29.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.93 0.871 . . . . 62.439999999999998 110.038 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.3 133.58 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.91 -1.041 . . . . 72.400000000000006 109.176 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -96.97 128.74 44.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.813 -0.63 . . . . 74.209999999999994 110.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.3 p -130.25 131.9 65.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.304 -0.628 . . . . 72.400000000000006 109.304 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -91.9 122.55 34.53 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.326 -0.62 . . . . 64.120000000000005 109.326 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 16.5 p -118.92 106.66 12.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.756 0.312 . . . . 55.340000000000003 111.7 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.48 104.95 0.69 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.581 -0.819 . . . . 74.099999999999994 113.042 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 18.8 Cg_exo -66.99 128.93 19.59 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.53 2.154 . . . . 74.0 110.478 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.44 143.48 32.07 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.826 -0.35 . . . . 74.140000000000001 111.703 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -131.97 157.12 44.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.307 -0.997 . . . . 74.400000000000006 108.307 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -142.59 154.82 44.77 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.557 -0.534 . . . . 74.310000000000002 109.557 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.68 139.64 30.36 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.849 -0.426 . . . . 72.299999999999997 109.849 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.6 mp -78.7 116.15 57.4 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.844 -0.799 . . . . 64.099999999999994 108.844 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.55 140.91 40.77 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.868 1.712 . . . . 73.239999999999995 110.156 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -107.19 87.4 2.5 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.453 -1.299 . . . . 72.439999999999998 113.671 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.0 0.69 7.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 104.261 -2.496 . . . . 70.409999999999997 104.261 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 8.9 m -68.78 -50.11 53.02 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.972 -1.922 . . . . 73.129999999999995 110.236 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 15.7 m -64.88 -16.45 63.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 121.791 0.805 . . . . 74.519999999999996 109.908 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -48.42 7.01 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.482 -0.781 . . . . 74.010000000000005 110.241 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 66.0 m -147.71 123.91 10.84 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.085 0.469 . . . . 74.340000000000003 111.19 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -42.42 97.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.996 0.739 . . . . 72.409999999999997 112.996 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.22 -40.26 81.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 65.140000000000001 110.573 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -67.03 -35.3 79.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.485 -0.779 . . . . 74.530000000000001 111.815 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -59.67 -48.39 81.84 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.964 0.412 . . . . 65.349999999999994 110.26 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.57 -47.93 90.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.645 -0.707 . . . . 74.150000000000006 110.501 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -66.6 -45.7 78.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.02 -0.536 . . . . 73.310000000000002 112.119 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -66.28 -47.12 74.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 111.813 0.301 . . . . 71.010000000000005 111.813 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.11 -39.07 89.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.517 0.562 . . . . 73.0 112.517 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.0 m -61.81 -42.21 98.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.715 0.293 . . . . 74.439999999999998 110.483 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.66 66.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 73.230000000000004 111.06 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.08 59.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.958 -0.565 . . . . 73.420000000000002 111.038 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . 0.438 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 116.52 -7.43 18.03 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.339 -0.934 . . . . 64.349999999999994 113.594 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.09 105.2 8.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.48 0.64 . . . . 73.530000000000001 109.717 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -111.74 5.16 27.67 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.723 -0.671 . . . . 72.439999999999998 111.629 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 23.1 mmt180 -113.8 111.45 21.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 73.400000000000006 108.343 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.61 156.54 43.21 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.297 0.57 . . . . 75.420000000000002 111.655 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -135.79 123.21 21.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.314 -2.106 . . . . 75.109999999999999 105.314 170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.97 122.36 36.38 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.9 155.19 35.96 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.063 -0.717 . . . . 61.200000000000003 109.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -128.08 138.45 52.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.847 0.356 . . . . 74.510000000000005 110.674 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.8 t -123.19 131.22 24.34 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.151 -1.425 . . . . 72.340000000000003 107.151 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.01 124.48 14.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.524 2.15 . . . . 74.239999999999995 110.139 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 24.8 m -134.98 160.85 36.99 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.64 -0.504 . . . . 64.510000000000005 109.64 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.81 146.22 87.09 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.482 -1.303 . . . . 74.310000000000002 107.482 175.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 464' ' ' VAL . 79.1 Cg_exo -52.26 -24.02 19.66 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 123.372 2.715 . . . . 75.230000000000004 114.306 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.51 -31.86 73.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.116 0.484 . . . . 74.430000000000007 110.857 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.37 5.08 44.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.02 0.378 . . . . 73.420000000000002 112.02 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.1 p -60.43 128.85 22.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 C-N-CA 120.087 -0.645 . . . . 75.319999999999993 110.779 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.1 83.14 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.888 -0.596 . . . . 55.420000000000002 112.584 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -116.38 148.22 40.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.165 -1.421 . . . . 75.230000000000004 107.165 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 433' ' ' SER . 62.0 t -84.05 136.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.038 -0.727 . . . . 71.400000000000006 109.038 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.44 -14.62 10.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.781 -0.768 . . . . 75.340000000000003 111.233 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.12 173.56 41.01 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.948 -0.861 . . . . 73.420000000000002 110.948 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.2 p -137.22 158.87 43.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.276 -1.009 . . . . 72.5 108.276 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.9 t-20 -69.54 -54.62 10.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 119.809 -0.756 . . . . 75.230000000000004 109.863 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.55 118.07 4.76 Favored 'Trans proline' 0 C--N 1.376 2.024 0 N-CA-C 107.574 -1.741 . . . . 74.430000000000007 107.574 172.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 475' ' ' ASN . 43.0 Cg_endo -69.17 139.71 42.97 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.732 1.621 . . . . 75.430000000000007 112.277 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.17 24.74 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.424 1.09 . . . . 62.5 112.466 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 473' ' ' PRO . 38.6 m-80 -108.32 -22.28 12.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.385 1.074 . . . . 75.299999999999997 109.822 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -131.67 160.09 36.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 C-N-CA 119.292 -0.963 . . . . 75.239999999999995 111.498 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.69 141.9 49.86 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 126.12 1.768 . . . . 64.420000000000002 110.54 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 56.3 m -133.76 149.7 51.46 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.12 -1.067 . . . . 74.530000000000001 108.12 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -76.61 157.95 31.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-O 120.803 0.335 . . . . 72.209999999999994 110.338 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.438 HG21 ' O ' ' A' ' 448' ' ' GLY . 50.8 mm -66.83 -16.34 20.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.112 0.958 . . . . 63.549999999999997 110.004 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' A' ' 392' ' ' SER . 12.4 t -99.35 2.59 45.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.37 -0.832 . . . . 74.439999999999998 110.009 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 10.1 m120 -83.32 146.07 28.71 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.515 -0.55 . . . . 75.239999999999995 109.515 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.47 114.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 74.519999999999996 107.271 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.49 119.47 35.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.109 -0.7 . . . . 75.209999999999994 109.109 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 3.4 mp -92.06 112.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 106.608 -1.627 . . . . 60.210000000000001 106.608 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.33 121.93 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.664 -1.236 . . . . 73.019999999999996 107.664 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.41 111.58 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 121.418 0.627 . . . . 71.329999999999998 110.015 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.2 140.83 17.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.361 -0.977 . . . . 74.530000000000001 108.361 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.93 100.37 1.22 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.504 -1.038 . . . . 53.149999999999999 110.504 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 50.2 m -141.97 130.07 22.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.595 -0.52 . . . . 61.229999999999997 109.595 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.224 0 N-CA-C 107.871 -2.092 . . . . 73.319999999999993 107.871 -178.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.502 0 N-CA-C 109.714 -1.354 . . . . 72.349999999999994 109.714 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -87.27 151.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 117.124 0.462 . . . . 74.340000000000003 111.376 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 16.8 m -88.39 146.92 24.99 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.551 -1.277 . . . . 65.129999999999995 107.551 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -89.26 75.85 7.71 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.715 . . . . 74.150000000000006 110.483 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -100.87 148.66 24.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.688 -1.142 . . . . 65.409999999999997 108.751 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 150.68 31.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.274 -0.639 . . . . 72.340000000000003 109.274 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.31 136.6 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.659 -1.978 . . . . 74.209999999999994 105.659 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.5 p -97.46 128.48 34.52 Favored Pre-proline 0 C--N 1.282 -2.331 0 C-N-CA 119.117 -1.033 . . . . 75.109999999999999 109.627 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.97 128.07 23.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.841 2.361 . . . . 75.409999999999997 112.425 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -68.81 119.62 13.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.75 -1.113 . . . . 74.040000000000006 110.765 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 30.5 m -82.95 25.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.983 -1.008 . . . . 71.519999999999996 112.817 -174.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 400' ' ' ILE . 11.2 ptt-85 -67.85 144.04 55.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 122.044 -0.41 . . . . 74.0 111.941 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.83 0.5 45.61 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.875 -0.679 . . . . 53.530000000000001 113.647 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 0.9 OUTLIER -126.45 -172.85 2.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.336 0.568 . . . . 74.329999999999998 110.338 -177.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.8 p -79.44 164.2 24.16 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 118.266 0.484 . . . . 65.319999999999993 110.513 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 61.4 p -63.67 -33.66 76.13 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.368 -0.604 . . . . 74.340000000000003 109.368 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.14 90.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.143 -0.935 . . . . 63.329999999999998 110.339 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -60.14 -42.82 95.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.648 -0.251 . . . . 73.010000000000005 110.984 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -51.51 69.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.691 0.62 . . . . 64.310000000000002 110.438 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.73 -46.19 96.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.644 -0.707 . . . . 74.329999999999998 110.517 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.11 98.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.69 -0.686 . . . . 74.310000000000002 112.177 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.9 m -60.77 -47.69 85.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.844 0.354 . . . . 72.439999999999998 110.835 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.05 -38.82 92.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.779 0.323 . . . . 75.319999999999993 111.295 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.85 -47.62 85.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.557 -0.747 . . . . 65.230000000000004 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -68.9 -27.96 66.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.968 -0.56 . . . . 73.219999999999999 111.559 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -81.61 -13.63 57.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 111.977 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.14 14.55 48.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.561 -0.828 . . . . 63.310000000000002 112.895 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -88.61 170.57 10.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.636 -0.505 . . . . 61.530000000000001 109.636 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 14.2 mmmm -100.47 159.25 15.3 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.501 -1.296 . . . . 75.5 107.501 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.36 146.38 34.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.406 0.622 . . . . 73.310000000000002 110.996 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -123.59 147.43 47.33 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 105.495 -2.039 . . . . 73.129999999999995 105.495 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.4 m -116.5 129.19 56.06 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 109.072 -0.714 . . . . 74.140000000000001 109.072 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.32 118.8 36.85 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.19 -2.152 . . . . 65.040000000000006 105.19 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.441 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -115.92 129.5 56.43 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.45 -0.574 . . . . 74.239999999999995 109.45 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -138.45 134.54 17.54 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 116.351 -0.386 . . . . 70.040000000000006 110.614 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -93.38 132.68 0.88 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.92 2.413 . . . . 74.129999999999995 110.85 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.0 t70 -175.22 171.39 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.124 -1.436 . . . . 73.340000000000003 107.124 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.8 m -114.39 -5.48 12.9 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.356 0.598 . . . . 74.420000000000002 110.323 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -87.9 -12.82 43.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.104 0.954 . . . . 63.109999999999999 108.94 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 12.5 pt -88.58 144.12 33.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.001 -1.0 . . . . 74.439999999999998 110.861 -177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.4 177.22 8.79 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.343 2.695 . . . . 75.239999999999995 110.76 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.53 160.75 10.85 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.002 2.468 . . . . 74.040000000000006 112.357 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.407 ' HB2' HG21 ' A' ' 420' ' ' VAL . 2.5 p-10 -57.74 -9.5 1.25 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 124.987 1.315 . . . . 74.219999999999999 113.631 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.89 114.46 11.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.839 -1.911 . . . . 70.540000000000006 105.839 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.52 118.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.171 0.986 . . . . 74.439999999999998 111.408 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 366' ' ' ARG . 7.8 tp -90.53 -32.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.895 -1.048 . . . . 75.519999999999996 109.86 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -157.87 157.38 28.17 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 109.592 -1.403 . . . . 73.329999999999998 109.592 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.0 p -116.47 -179.75 3.77 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.063 -0.717 . . . . 73.049999999999997 109.063 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.64 147.55 34.0 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 120.174 -0.611 . . . . 75.230000000000004 109.416 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.65 -7.38 2.15 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.373 3.382 . . . . 71.549999999999997 115.501 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.28 72.8 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.058 -0.349 . . . . 72.420000000000002 110.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.73 68.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.695 0.759 . . . . 75.219999999999999 110.107 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.7 -10.83 59.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.278 -0.874 . . . . 74.219999999999999 111.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 83.0 m -81.01 151.81 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.794 -1.187 . . . . 73.530000000000001 107.794 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.5 m -74.06 112.86 10.6 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.303 0.573 . . . . 72.530000000000001 109.7 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.42 159.69 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.081 -0.963 . . . . 63.219999999999999 109.47 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 36.6 m -74.16 146.82 43.17 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.202 -0.666 . . . . 51.420000000000002 109.202 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.3 35.5 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.874 0.369 . . . . 73.209999999999994 110.423 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.46 25.86 24.7 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.724 -0.671 . . . . 70.540000000000006 112.006 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 411' ' ' SER . 4.4 t70 -85.89 -175.68 5.68 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.792 -1.188 . . . . 72.439999999999998 107.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.7 pt-20 -114.06 133.76 55.32 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.672 -0.811 . . . . 62.43 111.357 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.37 129.74 62.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 109.315 -0.624 . . . . 72.230000000000004 109.315 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.9 t -88.18 123.17 32.55 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 122.085 0.945 . . . . 72.430000000000007 109.994 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.81 114.61 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 107.506 -1.294 . . . . 73.25 107.506 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.08 -1.082 . . . . 73.310000000000002 108.08 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 397' ' ' ASP . 14.8 p -121.41 135.96 59.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.253 0.549 . . . . 75.450000000000003 110.558 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 19.9 m -84.63 121.11 27.18 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.663 -0.866 . . . . 73.129999999999995 108.663 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -119.87 104.9 10.59 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.657 -0.247 . . . . 75.019999999999996 111.449 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.02 145.72 0.12 Allowed Glycine 0 CA--C 1.542 1.729 0 N-CA-C 115.962 1.145 . . . . 65.230000000000004 115.962 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 57.9 Cg_endo -82.07 128.47 5.74 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.565 1.51 . . . . 74.099999999999994 109.964 172.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 0.1 OUTLIER -73.55 156.9 37.65 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.608 -0.516 . . . . 62.130000000000003 109.608 -177.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.4 mt-30 -121.71 157.48 30.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.032 0.444 . . . . 74.349999999999994 110.779 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -145.59 145.02 30.82 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.857 -0.794 . . . . 73.540000000000006 108.857 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.29 138.93 32.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.668 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -84.09 124.76 73.96 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.859 -0.61 . . . . 74.530000000000001 110.18 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 74.7 Cg_exo -61.85 141.6 90.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.435 2.09 . . . . 62.009999999999998 111.032 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.81 20.41 2.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.334 0.494 . . . . 64.129999999999995 112.334 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.18 -6.37 10.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.34 -0.391 . . . . 64.310000000000002 111.902 -175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.0 m -51.44 -51.09 57.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.909 0.883 . . . . 72.129999999999995 112.435 -177.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.3 m -61.12 -27.18 68.2 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.765 0.826 . . . . 74.409999999999997 111.716 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.15 -48.32 8.69 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.687 0.279 . . . . 73.109999999999999 111.702 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.0 m -146.47 115.84 7.08 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.814 -0.354 . . . . 72.349999999999994 111.083 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -59.23 -44.01 92.34 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.682 -0.69 . . . . 73.0 110.937 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.65 -46.6 83.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 75.219999999999999 111.258 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.02 -35.46 78.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.498 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.98 -43.58 95.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.314 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.84 -42.65 95.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.956 -0.565 . . . . 65.340000000000003 110.179 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.6 mmtt -66.22 -43.23 87.27 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.159 0.504 . . . . 74.219999999999999 110.352 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.473 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 39.3 mmtm -62.93 -47.74 81.92 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.521 -0.763 . . . . 74.450000000000003 111.246 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.97 -32.7 73.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.597 0.592 . . . . 73.420000000000002 112.597 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 52.3 m -67.54 -41.21 84.67 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.611 -0.514 . . . . 75.230000000000004 109.611 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.17 -22.83 61.99 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.83 0.824 . . . . 75.340000000000003 110.587 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -8.89 59.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.326 -0.852 . . . . 70.5 110.423 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.13 -20.41 45.37 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.992 -0.549 . . . . 72.0 113.178 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -57.84 127.42 31.99 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.117 0.484 . . . . 75.329999999999998 111.874 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -129.12 12.92 6.05 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.389 -0.823 . . . . 60.310000000000002 111.208 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -115.75 111.04 19.96 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.332 -0.988 . . . . 75.430000000000007 108.332 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -132.93 148.59 52.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.106 0.479 . . . . 75.310000000000002 110.756 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -140.53 122.24 15.31 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 105.578 -2.008 . . . . 73.140000000000001 105.578 170.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.89 128.83 45.18 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.566 -0.531 . . . . 72.25 109.566 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.0 161.41 26.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.037 -0.727 . . . . 74.519999999999996 109.037 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -129.31 129.17 44.51 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.594 -0.891 . . . . 72.099999999999994 108.594 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -123.42 137.64 28.81 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 109.555 -0.535 . . . . 64.140000000000001 109.555 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.5 Cg_exo -61.87 134.01 47.77 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.303 2.002 . . . . 63.130000000000003 110.594 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.1 m -148.15 161.83 40.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.48 -0.563 . . . . 73.129999999999995 109.48 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 20.8 m -57.75 142.99 77.43 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 124.335 1.022 . . . . 55.149999999999999 108.261 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.604 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.13 -23.27 6.28 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.673 2.916 . . . . 71.200000000000003 114.579 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.34 -33.11 74.06 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.709 -0.62 . . . . 74.530000000000001 110.305 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.44 -9.86 28.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 112.482 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 461' ' ' PRO . 8.9 p -60.22 127.25 19.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 119.836 -0.746 . . . . 74.340000000000003 110.21 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.99 71.82 Favored Glycine 0 C--N 1.307 -1.043 0 C-N-CA 120.629 -0.796 . . . . 51.439999999999998 112.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -107.97 161.74 14.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.658 -0.867 . . . . 75.049999999999997 108.658 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 98.0 t -83.98 129.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.591 -0.892 . . . . 75.519999999999996 108.591 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.08 -13.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.964 -0.695 . . . . 75.140000000000001 111.471 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 160.3 12.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.661 -0.699 . . . . 63.109999999999999 111.637 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.8 p -119.34 149.39 41.89 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.696 -1.224 . . . . 71.030000000000001 107.696 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.453 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.91 -51.46 79.19 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.34 -0.544 . . . . 72.219999999999999 110.707 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.453 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.2 Cg_exo -82.44 115.81 2.58 Favored 'Trans proline' 0 C--N 1.368 1.595 0 N-CA-C 107.841 -1.638 . . . . 74.430000000000007 107.841 169.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.56 159.51 52.2 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.326 2.017 . . . . 73.519999999999996 113.657 -175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.448 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.63 -4.14 35.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.145 0.974 . . . . 50.409999999999997 111.706 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -105.34 11.12 33.17 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 109.072 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -127.75 156.4 42.5 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.669 0.747 . . . . 60.020000000000003 110.7 -175.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 14.8 m -102.76 115.7 31.12 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.403 -1.271 . . . . 73.519999999999996 107.625 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.4 m -117.68 148.32 42.09 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 110.237 -0.283 . . . . 74.019999999999996 110.237 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.51 156.95 38.08 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.386 -0.228 . . . . 74.0 110.386 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.3 -22.78 19.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.57 0.7 . . . . 72.530000000000001 110.215 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -87.4 1.98 51.79 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.893 0.854 . . . . 73.219999999999999 109.861 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.46 130.17 34.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.478 -1.675 . . . . 70.209999999999994 106.478 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.19 113.99 19.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.602 -0.518 . . . . 75.439999999999998 109.602 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.37 118.7 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 N-CA-C 108.68 -0.859 . . . . 71.439999999999998 108.68 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 77.0 mt -94.45 112.89 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 107.176 -1.416 . . . . 73.230000000000004 107.176 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.61 115.44 46.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 N-CA-C 107.49 -1.3 . . . . 73.439999999999998 107.49 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.6 mt -103.61 119.82 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 115.982 -0.554 . . . . 74.099999999999994 110.148 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.16 136.24 29.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.566 -0.902 . . . . 73.329999999999998 108.566 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -71.88 113.34 4.51 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.129 -1.188 . . . . 73.25 110.129 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.2 m -131.73 104.89 7.16 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.453 -0.573 . . . . 74.239999999999995 109.453 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.096 0 N-CA-C 108.812 -1.715 . . . . 55.229999999999997 108.812 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.436 0 N-CA-C 109.75 -1.34 . . . . 73.420000000000002 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.24 137.84 21.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 117.906 0.853 . . . . 75.439999999999998 109.599 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.1 p -109.16 154.39 22.4 Favored 'General case' 0 N--CA 1.39 -3.475 0 CA-C-N 116.134 -0.484 . . . . 74.109999999999999 110.303 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -96.8 38.07 1.25 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.874 0.845 . . . . 74.340000000000003 109.305 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -76.01 132.87 40.43 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.535 -1.211 . . . . 71.140000000000001 107.75 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.54 162.34 38.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.009 0.433 . . . . 74.340000000000003 111.664 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.23 137.33 37.9 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.233 -1.025 . . . . 73.5 108.233 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.98 133.68 20.22 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 109.343 -0.614 . . . . 73.040000000000006 109.343 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 147.03 87.54 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.89 2.394 . . . . 73.310000000000002 113.666 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.06 145.4 31.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.653 -0.703 . . . . 72.439999999999998 109.175 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.1 t -107.43 31.63 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.602 -1.629 . . . . 73.420000000000002 106.602 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.36 134.12 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.388 -1.733 . . . . 75.430000000000007 111.149 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.88 -5.19 57.96 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 111.373 -0.691 . . . . 60.420000000000002 111.373 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -119.25 -176.94 3.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 120.705 0.288 . . . . 75.340000000000003 110.225 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.6 p -72.02 158.7 35.5 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 111.531 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.5 t -63.1 -33.8 76.23 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.372 -0.603 . . . . 74.329999999999998 109.372 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.23 90.36 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.535 0.522 . . . . 72.219999999999999 110.356 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 116.332 -0.394 . . . . 73.019999999999996 110.648 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.424 ' O ' HD22 ' A' ' 377' ' ' LEU . . . -60.65 -51.4 69.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.577 -0.738 . . . . 60.200000000000003 111.035 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.95 -43.18 97.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.433 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.64 98.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 70.439999999999998 112.349 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 58.7 m -64.03 -47.34 80.6 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.355 0.598 . . . . 73.230000000000004 110.264 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 373' ' ' ALA . 4.4 mm? -64.34 -38.45 91.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 73.409999999999997 110.768 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.2 -45.95 91.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.653 -0.703 . . . . 73.340000000000003 110.072 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -66.22 -30.71 71.21 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.187 -0.461 . . . . 74.219999999999999 111.389 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.7 mmt-85 -78.95 -13.83 59.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.479 . . . . 75.209999999999994 111.012 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.9 13.5 56.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.889 -0.672 . . . . 74.299999999999997 113.228 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 59.4 m-85 -85.33 166.24 16.62 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.487 0.66 . . . . 75.299999999999997 111.755 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 55.8 mtmt -109.02 132.61 53.94 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.605 -1.257 . . . . 74.109999999999999 107.605 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.76 146.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.462 0.649 . . . . 75.430000000000007 112.651 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -109.5 127.73 54.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.887 -1.894 . . . . 72.430000000000007 105.887 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.4 m -107.34 117.65 34.64 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 106.663 -1.606 . . . . 73.329999999999998 106.663 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.23 118.52 36.15 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.116 -1.809 . . . . 75.310000000000002 106.116 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.43 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -113.03 128.0 56.38 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 109.164 -0.68 . . . . 75.329999999999998 109.164 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.21 138.71 33.48 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.938 -0.574 . . . . 73.0 110.364 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -82.63 146.04 13.27 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.92 1.746 . . . . 72.219999999999999 108.716 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.8 t0 -179.62 -175.0 0.32 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.349 -1.722 . . . . 75.239999999999995 106.349 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 51.4 m -135.11 0.26 2.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.158 0.504 . . . . 72.519999999999996 110.441 174.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 -14.95 49.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.221 -1.399 . . . . 61.219999999999999 107.221 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.418 HD11 ' CB ' ' A' ' 421' ' ' SER . 14.2 pt -91.86 145.47 31.1 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.086 -1.416 . . . . 74.299999999999997 111.189 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.41 -172.88 1.47 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 123.18 2.587 . . . . 72.230000000000004 108.838 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.58 161.7 7.36 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.35 2.033 . . . . 74.340000000000003 112.608 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -57.03 -8.12 0.6 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 125.228 1.411 . . . . 73.329999999999998 114.463 -174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -71.66 122.36 20.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.577 -1.268 . . . . 75.540000000000006 107.577 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.04 118.42 7.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 123.589 0.756 . . . . 73.420000000000002 111.645 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 400' ' ' ILE . 0.2 OUTLIER -96.4 -28.83 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.857 -0.61 . . . . 75.310000000000002 111.031 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.47 157.73 27.48 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 110.76 -0.936 . . . . 72.0 110.76 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.3 p -126.98 -177.88 4.2 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 123.283 0.633 . . . . 74.219999999999999 110.268 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.69 136.15 19.63 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.537 -1.653 . . . . 75.030000000000001 106.537 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.72 -16.67 2.48 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.406 3.404 . . . . 75.510000000000005 115.282 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.83 32.93 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 123.622 0.769 . . . . 74.200000000000003 111.854 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.44 -44.49 82.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.125 0.488 . . . . 71.430000000000007 111.034 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -86.09 -2.32 58.21 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.19 0.519 . . . . 73.040000000000006 111.662 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 67.1 m -81.55 146.79 29.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.846 -1.538 . . . . 72.420000000000002 106.846 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.2 m -74.66 112.74 11.17 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.168 -1.049 . . . . 72.540000000000006 108.168 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.23 166.81 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.519 -0.764 . . . . 74.340000000000003 111.064 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.2 t -74.51 144.66 44.01 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.108 -1.071 . . . . 63.009999999999998 108.108 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.43 114.67 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 71.310000000000002 110.521 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.34 40.68 4.16 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.668 -0.777 . . . . 71.120000000000005 111.767 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -93.2 -177.38 4.44 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.607 -1.257 . . . . 74.409999999999997 107.607 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 41.2 mt-10 -107.19 119.9 40.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.207 0.527 . . . . 65.150000000000006 111.957 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.21 130.59 61.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.538 -0.912 . . . . 75.120000000000005 108.538 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.4 t -95.05 130.76 41.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.355 0.598 . . . . 75.299999999999997 110.015 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.39 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.711 -0.848 . . . . 73.329999999999998 108.711 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -91.33 128.82 37.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.489 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.16 138.59 53.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.229 -0.896 . . . . 71.510000000000005 109.428 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.418 ' CB ' HD11 ' A' ' 394' ' ' ILE . 16.0 m -89.08 121.47 31.44 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.449 -0.575 . . . . 71.439999999999998 109.449 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.2 t -120.83 104.82 10.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 119.144 -1.022 . . . . 71.5 111.005 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 64.19 172.23 2.61 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.907 0.723 . . . . 70.129999999999995 114.907 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 72.9 Cg_endo -97.18 155.09 1.06 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 122.73 2.287 . . . . 72.349999999999994 113.322 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.452 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 4.5 mm-40 -84.87 141.37 30.48 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.78 -0.645 . . . . 74.319999999999993 110.247 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -117.26 147.37 42.6 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.458 -0.942 . . . . 73.310000000000002 108.458 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.29 155.39 39.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.561 -1.274 . . . . 75.209999999999994 107.561 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -88.81 138.16 31.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.79 -0.448 . . . . 74.25 109.79 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.8 mp -83.09 129.14 62.34 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.385 -0.968 . . . . 75.25 108.385 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.55 140.51 89.83 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.362 2.041 . . . . 74.219999999999999 112.356 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.03 -5.73 56.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.558 0.694 . . . . 73.239999999999995 110.18 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.36 -7.57 10.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.986 -1.006 . . . . 61.439999999999998 110.936 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.424 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 20.7 m -56.48 -41.76 77.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.304 -0.862 . . . . 64.450000000000003 111.228 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -61.74 -23.13 65.95 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.23 1.012 . . . . 75.219999999999999 111.77 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.12 -35.79 15.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.512 . . . . 74.230000000000004 111.888 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.4 m -148.68 119.48 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.08 -0.387 . . . . 64.450000000000003 110.849 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -58.13 -51.17 70.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 111.77 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.98 -43.6 98.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 75.209999999999994 111.605 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.67 -35.28 80.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.666 -0.697 . . . . 73.430000000000007 110.166 -177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.03 -51.39 69.83 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 123.775 0.672 . . . . 65.510000000000005 109.627 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.0 t -58.89 -44.12 90.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 72.409999999999997 110.48 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 73.5 mmtt -66.21 -46.64 76.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 75.230000000000004 111.762 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -66.0 -37.95 87.23 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.876 0.324 . . . . 64.239999999999995 111.876 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 440' ' ' ALA . 10.4 mp -65.21 -40.48 94.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.932 0.145 . . . . 74.439999999999998 111.286 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.2 m -61.25 -47.06 87.8 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.33 -0.619 . . . . 73.030000000000001 109.33 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.12 -24.96 65.98 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.851 -0.613 . . . . 70.299999999999997 111.696 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.2 -8.86 59.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 65.209999999999994 111.354 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.28 48.7 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.639 -0.791 . . . . 72.230000000000004 113.187 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.25 99.34 6.23 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.266 -0.549 . . . . 75.310000000000002 109.687 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.43 23.1 27.45 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.238 -0.745 . . . . 74.340000000000003 111.238 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -118.58 111.72 18.95 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.671 -1.233 . . . . 72.140000000000001 107.671 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -131.31 144.1 51.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.012 0.91 . . . . 72.510000000000005 113.06 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 18.4 tptm -140.3 123.4 16.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.548 -1.66 . . . . 75.439999999999998 106.525 170.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -95.99 135.16 38.13 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.555 -0.535 . . . . 74.510000000000005 109.555 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.0 153.02 51.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.025 -0.732 . . . . 73.450000000000003 109.025 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -121.8 129.37 52.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.886 0.374 . . . . 74.010000000000005 110.481 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.2 t -117.2 142.46 30.14 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 107.869 -1.16 . . . . 72.209999999999994 107.869 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.98 126.96 19.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.266 1.977 . . . . 74.019999999999996 109.968 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.6 t -137.96 -178.21 5.16 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.749 -0.834 . . . . 71.219999999999999 108.749 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.422 ' HB ' HD13 ' A' ' 463' ' ' LEU . 21.0 m -63.94 138.02 97.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.41 -1.33 . . . . 75.340000000000003 107.41 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.81 -29.31 33.82 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.629 2.886 . . . . 71.420000000000002 113.965 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -76.23 -19.06 58.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.921 0.711 . . . . 75.540000000000006 112.921 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.422 HD13 ' HB ' ' A' ' 460' ' ' THR . 10.4 mp -95.17 4.62 53.4 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.808 0.299 . . . . 73.5 111.808 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -60.15 126.35 17.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-O 121.335 0.588 . . . . 73.109999999999999 110.54 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.11 -0.16 66.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.748 -0.66 . . . . 54.310000000000002 112.09 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.57 152.29 24.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.985 -1.117 . . . . 73.349999999999994 107.985 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 56.4 t -84.07 141.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.06 -0.718 . . . . 72.120000000000005 109.06 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.22 -14.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.127 -0.629 . . . . 70.030000000000001 111.456 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.08 168.28 20.91 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.733 -0.947 . . . . 73.439999999999998 110.733 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.0 p -116.95 159.3 22.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.427 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -63.52 -54.69 41.27 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 119.96 -0.696 . . . . 65.310000000000002 111.132 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 18.3 Cg_exo -72.87 112.98 3.64 Favored 'Trans proline' 0 C--N 1.373 1.834 0 N-CA-C 107.465 -1.783 . . . . 73.549999999999997 107.465 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.465 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 49.5 Cg_endo -65.65 149.03 87.62 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.917 2.412 . . . . 75.109999999999999 114.938 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -77.8 -0.88 28.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 74.299999999999997 110.03 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -104.41 7.33 35.52 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.439 -1.255 . . . . 75.430000000000007 110.252 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.465 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 34.9 tt0 -159.01 165.48 33.92 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.906 -0.717 . . . . 65.530000000000001 109.593 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.2 m -92.52 126.4 37.59 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.633 -0.877 . . . . 71.430000000000007 108.633 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.9 m -125.96 148.85 49.15 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.939 -0.393 . . . . 75.319999999999993 109.939 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.9 148.19 50.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.632 0.253 . . . . 75.519999999999996 111.636 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.4 mm -66.41 -12.58 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.442 0 C-N-CA 124.388 1.075 . . . . 73.310000000000002 110.818 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.3 t -87.91 5.0 42.64 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.868 0.842 . . . . 75.409999999999997 110.328 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -90.96 135.43 33.74 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.382 -0.599 . . . . 73.319999999999993 109.382 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.69 122.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.964 -1.495 . . . . 71.530000000000001 106.964 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.23 118.59 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 C-N-CA 119.618 -0.833 . . . . 72.329999999999998 108.882 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 63.8 mt -92.93 112.24 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 105.935 -1.876 . . . . 75.319999999999993 105.935 174.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.4 109.13 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 106.688 -1.597 . . . . 73.340000000000003 106.688 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.0 mt -97.2 116.9 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 115.513 -0.767 . . . . 71.040000000000006 109.867 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 t -97.52 141.04 16.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.961 -1.125 . . . . 74.319999999999993 107.961 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -91.31 127.11 8.72 Favored Glycine 0 N--CA 1.407 -3.276 0 N-CA-C 109.849 -1.3 . . . . 71.430000000000007 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.7 m -136.39 128.83 30.28 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.348 -0.612 . . . . 72.409999999999997 109.348 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.287 0 N-CA-C 108.569 -1.812 . . . . 64.409999999999997 108.569 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.47 0 N-CA-C 109.392 -1.483 . . . . 54.340000000000003 109.392 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -93.45 135.41 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.094 -0.706 . . . . 65.209999999999994 109.094 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.6 p -78.99 143.1 36.04 Favored 'General case' 0 N--CA 1.385 -3.718 0 CA-C-N 116.251 -0.431 . . . . 71.200000000000003 110.712 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -97.74 77.89 2.57 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.683 -0.858 . . . . 75.310000000000002 108.683 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -100.71 135.53 42.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.706 -1.22 . . . . 73.299999999999997 107.706 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.14 149.72 20.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.803 -0.443 . . . . 72.030000000000001 109.803 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.298 -1.371 . . . . 65.120000000000005 107.298 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.415 HG13 ' HB1' ' A' ' 406' ' ' ALA . 3.6 p -97.82 118.66 63.71 Favored Pre-proline 0 C--N 1.282 -2.351 0 N-CA-C 108.637 -0.875 . . . . 72.329999999999998 108.637 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.7 160.68 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.77 2.313 . . . . 75.319999999999993 113.823 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.505 ' OD2' ' HD3' ' A' ' 366' ' ' ARG . 14.6 p-10 -72.33 119.58 16.74 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.243 -0.89 . . . . 52.299999999999997 109.976 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.64 35.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 125.564 1.546 . . . . 73.420000000000002 110.728 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.505 ' HD3' ' OD2' ' A' ' 364' ' ' ASP . 15.0 ptt180 -63.87 144.55 56.98 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.622 -1.627 . . . . 75.400000000000006 112.859 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.56 0.74 59.2 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.724 -0.75 . . . . 64.400000000000006 114.685 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.49 171.69 12.73 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.375 1.088 . . . . 73.340000000000003 110.995 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -71.59 156.77 39.02 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.261 -0.427 . . . . 75.349999999999994 110.547 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.404 ' O ' HD12 ' A' ' 374' ' ' ILE . 8.4 p -59.78 -37.12 78.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.945 0.403 . . . . 72.400000000000006 110.574 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.0 91.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.993 -0.548 . . . . 72.420000000000002 111.335 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.67 -41.88 74.92 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.487 -0.485 . . . . 74.329999999999998 110.406 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.99 -51.32 69.7 Favored 'General case' 0 C--O 1.239 0.532 0 O-C-N 123.809 0.693 . . . . 72.409999999999997 111.94 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 370' ' ' SER . 1.7 mp -60.64 -46.07 96.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.281 -0.418 . . . . 73.200000000000003 110.951 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.36 87.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.035 0.383 . . . . 73.209999999999994 112.035 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 79.1 m -60.83 -45.56 93.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.742 0.306 . . . . 73.239999999999995 111.197 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.62 -38.13 89.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.363 -0.38 . . . . 72.400000000000006 110.688 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.13 -46.15 90.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.125 0.97 . . . . 74.519999999999996 110.485 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -70.36 -18.66 63.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.757 -0.656 . . . . 73.120000000000005 111.263 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -88.49 -8.26 55.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.972 -0.558 . . . . 74.239999999999995 111.13 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.2 56.15 Favored Glycine 0 CA--C 1.504 -0.655 0 C-N-CA 120.986 -0.626 . . . . 61.350000000000001 113.353 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -80.83 150.27 29.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.226 0.536 . . . . 71.310000000000002 110.41 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -100.06 144.74 28.74 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.066 -1.457 . . . . 74.340000000000003 107.066 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.67 139.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.498 -174.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -116.19 127.75 55.04 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 74.329999999999998 107.246 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.7 m -104.7 123.75 48.17 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.265 -0.574 . . . . 70.150000000000006 110.086 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.53 119.71 39.67 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.55 -0.907 . . . . 71.140000000000001 108.55 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.41 127.52 52.11 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.913 -0.585 . . . . 73.209999999999994 109.635 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -134.97 139.59 32.55 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 111.773 0.286 . . . . 65.129999999999995 111.773 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 60.3 Cg_endo -89.19 145.23 5.13 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.424 2.082 . . . . 74.319999999999993 110.215 170.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.9 t70 -171.09 -176.64 1.99 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.502 -0.925 . . . . 73.109999999999999 108.502 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.554 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 3.5 m -98.65 -39.61 8.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.743 -1.577 . . . . 74.549999999999997 106.743 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -101.86 73.47 1.41 Allowed 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.406 -1.331 . . . . 72.010000000000005 107.406 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.443 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 14.5 pt -93.83 127.45 45.47 Favored Pre-proline 0 N--CA 1.419 -1.978 0 CA-C-N 113.016 -1.902 . . . . 75.420000000000002 111.593 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -69.86 124.33 10.93 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 N-CA-C 106.105 -2.306 . . . . 75.420000000000002 106.105 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 398' ' ' HIS . 14.9 Cg_endo -56.23 159.98 11.69 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.049 2.499 . . . . 75.109999999999999 113.749 -173.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.9 -8.81 3.4 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.375 1.07 . . . . 74.329999999999998 111.696 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.404 ' H ' ' C ' ' A' ' 396' ' ' PRO . 16.1 m170 -103.82 106.86 17.49 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.073 -2.195 . . . . 72.319999999999993 105.073 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.0 m -62.63 119.72 7.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 O-C-N 124.585 1.178 . . . . 71.329999999999998 113.378 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.59 -28.22 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 113.865 -1.516 . . . . 63.420000000000002 109.89 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.47 170.4 32.88 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 110.598 -1.001 . . . . 54.520000000000003 110.598 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 5.9 m -120.02 -178.21 3.6 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.389 -2.078 . . . . 70.430000000000007 105.389 177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -100.02 141.14 22.21 Favored Pre-proline 0 C--N 1.266 -3.024 0 N-CA-C 108.995 -0.742 . . . . 75.230000000000004 108.995 -178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -41.98 -26.32 0.47 Allowed 'Trans proline' 0 C--N 1.371 1.731 1 C-N-CA 125.555 4.17 . . . . 75.109999999999999 115.248 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.55 62.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.981 0.512 . . . . 74.409999999999997 110.683 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . 0.415 ' HB1' HG13 ' A' ' 362' ' ' VAL . . . -77.06 -44.47 30.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.678 -0.692 . . . . 71.319999999999993 110.856 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -7.62 54.54 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.69 -0.686 . . . . 72.230000000000004 111.936 -174.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.3 m -85.17 146.02 27.32 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.421 -0.955 . . . . 73.540000000000006 108.421 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.4 p -73.49 113.87 11.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 109.795 -0.446 . . . . 73.510000000000005 109.795 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 168.84 20.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.525 -0.546 . . . . 74.310000000000002 109.525 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.8 m -72.84 133.25 44.37 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.369 -0.974 . . . . 73.209999999999994 108.369 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -55.86 135.78 51.81 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 112.442 0.534 . . . . 75.5 112.442 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.86 47.04 4.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.082 -0.963 . . . . 74.420000000000002 111.094 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -108.68 178.88 4.35 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.981 -1.118 . . . . 75.409999999999997 107.981 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.79 122.13 40.53 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.801 0.44 . . . . 52.119999999999997 111.388 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -111.18 128.88 67.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.723 -0.843 . . . . 72.140000000000001 108.723 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -87.39 128.0 35.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.138 -0.69 . . . . 64.530000000000001 109.138 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.21 128.85 73.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.532 -0.914 . . . . 75.109999999999999 108.532 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -100.96 128.34 47.03 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.395 -0.366 . . . . 72.329999999999998 110.694 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.28 146.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.558 -1.275 . . . . 73.540000000000006 107.558 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.443 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 8.8 p -98.93 123.29 43.11 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.059 -0.657 . . . . 54.210000000000001 112.531 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -118.28 105.32 11.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.888 -0.596 . . . . 75.349999999999994 110.145 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 72.94 161.2 6.01 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 121.898 0.721 . . . . 24.239999999999998 114.497 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.0 Cg_endo -92.33 157.62 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.496 2.13 . . . . 75.010000000000005 110.871 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.8 131.63 42.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 120.092 -0.643 . . . . 61.149999999999999 110.219 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -121.08 138.96 53.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.681 -0.69 . . . . 74.510000000000005 109.611 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.429 ' HG2' ' HB2' ' A' ' 447' ' ' ALA . 0.1 OUTLIER -131.8 150.19 52.23 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 108.566 -0.902 . . . . 74.349999999999994 108.566 -175.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.98 131.65 34.23 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.064 -1.087 . . . . 72.230000000000004 108.064 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.08 125.23 82.11 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.372 -0.603 . . . . 72.140000000000001 109.372 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.37 141.25 73.86 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.255 1.97 . . . . 62.450000000000003 110.951 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.5 -5.26 59.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.466 0.651 . . . . 71.109999999999999 110.199 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.47 -1.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 74.420000000000002 111.165 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 7.2 p -65.6 -41.53 92.66 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.921 0.867 . . . . 75.230000000000004 109.708 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.4 m -65.84 -13.24 59.18 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 125.271 1.429 . . . . 71.319999999999993 111.213 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.18 -35.75 17.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.315 0.487 . . . . 74.120000000000005 112.315 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.0 m -157.94 125.21 5.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.909 -0.494 . . . . 50.149999999999999 110.522 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -57.58 -48.79 78.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.437 0.532 . . . . 73.019999999999996 112.437 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.0 76.71 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.439 -0.346 . . . . 52.450000000000003 111.888 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.88 -34.7 71.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.962 -0.563 . . . . 73.430000000000007 111.176 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.01 86.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.477 -0.329 . . . . 75.200000000000003 110.459 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.28 -42.33 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.822 -0.627 . . . . 74.019999999999996 109.935 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -61.62 -47.59 84.75 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 111.922 0.342 . . . . 73.209999999999994 111.922 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.55 -45.54 92.46 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.55 0.34 . . . . 75.439999999999998 111.54 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.28 -40.79 81.7 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.469 -0.492 . . . . 74.329999999999998 112.175 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.2 m -63.82 -39.33 93.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.956 0.407 . . . . 74.209999999999994 110.402 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.65 -25.96 65.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 75.409999999999997 110.946 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.429 ' HB2' ' HG2' ' A' ' 427' ' ' ARG . . . -86.88 -8.59 57.14 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.857 -0.61 . . . . 74.219999999999999 110.938 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.3 -15.98 13.01 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.558 -0.829 . . . . 72.439999999999998 114.08 176.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.36 113.15 3.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.995 0.898 . . . . 74.540000000000006 111.54 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.86 -12.57 11.17 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.823 -0.703 . . . . 72.109999999999999 111.422 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -91.06 111.19 22.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.1 -0.704 . . . . 75.230000000000004 109.1 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -136.07 154.49 51.01 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.54 0.685 . . . . 64.409999999999997 111.864 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -137.03 122.3 19.3 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 104.841 -2.281 . . . . 74.140000000000001 104.841 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -113.57 127.89 56.24 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.023 0.439 . . . . 74.239999999999995 110.625 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.06 165.29 27.96 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.701 -0.682 . . . . 73.150000000000006 110.034 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.96 141.15 47.12 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.771 -1.196 . . . . 74.319999999999993 107.771 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.6 t -116.93 129.57 25.22 Favored Pre-proline 0 N--CA 1.407 -2.607 0 N-CA-C 107.008 -1.479 . . . . 74.409999999999997 107.008 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.55 119.97 7.15 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 122.227 1.952 . . . . 73.340000000000003 109.791 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 2.9 p -148.24 -178.35 6.26 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 115.045 -0.98 . . . . 74.109999999999999 108.84 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.3 m -61.32 128.72 90.14 Favored Pre-proline 0 C--N 1.291 -1.941 0 N-CA-C 108.48 -0.933 . . . . 75.109999999999999 108.48 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.68 -22.94 10.29 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.646 2.898 . . . . 72.430000000000007 112.899 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.11 -30.17 69.09 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.34 0.656 . . . . 72.099999999999994 110.918 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.63 5.16 44.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.362 -0.381 . . . . 73.439999999999998 111.427 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.5 p -59.58 132.26 24.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 CA-C-O 121.15 0.5 . . . . 73.430000000000007 111.247 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.81 -10.79 73.82 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.689 -0.767 . . . . 70.010000000000005 112.748 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.67 147.01 30.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.38 -0.6 . . . . 74.439999999999998 109.38 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.86 135.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.125 -1.065 . . . . 75.019999999999996 108.125 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.97 -16.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.516 -0.874 . . . . 71.239999999999995 111.542 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.37 167.28 32.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.641 -0.79 . . . . 74.400000000000006 111.693 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.2 p -131.78 145.62 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.309 -0.996 . . . . 74.430000000000007 108.309 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.443 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -58.97 -53.8 62.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 120.337 -0.545 . . . . 75.530000000000001 110.532 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -70.84 118.39 5.67 Favored 'Trans proline' 0 C--N 1.376 2.011 0 N-CA-C 107.338 -1.831 . . . . 74.430000000000007 107.338 169.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.12 151.93 30.8 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.028 1.819 . . . . 75.150000000000006 113.685 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.74 -0.93 5.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.005 -0.998 . . . . 73.209999999999994 112.244 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -107.81 -3.02 19.43 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.497 -0.32 . . . . 75.140000000000001 110.69 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -118.19 157.0 27.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.442 0.639 . . . . 75.230000000000004 110.601 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 10.3 m -102.69 97.75 7.88 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 74.109999999999999 107.404 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 40.4 m -100.88 147.99 25.48 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.986 -0.552 . . . . 73.209999999999994 110.082 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.77 148.22 51.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.107 -0.497 . . . . 74.010000000000005 110.861 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.554 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 33.0 mm -69.81 -5.04 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 122.464 1.126 . . . . 74.340000000000003 109.996 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.4 p -87.49 0.9 54.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.598 0.714 . . . . 75.239999999999995 109.736 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 482' ' ' ASN . 0.8 OUTLIER -93.07 139.42 30.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.425 -0.807 . . . . 74.219999999999999 109.08 -179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.93 123.42 36.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.911 -1.144 . . . . 75.209999999999994 107.911 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.36 118.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 108.679 -0.86 . . . . 73.510000000000005 108.679 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.41 HD13 HD21 ' A' ' 471' ' ' ASN . 2.6 mp -92.4 113.65 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.204 -1.776 . . . . 73.200000000000003 106.204 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.43 114.64 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 N-CA-C 108.297 -1.001 . . . . 72.239999999999995 108.297 -176.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -106.9 123.07 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.358 -0.837 . . . . 65.400000000000006 111.214 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.36 144.0 11.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.75 -1.114 . . . . 74.340000000000003 108.486 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.58 113.42 4.61 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 108.904 -1.678 . . . . 73.209999999999994 108.904 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.9 m -139.63 113.11 8.4 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 109.178 -0.675 . . . . 71.329999999999998 109.178 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.417 -2.633 0 N-CA-C 108.499 -1.84 . . . . 62.0 108.499 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 110.243 -1.143 . . . . 43.049999999999997 110.243 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.17 145.79 16.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.39 0.614 . . . . 73.540000000000006 112.554 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.1 m -114.6 160.68 19.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.447 -1.686 . . . . 65.150000000000006 106.447 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -87.99 89.35 7.96 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.082 0.944 . . . . 74.040000000000006 111.823 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.72 126.24 51.93 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.594 -1.632 . . . . 72.400000000000006 106.594 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.51 154.25 23.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 110.177 -0.305 . . . . 75.140000000000001 110.177 -175.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -98.97 132.12 44.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.805 -1.183 . . . . 65.319999999999993 107.805 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.1 118.33 61.67 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.832 -0.747 . . . . 74.25 111.461 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.89 143.08 71.78 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.439 2.093 . . . . 71.540000000000006 112.189 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.614 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 4.0 p30 -82.68 177.9 8.46 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.225 -0.898 . . . . 73.209999999999994 111.239 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.52 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 17.1 m -138.67 29.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.478 -1.237 . . . . 74.420000000000002 108.537 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.614 ' HG3' ' OD1' ' A' ' 364' ' ' ASP 0.264 0.1 OUTLIER -64.15 146.74 53.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.438 0.903 . . . . 73.450000000000003 113.438 -174.049 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.2 0.2 41.04 Favored Glycine 0 C--N 1.308 -0.989 0 N-CA-C 110.368 -1.093 . . . . 71.200000000000003 110.368 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.52 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 46.7 mt-30 -116.44 -170.68 1.86 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.899 -0.778 . . . . 75.439999999999998 108.899 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.0 p -69.91 150.99 46.17 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.471 0.309 . . . . 74.230000000000004 111.132 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 374' ' ' ILE . 38.1 t -57.98 -36.15 72.19 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.443 -0.947 . . . . 65.209999999999994 108.443 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.3 94.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.308 -0.86 . . . . 75.010000000000005 112.237 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.88 -40.24 91.43 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.75 0.309 . . . . 75.310000000000002 110.199 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.18 88.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 72.319999999999993 110.637 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 370' ' ' SER . 76.5 mt -62.59 -46.39 96.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.68 -0.691 . . . . 74.140000000000001 110.202 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.34 79.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.997 -0.547 . . . . 73.0 112.087 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.545 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 85.5 m -60.73 -47.83 84.54 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.659 -0.246 . . . . 70.519999999999996 111.128 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.52 -38.04 89.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.71 0.263 . . . . 74.030000000000001 111.71 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -41.98 97.8 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 109.414 -0.587 . . . . 72.0 109.414 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -69.82 -22.93 63.26 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.473 -0.785 . . . . 74.140000000000001 112.107 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.2 mmt180 -84.96 -14.27 48.1 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.504 -0.554 . . . . 73.109999999999999 109.504 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.84 56.68 Favored Glycine 0 C--O 1.239 0.421 0 C-N-CA 120.895 -0.669 . . . . 53.520000000000003 112.201 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.33 149.26 25.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.966 -0.383 . . . . 74.530000000000001 109.966 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -100.18 132.35 45.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.782 -0.822 . . . . 75.319999999999993 108.782 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -121.88 137.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 113.232 0.827 . . . . 63.020000000000003 113.232 -174.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -110.56 127.87 55.4 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 107.309 -1.367 . . . . 71.219999999999999 107.309 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.0 m -99.33 121.82 41.62 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.136 -1.061 . . . . 70.219999999999999 108.136 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -111.49 119.5 38.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.251 -1.388 . . . . 73.150000000000006 107.251 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.46 128.69 55.34 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 109.431 -0.581 . . . . 72.329999999999998 109.431 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -133.04 146.25 60.42 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.904 -0.406 . . . . 74.400000000000006 109.904 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -93.08 128.87 0.74 Allowed 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.221 1.947 . . . . 74.450000000000003 109.81 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.0 t70 -173.14 -175.12 1.14 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.732 -1.21 . . . . 70.040000000000006 107.732 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.8 m -130.63 -0.68 4.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.753 0.787 . . . . 75.239999999999995 109.975 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -91.11 -0.63 57.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.881 1.324 . . . . 71.409999999999997 107.473 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.475 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.63 151.75 48.33 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.076 -1.42 . . . . 70.310000000000002 112.641 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.16 178.32 6.44 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.425 2.084 . . . . 73.450000000000003 109.698 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.96 158.13 18.24 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 121.923 1.749 . . . . 74.109999999999999 111.786 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.81 -7.21 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.842 0.829 . . . . 70.409999999999997 113.119 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -86.83 122.66 31.01 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.216 -2.513 . . . . 74.439999999999998 104.216 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 118.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.626 0.727 . . . . 75.209999999999994 111.811 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.8 mm -97.87 -28.37 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.533 -0.758 . . . . 72.519999999999996 111.004 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.94 157.99 27.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.039 -1.077 . . . . 62.240000000000002 111.794 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.8 p -114.16 -177.53 3.15 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 123.577 0.751 . . . . 75.109999999999999 111.123 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.06 143.73 27.04 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.109999999999999 107.705 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -40.25 -32.63 0.72 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 124.807 3.672 . . . . 74.099999999999994 114.715 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.09 -30.01 61.41 Favored 'General case' 0 C--O 1.208 -1.103 0 O-C-N 123.437 0.46 . . . . 72.420000000000002 111.608 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.72 -35.56 75.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.109 0.48 . . . . 73.040000000000006 111.021 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -95.66 -0.85 51.2 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.944 0.402 . . . . 72.530000000000001 111.939 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -98.29 155.94 16.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.322 -1.362 . . . . 71.150000000000006 107.322 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 11.3 p -74.31 112.7 10.73 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.723 -0.843 . . . . 73.329999999999998 108.723 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.51 169.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.439 -0.578 . . . . 74.209999999999994 109.439 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 20.3 m -69.65 146.9 51.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.298 -0.631 . . . . 64.519999999999996 109.298 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.81 108.17 2.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.821 -1.177 . . . . 73.299999999999997 107.821 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.61 59.68 1.26 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.444 -1.462 . . . . 74.340000000000003 109.444 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.3 t0 -109.94 -173.51 2.27 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.039 -1.097 . . . . 74.230000000000004 108.039 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -93.62 121.96 35.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.815 0.846 . . . . 74.230000000000004 110.079 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.647 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.8 mm -124.23 137.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.112 -1.44 . . . . 72.209999999999994 107.112 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.1 t -113.2 131.25 55.95 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 75.019999999999996 110.833 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 76.4 t -102.18 128.28 54.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.112 -0.949 . . . . 71.230000000000004 108.748 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -99.0 129.83 45.3 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.131 -0.486 . . . . 44.310000000000002 110.044 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 9.0 p -136.16 136.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.271 0.558 . . . . 73.230000000000004 109.705 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.475 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 8.2 m -89.59 123.75 33.94 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.942 -0.572 . . . . 73.209999999999994 110.982 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -119.18 105.83 11.76 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.193 -0.603 . . . . 72.340000000000003 110.015 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.08 129.32 0.5 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 120.649 -0.786 . . . . 71.430000000000007 114.792 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 17.0 Cg_exo -70.75 157.92 57.11 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.685 2.257 . . . . 75.430000000000007 110.582 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.01 155.52 19.78 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.361 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.7 mt-30 -127.84 138.78 52.82 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.827 -0.805 . . . . 72.25 108.827 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -135.52 157.68 46.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.093 -0.706 . . . . 74.209999999999994 109.093 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.64 139.35 32.86 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.653 -0.499 . . . . 75.530000000000001 109.653 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.442 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -80.47 127.34 76.21 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 108.66 -0.866 . . . . 74.450000000000003 108.66 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.53 141.57 62.3 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.842 2.361 . . . . 74.510000000000005 111.805 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.76 -15.5 48.28 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.511 0.672 . . . . 63.130000000000003 111.785 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.3 -10.55 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 121.399 0.619 . . . . 72.510000000000005 110.824 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.1 m -55.73 -45.4 77.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.583 0.753 . . . . 65.150000000000006 112.533 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 3.5 p -69.84 -15.67 63.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.345 0.593 . . . . 73.120000000000005 112.562 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.01 -37.99 13.92 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 111.003 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.9 m -146.98 122.22 10.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.062 0.458 . . . . 61.25 111.043 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -60.59 -42.27 96.38 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.789 0.835 . . . . 72.099999999999994 112.276 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.94 78.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.489 . . . . 73.420000000000002 110.822 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.75 -39.8 73.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.06 -0.518 . . . . 75.310000000000002 110.96 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.61 68.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.854 -0.612 . . . . 64.430000000000007 111.031 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.52 -43.83 90.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.785 0.661 . . . . 73.340000000000003 112.785 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.34 -48.53 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.801 -0.36 . . . . 73.439999999999998 111.774 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.84 -40.18 87.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 113.897 1.073 . . . . 74.549999999999997 113.897 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.39 -43.17 77.87 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.977 -0.689 . . . . 72.319999999999993 112.215 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.7 m -61.6 -43.98 97.85 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.024 0.44 . . . . 72.400000000000006 110.364 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.09 -25.1 62.47 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.795 -0.639 . . . . 72.430000000000007 111.765 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -12.69 59.77 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.172 0.51 . . . . 61.530000000000001 110.631 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.62 -19.01 8.58 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.337 -0.935 . . . . 71.340000000000003 112.791 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.2 103.82 1.67 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.008 -0.738 . . . . 74.310000000000002 109.008 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.68 11.59 18.48 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 111.029 -0.829 . . . . 75.340000000000003 111.029 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -108.87 111.05 22.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 106.68 -1.6 . . . . 73.010000000000005 106.68 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.98 155.82 49.68 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.268 0.556 . . . . 62.310000000000002 111.425 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 122.3 20.33 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 102.843 -3.021 . . . . 72.430000000000007 102.843 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -93.91 135.14 35.55 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.867 -0.42 . . . . 74.400000000000006 109.867 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 141.09 37.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.161 0.505 . . . . 72.510000000000005 110.741 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -118.96 129.36 55.12 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.058 -1.46 . . . . 75.230000000000004 107.058 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -125.36 145.35 50.62 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.448 -0.575 . . . . 75.030000000000001 109.448 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.422 ' HA ' ' HA2' ' A' ' 491' ' ' GLY . 13.4 Cg_exo -68.54 126.77 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.773 1.649 . . . . 63.039999999999999 110.378 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.6 m -135.71 172.92 12.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.984 -0.747 . . . . 75.150000000000006 108.984 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 25.6 m -62.81 140.09 97.26 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.402 -0.962 . . . . 74.519999999999996 108.402 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -49.32 -31.24 22.19 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.792 2.995 . . . . 75.140000000000001 113.782 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.69 -21.88 64.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.236 0.541 . . . . 71.329999999999998 111.434 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.72 -8.52 17.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.218 -0.446 . . . . 73.439999999999998 110.937 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 76.3 t -60.09 127.21 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 120.977 0.417 . . . . 61.049999999999997 110.641 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.54 59.08 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.881 -0.888 . . . . 71.329999999999998 110.881 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.22 162.42 13.21 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.663 -0.865 . . . . 74.420000000000002 108.663 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 93.1 t -83.83 128.59 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.773 -1.566 . . . . 75.329999999999998 106.773 173.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.42 -16.87 7.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.381 -0.928 . . . . 74.340000000000003 111.526 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.11 159.0 16.13 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 111.113 -0.795 . . . . 64.439999999999998 111.113 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.4 p -119.94 154.29 34.68 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.425 -1.694 . . . . 74.420000000000002 106.425 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.424 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.2 t30 -64.19 -49.94 70.72 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 119.43 -0.908 . . . . 74.340000000000003 110.349 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.4 Cg_exo -78.2 115.9 3.81 Favored 'Trans proline' 0 C--N 1.371 1.731 0 N-CA-C 108.051 -1.557 . . . . 72.25 108.051 168.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.54 149.93 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.077 1.852 . . . . 74.420000000000002 112.488 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.442 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.04 4.24 4.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.445 0.641 . . . . 63.25 112.596 -176.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -108.35 2.15 22.32 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.994 -0.548 . . . . 72.430000000000007 110.67 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -117.65 155.42 29.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.752 0.787 . . . . 75.129999999999995 111.556 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 426' ' ' GLN . 17.4 m -95.62 111.83 23.68 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.987 -1.486 . . . . 64.319999999999993 106.987 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.6 m -115.14 149.25 37.92 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.731 -0.47 . . . . 72.430000000000007 109.731 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -62.29 150.84 38.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.156 0.503 . . . . 74.040000000000006 111.226 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.26 -26.51 27.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.035 0.921 . . . . 74.329999999999998 109.353 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 m -89.87 5.14 47.57 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.967 -1.015 . . . . 72.150000000000006 110.117 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -83.62 135.3 34.66 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 107.609 -1.256 . . . . 64.310000000000002 107.609 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 58.8 t -79.01 114.5 19.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.249 -0.649 . . . . 75.140000000000001 109.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.77 119.52 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.082 -0.71 . . . . 74.340000000000003 109.082 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 3.0 mp -92.23 114.25 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.357 -1.72 . . . . 75.310000000000002 106.357 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.29 118.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.676 -1.231 . . . . 74.510000000000005 107.676 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.1 mt -110.32 117.33 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.587 0.708 . . . . 75.310000000000002 110.27 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.23 138.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.581 -0.736 . . . . 73.340000000000003 109.122 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.588 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.09 107.76 3.2 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.975 -0.85 . . . . 74.409999999999997 110.975 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.414 ' HA ' HG11 ' A' ' 464' ' ' VAL . 36.6 m -143.37 113.94 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.105 -0.702 . . . . 74.140000000000001 109.105 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 458' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.311 0 N-CA-C 110.183 -1.167 . . . . 74.109999999999999 110.183 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.031 0 N-CA-C 110.684 -0.966 . . . . 72.420000000000002 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 21.5 pt -126.47 158.83 36.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.167 0.483 . . . . 72.319999999999993 109.856 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 14.1 t -128.44 -173.37 2.94 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.625 -1.62 . . . . 75.129999999999995 106.625 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.83 65.41 8.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.255 1.026 . . . . 74.099999999999994 111.153 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.92 135.8 50.22 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.486 -2.042 . . . . 73.010000000000005 105.486 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.86 164.2 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 120.88 0.372 . . . . 74.040000000000006 111.13 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -94.29 137.14 33.8 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.8 -1.926 . . . . 75.319999999999993 105.8 173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.57 139.72 21.55 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 108.294 -1.002 . . . . 75.329999999999998 108.294 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -37.99 135.79 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.8 3.0 . . . . 63.409999999999997 113.835 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.78 88.96 1.33 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.791 -1.188 . . . . 71.400000000000006 107.791 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.42 -0.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 116.888 2.181 . . . . 73.340000000000003 116.888 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 145.25 56.5 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.032 -0.667 . . . . 74.239999999999995 112.231 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 0.48 45.29 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.802 -0.919 . . . . 74.120000000000005 110.802 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -117.3 172.51 7.26 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.608 -1.627 . . . . 71.209999999999994 106.608 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 91.0 p -81.3 153.67 26.95 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 118.482 -1.287 . . . . 62.310000000000002 107.865 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.46 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.5 m -56.65 -40.47 75.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.535 0.207 . . . . 74.140000000000001 110.897 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.67 -36.99 79.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.015 0.436 . . . . 71.310000000000002 111.395 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -67.5 -36.69 81.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.537 0.684 . . . . 73.409999999999997 109.508 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.44 90.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.495 -0.775 . . . . 73.319999999999993 110.134 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 370' ' ' SER . 70.5 mt -57.72 -46.42 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.696 0.398 . . . . 74.310000000000002 110.134 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.69 91.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.932 -0.576 . . . . 75.299999999999997 110.684 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.7 m -64.73 -47.59 77.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.412 -0.358 . . . . 72.409999999999997 111.095 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.29 -38.79 91.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 111.655 0.243 . . . . 73.25 111.655 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.11 -48.88 79.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.254 -0.647 . . . . 75.430000000000007 109.254 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -72.07 -16.47 62.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.2 -0.909 . . . . 72.5 111.935 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.91 -15.07 49.37 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.034 -1.098 . . . . 70.430000000000007 108.034 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.4 5.6 61.78 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.59 -0.732 . . . . 33.350000000000001 111.786 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -91.83 158.95 16.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.198 0.523 . . . . 73.239999999999995 111.745 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 75.1 mmtt -95.62 146.31 24.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.052 -1.092 . . . . 73.439999999999998 108.052 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.1 OUTLIER -126.72 144.04 38.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 121.209 0.528 . . . . 74.209999999999994 111.56 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -110.46 139.92 45.22 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.019 -2.215 . . . . 75.219999999999999 105.019 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -112.68 121.0 43.47 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 119.174 -1.01 . . . . 70.450000000000003 110.015 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.64 119.27 38.11 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.572 -1.64 . . . . 73.530000000000001 106.572 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -107.04 122.37 46.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.927 -0.768 . . . . 75.349999999999994 108.927 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.443 ' HE3' ' OD1' ' A' ' 419' ' ' ASN . 17.6 ptpt -121.15 116.97 30.87 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 113.12 0.785 . . . . 74.439999999999998 113.12 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -83.53 140.24 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.445 2.097 . . . . 74.230000000000004 109.205 168.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 175.18 -166.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.136 -2.542 . . . . 55.009999999999998 104.136 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.415 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 15.1 m -132.67 -4.03 3.28 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 118.907 0.776 . . . . 73.299999999999997 109.982 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.1 m -106.49 38.03 2.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.204 -2.147 . . . . 71.439999999999998 105.204 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.408 HG23 ' HB3' ' A' ' 391' ' ' ASP . 16.3 pt -87.1 151.16 51.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 113.176 -1.829 . . . . 74.129999999999995 113.078 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.07 137.33 34.31 Favored 'Trans proline' 0 N--CA 1.429 -2.306 0 N-CA-C 105.974 -2.356 . . . . 74.040000000000006 105.974 165.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 398' ' ' HIS . 49.9 Cg_exo -56.66 160.69 11.27 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.332 2.021 . . . . 73.209999999999994 111.787 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.67 -8.52 2.06 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.947 0.879 . . . . 75.120000000000005 111.722 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.0 m170 -103.45 111.05 23.31 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.778 -2.675 . . . . 74.430000000000007 103.778 171.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.52 119.34 6.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.962 0.887 . . . . 74.540000000000006 112.426 -166.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.4 -27.84 4.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.958 0 CA-C-N 114.528 -1.215 . . . . 75.239999999999995 112.14 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.48 27.31 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.65 -0.98 . . . . 72.049999999999997 110.65 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.5 p -114.69 -178.0 3.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.639 0.733 . . . . 65.319999999999993 112.375 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -104.18 136.48 19.18 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 107.437 -1.32 . . . . 73.530000000000001 107.437 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -48.91 -25.37 8.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.155 3.236 . . . . 73.310000000000002 115.327 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.96 -36.04 69.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.471 0.309 . . . . 75.209999999999994 110.976 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.94 83.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 74.109999999999999 110.769 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.45 -11.4 58.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.296 -0.865 . . . . 74.109999999999999 110.953 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.1 m -93.62 155.25 17.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.143 -1.058 . . . . 74.340000000000003 108.143 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 9.7 p -74.5 114.51 12.98 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 121.543 0.687 . . . . 74.019999999999996 110.154 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.1 m -123.87 169.23 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.333 -0.849 . . . . 72.420000000000002 109.574 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 65.6 m -62.41 149.34 42.79 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.978 0.418 . . . . 74.400000000000006 111.499 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.68 112.04 3.98 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.156 -1.053 . . . . 71.209999999999994 108.156 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.45 25.54 13.65 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.346 -0.931 . . . . 35.420000000000002 112.091 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.73 -173.88 4.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.0 pt-20 -108.72 132.87 53.52 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.472 0.653 . . . . 72.140000000000001 112.435 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 47.7 mm -119.86 131.48 72.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.221 -1.029 . . . . 74.400000000000006 108.221 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.3 t -89.45 131.35 35.55 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.379 0.609 . . . . 71.120000000000005 109.999 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.15 134.67 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 109.268 -0.641 . . . . 74.129999999999995 109.268 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.443 ' OD1' ' HE3' ' A' ' 389' ' ' LYS . 41.6 m-80 -103.6 129.8 50.93 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 111.655 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.8 p -134.29 142.09 41.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.13 -1.063 . . . . 75.430000000000007 108.13 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 12.9 p -101.72 123.12 45.18 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.338 -0.545 . . . . 63.420000000000002 111.761 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -120.14 107.01 12.51 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.423 -0.511 . . . . 73.430000000000007 111.546 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.89 142.61 6.59 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.714 -0.755 . . . . 72.120000000000005 114.342 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.5 Cg_endo -87.92 133.47 3.0 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.295 1.997 . . . . 75.299999999999997 111.625 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.474 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 8.7 mm-40 -72.83 134.05 44.72 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 122.211 -0.305 . . . . 72.109999999999999 110.537 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -123.27 134.01 54.12 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.776 -0.824 . . . . 75.319999999999993 108.776 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -131.99 150.94 52.02 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.893 -1.151 . . . . 74.120000000000005 107.893 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -82.33 138.95 34.38 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.403 -0.962 . . . . 75.120000000000005 108.403 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.9 mt -82.35 117.24 67.73 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.7 -0.852 . . . . 73.120000000000005 108.7 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.55 140.24 39.26 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.303 1.335 . . . . 73.319999999999993 110.884 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.46 84.37 5.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.333 1.063 . . . . 64.420000000000002 112.282 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.65 -5.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 113.645 -1.616 . . . . 74.530000000000001 106.726 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.449 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 7.7 m -62.74 -43.14 99.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.727 -1.579 . . . . 71.25 111.498 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.3 m -58.55 -21.31 52.19 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 122.957 0.503 . . . . 74.319999999999993 111.733 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.68 -48.08 64.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 122.289 -0.257 . . . . 74.299999999999997 110.59 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.1 t 178.45 161.85 0.66 Allowed 'General case' 0 C--O 1.249 1.054 0 N-CA-C 108.748 -0.834 . . . . 71.409999999999997 108.748 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -57.75 -42.65 84.39 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.987 0.915 . . . . 75.200000000000003 111.998 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.25 81.41 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.885 0.328 . . . . 63.109999999999999 111.885 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.78 -38.88 92.76 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.246 -0.434 . . . . 63.409999999999997 110.645 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -51.09 71.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.301 -0.863 . . . . 73.299999999999997 110.238 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.27 -43.12 98.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.536 -0.756 . . . . 74.040000000000006 111.364 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.491 ' HZ1' ' HB3' ' A' ' 442' ' ' LYS . 9.2 mtpm? -63.25 -49.37 74.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.247 0.462 . . . . 75.230000000000004 112.247 -176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -68.03 -41.3 82.35 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 113.099 0.777 . . . . 73.430000000000007 113.099 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 -41.04 90.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.678 -0.409 . . . . 71.049999999999997 112.044 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -66.39 -38.8 88.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.932 -0.396 . . . . 74.150000000000006 109.932 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.26 73.79 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.253 -0.43 . . . . 74.519999999999996 110.879 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.92 58.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.368 -0.378 . . . . 72.219999999999999 110.892 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.31 -20.34 9.67 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.865 -0.683 . . . . 70.099999999999994 113.97 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 105.68 1.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.37 . . . . 74.099999999999994 110.315 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.53 22.22 15.5 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 120.563 -0.827 . . . . 71.040000000000006 111.13 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.55 111.07 18.13 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.163 -1.051 . . . . 75.530000000000001 108.163 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.4 147.1 52.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.281 0.562 . . . . 75.420000000000002 111.26 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 8.1 tmtm? -138.67 123.45 18.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.768 -1.938 . . . . 72.450000000000003 105.768 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -98.53 135.47 40.02 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.612 -0.435 . . . . 62.130000000000003 111.072 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.01 148.48 50.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.506 -1.294 . . . . 75.519999999999996 107.506 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.25 130.34 46.12 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.788 -0.819 . . . . 73.420000000000002 108.788 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.9 p -130.93 143.93 51.42 Favored Pre-proline 0 C--N 1.291 -1.964 0 C-N-CA 120.463 -0.495 . . . . 64.400000000000006 110.888 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_exo -63.71 122.87 11.12 Favored 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.622 2.215 . . . . 73.239999999999995 110.281 175.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.8 m -130.06 162.63 28.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.495 -0.321 . . . . 73.420000000000002 111.203 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.4 m -60.26 142.65 89.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.638 1.175 . . . . 75.400000000000006 108.782 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 464' ' ' VAL . 90.9 Cg_exo -49.25 -24.06 7.72 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.108 3.205 . . . . 75.349999999999994 114.498 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.19 -19.21 64.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 111.886 0.328 . . . . 75.420000000000002 111.886 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.33 -11.45 12.55 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.841 0.682 . . . . 75.310000000000002 112.841 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 461' ' ' PRO . 22.4 m -59.93 134.71 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 112.672 0.619 . . . . 72.239999999999995 112.672 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.12 74.44 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.348 -0.842 . . . . 74.219999999999999 111.189 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -119.9 165.19 14.95 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-O 121.252 0.549 . . . . 74.120000000000005 109.646 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 92.6 t -84.02 134.96 25.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.767 -1.198 . . . . 74.340000000000003 107.767 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.71 -12.0 8.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 119.863 -0.735 . . . . 75.230000000000004 110.952 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.25 169.96 20.3 Favored Glycine 0 N--CA 1.414 -2.805 0 CA-C-N 115.346 -0.843 . . . . 71.430000000000007 111.263 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -116.62 150.63 37.77 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.136 -1.061 . . . . 75.25 108.136 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.427 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.3 t30 -64.12 -47.4 79.37 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.537 -0.465 . . . . 52.25 109.924 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.427 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 10.4 Cg_exo -76.23 117.29 4.59 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 107.6 -1.731 . . . . 74.400000000000006 107.6 167.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.74 144.18 88.43 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.082 1.855 . . . . 70.420000000000002 113.037 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.41 12.94 3.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.166 0.984 . . . . 71.230000000000004 110.394 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -109.18 1.58 20.4 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.967 -1.015 . . . . 62.299999999999997 108.619 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -125.17 159.39 31.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.174 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.4 m -93.6 115.77 28.26 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.358 -1.292 . . . . 74.25 108.822 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.1 m -116.02 148.54 40.05 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.965 -0.383 . . . . 72.510000000000005 109.965 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.51 152.24 46.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.449 0.3 . . . . 73.420000000000002 111.203 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.1 mm -62.83 -26.21 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 121.315 0.578 . . . . 73.030000000000001 111.961 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 13.0 t -96.28 5.03 51.86 Favored 'General case' 0 C--O 1.241 0.658 0 O-C-N 122.01 -0.431 . . . . 75.340000000000003 110.467 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -74.2 129.73 38.39 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.996 -1.113 . . . . 71.140000000000001 107.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 113.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.765 -0.828 . . . . 73.109999999999999 108.765 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.33 120.02 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.567 -0.742 . . . . 72.329999999999998 109.855 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 66.8 mt -91.54 112.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.895 -1.52 . . . . 64.420000000000002 106.895 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 120.4 53.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 107.937 -1.134 . . . . 75.120000000000005 107.937 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 24.0 mt -105.2 118.82 53.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.088 0.47 . . . . 75.310000000000002 110.111 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.08 134.92 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 115.79 -0.641 . . . . 73.430000000000007 109.339 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.64 106.23 3.09 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.516 -1.034 . . . . 64.540000000000006 110.516 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -122.07 119.11 30.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.925 -0.769 . . . . 72.450000000000003 108.925 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 CA-C-O 118.009 -1.44 . . . . 75.25 109.764 -177.282 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.465 0 N-CA-C 109.345 -1.502 . . . . 73.129999999999995 109.345 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.29 136.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.18 0.991 . . . . 75.530000000000001 111.847 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.5 m -131.85 -173.62 3.19 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 104.154 -2.536 . . . . 62.109999999999999 104.154 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -78.62 62.52 3.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.834 1.197 . . . . 74.239999999999995 109.85 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.58 134.25 38.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.518 -1.674 . . . . 64.439999999999998 108.203 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.2 154.75 37.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 120.985 0.421 . . . . 75.219999999999999 110.875 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.25 139.03 32.15 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.857 -2.275 . . . . 74.230000000000004 104.857 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.2 130.86 32.82 Favored Pre-proline 0 C--N 1.283 -2.325 0 C-N-CA 119.072 -1.051 . . . . 62.420000000000002 109.367 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -41.03 125.65 2.36 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.847 3.031 . . . . 73.349999999999994 112.069 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.86 157.16 38.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.26 -1.336 . . . . 74.409999999999997 109.471 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.82 -0.24 9.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.612 -0.435 . . . . 75.120000000000005 110.973 -173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.4 ptp180 -54.91 131.05 43.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.547 0.689 . . . . 75.420000000000002 112.612 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 101.74 -1.29 52.39 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.359 -0.837 . . . . 65.319999999999993 111.146 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -118.42 -178.06 3.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.502 -0.555 . . . . 73.140000000000001 109.502 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 82.9 p -87.87 171.23 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.619 0.6 . . . . 61.520000000000003 112.619 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 8.7 p -63.89 -39.09 93.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.03 -0.532 . . . . 74.349999999999994 109.989 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.38 87.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.593 -0.73 . . . . 74.420000000000002 110.033 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.83 -44.07 90.83 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 123.209 0.318 . . . . 53.149999999999999 111.533 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.98 -51.18 67.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.866 0.365 . . . . 73.040000000000006 111.099 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 378' ' ' GLN . 1.8 mp -68.32 -46.28 81.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 111.71 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.42 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.622 0.601 . . . . 61.450000000000003 112.622 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.531 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 22.9 m -66.94 -48.29 69.05 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.629 -0.429 . . . . 74.420000000000002 110.44 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.98 -37.47 87.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.091 -0.504 . . . . 73.329999999999998 112.209 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . 0.496 ' NE2' HD12 ' A' ' 384' ' ' ILE . 5.7 tp-100 -59.21 -47.65 84.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.446 -0.946 . . . . 74.409999999999997 108.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.01 -28.13 67.15 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.161 -0.927 . . . . 74.230000000000004 112.486 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.531 ' HD3' ' O ' ' A' ' 376' ' ' THR . 10.6 mpt_? -84.47 -8.81 58.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 111.051 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 88.81 16.78 57.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.212 -0.994 . . . . 73.129999999999995 113.232 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -80.2 156.12 27.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.108 0.48 . . . . 75.519999999999996 110.323 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 31.5 mmmt -90.32 132.9 35.31 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.614 -1.625 . . . . 74.019999999999996 106.614 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.496 HD12 ' NE2' ' A' ' 378' ' ' GLN . 0.2 OUTLIER -129.53 134.73 63.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 121.541 0.686 . . . . 73.400000000000006 112.086 -177.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -112.35 127.9 56.14 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.3 m -117.67 121.16 40.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.328 -0.619 . . . . 73.230000000000004 109.328 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.21 119.25 37.71 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.399 -1.704 . . . . 74.140000000000001 106.399 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -101.54 131.22 47.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.621 -0.881 . . . . 74.230000000000004 108.621 179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.9 122.06 15.11 Favored Pre-proline 0 C--N 1.287 -2.132 0 CA-C-N 116.277 -0.419 . . . . 62.43 111.775 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 425' ' ' GLU . 6.0 Cg_exo -81.41 132.4 7.99 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.959 1.772 . . . . 74.409999999999997 107.78 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 15.1 t70 -159.46 -162.26 1.02 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.548 -1.278 . . . . 64.409999999999997 107.548 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 67.3 m -145.14 1.58 0.97 Allowed 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 119.392 0.996 . . . . 64.109999999999999 112.789 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -131.12 22.12 4.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 122.609 1.195 . . . . 75.430000000000007 108.206 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.468 ' CG1' ' HB3' ' A' ' 391' ' ' ASP . 1.9 pp -88.91 152.47 48.59 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 113.625 -1.625 . . . . 62.109999999999999 112.996 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.51 157.18 53.27 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.791 1.661 . . . . 73.549999999999997 109.236 170.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.11 160.54 41.34 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 122.294 1.996 . . . . 72.340000000000003 111.104 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.425 ' HB2' HG11 ' A' ' 420' ' ' VAL . 3.6 p30 -60.4 -9.69 3.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.517 0.675 . . . . 75.140000000000001 111.943 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -84.53 111.06 19.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.456 -2.424 . . . . 62.310000000000002 104.456 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.18 118.52 4.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 122.07 0.938 . . . . 75.0 112.704 -167.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.3 tp -98.1 -31.1 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 75.540000000000006 109.386 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.98 156.77 27.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 108.894 -1.682 . . . . 70.430000000000007 108.894 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 22.2 p -114.5 -175.72 2.75 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 123.307 0.643 . . . . 74.420000000000002 111.306 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -99.58 137.84 20.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 106.464 -1.68 . . . . 74.209999999999994 106.464 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -42.97 -30.75 1.98 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.418 3.412 . . . . 60.219999999999999 114.64 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -38.3 64.62 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.931 0.492 . . . . 75.010000000000005 111.432 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.99 -27.87 62.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.729 0.776 . . . . 74.5 111.153 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.23 -8.06 49.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 110.665 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.6 m -92.54 156.53 17.07 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.947 -0.761 . . . . 73.340000000000003 108.947 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.1 m -74.15 112.79 10.64 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.606 -1.257 . . . . 74.329999999999998 107.606 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.28 170.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.932 -0.576 . . . . 73.120000000000005 109.749 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -83.96 140.07 32.15 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.404 -1.332 . . . . 61.43 107.404 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.1 2.14 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.135 0.493 . . . . 75.030000000000001 110.184 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.29 21.38 6.61 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.596 -0.812 . . . . 63.25 111.751 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -85.94 -171.33 3.53 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.474 -1.306 . . . . 70.340000000000003 107.474 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.9 pt-20 -107.91 138.87 43.4 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 118.831 0.741 . . . . 72.439999999999998 111.895 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.6 122.68 67.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.743 -1.206 . . . . 65.519999999999996 107.743 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -96.19 119.39 34.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.039 0.923 . . . . 73.530000000000001 110.249 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.72 126.66 68.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.053 -0.976 . . . . 71.420000000000002 109.33 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.7 128.87 44.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.437 -0.949 . . . . 74.209999999999994 108.437 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 78.0 t -121.73 130.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.382 -0.969 . . . . 73.030000000000001 108.382 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 122.91 37.99 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.776 -0.453 . . . . 75.129999999999995 109.776 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.5 t -117.16 105.28 12.08 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.84 0.829 . . . . 73.319999999999993 110.981 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 60.99 178.69 2.39 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.983 -1.008 . . . . 74.239999999999995 115.136 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 10.1 Cg_endo -90.82 131.93 1.58 Allowed 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.038 2.492 . . . . 73.230000000000004 111.757 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.4 tp10 -72.87 151.59 41.89 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.754 -0.462 . . . . 74.120000000000005 109.754 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.5 mt-30 -123.78 150.88 43.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.477 -0.783 . . . . 72.420000000000002 110.359 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -150.33 153.95 36.98 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.403 -1.332 . . . . 74.230000000000004 107.403 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 9.5 pt-20 -82.55 138.88 34.13 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.348 -0.982 . . . . 74.439999999999998 108.348 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 71.4 mt -80.43 124.32 82.37 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.608 -0.886 . . . . 74.439999999999998 108.608 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.86 140.06 59.55 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.069 1.179 . . . . 72.349999999999994 110.697 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.72 82.12 2.76 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 122.232 1.015 . . . . 65.319999999999993 111.94 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.86 1.43 6.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.197 -1.779 . . . . 75.150000000000006 106.197 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.457 ' HA ' ' HB1' ' A' ' 440' ' ' ALA . 5.0 m -67.8 -53.49 26.61 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 113.094 -1.866 . . . . 73.420000000000002 110.301 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 24.5 p -64.73 -19.12 65.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.431 0.9 . . . . 73.319999999999993 113.431 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.95 -38.21 13.01 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.711 1.004 . . . . 64.109999999999999 113.711 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 90.4 m -157.32 135.08 10.75 Favored 'General case' 0 CA--C 1.554 1.11 0 O-C-N 121.911 -0.493 . . . . 72.439999999999998 110.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -65.09 -47.28 77.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.543 0.737 . . . . 75.450000000000003 112.671 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.51 87.47 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.515 0.674 . . . . 74.219999999999999 110.865 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.54 -40.6 95.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.75 -1.114 . . . . 63.32 108.813 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.83 -51.67 68.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.784 -1.098 . . . . 73.120000000000005 111.705 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.72 -38.55 82.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.515 0.931 . . . . 75.430000000000007 113.515 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -66.53 -50.71 62.29 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 119.113 -1.035 . . . . 72.209999999999994 110.144 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.313 85.4 mttt -68.62 -39.73 80.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 115.58 1.696 . . . . 72.230000000000004 115.58 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.64 -43.38 89.65 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.745 -0.382 . . . . 74.510000000000005 111.795 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.1 m -69.24 -38.28 78.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.824 -0.35 . . . . 71.329999999999998 111.853 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.1 71.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.698 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.08 59.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 72.439999999999998 111.034 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . 0.424 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 124.39 -19.98 7.07 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.688 -0.767 . . . . 64.230000000000004 113.442 176.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -78.86 101.26 7.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.364 0.602 . . . . 74.120000000000005 111.0 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -119.99 17.47 9.96 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.013 -0.835 . . . . 73.430000000000007 111.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -107.57 111.16 23.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.791 -1.559 . . . . 74.510000000000005 106.791 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.39 160.25 34.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.145 0.794 . . . . 75.519999999999996 113.145 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 23.6 ttmm -151.91 127.39 10.02 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.715 -1.957 . . . . 73.329999999999998 105.715 170.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.72 134.92 39.38 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 120.67 0.271 . . . . 74.340000000000003 110.304 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.02 156.28 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.717 -0.475 . . . . 65.200000000000003 109.717 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.16 132.35 54.03 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.253 -0.647 . . . . 70.109999999999999 109.253 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.0 t -119.25 137.12 24.93 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.749 -0.834 . . . . 71.230000000000004 108.749 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.4 Cg_exo -61.56 119.78 7.08 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.061 1.841 . . . . 75.510000000000005 109.102 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.8 m -138.74 -178.46 5.32 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.066 -0.716 . . . . 71.150000000000006 109.066 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.8 m -58.95 131.44 86.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.361 -0.977 . . . . 75.150000000000006 108.361 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.9 -34.1 35.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.832 3.021 . . . . 73.310000000000002 114.538 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.71 -14.71 61.19 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 122.687 0.395 . . . . 72.319999999999993 112.006 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.39 7.58 45.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.769 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -59.49 125.93 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.781 0.8 . . . . 70.420000000000002 111.645 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.65 -5.01 79.86 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.882 -0.599 . . . . 70.409999999999997 112.427 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -102.77 145.59 29.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.093 -1.077 . . . . 74.340000000000003 108.093 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 433' ' ' SER . 54.4 t -83.89 129.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.721 -0.474 . . . . 75.010000000000005 109.721 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.94 -19.68 5.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.582 -0.447 . . . . 74.299999999999997 111.449 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.6 174.23 41.16 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.634 -0.986 . . . . 62.539999999999999 110.634 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -130.93 155.07 47.39 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.696 -0.853 . . . . 72.140000000000001 108.696 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -61.2 -53.43 63.22 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 120.795 -0.362 . . . . 65.040000000000006 110.854 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.1 Cg_exo -82.6 119.34 2.97 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 107.38 -1.815 . . . . 74.530000000000001 107.38 168.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.94 147.77 94.22 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.532 2.154 . . . . 72.519999999999996 113.848 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.65 2.92 20.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.473 -0.785 . . . . 74.329999999999998 112.524 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.7 -3.09 17.02 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.813 -0.554 . . . . 74.209999999999994 109.614 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -108.46 151.73 25.66 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.191 0.996 . . . . 73.310000000000002 112.201 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.431 HG22 ' HB3' ' A' ' 426' ' ' GLN . 26.6 m -84.24 114.01 21.52 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.625 -1.625 . . . . 71.129999999999995 108.668 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.2 m -120.42 150.13 41.28 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.506 0.722 . . . . 74.329999999999998 109.424 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.07 147.22 45.2 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.4 -0.592 . . . . 73.099999999999994 109.4 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.424 HG21 ' O ' ' A' ' 448' ' ' GLY . 1.9 mp -66.27 -11.68 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 122.246 1.022 . . . . 71.430000000000007 110.317 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 6.4 t -98.45 -0.66 43.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.279 -0.873 . . . . 73.150000000000006 109.379 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -78.61 142.19 37.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.63 -0.507 . . . . 72.140000000000001 109.63 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.05 113.52 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.263 -1.014 . . . . 73.040000000000006 108.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.0 t -87.81 118.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 108.606 -0.887 . . . . 72.510000000000005 108.606 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.4 mt -92.7 112.54 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 106.791 -1.559 . . . . 73.140000000000001 106.791 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.61 107.62 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 107.374 -1.343 . . . . 74.430000000000007 107.374 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.4 113.99 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 115.11 -0.95 . . . . 73.420000000000002 110.123 -174.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.32 138.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 114.959 -1.018 . . . . 65.120000000000005 108.335 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.09 130.64 11.06 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 110.254 -1.139 . . . . 71.340000000000003 110.254 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 26.6 m -140.78 120.07 13.0 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.293 -0.632 . . . . 74.430000000000007 109.293 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 107.807 -2.117 . . . . 72.219999999999999 107.807 178.68 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.28 0 N-CA-C 110.221 -1.151 . . . . 63.109999999999999 110.221 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.58 144.5 29.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 112.842 0.682 . . . . 74.219999999999999 112.842 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.3 m -132.04 143.23 49.9 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.605 -1.628 . . . . 73.230000000000004 106.605 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -77.52 86.03 3.87 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 122.038 0.923 . . . . 74.140000000000001 111.408 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -106.22 140.22 39.51 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.515 -1.661 . . . . 73.519999999999996 106.515 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.64 159.73 37.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 120.794 0.33 . . . . 74.329999999999998 111.132 -174.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -94.88 137.35 34.07 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.053 -1.091 . . . . 72.540000000000006 108.053 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.35 141.3 22.82 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.277 -0.638 . . . . 74.409999999999997 109.277 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.59 123.83 4.96 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 123.456 2.771 . . . . 73.140000000000001 113.699 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.526 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 21.5 t70 -74.59 134.84 42.08 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.218 -1.355 . . . . 70.510000000000005 108.838 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 35.0 m -91.41 29.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.732 1.012 . . . . 74.140000000000001 113.732 -169.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.526 ' NH1' ' HB3' ' A' ' 364' ' ' ASP . 35.2 ptt-85 -65.73 127.05 30.38 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.916 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.58 57.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.276 -0.964 . . . . 70.519999999999996 114.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 2.0 pt20 -120.97 169.66 10.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 117.491 0.646 . . . . 75.299999999999997 110.724 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 98.8 p -80.46 173.96 12.08 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.713 -0.395 . . . . 54.439999999999998 111.475 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.4 p -63.0 -33.87 76.35 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.275 -0.42 . . . . 61.030000000000001 110.617 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.547 -0.297 . . . . 54.119999999999997 110.505 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -62.03 -41.65 98.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.382 -0.372 . . . . 64.329999999999998 110.832 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.417 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -58.62 -51.54 69.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 71.109999999999999 110.602 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.43 -42.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 110.898 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.05 -46.06 92.22 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 112.036 0.384 . . . . 74.420000000000002 112.036 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.7 m -61.92 -47.92 82.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.297 . . . . 74.420000000000002 110.916 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.3 mm? -65.42 -38.38 89.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.379 -0.373 . . . . 73.030000000000001 111.66 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.88 -48.49 81.56 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.57 0.748 . . . . 73.209999999999994 109.442 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.43 -25.31 63.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 74.530000000000001 111.203 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -78.53 -15.29 58.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.97 -0.752 . . . . 75.409999999999997 108.97 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.17 56.88 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.357 -0.925 . . . . 73.319999999999993 111.829 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 22.6 m-85 -89.7 160.66 16.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.979 0.419 . . . . 75.239999999999995 110.613 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 53.8 mtmt -105.02 132.76 50.85 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.678 -1.23 . . . . 73.140000000000001 107.678 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 141.33 43.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.328 0.585 . . . . 72.150000000000006 112.373 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -118.49 136.64 53.7 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.046 -1.464 . . . . 74.109999999999999 107.046 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 m -99.64 125.33 45.46 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.752 -0.833 . . . . 71.310000000000002 108.752 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.82 120.33 41.61 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.584 -1.265 . . . . 73.319999999999993 107.584 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.13 121.88 31.89 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.288 -0.414 . . . . 65.439999999999998 109.911 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -123.77 125.23 25.98 Favored Pre-proline 0 C--N 1.312 -1.028 0 C-N-CA 119.564 -0.854 . . . . 73.430000000000007 110.208 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -89.11 147.11 5.46 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.735 2.29 . . . . 73.510000000000005 111.306 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.4 t70 177.13 -168.37 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.233 -1.766 . . . . 63.25 106.233 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 50.2 m -143.25 -1.29 1.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.585 0.63 . . . . 74.040000000000006 111.429 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.0 m -82.93 -10.65 58.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.099 -1.445 . . . . 74.340000000000003 107.099 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 421' ' ' SER . 11.2 pt -104.74 151.61 39.35 Favored Pre-proline 0 N--CA 1.427 -1.624 0 CA-C-N 114.042 -1.435 . . . . 73.030000000000001 109.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -86.25 -176.51 2.12 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.708 2.272 . . . . 72.25 111.521 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.65 163.32 3.95 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.515 2.81 . . . . 74.340000000000003 112.737 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.415 ' HB2' ' CG2' ' A' ' 420' ' ' VAL . 4.4 p-10 -55.87 -7.93 0.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.374 1.47 . . . . 70.400000000000006 114.33 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -63.51 115.4 4.63 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.087 -1.819 . . . . 74.430000000000007 106.087 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 21.3 t -64.88 118.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.778 0.799 . . . . 61.420000000000002 110.499 -172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.69 -29.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.041 -0.981 . . . . 74.439999999999998 109.91 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -171.57 160.58 32.6 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.43 -1.068 . . . . 51.310000000000002 110.43 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 -174.54 2.48 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.695 -1.224 . . . . 74.209999999999994 107.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.36 144.3 27.85 Favored Pre-proline 0 C--N 1.279 -2.474 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.98 -29.05 1.41 Allowed 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 124.676 3.584 . . . . 61.509999999999998 114.413 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.09 68.58 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.543 0.337 . . . . 63.039999999999999 111.162 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.66 58.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 65.109999999999999 110.96 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.29 0.14 53.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.472 0.654 . . . . 75.140000000000001 110.943 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.1 m -92.79 157.3 16.49 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.66 -1.608 . . . . 61.329999999999998 106.66 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.26 112.39 10.37 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.054 -1.091 . . . . 72.099999999999994 108.054 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.51 169.4 18.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.202 -0.908 . . . . 71.530000000000001 109.334 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 18.0 m -74.33 133.79 42.54 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.661 -0.496 . . . . 75.120000000000005 109.661 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.69 134.89 54.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.309 -0.405 . . . . 71.030000000000001 110.405 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 89.29 24.22 32.11 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.879 -0.677 . . . . 63.43 112.499 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.56 179.76 4.74 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.867 -0.79 . . . . 65.25 108.867 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.4 mt-10 -94.21 123.7 37.77 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 111.996 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.07 126.27 74.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.643 -1.244 . . . . 74.200000000000003 107.643 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -90.49 118.77 30.22 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.477 -0.934 . . . . 71.239999999999995 108.477 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.53 113.18 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.189 -1.041 . . . . 75.010000000000005 108.189 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -88.51 129.85 35.36 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.49 -0.929 . . . . 74.349999999999994 108.49 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 397' ' ' ASP . 12.4 p -123.5 146.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.163 -1.051 . . . . 74.420000000000002 108.163 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.408 ' HB3' HD11 ' A' ' 394' ' ' ILE . 3.5 p -84.59 119.71 25.52 Favored 'General case' 0 N--CA 1.411 -2.418 0 C-N-CA 119.372 -0.931 . . . . 71.099999999999994 108.79 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.8 m -121.8 106.69 11.52 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.968 -0.56 . . . . 71.209999999999994 110.916 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 84.99 129.35 2.01 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.649 -0.786 . . . . 64.329999999999998 114.183 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 52.3 Cg_endo -76.37 133.04 14.18 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 121.735 1.623 . . . . 63.340000000000003 109.536 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.31 137.15 46.47 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.475 0.655 . . . . 62.210000000000001 112.35 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 38.4 mt-30 -120.37 140.85 50.7 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.872 -1.058 . . . . 75.230000000000004 108.48 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.41 145.41 51.2 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.59 -1.263 . . . . 72.430000000000007 107.59 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 14.8 pt-20 -83.7 138.99 33.04 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.905 -0.718 . . . . 73.5 109.082 177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 80.8 mt -80.3 124.29 82.62 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.017 -1.105 . . . . 64.019999999999996 108.017 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.89 141.94 41.8 Favored 'Trans proline' 0 C--O 1.252 1.193 0 C-N-CA 122.164 1.909 . . . . 62.439999999999998 112.677 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -78.22 77.08 4.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.217 1.008 . . . . 73.420000000000002 109.414 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.25 -7.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.131 -1.395 . . . . 73.409999999999997 110.281 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 3.3 p -68.94 -31.93 71.16 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.854 -0.612 . . . . 73.120000000000005 111.116 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -62.26 -24.59 67.35 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 125.285 1.434 . . . . 74.400000000000006 113.18 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.64 -47.75 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 75.129999999999995 112.037 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.0 t -177.21 153.04 0.92 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.827 -0.805 . . . . 74.230000000000004 108.827 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -58.37 -38.66 77.73 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.823 0.849 . . . . 72.310000000000002 111.276 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.46 -47.99 78.02 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.554 0.534 . . . . 73.230000000000004 111.115 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 34.6 mm-40 -70.33 -38.31 74.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 111.178 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.27 -46.35 88.76 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.613 0.571 . . . . 65.230000000000004 110.763 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.46 -47.6 80.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.633 -0.427 . . . . 74.150000000000006 110.699 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 31.9 mmmt -63.46 -47.1 83.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.163 0.431 . . . . 74.200000000000003 112.163 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.9 mmtt -63.6 -45.51 90.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 72.129999999999995 110.578 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.14 -32.48 72.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.61 0.596 . . . . 74.140000000000001 112.61 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.7 m -66.25 -38.74 88.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.558 -0.534 . . . . 75.0 109.558 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.64 67.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.953 -0.567 . . . . 74.109999999999999 110.628 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.29 -13.55 59.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 71.230000000000004 110.63 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.62 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 120.227 -0.987 . . . . 53.109999999999999 113.743 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.44 132.97 47.18 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 117.705 0.753 . . . . 63.350000000000001 110.917 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.98 16.04 4.76 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.592 -0.813 . . . . 71.430000000000007 112.395 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 32.3 mmt180 -125.43 111.96 15.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.513 -1.292 . . . . 72.420000000000002 107.513 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.91 152.21 49.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.085 0.469 . . . . 75.140000000000001 111.118 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -146.05 123.26 11.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.989 -1.486 . . . . 73.319999999999993 106.989 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -91.27 134.81 34.27 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.241 -0.584 . . . . 72.299999999999997 110.31 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -129.78 145.67 51.55 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.217 -1.031 . . . . 73.219999999999999 108.217 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -118.7 139.08 52.11 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.088 -0.708 . . . . 71.319999999999993 109.088 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.7 m -132.39 136.21 27.62 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.717 -0.475 . . . . 72.120000000000005 109.717 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.61 120.99 8.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.875 2.383 . . . . 72.439999999999998 112.184 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 43.9 m -124.85 172.51 9.29 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.71 -0.677 . . . . 74.329999999999998 110.098 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.8 p -67.29 151.09 97.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 O-C-N 123.794 0.684 . . . . 53.439999999999998 109.972 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.538 ' O ' HG12 ' A' ' 464' ' ' VAL . 71.8 Cg_exo -53.51 -27.18 39.53 Favored 'Trans proline' 0 CA--C 1.55 1.281 0 C-N-CA 122.839 2.36 . . . . 74.230000000000004 113.422 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.18 -23.89 54.73 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.73 -0.606 . . . . 74.530000000000001 112.226 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 37.4 tp -107.41 -9.39 16.01 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.069 0.461 . . . . 72.439999999999998 110.505 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.3 p -59.44 133.57 24.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.793 -0.639 . . . . 73.140000000000001 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.52 -14.09 59.41 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.613 -0.803 . . . . 64.030000000000001 112.168 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.75 158.04 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.382 0.61 . . . . 73.219999999999999 110.563 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 87.7 t -84.28 137.5 20.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.71 -1.589 . . . . 73.040000000000006 106.71 173.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.74 -13.79 8.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.342 -0.943 . . . . 74.319999999999993 110.563 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.88 -173.6 29.57 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 109.952 -1.259 . . . . 64.25 109.952 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.2 p -116.3 151.37 35.99 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.39 -1.337 . . . . 74.150000000000006 107.39 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -59.37 -51.46 81.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.732 -0.47 . . . . 75.310000000000002 109.732 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.01 133.94 22.47 Favored 'Trans proline' 0 C--N 1.378 2.086 0 N-CA-C 108.59 -1.35 . . . . 74.230000000000004 108.59 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.48 150.54 86.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.752 2.301 . . . . 75.150000000000006 114.534 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.31 8.49 38.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.311 1.053 . . . . 61.109999999999999 110.948 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -109.04 3.4 22.04 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.307 -0.871 . . . . 53.549999999999997 109.975 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -141.77 159.54 42.01 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-O 121.807 0.813 . . . . 73.099999999999994 111.591 -172.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -76.68 133.97 39.38 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.608 -1.633 . . . . 65.239999999999995 111.411 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 38.4 m -131.52 149.31 52.57 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.653 -1.24 . . . . 72.25 107.653 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -78.61 153.33 31.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.927 0.785 . . . . 73.140000000000001 111.683 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 47.4 mm -69.28 -8.23 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 122.163 0.982 . . . . 71.340000000000003 110.624 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.9 t -105.44 1.25 27.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.712 -0.676 . . . . 71.010000000000005 109.692 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 9.1 m120 -87.05 147.49 25.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.816 -0.809 . . . . 74.230000000000004 108.816 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.54 121.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.244 -1.021 . . . . 72.129999999999995 108.244 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.4 t -91.89 118.97 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.903 -0.777 . . . . 73.109999999999999 108.903 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.99 113.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.183 -1.414 . . . . 70.109999999999999 107.183 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.52 119.92 48.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.949 -1.13 . . . . 73.319999999999993 107.949 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 48.2 mt -103.23 114.96 44.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.434 0.635 . . . . 74.040000000000006 110.86 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.32 131.23 45.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.909 -0.775 . . . . 74.510000000000005 108.909 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.0 100.4 1.87 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.279 -1.129 . . . . 74.400000000000006 110.279 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.406 ' HA ' HG23 ' A' ' 464' ' ' VAL . 30.7 t -136.71 103.98 5.38 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.765 -0.828 . . . . 74.310000000000002 108.765 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.533 0 N-CA-C 108.471 -1.851 . . . . 72.040000000000006 108.471 176.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.301 0 N-CA-C 110.412 -1.075 . . . . 43.049999999999997 110.412 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.31 152.87 37.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.981 0.39 . . . . 72.420000000000002 111.214 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 22.8 m -92.1 147.13 23.18 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.554 -1.276 . . . . 72.430000000000007 107.554 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.11 74.52 4.69 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 108.475 -0.935 . . . . 74.420000000000002 108.475 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.74 137.86 32.09 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-N 113.914 -1.493 . . . . 71.420000000000002 110.637 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.07 139.91 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.17 -0.923 . . . . 75.150000000000006 108.955 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.56 137.16 36.91 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.468 -1.679 . . . . 73.430000000000007 106.468 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -96.99 124.26 50.42 Favored Pre-proline 0 C--N 1.294 -1.838 0 C-N-CA 119.757 -0.777 . . . . 71.010000000000005 111.446 -170.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.87 146.31 2.46 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.814 3.676 . . . . 74.299999999999997 115.681 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -71.16 144.96 50.02 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.929 -1.032 . . . . 62.130000000000003 110.138 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -108.08 29.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.218 -1.401 . . . . 63.340000000000003 107.218 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -58.85 135.41 57.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.176 -1.375 . . . . 73.219999999999999 111.398 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 94.84 -15.35 63.57 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.97 -0.559 . . . . 65.230000000000004 112.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -107.19 175.26 5.56 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.588 -0.36 . . . . 73.319999999999993 110.724 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.6 p -75.57 158.12 32.93 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.825 0.345 . . . . 73.409999999999997 111.771 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.415 ' O ' HG13 ' A' ' 374' ' ' ILE . 44.6 t -63.25 -36.12 82.59 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.812 -0.81 . . . . 63.32 108.812 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.66 94.01 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 115.638 -0.71 . . . . 70.209999999999994 111.209 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.35 -41.38 98.55 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.127 -0.488 . . . . 73.510000000000005 109.89 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.43 83.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.461 -0.791 . . . . 63.399999999999999 110.934 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.36 -47.02 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.375 . . . . 71.299999999999997 110.301 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.95 79.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.969 -0.56 . . . . 43.229999999999997 111.855 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.7 m -62.72 -46.33 88.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.427 -0.352 . . . . 74.530000000000001 111.912 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -38.43 91.0 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.173 -0.211 . . . . 73.120000000000005 111.184 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.43 -47.2 86.38 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.922 0.889 . . . . 71.510000000000005 109.138 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.41 -20.16 62.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.129 -0.941 . . . . 73.310000000000002 111.706 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -86.79 -15.44 39.28 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.268 -0.641 . . . . 75.219999999999999 109.268 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.49 5.0 57.06 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.487 -0.863 . . . . 74.239999999999995 111.446 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -90.47 158.59 16.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.158 0.504 . . . . 74.319999999999993 110.479 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 22.6 mmtp -106.05 138.55 42.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.757 -1.571 . . . . 75.400000000000006 106.757 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.87 147.45 21.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 119.676 -0.81 . . . . 73.430000000000007 112.964 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.442 ' HB3' HG22 ' A' ' 417' ' ' THR . 21.6 ttt180 -116.95 130.09 56.47 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.842 -1.54 . . . . 75.400000000000006 106.842 174.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.7 p -98.6 117.73 33.7 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 119.978 -0.689 . . . . 75.230000000000004 109.415 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -114.74 119.78 37.84 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.341 -1.355 . . . . 75.239999999999995 107.341 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.81 126.14 55.11 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.722 -0.844 . . . . 75.209999999999994 108.722 176.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -122.42 133.65 24.5 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 120.257 -0.577 . . . . 75.340000000000003 111.033 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.19 140.32 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.091 2.527 . . . . 71.439999999999998 110.708 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.4 t70 179.75 -166.48 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.575 -1.269 . . . . 73.299999999999997 107.575 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.452 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 70.9 m -119.66 -11.15 9.46 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.422 0.63 . . . . 71.519999999999996 109.592 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -95.25 27.03 3.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.425 1.107 . . . . 73.450000000000003 108.234 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.4 pp -97.4 141.03 22.4 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 115.254 -0.884 . . . . 62.409999999999997 113.375 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.91 -179.99 4.4 Favored 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 123.239 2.626 . . . . 74.340000000000003 110.794 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 398' ' ' HIS . 77.7 Cg_exo -57.65 163.08 9.44 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.522 2.815 . . . . 72.019999999999996 112.563 173.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.14 -8.79 0.75 Allowed 'General case' 0 N--CA 1.522 3.149 0 C-N-CA 124.441 1.096 . . . . 71.530000000000001 112.25 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 396' ' ' PRO . 32.3 m170 -83.75 157.12 22.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.657 -0.868 . . . . 74.150000000000006 108.657 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.26 116.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 N-CA-C 105.414 -2.069 . . . . 72.430000000000007 105.414 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.8 tt -89.99 -29.22 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 122.342 1.068 . . . . 74.310000000000002 109.036 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.57 170.59 38.18 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 104.623 -3.391 . . . . 54.210000000000001 104.623 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -176.26 2.87 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 107.249 -1.389 . . . . 74.519999999999996 107.249 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.78 145.7 30.59 Favored Pre-proline 0 C--N 1.253 -3.623 0 N-CA-C 107.93 -1.137 . . . . 74.420000000000002 107.93 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.04 -36.03 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.879 3.719 . . . . 63.229999999999997 114.047 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.63 -37.07 65.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.127 0.571 . . . . 74.209999999999994 111.701 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.64 -28.98 30.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 110.496 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -83.73 -8.02 59.35 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.203 -0.908 . . . . 73.430000000000007 110.754 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 59.1 m -91.58 140.59 29.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.571 -1.27 . . . . 73.349999999999994 107.571 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 36.4 m -76.73 112.49 13.36 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.359 -0.978 . . . . 74.519999999999996 108.359 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.25 169.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.138 -0.937 . . . . 75.540000000000006 109.828 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 m -65.65 152.96 42.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.458 -0.942 . . . . 73.109999999999999 108.458 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.02 109.16 0.89 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.141 0.496 . . . . 75.129999999999995 111.293 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.16 1.27 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 115.596 -0.729 . . . . 74.519999999999996 111.78 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -134.96 -169.53 2.38 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.352 -1.721 . . . . 73.430000000000007 106.352 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 12.4 pt-20 -95.04 132.9 39.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.989 0.813 . . . . 74.329999999999998 111.617 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.97 119.4 61.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.576 -1.268 . . . . 73.530000000000001 107.576 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 385' ' ' ARG . 40.2 p -87.31 119.19 27.31 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.333 0.587 . . . . 73.230000000000004 109.849 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.99 121.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.161 -1.422 . . . . 75.340000000000003 107.161 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 7.9 p30 -107.95 125.78 51.91 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.446 0.641 . . . . 62.43 111.891 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 11.3 p -120.28 151.47 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.908 -1.042 . . . . 64.409999999999997 108.41 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.2 p -91.55 123.49 35.0 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 111.862 0.319 . . . . 74.030000000000001 111.862 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.9 t -119.04 106.13 12.11 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.806 -0.758 . . . . 75.530000000000001 111.667 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 66.29 161.23 0.98 Allowed Glycine 0 CA--C 1.552 2.401 0 N-CA-C 115.912 1.125 . . . . 71.420000000000002 115.912 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.2 Cg_endo -94.36 139.71 1.24 Allowed 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 122.708 2.272 . . . . 73.549999999999997 112.311 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.61 142.26 37.4 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.094 0.473 . . . . 73.129999999999995 111.735 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.6 mt-30 -122.54 147.14 46.73 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.243 -0.89 . . . . 73.230000000000004 108.636 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -135.44 163.73 29.39 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.523 -0.917 . . . . 73.439999999999998 108.523 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.63 135.7 33.86 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.856 -0.338 . . . . 74.230000000000004 110.592 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.496 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -80.83 119.29 75.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.068 -0.716 . . . . 73.420000000000002 109.068 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 444' ' ' LEU . 70.6 Cg_exo -56.05 141.17 87.12 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.94 2.427 . . . . 72.049999999999997 112.16 176.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -88.01 10.77 17.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 62.130000000000003 111.526 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.21 -5.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.275 0.559 . . . . 74.349999999999994 110.279 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -58.86 -40.71 85.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.01 -0.996 . . . . 75.409999999999997 110.932 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 0.6 OUTLIER -68.58 -16.95 64.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.812 0.845 . . . . 73.120000000000005 112.381 -179.003 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.26 -34.91 14.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.801 -0.636 . . . . 73.340000000000003 111.75 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 83.9 m -153.85 133.2 12.73 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.953 -0.467 . . . . 70.549999999999997 110.645 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.99 -41.63 97.44 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.074 0.55 . . . . 64.200000000000003 110.365 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 65.129999999999995 110.626 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 443' ' ' LYS . 21.2 mm-40 -63.66 -40.83 97.82 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.948 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.448 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -60.67 -51.15 70.61 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 123.56 0.538 . . . . 73.420000000000002 110.217 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.33 -50.36 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.481 -0.488 . . . . 55.32 112.033 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.94 -47.97 67.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.625 0.602 . . . . 73.140000000000001 112.625 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 439' ' ' GLU . 47.5 mmtm -67.14 -38.49 85.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.011 0.374 . . . . 74.510000000000005 112.011 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 440' ' ' ALA . 11.2 mp -67.89 -36.15 79.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.599 -0.44 . . . . 74.409999999999997 111.271 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.0 m -64.91 -39.2 93.16 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.309 -0.626 . . . . 73.540000000000006 109.309 176.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.57 71.07 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.97 -0.559 . . . . 72.299999999999997 110.788 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.47 -13.18 59.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 74.010000000000005 110.666 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.48 -20.63 8.29 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.425 -0.893 . . . . 55.350000000000001 113.561 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 445' ' ' THR . 98.1 m-85 -66.86 135.32 53.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 117.485 0.642 . . . . 73.010000000000005 111.369 -175.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.55 12.22 4.59 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 110.926 -0.87 . . . . 64.120000000000005 110.926 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -114.48 111.45 21.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.453 -1.314 . . . . 74.430000000000007 107.453 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.7 152.12 50.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.659 0.266 . . . . 74.209999999999994 110.72 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.45 124.22 14.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.151 -1.055 . . . . 70.209999999999994 108.151 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.93 127.11 33.63 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 110.188 -0.301 . . . . 72.129999999999995 110.188 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.61 158.12 44.02 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.612 -0.884 . . . . 70.010000000000005 108.612 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -125.14 150.31 47.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.794 0.331 . . . . 74.310000000000002 110.593 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 30.6 t -137.48 133.19 17.97 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 107.88 -1.156 . . . . 72.319999999999993 107.88 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.04 127.6 21.75 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.514 2.143 . . . . 71.120000000000005 109.599 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.6 m -148.26 174.74 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 122.118 -0.364 . . . . 71.129999999999995 111.277 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 3.3 m -56.31 132.36 75.89 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.703 0.801 . . . . 62.210000000000001 110.102 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -48.79 -31.73 20.33 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.056 3.171 . . . . 73.120000000000005 114.861 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -18.55 65.41 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.24 0.543 . . . . 74.400000000000006 111.264 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.463 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 6.6 mp -106.93 6.04 28.85 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.074 -0.512 . . . . 75.319999999999993 111.508 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.6 p -60.41 126.98 19.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.258 0.552 . . . . 74.239999999999995 110.989 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.81 0.36 83.79 Favored Glycine 0 C--N 1.309 -0.94 0 CA-C-N 115.83 -0.623 . . . . 73.540000000000006 111.934 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 89.0 mttt -112.52 159.14 19.1 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.921 -1.14 . . . . 73.409999999999997 107.921 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 57.3 t -83.99 132.71 30.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.564 -0.532 . . . . 74.329999999999998 109.564 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -98.59 -16.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.222 -0.591 . . . . 70.319999999999993 111.402 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.81 174.08 37.79 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.653 -0.703 . . . . 60.299999999999997 111.704 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.7 p -124.06 149.69 45.83 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.444 -0.947 . . . . 54.119999999999997 108.444 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.438 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.6 t-20 -62.48 -51.96 69.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 120.561 -0.456 . . . . 74.019999999999996 110.921 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 11.2 Cg_exo -73.62 133.84 19.42 Favored 'Trans proline' 0 C--N 1.377 2.059 0 N-CA-C 108.304 -1.46 . . . . 73.319999999999993 108.304 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 475' ' ' ASN . 40.4 Cg_endo -65.35 130.73 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.377 2.052 . . . . 75.329999999999998 113.216 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.58 17.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.531 1.157 . . . . 44.310000000000002 109.714 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 473' ' ' PRO . 11.4 m120 -108.6 -10.11 15.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.383 -1.281 . . . . 73.439999999999998 108.462 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -140.82 164.83 29.18 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-O 121.734 0.778 . . . . 65.519999999999996 111.368 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.7 m -84.45 124.89 31.84 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.182 -1.372 . . . . 72.519999999999996 109.431 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.2 m -125.62 149.46 48.38 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.373 -0.603 . . . . 75.310000000000002 109.373 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.66 146.74 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.537 0.208 . . . . 71.329999999999998 111.156 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.58 -22.09 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 121.755 0.788 . . . . 74.409999999999997 110.9 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 11.1 t -87.71 0.89 55.1 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.509 -0.768 . . . . 74.409999999999997 110.294 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.01 131.11 34.51 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.389 -0.967 . . . . 64.540000000000006 108.389 177.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.46 119.06 28.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.66 -0.867 . . . . 75.209999999999994 108.66 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.15 118.22 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.49 0 N-CA-C 108.115 -1.069 . . . . 73.340000000000003 108.115 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.83 112.75 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 106.341 -1.725 . . . . 75.420000000000002 106.341 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.89 119.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 108.54 -0.911 . . . . 74.25 108.54 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 23.2 mt -101.18 109.3 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 108.94 -0.763 . . . . 73.439999999999998 108.94 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 36.3 t -97.92 137.77 24.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.462 -0.79 . . . . 73.450000000000003 109.958 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -74.84 95.76 0.92 Allowed Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.488 -0.778 . . . . 75.319999999999993 111.212 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 38.1 m -142.88 112.84 7.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.775 -0.824 . . . . 75.439999999999998 108.775 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.012 0 N-CA-C 110.75 -0.94 . . . . 64.329999999999998 110.75 179.254 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.529 0 N-CA-C 110.138 -1.185 . . . . 43.049999999999997 110.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.13 141.63 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.371 -0.974 . . . . 75.530000000000001 108.371 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 12.4 m -101.56 138.94 37.9 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 120.983 0.42 . . . . 75.530000000000001 110.095 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -98.8 81.78 2.7 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.794 -1.558 . . . . 75.109999999999999 106.794 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.95 134.12 35.08 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 113.221 -1.809 . . . . 75.530000000000001 111.963 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.02 144.01 35.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.844 -1.071 . . . . 73.430000000000007 108.9 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.42 137.43 35.5 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.402 -1.703 . . . . 65.219999999999999 106.402 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.7 p -98.14 127.31 37.09 Favored Pre-proline 0 C--N 1.29 -1.989 0 C-N-CA 119.097 -1.041 . . . . 74.319999999999993 110.004 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.68 143.53 79.36 Favored 'Trans proline' 0 C--O 1.244 0.789 0 C-N-CA 123.031 2.487 . . . . 73.0 112.7 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -68.95 127.01 31.62 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.599 -0.728 . . . . 73.400000000000006 110.0 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 26.7 m -81.83 5.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.911 -0.586 . . . . 70.040000000000006 112.11 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -61.1 142.97 56.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.912 -0.585 . . . . 75.340000000000003 111.761 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.31 -9.78 53.92 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.884 -0.598 . . . . 63.119999999999997 111.868 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -119.38 -173.69 2.57 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.354 -0.61 . . . . 75.439999999999998 109.354 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 94.7 p -86.98 162.16 17.81 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 119.637 -0.825 . . . . 73.230000000000004 109.317 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 374' ' ' ILE . 74.1 p -61.93 -33.23 73.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.986 0.422 . . . . 72.420000000000002 110.065 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.67 97.45 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.878 -0.601 . . . . 73.310000000000002 110.862 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -62.31 -42.7 99.58 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 109.817 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.42 77.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.89 -1.05 . . . . 73.400000000000006 110.734 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.6 -47.26 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 75.329999999999998 110.477 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.44 78.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.271 -0.422 . . . . 73.319999999999993 111.937 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.7 m -61.55 -48.59 80.31 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.137 0.494 . . . . 72.209999999999994 110.635 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 74.6 mt -65.74 -38.19 88.46 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 75.230000000000004 111.739 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -61.05 -43.53 98.74 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.565 -0.531 . . . . 75.219999999999999 109.565 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.67 77.75 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.031 0.443 . . . . 62.310000000000002 111.017 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -78.27 -15.12 59.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.126 -0.488 . . . . 75.239999999999995 111.233 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.99 16.47 41.27 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.595 -1.288 . . . . 62.409999999999997 112.269 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.12 152.2 18.93 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.237 -0.653 . . . . 74.310000000000002 109.237 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 35.0 mmtp -94.31 141.2 28.84 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.529 -0.915 . . . . 73.120000000000005 108.529 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 133.96 67.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.331 0.586 . . . . 63.149999999999999 111.607 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -110.51 130.85 55.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.79 -1.189 . . . . 75.25 107.79 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 p -98.9 119.29 37.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 120.429 -0.509 . . . . 73.239999999999995 109.884 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.6 tt -111.43 119.13 37.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.459 -1.682 . . . . 74.140000000000001 106.459 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.536 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -106.36 122.57 46.52 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.325 0.583 . . . . 75.519999999999996 110.324 -177.389 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.03 131.31 24.44 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.326 -0.852 . . . . 65.109999999999999 111.119 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -91.12 130.73 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.916 2.411 . . . . 73.150000000000006 111.34 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 174.95 -170.36 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.733 -1.58 . . . . 74.310000000000002 106.733 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.1 m -113.36 -27.94 7.76 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.439 -1.319 . . . . 75.530000000000001 107.439 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 m -91.72 58.82 3.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.982 -1.488 . . . . 74.549999999999997 106.982 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.471 HG23 ' HB3' ' A' ' 391' ' ' ASP . 1.5 pp -115.9 151.58 46.58 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 114.009 -1.45 . . . . 64.219999999999999 113.005 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.9 119.53 5.71 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.217 1.945 . . . . 71.409999999999997 108.267 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.55 161.88 16.49 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 C-N-CA 123.386 2.724 . . . . 75.25 113.165 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.64 -8.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.947 0.899 . . . . 74.530000000000001 112.119 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 45.1 m170 -106.18 109.49 21.44 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 104.202 -2.518 . . . . 73.430000000000007 104.202 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.76 118.0 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 122.045 0.926 . . . . 61.399999999999999 111.986 -170.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -96.29 -27.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.776 -1.102 . . . . 74.450000000000003 112.105 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.437 ' N ' HD11 ' A' ' 400' ' ' ILE . . . -146.65 156.96 27.24 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 110.257 -1.137 . . . . 75.420000000000002 110.257 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.4 p -125.37 -178.58 4.27 Favored 'General case' 0 C--N 1.275 -2.645 0 C-N-CA 122.989 0.516 . . . . 73.109999999999999 109.799 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.95 133.57 20.96 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.509 -1.293 . . . . 63.229999999999997 107.509 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.15 -17.94 9.19 Favored 'Trans proline' 0 C--O 1.26 1.585 0 C-N-CA 123.875 3.05 . . . . 72.129999999999995 115.194 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.84 64.27 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 122.115 -0.365 . . . . 71.420000000000002 110.744 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.71 65.36 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 121.038 0.447 . . . . 53.399999999999999 110.836 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -13.39 60.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.082 0.468 . . . . 75.239999999999995 110.957 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 61.2 m -73.33 138.06 45.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.94 113.3 12.09 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.417 0.627 . . . . 65.019999999999996 110.066 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.36 170.08 8.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.169 -0.923 . . . . 74.540000000000006 109.56 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 27.6 m -70.12 132.35 45.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.021 -0.733 . . . . 61.539999999999999 109.021 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -51.91 113.99 1.17 Allowed 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.862 0.726 . . . . 63.43 112.301 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.04 57.87 1.28 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.816 -0.629 . . . . 63.329999999999998 112.675 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -114.31 -166.79 1.13 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.868 -1.531 . . . . 73.25 106.868 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.8 pt-20 -113.08 134.59 54.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 119.327 0.967 . . . . 75.209999999999994 112.596 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.95 135.9 54.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.29 -1.004 . . . . 73.329999999999998 108.29 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -94.73 125.96 39.72 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.401 0.62 . . . . 60.210000000000001 109.615 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.36 116.33 47.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.82 -1.178 . . . . 73.349999999999994 107.82 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.86 128.0 35.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.097 -0.705 . . . . 73.430000000000007 109.097 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.48 145.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.295 -0.411 . . . . 71.010000000000005 110.054 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 24.1 p -84.9 123.72 30.81 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.066 0.547 . . . . 72.140000000000001 112.117 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.8 t -118.38 106.58 12.88 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 120.022 -0.671 . . . . 74.450000000000003 109.352 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.0 109.5 0.05 OUTLIER Glycine 0 C--O 1.262 1.893 0 N-CA-C 115.028 0.771 . . . . 44.329999999999998 115.028 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 30.1 Cg_exo -64.75 127.69 19.31 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.3 1.333 . . . . 73.109999999999999 109.53 172.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 6.9 mm-40 -73.38 131.55 42.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 113.255 0.835 . . . . 74.420000000000002 113.255 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.5 mt-30 -123.22 133.72 54.19 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 106.891 -1.522 . . . . 72.319999999999993 106.891 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.676 -0.861 . . . . 74.439999999999998 108.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -83.43 138.21 33.57 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.782 -0.645 . . . . 74.329999999999998 109.311 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.3 mt -89.9 125.11 61.84 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.886 -0.413 . . . . 62.229999999999997 109.886 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.7 141.79 46.41 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.355 2.037 . . . . 72.120000000000005 112.745 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.22 6.87 30.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.104 -0.498 . . . . 73.150000000000006 111.676 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.3 p -76.89 -14.3 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.679 0.752 . . . . 74.030000000000001 109.673 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.9 m -53.21 -37.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.785 1.234 . . . . 64.409999999999997 112.754 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 4.3 p -69.54 -14.16 62.71 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 113.84 1.052 . . . . 73.409999999999997 113.84 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.75 -38.26 17.09 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 122.136 -0.352 . . . . 71.010000000000005 111.877 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 73.8 m -153.83 131.72 11.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.769 -0.456 . . . . 63.25 109.769 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -62.09 -43.52 98.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.094 0.557 . . . . 73.129999999999995 112.048 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.2 83.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.212 0.53 . . . . 74.329999999999998 110.374 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.26 -44.38 95.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.888 -1.051 . . . . 73.400000000000006 109.51 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.18 66.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 74.239999999999995 111.524 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.24 -38.86 81.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.668 0.618 . . . . 75.109999999999999 112.668 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -67.54 -46.71 72.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.508 -0.477 . . . . 74.340000000000003 111.071 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -64.83 -40.72 95.64 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 112.364 0.505 . . . . 74.209999999999994 112.364 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.5 mp -65.85 -41.4 91.74 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.583 -0.447 . . . . 74.420000000000002 111.498 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.7 m -62.09 -43.36 98.99 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.801 -0.444 . . . . 74.329999999999998 109.801 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.15 -16.87 62.56 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 111.757 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -89.73 -7.19 55.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.106 0.479 . . . . 75.409999999999997 110.363 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . 0.41 ' O ' HG21 ' A' ' 480' ' ' ILE . . . 110.9 -8.73 29.6 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.1 -0.571 . . . . 55.420000000000002 112.851 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -85.01 92.7 8.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.262 0.553 . . . . 73.530000000000001 110.151 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -100.16 -2.03 55.85 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.462 -1.055 . . . . 72.25 110.462 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -94.97 110.78 22.64 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.48 -0.933 . . . . 75.329999999999998 108.48 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -123.46 157.69 32.92 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.623 0.725 . . . . 74.140000000000001 111.477 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -149.54 131.41 15.14 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 103.934 -2.617 . . . . 72.219999999999999 103.934 173.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -111.0 135.07 52.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.961 -0.695 . . . . 74.319999999999993 111.394 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.36 135.69 37.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.802 -0.814 . . . . 75.540000000000006 108.802 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.9 129.21 56.66 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.399 -1.334 . . . . 75.340000000000003 107.399 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 45.3 p -121.11 150.32 53.31 Favored Pre-proline 0 C--N 1.284 -2.267 0 C-N-CA 120.597 -0.441 . . . . 71.209999999999994 110.503 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.9 Cg_exo -61.58 120.61 8.34 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.207 1.938 . . . . 60.240000000000002 110.431 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.9 t -127.38 -178.53 4.49 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.472 -1.677 . . . . 74.209999999999994 106.472 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 m -74.05 142.54 79.44 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 107.844 -1.169 . . . . 74.310000000000002 107.844 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.469 ' O ' HG12 ' A' ' 464' ' ' VAL . 99.1 Cg_exo -49.67 -23.29 7.89 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.593 2.862 . . . . 62.32 113.931 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.92 -11.82 60.04 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.227 0.536 . . . . 65.109999999999999 112.118 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.4 3.12 15.7 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.923 -0.486 . . . . 74.209999999999994 111.641 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.9 p -59.92 127.45 19.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.326 0.584 . . . . 71.340000000000003 111.662 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.88 -15.6 63.04 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 120.769 -0.729 . . . . 72.200000000000003 112.176 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -100.66 149.59 23.62 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.112 -0.699 . . . . 74.349999999999994 109.112 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 91.5 t -76.93 130.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.708 -1.219 . . . . 62.109999999999999 107.708 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.04 -22.6 4.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.939 -0.704 . . . . 72.450000000000003 111.949 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.49 -177.58 45.79 Favored Glycine 0 N--CA 1.423 -2.177 0 C-N-CA 120.778 -0.725 . . . . 51.240000000000002 111.373 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.7 p -136.01 154.88 50.93 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.449 -0.945 . . . . 72.420000000000002 108.449 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.495 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.5 t-20 -56.97 -51.85 78.54 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-O 119.151 -0.452 . . . . 75.120000000000005 111.435 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.6 Cg_endo -86.34 119.01 1.68 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 N-CA-C 107.15 -1.904 . . . . 74.120000000000005 107.15 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.47 162.21 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.197 1.932 . . . . 75.25 113.704 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.39 4.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.135 0.969 . . . . 74.019999999999996 111.104 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.86 -0.55 19.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.103 -0.953 . . . . 75.510000000000005 109.3 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -108.07 153.4 23.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.905 0.859 . . . . 73.219999999999999 112.031 -174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.1 m -112.09 93.66 4.56 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.655 -1.611 . . . . 74.109999999999999 107.358 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -100.91 148.58 24.83 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.23 -0.441 . . . . 73.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.484 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -63.16 152.83 36.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.995 0.426 . . . . 74.129999999999995 111.48 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.41 HG21 ' O ' ' A' ' 448' ' ' GLY . 1.7 mp -63.83 -21.41 28.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.641 0.734 . . . . 72.349999999999994 111.429 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.82 1.2 56.44 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.102 -0.499 . . . . 74.340000000000003 111.808 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.99 140.24 30.48 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.819 -0.438 . . . . 71.420000000000002 109.819 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 36.6 t -85.21 123.19 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.73 -0.668 . . . . 71.430000000000007 109.415 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.85 119.81 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 108.526 -0.916 . . . . 73.329999999999998 108.526 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.495 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 1.7 mp -91.89 112.76 26.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.652 -1.981 . . . . 72.409999999999997 105.652 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.75 119.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.591 -1.263 . . . . 65.299999999999997 107.591 -177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 38.8 mt -106.1 116.32 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.702 0.763 . . . . 72.239999999999995 110.57 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.13 142.85 13.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.502 -0.772 . . . . 70.230000000000004 108.959 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.63 117.53 4.59 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 111.183 -0.767 . . . . 62.509999999999998 111.183 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.4 m -116.34 106.99 14.26 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.163 -0.68 . . . . 75.450000000000003 109.163 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.086 0 N-CA-C 109.981 -1.248 . . . . 70.420000000000002 109.981 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.386 0 N-CA-C 110.043 -1.223 . . . . 60.030000000000001 110.043 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -92.78 149.85 4.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 117.487 0.643 . . . . 75.239999999999995 111.481 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 57.4 m -147.12 156.75 43.25 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.187 -1.783 . . . . 75.450000000000003 106.187 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -94.26 77.23 3.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.122 -1.436 . . . . 75.319999999999993 107.122 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.28 148.28 45.2 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.432 -1.713 . . . . 74.129999999999995 110.4 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.71 152.11 13.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 123.917 0.887 . . . . 73.230000000000004 108.987 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.92 136.32 36.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.873 -1.899 . . . . 75.400000000000006 105.873 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.5 127.01 32.53 Favored Pre-proline 0 C--N 1.284 -2.272 0 C-N-CA 119.89 -0.724 . . . . 72.329999999999998 111.122 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.36 133.71 57.51 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.986 2.457 . . . . 71.510000000000005 112.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -59.44 134.49 57.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.012 -0.995 . . . . 75.329999999999998 111.168 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 5.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.377 -0.829 . . . . 75.329999999999998 112.476 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.5 ptt-85 -65.69 137.72 57.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.657 -0.868 . . . . 74.209999999999994 108.657 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.37 0.37 50.39 Favored Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.687 -0.965 . . . . 54.420000000000002 110.687 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -130.15 176.76 7.83 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.483 -0.932 . . . . 74.340000000000003 108.483 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 88.4 p -87.94 167.8 13.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.736 -0.839 . . . . 75.030000000000001 108.736 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -61.29 -34.22 74.86 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.993 0.425 . . . . 73.420000000000002 110.346 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.06 -44.84 87.68 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.704 -0.68 . . . . 74.019999999999996 110.407 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -60.03 -44.98 94.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.528 -0.545 . . . . 64.409999999999997 109.528 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.08 67.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.226 -0.897 . . . . 73.219999999999999 111.018 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.5 -44.33 92.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.888 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.08 77.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.147 -0.479 . . . . 72.129999999999995 111.645 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 36.7 m -64.08 -47.52 79.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.547 -0.297 . . . . 73.299999999999997 111.199 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.13 -39.46 93.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.768 0.285 . . . . 72.430000000000007 111.768 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -60.04 -45.35 93.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.1 -0.704 . . . . 75.219999999999999 109.1 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -69.58 -27.65 65.29 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.169 -0.923 . . . . 75.329999999999998 112.025 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.589 ' HD3' ' O ' ' A' ' 376' ' ' THR . 8.5 mpt_? -85.62 -8.22 58.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.678 0.275 . . . . 72.140000000000001 110.999 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.27 14.35 54.21 Favored Glycine 0 CA--C 1.505 -0.594 0 C-N-CA 120.287 -0.959 . . . . 72.010000000000005 112.753 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -94.14 154.06 17.78 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.048 -0.723 . . . . 72.129999999999995 109.048 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.0 mmtp -104.79 133.6 49.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.263 -1.014 . . . . 71.120000000000005 108.263 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -117.82 144.86 24.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-O 121.524 0.678 . . . . 74.530000000000001 111.905 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -110.9 127.75 55.56 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 107.093 -1.447 . . . . 72.349999999999994 107.093 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.4 m -99.58 120.0 38.97 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.505 -1.665 . . . . 75.409999999999997 106.505 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.93 118.72 34.26 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.426 -1.324 . . . . 74.200000000000003 107.426 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.44 121.57 36.12 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.278 -1.378 . . . . 74.0 107.278 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.36 127.73 25.75 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 111.856 0.317 . . . . 75.310000000000002 111.856 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -87.99 131.59 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.522 2.148 . . . . 71.030000000000001 110.731 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.4 t70 174.06 -164.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.716 -1.587 . . . . 70.420000000000002 106.716 -178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.4 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 50.1 m -142.34 -0.53 1.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.343 0.657 . . . . 74.340000000000003 110.481 173.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -105.7 25.19 11.11 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 106.571 -1.64 . . . . 74.329999999999998 106.571 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 15.8 pt -115.13 151.41 45.66 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 113.708 -1.587 . . . . 74.299999999999997 110.212 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -74.45 147.58 36.72 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.035 1.823 . . . . 75.409999999999997 111.465 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.47 163.9 6.17 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.408 3.406 . . . . 73.109999999999999 112.288 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -56.28 -8.56 0.52 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 123.315 0.646 . . . . 73.140000000000001 112.006 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.1 m170 -91.63 113.37 25.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.213 -2.514 . . . . 74.530000000000001 104.213 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.18 118.32 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.358 0.599 . . . . 65.030000000000001 111.047 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.78 -29.49 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.206 -0.907 . . . . 74.430000000000007 109.049 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.18 157.12 27.28 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 110.432 -1.067 . . . . 71.140000000000001 110.432 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -126.03 -179.44 4.71 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 123.545 0.738 . . . . 52.409999999999997 110.418 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.33 140.29 21.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 72.340000000000003 108.639 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.39 -26.02 0.89 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 124.948 3.766 . . . . 62.43 115.53 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.34 -24.9 61.13 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 112.045 0.387 . . . . 74.450000000000003 112.045 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.74 69.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.475 0.655 . . . . 74.319999999999993 110.357 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -78.26 -11.99 59.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.59 -0.732 . . . . 63.219999999999999 111.65 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -78.82 137.46 37.71 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.063 -1.458 . . . . 72.230000000000004 107.063 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 m -82.54 112.27 19.3 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 72.329999999999998 107.712 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.6 167.42 18.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.566 -1.272 . . . . 74.329999999999998 107.566 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.2 p -61.01 147.66 42.83 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 123.46 0.704 . . . . 75.439999999999998 111.345 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.8 116.66 3.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.002 -0.544 . . . . 72.439999999999998 111.513 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.95 51.48 2.26 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.793 -0.64 . . . . 73.439999999999998 113.053 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.71 -170.14 1.69 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.803 -1.184 . . . . 74.329999999999998 107.803 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -99.05 135.27 40.7 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.494 0.664 . . . . 73.209999999999994 112.577 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.9 mm -125.17 138.76 53.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 124.796 1.239 . . . . 73.430000000000007 108.159 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 12.3 t -99.82 131.89 45.51 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.77 0.795 . . . . 65.099999999999994 111.701 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.3 t -108.15 120.71 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.459 -1.312 . . . . 74.430000000000007 107.459 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.74 129.04 41.83 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.341 -0.39 . . . . 74.5 111.458 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.75 131.3 73.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.835 -1.172 . . . . 75.409999999999997 107.835 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 49.6 p -85.96 121.85 29.18 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.099 -0.704 . . . . 72.409999999999997 109.099 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -119.45 106.7 12.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.197 -0.601 . . . . 75.430000000000007 111.1 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 71.03 125.89 0.06 OUTLIER Glycine 0 CA--C 1.544 1.874 0 N-CA-C 114.801 0.681 . . . . 74.310000000000002 114.801 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.1 Cg_exo -70.52 128.2 15.01 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.255 1.303 . . . . 71.349999999999994 109.44 173.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 15.2 mm-40 -72.3 144.78 48.21 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 112.463 0.542 . . . . 63.340000000000003 112.463 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.4 mt-30 -116.01 149.01 39.54 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.811 -1.086 . . . . 73.310000000000002 108.562 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -136.78 144.87 43.98 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.523 -0.917 . . . . 74.519999999999996 108.523 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 37.1 tt0 -81.74 119.25 23.62 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.122 -1.807 . . . . 71.040000000000006 106.122 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 62.1 mt -80.88 127.83 73.52 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.471 -0.937 . . . . 75.510000000000005 108.471 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 141.79 38.89 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.928 1.752 . . . . 62.009999999999998 110.627 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.84 73.89 10.28 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.373 1.083 . . . . 75.409999999999997 108.269 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.19 -4.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 113.668 -1.605 . . . . 74.129999999999995 107.34 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 8.7 m -67.13 -38.88 86.32 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 113.583 -1.644 . . . . 51.539999999999999 111.767 -176.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 16.3 p -69.84 -16.75 63.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 112.86 0.689 . . . . 74.519999999999996 112.86 -169.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.28 -48.99 11.29 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.545 -0.752 . . . . 72.450000000000003 111.656 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.2 m -157.59 130.19 7.39 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.03 -0.419 . . . . 72.239999999999995 110.116 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -55.88 -47.07 78.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.477 0.711 . . . . 72.409999999999997 112.218 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.76 84.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 71.099999999999994 111.306 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 35.4 mm-40 -67.5 -38.95 85.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 111.214 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 433' ' ' SER . . . -59.4 -50.85 72.37 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.614 0.572 . . . . 62.119999999999997 111.043 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.3 -45.34 98.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.516 -0.765 . . . . 75.209999999999994 110.624 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.11 -40.67 86.91 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 112.952 0.723 . . . . 75.239999999999995 112.952 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.8 mmtt -66.21 -47.18 74.7 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 110.084 -0.339 . . . . 72.530000000000001 110.084 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.647 0.61 . . . . 72.120000000000005 112.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.9 m -63.98 -39.04 93.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.907 -0.405 . . . . 74.239999999999995 109.907 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -27.02 63.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.551 . . . . 72.420000000000002 110.832 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 -13.65 59.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.336 -0.393 . . . . 65.439999999999998 111.249 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 129.96 -26.18 4.27 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.196 -1.002 . . . . 61.420000000000002 113.26 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -80.84 91.57 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.312 . . . . 72.519999999999996 110.17 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.48 26.86 16.93 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 120.512 -0.851 . . . . 71.239999999999995 111.71 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -124.77 111.84 16.01 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.587 -1.264 . . . . 73.109999999999999 107.587 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 158.97 37.2 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.777 0.799 . . . . 74.140000000000001 111.982 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.52 123.25 21.15 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.872 -1.899 . . . . 74.129999999999995 105.872 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.62 126.96 35.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.145 0.278 . . . . 74.420000000000002 110.49 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.409 ' C ' HD21 ' A' ' 456' ' ' ASN . . . -136.39 150.72 48.93 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.409 HD21 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -129.74 148.84 51.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.505 -0.554 . . . . 75.25 109.505 178.172 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 66.4 m -135.86 133.3 19.85 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 116.488 -0.324 . . . . 73.219999999999999 110.969 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.3 Cg_endo -61.79 121.57 9.73 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.715 2.277 . . . . 73.109999999999999 110.028 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.8 p -146.39 -178.36 6.11 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.878 -1.156 . . . . 64.340000000000003 107.878 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.476 ' HB ' HD21 ' A' ' 463' ' ' LEU . 9.3 m -52.2 122.98 26.11 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.17 -0.678 . . . . 73.219999999999999 109.17 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.02 -23.63 9.51 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.314 3.342 . . . . 73.540000000000006 115.197 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -75.4 -6.43 49.98 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.81 -0.556 . . . . 72.329999999999998 111.966 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.476 HD21 ' HB ' ' A' ' 460' ' ' THR . 4.4 mm? -98.69 5.02 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.099 -0.375 . . . . 73.209999999999994 110.955 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -59.67 126.7 17.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 CA-C-O 121.545 0.688 . . . . 74.219999999999999 111.489 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.84 -1.14 85.05 Favored Glycine 0 C--O 1.243 0.657 0 CA-C-N 115.748 -0.66 . . . . 50.119999999999997 111.772 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -111.1 144.42 40.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.148 -1.427 . . . . 74.030000000000001 107.148 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 434' ' ' THR . 61.8 t -83.82 134.9 25.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 109.496 -0.557 . . . . 73.430000000000007 109.496 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.37 -14.88 7.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.404 -0.518 . . . . 74.040000000000006 110.803 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.98 167.75 23.87 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 115.719 -0.673 . . . . 52.420000000000002 111.811 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.7 p -124.28 146.17 48.94 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.417 -1.327 . . . . 73.099999999999994 107.417 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.5 t-20 -56.54 -50.72 86.14 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 64.549999999999997 110.497 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.9 Cg_exo -81.4 104.95 1.54 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 105.41 -2.573 . . . . 73.209999999999994 105.41 163.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.0 Cg_endo -63.04 149.82 90.44 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.395 2.063 . . . . 74.409999999999997 114.248 -169.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.434 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.8 16.51 0.86 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.264 1.03 . . . . 74.340000000000003 110.106 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.502 ' H ' ' C ' ' A' ' 473' ' ' PRO . 0.8 OUTLIER -111.3 -3.64 15.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 124.918 1.287 . . . . 73.230000000000004 108.718 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -120.9 163.32 18.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.921 -1.036 . . . . 72.230000000000004 112.162 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 10.6 m -101.48 104.88 15.82 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.728 -1.582 . . . . 71.420000000000002 106.728 175.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.8 t -116.89 148.84 40.96 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.583 -0.525 . . . . 75.439999999999998 109.583 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.14 140.71 58.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.236 -0.438 . . . . 54.509999999999998 110.622 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.9 mm -60.58 -16.46 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 125.159 1.384 . . . . 63.130000000000003 111.776 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 10.4 t -87.93 3.62 47.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.264 -0.426 . . . . 75.049999999999997 111.185 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 479' ' ' ALA . 46.5 m-80 -91.12 140.61 29.65 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.751 0.31 . . . . 64.120000000000005 110.634 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.64 122.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.851 -1.166 . . . . 65.040000000000006 107.851 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.05 119.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 N-CA-C 108.605 -0.887 . . . . 72.040000000000006 108.605 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 47.0 mt -91.82 112.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 104.799 -2.297 . . . . 73.109999999999999 104.799 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.412 HD13 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.84 120.45 52.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 108.685 -0.857 . . . . 74.329999999999998 108.685 -173.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.78 118.73 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 121.559 0.695 . . . . 75.409999999999997 109.333 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.45 139.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.351 -0.981 . . . . 75.019999999999996 108.351 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.27 121.66 6.22 Favored Glycine 0 N--CA 1.42 -2.43 0 N-CA-C 108.471 -1.852 . . . . 75.329999999999998 108.471 175.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 7.1 t -140.45 103.88 4.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.15 -0.685 . . . . 71.0 109.15 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.609 0 N-CA-C 109.478 -1.449 . . . . 74.530000000000001 109.478 178.18 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.309 0 N-CA-C 110.563 -1.015 . . . . 75.340000000000003 110.563 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.81 144.9 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 121.261 0.553 . . . . 74.129999999999995 111.93 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.7 m -86.03 151.5 23.66 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.825 -1.176 . . . . 75.129999999999995 107.825 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -83.23 77.2 9.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.434 0.635 . . . . 74.510000000000005 110.062 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -78.65 125.55 29.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.242 -1.392 . . . . 74.120000000000005 107.242 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.82 156.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-O 120.972 0.415 . . . . 73.209999999999994 110.506 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.41 136.85 37.96 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.604 -1.628 . . . . 75.329999999999998 106.604 174.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.45 129.03 27.71 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 119.437 -0.905 . . . . 73.400000000000006 109.889 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 139.79 70.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.33 2.686 . . . . 74.310000000000002 113.21 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.66 137.49 55.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.839 -1.073 . . . . 72.540000000000006 109.107 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.0 m -103.43 14.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.986 0.422 . . . . 73.140000000000001 111.96 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 0.9 OUTLIER -65.29 138.82 58.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.23 -0.441 . . . . 75.150000000000006 111.558 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 -2.08 76.35 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 115.603 -0.726 . . . . 71.129999999999995 111.449 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -116.67 162.67 17.29 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.473 -0.566 . . . . 72.239999999999995 109.473 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 79.3 p -74.75 163.16 28.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 122.764 0.426 . . . . 74.329999999999998 111.774 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 21.5 p -60.91 -45.4 94.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.165 -0.47 . . . . 73.340000000000003 110.874 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.37 95.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.992 -0.549 . . . . 62.340000000000003 111.55 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.91 -39.73 83.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.056 -0.657 . . . . 74.540000000000006 109.905 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . 0.404 ' O ' HD22 ' A' ' 377' ' ' LEU . . . -60.99 -51.84 67.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.056 -0.52 . . . . 74.420000000000002 110.099 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.517 . . . . 62.509999999999998 110.7 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.39 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.462 -0.336 . . . . 74.319999999999993 111.673 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 98.3 m -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.689 -0.232 . . . . 74.420000000000002 111.18 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 373' ' ' ALA . 4.5 mm? -64.87 -42.44 94.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.811 0.339 . . . . 75.439999999999998 111.002 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.81 -48.43 80.64 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.854 0.861 . . . . 74.25 109.721 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -70.5 -25.35 63.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.506 -0.77 . . . . 70.219999999999999 111.584 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.4 -15.83 57.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.453 -0.573 . . . . 74.219999999999999 109.453 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.431 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.4 6.09 53.57 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 119.807 -1.187 . . . . 51.409999999999997 111.683 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.4 169.08 11.7 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.233 0.54 . . . . 74.510000000000005 109.88 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 74.9 mmtt -113.73 157.9 21.62 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.508 -1.293 . . . . 73.129999999999995 107.508 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.42 142.68 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 111.126 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -116.81 138.63 51.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.552 -1.647 . . . . 75.239999999999995 106.552 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 3.3 p -101.81 127.06 48.78 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.386 -0.525 . . . . 74.540000000000006 110.151 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.45 119.54 39.15 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.04 -1.467 . . . . 75.299999999999997 107.04 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.535 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 0.0 OUTLIER -114.85 134.12 55.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.416 -0.514 . . . . 75.030000000000001 111.252 -175.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -137.02 141.77 35.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.853 -0.612 . . . . 75.430000000000007 110.192 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.5 Cg_endo -97.04 143.57 0.76 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.155 2.57 . . . . 75.120000000000005 113.234 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.7 t70 163.55 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.996 -1.853 . . . . 73.319999999999993 105.996 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 m -122.18 -12.7 8.25 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.996 -0.742 . . . . 64.219999999999999 108.996 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.3 m -98.03 14.65 26.69 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 122.457 1.123 . . . . 74.340000000000003 108.769 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' A' ' 391' ' ' ASP . 9.9 pt -88.64 151.83 48.41 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 115.068 -0.969 . . . . 64.409999999999997 111.601 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.06 126.78 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.921 1.747 . . . . 73.230000000000004 110.78 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.85 161.99 9.52 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.718 2.945 . . . . 74.420000000000002 112.265 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 370' ' ' SER . 4.4 p-10 -57.03 -9.93 0.99 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.477 0.711 . . . . 75.040000000000006 112.399 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -91.89 113.84 26.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.536 -2.024 . . . . 55.409999999999997 105.536 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.88 119.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 124.362 1.039 . . . . 75.340000000000003 112.29 -167.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.8 mt -95.41 -31.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 72.299999999999997 109.928 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.57 157.96 27.56 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.518 -0.849 . . . . 74.310000000000002 111.472 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.9 p -129.04 -179.1 4.92 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.588 0.755 . . . . 73.400000000000006 109.599 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -101.74 142.35 24.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.02 -1.104 . . . . 73.540000000000006 108.02 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.65 -26.45 9.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.848 3.032 . . . . 74.400000000000006 114.075 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.69 46.41 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.366 0.666 . . . . 75.439999999999998 111.168 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.42 95.28 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.723 -0.671 . . . . 61.109999999999999 111.434 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.54 -5.95 58.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.413 0.523 . . . . 64.299999999999997 112.413 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 37.0 m -85.95 153.01 22.48 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.96 -1.496 . . . . 75.310000000000002 106.96 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.69 112.76 11.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.761 -0.776 . . . . 61.520000000000003 110.142 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.6 m -117.94 153.04 19.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 62.340000000000003 109.542 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -67.62 141.73 56.66 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.565 -0.531 . . . . 71.519999999999996 109.565 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.26 134.6 44.9 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.529 0.732 . . . . 74.319999999999993 112.594 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 84.09 37.48 11.27 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.455 -0.793 . . . . 64.409999999999997 113.991 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -95.91 176.22 6.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.192 -1.04 . . . . 74.25 108.192 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.2 pt-20 -111.07 120.0 40.89 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.189 0.811 . . . . 74.540000000000006 113.189 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.79 137.85 25.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 114.951 -1.022 . . . . 72.530000000000001 108.535 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.4 t -96.02 128.67 43.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.816 0.817 . . . . 74.329999999999998 110.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.48 129.03 59.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.538 -0.912 . . . . 65.510000000000005 108.538 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -85.01 127.99 34.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.385 -0.598 . . . . 65.420000000000002 109.385 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.95 135.09 64.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.502 -0.925 . . . . 73.010000000000005 108.502 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.8 p -84.24 122.08 28.38 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.246 -0.649 . . . . 55.409999999999997 109.246 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 39.9 m -120.3 104.96 10.47 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 120.049 -0.66 . . . . 62.299999999999997 112.443 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 70.62 131.07 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 N-CA-C 115.766 1.066 . . . . 73.329999999999998 115.766 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.4 Cg_exo -75.06 134.65 17.96 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.943 1.762 . . . . 73.430000000000007 109.491 173.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.2 mm-40 -72.84 148.8 44.12 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.249 0.547 . . . . 73.349999999999994 112.266 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.8 mt-30 -124.08 139.03 54.34 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.682 -1.144 . . . . 73.549999999999997 108.015 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 14.9 mmt-85 -130.45 154.64 47.53 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 116.163 -0.471 . . . . 72.349999999999994 109.771 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.64 138.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.579 -0.897 . . . . 74.299999999999997 108.579 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -94.28 109.64 43.74 Favored Pre-proline 0 C--O 1.203 -1.352 0 N-CA-C 109.005 -0.739 . . . . 75.109999999999999 109.005 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.01 140.56 34.94 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 121.549 1.5 . . . . 73.140000000000001 111.716 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -92.5 95.17 9.48 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 118.465 -1.294 . . . . 75.120000000000005 112.172 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.63 9.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 104.502 -2.407 . . . . 64.230000000000004 104.502 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.502 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 22.6 t -78.89 -48.11 15.24 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.058 -1.883 . . . . 74.230000000000004 109.188 -172.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 40.3 p -63.85 -19.97 65.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.631 0.729 . . . . 71.439999999999998 110.829 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.29 -49.27 6.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.05 -0.977 . . . . 74.120000000000005 110.083 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 4.7 p -151.03 125.59 9.56 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.105 0.479 . . . . 75.400000000000006 112.117 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -61.64 -47.12 86.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 73.019999999999996 110.927 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.26 -47.84 80.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.824 . . . . 74.319999999999993 112.134 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.97 -34.75 73.79 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.995 -0.548 . . . . 72.530000000000001 112.059 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 433' ' ' SER . . . -60.82 -44.75 96.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.571 -0.286 . . . . 74.340000000000003 110.357 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.29 -39.84 82.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.594 0.559 . . . . 74.150000000000006 110.157 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -60.82 -48.14 83.14 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.878 -0.601 . . . . 74.430000000000007 110.504 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.8 -47.53 71.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 111.068 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.94 -43.07 84.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.046 -0.979 . . . . 75.209999999999994 111.384 -173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.3 m -69.17 -39.57 78.66 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.967 0.413 . . . . 73.329999999999998 110.224 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -16.14 62.55 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.374 -0.375 . . . . 73.219999999999999 111.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.78 -13.79 59.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.215 0.531 . . . . 72.140000000000001 109.969 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.46 -25.26 7.39 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.737 -0.744 . . . . 70.019999999999996 112.14 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -57.43 127.1 30.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.972 0.415 . . . . 71.319999999999993 111.504 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -133.55 27.72 3.35 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 109.673 -1.371 . . . . 62.219999999999999 109.673 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -128.04 111.4 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.824 -1.547 . . . . 73.439999999999998 106.824 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -135.88 154.18 51.23 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.977 0.418 . . . . 64.239999999999995 110.782 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -146.13 123.25 11.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.624 -1.25 . . . . 73.299999999999997 107.624 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -108.84 132.19 54.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.942 -0.303 . . . . 70.230000000000004 110.697 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -147.68 166.3 27.87 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.898 -0.592 . . . . 65.230000000000004 109.518 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.497 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.8 m120 -112.74 143.65 43.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.303 -0.629 . . . . 74.409999999999997 109.303 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.6 t -127.17 141.48 40.86 Favored Pre-proline 0 C--N 1.288 -2.107 0 N-CA-C 107.739 -1.208 . . . . 74.209999999999994 107.739 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_endo -63.37 135.18 48.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.862 2.375 . . . . 75.530000000000001 112.427 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.3 p -148.13 -178.88 6.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 105.648 -1.982 . . . . 63.229999999999997 105.648 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.6 m -63.69 128.2 92.45 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.076 -1.453 . . . . 70.129999999999995 107.076 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.33 -28.24 14.97 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.272 3.315 . . . . 74.430000000000007 114.576 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.31 -9.88 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 111.911 0.337 . . . . 71.209999999999994 111.911 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.6 mp -103.3 11.97 36.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.458 -0.201 . . . . 75.019999999999996 110.458 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 13.0 p -59.0 127.32 18.03 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-O 121.611 0.719 . . . . 64.439999999999998 110.969 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.57 57.81 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.408 -0.815 . . . . 62.149999999999999 111.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.16 144.8 29.6 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.271 -1.011 . . . . 74.430000000000007 108.271 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 433' ' ' SER . 65.6 t -83.43 138.24 19.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 75.340000000000003 108.503 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -98.08 -11.37 8.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.22 -0.592 . . . . 75.239999999999995 111.615 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 150.68 -177.71 28.56 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 111.121 -0.792 . . . . 70.349999999999994 111.121 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 5.4 p -116.75 161.38 19.34 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.69 -0.856 . . . . 75.120000000000005 108.69 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.15 -55.37 44.75 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.259 -0.4 . . . . 75.019999999999996 111.323 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 133.67 18.69 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 N-CA-C 108.226 -1.49 . . . . 75.319999999999993 108.226 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 475' ' ' ASN . 26.5 Cg_endo -62.89 134.56 47.18 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.013 1.809 . . . . 75.219999999999999 111.598 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.92 19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.852 0.861 . . . . 73.230000000000004 113.045 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.549 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -110.54 -8.23 14.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.428 -0.953 . . . . 70.519999999999996 108.428 174.07 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -99.52 156.75 16.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.068 -0.969 . . . . 74.510000000000005 113.178 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 m -106.6 110.23 22.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.422 -1.717 . . . . 72.140000000000001 106.877 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -117.61 148.46 41.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.464 -0.198 . . . . 73.129999999999995 110.464 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.12 149.41 50.57 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.269 0.356 . . . . 74.140000000000001 111.018 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.95 -14.43 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 125.083 1.353 . . . . 72.420000000000002 111.837 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.17 4.01 44.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.7 0.8 . . . . 65.040000000000006 111.701 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -97.73 134.74 40.49 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.003 -0.544 . . . . 75.319999999999993 110.607 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.99 114.93 24.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.677 -0.86 . . . . 73.299999999999997 108.677 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.44 119.85 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.378 0.609 . . . . 72.150000000000006 109.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.72 120.24 41.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.43 -1.322 . . . . 74.430000000000007 107.43 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.29 118.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 107.836 -1.172 . . . . 75.219999999999999 107.836 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -111.46 122.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.173 0.987 . . . . 74.319999999999993 112.361 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.497 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 35.5 t -97.53 141.2 16.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.713 -1.13 . . . . 64.129999999999995 108.053 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.43 121.75 5.92 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 111.657 -0.577 . . . . 63.130000000000003 111.657 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.6 m -142.06 120.89 12.72 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.153 -0.684 . . . . 60.409999999999997 109.153 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.578 0 N-CA-C 109.665 -1.374 . . . . 74.439999999999998 109.665 178.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.31 0 N-CA-C 109.923 -1.271 . . . . 72.129999999999995 109.923 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.38 145.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 117.782 0.791 . . . . 74.510000000000005 112.121 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 6.8 m -104.41 159.34 15.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.621 -1.622 . . . . 73.140000000000001 106.621 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.87 60.15 3.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.786 0.803 . . . . 75.099999999999994 112.688 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -114.53 136.4 53.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.606 -1.627 . . . . 64.409999999999997 106.606 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.65 154.14 37.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 122.528 0.331 . . . . 74.329999999999998 110.176 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -95.0 136.65 35.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.489 -0.93 . . . . 74.25 108.489 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.96 142.04 23.94 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 116.148 -0.478 . . . . 72.400000000000006 111.814 -170.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.14 142.77 20.19 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 124.015 3.143 . . . . 74.099999999999994 113.414 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.21 125.69 29.73 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.471 -0.786 . . . . 75.010000000000005 109.651 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.28 27.05 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.569 1.176 . . . . 73.140000000000001 110.669 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 145.66 55.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.09 -0.959 . . . . 74.209999999999994 111.498 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 1.0 45.49 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.998 -0.62 . . . . 72.549999999999997 114.36 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -134.6 162.5 32.11 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 117.293 0.546 . . . . 60.530000000000001 110.883 -177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.4 p -66.93 159.89 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.227 0.329 . . . . 61.210000000000001 110.298 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 21.2 p -56.76 -40.5 75.92 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.586 0.231 . . . . 71.019999999999996 111.62 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.36 77.85 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 111.563 0.209 . . . . 74.450000000000003 111.563 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.71 -36.76 76.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.51 -0.552 . . . . 72.420000000000002 109.51 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.7 68.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.019 -0.537 . . . . 70.120000000000005 110.812 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.46 -38.0 76.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.764 -0.653 . . . . 74.239999999999995 110.607 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.07 99.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.964 -0.562 . . . . 74.209999999999994 110.338 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 50.6 m -61.21 -47.2 87.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.353 -0.385 . . . . 71.299999999999997 110.755 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.8 -38.64 91.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.433 0.158 . . . . 74.140000000000001 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.16 -46.78 89.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.366 -0.605 . . . . 73.129999999999995 109.366 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.27 -28.0 68.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.805 -0.634 . . . . 73.120000000000005 111.507 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -80.98 -14.57 57.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.365 -0.38 . . . . 74.200000000000003 111.42 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.09 48.11 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.858 -0.686 . . . . 65.230000000000004 113.667 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.91 161.97 14.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.491 0.646 . . . . 75.099999999999994 111.353 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -97.01 140.13 31.99 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.221 -1.77 . . . . 71.209999999999994 106.221 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.3 152.31 21.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.296 0.57 . . . . 75.540000000000006 112.316 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -136.16 128.99 31.04 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.934 -1.136 . . . . 72.120000000000005 107.934 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -100.58 132.83 45.77 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.187 -0.671 . . . . 73.040000000000006 109.187 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.55 119.14 35.79 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.666 -1.976 . . . . 71.310000000000002 105.666 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.37 122.19 46.49 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.974 -0.75 . . . . 62.210000000000001 108.974 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.509 ' HZ1' ' HB2' ' A' ' 389' ' ' LYS . 0.1 OUTLIER -134.54 133.3 21.33 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.023 -0.535 . . . . 74.040000000000006 111.9 -176.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.59 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -81.63 129.56 6.5 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.073 1.849 . . . . 75.530000000000001 108.288 169.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.4 -170.29 3.19 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.905 -1.518 . . . . 74.510000000000005 112.145 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.7 t -104.66 -40.63 5.94 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.318 -1.734 . . . . 53.549999999999997 106.318 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 395' ' ' PRO . 32.2 m -93.0 71.51 4.65 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.543 -1.651 . . . . 52.420000000000002 106.543 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 16.6 pt -89.58 112.96 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 113.241 -1.8 . . . . 73.239999999999995 113.587 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 393' ' ' THR . 6.3 Cg_exo -79.1 119.61 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 105.81 -2.419 . . . . 73.340000000000003 105.81 167.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 398' ' ' HIS . 52.5 Cg_exo -55.12 150.48 39.16 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 C-N-CA 122.631 2.221 . . . . 64.120000000000005 114.24 -170.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.481 ' HA ' ' CG1' ' A' ' 420' ' ' VAL . 29.8 t70 -60.06 -9.65 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.626 1.203 . . . . 51.100000000000001 111.722 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.413 ' H ' ' C ' ' A' ' 396' ' ' PRO . 19.6 m170 -109.51 115.51 30.06 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 103.292 -2.855 . . . . 74.200000000000003 103.292 176.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.17 117.98 4.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 123.695 0.622 . . . . 72.109999999999999 109.53 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.406 HD11 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.57 -29.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.987 -1.116 . . . . 72.200000000000003 107.987 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.37 168.47 27.81 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 109.387 -1.485 . . . . 62.229999999999997 109.387 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 81.2 p -113.93 -176.36 2.88 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.827 0.823 . . . . 73.099999999999994 111.365 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.31 142.89 25.48 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 105.654 -1.98 . . . . 70.230000000000004 105.654 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.62 -31.67 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.286 3.324 . . . . 74.049999999999997 114.441 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.08 67.42 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 112.381 0.512 . . . . 75.230000000000004 112.381 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.25 81.95 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 121.5 0.667 . . . . 74.310000000000002 110.125 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.83 -0.39 57.7 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.842 0.83 . . . . 73.120000000000005 110.604 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 93.8 m -85.55 143.99 28.17 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.008 -1.479 . . . . 75.019999999999996 107.008 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.0 m -74.84 114.61 13.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.867 -0.733 . . . . 71.420000000000002 109.381 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.96 170.17 8.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 124.823 1.249 . . . . 52.340000000000003 108.921 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 23.2 t -69.67 156.98 38.13 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.535 -0.543 . . . . 75.319999999999993 109.535 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -73.38 109.6 7.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.124 -1.065 . . . . 73.200000000000003 108.124 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.53 26.51 11.87 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.673 -0.971 . . . . 52.350000000000001 110.673 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.8 t0 -76.99 -171.57 2.03 Favored 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.807 -0.812 . . . . 71.109999999999999 108.807 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.68 127.46 53.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.463 0.649 . . . . 70.209999999999994 111.129 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.63 120.1 61.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.202 -1.036 . . . . 74.230000000000004 108.202 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -97.88 128.23 44.34 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.642 -0.873 . . . . 65.510000000000005 108.642 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.57 119.58 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.717 -0.475 . . . . 71.120000000000005 109.717 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.7 121.88 33.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.459 -0.941 . . . . 74.439999999999998 108.459 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 397' ' ' ASP . 23.6 t -128.83 144.72 37.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.426 -0.953 . . . . 75.319999999999993 108.426 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 71.9 p -98.03 128.92 44.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.306 -0.958 . . . . 75.209999999999994 110.9 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 60.6 m -118.73 105.56 11.69 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.069 -1.456 . . . . 74.319999999999993 107.069 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 80.53 145.1 3.97 Favored Glycine 0 CA--C 1.546 2.011 0 C-N-CA 120.973 -0.632 . . . . 52.539999999999999 113.445 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -87.95 153.2 7.16 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 121.903 1.735 . . . . 63.229999999999997 110.38 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 146.17 47.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.177 -0.675 . . . . 73.439999999999998 109.177 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 42.0 mt-30 -128.74 124.13 34.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.632 -0.877 . . . . 73.450000000000003 108.632 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.14 159.51 34.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.469 -1.308 . . . . 73.25 107.469 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.65 139.87 30.12 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 110.209 -0.293 . . . . 75.329999999999998 110.209 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.61 131.89 63.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.631 -0.877 . . . . 74.400000000000006 108.631 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.4 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.24 151.07 60.25 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.466 2.111 . . . . 72.310000000000002 111.905 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.19 -6.55 44.49 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.485 -0.325 . . . . 71.209999999999994 110.702 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.4 HG12 ' HB2' ' A' ' 430' ' ' PRO . 11.9 p -65.84 -15.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 122.123 0.964 . . . . 75.109999999999999 109.69 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 14.0 m -52.73 -32.95 45.77 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.889 1.676 . . . . 74.230000000000004 112.084 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 85.5 m -59.8 -34.33 72.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.53 0.732 . . . . 74.430000000000007 112.585 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.45 -37.69 83.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.307 0.854 . . . . 71.340000000000003 113.307 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.8 m -158.3 133.53 8.66 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.723 -0.473 . . . . 72.319999999999993 109.723 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.61 -49.35 75.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.559 . . . . 74.319999999999993 111.724 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.44 85.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.943 -0.571 . . . . 72.299999999999997 110.449 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.25 -41.96 99.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.933 -1.03 . . . . 64.299999999999997 109.834 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.47 69.23 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.355 -0.839 . . . . 74.510000000000005 110.582 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.34 -40.0 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.584 -0.735 . . . . 74.519999999999996 110.405 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -60.8 -46.34 90.88 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.607 -0.27 . . . . 74.319999999999993 111.064 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -47.6 83.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.268 0.355 . . . . 73.430000000000007 111.86 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.36 -40.55 85.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.946 0.721 . . . . 74.439999999999998 112.946 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.2 m -61.8 -43.44 98.83 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.065 0.46 . . . . 73.409999999999997 110.158 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.53 -22.33 61.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.696 -0.684 . . . . 75.450000000000003 111.553 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.21 -13.09 57.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.005 0.431 . . . . 73.219999999999999 111.061 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -19.12 8.91 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.443 -0.884 . . . . 61.439999999999998 112.715 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.27 110.86 6.17 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.017 -0.734 . . . . 73.319999999999993 109.017 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -120.08 17.08 9.97 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.457 -0.878 . . . . 72.420000000000002 111.602 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -119.4 111.4 18.1 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.872 -1.159 . . . . 65.120000000000005 107.872 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.25 152.37 50.58 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.082 0.468 . . . . 74.439999999999998 111.892 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -138.69 126.22 21.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.756 -1.572 . . . . 74.409999999999997 106.756 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -93.4 126.25 38.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 121.229 -0.189 . . . . 72.310000000000002 111.001 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.82 161.16 38.22 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.114 0.483 . . . . 70.439999999999998 110.111 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.06 133.29 53.67 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.059 0.457 . . . . 71.129999999999995 110.179 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 5.1 p -116.97 133.43 23.1 Favored Pre-proline 0 N--CA 1.413 -2.28 0 CA-C-N 115.583 -0.735 . . . . 71.439999999999998 109.482 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.8 123.66 13.06 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.435 2.09 . . . . 71.439999999999998 110.609 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 8.7 t -148.16 -177.99 6.05 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.557 -1.275 . . . . 65.299999999999997 107.557 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 463' ' ' LEU . 20.5 m -51.65 116.45 7.92 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.139 0.976 . . . . 73.200000000000003 110.492 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.92 -28.75 19.21 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 124.329 3.353 . . . . 74.140000000000001 116.065 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.19 -25.93 58.63 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.746 -0.596 . . . . 74.430000000000007 112.366 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 460' ' ' THR . 3.2 pp -92.8 12.04 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.695 -0.402 . . . . 71.209999999999994 112.038 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.6 p -53.29 130.85 15.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.428 0.632 . . . . 72.140000000000001 111.228 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.84 -13.32 59.21 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.819 -0.912 . . . . 61.32 110.819 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.01 147.25 26.41 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.305 0.574 . . . . 74.420000000000002 109.773 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 434' ' ' THR . 52.7 t -83.68 129.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.478 -0.783 . . . . 72.400000000000006 110.004 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -15.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 118.571 -1.251 . . . . 71.200000000000003 110.724 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.51 37.95 Favored Glycine 0 N--CA 1.418 -2.516 0 CA-C-N 115.331 -0.849 . . . . 62.43 111.146 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 2.9 p -136.15 161.87 34.53 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.41 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 7.7 t30 -62.97 -49.76 80.12 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 120.75 -0.38 . . . . 71.219999999999999 110.87 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.44 141.71 47.3 Favored 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 106.586 -2.121 . . . . 64.209999999999994 106.586 167.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.48 127.24 21.24 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.771 1.648 . . . . 63.539999999999999 112.699 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 -1.69 21.07 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.885 0.874 . . . . 73.109999999999999 113.162 -174.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -110.02 -4.27 15.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.028 -0.42 . . . . 72.420000000000002 110.136 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -121.3 176.51 5.6 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 114.626 1.343 . . . . 75.400000000000006 114.626 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 2.3 m -80.48 132.65 35.73 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.708 -1.587 . . . . 65.319999999999993 110.334 -176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.7 p -137.26 149.54 47.2 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.605 -0.887 . . . . 73.209999999999994 108.605 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.23 148.55 45.41 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 120.206 -0.598 . . . . 64.109999999999999 111.262 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.76 -28.24 44.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.865 0.84 . . . . 75.510000000000005 110.878 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 p -88.0 5.48 40.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.954 -1.021 . . . . 63.450000000000003 111.434 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.0 135.83 33.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.111 -1.44 . . . . 71.109999999999999 107.111 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 53.0 t -79.83 112.91 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.351 -1.351 . . . . 64.549999999999997 107.351 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.25 118.81 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 109.083 -0.71 . . . . 74.340000000000003 109.083 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 60.8 mt -92.6 113.39 27.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 106.469 -1.678 . . . . 74.329999999999998 106.469 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.18 116.46 39.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 108.545 -0.909 . . . . 74.140000000000001 108.545 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 12.3 pt -102.9 117.06 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.491 1.139 . . . . 71.430000000000007 111.571 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.67 132.88 40.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.557 -1.275 . . . . 73.340000000000003 107.557 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -68.92 113.58 5.31 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.773 -1.331 . . . . 74.310000000000002 109.773 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 8.7 m -135.01 103.72 5.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.759 -0.46 . . . . 72.019999999999996 109.759 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 108.399 -1.88 . . . . 65.310000000000002 108.399 178.837 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.36 0 N-CA-C 110.169 -1.172 . . . . 74.109999999999999 110.169 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 356' ' ' ILE . 2.8 pp -98.28 133.18 41.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.372 0.606 . . . . 74.230000000000004 111.856 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 7.2 t -132.33 146.07 51.72 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.628 -0.715 . . . . 70.329999999999998 109.879 -177.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -83.21 77.48 9.76 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.752 0.787 . . . . 75.340000000000003 111.95 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.35 148.07 44.85 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.679 -2.341 . . . . 73.200000000000003 104.679 172.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.74 152.92 19.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 119.522 -0.871 . . . . 74.299999999999997 113.149 -167.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.28 137.07 34.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.417 -1.697 . . . . 74.409999999999997 106.417 172.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.93 131.56 27.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 C-N-CA 119.27 -0.972 . . . . 73.219999999999999 109.711 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.65 150.74 51.04 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.7 2.933 . . . . 70.209999999999994 114.026 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -72.76 -30.13 63.88 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 110.459 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 42.5 t 66.77 27.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 124.193 1.949 . . . . 73.319999999999993 107.097 -174.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 28.0 ptt180 -58.17 125.08 21.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 112.464 -2.153 . . . . 70.140000000000001 113.362 -176.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.52 -16.78 54.63 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.863 -1.062 . . . . 54.32 111.719 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -103.89 170.23 8.04 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.796 0.439 . . . . 72.5 110.006 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.9 p -71.75 160.86 31.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.185 0.517 . . . . 71.549999999999997 111.998 -175.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 374' ' ' ILE . 11.3 p -62.05 -33.85 75.17 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.637 -0.711 . . . . 74.209999999999994 110.245 174.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.5 98.58 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.011 -0.54 . . . . 71.439999999999998 110.688 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.91 -39.83 79.44 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.847 -0.341 . . . . 72.519999999999996 110.249 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.3 72.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.187 -0.46 . . . . 43.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 370' ' ' SER . 1.7 mp -58.77 -45.26 91.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.661 178.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.55 83.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.169 -0.469 . . . . 72.549999999999997 111.769 -179.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.3 m -61.62 -47.44 85.39 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.585 0.354 . . . . 73.420000000000002 111.229 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.84 -38.67 91.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.619 0.229 . . . . 74.129999999999995 111.619 178.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -46.16 90.12 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.501 0.72 . . . . 74.310000000000002 109.496 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -70.9 -16.62 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.32 -0.854 . . . . 64.120000000000005 112.484 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -87.31 -14.09 41.81 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.583 -0.895 . . . . 72.519999999999996 108.583 176.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.616 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.75 -2.67 55.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-N 115.089 -0.96 . . . . 74.120000000000005 111.976 178.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.72 150.6 34.42 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.162 0.506 . . . . 72.040000000000006 111.271 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 145.03 25.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.26 -1.756 . . . . 75.140000000000001 106.26 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.61 135.72 60.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.887 1.069 . . . . 73.530000000000001 113.887 -174.108 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -111.03 132.07 54.54 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.647 -1.983 . . . . 61.520000000000003 105.647 172.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.1 m -119.52 122.73 42.31 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.236 -0.586 . . . . 71.450000000000003 110.378 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.23 127.45 55.61 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.872 -1.159 . . . . 72.140000000000001 107.872 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.508 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -108.82 122.48 47.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.084 -0.71 . . . . 63.130000000000003 109.084 -179.257 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.2 OUTLIER -122.0 132.77 24.18 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.283 -0.417 . . . . 65.540000000000006 110.76 -177.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -97.56 137.6 0.44 Allowed 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 122.3 2.0 . . . . 74.510000000000005 113.152 176.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 13.8 t70 164.85 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 126.645 1.978 . . . . 74.209999999999994 106.277 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 391' ' ' ASP . 25.9 m -138.27 -8.48 1.52 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 118.901 0.773 . . . . 64.439999999999998 111.909 -179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.79 -3.32 57.5 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 122.156 0.979 . . . . 74.430000000000007 109.601 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 7.4 pt -99.69 151.7 37.55 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 113.982 -1.463 . . . . 74.299999999999997 110.368 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.43 131.91 48.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.302 2.668 . . . . 64.230000000000004 113.932 -178.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -55.3 164.54 3.78 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 124.913 3.742 . . . . 73.129999999999995 113.511 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.419 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 17.1 t70 -55.25 -9.9 0.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.493 1.517 . . . . 73.340000000000003 113.457 -174.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -87.58 124.31 33.37 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.921 -1.14 . . . . 74.519999999999996 107.921 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 44.8 t -63.16 119.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.607 -0.724 . . . . 75.329999999999998 109.845 -173.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.6 tp -90.5 -32.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.587 -0.733 . . . . 74.120000000000005 109.48 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -174.88 169.11 41.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.842 -0.903 . . . . 53.100000000000001 110.842 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.8 p -114.48 -176.69 2.96 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.066 0.947 . . . . 75.129999999999995 108.696 176.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.49 143.49 26.52 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 108.563 -0.903 . . . . 71.340000000000003 108.563 -176.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -37.23 -30.7 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.8 1 C-N-CA 125.394 4.063 . . . . 75.409999999999997 115.593 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.76 -32.15 70.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.126 0.489 . . . . 75.409999999999997 110.972 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.52 25.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.619 -0.718 . . . . 73.349999999999994 110.373 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -88.57 -7.09 57.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.393 -0.822 . . . . 74.0 111.661 -173.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.3 m -95.39 162.22 13.75 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.144 -1.428 . . . . 71.25 107.144 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 28.8 m -74.26 113.34 11.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 120.059 -0.656 . . . . 74.430000000000007 110.16 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.48 165.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.304 -0.862 . . . . 75.409999999999997 109.761 178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.8 m -75.51 141.64 42.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.96 129.93 42.01 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.294 0.569 . . . . 74.319999999999993 110.226 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 103.01 11.14 35.14 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.524 -0.846 . . . . 65.420000000000002 111.896 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.17 173.74 10.97 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.68 -1.23 . . . . 75.420000000000002 107.68 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -110.63 122.62 48.23 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.644 0.735 . . . . 74.409999999999997 111.366 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.8 mm -113.05 133.42 58.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.181 -0.918 . . . . 74.409999999999997 109.779 -175.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -102.69 124.87 49.02 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.479 -0.934 . . . . 72.0 108.479 177.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.48 134.39 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.596 -0.52 . . . . 72.400000000000006 109.596 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -110.05 129.23 55.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.186 -0.672 . . . . 73.310000000000002 109.186 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -128.59 141.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.838 -1.074 . . . . 74.310000000000002 108.211 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 10.6 m -95.9 122.62 38.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.546 -0.862 . . . . 72.510000000000005 110.102 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 59.8 p -117.82 107.48 14.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.758 -0.655 . . . . 75.120000000000005 110.985 -177.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.32 136.62 2.02 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.809 -0.632 . . . . 70.310000000000002 113.486 177.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 71.1 Cg_endo -75.67 155.02 39.82 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.33 2.02 . . . . 73.230000000000004 111.634 178.037 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.21 143.86 30.17 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 74.519999999999996 108.918 174.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.7 mt-30 -127.51 135.53 50.49 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.719 -1.215 . . . . 74.209999999999994 107.719 175.056 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -131.99 157.1 44.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.873 -0.788 . . . . 74.230000000000004 108.873 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.13 138.94 31.0 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.206 -1.405 . . . . 73.209999999999994 107.206 174.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -80.21 113.67 40.67 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.332 -0.618 . . . . 74.019999999999996 109.332 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.65 140.61 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.792 1.661 . . . . 61.130000000000003 109.878 176.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -107.47 97.58 7.3 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.375 1.083 . . . . 72.239999999999995 113.603 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.27 5.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 105.349 -2.093 . . . . 75.140000000000001 105.349 169.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 12.8 m -72.07 -46.42 56.95 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 113.447 -1.706 . . . . 71.540000000000006 110.393 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 23.1 p -65.37 -23.29 66.94 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.208 -0.906 . . . . 63.009999999999998 110.962 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.42 -48.07 7.34 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.461 -0.79 . . . . 73.439999999999998 111.326 -179.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.3 m -143.79 113.41 7.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.251 -178.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -55.48 -51.83 65.64 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.371 1.068 . . . . 74.310000000000002 112.608 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.46 -43.65 96.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.401 . . . . 74.329999999999998 111.212 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.66 -35.06 79.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.822 -0.627 . . . . 73.219999999999999 110.47 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.72 -48.52 81.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 116.012 -0.54 . . . . 63.5 110.666 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.43 -43.3 90.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-N 115.17 -0.923 . . . . 71.129999999999995 109.834 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 71.5 mmtt -66.43 -47.53 72.9 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 110.524 -177.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.57 -41.46 88.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 112.123 -177.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.31 -32.98 73.5 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.574 0.583 . . . . 75.420000000000002 112.574 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.4 m -66.96 -43.26 83.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.842 -0.799 . . . . 75.219999999999999 108.842 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.16 62.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.976 -0.556 . . . . 70.230000000000004 111.042 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.81 -13.11 59.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.413 0.625 . . . . 75.450000000000003 110.005 177.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.36 -6.31 45.79 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-O 119.223 -0.765 . . . . 53.109999999999999 114.016 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.17 130.71 44.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.118 0.959 . . . . 75.439999999999998 110.562 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.6 2.82 10.22 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.061 -1.066 . . . . 73.530000000000001 113.478 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.44 114.29 19.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.895 -0.779 . . . . 73.420000000000002 108.895 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -131.96 161.95 31.88 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.11 0.481 . . . . 75.530000000000001 110.731 -176.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 1.4 tpmt? -149.23 122.94 9.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 74.239999999999995 105.53 172.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -107.74 134.87 50.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.042 0.449 . . . . 72.129999999999995 111.193 -176.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.4 145.35 47.22 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.369 -0.832 . . . . 75.109999999999999 109.12 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 31.2 m-80 -117.65 129.51 55.79 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.372 -1.344 . . . . 63.420000000000002 107.372 175.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.8 t -130.23 147.37 65.46 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.853 -0.795 . . . . 65.230000000000004 108.853 -176.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -61.51 130.99 33.8 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 122.632 2.222 . . . . 74.519999999999996 111.489 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 55.1 p -136.23 -177.93 4.93 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.782 -1.192 . . . . 73.439999999999998 107.782 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 9.1 m -66.12 136.73 95.49 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 106.17 -1.789 . . . . 75.450000000000003 106.17 172.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.15 -28.16 19.06 Favored 'Trans proline' 0 C--O 1.207 -1.058 0 C-N-CA 123.583 2.855 . . . . 71.310000000000002 113.334 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -62.24 -16.76 55.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.496 0.554 . . . . 74.400000000000006 112.496 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -107.59 6.0 27.49 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.108 -0.37 . . . . 71.030000000000001 110.866 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.76 127.44 19.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.446 0.641 . . . . 64.319999999999993 111.807 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.56 -3.37 85.14 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.495 -0.775 . . . . 71.150000000000006 112.692 175.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -112.1 160.79 17.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.499 -0.926 . . . . 72.030000000000001 108.499 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.49 131.34 34.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.588 -0.893 . . . . 73.430000000000007 108.588 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.48 -20.75 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.239 0.543 . . . . 74.120000000000005 111.437 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.35 166.73 30.59 Favored Glycine 0 N--CA 1.418 -2.559 0 C-N-CA 120.46 -0.876 . . . . 64.420000000000002 111.891 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.0 p -125.01 144.2 50.51 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.194 -1.41 . . . . 75.239999999999995 107.194 177.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.7 t-20 -57.41 -48.19 97.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 120.604 -0.438 . . . . 63.119999999999997 110.899 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -78.25 121.04 5.12 Favored 'Trans proline' 0 C--N 1.37 1.66 0 N-CA-C 107.952 -1.595 . . . . 74.030000000000001 107.952 168.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.13 140.79 80.11 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.377 2.052 . . . . 74.340000000000003 112.401 -176.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.423 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.17 11.59 0.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.675 0.79 . . . . 62.119999999999997 112.754 -176.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -109.81 -0.16 18.52 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.882 -0.414 . . . . 73.219999999999999 109.882 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.431 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.1 OUTLIER -124.65 160.99 27.24 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.645 0.735 . . . . 74.239999999999995 111.473 -173.279 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.1 m -91.16 132.69 35.91 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.961 -1.472 . . . . 63.539999999999999 109.732 -177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.2 m -132.11 148.4 52.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.949 -0.76 . . . . 63.340000000000003 108.949 177.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.75 159.67 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.261 0.553 . . . . 44.100000000000001 111.848 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.0 -27.2 31.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.545 0.688 . . . . 74.439999999999998 109.835 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.1 t -88.11 5.12 42.73 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.255 -0.884 . . . . 64.140000000000001 109.905 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.76 136.83 35.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.989 -1.486 . . . . 72.530000000000001 106.989 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 65.0 t -82.57 116.36 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.942 0.401 . . . . 72.340000000000003 109.99 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.81 118.57 33.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.355 -0.98 . . . . 74.329999999999998 108.355 177.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.2 mp -92.78 112.95 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.017 -1.475 . . . . 73.439999999999998 107.017 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.65 118.3 49.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.164 -1.051 . . . . 73.540000000000006 108.164 -177.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 28.8 mt -107.45 119.5 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 121.472 0.654 . . . . 74.439999999999998 109.986 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.439 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 22.1 t -97.99 139.26 20.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.446 -0.946 . . . . 74.040000000000006 108.446 -178.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.87 124.5 7.01 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.193 -0.763 . . . . 61.409999999999997 111.193 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 20.1 t -131.87 103.64 6.43 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.821 -1.177 . . . . 75.25 107.821 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.249 0 N-CA-C 109.756 -1.338 . . . . 71.329999999999998 109.756 179.222 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.867 0 N-CA-C 110.136 -1.186 . . . . 61.109999999999999 110.136 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.46 157.47 43.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 122.535 0.334 . . . . 75.299999999999997 111.104 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.6 t -66.9 131.02 45.02 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 108.577 -0.897 . . . . 63.439999999999998 108.577 173.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -90.29 84.51 6.06 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.461 -0.79 . . . . 74.450000000000003 111.202 -173.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -94.19 131.91 39.28 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.32 -0.993 . . . . 75.239999999999995 108.32 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.41 161.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 116.54 -0.3 . . . . 72.109999999999999 110.832 -173.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 137.08 37.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.388 -0.967 . . . . 75.109999999999999 108.388 175.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.0 135.14 21.54 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.695 -0.483 . . . . 70.519999999999996 109.695 -176.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.6 150.92 86.13 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.256 1.97 . . . . 71.310000000000002 112.012 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.576 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 3.2 p30 -79.09 179.75 7.17 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.384 -0.825 . . . . 74.349999999999994 110.674 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.67 26.4 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 N-CA-C 107.433 -1.321 . . . . 73.439999999999998 107.433 176.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.576 ' HG3' ' OD1' ' A' ' 364' ' ' ASP . 0.9 OUTLIER -66.25 139.47 58.08 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.563 0.579 . . . . 74.230000000000004 112.563 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.65 0.24 59.28 Favored Glycine 0 C--N 1.307 -1.081 0 N-CA-C 111.577 -0.609 . . . . 53.200000000000003 111.577 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -122.57 -168.12 1.68 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.907 0.483 . . . . 70.099999999999994 109.718 -178.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -89.1 158.18 18.04 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.757 0.313 . . . . 75.019999999999996 110.548 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 31.1 t -63.37 -33.73 76.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.831 -0.803 . . . . 70.310000000000002 108.831 173.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.1 88.56 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.556 -0.747 . . . . 75.140000000000001 110.83 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.73 -43.92 87.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.491 -0.559 . . . . 72.439999999999998 109.491 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.5 -45.85 80.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.563 -0.744 . . . . 75.230000000000004 111.788 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.17 -48.06 89.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 123.382 0.426 . . . . 73.430000000000007 110.853 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.51 70.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.374 0.509 . . . . 71.439999999999998 112.374 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.616 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.0 m -61.35 -48.07 82.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.252 -0.431 . . . . 71.530000000000001 111.492 -177.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.92 -37.84 88.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.703 0.287 . . . . 73.129999999999995 111.398 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -60.59 -44.62 96.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.402 0.681 . . . . 73.25 109.879 177.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.08 -22.64 64.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.729 -0.668 . . . . 74.340000000000003 111.284 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.2 mmt180 -84.13 -14.27 50.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.088 0.47 . . . . 74.349999999999994 109.843 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.425 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 99.54 4.68 55.95 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.707 -0.679 . . . . 72.349999999999994 112.554 176.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.88 160.54 17.16 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 120.84 0.353 . . . . 74.200000000000003 110.487 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.37 142.82 32.21 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.69 -1.596 . . . . 74.219999999999999 106.69 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.09 132.61 67.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.996 -0.681 . . . . 75.049999999999997 111.384 -178.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -109.11 126.51 53.27 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 105.751 -1.944 . . . . 72.25 105.751 176.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 m -116.05 118.19 32.2 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 120.305 -0.558 . . . . 73.519999999999996 110.302 -173.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.06 119.18 34.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.097 -1.446 . . . . 74.140000000000001 107.097 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -118.1 133.53 55.82 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.956 -0.757 . . . . 75.409999999999997 108.956 178.177 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -139.47 148.85 58.01 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 109.432 -0.581 . . . . 74.010000000000005 109.432 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.07 136.61 16.51 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 108.158 -1.516 . . . . 74.409999999999997 108.158 167.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t0 -173.15 164.73 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.032 -2.21 . . . . 63.020000000000003 105.032 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.452 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.3 t -115.96 -9.39 11.78 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 118.89 0.768 . . . . 75.129999999999995 110.664 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.8 m -79.5 -18.01 52.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.925 0.869 . . . . 75.319999999999993 109.386 -176.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.7 pt -103.48 150.87 38.47 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 72.049999999999997 110.333 -178.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 46.8 Cg_endo -78.74 -166.74 0.43 Allowed 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 124.425 3.416 . . . . 73.319999999999993 113.123 -174.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 9.3 Cg_endo -55.74 163.91 5.03 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.292 2.661 . . . . 71.239999999999995 112.011 168.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.44 -7.89 0.46 Allowed 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.886 1.674 . . . . 51.200000000000003 113.631 -174.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -73.28 116.63 14.05 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.309 -0.997 . . . . 63.539999999999999 108.309 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.87 119.2 11.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.384 -0.825 . . . . 75.329999999999998 110.817 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.93 -27.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.695 -0.684 . . . . 73.230000000000004 111.682 -177.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.08 158.33 27.65 Favored Glycine 0 N--CA 1.423 -2.19 0 C-N-CA 120.021 -1.085 . . . . 73.329999999999998 110.652 -178.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -113.22 -178.21 3.32 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.758 -0.46 . . . . 75.519999999999996 109.758 -178.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.93 131.99 22.65 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 108.338 -0.986 . . . . 65.519999999999996 108.338 -177.068 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -44.32 -32.52 5.29 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 124.521 3.481 . . . . 73.219999999999999 115.158 -176.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.89 68.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.371 -0.377 . . . . 61.200000000000003 111.581 -177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.54 79.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.44 0.638 . . . . 71.319999999999993 110.579 178.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -88.81 1.07 55.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.202 -0.599 . . . . 70.140000000000001 111.118 -178.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.7 m -86.35 150.04 24.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.715 -1.217 . . . . 73.420000000000002 107.715 172.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.58 112.43 10.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.53 169.98 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.859 -0.609 . . . . 75.219999999999999 110.77 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -63.19 142.99 58.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.754 -0.657 . . . . 63.130000000000003 109.967 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.96 109.74 2.65 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.562 -0.533 . . . . 74.420000000000002 109.562 177.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 106.01 33.56 3.46 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.578 -0.82 . . . . 74.430000000000007 112.079 -178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -90.4 177.26 6.44 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.084 -1.08 . . . . 63.450000000000003 108.084 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.04 120.17 36.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.22 0.533 . . . . 72.510000000000005 111.158 -177.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.84 126.03 59.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.126 -1.435 . . . . 75.209999999999994 107.126 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.1 t -93.62 125.21 38.1 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.275 1.036 . . . . 72.030000000000001 111.556 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.02 120.01 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 73.239999999999995 107.655 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.82 119.11 32.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.813 -0.63 . . . . 53.420000000000002 109.301 178.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 21.5 t -117.22 142.12 32.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.617 -0.72 . . . . 75.439999999999998 109.809 -175.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 1.9 p -102.27 121.55 42.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 116.071 -0.513 . . . . 63.020000000000003 110.309 177.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.1 p -119.75 105.46 11.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.236 -0.585 . . . . 74.129999999999995 110.861 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.93 120.74 0.18 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 121.143 -0.551 . . . . 72.340000000000003 113.639 178.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 55.7 Cg_endo -75.22 128.95 11.71 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.239 1.959 . . . . 74.319999999999993 111.654 176.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -73.33 135.1 44.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.351 0.871 . . . . 75.099999999999994 113.351 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.5 mt-30 -128.04 142.44 51.22 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.28 -1.378 . . . . 63.119999999999997 107.28 172.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -129.56 151.78 49.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.642 -0.873 . . . . 74.310000000000002 108.642 -178.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 39.9 mt-10 -83.45 133.91 34.89 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.886 -0.413 . . . . 74.510000000000005 109.886 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 61.2 mt -81.96 128.53 68.06 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.507 -1.294 . . . . 63.229999999999997 107.507 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.87 140.37 35.03 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 121.141 1.228 . . . . 72.219999999999999 111.122 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.29 72.62 5.33 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.057 0.932 . . . . 73.129999999999995 110.813 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.1 16.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.953 -1.476 . . . . 74.109999999999999 108.454 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -81.26 -24.85 37.04 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.991 -1.004 . . . . 71.040000000000006 110.586 -175.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 3.1 p -69.26 -13.73 62.56 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 113.103 0.779 . . . . 72.209999999999994 113.103 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.61 -47.63 72.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.642 0.608 . . . . 72.439999999999998 112.642 -177.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.1 m -162.37 137.94 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.394 -0.965 . . . . 75.129999999999995 108.394 -178.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -53.77 -50.12 66.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.8 0.44 . . . . 72.439999999999998 111.826 178.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.98 90.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.361 0.413 . . . . 72.120000000000005 111.076 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 72.9 mm-40 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 71.319999999999993 111.17 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.09 92.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.82 0.7 . . . . 74.439999999999998 110.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.84 -42.51 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 64.510000000000005 109.975 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -67.08 -44.99 78.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.288 -0.414 . . . . 74.530000000000001 111.036 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 32.9 mmmt -61.97 -46.28 89.95 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.009 0.193 . . . . 75.040000000000006 110.887 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.18 81.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.486 0.551 . . . . 72.519999999999996 112.486 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 64.0 m -62.44 -40.85 97.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.807 -0.442 . . . . 65.530000000000001 109.807 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.45 -29.75 68.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.040000000000006 111.206 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -6.75 57.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 73.420000000000002 111.198 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.2 -2.82 33.14 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.06 -0.59 . . . . 73.310000000000002 113.412 175.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -93.63 96.0 9.56 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.665 -0.495 . . . . 74.109999999999999 109.665 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -104.38 -3.91 43.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.115 -0.794 . . . . 63.119999999999997 111.115 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -93.92 112.08 23.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.514 -0.921 . . . . 72.120000000000005 108.514 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.67 150.99 48.68 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.469 0.652 . . . . 72.340000000000003 112.011 -175.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -134.28 122.41 22.67 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 105.067 -2.197 . . . . 73.340000000000003 105.067 172.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -97.9 129.81 44.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.07 -0.652 . . . . 53.140000000000001 112.435 -174.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.69 150.97 50.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.142 -1.429 . . . . 72.409999999999997 107.142 175.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.551 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 35.9 m-80 -129.44 149.5 51.19 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.634 -0.506 . . . . 73.129999999999995 109.634 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.2 t -128.97 133.61 25.4 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 107.438 -1.319 . . . . 73.230000000000004 107.438 177.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.5 Cg_exo -61.9 118.73 5.63 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.493 1.462 . . . . 72.150000000000006 108.622 176.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.9 m -128.07 168.27 15.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.188 0.518 . . . . 74.430000000000007 111.852 -172.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 21.0 p -69.55 151.89 96.49 Favored Pre-proline 0 N--CA 1.417 -2.095 0 CA-C-N 114.705 -1.134 . . . . 72.25 110.452 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.513 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.2 Cg_endo -52.13 -24.48 20.26 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.827 3.018 . . . . 65.519999999999996 114.937 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.44 -30.56 57.42 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.721 -0.612 . . . . 74.120000000000005 112.282 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.71 -3.26 49.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.178 0.436 . . . . 64.109999999999999 112.178 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.2 p -60.2 127.16 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.116 0.484 . . . . 71.530000000000001 110.636 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.57 82.58 Favored Glycine 0 C--O 1.248 1.009 0 CA-C-N 115.773 -0.649 . . . . 53.100000000000001 111.746 177.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -110.66 154.37 23.92 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.019 -0.734 . . . . 73.200000000000003 109.019 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 434' ' ' THR . 57.5 t -84.61 135.06 25.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 N-CA-C 106.644 -1.613 . . . . 54.030000000000001 106.644 175.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.43 -27.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.042 -1.463 . . . . 75.120000000000005 110.687 178.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.01 163.7 34.0 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.797 -0.921 . . . . 74.109999999999999 110.797 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.6 p -119.02 154.49 33.01 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.941 -1.133 . . . . 73.0 107.941 177.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.439 ' HB3' ' HB ' ' A' ' 485' ' ' ILE . 24.4 t-20 -69.38 -51.26 17.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 119.619 -0.833 . . . . 65.129999999999995 110.627 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 22.5 Cg_exo -68.35 141.32 51.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 107.443 -1.791 . . . . 64.420000000000002 107.443 168.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.19 126.85 19.56 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 122.168 1.912 . . . . 71.409999999999997 112.984 -175.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.19 4.47 26.57 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.144 -0.934 . . . . 72.010000000000005 111.785 -175.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.6 OUTLIER -109.67 -11.62 14.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.351 175.537 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -114.08 -179.73 3.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.606 1.706 . . . . 72.030000000000001 115.606 -168.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.8 m -88.2 116.18 26.22 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.866 -1.97 . . . . 72.340000000000003 110.676 -174.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.8 m -121.36 148.18 44.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.19 -0.67 . . . . 73.510000000000005 109.19 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.9 149.18 50.06 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 122.392 0.277 . . . . 72.099999999999994 111.122 -177.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 43.2 mm -68.9 -26.02 31.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.195 0.521 . . . . 75.120000000000005 111.019 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -88.83 -0.5 57.41 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.501 -0.75 . . . . 52.009999999999998 110.049 177.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -70.42 130.94 43.24 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.473 -0.566 . . . . 74.310000000000002 109.473 -176.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.87 113.18 18.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.564 -1.273 . . . . 74.209999999999994 107.564 177.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.1 t -87.16 120.06 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-O 121.321 0.581 . . . . 74.540000000000006 109.871 -176.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 45.4 mt -91.2 112.28 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.605 -1.998 . . . . 73.439999999999998 105.605 177.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 121.45 60.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.667 0 CA-C-N 115.016 -0.993 . . . . 72.329999999999998 108.404 -174.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 2.4 mp -99.22 117.87 44.97 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.767 0.794 . . . . 75.040000000000006 109.049 -177.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.551 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 26.7 t -97.66 141.36 16.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.809 -1.087 . . . . 64.549999999999997 108.54 -176.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -89.4 116.81 4.79 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.49 -1.444 . . . . 72.140000000000001 109.49 175.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.0 t -136.6 138.93 41.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.006 -1.109 . . . . 75.530000000000001 108.006 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.562 0 N-CA-C 108.555 -1.818 . . . . 55.420000000000002 108.555 179.675 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.928 0 N-CA-C 110.261 -1.136 . . . . 73.129999999999995 110.261 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -104.22 157.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.977 0.388 . . . . 73.439999999999998 111.842 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.0 t -145.39 166.21 26.25 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.618 -1.623 . . . . 73.510000000000005 106.618 176.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -87.23 45.36 1.26 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.896 0.855 . . . . 74.200000000000003 111.11 -175.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 411' ' ' SER . 28.1 m-20 -131.67 133.07 44.5 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.491 -1.67 . . . . 71.310000000000002 106.491 178.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.97 165.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 114.682 1.364 . . . . 71.439999999999998 114.682 -166.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -93.11 137.03 32.83 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.507 -1.664 . . . . 74.099999999999994 106.507 174.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.66 141.61 23.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.109 -0.636 . . . . 74.200000000000003 111.078 -171.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.63 129.92 16.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.569 1.513 . . . . 72.319999999999993 111.435 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 8.1 p-10 -80.12 133.78 36.11 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.355 -0.839 . . . . 63.009999999999998 110.372 -179.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.9 t -87.74 47.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.443 1.116 . . . . 73.140000000000001 110.513 -172.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.3 ptm180 -66.88 139.97 57.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.134 -0.939 . . . . 75.25 111.544 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.05 0.18 60.15 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 116.117 -0.492 . . . . 73.129999999999995 112.906 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -120.35 175.35 6.01 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 122.509 -0.406 . . . . 74.150000000000006 110.154 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.3 p -72.98 157.24 37.8 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.218 -0.29 . . . . 54.100000000000001 110.218 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.487 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.2 p -59.78 -39.05 83.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.848 -0.427 . . . . 72.109999999999999 109.848 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.77 93.25 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.412 -0.813 . . . . 70.439999999999998 111.993 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -67.13 -41.99 85.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 -178.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.3 78.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.421 -0.809 . . . . 64.209999999999994 111.189 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 370' ' ' SER . 98.7 mt -58.63 -44.83 90.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.577 -0.527 . . . . 75.450000000000003 109.577 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.66 74.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.25 -0.886 . . . . 62.109999999999999 112.063 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 29.1 m -66.12 -48.66 70.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.415 0.626 . . . . 74.120000000000005 109.872 -179.016 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.89 -39.83 91.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.782 -0.645 . . . . 74.439999999999998 110.581 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.6 -44.9 96.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 74.140000000000001 110.668 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -70.08 -21.31 63.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.153 0.501 . . . . 64.549999999999997 111.261 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -86.98 -14.65 41.08 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.158 -0.474 . . . . 72.299999999999997 111.458 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.26 8.05 66.89 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.261 -0.971 . . . . 75.0 112.657 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -75.36 163.75 27.12 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.158 -0.682 . . . . 73.5 109.158 178.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.8 mmtm -103.29 132.85 49.22 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.349 -0.982 . . . . 74.5 108.349 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.17 153.87 39.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 121.742 0.782 . . . . 74.109999999999999 112.823 -175.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -123.33 128.23 49.64 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.529 -1.669 . . . . 64.329999999999998 106.78 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.6 m -106.25 117.75 34.85 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.114 -1.069 . . . . 74.420000000000002 108.114 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.4 tm? -111.66 118.93 37.0 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 107.741 -1.207 . . . . 74.049999999999997 107.741 -176.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.41 122.2 46.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.32 -0.993 . . . . 75.0 108.32 174.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -125.87 136.29 28.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 C-N-CA 120.446 -0.502 . . . . 72.340000000000003 111.706 -176.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.416 ' C ' ' HG3' ' A' ' 425' ' ' GLU . 2.4 Cg_endo -85.51 131.43 4.04 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 122.197 1.932 . . . . 72.519999999999996 108.163 167.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -175.3 -173.67 0.67 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.431 -2.063 . . . . 73.5 105.431 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 49.7 m -117.36 -6.6 11.24 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.943 0.877 . . . . 63.329999999999998 109.116 175.032 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.9 m -98.36 35.45 1.78 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.717 -1.586 . . . . 75.340000000000003 106.717 175.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.4 pp -88.33 146.43 37.86 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.893 -1.049 . . . . 73.230000000000004 112.131 -176.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.09 178.44 5.89 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.148 1.899 . . . . 70.310000000000002 109.399 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 398' ' ' HIS . 16.5 Cg_exo -71.28 161.37 45.95 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 121.609 1.539 . . . . 75.049999999999997 110.648 172.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -9.0 3.52 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.418 1.104 . . . . 75.239999999999995 111.095 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 396' ' ' PRO . 34.0 m80 -110.42 137.07 48.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 105.379 -2.082 . . . . 74.400000000000006 105.379 -179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.54 118.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 123.453 0.471 . . . . 63.109999999999999 109.748 -173.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.424 ' O ' HD11 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.31 -29.32 4.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.769 -1.567 . . . . 72.209999999999994 106.769 178.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.66 168.6 41.67 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 108.995 -1.642 . . . . 61.25 108.995 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 402' ' ' THR . . . . . 0.421 ' OG1' ' HB2' ' A' ' 364' ' ' ASP . 10.9 m -114.33 -177.07 3.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.583 -1.636 . . . . 72.400000000000006 106.583 178.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -97.53 140.06 21.77 Favored Pre-proline 0 C--N 1.26 -3.307 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 -175.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -33.81 -30.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 1 C-N-CA 126.209 4.606 . . . . 75.510000000000005 115.53 -177.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.82 47.16 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 123.611 0.765 . . . . 74.230000000000004 112.014 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.87 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 74.349999999999994 111.612 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -81.56 -0.6 42.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.837 0.68 . . . . 74.420000000000002 112.837 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 58.8 m -88.37 155.68 19.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.12 -1.437 . . . . 74.299999999999997 107.12 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.7 m -73.12 114.02 10.82 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.492 0.663 . . . . 74.310000000000002 109.273 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.74 170.29 5.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.305 -0.861 . . . . 72.25 109.537 -178.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 411' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 8.5 t -71.01 149.14 46.92 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 109.219 -0.66 . . . . 74.439999999999998 109.219 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.22 109.66 2.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.442 -0.948 . . . . 73.219999999999999 108.442 177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.36 32.62 9.36 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.923 -0.871 . . . . 50.310000000000002 110.923 -176.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.6 t0 -87.05 -174.9 5.13 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 107.831 -1.174 . . . . 63.109999999999999 107.831 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 7.9 pt-20 -97.45 138.11 35.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.51 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -125.01 124.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.933 -1.136 . . . . 73.209999999999994 107.933 175.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -90.86 125.95 35.89 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.846 0.831 . . . . 71.349999999999994 110.533 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.99 117.71 56.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.15 -1.055 . . . . 70.299999999999997 108.15 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 5.3 p30 -106.33 129.44 54.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.308 0.575 . . . . 74.239999999999995 112.468 -177.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.8 152.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.763 -1.108 . . . . 73.420000000000002 108.588 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.439 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 31.1 p -88.56 123.29 32.91 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.672 0.619 . . . . 71.120000000000005 112.672 -174.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 p -119.87 103.46 9.36 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.13 -1.028 . . . . 73.430000000000007 110.067 169.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.13 0.12 Allowed Glycine 0 CA--C 1.553 2.428 0 N-CA-C 115.473 0.949 . . . . 74.209999999999994 115.473 177.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.8 Cg_endo -85.47 133.65 4.61 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.202 1.935 . . . . 71.209999999999994 110.652 173.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.416 ' HG3' ' C ' ' A' ' 390' ' ' PRO . 10.0 mt-10 -76.44 145.19 39.45 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 113.167 0.803 . . . . 75.329999999999998 113.167 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.9 mt-30 -120.66 157.23 30.04 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.183 -1.371 . . . . 74.420000000000002 108.748 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -143.17 156.62 44.81 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.413 -1.329 . . . . 73.439999999999998 107.413 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.8 138.86 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.132 -1.062 . . . . 72.420000000000002 108.132 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -79.52 132.14 62.84 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 75.349999999999994 108.687 -177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -53.19 141.53 58.64 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.607 2.205 . . . . 74.140000000000001 113.224 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.13 -17.72 48.91 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.505 -1.225 . . . . 73.010000000000005 112.19 -175.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.5 m -75.47 5.41 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.448 0.907 . . . . 64.230000000000004 113.448 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 48.3 m -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.264 0.839 . . . . 72.319999999999993 113.264 -175.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 52.5 m -68.92 -13.91 62.72 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.973 0.509 . . . . 74.140000000000001 112.365 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.16 -45.51 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.61 0.596 . . . . 73.040000000000006 112.61 -175.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 48.1 m -162.73 145.22 10.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.525 -1.287 . . . . 72.319999999999993 107.525 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -56.84 -42.93 80.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.329 . . . . 74.010000000000005 111.102 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -62.62 -36.76 83.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 71.019999999999996 111.048 179.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.8 -44.77 76.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.07 -0.715 . . . . 64.340000000000003 109.07 -178.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.18 70.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.545 -1.207 . . . . 72.230000000000004 110.773 -179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.43 -38.29 80.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 -177.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.8 mmtt -65.3 -49.02 71.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.9 -0.72 . . . . 74.319999999999993 110.166 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.01 -42.57 84.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.116 0.784 . . . . 74.299999999999997 113.116 -177.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.37 -43.69 76.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.231 0.456 . . . . 71.5 112.231 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -63.31 -41.86 98.97 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.951 0.405 . . . . 72.299999999999997 110.628 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.0 -24.64 62.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.96 -0.564 . . . . 63.149999999999999 111.602 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.56 -5.83 59.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 70.209999999999994 111.453 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.59 -17.73 25.47 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.473 -0.87 . . . . 63.030000000000001 112.204 178.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.04 67.89 7.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.201 0.524 . . . . 74.129999999999995 109.921 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -96.2 32.49 6.38 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.67 -0.972 . . . . 75.420000000000002 110.67 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -118.7 110.42 17.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.023 -1.843 . . . . 65.120000000000005 106.023 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.89 154.15 47.6 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.339 1.066 . . . . 74.299999999999997 113.084 -176.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.58 123.11 12.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 104.998 -2.223 . . . . 74.430000000000007 104.998 168.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -98.11 135.34 39.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.207 0.527 . . . . 74.329999999999998 111.469 -172.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.416 ' C ' HD21 ' A' ' 456' ' ' ASN . . . -127.09 148.01 50.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.425 -1.324 . . . . 65.420000000000002 107.425 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.416 HD21 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -124.44 141.42 52.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.088 -1.078 . . . . 63.520000000000003 108.088 178.253 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.2 m -140.36 147.14 48.51 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 108.862 -0.792 . . . . 74.439999999999998 108.862 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 490' ' ' SER . 33.8 Cg_exo -61.45 129.66 28.95 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.708 2.272 . . . . 75.299999999999997 111.678 -176.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -145.83 164.68 31.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 111.035 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -61.37 144.6 91.75 Favored Pre-proline 0 N--CA 1.442 -0.864 0 O-C-N 124.27 0.981 . . . . 74.120000000000005 110.463 178.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.37 -34.28 31.93 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.996 3.131 . . . . 74.219999999999999 113.832 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.77 -15.3 62.66 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.381 0.511 . . . . 75.530000000000001 112.381 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 -8.52 14.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.504 -0.316 . . . . 75.450000000000003 111.775 176.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 81.3 t -60.35 126.94 19.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 120.953 0.406 . . . . 74.319999999999993 110.546 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.87 -3.16 70.36 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 110.962 -0.855 . . . . 75.099999999999994 110.962 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -116.38 155.44 28.48 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.086 -1.079 . . . . 75.310000000000002 108.086 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 486' ' ' ILE . 45.5 t -84.57 127.36 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.511 -0.551 . . . . 62.420000000000002 109.511 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.85 -18.14 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.929 -0.708 . . . . 74.120000000000005 111.405 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.19 161.7 28.04 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.574 -0.822 . . . . 73.140000000000001 111.708 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 15.9 p -132.92 155.47 49.01 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.366 -1.346 . . . . 73.439999999999998 107.366 177.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -59.53 -57.85 23.87 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 120.516 -0.474 . . . . 73.329999999999998 110.103 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.19 125.21 5.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 109.09 -1.158 . . . . 74.519999999999996 109.09 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -62.36 144.17 94.7 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.057 1.838 . . . . 72.109999999999999 112.044 -177.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -73.29 5.98 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.159 0.984 . . . . 65.319999999999993 112.674 -174.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -109.0 -14.51 14.54 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 110.029 176.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.97 150.64 20.18 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.156 0.979 . . . . 74.239999999999995 111.717 -172.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 19.4 m -85.23 111.42 19.82 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 113.588 -1.642 . . . . 71.219999999999999 107.769 178.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.0 m -118.19 148.56 42.25 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.917 -0.583 . . . . 73.120000000000005 110.036 -175.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.58 146.72 52.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 122.587 0.355 . . . . 70.430000000000007 110.781 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.597 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 48.3 mm -67.21 -14.68 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 CA-C-O 122.171 0.986 . . . . 74.510000000000005 110.306 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.0 t -92.16 5.52 50.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.603 -0.726 . . . . 71.310000000000002 110.358 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.459 ' ND2' ' HB1' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -89.66 133.76 34.49 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 110.062 -0.347 . . . . 72.329999999999998 110.062 178.399 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 122.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.855 -1.165 . . . . 71.209999999999994 107.855 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.77 119.79 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 120.19 -0.604 . . . . 75.319999999999993 109.49 -178.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.35 112.51 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.596 -2.372 . . . . 75.510000000000005 104.596 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.73 118.93 56.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 114.959 -1.018 . . . . 74.120000000000005 108.754 -173.528 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 41.2 mt -100.16 116.49 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.994 -0.743 . . . . 74.129999999999995 108.994 -177.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.6 138.14 23.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.692 -1.225 . . . . 73.519999999999996 107.692 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.48 114.69 3.93 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.285 -1.526 . . . . 64.340000000000003 109.285 177.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.7 m -142.9 143.93 32.23 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 122.009 -0.7 . . . . 74.140000000000001 109.667 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.364 0 N-CA-C 108.693 -1.763 . . . . 53.130000000000003 108.693 178.252 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.86 0 N-CA-C 111.171 -0.771 . . . . 72.349999999999994 111.171 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.47 157.75 23.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.829 0.314 . . . . 70.140000000000001 111.075 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.4 t -132.47 162.86 30.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.457 -0.571 . . . . 71.150000000000006 109.457 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.414 ' HA ' ' HE ' ' A' ' 358' ' ' ARG . 3.5 mmp_? -114.21 92.96 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.608 0.718 . . . . 73.450000000000003 110.046 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -117.88 145.15 44.83 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.675 -1.602 . . . . 72.030000000000001 106.675 177.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.94 149.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.585 0.231 . . . . 74.420000000000002 110.45 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.8 136.48 36.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.637 -0.875 . . . . 74.109999999999999 108.637 177.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.86 127.49 37.04 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 120.329 -0.548 . . . . 75.109999999999999 110.389 -175.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -56.05 148.83 56.34 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.086 2.524 . . . . 60.0 113.388 179.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 146.3 53.03 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.392 -0.822 . . . . 74.230000000000004 111.493 -178.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.531 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 24.2 m -96.37 25.31 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 122.337 1.065 . . . . 72.040000000000006 109.659 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -65.32 137.17 57.35 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.778 -1.101 . . . . 75.439999999999998 111.995 -177.276 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.43 0.91 47.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.451 -0.88 . . . . 73.450000000000003 114.001 176.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 1.8 pt20 -125.83 -172.16 2.54 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.193 -0.669 . . . . 55.219999999999999 109.193 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.3 p -90.11 164.48 14.45 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.81 -0.756 . . . . 74.310000000000002 109.701 179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 374' ' ' ILE . 3.8 p -62.09 -33.61 74.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.798 0.332 . . . . 74.239999999999995 110.305 175.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.66 98.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.794 -0.639 . . . . 73.420000000000002 109.962 176.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.321 -0.4 . . . . 72.25 110.108 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.29 70.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.763 0.665 . . . . 72.219999999999999 110.47 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 370' ' ' SER . 91.0 mt -60.25 -46.51 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.646 -0.706 . . . . 74.0 110.046 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.29 -46.99 84.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.105 -0.498 . . . . 74.200000000000003 111.905 -178.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.83 -47.84 76.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.516 -0.311 . . . . 74.230000000000004 110.431 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.17 -38.01 89.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.561 -0.29 . . . . 73.120000000000005 111.695 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -59.77 -46.92 87.67 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.601 0.76 . . . . 74.010000000000005 109.11 177.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -67.97 -30.73 70.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.558 -0.746 . . . . 72.349999999999994 111.193 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -80.09 -11.29 59.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.839 -0.619 . . . . 64.140000000000001 111.917 178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.72 12.46 58.04 Favored Glycine 0 CA--C 1.497 -1.034 0 C-N-CA 120.284 -0.96 . . . . 62.539999999999999 112.953 174.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.21 146.46 24.74 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.972 0.415 . . . . 74.049999999999997 109.954 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 34.0 mmtp -88.3 132.82 34.25 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.832 -1.914 . . . . 74.530000000000001 105.832 -178.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 141.45 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 119.899 -0.72 . . . . 73.310000000000002 111.674 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -115.99 127.98 55.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.175 -1.417 . . . . 75.310000000000002 107.175 177.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.6 m -101.06 119.27 38.5 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.597 -0.841 . . . . 73.140000000000001 109.709 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -111.73 119.65 39.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.64 -1.244 . . . . 74.430000000000007 107.64 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.446 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -96.27 122.6 39.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.648 -0.706 . . . . 72.209999999999994 109.25 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -123.79 115.89 27.87 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 115.737 -0.665 . . . . 73.439999999999998 111.883 -177.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.59 134.7 6.62 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.18 1.92 . . . . 64.530000000000001 110.569 174.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.5 t70 175.71 -168.42 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 105.396 -2.076 . . . . 74.040000000000006 105.396 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.6 m -132.43 -11.0 3.2 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 118.38 0.537 . . . . 74.319999999999993 111.42 176.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 44.9 p -99.13 14.35 29.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.357 1.075 . . . . 63.100000000000001 109.5 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 1.5 pp -88.59 152.6 49.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 CA-C-N 113.877 -1.511 . . . . 74.010000000000005 112.583 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.66 138.65 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.152 1.901 . . . . 73.140000000000001 109.921 174.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.25 154.5 40.05 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.796 2.33 . . . . 64.120000000000005 111.893 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.32 -8.48 3.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.506 0.67 . . . . 74.530000000000001 111.866 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -95.66 109.19 21.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.143 -2.169 . . . . 74.209999999999994 105.143 172.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.8 119.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.232 1.015 . . . . 72.030000000000001 112.85 -169.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.46 -29.02 3.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.063 -1.426 . . . . 73.5 110.504 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.54 28.88 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.029 -1.228 . . . . 71.430000000000007 110.029 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 -175.23 2.63 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.874 -0.787 . . . . 73.349999999999994 108.874 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.31 140.93 21.83 Favored Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 115.777 -0.647 . . . . 75.319999999999993 109.795 -172.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.27 -24.77 6.24 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 125.077 3.852 . . . . 64.120000000000005 115.059 -177.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.01 -29.34 69.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.591 0.234 . . . . 53.420000000000002 110.981 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.33 57.96 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 121.673 0.749 . . . . 73.25 110.13 178.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.4 -9.68 59.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.359 -0.837 . . . . 75.310000000000002 110.733 -178.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.2 m -87.53 151.08 23.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.613 -0.884 . . . . 73.430000000000007 108.613 177.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 66.3 m -74.17 116.81 15.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.412 0.625 . . . . 72.109999999999999 109.636 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.09 169.97 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.444 -0.798 . . . . 73.150000000000006 109.501 -177.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.0 t -79.02 155.4 28.85 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.746 -1.205 . . . . 74.030000000000001 107.746 176.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.3 110.74 4.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.244 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.07 37.7 1.63 Allowed Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.585 -0.734 . . . . 75.329999999999998 111.707 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.31 178.57 5.93 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.722 -1.214 . . . . 71.140000000000001 107.722 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.0 mt-10 -100.19 108.97 21.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 111.525 -176.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.01 126.78 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.377 -1.342 . . . . 75.0 107.377 177.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 72.5 p -90.71 123.49 34.34 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.296 -0.562 . . . . 54.100000000000001 109.763 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.34 121.07 47.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.18 -1.045 . . . . 75.299999999999997 108.18 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -92.24 124.6 36.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.313 -0.625 . . . . 71.510000000000005 109.313 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.7 p -126.26 131.03 71.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.89 -1.152 . . . . 72.150000000000006 107.89 175.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 39.9 m -94.4 122.13 36.65 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.413 -0.915 . . . . 74.040000000000006 108.945 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 19.8 m -119.36 107.07 12.92 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.527 -0.761 . . . . 74.540000000000006 110.623 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 80.02 147.5 4.65 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 121.244 -0.503 . . . . 54.409999999999997 113.482 177.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.4 Cg_endo -85.01 154.48 11.22 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.186 1.924 . . . . 74.340000000000003 110.762 174.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 4.5 mm-40 -83.43 126.64 32.96 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 119.97 -0.692 . . . . 74.010000000000005 111.347 176.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 48.3 mt-30 -100.7 127.69 47.01 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.616 -1.253 . . . . 73.540000000000006 107.616 175.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 449' ' ' PHE . 10.1 tpt180 -122.2 149.41 43.7 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.941 -1.133 . . . . 71.439999999999998 107.941 -173.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -83.11 138.61 33.61 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 122.83 0.452 . . . . 75.319999999999993 111.423 -176.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.6 131.38 40.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 109.849 -0.426 . . . . 75.209999999999994 109.849 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -70.36 141.73 43.54 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.152 2.568 . . . . 71.209999999999994 113.443 176.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.01 -22.25 31.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.913 0.885 . . . . 72.329999999999998 110.061 -178.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.21 -3.55 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 121.877 0.846 . . . . 62.109999999999999 111.223 -175.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 8.7 p -61.03 -31.87 71.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.222 1.009 . . . . 74.319999999999993 111.409 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.4 m -67.38 -26.58 66.53 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.707 0.803 . . . . 73.120000000000005 112.537 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.34 -41.67 47.56 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.583 0.586 . . . . 72.439999999999998 112.583 -172.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.5 m -148.01 139.72 23.84 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.135 -0.691 . . . . 75.109999999999999 109.135 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -61.19 -38.86 88.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.669 -0.493 . . . . 74.510000000000005 109.669 176.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.13 -47.74 84.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.773 -0.649 . . . . 74.420000000000002 110.336 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -36.61 84.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.192 0.307 . . . . 64.239999999999995 111.649 177.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.403 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.43 -51.35 69.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.086 -0.338 . . . . 71.129999999999995 110.086 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.85 -45.76 90.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.278 -0.419 . . . . 75.530000000000001 110.657 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -63.45 -47.41 81.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.477 0.547 . . . . 74.319999999999993 112.477 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -66.28 -40.87 90.35 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.837 0.31 . . . . 72.409999999999997 111.837 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.62 -43.44 89.57 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.552 -0.459 . . . . 74.420000000000002 110.908 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 75.5 m -62.68 -40.49 97.28 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 110.015 -0.365 . . . . 72.420000000000002 110.015 178.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.2 -26.52 64.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.265 -0.425 . . . . 62.340000000000003 111.965 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.96 -13.65 50.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.749 -0.205 . . . . 73.239999999999995 111.25 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.48 -0.03 26.33 Favored Glycine 0 C--N 1.319 -0.409 0 C-N-CA 120.267 -0.968 . . . . 63.420000000000002 113.023 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 81.5 m-85 -83.62 106.91 15.72 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 122.527 -0.396 . . . . 75.219999999999999 110.016 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.4 19.3 13.08 Favored Glycine 0 C--N 1.297 -1.606 0 N-CA-C 110.009 -1.236 . . . . 53.119999999999997 110.009 176.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -113.12 111.02 21.4 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.172 -1.788 . . . . 63.100000000000001 106.172 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -131.46 148.66 52.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 72.450000000000003 111.63 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -142.16 123.04 14.41 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.935 -1.505 . . . . 73.420000000000002 106.935 172.2 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -104.1 135.76 45.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.916 0.339 . . . . 74.099999999999994 111.916 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.66 156.15 47.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.71 -0.478 . . . . 65.329999999999998 109.71 175.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.78 137.96 54.26 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.799 -0.815 . . . . 74.439999999999998 108.799 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 47.6 m -141.55 147.66 46.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 120.482 -0.487 . . . . 71.409999999999997 111.14 178.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_endo -65.98 125.49 14.26 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.973 2.449 . . . . 65.310000000000002 111.328 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 16.5 t -138.88 -176.49 4.51 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.318 -1.364 . . . . 61.43 107.318 -176.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.6 m -56.64 129.79 76.81 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.898 -0.778 . . . . 74.319999999999993 108.898 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.01 -25.64 12.93 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 124.023 3.149 . . . . 65.329999999999998 114.262 -178.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.41 -24.36 57.12 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.801 0.334 . . . . 73.540000000000006 111.683 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.64 12.18 34.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.639 -0.255 . . . . 71.129999999999995 111.51 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.55 126.39 17.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.849 0.833 . . . . 73.409999999999997 110.787 177.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.17 -6.86 72.51 Favored Glycine 0 C--N 1.306 -1.106 0 CA-C-N 115.194 -0.912 . . . . 72.030000000000001 111.74 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -100.88 152.21 20.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.627 -0.508 . . . . 73.299999999999997 109.627 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.6 136.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.828 -0.805 . . . . 75.439999999999998 108.828 -179.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.04 -16.59 7.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.179 -1.008 . . . . 75.5 110.734 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.91 -179.27 26.81 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.38 -0.827 . . . . 74.319999999999993 111.714 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.9 p -116.82 161.87 18.6 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.286 -1.376 . . . . 75.109999999999999 107.286 178.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.17 -54.58 32.12 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.801 -1.16 . . . . 74.030000000000001 110.602 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.43 120.39 6.92 Favored 'Trans proline' 0 C--N 1.372 1.811 0 N-CA-C 105.963 -2.36 . . . . 73.120000000000005 105.963 166.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.7 Cg_endo -62.68 158.76 40.26 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 122.173 1.915 . . . . 64.549999999999997 113.798 -171.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.6 11.82 0.44 Allowed 'General case' 0 C--O 1.21 -0.975 0 CA-C-O 122.377 1.084 . . . . 72.349999999999994 111.6 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -109.13 -8.09 15.21 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.725 -1.213 . . . . 71.010000000000005 107.725 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -100.39 159.66 14.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.072 -0.967 . . . . 71.010000000000005 111.99 -171.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.1 m -114.66 108.12 16.39 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.428 -1.693 . . . . 74.099999999999994 106.428 177.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.8 p -112.24 143.19 43.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 122.128 -0.358 . . . . 71.450000000000003 111.954 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -63.99 144.37 57.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 72.420000000000002 110.34 176.051 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.17 -4.57 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.424 1.089 . . . . 74.439999999999998 111.758 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.7 p -87.17 -5.88 58.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.321 -0.862 . . . . 75.109999999999999 110.377 178.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -92.46 139.05 30.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.795 -0.639 . . . . 75.239999999999995 109.405 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.42 122.2 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.496 -1.668 . . . . 75.140000000000001 106.496 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.52 120.35 36.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.875 -0.787 . . . . 74.430000000000007 108.875 -175.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 121.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 108.056 -1.09 . . . . 72.25 108.056 -177.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.25 118.04 56.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.171 -0.922 . . . . 75.129999999999995 108.78 -177.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.29 119.24 48.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-N 115.414 -0.812 . . . . 71.319999999999993 109.482 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.6 t -97.63 133.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.246 -1.39 . . . . 74.109999999999999 107.246 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.02 125.25 7.11 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 111.425 -0.67 . . . . 72.530000000000001 111.425 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -129.52 107.01 9.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.553 -1.647 . . . . 71.450000000000003 106.553 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.416 -2.638 0 CA-C-O 118.478 -1.179 . . . . 74.150000000000006 111.45 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.247 -1.141 . . . . 51.049999999999997 110.247 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -106.82 156.99 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.871 0.336 . . . . 74.150000000000006 110.925 -179.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.7 m -114.75 132.26 56.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.934 -0.765 . . . . 71.530000000000001 108.934 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -102.17 28.1 6.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.341 1.067 . . . . 74.129999999999995 110.626 -177.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -114.03 146.41 40.22 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 106.374 -1.713 . . . . 53.219999999999999 106.374 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.5 162.24 15.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 120.893 0.378 . . . . 72.230000000000004 110.992 -172.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -95.01 136.31 35.48 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.856 -1.164 . . . . 74.200000000000003 107.856 178.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 130.9 27.84 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.077 -0.712 . . . . 64.109999999999999 109.077 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -62.39 117.61 4.48 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.335 1.356 . . . . 75.239999999999995 109.023 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.28 166.81 22.26 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.454 -0.794 . . . . 75.299999999999997 109.965 -176.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.72 40.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 122.954 1.359 . . . . 70.140000000000001 111.859 -168.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -66.3 145.81 55.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.929 -1.032 . . . . 74.239999999999995 110.449 172.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.71 0.51 39.68 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 114.33 0.492 . . . . 74.109999999999999 114.33 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . 0.285 0.5 OUTLIER -145.71 172.1 13.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.68 0.74 . . . . 74.400000000000006 112.804 175.592 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.3 p -54.12 154.7 4.09 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.811 1.244 . . . . 74.319999999999993 113.261 -175.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 9.1 p -57.69 -38.86 75.91 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.439 -0.8 . . . . 73.299999999999997 111.267 177.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.75 84.38 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 45.310000000000002 111.052 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.43 -37.03 77.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.103 0.478 . . . . 71.519999999999996 109.74 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.89 67.92 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.446 -0.797 . . . . 63.009999999999998 111.48 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.24 -43.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.79 -0.641 . . . . 74.430000000000007 111.367 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.38 -36.27 83.16 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.917 0.339 . . . . 71.120000000000005 111.917 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.9 m -65.89 -47.61 74.24 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.011 0.434 . . . . 75.129999999999995 110.629 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.98 -38.51 91.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.011 -0.541 . . . . 72.150000000000006 110.802 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -59.35 -42.73 92.22 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.138 0.975 . . . . 71.010000000000005 109.601 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.02 -30.68 69.97 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.965 -0.561 . . . . 73.430000000000007 112.29 178.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -80.97 -9.81 59.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.833 0.349 . . . . 70.540000000000006 111.397 176.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.15 12.64 54.6 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.864 -0.607 . . . . 73.340000000000003 113.526 173.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -91.29 149.18 21.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.12 0.486 . . . . 75.329999999999998 110.514 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 24.4 mmtp -90.5 137.06 32.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.167 -1.79 . . . . 73.239999999999995 106.167 -176.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.21 139.56 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 C-N-CA 118.969 -1.092 . . . . 75.319999999999993 113.526 -175.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -111.31 144.76 39.98 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.638 -1.616 . . . . 74.209999999999994 106.638 172.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.2 m -132.43 124.65 29.03 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.412 -0.958 . . . . 73.439999999999998 108.412 178.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -115.1 119.81 37.67 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.106 -1.442 . . . . 74.310000000000002 107.106 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.513 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -111.36 135.5 51.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.343 -0.614 . . . . 74.549999999999997 109.343 -178.971 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -139.81 132.93 15.25 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.237 -0.585 . . . . 74.200000000000003 111.797 176.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -78.64 140.15 16.47 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.371 2.047 . . . . 74.150000000000006 109.018 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -170.42 -174.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.716 -1.587 . . . . 74.140000000000001 106.716 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 t -108.53 -34.84 6.63 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.714 -1.217 . . . . 74.239999999999995 107.714 177.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.1 p -87.62 40.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.911 0.862 . . . . 71.129999999999995 110.033 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.442 HG23 ' HB3' ' A' ' 391' ' ' ASP . 23.2 pt -88.23 141.89 31.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.139 -0.937 . . . . 74.25 111.85 -176.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 172.79 15.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 106.983 -1.968 . . . . 71.329999999999998 106.983 167.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.402 ' C ' ' H ' ' A' ' 398' ' ' HIS . 18.7 Cg_exo -69.15 147.42 66.73 Favored 'Trans proline' 0 C--O 1.209 -0.941 0 C-N-CA 121.373 1.382 . . . . 73.340000000000003 110.778 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.0 -7.16 10.58 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.158 0.98 . . . . 61.409999999999997 111.816 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 396' ' ' PRO . 37.0 m80 -84.28 121.22 27.19 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.691 -2.707 . . . . 74.530000000000001 103.691 173.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.61 117.1 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.512 0.672 . . . . 73.530000000000001 110.372 -170.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.35 -28.18 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 114.893 -1.049 . . . . 74.319999999999993 109.39 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.68 157.82 27.48 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.374 -1.49 . . . . 54.299999999999997 109.374 -178.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -128.11 -174.8 3.31 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 123.679 0.792 . . . . 75.040000000000006 110.663 -173.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.65 129.13 29.51 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.648 -1.241 . . . . 64.340000000000003 107.648 -176.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -50.62 -27.75 20.33 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.202 3.268 . . . . 65.209999999999994 115.193 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.07 -26.0 67.34 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 111.926 0.343 . . . . 74.430000000000007 111.926 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.73 -36.03 81.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.756 0.788 . . . . 72.200000000000003 109.925 176.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -90.26 -2.25 58.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.543 -0.753 . . . . 73.340000000000003 111.216 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -91.31 165.14 13.59 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.061 -1.459 . . . . 71.140000000000001 107.061 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 56.9 p -74.36 113.63 11.81 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.177 0.513 . . . . 74.450000000000003 111.297 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.84 163.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.73 -0.668 . . . . 72.120000000000005 109.466 177.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.7 m -77.7 157.99 29.86 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.514 -0.55 . . . . 41.219999999999999 109.514 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.27 109.74 3.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.385 -0.598 . . . . 74.420000000000002 109.385 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 97.29 25.49 11.03 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.804 -0.712 . . . . 64.510000000000005 112.492 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.6 -172.16 3.7 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.261 -1.015 . . . . 74.209999999999994 108.261 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.0 pt-20 -107.77 139.41 42.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 118.665 0.666 . . . . 74.140000000000001 112.169 -176.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.06 136.52 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.753 -1.203 . . . . 72.319999999999993 107.753 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 10.8 t -108.37 130.93 55.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.611 0.719 . . . . 71.450000000000003 110.675 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 67.5 t -113.79 127.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.182 -0.917 . . . . 73.409999999999997 108.555 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -97.6 127.9 43.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.337 -0.616 . . . . 73.109999999999999 109.337 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 64.0 t -120.96 143.74 32.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.275 -1.009 . . . . 74.409999999999997 108.275 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.6 p -100.79 122.6 43.67 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.176 -0.675 . . . . 63.200000000000003 109.176 178.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 21.1 p -118.64 105.12 11.27 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.662 -0.815 . . . . 73.439999999999998 111.522 -178.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.65 152.22 1.66 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.936 0.735 . . . . 74.430000000000007 114.936 177.609 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.2 Cg_exo -80.76 148.32 17.66 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.296 1.998 . . . . 71.25 110.506 173.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.65 150.61 42.84 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.861 -0.609 . . . . 75.510000000000005 111.934 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.436 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.9 mt-30 -125.78 145.59 50.14 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.439 -0.949 . . . . 72.129999999999995 108.439 174.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -148.15 156.92 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.013 -1.106 . . . . 74.319999999999993 108.013 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 44.5 tt0 -83.45 136.56 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.923 -0.399 . . . . 74.200000000000003 109.923 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.06 131.08 52.28 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 106.762 -1.57 . . . . 75.099999999999994 106.762 176.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.441 ' CG ' ' HB3' ' A' ' 443' ' ' LYS . 32.1 Cg_endo -70.11 141.3 43.45 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.119 1.212 . . . . 65.430000000000007 110.656 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.36 -5.63 56.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.219 0.533 . . . . 75.040000000000006 111.743 -175.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 430' ' ' PRO . 34.2 m -76.7 -3.83 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 75.409999999999997 111.019 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.9 m -59.98 -27.58 66.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 63.109999999999999 110.786 178.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 37.6 p -69.15 -12.54 61.76 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.516 -0.766 . . . . 75.019999999999996 112.324 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.99 -47.66 17.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.795 0.665 . . . . 74.439999999999998 112.795 -177.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 27.0 m -153.77 141.06 19.6 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.662 -0.649 . . . . 63.210000000000001 109.921 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -56.18 -50.78 70.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.995 0.518 . . . . 72.219999999999999 112.208 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.32 -45.21 76.35 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.247 0.546 . . . . 63.100000000000001 111.22 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.38 -38.51 78.06 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.001 -0.999 . . . . 74.349999999999994 110.337 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -47.26 86.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.382 0.426 . . . . 64.340000000000003 110.328 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.47 -45.73 93.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.102 -0.499 . . . . 65.530000000000001 110.585 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.59 -41.63 88.2 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.753 0.279 . . . . 73.200000000000003 111.753 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.441 ' HB3' ' CG ' ' A' ' 430' ' ' PRO . 72.1 mmtt -62.77 -42.1 99.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.767 0.318 . . . . 71.530000000000001 111.616 178.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.31 -39.53 82.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.275 -0.421 . . . . 71.219999999999999 111.248 176.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 63.5 m -62.54 -39.58 94.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.573 -0.528 . . . . 74.400000000000006 109.573 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.63 65.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.628 . . . . 65.349999999999994 111.076 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -13.48 56.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.954 0.407 . . . . 63.509999999999998 110.154 177.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.32 -17.09 14.59 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.082 -0.58 . . . . 54.140000000000001 113.225 176.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.59 117.59 13.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.976 0.388 . . . . 71.129999999999995 111.062 -175.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.41 10.74 16.81 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 110.552 -1.019 . . . . 72.5 110.552 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -105.89 111.72 24.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.416 -1.327 . . . . 73.510000000000005 107.416 -177.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -132.77 146.87 52.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.375 0.607 . . . . 62.340000000000003 112.21 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 43.7 tptt -143.01 122.96 13.52 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.771 -1.566 . . . . 74.120000000000005 106.771 172.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -99.59 134.93 41.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.785 0.326 . . . . 65.420000000000002 110.581 -176.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -134.18 150.79 51.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.217 -1.031 . . . . 75.530000000000001 108.217 176.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.43 140.47 51.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.781 -0.452 . . . . 72.549999999999997 109.781 178.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.5 t -127.03 137.37 30.47 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.424 -1.324 . . . . 72.299999999999997 107.424 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.9 Cg_exo -61.23 119.5 6.68 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.338 2.025 . . . . 75.439999999999998 111.189 -177.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.2 m -131.34 -179.84 5.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.527 -0.76 . . . . 63.140000000000001 109.174 -176.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.431 ' HB ' HD11 ' A' ' 463' ' ' LEU . 62.7 m -68.45 136.78 90.9 Favored Pre-proline 0 N--CA 1.428 -1.568 0 N-CA-C 107.848 -1.168 . . . . 75.219999999999999 107.848 174.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.8 -22.88 7.69 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.846 3.697 . . . . 73.230000000000004 114.707 -176.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.58 -17.56 60.0 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.002 0.43 . . . . 74.140000000000001 111.356 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . 0.431 HD11 ' HB ' ' A' ' 460' ' ' THR . 7.3 mp -99.67 11.49 39.07 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.959 0.355 . . . . 74.430000000000007 111.959 -178.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 31.0 m -59.61 127.72 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.217 0.532 . . . . 74.140000000000001 111.629 176.092 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.49 -1.42 88.36 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 115.539 -0.755 . . . . 71.209999999999994 111.839 178.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 463' ' ' LEU . 62.8 tttp -101.54 138.94 37.87 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.122 -1.066 . . . . 73.319999999999993 108.122 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.417 ' CG2' HD12 ' A' ' 486' ' ' ILE . 60.0 t -84.11 128.08 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.987 0.423 . . . . 71.430000000000007 110.38 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.98 -16.9 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 112.165 0.432 . . . . 73.239999999999995 112.165 -177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.43 166.01 33.5 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.795 -0.717 . . . . 74.420000000000002 111.769 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.8 p -135.77 155.55 50.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.45 -0.945 . . . . 75.0 108.45 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.43 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.88 -55.62 42.92 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.421 -0.323 . . . . 74.340000000000003 111.847 176.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.6 Cg_exo -76.8 142.71 22.85 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 108.162 -1.514 . . . . 74.420000000000002 108.162 172.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.473 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 30.8 Cg_endo -61.92 127.46 21.46 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.287 1.992 . . . . 72.519999999999996 111.761 -177.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.83 2.58 22.6 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.065 -0.971 . . . . 65.239999999999995 112.013 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -111.32 3.48 18.33 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.328 -0.396 . . . . 75.329999999999998 110.668 177.32 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.473 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 8.7 tp-100 -129.57 166.07 20.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.493 0.663 . . . . 64.319999999999993 111.539 -170.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 62.6 m -81.85 124.18 29.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.644 -1.162 . . . . 73.430000000000007 109.799 176.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -127.37 149.47 50.05 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.761 0.424 . . . . 74.409999999999997 110.008 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.429 ' HB3' ' ND2' ' A' ' 482' ' ' ASN . . . -72.16 135.71 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.629 0.252 . . . . 73.140000000000001 110.63 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.1 mm -62.94 -14.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.88 1.272 . . . . 72.519999999999996 112.282 -174.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -87.51 -2.55 58.69 Favored 'General case' 0 C--N 1.313 -1.003 0 O-C-N 121.6 -0.688 . . . . 75.140000000000001 110.635 -177.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 44.4 m-80 -84.61 136.98 33.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.473 -0.565 . . . . 74.540000000000006 109.473 178.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.85 124.45 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.278 -1.008 . . . . 75.25 108.278 176.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.96 119.09 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 C-N-CA 119.239 -0.984 . . . . 74.450000000000003 109.005 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 2.9 mp -91.7 112.66 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 N-CA-C 104.557 -2.386 . . . . 75.310000000000002 104.557 173.199 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.417 HD12 ' CG2' ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.03 118.55 52.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.09 -1.078 . . . . 73.340000000000003 108.09 -175.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 3.1 mp -99.63 118.35 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.578 0.704 . . . . 73.439999999999998 109.356 -176.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.81 141.3 16.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 107.798 -1.186 . . . . 72.540000000000006 107.798 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.9 124.29 6.52 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.002 -1.239 . . . . 64.25 110.002 177.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.1 t -141.52 136.49 31.22 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.613 -0.884 . . . . 74.340000000000003 108.613 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.665 0 N-CA-C 109.395 -1.482 . . . . 74.439999999999998 109.395 -179.577 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.893 0 N-CA-C 110.616 -0.994 . . . . 73.040000000000006 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 356' ' ' ILE 0.278 2.6 pp -111.59 117.74 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.282 1.039 . . . . 74.409999999999997 113.281 -179.666 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 25.5 m -161.44 135.27 6.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 104.036 -2.579 . . . . 75.230000000000004 104.036 176.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -81.21 86.1 6.26 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.603 -1.239 . . . . 74.219999999999999 112.963 -177.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.91 135.59 48.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 105.817 -1.92 . . . . 74.230000000000004 105.817 172.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.88 149.34 21.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 C-N-CA 120.146 -0.622 . . . . 73.430000000000007 110.822 -175.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -94.28 137.22 33.7 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 105.756 -1.942 . . . . 74.420000000000002 105.756 173.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.09 124.79 52.91 Favored Pre-proline 0 C--N 1.279 -2.487 0 C-N-CA 118.342 -1.343 . . . . 72.239999999999995 110.536 -169.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -51.06 129.25 27.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.57 2.847 . . . . 61.329999999999998 113.006 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.3 140.4 43.09 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.492 -1.231 . . . . 71.310000000000002 111.285 -175.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.41 20.28 5.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.635 -1.246 . . . . 75.420000000000002 107.635 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -64.64 133.38 52.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.961 -1.018 . . . . 72.409999999999997 111.457 -178.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 0.19 46.58 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.071 -0.968 . . . . 54.229999999999997 110.905 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -125.22 -179.81 4.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.991 -0.744 . . . . 73.019999999999996 108.991 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 93.9 p -72.48 143.04 48.55 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.485 0.584 . . . . 64.209999999999994 111.389 -176.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 374' ' ' ILE . 27.9 m -62.34 -33.65 75.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.971 178.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.67 94.44 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-N 116.299 -0.409 . . . . 73.030000000000001 111.062 178.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.99 -35.07 76.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 109.889 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.69 92.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.84 -0.618 . . . . 74.420000000000002 110.516 176.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.469 HG22 HG13 ' A' ' 384' ' ' ILE . 82.6 mt -57.79 -46.91 87.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 122.644 0.377 . . . . 75.400000000000006 110.078 178.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.6 94.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.972 -0.558 . . . . 74.299999999999997 111.288 179.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 57.0 m -61.66 -47.64 84.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.894 -0.594 . . . . 72.209999999999994 110.952 -179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.3 -38.45 91.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.388 -0.369 . . . . 75.040000000000006 111.465 178.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.87 -42.89 94.71 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.65 0.594 . . . . 74.439999999999998 109.6 178.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.356 0.873 . . . . 53.130000000000003 113.356 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.96 -14.71 53.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.127 0.489 . . . . 72.150000000000006 110.022 173.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.43 53.51 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.941 -0.572 . . . . 63.100000000000001 112.874 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.458 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 43.3 m-85 -84.19 152.96 23.93 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.427 0.632 . . . . 73.120000000000005 111.938 -177.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.64 134.54 34.6 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.008 -1.479 . . . . 75.400000000000006 107.008 177.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.469 HG13 HG22 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -117.47 136.64 53.97 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 C-N-CA 119.197 -1.001 . . . . 73.030000000000001 111.874 -179.14 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -111.69 128.38 56.05 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.003 -1.908 . . . . 74.510000000000005 105.976 178.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.0 m -111.41 136.65 50.26 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 119.403 -0.919 . . . . 64.329999999999998 109.444 -178.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -120.18 117.89 29.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.513 -1.662 . . . . 74.109999999999999 106.513 176.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 122.05 46.11 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.484 -1.673 . . . . 74.140000000000001 106.484 177.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -139.61 148.38 55.75 Favored Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 118.893 -1.123 . . . . 75.409999999999997 110.746 178.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 85.1 Cg_endo -85.48 163.74 10.96 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.274 1.983 . . . . 63.549999999999997 109.584 170.301 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.576 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.2 t70 165.22 -173.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.754 -2.313 . . . . 71.109999999999999 104.754 176.023 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.427 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 8.4 t -115.84 -25.39 7.77 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.566 -1.642 . . . . 72.510000000000005 106.566 174.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 9.9 m -98.47 69.2 1.9 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.621 -2.363 . . . . 75.439999999999998 104.621 171.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.41 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 4.4 pt -95.97 138.56 21.66 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 113.673 -1.603 . . . . 72.019999999999996 112.921 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 421' ' ' SER . 16.7 Cg_exo -70.4 114.35 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 106.224 -2.26 . . . . 74.0 106.224 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 398' ' ' HIS . 24.0 Cg_endo -57.11 160.34 13.12 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.514 2.809 . . . . 72.540000000000006 115.54 -169.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.06 -6.86 2.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.107 0.963 . . . . 74.319999999999993 112.003 176.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 396' ' ' PRO . 63.9 m170 -107.47 120.15 41.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 103.662 -2.718 . . . . 72.099999999999994 103.662 171.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.97 117.97 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.088 0.947 . . . . 75.230000000000004 109.822 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.91 -28.87 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.947 -1.024 . . . . 74.340000000000003 110.441 -174.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.44 157.98 27.56 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.973 -1.251 . . . . 73.25 109.973 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.7 p -118.28 -178.76 3.59 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 123.194 0.598 . . . . 73.439999999999998 109.97 -177.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -102.08 155.2 36.74 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.374 -0.602 . . . . 64.109999999999999 109.374 -176.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.4 -30.66 64.44 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.085 2.523 . . . . 75.540000000000006 113.902 -176.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.15 -30.7 65.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.895 0.378 . . . . 65.329999999999998 110.244 -175.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.54 65.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.594 0.711 . . . . 52.109999999999999 110.05 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 407' ' ' ASN . 0.9 OUTLIER -95.8 -4.64 43.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 111.876 -177.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.1 m -100.16 155.39 17.77 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.244 -1.391 . . . . 63.109999999999999 107.244 176.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 55.2 p -74.77 113.17 11.74 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.191 -0.604 . . . . 75.019999999999996 109.584 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.09 169.93 15.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 116.043 -0.526 . . . . 74.349999999999994 110.772 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.0 p -62.36 133.13 54.64 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.702 -0.681 . . . . 73.109999999999999 109.396 175.241 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.46 109.33 4.73 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.956 -0.387 . . . . 73.230000000000004 109.956 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.91 10.08 5.43 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 120.137 -1.03 . . . . 45.530000000000001 112.339 -178.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.1 -174.02 4.49 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.785 -0.82 . . . . 74.409999999999997 108.785 -177.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.01 132.16 34.12 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 118.955 0.798 . . . . 72.140000000000001 112.589 -175.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.67 135.24 59.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 106.474 -1.676 . . . . 74.040000000000006 106.474 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.9 t -96.84 130.94 44.04 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 122.086 0.946 . . . . 71.409999999999997 111.764 -177.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.33 122.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 114.577 -1.192 . . . . 74.319999999999993 108.453 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -95.89 129.01 43.27 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.745 -0.661 . . . . 73.420000000000002 111.447 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.83 130.81 52.93 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 108.14 -1.059 . . . . 75.340000000000003 108.14 177.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 395' ' ' PRO . 36.6 p -88.09 121.45 30.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.491 -0.559 . . . . 74.329999999999998 109.491 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 m -120.89 104.82 10.14 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 119.767 -0.773 . . . . 74.340000000000003 110.645 177.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.69 125.39 1.59 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 120.546 -0.835 . . . . 71.540000000000006 113.93 176.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 56.2 Cg_endo -86.49 130.31 3.28 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.33 2.02 . . . . 75.219999999999999 112.562 176.17 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' A' ' 391' ' ' ASP . 47.6 mt-10 -89.4 137.5 32.27 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.465 0.65 . . . . 75.329999999999998 112.12 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.47 150.45 48.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.546 -1.65 . . . . 74.219999999999999 106.546 173.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 449' ' ' PHE . 3.4 tpt180 -136.27 148.46 48.02 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.307 -0.998 . . . . 75.109999999999999 108.307 -174.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.9 136.5 34.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.513 -0.921 . . . . 65.329999999999998 108.513 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.8 mt -81.8 131.54 57.11 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.834 -0.802 . . . . 71.409999999999997 108.834 -178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.65 140.6 87.36 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.583 1.522 . . . . 72.319999999999993 111.876 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.32 0.77 55.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 111.191 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -76.12 -7.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.446 0.641 . . . . 71.230000000000004 109.464 176.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 467' ' ' VAL . 4.9 p -54.96 -49.68 70.78 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.361 -0.836 . . . . 63.450000000000003 111.687 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 2.1 m -63.79 -22.28 66.83 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.361 1.065 . . . . 71.530000000000001 111.761 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.27 -42.47 13.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.263 0.468 . . . . 74.230000000000004 112.263 -173.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.4 m -145.21 124.12 12.71 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.542 -0.724 . . . . 73.109999999999999 110.905 -178.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.24 -53.52 55.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.724 0.639 . . . . 75.420000000000002 112.724 -178.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.43 94.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.737 0.303 . . . . 73.019999999999996 111.495 -176.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.53 -37.68 88.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.652 -0.704 . . . . 73.109999999999999 109.407 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 433' ' ' SER . . . -60.32 -47.18 87.15 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.922 -0.581 . . . . 73.129999999999995 110.76 -179.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.35 -45.71 93.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 75.109999999999999 110.414 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 9.9 mmpt? -64.46 -47.27 79.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 65.5 110.967 -178.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.14 -38.88 89.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.329 -0.396 . . . . 73.349999999999994 111.476 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.2 -43.41 86.83 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.338 0.399 . . . . 73.0 110.366 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 24.3 m -66.84 -46.01 76.45 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.404 0.621 . . . . 75.019999999999996 109.785 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.31 -15.97 63.45 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.374 -0.83 . . . . 73.099999999999994 112.053 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.56 59.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.464 . . . . 64.120000000000005 109.985 178.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.08 -16.4 11.97 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.748 -0.739 . . . . 60.130000000000003 112.036 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 93.6 m-85 -77.49 108.66 10.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.782 0.325 . . . . 75.310000000000002 110.503 -179.053 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.37 20.64 15.83 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.554 -1.019 . . . . 74.209999999999994 110.554 176.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -114.17 111.91 22.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 106.507 -1.664 . . . . 75.140000000000001 106.507 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.49 153.22 45.42 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.438 0.532 . . . . 75.450000000000003 112.438 -170.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 56.4 tptt -150.9 123.41 8.46 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 105.451 -2.055 . . . . 73.510000000000005 105.451 172.441 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -121.96 134.82 54.83 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.315 -0.554 . . . . 73.140000000000001 111.584 -173.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -142.38 165.02 28.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.514 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.447 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.7 m120 -116.44 142.07 47.35 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.719 -0.845 . . . . 74.140000000000001 108.719 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 19.1 t -131.04 138.55 33.22 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 108.749 -0.834 . . . . 73.010000000000005 108.749 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_exo -61.56 121.1 9.07 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.303 2.002 . . . . 72.329999999999998 110.558 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.3 m -134.26 -178.55 5.09 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 63.130000000000003 107.62 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 16.5 p -68.24 150.24 97.8 Favored Pre-proline 0 N--CA 1.427 -1.586 0 C-N-CA 120.563 -0.455 . . . . 73.530000000000001 109.822 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . 0.477 ' O ' HG11 ' A' ' 464' ' ' VAL . 15.0 Cg_endo -55.69 -23.59 41.71 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.488 2.792 . . . . 73.109999999999999 113.137 -177.44 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -75.36 -18.45 59.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.869 0.366 . . . . 72.230000000000004 111.871 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.72 -4.45 40.7 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.992 -0.443 . . . . 73.349999999999994 112.102 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.8 p -59.51 136.58 22.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-O 120.717 0.294 . . . . 74.530000000000001 110.935 -178.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.32 84.04 Favored Glycine 0 C--N 1.311 -0.831 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.389 177.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -124.19 158.87 31.38 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 109.668 -0.493 . . . . 72.519999999999996 109.668 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 434' ' ' THR . 58.1 t -83.93 137.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.8 -1.556 . . . . 70.409999999999997 106.8 178.914 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.54 -10.66 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.013 -1.475 . . . . 72.109999999999999 110.267 178.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 146.56 174.54 18.76 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 115.424 -0.807 . . . . 74.120000000000005 111.524 175.496 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.0 p -116.58 152.22 34.61 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.97 -1.122 . . . . 74.209999999999994 107.97 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -66.79 -46.06 55.53 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 118.74 -1.184 . . . . 65.239999999999995 111.874 178.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.39 110.15 3.0 Favored 'Trans proline' 0 C--N 1.362 1.261 0 N-CA-C 106.887 -2.005 . . . . 75.319999999999993 106.887 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.02 162.31 32.04 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.292 1.995 . . . . 75.239999999999995 114.286 -171.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -72.73 -5.15 35.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.348 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.49 6.05 49.99 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.421 -1.263 . . . . 71.519999999999996 109.616 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -135.62 162.48 32.59 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.109 -0.701 . . . . 74.109999999999999 109.109 -177.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.7 m -104.47 111.73 24.51 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.235 -1.765 . . . . 73.319999999999993 106.235 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 14.9 t -106.55 148.3 28.4 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.332 -0.547 . . . . 74.540000000000006 109.874 -175.379 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.25 141.03 58.92 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.283 -0.417 . . . . 53.100000000000001 110.41 178.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.427 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 28.9 mm -60.92 -22.61 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.467 0.707 . . . . 72.400000000000006 112.876 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.0 t -91.55 4.43 52.62 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.692 0.758 . . . . 73.540000000000006 110.123 -178.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.67 138.55 34.1 Favored 'General case' 0 CA--C 1.481 -1.687 0 O-C-N 122.015 -0.428 . . . . 74.0 110.47 177.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.54 116.32 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 108.887 -0.783 . . . . 73.519999999999996 108.887 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.08 120.22 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 108.189 -1.041 . . . . 73.340000000000003 108.189 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 0.2 OUTLIER -92.73 117.07 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 106.93 -1.507 . . . . 70.439999999999998 106.93 -178.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 112.4 39.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.948 -1.024 . . . . 64.349999999999994 108.347 -177.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.75 124.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.588 -0.733 . . . . 75.530000000000001 109.275 -177.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.447 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 28.0 t -97.59 134.45 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.248 -1.39 . . . . 73.010000000000005 107.248 178.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -84.07 131.85 10.68 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 110.992 -0.843 . . . . 50.109999999999999 110.992 -178.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.3 t -141.04 132.39 26.71 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.82 -0.808 . . . . 61.130000000000003 108.82 178.318 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.07 0 N-CA-C 109.244 -1.542 . . . . 65.510000000000005 109.244 174.575 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.691 0 N-CA-C 110.49 -1.044 . . . . 62.119999999999997 110.49 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -87.2 145.75 7.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 117.582 0.691 . . . . 71.129999999999995 110.9 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 18.9 m -152.53 137.48 17.19 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.152 -1.425 . . . . 64.319999999999993 107.152 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.42 70.48 4.32 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.551 0.691 . . . . 74.219999999999999 110.936 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -106.7 138.85 42.12 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.972 -1.122 . . . . 64.140000000000001 107.972 176.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.2 150.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 112.398 0.518 . . . . 72.109999999999999 112.398 -170.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -96.4 136.55 36.75 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.538 -1.282 . . . . 63.439999999999998 107.538 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.68 131.3 27.22 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.916 -0.713 . . . . 52.149999999999999 110.079 -175.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.14 142.13 78.46 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.392 2.728 . . . . 70.400000000000006 113.946 -178.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.44 139.39 36.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.698 -1.137 . . . . 73.329999999999998 109.985 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.6 t -113.24 30.98 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 122.51 1.147 . . . . 73.140000000000001 109.794 -175.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.421 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.7 ppt_? -65.39 144.58 56.99 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.582 -0.736 . . . . 75.420000000000002 112.525 178.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 93.4 -5.81 74.61 Favored Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.94 -0.573 . . . . 75.329999999999998 111.699 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -117.34 176.01 5.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.294 -0.632 . . . . 74.409999999999997 109.294 -175.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.8 p -73.92 154.11 39.53 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.742 0.306 . . . . 74.150000000000006 111.139 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.2 -36.1 82.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.752 0.311 . . . . 64.030000000000001 110.619 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.97 93.62 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.104 -0.498 . . . . 74.439999999999998 111.033 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.77 -43.55 92.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.747 -0.464 . . . . 73.209999999999994 109.747 177.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.53 69.6 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.964 -0.562 . . . . 73.549999999999997 111.084 -179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.62 -42.47 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.347 -0.388 . . . . 73.409999999999997 111.157 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.39 93.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.433 -0.348 . . . . 74.310000000000002 110.993 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 376' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 61.9 m -61.88 -47.24 85.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.551 -0.295 . . . . 71.400000000000006 110.882 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.89 -38.81 92.46 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.621 -0.263 . . . . 73.109999999999999 110.941 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -59.88 -46.92 87.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.908 0.755 . . . . 73.400000000000006 109.647 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -66.43 -27.41 67.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.78 -0.646 . . . . 62.009999999999998 111.774 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 376' ' ' THR . 11.8 mmt180 -81.21 -14.94 57.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.402 -0.363 . . . . 74.239999999999995 110.797 178.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.73 53.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.439 -0.886 . . . . 73.219999999999999 112.029 178.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.16 158.65 15.37 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.385 -0.598 . . . . 74.140000000000001 109.385 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.53 161.43 13.64 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.232 -1.025 . . . . 74.040000000000006 108.232 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 154.98 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.872 0.844 . . . . 72.239999999999995 112.79 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.455 ' HB3' HG21 ' A' ' 417' ' ' THR . 6.7 ttp180 -141.99 129.74 21.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.885 -1.154 . . . . 72.0 107.885 175.445 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.3 m -100.51 130.38 46.58 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.7 -0.481 . . . . 75.340000000000003 109.7 -177.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.94 119.11 36.79 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.708 -1.59 . . . . 74.140000000000001 106.708 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 123.84 39.41 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 72.230000000000004 108.724 177.507 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -114.57 118.13 41.73 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.747 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 3.0 Cg_endo -88.31 128.43 2.2 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 N-CA-C 107.456 -1.786 . . . . 74.120000000000005 107.456 167.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 -163.88 -178.09 5.47 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.665 -1.214 . . . . 73.140000000000001 110.731 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.2 m -88.87 -42.18 12.01 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.195 -1.78 . . . . 72.150000000000006 106.195 175.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.4 m -88.69 63.43 6.91 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.458 -1.246 . . . . 61.109999999999999 108.636 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 394' ' ' ILE . 2.3 pp -98.77 112.97 63.93 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 114.156 1.169 . . . . 73.299999999999997 114.156 179.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . 0.445 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 73.8 Cg_endo -80.44 170.37 16.04 Favored 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.09 1.86 . . . . 73.219999999999999 110.369 171.391 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.72 162.65 17.8 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.391 2.727 . . . . 70.019999999999996 112.691 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.66 -8.7 0.95 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 124.218 1.007 . . . . 64.099999999999994 113.135 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -79.78 159.72 26.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.783 -1.192 . . . . 75.530000000000001 107.783 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.56 117.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 105.942 -1.873 . . . . 73.200000000000003 105.942 175.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . 0.443 HD11 ' N ' ' A' ' 401' ' ' GLY . 2.6 pp -92.91 -28.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.408 0.623 . . . . 74.319999999999993 111.79 -178.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.443 ' N ' HD11 ' A' ' 400' ' ' ILE . . . -160.99 158.1 29.67 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.717 -1.753 . . . . 75.310000000000002 108.717 178.702 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -114.43 -179.85 3.75 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 109.189 -0.671 . . . . 75.530000000000001 109.189 179.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.12 140.94 21.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.225 -1.028 . . . . 72.519999999999996 108.225 178.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.69 -29.46 2.34 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.0 3.134 . . . . 74.450000000000003 114.536 177.576 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.63 60.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.209 0.603 . . . . 64.420000000000002 111.98 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.16 65.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 72.420000000000002 109.857 177.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 4.7 52.32 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.328 -0.851 . . . . 72.549999999999997 110.735 -174.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -92.64 146.39 23.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 105.118 -2.178 . . . . 73.099999999999994 105.118 171.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.5 m -74.37 123.44 24.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 118.797 0.726 . . . . 74.310000000000002 110.171 -178.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.8 169.67 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.772 -1.196 . . . . 72.230000000000004 107.772 -177.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.8 m -66.7 138.86 57.71 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.266 -1.013 . . . . 70.310000000000002 108.266 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.18 111.36 3.89 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.079 -0.341 . . . . 75.510000000000005 110.079 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.63 43.33 0.97 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.752 -0.737 . . . . 65.030000000000001 112.162 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.65 -179.36 3.79 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.354 -1.721 . . . . 73.510000000000005 106.354 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -102.65 135.29 44.55 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.505 0.669 . . . . 75.109999999999999 111.725 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.7 mm -110.28 128.47 66.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.372 -1.344 . . . . 74.140000000000001 107.372 176.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.455 HG21 ' HB3' ' A' ' 385' ' ' ARG . 69.4 p -100.42 130.71 46.55 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.577 -0.527 . . . . 70.420000000000002 109.577 -177.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.48 122.63 69.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.013 -0.54 . . . . 74.319999999999993 110.177 -176.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -91.17 129.46 37.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.141 0.496 . . . . 74.530000000000001 110.998 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.44 146.95 30.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.286 -1.376 . . . . 64.310000000000002 107.286 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.445 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 13.5 m -90.57 122.65 33.56 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.822 -0.751 . . . . 72.430000000000007 111.815 -176.417 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 32.8 m -120.37 106.16 11.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 109.539 -0.541 . . . . 75.109999999999999 109.539 174.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 77.32 130.57 0.47 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 120.889 -0.672 . . . . 64.430000000000007 114.772 176.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.4 Cg_exo -78.6 144.18 19.63 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.702 1.601 . . . . 65.319999999999993 109.425 171.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 146.06 47.96 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 116.292 -0.413 . . . . 71.450000000000003 109.906 -178.261 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.5 mt-30 -121.52 141.29 51.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.168 -0.924 . . . . 74.400000000000006 108.65 -176.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -143.45 158.68 43.45 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.954 -1.498 . . . . 73.519999999999996 106.954 -177.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.6 OUTLIER -90.1 139.62 30.45 Favored 'General case' 0 C--N 1.28 -2.419 0 O-C-N 123.088 0.242 . . . . 71.540000000000006 110.854 179.512 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -80.03 119.86 77.95 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.788 -1.56 . . . . 72.25 106.788 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.82 140.74 67.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.702 2.268 . . . . 75.219999999999999 113.589 -178.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.61 -22.58 62.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.771 -1.104 . . . . 73.310000000000002 112.364 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.18 2.98 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.679 -0.692 . . . . 74.349999999999994 111.748 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.9 t -62.75 -27.14 69.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.309 0.644 . . . . 74.439999999999998 110.597 179.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 434' ' ' THR . . . . . 0.428 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 28.0 p -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 112.851 0.685 . . . . 72.219999999999999 112.851 -177.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 82.6 mt -67.26 -49.01 66.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.912 1.079 . . . . 74.030000000000001 113.912 -171.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.6 m -160.43 148.8 16.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.592 -0.892 . . . . 74.019999999999996 108.592 -175.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.51 -49.83 75.98 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.873 0.694 . . . . 74.140000000000001 112.873 -177.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.01 89.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.714 0.293 . . . . 74.409999999999997 110.942 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.22 -46.32 90.9 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.639 -0.874 . . . . 73.209999999999994 108.639 177.195 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.66 76.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.948 -1.024 . . . . 63.310000000000002 110.409 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.82 -48.08 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.362 -0.381 . . . . 72.439999999999998 111.089 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.868 0.322 . . . . 73.439999999999998 111.868 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -66.33 -42.12 88.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 111.902 0.334 . . . . 72.049999999999997 111.902 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.43 -38.63 81.38 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.975 -0.29 . . . . 75.340000000000003 111.741 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 86.4 m -62.31 -40.46 96.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.736 -0.468 . . . . 74.209999999999994 109.736 177.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.46 -26.61 66.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.916 -0.584 . . . . 73.310000000000002 111.042 178.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 -13.01 56.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.211 0.529 . . . . 70.519999999999996 110.47 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.55 29.74 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.944 -0.646 . . . . 73.030000000000001 113.267 178.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -78.29 102.65 7.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 117.362 0.581 . . . . 74.519999999999996 109.597 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.73 15.83 34.24 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.694 -0.765 . . . . 65.239999999999995 111.301 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -118.21 110.63 17.8 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.733 -1.21 . . . . 75.129999999999995 107.733 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.35 150.26 45.7 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.589 -176.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 453' ' ' LYS . 0.4 OUTLIER -141.88 122.87 14.55 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.454 -2.054 . . . . 73.219999999999999 105.454 171.239 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.57 134.62 39.56 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.008 -0.677 . . . . 75.549999999999997 109.61 -178.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.19 141.47 49.09 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.938 -1.134 . . . . 74.299999999999997 107.938 176.287 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . 0.528 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.5 m-80 -116.57 140.12 49.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.598 -1.26 . . . . 74.209999999999994 107.598 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -138.62 150.35 65.66 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 109.846 -0.427 . . . . 75.340000000000003 109.846 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_endo -60.71 120.22 7.83 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.496 2.131 . . . . 73.219999999999999 112.184 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -127.27 -178.45 4.45 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.027 -1.471 . . . . 63.140000000000001 107.027 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.0 t -68.88 137.95 90.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.968 -0.752 . . . . 70.430000000000007 108.968 176.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.15 -23.74 23.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.741 2.961 . . . . 74.0 113.98 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.7 -23.95 58.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.797 0.332 . . . . 75.319999999999993 111.677 -177.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.33 12.57 31.54 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.334 0.494 . . . . 72.420000000000002 112.334 -177.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.31 126.74 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.388 0.613 . . . . 74.319999999999993 111.143 179.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.55 0.07 61.11 Favored Glycine 0 C--N 1.309 -0.968 0 CA-C-N 115.987 -0.551 . . . . 64.120000000000005 112.266 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.63 144.84 30.51 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.668 -1.234 . . . . 75.349999999999994 107.668 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 84.3 t -82.28 126.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.86 -1.163 . . . . 73.239999999999995 107.86 177.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.46 -15.13 7.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.34 -0.544 . . . . 74.349999999999994 112.01 -175.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.02 177.24 33.95 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 120.451 -0.88 . . . . 74.140000000000001 111.576 178.001 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 8.7 p -125.23 158.81 33.12 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.226 -1.027 . . . . 72.010000000000005 108.226 179.089 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -54.35 46.47 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 120.338 -0.545 . . . . 73.099999999999994 110.52 176.103 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -78.14 108.6 2.53 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 106.037 -2.332 . . . . 64.129999999999995 106.037 164.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 149.87 89.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.601 2.201 . . . . 74.219999999999999 114.798 -169.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.46 7.65 2.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.742 1.217 . . . . 70.420000000000002 111.987 -177.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.1 -3.05 16.63 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.474 -0.784 . . . . 74.230000000000004 110.605 177.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -129.06 169.65 14.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.036 0.446 . . . . 73.129999999999995 111.335 -171.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 477' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 15.7 m -102.43 135.54 43.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.265 1.026 . . . . 74.519999999999996 108.789 -179.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.8 t -137.46 148.07 45.81 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.425 -0.583 . . . . 72.420000000000002 109.425 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.91 145.6 53.53 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.964 -0.384 . . . . 75.420000000000002 109.964 175.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.9 mm -70.17 -3.33 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.125 0.964 . . . . 74.030000000000001 111.396 -177.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -86.81 5.37 36.91 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.762 0.792 . . . . 74.299999999999997 110.325 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -110.45 138.09 47.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.358 -0.837 . . . . 74.219999999999999 109.473 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.86 124.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.281 -1.007 . . . . 75.400000000000006 108.281 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.0 t -87.36 118.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 C-N-CA 119.074 -1.051 . . . . 74.329999999999998 108.486 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 56.2 mt -93.95 112.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.081 -1.451 . . . . 72.200000000000003 107.081 176.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.62 122.28 50.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.33 -0.989 . . . . 73.299999999999997 108.33 -176.504 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 26.9 mt -100.87 119.92 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.318 0.58 . . . . 74.319999999999993 110.499 -174.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.528 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 88.9 t -97.99 128.77 49.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.959 -1.126 . . . . 63.229999999999997 107.959 178.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.31 115.42 6.03 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.184 -0.766 . . . . 75.129999999999995 111.184 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 37.5 m -120.35 109.88 15.88 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.334 -0.617 . . . . 63.140000000000001 109.334 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.356 0 N-CA-C 109.478 -1.449 . . . . 75.420000000000002 109.478 -179.211 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.814 0 N-CA-C 109.921 -1.272 . . . . 43.240000000000002 109.921 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.98 148.06 23.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 117.195 0.498 . . . . 74.409999999999997 111.029 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.0 m -109.08 146.79 33.42 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.504 -1.665 . . . . 73.030000000000001 106.504 172.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -82.52 78.7 9.12 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.516 0.674 . . . . 75.5 109.318 178.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 409' ' ' SER . 4.3 p-10 -107.89 131.34 54.61 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.844 -1.071 . . . . 72.25 109.1 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.6 m -134.32 153.89 36.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.722 -0.473 . . . . 74.239999999999995 109.722 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -100.86 137.07 39.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.851 -1.166 . . . . 72.25 107.851 175.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.87 124.5 47.68 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 119.556 -0.858 . . . . 73.209999999999994 110.804 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.1 145.05 98.99 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.89 2.393 . . . . 75.329999999999998 112.355 177.29 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.98 166.1 16.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.872 -0.603 . . . . 74.200000000000003 110.451 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.7 t -117.47 41.68 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.495 1.14 . . . . 74.530000000000001 108.488 -175.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -52.57 128.66 26.78 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.344 -1.298 . . . . 75.510000000000005 113.79 -175.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.76 -18.65 57.02 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 115.503 -0.771 . . . . 72.319999999999993 113.228 173.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -97.73 166.7 11.36 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.613 0.245 . . . . 64.530000000000001 111.198 -176.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 81.2 p -63.3 145.04 56.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.511 . . . . 64.409999999999997 110.684 -175.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.9 p -63.66 -34.08 77.05 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.951 -0.3 . . . . 64.239999999999995 110.275 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.32 88.73 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.193 -0.458 . . . . 61.310000000000002 110.358 176.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -35.08 79.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 110.23 178.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -50.44 71.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 72.209999999999994 110.797 178.134 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.27 -43.96 87.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 123.416 0.448 . . . . 74.409999999999997 110.407 178.504 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.36 90.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 110.74 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -46.94 86.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.736 -0.211 . . . . 73.430000000000007 110.831 178.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.98 -39.3 93.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.198 -0.201 . . . . 65.420000000000002 110.753 177.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.2 -44.34 97.45 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.223 0.609 . . . . 64.329999999999998 110.272 179.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.43 -26.27 64.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.779 -0.646 . . . . 65.140000000000001 111.805 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -81.56 -13.5 57.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 110.96 175.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.505 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 94.59 16.58 42.13 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.272 -0.965 . . . . 71.120000000000005 112.368 177.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.56 159.79 14.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.034 -0.728 . . . . 72.109999999999999 109.034 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . 0.415 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 33.5 mmtp -104.9 157.51 17.17 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.263 -1.384 . . . . 74.230000000000004 107.263 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.401 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -136.9 157.48 35.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.451 0.643 . . . . 74.209999999999994 112.04 -175.598 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.417 ' HB3' HG21 ' A' ' 417' ' ' THR . 37.8 ttm105 -127.41 133.11 50.01 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.612 -1.996 . . . . 71.120000000000005 105.612 171.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.7 m -122.32 121.28 36.36 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.204 -0.665 . . . . 70.439999999999998 109.204 -175.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.35 119.2 35.49 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.59 -1.263 . . . . 74.430000000000007 107.59 178.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -113.5 124.1 51.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.642 -0.503 . . . . 74.349999999999994 109.642 178.283 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -132.76 144.28 52.22 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 120.604 -0.439 . . . . 72.450000000000003 110.777 -177.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.82 144.15 13.6 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 N-CA-C 107.662 -1.707 . . . . 75.549999999999997 107.662 166.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.2 t70 -153.42 172.69 16.71 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 118.62 -1.232 . . . . 75.209999999999994 110.227 -176.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.8 m -87.38 -34.72 18.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.731 -1.581 . . . . 74.409999999999997 106.731 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.0 p -108.02 70.24 0.76 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 113.905 -1.498 . . . . 72.019999999999996 109.426 177.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.0 pp -90.0 121.74 68.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.35 1.241 . . . . 73.0 114.35 179.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.42 172.88 10.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.557 2.171 . . . . 74.420000000000002 108.516 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.73 153.54 61.59 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 122.157 1.905 . . . . 74.129999999999995 111.594 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -6.87 11.62 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.623 0.725 . . . . 65.439999999999998 111.935 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -82.26 143.53 31.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.917 -1.038 . . . . 75.019999999999996 108.858 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.92 118.01 22.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.938 -1.105 . . . . 64.299999999999997 108.889 -178.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.47 -47.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.014 -1.106 . . . . 75.340000000000003 108.014 -178.283 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.55 170.48 35.8 Favored Glycine 0 N--CA 1.403 -3.543 0 N-CA-C 109.6 -1.4 . . . . 54.240000000000002 109.6 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -119.05 -178.7 3.62 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 108.482 -0.933 . . . . 75.299999999999997 108.482 179.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.74 154.71 37.01 Favored Pre-proline 0 C--N 1.282 -2.342 0 N-CA-C 108.326 -0.99 . . . . 75.200000000000003 108.326 176.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -31.9 -32.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.856 1 C-N-CA 125.861 4.374 . . . . 73.319999999999993 116.159 -176.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -47.26 -35.0 7.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.321 1.048 . . . . 71.239999999999995 112.925 -178.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.27 -49.76 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.068 0.461 . . . . 64.510000000000005 112.023 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.68 -0.4 56.19 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.806 0.669 . . . . 73.200000000000003 112.806 -176.012 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.9 m -87.73 164.24 16.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.439999999999998 107.723 175.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 409' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 359' ' ' ASP . 2.5 p -74.23 113.57 11.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.87 0.843 . . . . 64.400000000000006 112.336 -176.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.62 170.13 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.951 -1.022 . . . . 73.219999999999999 108.856 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.3 t -90.26 151.73 21.38 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.792 -1.188 . . . . 74.510000000000005 107.792 176.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.12 130.92 45.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.328 -0.619 . . . . 71.109999999999999 109.328 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 91.28 25.78 22.95 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.575 -0.822 . . . . 72.200000000000003 112.399 -179.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.01 -175.63 3.93 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.833 -0.803 . . . . 62.310000000000002 108.833 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 29.3 mt-10 -105.43 126.78 52.51 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 118.517 0.598 . . . . 73.329999999999998 111.448 -175.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.59 124.97 60.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.031 -0.729 . . . . 72.219999999999999 109.031 175.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 385' ' ' ARG . 24.8 p -92.25 127.81 37.87 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 109.871 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 82.4 t -124.22 130.85 73.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.427 -176.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -96.87 128.59 43.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.717 -0.674 . . . . 75.25 109.414 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 42.5 t -124.57 140.36 48.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.737 -0.838 . . . . 75.010000000000005 108.737 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.2 p -103.3 122.76 45.46 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.995 0.426 . . . . 72.439999999999998 110.921 179.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 25.7 p -118.61 104.93 11.1 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.619 -0.264 . . . . 73.25 110.468 177.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.01 156.11 0.74 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 114.823 0.689 . . . . 61.329999999999998 114.823 177.513 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 2.4 Cg_endo -84.27 149.4 11.86 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.249 1.966 . . . . 51.130000000000003 110.795 173.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.72 149.41 31.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.776 -0.647 . . . . 72.299999999999997 112.678 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.6 mt-30 -107.01 151.88 24.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.579 -1.267 . . . . 75.049999999999997 107.579 176.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.88 164.38 30.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.325 -0.991 . . . . 74.319999999999993 108.325 -179.116 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.01 138.3 33.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.56 -0.533 . . . . 70.299999999999997 109.56 -178.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.2 mt -83.79 123.66 75.81 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 105.932 -1.877 . . . . 74.030000000000001 105.932 174.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.4 141.23 82.31 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.687 2.258 . . . . 72.310000000000002 113.306 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.46 -22.26 25.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.395 -0.821 . . . . 74.230000000000004 110.539 -177.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.49 -12.59 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.695 0.759 . . . . 75.329999999999998 110.507 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 17.6 m -53.9 -36.7 62.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.287 1.035 . . . . 71.209999999999994 112.012 -179.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 8.9 p -69.48 -12.99 62.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.463 0.912 . . . . 75.349999999999994 113.463 -178.162 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . 0.475 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.4 mt -89.97 -41.07 11.96 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.753 0.649 . . . . 62.039999999999999 112.753 -178.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 91.6 m -149.24 125.82 11.0 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.979 -0.378 . . . . 74.430000000000007 109.979 -176.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.75 -48.17 80.4 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.735 . . . . 75.540000000000006 112.983 -178.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.23 90.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 110.95 -178.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 13.8 mm-40 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.953 -0.567 . . . . 71.450000000000003 109.923 179.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.87 -51.08 71.25 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.766 -0.652 . . . . 71.109999999999999 109.736 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.76 -43.8 96.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.743 -0.662 . . . . 74.329999999999998 110.742 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.46 -48.57 74.74 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.167 0.432 . . . . 75.430000000000007 112.167 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 74.4 mmtt -67.62 -39.71 84.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.831 0.348 . . . . 74.409999999999997 111.415 -178.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.05 -39.77 93.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.562 -0.532 . . . . 74.439999999999998 109.562 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 94.3 m -67.45 -41.25 85.02 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.864 -0.607 . . . . 64.299999999999997 110.2 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.24 -16.78 63.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.199 -0.455 . . . . 72.5 111.774 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.9 -3.37 59.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.305 -0.407 . . . . 74.299999999999997 110.807 177.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.11 33.84 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.968 -0.634 . . . . 63.140000000000001 113.178 176.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -67.43 139.21 57.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.694 0.283 . . . . 74.040000000000006 110.828 -177.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -142.3 1.08 1.6 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.779 -0.725 . . . . 70.140000000000001 112.615 -179.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -104.0 111.3 23.8 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.535 -1.283 . . . . 73.340000000000003 107.535 178.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -127.28 144.67 51.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.309 -0.405 . . . . 74.230000000000004 110.29 -174.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -134.8 123.49 23.63 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.64 -1.985 . . . . 72.420000000000002 105.64 171.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -107.63 132.11 53.66 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 118.099 0.409 . . . . 75.450000000000003 111.139 -174.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.0 163.22 30.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.1 -0.5 . . . . 74.349999999999994 109.719 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -121.58 131.81 54.33 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.34 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -123.27 144.56 44.02 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 106.799 -1.556 . . . . 73.019999999999996 106.799 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.67 133.5 24.03 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 121.866 1.711 . . . . 73.329999999999998 111.057 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.1 m -143.75 174.97 10.34 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.583 -0.895 . . . . 71.340000000000003 108.583 -178.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 27.2 p -65.35 149.63 96.81 Favored Pre-proline 0 C--N 1.311 -1.09 0 O-C-N 123.463 0.477 . . . . 75.540000000000006 109.842 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.47 -36.26 38.83 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 72.420000000000002 112.365 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -69.26 -22.02 63.86 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.976 0.732 . . . . 72.530000000000001 112.976 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.34 -9.77 21.94 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.778 -0.369 . . . . 74.010000000000005 111.637 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -59.9 126.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 CA-C-O 121.089 0.471 . . . . 74.010000000000005 110.372 177.014 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.24 -7.19 58.32 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.1 -0.8 . . . . 73.239999999999995 111.1 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.8 mptp? -107.34 156.27 19.08 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.792 -0.818 . . . . 74.049999999999997 108.792 177.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.1 t -84.15 127.58 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.654 -1.239 . . . . 71.400000000000006 107.654 175.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.9 -19.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.138 0.792 . . . . 73.319999999999993 113.138 -175.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.36 167.96 31.51 Favored Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.422 -0.894 . . . . 73.519999999999996 111.325 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.6 p -136.96 154.18 50.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.043 -1.465 . . . . 72.310000000000002 107.043 179.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -69.31 -48.68 25.46 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 118.984 -1.086 . . . . 74.219999999999999 109.369 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.85 106.72 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 N-CA-C 106.937 -1.986 . . . . 75.439999999999998 106.937 165.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 475' ' ' ASN . 39.1 Cg_endo -65.06 151.62 85.1 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.879 2.386 . . . . 70.140000000000001 115.084 -169.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.408 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.0 12.68 0.81 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.76 1.224 . . . . 74.400000000000006 111.35 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 473' ' ' PRO . 44.8 m-80 -110.3 -15.59 13.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.577 -0.738 . . . . 74.519999999999996 110.493 179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.08 154.68 22.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.848 0.832 . . . . 74.319999999999993 111.499 -171.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -87.74 110.61 20.58 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.014 -1.476 . . . . 65.349999999999994 107.014 178.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.5 m -112.83 148.52 34.68 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.772 -0.194 . . . . 74.200000000000003 111.134 -174.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.18 142.44 58.41 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.175 0.59 . . . . 73.319999999999993 110.66 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.0 mm -64.7 -21.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.495 0.664 . . . . 71.140000000000001 111.147 -179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.6 p -87.14 1.83 51.79 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 116.006 -0.543 . . . . 74.239999999999995 111.412 -177.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -89.75 145.45 25.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 116.191 -0.459 . . . . 75.450000000000003 111.107 178.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.34 122.75 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.719 -0.845 . . . . 74.150000000000006 108.719 176.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.08 120.74 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 108.66 -0.867 . . . . 71.340000000000003 108.66 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -92.21 112.74 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.711 -1.218 . . . . 73.150000000000006 107.711 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.56 105.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.693 -1.225 . . . . 71.099999999999994 107.693 -177.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.43 118.29 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.034 -0.985 . . . . 73.439999999999998 109.338 -176.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.7 t -97.32 138.54 21.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.568 -1.271 . . . . 75.019999999999996 107.568 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -81.55 108.48 2.88 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 109.424 -1.471 . . . . 74.319999999999993 109.424 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 13.3 t -142.67 118.02 10.23 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 62.109999999999999 108.566 179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.316 0 N-CA-C 108.834 -1.706 . . . . 75.420000000000002 108.834 179.34 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.268 0 N-CA-C 109.773 -1.331 . . . . 62.229999999999997 109.773 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.25 157.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 117.071 0.436 . . . . 74.519999999999996 110.981 178.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 12.8 t -125.62 169.21 12.73 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.107 -1.071 . . . . 63.32 108.107 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -107.89 92.32 4.02 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 122.204 1.002 . . . . 73.239999999999995 110.012 177.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -117.21 148.68 41.41 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.054 -1.885 . . . . 75.209999999999994 107.623 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.62 161.5 32.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.033 0.444 . . . . 62.43 111.208 -173.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -100.69 136.32 40.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.644 -1.243 . . . . 74.099999999999994 107.644 173.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -98.49 133.2 22.92 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.149 -1.056 . . . . 64.319999999999993 108.149 -177.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.83 164.27 36.22 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 121.966 1.777 . . . . 70.209999999999994 113.67 -176.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 366' ' ' ARG . 4.1 m-20 -67.51 120.89 14.69 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.844 -1.071 . . . . 54.530000000000001 108.244 176.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.83 30.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.582 0 CA-C-O 123.067 1.413 . . . . 75.340000000000003 110.146 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 364' ' ' ASP . 15.1 ptt85 -62.49 144.09 56.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.716 -1.584 . . . . 73.430000000000007 113.041 -177.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.01 0.47 48.29 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.303 -0.862 . . . . 61.210000000000001 114.164 173.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -132.77 175.88 8.95 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.824 0.812 . . . . 74.430000000000007 111.569 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 97.3 p -74.77 171.45 13.94 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.636 0.374 . . . . 75.540000000000006 111.028 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 14.6 m -61.85 -45.66 92.84 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.99 0.424 . . . . 75.209999999999994 110.09 178.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.83 80.4 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.106 -0.497 . . . . 74.25 111.195 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.47 -42.23 79.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.23 -0.441 . . . . 75.450000000000003 110.701 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.77 81.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 75.010000000000005 110.287 178.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.6 mt -58.71 -42.58 85.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 75.400000000000006 110.715 178.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.23 -47.17 77.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.295 -0.412 . . . . 64.239999999999995 110.985 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 43.7 m -60.77 -45.57 93.81 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 116.511 -0.313 . . . . 75.340000000000003 111.401 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.64 -38.93 92.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.737 0.303 . . . . 72.540000000000006 111.01 176.061 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.24 -43.3 99.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.704 -0.68 . . . . 74.209999999999994 109.839 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -29.03 70.11 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.885 -0.598 . . . . 74.340000000000003 110.691 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -83.85 -12.12 56.0 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.872 -0.604 . . . . 73.049999999999997 109.709 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 96.92 0.85 60.04 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.997 -0.62 . . . . 71.310000000000002 112.416 177.256 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 43.9 m-85 -79.18 157.15 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.034 0.445 . . . . 74.5 111.851 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.8 137.83 40.5 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 106.711 -1.589 . . . . 71.230000000000004 106.711 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.63 140.26 46.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 113.96 1.096 . . . . 73.120000000000005 113.96 -177.053 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -110.69 130.89 55.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.03 -1.841 . . . . 75.319999999999993 106.03 173.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.9 m -112.64 118.09 34.08 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.782 -0.822 . . . . 54.340000000000003 108.782 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.44 118.33 32.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.943 -1.502 . . . . 75.510000000000005 106.943 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.67 122.44 47.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.072 -0.714 . . . . 72.5 109.072 177.536 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 389' ' ' LYS . 0.1 OUTLIER -127.38 133.45 25.09 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.009 -0.541 . . . . 74.319999999999993 110.068 -179.631 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.416 ' N ' ' HB ' ' A' ' 422' ' ' THR . 57.8 Cg_endo -76.19 139.67 21.55 Favored 'Trans proline' 0 C--O 1.257 1.431 0 C-N-CA 122.371 2.047 . . . . 74.400000000000006 109.326 172.092 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 172.78 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.491 -1.299 . . . . 62.520000000000003 107.491 -176.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.444 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 57.4 m -141.68 -14.38 0.84 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.876 -0.515 . . . . 71.400000000000006 111.928 176.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.5 p -91.37 19.35 6.13 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.364 1.078 . . . . 63.43 109.847 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.8 pt -104.57 150.95 39.11 Favored Pre-proline 0 C--N 1.296 -1.735 0 CA-C-N 114.571 -1.195 . . . . 74.239999999999995 111.839 -173.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 145.23 38.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.494 2.129 . . . . 72.439999999999998 111.291 177.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.48 162.84 7.51 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.26 3.307 . . . . 73.030000000000001 113.362 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.91 -11.78 1.15 Allowed 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 124.257 1.023 . . . . 72.200000000000003 112.451 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -101.97 109.15 20.81 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.082 -2.192 . . . . 73.400000000000006 105.082 176.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.3 p -62.14 120.64 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.079 0.942 . . . . 65.230000000000004 112.302 -170.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.03 -27.9 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.546 -1.206 . . . . 75.530000000000001 110.318 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.62 158.09 27.56 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 119.817 -1.182 . . . . 73.239999999999995 111.97 -177.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.1 p -114.6 -175.58 2.71 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.253 0.621 . . . . 73.109999999999999 110.249 -177.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -100.05 134.77 20.66 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.805 -1.554 . . . . 73.099999999999994 106.805 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.72 -27.94 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 1 C-N-CA 125.395 4.063 . . . . 74.310000000000002 115.939 -175.583 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.85 -24.16 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.76 0.314 . . . . 51.520000000000003 111.055 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.87 40.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.018 -0.537 . . . . 71.530000000000001 110.816 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -79.26 -2.32 40.66 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.291 0.567 . . . . 74.519999999999996 112.249 -179.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 84.2 m -84.86 146.84 27.1 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.391 -1.337 . . . . 73.030000000000001 107.391 172.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -75.43 119.6 19.73 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.903 -0.719 . . . . 74.329999999999998 110.001 -179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.02 169.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 123.898 0.879 . . . . 71.5 109.225 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.0 t -75.61 142.05 42.73 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.439 -0.949 . . . . 73.310000000000002 108.439 178.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -64.27 109.76 2.0 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.215 -0.661 . . . . 74.120000000000005 109.215 178.092 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 122.96 25.88 1.8 Allowed Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.765 -0.934 . . . . 73.209999999999994 110.765 -175.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.02 -178.29 4.02 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.047 -1.094 . . . . 52.340000000000003 108.047 -178.169 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.33 120.92 35.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.903 0.859 . . . . 75.519999999999996 112.918 -176.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.1 mm -110.96 121.35 63.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.501 -0.926 . . . . 73.400000000000006 108.501 176.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.9 t -93.81 121.39 35.2 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.549 0.69 . . . . 70.030000000000001 110.037 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.3 t -107.05 126.85 63.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.387 -0.968 . . . . 61.439999999999998 108.387 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -99.75 120.19 39.33 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.244 -0.65 . . . . 64.329999999999998 109.244 -179.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.0 t -113.07 142.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.764 -0.828 . . . . 75.439999999999998 108.764 -178.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.0 p -84.87 127.38 34.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.898 1.332 . . . . 74.329999999999998 113.792 -178.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.416 ' HB ' ' N ' ' A' ' 390' ' ' PRO . 8.8 m -101.46 156.84 17.23 Favored 'General case' 1 N--CA 1.376 -4.156 0 N-CA-C 104.092 -2.558 . . . . 74.230000000000004 104.092 170.238 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -34.84 150.64 0.01 OUTLIER Glycine 0 C--N 1.284 -2.357 0 N-CA-C 117.435 1.734 . . . . 74.150000000000006 117.435 -176.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 50.9 Cg_exo -54.71 132.2 50.27 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.128 2.552 . . . . 74.150000000000006 112.918 179.007 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -72.25 140.6 48.73 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.142 -0.935 . . . . 73.299999999999997 109.933 176.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.2 mt-30 -120.3 148.11 44.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.251 -1.018 . . . . 61.43 108.251 176.325 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -144.56 164.64 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.615 -1.254 . . . . 75.120000000000005 107.615 -176.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.39 138.84 34.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.993 -1.114 . . . . 74.299999999999997 107.993 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.5 mt -80.8 120.47 79.05 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.168 -1.049 . . . . 73.140000000000001 108.168 178.298 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.46 141.55 51.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.96 2.44 . . . . 64.409999999999997 113.69 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.44 -15.65 56.27 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.733 -1.121 . . . . 75.150000000000006 111.253 -176.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.31 -14.62 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.396 -0.82 . . . . 75.329999999999998 110.838 -178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.0 m -53.74 -40.04 65.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.922 0.889 . . . . 73.310000000000002 112.388 -178.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.8 p -69.08 -12.84 62.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 113.384 0.883 . . . . 75.299999999999997 113.384 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -82.7 -48.35 10.97 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.362 -0.535 . . . . 72.530000000000001 110.716 -178.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 75.1 m -157.29 141.74 16.49 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 110.285 -0.265 . . . . 72.510000000000005 110.285 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -56.7 -44.19 81.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.695 1.198 . . . . 74.530000000000001 111.486 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.61 78.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.915 0.388 . . . . 74.109999999999999 110.482 177.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.11 -42.0 94.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.836 -0.62 . . . . 65.519999999999996 110.935 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 444' ' ' LEU . . . -60.79 -51.69 68.27 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.599 0.562 . . . . 73.409999999999997 110.662 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.57 -49.18 81.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.948 -0.301 . . . . 74.200000000000003 111.515 -177.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.06 -47.58 70.86 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.569 0.581 . . . . 72.040000000000006 112.569 -178.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -67.05 -38.03 85.12 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.255 0.835 . . . . 71.209999999999994 113.255 -178.566 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.42 -36.46 84.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.269 -0.572 . . . . 73.420000000000002 111.115 174.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 44.9 m -67.35 -39.95 85.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 177.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.95 68.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.157 0.503 . . . . 74.239999999999995 110.605 177.331 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.64 59.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.302 -0.408 . . . . 55.100000000000001 110.34 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.92 -21.3 8.99 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 119.163 -0.799 . . . . 43.340000000000003 114.697 174.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -55.88 128.33 34.56 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.408 0.892 . . . . 74.450000000000003 113.408 -172.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.46 -1.18 23.31 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.251 -0.886 . . . . 71.340000000000003 114.293 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 10.7 mmm180 -124.12 111.66 16.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 117.699 0.749 . . . . 73.030000000000001 110.549 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -119.07 150.99 39.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.271 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -145.56 136.1 24.21 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.399 -1.704 . . . . 74.209999999999994 106.399 172.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -106.64 134.12 50.28 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.809 0.338 . . . . 73.150000000000006 110.148 -176.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.93 159.14 42.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.231 -0.655 . . . . 62.030000000000001 109.231 177.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -129.35 134.54 47.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.43 -0.952 . . . . 64.409999999999997 108.43 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 t -125.14 146.13 52.82 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 108.997 -0.742 . . . . 74.109999999999999 108.997 -177.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 490' ' ' SER . 40.4 Cg_exo -61.57 123.6 13.04 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.332 2.021 . . . . 75.319999999999993 109.244 173.769 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.5 m -139.26 -179.78 6.07 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 110.211 -0.292 . . . . 72.510000000000005 110.211 -176.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.6 m -56.18 133.5 75.11 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 108.384 -0.969 . . . . 74.420000000000002 108.384 175.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.01 -31.16 33.58 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.828 3.018 . . . . 72.209999999999994 114.173 -175.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.73 -11.23 59.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 111.962 0.356 . . . . 75.430000000000007 111.962 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.69 2.29 38.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.498 -0.319 . . . . 74.420000000000002 111.16 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.7 p -59.62 126.96 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 120.277 -0.569 . . . . 74.340000000000003 110.689 178.032 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.79 78.24 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.161 -1.019 . . . . 72.439999999999998 111.963 178.407 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -125.42 147.21 49.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.584 -0.895 . . . . 75.439999999999998 108.584 177.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.65 128.64 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.193 -0.669 . . . . 75.409999999999997 109.193 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.66 -5.39 9.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.126 -1.03 . . . . 75.219999999999999 111.226 -178.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.73 29.39 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.534 -0.841 . . . . 74.010000000000005 111.805 176.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.2 p -116.34 153.34 32.17 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.896 -1.15 . . . . 74.25 107.896 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 28.4 t-20 -60.75 -50.35 85.56 Favored Pre-proline 0 C--N 1.317 -0.838 0 O-C-N 123.35 0.406 . . . . 75.329999999999998 111.285 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_exo -77.98 131.28 10.92 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 N-CA-C 107.413 -1.803 . . . . 64.540000000000006 107.413 168.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . 0.4 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.5 Cg_endo -62.46 142.14 89.34 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.373 2.049 . . . . 75.530000000000001 113.552 -175.773 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.99 4.18 15.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.976 0.893 . . . . 72.310000000000002 110.827 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -108.56 3.24 22.79 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.763 -1.108 . . . . 71.109999999999999 108.652 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . 0.4 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 36.1 tt0 -121.83 165.21 16.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.106 -1.072 . . . . 74.530000000000001 108.106 -178.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 2.8 m -98.77 129.64 45.2 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.029 -1.1 . . . . 75.319999999999993 108.029 -179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 47.5 m -124.42 148.59 47.5 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 -178.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.25 153.75 40.49 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.388 0.514 . . . . 75.519999999999996 112.388 -178.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.26 -29.46 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.359 0.6 . . . . 73.409999999999997 110.694 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 14.6 t -90.18 2.82 54.94 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.541 0.686 . . . . 72.310000000000002 109.949 177.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 46.1 t30 -86.08 141.55 29.35 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.037 -1.097 . . . . 73.329999999999998 108.037 -178.055 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.47 112.71 17.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 120.051 -0.66 . . . . 72.400000000000006 109.22 -178.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.1 119.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 N-CA-C 107.514 -1.291 . . . . 72.530000000000001 107.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 41.0 mt -98.22 121.03 48.33 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.451 -1.314 . . . . 75.310000000000002 107.451 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.93 120.22 51.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.809 -1.182 . . . . 63.549999999999997 107.809 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.59 123.63 60.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-O 121.527 0.679 . . . . 72.319999999999993 110.048 -176.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.98 137.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.946 -1.131 . . . . 70.299999999999997 107.946 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.57 127.98 8.97 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.424 -1.07 . . . . 65.150000000000006 110.424 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.3 t -133.94 103.89 6.02 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.179 -1.045 . . . . 73.409999999999997 108.179 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.193 0 N-CA-C 108.877 -1.689 . . . . 71.409999999999997 108.877 -178.007 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.293 0 N-CA-C 109.82 -1.312 . . . . 63.530000000000001 109.82 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.71 141.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 C-N-CA 119.866 -0.734 . . . . 72.230000000000004 109.241 174.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.9 m -117.23 160.04 21.71 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 108.398 -0.964 . . . . 73.140000000000001 108.398 -175.024 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -97.17 56.93 1.42 Allowed 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.519 -1.289 . . . . 64.430000000000007 107.519 171.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -85.65 127.14 34.4 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.589 -1.641 . . . . 75.450000000000003 109.892 -178.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.98 152.23 20.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 110.931 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.54 136.7 43.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.151 -0.477 . . . . 71.109999999999999 109.941 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.95 133.77 20.18 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 109.301 -0.629 . . . . 75.219999999999999 109.301 -176.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.65 159.51 53.21 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.604 2.202 . . . . 71.140000000000001 114.635 -175.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.37 142.96 50.36 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.28 -0.873 . . . . 72.319999999999993 109.166 176.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 6.7 t -107.08 21.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.044 -1.095 . . . . 72.109999999999999 108.044 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 6.0 ptp180 -58.57 145.37 39.61 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.08 -0.964 . . . . 75.450000000000003 112.379 -177.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.4 1.06 43.92 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 113.317 178.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 7.6 pt20 -138.58 -175.45 4.13 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.263 -1.014 . . . . 73.310000000000002 108.263 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 96.1 p -76.48 163.82 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 119.609 1.095 . . . . 74.239999999999995 112.316 -172.576 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.7 p -61.85 -34.09 75.34 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.758 -0.655 . . . . 71.030000000000001 109.335 173.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.77 91.73 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.143 -0.935 . . . . 72.239999999999995 109.781 176.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.06 -42.11 89.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.58 -0.736 . . . . 75.329999999999998 110.619 177.206 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.93 -47.39 85.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.722 -0.672 . . . . 64.239999999999995 111.224 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.45 -46.12 89.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.087 -0.506 . . . . 75.010000000000005 110.013 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.15 93.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.63 . . . . 54.149999999999999 111.477 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 64.9 m -66.24 -48.25 71.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.145 -0.48 . . . . 64.340000000000003 111.088 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.27 -38.7 91.1 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.325 -0.234 . . . . 74.209999999999994 111.225 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.71 -48.17 82.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.823 -0.806 . . . . 63.119999999999997 108.823 178.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -70.33 -17.31 63.07 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.684 1.364 . . . . 74.239999999999995 114.684 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -89.61 -14.19 35.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.353 -0.539 . . . . 73.340000000000003 111.113 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.11 16.25 30.79 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.345 -0.931 . . . . 63.329999999999998 113.25 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -96.72 154.67 17.15 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.857 -0.423 . . . . 74.230000000000004 109.857 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -95.61 143.44 26.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.091 -1.448 . . . . 74.140000000000001 107.091 178.325 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 384' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -132.75 148.21 31.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.363 0.601 . . . . 65.010000000000005 112.398 -178.802 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 385' ' ' ARG . . . . . 0.432 ' HB3' HG23 ' A' ' 417' ' ' THR . 19.5 ttm-85 -118.28 144.88 45.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.705 -1.591 . . . . 74.219999999999999 106.705 174.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.3 m -98.46 121.58 40.58 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.008 -1.478 . . . . 73.340000000000003 107.008 176.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.34 119.47 38.96 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.872 -1.899 . . . . 74.439999999999998 105.872 -179.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.503 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -110.91 122.06 46.93 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.368 0.604 . . . . 75.120000000000005 110.892 -174.619 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 389' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.3 OUTLIER -116.15 119.32 36.88 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 115.402 -0.817 . . . . 73.230000000000004 111.48 -177.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 5.8 Cg_endo -93.25 145.53 2.26 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.031 2.487 . . . . 65.209999999999994 111.662 173.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 391' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 12.0 t70 160.82 -164.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 104.861 -2.274 . . . . 64.230000000000004 104.861 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 392' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 394' ' ' ILE . 14.8 m -132.8 1.68 3.65 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 119.533 1.06 . . . . 72.239999999999995 110.316 175.031 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -97.32 24.39 6.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 106.385 -1.709 . . . . 74.519999999999996 106.385 174.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 394' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 392' ' ' SER . 19.8 pt -89.64 151.57 45.97 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 112.527 -2.124 . . . . 73.319999999999993 110.304 -178.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.55 173.01 15.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 121.837 1.691 . . . . 73.420000000000002 108.652 170.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 396' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 398' ' ' HIS . 50.8 Cg_exo -58.01 160.92 14.28 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.161 1.907 . . . . 73.040000000000006 112.598 174.653 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.01 -8.07 0.94 Allowed 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.923 1.689 . . . . 70.019999999999996 112.781 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' A' ' 368' ' ' GLN . 42.9 m80 -82.42 175.47 10.2 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.452 1.101 . . . . 70.439999999999998 108.467 179.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.6 p -91.8 117.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 118.457 -1.297 . . . . 73.319999999999993 109.592 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.81 -28.76 2.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.672 -1.149 . . . . 71.439999999999998 109.808 177.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.34 160.8 27.92 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 119.79 -1.195 . . . . 70.420000000000002 112.192 -173.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 52.4 p -122.43 -174.46 2.91 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.282 1.033 . . . . 71.219999999999999 111.225 -172.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -98.17 142.07 23.98 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 105.896 -1.89 . . . . 71.019999999999996 105.896 -175.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.31 -36.14 6.08 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.795 2.996 . . . . 74.120000000000005 113.647 178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -68.54 -8.21 39.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.962 -0.563 . . . . 61.310000000000002 112.496 -178.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -81.75 -51.45 8.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.548 -0.461 . . . . 72.140000000000001 110.64 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.35 -5.12 59.24 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 120.646 -0.421 . . . . 74.230000000000004 112.043 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.5 m -97.06 142.25 29.23 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 72.420000000000002 106.624 174.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.7 p -74.24 113.74 11.8 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.763 0.792 . . . . 72.430000000000007 111.771 -177.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.25 170.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.887 -1.051 . . . . 74.340000000000003 109.462 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 48.1 m -67.02 138.56 57.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.561 -0.903 . . . . 73.109999999999999 108.561 175.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.81 109.92 0.81 Allowed 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.007 0.523 . . . . 73.239999999999995 111.483 -177.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.93 43.64 1.62 Allowed Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.582 -0.735 . . . . 65.129999999999995 111.997 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -94.39 -167.62 1.7 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.406 -1.331 . . . . 63.310000000000002 107.406 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.36 124.4 52.17 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.695 0.759 . . . . 73.299999999999997 111.612 -179.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 416' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 43.7 mm -114.44 135.53 53.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.012 -0.994 . . . . 65.420000000000002 108.554 -176.063 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 417' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 385' ' ' ARG . 71.1 p -94.32 127.07 39.96 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.34 -0.944 . . . . 73.140000000000001 109.689 175.462 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.28 130.13 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.242 -1.021 . . . . 75.219999999999999 108.242 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -96.69 128.81 43.99 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 116.401 -0.363 . . . . 75.219999999999999 110.595 -175.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 12.6 p -134.33 141.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.391 -0.966 . . . . 75.129999999999995 108.391 176.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 421' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 73.2 p -94.1 122.53 36.71 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.474 -0.565 . . . . 53.32 109.474 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 422' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 388' ' ' GLN . 12.2 t -120.14 107.5 13.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.857 -0.737 . . . . 74.230000000000004 111.992 177.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.04 120.65 1.59 Allowed Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.839 -1.172 . . . . 70.209999999999994 114.431 174.229 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 424' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.2 Cg_exo -75.94 128.56 10.84 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.898 1.732 . . . . 72.219999999999999 110.207 173.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.439 ' O ' HG12 ' A' ' 480' ' ' ILE . 6.4 mm-40 -74.99 125.75 29.57 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.687 -0.486 . . . . 75.420000000000002 109.687 177.275 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 49.1 mt-30 -110.29 139.08 45.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.083 -0.71 . . . . 73.129999999999995 109.083 177.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 427' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 1.1 tpt180 -132.64 165.45 24.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.995 0.426 . . . . 73.430000000000007 111.579 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.76 139.24 34.96 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.158 0.983 . . . . 75.340000000000003 111.2 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.67 119.82 76.36 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.278 -1.749 . . . . 64.140000000000001 106.278 172.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.25 141.35 81.87 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.651 2.234 . . . . 74.329999999999998 113.368 -178.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 -20.96 23.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.069 -0.969 . . . . 54.32 110.426 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.39 -11.73 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.407 0.623 . . . . 72.030000000000001 110.624 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.2 m -53.0 -41.03 64.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.486 1.114 . . . . 62.420000000000002 112.485 -178.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 3.1 p -68.2 -13.63 62.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.557 0.947 . . . . 74.450000000000003 113.557 -176.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 76.3 mt -86.86 -36.92 18.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.651 0.263 . . . . 64.109999999999999 111.306 -178.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.9 m -158.37 134.15 9.0 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 122.222 -0.299 . . . . 73.310000000000002 110.415 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.05 -46.42 89.21 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.703 0.631 . . . . 74.25 112.703 -178.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.14 -41.23 87.82 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.704 0.287 . . . . 74.230000000000004 110.468 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -63.71 -39.45 94.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.725 -0.671 . . . . 61.539999999999999 110.41 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.87 -50.92 71.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.47 0.481 . . . . 43.119999999999997 109.837 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.44 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 75.120000000000005 110.467 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 442' ' ' LYS . 6.3 mmpt? -61.04 -46.05 92.26 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.996 -0.547 . . . . 73.150000000000006 111.267 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.43 -41.98 96.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.246 0.462 . . . . 74.239999999999995 112.246 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -43.43 96.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.936 0.398 . . . . 72.310000000000002 111.024 176.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.9 m -68.08 -39.63 82.88 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.787 -0.642 . . . . 74.420000000000002 110.333 -178.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.3 62.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 63.020000000000003 111.184 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.76 -12.84 59.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.156 0.503 . . . . 65.239999999999995 109.728 176.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.53 0.7 40.26 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-O 119.168 -0.795 . . . . 74.409999999999997 114.469 174.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.96 137.38 57.1 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.099 0.95 . . . . 74.140000000000001 112.106 -178.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -125.08 13.57 7.53 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.204 -0.759 . . . . 73.299999999999997 111.204 178.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.23 111.37 13.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.504 -0.924 . . . . 71.310000000000002 108.504 -178.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.08 152.74 47.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.89 -0.595 . . . . 74.450000000000003 109.94 -175.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -150.09 122.71 8.58 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.927 -1.138 . . . . 70.299999999999997 107.927 172.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.73 131.98 45.36 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.796 -0.446 . . . . 72.409999999999997 109.796 -177.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -123.57 141.17 52.27 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.315 -1.365 . . . . 73.409999999999997 107.315 175.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -119.28 129.59 54.98 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.219 0.533 . . . . 72.109999999999999 110.288 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.2 t -119.94 130.84 24.64 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 108.506 -0.924 . . . . 74.209999999999994 108.506 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.73 121.81 10.09 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.45 2.1 . . . . 72.420000000000002 109.699 177.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.4 m -133.95 160.28 38.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.916 -0.314 . . . . 72.519999999999996 110.417 -176.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 460' ' ' THR . . . . . 0.529 ' HB ' ' OE1' ' A' ' 462' ' ' GLU . 14.2 p -64.65 159.06 64.47 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 124.856 1.262 . . . . 75.140000000000001 111.81 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.77 -31.13 24.89 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.789 2.992 . . . . 73.129999999999995 113.285 177.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 462' ' ' GLU . . . . . 0.529 ' OE1' ' HB ' ' A' ' 460' ' ' THR . 1.5 pm0 -75.36 -24.54 57.31 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.193 0.812 . . . . 73.409999999999997 113.193 178.115 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.17 -18.67 14.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.211 0.448 . . . . 72.510000000000005 112.211 -179.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.9 p -59.5 130.44 23.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.413 0.625 . . . . 72.310000000000002 111.29 -179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -4.61 64.01 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.743 -0.662 . . . . 65.019999999999996 111.971 178.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 157.05 28.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.227 0.537 . . . . 74.109999999999999 109.95 177.295 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 94.6 t -83.79 136.51 22.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.496 -1.298 . . . . 65.129999999999995 107.496 176.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.31 -16.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.543 -0.863 . . . . 73.219999999999999 111.301 -177.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.1 175.62 32.32 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.561 -0.745 . . . . 43.520000000000003 111.629 178.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.0 p -122.01 158.99 27.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.385 -0.969 . . . . 75.030000000000001 108.385 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 471' ' ' ASN . . . . . 0.403 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -64.97 -57.0 17.19 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 119.086 -0.483 . . . . 74.120000000000005 110.666 175.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 472' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.0 Cg_endo -79.63 121.14 4.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 N-CA-C 107.951 -1.596 . . . . 72.430000000000007 107.951 170.176 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 161.29 46.5 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.537 2.158 . . . . 75.129999999999995 113.969 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -69.6 6.59 1.06 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.887 1.275 . . . . 73.319999999999993 113.283 -177.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -108.15 -4.49 17.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.158 -0.682 . . . . 75.010000000000005 109.158 179.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -99.92 161.44 13.61 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.604 -0.726 . . . . 74.409999999999997 109.936 -177.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.0 m -128.92 101.03 5.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.996 -1.483 . . . . 55.299999999999997 106.996 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.9 p -104.41 149.05 25.75 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.139 -0.482 . . . . 71.25 111.576 -174.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 479' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.8 153.53 24.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 74.319999999999993 111.015 177.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 480' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 425' ' ' GLU . 48.2 mm -61.0 -15.1 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 C-N-CA 123.924 0.89 . . . . 65.530000000000001 112.074 -179.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.0 t -94.99 -4.09 47.26 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.8 -0.563 . . . . 72.439999999999998 110.238 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 130.89 37.83 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.98 -0.748 . . . . 70.310000000000002 108.98 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.31 113.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.68 -0.859 . . . . 75.540000000000006 108.68 -179.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.45 120.04 36.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 109.081 -0.711 . . . . 64.219999999999999 109.081 179.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.8 mp -92.34 113.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 73.530000000000001 107.122 177.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.92 121.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.124 -1.065 . . . . 74.239999999999995 108.124 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 39.7 mt -101.16 116.32 44.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.566 0.698 . . . . 71.219999999999999 110.474 -175.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.5 t -98.1 132.72 42.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.245 -0.889 . . . . 73.239999999999995 109.045 -176.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.7 98.68 1.93 Allowed Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 109.207 -1.557 . . . . 63.420000000000002 109.207 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 18.0 t -140.85 111.89 7.17 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.902 -0.777 . . . . 70.439999999999998 108.902 -176.041 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.92 0 N-CA-C 109.636 -1.386 . . . . 73.040000000000006 109.636 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 108.425 -0.954 . . . . 73.24 108.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 22.7 m -131.27 158.48 43.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 123.102 0.561 . . . . 74.32 109.53 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -95.71 137.25 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.726 -0.842 . . . . 63.42 108.726 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.36 124.52 36.97 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-O 120.828 0.347 . . . . 70.25 110.519 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.01 142.64 96.85 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.16 2.573 . . . . 64.13 113.304 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.71 149.96 34.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.742 -1.117 . . . . 54.14 110.167 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.83 31.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.987 1.375 . . . . 63.0 108.006 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -64.44 133.97 53.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.057 -1.429 . . . . 74.32 110.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.18 -0.13 47.49 Favored Glycine 0 C--N 1.317 -0.495 0 C-N-CA 121.407 -0.425 . . . . 71.24 112.326 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.23 -176.88 3.94 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.615 -0.883 . . . . 72.43 108.615 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 91.6 p -81.3 168.41 18.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 118.407 0.548 . . . . 71.44 110.266 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 374' ' ' ILE . 1.8 p -63.15 -34.83 78.46 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.637 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.91 -39.25 93.98 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.731 0.412 . . . . 71.52 110.548 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -59.57 -42.83 93.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.019 0.438 . . . . 74.32 110.106 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.89 81.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.745 . . . . 73.31 110.343 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 370' ' ' SER . 80.9 mt -58.4 -46.34 89.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.654 -0.703 . . . . 53.41 110.546 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -46.98 78.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.317 -0.401 . . . . 73.04 111.705 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 74.0 m -60.9 -47.53 85.98 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.727 0.298 . . . . 71.23 111.291 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.57 -39.51 93.88 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.045 -0.262 . . . . 75.24 110.998 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -61.07 -42.92 99.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.459 0.703 . . . . 71.54 109.727 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -63.02 -33.71 76.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.778 -0.646 . . . . 75.41 111.323 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -83.84 -10.2 58.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.057 -0.52 . . . . 75.54 111.743 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.98 0.28 56.19 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.249 -0.977 . . . . 63.23 112.497 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 53.6 m-85 -78.07 151.11 33.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.675 -0.491 . . . . 70.43 109.675 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 383' ' ' LYS . 3.0 mptp? -102.06 147.19 26.89 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.867 -1.531 . . . . 73.43 106.867 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.69 141.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-O 121.378 0.609 . . . . 72.11 111.623 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -118.65 127.97 54.08 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.334 -1.358 . . . . 73.04 107.334 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.4 m -99.71 123.95 44.48 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 109.277 -0.638 . . . . 73.51 109.277 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.63 119.57 39.14 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.302 -1.74 . . . . 73.04 106.302 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 17.1 pm0 -119.18 141.29 48.99 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 110.155 -0.313 . . . . 75.51 110.155 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 11.0 ptpt -139.4 134.89 16.69 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 116.057 -0.52 . . . . 73.55 111.109 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 6.1 Cg_exo -82.7 134.24 7.33 Favored 'Trans proline' 0 C--O 1.246 0.893 0 N-CA-C 106.737 -2.063 . . . . 64.45 106.737 165.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.429 ' HB2' ' HD3' ' A' ' 389' ' ' LYS . 5.0 t70 -154.38 -176.73 6.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.182 -1.407 . . . . 55.03 112.239 -171.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.9 t -92.44 -41.09 10.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.017 -1.845 . . . . 71.42 106.017 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -101.83 74.52 1.49 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.92 -1.511 . . . . 75.51 106.92 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 421' ' ' SER . 2.1 pp -88.64 121.02 70.31 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 115.435 1.643 . . . . 71.13 115.435 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.588 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 16.5 Cg_exo -75.48 157.37 40.8 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.78 2.32 . . . . 45.54 109.519 164.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.64 160.91 47.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.33 2.02 . . . . 74.11 111.864 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.59 -6.91 5.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.041 0.756 . . . . 71.54 113.041 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -90.59 166.74 13.03 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.409 -0.814 . . . . 61.53 108.938 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.07 117.76 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.076 -0.713 . . . . 71.54 109.076 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -106.43 -28.63 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.346 -0.613 . . . . 75.03 109.346 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 168.16 28.09 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.957 -1.657 . . . . 70.21 108.957 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 p -132.58 -177.76 4.62 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-O 120.96 0.41 . . . . 63.14 110.698 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -100.94 138.78 20.11 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.947 -1.131 . . . . 65.03 107.947 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.9 -29.54 3.76 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 124.573 3.515 . . . . 75.14 114.703 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.58 -28.39 54.79 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.236 0.614 . . . . 61.34 112.0 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.66 54.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.944 0.402 . . . . 23.53 111.203 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -6.76 59.25 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.557 0.577 . . . . 71.33 112.557 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.5 m -86.02 147.69 26.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.649 -1.612 . . . . 71.53 106.649 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.0 m -74.45 112.83 11.01 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.417 -0.957 . . . . 65.12 108.417 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.67 165.06 29.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.047 -0.723 . . . . 71.34 109.047 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 50.3 m -69.23 134.13 48.81 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 120.6 -0.44 . . . . 72.34 110.242 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.89 112.01 2.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 63.24 110.218 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.53 24.21 5.1 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.537 -1.025 . . . . 74.24 110.537 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.99 -169.12 2.43 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.409 -1.33 . . . . 72.11 107.409 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.1 125.05 53.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.814 -0.554 . . . . 75.53 110.209 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -111.42 125.65 68.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.926 -0.579 . . . . 61.51 109.442 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.2 t -89.59 130.74 35.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.086 -0.709 . . . . 72.45 109.086 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 65.9 t -108.67 118.78 56.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.083 -1.08 . . . . 74.11 108.083 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.4 121.65 34.09 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.164 -0.68 . . . . 72.34 109.164 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 13.8 p -133.96 152.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.432 -1.321 . . . . 64.45 107.432 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.588 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 43.7 m -126.74 130.82 51.09 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 121.574 -0.703 . . . . 72.25 110.224 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -118.05 106.66 13.13 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.522 0.677 . . . . 65.51 110.995 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 79.33 141.24 2.19 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.205 -0.907 . . . . 43.04 114.204 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 24.0 Cg_endo -74.28 147.56 37.49 Favored 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 121.09 1.193 . . . . 74.1 109.465 172.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -72.77 164.91 25.83 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.887 -0.597 . . . . 73.32 109.628 -177.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -125.48 154.23 42.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.934 -1.136 . . . . 75.54 107.934 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.2 OUTLIER -141.9 153.48 44.44 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -83.06 138.86 33.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.962 -1.866 . . . . 73.12 105.962 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.2 mt -80.3 115.55 55.52 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 120.587 -0.445 . . . . 73.31 110.332 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.16 141.08 38.81 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.31 1.34 . . . . 70.43 109.969 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.6 78.77 9.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.619 1.2 . . . . 54.41 110.393 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.47 -10.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.531 -1.668 . . . . 71.35 107.588 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.6 m -59.9 -50.02 75.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.224 -1.353 . . . . 74.11 110.486 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 21.4 m -57.95 -13.56 4.76 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 125.598 1.559 . . . . 72.44 113.063 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.23 -47.08 11.18 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.731 -0.606 . . . . 73.11 110.681 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 26.6 m -160.82 145.68 14.14 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.652 -0.87 . . . . 73.2 108.652 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.57 -44.36 89.72 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 122.995 0.518 . . . . 53.31 111.085 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.76 84.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.815 -0.63 . . . . 73.55 110.748 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.451 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.5 mm-40 -61.89 -43.46 98.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.47 -0.786 . . . . 74.02 111.262 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -52.15 66.61 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 123.543 0.527 . . . . 55.42 110.729 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.76 -51.05 49.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.06 -0.518 . . . . 70.31 112.057 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -69.28 -44.94 70.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 114.04 1.126 . . . . 71.13 114.04 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.33 -38.39 84.82 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.978 -0.289 . . . . 73.33 111.312 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.15 -32.62 73.01 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.213 -0.595 . . . . 71.31 111.499 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.7 m -64.24 -40.38 95.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.999 -0.741 . . . . 75.22 108.999 174.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.65 66.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.711 -0.677 . . . . 75.2 110.798 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -12.4 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.164 0.507 . . . . 61.02 110.303 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.15 -27.57 5.56 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.886 -0.673 . . . . 73.15 113.713 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 445' ' ' THR . 88.8 m-85 -62.09 142.14 57.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.236 0.518 . . . . 71.42 111.392 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.89 13.71 4.42 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.59 -1.291 . . . . 53.21 113.278 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -128.35 113.82 16.08 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.321 -0.517 . . . . 73.24 110.049 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.1 152.36 47.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.199 0.523 . . . . 72.42 111.515 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -143.17 123.81 14.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.74 -1.578 . . . . 72.42 106.74 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -94.72 134.71 37.02 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.008 0.432 . . . . 73.44 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.73 159.69 41.28 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.741 -1.207 . . . . 75.24 107.741 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.663 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.1 m-80 -128.32 140.64 51.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.535 -0.913 . . . . 74.11 108.535 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.0 m -125.17 137.58 30.02 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 109.164 -0.68 . . . . 73.01 109.164 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 15.9 Cg_endo -61.55 121.39 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.414 2.076 . . . . 71.04 111.265 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.7 m -133.44 171.41 14.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.288 -0.634 . . . . 54.14 109.288 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.4 m -58.67 143.28 82.28 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 123.823 0.849 . . . . 64.02 108.867 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.1 Cg_endo -50.6 -25.91 15.76 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.553 2.835 . . . . 63.25 113.027 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.41 -18.71 65.51 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.215 0.45 . . . . 71.14 112.215 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.22 5.17 18.26 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.281 -0.262 . . . . 74.34 111.126 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.6 p -60.25 127.3 19.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.006 0.432 . . . . 74.11 110.895 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.03 82.06 Favored Glycine 0 C--N 1.308 -0.978 0 C-N-CA 120.469 -0.872 . . . . 75.33 112.453 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -111.28 153.41 25.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.568 -0.901 . . . . 64.35 108.568 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 434' ' ' THR . 86.5 t -84.03 135.55 24.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.814 -1.55 . . . . 54.23 106.814 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.75 -5.15 9.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 118.804 -1.158 . . . . 75.54 111.527 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 145.23 -153.67 25.42 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 111.066 -0.814 . . . . 61.24 111.066 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.1 p -116.79 160.38 20.9 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.489 -0.93 . . . . 52.12 108.489 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.4 t30 -74.08 -51.4 4.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 119.491 -0.884 . . . . 53.12 110.188 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.1 Cg_exo -71.03 152.39 62.71 Favored 'Trans proline' 0 C--N 1.381 2.288 0 N-CA-C 108.122 -1.53 . . . . 64.24 108.122 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.28 127.04 19.93 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.908 1.738 . . . . 75.25 111.775 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.79 -23.26 61.54 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.822 0.82 . . . . 45.53 110.753 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.54 0.18 47.64 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.592 -0.731 . . . . 74.12 110.422 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.46 150.57 20.46 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 109.182 -0.673 . . . . 73.42 109.182 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -88.23 106.95 18.54 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.55 -1.278 . . . . 74.43 107.55 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -106.51 148.27 28.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.618 -0.265 . . . . 50.35 110.921 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.14 157.83 36.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.395 0.517 . . . . 72.25 112.395 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 425' ' ' GLU . 40.5 mm -60.15 -35.61 62.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.684 0.754 . . . . 74.13 110.79 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.6 p -91.62 5.19 50.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.141 -0.936 . . . . 60.12 112.278 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -83.22 141.27 32.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.744 -1.206 . . . . 75.11 107.744 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.44 113.44 22.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.048 0.451 . . . . 71.03 110.618 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.06 119.81 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 108.898 -0.778 . . . . 71.34 108.898 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 60.6 mt -92.9 113.36 27.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.663 -1.236 . . . . 72.0 107.663 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.52 123.3 48.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 107.953 -1.128 . . . . 63.24 107.953 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 17.6 pt -107.24 122.77 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.713 0.768 . . . . 71.32 111.798 -176.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.663 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 60.2 t -98.67 139.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.164 -0.925 . . . . 61.45 108.988 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.87 118.47 4.69 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.744 -0.942 . . . . 63.33 110.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 52.9 m -141.09 129.78 22.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.59 -0.359 . . . . 72.11 110.216 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 106.411 -2.676 . . . . 45.54 106.411 177.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 409' ' ' SER . 17.3 m-20 . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 107.653 -1.239 . . . . 73.33 107.653 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.81 155.14 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 116.476 -0.329 . . . . 62.55 110.486 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -95.2 136.97 34.89 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.556 -1.646 . . . . 74.23 106.556 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.62 138.27 19.59 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 116.265 -0.425 . . . . 72.53 110.27 -172.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.12 126.69 17.76 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.961 2.441 . . . . 65.11 112.814 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.21 153.77 42.7 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 114.482 -1.235 . . . . 75.34 110.457 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.1 m -109.75 3.59 9.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 114.239 1.2 . . . . 32.42 114.239 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -62.94 130.29 44.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.077 0.465 . . . . 74.33 110.229 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.05 -2.9 47.8 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.815 -0.707 . . . . 75.12 111.723 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -115.5 167.92 10.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.868 -0.79 . . . . 73.42 108.868 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 87.6 p -78.1 164.53 24.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.416 -0.587 . . . . 73.33 109.416 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 30.1 p -58.18 -45.53 87.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.155 0.503 . . . . 41.54 110.21 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.75 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.47 -0.787 . . . . 63.21 111.77 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.22 -34.74 76.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.465 0.65 . . . . 52.3 109.56 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.21 69.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 61.22 110.158 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.2 mt -58.75 -45.45 91.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.941 -0.572 . . . . 62.11 110.07 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.1 92.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.623 -0.717 . . . . 64.03 111.721 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 78.5 m -63.29 -48.66 77.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.243 -0.435 . . . . 75.25 111.816 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.86 -41.53 91.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.653 -0.249 . . . . 64.34 111.532 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -59.68 -41.59 91.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.905 0.753 . . . . 75.43 110.09 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -69.34 -31.34 69.71 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.249 -0.432 . . . . 70.22 111.184 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -79.13 -14.79 58.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.375 -0.375 . . . . 70.43 110.799 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.4 15.24 51.53 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.651 -0.785 . . . . 73.13 111.827 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -93.52 160.32 14.84 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.928 -0.397 . . . . 74.45 109.928 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.9 mmtp -104.66 135.35 46.22 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.025 -0.731 . . . . 74.41 109.025 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.38 138.59 49.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-O 121.256 0.55 . . . . 64.41 111.584 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -110.88 128.55 55.84 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.539 -1.282 . . . . 74.22 107.539 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.8 m -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 108.028 -1.101 . . . . 71.34 108.028 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 125.3 53.79 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 103.636 -2.727 . . . . 72.14 103.636 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.0 pm0 -125.75 142.78 51.35 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 120.001 -0.68 . . . . 43.03 110.594 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -134.01 131.84 21.08 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 120.724 -0.39 . . . . 74.13 110.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.35 134.74 6.87 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.97 1.78 . . . . 44.51 109.2 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 -171.95 -176.04 1.62 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.467 -1.679 . . . . 62.23 106.467 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 68.3 m -129.53 -8.49 4.62 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.422 0.629 . . . . 64.13 111.084 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -94.29 3.45 55.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.815 -1.18 . . . . 52.11 107.815 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.2 pp -88.52 151.05 47.65 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.513 -1.222 . . . . 72.34 113.4 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.65 172.03 11.58 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 122.538 2.159 . . . . 73.44 110.13 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.69 161.57 9.83 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.149 2.566 . . . . 63.4 112.255 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.471 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 p-10 -57.14 -9.05 0.8 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 124.711 1.204 . . . . 63.34 113.04 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 30.6 m170 -67.66 136.74 54.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.745 -1.576 . . . . 65.23 106.745 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.63 118.31 11.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.766 -0.374 . . . . 75.24 110.541 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.2 tp -93.16 -41.18 12.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.038 -0.727 . . . . 63.51 109.038 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.39 157.61 27.44 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.08 -1.208 . . . . 72.4 110.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -124.34 -178.49 4.12 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.964 0.906 . . . . 44.25 109.716 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 155.14 36.77 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 107.458 -1.312 . . . . 65.14 107.458 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.66 -15.06 5.95 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.977 3.118 . . . . 64.45 115.805 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.12 -21.91 64.17 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 112.741 0.645 . . . . 74.23 112.741 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.79 -50.84 31.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.607 . . . . 43.54 111.076 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -85.05 -7.9 58.91 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.613 0.597 . . . . 74.1 112.613 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 56.5 m -91.51 139.34 30.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.48 -1.304 . . . . 73.42 107.48 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 359' ' ' ASP . 40.1 m -75.0 113.54 12.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.211 0.529 . . . . 55.32 109.954 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 411' ' ' SER . 2.4 t -124.75 169.48 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 107.271 -1.381 . . . . 74.44 107.271 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 410' ' ' VAL . 21.9 m -68.27 148.52 50.67 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.104 0.478 . . . . 43.34 111.409 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.36 111.03 3.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.941 -0.572 . . . . 64.43 110.338 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.16 20.39 8.35 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.656 -0.783 . . . . 64.32 112.338 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -89.49 -170.73 2.95 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.628 -0.879 . . . . 62.22 108.628 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.5 pt-20 -112.45 124.54 52.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.118 1.155 . . . . 73.34 114.118 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.02 138.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.269 -1.382 . . . . 74.41 107.269 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -103.01 121.43 42.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.324 -0.95 . . . . 50.31 111.578 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.62 119.95 46.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.085 -1.08 . . . . 53.3 108.085 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -93.89 118.01 30.88 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.587 -0.523 . . . . 64.35 109.587 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.4 t -122.06 140.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.593 -0.73 . . . . 72.1 109.859 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.7 m -94.66 121.68 36.48 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.769 -1.197 . . . . 70.43 107.769 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.3 p -119.15 106.29 12.22 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.905 -0.318 . . . . 54.21 111.647 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.81 147.34 2.39 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 115.069 0.788 . . . . 63.12 115.069 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.7 Cg_endo -81.04 147.4 16.56 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.011 1.807 . . . . 72.44 111.161 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.58 149.19 26.05 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.788 -0.449 . . . . 65.31 109.788 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.8 mt-30 -129.1 155.67 45.08 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.935 -0.765 . . . . 73.4 108.935 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -146.76 164.24 33.4 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.448 -1.315 . . . . 72.12 107.448 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 138.86 31.52 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 110.441 -0.207 . . . . 75.33 110.441 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -83.07 119.26 73.89 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.729 -0.841 . . . . 75.02 108.729 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.43 141.27 89.8 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.584 2.189 . . . . 74.14 112.331 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -79.78 -7.04 58.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.904 -0.589 . . . . 52.22 111.499 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.446 HG23 HD12 ' A' ' 435' ' ' LEU . 13.3 p -66.58 -16.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.685 0.794 . . . . 72.22 110.74 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 23.6 m -49.89 -47.04 52.25 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.475 1.11 . . . . 72.43 113.155 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 m -59.04 -22.04 60.06 Favored 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 124.553 1.141 . . . . 61.41 112.467 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 432' ' ' VAL . 75.8 mt -78.1 -44.16 26.97 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 112.529 0.566 . . . . 62.55 112.529 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.3 m -160.63 136.2 8.09 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.245 -0.65 . . . . 73.0 109.245 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -60.78 -45.42 94.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.238 0.458 . . . . 73.34 112.238 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.15 80.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.49 0.662 . . . . 74.11 110.749 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.47 -43.72 69.21 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.63 -0.714 . . . . 73.11 109.953 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.16 -51.72 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.431 -0.804 . . . . 55.42 111.453 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.4 -41.19 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.886 -0.597 . . . . 64.43 111.369 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -67.69 -47.03 70.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.783 -0.367 . . . . 52.23 111.847 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.18 -38.55 88.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.971 0.36 . . . . 74.52 111.971 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.854 -0.338 . . . . 62.3 111.576 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 98.6 m -65.78 -38.77 89.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.363 0.125 . . . . 72.21 111.243 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.36 70.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.17 0.509 . . . . 72.45 110.467 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.17 -13.79 58.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.947 -0.569 . . . . 60.24 111.027 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.81 8.82 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.038 -1.077 . . . . 50.01 114.113 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' THR . 93.2 m-85 -78.89 111.52 15.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 117.91 0.855 . . . . 72.44 110.189 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -112.14 -21.64 6.2 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.426 -0.892 . . . . 62.0 112.495 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -95.15 111.47 23.3 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.491 -0.559 . . . . 72.24 109.491 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.03 159.03 25.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.444 0.64 . . . . 72.11 110.885 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -137.93 123.19 19.35 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 103.813 -2.662 . . . . 64.1 103.813 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -101.28 125.93 47.96 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.459 -0.496 . . . . 72.12 110.845 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.84 35.1 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.168 -0.679 . . . . 72.32 109.168 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.01 139.49 47.25 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.736 -0.468 . . . . 71.21 109.736 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 32.4 p -117.86 136.16 23.64 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 109.49 -0.559 . . . . 71.02 109.49 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.5 Cg_exo -61.43 120.53 8.24 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.428 2.085 . . . . 52.34 109.977 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.6 m -133.11 167.55 20.12 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.108 -0.496 . . . . 21.23 111.149 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 464' ' ' VAL . 4.6 p -76.89 156.24 82.56 Favored Pre-proline 0 N--CA 1.432 -1.369 0 C-N-CA 123.66 0.784 . . . . 73.43 109.377 174.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -49.71 -27.75 15.87 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 124.225 3.283 . . . . 74.13 114.157 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.37 -18.33 59.99 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.139 -0.482 . . . . 73.13 112.05 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.93 -18.29 13.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.642 0.258 . . . . 61.12 110.563 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 91.3 t -59.5 127.0 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.976 -0.557 . . . . 72.42 111.366 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.52 -4.46 58.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.033 -0.603 . . . . 51.3 111.813 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -122.87 161.05 24.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.878 0.37 . . . . 74.22 110.103 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.95 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.909 -0.775 . . . . 71.24 108.909 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.61 -25.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.559 -0.857 . . . . 72.05 111.31 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 174.21 38.18 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.208 -0.757 . . . . 64.23 111.208 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -126.3 154.84 42.88 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.967 -0.753 . . . . 74.32 108.967 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.9 t30 -65.08 -53.28 42.41 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.248 -0.581 . . . . 62.32 110.982 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.8 Cg_exo -71.95 123.44 9.31 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 107.744 -1.675 . . . . 75.54 107.744 170.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 33.7 Cg_endo -62.7 137.45 63.72 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 122.885 2.39 . . . . 64.32 114.4 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.518 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.42 7.92 8.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.145 -0.934 . . . . 71.25 110.613 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -108.37 -4.66 17.21 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.302 -0.863 . . . . 60.12 109.548 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 28.9 mt-30 -137.24 175.67 9.4 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.268 1.032 . . . . 65.1 113.401 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 426' ' ' GLN . 29.5 m -94.3 130.5 40.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.157 -1.838 . . . . 72.23 109.449 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 429' ' ' ILE . 20.1 m -131.49 149.59 52.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.144 -0.687 . . . . 64.41 109.144 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.05 154.76 29.75 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.96 0.726 . . . . 71.34 112.96 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.08 -15.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.208 1.004 . . . . 71.55 108.37 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.64 -5.29 59.17 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.039 -0.982 . . . . 65.43 108.899 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -87.7 128.84 35.3 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.122 -1.436 . . . . 71.2 107.122 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.36 124.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.195 -1.039 . . . . 73.22 108.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.33 118.69 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 C-N-CA 120.194 -0.602 . . . . 71.23 109.65 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.16 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 105.034 -2.21 . . . . 74.42 105.034 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 121.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 107.588 -1.264 . . . . 70.22 107.588 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.78 119.11 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 121.322 0.582 . . . . 73.04 110.455 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.14 134.92 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.508 -0.923 . . . . 73.33 108.508 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.06 115.24 4.16 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.222 -1.151 . . . . 52.12 110.222 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 39.8 p -142.39 145.93 34.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.986 0.393 . . . . 71.02 110.39 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.912 0 N-CA-C 108.004 -2.038 . . . . 61.42 108.004 177.697 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 CA--C 1.485 -1.542 0 N-CA-C 107.417 -1.327 . . . . 62.43 107.417 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.24 142.25 32.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.153 0.501 . . . . 73.14 111.242 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -95.25 136.05 36.07 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.51 -1.663 . . . . 62.41 106.51 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.9 p -97.17 135.4 21.93 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 119.742 -0.783 . . . . 71.33 110.611 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.0 129.85 32.39 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.767 2.311 . . . . 70.13 111.282 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.63 147.83 52.18 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.041 . . . . 72.31 109.519 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.8 m -109.19 5.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 116.424 -0.353 . . . . 75.43 111.413 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -52.74 135.32 35.57 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.788 0.835 . . . . 70.25 111.758 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.48 1.56 59.06 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.469 -0.872 . . . . 64.01 112.946 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -121.21 179.8 4.29 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.185 -0.597 . . . . 74.34 110.639 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.2 p -73.25 149.65 42.62 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.962 -0.755 . . . . 72.3 108.962 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.0 p -63.43 -33.34 75.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.082 0.468 . . . . 75.21 110.39 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.62 86.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.412 -0.813 . . . . 70.23 111.594 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.98 -38.36 85.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.854 0.359 . . . . 42.42 110.167 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.92 78.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.968 -1.015 . . . . 71.24 110.174 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 85.0 mt -69.05 -46.21 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.804 -0.635 . . . . 71.02 110.644 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.07 -47.07 88.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.641 0.608 . . . . 63.24 112.641 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.5 m -65.49 -44.25 87.64 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 75.15 109.878 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 416' ' ' ILE . 13.3 tp -64.78 -37.75 88.65 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.924 -1.035 . . . . 73.44 110.351 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -60.51 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.984 1.313 . . . . 75.24 110.369 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -67.37 -22.64 65.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.994 -0.548 . . . . 64.41 110.805 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -85.36 -8.67 58.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.885 -0.598 . . . . 71.41 111.72 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 86.24 9.89 75.54 Favored Glycine 0 C--O 1.253 1.315 0 C-N-CA 120.912 -0.661 . . . . 52.33 113.915 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 54.8 m-85 -77.85 151.8 33.71 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.102 0.477 . . . . 64.41 110.217 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -88.26 132.74 34.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.199 -1.778 . . . . 74.54 106.199 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.29 134.98 59.18 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.804 0 CA-C-O 121.759 0.79 . . . . 53.54 110.956 -173.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -110.36 126.51 54.33 Favored 'General case' 0 C--N 1.268 -2.961 0 N-CA-C 104.743 -2.318 . . . . 73.12 104.743 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.5 m -112.73 118.86 36.16 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 108.242 -1.021 . . . . 51.21 108.242 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.52 118.89 36.98 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.45 -1.315 . . . . 72.01 107.45 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.7 pm0 -112.84 124.72 53.23 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.992 -1.114 . . . . 72.31 107.992 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -125.45 137.07 29.16 Favored Pre-proline 0 C--N 1.284 -2.24 0 C-N-CA 119.577 -0.849 . . . . 74.22 111.131 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -88.54 128.34 2.09 Favored 'Trans proline' 0 N--CA 1.426 -2.454 0 N-CA-C 107.972 -1.588 . . . . 54.23 107.972 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 48.4 t0 -174.47 170.42 3.55 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.364 -1.347 . . . . 62.34 107.364 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 24.0 m -106.61 -18.69 13.89 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.536 0.684 . . . . 51.24 109.219 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.7 m -90.61 36.91 0.9 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 123.191 1.472 . . . . 74.32 107.71 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 391' ' ' ASP . 28.1 pt -88.8 141.69 30.05 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 114.285 -1.325 . . . . 73.41 110.72 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -73.66 173.86 13.2 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.129 1.886 . . . . 60.4 108.39 166.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.72 161.59 35.21 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.958 1.772 . . . . 65.12 111.772 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.89 -13.28 2.5 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 124.071 0.948 . . . . 62.21 111.969 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -99.61 122.55 42.82 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.696 -2.335 . . . . 64.34 104.696 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.0 117.88 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.88 0.847 . . . . 72.43 109.808 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.7 tp -90.97 -29.28 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.38 -0.827 . . . . 72.22 110.294 -174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.46 157.82 27.8 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 120.516 -0.849 . . . . 62.11 111.408 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 65.1 p -125.58 -176.91 3.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.165 -1.05 . . . . 64.22 108.165 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -101.71 139.92 20.77 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.649 -0.871 . . . . 53.55 108.649 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -48.64 -14.46 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 124.396 3.397 . . . . 51.14 115.414 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.15 64.79 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 120.829 0.347 . . . . 75.13 110.244 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.3 -27.68 63.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.534 0.683 . . . . 73.2 110.678 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -90.32 -3.72 57.58 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.609 -0.723 . . . . 74.35 109.554 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 41.4 m -91.32 156.94 17.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.634 -1.247 . . . . 33.21 107.634 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 p -74.37 112.57 10.66 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.698 0.761 . . . . 54.41 111.056 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.48 170.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.037 -0.983 . . . . 71.55 108.903 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 75.4 p -75.8 158.73 31.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.813 -0.755 . . . . 73.42 110.835 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.54 109.94 2.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.375 -0.972 . . . . 73.34 108.375 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 92.23 29.2 11.63 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.279 -0.728 . . . . 44.51 111.279 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.3 t70 -76.79 -174.51 3.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.964 0.505 . . . . 74.3 109.655 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.53 126.97 42.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.161 0.505 . . . . 62.13 112.178 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.493 ' HB ' HD21 ' A' ' 377' ' ' LEU . 51.0 mm -121.16 127.22 75.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.472 -0.936 . . . . 75.05 108.472 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -94.38 119.13 32.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.134 0.969 . . . . 72.01 110.813 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.06 131.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.991 -1.114 . . . . 70.11 107.991 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -101.57 128.7 47.72 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.818 -0.438 . . . . 62.52 109.818 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 38.9 t -132.07 131.74 61.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.205 -1.035 . . . . 54.32 108.205 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 19.0 m -91.89 122.28 34.27 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.408 -0.59 . . . . 72.04 109.408 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.4 m -120.6 106.04 11.38 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.995 -0.372 . . . . 72.41 109.995 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 73.72 118.12 0.08 OUTLIER Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.88 0.712 . . . . 52.14 114.88 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.8 Cg_exo -71.34 138.25 32.56 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 121.919 1.746 . . . . 63.35 109.391 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 2.8 mm-40 -78.44 142.8 37.27 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 114.597 1.332 . . . . 75.44 114.597 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.82 133.56 55.31 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 113.435 -1.711 . . . . 70.32 108.674 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.14 157.8 35.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.203 -1.777 . . . . 75.52 106.203 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.81 137.41 33.72 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.609 -0.436 . . . . 75.54 110.409 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 67.4 mt -86.16 128.66 56.83 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.056 -1.461 . . . . 75.42 107.056 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.36 141.4 38.83 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.503 1.469 . . . . 62.23 112.683 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.147 0.499 . . . . 65.13 111.171 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 430' ' ' PRO . 8.9 p -65.9 -14.84 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.841 0.829 . . . . 73.52 109.851 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.7 m -52.75 -41.53 64.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.751 1.22 . . . . 71.51 111.953 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.8 m -64.15 -13.62 49.51 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.024 0.93 . . . . 60.45 112.083 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.73 -45.44 14.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.3 0.482 . . . . 52.4 112.3 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 86.9 m -156.05 135.68 12.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.65 -0.5 . . . . 74.01 109.65 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 441' ' ' VAL . 62.7 t80 -57.43 -53.57 56.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.153 0.797 . . . . 74.52 113.153 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.04 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.004 0.43 . . . . 73.44 111.248 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -62.02 -43.21 99.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.013 -0.994 . . . . 71.34 108.862 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.26 -48.88 79.85 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.364 -0.834 . . . . 72.24 110.619 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.9 t -58.93 -47.07 90.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.794 -0.639 . . . . 71.12 111.275 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.6 mmpt? -64.95 -46.51 81.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.704 -0.226 . . . . 65.44 111.213 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.69 -38.77 92.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.396 -0.365 . . . . 51.41 111.472 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.533 HD23 ' CE2' ' A' ' 452' ' ' PHE . 30.5 tp -67.29 -39.94 86.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.267 -0.424 . . . . 60.15 109.871 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.8 m -65.76 -38.86 90.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.261 -0.644 . . . . 72.11 109.261 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.59 73.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.55 -0.75 . . . . 62.44 111.138 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.24 31.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.795 -0.639 . . . . 74.41 110.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.7 -17.61 49.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.341 -0.457 . . . . 55.03 112.575 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.454 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 70.7 m-85 -83.11 83.83 7.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.381 0.61 . . . . 63.45 110.558 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -98.04 17.02 59.35 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.769 -0.932 . . . . 75.33 110.769 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -103.86 110.56 22.73 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.814 -1.551 . . . . 64.44 106.814 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PHE . . . . . 0.533 ' CE2' HD23 ' A' ' 444' ' ' LEU . 93.4 m-85 -119.41 152.45 36.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.522 0.677 . . . . 65.15 112.073 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.1 OUTLIER -147.1 121.0 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.231 -2.137 . . . . 74.25 105.231 170.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -91.0 130.37 36.92 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.601 0.715 . . . . 73.43 111.584 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.19 152.84 46.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.4 -1.333 . . . . 75.31 107.4 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -132.12 149.8 52.31 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.151 0.501 . . . . 63.43 110.726 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.5 m -132.78 131.72 22.19 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 115.603 -0.726 . . . . 73.54 109.204 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 490' ' ' SER . 31.6 Cg_exo -61.51 120.01 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.004 1.802 . . . . 73.21 108.274 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.572 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 17.0 m -130.0 177.24 7.43 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.762 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 43.1 m -67.15 139.27 95.07 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.637 -1.246 . . . . 71.14 107.637 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.72 -23.62 8.56 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.806 3.004 . . . . 70.41 114.168 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -61.4 -32.29 72.22 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.347 0.659 . . . . 55.33 111.155 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.07 0.73 56.08 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.386 0.513 . . . . 70.51 112.386 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 461' ' ' PRO . 10.4 p -59.89 126.95 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.247 0.546 . . . . 71.44 111.114 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.47 78.31 Favored Glycine 0 C--O 1.244 0.767 0 C-N-CA 120.686 -0.769 . . . . 70.51 112.191 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.79 148.3 33.85 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.986 -0.746 . . . . 62.4 108.986 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 486' ' ' ILE . 58.7 t -84.14 132.74 30.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.061 -1.088 . . . . 74.05 108.061 175.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.68 -26.81 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.422 -0.911 . . . . 54.03 111.134 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.75 169.65 40.34 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.626 -0.797 . . . . 65.22 111.39 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.2 p -127.46 149.07 50.27 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.507 -0.924 . . . . 72.41 108.507 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.506 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.7 t30 -62.35 -52.78 63.7 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 119.327 -0.368 . . . . 73.13 110.725 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.1 Cg_exo -73.7 142.73 32.71 Favored 'Trans proline' 0 C--N 1.374 1.871 0 N-CA-C 108.178 -1.508 . . . . 75.12 108.178 171.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 126.79 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.262 1.975 . . . . 71.11 112.786 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.33 3.64 26.99 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.169 0.985 . . . . 53.42 110.253 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -111.66 4.24 18.45 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.842 -1.072 . . . . 65.24 110.922 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -137.08 164.81 27.54 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.067 0.937 . . . . 75.52 111.939 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.84 125.54 29.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.299 -1.773 . . . . 71.43 108.94 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -130.82 148.32 52.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.186 -0.672 . . . . 61.31 109.186 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -69.97 140.93 53.06 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.292 0.091 . . . . 51.22 111.039 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.453 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 1.9 mp -60.76 -18.81 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.954 1.302 . . . . 75.22 111.931 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.23 5.11 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 72.34 112.063 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.97 132.29 33.84 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.672 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.3 t -79.89 114.77 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.936 -1.876 . . . . 63.32 105.936 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.04 120.54 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-O 121.255 0.55 . . . . 73.44 109.829 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 68.4 mt -91.23 112.25 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.287 -1.746 . . . . 73.42 106.287 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.39 119.39 51.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 114.658 -1.156 . . . . 72.1 108.064 -175.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 25.7 mt -99.83 115.97 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-O 121.508 0.671 . . . . 71.45 109.559 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.65 140.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.353 -0.98 . . . . 63.22 108.353 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 121.95 5.59 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 109.062 -1.615 . . . . 75.54 109.062 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.8 m -140.08 125.2 18.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 122.035 -0.685 . . . . 63.43 110.212 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.413 -2.837 0 N-CA-C 107.818 -2.113 . . . . 75.31 107.818 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.169 -1.049 . . . . 74.42 108.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.11 145.05 29.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.885 -0.413 . . . . 73.34 109.885 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -95.71 137.39 34.84 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.172 -1.047 . . . . 73.52 108.172 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.09 136.08 21.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 C-N-CA 120.57 -0.452 . . . . 34.22 109.991 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 154.6 12.18 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.711 2.941 . . . . 72.44 115.165 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.59 101.64 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 73.34 110.308 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.85 -3.65 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.25 0.548 . . . . 74.33 111.712 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.486 -0.779 . . . . 74.01 109.903 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.2 58.97 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.655 -0.978 . . . . 64.51 110.655 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -124.44 170.17 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.587 -1.264 . . . . 71.31 107.587 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.8 p -74.98 157.1 35.51 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.684 -0.487 . . . . 73.5 109.684 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.4 p -62.17 -37.86 86.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.016 0.436 . . . . 54.12 110.461 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.28 94.74 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.872 -0.604 . . . . 65.44 110.897 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.65 -37.46 76.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.505 -0.316 . . . . 73.25 110.952 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.33 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.66 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -42.62 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.258 0.348 . . . . 70.22 111.173 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.61 88.22 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.388 -0.369 . . . . 65.34 111.09 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.1 m -63.58 -46.63 84.98 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.599 -0.273 . . . . 64.53 110.743 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.18 -41.86 96.92 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.986 -0.375 . . . . 73.11 109.986 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -59.82 -46.6 88.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 70.03 110.439 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.37 -33.91 76.93 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 112.657 0.614 . . . . 74.32 112.657 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -84.83 -4.23 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.09 -0.505 . . . . 63.43 112.159 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.46 7.85 64.74 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 119.88 -1.152 . . . . 53.53 113.146 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -83.76 167.65 16.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.516 -0.55 . . . . 60.25 109.516 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 30.6 mmtp -105.79 161.58 14.3 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.293 -1.373 . . . . 54.43 107.293 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 151.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-O 121.881 0.848 . . . . 74.13 112.576 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 417' ' ' THR . 29.5 ttm-85 -137.05 141.07 42.43 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.567 -2.012 . . . . 71.12 105.567 172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -135.24 133.08 38.6 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.331 -0.618 . . . . 73.41 109.331 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.71 119.94 36.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.335 -0.987 . . . . 74.33 108.335 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -95.58 122.43 38.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.099 -1.075 . . . . 54.12 108.099 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 122.71 21.87 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 113.067 0.766 . . . . 74.34 113.067 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.52 129.07 4.19 Favored 'Trans proline' 0 C--O 1.247 0.933 0 N-CA-C 106.719 -2.07 . . . . 73.44 106.719 165.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.4 t70 -163.68 -176.03 4.44 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 63.41 109.042 -171.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 p -100.77 -23.72 14.55 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.34 -0.985 . . . . 64.3 108.34 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.2 m -89.3 35.45 0.81 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.279 -1.328 . . . . 71.5 108.983 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.8 pt -88.18 123.5 68.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 114.37 1.248 . . . . 73.23 114.37 -171.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 2.5 Cg_endo -85.15 174.89 6.86 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.861 2.374 . . . . 72.32 108.126 165.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.16 160.94 35.93 Favored 'Trans proline' 0 C--O 1.212 -0.817 0 C-N-CA 122.475 2.117 . . . . 71.21 111.261 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.22 -7.47 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.906 0.706 . . . . 74.52 112.906 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.87 147.77 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.033 -1.839 . . . . 74.45 106.033 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.37 116.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.186 -1.413 . . . . 42.41 107.186 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.5 mm -90.54 -39.77 12.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.299 -0.63 . . . . 70.33 109.299 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 157.67 27.48 Favored Glycine 0 N--CA 1.411 -3.013 0 CA-C-N 115.214 -0.903 . . . . 64.51 111.01 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -122.32 -179.68 4.26 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.49 -0.929 . . . . 62.3 108.49 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.33 139.92 20.67 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 108.948 -0.76 . . . . 71.45 108.948 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.37 -24.47 1.03 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 124.618 3.546 . . . . 73.03 114.84 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.5 63.37 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 123.133 0.573 . . . . 62.41 111.456 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.97 94.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.64 0.734 . . . . 74.11 110.464 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -4.75 57.62 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.531 -0.759 . . . . 72.24 111.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.9 m -88.83 152.85 21.51 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.938 -1.505 . . . . 63.54 106.938 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.5 m -74.12 113.53 11.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.953 0.882 . . . . 24.43 110.688 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.6 170.71 5.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.342 -1.299 . . . . 73.41 110.061 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 136.36 57.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.765 -0.652 . . . . 71.22 111.61 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.45 119.95 13.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.508 -0.553 . . . . 73.3 109.508 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 87.3 32.12 14.81 Favored Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 121.1 -0.572 . . . . 40.41 112.133 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.53 174.99 6.84 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.939 -0.763 . . . . 65.02 108.939 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 12.3 pt-20 -100.35 121.22 41.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.831 0.824 . . . . 71.33 112.782 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.76 124.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.667 -1.235 . . . . 73.23 107.667 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 13.4 t -91.85 130.29 37.65 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.532 0.682 . . . . 61.03 109.891 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 130.74 64.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.021 -0.991 . . . . 63.12 108.422 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -97.53 127.9 43.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.406 -0.961 . . . . 65.54 108.406 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.02 135.11 62.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.609 -0.886 . . . . 72.35 108.609 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 47.0 m -106.51 123.94 48.85 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.833 -0.542 . . . . 75.32 111.7 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.5 p -118.2 105.54 11.9 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.69 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.09 146.03 2.19 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.059 0.784 . . . . 33.22 115.059 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 76.7 Cg_endo -81.74 149.65 16.25 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.344 2.029 . . . . 75.33 111.753 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.05 144.76 40.6 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.52 -0.764 . . . . 72.31 110.849 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.537 ' HB3' HG22 ' A' ' 477' ' ' THR . 45.5 mt-30 -118.85 156.88 28.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 71.22 110.675 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.494 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 6.1 tpm_? -153.51 154.66 34.76 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.848 -1.538 . . . . 64.21 106.848 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.1 OUTLIER -93.8 140.17 29.98 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.02 -0.733 . . . . 65.03 109.02 176.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.8 mp -78.98 126.47 82.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.851 -1.166 . . . . 74.1 107.851 -175.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.97 140.32 79.53 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.203 1.936 . . . . 70.43 112.176 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.77 12.9 28.37 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.789 0.804 . . . . 73.02 110.08 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.2 -12.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.919 -1.037 . . . . 73.01 108.965 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.0 m -52.76 -40.51 63.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.503 -1.226 . . . . 72.31 112.624 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -63.01 -17.91 62.73 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.365 1.246 . . . . 71.23 114.365 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.36 -44.91 15.56 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.086 0.47 . . . . 61.41 111.689 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 65.6 m -150.2 133.22 16.16 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.896 -0.503 . . . . 74.43 109.969 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -58.37 -45.31 88.47 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.467 0.479 . . . . 75.01 111.163 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.16 -42.37 80.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.042 -0.526 . . . . 55.52 110.694 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.75 -39.39 94.15 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 116.064 -0.516 . . . . 71.1 111.398 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.49 -50.53 73.18 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.526 0.516 . . . . 53.45 109.768 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.03 -45.9 95.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.102 -0.499 . . . . 61.34 110.673 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.47 -47.72 75.13 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.813 0.301 . . . . 74.55 111.813 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -66.32 -40.24 89.81 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.11 111.688 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.1 mp -67.0 -38.43 85.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.619 -0.432 . . . . 72.4 111.608 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 68.9 m -64.81 -38.8 92.19 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.478 -0.564 . . . . 54.13 109.478 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.85 65.24 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.395 0.616 . . . . 74.41 110.455 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.494 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.44 -13.22 59.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.482 0.658 . . . . 73.24 110.296 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.22 -13.32 26.14 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.691 -0.766 . . . . 51.12 113.651 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -71.62 114.96 10.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.525 -0.546 . . . . 73.33 109.525 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.97 17.38 8.67 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.45 -0.881 . . . . 71.44 111.58 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -120.58 111.25 17.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.478 -1.675 . . . . 75.21 106.478 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.3 155.01 39.42 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.772 0.796 . . . . 74.41 112.882 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 4.5 tppp? -145.17 125.08 13.47 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.598 -1.63 . . . . 74.32 106.598 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -100.44 126.08 46.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.169 0.509 . . . . 64.02 110.888 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.64 156.43 37.51 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.431 -0.952 . . . . 70.31 108.431 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.139 0.495 . . . . 74.21 110.302 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.4 m -133.94 144.57 52.21 Favored Pre-proline 0 C--N 1.286 -2.183 0 N-CA-C 109.171 -0.677 . . . . 72.31 109.171 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_endo -62.54 122.82 11.35 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 123.257 2.638 . . . . 72.43 113.21 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.7 m -132.87 170.73 14.9 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.537 -0.912 . . . . 71.21 108.537 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.7 m -69.72 145.61 94.95 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 107.678 -1.23 . . . . 74.22 107.678 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.558 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.8 Cg_endo -49.36 -23.76 7.67 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 124.129 3.219 . . . . 63.35 114.255 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.84 -30.11 71.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.368 0.604 . . . . 64.32 110.43 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.35 1.35 35.42 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.821 -0.627 . . . . 72.13 112.581 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.6 p -60.18 126.29 17.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 119.415 -0.914 . . . . 64.23 110.72 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.92 -5.94 72.83 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.598 -0.81 . . . . 65.41 112.169 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.88 155.61 17.85 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.927 -0.768 . . . . 72.34 108.927 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 486' ' ' ILE . 66.3 t -84.67 131.59 33.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.923 -0.769 . . . . 72.34 108.923 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.13 -14.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.838 -0.745 . . . . 64.35 110.903 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.53 -177.65 41.87 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 115.567 -0.742 . . . . 74.23 111.441 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.9 p -130.44 150.03 51.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.9 t30 -63.87 -51.36 64.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 120.262 -0.575 . . . . 23.33 110.307 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.3 Cg_exo -75.41 130.48 12.91 Favored 'Trans proline' 0 C--N 1.375 1.955 0 N-CA-C 108.376 -1.432 . . . . 71.45 108.376 170.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.429 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 37.5 Cg_endo -62.94 136.53 57.46 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.697 2.264 . . . . 64.21 113.399 -175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.62 6.84 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.066 0.936 . . . . 53.31 109.845 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -104.61 2.59 30.81 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.857 -1.065 . . . . 61.54 109.664 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 44.4 tp60 -145.97 173.71 11.91 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.975 -0.69 . . . . 74.31 110.923 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 426' ' ' GLN . 18.2 m -102.26 140.62 36.3 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 124.308 1.043 . . . . 74.34 110.948 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 429' ' ' ILE . 77.8 p -137.84 150.38 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.373 -0.602 . . . . 74.51 109.373 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.5 146.68 51.7 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.885 -0.326 . . . . 73.33 110.38 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.76 -11.13 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 124.052 0.941 . . . . 54.42 111.629 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 5.5 p -87.04 5.79 35.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.412 0.625 . . . . 70.43 111.065 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -93.01 142.12 27.64 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.656 -0.702 . . . . 61.31 110.362 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 52.4 t -85.79 115.18 26.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.946 -1.501 . . . . 74.33 106.946 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 81.9 t -86.58 119.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-O 121.467 0.651 . . . . 55.31 109.998 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 49.0 mt -92.36 112.9 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 107.302 -1.37 . . . . 72.4 107.302 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.38 127.13 49.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.451 -1.315 . . . . 73.35 107.451 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 15.6 mm -102.27 113.13 37.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.132 0.491 . . . . 72.11 109.943 -173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.3 141.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.673 -0.862 . . . . 62.3 108.673 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.52 121.12 6.1 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 111.035 -0.826 . . . . 72.21 111.035 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.5 m -141.39 143.76 34.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.582 -0.896 . . . . 64.23 108.582 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.562 0 CA-C-O 118.229 -1.317 . . . . 74.2 110.538 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 74.14 108.419 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.41 151.77 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.362 -0.607 . . . . 64.22 109.362 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -95.15 136.99 34.8 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.289 -1.374 . . . . 72.32 107.289 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.0 p -100.04 121.8 52.72 Favored Pre-proline 0 C--N 1.287 -2.122 0 N-CA-C 108.914 -0.772 . . . . 51.11 108.914 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.94 136.8 63.53 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.602 2.201 . . . . 74.52 113.046 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.545 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 7.5 p-10 -72.61 137.23 46.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.254 -0.885 . . . . 73.1 110.004 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 368' ' ' GLN . 5.8 t -89.82 45.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 122.585 1.183 . . . . 71.3 110.482 -170.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.545 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.8 ptm85 -65.51 136.29 56.23 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.418 -1.265 . . . . 64.25 110.921 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.48 0.55 62.79 Favored Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.79 -0.719 . . . . 50.31 113.024 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.417 ' HB2' HG12 ' A' ' 365' ' ' VAL . 44.9 mt-30 -125.95 172.12 10.19 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 122.586 -0.361 . . . . 72.23 110.13 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.1 p -77.14 167.14 22.27 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.626 0.251 . . . . 74.55 110.604 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.7 p -63.04 -33.96 76.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.078 0.465 . . . . 72.2 110.03 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.5 97.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.719 -0.673 . . . . 34.21 110.258 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.83 -41.43 95.75 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.539 -0.541 . . . . 55.42 109.539 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.74 80.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.108 -0.497 . . . . 71.22 110.784 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.15 -46.02 88.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.701 -0.681 . . . . 72.22 110.079 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.42 86.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.819 -0.628 . . . . 52.52 111.61 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.2 m -60.58 -47.11 87.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.326 0.25 . . . . 55.22 111.552 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.55 -42.02 95.97 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.533 -0.467 . . . . 60.21 110.593 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -59.83 -41.56 91.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.597 0.759 . . . . 74.52 109.806 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.71 -29.27 67.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.384 -0.825 . . . . 53.33 111.12 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -82.68 -14.4 54.72 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.458 -0.571 . . . . 51.23 109.458 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.564 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.45 -2.63 56.19 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.822 -0.626 . . . . 53.31 111.692 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 46.5 m-85 -81.5 156.71 25.15 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.937 0.398 . . . . 74.51 110.075 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -105.16 147.78 27.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.371 -1.344 . . . . 62.53 107.371 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.75 142.73 30.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 121.957 0.884 . . . . 73.53 112.748 -175.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 417' ' ' THR . 58.2 ttt180 -119.06 133.39 55.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.014 -1.847 . . . . 61.23 106.014 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.9 m -104.94 125.66 51.18 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.499 -0.88 . . . . 74.3 111.36 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.2 tm? -111.51 119.33 38.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.234 -2.135 . . . . 74.4 105.234 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.1 pm0 -112.85 122.63 48.23 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 109.292 -0.633 . . . . 73.54 109.292 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -115.78 127.38 26.83 Favored Pre-proline 0 C--N 1.289 -2.034 0 C-N-CA 119.939 -0.705 . . . . 63.13 111.287 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -87.39 128.9 2.64 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 N-CA-C 107.234 -1.871 . . . . 61.42 107.234 167.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 394' ' ' ILE . 6.9 t70 -142.66 -179.4 6.29 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.639 -1.225 . . . . 61.32 110.199 -173.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.4 m -98.15 -33.47 11.12 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.365 -1.346 . . . . 60.53 107.365 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 34.5 m -101.57 71.13 1.31 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.178 -1.415 . . . . 74.41 107.178 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 391' ' ' ASP . 18.8 pt -100.85 125.32 38.92 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.867 -1.06 . . . . 74.22 111.97 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.57 175.86 3.68 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 N-CA-C 107.66 -1.708 . . . . 72.4 107.66 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 162.45 16.07 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.083 1.855 . . . . 74.45 109.992 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -56.81 -8.42 0.6 Allowed 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.254 1.022 . . . . 64.45 113.034 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.9 m80 -62.7 131.74 49.95 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.075 -0.713 . . . . 64.34 109.075 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.61 118.43 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 CA-C-N 115.645 -0.707 . . . . 73.1 109.159 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.2 pp -91.13 -28.03 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.105 -0.952 . . . . 72.35 110.359 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.435 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -169.42 157.31 29.04 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.515 -1.434 . . . . 72.4 109.515 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 403' ' ' ASP . 8.9 m -114.42 -177.18 3.07 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 106.332 -1.729 . . . . 62.43 106.332 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.604 ' H ' HG22 ' A' ' 402' ' ' THR . 10.5 t70 -97.96 138.72 20.99 Favored Pre-proline 0 C--N 1.267 -2.996 0 N-CA-C 109.092 -0.707 . . . . 73.21 109.092 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.48 -25.7 0.88 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 125.098 3.865 . . . . 72.34 115.463 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.73 68.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.954 0.407 . . . . 54.23 110.72 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.8 -38.57 62.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.775 0.798 . . . . 71.03 109.79 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.26 -5.08 48.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.903 -1.044 . . . . 63.21 110.704 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.4 m -86.8 147.87 25.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.044 -1.095 . . . . 72.52 108.044 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.9 p -74.52 112.97 11.24 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.329 -0.619 . . . . 65.31 109.329 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.28 169.22 22.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.349 -0.982 . . . . 74.22 108.349 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.1 p -80.14 137.75 36.78 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.003 -1.079 . . . . 65.53 110.432 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -60.36 138.61 57.94 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.218 -0.446 . . . . 55.25 110.655 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 100.92 15.63 28.13 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.192 -1.004 . . . . 70.35 110.779 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.51 -174.32 4.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.952 -1.499 . . . . 43.13 106.952 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 126.49 55.33 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.431 0.634 . . . . 65.23 110.926 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.01 119.44 61.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 116.138 -0.483 . . . . 75.42 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 4.9 t -85.13 118.93 24.99 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.899 0.857 . . . . 73.12 109.728 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.84 122.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.01 -0.995 . . . . 72.23 108.387 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 9.6 p30 -90.66 128.71 36.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.448 0.642 . . . . 74.44 110.461 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.0 143.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.333 -1.358 . . . . 63.31 107.333 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 2.1 p -88.04 120.02 28.98 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 119.143 -1.023 . . . . 73.34 108.898 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.0 m -120.2 105.31 10.84 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.962 -0.755 . . . . 74.35 108.962 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 75.73 166.13 19.57 Favored Glycine 0 C--O 1.259 1.677 0 CA-C-O 122.118 0.843 . . . . 43.32 114.293 177.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -96.0 157.32 1.42 Allowed 'Trans proline' 0 N--CA 1.429 -2.265 0 C-N-CA 122.998 2.466 . . . . 73.24 112.866 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.59 20.22 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.524 -2.028 . . . . 74.21 105.524 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -120.1 152.73 37.17 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.746 -0.465 . . . . 75.54 109.746 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.0 OUTLIER -146.84 156.68 43.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.067 -1.086 . . . . 75.45 108.067 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 49.2 mt-10 -83.93 140.15 32.13 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.348 -0.982 . . . . 73.12 108.348 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -79.59 119.24 76.2 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 106.634 -1.617 . . . . 71.13 106.634 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.49 140.36 94.34 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 121.675 1.584 . . . . 70.32 111.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.44 -0.68 56.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.441 0.638 . . . . 74.11 110.88 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.29 -6.54 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.887 0.851 . . . . 74.55 109.562 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 10.6 p -63.72 -28.17 69.71 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.148 -0.933 . . . . 63.33 112.105 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 20.6 p -65.32 -13.92 59.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 113.453 0.909 . . . . 64.21 113.453 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.7 -48.55 68.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.694 0.257 . . . . 63.41 111.694 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 12.3 t -174.32 165.49 4.01 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 121.234 -0.186 . . . . 75.22 110.545 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.47 -52.54 65.2 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.319 1.048 . . . . 61.4 112.666 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.83 84.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.396 -0.366 . . . . 61.35 111.593 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.67 -45.96 90.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 63.31 109.956 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.22 78.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 52.5 111.129 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.62 -46.81 95.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 116.275 -0.42 . . . . 75.13 110.907 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.48 -47.69 82.88 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.079 0.4 . . . . 75.12 112.079 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.08 -46.3 84.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.202 0.445 . . . . 62.04 112.202 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.91 -36.72 80.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.562 0.578 . . . . 65.41 112.562 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.1 m -64.44 -40.85 96.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.044 0.449 . . . . 55.42 110.075 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.59 63.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.461 0.648 . . . . 65.23 110.42 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.32 -12.89 59.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.628 -0.714 . . . . 72.44 110.049 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.84 -19.66 10.23 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.639 -0.709 . . . . 64.12 113.173 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.28 102.93 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.071 0.463 . . . . 75.53 110.489 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.22 19.85 33.93 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.744 -0.741 . . . . 64.22 111.914 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -123.63 111.48 16.27 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.411 -0.588 . . . . 70.21 109.411 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.14 158.28 39.42 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.437 0.636 . . . . 74.11 111.656 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.65 126.85 16.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.476 -1.676 . . . . 64.55 106.476 170.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -87.52 132.54 34.0 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.037 -0.357 . . . . 71.52 110.037 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.72 161.5 37.4 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.285 -1.006 . . . . 45.45 108.285 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.415 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 23.5 m-80 -133.93 149.84 51.29 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 122.537 0.335 . . . . 71.34 110.305 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 31.1 t -128.52 131.46 23.78 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 107.246 -1.39 . . . . 72.51 107.246 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.7 Cg_endo -61.8 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.764 1.642 . . . . 72.31 109.209 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 19.4 m -126.97 175.46 8.06 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.157 -0.474 . . . . 65.32 109.98 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.6 m -63.92 133.17 95.49 Favored Pre-proline 0 N--CA 1.424 -1.746 0 N-CA-C 106.289 -1.745 . . . . 54.23 106.289 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.54 -23.91 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.367 2.712 . . . . 73.5 114.027 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -67.04 -21.36 65.92 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.185 0.439 . . . . 71.03 112.185 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.2 7.84 40.74 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 121.904 -0.497 . . . . 63.3 111.622 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.2 p -59.25 127.36 18.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 CA-C-O 121.321 0.581 . . . . 73.33 110.843 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.76 -6.72 70.33 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 115.543 -0.753 . . . . 44.45 112.104 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -100.64 151.12 22.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.875 -0.787 . . . . 75.45 108.875 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.2 t -84.19 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.773 -0.825 . . . . 75.42 108.773 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.49 -16.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 120.168 -0.613 . . . . 53.3 112.38 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.19 160.23 12.34 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.019 -0.832 . . . . 52.13 111.019 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 486' ' ' ILE . 7.9 p -119.32 149.65 41.45 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.631 -1.248 . . . . 51.14 107.631 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.6 t30 -59.28 -49.7 91.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 119.797 -0.761 . . . . 62.23 110.731 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -76.07 117.6 4.72 Favored 'Trans proline' 0 C--N 1.372 1.812 0 N-CA-C 107.642 -1.715 . . . . 54.5 107.642 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.484 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.2 Cg_endo -62.9 142.95 90.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.888 2.392 . . . . 60.23 114.744 -173.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.419 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.27 0.12 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.814 -1.084 . . . . 64.15 113.24 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -109.14 0.12 19.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.29 -0.881 . . . . 73.03 109.517 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.484 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 6.5 tp-100 -117.74 162.11 18.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.725 0.774 . . . . 65.22 111.926 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 9.3 m -97.34 132.22 43.27 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.255 -1.338 . . . . 74.3 108.6 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.1 m -136.47 149.0 47.98 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.985 -0.376 . . . . 50.04 109.985 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.3 141.85 52.31 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 74.11 109.942 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.9 -17.0 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 114.454 1.279 . . . . 70.34 114.454 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.0 p -88.9 5.29 44.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.676 -0.64 . . . . 71.14 112.022 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -90.3 147.63 23.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.311 -0.625 . . . . 62.02 109.311 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.4 t -83.25 119.55 32.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.629 -0.878 . . . . 63.14 108.629 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.93 119.18 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 108.507 -0.923 . . . . 73.3 108.507 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.5 112.73 26.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.182 -1.784 . . . . 63.35 106.182 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.69 113.37 36.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.478 -1.304 . . . . 73.3 107.478 -177.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 22.4 mt -101.95 121.13 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.693 -0.685 . . . . 73.33 109.84 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.415 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 38.2 t -97.36 143.68 12.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.41 -0.959 . . . . 72.35 108.41 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -89.82 118.09 5.16 Favored Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 110.177 -1.169 . . . . 64.44 110.177 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 50.9 m -134.93 136.85 42.6 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.68 -0.859 . . . . 70.0 108.68 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.42 -2.373 0 N-CA-C 109.065 -1.614 . . . . 73.13 109.065 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 109.327 -0.62 . . . . 75.22 109.327 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.34 157.71 29.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.373 -0.376 . . . . 74.23 110.104 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.98 136.88 34.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.108 -1.442 . . . . 63.03 107.108 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.9 137.47 20.93 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 120.194 -0.602 . . . . 22.14 110.644 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -43.63 124.21 4.2 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 124.068 3.178 . . . . 72.42 114.67 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.4 ' CG ' ' HE ' ' A' ' 366' ' ' ARG . 9.8 t70 -76.29 138.07 40.3 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.244 -1.391 . . . . 74.22 107.244 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.569 HG23 HG11 ' A' ' 399' ' ' VAL . 31.0 m -102.16 23.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 113.545 0.943 . . . . 71.34 113.545 -170.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 401' ' ' GLY . 20.6 ptp180 -62.73 135.04 57.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.314 0.578 . . . . 71.0 111.82 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.88 -3.78 77.9 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.139 -0.784 . . . . 54.25 111.139 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.96 160.19 19.85 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.624 -0.51 . . . . 72.12 109.624 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 67.9 p -75.65 158.34 32.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 110.37 -0.233 . . . . 55.22 110.37 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.477 ' O ' HD13 ' A' ' 374' ' ' ILE . 17.9 p -63.13 -37.13 86.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 120.771 0.32 . . . . 53.32 110.449 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.08 90.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.249 -0.432 . . . . 64.42 110.584 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.89 -34.94 79.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.125 0.488 . . . . 61.41 110.487 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.526 -0.761 . . . . 30.42 110.371 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 384' ' ' ILE . 1.4 mp -58.55 -44.37 89.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.748 -0.66 . . . . 63.21 110.213 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.79 84.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.219 -0.446 . . . . 62.44 112.133 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 85.5 m -60.83 -47.17 87.58 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.647 0.24 . . . . 72.41 111.647 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.51 -39.02 93.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.779 0.323 . . . . 71.53 110.921 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -63.12 -46.0 89.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.345 -0.843 . . . . 71.12 109.601 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -70.57 -24.43 62.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.901 -0.59 . . . . 74.32 112.238 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -81.14 -15.3 56.26 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.144 -0.622 . . . . 72.15 111.584 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 98.98 14.84 35.24 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.679 -1.248 . . . . 73.05 111.888 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 48.6 m-85 -97.26 168.86 10.16 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.548 -0.908 . . . . 72.23 108.548 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.5 mmtp -113.49 157.25 22.23 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.514 -1.291 . . . . 65.3 107.514 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -135.0 142.37 40.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 121.293 0.568 . . . . 74.4 111.802 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -112.18 128.02 56.11 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.836 -1.542 . . . . 74.32 106.836 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.6 m -100.44 123.68 44.98 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 119.329 -0.948 . . . . 63.42 108.522 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.98 119.41 38.97 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 105.421 -2.066 . . . . 60.21 105.421 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.4 pm0 -107.99 122.05 46.05 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.529 -0.915 . . . . 72.32 108.529 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 137.82 31.09 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.566 -0.454 . . . . 63.45 111.143 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.3 Cg_endo -93.1 148.88 2.52 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.735 2.29 . . . . 71.41 111.487 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 394' ' ' ILE . 4.9 t70 170.06 174.75 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.758 -1.571 . . . . 74.21 106.758 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.686 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 22.0 m -99.3 -33.97 10.51 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.823 -0.806 . . . . 73.24 108.823 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.8 p -94.71 63.19 2.81 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 122.538 1.161 . . . . 64.11 108.255 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.592 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -95.6 151.57 38.6 Favored Pre-proline 0 N--CA 1.424 -1.742 0 CA-C-N 113.644 -1.617 . . . . 71.52 112.51 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.42 143.73 58.88 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 N-CA-C 107.24 -1.869 . . . . 73.03 107.24 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.92 148.67 66.05 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.242 1.962 . . . . 64.54 111.461 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.91 -9.68 10.68 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.019 0.914 . . . . 52.42 110.734 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -96.52 125.99 41.39 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 103.708 -2.701 . . . . 74.41 103.708 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 365' ' ' VAL . 31.2 t -62.37 119.25 5.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.576 0.703 . . . . 75.2 111.969 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.6 tp -84.97 -29.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.369 -0.832 . . . . 70.1 109.367 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 366' ' ' ARG . . . -170.07 160.32 33.18 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.603 -1.399 . . . . 65.44 109.603 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 403' ' ' ASP . 0.7 OUTLIER -113.14 -175.66 2.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 105.825 -1.917 . . . . 72.24 105.825 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.439 ' H ' HG22 ' A' ' 402' ' ' THR . 17.3 t70 -99.38 136.58 20.38 Favored Pre-proline 0 C--N 1.265 -3.089 0 N-CA-C 109.71 -0.478 . . . . 74.24 109.71 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -33.73 -31.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 1 C-N-CA 126.069 4.513 . . . . 74.44 115.88 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.56 -31.92 66.6 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 122.652 0.381 . . . . 73.51 111.0 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -35.3 64.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.364 0.602 . . . . 75.21 110.58 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.93 -15.08 59.29 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.01 -0.541 . . . . 74.34 110.183 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 70.8 m -86.35 147.09 26.2 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.241 -1.022 . . . . 73.54 108.241 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.7 m -74.81 112.9 11.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.008 -1.108 . . . . 63.33 108.008 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.05 170.22 18.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.663 -0.699 . . . . 74.04 110.845 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.1 p -65.91 131.52 46.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.403 -0.817 . . . . 53.23 110.628 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.94 113.46 4.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.077 0.465 . . . . 64.41 110.114 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.29 -2.07 9.66 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.393 -0.908 . . . . 60.22 112.342 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.78 158.87 32.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.057 -0.349 . . . . 75.33 110.057 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.9 pt-20 -87.29 121.4 29.68 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.371 0.605 . . . . 53.21 111.273 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.82 131.15 45.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.851 -1.166 . . . . 70.44 107.851 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -91.55 130.0 37.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.506 0.67 . . . . 51.53 110.301 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.8 t -117.57 125.46 74.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.591 -1.263 . . . . 73.22 107.591 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.9 129.2 43.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.008 -0.367 . . . . 64.51 110.008 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.5 p -125.58 147.95 30.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.98 -1.119 . . . . 65.53 107.98 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 5.8 p -96.51 123.34 40.14 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.056 0.455 . . . . 65.23 112.197 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 t -117.61 106.08 12.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.168 -0.613 . . . . 73.14 111.393 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 74.48 130.19 0.21 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.517 0.967 . . . . 65.53 115.517 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 22.8 Cg_exo -68.43 145.99 66.95 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.943 1.762 . . . . 44.22 109.294 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.31 147.24 31.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.084 0.772 . . . . 65.55 113.084 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.4 mt-30 -123.21 137.43 54.88 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.41 107.732 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -137.15 164.4 28.54 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.451 -0.574 . . . . 75.22 109.451 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -82.49 137.8 34.53 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.277 -1.008 . . . . 72.12 108.277 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.4 mt -80.85 114.35 47.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.543 -0.91 . . . . 64.03 108.543 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 140.74 37.27 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.343 1.362 . . . . 52.45 110.296 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.76 96.57 5.55 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.133 1.161 . . . . 73.4 114.133 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.3 6.76 3.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.112 -2.921 . . . . 70.34 103.112 165.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 4.6 m -71.05 -46.37 62.13 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 112.176 -2.284 . . . . 73.13 110.86 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 466' ' ' LYS . 21.6 m -57.01 -31.77 65.46 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.529 0.681 . . . . 75.12 110.031 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.82 -48.19 8.42 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.728 -0.669 . . . . 73.05 111.723 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 57.7 m -132.38 122.95 25.81 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 121.991 -0.443 . . . . 53.42 112.145 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -60.91 -40.57 93.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.98 0.912 . . . . 73.04 111.531 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.14 93.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 44.43 110.302 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -65.39 -35.62 81.5 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.446 -0.797 . . . . 60.45 111.384 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.22 94.1 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.632 0.583 . . . . 62.34 109.487 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.23 -49.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.769 -0.651 . . . . 74.35 110.691 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -65.09 -49.23 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.434 0.531 . . . . 72.51 112.434 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 30.6 mmtp -68.02 -38.66 82.84 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.912 0.708 . . . . 64.23 112.912 -174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.44 -37.1 79.92 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.291 -0.564 . . . . 72.44 111.462 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.7 m -64.41 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.274 -0.639 . . . . 73.54 109.274 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.31 77.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.763 -0.653 . . . . 74.31 111.03 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -14.66 58.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.092 0.472 . . . . 73.52 110.225 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.41 -23.46 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-O 119.531 -0.594 . . . . 32.51 113.86 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 480' ' ' ILE . 99.0 m-85 -55.66 122.97 12.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.003 0.521 . . . . 75.13 111.962 -174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.01 8.66 5.73 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.48 -0.782 . . . . 74.42 111.62 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -110.23 110.62 21.52 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.735 -1.58 . . . . 75.34 106.735 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.37 150.29 52.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.918 0.866 . . . . 75.32 112.418 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 27.6 tptp -139.07 122.93 17.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.272 -1.751 . . . . 64.43 106.272 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -93.32 135.75 34.25 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 110.053 -0.351 . . . . 75.12 110.053 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.09 152.22 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.556 -0.535 . . . . 54.23 109.556 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -118.66 129.4 55.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.585 -0.895 . . . . 51.44 108.585 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.9 t -126.6 137.88 31.31 Favored Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.788 -1.19 . . . . 52.35 107.788 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.82 135.16 46.96 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.679 2.253 . . . . 64.13 110.427 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -148.18 169.86 19.11 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.465 -0.939 . . . . 73.14 108.465 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.6 m -65.46 144.12 98.87 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.785 0.834 . . . . 64.44 109.214 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.612 ' O ' HG12 ' A' ' 464' ' ' VAL . 93.3 Cg_exo -49.29 -23.47 7.04 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.915 3.076 . . . . 71.43 114.745 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -68.86 -31.98 71.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 71.21 111.142 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.39 -12.24 21.62 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.907 -0.588 . . . . 64.11 111.305 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.3 p -60.19 126.95 18.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-O 121.464 0.65 . . . . 73.42 110.448 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 98.6 -13.35 62.7 Favored Glycine 0 C--N 1.301 -1.383 0 N-CA-C 111.284 -0.726 . . . . 20.24 111.284 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 434' ' ' THR . 11.7 mptt -103.02 163.47 12.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.775 -0.824 . . . . 72.41 108.775 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.2 135.71 24.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.07 -1.085 . . . . 72.13 108.07 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.02 -12.06 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.399 -0.92 . . . . 70.51 110.546 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 151.93 176.46 24.66 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 115.198 -0.91 . . . . 35.03 112.082 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.4 p -116.41 149.46 39.38 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.607 -1.257 . . . . 64.24 107.607 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.9 t-20 -64.68 -49.38 70.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 120.201 -0.599 . . . . 74.5 111.489 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.2 Cg_exo -68.6 146.18 66.5 Favored 'Trans proline' 0 C--N 1.372 1.8 0 N-CA-C 108.724 -1.298 . . . . 74.23 108.724 170.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.69 126.52 18.41 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.522 2.148 . . . . 61.15 112.886 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.86 2.06 36.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.654 0.74 . . . . 70.11 111.608 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -109.9 -1.56 17.7 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.069 -0.514 . . . . 75.44 110.903 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -131.94 159.01 39.94 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.704 0.764 . . . . 71.21 111.39 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -67.19 106.93 2.16 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.656 -1.611 . . . . 63.03 109.874 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.6 m -108.52 150.03 28.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.83 -0.804 . . . . 75.31 108.83 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.72 144.66 47.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.183 -0.673 . . . . 71.11 109.183 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.686 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 50.2 mm -70.7 -13.78 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.185 0.993 . . . . 70.53 109.16 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 392' ' ' SER . 1.3 p -87.8 -11.02 49.22 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.703 -1.135 . . . . 63.45 109.78 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.34 138.56 47.39 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.456 -0.942 . . . . 63.03 108.456 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.52 113.86 19.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.374 -1.343 . . . . 64.05 107.374 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.54 118.37 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 C-N-CA 119.526 -0.87 . . . . 72.14 108.825 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.1 mp -92.35 112.14 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 105.783 -1.932 . . . . 71.34 105.783 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 114.3 33.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.545 -1.65 . . . . 61.22 106.545 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 18.9 mt -104.27 116.93 48.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.633 -0.712 . . . . 74.12 110.216 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.74 137.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.243 -1.021 . . . . 74.13 108.243 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.62 99.33 1.0 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 109.633 -1.387 . . . . 74.33 109.633 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.2 m -142.79 105.73 4.54 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 122.742 0.417 . . . . 74.03 109.971 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.165 0 N-CA-C 109.398 -1.481 . . . . 62.33 109.398 178.153 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 107.695 -1.224 . . . . 63.21 107.695 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 19.9 m -136.09 156.6 37.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.511 -0.552 . . . . 64.45 109.511 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -94.7 136.25 35.23 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.803 -1.925 . . . . 74.52 105.803 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.5 m -97.71 141.11 22.49 Favored Pre-proline 0 C--N 1.282 -2.341 0 C-N-CA 119.128 -1.029 . . . . 74.43 110.948 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.95 133.19 56.55 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.124 2.549 . . . . 73.1 113.146 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.16 126.2 28.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.032 -0.985 . . . . 72.34 110.39 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.6 m -91.79 10.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 73.52 112.109 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.94 141.37 58.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 64.0 109.838 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.65 -0.14 45.94 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.489 -0.644 . . . . 74.51 111.489 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 49.3 mt-30 -120.7 -179.22 3.93 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.315 -0.624 . . . . 72.15 109.315 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.7 p -86.04 169.96 12.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.727 -0.789 . . . . 71.11 109.342 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.3 p -61.81 -38.98 90.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.739 0.304 . . . . 51.31 111.118 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.14 87.57 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.247 -0.433 . . . . 65.11 110.93 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 62.4 m-20 -60.94 -43.66 98.35 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.199 -0.297 . . . . 74.42 110.199 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.91 75.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.524 -0.762 . . . . 63.21 110.198 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -58.28 -46.14 88.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.745 -0.661 . . . . 73.42 110.651 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.13 89.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.064 -0.517 . . . . 51.24 111.448 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 94.3 m -64.77 -48.25 75.2 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 120.575 0.226 . . . . 74.22 111.275 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.21 -38.71 91.29 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.436 -0.506 . . . . 72.23 110.892 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -60.02 -46.71 88.62 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.654 0.596 . . . . 61.41 109.908 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.4 -36.88 85.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.907 -0.588 . . . . 71.5 111.833 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 376' ' ' THR . 4.8 mpt_? -79.5 -14.45 58.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.54 111.652 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.3 16.35 32.57 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.387 -0.911 . . . . 72.34 113.523 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.19 166.96 12.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.912 0.387 . . . . 53.55 110.432 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 29.0 mmmt -99.93 153.14 19.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.193 -1.41 . . . . 73.11 107.193 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.469 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -130.19 138.47 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.432 0.634 . . . . 71.12 112.593 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 417' ' ' THR . 14.0 ttm180 -115.46 135.93 53.6 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.05 -1.463 . . . . 74.31 107.05 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.6 m -99.6 128.11 45.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 119.351 -0.94 . . . . 64.43 110.525 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.77 119.54 38.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.928 -1.879 . . . . 73.4 105.928 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.438 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 15.2 pm0 -114.02 128.4 56.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 120.883 0.373 . . . . 62.52 110.142 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 0.6 OUTLIER -121.53 115.7 30.97 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 112.11 0.411 . . . . 64.21 112.11 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 1.9 Cg_endo -87.94 134.4 3.15 Favored 'Trans proline' 0 C--O 1.256 1.386 0 C-N-CA 123.306 2.67 . . . . 63.43 111.825 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t70 172.2 -169.32 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 106.374 -1.713 . . . . 71.2 106.374 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 21.3 m -120.52 -12.86 8.87 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.473 0.654 . . . . 63.53 109.399 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -90.84 14.41 13.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.567 1.175 . . . . 74.32 108.291 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.413 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.54 151.08 47.65 Favored Pre-proline 0 N--CA 1.424 -1.763 0 CA-C-N 114.739 -1.119 . . . . 44.33 110.931 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.73 171.29 18.28 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.104 1.87 . . . . 73.2 111.35 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.53 163.03 7.34 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.504 2.803 . . . . 72.13 111.752 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.68 -7.26 0.64 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.214 1.006 . . . . 64.12 112.973 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 42.5 m170 -83.38 142.15 31.23 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.826 -0.805 . . . . 64.42 108.826 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.47 117.92 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-O 121.864 0.84 . . . . 62.41 109.544 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.76 -27.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.933 -1.03 . . . . 74.31 110.471 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.87 161.15 28.08 Favored Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 109.515 -1.434 . . . . 71.52 109.515 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.2 p -113.58 -178.48 3.39 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 121.035 0.445 . . . . 71.12 111.328 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.55 132.09 22.2 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.026 -1.472 . . . . 51.32 107.026 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.55 -30.04 11.42 Favored 'Trans proline' 0 N--CA 1.481 0.769 0 C-N-CA 124.137 3.225 . . . . 72.02 114.92 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.9 67.12 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 111.57 0.211 . . . . 71.35 111.57 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.68 -33.45 60.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.451 0.643 . . . . 73.5 110.28 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -86.17 -10.36 54.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.6 -0.727 . . . . 74.24 110.474 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 46.3 m -83.48 153.19 24.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.131 -1.433 . . . . 72.41 107.131 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.4 m -74.39 113.24 11.39 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.686 -0.806 . . . . 74.2 109.858 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.89 169.4 15.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 123.947 0.899 . . . . 75.1 109.075 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.3 t -78.96 146.96 33.14 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.913 -0.773 . . . . 74.25 108.913 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -70.87 113.22 7.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.061 -0.718 . . . . 75.11 109.061 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.71 9.1 11.45 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.384 -0.826 . . . . 53.35 111.722 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.0 -173.53 4.77 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.297 -1.371 . . . . 72.3 107.297 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 9.4 pt-20 -106.36 141.36 37.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.741 -0.784 . . . . 75.2 111.632 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -118.89 137.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.897 -1.149 . . . . 75.54 107.897 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 385' ' ' ARG . 68.4 p -92.64 130.53 38.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 120.988 0.423 . . . . 62.33 110.264 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.6 128.14 55.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.195 -1.039 . . . . 74.33 108.195 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.67 128.87 45.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.973 -0.38 . . . . 74.14 109.973 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 10.1 p -137.53 142.43 36.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.085 -0.709 . . . . 73.4 109.085 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 14.6 m -88.1 122.26 31.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.53 -0.544 . . . . 74.25 109.53 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 41.2 p -119.62 107.45 13.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.628 -0.26 . . . . 63.43 111.435 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 86.35 131.41 2.92 Favored Glycine 0 C--N 1.299 -1.522 0 C-N-CA 120.437 -0.887 . . . . 50.33 114.004 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 97.1 Cg_endo -82.3 157.83 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.635 2.223 . . . . 74.4 111.378 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 2.9 mm-40 -85.67 124.19 31.92 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.568 -0.53 . . . . 70.52 109.568 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 62.5 mt-30 -120.51 130.91 54.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.039 -1.097 . . . . 62.33 108.039 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -131.18 152.06 50.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 74.51 108.51 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -89.81 138.49 31.44 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 109.821 -0.437 . . . . 73.31 109.821 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -80.3 119.38 76.26 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.085 -0.709 . . . . 62.52 109.085 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.51 141.4 97.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.765 2.31 . . . . 75.32 111.864 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.58 8.98 25.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.33 0.492 . . . . 73.51 112.33 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.43 -7.86 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.998 0.904 . . . . 74.34 108.767 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 p -59.2 -42.85 91.91 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.982 -1.008 . . . . 72.14 111.845 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 6.5 p -69.4 -16.72 63.57 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.543 0.737 . . . . 74.25 112.367 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.25 -32.82 19.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.383 -0.371 . . . . 63.33 111.94 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.4 m -151.72 123.99 8.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.448 -0.575 . . . . 73.21 109.448 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.86 -45.42 92.66 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.275 0.472 . . . . 73.13 112.275 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.25 -43.89 95.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 75.3 110.135 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.11 -37.65 88.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.138 -0.937 . . . . 74.23 109.949 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.093 -0.503 . . . . 73.42 110.51 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.27 -43.42 98.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.697 -0.683 . . . . 55.25 110.033 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 30.8 mmmt -64.67 -47.43 78.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.398 -0.364 . . . . 72.11 111.368 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -63.83 -38.85 92.63 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.189 -0.459 . . . . 73.53 111.982 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.0 -39.41 90.27 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.01 -0.737 . . . . 60.44 109.01 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.7 m -66.75 -45.91 77.07 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.335 -0.848 . . . . 72.53 110.163 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.83 -22.93 65.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.862 0.865 . . . . 64.11 112.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.68 -11.04 59.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.413 0.625 . . . . 34.04 110.628 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.38 -15.89 19.96 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.679 -0.772 . . . . 61.12 112.986 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HA ' HG23 ' A' ' 480' ' ' ILE . 98.3 m-85 -67.54 124.7 23.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.928 0.394 . . . . 35.21 111.182 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.78 13.17 9.28 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.028 -0.829 . . . . 21.21 111.028 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -111.95 111.26 22.06 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 70.4 107.458 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -126.0 146.41 49.89 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 121.097 -0.241 . . . . 74.33 110.921 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 25.3 ttmm -153.17 122.66 6.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.353 -1.351 . . . . 63.21 107.353 171.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.46 135.3 43.19 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.247 0.546 . . . . 64.34 111.825 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.73 158.04 28.36 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.044 -1.095 . . . . 71.32 108.044 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.41 134.48 51.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.844 -0.799 . . . . 61.23 108.844 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.2 t -138.79 131.16 15.73 Favored Pre-proline 0 C--N 1.287 -2.137 0 N-CA-C 108.655 -0.868 . . . . 21.34 108.655 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 128.56 21.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.994 1.796 . . . . 65.44 109.151 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.7 t -137.13 -178.75 5.34 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.541 -0.911 . . . . 54.41 108.541 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 12.0 m -51.1 131.06 31.27 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.925 1.29 . . . . 74.43 109.484 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.79 -33.05 31.3 Favored 'Trans proline' 0 C--N 1.364 1.371 0 C-N-CA 123.815 3.01 . . . . 62.25 114.065 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -67.44 -32.24 72.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 72.11 111.668 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.33 -9.7 40.94 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.165 -0.334 . . . . 72.3 111.51 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 42.1 t -59.17 129.97 22.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 CA-C-N 115.749 -0.66 . . . . 61.22 111.861 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.34 1.28 56.8 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.841 -1.072 . . . . 52.21 110.937 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -131.22 166.33 21.41 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 109.128 -0.693 . . . . 72.43 109.128 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 486' ' ' ILE . 49.3 t -80.95 136.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.927 -0.768 . . . . 54.53 108.927 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.29 -16.54 7.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.13 -0.628 . . . . 74.41 111.564 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.61 163.79 22.14 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.26 -0.882 . . . . 50.33 110.999 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 486' ' ' ILE . 9.5 p -122.37 157.57 31.54 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.006 -1.479 . . . . 65.32 107.006 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.449 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.3 m120 -62.23 -54.51 48.85 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 119.058 -1.057 . . . . 73.3 111.298 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 13.9 Cg_exo -74.83 112.82 3.65 Favored 'Trans proline' 0 C--N 1.371 1.757 0 N-CA-C 107.801 -1.654 . . . . 65.5 107.801 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.36 162.07 43.36 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.391 2.061 . . . . 74.2 114.523 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.9 -4.01 32.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.864 -1.062 . . . . 63.44 111.553 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -108.23 12.24 26.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.098 -0.501 . . . . 51.34 109.814 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -125.63 151.77 46.06 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.461 0.648 . . . . 72.44 110.675 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.7 m -104.44 101.95 11.62 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.053 -1.462 . . . . 70.11 107.053 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.7 m -106.73 145.34 32.16 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.503 -0.317 . . . . 50.55 111.272 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.74 145.99 54.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.066 -0.516 . . . . 74.53 110.665 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 48.3 mm -67.25 -9.1 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 124.375 1.07 . . . . 75.04 111.42 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.8 p -86.88 -2.91 58.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.665 0.745 . . . . 74.12 110.71 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -95.82 133.93 39.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.544 -0.753 . . . . 72.23 109.382 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.28 119.37 28.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.932 -1.136 . . . . 74.2 107.932 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.18 119.15 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.628 -0.879 . . . . 64.31 108.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.3 mt -93.85 112.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.133 -1.432 . . . . 65.34 107.133 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.98 117.19 46.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.659 -1.155 . . . . 70.2 108.823 -175.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 35.0 mt -99.93 119.8 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.374 0.606 . . . . 73.54 110.09 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.43 124.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 63.53 108.851 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.7 96.38 1.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.45 -1.86 . . . . 75.15 108.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.491 ' HA ' HG13 ' A' ' 464' ' ' VAL . 5.1 p -142.79 131.51 22.66 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 110.071 -0.344 . . . . 72.25 110.071 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.0 0 N-CA-C 106.851 -2.499 . . . . 64.13 106.851 176.787 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 CA--C 1.499 -0.999 0 N-CA-C 108.28 -1.008 . . . . 62.44 108.28 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.46 153.65 39.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.514 -0.55 . . . . 73.32 109.514 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -95.43 138.59 32.91 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.04 -1.096 . . . . 63.24 108.04 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.59 126.62 42.65 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.335 -0.617 . . . . 65.11 109.335 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.1 141.75 89.76 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.413 2.742 . . . . 63.43 114.995 -174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.15 138.28 31.63 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.683 -1.228 . . . . 74.43 107.683 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 373' ' ' ALA . 15.7 m -116.05 27.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-O 121.936 0.874 . . . . 64.32 109.073 174.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -55.45 144.23 26.44 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.823 -1.535 . . . . 71.1 111.694 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.92 44.65 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.961 -0.856 . . . . 40.12 110.961 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -127.18 -173.3 2.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.963 -0.384 . . . . 73.22 109.963 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.9 p -70.82 151.37 44.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.755 0.312 . . . . 73.05 111.385 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 p -63.43 -36.46 83.81 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.346 -0.388 . . . . 54.24 111.411 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.76 88.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.546 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.41 -36.52 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 71.41 110.637 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -59.78 -51.16 70.93 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.99 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.34 -43.58 98.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.831 -0.622 . . . . 74.02 110.774 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.33 94.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.448 -0.342 . . . . 74.04 111.829 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.2 m -63.93 -47.07 81.95 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.961 0.41 . . . . 53.21 110.105 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.49 -38.1 89.84 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -59.89 -45.24 93.14 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.174 0.989 . . . . 75.44 109.846 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -70.17 -16.55 63.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 74.22 111.991 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -86.86 -14.14 42.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.639 -0.874 . . . . 74.52 108.639 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.86 5.2 62.91 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.53 -0.843 . . . . 61.3 111.668 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 35.6 m-85 -86.15 149.72 24.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.212 0.529 . . . . 73.12 110.291 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 13.9 mmmm -91.41 153.22 20.02 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.216 -1.401 . . . . 63.33 107.216 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.03 147.46 25.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 C-N-CA 120.3 -0.56 . . . . 74.21 111.421 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -111.07 132.22 54.43 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.012 -1.848 . . . . 73.13 106.012 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.5 m -115.72 118.2 32.37 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.372 -0.973 . . . . 71.15 108.372 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.59 119.02 36.71 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.817 -1.179 . . . . 72.53 107.817 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.7 pm0 -104.36 131.79 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.23 0.538 . . . . 73.41 110.187 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -136.76 130.61 17.82 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.707 -0.678 . . . . 74.13 110.836 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.36 135.55 4.46 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.494 2.129 . . . . 73.15 111.616 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 34.4 t70 168.56 166.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.168 1.387 . . . . 52.22 107.305 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.602 ' O ' ' HB ' ' A' ' 481' ' ' THR . 9.4 p -123.25 8.19 9.12 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 113.096 0.776 . . . . 74.11 113.096 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -82.34 -24.51 34.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.132 -1.803 . . . . 51.32 106.132 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.432 ' H ' HG12 ' A' ' 394' ' ' ILE . 6.7 pt -88.91 148.65 41.76 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.721 -2.036 . . . . 73.13 109.718 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.63 173.01 14.01 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.098 2.532 . . . . 75.04 112.268 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.14 162.78 6.98 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 123.558 2.838 . . . . 70.25 112.69 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.46 -8.21 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.631 1.172 . . . . 74.41 113.993 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -75.47 115.69 15.4 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.396 -1.705 . . . . 75.22 106.396 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.48 117.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.018 0.437 . . . . 43.44 110.456 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.57 -27.21 3.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.641 -0.709 . . . . 64.34 110.137 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.29 157.02 27.04 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.072 -1.211 . . . . 62.04 110.072 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.9 p -128.12 -176.52 3.82 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 124.493 1.117 . . . . 63.14 111.076 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.83 132.92 22.15 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.524 -1.287 . . . . 74.1 107.524 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.59 -20.34 12.05 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.786 2.991 . . . . 71.43 114.175 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.63 61.29 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 122.453 0.301 . . . . 72.11 110.922 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.67 -41.15 84.19 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.54 110.337 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.16 -3.87 59.09 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 120.261 -0.575 . . . . 72.24 111.534 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.4 m -80.13 131.54 35.76 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.671 -1.603 . . . . 54.41 106.671 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.8 m -74.61 113.3 11.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.032 -0.667 . . . . 75.3 110.086 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.25 167.73 24.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.246 -0.888 . . . . 54.11 109.335 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.17 50.35 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 109.459 -0.571 . . . . 64.12 109.459 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -62.51 130.8 46.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.369 0.668 . . . . 45.44 111.981 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 109.35 16.48 11.08 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.604 -0.808 . . . . 54.51 113.809 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.18 175.57 7.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.346 -1.353 . . . . 72.24 107.346 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 10.7 pt-20 -109.4 140.2 43.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.078 0.466 . . . . 73.01 112.026 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.0 133.24 65.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.259 -1.015 . . . . 52.55 108.259 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -89.78 118.67 29.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.93 0.871 . . . . 62.44 110.038 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.3 133.58 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.91 -1.041 . . . . 72.4 109.176 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -96.97 128.74 44.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.813 -0.63 . . . . 74.21 110.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.3 p -130.25 131.9 65.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.304 -0.628 . . . . 52.24 109.304 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -91.9 122.55 34.53 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.326 -0.62 . . . . 64.12 109.326 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 16.5 p -118.92 106.66 12.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.756 0.312 . . . . 32.41 111.7 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.48 104.95 0.69 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.581 -0.819 . . . . 74.1 113.042 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 18.8 Cg_exo -66.99 128.93 19.59 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.53 2.154 . . . . 74.0 110.478 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.44 143.48 32.07 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.826 -0.35 . . . . 74.14 111.703 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -131.97 157.12 44.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.307 -0.997 . . . . 72.54 108.307 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -142.59 154.82 44.77 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.557 -0.534 . . . . 74.31 109.557 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.68 139.64 30.36 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.849 -0.426 . . . . 63.33 109.849 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.6 mp -78.7 116.15 57.4 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.844 -0.799 . . . . 62.52 108.844 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.55 140.91 40.77 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.868 1.712 . . . . 64.1 110.156 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -107.19 87.4 2.5 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.453 -1.299 . . . . 72.44 113.671 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.0 0.69 7.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 104.261 -2.496 . . . . 70.41 104.261 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.9 m -68.78 -50.11 53.02 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.972 -1.922 . . . . 72.14 110.236 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.408 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 15.7 m -64.88 -16.45 63.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 121.791 0.805 . . . . 74.52 109.908 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -48.42 7.01 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.482 -0.781 . . . . 74.01 110.241 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 66.0 m -147.71 123.91 10.84 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.085 0.469 . . . . 43.34 111.19 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -42.42 97.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.996 0.739 . . . . 71.12 112.996 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.22 -40.26 81.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 54.34 110.573 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -67.03 -35.3 79.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.485 -0.779 . . . . 74.53 111.815 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.67 -48.39 81.84 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.964 0.412 . . . . 65.35 110.26 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.57 -47.93 90.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.645 -0.707 . . . . 62.22 110.501 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -66.6 -45.7 78.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.02 -0.536 . . . . 73.13 112.119 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -66.28 -47.12 74.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 111.813 0.301 . . . . 71.01 111.813 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.11 -39.07 89.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.517 0.562 . . . . 73.0 112.517 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.0 m -61.81 -42.21 98.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.715 0.293 . . . . 65.14 110.483 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.66 66.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 62.02 111.06 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.08 59.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.958 -0.565 . . . . 64.13 111.038 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 116.52 -7.43 18.03 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.339 -0.934 . . . . 62.44 113.594 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.09 105.2 8.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.48 0.64 . . . . 65.34 109.717 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -111.74 5.16 27.67 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.723 -0.671 . . . . 72.44 111.629 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 23.1 mmt180 -113.8 111.45 21.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 64.44 108.343 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.61 156.54 43.21 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.297 0.57 . . . . 75.42 111.655 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -135.79 123.21 21.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.314 -2.106 . . . . 75.11 105.314 170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.97 122.36 36.38 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.9 155.19 35.96 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.063 -0.717 . . . . 60.44 109.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.08 138.45 52.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.847 0.356 . . . . 71.31 110.674 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.8 t -123.19 131.22 24.34 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.151 -1.425 . . . . 64.11 107.151 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.01 124.48 14.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.524 2.15 . . . . 62.25 110.139 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 24.8 m -134.98 160.85 36.99 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.64 -0.504 . . . . 62.5 109.64 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 461' ' ' PRO . 0.2 OUTLIER -60.81 146.22 87.09 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.482 -1.303 . . . . 74.31 107.482 175.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 464' ' ' VAL . 79.1 Cg_exo -52.26 -24.02 19.66 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 123.372 2.715 . . . . 75.23 114.306 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.51 -31.86 73.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.116 0.484 . . . . 74.43 110.857 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.37 5.08 44.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.02 0.378 . . . . 73.42 112.02 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.1 p -60.43 128.85 22.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 C-N-CA 120.087 -0.645 . . . . 65.23 110.779 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.1 83.14 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.888 -0.596 . . . . 54.12 112.584 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 434' ' ' THR . 85.9 tttt -116.38 148.22 40.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.165 -1.421 . . . . 75.23 107.165 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 433' ' ' SER . 62.0 t -84.05 136.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.038 -0.727 . . . . 71.4 109.038 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -109.44 -14.62 10.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.781 -0.768 . . . . 75.34 111.233 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.12 173.56 41.01 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.948 -0.861 . . . . 73.42 110.948 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.2 p -137.22 158.87 43.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.276 -1.009 . . . . 62.03 108.276 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.9 t-20 -69.54 -54.62 10.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 119.809 -0.756 . . . . 71.04 109.863 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.55 118.07 4.76 Favored 'Trans proline' 0 C--N 1.376 2.024 0 N-CA-C 107.574 -1.741 . . . . 72.34 107.574 172.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 475' ' ' ASN . 43.0 Cg_endo -69.17 139.71 42.97 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.732 1.621 . . . . 62.45 112.277 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.17 24.74 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.424 1.09 . . . . 52.02 112.466 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 473' ' ' PRO . 38.6 m-80 -108.32 -22.28 12.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.385 1.074 . . . . 75.3 109.822 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -131.67 160.09 36.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 C-N-CA 119.292 -0.963 . . . . 61.14 111.498 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.69 141.9 49.86 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 126.12 1.768 . . . . 64.42 110.54 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 56.3 m -133.76 149.7 51.46 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.12 -1.067 . . . . 74.53 108.12 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -76.61 157.95 31.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-O 120.803 0.335 . . . . 72.21 110.338 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 448' ' ' GLY . 50.8 mm -66.83 -16.34 20.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.112 0.958 . . . . 33.12 110.004 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 392' ' ' SER . 12.4 t -99.35 2.59 45.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.37 -0.832 . . . . 73.22 110.009 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 10.1 m120 -83.32 146.07 28.71 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.515 -0.55 . . . . 55.42 109.515 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.47 114.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 71.3 107.271 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.49 119.47 35.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.109 -0.7 . . . . 75.21 109.109 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 3.4 mp -92.06 112.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 106.608 -1.627 . . . . 60.21 106.608 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.33 121.93 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.664 -1.236 . . . . 73.02 107.664 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.41 111.58 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 121.418 0.627 . . . . 71.12 110.015 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.2 140.83 17.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.361 -0.977 . . . . 74.24 108.361 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.93 100.37 1.22 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.504 -1.038 . . . . 53.15 110.504 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 50.2 m -141.97 130.07 22.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.595 -0.52 . . . . 61.23 109.595 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.224 0 N-CA-C 107.871 -2.092 . . . . 73.32 107.871 -178.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 . . . . . 0 CA--C 1.492 -1.262 0 N-CA-C 108.751 -0.833 . . . . 65.41 108.751 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 150.68 31.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.274 -0.639 . . . . 64.22 109.274 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -95.31 136.6 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.659 -1.978 . . . . 72.44 105.659 174.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.5 p -97.46 128.48 34.52 Favored Pre-proline 0 C--N 1.282 -2.331 0 C-N-CA 119.117 -1.033 . . . . 70.41 109.627 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.97 128.07 23.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.841 2.361 . . . . 75.41 112.425 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -68.81 119.62 13.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.75 -1.113 . . . . 73.21 110.765 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 30.5 m -82.95 25.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.983 -1.008 . . . . 64.3 112.817 -174.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 400' ' ' ILE . 11.2 ptt-85 -67.85 144.04 55.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 122.044 -0.41 . . . . 74.0 111.941 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.83 0.5 45.61 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.875 -0.679 . . . . 53.53 113.647 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 0.9 OUTLIER -126.45 -172.85 2.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.336 0.568 . . . . 74.33 110.338 -177.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.8 p -79.44 164.2 24.16 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 118.266 0.484 . . . . 65.32 110.513 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 61.4 p -63.67 -33.66 76.13 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.368 -0.604 . . . . 50.01 109.368 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.14 90.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.143 -0.935 . . . . 42.45 110.339 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 368' ' ' GLN . 40.0 m-20 -60.14 -42.82 95.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.648 -0.251 . . . . 64.21 110.984 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -51.51 69.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.691 0.62 . . . . 64.31 110.438 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 384' ' ' ILE . 78.3 mt -60.73 -46.19 96.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.644 -0.707 . . . . 55.31 110.517 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.11 98.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.69 -0.686 . . . . 71.14 112.177 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.9 m -60.77 -47.69 85.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.844 0.354 . . . . 70.21 110.835 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.05 -38.82 92.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.779 0.323 . . . . 74.41 111.295 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.85 -47.62 85.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.557 -0.747 . . . . 52.24 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -68.9 -27.96 66.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.968 -0.56 . . . . 72.34 111.559 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -81.61 -13.63 57.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.222 -0.445 . . . . 74.32 111.977 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.14 14.55 48.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.561 -0.828 . . . . 63.31 112.895 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -88.61 170.57 10.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.636 -0.505 . . . . 61.53 109.636 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 14.2 mmmm -100.47 159.25 15.3 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.501 -1.296 . . . . 75.5 107.501 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.402 HG13 HG23 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -130.36 146.38 34.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.406 0.622 . . . . 73.31 110.996 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -123.59 147.43 47.33 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 105.495 -2.039 . . . . 73.13 105.495 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.4 m -116.5 129.19 56.06 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 109.072 -0.714 . . . . 74.14 109.072 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.32 118.8 36.85 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.19 -2.152 . . . . 65.04 105.19 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -115.92 129.5 56.43 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.45 -0.574 . . . . 61.35 109.45 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -138.45 134.54 17.54 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 116.351 -0.386 . . . . 70.04 110.614 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -93.38 132.68 0.88 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.92 2.413 . . . . 74.13 110.85 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.0 t70 -175.22 171.39 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.124 -1.436 . . . . 73.34 107.124 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.8 m -114.39 -5.48 12.9 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.356 0.598 . . . . 74.42 110.323 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -87.9 -12.82 43.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.104 0.954 . . . . 62.1 108.94 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 394' ' ' ILE . 12.5 pt -88.58 144.12 33.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.001 -1.0 . . . . 65.14 110.861 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.4 177.22 8.79 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.343 2.695 . . . . 75.24 110.76 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.53 160.75 10.85 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.002 2.468 . . . . 64.33 112.357 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.463 ' HB2' HG23 ' A' ' 420' ' ' VAL . 2.5 p-10 -57.74 -9.5 1.25 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 124.987 1.315 . . . . 63.54 113.631 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.89 114.46 11.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.839 -1.911 . . . . 70.54 105.839 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.52 118.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.171 0.986 . . . . 61.43 111.408 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 366' ' ' ARG . 7.8 tp -90.53 -32.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.895 -1.048 . . . . 75.52 109.86 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -157.87 157.38 28.17 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 109.592 -1.403 . . . . 73.33 109.592 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.0 p -116.47 -179.75 3.77 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.063 -0.717 . . . . 73.05 109.063 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.64 147.55 34.0 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 120.174 -0.611 . . . . 75.23 109.416 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.65 -7.38 2.15 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.373 3.382 . . . . 71.55 115.501 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.28 72.8 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.058 -0.349 . . . . 72.42 110.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.73 68.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.695 0.759 . . . . 61.41 110.107 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.7 -10.83 59.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.278 -0.874 . . . . 70.35 111.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 83.0 m -81.01 151.81 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.794 -1.187 . . . . 73.1 107.794 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.5 m -74.06 112.86 10.6 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.303 0.573 . . . . 72.53 109.7 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.42 159.69 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.081 -0.963 . . . . 61.34 109.47 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 36.6 m -74.16 146.82 43.17 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.202 -0.666 . . . . 51.42 109.202 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.3 35.5 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.874 0.369 . . . . 73.21 110.423 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.46 25.86 24.7 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.724 -0.671 . . . . 53.24 112.006 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 411' ' ' SER . 4.4 t70 -85.89 -175.68 5.68 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.792 -1.188 . . . . 72.44 107.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.7 pt-20 -114.06 133.76 55.32 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.672 -0.811 . . . . 62.43 111.357 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.37 129.74 62.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 109.315 -0.624 . . . . 61.32 109.315 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.9 t -88.18 123.17 32.55 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 122.085 0.945 . . . . 71.01 109.994 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.81 114.61 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 107.506 -1.294 . . . . 73.25 107.506 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.08 -1.082 . . . . 62.1 108.08 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 397' ' ' ASP . 14.8 p -121.41 135.96 59.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.253 0.549 . . . . 75.45 110.558 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 19.9 m -84.63 121.11 27.18 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.663 -0.866 . . . . 73.13 108.663 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -119.87 104.9 10.59 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.657 -0.247 . . . . 73.34 111.449 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.02 145.72 0.12 Allowed Glycine 0 CA--C 1.542 1.729 0 N-CA-C 115.962 1.145 . . . . 65.23 115.962 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 57.9 Cg_endo -82.07 128.47 5.74 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.565 1.51 . . . . 74.1 109.964 172.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 0.1 OUTLIER -73.55 156.9 37.65 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.608 -0.516 . . . . 62.13 109.608 -177.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.4 mt-30 -121.71 157.48 30.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.032 0.444 . . . . 65.44 110.779 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.495 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 22.2 tpt180 -145.59 145.02 30.82 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.857 -0.794 . . . . 62.41 108.857 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.29 138.93 32.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.668 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -84.09 124.76 73.96 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.859 -0.61 . . . . 74.24 110.18 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 74.7 Cg_exo -61.85 141.6 90.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.435 2.09 . . . . 51.51 111.032 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.81 20.41 2.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.334 0.494 . . . . 64.13 112.334 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.418 HG21 ' HG3' ' A' ' 443' ' ' LYS . 23.7 m -84.18 -6.37 10.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.34 -0.391 . . . . 64.14 111.902 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.0 m -51.44 -51.09 57.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.909 0.883 . . . . 65.23 112.435 -177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.3 m -61.12 -27.18 68.2 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.765 0.826 . . . . 74.41 111.716 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.15 -48.32 8.69 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.687 0.279 . . . . 51.52 111.702 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 439' ' ' GLU . 48.0 m -146.47 115.84 7.08 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.814 -0.354 . . . . 51.02 111.083 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -59.23 -44.01 92.34 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.682 -0.69 . . . . 72.45 110.937 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.65 -46.6 83.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 71.33 111.258 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 436' ' ' THR . 36.5 tt0 -68.02 -35.46 78.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.36 -0.382 . . . . 74.24 110.498 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.98 -43.58 95.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.314 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.84 -42.65 95.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.956 -0.565 . . . . 65.34 110.179 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.6 mmtt -66.22 -43.23 87.27 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.159 0.504 . . . . 73.55 110.352 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 39.3 mmtm -62.93 -47.74 81.92 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.521 -0.763 . . . . 74.45 111.246 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.97 -32.7 73.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.597 0.592 . . . . 73.42 112.597 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 52.3 m -67.54 -41.21 84.67 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.611 -0.514 . . . . 74.32 109.611 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.17 -22.83 61.99 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.83 0.824 . . . . 72.42 110.587 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.495 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.85 -8.89 59.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.326 -0.852 . . . . 70.5 110.423 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.13 -20.41 45.37 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.992 -0.549 . . . . 72.0 113.178 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -57.84 127.42 31.99 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.117 0.484 . . . . 75.33 111.874 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -129.12 12.92 6.05 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.389 -0.823 . . . . 53.35 111.208 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -115.75 111.04 19.96 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.332 -0.988 . . . . 75.43 108.332 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -132.93 148.59 52.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.106 0.479 . . . . 75.31 110.756 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -140.53 122.24 15.31 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 105.578 -2.008 . . . . 73.14 105.578 170.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.89 128.83 45.18 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.566 -0.531 . . . . 72.25 109.566 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.0 161.41 26.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.037 -0.727 . . . . 74.52 109.037 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -129.31 129.17 44.51 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.594 -0.891 . . . . 71.42 108.594 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -123.42 137.64 28.81 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 109.555 -0.535 . . . . 64.14 109.555 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.5 Cg_exo -61.87 134.01 47.77 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.303 2.002 . . . . 63.13 110.594 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.1 m -148.15 161.83 40.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.48 -0.563 . . . . 73.13 109.48 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 20.8 m -57.75 142.99 77.43 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 124.335 1.022 . . . . 55.14 108.261 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.613 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.13 -23.27 6.28 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.673 2.916 . . . . 70.2 114.579 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.34 -33.11 74.06 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.709 -0.62 . . . . 74.53 110.305 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.44 -9.86 28.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.818 -0.628 . . . . 72.54 112.482 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 461' ' ' PRO . 8.9 p -60.22 127.25 19.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 119.836 -0.746 . . . . 74.34 110.21 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.99 71.82 Favored Glycine 0 C--N 1.307 -1.043 0 C-N-CA 120.629 -0.796 . . . . 51.44 112.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -107.97 161.74 14.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.658 -0.867 . . . . 75.05 108.658 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 486' ' ' ILE . 98.0 t -83.98 129.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.591 -0.892 . . . . 75.52 108.591 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.08 -13.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.964 -0.695 . . . . 75.14 111.471 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 160.3 12.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.661 -0.699 . . . . 63.11 111.637 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.8 p -119.34 149.39 41.89 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.696 -1.224 . . . . 54.43 107.696 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.498 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.91 -51.46 79.19 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.34 -0.544 . . . . 62.35 110.707 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.2 Cg_exo -82.44 115.81 2.58 Favored 'Trans proline' 0 C--N 1.368 1.595 0 N-CA-C 107.841 -1.638 . . . . 74.43 107.841 169.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 39.5 Cg_endo -67.56 159.51 52.2 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.326 2.017 . . . . 73.52 113.657 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.63 -4.14 35.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.145 0.974 . . . . 35.45 111.706 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -105.34 11.12 33.17 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.259 -0.882 . . . . 74.3 109.072 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.406 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 35.0 tt0 -127.75 156.4 42.5 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.669 0.747 . . . . 60.02 110.7 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 426' ' ' GLN . 14.8 m -102.76 115.7 31.12 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.403 -1.271 . . . . 73.52 107.625 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.4 m -117.68 148.32 42.09 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 110.237 -0.283 . . . . 74.02 110.237 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.51 156.95 38.08 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.386 -0.228 . . . . 35.14 110.386 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.3 -22.78 19.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.57 0.7 . . . . 72.53 110.215 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -87.4 1.98 51.79 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.893 0.854 . . . . 70.44 109.861 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.46 130.17 34.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.478 -1.675 . . . . 70.21 106.478 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.19 113.99 19.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.602 -0.518 . . . . 75.44 109.602 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.37 118.7 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 N-CA-C 108.68 -0.859 . . . . 60.34 108.68 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.403 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.0 mt -94.45 112.89 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 107.176 -1.416 . . . . 73.23 107.176 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.61 115.44 46.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 N-CA-C 107.49 -1.3 . . . . 73.44 107.49 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.6 mt -103.61 119.82 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 115.982 -0.554 . . . . 74.1 110.148 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.16 136.24 29.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.566 -0.902 . . . . 73.33 108.566 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -71.88 113.34 4.51 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.129 -1.188 . . . . 65.25 110.129 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.2 m -131.73 104.89 7.16 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.453 -0.573 . . . . 74.24 109.453 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.096 0 N-CA-C 108.812 -1.715 . . . . 42.45 108.812 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.75 -1.204 . . . . 71.14 107.75 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.54 162.34 38.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.009 0.433 . . . . 74.34 111.664 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -99.23 137.33 37.9 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.233 -1.025 . . . . 52.21 108.233 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.98 133.68 20.22 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 109.343 -0.614 . . . . 63.14 109.343 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 147.03 87.54 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.89 2.394 . . . . 73.31 113.666 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.06 145.4 31.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.653 -0.703 . . . . 72.44 109.175 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.1 t -107.43 31.63 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.602 -1.629 . . . . 43.54 106.602 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.36 134.12 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.388 -1.733 . . . . 75.43 111.149 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.88 -5.19 57.96 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 111.373 -0.691 . . . . 43.24 111.373 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -119.25 -176.94 3.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 120.705 0.288 . . . . 63.22 110.225 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.6 p -72.02 158.7 35.5 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.207 -0.451 . . . . 71.43 111.531 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.5 t -63.1 -33.8 76.23 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.372 -0.603 . . . . 72.52 109.372 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.23 90.36 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.535 0.522 . . . . 72.22 110.356 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 116.332 -0.394 . . . . 73.02 110.648 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.65 -51.4 69.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.577 -0.738 . . . . 60.2 111.035 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.95 -43.18 97.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.433 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.64 98.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 52.21 112.349 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 58.7 m -64.03 -47.34 80.6 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.355 0.598 . . . . 73.23 110.264 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.4 mm? -64.34 -38.45 91.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 72.43 110.768 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -62.2 -45.95 91.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.653 -0.703 . . . . 64.01 110.072 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -66.22 -30.71 71.21 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.187 -0.461 . . . . 71.31 111.389 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.7 mmt-85 -78.95 -13.83 59.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.479 . . . . 75.21 111.012 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.9 13.5 56.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.889 -0.672 . . . . 74.3 113.228 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.427 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 59.4 m-85 -85.33 166.24 16.62 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.487 0.66 . . . . 75.3 111.755 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 55.8 mtmt -109.02 132.61 53.94 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.605 -1.257 . . . . 74.11 107.605 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.76 146.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.462 0.649 . . . . 71.15 112.651 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -109.5 127.73 54.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.887 -1.894 . . . . 65.32 105.887 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.4 m -107.34 117.65 34.64 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 106.663 -1.606 . . . . 73.33 106.663 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.23 118.52 36.15 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.116 -1.809 . . . . 60.21 106.116 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 13.8 pm0 -113.03 128.0 56.38 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 109.164 -0.68 . . . . 75.33 109.164 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.21 138.71 33.48 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.938 -0.574 . . . . 63.44 110.364 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -82.63 146.04 13.27 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.92 1.746 . . . . 64.23 108.716 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.8 t0 -179.62 -175.0 0.32 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.349 -1.722 . . . . 71.21 106.349 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 51.4 m -135.11 0.26 2.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.158 0.504 . . . . 71.13 110.441 174.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 -14.95 49.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.221 -1.399 . . . . 61.22 107.221 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 421' ' ' SER . 14.2 pt -91.86 145.47 31.1 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.086 -1.416 . . . . 73.33 111.189 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.41 -172.88 1.47 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 123.18 2.587 . . . . 53.11 108.838 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.58 161.7 7.36 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.35 2.033 . . . . 63.0 112.608 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.2 p-10 -57.03 -8.12 0.6 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 125.228 1.411 . . . . 73.33 114.463 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -71.66 122.36 20.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.577 -1.268 . . . . 72.04 107.577 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.04 118.42 7.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 123.589 0.756 . . . . 73.13 111.645 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.567 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -96.4 -28.83 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.857 -0.61 . . . . 74.12 111.031 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.47 157.73 27.48 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 110.76 -0.936 . . . . 63.35 110.76 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.3 p -126.98 -177.88 4.2 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 123.283 0.633 . . . . 74.22 110.268 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.69 136.15 19.63 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.537 -1.653 . . . . 75.03 106.537 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.72 -16.67 2.48 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.406 3.404 . . . . 71.41 115.282 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.83 32.93 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 123.622 0.769 . . . . 74.2 111.854 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.44 -44.49 82.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.125 0.488 . . . . 71.43 111.034 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -86.09 -2.32 58.21 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.19 0.519 . . . . 73.04 111.662 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 67.1 m -81.55 146.79 29.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.846 -1.538 . . . . 61.35 106.846 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.2 m -74.66 112.74 11.17 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.168 -1.049 . . . . 72.54 108.168 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.23 166.81 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.519 -0.764 . . . . 71.14 111.064 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.2 t -74.51 144.66 44.01 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.108 -1.071 . . . . 33.12 108.108 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.43 114.67 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 71.31 110.521 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.34 40.68 4.16 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.668 -0.777 . . . . 35.04 111.767 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -93.2 -177.38 4.44 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.607 -1.257 . . . . 74.04 107.607 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 41.2 mt-10 -107.19 119.9 40.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.207 0.527 . . . . 65.15 111.957 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.21 130.59 61.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.538 -0.912 . . . . 71.32 108.538 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.4 t -95.05 130.76 41.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.355 0.598 . . . . 70.22 110.015 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.39 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.711 -0.848 . . . . 73.33 108.711 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -91.33 128.82 37.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.059 0.457 . . . . 74.44 110.489 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 397' ' ' ASP . 46.8 t -125.16 138.59 53.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.229 -0.896 . . . . 61.22 109.428 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.481 ' HB3' HD12 ' A' ' 394' ' ' ILE . 16.0 m -89.08 121.47 31.44 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.449 -0.575 . . . . 60.02 109.449 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.2 t -120.83 104.82 10.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 119.144 -1.022 . . . . 71.5 111.005 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 64.19 172.23 2.61 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.907 0.723 . . . . 63.42 114.907 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 72.9 Cg_endo -97.18 155.09 1.06 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 122.73 2.287 . . . . 62.42 113.322 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 4.5 mm-40 -84.87 141.37 30.48 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.78 -0.645 . . . . 70.34 110.247 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -117.26 147.37 42.6 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.458 -0.942 . . . . 73.31 108.458 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.29 155.39 39.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.561 -1.274 . . . . 64.23 107.561 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -88.81 138.16 31.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.79 -0.448 . . . . 74.25 109.79 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -83.09 129.14 62.34 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.385 -0.968 . . . . 75.25 108.385 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.55 140.51 89.83 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.362 2.041 . . . . 51.41 112.356 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.03 -5.73 56.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.558 0.694 . . . . 73.24 110.18 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.36 -7.57 10.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.986 -1.006 . . . . 61.44 110.936 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 20.7 m -56.48 -41.76 77.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.304 -0.862 . . . . 64.45 111.228 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -61.74 -23.13 65.95 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.23 1.012 . . . . 64.34 111.77 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.12 -35.79 15.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.512 . . . . 74.23 111.888 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 439' ' ' GLU . 50.4 m -148.68 119.48 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.08 -0.387 . . . . 53.24 110.849 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -58.13 -51.17 70.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.639 0.776 . . . . 73.33 111.77 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.98 -43.6 98.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 64.12 111.605 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 436' ' ' THR . 35.3 tt0 -65.67 -35.28 80.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.666 -0.697 . . . . 73.43 110.166 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.03 -51.39 69.83 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 123.775 0.672 . . . . 55.03 109.627 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.0 t -58.89 -44.12 90.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 50.32 110.48 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 73.5 mmtt -66.21 -46.64 76.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 52.24 111.762 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 33.1 mmtp -66.0 -37.95 87.23 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.876 0.324 . . . . 52.2 111.876 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 440' ' ' ALA . 10.4 mp -65.21 -40.48 94.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.932 0.145 . . . . 74.44 111.286 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.2 m -61.25 -47.06 87.8 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.33 -0.619 . . . . 64.13 109.33 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.12 -24.96 65.98 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.851 -0.613 . . . . 70.3 111.696 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.2 -8.86 59.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 65.21 111.354 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.28 48.7 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.639 -0.791 . . . . 42.2 113.187 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.25 99.34 6.23 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.266 -0.549 . . . . 73.44 109.687 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.43 23.1 27.45 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.238 -0.745 . . . . 73.22 111.238 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -118.58 111.72 18.95 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.671 -1.233 . . . . 72.14 107.671 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -131.31 144.1 51.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.012 0.91 . . . . 72.51 113.06 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 18.4 tptm -140.3 123.4 16.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.548 -1.66 . . . . 64.43 106.525 170.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -95.99 135.16 38.13 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.555 -0.535 . . . . 74.51 109.555 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.0 153.02 51.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.025 -0.732 . . . . 73.45 109.025 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -121.8 129.37 52.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.886 0.374 . . . . 74.01 110.481 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.2 t -117.2 142.46 30.14 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 107.869 -1.16 . . . . 62.33 107.869 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.98 126.96 19.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.266 1.977 . . . . 71.41 109.968 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.6 t -137.96 -178.21 5.16 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.749 -0.834 . . . . 60.23 108.749 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.462 ' HB ' HD13 ' A' ' 463' ' ' LEU . 21.0 m -63.94 138.02 97.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.41 -1.33 . . . . 75.34 107.41 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.47 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.81 -29.31 33.82 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.629 2.886 . . . . 71.42 113.965 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -76.23 -19.06 58.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.921 0.711 . . . . 63.44 112.921 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 460' ' ' THR . 10.4 mp -95.17 4.62 53.4 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.808 0.299 . . . . 65.24 111.808 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -60.15 126.35 17.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-O 121.335 0.588 . . . . 73.11 110.54 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.11 -0.16 66.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.748 -0.66 . . . . 54.31 112.09 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.57 152.29 24.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.985 -1.117 . . . . 73.35 107.985 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 486' ' ' ILE . 56.4 t -84.07 141.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.06 -0.718 . . . . 72.12 109.06 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.22 -14.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.127 -0.629 . . . . 55.12 111.456 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.08 168.28 20.91 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.733 -0.947 . . . . 63.14 110.733 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.0 p -116.95 159.3 22.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -63.52 -54.69 41.27 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 119.96 -0.696 . . . . 62.41 111.132 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 18.3 Cg_exo -72.87 112.98 3.64 Favored 'Trans proline' 0 C--N 1.373 1.834 0 N-CA-C 107.465 -1.783 . . . . 71.12 107.465 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 49.5 Cg_endo -65.65 149.03 87.62 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.917 2.412 . . . . 72.42 114.938 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.8 -0.88 28.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 70.33 110.03 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -104.41 7.33 35.52 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.439 -1.255 . . . . 75.43 110.252 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 34.9 tt0 -159.01 165.48 33.92 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.906 -0.717 . . . . 65.53 109.593 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.2 m -92.52 126.4 37.59 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.633 -0.877 . . . . 71.43 108.633 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.9 m -125.96 148.85 49.15 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.939 -0.393 . . . . 75.32 109.939 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.9 148.19 50.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.632 0.253 . . . . 75.52 111.636 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.4 mm -66.41 -12.58 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.442 0 C-N-CA 124.388 1.075 . . . . 62.01 110.818 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.3 t -87.91 5.0 42.64 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.868 0.842 . . . . 75.41 110.328 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -90.96 135.43 33.74 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.382 -0.599 . . . . 72.53 109.382 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.69 122.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.964 -1.495 . . . . 64.14 106.964 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.23 118.59 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 C-N-CA 119.618 -0.833 . . . . 61.42 108.882 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 63.8 mt -92.93 112.24 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 105.935 -1.876 . . . . 75.32 105.935 174.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -94.4 109.13 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 106.688 -1.597 . . . . 73.34 106.688 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.0 mt -97.2 116.9 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 115.513 -0.767 . . . . 65.33 109.867 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 t -97.52 141.04 16.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.961 -1.125 . . . . 62.44 107.961 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -91.31 127.11 8.72 Favored Glycine 0 N--CA 1.407 -3.276 0 N-CA-C 109.849 -1.3 . . . . 71.43 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.7 m -136.39 128.83 30.28 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.348 -0.612 . . . . 72.41 109.348 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.287 0 N-CA-C 108.569 -1.812 . . . . 64.41 108.569 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 CA--C 1.492 -1.272 0 N-CA-C 107.706 -1.22 . . . . 73.3 107.706 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.14 149.72 20.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.803 -0.443 . . . . 72.03 109.803 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.298 -1.371 . . . . 63.54 107.298 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 406' ' ' ALA . 3.6 p -97.82 118.66 63.71 Favored Pre-proline 0 C--N 1.282 -2.351 0 N-CA-C 108.637 -0.875 . . . . 71.15 108.637 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.7 160.68 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.77 2.313 . . . . 75.32 113.823 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 366' ' ' ARG . 14.6 p-10 -72.33 119.58 16.74 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.243 -0.89 . . . . 44.31 109.976 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.64 35.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 125.564 1.546 . . . . 72.53 110.728 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 364' ' ' ASP . 15.0 ptt180 -63.87 144.55 56.98 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.622 -1.627 . . . . 72.33 112.859 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.56 0.74 59.2 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.724 -0.75 . . . . 41.03 114.685 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.49 171.69 12.73 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.375 1.088 . . . . 73.34 110.995 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -71.59 156.77 39.02 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.261 -0.427 . . . . 45.32 110.547 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 374' ' ' ILE . 8.4 p -59.78 -37.12 78.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.945 0.403 . . . . 72.4 110.574 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.0 91.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.993 -0.548 . . . . 62.24 111.335 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.67 -41.88 74.92 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.487 -0.485 . . . . 74.33 110.406 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.99 -51.32 69.7 Favored 'General case' 0 C--O 1.239 0.532 0 O-C-N 123.809 0.693 . . . . 72.41 111.94 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -60.64 -46.07 96.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.281 -0.418 . . . . 72.04 110.951 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.36 87.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.035 0.383 . . . . 73.21 112.035 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 79.1 m -60.83 -45.56 93.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.742 0.306 . . . . 53.43 111.197 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.62 -38.13 89.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.363 -0.38 . . . . 72.4 110.688 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -60.13 -46.15 90.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.125 0.97 . . . . 74.52 110.485 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -70.36 -18.66 63.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.757 -0.656 . . . . 71.24 111.263 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 380' ' ' ARG . 25.1 mmt180 -88.49 -8.26 55.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.972 -0.558 . . . . 74.14 111.13 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.2 56.15 Favored Glycine 0 CA--C 1.504 -0.655 0 C-N-CA 120.986 -0.626 . . . . 61.35 113.353 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -80.83 150.27 29.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.226 0.536 . . . . 71.31 110.41 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -100.06 144.74 28.74 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.066 -1.457 . . . . 73.22 107.066 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -135.67 139.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-O 121.152 0.501 . . . . 74.12 111.498 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -116.19 127.75 55.04 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 62.33 107.246 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.7 m -104.7 123.75 48.17 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.265 -0.574 . . . . 63.55 110.086 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.53 119.71 39.67 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.55 -0.907 . . . . 62.44 108.55 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -104.41 127.52 52.11 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.913 -0.585 . . . . 64.54 109.635 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -134.97 139.59 32.55 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 111.773 0.286 . . . . 64.45 111.773 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 60.3 Cg_endo -89.19 145.23 5.13 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.424 2.082 . . . . 73.25 110.215 170.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.9 t70 -171.09 -176.64 1.99 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.502 -0.925 . . . . 73.11 108.502 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.544 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 3.5 m -98.65 -39.61 8.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.743 -1.577 . . . . 74.55 106.743 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -101.86 73.47 1.41 Allowed 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.406 -1.331 . . . . 72.01 107.406 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 14.5 pt -93.83 127.45 45.47 Favored Pre-proline 0 N--CA 1.419 -1.978 0 CA-C-N 113.016 -1.902 . . . . 73.25 111.593 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -69.86 124.33 10.93 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 N-CA-C 106.105 -2.306 . . . . 75.42 106.105 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.23 159.98 11.69 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.049 2.499 . . . . 75.11 113.749 -173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.9 -8.81 3.4 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.375 1.07 . . . . 74.33 111.696 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -103.82 106.86 17.49 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.073 -2.195 . . . . 72.32 105.073 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.0 m -62.63 119.72 7.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 O-C-N 124.585 1.178 . . . . 71.33 113.378 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.59 -28.22 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 113.865 -1.516 . . . . 63.42 109.89 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.47 170.4 32.88 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 110.598 -1.001 . . . . 23.41 110.598 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 403' ' ' ASP . 5.9 m -120.02 -178.21 3.6 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.389 -2.078 . . . . 54.42 105.389 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.492 ' H ' HG22 ' A' ' 402' ' ' THR . 26.9 t70 -100.02 141.14 22.21 Favored Pre-proline 0 C--N 1.266 -3.024 0 N-CA-C 108.995 -0.742 . . . . 75.23 108.995 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -41.98 -26.32 0.47 Allowed 'Trans proline' 0 C--N 1.371 1.731 1 C-N-CA 125.555 4.17 . . . . 75.11 115.248 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.55 62.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.981 0.512 . . . . 74.05 110.683 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 362' ' ' VAL . . . -77.06 -44.47 30.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.678 -0.692 . . . . 61.41 110.856 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -75.41 -7.62 54.54 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.69 -0.686 . . . . 72.23 111.936 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.3 m -85.17 146.02 27.32 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.421 -0.955 . . . . 73.54 108.421 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.4 p -73.49 113.87 11.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 109.795 -0.446 . . . . 73.51 109.795 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 168.84 20.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.525 -0.546 . . . . 73.33 109.525 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.8 m -72.84 133.25 44.37 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.369 -0.974 . . . . 71.12 108.369 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -55.86 135.78 51.81 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 112.442 0.534 . . . . 53.12 112.442 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.86 47.04 4.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.082 -0.963 . . . . 62.51 111.094 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -108.68 178.88 4.35 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.981 -1.118 . . . . 75.41 107.981 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.79 122.13 40.53 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.801 0.44 . . . . 52.12 111.388 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -111.18 128.88 67.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.723 -0.843 . . . . 61.44 108.723 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -87.39 128.0 35.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.138 -0.69 . . . . 53.33 109.138 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.21 128.85 73.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.532 -0.914 . . . . 75.11 108.532 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -100.96 128.34 47.03 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.395 -0.366 . . . . 72.21 110.694 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.28 146.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.558 -1.275 . . . . 73.54 107.558 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 8.8 p -98.93 123.29 43.11 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.059 -0.657 . . . . 45.45 112.531 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -118.28 105.32 11.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.888 -0.596 . . . . 75.35 110.145 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 72.94 161.2 6.01 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 121.898 0.721 . . . . 24.24 114.497 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.0 Cg_endo -92.33 157.62 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.496 2.13 . . . . 75.01 110.871 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.8 131.63 42.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 120.092 -0.643 . . . . 52.03 110.219 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -121.08 138.96 53.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.681 -0.69 . . . . 74.14 109.611 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.1 OUTLIER -131.8 150.19 52.23 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 108.566 -0.902 . . . . 64.44 108.566 -175.126 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.7 OUTLIER -85.98 131.65 34.23 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.064 -1.087 . . . . 72.23 108.064 176.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.08 125.23 82.11 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.37 141.25 73.86 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.255 1.97 . . . . 62.45 110.951 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.5 -5.26 59.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.466 0.651 . . . . 61.41 110.199 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.47 -1.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 74.42 111.165 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.2 p -65.6 -41.53 92.66 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.921 0.867 . . . . 71.25 109.708 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.4 m -65.84 -13.24 59.18 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 125.271 1.429 . . . . 71.22 111.213 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.18 -35.75 17.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.315 0.487 . . . . 64.24 112.315 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.0 m -157.94 125.21 5.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.909 -0.494 . . . . 44.45 110.522 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -57.58 -48.79 78.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.437 0.532 . . . . 73.02 112.437 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.0 76.71 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.439 -0.346 . . . . 45.23 111.888 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.88 -34.7 71.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.962 -0.563 . . . . 53.01 111.176 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.18 -47.01 86.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.477 -0.329 . . . . 75.2 110.459 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.28 -42.33 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.822 -0.627 . . . . 74.02 109.935 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -61.62 -47.59 84.75 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 111.922 0.342 . . . . 64.44 111.922 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.55 -45.54 92.46 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.55 0.34 . . . . 64.33 111.54 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.28 -40.79 81.7 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.469 -0.492 . . . . 45.1 112.175 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.2 m -63.82 -39.33 93.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.956 0.407 . . . . 61.44 110.402 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.65 -25.96 65.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 54.54 110.946 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -86.88 -8.59 57.14 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.857 -0.61 . . . . 70.44 110.938 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.3 -15.98 13.01 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.558 -0.829 . . . . 34.54 114.08 176.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.36 113.15 3.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.995 0.898 . . . . 74.54 111.54 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.86 -12.57 11.17 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.823 -0.703 . . . . 42.34 111.422 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -91.06 111.19 22.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.1 -0.704 . . . . 75.23 109.1 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -136.07 154.49 51.01 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.54 0.685 . . . . 52.22 111.864 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -137.03 122.3 19.3 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 104.841 -2.281 . . . . 63.31 104.841 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -113.57 127.89 56.24 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.023 0.439 . . . . 72.42 110.625 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.06 165.29 27.96 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.701 -0.682 . . . . 63.33 110.034 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.96 141.15 47.12 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.771 -1.196 . . . . 63.21 107.771 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.6 t -116.93 129.57 25.22 Favored Pre-proline 0 N--CA 1.407 -2.607 0 N-CA-C 107.008 -1.479 . . . . 74.41 107.008 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.55 119.97 7.15 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 122.227 1.952 . . . . 61.01 109.791 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 2.9 p -148.24 -178.35 6.26 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 115.045 -0.98 . . . . 64.24 108.84 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.3 m -61.32 128.72 90.14 Favored Pre-proline 0 C--N 1.291 -1.941 0 N-CA-C 108.48 -0.933 . . . . 75.11 108.48 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.68 -22.94 10.29 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.646 2.898 . . . . 65.21 112.899 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.11 -30.17 69.09 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.34 0.656 . . . . 72.1 110.918 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.63 5.16 44.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.427 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.5 p -59.58 132.26 24.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 CA-C-O 121.15 0.5 . . . . 43.31 111.247 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.81 -10.79 73.82 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.689 -0.767 . . . . 41.31 112.748 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.67 147.01 30.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.38 -0.6 . . . . 73.43 109.38 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -83.86 135.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.125 -1.065 . . . . 61.22 108.125 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.97 -16.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.516 -0.874 . . . . 71.24 111.542 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.37 167.28 32.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.641 -0.79 . . . . 74.4 111.693 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.2 p -131.78 145.62 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.309 -0.996 . . . . 74.02 108.309 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -58.97 -53.8 62.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 120.337 -0.545 . . . . 75.53 110.532 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -70.84 118.39 5.67 Favored 'Trans proline' 0 C--N 1.376 2.011 0 N-CA-C 107.338 -1.831 . . . . 71.43 107.338 169.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.12 151.93 30.8 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.028 1.819 . . . . 75.15 113.685 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -68.74 -0.93 5.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.005 -0.998 . . . . 70.15 112.244 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -107.81 -3.02 19.43 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.497 -0.32 . . . . 75.14 110.69 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -118.19 157.0 27.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.442 0.639 . . . . 71.51 110.601 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 10.3 m -102.69 97.75 7.88 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 61.34 107.404 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 40.4 m -100.88 147.99 25.48 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.986 -0.552 . . . . 73.21 110.082 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.77 148.22 51.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.107 -0.497 . . . . 61.22 110.861 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 33.0 mm -69.81 -5.04 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 122.464 1.126 . . . . 73.21 109.996 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.4 p -87.49 0.9 54.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.598 0.714 . . . . 60.12 109.736 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -93.07 139.42 30.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.425 -0.807 . . . . 74.22 109.08 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.93 123.42 36.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.911 -1.144 . . . . 75.21 107.911 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.36 118.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 108.679 -0.86 . . . . 73.51 108.679 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.4 113.65 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.204 -1.776 . . . . 73.2 106.204 175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -112.43 114.64 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 N-CA-C 108.297 -1.001 . . . . 72.24 108.297 -176.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -106.9 123.07 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.358 -0.837 . . . . 53.22 111.214 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.36 144.0 11.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.75 -1.114 . . . . 74.04 108.486 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.58 113.42 4.61 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 108.904 -1.678 . . . . 70.3 108.904 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.9 m -139.63 113.11 8.4 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 109.178 -0.675 . . . . 65.41 109.178 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.417 -2.633 0 N-CA-C 108.499 -1.84 . . . . 62.0 108.499 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 106.594 -1.632 . . . . 72.4 106.594 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.51 154.25 23.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 110.177 -0.305 . . . . 74.45 110.177 -175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -98.97 132.12 44.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.805 -1.183 . . . . 65.32 107.805 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.1 118.33 61.67 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.832 -0.747 . . . . 72.33 111.461 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.89 143.08 71.78 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.439 2.093 . . . . 64.01 112.189 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.623 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 4.0 p30 -82.68 177.9 8.46 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.225 -0.898 . . . . 73.21 111.239 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.67 29.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.478 -1.237 . . . . 74.42 108.537 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.623 ' HG3' ' OD1' ' A' ' 364' ' ' ASP 0.264 0.1 OUTLIER -64.15 146.74 53.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.438 0.903 . . . . 73.45 113.438 -174.049 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.2 0.2 41.04 Favored Glycine 0 C--N 1.308 -0.989 0 N-CA-C 110.368 -1.093 . . . . 54.41 110.368 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -116.44 -170.68 1.86 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.899 -0.778 . . . . 72.44 108.899 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.0 p -69.91 150.99 46.17 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.471 0.309 . . . . 63.32 111.132 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 374' ' ' ILE . 38.1 t -57.98 -36.15 72.19 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.443 -0.947 . . . . 61.53 108.443 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.3 94.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.308 -0.86 . . . . 75.01 112.237 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.88 -40.24 91.43 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.75 0.309 . . . . 75.31 110.199 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.18 88.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 72.32 110.637 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 370' ' ' SER . 76.5 mt -62.59 -46.39 96.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.68 -0.691 . . . . 70.05 110.202 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.34 79.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.997 -0.547 . . . . 51.14 112.087 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 85.5 m -60.73 -47.83 84.54 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.659 -0.246 . . . . 70.52 111.128 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.52 -38.04 89.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.71 0.263 . . . . 64.14 111.71 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -61.21 -41.98 97.8 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 109.414 -0.587 . . . . 72.0 109.414 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -69.82 -22.93 63.26 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.473 -0.785 . . . . 74.14 112.107 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.2 mmt180 -84.96 -14.27 48.1 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.504 -0.554 . . . . 72.32 109.504 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.84 56.68 Favored Glycine 0 C--O 1.239 0.421 0 C-N-CA 120.895 -0.669 . . . . 53.52 112.201 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.33 149.26 25.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.966 -0.383 . . . . 74.53 109.966 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -100.18 132.35 45.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.782 -0.822 . . . . 74.04 108.782 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -121.88 137.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 113.232 0.827 . . . . 61.23 113.232 -174.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -110.56 127.87 55.4 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 107.309 -1.367 . . . . 71.22 107.309 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.0 m -99.33 121.82 41.62 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.136 -1.061 . . . . 51.53 108.136 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -111.49 119.5 38.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.251 -1.388 . . . . 73.14 107.251 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 11.0 pm0 -109.46 128.69 55.34 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 109.431 -0.581 . . . . 71.11 109.431 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -133.04 146.25 60.42 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.904 -0.406 . . . . 73.24 109.904 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -93.08 128.87 0.74 Allowed 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.221 1.947 . . . . 74.45 109.81 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.0 t70 -173.14 -175.12 1.14 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.732 -1.21 . . . . 70.04 107.732 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.8 m -130.63 -0.68 4.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.753 0.787 . . . . 54.14 109.975 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -91.11 -0.63 57.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.881 1.324 . . . . 71.41 107.473 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.481 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.63 151.75 48.33 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.076 -1.42 . . . . 70.31 112.641 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.16 178.32 6.44 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.425 2.084 . . . . 73.45 109.698 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.96 158.13 18.24 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 121.923 1.749 . . . . 74.11 111.786 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.81 -7.21 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.842 0.829 . . . . 70.41 113.119 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -86.83 122.66 31.01 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.216 -2.513 . . . . 51.23 104.216 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 118.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.626 0.727 . . . . 75.11 111.811 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.8 mm -97.87 -28.37 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.533 -0.758 . . . . 72.41 111.004 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.94 157.99 27.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.039 -1.077 . . . . 52.4 111.794 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.8 p -114.16 -177.53 3.15 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 123.577 0.751 . . . . 72.33 111.123 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.06 143.73 27.04 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.11 107.705 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -40.25 -32.63 0.72 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 124.807 3.672 . . . . 74.1 114.715 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.09 -30.01 61.41 Favored 'General case' 0 C--O 1.208 -1.103 0 O-C-N 123.437 0.46 . . . . 72.42 111.608 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.72 -35.56 75.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.109 0.48 . . . . 73.04 111.021 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -95.66 -0.85 51.2 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.944 0.402 . . . . 72.53 111.939 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -98.29 155.94 16.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.322 -1.362 . . . . 71.15 107.322 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 11.3 p -74.31 112.7 10.73 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.723 -0.843 . . . . 73.33 108.723 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.51 169.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.439 -0.578 . . . . 73.31 109.439 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 20.3 m -69.65 146.9 51.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.298 -0.631 . . . . 63.44 109.298 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.81 108.17 2.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.821 -1.177 . . . . 53.41 107.821 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.61 59.68 1.26 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.444 -1.462 . . . . 71.21 109.444 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.3 t0 -109.94 -173.51 2.27 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.039 -1.097 . . . . 74.23 108.039 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -93.62 121.96 35.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.815 0.846 . . . . 74.23 110.079 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.8 mm -124.23 137.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.112 -1.44 . . . . 63.43 107.112 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.1 t -113.2 131.25 55.95 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 61.22 110.833 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 76.4 t -102.18 128.28 54.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.112 -0.949 . . . . 71.23 108.748 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -99.0 129.83 45.3 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.131 -0.486 . . . . 41.11 110.044 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 9.0 p -136.16 136.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.271 0.558 . . . . 64.34 109.705 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.481 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 8.2 m -89.59 123.75 33.94 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.942 -0.572 . . . . 42.32 110.982 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -119.18 105.83 11.76 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.193 -0.603 . . . . 60.11 110.015 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.08 129.32 0.5 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 120.649 -0.786 . . . . 71.32 114.792 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 17.0 Cg_exo -70.75 157.92 57.11 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.685 2.257 . . . . 75.43 110.582 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.01 155.52 19.78 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.974 0.416 . . . . 73.44 110.361 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.7 mt-30 -127.84 138.78 52.82 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.827 -0.805 . . . . 63.43 108.827 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -135.52 157.68 46.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.093 -0.706 . . . . 73.22 109.093 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.64 139.35 32.86 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.653 -0.499 . . . . 75.53 109.653 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -80.47 127.34 76.21 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 108.66 -0.866 . . . . 64.53 108.66 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.53 141.57 62.3 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.842 2.361 . . . . 72.41 111.805 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.76 -15.5 48.28 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.511 0.672 . . . . 63.13 111.785 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.3 -10.55 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 121.399 0.619 . . . . 64.41 110.824 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.1 m -55.73 -45.4 77.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.583 0.753 . . . . 65.15 112.533 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.5 p -69.84 -15.67 63.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.345 0.593 . . . . 62.14 112.562 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.01 -37.99 13.92 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.215 -0.448 . . . . 64.2 111.003 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.9 m -146.98 122.22 10.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.062 0.458 . . . . 53.4 111.043 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -60.59 -42.27 96.38 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.789 0.835 . . . . 64.13 112.276 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.94 78.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.489 . . . . 73.42 110.822 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.75 -39.8 73.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.06 -0.518 . . . . 75.31 110.96 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.61 68.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.854 -0.612 . . . . 64.42 111.031 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.52 -43.83 90.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.785 0.661 . . . . 63.53 112.785 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.34 -48.53 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.801 -0.36 . . . . 71.3 111.774 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.84 -40.18 87.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 113.897 1.073 . . . . 74.55 113.897 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.39 -43.17 77.87 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.977 -0.689 . . . . 72.32 112.215 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.7 m -61.6 -43.98 97.85 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.024 0.44 . . . . 72.4 110.364 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.09 -25.1 62.47 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.795 -0.639 . . . . 60.13 111.765 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -12.69 59.77 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.172 0.51 . . . . 61.53 110.631 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.62 -19.01 8.58 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.337 -0.935 . . . . 35.41 112.791 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.2 103.82 1.67 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.008 -0.738 . . . . 54.14 109.008 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.68 11.59 18.48 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 111.029 -0.829 . . . . 75.34 111.029 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -108.87 111.05 22.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 106.68 -1.6 . . . . 72.3 106.68 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.98 155.82 49.68 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.268 0.556 . . . . 62.31 111.425 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 122.3 20.33 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 102.843 -3.021 . . . . 72.43 102.843 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -93.91 135.14 35.55 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.867 -0.42 . . . . 74.4 109.867 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 141.09 37.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.161 0.505 . . . . 72.51 110.741 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -118.96 129.36 55.12 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.058 -1.46 . . . . 75.23 107.058 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -125.36 145.35 50.62 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.448 -0.575 . . . . 74.45 109.448 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 491' ' ' GLY . 13.4 Cg_exo -68.54 126.77 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.773 1.649 . . . . 51.44 110.378 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.6 m -135.71 172.92 12.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.984 -0.747 . . . . 75.15 108.984 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 463' ' ' LEU . 25.6 m -62.81 140.09 97.26 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.402 -0.962 . . . . 74.52 108.402 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -49.32 -31.24 22.19 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.792 2.995 . . . . 62.33 113.782 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.69 -21.88 64.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.236 0.541 . . . . 64.13 111.434 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.2 mm? -105.72 -8.52 17.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.937 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 76.3 t -60.09 127.21 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 120.977 0.417 . . . . 61.05 110.641 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.54 59.08 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.881 -0.888 . . . . 71.33 110.881 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.22 162.42 13.21 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.663 -0.865 . . . . 72.22 108.663 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 93.1 t -83.83 128.59 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.773 -1.566 . . . . 75.33 106.773 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.42 -16.87 7.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.381 -0.928 . . . . 74.34 111.526 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.11 159.0 16.13 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 111.113 -0.795 . . . . 62.43 111.113 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.4 p -119.94 154.29 34.68 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.425 -1.694 . . . . 74.42 106.425 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 7.2 t30 -64.19 -49.94 70.72 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 119.43 -0.908 . . . . 72.21 110.349 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.4 Cg_exo -78.2 115.9 3.81 Favored 'Trans proline' 0 C--N 1.371 1.731 0 N-CA-C 108.051 -1.557 . . . . 65.52 108.051 168.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.54 149.93 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.077 1.852 . . . . 72.44 112.488 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.04 4.24 4.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.445 0.641 . . . . 63.25 112.596 -176.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -108.35 2.15 22.32 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.994 -0.548 . . . . 62.22 110.67 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -117.65 155.42 29.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.752 0.787 . . . . 64.43 111.556 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 17.4 m -95.62 111.83 23.68 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.987 -1.486 . . . . 64.32 106.987 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.6 m -115.14 149.25 37.92 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.731 -0.47 . . . . 72.43 109.731 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -62.29 150.84 38.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.156 0.503 . . . . 55.34 111.226 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.26 -26.51 27.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.035 0.921 . . . . 73.02 109.353 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 m -89.87 5.14 47.57 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.967 -1.015 . . . . 34.1 110.117 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 43.7 t-20 -83.62 135.3 34.66 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 107.609 -1.256 . . . . 64.24 107.609 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 58.8 t -79.01 114.5 19.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.249 -0.649 . . . . 73.24 109.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.77 119.52 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.082 -0.71 . . . . 72.32 109.082 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 3.0 mp -92.23 114.25 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.357 -1.72 . . . . 75.31 106.357 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.29 118.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.676 -1.231 . . . . 74.51 107.676 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.1 mt -110.32 117.33 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.587 0.708 . . . . 74.45 110.27 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.23 138.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.581 -0.736 . . . . 73.34 109.122 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.09 107.76 3.2 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.975 -0.85 . . . . 74.41 110.975 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.478 ' HA ' HG13 ' A' ' 464' ' ' VAL . 36.6 m -143.37 113.94 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.105 -0.702 . . . . 72.21 109.105 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 458' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.311 0 N-CA-C 110.183 -1.167 . . . . 74.11 110.183 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 105.486 -2.042 . . . . 73.01 105.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.86 164.2 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 120.88 0.372 . . . . 74.04 111.13 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -94.29 137.14 33.8 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.8 -1.926 . . . . 75.32 105.8 173.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.57 139.72 21.55 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 108.294 -1.002 . . . . 63.51 108.294 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -37.99 135.79 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.8 3.0 . . . . 63.41 113.835 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.78 88.96 1.33 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.791 -1.188 . . . . 71.4 107.791 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.42 -0.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 116.888 2.181 . . . . 55.12 116.888 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 145.25 56.5 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.032 -0.667 . . . . 74.13 112.231 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 0.48 45.29 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.802 -0.919 . . . . 42.34 110.802 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -117.3 172.51 7.26 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.608 -1.627 . . . . 71.21 106.608 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 91.0 p -81.3 153.67 26.95 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 118.482 -1.287 . . . . 62.31 107.865 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.5 m -56.65 -40.47 75.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.535 0.207 . . . . 74.14 110.897 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.67 -36.99 79.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.015 0.436 . . . . 71.31 111.395 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -67.5 -36.69 81.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.537 0.684 . . . . 72.33 109.508 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.44 90.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.495 -0.775 . . . . 65.33 110.134 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 370' ' ' SER . 70.5 mt -57.72 -46.42 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.696 0.398 . . . . 71.21 110.134 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.69 91.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.932 -0.576 . . . . 72.23 110.684 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.7 m -64.73 -47.59 77.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.412 -0.358 . . . . 71.45 111.095 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.29 -38.79 91.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 111.655 0.243 . . . . 44.35 111.655 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -60.11 -48.88 79.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.254 -0.647 . . . . 70.02 109.254 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -72.07 -16.47 62.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.2 -0.909 . . . . 72.5 111.935 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.91 -15.07 49.37 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.034 -1.098 . . . . 63.41 108.034 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.4 5.6 61.78 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.59 -0.732 . . . . 33.35 111.786 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 26.2 m-85 -91.83 158.95 16.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.198 0.523 . . . . 61.23 111.745 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 75.1 mmtt -95.62 146.31 24.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.052 -1.092 . . . . 73.44 108.052 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.72 144.04 38.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 121.209 0.528 . . . . 74.21 111.56 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -110.46 139.92 45.22 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.019 -2.215 . . . . 71.2 105.019 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -112.68 121.0 43.47 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 119.174 -1.01 . . . . 55.34 110.015 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.64 119.27 38.11 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.572 -1.64 . . . . 73.53 106.572 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.465 ' HB2' HG22 ' A' ' 422' ' ' THR . 14.3 pm0 -107.04 122.37 46.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.927 -0.768 . . . . 75.35 108.927 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.445 ' HE3' ' OD1' ' A' ' 419' ' ' ASN . 17.6 ptpt -121.15 116.97 30.87 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 113.12 0.785 . . . . 74.44 113.12 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.3 Cg_exo -83.53 140.24 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.445 2.097 . . . . 70.22 109.205 168.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 175.18 -166.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.136 -2.542 . . . . 31.02 104.136 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 15.1 m -132.67 -4.03 3.28 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 118.907 0.776 . . . . 43.22 109.982 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.1 m -106.49 38.03 2.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.204 -2.147 . . . . 53.44 105.204 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.55 HG23 ' HB3' ' A' ' 391' ' ' ASP . 16.3 pt -87.1 151.16 51.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 113.176 -1.829 . . . . 72.54 113.078 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.07 137.33 34.31 Favored 'Trans proline' 0 N--CA 1.429 -2.306 0 N-CA-C 105.974 -2.356 . . . . 65.23 105.974 165.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.66 160.69 11.27 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.332 2.021 . . . . 64.45 111.787 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.67 -8.52 2.06 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.947 0.879 . . . . 75.12 111.722 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.0 m170 -103.45 111.05 23.31 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.778 -2.675 . . . . 74.43 103.778 171.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.52 119.34 6.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.962 0.887 . . . . 73.11 112.426 -166.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.4 -27.84 4.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.958 0 CA-C-N 114.528 -1.215 . . . . 73.22 112.14 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.48 27.31 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.65 -0.98 . . . . 72.05 110.65 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.5 p -114.69 -178.0 3.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.639 0.733 . . . . 52.13 112.375 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -104.18 136.48 19.18 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 107.437 -1.32 . . . . 73.53 107.437 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -48.91 -25.37 8.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.155 3.236 . . . . 73.31 115.327 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.96 -36.04 69.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.471 0.309 . . . . 75.21 110.976 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.94 83.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 74.11 110.769 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.45 -11.4 58.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.296 -0.865 . . . . 63.44 110.953 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.1 m -93.62 155.25 17.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.143 -1.058 . . . . 74.34 108.143 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 9.7 p -74.5 114.51 12.98 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 121.543 0.687 . . . . 74.02 110.154 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.1 m -123.87 169.23 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.333 -0.849 . . . . 72.42 109.574 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 65.6 m -62.41 149.34 42.79 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.978 0.418 . . . . 74.4 111.499 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.68 112.04 3.98 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.156 -1.053 . . . . 71.21 108.156 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.45 25.54 13.65 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.346 -0.931 . . . . 23.11 112.091 -177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.73 -173.88 4.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.379 -0.971 . . . . 63.41 108.379 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.0 pt-20 -108.72 132.87 53.52 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.472 0.653 . . . . 64.44 112.435 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 47.7 mm -119.86 131.48 72.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.221 -1.029 . . . . 74.3 108.221 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.3 t -89.45 131.35 35.55 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.379 0.609 . . . . 64.31 109.999 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.15 134.67 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 109.268 -0.641 . . . . 73.21 109.268 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' ASN . . . . . 0.445 ' OD1' ' HE3' ' A' ' 389' ' ' LYS . 41.6 m-80 -103.6 129.8 50.93 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.161 -0.472 . . . . 74.34 111.655 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.8 p -134.29 142.09 41.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.13 -1.063 . . . . 75.43 108.13 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 12.9 p -101.72 123.12 45.18 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.338 -0.545 . . . . 62.01 111.761 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 388' ' ' GLN . 9.3 t -120.14 107.01 12.51 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.423 -0.511 . . . . 73.43 111.546 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.89 142.61 6.59 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.714 -0.755 . . . . 61.11 114.342 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.5 Cg_endo -87.92 133.47 3.0 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.295 1.997 . . . . 75.3 111.625 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.458 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 8.7 mm-40 -72.83 134.05 44.72 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 122.211 -0.305 . . . . 72.11 110.537 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HB3' HG22 ' A' ' 477' ' ' THR . 47.2 mt-30 -123.27 134.01 54.12 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.776 -0.824 . . . . 61.15 108.776 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -131.99 150.94 52.02 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.893 -1.151 . . . . 74.12 107.893 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 1.5 pm0 -82.33 138.95 34.38 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.403 -0.962 . . . . 75.12 108.403 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.9 mt -82.35 117.24 67.73 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.7 -0.852 . . . . 70.23 108.7 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.55 140.24 39.26 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.303 1.335 . . . . 72.5 110.884 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.46 84.37 5.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.333 1.063 . . . . 64.42 112.282 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.65 -5.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 113.645 -1.616 . . . . 63.2 106.726 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.7 m -62.74 -43.14 99.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.727 -1.579 . . . . 63.43 111.498 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.3 m -58.55 -21.31 52.19 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 122.957 0.503 . . . . 74.32 111.733 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.68 -48.08 64.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 122.289 -0.257 . . . . 62.52 110.59 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.1 t 178.45 161.85 0.66 Allowed 'General case' 0 C--O 1.249 1.054 0 N-CA-C 108.748 -0.834 . . . . 71.41 108.748 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -57.75 -42.65 84.39 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.987 0.915 . . . . 75.2 111.998 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.25 81.41 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.885 0.328 . . . . 61.44 111.885 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.78 -38.88 92.76 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.246 -0.434 . . . . 63.41 110.645 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -51.09 71.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.301 -0.863 . . . . 73.3 110.238 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.27 -43.12 98.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.536 -0.756 . . . . 74.04 111.364 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -63.25 -49.37 74.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.247 0.462 . . . . 70.02 112.247 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -68.03 -41.3 82.35 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 113.099 0.777 . . . . 73.43 113.099 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 -41.04 90.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.678 -0.409 . . . . 55.14 112.044 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -66.39 -38.8 88.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.932 -0.396 . . . . 64.2 109.932 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.26 73.79 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.253 -0.43 . . . . 74.52 110.879 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.92 58.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.368 -0.378 . . . . 72.22 110.892 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.31 -20.34 9.67 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.865 -0.683 . . . . 54.15 113.97 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 105.68 1.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.37 . . . . 74.1 110.315 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.53 22.22 15.5 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 120.563 -0.827 . . . . 71.04 111.13 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.55 111.07 18.13 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.163 -1.051 . . . . 75.53 108.163 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.4 147.1 52.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.281 0.562 . . . . 75.42 111.26 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 8.1 tmtm? -138.67 123.45 18.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.768 -1.938 . . . . 72.45 105.768 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -98.53 135.47 40.02 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.612 -0.435 . . . . 62.13 111.072 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.01 148.48 50.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.506 -1.294 . . . . 53.25 107.506 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -129.25 130.34 46.12 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.788 -0.819 . . . . 51.4 108.788 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 36.9 p -130.93 143.93 51.42 Favored Pre-proline 0 C--N 1.291 -1.964 0 C-N-CA 120.463 -0.495 . . . . 62.02 110.888 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_exo -63.71 122.87 11.12 Favored 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.622 2.215 . . . . 72.25 110.281 175.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.8 m -130.06 162.63 28.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.495 -0.321 . . . . 73.42 111.203 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.4 m -60.26 142.65 89.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.638 1.175 . . . . 74.42 108.782 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.561 ' O ' HG22 ' A' ' 464' ' ' VAL . 90.9 Cg_exo -49.25 -24.06 7.72 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.108 3.205 . . . . 75.35 114.498 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.19 -19.21 64.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 111.886 0.328 . . . . 75.42 111.886 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.33 -11.45 12.55 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.841 0.682 . . . . 64.3 112.841 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 461' ' ' PRO . 22.4 m -59.93 134.71 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 112.672 0.619 . . . . 65.45 112.672 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.12 74.44 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.348 -0.842 . . . . 74.22 111.189 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -119.9 165.19 14.95 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-O 121.252 0.549 . . . . 74.12 109.646 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 92.6 t -84.02 134.96 25.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.767 -1.198 . . . . 74.34 107.767 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.71 -12.0 8.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 119.863 -0.735 . . . . 75.23 110.952 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.25 169.96 20.3 Favored Glycine 0 N--CA 1.414 -2.805 0 CA-C-N 115.346 -0.843 . . . . 71.43 111.263 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -116.62 150.63 37.77 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.136 -1.061 . . . . 72.02 108.136 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.3 t30 -64.12 -47.4 79.37 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.537 -0.465 . . . . 52.25 109.924 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 10.4 Cg_exo -76.23 117.29 4.59 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 107.6 -1.731 . . . . 65.52 107.6 167.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.74 144.18 88.43 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.082 1.855 . . . . 63.01 113.037 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.41 12.94 3.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.166 0.984 . . . . 71.23 110.394 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -109.18 1.58 20.4 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.967 -1.015 . . . . 62.23 108.619 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -125.17 159.39 31.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.629 0.728 . . . . 74.12 111.174 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -93.6 115.77 28.26 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.358 -1.292 . . . . 74.25 108.822 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.1 m -116.02 148.54 40.05 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.965 -0.383 . . . . 72.51 109.965 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.51 152.24 46.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.449 0.3 . . . . 63.22 111.203 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 46.1 mm -62.83 -26.21 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 121.315 0.578 . . . . 71.31 111.961 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 13.0 t -96.28 5.03 51.86 Favored 'General case' 0 C--O 1.241 0.658 0 O-C-N 122.01 -0.431 . . . . 75.34 110.467 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -74.2 129.73 38.39 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.996 -1.113 . . . . 63.53 107.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 113.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.765 -0.828 . . . . 73.11 108.765 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.33 120.02 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.567 -0.742 . . . . 72.33 109.855 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 66.8 mt -91.54 112.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.895 -1.52 . . . . 64.42 106.895 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 120.4 53.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 107.937 -1.134 . . . . 55.12 107.937 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 24.0 mt -105.2 118.82 53.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.088 0.47 . . . . 75.31 110.111 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.08 134.92 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 115.79 -0.641 . . . . 73.43 109.339 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.64 106.23 3.09 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.516 -1.034 . . . . 64.04 110.516 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -122.07 119.11 30.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.925 -0.769 . . . . 53.15 108.925 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 CA-C-O 118.009 -1.44 . . . . 54.22 109.764 -177.282 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.431 -1.399 0 N-CA-C 108.203 -1.036 . . . . 63.54 108.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.2 154.75 37.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 120.985 0.421 . . . . 75.15 110.875 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -95.25 139.03 32.15 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.857 -2.275 . . . . 74.23 104.857 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.2 130.86 32.82 Favored Pre-proline 0 C--N 1.283 -2.325 0 C-N-CA 119.072 -1.051 . . . . 54.31 109.367 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -41.03 125.65 2.36 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.847 3.031 . . . . 73.35 112.069 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.86 157.16 38.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.26 -1.336 . . . . 42.43 109.471 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.82 -0.24 9.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.612 -0.435 . . . . 62.41 110.973 -173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.4 ptp180 -54.91 131.05 43.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.547 0.689 . . . . 72.45 112.612 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 101.74 -1.29 52.39 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.359 -0.837 . . . . 65.32 111.146 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -118.42 -178.06 3.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.502 -0.555 . . . . 73.14 109.502 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 82.9 p -87.87 171.23 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.619 0.6 . . . . 54.01 112.619 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 8.7 p -63.89 -39.09 93.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.03 -0.532 . . . . 54.45 109.989 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.38 87.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.593 -0.73 . . . . 74.42 110.033 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.83 -44.07 90.83 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 123.209 0.318 . . . . 31.33 111.533 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.98 -51.18 67.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.866 0.365 . . . . 73.04 111.099 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 378' ' ' GLN . 1.8 mp -68.32 -46.28 81.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.139 -0.482 . . . . 64.43 111.71 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.42 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.622 0.601 . . . . 61.45 112.622 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.545 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 22.9 m -66.94 -48.29 69.05 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.629 -0.429 . . . . 74.42 110.44 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.98 -37.47 87.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.091 -0.504 . . . . 73.33 112.209 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 374' ' ' ILE . 40.1 tp60 -59.21 -47.65 84.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.446 -0.946 . . . . 74.41 108.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.01 -28.13 67.15 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.161 -0.927 . . . . 63.15 112.486 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 376' ' ' THR . 10.6 mpt_? -84.47 -8.81 58.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.818 0.342 . . . . 74.42 111.051 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 88.81 16.78 57.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.212 -0.994 . . . . 73.13 113.232 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -80.2 156.12 27.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.108 0.48 . . . . 53.04 110.323 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 31.5 mmmt -90.32 132.9 35.31 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.614 -1.625 . . . . 72.42 106.614 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.53 134.73 63.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 121.541 0.686 . . . . 71.51 112.086 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -112.35 127.9 56.14 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.858 -1.534 . . . . 74.43 106.858 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.3 m -117.67 121.16 40.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.328 -0.619 . . . . 73.23 109.328 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.21 119.25 37.71 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.399 -1.704 . . . . 74.14 106.399 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 14.6 pm0 -101.54 131.22 47.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.621 -0.881 . . . . 62.3 108.621 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.9 122.06 15.11 Favored Pre-proline 0 C--N 1.287 -2.132 0 CA-C-N 116.277 -0.419 . . . . 54.21 111.775 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 425' ' ' GLU . 6.0 Cg_exo -81.41 132.4 7.99 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.959 1.772 . . . . 74.41 107.78 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 15.1 t70 -159.46 -162.26 1.02 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.548 -1.278 . . . . 64.41 107.548 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 67.3 m -145.14 1.58 0.97 Allowed 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 119.392 0.996 . . . . 64.11 112.789 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -131.12 22.12 4.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 122.609 1.195 . . . . 75.43 108.206 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 391' ' ' ASP . 1.9 pp -88.91 152.47 48.59 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 113.625 -1.625 . . . . 41.21 112.996 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.51 157.18 53.27 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.791 1.661 . . . . 41.42 109.236 170.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.11 160.54 41.34 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 122.294 1.996 . . . . 72.34 111.104 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.537 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.6 p30 -60.4 -9.69 3.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.517 0.675 . . . . 75.14 111.943 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -84.53 111.06 19.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.456 -2.424 . . . . 50.41 104.456 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.18 118.52 4.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 122.07 0.938 . . . . 75.0 112.704 -167.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.3 tp -98.1 -31.1 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 74.03 109.386 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.98 156.77 27.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 108.894 -1.682 . . . . 54.22 108.894 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 22.2 p -114.5 -175.72 2.75 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 123.307 0.643 . . . . 60.41 111.306 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -99.58 137.84 20.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 106.464 -1.68 . . . . 74.21 106.464 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -42.97 -30.75 1.98 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.418 3.412 . . . . 55.43 114.64 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -38.3 64.62 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.931 0.492 . . . . 74.34 111.432 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.99 -27.87 62.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.729 0.776 . . . . 74.0 111.153 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.23 -8.06 49.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.817 -0.629 . . . . 74.32 110.665 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.6 m -92.54 156.53 17.07 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.947 -0.761 . . . . 63.33 108.947 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.1 m -74.15 112.79 10.64 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.606 -1.257 . . . . 74.33 107.606 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.28 170.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.932 -0.576 . . . . 73.11 109.749 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -83.96 140.07 32.15 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.404 -1.332 . . . . 61.43 107.404 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.1 2.14 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.135 0.493 . . . . 75.03 110.184 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.29 21.38 6.61 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.596 -0.812 . . . . 63.25 111.751 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -85.94 -171.33 3.53 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.474 -1.306 . . . . 61.01 107.474 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.9 pt-20 -107.91 138.87 43.4 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 118.831 0.741 . . . . 72.44 111.895 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.6 122.68 67.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.743 -1.206 . . . . 53.33 107.743 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -96.19 119.39 34.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.039 0.923 . . . . 73.53 110.249 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.72 126.66 68.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.053 -0.976 . . . . 71.42 109.33 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.7 128.87 44.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.437 -0.949 . . . . 61.52 108.437 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 397' ' ' ASP . 78.0 t -121.73 130.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.382 -0.969 . . . . 73.03 108.382 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 122.91 37.99 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.776 -0.453 . . . . 75.13 109.776 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.5 t -117.16 105.28 12.08 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.84 0.829 . . . . 73.32 110.981 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 60.99 178.69 2.39 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.983 -1.008 . . . . 74.24 115.136 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 10.1 Cg_endo -90.82 131.93 1.58 Allowed 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.038 2.492 . . . . 73.23 111.757 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.4 tp10 -72.87 151.59 41.89 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.754 -0.462 . . . . 74.12 109.754 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.5 mt-30 -123.78 150.88 43.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.477 -0.783 . . . . 72.42 110.359 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 427' ' ' ARG . 26.1 tpt180 -150.33 153.95 36.98 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.403 -1.332 . . . . 74.23 107.403 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.55 138.88 34.13 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.348 -0.982 . . . . 73.2 108.348 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 71.4 mt -80.43 124.32 82.37 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.608 -0.886 . . . . 71.32 108.608 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.86 140.06 59.55 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.069 1.179 . . . . 65.0 110.697 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.72 82.12 2.76 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 122.232 1.015 . . . . 65.32 111.94 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.86 1.43 6.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.197 -1.779 . . . . 44.33 106.197 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.0 m -67.8 -53.49 26.61 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 113.094 -1.866 . . . . 73.42 110.301 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 24.5 p -64.73 -19.12 65.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.431 0.9 . . . . 73.32 113.431 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.95 -38.21 13.01 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.711 1.004 . . . . 63.04 113.711 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 90.4 m -157.32 135.08 10.75 Favored 'General case' 0 CA--C 1.554 1.11 0 O-C-N 121.911 -0.493 . . . . 71.32 110.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -65.09 -47.28 77.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.543 0.737 . . . . 75.45 112.671 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.51 87.47 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.515 0.674 . . . . 63.02 110.865 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.54 -40.6 95.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.75 -1.114 . . . . 63.15 108.813 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.83 -51.67 68.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.784 -1.098 . . . . 65.43 111.705 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.72 -38.55 82.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.515 0.931 . . . . 61.25 113.515 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -66.53 -50.71 62.29 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 119.113 -1.035 . . . . 70.41 110.144 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.313 85.4 mttt -68.62 -39.73 80.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 115.58 1.696 . . . . 72.23 115.58 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.64 -43.38 89.65 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.745 -0.382 . . . . 52.1 111.795 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.1 m -69.24 -38.28 78.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.824 -0.35 . . . . 71.33 111.853 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.1 71.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.818 0.342 . . . . 75.52 110.698 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.08 59.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 72.44 111.034 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.39 -19.98 7.07 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.688 -0.767 . . . . 64.23 113.442 176.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -78.86 101.26 7.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.364 0.602 . . . . 74.12 111.0 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -119.99 17.47 9.96 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.013 -0.835 . . . . 73.43 111.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -107.57 111.16 23.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.791 -1.559 . . . . 74.51 106.791 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.39 160.25 34.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.145 0.794 . . . . 75.52 113.145 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 23.6 ttmm -151.91 127.39 10.02 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.715 -1.957 . . . . 73.33 105.715 170.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.72 134.92 39.38 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 120.67 0.271 . . . . 70.31 110.304 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.02 156.28 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.717 -0.475 . . . . 65.2 109.717 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -123.16 132.35 54.03 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.253 -0.647 . . . . 70.11 109.253 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.0 t -119.25 137.12 24.93 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.749 -0.834 . . . . 71.23 108.749 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.4 Cg_exo -61.56 119.78 7.08 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.061 1.841 . . . . 75.51 109.102 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.8 m -138.74 -178.46 5.32 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.066 -0.716 . . . . 71.0 109.066 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.8 m -58.95 131.44 86.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.361 -0.977 . . . . 75.15 108.361 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.9 -34.1 35.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.832 3.021 . . . . 73.31 114.538 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.71 -14.71 61.19 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 122.687 0.395 . . . . 72.32 112.006 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.39 7.58 45.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.204 -0.453 . . . . 71.05 110.769 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -59.49 125.93 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.781 0.8 . . . . 70.42 111.645 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.65 -5.01 79.86 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.882 -0.599 . . . . 70.11 112.427 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -102.77 145.59 29.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.093 -1.077 . . . . 74.34 108.093 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 54.4 t -83.89 129.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.721 -0.474 . . . . 75.01 109.721 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.94 -19.68 5.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.582 -0.447 . . . . 64.31 111.449 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.6 174.23 41.16 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.634 -0.986 . . . . 62.54 110.634 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -130.93 155.07 47.39 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.696 -0.853 . . . . 72.14 108.696 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -61.2 -53.43 63.22 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 120.795 -0.362 . . . . 65.04 110.854 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.1 Cg_exo -82.6 119.34 2.97 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 107.38 -1.815 . . . . 74.53 107.38 168.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.94 147.77 94.22 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.532 2.154 . . . . 72.52 113.848 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.65 2.92 20.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.473 -0.785 . . . . 74.33 112.524 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.7 -3.09 17.02 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.813 -0.554 . . . . 71.32 109.614 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -108.46 151.73 25.66 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.191 0.996 . . . . 73.31 112.201 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 426' ' ' GLN . 26.6 m -84.24 114.01 21.52 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.625 -1.625 . . . . 70.02 108.668 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.2 m -120.42 150.13 41.28 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.506 0.722 . . . . 74.33 109.424 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.07 147.22 45.2 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.4 -0.592 . . . . 73.1 109.4 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.9 mp -66.27 -11.68 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 122.246 1.022 . . . . 71.43 110.317 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 6.4 t -98.45 -0.66 43.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.279 -0.873 . . . . 51.32 109.379 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -78.61 142.19 37.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.63 -0.507 . . . . 64.25 109.63 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.05 113.52 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.263 -1.014 . . . . 35.41 108.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.0 t -87.81 118.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 108.606 -0.887 . . . . 72.51 108.606 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.4 mt -92.7 112.54 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 106.791 -1.559 . . . . 45.31 106.791 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -93.61 107.62 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 107.374 -1.343 . . . . 74.43 107.374 -177.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.4 113.99 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 115.11 -0.95 . . . . 72.24 110.123 -174.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.32 138.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 114.959 -1.018 . . . . 65.12 108.335 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.09 130.64 11.06 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 110.254 -1.139 . . . . 32.44 110.254 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 26.6 m -140.78 120.07 13.0 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.293 -0.632 . . . . 74.0 109.293 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 107.807 -2.117 . . . . 42.3 107.807 178.68 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 106.515 -1.661 . . . . 54.33 106.515 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.64 159.73 37.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 120.794 0.33 . . . . 74.11 111.132 -174.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -94.88 137.35 34.07 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.053 -1.091 . . . . 72.54 108.053 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.35 141.3 22.82 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.277 -0.638 . . . . 74.41 109.277 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.59 123.83 4.96 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 123.456 2.771 . . . . 71.32 113.699 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.536 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 21.5 t70 -74.59 134.84 42.08 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.218 -1.355 . . . . 61.03 108.838 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 35.0 m -91.41 29.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.732 1.012 . . . . 73.14 113.732 -169.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 364' ' ' ASP . 35.2 ptt-85 -65.73 127.05 30.38 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.159 -0.473 . . . . 72.31 110.916 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.58 57.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.276 -0.964 . . . . 44.35 114.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 2.0 pt20 -120.97 169.66 10.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 117.491 0.646 . . . . 74.12 110.724 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 98.8 p -80.46 173.96 12.08 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.713 -0.395 . . . . 54.44 111.475 -174.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.4 p -63.0 -33.87 76.35 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.275 -0.42 . . . . 54.14 110.617 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.547 -0.297 . . . . 54.12 110.505 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -62.03 -41.65 98.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.382 -0.372 . . . . 64.33 110.832 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.426 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -58.62 -51.54 69.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 71.11 110.602 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.43 -42.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.1 -0.5 . . . . 73.14 110.898 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.05 -46.06 92.22 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 112.036 0.384 . . . . 74.42 112.036 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.7 m -61.92 -47.92 82.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.297 . . . . 52.2 110.916 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.3 mm? -65.42 -38.38 89.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.379 -0.373 . . . . 73.03 111.66 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -60.88 -48.49 81.56 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.57 0.748 . . . . 70.34 109.442 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.43 -25.31 63.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 74.53 111.203 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -78.53 -15.29 58.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.97 -0.752 . . . . 75.41 108.97 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.17 56.88 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.357 -0.925 . . . . 73.32 111.829 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 22.6 m-85 -89.7 160.66 16.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.979 0.419 . . . . 75.24 110.613 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 53.8 mtmt -105.02 132.76 50.85 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.678 -1.23 . . . . 73.14 107.678 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 141.33 43.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.328 0.585 . . . . 64.42 112.373 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -118.49 136.64 53.7 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.046 -1.464 . . . . 74.11 107.046 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 m -99.64 125.33 45.46 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.752 -0.833 . . . . 71.31 108.752 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.82 120.33 41.61 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.584 -1.265 . . . . 61.32 107.584 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.13 121.88 31.89 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.288 -0.414 . . . . 65.44 109.911 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -123.77 125.23 25.98 Favored Pre-proline 0 C--N 1.312 -1.028 0 C-N-CA 119.564 -0.854 . . . . 63.54 110.208 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -89.11 147.11 5.46 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.735 2.29 . . . . 73.51 111.306 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.4 t70 177.13 -168.37 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.233 -1.766 . . . . 63.25 106.233 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 50.2 m -143.25 -1.29 1.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.585 0.63 . . . . 74.04 111.429 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.0 m -82.93 -10.65 58.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.099 -1.445 . . . . 74.34 107.099 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 421' ' ' SER . 11.2 pt -104.74 151.61 39.35 Favored Pre-proline 0 N--CA 1.427 -1.624 0 CA-C-N 114.042 -1.435 . . . . 71.44 109.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -86.25 -176.51 2.12 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.708 2.272 . . . . 63.41 111.521 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.65 163.32 3.95 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.515 2.81 . . . . 54.15 112.737 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.442 ' HB2' ' CG2' ' A' ' 420' ' ' VAL . 4.4 p-10 -55.87 -7.93 0.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.374 1.47 . . . . 63.25 114.33 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.5 m80 -63.51 115.4 4.63 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.087 -1.819 . . . . 70.22 106.087 174.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 365' ' ' VAL . 21.3 t -64.88 118.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.778 0.799 . . . . 53.03 110.499 -172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.69 -29.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.041 -0.981 . . . . 74.11 109.91 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -171.57 160.58 32.6 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.43 -1.068 . . . . 24.33 110.43 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 -174.54 2.48 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.695 -1.224 . . . . 72.41 107.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.36 144.3 27.85 Favored Pre-proline 0 C--N 1.279 -2.474 0 N-CA-C 108.688 -0.856 . . . . 70.33 108.688 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.98 -29.05 1.41 Allowed 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 124.676 3.584 . . . . 61.51 114.413 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.09 68.58 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.543 0.337 . . . . 63.04 111.162 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.66 58.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 64.4 110.96 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.29 0.14 53.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.472 0.654 . . . . 75.14 110.943 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.1 m -92.79 157.3 16.49 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.66 -1.608 . . . . 61.33 106.66 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.26 112.39 10.37 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.054 -1.091 . . . . 53.24 108.054 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.51 169.4 18.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.202 -0.908 . . . . 71.53 109.334 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 18.0 m -74.33 133.79 42.54 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.661 -0.496 . . . . 61.23 109.661 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.69 134.89 54.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.309 -0.405 . . . . 71.03 110.405 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.29 24.22 32.11 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.879 -0.677 . . . . 63.43 112.499 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.56 179.76 4.74 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.867 -0.79 . . . . 65.25 108.867 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.4 mt-10 -94.21 123.7 37.77 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.162 0.506 . . . . 73.34 111.996 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.07 126.27 74.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.643 -1.244 . . . . 43.42 107.643 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -90.49 118.77 30.22 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.477 -0.934 . . . . 71.24 108.477 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.53 113.18 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.189 -1.041 . . . . 70.14 108.189 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -88.51 129.85 35.36 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.49 -0.929 . . . . 74.35 108.49 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 397' ' ' ASP . 12.4 p -123.5 146.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.163 -1.051 . . . . 55.35 108.163 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.512 ' HB3' HD12 ' A' ' 394' ' ' ILE . 3.5 p -84.59 119.71 25.52 Favored 'General case' 0 N--CA 1.411 -2.418 0 C-N-CA 119.372 -0.931 . . . . 71.1 108.79 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.8 m -121.8 106.69 11.52 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.968 -0.56 . . . . 71.21 110.916 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 84.99 129.35 2.01 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.649 -0.786 . . . . 64.33 114.183 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 52.3 Cg_endo -76.37 133.04 14.18 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 121.735 1.623 . . . . 53.41 109.536 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.31 137.15 46.47 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.475 0.655 . . . . 51.12 112.35 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 38.4 mt-30 -120.37 140.85 50.7 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.872 -1.058 . . . . 75.23 108.48 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.41 145.41 51.2 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.59 -1.263 . . . . 72.43 107.59 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 14.8 pt-20 -83.7 138.99 33.04 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.905 -0.718 . . . . 73.5 109.082 177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 80.8 mt -80.3 124.29 82.62 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.017 -1.105 . . . . 55.01 108.017 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.89 141.94 41.8 Favored 'Trans proline' 0 C--O 1.252 1.193 0 C-N-CA 122.164 1.909 . . . . 62.44 112.677 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -78.22 77.08 4.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.217 1.008 . . . . 63.53 109.414 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.25 -7.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.131 -1.395 . . . . 73.41 110.281 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 3.3 p -68.94 -31.93 71.16 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.854 -0.612 . . . . 71.14 111.116 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 1.2 p -62.26 -24.59 67.35 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 125.285 1.434 . . . . 74.4 113.18 -177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.64 -47.75 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 75.13 112.037 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.0 t -177.21 153.04 0.92 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.827 -0.805 . . . . 74.23 108.827 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -58.37 -38.66 77.73 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.823 0.849 . . . . 72.31 111.276 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.46 -47.99 78.02 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.554 0.534 . . . . 63.44 111.115 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 34.6 mm-40 -70.33 -38.31 74.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.196 -0.457 . . . . 73.33 111.178 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.27 -46.35 88.76 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.613 0.571 . . . . 54.14 110.763 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.46 -47.6 80.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.633 -0.427 . . . . 71.23 110.699 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 31.9 mmmt -63.46 -47.1 83.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.163 0.431 . . . . 73.12 112.163 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.9 mmtt -63.6 -45.51 90.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 71.14 110.578 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.14 -32.48 72.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.61 0.596 . . . . 64.0 112.61 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.7 m -66.25 -38.74 88.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.558 -0.534 . . . . 75.0 109.558 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.64 67.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.953 -0.567 . . . . 72.52 110.628 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.29 -13.55 59.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 63.51 110.63 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.62 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 120.227 -0.987 . . . . 50.12 113.743 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.44 132.97 47.18 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 117.705 0.753 . . . . 63.35 110.917 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.98 16.04 4.76 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.592 -0.813 . . . . 71.43 112.395 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 32.3 mmt180 -125.43 111.96 15.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.513 -1.292 . . . . 72.42 107.513 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.91 152.21 49.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.085 0.469 . . . . 75.14 111.118 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -146.05 123.26 11.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.989 -1.486 . . . . 71.22 106.989 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -91.27 134.81 34.27 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.241 -0.584 . . . . 50.02 110.31 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -129.78 145.67 51.55 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.217 -1.031 . . . . 64.34 108.217 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -118.7 139.08 52.11 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.088 -0.708 . . . . 53.2 109.088 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.7 m -132.39 136.21 27.62 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.717 -0.475 . . . . 72.12 109.717 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.61 120.99 8.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.875 2.383 . . . . 72.44 112.184 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 43.9 m -124.85 172.51 9.29 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.71 -0.677 . . . . 74.33 110.098 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.8 p -67.29 151.09 97.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 O-C-N 123.794 0.684 . . . . 53.44 109.972 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.544 ' O ' HG12 ' A' ' 464' ' ' VAL . 71.8 Cg_exo -53.51 -27.18 39.53 Favored 'Trans proline' 0 CA--C 1.55 1.281 0 C-N-CA 122.839 2.36 . . . . 74.23 113.422 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.18 -23.89 54.73 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.73 -0.606 . . . . 74.53 112.226 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 37.4 tp -107.41 -9.39 16.01 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.069 0.461 . . . . 62.52 110.505 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.3 p -59.44 133.57 24.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.793 -0.639 . . . . 73.14 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.52 -14.09 59.41 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.613 -0.803 . . . . 64.03 112.168 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.75 158.04 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.382 0.61 . . . . 54.52 110.563 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 87.7 t -84.28 137.5 20.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.71 -1.589 . . . . 71.51 106.71 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.74 -13.79 8.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.342 -0.943 . . . . 74.32 110.563 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.88 -173.6 29.57 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 109.952 -1.259 . . . . 63.3 109.952 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.2 p -116.3 151.37 35.99 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.39 -1.337 . . . . 63.42 107.39 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -59.37 -51.46 81.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.732 -0.47 . . . . 75.31 109.732 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.01 133.94 22.47 Favored 'Trans proline' 0 C--N 1.378 2.086 0 N-CA-C 108.59 -1.35 . . . . 74.23 108.59 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.48 150.54 86.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.752 2.301 . . . . 72.24 114.534 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.31 8.49 38.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.311 1.053 . . . . 41.24 110.948 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -109.04 3.4 22.04 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.307 -0.871 . . . . 53.55 109.975 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -141.77 159.54 42.01 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-O 121.807 0.813 . . . . 73.1 111.591 -172.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -76.68 133.97 39.38 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.608 -1.633 . . . . 65.24 111.411 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 38.4 m -131.52 149.31 52.57 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.653 -1.24 . . . . 72.25 107.653 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -78.61 153.33 31.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.927 0.785 . . . . 73.14 111.683 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 47.4 mm -69.28 -8.23 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 122.163 0.982 . . . . 71.34 110.624 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 8.9 t -105.44 1.25 27.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.712 -0.676 . . . . 53.33 109.692 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 9.1 m120 -87.05 147.49 25.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.816 -0.809 . . . . 74.14 108.816 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.54 121.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.244 -1.021 . . . . 61.31 108.244 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.4 t -91.89 118.97 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.903 -0.777 . . . . 63.43 108.903 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.99 113.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.183 -1.414 . . . . 70.11 107.183 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.52 119.92 48.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.949 -1.13 . . . . 71.11 107.949 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 48.2 mt -103.23 114.96 44.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.434 0.635 . . . . 63.35 110.86 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.32 131.23 45.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.909 -0.775 . . . . 72.54 108.909 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.0 100.4 1.87 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.279 -1.129 . . . . 73.31 110.279 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 30.7 t -136.71 103.98 5.38 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.765 -0.828 . . . . 74.31 108.765 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.533 0 N-CA-C 108.471 -1.851 . . . . 72.04 108.471 176.436 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 121.23 0.538 . . . . 71.42 110.637 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.07 139.91 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.17 -0.923 . . . . 75.15 108.955 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.56 137.16 36.91 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.468 -1.679 . . . . 73.43 106.468 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 363' ' ' PRO . 14.8 p -96.99 124.26 50.42 Favored Pre-proline 0 C--N 1.294 -1.838 0 C-N-CA 119.757 -0.777 . . . . 63.22 111.446 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 362' ' ' VAL . 1.5 Cg_endo -44.87 146.31 2.46 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.814 3.676 . . . . 74.3 115.681 -175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -71.16 144.96 50.02 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.929 -1.032 . . . . 62.13 110.138 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -108.08 29.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.218 -1.401 . . . . 63.34 107.218 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -58.85 135.41 57.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.176 -1.375 . . . . 73.11 111.398 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 94.84 -15.35 63.57 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.97 -0.559 . . . . 65.23 112.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -107.19 175.26 5.56 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.588 -0.36 . . . . 73.32 110.724 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.6 p -75.57 158.12 32.93 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.825 0.345 . . . . 71.45 111.771 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 374' ' ' ILE . 44.6 t -63.25 -36.12 82.59 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.812 -0.81 . . . . 63.32 108.812 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.66 94.01 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 115.638 -0.71 . . . . 65.43 111.209 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.35 -41.38 98.55 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.127 -0.488 . . . . 73.51 109.89 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.43 83.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.461 -0.791 . . . . 63.4 110.934 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.36 -47.02 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.375 . . . . 54.22 110.301 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.95 79.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.969 -0.56 . . . . 43.23 111.855 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.7 m -62.72 -46.33 88.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.427 -0.352 . . . . 64.31 111.912 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -38.43 91.0 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.173 -0.211 . . . . 55.33 111.184 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.43 -47.2 86.38 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.922 0.889 . . . . 71.51 109.138 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.41 -20.16 62.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.129 -0.941 . . . . 73.31 111.706 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -86.79 -15.44 39.28 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.268 -0.641 . . . . 64.33 109.268 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.49 5.0 57.06 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.487 -0.863 . . . . 74.24 111.446 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -90.47 158.59 16.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.158 0.504 . . . . 74.32 110.479 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 22.6 mmtp -106.05 138.55 42.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.757 -1.571 . . . . 62.22 106.757 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.87 147.45 21.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 119.676 -0.81 . . . . 71.54 112.964 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 417' ' ' THR . 21.6 ttt180 -116.95 130.09 56.47 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.842 -1.54 . . . . 75.4 106.842 174.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.7 p -98.6 117.73 33.7 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 119.978 -0.689 . . . . 74.03 109.415 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -114.74 119.78 37.84 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.341 -1.355 . . . . 74.03 107.341 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 11.9 pm0 -112.81 126.14 55.11 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.722 -0.844 . . . . 74.42 108.722 176.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -122.42 133.65 24.5 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 120.257 -0.577 . . . . 73.11 111.033 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.19 140.32 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.091 2.527 . . . . 65.41 110.708 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.4 t70 179.75 -166.48 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.575 -1.269 . . . . 73.3 107.575 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 70.9 m -119.66 -11.15 9.46 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.422 0.63 . . . . 71.52 109.592 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -95.25 27.03 3.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.425 1.107 . . . . 73.45 108.234 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.4 pp -97.4 141.03 22.4 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 115.254 -0.884 . . . . 61.33 113.375 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.91 -179.99 4.4 Favored 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 123.239 2.626 . . . . 74.34 110.794 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.65 163.08 9.44 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.522 2.815 . . . . 72.02 112.563 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.14 -8.79 0.75 Allowed 'General case' 0 N--CA 1.522 3.149 0 C-N-CA 124.441 1.096 . . . . 71.53 112.25 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -83.75 157.12 22.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.657 -0.868 . . . . 74.15 108.657 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.26 116.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 N-CA-C 105.414 -2.069 . . . . 64.43 105.414 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.8 tt -89.99 -29.22 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 122.342 1.068 . . . . 72.43 109.036 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.57 170.59 38.18 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 104.623 -3.391 . . . . 54.21 104.623 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -176.26 2.87 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 107.249 -1.389 . . . . 74.52 107.249 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.78 145.7 30.59 Favored Pre-proline 0 C--N 1.253 -3.623 0 N-CA-C 107.93 -1.137 . . . . 74.42 107.93 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.04 -36.03 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.879 3.719 . . . . 41.05 114.047 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.63 -37.07 65.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.127 0.571 . . . . 64.03 111.701 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.64 -28.98 30.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.435 0.636 . . . . 71.24 110.496 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -83.73 -8.02 59.35 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.203 -0.908 . . . . 73.14 110.754 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 59.1 m -91.58 140.59 29.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.571 -1.27 . . . . 64.15 107.571 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 36.4 m -76.73 112.49 13.36 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.359 -0.978 . . . . 71.33 108.359 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.25 169.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.138 -0.937 . . . . 74.02 109.828 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 m -65.65 152.96 42.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.458 -0.942 . . . . 73.11 108.458 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.02 109.16 0.89 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.141 0.496 . . . . 75.13 111.293 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.16 1.27 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 115.596 -0.729 . . . . 73.53 111.78 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -134.96 -169.53 2.38 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.352 -1.721 . . . . 73.43 106.352 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 12.4 pt-20 -95.04 132.9 39.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.989 0.813 . . . . 74.33 111.617 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.97 119.4 61.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.576 -1.268 . . . . 72.44 107.576 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 385' ' ' ARG . 40.2 p -87.31 119.19 27.31 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.333 0.587 . . . . 73.23 109.849 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.99 121.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.161 -1.422 . . . . 75.34 107.161 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 7.9 p30 -107.95 125.78 51.91 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.446 0.641 . . . . 62.43 111.891 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 11.3 p -120.28 151.47 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.908 -1.042 . . . . 63.42 108.41 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.2 p -91.55 123.49 35.0 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 111.862 0.319 . . . . 64.31 111.862 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.9 t -119.04 106.13 12.11 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.806 -0.758 . . . . 75.53 111.667 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 66.29 161.23 0.98 Allowed Glycine 0 CA--C 1.552 2.401 0 N-CA-C 115.912 1.125 . . . . 71.42 115.912 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.2 Cg_endo -94.36 139.71 1.24 Allowed 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 122.708 2.272 . . . . 63.4 112.311 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 8.0 mm-40 -78.61 142.26 37.4 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.094 0.473 . . . . 73.13 111.735 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.6 mt-30 -122.54 147.14 46.73 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.243 -0.89 . . . . 72.01 108.636 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -135.44 163.73 29.39 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.523 -0.917 . . . . 73.44 108.523 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.63 135.7 33.86 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.856 -0.338 . . . . 74.23 110.592 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -80.83 119.29 75.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.068 -0.716 . . . . 61.45 109.068 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 444' ' ' LEU . 70.6 Cg_exo -56.05 141.17 87.12 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.94 2.427 . . . . 72.05 112.16 176.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -88.01 10.77 17.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 62.13 111.526 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.21 -5.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.275 0.559 . . . . 63.21 110.279 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -58.86 -40.71 85.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.01 -0.996 . . . . 75.41 110.932 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.493 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 0.6 OUTLIER -68.58 -16.95 64.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.812 0.845 . . . . 72.42 112.381 -179.003 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.26 -34.91 14.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.801 -0.636 . . . . 73.34 111.75 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 83.9 m -153.85 133.2 12.73 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.953 -0.467 . . . . 70.55 110.645 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.99 -41.63 97.44 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.074 0.55 . . . . 64.2 110.365 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 65.13 110.626 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.66 -40.83 97.82 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.948 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.67 -51.15 70.61 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 123.56 0.538 . . . . 72.33 110.217 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.33 -50.36 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.481 -0.488 . . . . 32.24 112.033 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.94 -47.97 67.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.625 0.602 . . . . 73.14 112.625 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -67.14 -38.49 85.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.011 0.374 . . . . 71.14 112.011 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.2 mp -67.89 -36.15 79.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.599 -0.44 . . . . 51.41 111.271 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.0 m -64.91 -39.2 93.16 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.309 -0.626 . . . . 73.54 109.309 176.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.57 71.07 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.97 -0.559 . . . . 72.3 110.788 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.47 -13.18 59.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 61.32 110.666 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.48 -20.63 8.29 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.425 -0.893 . . . . 42.2 113.561 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 445' ' ' THR . 98.1 m-85 -66.86 135.32 53.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 117.485 0.642 . . . . 63.31 111.369 -175.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.55 12.22 4.59 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 110.926 -0.87 . . . . 64.12 110.926 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -114.48 111.45 21.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.453 -1.314 . . . . 74.43 107.453 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.7 152.12 50.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.659 0.266 . . . . 74.21 110.72 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.45 124.22 14.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.151 -1.055 . . . . 64.02 108.151 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.93 127.11 33.63 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 110.188 -0.301 . . . . 72.13 110.188 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.61 158.12 44.02 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.612 -0.884 . . . . 62.44 108.612 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -125.14 150.31 47.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.794 0.331 . . . . 70.42 110.593 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 30.6 t -137.48 133.19 17.97 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 107.88 -1.156 . . . . 65.25 107.88 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.04 127.6 21.75 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.514 2.143 . . . . 71.12 109.599 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.6 m -148.26 174.74 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 122.118 -0.364 . . . . 71.13 111.277 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 463' ' ' LEU . 3.3 m -56.31 132.36 75.89 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.703 0.801 . . . . 62.0 110.102 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.523 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -48.79 -31.73 20.33 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.056 3.171 . . . . 52.21 114.861 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -18.55 65.41 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.24 0.543 . . . . 74.4 111.264 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 6.6 mp -106.93 6.04 28.85 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.074 -0.512 . . . . 75.32 111.508 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.6 p -60.41 126.98 19.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.258 0.552 . . . . 64.53 110.989 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.81 0.36 83.79 Favored Glycine 0 C--N 1.309 -0.94 0 CA-C-N 115.83 -0.623 . . . . 62.14 111.934 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 89.0 mttt -112.52 159.14 19.1 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.921 -1.14 . . . . 73.21 107.921 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 57.3 t -83.99 132.71 30.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.564 -0.532 . . . . 74.33 109.564 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -98.59 -16.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.222 -0.591 . . . . 70.32 111.402 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.81 174.08 37.79 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.653 -0.703 . . . . 35.42 111.704 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.7 p -124.06 149.69 45.83 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.444 -0.947 . . . . 54.12 108.444 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.6 t-20 -62.48 -51.96 69.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 120.561 -0.456 . . . . 74.02 110.921 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 11.2 Cg_exo -73.62 133.84 19.42 Favored 'Trans proline' 0 C--N 1.377 2.059 0 N-CA-C 108.304 -1.46 . . . . 73.32 108.304 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 475' ' ' ASN . 40.4 Cg_endo -65.35 130.73 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.377 2.052 . . . . 75.33 113.216 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.58 17.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.531 1.157 . . . . 44.31 109.714 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 473' ' ' PRO . 62.0 m-20 -108.6 -10.11 15.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.383 -1.281 . . . . 73.44 108.462 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -140.82 164.83 29.18 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-O 121.734 0.778 . . . . 63.34 111.368 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.7 m -84.45 124.89 31.84 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.182 -1.372 . . . . 64.42 109.431 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.2 m -125.62 149.46 48.38 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.373 -0.603 . . . . 75.31 109.373 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.66 146.74 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.537 0.208 . . . . 63.13 111.156 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.58 -22.09 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 121.755 0.788 . . . . 73.14 110.9 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 11.1 t -87.71 0.89 55.1 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.509 -0.768 . . . . 74.41 110.294 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -85.01 131.11 34.51 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.389 -0.967 . . . . 64.54 108.389 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.46 119.06 28.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.66 -0.867 . . . . 75.21 108.66 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.15 118.22 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.49 0 N-CA-C 108.115 -1.069 . . . . 72.03 108.115 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.83 112.75 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 106.341 -1.725 . . . . 75.42 106.341 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.89 119.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 108.54 -0.911 . . . . 74.25 108.54 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 23.2 mt -101.18 109.3 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 108.94 -0.763 . . . . 73.43 108.94 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 36.3 t -97.92 137.77 24.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.462 -0.79 . . . . 73.45 109.958 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -74.84 95.76 0.92 Allowed Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.488 -0.778 . . . . 61.01 111.212 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 38.1 m -142.88 112.84 7.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.775 -0.824 . . . . 74.53 108.775 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.012 0 N-CA-C 110.75 -0.94 . . . . 51.22 110.75 179.254 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.596 0.712 . . . . 75.53 111.963 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.02 144.01 35.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.844 -1.071 . . . . 73.43 108.9 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -96.42 137.43 35.5 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.402 -1.703 . . . . 65.22 106.402 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.7 p -98.14 127.31 37.09 Favored Pre-proline 0 C--N 1.29 -1.989 0 C-N-CA 119.097 -1.041 . . . . 51.2 110.004 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.68 143.53 79.36 Favored 'Trans proline' 0 C--O 1.244 0.789 0 C-N-CA 123.031 2.487 . . . . 73.0 112.7 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -68.95 127.01 31.62 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.599 -0.728 . . . . 73.4 110.0 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 26.7 m -81.83 5.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.911 -0.586 . . . . 63.11 112.11 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -61.1 142.97 56.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.912 -0.585 . . . . 70.43 111.761 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.31 -9.78 53.92 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.884 -0.598 . . . . 54.32 111.868 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -119.38 -173.69 2.57 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.354 -0.61 . . . . 65.14 109.354 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 94.7 p -86.98 162.16 17.81 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 119.637 -0.825 . . . . 73.23 109.317 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.452 ' O ' HG13 ' A' ' 374' ' ' ILE . 74.1 p -61.93 -33.23 73.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.986 0.422 . . . . 63.14 110.065 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.67 97.45 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.878 -0.601 . . . . 73.31 110.862 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -62.31 -42.7 99.58 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.093 0.473 . . . . 73.32 109.817 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.42 77.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.89 -1.05 . . . . 64.13 110.734 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.6 -47.26 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 75.33 110.477 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.44 78.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.271 -0.422 . . . . 73.32 111.937 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.7 m -61.55 -48.59 80.31 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.137 0.494 . . . . 70.13 110.635 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 74.6 mt -65.74 -38.19 88.46 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 62.43 111.739 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -61.05 -43.53 98.74 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.565 -0.531 . . . . 75.22 109.565 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.78 -34.67 77.75 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.031 0.443 . . . . 62.11 111.017 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -78.27 -15.12 59.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.126 -0.488 . . . . 70.22 111.233 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.99 16.47 41.27 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.595 -1.288 . . . . 52.32 112.269 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.12 152.2 18.93 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.237 -0.653 . . . . 74.12 109.237 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 35.0 mmtp -94.31 141.2 28.84 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.529 -0.915 . . . . 73.12 108.529 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 133.96 67.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.331 0.586 . . . . 51.2 111.607 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -110.51 130.85 55.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.79 -1.189 . . . . 64.12 107.79 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 p -98.9 119.29 37.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 120.429 -0.509 . . . . 73.24 109.884 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.6 tt -111.43 119.13 37.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.459 -1.682 . . . . 63.14 106.459 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 14.0 pm0 -106.36 122.57 46.52 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.325 0.583 . . . . 75.52 110.324 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.03 131.31 24.44 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.326 -0.852 . . . . 63.41 111.119 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -91.12 130.73 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.916 2.411 . . . . 73.15 111.34 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 174.95 -170.36 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.733 -1.58 . . . . 74.31 106.733 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.1 m -113.36 -27.94 7.76 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.439 -1.319 . . . . 75.53 107.439 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 m -91.72 58.82 3.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.982 -1.488 . . . . 74.55 106.982 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 391' ' ' ASP . 1.5 pp -115.9 151.58 46.58 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 114.009 -1.45 . . . . 44.44 113.005 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 394' ' ' ILE . 7.3 Cg_exo -74.9 119.53 5.71 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.217 1.945 . . . . 64.33 108.267 169.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.55 161.88 16.49 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 C-N-CA 123.386 2.724 . . . . 71.41 113.165 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.64 -8.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.947 0.899 . . . . 74.53 112.119 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 45.1 m170 -106.18 109.49 21.44 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 104.202 -2.518 . . . . 55.03 104.202 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.76 118.0 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 122.045 0.926 . . . . 61.4 111.986 -170.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -96.29 -27.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.776 -1.102 . . . . 72.13 112.105 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -146.65 156.96 27.24 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 110.257 -1.137 . . . . 73.12 110.257 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.4 p -125.37 -178.58 4.27 Favored 'General case' 0 C--N 1.275 -2.645 0 C-N-CA 122.989 0.516 . . . . 73.11 109.799 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.95 133.57 20.96 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.509 -1.293 . . . . 63.23 107.509 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.15 -17.94 9.19 Favored 'Trans proline' 0 C--O 1.26 1.585 0 C-N-CA 123.875 3.05 . . . . 65.51 115.194 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.84 64.27 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 122.115 -0.365 . . . . 71.31 110.744 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.71 65.36 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 121.038 0.447 . . . . 53.4 110.836 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -76.06 -13.39 60.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.082 0.468 . . . . 75.24 110.957 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 61.2 m -73.33 138.06 45.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.599 -0.889 . . . . 73.11 108.599 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.94 113.3 12.09 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.417 0.627 . . . . 64.11 110.066 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.36 170.08 8.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.169 -0.923 . . . . 65.14 109.56 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 27.6 m -70.12 132.35 45.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.021 -0.733 . . . . 34.14 109.021 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -51.91 113.99 1.17 Allowed 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.862 0.726 . . . . 61.21 112.301 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.04 57.87 1.28 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.816 -0.629 . . . . 63.04 112.675 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -114.31 -166.79 1.13 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.868 -1.531 . . . . 73.12 106.868 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.8 pt-20 -113.08 134.59 54.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 119.327 0.967 . . . . 75.21 112.596 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.95 135.9 54.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.29 -1.004 . . . . 73.33 108.29 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -94.73 125.96 39.72 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.401 0.62 . . . . 60.21 109.615 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.36 116.33 47.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.82 -1.178 . . . . 73.35 107.82 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.86 128.0 35.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.097 -0.705 . . . . 71.5 109.097 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.48 145.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.295 -0.411 . . . . 71.01 110.054 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 24.1 p -84.9 123.72 30.81 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.066 0.547 . . . . 63.45 112.117 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.8 t -118.38 106.58 12.88 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 120.022 -0.671 . . . . 54.41 109.352 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.0 109.5 0.05 OUTLIER Glycine 0 C--O 1.262 1.893 0 N-CA-C 115.028 0.771 . . . . 33.42 115.028 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 30.1 Cg_exo -64.75 127.69 19.31 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.3 1.333 . . . . 62.43 109.53 172.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 6.9 mm-40 -73.38 131.55 42.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 113.255 0.835 . . . . 74.34 113.255 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.5 mt-30 -123.22 133.72 54.19 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 106.891 -1.522 . . . . 72.32 106.891 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.676 -0.861 . . . . 55.5 108.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -83.43 138.21 33.57 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.782 -0.645 . . . . 72.33 109.311 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.3 mt -89.9 125.11 61.84 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.886 -0.413 . . . . 61.34 109.886 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HB2' HG12 ' A' ' 432' ' ' VAL . 48.7 Cg_endo -69.7 141.79 46.41 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.355 2.037 . . . . 72.12 112.745 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.22 6.87 30.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.104 -0.498 . . . . 73.15 111.676 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 430' ' ' PRO . 10.3 p -76.89 -14.3 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.679 0.752 . . . . 62.14 109.673 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.9 m -53.21 -37.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.785 1.234 . . . . 61.12 112.754 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.553 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 4.3 p -69.54 -14.16 62.71 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 113.84 1.052 . . . . 73.41 113.84 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.75 -38.26 17.09 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 122.136 -0.352 . . . . 71.01 111.877 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 73.8 m -153.83 131.72 11.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.769 -0.456 . . . . 60.3 109.769 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -62.09 -43.52 98.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.094 0.557 . . . . 72.23 112.048 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.2 83.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.212 0.53 . . . . 50.33 110.374 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.26 -44.38 95.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.888 -1.051 . . . . 73.4 109.51 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.18 66.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 74.24 111.524 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.24 -38.86 81.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.668 0.618 . . . . 62.43 112.668 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -67.54 -46.71 72.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.508 -0.477 . . . . 70.22 111.071 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -64.83 -40.72 95.64 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 112.364 0.505 . . . . 61.2 112.364 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.5 mp -65.85 -41.4 91.74 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.583 -0.447 . . . . 72.42 111.498 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.7 m -62.09 -43.36 98.99 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.801 -0.444 . . . . 54.3 109.801 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.15 -16.87 62.56 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.095 -0.502 . . . . 70.41 111.757 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -89.73 -7.19 55.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.106 0.479 . . . . 45.12 110.363 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 110.9 -8.73 29.6 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.1 -0.571 . . . . 55.42 112.851 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -85.01 92.7 8.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.262 0.553 . . . . 73.53 110.151 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -100.16 -2.03 55.85 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.462 -1.055 . . . . 42.34 110.462 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -94.97 110.78 22.64 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.48 -0.933 . . . . 75.33 108.48 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -123.46 157.69 32.92 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.623 0.725 . . . . 74.14 111.477 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 485' ' ' ILE . 59.1 tptt -149.54 131.41 15.14 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 103.934 -2.617 . . . . 72.22 103.934 173.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -111.0 135.07 52.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.961 -0.695 . . . . 73.31 111.394 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.36 135.69 37.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.802 -0.814 . . . . 75.54 108.802 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -114.9 129.21 56.66 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.399 -1.334 . . . . 75.34 107.399 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 45.3 p -121.11 150.32 53.31 Favored Pre-proline 0 C--N 1.284 -2.267 0 C-N-CA 120.597 -0.441 . . . . 64.24 110.503 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.9 Cg_exo -61.58 120.61 8.34 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.207 1.938 . . . . 54.52 110.431 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.9 t -127.38 -178.53 4.49 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.472 -1.677 . . . . 72.32 106.472 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 m -74.05 142.54 79.44 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 107.844 -1.169 . . . . 74.2 107.844 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 99.1 Cg_exo -49.67 -23.29 7.89 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.593 2.862 . . . . 61.13 113.931 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.92 -11.82 60.04 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.227 0.536 . . . . 65.11 112.118 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.4 3.12 15.7 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.923 -0.486 . . . . 74.21 111.641 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.9 p -59.92 127.45 19.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.326 0.584 . . . . 71.34 111.662 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.88 -15.6 63.04 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 120.769 -0.729 . . . . 52.11 112.176 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -100.66 149.59 23.62 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.112 -0.699 . . . . 74.35 109.112 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 91.5 t -76.93 130.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.708 -1.219 . . . . 62.11 107.708 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.04 -22.6 4.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.939 -0.704 . . . . 72.45 111.949 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.49 -177.58 45.79 Favored Glycine 0 N--CA 1.423 -2.177 0 C-N-CA 120.778 -0.725 . . . . 51.24 111.373 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 486' ' ' ILE . 6.7 p -136.01 154.88 50.93 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.449 -0.945 . . . . 72.42 108.449 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.531 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.5 t-20 -56.97 -51.85 78.54 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-O 119.151 -0.452 . . . . 75.12 111.435 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.6 Cg_endo -86.34 119.01 1.68 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 N-CA-C 107.15 -1.904 . . . . 74.12 107.15 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.47 162.21 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.197 1.932 . . . . 61.35 113.704 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.39 4.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.135 0.969 . . . . 53.33 111.104 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.86 -0.55 19.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.103 -0.953 . . . . 42.24 109.3 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -108.07 153.4 23.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.905 0.859 . . . . 64.42 112.031 -174.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.1 m -112.09 93.66 4.56 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.655 -1.611 . . . . 74.11 107.358 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -100.91 148.58 24.83 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.23 -0.441 . . . . 61.33 111.278 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.16 152.83 36.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.995 0.426 . . . . 34.42 111.48 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 448' ' ' GLY . 1.7 mp -63.83 -21.41 28.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.641 0.734 . . . . 72.25 111.429 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.82 1.2 56.44 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.102 -0.499 . . . . 63.11 111.808 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -85.99 140.24 30.48 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.819 -0.438 . . . . 71.42 109.819 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 36.6 t -85.21 123.19 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.73 -0.668 . . . . 71.43 109.415 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.85 119.81 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 108.526 -0.916 . . . . 72.25 108.526 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 1.7 mp -91.89 112.76 26.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.652 -1.981 . . . . 72.02 105.652 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -92.75 119.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.591 -1.263 . . . . 60.52 107.591 -177.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 38.8 mt -106.1 116.32 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.702 0.763 . . . . 72.24 110.57 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.13 142.85 13.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.502 -0.772 . . . . 70.23 108.959 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.63 117.53 4.59 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 111.183 -0.767 . . . . 62.51 111.183 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.4 m -116.34 106.99 14.26 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.163 -0.68 . . . . 75.45 109.163 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.086 0 N-CA-C 109.981 -1.248 . . . . 70.42 109.981 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.432 -1.337 0 CA-C-O 120.928 0.394 . . . . 74.13 110.4 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.71 152.11 13.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 123.917 0.887 . . . . 62.22 108.987 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -95.92 136.32 36.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.873 -1.899 . . . . 65.51 105.873 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.5 127.01 32.53 Favored Pre-proline 0 C--N 1.284 -2.272 0 C-N-CA 119.89 -0.724 . . . . 71.01 111.122 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.36 133.71 57.51 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.986 2.457 . . . . 71.51 112.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -59.44 134.49 57.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.012 -0.995 . . . . 75.33 111.168 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 5.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.377 -0.829 . . . . 72.41 112.476 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.5 ptt-85 -65.69 137.72 57.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.657 -0.868 . . . . 74.21 108.657 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.37 0.37 50.39 Favored Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.687 -0.965 . . . . 53.42 110.687 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 48.9 mt-30 -130.15 176.76 7.83 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.483 -0.932 . . . . 60.41 108.483 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 88.4 p -87.94 167.8 13.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.736 -0.839 . . . . 75.03 108.736 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -61.29 -34.22 74.86 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.993 0.425 . . . . 73.42 110.346 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.06 -44.84 87.68 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.704 -0.68 . . . . 70.2 110.407 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 48.8 m-20 -60.03 -44.98 94.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.528 -0.545 . . . . 64.41 109.528 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.08 67.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.226 -0.897 . . . . 73.22 111.018 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.5 -44.33 92.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.169 -0.469 . . . . 72.35 110.888 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.08 77.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.147 -0.479 . . . . 61.34 111.645 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.601 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 36.7 m -64.08 -47.52 79.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.547 -0.297 . . . . 73.3 111.199 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.13 -39.46 93.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.768 0.285 . . . . 72.43 111.768 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -60.04 -45.35 93.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.1 -0.704 . . . . 74.24 109.1 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -69.58 -27.65 65.29 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.169 -0.923 . . . . 75.33 112.025 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.601 ' HD3' ' O ' ' A' ' 376' ' ' THR . 8.5 mpt_? -85.62 -8.22 58.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.678 0.275 . . . . 71.43 110.999 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.27 14.35 54.21 Favored Glycine 0 CA--C 1.505 -0.594 0 C-N-CA 120.287 -0.959 . . . . 72.01 112.753 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -94.14 154.06 17.78 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.048 -0.723 . . . . 64.14 109.048 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.0 mmtp -104.79 133.6 49.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.263 -1.014 . . . . 62.31 108.263 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -117.82 144.86 24.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-O 121.524 0.678 . . . . 74.53 111.905 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -110.9 127.75 55.56 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 107.093 -1.447 . . . . 72.35 107.093 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.4 m -99.58 120.0 38.97 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.505 -1.665 . . . . 75.41 106.505 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.93 118.72 34.26 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.426 -1.324 . . . . 52.45 107.426 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.44 121.57 36.12 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.278 -1.378 . . . . 74.0 107.278 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.36 127.73 25.75 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 111.856 0.317 . . . . 70.42 111.856 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -87.99 131.59 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.522 2.148 . . . . 60.32 110.731 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.4 t70 174.06 -164.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.716 -1.587 . . . . 70.42 106.716 -178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 50.1 m -142.34 -0.53 1.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.343 0.657 . . . . 64.3 110.481 173.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -105.7 25.19 11.11 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 106.571 -1.64 . . . . 74.33 106.571 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 15.8 pt -115.13 151.41 45.66 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 113.708 -1.587 . . . . 72.55 110.212 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 63.2 Cg_endo -74.45 147.58 36.72 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.035 1.823 . . . . 75.13 111.465 176.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 54.0 Cg_exo -56.47 163.9 6.17 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.408 3.406 . . . . 73.11 112.288 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -56.28 -8.56 0.52 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 123.315 0.646 . . . . 73.14 112.006 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.1 m170 -91.63 113.37 25.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.213 -2.514 . . . . 74.53 104.213 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.18 118.32 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.358 0.599 . . . . 63.21 111.047 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.78 -29.49 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.206 -0.907 . . . . 74.34 109.049 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.18 157.12 27.28 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 110.432 -1.067 . . . . 71.14 110.432 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -126.03 -179.44 4.71 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 123.545 0.738 . . . . 52.35 110.418 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.33 140.29 21.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 61.3 108.639 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.39 -26.02 0.89 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 124.948 3.766 . . . . 62.43 115.53 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.34 -24.9 61.13 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 112.045 0.387 . . . . 74.45 112.045 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.74 69.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.475 0.655 . . . . 74.32 110.357 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -78.26 -11.99 59.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.59 -0.732 . . . . 63.22 111.65 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -78.82 137.46 37.71 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.063 -1.458 . . . . 70.41 107.063 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 m -82.54 112.27 19.3 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 71.41 107.712 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.6 167.42 18.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.566 -1.272 . . . . 74.33 107.566 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.2 p -61.01 147.66 42.83 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 123.46 0.704 . . . . 60.51 111.345 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.8 116.66 3.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.002 -0.544 . . . . 63.23 111.513 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.95 51.48 2.26 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.793 -0.64 . . . . 73.44 113.053 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.71 -170.14 1.69 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.803 -1.184 . . . . 74.33 107.803 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -99.05 135.27 40.7 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.494 0.664 . . . . 73.21 112.577 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.9 mm -125.17 138.76 53.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 124.796 1.239 . . . . 73.43 108.159 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 12.3 t -99.82 131.89 45.51 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.77 0.795 . . . . 65.1 111.701 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.3 t -108.15 120.71 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.459 -1.312 . . . . 73.52 107.459 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.74 129.04 41.83 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.341 -0.39 . . . . 74.5 111.458 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.75 131.3 73.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.835 -1.172 . . . . 64.12 107.835 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 49.6 p -85.96 121.85 29.18 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.099 -0.704 . . . . 72.41 109.099 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -119.45 106.7 12.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.197 -0.601 . . . . 73.15 111.1 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 71.03 125.89 0.06 OUTLIER Glycine 0 CA--C 1.544 1.874 0 N-CA-C 114.801 0.681 . . . . 65.02 114.801 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.1 Cg_exo -70.52 128.2 15.01 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.255 1.303 . . . . 64.4 109.44 173.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 15.2 mm-40 -72.3 144.78 48.21 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 112.463 0.542 . . . . 63.34 112.463 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.4 mt-30 -116.01 149.01 39.54 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.811 -1.086 . . . . 63.12 108.562 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -136.78 144.87 43.98 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.523 -0.917 . . . . 70.4 108.523 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 37.1 tt0 -81.74 119.25 23.62 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.122 -1.807 . . . . 71.04 106.122 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 62.1 mt -80.88 127.83 73.52 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.471 -0.937 . . . . 74.51 108.471 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 141.79 38.89 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.928 1.752 . . . . 62.01 110.627 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.84 73.89 10.28 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.373 1.083 . . . . 72.15 108.269 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.19 -4.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 113.668 -1.605 . . . . 74.13 107.34 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.609 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.7 m -67.13 -38.88 86.32 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 113.583 -1.644 . . . . 44.23 111.767 -176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 16.3 p -69.84 -16.75 63.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 112.86 0.689 . . . . 54.4 112.86 -169.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.28 -48.99 11.29 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.545 -0.752 . . . . 61.23 111.656 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.2 m -157.59 130.19 7.39 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.03 -0.419 . . . . 63.43 110.116 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -55.88 -47.07 78.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.477 0.711 . . . . 72.41 112.218 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.76 84.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 64.12 111.306 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 35.4 mm-40 -67.5 -38.95 85.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.164 -0.471 . . . . 75.31 111.214 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.4 -50.85 72.37 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.614 0.572 . . . . 62.12 111.043 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.3 -45.34 98.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.516 -0.765 . . . . 75.21 110.624 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.11 -40.67 86.91 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 112.952 0.723 . . . . 52.34 112.952 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.8 mmtt -66.21 -47.18 74.7 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 110.084 -0.339 . . . . 72.53 110.084 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.647 0.61 . . . . 71.52 112.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.9 m -63.98 -39.04 93.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.907 -0.405 . . . . 71.23 109.907 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -27.02 63.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.551 . . . . 65.13 110.832 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 -13.65 59.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.336 -0.393 . . . . 54.54 111.249 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 129.96 -26.18 4.27 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.196 -1.002 . . . . 50.44 113.26 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -80.84 91.57 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.312 . . . . 72.52 110.17 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.48 26.86 16.93 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 120.512 -0.851 . . . . 70.41 111.71 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -124.77 111.84 16.01 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.587 -1.264 . . . . 71.24 107.587 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 158.97 37.2 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.777 0.799 . . . . 74.14 111.982 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.52 123.25 21.15 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.872 -1.899 . . . . 61.43 105.872 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.62 126.96 35.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.145 0.278 . . . . 72.43 110.49 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.72 48.93 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.829 -0.804 . . . . 74.42 108.829 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -129.74 148.84 51.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.505 -0.554 . . . . 75.25 109.505 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 66.4 m -135.86 133.3 19.85 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 116.488 -0.324 . . . . 73.22 110.969 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.3 Cg_endo -61.79 121.57 9.73 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.715 2.277 . . . . 71.44 110.028 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.8 p -146.39 -178.36 6.11 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.878 -1.156 . . . . 64.34 107.878 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.514 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.3 m -52.2 122.98 26.11 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.17 -0.678 . . . . 64.44 109.17 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.02 -23.63 9.51 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.314 3.342 . . . . 73.54 115.197 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -75.4 -6.43 49.98 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.81 -0.556 . . . . 44.3 111.966 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 460' ' ' THR . 4.4 mm? -98.69 5.02 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.099 -0.375 . . . . 73.11 110.955 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -59.67 126.7 17.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 CA-C-O 121.545 0.688 . . . . 71.52 111.489 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.84 -1.14 85.05 Favored Glycine 0 C--O 1.243 0.657 0 CA-C-N 115.748 -0.66 . . . . 32.44 111.772 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -111.1 144.42 40.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.148 -1.427 . . . . 71.21 107.148 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 61.8 t -83.82 134.9 25.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 109.496 -0.557 . . . . 55.24 109.496 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.37 -14.88 7.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.404 -0.518 . . . . 74.04 110.803 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.98 167.75 23.87 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 115.719 -0.673 . . . . 52.42 111.811 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 486' ' ' ILE . 14.7 p -124.28 146.17 48.94 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.417 -1.327 . . . . 62.21 107.417 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.5 t-20 -56.54 -50.72 86.14 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 63.21 110.497 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.9 Cg_exo -81.4 104.95 1.54 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 105.41 -2.573 . . . . 73.21 105.41 163.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.0 Cg_endo -63.04 149.82 90.44 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.395 2.063 . . . . 60.31 114.248 -169.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.8 16.51 0.86 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.264 1.03 . . . . 74.34 110.106 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 473' ' ' PRO . 3.9 m-20 -111.3 -3.64 15.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 124.918 1.287 . . . . 65.43 108.718 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -120.9 163.32 18.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.921 -1.036 . . . . 72.23 112.162 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 10.6 m -101.48 104.88 15.82 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.728 -1.582 . . . . 71.42 106.728 175.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.8 t -116.89 148.84 40.96 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.583 -0.525 . . . . 51.24 109.583 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.14 140.71 58.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.236 -0.438 . . . . 54.13 110.622 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.9 mm -60.58 -16.46 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 125.159 1.384 . . . . 63.13 111.776 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 10.4 t -87.93 3.62 47.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.264 -0.426 . . . . 75.05 111.185 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 46.5 m-80 -91.12 140.61 29.65 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.751 0.31 . . . . 64.12 110.634 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.64 122.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.851 -1.166 . . . . 41.21 107.851 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.05 119.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 N-CA-C 108.605 -0.887 . . . . 71.32 108.605 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 47.0 mt -91.82 112.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 104.799 -2.297 . . . . 63.41 104.799 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.84 120.45 52.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 108.685 -0.857 . . . . 74.33 108.685 -173.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.78 118.73 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 121.559 0.695 . . . . 75.41 109.333 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.45 139.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.351 -0.981 . . . . 75.02 108.351 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.27 121.66 6.22 Favored Glycine 0 N--CA 1.42 -2.43 0 N-CA-C 108.471 -1.852 . . . . 61.11 108.471 175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 7.1 t -140.45 103.88 4.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.15 -0.685 . . . . 54.44 109.15 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.609 0 N-CA-C 109.478 -1.449 . . . . 74.53 109.478 178.18 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 107.242 -1.392 . . . . 74.12 107.242 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.82 156.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-O 120.972 0.415 . . . . 71.11 110.506 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -98.41 136.85 37.96 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.604 -1.628 . . . . 74.11 106.604 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.45 129.03 27.71 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 119.437 -0.905 . . . . 73.4 109.889 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 139.79 70.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.33 2.686 . . . . 74.31 113.21 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.66 137.49 55.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.839 -1.073 . . . . 65.11 109.107 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.0 m -103.43 14.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.986 0.422 . . . . 64.41 111.96 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 0.9 OUTLIER -65.29 138.82 58.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.558 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 -2.08 76.35 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 115.603 -0.726 . . . . 45.31 111.449 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -116.67 162.67 17.29 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.473 -0.566 . . . . 53.22 109.473 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 79.3 p -74.75 163.16 28.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 122.764 0.426 . . . . 74.33 111.774 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 21.5 p -60.91 -45.4 94.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.874 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.37 95.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.992 -0.549 . . . . 62.34 111.55 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.91 -39.73 83.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.056 -0.657 . . . . 73.31 109.905 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.99 -51.84 67.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.056 -0.52 . . . . 53.41 110.099 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.517 . . . . 62.51 110.7 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.39 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.462 -0.336 . . . . 73.45 111.673 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 98.3 m -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.689 -0.232 . . . . 53.32 111.18 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.5 mm? -64.87 -42.44 94.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.811 0.339 . . . . 74.43 111.002 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -61.81 -48.43 80.64 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.854 0.861 . . . . 74.25 109.721 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -70.5 -25.35 63.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.506 -0.77 . . . . 70.22 111.584 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.4 -15.83 57.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.453 -0.573 . . . . 72.33 109.453 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.4 6.09 53.57 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 119.807 -1.187 . . . . 51.41 111.683 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.4 169.08 11.7 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.233 0.54 . . . . 74.51 109.88 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 74.9 mmtt -113.73 157.9 21.62 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.508 -1.293 . . . . 34.22 107.508 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.42 142.68 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 121.093 0.473 . . . . 73.32 111.126 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -116.81 138.63 51.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.552 -1.647 . . . . 63.13 106.552 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 3.3 p -101.81 127.06 48.78 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.386 -0.525 . . . . 72.44 110.151 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.45 119.54 39.15 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.04 -1.467 . . . . 75.13 107.04 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 15.2 pm0 -114.85 134.12 55.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.416 -0.514 . . . . 75.03 111.252 -175.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -137.02 141.77 35.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.853 -0.612 . . . . 75.43 110.192 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.5 Cg_endo -97.04 143.57 0.76 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.155 2.57 . . . . 73.3 113.234 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.656 ' HB3' HG23 ' A' ' 394' ' ' ILE . 7.7 t70 163.55 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.996 -1.853 . . . . 71.3 105.996 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 m -122.18 -12.7 8.25 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.996 -0.742 . . . . 64.22 108.996 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.3 m -98.03 14.65 26.69 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 122.457 1.123 . . . . 54.22 108.769 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.656 HG23 ' HB3' ' A' ' 391' ' ' ASP . 9.9 pt -88.64 151.83 48.41 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 115.068 -0.969 . . . . 64.22 111.601 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.06 126.78 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.921 1.747 . . . . 71.31 110.78 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.85 161.99 9.52 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.718 2.945 . . . . 73.32 112.265 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 370' ' ' SER . 4.4 p-10 -57.03 -9.93 0.99 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.477 0.711 . . . . 74.52 112.399 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -91.89 113.84 26.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.536 -2.024 . . . . 53.12 105.536 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.88 119.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 124.362 1.039 . . . . 75.34 112.29 -167.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.8 mt -95.41 -31.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 65.54 109.928 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.57 157.96 27.56 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.518 -0.849 . . . . 74.31 111.472 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.9 p -129.04 -179.1 4.92 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.588 0.755 . . . . 73.4 109.599 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -101.74 142.35 24.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.02 -1.104 . . . . 73.54 108.02 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.65 -26.45 9.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.848 3.032 . . . . 74.4 114.075 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.69 46.41 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.366 0.666 . . . . 75.44 111.168 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.42 95.28 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.723 -0.671 . . . . 35.14 111.434 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -87.54 -5.95 58.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.413 0.523 . . . . 53.55 112.413 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 37.0 m -85.95 153.01 22.48 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.96 -1.496 . . . . 72.45 106.96 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.69 112.76 11.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.761 -0.776 . . . . 61.52 110.142 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.6 m -117.94 153.04 19.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 62.34 109.542 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -67.62 141.73 56.66 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.565 -0.531 . . . . 51.51 109.565 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.26 134.6 44.9 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.529 0.732 . . . . 72.1 112.594 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 84.09 37.48 11.27 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.455 -0.793 . . . . 24.2 113.991 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -95.91 176.22 6.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.192 -1.04 . . . . 74.25 108.192 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 6.2 pt-20 -111.07 120.0 40.89 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.189 0.811 . . . . 71.24 113.189 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.79 137.85 25.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 114.951 -1.022 . . . . 60.42 108.535 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.4 t -96.02 128.67 43.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.816 0.817 . . . . 72.44 110.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.48 129.03 59.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.538 -0.912 . . . . 64.24 108.538 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -85.01 127.99 34.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.385 -0.598 . . . . 65.42 109.385 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.95 135.09 64.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.502 -0.925 . . . . 64.43 108.502 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.8 p -84.24 122.08 28.38 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.246 -0.649 . . . . 55.41 109.246 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 39.9 m -120.3 104.96 10.47 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 120.049 -0.66 . . . . 52.3 112.443 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 70.62 131.07 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 N-CA-C 115.766 1.066 . . . . 31.15 115.766 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.4 Cg_exo -75.06 134.65 17.96 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.943 1.762 . . . . 73.43 109.491 173.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.2 mm-40 -72.84 148.8 44.12 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.249 0.547 . . . . 72.11 112.266 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.8 mt-30 -124.08 139.03 54.34 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.682 -1.144 . . . . 73.55 108.015 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 14.9 mmt-85 -130.45 154.64 47.53 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 116.163 -0.471 . . . . 72.35 109.771 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.64 138.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.579 -0.897 . . . . 74.3 108.579 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -94.28 109.64 43.74 Favored Pre-proline 0 C--O 1.203 -1.352 0 N-CA-C 109.005 -0.739 . . . . 75.11 109.005 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.01 140.56 34.94 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 121.549 1.5 . . . . 73.14 111.716 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -92.5 95.17 9.48 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 118.465 -1.294 . . . . 75.12 112.172 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.63 9.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 104.502 -2.407 . . . . 64.23 104.502 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 22.6 t -78.89 -48.11 15.24 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.058 -1.883 . . . . 74.23 109.188 -172.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 40.3 p -63.85 -19.97 65.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.631 0.729 . . . . 71.44 110.829 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.29 -49.27 6.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.05 -0.977 . . . . 74.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 4.7 p -151.03 125.59 9.56 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.105 0.479 . . . . 75.4 112.117 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -61.64 -47.12 86.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 73.02 110.927 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.26 -47.84 80.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.824 . . . . 72.21 112.134 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.97 -34.75 73.79 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.995 -0.548 . . . . 72.53 112.059 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.82 -44.75 96.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.571 -0.286 . . . . 64.13 110.357 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.29 -39.84 82.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.594 0.559 . . . . 74.15 110.157 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -60.82 -48.14 83.14 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.878 -0.601 . . . . 72.43 110.504 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.8 -47.53 71.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 73.12 111.068 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.94 -43.07 84.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.046 -0.979 . . . . 75.21 111.384 -173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.3 m -69.17 -39.57 78.66 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.967 0.413 . . . . 73.33 110.224 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -16.14 62.55 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.374 -0.375 . . . . 53.01 111.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.78 -13.79 59.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.215 0.531 . . . . 62.44 109.969 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.46 -25.26 7.39 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.737 -0.744 . . . . 12.01 112.14 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -57.43 127.1 30.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.972 0.415 . . . . 65.24 111.504 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -133.55 27.72 3.35 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 109.673 -1.371 . . . . 62.21 109.673 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -128.04 111.4 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.824 -1.547 . . . . 62.12 106.824 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -135.88 154.18 51.23 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.977 0.418 . . . . 64.24 110.782 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -146.13 123.25 11.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.624 -1.25 . . . . 73.3 107.624 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -108.84 132.19 54.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.942 -0.303 . . . . 51.22 110.697 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -147.68 166.3 27.87 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.898 -0.592 . . . . 65.23 109.518 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -112.74 143.65 43.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.303 -0.629 . . . . 72.22 109.303 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.6 t -127.17 141.48 40.86 Favored Pre-proline 0 C--N 1.288 -2.107 0 N-CA-C 107.739 -1.208 . . . . 74.21 107.739 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_endo -63.37 135.18 48.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.862 2.375 . . . . 75.53 112.427 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.3 p -148.13 -178.88 6.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 105.648 -1.982 . . . . 63.23 105.648 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD13 ' A' ' 463' ' ' LEU . 31.6 m -63.69 128.2 92.45 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.076 -1.453 . . . . 70.13 107.076 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.33 -28.24 14.97 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.272 3.315 . . . . 74.43 114.576 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.31 -9.88 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 111.911 0.337 . . . . 61.24 111.911 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.6 mp -103.3 11.97 36.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.458 -0.201 . . . . 61.22 110.458 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 13.0 p -59.0 127.32 18.03 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-O 121.611 0.719 . . . . 64.44 110.969 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.57 57.81 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.408 -0.815 . . . . 34.12 111.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.16 144.8 29.6 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.271 -1.011 . . . . 74.43 108.271 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 433' ' ' SER . 65.6 t -83.43 138.24 19.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 72.43 108.503 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -98.08 -11.37 8.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.22 -0.592 . . . . 55.14 111.615 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 150.68 -177.71 28.56 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 111.121 -0.792 . . . . 61.23 111.121 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 5.4 p -116.75 161.38 19.34 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.69 -0.856 . . . . 64.05 108.69 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.15 -55.37 44.75 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.259 -0.4 . . . . 74.53 111.323 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 133.67 18.69 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 N-CA-C 108.226 -1.49 . . . . 75.32 108.226 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 134.56 47.18 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.013 1.809 . . . . 75.14 111.598 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.92 19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.852 0.861 . . . . 73.23 113.045 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -110.54 -8.23 14.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.428 -0.953 . . . . 70.14 108.428 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -99.52 156.75 16.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.068 -0.969 . . . . 74.51 113.178 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 m -106.6 110.23 22.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.422 -1.717 . . . . 63.35 106.877 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -117.61 148.46 41.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.464 -0.198 . . . . 64.23 110.464 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.12 149.41 50.57 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.269 0.356 . . . . 74.14 111.018 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.95 -14.43 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 125.083 1.353 . . . . 72.42 111.837 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.17 4.01 44.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.7 0.8 . . . . 64.13 111.701 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -97.73 134.74 40.49 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.003 -0.544 . . . . 72.3 110.607 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.99 114.93 24.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.677 -0.86 . . . . 73.3 108.677 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.44 119.85 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.378 0.609 . . . . 72.15 109.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.72 120.24 41.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.43 -1.322 . . . . 74.43 107.43 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.29 118.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 107.836 -1.172 . . . . 75.22 107.836 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -111.46 122.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.173 0.987 . . . . 74.32 112.361 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 35.5 t -97.53 141.2 16.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.713 -1.13 . . . . 64.1 108.053 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.43 121.75 5.92 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 111.657 -0.577 . . . . 21.14 111.657 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.6 m -142.06 120.89 12.72 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.153 -0.684 . . . . 60.41 109.153 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.578 0 N-CA-C 109.665 -1.374 . . . . 74.44 109.665 178.976 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 106.606 -1.627 . . . . 63.45 106.606 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.65 154.14 37.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 122.528 0.331 . . . . 73.33 110.176 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -95.0 136.65 35.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.489 -0.93 . . . . 74.25 108.489 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.96 142.04 23.94 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 116.148 -0.478 . . . . 72.4 111.814 -170.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.14 142.77 20.19 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 124.015 3.143 . . . . 74.1 113.414 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.21 125.69 29.73 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.471 -0.786 . . . . 75.01 109.651 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.28 27.05 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.569 1.176 . . . . 73.01 110.669 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 145.66 55.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.09 -0.959 . . . . 74.21 111.498 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 1.0 45.49 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.998 -0.62 . . . . 65.03 114.36 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 373' ' ' ALA . 7.7 pt20 -134.6 162.5 32.11 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 117.293 0.546 . . . . 44.45 110.883 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.4 p -66.93 159.89 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.227 0.329 . . . . 61.21 110.298 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 21.2 p -56.76 -40.5 75.92 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.586 0.231 . . . . 71.02 111.62 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.36 77.85 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 111.563 0.209 . . . . 74.35 111.563 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.71 -36.76 76.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.51 -0.552 . . . . 72.42 109.51 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.4 ' HA ' ' OE1' ' A' ' 368' ' ' GLN . . . -60.5 -51.7 68.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.019 -0.537 . . . . 70.12 110.812 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.46 -38.0 76.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.764 -0.653 . . . . 73.21 110.607 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.07 99.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.964 -0.562 . . . . 74.01 110.338 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 50.6 m -61.21 -47.2 87.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.353 -0.385 . . . . 71.3 110.755 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.8 -38.64 91.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.433 0.158 . . . . 74.14 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -61.16 -46.78 89.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.366 -0.605 . . . . 72.35 109.366 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.27 -28.0 68.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.805 -0.634 . . . . 73.12 111.507 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -80.98 -14.57 57.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.365 -0.38 . . . . 70.44 111.42 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.09 48.11 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.858 -0.686 . . . . 65.23 113.667 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.91 161.97 14.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.491 0.646 . . . . 75.1 111.353 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -97.01 140.13 31.99 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.221 -1.77 . . . . 63.13 106.221 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.3 152.31 21.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.296 0.57 . . . . 54.42 112.316 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -136.16 128.99 31.04 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.934 -1.136 . . . . 64.53 107.934 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -100.58 132.83 45.77 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.187 -0.671 . . . . 73.04 109.187 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.55 119.14 35.79 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.666 -1.976 . . . . 71.31 105.666 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -108.37 122.19 46.49 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.974 -0.75 . . . . 53.4 108.974 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.54 133.3 21.33 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.023 -0.535 . . . . 74.04 111.9 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -81.63 129.56 6.5 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.073 1.849 . . . . 73.31 108.288 169.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.4 -170.29 3.19 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.905 -1.518 . . . . 74.51 112.145 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.7 t -104.66 -40.63 5.94 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.318 -1.734 . . . . 42.02 106.318 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 395' ' ' PRO . 32.2 m -93.0 71.51 4.65 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.543 -1.651 . . . . 44.02 106.543 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 16.6 pt -89.58 112.96 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 113.241 -1.8 . . . . 65.32 113.587 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 393' ' ' THR . 6.3 Cg_exo -79.1 119.61 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 105.81 -2.419 . . . . 73.34 105.81 167.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.12 150.48 39.16 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 C-N-CA 122.631 2.221 . . . . 63.22 114.24 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.531 ' HA ' HG13 ' A' ' 420' ' ' VAL . 29.8 t70 -60.06 -9.65 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.626 1.203 . . . . 51.1 111.722 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -109.51 115.51 30.06 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 103.292 -2.855 . . . . 74.2 103.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.17 117.98 4.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 123.695 0.622 . . . . 72.11 109.53 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.57 -29.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.987 -1.116 . . . . 71.35 107.987 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.37 168.47 27.81 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 109.387 -1.485 . . . . 62.23 109.387 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 81.2 p -113.93 -176.36 2.88 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.827 0.823 . . . . 71.23 111.365 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.31 142.89 25.48 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 105.654 -1.98 . . . . 61.4 105.654 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.62 -31.67 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.286 3.324 . . . . 63.45 114.441 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.08 67.42 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 112.381 0.512 . . . . 74.03 112.381 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.25 81.95 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 121.5 0.667 . . . . 74.31 110.125 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.83 -0.39 57.7 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.842 0.83 . . . . 73.12 110.604 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 93.8 m -85.55 143.99 28.17 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.008 -1.479 . . . . 74.14 107.008 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.0 m -74.84 114.61 13.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.867 -0.733 . . . . 63.02 109.381 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.96 170.17 8.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 124.823 1.249 . . . . 52.34 108.921 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 23.2 t -69.67 156.98 38.13 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.535 -0.543 . . . . 75.32 109.535 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -73.38 109.6 7.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.124 -1.065 . . . . 52.43 108.124 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.53 26.51 11.87 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.673 -0.971 . . . . 52.35 110.673 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.8 t0 -76.99 -171.57 2.03 Favored 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.807 -0.812 . . . . 63.15 108.807 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.68 127.46 53.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.463 0.649 . . . . 61.11 111.129 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.63 120.1 61.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.202 -1.036 . . . . 74.11 108.202 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -97.88 128.23 44.34 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.642 -0.873 . . . . 43.34 108.642 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.57 119.58 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.717 -0.475 . . . . 63.11 109.717 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.7 121.88 33.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.459 -0.941 . . . . 61.11 108.459 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 397' ' ' ASP . 23.6 t -128.83 144.72 37.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.426 -0.953 . . . . 75.32 108.426 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 71.9 p -98.03 128.92 44.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.306 -0.958 . . . . 54.03 110.9 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 60.6 m -118.73 105.56 11.69 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.069 -1.456 . . . . 74.32 107.069 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 80.53 145.1 3.97 Favored Glycine 0 CA--C 1.546 2.011 0 C-N-CA 120.973 -0.632 . . . . 34.22 113.445 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -87.95 153.2 7.16 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 121.903 1.735 . . . . 63.23 110.38 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 146.17 47.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.177 -0.675 . . . . 73.44 109.177 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 42.0 mt-30 -128.74 124.13 34.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.632 -0.877 . . . . 73.45 108.632 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.14 159.51 34.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.469 -1.308 . . . . 72.23 107.469 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.65 139.87 30.12 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 110.209 -0.293 . . . . 71.13 110.209 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.61 131.89 63.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.631 -0.877 . . . . 74.4 108.631 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.438 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.24 151.07 60.25 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.466 2.111 . . . . 44.21 111.905 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.19 -6.55 44.49 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.485 -0.325 . . . . 71.21 110.702 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 430' ' ' PRO . 11.9 p -65.84 -15.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 122.123 0.964 . . . . 62.33 109.69 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 14.0 m -52.73 -32.95 45.77 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.889 1.676 . . . . 73.23 112.084 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 85.5 m -59.8 -34.33 72.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.53 0.732 . . . . 74.43 112.585 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.45 -37.69 83.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.307 0.854 . . . . 71.32 113.307 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.8 m -158.3 133.53 8.66 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.723 -0.473 . . . . 72.32 109.723 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.61 -49.35 75.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.559 . . . . 73.35 111.724 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.44 85.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.943 -0.571 . . . . 72.3 110.449 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.25 -41.96 99.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.933 -1.03 . . . . 64.3 109.834 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.47 69.23 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.355 -0.839 . . . . 74.42 110.582 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.34 -40.0 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.584 -0.735 . . . . 74.52 110.405 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -60.8 -46.34 90.88 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.607 -0.27 . . . . 74.22 111.064 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -47.6 83.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.268 0.355 . . . . 65.33 111.86 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.36 -40.55 85.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.946 0.721 . . . . 42.51 112.946 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 57.2 m -61.8 -43.44 98.83 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.065 0.46 . . . . 73.41 110.158 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.53 -22.33 61.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.696 -0.684 . . . . 73.31 111.553 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.21 -13.09 57.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.005 0.431 . . . . 73.22 111.061 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -19.12 8.91 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.443 -0.884 . . . . 61.44 112.715 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 445' ' ' THR . 91.0 m-85 -71.27 110.86 6.17 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.017 -0.734 . . . . 60.02 109.017 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -120.08 17.08 9.97 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.457 -0.878 . . . . 53.2 111.602 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -119.4 111.4 18.1 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.872 -1.159 . . . . 61.13 107.872 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.25 152.37 50.58 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.082 0.468 . . . . 74.44 111.892 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -138.69 126.22 21.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.756 -1.572 . . . . 74.41 106.756 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -93.4 126.25 38.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 121.229 -0.189 . . . . 64.23 111.001 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.82 161.16 38.22 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.114 0.483 . . . . 63.13 110.111 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -124.06 133.29 53.67 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.059 0.457 . . . . 61.42 110.179 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 5.1 p -116.97 133.43 23.1 Favored Pre-proline 0 N--CA 1.413 -2.28 0 CA-C-N 115.583 -0.735 . . . . 35.31 109.482 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 36.1 Cg_exo -61.8 123.66 13.06 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.435 2.09 . . . . 71.44 110.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 8.7 t -148.16 -177.99 6.05 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.557 -1.275 . . . . 63.43 107.557 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 463' ' ' LEU . 20.5 m -51.65 116.45 7.92 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.139 0.976 . . . . 73.2 110.492 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.92 -28.75 19.21 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 124.329 3.353 . . . . 73.51 116.065 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.19 -25.93 58.63 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.746 -0.596 . . . . 73.03 112.366 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 460' ' ' THR . 3.2 pp -92.8 12.04 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.695 -0.402 . . . . 71.21 112.038 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.6 p -53.29 130.85 15.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.428 0.632 . . . . 70.01 111.228 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.84 -13.32 59.21 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.819 -0.912 . . . . 61.32 110.819 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.01 147.25 26.41 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.305 0.574 . . . . 34.42 109.773 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 434' ' ' THR . 52.7 t -83.68 129.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.478 -0.783 . . . . 62.21 110.004 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -15.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 118.571 -1.251 . . . . 62.14 110.724 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.51 37.95 Favored Glycine 0 N--CA 1.418 -2.516 0 CA-C-N 115.331 -0.849 . . . . 44.42 111.146 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 486' ' ' ILE . 2.9 p -136.15 161.87 34.53 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.915 -1.143 . . . . 73.24 107.915 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.7 t30 -62.97 -49.76 80.12 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 120.75 -0.38 . . . . 71.22 110.87 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 13.5 Cg_exo -69.44 141.71 47.3 Favored 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 106.586 -2.121 . . . . 43.41 106.586 167.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.48 127.24 21.24 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.771 1.648 . . . . 41.14 112.699 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 -1.69 21.07 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.885 0.874 . . . . 53.31 113.162 -174.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -110.02 -4.27 15.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.028 -0.42 . . . . 72.42 110.136 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -121.3 176.51 5.6 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 114.626 1.343 . . . . 75.4 114.626 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -80.48 132.65 35.73 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.708 -1.587 . . . . 54.21 110.334 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.7 p -137.26 149.54 47.2 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.605 -0.887 . . . . 64.44 108.605 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.23 148.55 45.41 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 120.206 -0.598 . . . . 61.34 111.262 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.76 -28.24 44.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.865 0.84 . . . . 75.51 110.878 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 p -88.0 5.48 40.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.954 -1.021 . . . . 63.45 111.434 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.0 135.83 33.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.111 -1.44 . . . . 63.01 107.111 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 53.0 t -79.83 112.91 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.351 -1.351 . . . . 64.55 107.351 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.25 118.81 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 109.083 -0.71 . . . . 62.13 109.083 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 60.8 mt -92.6 113.39 27.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 106.469 -1.678 . . . . 73.11 106.469 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -97.18 116.46 39.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 108.545 -0.909 . . . . 74.14 108.545 -175.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 12.3 pt -102.9 117.06 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.491 1.139 . . . . 55.04 111.571 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.67 132.88 40.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.557 -1.275 . . . . 63.3 107.557 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -68.92 113.58 5.31 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.773 -1.331 . . . . 74.31 109.773 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 8.7 m -135.01 103.72 5.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.759 -0.46 . . . . 72.02 109.759 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 108.399 -1.88 . . . . 65.31 108.399 178.837 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.492 -1.274 0 N-CA-C 104.679 -2.341 . . . . 73.2 104.679 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.74 152.92 19.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 119.522 -0.871 . . . . 71.23 113.149 -167.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -95.28 137.07 34.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.417 -1.697 . . . . 74.41 106.417 172.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.93 131.56 27.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 C-N-CA 119.27 -0.972 . . . . 73.22 109.711 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.65 150.74 51.04 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.7 2.933 . . . . 53.12 114.026 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -72.76 -30.13 63.88 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.077 -0.965 . . . . 74.45 110.459 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 368' ' ' GLN . 42.5 t 66.77 27.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 124.193 1.949 . . . . 73.32 107.097 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 28.0 ptt180 -58.17 125.08 21.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 112.464 -2.153 . . . . 70.14 113.362 -176.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.52 -16.78 54.63 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.863 -1.062 . . . . 45.51 111.719 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.491 ' HB2' HG12 ' A' ' 365' ' ' VAL . 41.7 mt-30 -103.89 170.23 8.04 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.796 0.439 . . . . 72.5 110.006 -176.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.9 p -71.75 160.86 31.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.185 0.517 . . . . 61.13 111.998 -175.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 11.3 p -62.05 -33.85 75.17 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.637 -0.711 . . . . 55.41 110.245 174.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.5 98.58 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.011 -0.54 . . . . 52.21 110.688 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.91 -39.83 79.44 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.847 -0.341 . . . . 63.25 110.249 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.3 72.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.187 -0.46 . . . . 43.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.77 -45.26 91.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.661 178.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.55 83.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.169 -0.469 . . . . 70.02 111.769 -179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.3 m -61.62 -47.44 85.39 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.585 0.354 . . . . 73.42 111.229 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.84 -38.67 91.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.619 0.229 . . . . 31.11 111.619 178.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -59.83 -46.16 90.12 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.501 0.72 . . . . 41.23 109.496 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -70.9 -16.62 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.32 -0.854 . . . . 61.4 112.484 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -87.31 -14.09 41.81 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.583 -0.895 . . . . 64.04 108.583 176.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.627 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.75 -2.67 55.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-N 115.089 -0.96 . . . . 74.12 111.976 178.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.72 150.6 34.42 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.162 0.506 . . . . 72.04 111.271 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 145.03 25.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.26 -1.756 . . . . 63.2 106.26 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.61 135.72 60.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.887 1.069 . . . . 73.53 113.887 -174.108 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -111.03 132.07 54.54 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.647 -1.983 . . . . 50.13 105.647 172.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.1 m -119.52 122.73 42.31 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.236 -0.586 . . . . 71.45 110.378 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.23 127.45 55.61 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.872 -1.159 . . . . 72.14 107.872 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 13.4 pm0 -108.82 122.48 47.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.2 OUTLIER -122.0 132.77 24.18 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.283 -0.417 . . . . 64.14 110.76 -177.865 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -97.56 137.6 0.44 Allowed 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 122.3 2.0 . . . . 74.51 113.152 176.389 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 13.8 t70 164.85 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 126.645 1.978 . . . . 74.21 106.277 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.9 m -138.27 -8.48 1.52 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 118.901 0.773 . . . . 51.33 111.909 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.79 -3.32 57.5 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 122.156 0.979 . . . . 73.22 109.601 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 391' ' ' ASP . 7.4 pt -99.69 151.7 37.55 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 113.982 -1.463 . . . . 71.31 110.368 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 51.2 Cg_exo -56.43 131.91 48.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.302 2.668 . . . . 51.02 113.932 -178.44 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 70.0 Cg_exo -55.3 164.54 3.78 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 124.913 3.742 . . . . 61.23 113.511 177.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.438 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 17.1 t70 -55.25 -9.9 0.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.493 1.517 . . . . 73.34 113.457 -174.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -87.58 124.31 33.37 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.921 -1.14 . . . . 70.04 107.921 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 44.8 t -63.16 119.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.607 -0.724 . . . . 75.33 109.845 -173.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.6 tp -90.5 -32.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.587 -0.733 . . . . 74.12 109.48 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -174.88 169.11 41.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.842 -0.903 . . . . 53.1 110.842 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.8 p -114.48 -176.69 2.96 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.066 0.947 . . . . 75.13 108.696 176.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.49 143.49 26.52 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 108.563 -0.903 . . . . 71.34 108.563 -176.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -37.23 -30.7 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.8 1 C-N-CA 125.394 4.063 . . . . 75.2 115.593 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.76 -32.15 70.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.126 0.489 . . . . 71.12 110.972 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.52 25.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.619 -0.718 . . . . 33.44 110.373 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -88.57 -7.09 57.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.393 -0.822 . . . . 74.0 111.661 -173.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.3 m -95.39 162.22 13.75 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.144 -1.428 . . . . 71.25 107.144 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 28.8 m -74.26 113.34 11.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 120.059 -0.656 . . . . 41.25 110.16 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.48 165.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.304 -0.862 . . . . 71.11 109.761 178.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.8 m -75.51 141.64 42.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.555 -0.535 . . . . 74.33 109.555 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.96 129.93 42.01 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.294 0.569 . . . . 45.25 110.226 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 103.01 11.14 35.14 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.524 -0.846 . . . . 44.42 111.896 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.17 173.74 10.97 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.68 -1.23 . . . . 75.42 107.68 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -110.63 122.62 48.23 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.644 0.735 . . . . 70.02 111.366 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.8 mm -113.05 133.42 58.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.181 -0.918 . . . . 74.41 109.779 -175.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -102.69 124.87 49.02 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.479 -0.934 . . . . 72.0 108.479 177.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.48 134.39 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.596 -0.52 . . . . 72.4 109.596 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -110.05 129.23 55.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.186 -0.672 . . . . 65.14 109.186 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -128.59 141.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.838 -1.074 . . . . 74.31 108.211 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 10.6 m -95.9 122.62 38.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.546 -0.862 . . . . 72.45 110.102 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 59.8 p -117.82 107.48 14.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.758 -0.655 . . . . 75.12 110.985 -177.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.32 136.62 2.02 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.809 -0.632 . . . . 53.24 113.486 177.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 71.1 Cg_endo -75.67 155.02 39.82 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.33 2.02 . . . . 72.05 111.634 178.037 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.21 143.86 30.17 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 74.52 108.918 174.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.7 mt-30 -127.51 135.53 50.49 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.719 -1.215 . . . . 74.21 107.719 175.056 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -131.99 157.1 44.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.873 -0.788 . . . . 73.12 108.873 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.13 138.94 31.0 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.206 -1.405 . . . . 73.21 107.206 174.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -80.21 113.67 40.67 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.332 -0.618 . . . . 73.3 109.332 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.65 140.61 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.792 1.661 . . . . 53.52 109.878 176.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -107.47 97.58 7.3 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.375 1.083 . . . . 62.24 113.603 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.27 5.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 105.349 -2.093 . . . . 75.14 105.349 169.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.715 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 12.8 m -72.07 -46.42 56.95 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 113.447 -1.706 . . . . 53.25 110.393 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 23.1 p -65.37 -23.29 66.94 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.208 -0.906 . . . . 45.33 110.962 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.42 -48.07 7.34 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.461 -0.79 . . . . 73.44 111.326 -179.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.3 m -143.79 113.41 7.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.098 0.475 . . . . 72.31 111.251 -178.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -55.48 -51.83 65.64 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.371 1.068 . . . . 72.43 112.608 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.46 -43.65 96.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.401 . . . . 63.2 111.212 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.66 -35.06 79.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.822 -0.627 . . . . 73.22 110.47 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.715 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.72 -48.52 81.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 116.012 -0.54 . . . . 55.22 110.666 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.43 -43.3 90.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-N 115.17 -0.923 . . . . 64.4 109.834 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 71.5 mmtt -66.43 -47.53 72.9 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.865 -0.607 . . . . 74.44 110.524 -177.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.57 -41.46 88.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.751 -0.659 . . . . 74.24 112.123 -177.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.31 -32.98 73.5 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.574 0.583 . . . . 75.42 112.574 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.4 m -66.96 -43.26 83.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.842 -0.799 . . . . 75.22 108.842 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.16 62.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.976 -0.556 . . . . 65.02 111.042 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.81 -13.11 59.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.413 0.625 . . . . 75.45 110.005 177.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.36 -6.31 45.79 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-O 119.223 -0.765 . . . . 53.11 114.016 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.17 130.71 44.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.118 0.959 . . . . 75.05 110.562 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.6 2.82 10.22 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.061 -1.066 . . . . 73.53 113.478 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.44 114.29 19.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.895 -0.779 . . . . 72.42 108.895 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -131.96 161.95 31.88 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.11 0.481 . . . . 74.24 110.731 -176.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 1.4 tpmt? -149.23 122.94 9.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 71.22 105.53 172.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -107.74 134.87 50.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.042 0.449 . . . . 72.13 111.193 -176.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.4 145.35 47.22 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.369 -0.832 . . . . 70.51 109.12 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 31.2 m-80 -117.65 129.51 55.79 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.372 -1.344 . . . . 63.42 107.372 175.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.8 t -130.23 147.37 65.46 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.853 -0.795 . . . . 65.23 108.853 -176.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -61.51 130.99 33.8 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 122.632 2.222 . . . . 71.14 111.489 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 55.1 p -136.23 -177.93 4.93 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.782 -1.192 . . . . 65.34 107.782 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.1 m -66.12 136.73 95.49 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 106.17 -1.789 . . . . 75.45 106.17 172.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.15 -28.16 19.06 Favored 'Trans proline' 0 C--O 1.207 -1.058 0 C-N-CA 123.583 2.855 . . . . 62.53 113.334 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -62.24 -16.76 55.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.496 0.554 . . . . 65.34 112.496 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.432 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.0 mm? -107.59 6.0 27.49 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.108 -0.37 . . . . 71.03 110.866 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.76 127.44 19.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.446 0.641 . . . . 64.32 111.807 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.56 -3.37 85.14 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.495 -0.775 . . . . 71.15 112.692 175.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -112.1 160.79 17.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.499 -0.926 . . . . 64.13 108.499 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.49 131.34 34.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.588 -0.893 . . . . 64.45 108.588 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.48 -20.75 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.239 0.543 . . . . 74.12 111.437 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.35 166.73 30.59 Favored Glycine 0 N--CA 1.418 -2.559 0 C-N-CA 120.46 -0.876 . . . . 34.11 111.891 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 486' ' ' ILE . 11.0 p -125.01 144.2 50.51 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.194 -1.41 . . . . 75.24 107.194 177.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.456 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.7 t-20 -57.41 -48.19 97.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 120.604 -0.438 . . . . 63.12 110.899 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -78.25 121.04 5.12 Favored 'Trans proline' 0 C--N 1.37 1.66 0 N-CA-C 107.952 -1.595 . . . . 72.23 107.952 168.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.13 140.79 80.11 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.377 2.052 . . . . 74.25 112.401 -176.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.17 11.59 0.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.675 0.79 . . . . 62.12 112.754 -176.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -109.81 -0.16 18.52 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.882 -0.414 . . . . 45.12 109.882 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -124.65 160.99 27.24 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.645 0.735 . . . . 71.4 111.473 -173.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 4.1 m -91.16 132.69 35.91 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.961 -1.472 . . . . 63.54 109.732 -177.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.2 m -132.11 148.4 52.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.949 -0.76 . . . . 63.34 108.949 177.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.75 159.67 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.261 0.553 . . . . 44.1 111.848 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.0 -27.2 31.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.545 0.688 . . . . 73.31 109.835 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.1 t -88.11 5.12 42.73 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.255 -0.884 . . . . 61.31 109.905 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.76 136.83 35.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.989 -1.486 . . . . 72.53 106.989 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 65.0 t -82.57 116.36 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.942 0.401 . . . . 72.34 109.99 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.81 118.57 33.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.355 -0.98 . . . . 74.33 108.355 177.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.78 112.95 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.017 -1.475 . . . . 73.44 107.017 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.477 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -102.65 118.3 49.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.164 -1.051 . . . . 73.54 108.164 -177.948 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 28.8 mt -107.45 119.5 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 121.472 0.654 . . . . 74.44 109.986 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.442 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 22.1 t -97.99 139.26 20.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.446 -0.946 . . . . 71.25 108.446 -178.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.87 124.5 7.01 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.193 -0.763 . . . . 61.41 111.193 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 20.1 t -131.87 103.64 6.43 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.821 -1.177 . . . . 75.25 107.821 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.249 0 N-CA-C 109.756 -1.338 . . . . 41.45 109.756 179.222 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.32 -0.993 . . . . 75.24 108.32 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.41 161.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 116.54 -0.3 . . . . 43.44 110.832 -173.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -97.71 137.08 37.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.388 -0.967 . . . . 73.25 108.388 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.0 135.14 21.54 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.695 -0.483 . . . . 70.52 109.695 -176.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.6 150.92 86.13 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.256 1.97 . . . . 71.31 112.012 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.579 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 3.2 p30 -79.09 179.75 7.17 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.384 -0.825 . . . . 74.35 110.674 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.67 26.4 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 N-CA-C 107.433 -1.321 . . . . 73.44 107.433 176.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.579 ' HG3' ' OD1' ' A' ' 364' ' ' ASP . 0.9 OUTLIER -66.25 139.47 58.08 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.563 0.579 . . . . 74.23 112.563 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.65 0.24 59.28 Favored Glycine 0 C--N 1.307 -1.081 0 N-CA-C 111.577 -0.609 . . . . 44.42 111.577 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -122.57 -168.12 1.68 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.907 0.483 . . . . 70.1 109.718 -178.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -89.1 158.18 18.04 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.757 0.313 . . . . 63.4 110.548 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 31.1 t -63.37 -33.73 76.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.831 -0.803 . . . . 70.31 108.831 173.265 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.1 88.56 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.556 -0.747 . . . . 72.32 110.83 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.73 -43.92 87.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.491 -0.559 . . . . 72.44 109.491 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.5 -45.85 80.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.563 -0.744 . . . . 72.44 111.788 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.17 -48.06 89.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 123.382 0.426 . . . . 72.53 110.853 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.51 70.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.374 0.509 . . . . 71.24 112.374 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.0 m -61.35 -48.07 82.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.252 -0.431 . . . . 55.12 111.492 -177.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.92 -37.84 88.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.703 0.287 . . . . 64.31 111.398 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -60.59 -44.62 96.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.402 0.681 . . . . 73.25 109.879 177.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.08 -22.64 64.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.729 -0.668 . . . . 74.34 111.284 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.2 mmt180 -84.13 -14.27 50.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.088 0.47 . . . . 74.35 109.843 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 99.54 4.68 55.95 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.707 -0.679 . . . . 63.45 112.554 176.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.88 160.54 17.16 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 120.84 0.353 . . . . 71.35 110.487 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.37 142.82 32.21 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.69 -1.596 . . . . 74.22 106.69 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.09 132.61 67.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.996 -0.681 . . . . 72.2 111.384 -178.492 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -109.11 126.51 53.27 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 105.751 -1.944 . . . . 70.42 105.751 176.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 m -116.05 118.19 32.2 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 120.305 -0.558 . . . . 73.52 110.302 -173.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.06 119.18 34.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.097 -1.446 . . . . 65.41 107.097 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 17.5 pm0 -118.1 133.53 55.82 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.956 -0.757 . . . . 73.31 108.956 178.177 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -139.47 148.85 58.01 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 109.432 -0.581 . . . . 63.44 109.432 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.07 136.61 16.51 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 108.158 -1.516 . . . . 74.41 108.158 167.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t0 -173.15 164.73 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.032 -2.21 . . . . 63.02 105.032 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.3 t -115.96 -9.39 11.78 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 118.89 0.768 . . . . 75.13 110.664 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.8 m -79.5 -18.01 52.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.925 0.869 . . . . 75.32 109.386 -176.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 421' ' ' SER . 9.7 pt -103.48 150.87 38.47 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 65.54 110.333 -178.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 46.8 Cg_endo -78.74 -166.74 0.43 Allowed 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 124.425 3.416 . . . . 73.32 113.123 -174.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 396' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 9.3 Cg_endo -55.74 163.91 5.03 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.292 2.661 . . . . 71.24 112.011 168.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.44 -7.89 0.46 Allowed 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.886 1.674 . . . . 51.2 113.631 -174.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -73.28 116.63 14.05 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.309 -0.997 . . . . 63.54 108.309 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.87 119.2 11.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.384 -0.825 . . . . 75.33 110.817 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.422 HD13 ' HG3' ' A' ' 395' ' ' PRO . 41.2 pt -91.93 -27.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.695 -0.684 . . . . 70.42 111.682 -177.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.08 158.33 27.65 Favored Glycine 0 N--CA 1.423 -2.19 0 C-N-CA 120.021 -1.085 . . . . 73.33 110.652 -178.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -113.22 -178.21 3.32 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.758 -0.46 . . . . 75.52 109.758 -178.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.93 131.99 22.65 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 108.338 -0.986 . . . . 65.11 108.338 -177.068 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -44.32 -32.52 5.29 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 124.521 3.481 . . . . 63.13 115.158 -176.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.89 68.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.371 -0.377 . . . . 61.13 111.581 -177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.54 79.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.11 110.579 178.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -88.81 1.07 55.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.202 -0.599 . . . . 70.14 111.118 -178.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.7 m -86.35 150.04 24.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.715 -1.217 . . . . 52.54 107.715 172.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.58 112.43 10.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.53 169.98 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.859 -0.609 . . . . 72.54 110.77 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -63.19 142.99 58.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.754 -0.657 . . . . 54.53 109.967 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.96 109.74 2.65 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.562 -0.533 . . . . 74.42 109.562 177.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 106.01 33.56 3.46 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.578 -0.82 . . . . 72.33 112.079 -178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -90.4 177.26 6.44 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.084 -1.08 . . . . 63.45 108.084 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.04 120.17 36.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.22 0.533 . . . . 72.51 111.158 -177.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.84 126.03 59.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.126 -1.435 . . . . 73.5 107.126 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.1 t -93.62 125.21 38.1 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.275 1.036 . . . . 72.03 111.556 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.02 120.01 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 60.31 107.655 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.82 119.11 32.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.813 -0.63 . . . . 51.54 109.301 178.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 21.5 t -117.22 142.12 32.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.617 -0.72 . . . . 75.44 109.809 -175.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 394' ' ' ILE . 1.9 p -102.27 121.55 42.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 116.071 -0.513 . . . . 44.12 110.309 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.1 p -119.75 105.46 11.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.236 -0.585 . . . . 61.1 110.861 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.93 120.74 0.18 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 121.143 -0.551 . . . . 53.13 113.639 178.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 55.7 Cg_endo -75.22 128.95 11.71 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.239 1.959 . . . . 54.14 111.654 176.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -73.33 135.1 44.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.351 0.871 . . . . 74.42 113.351 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.5 mt-30 -128.04 142.44 51.22 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.28 -1.378 . . . . 42.12 107.28 172.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -129.56 151.78 49.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.642 -0.873 . . . . 65.01 108.642 -178.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 39.9 mt-10 -83.45 133.91 34.89 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.886 -0.413 . . . . 74.12 109.886 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 61.2 mt -81.96 128.53 68.06 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.507 -1.294 . . . . 55.43 107.507 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.87 140.37 35.03 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 121.141 1.228 . . . . 72.22 111.122 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.29 72.62 5.33 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.057 0.932 . . . . 73.13 110.813 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.1 16.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.953 -1.476 . . . . 44.35 108.454 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -81.26 -24.85 37.04 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.991 -1.004 . . . . 71.04 110.586 -175.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 3.1 p -69.26 -13.73 62.56 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 113.103 0.779 . . . . 72.21 113.103 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.61 -47.63 72.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.642 0.608 . . . . 72.44 112.642 -177.339 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.1 m -162.37 137.94 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.394 -0.965 . . . . 75.13 108.394 -178.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -53.77 -50.12 66.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.8 0.44 . . . . 72.44 111.826 178.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -58.84 -42.98 90.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.361 0.413 . . . . 72.12 111.076 -179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 72.9 mm-40 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 65.12 111.17 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.09 92.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.82 0.7 . . . . 74.44 110.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.84 -42.51 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 64.51 109.975 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.3 mmtp -67.08 -44.99 78.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.288 -0.414 . . . . 70.32 111.036 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 32.9 mmmt -61.97 -46.28 89.95 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.009 0.193 . . . . 74.15 110.887 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.18 81.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.486 0.551 . . . . 72.52 112.486 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 64.0 m -62.44 -40.85 97.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.807 -0.442 . . . . 63.54 109.807 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.45 -29.75 68.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.206 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -6.75 57.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 73.42 111.198 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.2 -2.82 33.14 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.06 -0.59 . . . . 73.31 113.412 175.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -93.63 96.0 9.56 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.665 -0.495 . . . . 74.11 109.665 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -104.38 -3.91 43.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.115 -0.794 . . . . 52.14 111.115 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -93.92 112.08 23.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.514 -0.921 . . . . 72.12 108.514 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.67 150.99 48.68 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.469 0.652 . . . . 72.34 112.011 -175.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -134.28 122.41 22.67 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 105.067 -2.197 . . . . 73.34 105.067 172.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -97.9 129.81 44.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.07 -0.652 . . . . 53.14 112.435 -174.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.69 150.97 50.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.142 -1.429 . . . . 65.52 107.142 175.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.554 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 35.9 m-80 -129.44 149.5 51.19 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.634 -0.506 . . . . 73.13 109.634 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.2 t -128.97 133.61 25.4 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 107.438 -1.319 . . . . 73.23 107.438 177.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.5 Cg_exo -61.9 118.73 5.63 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.493 1.462 . . . . 72.15 108.622 176.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.9 m -128.07 168.27 15.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.188 0.518 . . . . 62.23 111.852 -172.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 21.0 p -69.55 151.89 96.49 Favored Pre-proline 0 N--CA 1.417 -2.095 0 CA-C-N 114.705 -1.134 . . . . 55.21 110.452 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.2 Cg_endo -52.13 -24.48 20.26 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.827 3.018 . . . . 65.52 114.937 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.44 -30.56 57.42 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.721 -0.612 . . . . 74.12 112.282 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.71 -3.26 49.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.178 0.436 . . . . 63.31 112.178 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.2 p -60.2 127.16 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.116 0.484 . . . . 71.53 110.636 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.57 82.58 Favored Glycine 0 C--O 1.248 1.009 0 CA-C-N 115.773 -0.649 . . . . 53.1 111.746 177.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -110.66 154.37 23.92 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.019 -0.734 . . . . 40.15 109.019 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 486' ' ' ILE . 57.5 t -84.61 135.06 25.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 N-CA-C 106.644 -1.613 . . . . 54.03 106.644 175.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -100.43 -27.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.042 -1.463 . . . . 73.43 110.687 178.112 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.01 163.7 34.0 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.797 -0.921 . . . . 74.11 110.797 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 486' ' ' ILE . 12.6 p -119.02 154.49 33.01 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.941 -1.133 . . . . 73.0 107.941 177.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HB ' ' A' ' 485' ' ' ILE . 24.4 t-20 -69.38 -51.26 17.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 119.619 -0.833 . . . . 64.1 110.627 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.442 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 22.5 Cg_exo -68.35 141.32 51.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 107.443 -1.791 . . . . 64.42 107.443 168.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.19 126.85 19.56 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 122.168 1.912 . . . . 71.41 112.984 -175.669 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.19 4.47 26.57 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.144 -0.934 . . . . 72.01 111.785 -175.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.67 -11.62 14.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.473 0.654 . . . . 75.43 109.351 175.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -114.08 -179.73 3.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.606 1.706 . . . . 72.03 115.606 -168.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.8 m -88.2 116.18 26.22 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.866 -1.97 . . . . 72.34 110.676 -174.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.8 m -121.36 148.18 44.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.19 -0.67 . . . . 73.51 109.19 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.9 149.18 50.06 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 122.392 0.277 . . . . 72.1 111.122 -177.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 43.2 mm -68.9 -26.02 31.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.195 0.521 . . . . 64.5 111.019 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -88.83 -0.5 57.41 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.501 -0.75 . . . . 52.01 110.049 177.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -70.42 130.94 43.24 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.473 -0.566 . . . . 74.31 109.473 -176.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.87 113.18 18.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.564 -1.273 . . . . 74.21 107.564 177.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 60.1 t -87.16 120.06 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-O 121.321 0.581 . . . . 74.54 109.871 -176.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 45.4 mt -91.2 112.28 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.605 -1.998 . . . . 73.44 105.605 177.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.2 121.45 60.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.667 0 CA-C-N 115.016 -0.993 . . . . 71.15 108.404 -174.878 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.455 HG22 HD11 ' A' ' 468' ' ' ILE . 2.4 mp -99.22 117.87 44.97 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.767 0.794 . . . . 74.22 109.049 -177.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.554 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 26.7 t -97.66 141.36 16.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.809 -1.087 . . . . 53.41 108.54 -176.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -89.4 116.81 4.79 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.49 -1.444 . . . . 72.14 109.49 175.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.0 t -136.6 138.93 41.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.006 -1.109 . . . . 75.53 108.006 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.562 0 N-CA-C 108.555 -1.818 . . . . 55.42 108.555 179.675 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 411' ' ' SER . 28.1 m-20 . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 106.491 -1.67 . . . . 71.31 106.491 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.97 165.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 114.682 1.364 . . . . 53.44 114.682 -166.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -93.11 137.03 32.83 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.507 -1.664 . . . . 73.2 106.507 174.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.66 141.61 23.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.109 -0.636 . . . . 74.2 111.078 -171.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.63 129.92 16.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.569 1.513 . . . . 62.25 111.435 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 8.1 p-10 -80.12 133.78 36.11 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.355 -0.839 . . . . 63.01 110.372 -179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.9 t -87.74 47.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.443 1.116 . . . . 72.44 110.513 -172.074 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.3 ptm180 -66.88 139.97 57.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.134 -0.939 . . . . 75.25 111.544 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.05 0.18 60.15 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 116.117 -0.492 . . . . 70.04 112.906 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -120.35 175.35 6.01 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 122.509 -0.406 . . . . 74.15 110.154 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.3 p -72.98 157.24 37.8 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.218 -0.29 . . . . 43.34 110.218 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.2 p -59.78 -39.05 83.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.848 -0.427 . . . . 72.11 109.848 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.77 93.25 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.412 -0.813 . . . . 63.12 111.993 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -67.13 -41.99 85.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.807 -0.812 . . . . 74.32 108.807 -178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.3 78.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.421 -0.809 . . . . 64.21 111.189 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 370' ' ' SER . 98.7 mt -58.63 -44.83 90.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.577 -0.527 . . . . 74.32 109.577 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.66 74.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.25 -0.886 . . . . 52.31 112.063 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 29.1 m -66.12 -48.66 70.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.415 0.626 . . . . 73.1 109.872 -179.016 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.89 -39.83 91.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.782 -0.645 . . . . 52.34 110.581 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -61.6 -44.9 96.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 74.14 110.668 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -70.08 -21.31 63.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.153 0.501 . . . . 44.1 111.261 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -86.98 -14.65 41.08 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.158 -0.474 . . . . 72.3 111.458 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.26 8.05 66.89 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.261 -0.971 . . . . 75.0 112.657 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -75.36 163.75 27.12 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.158 -0.682 . . . . 64.52 109.158 178.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.8 mmtm -103.29 132.85 49.22 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.349 -0.982 . . . . 63.31 108.349 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.17 153.87 39.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 121.742 0.782 . . . . 62.21 112.823 -175.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -123.33 128.23 49.64 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.529 -1.669 . . . . 64.33 106.78 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.6 m -106.25 117.75 34.85 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.114 -1.069 . . . . 71.44 108.114 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 387' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.4 tm? -111.66 118.93 37.0 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 107.741 -1.207 . . . . 74.05 107.741 -176.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.9 pm0 -108.41 122.2 46.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.32 -0.993 . . . . 64.32 108.32 174.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -125.87 136.29 28.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 C-N-CA 120.446 -0.502 . . . . 72.34 111.706 -176.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.431 ' C ' ' HG3' ' A' ' 425' ' ' GLU . 2.4 Cg_endo -85.51 131.43 4.04 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 122.197 1.932 . . . . 72.52 108.163 167.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -175.3 -173.67 0.67 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.431 -2.063 . . . . 73.5 105.431 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.603 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 49.7 m -117.36 -6.6 11.24 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.943 0.877 . . . . 62.21 109.116 175.032 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.9 m -98.36 35.45 1.78 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.717 -1.586 . . . . 75.34 106.717 175.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.4 pp -88.33 146.43 37.86 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.893 -1.049 . . . . 73.23 112.131 -176.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.09 178.44 5.89 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.148 1.899 . . . . 51.13 109.399 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.28 161.37 45.95 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 121.609 1.539 . . . . 75.05 110.648 172.78 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -9.0 3.52 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.418 1.104 . . . . 75.24 111.095 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -110.42 137.07 48.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 105.379 -2.082 . . . . 74.4 105.379 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.54 118.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 123.453 0.471 . . . . 45.15 109.748 -173.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.31 -29.32 4.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.769 -1.567 . . . . 55.31 106.769 178.643 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.66 168.6 41.67 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 108.995 -1.642 . . . . 61.25 108.995 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 402' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 403' ' ' ASP . 10.9 m -114.33 -177.07 3.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.583 -1.636 . . . . 72.31 106.583 178.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 402' ' ' THR . 13.9 t70 -97.53 140.06 21.77 Favored Pre-proline 0 C--N 1.26 -3.307 0 N-CA-C 106.852 -1.536 . . . . 71.3 106.852 -175.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -33.81 -30.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 1 C-N-CA 126.209 4.606 . . . . 71.53 115.53 -177.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.82 47.16 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 123.611 0.765 . . . . 74.23 112.014 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.87 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 62.22 111.612 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -81.56 -0.6 42.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.837 0.68 . . . . 74.42 112.837 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 58.8 m -88.37 155.68 19.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.12 -1.437 . . . . 54.1 107.12 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.7 m -73.12 114.02 10.82 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.492 0.663 . . . . 74.31 109.273 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.74 170.29 5.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.305 -0.861 . . . . 63.42 109.537 -178.34 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 411' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 8.5 t -71.01 149.14 46.92 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 109.219 -0.66 . . . . 74.44 109.219 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.22 109.66 2.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.442 -0.948 . . . . 73.22 108.442 177.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.36 32.62 9.36 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.923 -0.871 . . . . 50.31 110.923 -176.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.6 t0 -87.05 -174.9 5.13 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 107.831 -1.174 . . . . 62.43 107.831 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 7.9 pt-20 -97.45 138.11 35.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.049 0.452 . . . . 74.42 111.51 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -125.01 124.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.933 -1.136 . . . . 51.41 107.933 175.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -90.86 125.95 35.89 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.846 0.831 . . . . 71.35 110.533 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.99 117.71 56.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.15 -1.055 . . . . 70.3 108.15 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 419' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 5.3 p30 -106.33 129.44 54.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.308 0.575 . . . . 74.24 112.468 -177.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.8 152.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.763 -1.108 . . . . 54.21 108.588 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 31.1 p -88.56 123.29 32.91 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.672 0.619 . . . . 70.44 112.672 -174.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 p -119.87 103.46 9.36 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.13 -1.028 . . . . 62.41 110.067 169.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.13 0.12 Allowed Glycine 0 CA--C 1.553 2.428 0 N-CA-C 115.473 0.949 . . . . 51.13 115.473 177.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.8 Cg_endo -85.47 133.65 4.61 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.202 1.935 . . . . 64.01 110.652 173.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 390' ' ' PRO . 10.0 mt-10 -76.44 145.19 39.45 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 113.167 0.803 . . . . 64.34 113.167 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.9 mt-30 -120.66 157.23 30.04 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.183 -1.371 . . . . 74.42 108.748 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -143.17 156.62 44.81 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.413 -1.329 . . . . 73.44 107.413 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.8 138.86 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.132 -1.062 . . . . 72.42 108.132 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 68.6 mt -79.52 132.14 62.84 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 73.54 108.687 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -53.19 141.53 58.64 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.607 2.205 . . . . 74.14 113.224 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.13 -17.72 48.91 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.505 -1.225 . . . . 73.01 112.19 -175.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.5 m -75.47 5.41 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.448 0.907 . . . . 64.23 113.448 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 48.3 m -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.264 0.839 . . . . 71.32 113.264 -175.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 52.5 m -68.92 -13.91 62.72 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.973 0.509 . . . . 62.42 112.365 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.16 -45.51 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.61 0.596 . . . . 73.04 112.61 -175.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 436' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 439' ' ' GLU . 48.1 m -162.73 145.22 10.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.525 -1.287 . . . . 51.22 107.525 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -56.84 -42.93 80.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.329 . . . . 64.33 111.102 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 438' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -62.62 -36.76 83.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 55.11 111.048 179.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 436' ' ' THR . 6.5 tp10 -67.8 -44.77 76.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.07 -0.715 . . . . 64.34 109.07 -178.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.92 -51.18 70.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.545 -1.207 . . . . 72.23 110.773 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.43 -38.29 80.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 113.439 0.903 . . . . 74.11 113.439 -177.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.8 mmtt -65.3 -49.02 71.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.9 -0.72 . . . . 74.32 110.166 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.01 -42.57 84.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.116 0.784 . . . . 74.3 113.116 -177.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.37 -43.69 76.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.231 0.456 . . . . 71.5 112.231 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -63.31 -41.86 98.97 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.951 0.405 . . . . 72.3 110.628 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.0 -24.64 62.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.96 -0.564 . . . . 61.3 111.602 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.56 -5.83 59.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 70.21 111.453 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.59 -17.73 25.47 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.473 -0.87 . . . . 63.03 112.204 178.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.04 67.89 7.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.201 0.524 . . . . 65.25 109.921 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -96.2 32.49 6.38 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.67 -0.972 . . . . 73.44 110.67 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -118.7 110.42 17.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.023 -1.843 . . . . 65.12 106.023 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.89 154.15 47.6 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.339 1.066 . . . . 74.3 113.084 -176.113 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.58 123.11 12.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 104.998 -2.223 . . . . 74.43 104.998 168.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.11 135.34 39.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.207 0.527 . . . . 74.33 111.469 -172.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.421 ' HB3' HG12 ' A' ' 487' ' ' ILE . . . -127.09 148.01 50.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.425 -1.324 . . . . 65.42 107.425 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -124.44 141.42 52.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.088 -1.078 . . . . 63.52 108.088 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.2 m -140.36 147.14 48.51 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 108.862 -0.792 . . . . 51.44 108.862 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 490' ' ' SER . 33.8 Cg_exo -61.45 129.66 28.95 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.708 2.272 . . . . 74.45 111.678 -176.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -145.83 164.68 31.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.154 -0.476 . . . . 73.13 111.035 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -61.37 144.6 91.75 Favored Pre-proline 0 N--CA 1.442 -0.864 0 O-C-N 124.27 0.981 . . . . 74.12 110.463 178.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.37 -34.28 31.93 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.996 3.131 . . . . 74.22 113.832 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.77 -15.3 62.66 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.381 0.511 . . . . 75.53 112.381 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 -8.52 14.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.504 -0.316 . . . . 71.44 111.775 176.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 81.3 t -60.35 126.94 19.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 120.953 0.406 . . . . 74.32 110.546 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.87 -3.16 70.36 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 110.962 -0.855 . . . . 75.1 110.962 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -116.38 155.44 28.48 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.086 -1.079 . . . . 75.31 108.086 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 486' ' ' ILE . 45.5 t -84.57 127.36 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.511 -0.551 . . . . 62.42 109.511 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.85 -18.14 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.929 -0.708 . . . . 74.12 111.405 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.19 161.7 28.04 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.574 -0.822 . . . . 53.51 111.708 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 486' ' ' ILE . 15.9 p -132.92 155.47 49.01 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.366 -1.346 . . . . 71.53 107.366 177.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -59.53 -57.85 23.87 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 120.516 -0.474 . . . . 73.33 110.103 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.19 125.21 5.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 109.09 -1.158 . . . . 74.52 109.09 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -62.36 144.17 94.7 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.057 1.838 . . . . 72.11 112.044 -177.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.29 5.98 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.159 0.984 . . . . 65.32 112.674 -174.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -109.0 -14.51 14.54 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.176 -0.466 . . . . 71.25 110.029 176.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.97 150.64 20.18 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.156 0.979 . . . . 74.24 111.717 -172.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 426' ' ' GLN . 19.4 m -85.23 111.42 19.82 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 113.588 -1.642 . . . . 63.35 107.769 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.0 m -118.19 148.56 42.25 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.917 -0.583 . . . . 73.12 110.036 -175.022 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.58 146.72 52.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 122.587 0.355 . . . . 70.43 110.781 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.603 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 48.3 mm -67.21 -14.68 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 CA-C-O 122.171 0.986 . . . . 71.13 110.306 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.0 t -92.16 5.52 50.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.603 -0.726 . . . . 63.41 110.358 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -89.66 133.76 34.49 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 110.062 -0.347 . . . . 72.33 110.062 178.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 122.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.855 -1.165 . . . . 71.21 107.855 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.77 119.79 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 120.19 -0.604 . . . . 75.32 109.49 -178.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.35 112.51 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.596 -2.372 . . . . 75.51 104.596 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.73 118.93 56.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 114.959 -1.018 . . . . 62.54 108.754 -173.528 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' A' ' 455' ' ' ALA . 41.2 mt -100.16 116.49 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.994 -0.743 . . . . 73.23 108.994 -177.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.6 138.14 23.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.692 -1.225 . . . . 73.52 107.692 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.48 114.69 3.93 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.285 -1.526 . . . . 44.21 109.285 177.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.7 m -142.9 143.93 32.23 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 122.009 -0.7 . . . . 62.02 109.667 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.364 0 N-CA-C 108.693 -1.763 . . . . 51.0 108.693 178.252 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.502 -0.897 0 N-CA-C 106.675 -1.602 . . . . 70.51 106.675 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.94 149.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.585 0.231 . . . . 74.42 110.45 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -95.8 136.48 36.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.637 -0.875 . . . . 74.11 108.637 177.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 8.6 p -97.86 127.49 37.04 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 120.329 -0.548 . . . . 74.01 110.389 -175.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 74.4 Cg_exo -56.05 148.83 56.34 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.086 2.524 . . . . 33.45 113.388 179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 146.3 53.03 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.392 -0.822 . . . . 73.44 111.493 -178.493 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 24.2 m -96.37 25.31 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 122.337 1.065 . . . . 72.04 109.659 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -65.32 137.17 57.35 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.778 -1.101 . . . . 75.44 111.995 -177.276 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.43 0.91 47.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.451 -0.88 . . . . 63.04 114.001 176.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 1.8 pt20 -125.83 -172.16 2.54 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.193 -0.669 . . . . 55.22 109.193 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 80.3 p -90.11 164.48 14.45 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.81 -0.756 . . . . 62.31 109.701 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 374' ' ' ILE . 3.8 p -62.09 -33.61 74.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.798 0.332 . . . . 74.24 110.305 175.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.66 98.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.794 -0.639 . . . . 63.12 109.962 176.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.321 -0.4 . . . . 72.25 110.108 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.29 70.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.763 0.665 . . . . 72.22 110.47 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 370' ' ' SER . 91.0 mt -60.25 -46.51 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.646 -0.706 . . . . 71.54 110.046 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.29 -46.99 84.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.105 -0.498 . . . . 74.2 111.905 -178.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.83 -47.84 76.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.516 -0.311 . . . . 72.05 110.431 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.17 -38.01 89.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.561 -0.29 . . . . 73.12 111.695 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -59.77 -46.92 87.67 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.601 0.76 . . . . 71.21 109.11 177.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -67.97 -30.73 70.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.558 -0.746 . . . . 72.35 111.193 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -80.09 -11.29 59.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.839 -0.619 . . . . 63.43 111.917 178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.72 12.46 58.04 Favored Glycine 0 CA--C 1.497 -1.034 0 C-N-CA 120.284 -0.96 . . . . 40.11 112.953 174.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.21 146.46 24.74 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.972 0.415 . . . . 72.32 109.954 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 34.0 mmtp -88.3 132.82 34.25 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.832 -1.914 . . . . 70.22 105.832 -178.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 141.45 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 119.899 -0.72 . . . . 73.31 111.674 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -115.99 127.98 55.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.175 -1.417 . . . . 73.32 107.175 177.179 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.6 m -101.06 119.27 38.5 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.597 -0.841 . . . . 71.12 109.709 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -111.73 119.65 39.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.64 -1.244 . . . . 73.44 107.64 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.4 pm0 -96.27 122.6 39.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.648 -0.706 . . . . 63.42 109.25 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -123.79 115.89 27.87 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 115.737 -0.665 . . . . 73.44 111.883 -177.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.59 134.7 6.62 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.18 1.92 . . . . 33.44 110.569 174.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.5 t70 175.71 -168.42 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 105.396 -2.076 . . . . 74.04 105.396 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.6 m -132.43 -11.0 3.2 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 118.38 0.537 . . . . 74.25 111.42 176.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 44.9 p -99.13 14.35 29.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.357 1.075 . . . . 61.4 109.5 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.401 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 1.5 pp -88.59 152.6 49.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 CA-C-N 113.877 -1.511 . . . . 71.52 112.583 -176.277 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.66 138.65 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.152 1.901 . . . . 72.31 109.921 174.052 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.25 154.5 40.05 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.796 2.33 . . . . 64.12 111.893 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.32 -8.48 3.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.506 0.67 . . . . 74.53 111.866 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 35.6 m170 -95.66 109.19 21.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.143 -2.169 . . . . 74.21 105.143 172.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.8 119.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.232 1.015 . . . . 61.35 112.85 -169.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.46 -29.02 3.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.063 -1.426 . . . . 73.5 110.504 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.54 28.88 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.029 -1.228 . . . . 63.41 110.029 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 -175.23 2.63 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.874 -0.787 . . . . 61.33 108.874 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.31 140.93 21.83 Favored Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 115.777 -0.647 . . . . 75.32 109.795 -172.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.27 -24.77 6.24 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 125.077 3.852 . . . . 43.35 115.059 -177.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.01 -29.34 69.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.591 0.234 . . . . 53.42 110.981 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.33 57.96 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 121.673 0.749 . . . . 44.21 110.13 178.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.4 -9.68 59.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.359 -0.837 . . . . 70.21 110.733 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.2 m -87.53 151.08 23.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.613 -0.884 . . . . 73.43 108.613 177.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 66.3 m -74.17 116.81 15.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.412 0.625 . . . . 54.3 109.636 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.09 169.97 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.444 -0.798 . . . . 73.15 109.501 -177.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.0 t -79.02 155.4 28.85 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.746 -1.205 . . . . 73.52 107.746 176.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.3 110.74 4.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.056 0.455 . . . . 74.33 110.244 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.07 37.7 1.63 Allowed Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.585 -0.734 . . . . 34.22 111.707 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.31 178.57 5.93 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.722 -1.214 . . . . 65.24 107.722 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.0 mt-10 -100.19 108.97 21.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.253 0.549 . . . . 74.13 111.525 -176.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.01 126.78 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.377 -1.342 . . . . 70.13 107.377 177.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 72.5 p -90.71 123.49 34.34 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.296 -0.562 . . . . 52.12 109.763 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.34 121.07 47.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.18 -1.045 . . . . 74.14 108.18 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -92.24 124.6 36.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.313 -0.625 . . . . 71.51 109.313 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.7 p -126.26 131.03 71.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.89 -1.152 . . . . 72.15 107.89 175.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 39.9 m -94.4 122.13 36.65 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.413 -0.915 . . . . 74.04 108.945 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 19.8 m -119.36 107.07 12.92 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.527 -0.761 . . . . 74.54 110.623 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 80.02 147.5 4.65 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 121.244 -0.503 . . . . 54.41 113.482 177.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.4 Cg_endo -85.01 154.48 11.22 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.186 1.924 . . . . 74.34 110.762 174.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 4.5 mm-40 -83.43 126.64 32.96 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 119.97 -0.692 . . . . 72.01 111.347 176.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 48.3 mt-30 -100.7 127.69 47.01 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.616 -1.253 . . . . 73.54 107.616 175.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 449' ' ' PHE . 10.1 tpt180 -122.2 149.41 43.7 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.941 -1.133 . . . . 70.41 107.941 -173.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -83.11 138.61 33.61 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 122.83 0.452 . . . . 75.32 111.423 -176.511 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.9 mt -89.6 131.38 40.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 109.849 -0.426 . . . . 75.21 109.849 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.6 Cg_exo -70.36 141.73 43.54 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.152 2.568 . . . . 53.05 113.443 176.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.01 -22.25 31.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.913 0.885 . . . . 42.43 110.061 -178.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.21 -3.55 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 121.877 0.846 . . . . 62.11 111.223 -175.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 8.7 p -61.03 -31.87 71.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.222 1.009 . . . . 74.32 111.409 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.4 m -67.38 -26.58 66.53 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.707 0.803 . . . . 72.11 112.537 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.34 -41.67 47.56 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.583 0.586 . . . . 72.44 112.583 -172.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.5 m -148.01 139.72 23.84 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.135 -0.691 . . . . 64.13 109.135 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -61.19 -38.86 88.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.669 -0.493 . . . . 74.51 109.669 176.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.13 -47.74 84.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.773 -0.649 . . . . 74.42 110.336 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -36.61 84.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.192 0.307 . . . . 64.24 111.649 177.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.43 -51.35 69.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.086 -0.338 . . . . 45.31 110.086 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.85 -45.76 90.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.278 -0.419 . . . . 54.44 110.657 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -63.45 -47.41 81.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.477 0.547 . . . . 73.43 112.477 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -66.28 -40.87 90.35 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.837 0.31 . . . . 72.41 111.837 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.62 -43.44 89.57 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.552 -0.459 . . . . 74.42 110.908 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 75.5 m -62.68 -40.49 97.28 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 110.015 -0.365 . . . . 72.42 110.015 178.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.2 -26.52 64.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.265 -0.425 . . . . 62.34 111.965 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.96 -13.65 50.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.749 -0.205 . . . . 73.24 111.25 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.48 -0.03 26.33 Favored Glycine 0 C--N 1.319 -0.409 0 C-N-CA 120.267 -0.968 . . . . 63.42 113.023 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 81.5 m-85 -83.62 106.91 15.72 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 122.527 -0.396 . . . . 75.22 110.016 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.4 19.3 13.08 Favored Glycine 0 C--N 1.297 -1.606 0 N-CA-C 110.009 -1.236 . . . . 24.35 110.009 176.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -113.12 111.02 21.4 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.172 -1.788 . . . . 63.1 106.172 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -131.46 148.66 52.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 72.45 111.63 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -142.16 123.04 14.41 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.935 -1.505 . . . . 73.42 106.935 172.2 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -104.1 135.76 45.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.916 0.339 . . . . 74.1 111.916 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.66 156.15 47.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.71 -0.478 . . . . 33.31 109.71 175.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -120.78 137.96 54.26 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.799 -0.815 . . . . 74.44 108.799 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 47.6 m -141.55 147.66 46.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 120.482 -0.487 . . . . 70.31 111.14 178.149 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_endo -65.98 125.49 14.26 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.973 2.449 . . . . 65.31 111.328 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 16.5 t -138.88 -176.49 4.51 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.318 -1.364 . . . . 61.43 107.318 -176.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.6 m -56.64 129.79 76.81 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.898 -0.778 . . . . 52.11 108.898 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.01 -25.64 12.93 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 124.023 3.149 . . . . 52.43 114.262 -178.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.41 -24.36 57.12 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.801 0.334 . . . . 72.32 111.683 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.64 12.18 34.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.639 -0.255 . . . . 45.32 111.51 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.55 126.39 17.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.849 0.833 . . . . 63.1 110.787 177.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.17 -6.86 72.51 Favored Glycine 0 C--N 1.306 -1.106 0 CA-C-N 115.194 -0.912 . . . . 72.03 111.74 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -100.88 152.21 20.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.627 -0.508 . . . . 73.3 109.627 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 58.4 t -84.6 136.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.828 -0.805 . . . . 71.31 108.828 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.04 -16.59 7.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.179 -1.008 . . . . 71.44 110.734 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.91 -179.27 26.81 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.38 -0.827 . . . . 74.32 111.714 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.9 p -116.82 161.87 18.6 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.286 -1.376 . . . . 75.11 107.286 178.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.17 -54.58 32.12 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.801 -1.16 . . . . 74.03 110.602 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.43 120.39 6.92 Favored 'Trans proline' 0 C--N 1.372 1.811 0 N-CA-C 105.963 -2.36 . . . . 60.23 105.963 166.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.7 Cg_endo -62.68 158.76 40.26 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 122.173 1.915 . . . . 62.44 113.798 -171.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.6 11.82 0.44 Allowed 'General case' 0 C--O 1.21 -0.975 0 CA-C-O 122.377 1.084 . . . . 51.11 111.6 178.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 475' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 473' ' ' PRO . 2.6 m-20 -109.13 -8.09 15.21 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.725 -1.213 . . . . 64.32 107.725 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -100.39 159.66 14.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.072 -0.967 . . . . 71.01 111.99 -171.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.1 m -114.66 108.12 16.39 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.428 -1.693 . . . . 74.1 106.428 177.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.8 p -112.24 143.19 43.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 122.128 -0.358 . . . . 64.54 111.954 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -63.99 144.37 57.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 72.42 110.34 176.051 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.17 -4.57 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.424 1.089 . . . . 42.41 111.758 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.7 p -87.17 -5.88 58.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.321 -0.862 . . . . 75.11 110.377 178.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -92.46 139.05 30.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.795 -0.639 . . . . 75.24 109.405 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.42 122.2 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.496 -1.668 . . . . 72.43 106.496 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.52 120.35 36.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.875 -0.787 . . . . 74.43 108.875 -175.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 121.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 108.056 -1.09 . . . . 71.52 108.056 -177.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -110.25 118.04 56.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.171 -0.922 . . . . 70.11 108.78 -177.069 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.29 119.24 48.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-N 115.414 -0.812 . . . . 71.32 109.482 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.6 t -97.63 133.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.246 -1.39 . . . . 64.23 107.246 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.02 125.25 7.11 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 111.425 -0.67 . . . . 72.53 111.425 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -129.52 107.01 9.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.553 -1.647 . . . . 71.45 106.553 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 491' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.416 -2.638 0 CA-C-O 118.478 -1.179 . . . . 74.15 111.45 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 106.374 -1.713 . . . . 53.22 106.374 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.5 162.24 15.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 120.893 0.378 . . . . 72.23 110.992 -172.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -95.01 136.31 35.48 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.856 -1.164 . . . . 60.35 107.856 178.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 130.9 27.84 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.077 -0.712 . . . . 64.11 109.077 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -62.39 117.61 4.48 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.335 1.356 . . . . 72.11 109.023 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.28 166.81 22.26 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.454 -0.794 . . . . 74.54 109.965 -176.039 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.72 40.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 122.954 1.359 . . . . 52.14 111.859 -168.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -66.3 145.81 55.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.929 -1.032 . . . . 74.24 110.449 172.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.71 0.51 39.68 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 114.33 0.492 . . . . 74.11 114.33 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . 0.285 0.5 OUTLIER -145.71 172.1 13.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.68 0.74 . . . . 70.1 112.804 175.592 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.3 p -54.12 154.7 4.09 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.811 1.244 . . . . 74.32 113.261 -175.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 9.1 p -57.69 -38.86 75.91 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.439 -0.8 . . . . 73.14 111.267 177.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.75 84.38 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 45.31 111.052 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.43 -37.03 77.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.103 0.478 . . . . 53.13 109.74 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.89 67.92 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.446 -0.797 . . . . 62.2 111.48 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.24 -43.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.79 -0.641 . . . . 55.45 111.367 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.38 -36.27 83.16 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.917 0.339 . . . . 71.12 111.917 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.9 m -65.89 -47.61 74.24 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.011 0.434 . . . . 75.13 110.629 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.98 -38.51 91.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.011 -0.541 . . . . 72.15 110.802 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.35 -42.73 92.22 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.138 0.975 . . . . 71.01 109.601 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.02 -30.68 69.97 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.965 -0.561 . . . . 73.43 112.29 178.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -80.97 -9.81 59.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.833 0.349 . . . . 65.31 111.397 176.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.15 12.64 54.6 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.864 -0.607 . . . . 73.34 113.526 173.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -91.29 149.18 21.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.12 0.486 . . . . 75.33 110.514 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 24.4 mmtp -90.5 137.06 32.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.167 -1.79 . . . . 73.24 106.167 -176.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -119.21 139.56 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 C-N-CA 118.969 -1.092 . . . . 75.13 113.526 -175.459 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -111.31 144.76 39.98 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.638 -1.616 . . . . 73.11 106.638 172.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.2 m -132.43 124.65 29.03 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.412 -0.958 . . . . 73.44 108.412 178.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -115.1 119.81 37.67 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.106 -1.442 . . . . 71.22 107.106 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.7 pm0 -111.36 135.5 51.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.343 -0.614 . . . . 72.31 109.343 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 391' ' ' ASP . 19.6 ptmt -139.81 132.93 15.25 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.237 -0.585 . . . . 74.2 111.797 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.6 Cg_exo -78.64 140.15 16.47 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.371 2.047 . . . . 74.15 109.018 167.503 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 394' ' ' ILE . 9.1 t70 -170.42 -174.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.716 -1.587 . . . . 73.14 106.716 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 t -108.53 -34.84 6.63 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.714 -1.217 . . . . 74.24 107.714 177.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.1 p -87.62 40.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.911 0.862 . . . . 71.13 110.033 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 391' ' ' ASP . 23.2 pt -88.23 141.89 31.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.139 -0.937 . . . . 44.41 111.85 -176.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 172.79 15.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 106.983 -1.968 . . . . 64.41 106.983 167.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.15 147.42 66.73 Favored 'Trans proline' 0 C--O 1.209 -0.941 0 C-N-CA 121.373 1.382 . . . . 73.34 110.778 176.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.0 -7.16 10.58 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.158 0.98 . . . . 61.41 111.816 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -84.28 121.22 27.19 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.691 -2.707 . . . . 74.53 103.691 173.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.61 117.1 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.512 0.672 . . . . 71.01 110.372 -170.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.35 -28.18 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 114.893 -1.049 . . . . 71.12 109.39 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.68 157.82 27.48 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.374 -1.49 . . . . 54.15 109.374 -178.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -128.11 -174.8 3.31 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 123.679 0.792 . . . . 72.12 110.663 -173.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.65 129.13 29.51 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.648 -1.241 . . . . 60.43 107.648 -176.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -50.62 -27.75 20.33 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.202 3.268 . . . . 61.33 115.193 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.07 -26.0 67.34 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 111.926 0.343 . . . . 54.43 111.926 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.73 -36.03 81.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.756 0.788 . . . . 72.2 109.925 176.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -90.26 -2.25 58.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.543 -0.753 . . . . 73.21 111.216 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -91.31 165.14 13.59 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.061 -1.459 . . . . 71.14 107.061 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 56.9 p -74.36 113.63 11.81 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.177 0.513 . . . . 74.45 111.297 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.84 163.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.73 -0.668 . . . . 65.34 109.466 177.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.7 m -77.7 157.99 29.86 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.514 -0.55 . . . . 41.22 109.514 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.27 109.74 3.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.385 -0.598 . . . . 61.41 109.385 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 97.29 25.49 11.03 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.804 -0.712 . . . . 64.51 112.492 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.6 -172.16 3.7 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.261 -1.015 . . . . 72.31 108.261 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.0 pt-20 -107.77 139.41 42.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 118.665 0.666 . . . . 74.14 112.169 -176.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.06 136.52 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.753 -1.203 . . . . 65.42 107.753 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 10.8 t -108.37 130.93 55.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.611 0.719 . . . . 71.45 110.675 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 67.5 t -113.79 127.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.182 -0.917 . . . . 65.25 108.555 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -97.6 127.9 43.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.337 -0.616 . . . . 64.2 109.337 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 64.0 t -120.96 143.74 32.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.275 -1.009 . . . . 72.33 108.275 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.6 p -100.79 122.6 43.67 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.176 -0.675 . . . . 63.2 109.176 178.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 21.1 p -118.64 105.12 11.27 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.662 -0.815 . . . . 72.2 111.522 -178.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 72.65 152.22 1.66 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.936 0.735 . . . . 74.43 114.936 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.2 Cg_exo -80.76 148.32 17.66 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.296 1.998 . . . . 70.43 110.506 173.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.65 150.61 42.84 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.861 -0.609 . . . . 75.51 111.934 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.9 mt-30 -125.78 145.59 50.14 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.439 -0.949 . . . . 72.13 108.439 174.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 480' ' ' ILE . 4.7 tpt180 -148.15 156.92 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.013 -1.106 . . . . 71.43 108.013 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 44.5 tt0 -83.45 136.56 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.923 -0.399 . . . . 74.2 109.923 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.06 131.08 52.28 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 106.762 -1.57 . . . . 75.1 106.762 176.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 430' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 443' ' ' LYS . 32.1 Cg_endo -70.11 141.3 43.45 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.119 1.212 . . . . 65.43 110.656 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.36 -5.63 56.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.219 0.533 . . . . 75.04 111.743 -175.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 430' ' ' PRO . 34.2 m -76.7 -3.83 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 75.31 111.019 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.9 m -59.98 -27.58 66.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 41.32 110.786 178.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 37.6 p -69.15 -12.54 61.76 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.516 -0.766 . . . . 75.02 112.324 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.99 -47.66 17.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.795 0.665 . . . . 74.44 112.795 -177.153 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 27.0 m -153.77 141.06 19.6 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.662 -0.649 . . . . 62.33 109.921 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -56.18 -50.78 70.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.995 0.518 . . . . 72.22 112.208 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.32 -45.21 76.35 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.247 0.546 . . . . 63.1 111.22 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.38 -38.51 78.06 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.001 -0.999 . . . . 74.35 110.337 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -47.26 86.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.382 0.426 . . . . 64.34 110.328 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.47 -45.73 93.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.102 -0.499 . . . . 65.21 110.585 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.59 -41.63 88.2 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.753 0.279 . . . . 53.34 111.753 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.455 ' HB3' ' CG ' ' A' ' 430' ' ' PRO . 72.1 mmtt -62.77 -42.1 99.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.767 0.318 . . . . 54.53 111.616 178.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.31 -39.53 82.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.275 -0.421 . . . . 64.51 111.248 176.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 63.5 m -62.54 -39.58 94.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.573 -0.528 . . . . 73.04 109.573 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.63 65.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.628 . . . . 65.35 111.076 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -13.48 56.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.954 0.407 . . . . 44.4 110.154 177.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.32 -17.09 14.59 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.082 -0.58 . . . . 54.14 113.225 176.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.59 117.59 13.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.976 0.388 . . . . 71.12 111.062 -175.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.41 10.74 16.81 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 110.552 -1.019 . . . . 55.44 110.552 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -105.89 111.72 24.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.416 -1.327 . . . . 62.42 107.416 -177.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -132.77 146.87 52.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.375 0.607 . . . . 62.34 112.21 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -143.01 122.96 13.52 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.771 -1.566 . . . . 65.12 106.771 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -99.59 134.93 41.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.785 0.326 . . . . 64.4 110.581 -176.451 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -134.18 150.79 51.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.217 -1.031 . . . . 53.33 108.217 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.43 140.47 51.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.781 -0.452 . . . . 62.14 109.781 178.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 457' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 8.5 t -127.03 137.37 30.47 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.424 -1.324 . . . . 72.3 107.424 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.9 Cg_exo -61.23 119.5 6.68 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.338 2.025 . . . . 75.44 111.189 -177.682 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.2 m -131.34 -179.84 5.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.527 -0.76 . . . . 61.1 109.174 -176.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.467 ' HB ' HD13 ' A' ' 463' ' ' LEU . 62.7 m -68.45 136.78 90.9 Favored Pre-proline 0 N--CA 1.428 -1.568 0 N-CA-C 107.848 -1.168 . . . . 73.12 107.848 174.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.8 -22.88 7.69 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.846 3.697 . . . . 73.23 114.707 -176.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.58 -17.56 60.0 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.002 0.43 . . . . 74.14 111.356 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 463' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.3 mp -99.67 11.49 39.07 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.959 0.355 . . . . 73.14 111.959 -178.061 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 31.0 m -59.61 127.72 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.217 0.532 . . . . 61.32 111.629 176.092 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.49 -1.42 88.36 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 115.539 -0.755 . . . . 71.21 111.839 178.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 463' ' ' LEU . 62.8 tttp -101.54 138.94 37.87 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.122 -1.066 . . . . 62.33 108.122 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 486' ' ' ILE . 60.0 t -84.11 128.08 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.987 0.423 . . . . 63.24 110.38 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.98 -16.9 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 112.165 0.432 . . . . 63.11 112.165 -177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.43 166.01 33.5 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.795 -0.717 . . . . 74.42 111.769 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.8 p -135.77 155.55 50.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.45 -0.945 . . . . 75.0 108.45 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.88 -55.62 42.92 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.421 -0.323 . . . . 71.41 111.847 176.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.6 Cg_exo -76.8 142.71 22.85 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 108.162 -1.514 . . . . 74.42 108.162 172.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 30.8 Cg_endo -61.92 127.46 21.46 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.287 1.992 . . . . 72.52 111.761 -177.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.83 2.58 22.6 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.065 -0.971 . . . . 65.24 112.013 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -111.32 3.48 18.33 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.328 -0.396 . . . . 75.21 110.668 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.526 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 59.1 tp60 -129.57 166.07 20.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.493 0.663 . . . . 60.45 111.539 -170.049 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 62.6 m -81.85 124.18 29.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.644 -1.162 . . . . 55.23 109.799 176.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -127.37 149.47 50.05 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.761 0.424 . . . . 74.41 110.008 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.16 135.71 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.629 0.252 . . . . 73.14 110.63 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 427' ' ' ARG . 42.1 mm -62.94 -14.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.88 1.272 . . . . 71.14 112.282 -174.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -87.51 -2.55 58.69 Favored 'General case' 0 C--N 1.313 -1.003 0 O-C-N 121.6 -0.688 . . . . 62.24 110.635 -177.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 44.4 m-80 -84.61 136.98 33.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.473 -0.565 . . . . 73.3 109.473 178.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.85 124.45 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.278 -1.008 . . . . 62.23 108.278 176.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.96 119.09 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 C-N-CA 119.239 -0.984 . . . . 74.45 109.005 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.9 mp -91.7 112.66 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 N-CA-C 104.557 -2.386 . . . . 75.31 104.557 173.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.03 118.55 52.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.09 -1.078 . . . . 64.2 108.09 -175.844 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.63 118.35 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.578 0.704 . . . . 71.23 109.356 -176.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.81 141.3 16.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 107.798 -1.186 . . . . 72.54 107.798 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.9 124.29 6.52 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.002 -1.239 . . . . 64.25 110.002 177.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.1 t -141.52 136.49 31.22 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.613 -0.884 . . . . 71.44 108.613 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.665 0 N-CA-C 109.395 -1.482 . . . . 74.44 109.395 -179.577 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 105.817 -1.92 . . . . 74.23 105.817 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.88 149.34 21.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 C-N-CA 120.146 -0.622 . . . . 54.44 110.822 -175.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -94.28 137.22 33.7 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 105.756 -1.942 . . . . 74.42 105.756 173.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.09 124.79 52.91 Favored Pre-proline 0 C--N 1.279 -2.487 0 C-N-CA 118.342 -1.343 . . . . 72.24 110.536 -169.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -51.06 129.25 27.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.57 2.847 . . . . 61.33 113.006 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.3 140.4 43.09 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.492 -1.231 . . . . 61.15 111.285 -175.458 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.41 20.28 5.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.635 -1.246 . . . . 41.11 107.635 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -64.64 133.38 52.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.961 -1.018 . . . . 72.32 111.457 -178.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 0.19 46.58 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.071 -0.968 . . . . 51.1 110.905 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -125.22 -179.81 4.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.991 -0.744 . . . . 73.02 108.991 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 93.9 p -72.48 143.04 48.55 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.485 0.584 . . . . 63.2 111.389 -176.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 374' ' ' ILE . 27.9 m -62.34 -33.65 75.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.221 -0.445 . . . . 51.13 110.971 178.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.67 94.44 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-N 116.299 -0.409 . . . . 72.04 111.062 178.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.99 -35.07 76.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 75.31 109.889 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.69 92.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.84 -0.618 . . . . 74.42 110.516 176.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 384' ' ' ILE . 82.6 mt -57.79 -46.91 87.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 122.644 0.377 . . . . 75.4 110.078 178.825 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.6 94.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.972 -0.558 . . . . 53.12 111.288 179.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 57.0 m -61.66 -47.64 84.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.894 -0.594 . . . . 72.21 110.952 -179.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.3 -38.45 91.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.388 -0.369 . . . . 75.04 111.465 178.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.87 -42.89 94.71 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.65 0.594 . . . . 73.02 109.6 178.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.356 0.873 . . . . 53.13 113.356 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.96 -14.71 53.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.127 0.489 . . . . 52.01 110.022 173.097 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.43 53.51 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.941 -0.572 . . . . 52.22 112.874 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 43.3 m-85 -84.19 152.96 23.93 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.427 0.632 . . . . 73.12 111.938 -177.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.64 134.54 34.6 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.008 -1.479 . . . . 74.01 107.008 177.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -117.47 136.64 53.97 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 C-N-CA 119.197 -1.001 . . . . 72.32 111.874 -179.14 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -111.69 128.38 56.05 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.003 -1.908 . . . . 74.51 105.976 178.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.0 m -111.41 136.65 50.26 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 119.403 -0.919 . . . . 42.12 109.444 -178.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -120.18 117.89 29.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.513 -1.662 . . . . 74.11 106.513 176.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 122.05 46.11 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.484 -1.673 . . . . 62.41 106.484 177.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -139.61 148.38 55.75 Favored Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 118.893 -1.123 . . . . 75.41 110.746 178.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 85.1 Cg_endo -85.48 163.74 10.96 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.274 1.983 . . . . 61.2 109.584 170.301 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.2 t70 165.22 -173.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.754 -2.313 . . . . 71.11 104.754 176.023 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.4 t -115.84 -25.39 7.77 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.566 -1.642 . . . . 72.51 106.566 174.251 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 9.9 m -98.47 69.2 1.9 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.621 -2.363 . . . . 75.44 104.621 171.169 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 421' ' ' SER . 4.4 pt -95.97 138.56 21.66 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 113.673 -1.603 . . . . 51.24 112.921 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 421' ' ' SER . 16.7 Cg_exo -70.4 114.35 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 106.224 -2.26 . . . . 72.24 106.224 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.11 160.34 13.12 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.514 2.809 . . . . 52.42 115.54 -169.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.06 -6.86 2.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.107 0.963 . . . . 74.32 112.003 176.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.9 m170 -107.47 120.15 41.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 103.662 -2.718 . . . . 72.1 103.662 171.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.97 117.97 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.088 0.947 . . . . 71.03 109.822 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.91 -28.87 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.947 -1.024 . . . . 44.4 110.441 -174.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.44 157.98 27.56 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.973 -1.251 . . . . 73.25 109.973 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.7 p -118.28 -178.76 3.59 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 123.194 0.598 . . . . 72.55 109.97 -177.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -102.08 155.2 36.74 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.374 -0.602 . . . . 64.11 109.374 -176.125 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.4 -30.66 64.44 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.085 2.523 . . . . 75.54 113.902 -176.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.15 -30.7 65.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.895 0.378 . . . . 65.33 110.244 -175.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.54 65.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.594 0.711 . . . . 50.42 110.05 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 407' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 407' ' ' ASN . 0.9 OUTLIER -95.8 -4.64 43.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.577 -0.738 . . . . 71.14 111.876 -177.937 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.1 m -100.16 155.39 17.77 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.244 -1.391 . . . . 54.14 107.244 176.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 55.2 p -74.77 113.17 11.74 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.191 -0.604 . . . . 75.02 109.584 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.09 169.93 15.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 116.043 -0.526 . . . . 44.22 110.772 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.0 p -62.36 133.13 54.64 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.702 -0.681 . . . . 73.11 109.396 175.241 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.46 109.33 4.73 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.956 -0.387 . . . . 73.23 109.956 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.91 10.08 5.43 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 120.137 -1.03 . . . . 45.53 112.339 -178.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.1 -174.02 4.49 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.785 -0.82 . . . . 74.41 108.785 -177.151 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.01 132.16 34.12 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 118.955 0.798 . . . . 72.14 112.589 -175.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.67 135.24 59.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 106.474 -1.676 . . . . 73.32 106.474 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.9 t -96.84 130.94 44.04 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 122.086 0.946 . . . . 71.41 111.764 -177.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.33 122.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 114.577 -1.192 . . . . 65.24 108.453 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -95.89 129.01 43.27 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.745 -0.661 . . . . 71.5 111.447 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.83 130.81 52.93 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 108.14 -1.059 . . . . 75.34 108.14 177.449 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.49 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 36.6 p -88.09 121.45 30.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.491 -0.559 . . . . 74.33 109.491 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 m -120.89 104.82 10.14 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 119.767 -0.773 . . . . 63.31 110.645 177.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.69 125.39 1.59 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 120.546 -0.835 . . . . 71.54 113.93 176.446 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 56.2 Cg_endo -86.49 130.31 3.28 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.33 2.02 . . . . 61.12 112.562 176.17 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.461 ' OE1' ' HA ' ' A' ' 391' ' ' ASP . 47.6 mt-10 -89.4 137.5 32.27 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.465 0.65 . . . . 75.33 112.12 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.47 150.45 48.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.546 -1.65 . . . . 74.22 106.546 173.57 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 480' ' ' ILE . 3.4 tpt180 -136.27 148.46 48.02 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.307 -0.998 . . . . 73.42 108.307 -174.049 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.9 136.5 34.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.513 -0.921 . . . . 65.33 108.513 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 70.8 mt -81.8 131.54 57.11 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.834 -0.802 . . . . 71.34 108.834 -178.623 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.65 140.6 87.36 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.583 1.522 . . . . 72.14 111.876 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.32 0.77 55.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.124 0.488 . . . . 72.24 111.191 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -76.12 -7.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.446 0.641 . . . . 41.12 109.464 176.229 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.9 p -54.96 -49.68 70.78 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.361 -0.836 . . . . 63.45 111.687 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 2.1 m -63.79 -22.28 66.83 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.361 1.065 . . . . 70.0 111.761 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.27 -42.47 13.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.263 0.468 . . . . 74.23 112.263 -173.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.4 m -145.21 124.12 12.71 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.542 -0.724 . . . . 73.11 110.905 -178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.24 -53.52 55.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.724 0.639 . . . . 75.42 112.724 -178.156 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.43 94.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.737 0.303 . . . . 73.02 111.495 -176.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.53 -37.68 88.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.652 -0.704 . . . . 73.11 109.407 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.32 -47.18 87.15 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.922 -0.581 . . . . 54.23 110.76 -179.079 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.35 -45.71 93.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 61.11 110.414 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 9.9 mmpt? -64.46 -47.27 79.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 65.32 110.967 -178.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.14 -38.88 89.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.329 -0.396 . . . . 73.35 111.476 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.2 -43.41 86.83 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.338 0.399 . . . . 64.04 110.366 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 24.3 m -66.84 -46.01 76.45 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.404 0.621 . . . . 61.44 109.785 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.31 -15.97 63.45 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.374 -0.83 . . . . 73.1 112.053 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.56 59.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.464 . . . . 64.12 109.985 178.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.08 -16.4 11.97 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.748 -0.739 . . . . 23.35 112.036 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 449' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 93.6 m-85 -77.49 108.66 10.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.782 0.325 . . . . 64.35 110.503 -179.053 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.37 20.64 15.83 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.554 -1.019 . . . . 74.21 110.554 176.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -114.17 111.91 22.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 106.507 -1.664 . . . . 65.42 106.507 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.49 153.22 45.42 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.438 0.532 . . . . 72.13 112.438 -170.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 56.4 tptt -150.9 123.41 8.46 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 105.451 -2.055 . . . . 73.51 105.451 172.441 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -121.96 134.82 54.83 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.315 -0.554 . . . . 65.32 111.584 -173.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -142.38 165.02 28.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.1 -0.5 . . . . 62.42 110.514 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -116.44 142.07 47.35 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.719 -0.845 . . . . 62.33 108.719 176.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 19.1 t -131.04 138.55 33.22 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 108.749 -0.834 . . . . 73.01 108.749 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_exo -61.56 121.1 9.07 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.303 2.002 . . . . 72.33 110.558 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.3 m -134.26 -178.55 5.09 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 63.13 107.62 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 16.5 p -68.24 150.24 97.8 Favored Pre-proline 0 N--CA 1.427 -1.586 0 C-N-CA 120.563 -0.455 . . . . 73.53 109.822 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 461' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 464' ' ' VAL . 15.0 Cg_endo -55.69 -23.59 41.71 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.488 2.792 . . . . 71.42 113.137 -177.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -75.36 -18.45 59.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.869 0.366 . . . . 72.23 111.871 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.72 -4.45 40.7 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.992 -0.443 . . . . 73.04 112.102 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.8 p -59.51 136.58 22.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-O 120.717 0.294 . . . . 70.43 110.935 -178.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.32 84.04 Favored Glycine 0 C--N 1.311 -0.831 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.389 177.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -124.19 158.87 31.38 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 109.668 -0.493 . . . . 72.12 109.668 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 434' ' ' THR . 58.1 t -83.93 137.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.8 -1.556 . . . . 45.44 106.8 178.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -96.54 -10.66 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.013 -1.475 . . . . 72.11 110.267 178.133 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 146.56 174.54 18.76 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 115.424 -0.807 . . . . 44.55 111.524 175.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.0 p -116.58 152.22 34.61 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.97 -1.122 . . . . 74.21 107.97 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -66.79 -46.06 55.53 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 118.74 -1.184 . . . . 65.24 111.874 178.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.39 110.15 3.0 Favored 'Trans proline' 0 C--N 1.362 1.261 0 N-CA-C 106.887 -2.005 . . . . 54.12 106.887 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.02 162.31 32.04 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.292 1.995 . . . . 75.14 114.286 -171.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.73 -5.15 35.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.753 1.221 . . . . 75.13 110.348 177.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.49 6.05 49.99 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.421 -1.263 . . . . 71.52 109.616 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -135.62 162.48 32.59 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.109 -0.701 . . . . 74.11 109.109 -177.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.7 m -104.47 111.73 24.51 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.235 -1.765 . . . . 70.02 106.235 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 14.9 t -106.55 148.3 28.4 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.332 -0.547 . . . . 74.54 109.874 -175.379 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.25 141.03 58.92 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.283 -0.417 . . . . 35.43 110.41 178.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 28.9 mm -60.92 -22.61 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.467 0.707 . . . . 61.13 112.876 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.0 t -91.55 4.43 52.62 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.692 0.758 . . . . 64.32 110.123 -178.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.67 138.55 34.1 Favored 'General case' 0 CA--C 1.481 -1.687 0 O-C-N 122.015 -0.428 . . . . 74.0 110.47 177.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.54 116.32 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 108.887 -0.783 . . . . 71.33 108.887 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.08 120.22 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 108.189 -1.041 . . . . 71.13 108.189 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 0.2 OUTLIER -92.73 117.07 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 106.93 -1.507 . . . . 61.41 106.93 -178.939 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 112.4 39.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.948 -1.024 . . . . 42.32 108.347 -177.335 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 485' ' ' ILE . 3.3 mp -102.75 124.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.588 -0.733 . . . . 75.53 109.275 -177.255 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 t -97.59 134.45 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.248 -1.39 . . . . 65.3 107.248 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -84.07 131.85 10.68 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 110.992 -0.843 . . . . 50.11 110.992 -178.368 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.3 t -141.04 132.39 26.71 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.82 -0.808 . . . . 53.25 108.82 178.318 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.07 0 N-CA-C 109.244 -1.542 . . . . 65.51 109.244 174.575 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 107.972 -1.122 . . . . 64.14 107.972 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.2 150.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 112.398 0.518 . . . . 72.11 112.398 -170.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -96.4 136.55 36.75 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.538 -1.282 . . . . 53.25 107.538 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.68 131.3 27.22 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.916 -0.713 . . . . 52.15 110.079 -175.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.14 142.13 78.46 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.392 2.728 . . . . 70.4 113.946 -178.046 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.44 139.39 36.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.698 -1.137 . . . . 73.33 109.985 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 373' ' ' ALA . 12.6 t -113.24 30.98 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 122.51 1.147 . . . . 73.14 109.794 -175.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.7 ppt_? -65.39 144.58 56.99 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.582 -0.736 . . . . 74.41 112.525 178.28 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 93.4 -5.81 74.61 Favored Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.94 -0.573 . . . . 75.33 111.699 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -117.34 176.01 5.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.294 -0.632 . . . . 74.32 109.294 -175.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.8 p -73.92 154.11 39.53 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.742 0.306 . . . . 72.43 111.139 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.2 -36.1 82.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.752 0.311 . . . . 64.03 110.619 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.97 93.62 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.104 -0.498 . . . . 53.34 111.033 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.77 -43.55 92.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.747 -0.464 . . . . 73.21 109.747 177.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -58.77 -51.53 69.6 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.964 -0.562 . . . . 73.55 111.084 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.62 -42.47 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.347 -0.388 . . . . 73.41 111.157 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.39 93.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.433 -0.348 . . . . 74.31 110.993 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 376' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 61.9 m -61.88 -47.24 85.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.551 -0.295 . . . . 60.43 110.882 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.89 -38.81 92.46 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.621 -0.263 . . . . 73.11 110.941 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.88 -46.92 87.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.908 0.755 . . . . 73.4 109.647 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -66.43 -27.41 67.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.78 -0.646 . . . . 62.01 111.774 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 380' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 376' ' ' THR . 11.8 mmt180 -81.21 -14.94 57.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.402 -0.363 . . . . 64.51 110.797 178.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.73 53.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.439 -0.886 . . . . 73.22 112.029 178.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.16 158.65 15.37 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.385 -0.598 . . . . 54.44 109.385 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.53 161.43 13.64 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.232 -1.025 . . . . 61.31 108.232 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 154.98 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.872 0.844 . . . . 71.53 112.79 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 417' ' ' THR . 6.7 ttp180 -141.99 129.74 21.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.885 -1.154 . . . . 72.0 107.885 175.445 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.3 m -100.51 130.38 46.58 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.7 -0.481 . . . . 71.0 109.7 -177.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.94 119.11 36.79 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.708 -1.59 . . . . 73.23 106.708 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -95.66 123.84 39.41 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 72.23 108.724 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -114.57 118.13 41.73 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 116.268 -0.424 . . . . 74.54 111.747 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 3.0 Cg_endo -88.31 128.43 2.2 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 N-CA-C 107.456 -1.786 . . . . 61.15 107.456 167.249 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 -163.88 -178.09 5.47 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.665 -1.214 . . . . 73.14 110.731 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.2 m -88.87 -42.18 12.01 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.195 -1.78 . . . . 64.1 106.195 175.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.4 m -88.69 63.43 6.91 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.458 -1.246 . . . . 61.11 108.636 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 394' ' ' ILE . 2.3 pp -98.77 112.97 63.93 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 114.156 1.169 . . . . 63.05 114.156 179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 73.8 Cg_endo -80.44 170.37 16.04 Favored 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.09 1.86 . . . . 70.34 110.369 171.391 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.72 162.65 17.8 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.391 2.727 . . . . 63.24 112.691 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.66 -8.7 0.95 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 124.218 1.007 . . . . 64.1 113.135 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -79.78 159.72 26.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.783 -1.192 . . . . 74.23 107.783 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.56 117.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 105.942 -1.873 . . . . 73.2 105.942 175.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 400' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.6 pp -92.91 -28.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.408 0.623 . . . . 74.32 111.79 -178.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -160.99 158.1 29.67 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.717 -1.753 . . . . 42.2 108.717 178.702 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -114.43 -179.85 3.75 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 109.189 -0.671 . . . . 75.53 109.189 179.27 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.12 140.94 21.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.225 -1.028 . . . . 72.52 108.225 178.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.69 -29.46 2.34 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.0 3.134 . . . . 44.53 114.536 177.576 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.63 60.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.209 0.603 . . . . 64.42 111.98 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.16 65.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 61.51 109.857 177.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 4.7 52.32 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.328 -0.851 . . . . 72.55 110.735 -174.122 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -92.64 146.39 23.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 105.118 -2.178 . . . . 73.1 105.118 171.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.5 m -74.37 123.44 24.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 118.797 0.726 . . . . 74.12 110.171 -178.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.8 169.67 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.772 -1.196 . . . . 60.41 107.772 -177.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.8 m -66.7 138.86 57.71 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.266 -1.013 . . . . 55.43 108.266 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.18 111.36 3.89 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.079 -0.341 . . . . 73.23 110.079 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.63 43.33 0.97 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.752 -0.737 . . . . 51.22 112.162 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.65 -179.36 3.79 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.354 -1.721 . . . . 62.32 106.354 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -102.65 135.29 44.55 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.505 0.669 . . . . 75.11 111.725 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.7 mm -110.28 128.47 66.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.372 -1.344 . . . . 63.21 107.372 176.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 385' ' ' ARG . 69.4 p -100.42 130.71 46.55 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.577 -0.527 . . . . 70.42 109.577 -177.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.48 122.63 69.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.013 -0.54 . . . . 74.32 110.177 -176.316 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -91.17 129.46 37.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.141 0.496 . . . . 44.41 110.998 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.44 146.95 30.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.286 -1.376 . . . . 64.24 107.286 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.423 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 13.5 m -90.57 122.65 33.56 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.822 -0.751 . . . . 72.43 111.815 -176.417 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 32.8 m -120.37 106.16 11.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 109.539 -0.541 . . . . 64.12 109.539 174.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 77.32 130.57 0.47 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 120.889 -0.672 . . . . 63.24 114.772 176.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.4 Cg_exo -78.6 144.18 19.63 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.702 1.601 . . . . 63.42 109.425 171.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 146.06 47.96 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 116.292 -0.413 . . . . 71.45 109.906 -178.261 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.5 mt-30 -121.52 141.29 51.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.168 -0.924 . . . . 74.4 108.65 -176.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -143.45 158.68 43.45 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.954 -1.498 . . . . 73.52 106.954 -177.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.6 OUTLIER -90.1 139.62 30.45 Favored 'General case' 0 C--N 1.28 -2.419 0 O-C-N 123.088 0.242 . . . . 71.54 110.854 179.512 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -80.03 119.86 77.95 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.788 -1.56 . . . . 72.25 106.788 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.82 140.74 67.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.702 2.268 . . . . 74.34 113.589 -178.461 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.61 -22.58 62.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.771 -1.104 . . . . 73.31 112.364 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.18 2.98 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.679 -0.692 . . . . 71.35 111.748 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.9 t -62.75 -27.14 69.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.309 0.644 . . . . 74.44 110.597 179.163 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 28.0 p -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 112.851 0.685 . . . . 72.22 112.851 -177.42 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 82.6 mt -67.26 -49.01 66.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.912 1.079 . . . . 43.41 113.912 -171.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.6 m -160.43 148.8 16.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.592 -0.892 . . . . 74.02 108.592 -175.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.51 -49.83 75.98 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.873 0.694 . . . . 73.13 112.873 -177.769 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.01 89.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.714 0.293 . . . . 74.41 110.942 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.22 -46.32 90.9 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.639 -0.874 . . . . 72.21 108.639 177.195 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.66 76.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.948 -1.024 . . . . 63.31 110.409 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.82 -48.08 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.362 -0.381 . . . . 72.44 111.089 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.868 0.322 . . . . 73.44 111.868 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -66.33 -42.12 88.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 111.902 0.334 . . . . 72.05 111.902 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.43 -38.63 81.38 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.975 -0.29 . . . . 74.21 111.741 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 86.4 m -62.31 -40.46 96.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.736 -0.468 . . . . 74.21 109.736 177.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.46 -26.61 66.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.916 -0.584 . . . . 44.22 111.042 178.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 -13.01 56.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.211 0.529 . . . . 44.14 110.47 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.55 29.74 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.944 -0.646 . . . . 73.03 113.267 178.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -78.29 102.65 7.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 117.362 0.581 . . . . 74.22 109.597 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.73 15.83 34.24 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.694 -0.765 . . . . 44.53 111.301 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -118.21 110.63 17.8 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.733 -1.21 . . . . 75.13 107.733 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.35 150.26 45.7 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.028 0.442 . . . . 74.12 110.589 -176.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.522 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.4 OUTLIER -141.88 122.87 14.55 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.454 -2.054 . . . . 73.22 105.454 171.239 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -96.57 134.62 39.56 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.008 -0.677 . . . . 73.32 109.61 -178.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.19 141.47 49.09 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.938 -1.134 . . . . 74.3 107.938 176.287 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 456' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.5 m-80 -116.57 140.12 49.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.598 -1.26 . . . . 74.21 107.598 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -138.62 150.35 65.66 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 109.846 -0.427 . . . . 75.34 109.846 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_endo -60.71 120.22 7.83 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.496 2.131 . . . . 73.22 112.184 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -127.27 -178.45 4.45 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.027 -1.471 . . . . 63.14 107.027 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.0 t -68.88 137.95 90.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.968 -0.752 . . . . 70.43 108.968 176.571 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.15 -23.74 23.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.741 2.961 . . . . 70.43 113.98 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.7 -23.95 58.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.797 0.332 . . . . 75.32 111.677 -177.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.33 12.57 31.54 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.334 0.494 . . . . 72.42 112.334 -177.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.6 p -59.31 126.74 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.388 0.613 . . . . 71.34 111.143 179.311 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.55 0.07 61.11 Favored Glycine 0 C--N 1.309 -0.968 0 CA-C-N 115.987 -0.551 . . . . 51.44 112.266 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.63 144.84 30.51 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.668 -1.234 . . . . 75.34 107.668 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 84.3 t -82.28 126.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.86 -1.163 . . . . 73.24 107.86 177.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.46 -15.13 7.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.34 -0.544 . . . . 74.35 112.01 -175.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.02 177.24 33.95 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 120.451 -0.88 . . . . 74.14 111.576 178.001 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 470' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 486' ' ' ILE . 8.7 p -125.23 158.81 33.12 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.226 -1.027 . . . . 72.01 108.226 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 4.5 m-20 -63.14 -54.35 46.47 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 120.338 -0.545 . . . . 73.1 110.52 176.103 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 7.6 Cg_exo -78.14 108.6 2.53 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 106.037 -2.332 . . . . 64.13 106.037 164.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 149.87 89.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.601 2.201 . . . . 71.32 114.798 -169.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.46 7.65 2.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.742 1.217 . . . . 70.42 111.987 -177.468 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.1 -3.05 16.63 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.474 -0.784 . . . . 63.12 110.605 177.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -129.06 169.65 14.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.036 0.446 . . . . 72.13 111.335 -171.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 15.7 m -102.43 135.54 43.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.265 1.026 . . . . 74.52 108.789 -179.025 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.8 t -137.46 148.07 45.81 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.425 -0.583 . . . . 71.2 109.425 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.91 145.6 53.53 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.964 -0.384 . . . . 63.14 109.964 175.056 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.9 mm -70.17 -3.33 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.125 0.964 . . . . 72.15 111.396 -177.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -86.81 5.37 36.91 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.762 0.792 . . . . 65.44 110.325 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -110.45 138.09 47.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.358 -0.837 . . . . 65.3 109.473 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.86 124.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.281 -1.007 . . . . 75.4 108.281 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.0 t -87.36 118.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 C-N-CA 119.074 -1.051 . . . . 61.04 108.486 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 56.2 mt -93.95 112.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.081 -1.451 . . . . 70.43 107.081 176.831 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -98.62 122.28 50.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.33 -0.989 . . . . 64.53 108.33 -176.504 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 487' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 26.9 mt -100.87 119.92 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.318 0.58 . . . . 74.32 110.499 -174.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.534 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 88.9 t -97.99 128.77 49.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.959 -1.126 . . . . 61.3 107.959 178.675 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.31 115.42 6.03 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.184 -0.766 . . . . 75.13 111.184 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 37.5 m -120.35 109.88 15.88 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.334 -0.617 . . . . 61.23 109.334 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.356 0 N-CA-C 109.478 -1.449 . . . . 75.42 109.478 -179.211 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 409' ' ' SER . 4.3 p-10 . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 109.1 -0.704 . . . . 72.25 109.1 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.6 m -134.32 153.89 36.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.722 -0.473 . . . . 63.02 109.722 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -100.86 137.07 39.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.851 -1.166 . . . . 72.01 107.851 175.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.87 124.5 47.68 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 119.556 -0.858 . . . . 64.14 110.804 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.1 145.05 98.99 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.89 2.393 . . . . 75.33 112.355 177.29 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.98 166.1 16.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.872 -0.603 . . . . 74.2 110.451 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.4 HG12 ' HB2' ' A' ' 368' ' ' GLN . 15.7 t -117.47 41.68 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.495 1.14 . . . . 53.21 108.488 -175.041 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -52.57 128.66 26.78 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.344 -1.298 . . . . 75.51 113.79 -175.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.76 -18.65 57.02 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 115.503 -0.771 . . . . 72.32 113.228 173.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.4 ' HB2' HG12 ' A' ' 365' ' ' VAL . 95.4 mt-30 -97.73 166.7 11.36 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.613 0.245 . . . . 62.34 111.198 -176.673 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 81.2 p -63.3 145.04 56.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.511 . . . . 33.42 110.684 -175.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.9 p -63.66 -34.08 77.05 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.951 -0.3 . . . . 63.05 110.275 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.32 88.73 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.193 -0.458 . . . . 60.21 110.358 176.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -35.08 79.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.054 -0.521 . . . . 74.52 110.23 178.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -50.44 71.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 72.21 110.797 178.134 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.27 -43.96 87.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 123.416 0.448 . . . . 63.21 110.407 178.504 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.36 90.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 73.42 110.74 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -46.94 86.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.736 -0.211 . . . . 54.41 110.831 178.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.98 -39.3 93.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.198 -0.201 . . . . 53.3 110.753 177.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -61.2 -44.34 97.45 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.223 0.609 . . . . 64.33 110.272 179.132 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.43 -26.27 64.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.779 -0.646 . . . . 60.34 111.805 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -81.56 -13.5 57.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.226 -0.443 . . . . 63.05 110.96 175.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 94.59 16.58 42.13 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.272 -0.965 . . . . 71.12 112.368 177.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.56 159.79 14.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.034 -0.728 . . . . 43.05 109.034 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 33.5 mmtp -104.9 157.51 17.17 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.263 -1.384 . . . . 64.04 107.263 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -136.9 157.48 35.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.451 0.643 . . . . 73.15 112.04 -175.598 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 417' ' ' THR . 37.8 ttm105 -127.41 133.11 50.01 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.612 -1.996 . . . . 71.04 105.612 171.637 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.7 m -122.32 121.28 36.36 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.204 -0.665 . . . . 54.12 109.204 -175.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.35 119.2 35.49 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.59 -1.263 . . . . 74.43 107.59 178.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 11.7 pm0 -113.5 124.1 51.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.642 -0.503 . . . . 73.52 109.642 178.283 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -132.76 144.28 52.22 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 120.604 -0.439 . . . . 72.45 110.777 -177.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.82 144.15 13.6 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 N-CA-C 107.662 -1.707 . . . . 75.24 107.662 166.326 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.474 ' HB3' HG23 ' A' ' 394' ' ' ILE . 8.2 t70 -153.42 172.69 16.71 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 118.62 -1.232 . . . . 75.21 110.227 -176.3 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.8 m -87.38 -34.72 18.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.731 -1.581 . . . . 43.21 106.731 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.0 p -108.02 70.24 0.76 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 113.905 -1.498 . . . . 54.14 109.426 177.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.0 pp -90.0 121.74 68.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.35 1.241 . . . . 73.0 114.35 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.42 172.88 10.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.557 2.171 . . . . 74.42 108.516 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.73 153.54 61.59 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 122.157 1.905 . . . . 73.33 111.594 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -6.87 11.62 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.623 0.725 . . . . 63.23 111.935 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -82.26 143.53 31.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.917 -1.038 . . . . 75.02 108.858 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.92 118.01 22.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.938 -1.105 . . . . 64.3 108.889 -178.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.47 -47.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.014 -1.106 . . . . 70.11 108.014 -178.283 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.55 170.48 35.8 Favored Glycine 0 N--CA 1.403 -3.543 0 N-CA-C 109.6 -1.4 . . . . 52.11 109.6 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -119.05 -178.7 3.62 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 108.482 -0.933 . . . . 75.3 108.482 179.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.74 154.71 37.01 Favored Pre-proline 0 C--N 1.282 -2.342 0 N-CA-C 108.326 -0.99 . . . . 75.2 108.326 176.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -31.9 -32.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.856 1 C-N-CA 125.861 4.374 . . . . 71.33 116.159 -176.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -47.26 -35.0 7.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.321 1.048 . . . . 71.24 112.925 -178.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.27 -49.76 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.068 0.461 . . . . 64.5 112.023 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -86.68 -0.4 56.19 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.806 0.669 . . . . 71.21 112.806 -176.012 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.9 m -87.73 164.24 16.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.44 107.723 175.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 409' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 359' ' ' ASP . 2.5 p -74.23 113.57 11.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.87 0.843 . . . . 64.4 112.336 -176.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.62 170.13 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.951 -1.022 . . . . 73.22 108.856 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.3 t -90.26 151.73 21.38 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.792 -1.188 . . . . 73.43 107.792 176.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.12 130.92 45.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.328 -0.619 . . . . 71.11 109.328 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 91.28 25.78 22.95 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.575 -0.822 . . . . 72.2 112.399 -179.175 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.01 -175.63 3.93 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.833 -0.803 . . . . 62.31 108.833 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 29.3 mt-10 -105.43 126.78 52.51 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 118.517 0.598 . . . . 73.33 111.448 -175.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.59 124.97 60.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.031 -0.729 . . . . 65.41 109.031 175.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 385' ' ' ARG . 24.8 p -92.25 127.81 37.87 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.155 -0.475 . . . . 73.21 109.871 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 82.4 t -124.22 130.85 73.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.427 -176.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -96.87 128.59 43.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.717 -0.674 . . . . 75.25 109.414 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 42.5 t -124.57 140.36 48.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.737 -0.838 . . . . 73.11 108.737 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.2 p -103.3 122.76 45.46 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.995 0.426 . . . . 54.53 110.921 179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 25.7 p -118.61 104.93 11.1 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.619 -0.264 . . . . 73.25 110.468 177.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.01 156.11 0.74 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 114.823 0.689 . . . . 52.43 114.823 177.513 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 2.4 Cg_endo -84.27 149.4 11.86 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.249 1.966 . . . . 51.13 110.795 173.54 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.72 149.41 31.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.776 -0.647 . . . . 72.3 112.678 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.6 mt-30 -107.01 151.88 24.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.579 -1.267 . . . . 75.05 107.579 176.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 480' ' ' ILE . 0.9 OUTLIER -143.88 164.38 30.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.325 -0.991 . . . . 63.45 108.325 -179.116 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.01 138.3 33.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.56 -0.533 . . . . 65.43 109.56 -178.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.2 mt -83.79 123.66 75.81 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 105.932 -1.877 . . . . 74.03 105.932 174.099 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.4 141.23 82.31 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.687 2.258 . . . . 72.31 113.306 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.46 -22.26 25.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.395 -0.821 . . . . 71.2 110.539 -177.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.49 -12.59 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.695 0.759 . . . . 75.33 110.507 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 17.6 m -53.9 -36.7 62.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.287 1.035 . . . . 71.21 112.012 -179.063 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 8.9 p -69.48 -12.99 62.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.463 0.912 . . . . 75.35 113.463 -178.162 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 435' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.4 mt -89.97 -41.07 11.96 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.753 0.649 . . . . 55.11 112.753 -178.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 91.6 m -149.24 125.82 11.0 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.979 -0.378 . . . . 74.22 109.979 -176.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.75 -48.17 80.4 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.735 . . . . 75.54 112.983 -178.514 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.23 90.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.026 0.441 . . . . 74.42 110.95 -178.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 13.8 mm-40 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.953 -0.567 . . . . 71.45 109.923 179.294 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.87 -51.08 71.25 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.766 -0.652 . . . . 71.11 109.736 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.76 -43.8 96.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.743 -0.662 . . . . 74.33 110.742 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.46 -48.57 74.74 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.167 0.432 . . . . 75.43 112.167 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 443' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 74.4 mmtt -67.62 -39.71 84.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.831 0.348 . . . . 74.41 111.415 -178.055 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.05 -39.77 93.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.562 -0.532 . . . . 54.54 109.562 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 94.3 m -67.45 -41.25 85.02 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.864 -0.607 . . . . 62.43 110.2 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.24 -16.78 63.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.199 -0.455 . . . . 72.5 111.774 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.9 -3.37 59.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.305 -0.407 . . . . 74.3 110.807 177.528 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.11 33.84 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.968 -0.634 . . . . 21.33 113.178 176.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -67.43 139.21 57.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.694 0.283 . . . . 74.04 110.828 -177.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -142.3 1.08 1.6 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.779 -0.725 . . . . 70.14 112.615 -179.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -104.0 111.3 23.8 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.535 -1.283 . . . . 71.31 107.535 178.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -127.28 144.67 51.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.309 -0.405 . . . . 71.2 110.29 -174.037 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -134.8 123.49 23.63 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.64 -1.985 . . . . 72.42 105.64 171.547 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -107.63 132.11 53.66 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 118.099 0.409 . . . . 75.45 111.139 -174.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.0 163.22 30.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.1 -0.5 . . . . 71.31 109.719 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.58 131.81 54.33 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 120.865 0.364 . . . . 74.51 110.34 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -123.27 144.56 44.02 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 106.799 -1.556 . . . . 72.22 106.799 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.67 133.5 24.03 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 121.866 1.711 . . . . 41.22 111.057 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.1 m -143.75 174.97 10.34 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.583 -0.895 . . . . 54.45 108.583 -178.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 27.2 p -65.35 149.63 96.81 Favored Pre-proline 0 C--N 1.311 -1.09 0 O-C-N 123.463 0.477 . . . . 75.54 109.842 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.47 -36.26 38.83 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 72.42 112.365 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -69.26 -22.02 63.86 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.976 0.732 . . . . 72.53 112.976 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.34 -9.77 21.94 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.778 -0.369 . . . . 74.01 111.637 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -59.9 126.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 CA-C-O 121.089 0.471 . . . . 71.44 110.372 177.014 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.24 -7.19 58.32 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.1 -0.8 . . . . 62.1 111.1 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.8 mptp? -107.34 156.27 19.08 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.792 -0.818 . . . . 54.31 108.792 177.721 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HD11 ' A' ' 486' ' ' ILE . 59.1 t -84.15 127.58 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.654 -1.239 . . . . 71.4 107.654 175.637 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.9 -19.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.138 0.792 . . . . 72.4 113.138 -175.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.36 167.96 31.51 Favored Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.422 -0.894 . . . . 73.52 111.325 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.6 p -136.96 154.18 50.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.043 -1.465 . . . . 55.14 107.043 179.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -69.31 -48.68 25.46 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 118.984 -1.086 . . . . 74.22 109.369 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.85 106.72 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 N-CA-C 106.937 -1.986 . . . . 75.44 106.937 165.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.06 151.62 85.1 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.879 2.386 . . . . 64.24 115.084 -169.009 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.0 12.68 0.81 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.76 1.224 . . . . 74.4 111.35 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -110.3 -15.59 13.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.577 -0.738 . . . . 74.52 110.493 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.08 154.68 22.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.848 0.832 . . . . 72.23 111.499 -171.843 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -87.74 110.61 20.58 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.014 -1.476 . . . . 65.35 107.014 178.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.5 m -112.83 148.52 34.68 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.772 -0.194 . . . . 74.12 111.134 -174.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.18 142.44 58.41 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.175 0.59 . . . . 64.32 110.66 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 427' ' ' ARG . 48.0 mm -64.7 -21.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.495 0.664 . . . . 71.14 111.147 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.6 p -87.14 1.83 51.79 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 116.006 -0.543 . . . . 74.24 111.412 -177.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -89.75 145.45 25.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.107 178.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.34 122.75 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.719 -0.845 . . . . 71.11 108.719 176.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.08 120.74 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 108.66 -0.867 . . . . 63.3 108.66 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -92.21 112.74 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.711 -1.218 . . . . 73.15 107.711 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.56 105.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.693 -1.225 . . . . 61.54 107.693 -177.379 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.43 118.29 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.034 -0.985 . . . . 73.3 109.338 -176.766 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.7 t -97.32 138.54 21.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.568 -1.271 . . . . 54.43 107.568 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -81.55 108.48 2.88 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 109.424 -1.471 . . . . 74.32 109.424 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.452 ' HA ' HG13 ' A' ' 464' ' ' VAL . 13.3 t -142.67 118.02 10.23 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 62.11 108.566 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.316 0 N-CA-C 108.834 -1.706 . . . . 75.42 108.834 179.34 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 107.623 -1.251 . . . . 52.14 107.623 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.62 161.5 32.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.033 0.444 . . . . 42.43 111.208 -173.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -100.69 136.32 40.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.644 -1.243 . . . . 72.45 107.644 173.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -98.49 133.2 22.92 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.149 -1.056 . . . . 64.32 108.149 -177.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.83 164.27 36.22 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 121.966 1.777 . . . . 70.21 113.67 -176.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 364' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 366' ' ' ARG . 4.1 m-20 -67.51 120.89 14.69 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.844 -1.071 . . . . 53.1 108.244 176.381 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.83 30.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.582 0 CA-C-O 123.067 1.413 . . . . 75.34 110.146 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 15.1 ptt85 -62.49 144.09 56.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.716 -1.584 . . . . 72.24 113.041 -177.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.01 0.47 48.29 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.303 -0.862 . . . . 61.21 114.164 173.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -132.77 175.88 8.95 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.824 0.812 . . . . 71.05 111.569 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 97.3 p -74.77 171.45 13.94 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.636 0.374 . . . . 75.54 111.028 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 14.6 m -61.85 -45.66 92.84 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.99 0.424 . . . . 75.21 110.09 178.346 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.83 80.4 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.106 -0.497 . . . . 74.25 111.195 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.47 -42.23 79.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.23 -0.441 . . . . 75.45 110.701 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.77 81.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 75.01 110.287 178.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.6 mt -58.71 -42.58 85.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 61.14 110.715 178.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.23 -47.17 77.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.295 -0.412 . . . . 64.24 110.985 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 43.7 m -60.77 -45.57 93.81 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 116.511 -0.313 . . . . 72.23 111.401 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.64 -38.93 92.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.737 0.303 . . . . 54.05 111.01 176.061 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.24 -43.3 99.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.704 -0.68 . . . . 74.21 109.839 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -64.37 -29.03 70.11 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.885 -0.598 . . . . 74.34 110.691 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -83.85 -12.12 56.0 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.872 -0.604 . . . . 73.05 109.709 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 381' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 96.92 0.85 60.04 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.997 -0.62 . . . . 71.31 112.416 177.256 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 43.9 m-85 -79.18 157.15 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.034 0.445 . . . . 73.34 111.851 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.8 137.83 40.5 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 106.711 -1.589 . . . . 64.45 106.711 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.63 140.26 46.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 113.96 1.096 . . . . 72.43 113.96 -177.053 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -110.69 130.89 55.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.03 -1.841 . . . . 75.32 106.03 173.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.9 m -112.64 118.09 34.08 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.782 -0.822 . . . . 53.02 108.782 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.44 118.33 32.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.943 -1.502 . . . . 75.51 106.943 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 4.6 pm0 -109.67 122.44 47.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.072 -0.714 . . . . 51.43 109.072 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.38 133.45 25.09 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.009 -0.541 . . . . 74.32 110.068 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.408 ' N ' ' HB ' ' A' ' 422' ' ' THR . 57.8 Cg_endo -76.19 139.67 21.55 Favored 'Trans proline' 0 C--O 1.257 1.431 0 C-N-CA 122.371 2.047 . . . . 62.11 109.326 172.092 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 172.78 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.491 -1.299 . . . . 62.52 107.491 -176.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 57.4 m -141.68 -14.38 0.84 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.876 -0.515 . . . . 71.4 111.928 176.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.5 p -91.37 19.35 6.13 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.364 1.078 . . . . 61.21 109.847 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.8 pt -104.57 150.95 39.11 Favored Pre-proline 0 C--N 1.296 -1.735 0 CA-C-N 114.571 -1.195 . . . . 71.34 111.839 -173.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 145.23 38.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.494 2.129 . . . . 72.44 111.291 177.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.48 162.84 7.51 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.26 3.307 . . . . 73.03 113.362 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.91 -11.78 1.15 Allowed 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 124.257 1.023 . . . . 62.21 112.451 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -101.97 109.15 20.81 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.082 -2.192 . . . . 73.31 105.082 176.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.3 p -62.14 120.64 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.079 0.942 . . . . 65.23 112.302 -170.255 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.03 -27.9 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.546 -1.206 . . . . 53.24 110.318 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.62 158.09 27.56 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 119.817 -1.182 . . . . 35.23 111.97 -177.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.1 p -114.6 -175.58 2.71 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.253 0.621 . . . . 72.51 110.249 -177.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -100.05 134.77 20.66 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.805 -1.554 . . . . 73.1 106.805 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.72 -27.94 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 1 C-N-CA 125.395 4.063 . . . . 64.33 115.939 -175.583 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.85 -24.16 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.76 0.314 . . . . 51.52 111.055 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.87 40.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.018 -0.537 . . . . 71.53 110.816 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -79.26 -2.32 40.66 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.291 0.567 . . . . 64.1 112.249 -179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 84.2 m -84.86 146.84 27.1 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.391 -1.337 . . . . 73.03 107.391 172.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -75.43 119.6 19.73 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.903 -0.719 . . . . 51.15 110.001 -179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.02 169.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 123.898 0.879 . . . . 63.11 109.225 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.0 t -75.61 142.05 42.73 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.439 -0.949 . . . . 73.31 108.439 178.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -64.27 109.76 2.0 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.215 -0.661 . . . . 74.12 109.215 178.092 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 122.96 25.88 1.8 Allowed Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.765 -0.934 . . . . 73.03 110.765 -175.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.02 -178.29 4.02 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.047 -1.094 . . . . 51.32 108.047 -178.169 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.33 120.92 35.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.903 0.859 . . . . 63.13 112.918 -176.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.1 mm -110.96 121.35 63.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.501 -0.926 . . . . 73.4 108.501 176.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.9 t -93.81 121.39 35.2 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.549 0.69 . . . . 70.03 110.037 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.3 t -107.05 126.85 63.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.387 -0.968 . . . . 55.32 108.387 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -99.75 120.19 39.33 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.244 -0.65 . . . . 62.04 109.244 -179.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.0 t -113.07 142.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.764 -0.828 . . . . 75.44 108.764 -178.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.0 p -84.87 127.38 34.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.898 1.332 . . . . 74.33 113.792 -178.208 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.408 ' HB ' ' N ' ' A' ' 390' ' ' PRO . 8.8 m -101.46 156.84 17.23 Favored 'General case' 1 N--CA 1.376 -4.156 0 N-CA-C 104.092 -2.558 . . . . 74.01 104.092 170.238 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -34.84 150.64 0.01 OUTLIER Glycine 0 C--N 1.284 -2.357 0 N-CA-C 117.435 1.734 . . . . 74.15 117.435 -176.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 50.9 Cg_exo -54.71 132.2 50.27 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.128 2.552 . . . . 73.2 112.918 179.007 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -72.25 140.6 48.73 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.142 -0.935 . . . . 65.34 109.933 176.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.2 mt-30 -120.3 148.11 44.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.251 -1.018 . . . . 61.43 108.251 176.325 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -144.56 164.64 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.615 -1.254 . . . . 75.12 107.615 -176.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.39 138.84 34.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.993 -1.114 . . . . 53.3 107.993 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 429' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.5 mt -80.8 120.47 79.05 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.168 -1.049 . . . . 62.21 108.168 178.298 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.46 141.55 51.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.96 2.44 . . . . 64.41 113.69 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.44 -15.65 56.27 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.733 -1.121 . . . . 75.15 111.253 -176.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.31 -14.62 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.396 -0.82 . . . . 75.33 110.838 -178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.0 m -53.74 -40.04 65.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.922 0.889 . . . . 73.31 112.388 -178.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.8 p -69.08 -12.84 62.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 113.384 0.883 . . . . 75.3 113.384 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -82.7 -48.35 10.97 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.362 -0.535 . . . . 65.43 110.716 -178.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 75.1 m -157.29 141.74 16.49 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 110.285 -0.265 . . . . 72.51 110.285 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -56.7 -44.19 81.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.695 1.198 . . . . 74.53 111.486 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.61 78.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.915 0.388 . . . . 70.03 110.482 177.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.11 -42.0 94.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.836 -0.62 . . . . 65.52 110.935 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 440' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.79 -51.69 68.27 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.599 0.562 . . . . 73.41 110.662 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.57 -49.18 81.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.948 -0.301 . . . . 74.2 111.515 -177.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.06 -47.58 70.86 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.569 0.581 . . . . 70.22 112.569 -178.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -67.05 -38.03 85.12 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.255 0.835 . . . . 71.21 113.255 -178.566 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 444' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.42 -36.46 84.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.269 -0.572 . . . . 52.33 111.115 174.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 44.9 m -67.35 -39.95 85.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.169 -0.678 . . . . 64.41 109.169 177.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.95 68.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.157 0.503 . . . . 74.24 110.605 177.331 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.64 59.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.302 -0.408 . . . . 51.02 110.34 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.92 -21.3 8.99 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 119.163 -0.799 . . . . 43.34 114.697 174.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -55.88 128.33 34.56 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.408 0.892 . . . . 55.22 113.408 -172.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.46 -1.18 23.31 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.251 -0.886 . . . . 33.21 114.293 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 451' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 10.7 mmm180 -124.12 111.66 16.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 117.699 0.749 . . . . 63.14 110.549 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -119.07 150.99 39.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.635 . . . . 71.44 110.271 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -145.56 136.1 24.21 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.399 -1.704 . . . . 72.31 106.399 172.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -106.64 134.12 50.28 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.809 0.338 . . . . 73.15 110.148 -176.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.93 159.14 42.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.231 -0.655 . . . . 62.03 109.231 177.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -129.35 134.54 47.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.43 -0.952 . . . . 64.41 108.43 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 t -125.14 146.13 52.82 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 108.997 -0.742 . . . . 42.42 108.997 -177.173 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 458' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 490' ' ' SER . 40.4 Cg_exo -61.57 123.6 13.04 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.332 2.021 . . . . 75.32 109.244 173.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.5 m -139.26 -179.78 6.07 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 110.211 -0.292 . . . . 71.53 110.211 -176.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.6 m -56.18 133.5 75.11 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 108.384 -0.969 . . . . 60.25 108.384 175.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.01 -31.16 33.58 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.828 3.018 . . . . 72.21 114.173 -175.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.73 -11.23 59.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 111.962 0.356 . . . . 75.43 111.962 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.69 2.29 38.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.498 -0.319 . . . . 74.42 111.16 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.7 p -59.62 126.96 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 120.277 -0.569 . . . . 73.53 110.689 178.032 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.79 78.24 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.161 -1.019 . . . . 72.44 111.963 178.407 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -125.42 147.21 49.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.584 -0.895 . . . . 71.15 108.584 177.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.65 128.64 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.193 -0.669 . . . . 74.45 109.193 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.66 -5.39 9.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.126 -1.03 . . . . 75.22 111.226 -178.608 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.73 29.39 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.534 -0.841 . . . . 74.01 111.805 176.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.2 p -116.34 153.34 32.17 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.896 -1.15 . . . . 71.23 107.896 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 28.4 t-20 -60.75 -50.35 85.56 Favored Pre-proline 0 C--N 1.317 -0.838 0 O-C-N 123.35 0.406 . . . . 75.33 111.285 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_exo -77.98 131.28 10.92 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 N-CA-C 107.413 -1.803 . . . . 51.51 107.413 168.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.5 Cg_endo -62.46 142.14 89.34 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.373 2.049 . . . . 75.53 113.552 -175.773 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.99 4.18 15.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.976 0.893 . . . . 54.14 110.827 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -108.56 3.24 22.79 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.763 -1.108 . . . . 71.11 108.652 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 476' ' ' GLN . . . . . 0.406 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 36.1 tt0 -121.83 165.21 16.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.106 -1.072 . . . . 74.53 108.106 -178.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 477' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.8 m -98.77 129.64 45.2 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.029 -1.1 . . . . 61.34 108.029 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 47.5 m -124.42 148.59 47.5 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 -178.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.25 153.75 40.49 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.388 0.514 . . . . 75.52 112.388 -178.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.7 mp -66.26 -29.46 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.359 0.6 . . . . 62.11 110.694 177.392 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 14.6 t -90.18 2.82 54.94 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.541 0.686 . . . . 72.31 109.949 177.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 482' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 46.1 t30 -86.08 141.55 29.35 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.037 -1.097 . . . . 73.33 108.037 -178.055 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.47 112.71 17.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 120.051 -0.66 . . . . 72.4 109.22 -178.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.1 119.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 N-CA-C 107.514 -1.291 . . . . 61.04 107.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 41.0 mt -98.22 121.03 48.33 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.451 -1.314 . . . . 61.3 107.451 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.93 120.22 51.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.809 -1.182 . . . . 63.55 107.809 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.59 123.63 60.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-O 121.527 0.679 . . . . 72.32 110.048 -176.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.98 137.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.946 -1.131 . . . . 70.3 107.946 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 489' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.57 127.98 8.97 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.424 -1.07 . . . . 54.53 110.424 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.3 t -133.94 103.89 6.02 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.179 -1.045 . . . . 72.23 108.179 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.193 0 N-CA-C 108.877 -1.689 . . . . 54.41 108.877 -178.007 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-O 121.314 0.578 . . . . 75.45 109.892 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.98 152.23 20.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.474 -0.785 . . . . 74.23 110.931 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -104.54 136.7 43.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.151 -0.477 . . . . 71.11 109.941 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.95 133.77 20.18 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 109.301 -0.629 . . . . 32.23 109.301 -176.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.65 159.51 53.21 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.604 2.202 . . . . 71.14 114.635 -175.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.37 142.96 50.36 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.28 -0.873 . . . . 72.2 109.166 176.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 6.7 t -107.08 21.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.044 -1.095 . . . . 71.4 108.044 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 6.0 ptp180 -58.57 145.37 39.61 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.08 -0.964 . . . . 71.44 112.379 -177.432 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.4 1.06 43.92 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.729 -0.748 . . . . 72.34 113.317 178.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 368' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 7.6 pt20 -138.58 -175.45 4.13 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.263 -1.014 . . . . 73.31 108.263 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 369' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.1 p -76.48 163.82 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 119.609 1.095 . . . . 74.24 112.316 -172.576 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.7 p -61.85 -34.09 75.34 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.758 -0.655 . . . . 71.03 109.335 173.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.77 91.73 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.143 -0.935 . . . . 72.24 109.781 176.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.06 -42.11 89.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.58 -0.736 . . . . 75.33 110.619 177.206 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 373' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 399' ' ' VAL . . . -59.93 -47.39 85.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.722 -0.672 . . . . 50.1 111.224 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.45 -46.12 89.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.087 -0.506 . . . . 75.01 110.013 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.15 93.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.63 . . . . 54.15 111.477 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 64.9 m -66.24 -48.25 71.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.145 -0.48 . . . . 61.13 111.088 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.27 -38.7 91.1 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.325 -0.234 . . . . 74.21 111.225 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -59.71 -48.17 82.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.823 -0.806 . . . . 63.12 108.823 178.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -70.33 -17.31 63.07 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.684 1.364 . . . . 64.02 114.684 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -89.61 -14.19 35.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.353 -0.539 . . . . 71.2 111.113 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.11 16.25 30.79 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.345 -0.931 . . . . 44.11 113.25 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -96.72 154.67 17.15 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.857 -0.423 . . . . 74.23 109.857 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 383' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.1 mmtp -95.61 143.44 26.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.091 -1.448 . . . . 74.13 107.091 178.325 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -132.75 148.21 31.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.363 0.601 . . . . 65.01 112.398 -178.802 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 385' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 417' ' ' THR . 19.5 ttm-85 -118.28 144.88 45.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.705 -1.591 . . . . 73.43 106.705 174.004 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.3 m -98.46 121.58 40.58 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.008 -1.478 . . . . 73.34 107.008 176.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.34 119.47 38.96 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.872 -1.899 . . . . 74.44 105.872 -179.068 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HB2' HG22 ' A' ' 422' ' ' THR . 14.7 pm0 -110.91 122.06 46.93 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.368 0.604 . . . . 73.1 110.892 -174.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 389' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.3 OUTLIER -116.15 119.32 36.88 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 115.402 -0.817 . . . . 64.5 111.48 -177.791 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 390' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 5.8 Cg_endo -93.25 145.53 2.26 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.031 2.487 . . . . 44.22 111.662 173.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 391' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 12.0 t70 160.82 -164.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 104.861 -2.274 . . . . 64.23 104.861 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 392' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 14.8 m -132.8 1.68 3.65 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 119.533 1.06 . . . . 71.05 110.316 175.031 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -97.32 24.39 6.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 106.385 -1.709 . . . . 74.52 106.385 174.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 394' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 421' ' ' SER . 19.8 pt -89.64 151.57 45.97 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 112.527 -2.124 . . . . 65.13 110.304 -178.274 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.55 173.01 15.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 121.837 1.691 . . . . 73.42 108.652 170.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.01 160.92 14.28 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.161 1.907 . . . . 52.0 112.598 174.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.01 -8.07 0.94 Allowed 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.923 1.689 . . . . 63.32 112.781 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.423 ' HB3' ' O ' ' A' ' 368' ' ' GLN . 42.9 m80 -82.42 175.47 10.2 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.452 1.101 . . . . 70.44 108.467 179.404 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 373' ' ' ALA . 7.6 p -91.8 117.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 118.457 -1.297 . . . . 73.32 109.592 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.81 -28.76 2.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.672 -1.149 . . . . 71.44 109.808 177.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.34 160.8 27.92 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 119.79 -1.195 . . . . 52.14 112.192 -173.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 52.4 p -122.43 -174.46 2.91 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.282 1.033 . . . . 71.22 111.225 -172.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.437 ' HB3' HG23 ' A' ' 416' ' ' ILE . 6.5 t70 -98.17 142.07 23.98 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 105.896 -1.89 . . . . 71.02 105.896 -175.303 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.31 -36.14 6.08 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.795 2.996 . . . . 74.12 113.647 178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -68.54 -8.21 39.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.962 -0.563 . . . . 52.15 112.496 -178.13 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -81.75 -51.45 8.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.548 -0.461 . . . . 71.24 110.64 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.35 -5.12 59.24 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 120.646 -0.421 . . . . 61.41 112.043 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.5 m -97.06 142.25 29.23 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 72.42 106.624 174.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.7 p -74.24 113.74 11.8 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.763 0.792 . . . . 72.43 111.771 -177.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.25 170.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.887 -1.051 . . . . 73.2 109.462 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 48.1 m -67.02 138.56 57.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.561 -0.903 . . . . 73.11 108.561 175.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.81 109.92 0.81 Allowed 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.007 0.523 . . . . 73.24 111.483 -177.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.93 43.64 1.62 Allowed Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.582 -0.735 . . . . 65.13 111.997 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -94.39 -167.62 1.7 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.406 -1.331 . . . . 63.31 107.406 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 415' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.2 pt-20 -111.36 124.4 52.17 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.695 0.759 . . . . 64.01 111.612 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 416' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 403' ' ' ASP . 43.7 mm -114.44 135.53 53.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.012 -0.994 . . . . 65.42 108.554 -176.063 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 385' ' ' ARG . 71.1 p -94.32 127.07 39.96 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.34 -0.944 . . . . 73.14 109.689 175.462 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.28 130.13 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.242 -1.021 . . . . 72.13 108.242 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -96.69 128.81 43.99 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 116.401 -0.363 . . . . 71.42 110.595 -175.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 12.6 p -134.33 141.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.391 -0.966 . . . . 75.02 108.391 176.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 421' ' ' SER . . . . . 0.576 ' HB2' HD12 ' A' ' 394' ' ' ILE . 73.2 p -94.1 122.53 36.71 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.474 -0.565 . . . . 52.01 109.474 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 422' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 388' ' ' GLN . 12.2 t -120.14 107.5 13.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.857 -0.737 . . . . 74.23 111.992 177.36 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.04 120.65 1.59 Allowed Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.839 -1.172 . . . . 64.11 114.431 174.229 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 424' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.2 Cg_exo -75.94 128.56 10.84 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.898 1.732 . . . . 62.21 110.207 173.267 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 480' ' ' ILE . 6.4 mm-40 -74.99 125.75 29.57 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.687 -0.486 . . . . 54.34 109.687 177.275 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 49.1 mt-30 -110.29 139.08 45.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.083 -0.71 . . . . 71.51 109.083 177.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 427' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 1.1 tpt180 -132.64 165.45 24.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.995 0.426 . . . . 73.3 111.579 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.76 139.24 34.96 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.158 0.983 . . . . 75.34 111.2 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.67 119.82 76.36 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.278 -1.749 . . . . 60.52 106.278 172.011 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.25 141.35 81.87 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.651 2.234 . . . . 61.22 113.368 -178.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 -20.96 23.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.069 -0.969 . . . . 54.32 110.426 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.39 -11.73 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.407 0.623 . . . . 63.41 110.624 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.2 m -53.0 -41.03 64.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.486 1.114 . . . . 62.42 112.485 -178.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.1 p -68.2 -13.63 62.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.557 0.947 . . . . 74.23 113.557 -176.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 76.3 mt -86.86 -36.92 18.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.651 0.263 . . . . 64.11 111.306 -178.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.9 m -158.37 134.15 9.0 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 122.222 -0.299 . . . . 72.21 110.415 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.05 -46.42 89.21 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.703 0.631 . . . . 73.33 112.703 -178.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.14 -41.23 87.82 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.704 0.287 . . . . 60.45 110.468 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -63.71 -39.45 94.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.725 -0.671 . . . . 54.43 110.41 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.87 -50.92 71.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.47 0.481 . . . . 24.54 109.837 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.44 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 43.34 110.467 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 6.3 mmpt? -61.04 -46.05 92.26 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.996 -0.547 . . . . 73.15 111.267 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.43 -41.98 96.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.246 0.462 . . . . 74.24 112.246 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -43.43 96.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.936 0.398 . . . . 71.11 111.024 176.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.9 m -68.08 -39.63 82.88 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.787 -0.642 . . . . 74.13 110.333 -178.503 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.3 62.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 63.02 111.184 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.76 -12.84 59.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.156 0.503 . . . . 62.4 109.728 176.524 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.53 0.7 40.26 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-O 119.168 -0.795 . . . . 74.41 114.469 174.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.96 137.38 57.1 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.099 0.95 . . . . 74.14 112.106 -178.079 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -125.08 13.57 7.53 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.204 -0.759 . . . . 73.3 111.204 178.291 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.23 111.37 13.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.504 -0.924 . . . . 63.11 108.504 -178.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.08 152.74 47.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.89 -0.595 . . . . 74.45 109.94 -175.041 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 453' ' ' LYS . . . . . 0.414 ' HD3' HG13 ' A' ' 485' ' ' ILE . 64.0 tttp -150.09 122.71 8.58 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.927 -1.138 . . . . 70.3 107.927 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.73 131.98 45.36 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.796 -0.446 . . . . 65.11 109.796 -177.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -123.57 141.17 52.27 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.315 -1.365 . . . . 73.41 107.315 175.554 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -119.28 129.59 54.98 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.219 0.533 . . . . 72.11 110.288 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.2 t -119.94 130.84 24.64 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 108.506 -0.924 . . . . 74.21 108.506 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.73 121.81 10.09 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.45 2.1 . . . . 52.32 109.699 177.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.4 m -133.95 160.28 38.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.916 -0.314 . . . . 63.31 110.417 -176.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 460' ' ' THR . . . . . 0.525 ' HB ' ' OE1' ' A' ' 462' ' ' GLU . 14.2 p -64.65 159.06 64.47 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 124.856 1.262 . . . . 73.43 111.81 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.77 -31.13 24.89 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.789 2.992 . . . . 64.03 113.285 177.499 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 462' ' ' GLU . . . . . 0.525 ' OE1' ' HB ' ' A' ' 460' ' ' THR . 1.5 pm0 -75.36 -24.54 57.31 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.193 0.812 . . . . 73.31 113.193 178.115 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.17 -18.67 14.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.211 0.448 . . . . 71.0 112.211 -179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 464' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.9 p -59.5 130.44 23.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.413 0.625 . . . . 64.31 111.29 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -4.61 64.01 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.743 -0.662 . . . . 61.13 111.971 178.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 157.05 28.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.227 0.537 . . . . 64.54 109.95 177.295 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.79 136.51 22.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.496 -1.298 . . . . 65.13 107.496 176.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.31 -16.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.543 -0.863 . . . . 55.31 111.301 -177.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.1 175.62 32.32 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.561 -0.745 . . . . 43.04 111.629 178.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.0 p -122.01 158.99 27.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.385 -0.969 . . . . 75.03 108.385 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -64.97 -57.0 17.19 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 119.086 -0.483 . . . . 74.12 110.666 175.374 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.0 Cg_endo -79.63 121.14 4.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 N-CA-C 107.951 -1.596 . . . . 71.22 107.951 170.176 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 161.29 46.5 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.537 2.158 . . . . 75.13 113.969 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -69.6 6.59 1.06 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.887 1.275 . . . . 73.32 113.283 -177.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -108.15 -4.49 17.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 179.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -99.92 161.44 13.61 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.604 -0.726 . . . . 74.41 109.936 -177.223 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.0 m -128.92 101.03 5.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.996 -1.483 . . . . 55.3 106.996 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.9 p -104.41 149.05 25.75 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.139 -0.482 . . . . 54.13 111.576 -174.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.8 153.53 24.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 52.0 111.015 177.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 480' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 48.2 mm -61.0 -15.1 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 C-N-CA 123.924 0.89 . . . . 65.53 112.074 -179.153 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 481' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 15.0 t -94.99 -4.09 47.26 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.8 -0.563 . . . . 72.44 110.238 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -77.25 130.89 37.83 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.98 -0.748 . . . . 54.14 108.98 179.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.31 113.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.68 -0.859 . . . . 75.54 108.68 -179.023 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.45 120.04 36.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 109.081 -0.711 . . . . 60.2 109.081 179.24 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 485' ' ' ILE . . . . . 0.414 HG13 ' HD3' ' A' ' 453' ' ' LYS . 3.8 mp -92.34 113.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 61.45 107.122 177.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.92 121.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.124 -1.065 . . . . 74.14 108.124 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 39.7 mt -101.16 116.32 44.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.566 0.698 . . . . 71.22 110.474 -175.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.5 t -98.1 132.72 42.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.245 -0.889 . . . . 65.33 109.045 -176.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.7 98.68 1.93 Allowed Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 109.207 -1.557 . . . . 63.42 109.207 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 490' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 464' ' ' VAL . 18.0 t -140.85 111.89 7.17 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.902 -0.777 . . . . 70.44 108.902 -176.041 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.92 0 N-CA-C 109.636 -1.386 . . . . 73.04 109.636 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 110.691 -0.964 . . . . 54.55 110.691 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.68 153.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 117.174 0.487 . . . . 53.14 110.478 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.8 t -123.62 -173.38 2.73 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 107.338 -1.356 . . . . 75.35 107.338 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -92.82 100.64 13.08 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.986 -0.686 . . . . 74.1 109.715 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -115.67 127.79 55.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.425 -0.954 . . . . 73.24 108.425 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 22.7 m -131.27 158.48 43.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 123.102 0.561 . . . . 74.32 109.53 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -95.71 137.25 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.726 -0.842 . . . . 63.42 108.726 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.36 124.52 36.97 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-O 120.828 0.347 . . . . 70.25 110.519 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.01 142.64 96.85 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.16 2.573 . . . . 64.13 113.304 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.71 149.96 34.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.742 -1.117 . . . . 54.14 110.167 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.83 31.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.987 1.375 . . . . 63.0 108.006 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -64.44 133.97 53.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.057 -1.429 . . . . 74.32 110.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.18 -0.13 47.49 Favored Glycine 0 C--N 1.317 -0.495 0 C-N-CA 121.407 -0.425 . . . . 71.24 112.326 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.23 -176.88 3.94 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.615 -0.883 . . . . 72.43 108.615 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 91.6 p -81.3 168.41 18.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 118.407 0.548 . . . . 71.44 110.266 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 374' ' ' ILE . 1.8 p -63.15 -34.83 78.46 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 116.166 -0.47 . . . . 64.34 110.637 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.91 -39.25 93.98 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.731 0.412 . . . . 71.52 110.548 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -59.57 -42.83 93.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.019 0.438 . . . . 74.32 110.106 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.89 81.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.745 . . . . 73.31 110.343 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 370' ' ' SER . 80.9 mt -58.4 -46.34 89.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.654 -0.703 . . . . 53.41 110.546 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -46.98 78.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.317 -0.401 . . . . 73.04 111.705 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 74.0 m -60.9 -47.53 85.98 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.727 0.298 . . . . 71.23 111.291 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.57 -39.51 93.88 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.045 -0.262 . . . . 75.24 110.998 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -61.07 -42.92 99.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.459 0.703 . . . . 71.54 109.727 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -63.02 -33.71 76.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.778 -0.646 . . . . 75.41 111.323 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -83.84 -10.2 58.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.057 -0.52 . . . . 75.54 111.743 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.98 0.28 56.19 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.249 -0.977 . . . . 63.23 112.497 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 53.6 m-85 -78.07 151.11 33.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.675 -0.491 . . . . 70.43 109.675 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 383' ' ' LYS . 3.0 mptp? -102.06 147.19 26.89 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.867 -1.531 . . . . 73.43 106.867 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.69 141.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-O 121.378 0.609 . . . . 72.11 111.623 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -118.65 127.97 54.08 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.334 -1.358 . . . . 73.04 107.334 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.4 m -99.71 123.95 44.48 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 109.277 -0.638 . . . . 73.51 109.277 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.63 119.57 39.14 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.302 -1.74 . . . . 73.04 106.302 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 17.1 pm0 -119.18 141.29 48.99 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 110.155 -0.313 . . . . 75.51 110.155 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 11.0 ptpt -139.4 134.89 16.69 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 116.057 -0.52 . . . . 73.55 111.109 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 6.1 Cg_exo -82.7 134.24 7.33 Favored 'Trans proline' 0 C--O 1.246 0.893 0 N-CA-C 106.737 -2.063 . . . . 64.45 106.737 165.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.429 ' HB2' ' HD3' ' A' ' 389' ' ' LYS . 5.0 t70 -154.38 -176.73 6.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.182 -1.407 . . . . 55.03 112.239 -171.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.9 t -92.44 -41.09 10.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.017 -1.845 . . . . 71.42 106.017 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -101.83 74.52 1.49 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.92 -1.511 . . . . 75.51 106.92 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 421' ' ' SER . 2.1 pp -88.64 121.02 70.31 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 115.435 1.643 . . . . 71.13 115.435 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.588 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 16.5 Cg_exo -75.48 157.37 40.8 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.78 2.32 . . . . 45.54 109.519 164.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.64 160.91 47.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.33 2.02 . . . . 74.11 111.864 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.59 -6.91 5.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.041 0.756 . . . . 71.54 113.041 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -90.59 166.74 13.03 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.409 -0.814 . . . . 61.53 108.938 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.07 117.76 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.076 -0.713 . . . . 71.54 109.076 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -106.43 -28.63 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.346 -0.613 . . . . 75.03 109.346 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 168.16 28.09 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.957 -1.657 . . . . 70.21 108.957 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 p -132.58 -177.76 4.62 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-O 120.96 0.41 . . . . 63.14 110.698 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -100.94 138.78 20.11 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.947 -1.131 . . . . 65.03 107.947 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.9 -29.54 3.76 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 124.573 3.515 . . . . 75.14 114.703 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.58 -28.39 54.79 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.236 0.614 . . . . 61.34 112.0 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.66 54.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.944 0.402 . . . . 23.53 111.203 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -6.76 59.25 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.557 0.577 . . . . 71.33 112.557 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.5 m -86.02 147.69 26.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.649 -1.612 . . . . 71.53 106.649 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.0 m -74.45 112.83 11.01 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.417 -0.957 . . . . 65.12 108.417 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.67 165.06 29.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.047 -0.723 . . . . 71.34 109.047 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 50.3 m -69.23 134.13 48.81 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 120.6 -0.44 . . . . 72.34 110.242 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.89 112.01 2.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 63.24 110.218 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.53 24.21 5.1 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.537 -1.025 . . . . 74.24 110.537 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.99 -169.12 2.43 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.409 -1.33 . . . . 72.11 107.409 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.1 125.05 53.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.814 -0.554 . . . . 75.53 110.209 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -111.42 125.65 68.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.926 -0.579 . . . . 61.51 109.442 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.2 t -89.59 130.74 35.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.086 -0.709 . . . . 72.45 109.086 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 65.9 t -108.67 118.78 56.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.083 -1.08 . . . . 74.11 108.083 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.4 121.65 34.09 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.164 -0.68 . . . . 72.34 109.164 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 13.8 p -133.96 152.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.432 -1.321 . . . . 64.45 107.432 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.588 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 43.7 m -126.74 130.82 51.09 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 121.574 -0.703 . . . . 72.25 110.224 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -118.05 106.66 13.13 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.522 0.677 . . . . 65.51 110.995 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 79.33 141.24 2.19 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.205 -0.907 . . . . 43.04 114.204 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 24.0 Cg_endo -74.28 147.56 37.49 Favored 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 121.09 1.193 . . . . 74.1 109.465 172.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -72.77 164.91 25.83 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.887 -0.597 . . . . 73.32 109.628 -177.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -125.48 154.23 42.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.934 -1.136 . . . . 75.54 107.934 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.2 OUTLIER -141.9 153.48 44.44 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -83.06 138.86 33.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.962 -1.866 . . . . 73.12 105.962 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.2 mt -80.3 115.55 55.52 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 120.587 -0.445 . . . . 73.31 110.332 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.16 141.08 38.81 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.31 1.34 . . . . 70.43 109.969 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.6 78.77 9.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.619 1.2 . . . . 54.41 110.393 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.47 -10.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.531 -1.668 . . . . 71.35 107.588 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.6 m -59.9 -50.02 75.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.224 -1.353 . . . . 74.11 110.486 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 21.4 m -57.95 -13.56 4.76 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 125.598 1.559 . . . . 72.44 113.063 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.23 -47.08 11.18 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.731 -0.606 . . . . 73.11 110.681 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 26.6 m -160.82 145.68 14.14 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.652 -0.87 . . . . 73.2 108.652 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.57 -44.36 89.72 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 122.995 0.518 . . . . 53.31 111.085 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.76 84.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.815 -0.63 . . . . 73.55 110.748 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.451 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.5 mm-40 -61.89 -43.46 98.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.47 -0.786 . . . . 74.02 111.262 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -52.15 66.61 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 123.543 0.527 . . . . 55.42 110.729 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.76 -51.05 49.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.06 -0.518 . . . . 70.31 112.057 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -69.28 -44.94 70.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 114.04 1.126 . . . . 71.13 114.04 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.33 -38.39 84.82 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.978 -0.289 . . . . 73.33 111.312 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.15 -32.62 73.01 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.213 -0.595 . . . . 71.31 111.499 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.7 m -64.24 -40.38 95.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.999 -0.741 . . . . 75.22 108.999 174.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.65 66.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.711 -0.677 . . . . 75.2 110.798 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -12.4 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.164 0.507 . . . . 61.02 110.303 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.15 -27.57 5.56 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.886 -0.673 . . . . 73.15 113.713 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 445' ' ' THR . 88.8 m-85 -62.09 142.14 57.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.236 0.518 . . . . 71.42 111.392 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.89 13.71 4.42 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.59 -1.291 . . . . 53.21 113.278 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -128.35 113.82 16.08 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.321 -0.517 . . . . 73.24 110.049 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.1 152.36 47.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.199 0.523 . . . . 72.42 111.515 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -143.17 123.81 14.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.74 -1.578 . . . . 72.42 106.74 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -94.72 134.71 37.02 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.008 0.432 . . . . 73.44 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.73 159.69 41.28 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.741 -1.207 . . . . 75.24 107.741 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.663 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.1 m-80 -128.32 140.64 51.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.535 -0.913 . . . . 74.11 108.535 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.0 m -125.17 137.58 30.02 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 109.164 -0.68 . . . . 73.01 109.164 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 15.9 Cg_endo -61.55 121.39 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.414 2.076 . . . . 71.04 111.265 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.7 m -133.44 171.41 14.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.288 -0.634 . . . . 54.14 109.288 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.4 m -58.67 143.28 82.28 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 123.823 0.849 . . . . 64.02 108.867 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.1 Cg_endo -50.6 -25.91 15.76 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.553 2.835 . . . . 63.25 113.027 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.41 -18.71 65.51 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.215 0.45 . . . . 71.14 112.215 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.22 5.17 18.26 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.281 -0.262 . . . . 74.34 111.126 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.6 p -60.25 127.3 19.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.006 0.432 . . . . 74.11 110.895 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.03 82.06 Favored Glycine 0 C--N 1.308 -0.978 0 C-N-CA 120.469 -0.872 . . . . 75.33 112.453 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -111.28 153.41 25.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.568 -0.901 . . . . 64.35 108.568 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 434' ' ' THR . 86.5 t -84.03 135.55 24.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.814 -1.55 . . . . 54.23 106.814 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.511 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.75 -5.15 9.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 118.804 -1.158 . . . . 75.54 111.527 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 145.23 -153.67 25.42 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 111.066 -0.814 . . . . 61.24 111.066 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.1 p -116.79 160.38 20.9 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.489 -0.93 . . . . 52.12 108.489 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.4 t30 -74.08 -51.4 4.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 119.491 -0.884 . . . . 53.12 110.188 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.1 Cg_exo -71.03 152.39 62.71 Favored 'Trans proline' 0 C--N 1.381 2.288 0 N-CA-C 108.122 -1.53 . . . . 64.24 108.122 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.28 127.04 19.93 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.908 1.738 . . . . 75.25 111.775 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.79 -23.26 61.54 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.822 0.82 . . . . 45.53 110.753 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.54 0.18 47.64 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.592 -0.731 . . . . 74.12 110.422 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.46 150.57 20.46 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 109.182 -0.673 . . . . 73.42 109.182 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -88.23 106.95 18.54 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.55 -1.278 . . . . 74.43 107.55 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -106.51 148.27 28.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.618 -0.265 . . . . 50.35 110.921 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.14 157.83 36.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.395 0.517 . . . . 72.25 112.395 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 425' ' ' GLU . 40.5 mm -60.15 -35.61 62.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.684 0.754 . . . . 74.13 110.79 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.6 p -91.62 5.19 50.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.141 -0.936 . . . . 60.12 112.278 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -83.22 141.27 32.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.744 -1.206 . . . . 75.11 107.744 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.44 113.44 22.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.048 0.451 . . . . 71.03 110.618 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.06 119.81 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 108.898 -0.778 . . . . 71.34 108.898 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 60.6 mt -92.9 113.36 27.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.663 -1.236 . . . . 72.0 107.663 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.52 123.3 48.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 107.953 -1.128 . . . . 63.24 107.953 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 17.6 pt -107.24 122.77 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.713 0.768 . . . . 71.32 111.798 -176.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.663 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 60.2 t -98.67 139.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.164 -0.925 . . . . 61.45 108.988 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.87 118.47 4.69 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.744 -0.942 . . . . 63.33 110.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 52.9 m -141.09 129.78 22.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.59 -0.359 . . . . 72.11 110.216 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 106.411 -2.676 . . . . 45.54 106.411 177.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.3 0 N-CA-C 109.935 -1.266 . . . . 53.35 109.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.406 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.4 pp -112.13 142.65 23.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.388 0.614 . . . . 75.22 112.603 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.5 m -96.88 142.4 28.91 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.972 -1.492 . . . . 73.54 106.972 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -122.57 127.63 49.7 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.658 -1.238 . . . . 63.51 107.658 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 409' ' ' SER . 17.3 m-20 -101.67 126.7 48.56 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 107.653 -1.239 . . . . 73.33 107.653 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.81 155.14 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 116.476 -0.329 . . . . 62.55 110.486 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -95.2 136.97 34.89 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.556 -1.646 . . . . 74.23 106.556 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.62 138.27 19.59 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 116.265 -0.425 . . . . 72.53 110.27 -172.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.12 126.69 17.76 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.961 2.441 . . . . 65.11 112.814 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.21 153.77 42.7 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 114.482 -1.235 . . . . 75.34 110.457 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.1 m -109.75 3.59 9.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 114.239 1.2 . . . . 32.42 114.239 -174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -62.94 130.29 44.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.077 0.465 . . . . 74.33 110.229 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.05 -2.9 47.8 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.815 -0.707 . . . . 75.12 111.723 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -115.5 167.92 10.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.868 -0.79 . . . . 73.42 108.868 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 87.6 p -78.1 164.53 24.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.416 -0.587 . . . . 73.33 109.416 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 30.1 p -58.18 -45.53 87.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.155 0.503 . . . . 41.54 110.21 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.75 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.47 -0.787 . . . . 63.21 111.77 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.22 -34.74 76.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.465 0.65 . . . . 52.3 109.56 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.21 69.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 61.22 110.158 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.2 mt -58.75 -45.45 91.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.941 -0.572 . . . . 62.11 110.07 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.1 92.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.623 -0.717 . . . . 64.03 111.721 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 78.5 m -63.29 -48.66 77.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.243 -0.435 . . . . 75.25 111.816 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.86 -41.53 91.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.653 -0.249 . . . . 64.34 111.532 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -59.68 -41.59 91.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.905 0.753 . . . . 75.43 110.09 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -69.34 -31.34 69.71 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.249 -0.432 . . . . 70.22 111.184 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -79.13 -14.79 58.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.375 -0.375 . . . . 70.43 110.799 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.4 15.24 51.53 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.651 -0.785 . . . . 73.13 111.827 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -93.52 160.32 14.84 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.928 -0.397 . . . . 74.45 109.928 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.9 mmtp -104.66 135.35 46.22 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.025 -0.731 . . . . 74.41 109.025 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.38 138.59 49.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-O 121.256 0.55 . . . . 64.41 111.584 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -110.88 128.55 55.84 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.539 -1.282 . . . . 74.22 107.539 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.8 m -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 108.028 -1.101 . . . . 71.34 108.028 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 125.3 53.79 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 103.636 -2.727 . . . . 72.14 103.636 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.0 pm0 -125.75 142.78 51.35 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 120.001 -0.68 . . . . 43.03 110.594 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -134.01 131.84 21.08 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 120.724 -0.39 . . . . 74.13 110.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.35 134.74 6.87 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.97 1.78 . . . . 44.51 109.2 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 -171.95 -176.04 1.62 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.467 -1.679 . . . . 62.23 106.467 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 68.3 m -129.53 -8.49 4.62 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.422 0.629 . . . . 64.13 111.084 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -94.29 3.45 55.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.815 -1.18 . . . . 52.11 107.815 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.2 pp -88.52 151.05 47.65 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.513 -1.222 . . . . 72.34 113.4 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.65 172.03 11.58 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 122.538 2.159 . . . . 73.44 110.13 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.69 161.57 9.83 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.149 2.566 . . . . 63.4 112.255 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.471 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 p-10 -57.14 -9.05 0.8 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 124.711 1.204 . . . . 63.34 113.04 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 30.6 m170 -67.66 136.74 54.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.745 -1.576 . . . . 65.23 106.745 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.63 118.31 11.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.766 -0.374 . . . . 75.24 110.541 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.2 tp -93.16 -41.18 12.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.038 -0.727 . . . . 63.51 109.038 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.39 157.61 27.44 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.08 -1.208 . . . . 72.4 110.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -124.34 -178.49 4.12 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.964 0.906 . . . . 44.25 109.716 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 155.14 36.77 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 107.458 -1.312 . . . . 65.14 107.458 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.66 -15.06 5.95 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.977 3.118 . . . . 64.45 115.805 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.12 -21.91 64.17 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 112.741 0.645 . . . . 74.23 112.741 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.79 -50.84 31.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.607 . . . . 43.54 111.076 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -85.05 -7.9 58.91 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.613 0.597 . . . . 74.1 112.613 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 56.5 m -91.51 139.34 30.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.48 -1.304 . . . . 73.42 107.48 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 359' ' ' ASP . 40.1 m -75.0 113.54 12.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.211 0.529 . . . . 55.32 109.954 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 411' ' ' SER . 2.4 t -124.75 169.48 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 107.271 -1.381 . . . . 74.44 107.271 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 410' ' ' VAL . 21.9 m -68.27 148.52 50.67 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.104 0.478 . . . . 43.34 111.409 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.36 111.03 3.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.941 -0.572 . . . . 64.43 110.338 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.16 20.39 8.35 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.656 -0.783 . . . . 64.32 112.338 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -89.49 -170.73 2.95 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.628 -0.879 . . . . 62.22 108.628 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.5 pt-20 -112.45 124.54 52.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.118 1.155 . . . . 73.34 114.118 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.02 138.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.269 -1.382 . . . . 74.41 107.269 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -103.01 121.43 42.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.324 -0.95 . . . . 50.31 111.578 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.62 119.95 46.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.085 -1.08 . . . . 53.3 108.085 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -93.89 118.01 30.88 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.587 -0.523 . . . . 64.35 109.587 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.4 t -122.06 140.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.593 -0.73 . . . . 72.1 109.859 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.7 m -94.66 121.68 36.48 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.769 -1.197 . . . . 70.43 107.769 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.3 p -119.15 106.29 12.22 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.905 -0.318 . . . . 54.21 111.647 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.81 147.34 2.39 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 115.069 0.788 . . . . 63.12 115.069 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.7 Cg_endo -81.04 147.4 16.56 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.011 1.807 . . . . 72.44 111.161 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.58 149.19 26.05 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.788 -0.449 . . . . 65.31 109.788 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.8 mt-30 -129.1 155.67 45.08 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.935 -0.765 . . . . 73.4 108.935 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -146.76 164.24 33.4 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.448 -1.315 . . . . 72.12 107.448 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 138.86 31.52 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 110.441 -0.207 . . . . 75.33 110.441 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -83.07 119.26 73.89 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.729 -0.841 . . . . 75.02 108.729 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.43 141.27 89.8 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.584 2.189 . . . . 74.14 112.331 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -79.78 -7.04 58.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.904 -0.589 . . . . 52.22 111.499 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.446 HG23 HD12 ' A' ' 435' ' ' LEU . 13.3 p -66.58 -16.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.685 0.794 . . . . 72.22 110.74 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 23.6 m -49.89 -47.04 52.25 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.475 1.11 . . . . 72.43 113.155 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 m -59.04 -22.04 60.06 Favored 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 124.553 1.141 . . . . 61.41 112.467 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 432' ' ' VAL . 75.8 mt -78.1 -44.16 26.97 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 112.529 0.566 . . . . 62.55 112.529 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.3 m -160.63 136.2 8.09 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.245 -0.65 . . . . 73.0 109.245 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -60.78 -45.42 94.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.238 0.458 . . . . 73.34 112.238 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.15 80.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.49 0.662 . . . . 74.11 110.749 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.47 -43.72 69.21 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.63 -0.714 . . . . 73.11 109.953 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.16 -51.72 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.431 -0.804 . . . . 55.42 111.453 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.4 -41.19 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.886 -0.597 . . . . 64.43 111.369 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -67.69 -47.03 70.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.783 -0.367 . . . . 52.23 111.847 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.18 -38.55 88.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.971 0.36 . . . . 74.52 111.971 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.854 -0.338 . . . . 62.3 111.576 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 98.6 m -65.78 -38.77 89.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.363 0.125 . . . . 72.21 111.243 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.36 70.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.17 0.509 . . . . 72.45 110.467 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.17 -13.79 58.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.947 -0.569 . . . . 60.24 111.027 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.81 8.82 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.038 -1.077 . . . . 50.01 114.113 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' THR . 93.2 m-85 -78.89 111.52 15.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 117.91 0.855 . . . . 72.44 110.189 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -112.14 -21.64 6.2 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.426 -0.892 . . . . 62.0 112.495 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -95.15 111.47 23.3 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.491 -0.559 . . . . 72.24 109.491 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.03 159.03 25.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.444 0.64 . . . . 72.11 110.885 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -137.93 123.19 19.35 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 103.813 -2.662 . . . . 64.1 103.813 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -101.28 125.93 47.96 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.459 -0.496 . . . . 72.12 110.845 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.84 35.1 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.168 -0.679 . . . . 72.32 109.168 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.01 139.49 47.25 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.736 -0.468 . . . . 71.21 109.736 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 32.4 p -117.86 136.16 23.64 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 109.49 -0.559 . . . . 71.02 109.49 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.5 Cg_exo -61.43 120.53 8.24 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.428 2.085 . . . . 52.34 109.977 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.6 m -133.11 167.55 20.12 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.108 -0.496 . . . . 21.23 111.149 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 464' ' ' VAL . 4.6 p -76.89 156.24 82.56 Favored Pre-proline 0 N--CA 1.432 -1.369 0 C-N-CA 123.66 0.784 . . . . 73.43 109.377 174.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -49.71 -27.75 15.87 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 124.225 3.283 . . . . 74.13 114.157 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.37 -18.33 59.99 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.139 -0.482 . . . . 73.13 112.05 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.93 -18.29 13.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.642 0.258 . . . . 61.12 110.563 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 91.3 t -59.5 127.0 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.976 -0.557 . . . . 72.42 111.366 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.52 -4.46 58.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.033 -0.603 . . . . 51.3 111.813 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -122.87 161.05 24.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.878 0.37 . . . . 74.22 110.103 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.95 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.909 -0.775 . . . . 71.24 108.909 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.61 -25.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.559 -0.857 . . . . 72.05 111.31 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 174.21 38.18 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.208 -0.757 . . . . 64.23 111.208 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -126.3 154.84 42.88 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.967 -0.753 . . . . 74.32 108.967 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.9 t30 -65.08 -53.28 42.41 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.248 -0.581 . . . . 62.32 110.982 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.8 Cg_exo -71.95 123.44 9.31 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 107.744 -1.675 . . . . 75.54 107.744 170.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 33.7 Cg_endo -62.7 137.45 63.72 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 122.885 2.39 . . . . 64.32 114.4 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.518 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.42 7.92 8.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.145 -0.934 . . . . 71.25 110.613 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -108.37 -4.66 17.21 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.302 -0.863 . . . . 60.12 109.548 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 28.9 mt-30 -137.24 175.67 9.4 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.268 1.032 . . . . 65.1 113.401 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 426' ' ' GLN . 29.5 m -94.3 130.5 40.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.157 -1.838 . . . . 72.23 109.449 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 429' ' ' ILE . 20.1 m -131.49 149.59 52.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.144 -0.687 . . . . 64.41 109.144 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.05 154.76 29.75 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.96 0.726 . . . . 71.34 112.96 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.08 -15.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.208 1.004 . . . . 71.55 108.37 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.64 -5.29 59.17 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.039 -0.982 . . . . 65.43 108.899 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -87.7 128.84 35.3 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.122 -1.436 . . . . 71.2 107.122 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.36 124.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.195 -1.039 . . . . 73.22 108.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.33 118.69 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 C-N-CA 120.194 -0.602 . . . . 71.23 109.65 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.16 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 105.034 -2.21 . . . . 74.42 105.034 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 121.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 107.588 -1.264 . . . . 70.22 107.588 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.78 119.11 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 121.322 0.582 . . . . 73.04 110.455 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.14 134.92 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.508 -0.923 . . . . 73.33 108.508 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.06 115.24 4.16 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.222 -1.151 . . . . 52.12 110.222 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 39.8 p -142.39 145.93 34.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.986 0.393 . . . . 71.02 110.39 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.912 0 N-CA-C 108.004 -2.038 . . . . 61.42 108.004 177.697 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.667 0 N-CA-C 111.224 -0.75 . . . . 43.05 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.451 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.8 pp -75.77 133.22 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 121.547 0.689 . . . . 74.23 110.942 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.2 t -136.96 157.49 46.62 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 23.42 109.769 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 358' ' ' ARG . 23.7 mmt180 -107.35 84.8 2.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.756 0.788 . . . . 72.42 109.879 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -115.36 144.22 44.11 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.417 -1.327 . . . . 62.43 107.417 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.24 142.25 32.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.153 0.501 . . . . 73.14 111.242 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -95.25 136.05 36.07 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.51 -1.663 . . . . 62.41 106.51 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.9 p -97.17 135.4 21.93 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 119.742 -0.783 . . . . 71.33 110.611 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.0 129.85 32.39 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.767 2.311 . . . . 70.13 111.282 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.63 147.83 52.18 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.041 . . . . 72.31 109.519 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.8 m -109.19 5.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 116.424 -0.353 . . . . 75.43 111.413 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -52.74 135.32 35.57 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.788 0.835 . . . . 70.25 111.758 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.48 1.56 59.06 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.469 -0.872 . . . . 64.01 112.946 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -121.21 179.8 4.29 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.185 -0.597 . . . . 74.34 110.639 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.2 p -73.25 149.65 42.62 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.962 -0.755 . . . . 72.3 108.962 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.0 p -63.43 -33.34 75.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.082 0.468 . . . . 75.21 110.39 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.62 86.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.412 -0.813 . . . . 70.23 111.594 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.98 -38.36 85.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.854 0.359 . . . . 42.42 110.167 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.92 78.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.968 -1.015 . . . . 71.24 110.174 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 85.0 mt -69.05 -46.21 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.804 -0.635 . . . . 71.02 110.644 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.07 -47.07 88.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.641 0.608 . . . . 63.24 112.641 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.5 m -65.49 -44.25 87.64 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 75.15 109.878 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 416' ' ' ILE . 13.3 tp -64.78 -37.75 88.65 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.924 -1.035 . . . . 73.44 110.351 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -60.51 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.984 1.313 . . . . 75.24 110.369 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -67.37 -22.64 65.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.994 -0.548 . . . . 64.41 110.805 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -85.36 -8.67 58.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.885 -0.598 . . . . 71.41 111.72 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 86.24 9.89 75.54 Favored Glycine 0 C--O 1.253 1.315 0 C-N-CA 120.912 -0.661 . . . . 52.33 113.915 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 54.8 m-85 -77.85 151.8 33.71 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.102 0.477 . . . . 64.41 110.217 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -88.26 132.74 34.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.199 -1.778 . . . . 74.54 106.199 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.29 134.98 59.18 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.804 0 CA-C-O 121.759 0.79 . . . . 53.54 110.956 -173.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -110.36 126.51 54.33 Favored 'General case' 0 C--N 1.268 -2.961 0 N-CA-C 104.743 -2.318 . . . . 73.12 104.743 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.5 m -112.73 118.86 36.16 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 108.242 -1.021 . . . . 51.21 108.242 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.52 118.89 36.98 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.45 -1.315 . . . . 72.01 107.45 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.7 pm0 -112.84 124.72 53.23 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.992 -1.114 . . . . 72.31 107.992 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -125.45 137.07 29.16 Favored Pre-proline 0 C--N 1.284 -2.24 0 C-N-CA 119.577 -0.849 . . . . 74.22 111.131 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -88.54 128.34 2.09 Favored 'Trans proline' 0 N--CA 1.426 -2.454 0 N-CA-C 107.972 -1.588 . . . . 54.23 107.972 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 48.4 t0 -174.47 170.42 3.55 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.364 -1.347 . . . . 62.34 107.364 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 24.0 m -106.61 -18.69 13.89 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.536 0.684 . . . . 51.24 109.219 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.7 m -90.61 36.91 0.9 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 123.191 1.472 . . . . 74.32 107.71 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 391' ' ' ASP . 28.1 pt -88.8 141.69 30.05 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 114.285 -1.325 . . . . 73.41 110.72 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -73.66 173.86 13.2 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.129 1.886 . . . . 60.4 108.39 166.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.72 161.59 35.21 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.958 1.772 . . . . 65.12 111.772 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.89 -13.28 2.5 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 124.071 0.948 . . . . 62.21 111.969 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -99.61 122.55 42.82 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.696 -2.335 . . . . 64.34 104.696 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.0 117.88 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.88 0.847 . . . . 72.43 109.808 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.7 tp -90.97 -29.28 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.38 -0.827 . . . . 72.22 110.294 -174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.46 157.82 27.8 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 120.516 -0.849 . . . . 62.11 111.408 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 65.1 p -125.58 -176.91 3.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.165 -1.05 . . . . 64.22 108.165 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -101.71 139.92 20.77 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.649 -0.871 . . . . 53.55 108.649 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -48.64 -14.46 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 124.396 3.397 . . . . 51.14 115.414 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.15 64.79 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 120.829 0.347 . . . . 75.13 110.244 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.3 -27.68 63.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.534 0.683 . . . . 73.2 110.678 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -90.32 -3.72 57.58 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.609 -0.723 . . . . 74.35 109.554 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 41.4 m -91.32 156.94 17.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.634 -1.247 . . . . 33.21 107.634 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 p -74.37 112.57 10.66 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.698 0.761 . . . . 54.41 111.056 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.48 170.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.037 -0.983 . . . . 71.55 108.903 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 75.4 p -75.8 158.73 31.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.813 -0.755 . . . . 73.42 110.835 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.54 109.94 2.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.375 -0.972 . . . . 73.34 108.375 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 92.23 29.2 11.63 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.279 -0.728 . . . . 44.51 111.279 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.3 t70 -76.79 -174.51 3.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.964 0.505 . . . . 74.3 109.655 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.53 126.97 42.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.161 0.505 . . . . 62.13 112.178 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.493 ' HB ' HD21 ' A' ' 377' ' ' LEU . 51.0 mm -121.16 127.22 75.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.472 -0.936 . . . . 75.05 108.472 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -94.38 119.13 32.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.134 0.969 . . . . 72.01 110.813 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.06 131.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.991 -1.114 . . . . 70.11 107.991 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -101.57 128.7 47.72 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.818 -0.438 . . . . 62.52 109.818 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 38.9 t -132.07 131.74 61.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.205 -1.035 . . . . 54.32 108.205 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 19.0 m -91.89 122.28 34.27 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.408 -0.59 . . . . 72.04 109.408 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.4 m -120.6 106.04 11.38 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.995 -0.372 . . . . 72.41 109.995 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 73.72 118.12 0.08 OUTLIER Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.88 0.712 . . . . 52.14 114.88 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.8 Cg_exo -71.34 138.25 32.56 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 121.919 1.746 . . . . 63.35 109.391 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 2.8 mm-40 -78.44 142.8 37.27 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 114.597 1.332 . . . . 75.44 114.597 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.82 133.56 55.31 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 113.435 -1.711 . . . . 70.32 108.674 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.14 157.8 35.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.203 -1.777 . . . . 75.52 106.203 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.81 137.41 33.72 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.609 -0.436 . . . . 75.54 110.409 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 67.4 mt -86.16 128.66 56.83 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.056 -1.461 . . . . 75.42 107.056 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.36 141.4 38.83 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.503 1.469 . . . . 62.23 112.683 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.147 0.499 . . . . 65.13 111.171 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 430' ' ' PRO . 8.9 p -65.9 -14.84 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.841 0.829 . . . . 73.52 109.851 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.7 m -52.75 -41.53 64.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.751 1.22 . . . . 71.51 111.953 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.8 m -64.15 -13.62 49.51 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.024 0.93 . . . . 60.45 112.083 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.73 -45.44 14.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.3 0.482 . . . . 52.4 112.3 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 86.9 m -156.05 135.68 12.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.65 -0.5 . . . . 74.01 109.65 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 441' ' ' VAL . 62.7 t80 -57.43 -53.57 56.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.153 0.797 . . . . 74.52 113.153 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.04 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.004 0.43 . . . . 73.44 111.248 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -62.02 -43.21 99.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.013 -0.994 . . . . 71.34 108.862 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.26 -48.88 79.85 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.364 -0.834 . . . . 72.24 110.619 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.9 t -58.93 -47.07 90.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.794 -0.639 . . . . 71.12 111.275 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.6 mmpt? -64.95 -46.51 81.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.704 -0.226 . . . . 65.44 111.213 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.69 -38.77 92.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.396 -0.365 . . . . 51.41 111.472 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.533 HD23 ' CE2' ' A' ' 452' ' ' PHE . 30.5 tp -67.29 -39.94 86.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.267 -0.424 . . . . 60.15 109.871 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.8 m -65.76 -38.86 90.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.261 -0.644 . . . . 72.11 109.261 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.59 73.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.55 -0.75 . . . . 62.44 111.138 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.24 31.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.795 -0.639 . . . . 74.41 110.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.7 -17.61 49.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.341 -0.457 . . . . 55.03 112.575 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.454 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 70.7 m-85 -83.11 83.83 7.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.381 0.61 . . . . 63.45 110.558 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -98.04 17.02 59.35 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.769 -0.932 . . . . 75.33 110.769 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -103.86 110.56 22.73 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.814 -1.551 . . . . 64.44 106.814 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PHE . . . . . 0.533 ' CE2' HD23 ' A' ' 444' ' ' LEU . 93.4 m-85 -119.41 152.45 36.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.522 0.677 . . . . 65.15 112.073 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.1 OUTLIER -147.1 121.0 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.231 -2.137 . . . . 74.25 105.231 170.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -91.0 130.37 36.92 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.601 0.715 . . . . 73.43 111.584 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.19 152.84 46.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.4 -1.333 . . . . 75.31 107.4 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -132.12 149.8 52.31 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.151 0.501 . . . . 63.43 110.726 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.5 m -132.78 131.72 22.19 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 115.603 -0.726 . . . . 73.54 109.204 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 490' ' ' SER . 31.6 Cg_exo -61.51 120.01 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.004 1.802 . . . . 73.21 108.274 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.572 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 17.0 m -130.0 177.24 7.43 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.992 -0.549 . . . . 71.34 109.762 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 43.1 m -67.15 139.27 95.07 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.637 -1.246 . . . . 71.14 107.637 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.72 -23.62 8.56 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.806 3.004 . . . . 70.41 114.168 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -61.4 -32.29 72.22 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.347 0.659 . . . . 55.33 111.155 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.07 0.73 56.08 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.386 0.513 . . . . 70.51 112.386 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 461' ' ' PRO . 10.4 p -59.89 126.95 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.247 0.546 . . . . 71.44 111.114 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.47 78.31 Favored Glycine 0 C--O 1.244 0.767 0 C-N-CA 120.686 -0.769 . . . . 70.51 112.191 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.79 148.3 33.85 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.986 -0.746 . . . . 62.4 108.986 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 486' ' ' ILE . 58.7 t -84.14 132.74 30.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.061 -1.088 . . . . 74.05 108.061 175.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.68 -26.81 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.422 -0.911 . . . . 54.03 111.134 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.75 169.65 40.34 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.626 -0.797 . . . . 65.22 111.39 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.2 p -127.46 149.07 50.27 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.507 -0.924 . . . . 72.41 108.507 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.506 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.7 t30 -62.35 -52.78 63.7 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 119.327 -0.368 . . . . 73.13 110.725 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.1 Cg_exo -73.7 142.73 32.71 Favored 'Trans proline' 0 C--N 1.374 1.871 0 N-CA-C 108.178 -1.508 . . . . 75.12 108.178 171.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 126.79 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.262 1.975 . . . . 71.11 112.786 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.33 3.64 26.99 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.169 0.985 . . . . 53.42 110.253 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -111.66 4.24 18.45 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.842 -1.072 . . . . 65.24 110.922 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -137.08 164.81 27.54 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.067 0.937 . . . . 75.52 111.939 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.84 125.54 29.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.299 -1.773 . . . . 71.43 108.94 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -130.82 148.32 52.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.186 -0.672 . . . . 61.31 109.186 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -69.97 140.93 53.06 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.292 0.091 . . . . 51.22 111.039 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.453 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 1.9 mp -60.76 -18.81 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.954 1.302 . . . . 75.22 111.931 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.23 5.11 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 72.34 112.063 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.97 132.29 33.84 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.672 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.3 t -79.89 114.77 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.936 -1.876 . . . . 63.32 105.936 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.04 120.54 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-O 121.255 0.55 . . . . 73.44 109.829 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 68.4 mt -91.23 112.25 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.287 -1.746 . . . . 73.42 106.287 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.39 119.39 51.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 114.658 -1.156 . . . . 72.1 108.064 -175.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 25.7 mt -99.83 115.97 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-O 121.508 0.671 . . . . 71.45 109.559 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.65 140.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.353 -0.98 . . . . 63.22 108.353 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 121.95 5.59 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 109.062 -1.615 . . . . 75.54 109.062 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.8 m -140.08 125.2 18.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 122.035 -0.685 . . . . 63.43 110.212 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.413 -2.837 0 N-CA-C 107.818 -2.113 . . . . 75.31 107.818 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.949 0 N-CA-C 111.142 -0.783 . . . . 71.13 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.434 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.6 pp -121.22 132.72 69.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.777 0.799 . . . . 73.53 112.466 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 11.3 m -103.84 128.78 51.28 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.545 -1.65 . . . . 63.3 106.545 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -90.59 87.01 6.56 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.711 0.767 . . . . 73.42 111.486 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.41 146.1 34.75 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.396 -1.274 . . . . 74.42 108.169 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.11 145.05 29.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.885 -0.413 . . . . 73.34 109.885 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -95.71 137.39 34.84 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.172 -1.047 . . . . 73.52 108.172 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.09 136.08 21.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 C-N-CA 120.57 -0.452 . . . . 34.22 109.991 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 154.6 12.18 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.711 2.941 . . . . 72.44 115.165 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.59 101.64 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 73.34 110.308 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.85 -3.65 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.25 0.548 . . . . 74.33 111.712 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.486 -0.779 . . . . 74.01 109.903 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.2 58.97 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.655 -0.978 . . . . 64.51 110.655 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -124.44 170.17 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.587 -1.264 . . . . 71.31 107.587 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.8 p -74.98 157.1 35.51 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.684 -0.487 . . . . 73.5 109.684 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.4 p -62.17 -37.86 86.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.016 0.436 . . . . 54.12 110.461 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.28 94.74 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.872 -0.604 . . . . 65.44 110.897 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.65 -37.46 76.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.505 -0.316 . . . . 73.25 110.952 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.33 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.66 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -42.62 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.258 0.348 . . . . 70.22 111.173 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.61 88.22 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.388 -0.369 . . . . 65.34 111.09 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.1 m -63.58 -46.63 84.98 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.599 -0.273 . . . . 64.53 110.743 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.18 -41.86 96.92 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.986 -0.375 . . . . 73.11 109.986 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -59.82 -46.6 88.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 70.03 110.439 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.37 -33.91 76.93 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 112.657 0.614 . . . . 74.32 112.657 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -84.83 -4.23 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.09 -0.505 . . . . 63.43 112.159 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.46 7.85 64.74 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 119.88 -1.152 . . . . 53.53 113.146 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -83.76 167.65 16.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.516 -0.55 . . . . 60.25 109.516 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 30.6 mmtp -105.79 161.58 14.3 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.293 -1.373 . . . . 54.43 107.293 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 151.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-O 121.881 0.848 . . . . 74.13 112.576 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 417' ' ' THR . 29.5 ttm-85 -137.05 141.07 42.43 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.567 -2.012 . . . . 71.12 105.567 172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -135.24 133.08 38.6 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.331 -0.618 . . . . 73.41 109.331 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.71 119.94 36.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.335 -0.987 . . . . 74.33 108.335 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -95.58 122.43 38.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.099 -1.075 . . . . 54.12 108.099 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 122.71 21.87 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 113.067 0.766 . . . . 74.34 113.067 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.52 129.07 4.19 Favored 'Trans proline' 0 C--O 1.247 0.933 0 N-CA-C 106.719 -2.07 . . . . 73.44 106.719 165.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.4 t70 -163.68 -176.03 4.44 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 63.41 109.042 -171.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 p -100.77 -23.72 14.55 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.34 -0.985 . . . . 64.3 108.34 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.2 m -89.3 35.45 0.81 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.279 -1.328 . . . . 71.5 108.983 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.8 pt -88.18 123.5 68.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 114.37 1.248 . . . . 73.23 114.37 -171.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 2.5 Cg_endo -85.15 174.89 6.86 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.861 2.374 . . . . 72.32 108.126 165.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.16 160.94 35.93 Favored 'Trans proline' 0 C--O 1.212 -0.817 0 C-N-CA 122.475 2.117 . . . . 71.21 111.261 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.22 -7.47 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.906 0.706 . . . . 74.52 112.906 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.87 147.77 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.033 -1.839 . . . . 74.45 106.033 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.37 116.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.186 -1.413 . . . . 42.41 107.186 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.5 mm -90.54 -39.77 12.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.299 -0.63 . . . . 70.33 109.299 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 157.67 27.48 Favored Glycine 0 N--CA 1.411 -3.013 0 CA-C-N 115.214 -0.903 . . . . 64.51 111.01 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -122.32 -179.68 4.26 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.49 -0.929 . . . . 62.3 108.49 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.33 139.92 20.67 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 108.948 -0.76 . . . . 71.45 108.948 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.37 -24.47 1.03 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 124.618 3.546 . . . . 73.03 114.84 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.5 63.37 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 123.133 0.573 . . . . 62.41 111.456 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.97 94.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.64 0.734 . . . . 74.11 110.464 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -4.75 57.62 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.531 -0.759 . . . . 72.24 111.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.9 m -88.83 152.85 21.51 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.938 -1.505 . . . . 63.54 106.938 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.5 m -74.12 113.53 11.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.953 0.882 . . . . 24.43 110.688 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.6 170.71 5.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.342 -1.299 . . . . 73.41 110.061 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 136.36 57.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.765 -0.652 . . . . 71.22 111.61 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.45 119.95 13.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.508 -0.553 . . . . 73.3 109.508 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 87.3 32.12 14.81 Favored Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 121.1 -0.572 . . . . 40.41 112.133 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.53 174.99 6.84 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.939 -0.763 . . . . 65.02 108.939 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 12.3 pt-20 -100.35 121.22 41.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.831 0.824 . . . . 71.33 112.782 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.76 124.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.667 -1.235 . . . . 73.23 107.667 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 13.4 t -91.85 130.29 37.65 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.532 0.682 . . . . 61.03 109.891 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 130.74 64.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.021 -0.991 . . . . 63.12 108.422 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -97.53 127.9 43.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.406 -0.961 . . . . 65.54 108.406 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.02 135.11 62.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.609 -0.886 . . . . 72.35 108.609 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 47.0 m -106.51 123.94 48.85 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.833 -0.542 . . . . 75.32 111.7 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.5 p -118.2 105.54 11.9 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.69 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.09 146.03 2.19 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.059 0.784 . . . . 33.22 115.059 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 76.7 Cg_endo -81.74 149.65 16.25 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.344 2.029 . . . . 75.33 111.753 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.05 144.76 40.6 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.52 -0.764 . . . . 72.31 110.849 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.537 ' HB3' HG22 ' A' ' 477' ' ' THR . 45.5 mt-30 -118.85 156.88 28.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 71.22 110.675 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.494 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 6.1 tpm_? -153.51 154.66 34.76 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.848 -1.538 . . . . 64.21 106.848 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.1 OUTLIER -93.8 140.17 29.98 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.02 -0.733 . . . . 65.03 109.02 176.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.8 mp -78.98 126.47 82.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.851 -1.166 . . . . 74.1 107.851 -175.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.97 140.32 79.53 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.203 1.936 . . . . 70.43 112.176 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.77 12.9 28.37 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.789 0.804 . . . . 73.02 110.08 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.2 -12.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.919 -1.037 . . . . 73.01 108.965 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.0 m -52.76 -40.51 63.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.503 -1.226 . . . . 72.31 112.624 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -63.01 -17.91 62.73 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.365 1.246 . . . . 71.23 114.365 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.36 -44.91 15.56 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.086 0.47 . . . . 61.41 111.689 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 65.6 m -150.2 133.22 16.16 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.896 -0.503 . . . . 74.43 109.969 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -58.37 -45.31 88.47 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.467 0.479 . . . . 75.01 111.163 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.16 -42.37 80.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.042 -0.526 . . . . 55.52 110.694 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.75 -39.39 94.15 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 116.064 -0.516 . . . . 71.1 111.398 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.49 -50.53 73.18 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.526 0.516 . . . . 53.45 109.768 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.03 -45.9 95.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.102 -0.499 . . . . 61.34 110.673 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.47 -47.72 75.13 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.813 0.301 . . . . 74.55 111.813 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -66.32 -40.24 89.81 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.11 111.688 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.1 mp -67.0 -38.43 85.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.619 -0.432 . . . . 72.4 111.608 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 68.9 m -64.81 -38.8 92.19 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.478 -0.564 . . . . 54.13 109.478 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.85 65.24 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.395 0.616 . . . . 74.41 110.455 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.494 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.44 -13.22 59.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.482 0.658 . . . . 73.24 110.296 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.22 -13.32 26.14 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.691 -0.766 . . . . 51.12 113.651 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -71.62 114.96 10.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.525 -0.546 . . . . 73.33 109.525 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.97 17.38 8.67 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.45 -0.881 . . . . 71.44 111.58 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -120.58 111.25 17.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.478 -1.675 . . . . 75.21 106.478 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.3 155.01 39.42 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.772 0.796 . . . . 74.41 112.882 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 4.5 tppp? -145.17 125.08 13.47 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.598 -1.63 . . . . 74.32 106.598 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -100.44 126.08 46.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.169 0.509 . . . . 64.02 110.888 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.64 156.43 37.51 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.431 -0.952 . . . . 70.31 108.431 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.139 0.495 . . . . 74.21 110.302 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.4 m -133.94 144.57 52.21 Favored Pre-proline 0 C--N 1.286 -2.183 0 N-CA-C 109.171 -0.677 . . . . 72.31 109.171 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_endo -62.54 122.82 11.35 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 123.257 2.638 . . . . 72.43 113.21 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.7 m -132.87 170.73 14.9 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.537 -0.912 . . . . 71.21 108.537 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.7 m -69.72 145.61 94.95 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 107.678 -1.23 . . . . 74.22 107.678 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.558 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.8 Cg_endo -49.36 -23.76 7.67 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 124.129 3.219 . . . . 63.35 114.255 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.84 -30.11 71.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.368 0.604 . . . . 64.32 110.43 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.35 1.35 35.42 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.821 -0.627 . . . . 72.13 112.581 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.6 p -60.18 126.29 17.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 119.415 -0.914 . . . . 64.23 110.72 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.92 -5.94 72.83 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.598 -0.81 . . . . 65.41 112.169 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.88 155.61 17.85 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.927 -0.768 . . . . 72.34 108.927 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 486' ' ' ILE . 66.3 t -84.67 131.59 33.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.923 -0.769 . . . . 72.34 108.923 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.13 -14.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.838 -0.745 . . . . 64.35 110.903 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.53 -177.65 41.87 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 115.567 -0.742 . . . . 74.23 111.441 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.9 p -130.44 150.03 51.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.9 t30 -63.87 -51.36 64.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 120.262 -0.575 . . . . 23.33 110.307 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.3 Cg_exo -75.41 130.48 12.91 Favored 'Trans proline' 0 C--N 1.375 1.955 0 N-CA-C 108.376 -1.432 . . . . 71.45 108.376 170.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.429 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 37.5 Cg_endo -62.94 136.53 57.46 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.697 2.264 . . . . 64.21 113.399 -175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.62 6.84 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.066 0.936 . . . . 53.31 109.845 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -104.61 2.59 30.81 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.857 -1.065 . . . . 61.54 109.664 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 44.4 tp60 -145.97 173.71 11.91 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.975 -0.69 . . . . 74.31 110.923 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 426' ' ' GLN . 18.2 m -102.26 140.62 36.3 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 124.308 1.043 . . . . 74.34 110.948 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 429' ' ' ILE . 77.8 p -137.84 150.38 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.373 -0.602 . . . . 74.51 109.373 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.5 146.68 51.7 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.885 -0.326 . . . . 73.33 110.38 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.76 -11.13 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 124.052 0.941 . . . . 54.42 111.629 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 5.5 p -87.04 5.79 35.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.412 0.625 . . . . 70.43 111.065 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -93.01 142.12 27.64 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.656 -0.702 . . . . 61.31 110.362 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 52.4 t -85.79 115.18 26.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.946 -1.501 . . . . 74.33 106.946 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 81.9 t -86.58 119.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-O 121.467 0.651 . . . . 55.31 109.998 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 49.0 mt -92.36 112.9 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 107.302 -1.37 . . . . 72.4 107.302 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.38 127.13 49.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.451 -1.315 . . . . 73.35 107.451 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 15.6 mm -102.27 113.13 37.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.132 0.491 . . . . 72.11 109.943 -173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.3 141.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.673 -0.862 . . . . 62.3 108.673 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.52 121.12 6.1 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 111.035 -0.826 . . . . 72.21 111.035 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.5 m -141.39 143.76 34.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.582 -0.896 . . . . 64.23 108.582 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.562 0 CA-C-O 118.229 -1.317 . . . . 74.2 110.538 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.568 0 N-CA-C 109.484 -1.446 . . . . 43.05 109.484 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.01 144.73 29.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 118.017 0.908 . . . . 74.44 113.037 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.17 174.28 9.24 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.451 -1.314 . . . . 74.51 107.451 171.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -87.62 78.43 8.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.115 -1.034 . . . . 72.21 109.794 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.05 117.2 25.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.636 -1.166 . . . . 74.14 108.419 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.41 151.77 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.362 -0.607 . . . . 64.22 109.362 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -95.15 136.99 34.8 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.289 -1.374 . . . . 72.32 107.289 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.0 p -100.04 121.8 52.72 Favored Pre-proline 0 C--N 1.287 -2.122 0 N-CA-C 108.914 -0.772 . . . . 51.11 108.914 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.94 136.8 63.53 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.602 2.201 . . . . 74.52 113.046 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.545 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 7.5 p-10 -72.61 137.23 46.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.254 -0.885 . . . . 73.1 110.004 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 368' ' ' GLN . 5.8 t -89.82 45.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 122.585 1.183 . . . . 71.3 110.482 -170.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.545 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.8 ptm85 -65.51 136.29 56.23 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.418 -1.265 . . . . 64.25 110.921 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.48 0.55 62.79 Favored Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.79 -0.719 . . . . 50.31 113.024 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.417 ' HB2' HG12 ' A' ' 365' ' ' VAL . 44.9 mt-30 -125.95 172.12 10.19 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 122.586 -0.361 . . . . 72.23 110.13 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.1 p -77.14 167.14 22.27 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.626 0.251 . . . . 74.55 110.604 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.7 p -63.04 -33.96 76.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.078 0.465 . . . . 72.2 110.03 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.5 97.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.719 -0.673 . . . . 34.21 110.258 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.83 -41.43 95.75 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.539 -0.541 . . . . 55.42 109.539 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.74 80.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.108 -0.497 . . . . 71.22 110.784 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.15 -46.02 88.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.701 -0.681 . . . . 72.22 110.079 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.42 86.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.819 -0.628 . . . . 52.52 111.61 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.2 m -60.58 -47.11 87.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.326 0.25 . . . . 55.22 111.552 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.55 -42.02 95.97 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.533 -0.467 . . . . 60.21 110.593 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -59.83 -41.56 91.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.597 0.759 . . . . 74.52 109.806 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -68.71 -29.27 67.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.384 -0.825 . . . . 53.33 111.12 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -82.68 -14.4 54.72 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.458 -0.571 . . . . 51.23 109.458 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.564 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.45 -2.63 56.19 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.822 -0.626 . . . . 53.31 111.692 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 46.5 m-85 -81.5 156.71 25.15 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.937 0.398 . . . . 74.51 110.075 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -105.16 147.78 27.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.371 -1.344 . . . . 62.53 107.371 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.75 142.73 30.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 121.957 0.884 . . . . 73.53 112.748 -175.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 417' ' ' THR . 58.2 ttt180 -119.06 133.39 55.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.014 -1.847 . . . . 61.23 106.014 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.9 m -104.94 125.66 51.18 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.499 -0.88 . . . . 74.3 111.36 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.2 tm? -111.51 119.33 38.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.234 -2.135 . . . . 74.4 105.234 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.1 pm0 -112.85 122.63 48.23 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 109.292 -0.633 . . . . 73.54 109.292 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -115.78 127.38 26.83 Favored Pre-proline 0 C--N 1.289 -2.034 0 C-N-CA 119.939 -0.705 . . . . 63.13 111.287 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -87.39 128.9 2.64 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 N-CA-C 107.234 -1.871 . . . . 61.42 107.234 167.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 394' ' ' ILE . 6.9 t70 -142.66 -179.4 6.29 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.639 -1.225 . . . . 61.32 110.199 -173.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.4 m -98.15 -33.47 11.12 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.365 -1.346 . . . . 60.53 107.365 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 34.5 m -101.57 71.13 1.31 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.178 -1.415 . . . . 74.41 107.178 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 391' ' ' ASP . 18.8 pt -100.85 125.32 38.92 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.867 -1.06 . . . . 74.22 111.97 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.57 175.86 3.68 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 N-CA-C 107.66 -1.708 . . . . 72.4 107.66 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 162.45 16.07 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.083 1.855 . . . . 74.45 109.992 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -56.81 -8.42 0.6 Allowed 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.254 1.022 . . . . 64.45 113.034 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.9 m80 -62.7 131.74 49.95 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.075 -0.713 . . . . 64.34 109.075 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.61 118.43 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 CA-C-N 115.645 -0.707 . . . . 73.1 109.159 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.2 pp -91.13 -28.03 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.105 -0.952 . . . . 72.35 110.359 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.435 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -169.42 157.31 29.04 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.515 -1.434 . . . . 72.4 109.515 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 403' ' ' ASP . 8.9 m -114.42 -177.18 3.07 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 106.332 -1.729 . . . . 62.43 106.332 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.604 ' H ' HG22 ' A' ' 402' ' ' THR . 10.5 t70 -97.96 138.72 20.99 Favored Pre-proline 0 C--N 1.267 -2.996 0 N-CA-C 109.092 -0.707 . . . . 73.21 109.092 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.48 -25.7 0.88 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 125.098 3.865 . . . . 72.34 115.463 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.73 68.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.954 0.407 . . . . 54.23 110.72 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.8 -38.57 62.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.775 0.798 . . . . 71.03 109.79 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.26 -5.08 48.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.903 -1.044 . . . . 63.21 110.704 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.4 m -86.8 147.87 25.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.044 -1.095 . . . . 72.52 108.044 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.9 p -74.52 112.97 11.24 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.329 -0.619 . . . . 65.31 109.329 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.28 169.22 22.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.349 -0.982 . . . . 74.22 108.349 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.1 p -80.14 137.75 36.78 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.003 -1.079 . . . . 65.53 110.432 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -60.36 138.61 57.94 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.218 -0.446 . . . . 55.25 110.655 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 100.92 15.63 28.13 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.192 -1.004 . . . . 70.35 110.779 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.51 -174.32 4.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.952 -1.499 . . . . 43.13 106.952 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 126.49 55.33 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.431 0.634 . . . . 65.23 110.926 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.01 119.44 61.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 116.138 -0.483 . . . . 75.42 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 4.9 t -85.13 118.93 24.99 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.899 0.857 . . . . 73.12 109.728 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.84 122.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.01 -0.995 . . . . 72.23 108.387 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 9.6 p30 -90.66 128.71 36.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.448 0.642 . . . . 74.44 110.461 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.0 143.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.333 -1.358 . . . . 63.31 107.333 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 2.1 p -88.04 120.02 28.98 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 119.143 -1.023 . . . . 73.34 108.898 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.0 m -120.2 105.31 10.84 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.962 -0.755 . . . . 74.35 108.962 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 75.73 166.13 19.57 Favored Glycine 0 C--O 1.259 1.677 0 CA-C-O 122.118 0.843 . . . . 43.32 114.293 177.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -96.0 157.32 1.42 Allowed 'Trans proline' 0 N--CA 1.429 -2.265 0 C-N-CA 122.998 2.466 . . . . 73.24 112.866 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.59 20.22 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.524 -2.028 . . . . 74.21 105.524 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -120.1 152.73 37.17 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.746 -0.465 . . . . 75.54 109.746 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.0 OUTLIER -146.84 156.68 43.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.067 -1.086 . . . . 75.45 108.067 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 49.2 mt-10 -83.93 140.15 32.13 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.348 -0.982 . . . . 73.12 108.348 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -79.59 119.24 76.2 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 106.634 -1.617 . . . . 71.13 106.634 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.49 140.36 94.34 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 121.675 1.584 . . . . 70.32 111.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.44 -0.68 56.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.441 0.638 . . . . 74.11 110.88 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.29 -6.54 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.887 0.851 . . . . 74.55 109.562 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 10.6 p -63.72 -28.17 69.71 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.148 -0.933 . . . . 63.33 112.105 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 20.6 p -65.32 -13.92 59.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 113.453 0.909 . . . . 64.21 113.453 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.7 -48.55 68.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.694 0.257 . . . . 63.41 111.694 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 12.3 t -174.32 165.49 4.01 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 121.234 -0.186 . . . . 75.22 110.545 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.47 -52.54 65.2 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.319 1.048 . . . . 61.4 112.666 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.83 84.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.396 -0.366 . . . . 61.35 111.593 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.67 -45.96 90.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 63.31 109.956 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.22 78.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 52.5 111.129 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.62 -46.81 95.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 116.275 -0.42 . . . . 75.13 110.907 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.48 -47.69 82.88 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.079 0.4 . . . . 75.12 112.079 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.08 -46.3 84.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.202 0.445 . . . . 62.04 112.202 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.91 -36.72 80.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.562 0.578 . . . . 65.41 112.562 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.1 m -64.44 -40.85 96.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.044 0.449 . . . . 55.42 110.075 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.59 63.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.461 0.648 . . . . 65.23 110.42 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.32 -12.89 59.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.628 -0.714 . . . . 72.44 110.049 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.84 -19.66 10.23 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.639 -0.709 . . . . 64.12 113.173 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.28 102.93 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.071 0.463 . . . . 75.53 110.489 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.22 19.85 33.93 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.744 -0.741 . . . . 64.22 111.914 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -123.63 111.48 16.27 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.411 -0.588 . . . . 70.21 109.411 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.14 158.28 39.42 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.437 0.636 . . . . 74.11 111.656 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.65 126.85 16.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.476 -1.676 . . . . 64.55 106.476 170.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -87.52 132.54 34.0 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.037 -0.357 . . . . 71.52 110.037 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.72 161.5 37.4 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.285 -1.006 . . . . 45.45 108.285 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.415 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 23.5 m-80 -133.93 149.84 51.29 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 122.537 0.335 . . . . 71.34 110.305 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 31.1 t -128.52 131.46 23.78 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 107.246 -1.39 . . . . 72.51 107.246 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.7 Cg_endo -61.8 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.764 1.642 . . . . 72.31 109.209 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 19.4 m -126.97 175.46 8.06 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.157 -0.474 . . . . 65.32 109.98 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.6 m -63.92 133.17 95.49 Favored Pre-proline 0 N--CA 1.424 -1.746 0 N-CA-C 106.289 -1.745 . . . . 54.23 106.289 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.54 -23.91 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.367 2.712 . . . . 73.5 114.027 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -67.04 -21.36 65.92 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.185 0.439 . . . . 71.03 112.185 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.2 7.84 40.74 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 121.904 -0.497 . . . . 63.3 111.622 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.2 p -59.25 127.36 18.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 CA-C-O 121.321 0.581 . . . . 73.33 110.843 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.76 -6.72 70.33 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 115.543 -0.753 . . . . 44.45 112.104 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -100.64 151.12 22.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.875 -0.787 . . . . 75.45 108.875 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.2 t -84.19 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.773 -0.825 . . . . 75.42 108.773 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.49 -16.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 120.168 -0.613 . . . . 53.3 112.38 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.19 160.23 12.34 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.019 -0.832 . . . . 52.13 111.019 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 486' ' ' ILE . 7.9 p -119.32 149.65 41.45 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.631 -1.248 . . . . 51.14 107.631 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.6 t30 -59.28 -49.7 91.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 119.797 -0.761 . . . . 62.23 110.731 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -76.07 117.6 4.72 Favored 'Trans proline' 0 C--N 1.372 1.812 0 N-CA-C 107.642 -1.715 . . . . 54.5 107.642 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.484 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.2 Cg_endo -62.9 142.95 90.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.888 2.392 . . . . 60.23 114.744 -173.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.419 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.27 0.12 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.814 -1.084 . . . . 64.15 113.24 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -109.14 0.12 19.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.29 -0.881 . . . . 73.03 109.517 175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.484 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 6.5 tp-100 -117.74 162.11 18.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.725 0.774 . . . . 65.22 111.926 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 9.3 m -97.34 132.22 43.27 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.255 -1.338 . . . . 74.3 108.6 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.1 m -136.47 149.0 47.98 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.985 -0.376 . . . . 50.04 109.985 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.3 141.85 52.31 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 74.11 109.942 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.9 -17.0 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 114.454 1.279 . . . . 70.34 114.454 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.0 p -88.9 5.29 44.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.676 -0.64 . . . . 71.14 112.022 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -90.3 147.63 23.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.311 -0.625 . . . . 62.02 109.311 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.4 t -83.25 119.55 32.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.629 -0.878 . . . . 63.14 108.629 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.93 119.18 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 108.507 -0.923 . . . . 73.3 108.507 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.5 112.73 26.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.182 -1.784 . . . . 63.35 106.182 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.69 113.37 36.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.478 -1.304 . . . . 73.3 107.478 -177.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 22.4 mt -101.95 121.13 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.693 -0.685 . . . . 73.33 109.84 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.415 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 38.2 t -97.36 143.68 12.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.41 -0.959 . . . . 72.35 108.41 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -89.82 118.09 5.16 Favored Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 110.177 -1.169 . . . . 64.44 110.177 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 50.9 m -134.93 136.85 42.6 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.68 -0.859 . . . . 70.0 108.68 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.42 -2.373 0 N-CA-C 109.065 -1.614 . . . . 73.13 109.065 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.43 0 N-CA-C 109.216 -1.554 . . . . 43.05 109.216 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.69 140.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 117.911 0.855 . . . . 70.2 112.437 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.2 t -107.5 137.9 44.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.331 -0.849 . . . . 74.31 109.495 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -99.73 73.76 1.81 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.559 -0.904 . . . . 72.25 108.559 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -89.17 144.35 26.18 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.992 -1.004 . . . . 75.22 109.327 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.34 157.71 29.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.373 -0.376 . . . . 74.23 110.104 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.98 136.88 34.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.108 -1.442 . . . . 63.03 107.108 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.9 137.47 20.93 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 120.194 -0.602 . . . . 22.14 110.644 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -43.63 124.21 4.2 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 124.068 3.178 . . . . 72.42 114.67 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.4 ' CG ' ' HE ' ' A' ' 366' ' ' ARG . 9.8 t70 -76.29 138.07 40.3 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.244 -1.391 . . . . 74.22 107.244 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.569 HG23 HG11 ' A' ' 399' ' ' VAL . 31.0 m -102.16 23.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 113.545 0.943 . . . . 71.34 113.545 -170.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 401' ' ' GLY . 20.6 ptp180 -62.73 135.04 57.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.314 0.578 . . . . 71.0 111.82 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.88 -3.78 77.9 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.139 -0.784 . . . . 54.25 111.139 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -114.96 160.19 19.85 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.624 -0.51 . . . . 72.12 109.624 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 67.9 p -75.65 158.34 32.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 110.37 -0.233 . . . . 55.22 110.37 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.477 ' O ' HD13 ' A' ' 374' ' ' ILE . 17.9 p -63.13 -37.13 86.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 120.771 0.32 . . . . 53.32 110.449 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.08 90.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.249 -0.432 . . . . 64.42 110.584 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.89 -34.94 79.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.125 0.488 . . . . 61.41 110.487 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.526 -0.761 . . . . 30.42 110.371 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 384' ' ' ILE . 1.4 mp -58.55 -44.37 89.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.748 -0.66 . . . . 63.21 110.213 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.79 84.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.219 -0.446 . . . . 62.44 112.133 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 85.5 m -60.83 -47.17 87.58 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.647 0.24 . . . . 72.41 111.647 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.51 -39.02 93.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.779 0.323 . . . . 71.53 110.921 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 63.2 tp60 -63.12 -46.0 89.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.345 -0.843 . . . . 71.12 109.601 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -70.57 -24.43 62.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.901 -0.59 . . . . 74.32 112.238 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -81.14 -15.3 56.26 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.144 -0.622 . . . . 72.15 111.584 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 98.98 14.84 35.24 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.679 -1.248 . . . . 73.05 111.888 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 48.6 m-85 -97.26 168.86 10.16 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.548 -0.908 . . . . 72.23 108.548 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.5 mmtp -113.49 157.25 22.23 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.514 -1.291 . . . . 65.3 107.514 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -135.0 142.37 40.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 121.293 0.568 . . . . 74.4 111.802 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -112.18 128.02 56.11 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.836 -1.542 . . . . 74.32 106.836 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.6 m -100.44 123.68 44.98 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 119.329 -0.948 . . . . 63.42 108.522 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.98 119.41 38.97 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 105.421 -2.066 . . . . 60.21 105.421 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 15.4 pm0 -107.99 122.05 46.05 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.529 -0.915 . . . . 72.32 108.529 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 137.82 31.09 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.566 -0.454 . . . . 63.45 111.143 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.3 Cg_endo -93.1 148.88 2.52 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.735 2.29 . . . . 71.41 111.487 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 394' ' ' ILE . 4.9 t70 170.06 174.75 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.758 -1.571 . . . . 74.21 106.758 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.686 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 22.0 m -99.3 -33.97 10.51 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.823 -0.806 . . . . 73.24 108.823 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.8 p -94.71 63.19 2.81 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 122.538 1.161 . . . . 64.11 108.255 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.592 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -95.6 151.57 38.6 Favored Pre-proline 0 N--CA 1.424 -1.742 0 CA-C-N 113.644 -1.617 . . . . 71.52 112.51 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.42 143.73 58.88 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 N-CA-C 107.24 -1.869 . . . . 73.03 107.24 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.92 148.67 66.05 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.242 1.962 . . . . 64.54 111.461 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.91 -9.68 10.68 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.019 0.914 . . . . 52.42 110.734 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -96.52 125.99 41.39 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 103.708 -2.701 . . . . 74.41 103.708 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 365' ' ' VAL . 31.2 t -62.37 119.25 5.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.576 0.703 . . . . 75.2 111.969 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.6 tp -84.97 -29.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.369 -0.832 . . . . 70.1 109.367 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 366' ' ' ARG . . . -170.07 160.32 33.18 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.603 -1.399 . . . . 65.44 109.603 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 403' ' ' ASP . 0.7 OUTLIER -113.14 -175.66 2.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 105.825 -1.917 . . . . 72.24 105.825 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.439 ' H ' HG22 ' A' ' 402' ' ' THR . 17.3 t70 -99.38 136.58 20.38 Favored Pre-proline 0 C--N 1.265 -3.089 0 N-CA-C 109.71 -0.478 . . . . 74.24 109.71 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -33.73 -31.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 1 C-N-CA 126.069 4.513 . . . . 74.44 115.88 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.56 -31.92 66.6 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 122.652 0.381 . . . . 73.51 111.0 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -35.3 64.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.364 0.602 . . . . 75.21 110.58 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -77.93 -15.08 59.29 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.01 -0.541 . . . . 74.34 110.183 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 70.8 m -86.35 147.09 26.2 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.241 -1.022 . . . . 73.54 108.241 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.7 m -74.81 112.9 11.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.008 -1.108 . . . . 63.33 108.008 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.05 170.22 18.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.663 -0.699 . . . . 74.04 110.845 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.1 p -65.91 131.52 46.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.403 -0.817 . . . . 53.23 110.628 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.94 113.46 4.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.077 0.465 . . . . 64.41 110.114 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.29 -2.07 9.66 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.393 -0.908 . . . . 60.22 112.342 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.78 158.87 32.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.057 -0.349 . . . . 75.33 110.057 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.9 pt-20 -87.29 121.4 29.68 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.371 0.605 . . . . 53.21 111.273 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.82 131.15 45.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.851 -1.166 . . . . 70.44 107.851 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -91.55 130.0 37.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.506 0.67 . . . . 51.53 110.301 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.8 t -117.57 125.46 74.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.591 -1.263 . . . . 73.22 107.591 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.9 129.2 43.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.008 -0.367 . . . . 64.51 110.008 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.5 p -125.58 147.95 30.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.98 -1.119 . . . . 65.53 107.98 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 5.8 p -96.51 123.34 40.14 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.056 0.455 . . . . 65.23 112.197 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 t -117.61 106.08 12.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.168 -0.613 . . . . 73.14 111.393 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 74.48 130.19 0.21 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.517 0.967 . . . . 65.53 115.517 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 22.8 Cg_exo -68.43 145.99 66.95 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.943 1.762 . . . . 44.22 109.294 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.31 147.24 31.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.084 0.772 . . . . 65.55 113.084 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.4 mt-30 -123.21 137.43 54.88 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.41 107.732 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -137.15 164.4 28.54 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.451 -0.574 . . . . 75.22 109.451 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -82.49 137.8 34.53 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.277 -1.008 . . . . 72.12 108.277 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.4 mt -80.85 114.35 47.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.543 -0.91 . . . . 64.03 108.543 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 140.74 37.27 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.343 1.362 . . . . 52.45 110.296 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.76 96.57 5.55 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.133 1.161 . . . . 73.4 114.133 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.3 6.76 3.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.112 -2.921 . . . . 70.34 103.112 165.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 4.6 m -71.05 -46.37 62.13 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 112.176 -2.284 . . . . 73.13 110.86 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 466' ' ' LYS . 21.6 m -57.01 -31.77 65.46 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.529 0.681 . . . . 75.12 110.031 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.82 -48.19 8.42 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.728 -0.669 . . . . 73.05 111.723 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 57.7 m -132.38 122.95 25.81 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 121.991 -0.443 . . . . 53.42 112.145 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -60.91 -40.57 93.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.98 0.912 . . . . 73.04 111.531 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.14 93.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 44.43 110.302 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -65.39 -35.62 81.5 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.446 -0.797 . . . . 60.45 111.384 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.22 94.1 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.632 0.583 . . . . 62.34 109.487 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.23 -49.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.769 -0.651 . . . . 74.35 110.691 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -65.09 -49.23 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.434 0.531 . . . . 72.51 112.434 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 30.6 mmtp -68.02 -38.66 82.84 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.912 0.708 . . . . 64.23 112.912 -174.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.44 -37.1 79.92 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.291 -0.564 . . . . 72.44 111.462 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.7 m -64.41 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.274 -0.639 . . . . 73.54 109.274 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.31 77.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.763 -0.653 . . . . 74.31 111.03 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -14.66 58.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.092 0.472 . . . . 73.52 110.225 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.41 -23.46 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-O 119.531 -0.594 . . . . 32.51 113.86 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 480' ' ' ILE . 99.0 m-85 -55.66 122.97 12.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.003 0.521 . . . . 75.13 111.962 -174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.01 8.66 5.73 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.48 -0.782 . . . . 74.42 111.62 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -110.23 110.62 21.52 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.735 -1.58 . . . . 75.34 106.735 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.37 150.29 52.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.918 0.866 . . . . 75.32 112.418 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 27.6 tptp -139.07 122.93 17.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.272 -1.751 . . . . 64.43 106.272 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -93.32 135.75 34.25 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 110.053 -0.351 . . . . 75.12 110.053 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.09 152.22 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.556 -0.535 . . . . 54.23 109.556 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -118.66 129.4 55.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.585 -0.895 . . . . 51.44 108.585 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.9 t -126.6 137.88 31.31 Favored Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.788 -1.19 . . . . 52.35 107.788 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.82 135.16 46.96 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.679 2.253 . . . . 64.13 110.427 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -148.18 169.86 19.11 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.465 -0.939 . . . . 73.14 108.465 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.6 m -65.46 144.12 98.87 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.785 0.834 . . . . 64.44 109.214 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.612 ' O ' HG12 ' A' ' 464' ' ' VAL . 93.3 Cg_exo -49.29 -23.47 7.04 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.915 3.076 . . . . 71.43 114.745 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -68.86 -31.98 71.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 71.21 111.142 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.39 -12.24 21.62 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.907 -0.588 . . . . 64.11 111.305 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.3 p -60.19 126.95 18.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-O 121.464 0.65 . . . . 73.42 110.448 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 98.6 -13.35 62.7 Favored Glycine 0 C--N 1.301 -1.383 0 N-CA-C 111.284 -0.726 . . . . 20.24 111.284 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 434' ' ' THR . 11.7 mptt -103.02 163.47 12.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.775 -0.824 . . . . 72.41 108.775 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.2 135.71 24.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.07 -1.085 . . . . 72.13 108.07 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.02 -12.06 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.399 -0.92 . . . . 70.51 110.546 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 151.93 176.46 24.66 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 115.198 -0.91 . . . . 35.03 112.082 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.4 p -116.41 149.46 39.38 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.607 -1.257 . . . . 64.24 107.607 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.9 t-20 -64.68 -49.38 70.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 120.201 -0.599 . . . . 74.5 111.489 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.2 Cg_exo -68.6 146.18 66.5 Favored 'Trans proline' 0 C--N 1.372 1.8 0 N-CA-C 108.724 -1.298 . . . . 74.23 108.724 170.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.69 126.52 18.41 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.522 2.148 . . . . 61.15 112.886 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.86 2.06 36.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.654 0.74 . . . . 70.11 111.608 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -109.9 -1.56 17.7 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.069 -0.514 . . . . 75.44 110.903 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -131.94 159.01 39.94 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.704 0.764 . . . . 71.21 111.39 -173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -67.19 106.93 2.16 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.656 -1.611 . . . . 63.03 109.874 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.6 m -108.52 150.03 28.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.83 -0.804 . . . . 75.31 108.83 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.72 144.66 47.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.183 -0.673 . . . . 71.11 109.183 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.686 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 50.2 mm -70.7 -13.78 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.185 0.993 . . . . 70.53 109.16 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 392' ' ' SER . 1.3 p -87.8 -11.02 49.22 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.703 -1.135 . . . . 63.45 109.78 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.34 138.56 47.39 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.456 -0.942 . . . . 63.03 108.456 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.52 113.86 19.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.374 -1.343 . . . . 64.05 107.374 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.54 118.37 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 C-N-CA 119.526 -0.87 . . . . 72.14 108.825 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.1 mp -92.35 112.14 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 105.783 -1.932 . . . . 71.34 105.783 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 114.3 33.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.545 -1.65 . . . . 61.22 106.545 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 18.9 mt -104.27 116.93 48.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.633 -0.712 . . . . 74.12 110.216 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.74 137.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.243 -1.021 . . . . 74.13 108.243 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.62 99.33 1.0 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 109.633 -1.387 . . . . 74.33 109.633 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.2 m -142.79 105.73 4.54 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 122.742 0.417 . . . . 74.03 109.971 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.165 0 N-CA-C 109.398 -1.481 . . . . 62.33 109.398 178.153 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.329 0 N-CA-C 109.418 -1.473 . . . . 73.44 109.418 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.439 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.6 pp -92.11 132.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 117.768 0.784 . . . . 64.14 111.707 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.8 m -150.05 149.91 31.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.045 -1.835 . . . . 74.55 106.045 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.73 90.41 3.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 119.505 -0.878 . . . . 72.33 111.41 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -113.9 138.98 49.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.695 -1.224 . . . . 63.21 107.695 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 19.9 m -136.09 156.6 37.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.511 -0.552 . . . . 64.45 109.511 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -94.7 136.25 35.23 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.803 -1.925 . . . . 74.52 105.803 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.5 m -97.71 141.11 22.49 Favored Pre-proline 0 C--N 1.282 -2.341 0 C-N-CA 119.128 -1.029 . . . . 74.43 110.948 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.95 133.19 56.55 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.124 2.549 . . . . 73.1 113.146 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.16 126.2 28.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.032 -0.985 . . . . 72.34 110.39 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.6 m -91.79 10.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 73.52 112.109 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.94 141.37 58.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 64.0 109.838 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.65 -0.14 45.94 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.489 -0.644 . . . . 74.51 111.489 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 49.3 mt-30 -120.7 -179.22 3.93 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.315 -0.624 . . . . 72.15 109.315 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.7 p -86.04 169.96 12.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.727 -0.789 . . . . 71.11 109.342 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.3 p -61.81 -38.98 90.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.739 0.304 . . . . 51.31 111.118 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.14 87.57 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.247 -0.433 . . . . 65.11 110.93 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 62.4 m-20 -60.94 -43.66 98.35 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.199 -0.297 . . . . 74.42 110.199 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.91 75.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.524 -0.762 . . . . 63.21 110.198 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -58.28 -46.14 88.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.745 -0.661 . . . . 73.42 110.651 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.13 89.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.064 -0.517 . . . . 51.24 111.448 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 94.3 m -64.77 -48.25 75.2 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 120.575 0.226 . . . . 74.22 111.275 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.21 -38.71 91.29 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.436 -0.506 . . . . 72.23 110.892 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -60.02 -46.71 88.62 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.654 0.596 . . . . 61.41 109.908 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.4 -36.88 85.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.907 -0.588 . . . . 71.5 111.833 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 376' ' ' THR . 4.8 mpt_? -79.5 -14.45 58.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.54 111.652 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.3 16.35 32.57 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.387 -0.911 . . . . 72.34 113.523 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.19 166.96 12.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.912 0.387 . . . . 53.55 110.432 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 29.0 mmmt -99.93 153.14 19.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.193 -1.41 . . . . 73.11 107.193 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.469 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -130.19 138.47 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.432 0.634 . . . . 71.12 112.593 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 417' ' ' THR . 14.0 ttm180 -115.46 135.93 53.6 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.05 -1.463 . . . . 74.31 107.05 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.6 m -99.6 128.11 45.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 119.351 -0.94 . . . . 64.43 110.525 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.77 119.54 38.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.928 -1.879 . . . . 73.4 105.928 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.438 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 15.2 pm0 -114.02 128.4 56.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 120.883 0.373 . . . . 62.52 110.142 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 0.6 OUTLIER -121.53 115.7 30.97 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 112.11 0.411 . . . . 64.21 112.11 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 1.9 Cg_endo -87.94 134.4 3.15 Favored 'Trans proline' 0 C--O 1.256 1.386 0 C-N-CA 123.306 2.67 . . . . 63.43 111.825 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t70 172.2 -169.32 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 106.374 -1.713 . . . . 71.2 106.374 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 21.3 m -120.52 -12.86 8.87 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.473 0.654 . . . . 63.53 109.399 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -90.84 14.41 13.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.567 1.175 . . . . 74.32 108.291 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.413 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.54 151.08 47.65 Favored Pre-proline 0 N--CA 1.424 -1.763 0 CA-C-N 114.739 -1.119 . . . . 44.33 110.931 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.73 171.29 18.28 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.104 1.87 . . . . 73.2 111.35 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.53 163.03 7.34 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.504 2.803 . . . . 72.13 111.752 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.68 -7.26 0.64 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.214 1.006 . . . . 64.12 112.973 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 42.5 m170 -83.38 142.15 31.23 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.826 -0.805 . . . . 64.42 108.826 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.47 117.92 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-O 121.864 0.84 . . . . 62.41 109.544 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.76 -27.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.933 -1.03 . . . . 74.31 110.471 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.87 161.15 28.08 Favored Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 109.515 -1.434 . . . . 71.52 109.515 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.2 p -113.58 -178.48 3.39 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 121.035 0.445 . . . . 71.12 111.328 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.55 132.09 22.2 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.026 -1.472 . . . . 51.32 107.026 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.55 -30.04 11.42 Favored 'Trans proline' 0 N--CA 1.481 0.769 0 C-N-CA 124.137 3.225 . . . . 72.02 114.92 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.9 67.12 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 111.57 0.211 . . . . 71.35 111.57 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.68 -33.45 60.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.451 0.643 . . . . 73.5 110.28 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -86.17 -10.36 54.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.6 -0.727 . . . . 74.24 110.474 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 46.3 m -83.48 153.19 24.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.131 -1.433 . . . . 72.41 107.131 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.4 m -74.39 113.24 11.39 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.686 -0.806 . . . . 74.2 109.858 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.89 169.4 15.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 123.947 0.899 . . . . 75.1 109.075 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.3 t -78.96 146.96 33.14 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.913 -0.773 . . . . 74.25 108.913 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -70.87 113.22 7.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.061 -0.718 . . . . 75.11 109.061 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.71 9.1 11.45 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.384 -0.826 . . . . 53.35 111.722 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.0 -173.53 4.77 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.297 -1.371 . . . . 72.3 107.297 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 9.4 pt-20 -106.36 141.36 37.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.741 -0.784 . . . . 75.2 111.632 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -118.89 137.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.897 -1.149 . . . . 75.54 107.897 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 385' ' ' ARG . 68.4 p -92.64 130.53 38.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 120.988 0.423 . . . . 62.33 110.264 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.6 128.14 55.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.195 -1.039 . . . . 74.33 108.195 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -98.67 128.87 45.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.973 -0.38 . . . . 74.14 109.973 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 10.1 p -137.53 142.43 36.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.085 -0.709 . . . . 73.4 109.085 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 14.6 m -88.1 122.26 31.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.53 -0.544 . . . . 74.25 109.53 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 41.2 p -119.62 107.45 13.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.628 -0.26 . . . . 63.43 111.435 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 86.35 131.41 2.92 Favored Glycine 0 C--N 1.299 -1.522 0 C-N-CA 120.437 -0.887 . . . . 50.33 114.004 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 97.1 Cg_endo -82.3 157.83 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.635 2.223 . . . . 74.4 111.378 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 2.9 mm-40 -85.67 124.19 31.92 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.568 -0.53 . . . . 70.52 109.568 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 62.5 mt-30 -120.51 130.91 54.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.039 -1.097 . . . . 62.33 108.039 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -131.18 152.06 50.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 74.51 108.51 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -89.81 138.49 31.44 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 109.821 -0.437 . . . . 73.31 109.821 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -80.3 119.38 76.26 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.085 -0.709 . . . . 62.52 109.085 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.51 141.4 97.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.765 2.31 . . . . 75.32 111.864 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.58 8.98 25.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.33 0.492 . . . . 73.51 112.33 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.43 -7.86 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.998 0.904 . . . . 74.34 108.767 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 p -59.2 -42.85 91.91 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.982 -1.008 . . . . 72.14 111.845 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 6.5 p -69.4 -16.72 63.57 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.543 0.737 . . . . 74.25 112.367 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.25 -32.82 19.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.383 -0.371 . . . . 63.33 111.94 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.4 m -151.72 123.99 8.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.448 -0.575 . . . . 73.21 109.448 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.86 -45.42 92.66 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.275 0.472 . . . . 73.13 112.275 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.25 -43.89 95.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 75.3 110.135 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.11 -37.65 88.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.138 -0.937 . . . . 74.23 109.949 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.093 -0.503 . . . . 73.42 110.51 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.27 -43.42 98.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.697 -0.683 . . . . 55.25 110.033 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 30.8 mmmt -64.67 -47.43 78.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.398 -0.364 . . . . 72.11 111.368 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -63.83 -38.85 92.63 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.189 -0.459 . . . . 73.53 111.982 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.0 -39.41 90.27 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.01 -0.737 . . . . 60.44 109.01 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.7 m -66.75 -45.91 77.07 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.335 -0.848 . . . . 72.53 110.163 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.83 -22.93 65.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.862 0.865 . . . . 64.11 112.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.68 -11.04 59.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.413 0.625 . . . . 34.04 110.628 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.38 -15.89 19.96 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.679 -0.772 . . . . 61.12 112.986 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HA ' HG23 ' A' ' 480' ' ' ILE . 98.3 m-85 -67.54 124.7 23.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.928 0.394 . . . . 35.21 111.182 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.78 13.17 9.28 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.028 -0.829 . . . . 21.21 111.028 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -111.95 111.26 22.06 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 70.4 107.458 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -126.0 146.41 49.89 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 121.097 -0.241 . . . . 74.33 110.921 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 25.3 ttmm -153.17 122.66 6.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.353 -1.351 . . . . 63.21 107.353 171.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.46 135.3 43.19 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.247 0.546 . . . . 64.34 111.825 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.73 158.04 28.36 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.044 -1.095 . . . . 71.32 108.044 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.41 134.48 51.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.844 -0.799 . . . . 61.23 108.844 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.2 t -138.79 131.16 15.73 Favored Pre-proline 0 C--N 1.287 -2.137 0 N-CA-C 108.655 -0.868 . . . . 21.34 108.655 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 128.56 21.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.994 1.796 . . . . 65.44 109.151 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.7 t -137.13 -178.75 5.34 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.541 -0.911 . . . . 54.41 108.541 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 12.0 m -51.1 131.06 31.27 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.925 1.29 . . . . 74.43 109.484 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.79 -33.05 31.3 Favored 'Trans proline' 0 C--N 1.364 1.371 0 C-N-CA 123.815 3.01 . . . . 62.25 114.065 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -67.44 -32.24 72.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 72.11 111.668 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.33 -9.7 40.94 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.165 -0.334 . . . . 72.3 111.51 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 42.1 t -59.17 129.97 22.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 CA-C-N 115.749 -0.66 . . . . 61.22 111.861 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.34 1.28 56.8 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.841 -1.072 . . . . 52.21 110.937 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -131.22 166.33 21.41 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 109.128 -0.693 . . . . 72.43 109.128 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 486' ' ' ILE . 49.3 t -80.95 136.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.927 -0.768 . . . . 54.53 108.927 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.29 -16.54 7.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.13 -0.628 . . . . 74.41 111.564 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.61 163.79 22.14 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.26 -0.882 . . . . 50.33 110.999 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 486' ' ' ILE . 9.5 p -122.37 157.57 31.54 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.006 -1.479 . . . . 65.32 107.006 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.449 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.3 m120 -62.23 -54.51 48.85 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 119.058 -1.057 . . . . 73.3 111.298 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 13.9 Cg_exo -74.83 112.82 3.65 Favored 'Trans proline' 0 C--N 1.371 1.757 0 N-CA-C 107.801 -1.654 . . . . 65.5 107.801 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.36 162.07 43.36 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.391 2.061 . . . . 74.2 114.523 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.9 -4.01 32.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.864 -1.062 . . . . 63.44 111.553 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -108.23 12.24 26.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.098 -0.501 . . . . 51.34 109.814 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -125.63 151.77 46.06 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.461 0.648 . . . . 72.44 110.675 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.7 m -104.44 101.95 11.62 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.053 -1.462 . . . . 70.11 107.053 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.7 m -106.73 145.34 32.16 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.503 -0.317 . . . . 50.55 111.272 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.74 145.99 54.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.066 -0.516 . . . . 74.53 110.665 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 48.3 mm -67.25 -9.1 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 124.375 1.07 . . . . 75.04 111.42 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.8 p -86.88 -2.91 58.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.665 0.745 . . . . 74.12 110.71 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -95.82 133.93 39.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.544 -0.753 . . . . 72.23 109.382 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.28 119.37 28.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.932 -1.136 . . . . 74.2 107.932 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.18 119.15 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.628 -0.879 . . . . 64.31 108.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.3 mt -93.85 112.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.133 -1.432 . . . . 65.34 107.133 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.98 117.19 46.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.659 -1.155 . . . . 70.2 108.823 -175.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 35.0 mt -99.93 119.8 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.374 0.606 . . . . 73.54 110.09 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.43 124.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 63.53 108.851 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.7 96.38 1.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.45 -1.86 . . . . 75.15 108.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.491 ' HA ' HG13 ' A' ' 464' ' ' VAL . 5.1 p -142.79 131.51 22.66 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 110.071 -0.344 . . . . 72.25 110.071 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.0 0 N-CA-C 106.851 -2.499 . . . . 64.13 106.851 176.787 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 110.379 -1.088 . . . . 65.1 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.7 pp -82.4 127.15 39.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.16 0.505 . . . . 74.02 110.535 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 11.8 m -104.07 148.26 26.45 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.331 -0.988 . . . . 73.04 108.331 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.5 83.42 6.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.256 0.551 . . . . 75.22 109.749 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.33 129.51 35.86 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.28 -1.008 . . . . 62.44 108.28 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.46 153.65 39.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.514 -0.55 . . . . 73.32 109.514 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -95.43 138.59 32.91 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.04 -1.096 . . . . 63.24 108.04 176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.59 126.62 42.65 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.335 -0.617 . . . . 65.11 109.335 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.1 141.75 89.76 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.413 2.742 . . . . 63.43 114.995 -174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.15 138.28 31.63 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.683 -1.228 . . . . 74.43 107.683 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 373' ' ' ALA . 15.7 m -116.05 27.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-O 121.936 0.874 . . . . 64.32 109.073 174.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -55.45 144.23 26.44 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.823 -1.535 . . . . 71.1 111.694 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.92 44.65 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.961 -0.856 . . . . 40.12 110.961 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -127.18 -173.3 2.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.963 -0.384 . . . . 73.22 109.963 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.9 p -70.82 151.37 44.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.755 0.312 . . . . 73.05 111.385 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 p -63.43 -36.46 83.81 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.346 -0.388 . . . . 54.24 111.411 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.76 88.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.192 -0.458 . . . . 74.21 110.546 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.41 -36.52 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 71.41 110.637 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -59.78 -51.16 70.93 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.122 -0.49 . . . . 74.15 110.99 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.34 -43.58 98.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.831 -0.622 . . . . 74.02 110.774 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.33 94.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.448 -0.342 . . . . 74.04 111.829 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.2 m -63.93 -47.07 81.95 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.961 0.41 . . . . 53.21 110.105 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.49 -38.1 89.84 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -59.89 -45.24 93.14 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.174 0.989 . . . . 75.44 109.846 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -70.17 -16.55 63.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 74.22 111.991 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -86.86 -14.14 42.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.639 -0.874 . . . . 74.52 108.639 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.86 5.2 62.91 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.53 -0.843 . . . . 61.3 111.668 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 35.6 m-85 -86.15 149.72 24.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.212 0.529 . . . . 73.12 110.291 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 13.9 mmmm -91.41 153.22 20.02 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.216 -1.401 . . . . 63.33 107.216 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.03 147.46 25.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 C-N-CA 120.3 -0.56 . . . . 74.21 111.421 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -111.07 132.22 54.43 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.012 -1.848 . . . . 73.13 106.012 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.5 m -115.72 118.2 32.37 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.372 -0.973 . . . . 71.15 108.372 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.59 119.02 36.71 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.817 -1.179 . . . . 72.53 107.817 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.7 pm0 -104.36 131.79 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.23 0.538 . . . . 73.41 110.187 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -136.76 130.61 17.82 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.707 -0.678 . . . . 74.13 110.836 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.36 135.55 4.46 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.494 2.129 . . . . 73.15 111.616 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 34.4 t70 168.56 166.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.168 1.387 . . . . 52.22 107.305 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.602 ' O ' ' HB ' ' A' ' 481' ' ' THR . 9.4 p -123.25 8.19 9.12 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 113.096 0.776 . . . . 74.11 113.096 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -82.34 -24.51 34.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.132 -1.803 . . . . 51.32 106.132 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.432 ' H ' HG12 ' A' ' 394' ' ' ILE . 6.7 pt -88.91 148.65 41.76 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.721 -2.036 . . . . 73.13 109.718 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.63 173.01 14.01 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.098 2.532 . . . . 75.04 112.268 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.14 162.78 6.98 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 123.558 2.838 . . . . 70.25 112.69 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.46 -8.21 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.631 1.172 . . . . 74.41 113.993 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -75.47 115.69 15.4 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.396 -1.705 . . . . 75.22 106.396 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.48 117.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.018 0.437 . . . . 43.44 110.456 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.57 -27.21 3.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.641 -0.709 . . . . 64.34 110.137 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.29 157.02 27.04 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.072 -1.211 . . . . 62.04 110.072 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.9 p -128.12 -176.52 3.82 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 124.493 1.117 . . . . 63.14 111.076 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.83 132.92 22.15 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.524 -1.287 . . . . 74.1 107.524 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.59 -20.34 12.05 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.786 2.991 . . . . 71.43 114.175 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.63 61.29 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 122.453 0.301 . . . . 72.11 110.922 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.67 -41.15 84.19 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.54 110.337 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -87.16 -3.87 59.09 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 120.261 -0.575 . . . . 72.24 111.534 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.4 m -80.13 131.54 35.76 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.671 -1.603 . . . . 54.41 106.671 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.8 m -74.61 113.3 11.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.032 -0.667 . . . . 75.3 110.086 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.25 167.73 24.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.246 -0.888 . . . . 54.11 109.335 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.17 50.35 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 109.459 -0.571 . . . . 64.12 109.459 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -62.51 130.8 46.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.369 0.668 . . . . 45.44 111.981 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 109.35 16.48 11.08 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.604 -0.808 . . . . 54.51 113.809 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.18 175.57 7.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.346 -1.353 . . . . 72.24 107.346 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 10.7 pt-20 -109.4 140.2 43.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.078 0.466 . . . . 73.01 112.026 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.0 133.24 65.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.259 -1.015 . . . . 52.55 108.259 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -89.78 118.67 29.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.93 0.871 . . . . 62.44 110.038 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.3 133.58 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.91 -1.041 . . . . 72.4 109.176 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -96.97 128.74 44.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.813 -0.63 . . . . 74.21 110.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.3 p -130.25 131.9 65.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.304 -0.628 . . . . 52.24 109.304 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -91.9 122.55 34.53 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.326 -0.62 . . . . 64.12 109.326 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 16.5 p -118.92 106.66 12.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.756 0.312 . . . . 32.41 111.7 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.48 104.95 0.69 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.581 -0.819 . . . . 74.1 113.042 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 18.8 Cg_exo -66.99 128.93 19.59 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.53 2.154 . . . . 74.0 110.478 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.44 143.48 32.07 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.826 -0.35 . . . . 74.14 111.703 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -131.97 157.12 44.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.307 -0.997 . . . . 72.54 108.307 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -142.59 154.82 44.77 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.557 -0.534 . . . . 74.31 109.557 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.68 139.64 30.36 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.849 -0.426 . . . . 63.33 109.849 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.6 mp -78.7 116.15 57.4 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.844 -0.799 . . . . 62.52 108.844 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.55 140.91 40.77 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.868 1.712 . . . . 64.1 110.156 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -107.19 87.4 2.5 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.453 -1.299 . . . . 72.44 113.671 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.0 0.69 7.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 104.261 -2.496 . . . . 70.41 104.261 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.9 m -68.78 -50.11 53.02 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.972 -1.922 . . . . 72.14 110.236 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.408 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 15.7 m -64.88 -16.45 63.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 121.791 0.805 . . . . 74.52 109.908 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -48.42 7.01 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.482 -0.781 . . . . 74.01 110.241 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 66.0 m -147.71 123.91 10.84 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.085 0.469 . . . . 43.34 111.19 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -42.42 97.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.996 0.739 . . . . 71.12 112.996 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.22 -40.26 81.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 54.34 110.573 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -67.03 -35.3 79.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.485 -0.779 . . . . 74.53 111.815 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.67 -48.39 81.84 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.964 0.412 . . . . 65.35 110.26 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.57 -47.93 90.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.645 -0.707 . . . . 62.22 110.501 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -66.6 -45.7 78.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.02 -0.536 . . . . 73.13 112.119 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -66.28 -47.12 74.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 111.813 0.301 . . . . 71.01 111.813 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.11 -39.07 89.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.517 0.562 . . . . 73.0 112.517 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.0 m -61.81 -42.21 98.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.715 0.293 . . . . 65.14 110.483 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.66 66.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 62.02 111.06 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.08 59.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.958 -0.565 . . . . 64.13 111.038 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 116.52 -7.43 18.03 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.339 -0.934 . . . . 62.44 113.594 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.09 105.2 8.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.48 0.64 . . . . 65.34 109.717 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -111.74 5.16 27.67 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.723 -0.671 . . . . 72.44 111.629 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 23.1 mmt180 -113.8 111.45 21.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 64.44 108.343 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.61 156.54 43.21 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.297 0.57 . . . . 75.42 111.655 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -135.79 123.21 21.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.314 -2.106 . . . . 75.11 105.314 170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.97 122.36 36.38 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.9 155.19 35.96 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.063 -0.717 . . . . 60.44 109.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -128.08 138.45 52.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.847 0.356 . . . . 71.31 110.674 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.8 t -123.19 131.22 24.34 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.151 -1.425 . . . . 64.11 107.151 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.01 124.48 14.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.524 2.15 . . . . 62.25 110.139 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 24.8 m -134.98 160.85 36.99 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.64 -0.504 . . . . 62.5 109.64 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 461' ' ' PRO . 0.2 OUTLIER -60.81 146.22 87.09 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.482 -1.303 . . . . 74.31 107.482 175.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 464' ' ' VAL . 79.1 Cg_exo -52.26 -24.02 19.66 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 123.372 2.715 . . . . 75.23 114.306 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.51 -31.86 73.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.116 0.484 . . . . 74.43 110.857 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.37 5.08 44.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.02 0.378 . . . . 73.42 112.02 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.1 p -60.43 128.85 22.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 C-N-CA 120.087 -0.645 . . . . 65.23 110.779 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.1 83.14 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.888 -0.596 . . . . 54.12 112.584 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 434' ' ' THR . 85.9 tttt -116.38 148.22 40.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.165 -1.421 . . . . 75.23 107.165 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 433' ' ' SER . 62.0 t -84.05 136.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.038 -0.727 . . . . 71.4 109.038 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -109.44 -14.62 10.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.781 -0.768 . . . . 75.34 111.233 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.12 173.56 41.01 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.948 -0.861 . . . . 73.42 110.948 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.2 p -137.22 158.87 43.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.276 -1.009 . . . . 62.03 108.276 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.9 t-20 -69.54 -54.62 10.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 119.809 -0.756 . . . . 71.04 109.863 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.55 118.07 4.76 Favored 'Trans proline' 0 C--N 1.376 2.024 0 N-CA-C 107.574 -1.741 . . . . 72.34 107.574 172.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 475' ' ' ASN . 43.0 Cg_endo -69.17 139.71 42.97 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.732 1.621 . . . . 62.45 112.277 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.17 24.74 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.424 1.09 . . . . 52.02 112.466 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 473' ' ' PRO . 38.6 m-80 -108.32 -22.28 12.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.385 1.074 . . . . 75.3 109.822 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -131.67 160.09 36.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 C-N-CA 119.292 -0.963 . . . . 61.14 111.498 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.69 141.9 49.86 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 126.12 1.768 . . . . 64.42 110.54 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 56.3 m -133.76 149.7 51.46 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.12 -1.067 . . . . 74.53 108.12 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -76.61 157.95 31.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-O 120.803 0.335 . . . . 72.21 110.338 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 448' ' ' GLY . 50.8 mm -66.83 -16.34 20.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.112 0.958 . . . . 33.12 110.004 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 392' ' ' SER . 12.4 t -99.35 2.59 45.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.37 -0.832 . . . . 73.22 110.009 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 10.1 m120 -83.32 146.07 28.71 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.515 -0.55 . . . . 55.42 109.515 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.47 114.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 71.3 107.271 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.49 119.47 35.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.109 -0.7 . . . . 75.21 109.109 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 3.4 mp -92.06 112.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 106.608 -1.627 . . . . 60.21 106.608 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.33 121.93 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.664 -1.236 . . . . 73.02 107.664 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.41 111.58 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 121.418 0.627 . . . . 71.12 110.015 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.2 140.83 17.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.361 -0.977 . . . . 74.24 108.361 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.93 100.37 1.22 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.504 -1.038 . . . . 53.15 110.504 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 50.2 m -141.97 130.07 22.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.595 -0.52 . . . . 61.23 109.595 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.224 0 N-CA-C 107.871 -2.092 . . . . 73.32 107.871 -178.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.502 0 N-CA-C 109.714 -1.354 . . . . 72.35 109.714 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -87.27 151.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 117.124 0.462 . . . . 74.34 111.376 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 16.8 m -88.39 146.92 24.99 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.551 -1.277 . . . . 52.21 107.551 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -89.26 75.85 7.71 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.715 . . . . 74.15 110.483 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -100.87 148.66 24.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.688 -1.142 . . . . 65.41 108.751 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 150.68 31.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.274 -0.639 . . . . 64.22 109.274 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -95.31 136.6 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.659 -1.978 . . . . 72.44 105.659 174.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.5 p -97.46 128.48 34.52 Favored Pre-proline 0 C--N 1.282 -2.331 0 C-N-CA 119.117 -1.033 . . . . 70.41 109.627 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.97 128.07 23.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.841 2.361 . . . . 75.41 112.425 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -68.81 119.62 13.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.75 -1.113 . . . . 73.21 110.765 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 30.5 m -82.95 25.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.983 -1.008 . . . . 64.3 112.817 -174.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 400' ' ' ILE . 11.2 ptt-85 -67.85 144.04 55.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 122.044 -0.41 . . . . 74.0 111.941 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.83 0.5 45.61 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.875 -0.679 . . . . 53.53 113.647 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 0.9 OUTLIER -126.45 -172.85 2.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.336 0.568 . . . . 74.33 110.338 -177.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.8 p -79.44 164.2 24.16 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 118.266 0.484 . . . . 65.32 110.513 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 61.4 p -63.67 -33.66 76.13 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.368 -0.604 . . . . 50.01 109.368 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.14 90.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.143 -0.935 . . . . 42.45 110.339 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 368' ' ' GLN . 40.0 m-20 -60.14 -42.82 95.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.648 -0.251 . . . . 64.21 110.984 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -51.51 69.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.691 0.62 . . . . 64.31 110.438 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 384' ' ' ILE . 78.3 mt -60.73 -46.19 96.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.644 -0.707 . . . . 55.31 110.517 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.11 98.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.69 -0.686 . . . . 71.14 112.177 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.9 m -60.77 -47.69 85.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.844 0.354 . . . . 70.21 110.835 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.05 -38.82 92.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.779 0.323 . . . . 74.41 111.295 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.85 -47.62 85.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.557 -0.747 . . . . 52.24 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -68.9 -27.96 66.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.968 -0.56 . . . . 72.34 111.559 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -81.61 -13.63 57.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.222 -0.445 . . . . 74.32 111.977 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.14 14.55 48.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.561 -0.828 . . . . 63.31 112.895 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -88.61 170.57 10.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.636 -0.505 . . . . 61.53 109.636 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 14.2 mmmm -100.47 159.25 15.3 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.501 -1.296 . . . . 75.5 107.501 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.402 HG13 HG23 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -130.36 146.38 34.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.406 0.622 . . . . 73.31 110.996 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -123.59 147.43 47.33 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 105.495 -2.039 . . . . 73.13 105.495 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.4 m -116.5 129.19 56.06 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 109.072 -0.714 . . . . 74.14 109.072 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.32 118.8 36.85 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.19 -2.152 . . . . 65.04 105.19 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -115.92 129.5 56.43 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.45 -0.574 . . . . 61.35 109.45 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -138.45 134.54 17.54 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 116.351 -0.386 . . . . 70.04 110.614 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -93.38 132.68 0.88 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.92 2.413 . . . . 74.13 110.85 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.0 t70 -175.22 171.39 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.124 -1.436 . . . . 73.34 107.124 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.8 m -114.39 -5.48 12.9 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.356 0.598 . . . . 74.42 110.323 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -87.9 -12.82 43.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.104 0.954 . . . . 62.1 108.94 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 394' ' ' ILE . 12.5 pt -88.58 144.12 33.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.001 -1.0 . . . . 65.14 110.861 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.4 177.22 8.79 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.343 2.695 . . . . 75.24 110.76 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.53 160.75 10.85 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.002 2.468 . . . . 64.33 112.357 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.463 ' HB2' HG23 ' A' ' 420' ' ' VAL . 2.5 p-10 -57.74 -9.5 1.25 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 124.987 1.315 . . . . 63.54 113.631 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.89 114.46 11.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.839 -1.911 . . . . 70.54 105.839 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.52 118.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.171 0.986 . . . . 61.43 111.408 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 366' ' ' ARG . 7.8 tp -90.53 -32.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.895 -1.048 . . . . 75.52 109.86 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -157.87 157.38 28.17 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 109.592 -1.403 . . . . 73.33 109.592 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.0 p -116.47 -179.75 3.77 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.063 -0.717 . . . . 73.05 109.063 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.64 147.55 34.0 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 120.174 -0.611 . . . . 75.23 109.416 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.65 -7.38 2.15 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.373 3.382 . . . . 71.55 115.501 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.28 72.8 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.058 -0.349 . . . . 72.42 110.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.73 68.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.695 0.759 . . . . 61.41 110.107 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.7 -10.83 59.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.278 -0.874 . . . . 70.35 111.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 83.0 m -81.01 151.81 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.794 -1.187 . . . . 73.1 107.794 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.5 m -74.06 112.86 10.6 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.303 0.573 . . . . 72.53 109.7 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.42 159.69 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.081 -0.963 . . . . 61.34 109.47 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 36.6 m -74.16 146.82 43.17 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.202 -0.666 . . . . 51.42 109.202 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.3 35.5 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.874 0.369 . . . . 73.21 110.423 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.46 25.86 24.7 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.724 -0.671 . . . . 53.24 112.006 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 411' ' ' SER . 4.4 t70 -85.89 -175.68 5.68 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.792 -1.188 . . . . 72.44 107.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.7 pt-20 -114.06 133.76 55.32 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.672 -0.811 . . . . 62.43 111.357 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.37 129.74 62.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 109.315 -0.624 . . . . 61.32 109.315 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.9 t -88.18 123.17 32.55 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 122.085 0.945 . . . . 71.01 109.994 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.81 114.61 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 107.506 -1.294 . . . . 73.25 107.506 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.08 -1.082 . . . . 62.1 108.08 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 397' ' ' ASP . 14.8 p -121.41 135.96 59.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.253 0.549 . . . . 75.45 110.558 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 19.9 m -84.63 121.11 27.18 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.663 -0.866 . . . . 73.13 108.663 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -119.87 104.9 10.59 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.657 -0.247 . . . . 73.34 111.449 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.02 145.72 0.12 Allowed Glycine 0 CA--C 1.542 1.729 0 N-CA-C 115.962 1.145 . . . . 65.23 115.962 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 57.9 Cg_endo -82.07 128.47 5.74 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.565 1.51 . . . . 74.1 109.964 172.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 0.1 OUTLIER -73.55 156.9 37.65 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.608 -0.516 . . . . 62.13 109.608 -177.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.4 mt-30 -121.71 157.48 30.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.032 0.444 . . . . 65.44 110.779 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.495 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 22.2 tpt180 -145.59 145.02 30.82 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.857 -0.794 . . . . 62.41 108.857 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.29 138.93 32.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.668 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -84.09 124.76 73.96 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.859 -0.61 . . . . 74.24 110.18 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 74.7 Cg_exo -61.85 141.6 90.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.435 2.09 . . . . 51.51 111.032 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.81 20.41 2.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.334 0.494 . . . . 64.13 112.334 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.418 HG21 ' HG3' ' A' ' 443' ' ' LYS . 23.7 m -84.18 -6.37 10.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.34 -0.391 . . . . 64.14 111.902 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.0 m -51.44 -51.09 57.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.909 0.883 . . . . 65.23 112.435 -177.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.3 m -61.12 -27.18 68.2 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.765 0.826 . . . . 74.41 111.716 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.15 -48.32 8.69 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.687 0.279 . . . . 51.52 111.702 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 439' ' ' GLU . 48.0 m -146.47 115.84 7.08 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.814 -0.354 . . . . 51.02 111.083 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -59.23 -44.01 92.34 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.682 -0.69 . . . . 72.45 110.937 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.65 -46.6 83.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 71.33 111.258 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 436' ' ' THR . 36.5 tt0 -68.02 -35.46 78.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.36 -0.382 . . . . 74.24 110.498 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.98 -43.58 95.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.314 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.84 -42.65 95.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.956 -0.565 . . . . 65.34 110.179 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.6 mmtt -66.22 -43.23 87.27 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.159 0.504 . . . . 73.55 110.352 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 39.3 mmtm -62.93 -47.74 81.92 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.521 -0.763 . . . . 74.45 111.246 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.97 -32.7 73.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.597 0.592 . . . . 73.42 112.597 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 52.3 m -67.54 -41.21 84.67 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.611 -0.514 . . . . 74.32 109.611 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.17 -22.83 61.99 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.83 0.824 . . . . 72.42 110.587 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.495 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.85 -8.89 59.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.326 -0.852 . . . . 70.5 110.423 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.13 -20.41 45.37 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.992 -0.549 . . . . 72.0 113.178 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -57.84 127.42 31.99 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.117 0.484 . . . . 75.33 111.874 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -129.12 12.92 6.05 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.389 -0.823 . . . . 53.35 111.208 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -115.75 111.04 19.96 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.332 -0.988 . . . . 75.43 108.332 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -132.93 148.59 52.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.106 0.479 . . . . 75.31 110.756 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -140.53 122.24 15.31 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 105.578 -2.008 . . . . 73.14 105.578 170.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.89 128.83 45.18 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.566 -0.531 . . . . 72.25 109.566 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.0 161.41 26.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.037 -0.727 . . . . 74.52 109.037 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -129.31 129.17 44.51 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.594 -0.891 . . . . 71.42 108.594 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -123.42 137.64 28.81 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 109.555 -0.535 . . . . 64.14 109.555 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.5 Cg_exo -61.87 134.01 47.77 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.303 2.002 . . . . 63.13 110.594 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.1 m -148.15 161.83 40.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.48 -0.563 . . . . 73.13 109.48 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 20.8 m -57.75 142.99 77.43 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 124.335 1.022 . . . . 55.14 108.261 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.613 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.13 -23.27 6.28 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.673 2.916 . . . . 70.2 114.579 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.34 -33.11 74.06 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.709 -0.62 . . . . 74.53 110.305 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.44 -9.86 28.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.818 -0.628 . . . . 72.54 112.482 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 461' ' ' PRO . 8.9 p -60.22 127.25 19.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 119.836 -0.746 . . . . 74.34 110.21 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.99 71.82 Favored Glycine 0 C--N 1.307 -1.043 0 C-N-CA 120.629 -0.796 . . . . 51.44 112.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -107.97 161.74 14.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.658 -0.867 . . . . 75.05 108.658 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 486' ' ' ILE . 98.0 t -83.98 129.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.591 -0.892 . . . . 75.52 108.591 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.08 -13.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.964 -0.695 . . . . 75.14 111.471 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 160.3 12.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.661 -0.699 . . . . 63.11 111.637 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.8 p -119.34 149.39 41.89 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.696 -1.224 . . . . 54.43 107.696 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.498 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.91 -51.46 79.19 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.34 -0.544 . . . . 62.35 110.707 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.2 Cg_exo -82.44 115.81 2.58 Favored 'Trans proline' 0 C--N 1.368 1.595 0 N-CA-C 107.841 -1.638 . . . . 74.43 107.841 169.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 39.5 Cg_endo -67.56 159.51 52.2 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.326 2.017 . . . . 73.52 113.657 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.63 -4.14 35.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.145 0.974 . . . . 35.45 111.706 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -105.34 11.12 33.17 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.259 -0.882 . . . . 74.3 109.072 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.406 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 35.0 tt0 -127.75 156.4 42.5 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.669 0.747 . . . . 60.02 110.7 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 426' ' ' GLN . 14.8 m -102.76 115.7 31.12 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.403 -1.271 . . . . 73.52 107.625 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.4 m -117.68 148.32 42.09 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 110.237 -0.283 . . . . 74.02 110.237 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.51 156.95 38.08 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.386 -0.228 . . . . 35.14 110.386 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.3 -22.78 19.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.57 0.7 . . . . 72.53 110.215 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -87.4 1.98 51.79 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.893 0.854 . . . . 70.44 109.861 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.46 130.17 34.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.478 -1.675 . . . . 70.21 106.478 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.19 113.99 19.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.602 -0.518 . . . . 75.44 109.602 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.37 118.7 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 N-CA-C 108.68 -0.859 . . . . 60.34 108.68 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.403 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.0 mt -94.45 112.89 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 107.176 -1.416 . . . . 73.23 107.176 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.61 115.44 46.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 N-CA-C 107.49 -1.3 . . . . 73.44 107.49 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.6 mt -103.61 119.82 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 115.982 -0.554 . . . . 74.1 110.148 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.16 136.24 29.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.566 -0.902 . . . . 73.33 108.566 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -71.88 113.34 4.51 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.129 -1.188 . . . . 65.25 110.129 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.2 m -131.73 104.89 7.16 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.453 -0.573 . . . . 74.24 109.453 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.096 0 N-CA-C 108.812 -1.715 . . . . 42.45 108.812 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.436 0 N-CA-C 109.75 -1.34 . . . . 73.42 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.24 137.84 21.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 117.906 0.853 . . . . 75.44 109.599 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.1 p -109.16 154.39 22.4 Favored 'General case' 0 N--CA 1.39 -3.475 0 CA-C-N 116.134 -0.484 . . . . 74.11 110.303 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -96.8 38.07 1.25 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.874 0.845 . . . . 74.34 109.305 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -76.01 132.87 40.43 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.535 -1.211 . . . . 71.14 107.75 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.54 162.34 38.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.009 0.433 . . . . 74.34 111.664 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -99.23 137.33 37.9 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.233 -1.025 . . . . 52.21 108.233 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.98 133.68 20.22 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 109.343 -0.614 . . . . 63.14 109.343 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 147.03 87.54 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.89 2.394 . . . . 73.31 113.666 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.06 145.4 31.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.653 -0.703 . . . . 72.44 109.175 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.1 t -107.43 31.63 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.602 -1.629 . . . . 43.54 106.602 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.36 134.12 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.388 -1.733 . . . . 75.43 111.149 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.88 -5.19 57.96 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 111.373 -0.691 . . . . 43.24 111.373 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -119.25 -176.94 3.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 120.705 0.288 . . . . 63.22 110.225 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.6 p -72.02 158.7 35.5 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.207 -0.451 . . . . 71.43 111.531 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.5 t -63.1 -33.8 76.23 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.372 -0.603 . . . . 72.52 109.372 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.23 90.36 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.535 0.522 . . . . 72.22 110.356 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 116.332 -0.394 . . . . 73.02 110.648 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.65 -51.4 69.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.577 -0.738 . . . . 60.2 111.035 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.95 -43.18 97.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.433 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.64 98.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 52.21 112.349 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 58.7 m -64.03 -47.34 80.6 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.355 0.598 . . . . 73.23 110.264 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.4 mm? -64.34 -38.45 91.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 72.43 110.768 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -62.2 -45.95 91.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.653 -0.703 . . . . 64.01 110.072 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -66.22 -30.71 71.21 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.187 -0.461 . . . . 71.31 111.389 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.7 mmt-85 -78.95 -13.83 59.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.479 . . . . 75.21 111.012 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.9 13.5 56.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.889 -0.672 . . . . 74.3 113.228 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.427 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 59.4 m-85 -85.33 166.24 16.62 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.487 0.66 . . . . 75.3 111.755 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 55.8 mtmt -109.02 132.61 53.94 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.605 -1.257 . . . . 74.11 107.605 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.76 146.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.462 0.649 . . . . 71.15 112.651 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -109.5 127.73 54.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.887 -1.894 . . . . 65.32 105.887 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.4 m -107.34 117.65 34.64 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 106.663 -1.606 . . . . 73.33 106.663 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.23 118.52 36.15 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.116 -1.809 . . . . 60.21 106.116 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 13.8 pm0 -113.03 128.0 56.38 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 109.164 -0.68 . . . . 75.33 109.164 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.21 138.71 33.48 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.938 -0.574 . . . . 63.44 110.364 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -82.63 146.04 13.27 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.92 1.746 . . . . 64.23 108.716 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.8 t0 -179.62 -175.0 0.32 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.349 -1.722 . . . . 71.21 106.349 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 51.4 m -135.11 0.26 2.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.158 0.504 . . . . 71.13 110.441 174.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 -14.95 49.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.221 -1.399 . . . . 61.22 107.221 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 421' ' ' SER . 14.2 pt -91.86 145.47 31.1 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.086 -1.416 . . . . 73.33 111.189 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.41 -172.88 1.47 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 123.18 2.587 . . . . 53.11 108.838 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.58 161.7 7.36 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.35 2.033 . . . . 63.0 112.608 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.2 p-10 -57.03 -8.12 0.6 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 125.228 1.411 . . . . 73.33 114.463 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -71.66 122.36 20.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.577 -1.268 . . . . 72.04 107.577 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.04 118.42 7.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 123.589 0.756 . . . . 73.13 111.645 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.567 ' H ' HD13 ' A' ' 400' ' ' ILE . 0.2 OUTLIER -96.4 -28.83 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.857 -0.61 . . . . 74.12 111.031 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.47 157.73 27.48 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 110.76 -0.936 . . . . 63.35 110.76 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.3 p -126.98 -177.88 4.2 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 123.283 0.633 . . . . 74.22 110.268 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.69 136.15 19.63 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.537 -1.653 . . . . 75.03 106.537 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.72 -16.67 2.48 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.406 3.404 . . . . 71.41 115.282 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.83 32.93 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 123.622 0.769 . . . . 74.2 111.854 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.44 -44.49 82.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.125 0.488 . . . . 71.43 111.034 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -86.09 -2.32 58.21 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.19 0.519 . . . . 73.04 111.662 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 67.1 m -81.55 146.79 29.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.846 -1.538 . . . . 61.35 106.846 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.2 m -74.66 112.74 11.17 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.168 -1.049 . . . . 72.54 108.168 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.23 166.81 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.519 -0.764 . . . . 71.14 111.064 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.2 t -74.51 144.66 44.01 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.108 -1.071 . . . . 33.12 108.108 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.43 114.67 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 71.31 110.521 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.34 40.68 4.16 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.668 -0.777 . . . . 35.04 111.767 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -93.2 -177.38 4.44 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.607 -1.257 . . . . 74.04 107.607 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 41.2 mt-10 -107.19 119.9 40.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.207 0.527 . . . . 65.15 111.957 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.21 130.59 61.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.538 -0.912 . . . . 71.32 108.538 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.4 t -95.05 130.76 41.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.355 0.598 . . . . 70.22 110.015 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.39 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.711 -0.848 . . . . 73.33 108.711 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -91.33 128.82 37.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.059 0.457 . . . . 74.44 110.489 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 397' ' ' ASP . 46.8 t -125.16 138.59 53.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.229 -0.896 . . . . 61.22 109.428 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.481 ' HB3' HD12 ' A' ' 394' ' ' ILE . 16.0 m -89.08 121.47 31.44 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.449 -0.575 . . . . 60.02 109.449 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.2 t -120.83 104.82 10.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 119.144 -1.022 . . . . 71.5 111.005 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 64.19 172.23 2.61 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.907 0.723 . . . . 63.42 114.907 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 72.9 Cg_endo -97.18 155.09 1.06 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 122.73 2.287 . . . . 62.42 113.322 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 4.5 mm-40 -84.87 141.37 30.48 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.78 -0.645 . . . . 70.34 110.247 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -117.26 147.37 42.6 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.458 -0.942 . . . . 73.31 108.458 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.29 155.39 39.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.561 -1.274 . . . . 64.23 107.561 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -88.81 138.16 31.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.79 -0.448 . . . . 74.25 109.79 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -83.09 129.14 62.34 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.385 -0.968 . . . . 75.25 108.385 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.55 140.51 89.83 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.362 2.041 . . . . 51.41 112.356 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.03 -5.73 56.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.558 0.694 . . . . 73.24 110.18 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.36 -7.57 10.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.986 -1.006 . . . . 61.44 110.936 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 20.7 m -56.48 -41.76 77.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.304 -0.862 . . . . 64.45 111.228 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -61.74 -23.13 65.95 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.23 1.012 . . . . 64.34 111.77 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.12 -35.79 15.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.512 . . . . 74.23 111.888 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 439' ' ' GLU . 50.4 m -148.68 119.48 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.08 -0.387 . . . . 53.24 110.849 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -58.13 -51.17 70.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.639 0.776 . . . . 73.33 111.77 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.98 -43.6 98.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 64.12 111.605 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 436' ' ' THR . 35.3 tt0 -65.67 -35.28 80.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.666 -0.697 . . . . 73.43 110.166 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.03 -51.39 69.83 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 123.775 0.672 . . . . 55.03 109.627 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.0 t -58.89 -44.12 90.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 50.32 110.48 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 73.5 mmtt -66.21 -46.64 76.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 52.24 111.762 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 33.1 mmtp -66.0 -37.95 87.23 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.876 0.324 . . . . 52.2 111.876 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 440' ' ' ALA . 10.4 mp -65.21 -40.48 94.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.932 0.145 . . . . 74.44 111.286 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.2 m -61.25 -47.06 87.8 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.33 -0.619 . . . . 64.13 109.33 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.12 -24.96 65.98 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.851 -0.613 . . . . 70.3 111.696 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.2 -8.86 59.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 65.21 111.354 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.28 48.7 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.639 -0.791 . . . . 42.2 113.187 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.25 99.34 6.23 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.266 -0.549 . . . . 73.44 109.687 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.43 23.1 27.45 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.238 -0.745 . . . . 73.22 111.238 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -118.58 111.72 18.95 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.671 -1.233 . . . . 72.14 107.671 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -131.31 144.1 51.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.012 0.91 . . . . 72.51 113.06 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 18.4 tptm -140.3 123.4 16.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.548 -1.66 . . . . 64.43 106.525 170.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -95.99 135.16 38.13 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.555 -0.535 . . . . 74.51 109.555 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.0 153.02 51.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.025 -0.732 . . . . 73.45 109.025 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -121.8 129.37 52.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.886 0.374 . . . . 74.01 110.481 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.2 t -117.2 142.46 30.14 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 107.869 -1.16 . . . . 62.33 107.869 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.98 126.96 19.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.266 1.977 . . . . 71.41 109.968 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.6 t -137.96 -178.21 5.16 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.749 -0.834 . . . . 60.23 108.749 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.462 ' HB ' HD13 ' A' ' 463' ' ' LEU . 21.0 m -63.94 138.02 97.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.41 -1.33 . . . . 75.34 107.41 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.47 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.81 -29.31 33.82 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.629 2.886 . . . . 71.42 113.965 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -76.23 -19.06 58.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.921 0.711 . . . . 63.44 112.921 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 460' ' ' THR . 10.4 mp -95.17 4.62 53.4 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.808 0.299 . . . . 65.24 111.808 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -60.15 126.35 17.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-O 121.335 0.588 . . . . 73.11 110.54 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.11 -0.16 66.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.748 -0.66 . . . . 54.31 112.09 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.57 152.29 24.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.985 -1.117 . . . . 73.35 107.985 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 486' ' ' ILE . 56.4 t -84.07 141.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.06 -0.718 . . . . 72.12 109.06 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.22 -14.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.127 -0.629 . . . . 55.12 111.456 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.08 168.28 20.91 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.733 -0.947 . . . . 63.14 110.733 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.0 p -116.95 159.3 22.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -63.52 -54.69 41.27 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 119.96 -0.696 . . . . 62.41 111.132 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 18.3 Cg_exo -72.87 112.98 3.64 Favored 'Trans proline' 0 C--N 1.373 1.834 0 N-CA-C 107.465 -1.783 . . . . 71.12 107.465 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 49.5 Cg_endo -65.65 149.03 87.62 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.917 2.412 . . . . 72.42 114.938 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.8 -0.88 28.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 70.33 110.03 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -104.41 7.33 35.52 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.439 -1.255 . . . . 75.43 110.252 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 34.9 tt0 -159.01 165.48 33.92 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.906 -0.717 . . . . 65.53 109.593 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.2 m -92.52 126.4 37.59 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.633 -0.877 . . . . 71.43 108.633 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.9 m -125.96 148.85 49.15 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.939 -0.393 . . . . 75.32 109.939 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.9 148.19 50.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.632 0.253 . . . . 75.52 111.636 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.4 mm -66.41 -12.58 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.442 0 C-N-CA 124.388 1.075 . . . . 62.01 110.818 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.3 t -87.91 5.0 42.64 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.868 0.842 . . . . 75.41 110.328 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -90.96 135.43 33.74 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.382 -0.599 . . . . 72.53 109.382 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.69 122.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.964 -1.495 . . . . 64.14 106.964 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.23 118.59 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 C-N-CA 119.618 -0.833 . . . . 61.42 108.882 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 63.8 mt -92.93 112.24 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 105.935 -1.876 . . . . 75.32 105.935 174.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -94.4 109.13 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 106.688 -1.597 . . . . 73.34 106.688 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.0 mt -97.2 116.9 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 115.513 -0.767 . . . . 65.33 109.867 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 t -97.52 141.04 16.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.961 -1.125 . . . . 62.44 107.961 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -91.31 127.11 8.72 Favored Glycine 0 N--CA 1.407 -3.276 0 N-CA-C 109.849 -1.3 . . . . 71.43 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.7 m -136.39 128.83 30.28 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.348 -0.612 . . . . 72.41 109.348 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.287 0 N-CA-C 108.569 -1.812 . . . . 64.41 108.569 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.47 0 N-CA-C 109.392 -1.483 . . . . 54.34 109.392 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -93.45 135.41 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.094 -0.706 . . . . 55.25 109.094 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.6 p -78.99 143.1 36.04 Favored 'General case' 0 N--CA 1.385 -3.718 0 CA-C-N 116.251 -0.431 . . . . 65.54 110.712 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -97.74 77.89 2.57 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.683 -0.858 . . . . 75.31 108.683 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -100.71 135.53 42.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.706 -1.22 . . . . 73.3 107.706 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.14 149.72 20.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.803 -0.443 . . . . 72.03 109.803 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.298 -1.371 . . . . 63.54 107.298 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 406' ' ' ALA . 3.6 p -97.82 118.66 63.71 Favored Pre-proline 0 C--N 1.282 -2.351 0 N-CA-C 108.637 -0.875 . . . . 71.15 108.637 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.7 160.68 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.77 2.313 . . . . 75.32 113.823 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 366' ' ' ARG . 14.6 p-10 -72.33 119.58 16.74 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.243 -0.89 . . . . 44.31 109.976 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.64 35.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 125.564 1.546 . . . . 72.53 110.728 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 364' ' ' ASP . 15.0 ptt180 -63.87 144.55 56.98 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.622 -1.627 . . . . 72.33 112.859 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.56 0.74 59.2 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.724 -0.75 . . . . 41.03 114.685 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.49 171.69 12.73 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.375 1.088 . . . . 73.34 110.995 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -71.59 156.77 39.02 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.261 -0.427 . . . . 45.32 110.547 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 374' ' ' ILE . 8.4 p -59.78 -37.12 78.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.945 0.403 . . . . 72.4 110.574 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.0 91.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.993 -0.548 . . . . 62.24 111.335 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.67 -41.88 74.92 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.487 -0.485 . . . . 74.33 110.406 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.99 -51.32 69.7 Favored 'General case' 0 C--O 1.239 0.532 0 O-C-N 123.809 0.693 . . . . 72.41 111.94 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -60.64 -46.07 96.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.281 -0.418 . . . . 72.04 110.951 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.36 87.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.035 0.383 . . . . 73.21 112.035 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 79.1 m -60.83 -45.56 93.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.742 0.306 . . . . 53.43 111.197 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.62 -38.13 89.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.363 -0.38 . . . . 72.4 110.688 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -60.13 -46.15 90.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.125 0.97 . . . . 74.52 110.485 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -70.36 -18.66 63.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.757 -0.656 . . . . 71.24 111.263 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 380' ' ' ARG . 25.1 mmt180 -88.49 -8.26 55.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.972 -0.558 . . . . 74.14 111.13 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.2 56.15 Favored Glycine 0 CA--C 1.504 -0.655 0 C-N-CA 120.986 -0.626 . . . . 61.35 113.353 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -80.83 150.27 29.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.226 0.536 . . . . 71.31 110.41 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -100.06 144.74 28.74 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.066 -1.457 . . . . 73.22 107.066 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -135.67 139.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-O 121.152 0.501 . . . . 74.12 111.498 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -116.19 127.75 55.04 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 62.33 107.246 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.7 m -104.7 123.75 48.17 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.265 -0.574 . . . . 63.55 110.086 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.53 119.71 39.67 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.55 -0.907 . . . . 62.44 108.55 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 11.2 pm0 -104.41 127.52 52.11 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.913 -0.585 . . . . 64.54 109.635 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -134.97 139.59 32.55 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 111.773 0.286 . . . . 64.45 111.773 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 60.3 Cg_endo -89.19 145.23 5.13 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.424 2.082 . . . . 73.25 110.215 170.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.9 t70 -171.09 -176.64 1.99 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.502 -0.925 . . . . 73.11 108.502 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.544 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 3.5 m -98.65 -39.61 8.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.743 -1.577 . . . . 74.55 106.743 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -101.86 73.47 1.41 Allowed 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.406 -1.331 . . . . 72.01 107.406 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 14.5 pt -93.83 127.45 45.47 Favored Pre-proline 0 N--CA 1.419 -1.978 0 CA-C-N 113.016 -1.902 . . . . 73.25 111.593 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -69.86 124.33 10.93 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 N-CA-C 106.105 -2.306 . . . . 75.42 106.105 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.23 159.98 11.69 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.049 2.499 . . . . 75.11 113.749 -173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.9 -8.81 3.4 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.375 1.07 . . . . 74.33 111.696 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -103.82 106.86 17.49 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.073 -2.195 . . . . 72.32 105.073 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.0 m -62.63 119.72 7.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 O-C-N 124.585 1.178 . . . . 71.33 113.378 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.59 -28.22 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 113.865 -1.516 . . . . 63.42 109.89 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.47 170.4 32.88 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 110.598 -1.001 . . . . 23.41 110.598 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 403' ' ' ASP . 5.9 m -120.02 -178.21 3.6 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.389 -2.078 . . . . 54.42 105.389 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.492 ' H ' HG22 ' A' ' 402' ' ' THR . 26.9 t70 -100.02 141.14 22.21 Favored Pre-proline 0 C--N 1.266 -3.024 0 N-CA-C 108.995 -0.742 . . . . 75.23 108.995 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -41.98 -26.32 0.47 Allowed 'Trans proline' 0 C--N 1.371 1.731 1 C-N-CA 125.555 4.17 . . . . 75.11 115.248 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.55 62.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.981 0.512 . . . . 74.05 110.683 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 362' ' ' VAL . . . -77.06 -44.47 30.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.678 -0.692 . . . . 61.41 110.856 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -75.41 -7.62 54.54 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.69 -0.686 . . . . 72.23 111.936 -174.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.3 m -85.17 146.02 27.32 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.421 -0.955 . . . . 73.54 108.421 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.4 p -73.49 113.87 11.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 109.795 -0.446 . . . . 73.51 109.795 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 168.84 20.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.525 -0.546 . . . . 73.33 109.525 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.8 m -72.84 133.25 44.37 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.369 -0.974 . . . . 71.12 108.369 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -55.86 135.78 51.81 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 112.442 0.534 . . . . 53.12 112.442 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.86 47.04 4.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.082 -0.963 . . . . 62.51 111.094 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -108.68 178.88 4.35 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.981 -1.118 . . . . 75.41 107.981 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.79 122.13 40.53 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.801 0.44 . . . . 52.12 111.388 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -111.18 128.88 67.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.723 -0.843 . . . . 61.44 108.723 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -87.39 128.0 35.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.138 -0.69 . . . . 53.33 109.138 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.21 128.85 73.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.532 -0.914 . . . . 75.11 108.532 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -100.96 128.34 47.03 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.395 -0.366 . . . . 72.21 110.694 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.28 146.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.558 -1.275 . . . . 73.54 107.558 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 8.8 p -98.93 123.29 43.11 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.059 -0.657 . . . . 45.45 112.531 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -118.28 105.32 11.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.888 -0.596 . . . . 75.35 110.145 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 72.94 161.2 6.01 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 121.898 0.721 . . . . 24.24 114.497 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.0 Cg_endo -92.33 157.62 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.496 2.13 . . . . 75.01 110.871 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.8 131.63 42.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 120.092 -0.643 . . . . 52.03 110.219 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -121.08 138.96 53.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.681 -0.69 . . . . 74.14 109.611 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.1 OUTLIER -131.8 150.19 52.23 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 108.566 -0.902 . . . . 64.44 108.566 -175.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.7 OUTLIER -85.98 131.65 34.23 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.064 -1.087 . . . . 72.23 108.064 176.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.08 125.23 82.11 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.372 -0.603 . . . . 72.14 109.372 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.37 141.25 73.86 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.255 1.97 . . . . 62.45 110.951 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.5 -5.26 59.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.466 0.651 . . . . 61.41 110.199 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.47 -1.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 74.42 111.165 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.2 p -65.6 -41.53 92.66 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.921 0.867 . . . . 71.25 109.708 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.4 m -65.84 -13.24 59.18 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 125.271 1.429 . . . . 71.22 111.213 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.18 -35.75 17.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.315 0.487 . . . . 64.24 112.315 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.0 m -157.94 125.21 5.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.909 -0.494 . . . . 44.45 110.522 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -57.58 -48.79 78.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.437 0.532 . . . . 73.02 112.437 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.0 76.71 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.439 -0.346 . . . . 45.23 111.888 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.88 -34.7 71.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.962 -0.563 . . . . 53.01 111.176 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.18 -47.01 86.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.477 -0.329 . . . . 75.2 110.459 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.28 -42.33 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.822 -0.627 . . . . 74.02 109.935 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -61.62 -47.59 84.75 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 111.922 0.342 . . . . 64.44 111.922 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.55 -45.54 92.46 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.55 0.34 . . . . 64.33 111.54 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.28 -40.79 81.7 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.469 -0.492 . . . . 45.1 112.175 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.2 m -63.82 -39.33 93.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.956 0.407 . . . . 61.44 110.402 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.65 -25.96 65.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 54.54 110.946 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -86.88 -8.59 57.14 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.857 -0.61 . . . . 70.44 110.938 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.3 -15.98 13.01 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.558 -0.829 . . . . 34.54 114.08 176.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.36 113.15 3.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.995 0.898 . . . . 74.54 111.54 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.86 -12.57 11.17 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.823 -0.703 . . . . 42.34 111.422 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -91.06 111.19 22.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.1 -0.704 . . . . 75.23 109.1 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -136.07 154.49 51.01 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.54 0.685 . . . . 52.22 111.864 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -137.03 122.3 19.3 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 104.841 -2.281 . . . . 63.31 104.841 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -113.57 127.89 56.24 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.023 0.439 . . . . 72.42 110.625 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.06 165.29 27.96 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.701 -0.682 . . . . 63.33 110.034 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.96 141.15 47.12 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.771 -1.196 . . . . 63.21 107.771 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.6 t -116.93 129.57 25.22 Favored Pre-proline 0 N--CA 1.407 -2.607 0 N-CA-C 107.008 -1.479 . . . . 74.41 107.008 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.55 119.97 7.15 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 122.227 1.952 . . . . 61.01 109.791 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 2.9 p -148.24 -178.35 6.26 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 115.045 -0.98 . . . . 64.24 108.84 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.3 m -61.32 128.72 90.14 Favored Pre-proline 0 C--N 1.291 -1.941 0 N-CA-C 108.48 -0.933 . . . . 75.11 108.48 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.68 -22.94 10.29 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.646 2.898 . . . . 65.21 112.899 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.11 -30.17 69.09 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.34 0.656 . . . . 72.1 110.918 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.63 5.16 44.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.362 -0.381 . . . . 73.44 111.427 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.5 p -59.58 132.26 24.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 CA-C-O 121.15 0.5 . . . . 43.31 111.247 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.81 -10.79 73.82 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.689 -0.767 . . . . 41.31 112.748 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.67 147.01 30.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.38 -0.6 . . . . 73.43 109.38 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -83.86 135.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.125 -1.065 . . . . 61.22 108.125 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.97 -16.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.516 -0.874 . . . . 71.24 111.542 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.37 167.28 32.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.641 -0.79 . . . . 74.4 111.693 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.2 p -131.78 145.62 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.309 -0.996 . . . . 74.02 108.309 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -58.97 -53.8 62.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 120.337 -0.545 . . . . 75.53 110.532 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -70.84 118.39 5.67 Favored 'Trans proline' 0 C--N 1.376 2.011 0 N-CA-C 107.338 -1.831 . . . . 71.43 107.338 169.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.12 151.93 30.8 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.028 1.819 . . . . 75.15 113.685 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -68.74 -0.93 5.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.005 -0.998 . . . . 70.15 112.244 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -107.81 -3.02 19.43 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.497 -0.32 . . . . 75.14 110.69 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -118.19 157.0 27.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.442 0.639 . . . . 71.51 110.601 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 10.3 m -102.69 97.75 7.88 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 61.34 107.404 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 40.4 m -100.88 147.99 25.48 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.986 -0.552 . . . . 73.21 110.082 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.77 148.22 51.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.107 -0.497 . . . . 61.22 110.861 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 33.0 mm -69.81 -5.04 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 122.464 1.126 . . . . 73.21 109.996 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.4 p -87.49 0.9 54.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.598 0.714 . . . . 60.12 109.736 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -93.07 139.42 30.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.425 -0.807 . . . . 74.22 109.08 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.93 123.42 36.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.911 -1.144 . . . . 75.21 107.911 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.36 118.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 108.679 -0.86 . . . . 73.51 108.679 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.4 113.65 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.204 -1.776 . . . . 73.2 106.204 175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -112.43 114.64 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 N-CA-C 108.297 -1.001 . . . . 72.24 108.297 -176.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -106.9 123.07 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.358 -0.837 . . . . 53.22 111.214 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.36 144.0 11.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.75 -1.114 . . . . 74.04 108.486 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.58 113.42 4.61 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 108.904 -1.678 . . . . 70.3 108.904 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.9 m -139.63 113.11 8.4 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 109.178 -0.675 . . . . 65.41 109.178 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.417 -2.633 0 N-CA-C 108.499 -1.84 . . . . 62.0 108.499 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 110.243 -1.143 . . . . 43.05 110.243 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.17 145.79 16.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.39 0.614 . . . . 50.5 112.554 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.1 m -114.6 160.68 19.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.447 -1.686 . . . . 65.15 106.447 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' A' ' 358' ' ' ARG . 38.2 mmt180 -87.99 89.35 7.96 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.082 0.944 . . . . 73.03 111.823 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.72 126.24 51.93 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.594 -1.632 . . . . 72.4 106.594 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.51 154.25 23.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 110.177 -0.305 . . . . 74.45 110.177 -175.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -98.97 132.12 44.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.805 -1.183 . . . . 65.32 107.805 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.1 118.33 61.67 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.832 -0.747 . . . . 72.33 111.461 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.89 143.08 71.78 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.439 2.093 . . . . 64.01 112.189 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.623 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 4.0 p30 -82.68 177.9 8.46 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.225 -0.898 . . . . 73.21 111.239 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.67 29.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.478 -1.237 . . . . 74.42 108.537 176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.623 ' HG3' ' OD1' ' A' ' 364' ' ' ASP 0.264 0.1 OUTLIER -64.15 146.74 53.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.438 0.903 . . . . 73.45 113.438 -174.049 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.2 0.2 41.04 Favored Glycine 0 C--N 1.308 -0.989 0 N-CA-C 110.368 -1.093 . . . . 54.41 110.368 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -116.44 -170.68 1.86 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.899 -0.778 . . . . 72.44 108.899 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.0 p -69.91 150.99 46.17 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.471 0.309 . . . . 63.32 111.132 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 374' ' ' ILE . 38.1 t -57.98 -36.15 72.19 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.443 -0.947 . . . . 61.53 108.443 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.3 94.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.308 -0.86 . . . . 75.01 112.237 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.88 -40.24 91.43 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.75 0.309 . . . . 75.31 110.199 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.18 88.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 72.32 110.637 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 370' ' ' SER . 76.5 mt -62.59 -46.39 96.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.68 -0.691 . . . . 70.05 110.202 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.34 79.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.997 -0.547 . . . . 51.14 112.087 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 85.5 m -60.73 -47.83 84.54 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.659 -0.246 . . . . 70.52 111.128 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.52 -38.04 89.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.71 0.263 . . . . 64.14 111.71 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -61.21 -41.98 97.8 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 109.414 -0.587 . . . . 72.0 109.414 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -69.82 -22.93 63.26 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.473 -0.785 . . . . 74.14 112.107 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.2 mmt180 -84.96 -14.27 48.1 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.504 -0.554 . . . . 72.32 109.504 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.84 56.68 Favored Glycine 0 C--O 1.239 0.421 0 C-N-CA 120.895 -0.669 . . . . 53.52 112.201 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.33 149.26 25.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.966 -0.383 . . . . 74.53 109.966 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -100.18 132.35 45.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.782 -0.822 . . . . 74.04 108.782 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -121.88 137.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 113.232 0.827 . . . . 61.23 113.232 -174.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -110.56 127.87 55.4 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 107.309 -1.367 . . . . 71.22 107.309 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.0 m -99.33 121.82 41.62 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.136 -1.061 . . . . 51.53 108.136 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -111.49 119.5 38.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.251 -1.388 . . . . 73.14 107.251 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 11.0 pm0 -109.46 128.69 55.34 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 109.431 -0.581 . . . . 71.11 109.431 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -133.04 146.25 60.42 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.904 -0.406 . . . . 73.24 109.904 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -93.08 128.87 0.74 Allowed 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.221 1.947 . . . . 74.45 109.81 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.0 t70 -173.14 -175.12 1.14 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.732 -1.21 . . . . 70.04 107.732 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.8 m -130.63 -0.68 4.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.753 0.787 . . . . 54.14 109.975 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -91.11 -0.63 57.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.881 1.324 . . . . 71.41 107.473 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.481 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.63 151.75 48.33 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.076 -1.42 . . . . 70.31 112.641 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.16 178.32 6.44 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.425 2.084 . . . . 73.45 109.698 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.96 158.13 18.24 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 121.923 1.749 . . . . 74.11 111.786 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.81 -7.21 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.842 0.829 . . . . 70.41 113.119 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -86.83 122.66 31.01 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.216 -2.513 . . . . 51.23 104.216 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 118.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.626 0.727 . . . . 75.11 111.811 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.8 mm -97.87 -28.37 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.533 -0.758 . . . . 72.41 111.004 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.94 157.99 27.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.039 -1.077 . . . . 52.4 111.794 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.8 p -114.16 -177.53 3.15 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 123.577 0.751 . . . . 72.33 111.123 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.06 143.73 27.04 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.11 107.705 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -40.25 -32.63 0.72 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 124.807 3.672 . . . . 74.1 114.715 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.09 -30.01 61.41 Favored 'General case' 0 C--O 1.208 -1.103 0 O-C-N 123.437 0.46 . . . . 72.42 111.608 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.72 -35.56 75.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.109 0.48 . . . . 73.04 111.021 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -95.66 -0.85 51.2 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.944 0.402 . . . . 72.53 111.939 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -98.29 155.94 16.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.322 -1.362 . . . . 71.15 107.322 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 11.3 p -74.31 112.7 10.73 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.723 -0.843 . . . . 73.33 108.723 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.51 169.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.439 -0.578 . . . . 73.31 109.439 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 20.3 m -69.65 146.9 51.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.298 -0.631 . . . . 63.44 109.298 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.81 108.17 2.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.821 -1.177 . . . . 53.41 107.821 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.61 59.68 1.26 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.444 -1.462 . . . . 71.21 109.444 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.3 t0 -109.94 -173.51 2.27 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.039 -1.097 . . . . 74.23 108.039 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -93.62 121.96 35.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.815 0.846 . . . . 74.23 110.079 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.8 mm -124.23 137.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.112 -1.44 . . . . 63.43 107.112 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.1 t -113.2 131.25 55.95 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 61.22 110.833 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 76.4 t -102.18 128.28 54.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.112 -0.949 . . . . 71.23 108.748 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -99.0 129.83 45.3 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.131 -0.486 . . . . 41.11 110.044 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 9.0 p -136.16 136.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.271 0.558 . . . . 64.34 109.705 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.481 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 8.2 m -89.59 123.75 33.94 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.942 -0.572 . . . . 42.32 110.982 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -119.18 105.83 11.76 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.193 -0.603 . . . . 60.11 110.015 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.08 129.32 0.5 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 120.649 -0.786 . . . . 71.32 114.792 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 17.0 Cg_exo -70.75 157.92 57.11 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.685 2.257 . . . . 75.43 110.582 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.01 155.52 19.78 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.974 0.416 . . . . 73.44 110.361 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.7 mt-30 -127.84 138.78 52.82 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.827 -0.805 . . . . 63.43 108.827 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -135.52 157.68 46.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.093 -0.706 . . . . 73.22 109.093 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.64 139.35 32.86 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.653 -0.499 . . . . 75.53 109.653 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -80.47 127.34 76.21 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 108.66 -0.866 . . . . 64.53 108.66 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.53 141.57 62.3 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.842 2.361 . . . . 72.41 111.805 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.76 -15.5 48.28 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.511 0.672 . . . . 63.13 111.785 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.3 -10.55 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 121.399 0.619 . . . . 64.41 110.824 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.1 m -55.73 -45.4 77.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.583 0.753 . . . . 65.15 112.533 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.5 p -69.84 -15.67 63.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.345 0.593 . . . . 62.14 112.562 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.01 -37.99 13.92 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.215 -0.448 . . . . 64.2 111.003 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.9 m -146.98 122.22 10.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.062 0.458 . . . . 53.4 111.043 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -60.59 -42.27 96.38 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.789 0.835 . . . . 64.13 112.276 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.94 78.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.489 . . . . 73.42 110.822 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.75 -39.8 73.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.06 -0.518 . . . . 75.31 110.96 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.61 68.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.854 -0.612 . . . . 64.42 111.031 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.52 -43.83 90.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.785 0.661 . . . . 63.53 112.785 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.34 -48.53 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.801 -0.36 . . . . 71.3 111.774 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.84 -40.18 87.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 113.897 1.073 . . . . 74.55 113.897 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.39 -43.17 77.87 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.977 -0.689 . . . . 72.32 112.215 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.7 m -61.6 -43.98 97.85 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.024 0.44 . . . . 72.4 110.364 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.09 -25.1 62.47 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.795 -0.639 . . . . 60.13 111.765 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -12.69 59.77 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.172 0.51 . . . . 61.53 110.631 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.62 -19.01 8.58 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.337 -0.935 . . . . 35.41 112.791 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.2 103.82 1.67 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.008 -0.738 . . . . 54.14 109.008 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.68 11.59 18.48 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 111.029 -0.829 . . . . 75.34 111.029 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -108.87 111.05 22.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 106.68 -1.6 . . . . 72.3 106.68 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.98 155.82 49.68 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.268 0.556 . . . . 62.31 111.425 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 122.3 20.33 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 102.843 -3.021 . . . . 72.43 102.843 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -93.91 135.14 35.55 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.867 -0.42 . . . . 74.4 109.867 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 141.09 37.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.161 0.505 . . . . 72.51 110.741 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -118.96 129.36 55.12 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.058 -1.46 . . . . 75.23 107.058 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -125.36 145.35 50.62 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.448 -0.575 . . . . 74.45 109.448 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 491' ' ' GLY . 13.4 Cg_exo -68.54 126.77 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.773 1.649 . . . . 51.44 110.378 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.6 m -135.71 172.92 12.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.984 -0.747 . . . . 75.15 108.984 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 463' ' ' LEU . 25.6 m -62.81 140.09 97.26 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.402 -0.962 . . . . 74.52 108.402 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -49.32 -31.24 22.19 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.792 2.995 . . . . 62.33 113.782 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.69 -21.88 64.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.236 0.541 . . . . 64.13 111.434 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.2 mm? -105.72 -8.52 17.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.937 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 76.3 t -60.09 127.21 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 120.977 0.417 . . . . 61.05 110.641 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.54 59.08 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.881 -0.888 . . . . 71.33 110.881 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.22 162.42 13.21 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.663 -0.865 . . . . 72.22 108.663 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 93.1 t -83.83 128.59 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.773 -1.566 . . . . 75.33 106.773 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.42 -16.87 7.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.381 -0.928 . . . . 74.34 111.526 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.11 159.0 16.13 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 111.113 -0.795 . . . . 62.43 111.113 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.4 p -119.94 154.29 34.68 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.425 -1.694 . . . . 74.42 106.425 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 7.2 t30 -64.19 -49.94 70.72 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 119.43 -0.908 . . . . 72.21 110.349 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.4 Cg_exo -78.2 115.9 3.81 Favored 'Trans proline' 0 C--N 1.371 1.731 0 N-CA-C 108.051 -1.557 . . . . 65.52 108.051 168.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.54 149.93 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.077 1.852 . . . . 72.44 112.488 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.04 4.24 4.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.445 0.641 . . . . 63.25 112.596 -176.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -108.35 2.15 22.32 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.994 -0.548 . . . . 62.22 110.67 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -117.65 155.42 29.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.752 0.787 . . . . 64.43 111.556 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 17.4 m -95.62 111.83 23.68 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.987 -1.486 . . . . 64.32 106.987 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.6 m -115.14 149.25 37.92 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.731 -0.47 . . . . 72.43 109.731 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -62.29 150.84 38.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.156 0.503 . . . . 55.34 111.226 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.26 -26.51 27.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.035 0.921 . . . . 73.02 109.353 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 m -89.87 5.14 47.57 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.967 -1.015 . . . . 34.1 110.117 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 43.7 t-20 -83.62 135.3 34.66 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 107.609 -1.256 . . . . 64.24 107.609 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 58.8 t -79.01 114.5 19.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.249 -0.649 . . . . 73.24 109.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.77 119.52 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.082 -0.71 . . . . 72.32 109.082 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 3.0 mp -92.23 114.25 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.357 -1.72 . . . . 75.31 106.357 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.29 118.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.676 -1.231 . . . . 74.51 107.676 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.1 mt -110.32 117.33 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.587 0.708 . . . . 74.45 110.27 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.23 138.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.581 -0.736 . . . . 73.34 109.122 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.09 107.76 3.2 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.975 -0.85 . . . . 74.41 110.975 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.478 ' HA ' HG13 ' A' ' 464' ' ' VAL . 36.6 m -143.37 113.94 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.105 -0.702 . . . . 72.21 109.105 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 458' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.311 0 N-CA-C 110.183 -1.167 . . . . 74.11 110.183 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.031 0 N-CA-C 110.684 -0.966 . . . . 72.42 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 21.5 pt -126.47 158.83 36.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.167 0.483 . . . . 72.14 109.856 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 14.1 t -128.44 -173.37 2.94 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.625 -1.62 . . . . 73.34 106.625 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.83 65.41 8.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.255 1.026 . . . . 65.0 111.153 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.92 135.8 50.22 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.486 -2.042 . . . . 73.01 105.486 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.86 164.2 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 120.88 0.372 . . . . 74.04 111.13 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -94.29 137.14 33.8 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.8 -1.926 . . . . 75.32 105.8 173.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.57 139.72 21.55 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 108.294 -1.002 . . . . 63.51 108.294 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -37.99 135.79 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.8 3.0 . . . . 63.41 113.835 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.78 88.96 1.33 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.791 -1.188 . . . . 71.4 107.791 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.42 -0.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 116.888 2.181 . . . . 55.12 116.888 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 145.25 56.5 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.032 -0.667 . . . . 74.13 112.231 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 0.48 45.29 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.802 -0.919 . . . . 42.34 110.802 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -117.3 172.51 7.26 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.608 -1.627 . . . . 71.21 106.608 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 91.0 p -81.3 153.67 26.95 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 118.482 -1.287 . . . . 62.31 107.865 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.5 m -56.65 -40.47 75.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.535 0.207 . . . . 74.14 110.897 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.67 -36.99 79.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.015 0.436 . . . . 71.31 111.395 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -67.5 -36.69 81.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.537 0.684 . . . . 72.33 109.508 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.44 90.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.495 -0.775 . . . . 65.33 110.134 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 370' ' ' SER . 70.5 mt -57.72 -46.42 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.696 0.398 . . . . 71.21 110.134 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.69 91.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.932 -0.576 . . . . 72.23 110.684 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.7 m -64.73 -47.59 77.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.412 -0.358 . . . . 71.45 111.095 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.29 -38.79 91.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 111.655 0.243 . . . . 44.35 111.655 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -60.11 -48.88 79.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.254 -0.647 . . . . 70.02 109.254 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -72.07 -16.47 62.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.2 -0.909 . . . . 72.5 111.935 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.91 -15.07 49.37 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.034 -1.098 . . . . 63.41 108.034 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.4 5.6 61.78 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.59 -0.732 . . . . 33.35 111.786 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 26.2 m-85 -91.83 158.95 16.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.198 0.523 . . . . 61.23 111.745 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 75.1 mmtt -95.62 146.31 24.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.052 -1.092 . . . . 73.44 108.052 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.72 144.04 38.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 121.209 0.528 . . . . 74.21 111.56 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -110.46 139.92 45.22 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.019 -2.215 . . . . 71.2 105.019 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -112.68 121.0 43.47 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 119.174 -1.01 . . . . 55.34 110.015 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.64 119.27 38.11 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.572 -1.64 . . . . 73.53 106.572 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.465 ' HB2' HG22 ' A' ' 422' ' ' THR . 14.3 pm0 -107.04 122.37 46.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.927 -0.768 . . . . 75.35 108.927 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.445 ' HE3' ' OD1' ' A' ' 419' ' ' ASN . 17.6 ptpt -121.15 116.97 30.87 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 113.12 0.785 . . . . 74.44 113.12 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.3 Cg_exo -83.53 140.24 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.445 2.097 . . . . 70.22 109.205 168.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 175.18 -166.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.136 -2.542 . . . . 31.02 104.136 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 15.1 m -132.67 -4.03 3.28 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 118.907 0.776 . . . . 43.22 109.982 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.1 m -106.49 38.03 2.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.204 -2.147 . . . . 53.44 105.204 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.55 HG23 ' HB3' ' A' ' 391' ' ' ASP . 16.3 pt -87.1 151.16 51.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 113.176 -1.829 . . . . 72.54 113.078 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.07 137.33 34.31 Favored 'Trans proline' 0 N--CA 1.429 -2.306 0 N-CA-C 105.974 -2.356 . . . . 65.23 105.974 165.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.66 160.69 11.27 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.332 2.021 . . . . 64.45 111.787 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.67 -8.52 2.06 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.947 0.879 . . . . 75.12 111.722 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.0 m170 -103.45 111.05 23.31 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.778 -2.675 . . . . 74.43 103.778 171.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.52 119.34 6.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.962 0.887 . . . . 73.11 112.426 -166.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.4 -27.84 4.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.958 0 CA-C-N 114.528 -1.215 . . . . 73.22 112.14 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.48 27.31 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.65 -0.98 . . . . 72.05 110.65 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.5 p -114.69 -178.0 3.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.639 0.733 . . . . 52.13 112.375 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -104.18 136.48 19.18 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 107.437 -1.32 . . . . 73.53 107.437 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -48.91 -25.37 8.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.155 3.236 . . . . 73.31 115.327 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.96 -36.04 69.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.471 0.309 . . . . 75.21 110.976 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.94 83.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 74.11 110.769 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.45 -11.4 58.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.296 -0.865 . . . . 63.44 110.953 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.1 m -93.62 155.25 17.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.143 -1.058 . . . . 74.34 108.143 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 9.7 p -74.5 114.51 12.98 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 121.543 0.687 . . . . 74.02 110.154 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.1 m -123.87 169.23 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.333 -0.849 . . . . 72.42 109.574 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 65.6 m -62.41 149.34 42.79 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.978 0.418 . . . . 74.4 111.499 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.68 112.04 3.98 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.156 -1.053 . . . . 71.21 108.156 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.45 25.54 13.65 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.346 -0.931 . . . . 23.11 112.091 -177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.73 -173.88 4.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.379 -0.971 . . . . 63.41 108.379 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.0 pt-20 -108.72 132.87 53.52 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.472 0.653 . . . . 64.44 112.435 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 47.7 mm -119.86 131.48 72.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.221 -1.029 . . . . 74.3 108.221 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.3 t -89.45 131.35 35.55 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.379 0.609 . . . . 64.31 109.999 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.15 134.67 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 109.268 -0.641 . . . . 73.21 109.268 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.445 ' OD1' ' HE3' ' A' ' 389' ' ' LYS . 41.6 m-80 -103.6 129.8 50.93 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.161 -0.472 . . . . 74.34 111.655 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.8 p -134.29 142.09 41.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.13 -1.063 . . . . 75.43 108.13 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 12.9 p -101.72 123.12 45.18 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.338 -0.545 . . . . 62.01 111.761 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 388' ' ' GLN . 9.3 t -120.14 107.01 12.51 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.423 -0.511 . . . . 73.43 111.546 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.89 142.61 6.59 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.714 -0.755 . . . . 61.11 114.342 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.5 Cg_endo -87.92 133.47 3.0 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.295 1.997 . . . . 75.3 111.625 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.458 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 8.7 mm-40 -72.83 134.05 44.72 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 122.211 -0.305 . . . . 72.11 110.537 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HB3' HG22 ' A' ' 477' ' ' THR . 47.2 mt-30 -123.27 134.01 54.12 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.776 -0.824 . . . . 61.15 108.776 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -131.99 150.94 52.02 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.893 -1.151 . . . . 74.12 107.893 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 1.5 pm0 -82.33 138.95 34.38 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.403 -0.962 . . . . 75.12 108.403 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.9 mt -82.35 117.24 67.73 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.7 -0.852 . . . . 70.23 108.7 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.55 140.24 39.26 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.303 1.335 . . . . 72.5 110.884 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.46 84.37 5.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.333 1.063 . . . . 64.42 112.282 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.65 -5.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 113.645 -1.616 . . . . 63.2 106.726 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.7 m -62.74 -43.14 99.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.727 -1.579 . . . . 63.43 111.498 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.3 m -58.55 -21.31 52.19 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 122.957 0.503 . . . . 74.32 111.733 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.68 -48.08 64.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 122.289 -0.257 . . . . 62.52 110.59 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.1 t 178.45 161.85 0.66 Allowed 'General case' 0 C--O 1.249 1.054 0 N-CA-C 108.748 -0.834 . . . . 71.41 108.748 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -57.75 -42.65 84.39 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.987 0.915 . . . . 75.2 111.998 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.25 81.41 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.885 0.328 . . . . 61.44 111.885 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.78 -38.88 92.76 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.246 -0.434 . . . . 63.41 110.645 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -51.09 71.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.301 -0.863 . . . . 73.3 110.238 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.27 -43.12 98.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.536 -0.756 . . . . 74.04 111.364 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -63.25 -49.37 74.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.247 0.462 . . . . 70.02 112.247 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -68.03 -41.3 82.35 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 113.099 0.777 . . . . 73.43 113.099 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 -41.04 90.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.678 -0.409 . . . . 55.14 112.044 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -66.39 -38.8 88.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.932 -0.396 . . . . 64.2 109.932 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.26 73.79 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.253 -0.43 . . . . 74.52 110.879 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.92 58.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.368 -0.378 . . . . 72.22 110.892 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.31 -20.34 9.67 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.865 -0.683 . . . . 54.15 113.97 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 105.68 1.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.37 . . . . 74.1 110.315 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.53 22.22 15.5 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 120.563 -0.827 . . . . 71.04 111.13 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.55 111.07 18.13 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.163 -1.051 . . . . 75.53 108.163 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.4 147.1 52.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.281 0.562 . . . . 75.42 111.26 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 8.1 tmtm? -138.67 123.45 18.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.768 -1.938 . . . . 72.45 105.768 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -98.53 135.47 40.02 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.612 -0.435 . . . . 62.13 111.072 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.01 148.48 50.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.506 -1.294 . . . . 53.25 107.506 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -129.25 130.34 46.12 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.788 -0.819 . . . . 51.4 108.788 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 36.9 p -130.93 143.93 51.42 Favored Pre-proline 0 C--N 1.291 -1.964 0 C-N-CA 120.463 -0.495 . . . . 62.02 110.888 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_exo -63.71 122.87 11.12 Favored 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.622 2.215 . . . . 72.25 110.281 175.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.8 m -130.06 162.63 28.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.495 -0.321 . . . . 73.42 111.203 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.4 m -60.26 142.65 89.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.638 1.175 . . . . 74.42 108.782 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.561 ' O ' HG22 ' A' ' 464' ' ' VAL . 90.9 Cg_exo -49.25 -24.06 7.72 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.108 3.205 . . . . 75.35 114.498 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.19 -19.21 64.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 111.886 0.328 . . . . 75.42 111.886 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.33 -11.45 12.55 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.841 0.682 . . . . 64.3 112.841 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 461' ' ' PRO . 22.4 m -59.93 134.71 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 112.672 0.619 . . . . 65.45 112.672 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.12 74.44 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.348 -0.842 . . . . 74.22 111.189 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -119.9 165.19 14.95 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-O 121.252 0.549 . . . . 74.12 109.646 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 92.6 t -84.02 134.96 25.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.767 -1.198 . . . . 74.34 107.767 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.71 -12.0 8.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 119.863 -0.735 . . . . 75.23 110.952 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.25 169.96 20.3 Favored Glycine 0 N--CA 1.414 -2.805 0 CA-C-N 115.346 -0.843 . . . . 71.43 111.263 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -116.62 150.63 37.77 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.136 -1.061 . . . . 72.02 108.136 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.3 t30 -64.12 -47.4 79.37 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.537 -0.465 . . . . 52.25 109.924 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 10.4 Cg_exo -76.23 117.29 4.59 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 107.6 -1.731 . . . . 65.52 107.6 167.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.74 144.18 88.43 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.082 1.855 . . . . 63.01 113.037 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.41 12.94 3.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.166 0.984 . . . . 71.23 110.394 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -109.18 1.58 20.4 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.967 -1.015 . . . . 62.23 108.619 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -125.17 159.39 31.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.629 0.728 . . . . 74.12 111.174 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -93.6 115.77 28.26 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.358 -1.292 . . . . 74.25 108.822 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.1 m -116.02 148.54 40.05 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.965 -0.383 . . . . 72.51 109.965 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.51 152.24 46.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.449 0.3 . . . . 63.22 111.203 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 46.1 mm -62.83 -26.21 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 121.315 0.578 . . . . 71.31 111.961 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 13.0 t -96.28 5.03 51.86 Favored 'General case' 0 C--O 1.241 0.658 0 O-C-N 122.01 -0.431 . . . . 75.34 110.467 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -74.2 129.73 38.39 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.996 -1.113 . . . . 63.53 107.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 113.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.765 -0.828 . . . . 73.11 108.765 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.33 120.02 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.567 -0.742 . . . . 72.33 109.855 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 66.8 mt -91.54 112.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.895 -1.52 . . . . 64.42 106.895 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 120.4 53.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 107.937 -1.134 . . . . 55.12 107.937 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 24.0 mt -105.2 118.82 53.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.088 0.47 . . . . 75.31 110.111 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.08 134.92 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 115.79 -0.641 . . . . 73.43 109.339 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.64 106.23 3.09 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.516 -1.034 . . . . 64.04 110.516 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -122.07 119.11 30.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.925 -0.769 . . . . 53.15 108.925 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 CA-C-O 118.009 -1.44 . . . . 54.22 109.764 -177.282 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.465 0 N-CA-C 109.345 -1.502 . . . . 43.05 109.345 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.29 136.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.18 0.991 . . . . 73.33 111.847 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.5 m -131.85 -173.62 3.19 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 104.154 -2.536 . . . . 51.34 104.154 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -78.62 62.52 3.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.834 1.197 . . . . 65.21 109.85 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.58 134.25 38.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.518 -1.674 . . . . 63.54 108.203 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.2 154.75 37.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 120.985 0.421 . . . . 75.15 110.875 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -95.25 139.03 32.15 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.857 -2.275 . . . . 74.23 104.857 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.2 130.86 32.82 Favored Pre-proline 0 C--N 1.283 -2.325 0 C-N-CA 119.072 -1.051 . . . . 54.31 109.367 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -41.03 125.65 2.36 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.847 3.031 . . . . 73.35 112.069 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.86 157.16 38.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.26 -1.336 . . . . 42.43 109.471 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.82 -0.24 9.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.612 -0.435 . . . . 62.41 110.973 -173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.4 ptp180 -54.91 131.05 43.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.547 0.689 . . . . 72.45 112.612 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 101.74 -1.29 52.39 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.359 -0.837 . . . . 65.32 111.146 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -118.42 -178.06 3.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.502 -0.555 . . . . 73.14 109.502 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 82.9 p -87.87 171.23 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.619 0.6 . . . . 54.01 112.619 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 8.7 p -63.89 -39.09 93.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.03 -0.532 . . . . 54.45 109.989 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.38 87.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.593 -0.73 . . . . 74.42 110.033 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.83 -44.07 90.83 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 123.209 0.318 . . . . 31.33 111.533 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.98 -51.18 67.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.866 0.365 . . . . 73.04 111.099 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 378' ' ' GLN . 1.8 mp -68.32 -46.28 81.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.139 -0.482 . . . . 64.43 111.71 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.42 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.622 0.601 . . . . 61.45 112.622 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.545 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 22.9 m -66.94 -48.29 69.05 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.629 -0.429 . . . . 74.42 110.44 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.98 -37.47 87.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.091 -0.504 . . . . 73.33 112.209 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 374' ' ' ILE . 40.1 tp60 -59.21 -47.65 84.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.446 -0.946 . . . . 74.41 108.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.01 -28.13 67.15 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.161 -0.927 . . . . 63.15 112.486 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 376' ' ' THR . 10.6 mpt_? -84.47 -8.81 58.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.818 0.342 . . . . 74.42 111.051 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 88.81 16.78 57.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.212 -0.994 . . . . 73.13 113.232 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -80.2 156.12 27.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.108 0.48 . . . . 53.04 110.323 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 31.5 mmmt -90.32 132.9 35.31 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.614 -1.625 . . . . 72.42 106.614 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.53 134.73 63.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 121.541 0.686 . . . . 71.51 112.086 -177.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -112.35 127.9 56.14 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.858 -1.534 . . . . 74.43 106.858 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.3 m -117.67 121.16 40.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.328 -0.619 . . . . 73.23 109.328 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.21 119.25 37.71 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.399 -1.704 . . . . 74.14 106.399 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 14.6 pm0 -101.54 131.22 47.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.621 -0.881 . . . . 62.3 108.621 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.9 122.06 15.11 Favored Pre-proline 0 C--N 1.287 -2.132 0 CA-C-N 116.277 -0.419 . . . . 54.21 111.775 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 425' ' ' GLU . 6.0 Cg_exo -81.41 132.4 7.99 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.959 1.772 . . . . 74.41 107.78 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 15.1 t70 -159.46 -162.26 1.02 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.548 -1.278 . . . . 64.41 107.548 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 67.3 m -145.14 1.58 0.97 Allowed 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 119.392 0.996 . . . . 64.11 112.789 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -131.12 22.12 4.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 122.609 1.195 . . . . 75.43 108.206 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 391' ' ' ASP . 1.9 pp -88.91 152.47 48.59 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 113.625 -1.625 . . . . 41.21 112.996 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.51 157.18 53.27 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.791 1.661 . . . . 41.42 109.236 170.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.11 160.54 41.34 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 122.294 1.996 . . . . 72.34 111.104 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.537 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.6 p30 -60.4 -9.69 3.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.517 0.675 . . . . 75.14 111.943 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -84.53 111.06 19.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.456 -2.424 . . . . 50.41 104.456 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.18 118.52 4.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 122.07 0.938 . . . . 75.0 112.704 -167.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.3 tp -98.1 -31.1 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 74.03 109.386 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.98 156.77 27.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 108.894 -1.682 . . . . 54.22 108.894 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 22.2 p -114.5 -175.72 2.75 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 123.307 0.643 . . . . 60.41 111.306 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -99.58 137.84 20.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 106.464 -1.68 . . . . 74.21 106.464 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -42.97 -30.75 1.98 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.418 3.412 . . . . 55.43 114.64 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -38.3 64.62 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.931 0.492 . . . . 74.34 111.432 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.99 -27.87 62.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.729 0.776 . . . . 74.0 111.153 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.23 -8.06 49.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.817 -0.629 . . . . 74.32 110.665 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.6 m -92.54 156.53 17.07 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.947 -0.761 . . . . 63.33 108.947 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.1 m -74.15 112.79 10.64 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.606 -1.257 . . . . 74.33 107.606 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.28 170.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.932 -0.576 . . . . 73.11 109.749 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -83.96 140.07 32.15 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.404 -1.332 . . . . 61.43 107.404 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.1 2.14 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.135 0.493 . . . . 75.03 110.184 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.29 21.38 6.61 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.596 -0.812 . . . . 63.25 111.751 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -85.94 -171.33 3.53 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.474 -1.306 . . . . 61.01 107.474 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.9 pt-20 -107.91 138.87 43.4 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 118.831 0.741 . . . . 72.44 111.895 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.6 122.68 67.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.743 -1.206 . . . . 53.33 107.743 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -96.19 119.39 34.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.039 0.923 . . . . 73.53 110.249 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.72 126.66 68.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.053 -0.976 . . . . 71.42 109.33 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.7 128.87 44.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.437 -0.949 . . . . 61.52 108.437 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 397' ' ' ASP . 78.0 t -121.73 130.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.382 -0.969 . . . . 73.03 108.382 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 122.91 37.99 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.776 -0.453 . . . . 75.13 109.776 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.5 t -117.16 105.28 12.08 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.84 0.829 . . . . 73.32 110.981 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 60.99 178.69 2.39 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.983 -1.008 . . . . 74.24 115.136 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 10.1 Cg_endo -90.82 131.93 1.58 Allowed 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.038 2.492 . . . . 73.23 111.757 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.4 tp10 -72.87 151.59 41.89 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.754 -0.462 . . . . 74.12 109.754 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.5 mt-30 -123.78 150.88 43.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.477 -0.783 . . . . 72.42 110.359 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 427' ' ' ARG . 26.1 tpt180 -150.33 153.95 36.98 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.403 -1.332 . . . . 74.23 107.403 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.55 138.88 34.13 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.348 -0.982 . . . . 73.2 108.348 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 71.4 mt -80.43 124.32 82.37 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.608 -0.886 . . . . 71.32 108.608 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.86 140.06 59.55 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.069 1.179 . . . . 65.0 110.697 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.72 82.12 2.76 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 122.232 1.015 . . . . 65.32 111.94 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.86 1.43 6.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.197 -1.779 . . . . 44.33 106.197 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.0 m -67.8 -53.49 26.61 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 113.094 -1.866 . . . . 73.42 110.301 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 24.5 p -64.73 -19.12 65.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.431 0.9 . . . . 73.32 113.431 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.95 -38.21 13.01 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.711 1.004 . . . . 63.04 113.711 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 90.4 m -157.32 135.08 10.75 Favored 'General case' 0 CA--C 1.554 1.11 0 O-C-N 121.911 -0.493 . . . . 71.32 110.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -65.09 -47.28 77.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.543 0.737 . . . . 75.45 112.671 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.51 87.47 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.515 0.674 . . . . 63.02 110.865 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.54 -40.6 95.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.75 -1.114 . . . . 63.15 108.813 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.83 -51.67 68.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.784 -1.098 . . . . 65.43 111.705 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.72 -38.55 82.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.515 0.931 . . . . 61.25 113.515 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -66.53 -50.71 62.29 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 119.113 -1.035 . . . . 70.41 110.144 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.313 85.4 mttt -68.62 -39.73 80.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 115.58 1.696 . . . . 72.23 115.58 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.64 -43.38 89.65 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.745 -0.382 . . . . 52.1 111.795 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.1 m -69.24 -38.28 78.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.824 -0.35 . . . . 71.33 111.853 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.1 71.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.818 0.342 . . . . 75.52 110.698 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.08 59.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 72.44 111.034 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.39 -19.98 7.07 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.688 -0.767 . . . . 64.23 113.442 176.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -78.86 101.26 7.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.364 0.602 . . . . 74.12 111.0 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -119.99 17.47 9.96 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.013 -0.835 . . . . 73.43 111.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -107.57 111.16 23.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.791 -1.559 . . . . 74.51 106.791 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.39 160.25 34.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.145 0.794 . . . . 75.52 113.145 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 23.6 ttmm -151.91 127.39 10.02 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.715 -1.957 . . . . 73.33 105.715 170.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.72 134.92 39.38 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 120.67 0.271 . . . . 70.31 110.304 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.02 156.28 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.717 -0.475 . . . . 65.2 109.717 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -123.16 132.35 54.03 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.253 -0.647 . . . . 70.11 109.253 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.0 t -119.25 137.12 24.93 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.749 -0.834 . . . . 71.23 108.749 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.4 Cg_exo -61.56 119.78 7.08 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.061 1.841 . . . . 75.51 109.102 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.8 m -138.74 -178.46 5.32 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.066 -0.716 . . . . 71.0 109.066 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.8 m -58.95 131.44 86.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.361 -0.977 . . . . 75.15 108.361 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.9 -34.1 35.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.832 3.021 . . . . 73.31 114.538 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.71 -14.71 61.19 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 122.687 0.395 . . . . 72.32 112.006 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.39 7.58 45.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.204 -0.453 . . . . 71.05 110.769 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -59.49 125.93 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.781 0.8 . . . . 70.42 111.645 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.65 -5.01 79.86 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.882 -0.599 . . . . 70.11 112.427 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -102.77 145.59 29.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.093 -1.077 . . . . 74.34 108.093 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 54.4 t -83.89 129.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.721 -0.474 . . . . 75.01 109.721 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.94 -19.68 5.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.582 -0.447 . . . . 64.31 111.449 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.6 174.23 41.16 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.634 -0.986 . . . . 62.54 110.634 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -130.93 155.07 47.39 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.696 -0.853 . . . . 72.14 108.696 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -61.2 -53.43 63.22 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 120.795 -0.362 . . . . 65.04 110.854 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.1 Cg_exo -82.6 119.34 2.97 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 107.38 -1.815 . . . . 74.53 107.38 168.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.94 147.77 94.22 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.532 2.154 . . . . 72.52 113.848 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.65 2.92 20.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.473 -0.785 . . . . 74.33 112.524 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.7 -3.09 17.02 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.813 -0.554 . . . . 71.32 109.614 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -108.46 151.73 25.66 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.191 0.996 . . . . 73.31 112.201 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 426' ' ' GLN . 26.6 m -84.24 114.01 21.52 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.625 -1.625 . . . . 70.02 108.668 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.2 m -120.42 150.13 41.28 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.506 0.722 . . . . 74.33 109.424 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.07 147.22 45.2 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.4 -0.592 . . . . 73.1 109.4 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.9 mp -66.27 -11.68 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 122.246 1.022 . . . . 71.43 110.317 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 6.4 t -98.45 -0.66 43.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.279 -0.873 . . . . 51.32 109.379 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -78.61 142.19 37.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.63 -0.507 . . . . 64.25 109.63 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.05 113.52 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.263 -1.014 . . . . 35.41 108.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.0 t -87.81 118.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 108.606 -0.887 . . . . 72.51 108.606 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.4 mt -92.7 112.54 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 106.791 -1.559 . . . . 45.31 106.791 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -93.61 107.62 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 107.374 -1.343 . . . . 74.43 107.374 -177.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.4 113.99 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 115.11 -0.95 . . . . 72.24 110.123 -174.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.32 138.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 114.959 -1.018 . . . . 65.12 108.335 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.09 130.64 11.06 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 110.254 -1.139 . . . . 32.44 110.254 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 26.6 m -140.78 120.07 13.0 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.293 -0.632 . . . . 74.0 109.293 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 107.807 -2.117 . . . . 42.3 107.807 178.68 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.28 0 N-CA-C 110.221 -1.151 . . . . 43.05 110.221 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.58 144.5 29.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 112.842 0.682 . . . . 73.34 112.842 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.3 m -132.04 143.23 49.9 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.605 -1.628 . . . . 72.41 106.605 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -77.52 86.03 3.87 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 122.038 0.923 . . . . 63.52 111.408 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -106.22 140.22 39.51 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.515 -1.661 . . . . 54.33 106.515 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.64 159.73 37.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 120.794 0.33 . . . . 74.11 111.132 -174.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -94.88 137.35 34.07 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.053 -1.091 . . . . 72.54 108.053 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.35 141.3 22.82 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.277 -0.638 . . . . 74.41 109.277 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.59 123.83 4.96 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 123.456 2.771 . . . . 71.32 113.699 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.536 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 21.5 t70 -74.59 134.84 42.08 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.218 -1.355 . . . . 61.03 108.838 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 35.0 m -91.41 29.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.732 1.012 . . . . 73.14 113.732 -169.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 364' ' ' ASP . 35.2 ptt-85 -65.73 127.05 30.38 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.159 -0.473 . . . . 72.31 110.916 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.58 57.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.276 -0.964 . . . . 44.35 114.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 2.0 pt20 -120.97 169.66 10.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 117.491 0.646 . . . . 74.12 110.724 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 98.8 p -80.46 173.96 12.08 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.713 -0.395 . . . . 54.44 111.475 -174.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.4 p -63.0 -33.87 76.35 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.275 -0.42 . . . . 54.14 110.617 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.547 -0.297 . . . . 54.12 110.505 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -62.03 -41.65 98.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.382 -0.372 . . . . 64.33 110.832 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.426 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -58.62 -51.54 69.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 71.11 110.602 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.43 -42.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.1 -0.5 . . . . 73.14 110.898 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.05 -46.06 92.22 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 112.036 0.384 . . . . 74.42 112.036 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.7 m -61.92 -47.92 82.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.297 . . . . 52.2 110.916 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.3 mm? -65.42 -38.38 89.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.379 -0.373 . . . . 73.03 111.66 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -60.88 -48.49 81.56 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.57 0.748 . . . . 70.34 109.442 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.43 -25.31 63.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 74.53 111.203 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -78.53 -15.29 58.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.97 -0.752 . . . . 75.41 108.97 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.17 56.88 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.357 -0.925 . . . . 73.32 111.829 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 22.6 m-85 -89.7 160.66 16.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.979 0.419 . . . . 75.24 110.613 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 53.8 mtmt -105.02 132.76 50.85 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.678 -1.23 . . . . 73.14 107.678 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 141.33 43.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.328 0.585 . . . . 64.42 112.373 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -118.49 136.64 53.7 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.046 -1.464 . . . . 74.11 107.046 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 m -99.64 125.33 45.46 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.752 -0.833 . . . . 71.31 108.752 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.82 120.33 41.61 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.584 -1.265 . . . . 61.32 107.584 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.13 121.88 31.89 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.288 -0.414 . . . . 65.44 109.911 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -123.77 125.23 25.98 Favored Pre-proline 0 C--N 1.312 -1.028 0 C-N-CA 119.564 -0.854 . . . . 63.54 110.208 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -89.11 147.11 5.46 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.735 2.29 . . . . 73.51 111.306 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.4 t70 177.13 -168.37 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.233 -1.766 . . . . 63.25 106.233 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 50.2 m -143.25 -1.29 1.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.585 0.63 . . . . 74.04 111.429 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.0 m -82.93 -10.65 58.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.099 -1.445 . . . . 74.34 107.099 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 421' ' ' SER . 11.2 pt -104.74 151.61 39.35 Favored Pre-proline 0 N--CA 1.427 -1.624 0 CA-C-N 114.042 -1.435 . . . . 71.44 109.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -86.25 -176.51 2.12 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.708 2.272 . . . . 63.41 111.521 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.65 163.32 3.95 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.515 2.81 . . . . 54.15 112.737 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.442 ' HB2' ' CG2' ' A' ' 420' ' ' VAL . 4.4 p-10 -55.87 -7.93 0.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.374 1.47 . . . . 63.25 114.33 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.5 m80 -63.51 115.4 4.63 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.087 -1.819 . . . . 70.22 106.087 174.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 365' ' ' VAL . 21.3 t -64.88 118.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.778 0.799 . . . . 53.03 110.499 -172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.69 -29.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.041 -0.981 . . . . 74.11 109.91 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -171.57 160.58 32.6 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.43 -1.068 . . . . 24.33 110.43 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 -174.54 2.48 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.695 -1.224 . . . . 72.41 107.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.36 144.3 27.85 Favored Pre-proline 0 C--N 1.279 -2.474 0 N-CA-C 108.688 -0.856 . . . . 70.33 108.688 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.98 -29.05 1.41 Allowed 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 124.676 3.584 . . . . 61.51 114.413 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.09 68.58 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.543 0.337 . . . . 63.04 111.162 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.66 58.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 64.4 110.96 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.29 0.14 53.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.472 0.654 . . . . 75.14 110.943 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.1 m -92.79 157.3 16.49 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.66 -1.608 . . . . 61.33 106.66 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.26 112.39 10.37 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.054 -1.091 . . . . 53.24 108.054 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.51 169.4 18.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.202 -0.908 . . . . 71.53 109.334 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 18.0 m -74.33 133.79 42.54 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.661 -0.496 . . . . 61.23 109.661 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.69 134.89 54.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.309 -0.405 . . . . 71.03 110.405 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.29 24.22 32.11 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.879 -0.677 . . . . 63.43 112.499 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.56 179.76 4.74 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.867 -0.79 . . . . 65.25 108.867 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.4 mt-10 -94.21 123.7 37.77 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.162 0.506 . . . . 73.34 111.996 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.07 126.27 74.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.643 -1.244 . . . . 43.42 107.643 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -90.49 118.77 30.22 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.477 -0.934 . . . . 71.24 108.477 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.53 113.18 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.189 -1.041 . . . . 70.14 108.189 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -88.51 129.85 35.36 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.49 -0.929 . . . . 74.35 108.49 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 397' ' ' ASP . 12.4 p -123.5 146.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.163 -1.051 . . . . 55.35 108.163 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.512 ' HB3' HD12 ' A' ' 394' ' ' ILE . 3.5 p -84.59 119.71 25.52 Favored 'General case' 0 N--CA 1.411 -2.418 0 C-N-CA 119.372 -0.931 . . . . 71.1 108.79 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.8 m -121.8 106.69 11.52 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.968 -0.56 . . . . 71.21 110.916 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 84.99 129.35 2.01 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.649 -0.786 . . . . 64.33 114.183 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 52.3 Cg_endo -76.37 133.04 14.18 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 121.735 1.623 . . . . 53.41 109.536 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.31 137.15 46.47 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.475 0.655 . . . . 51.12 112.35 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 38.4 mt-30 -120.37 140.85 50.7 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.872 -1.058 . . . . 75.23 108.48 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.41 145.41 51.2 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.59 -1.263 . . . . 72.43 107.59 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 14.8 pt-20 -83.7 138.99 33.04 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.905 -0.718 . . . . 73.5 109.082 177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 80.8 mt -80.3 124.29 82.62 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.017 -1.105 . . . . 55.01 108.017 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.89 141.94 41.8 Favored 'Trans proline' 0 C--O 1.252 1.193 0 C-N-CA 122.164 1.909 . . . . 62.44 112.677 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -78.22 77.08 4.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.217 1.008 . . . . 63.53 109.414 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.25 -7.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.131 -1.395 . . . . 73.41 110.281 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 3.3 p -68.94 -31.93 71.16 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.854 -0.612 . . . . 71.14 111.116 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 1.2 p -62.26 -24.59 67.35 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 125.285 1.434 . . . . 74.4 113.18 -177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.64 -47.75 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 75.13 112.037 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.0 t -177.21 153.04 0.92 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.827 -0.805 . . . . 74.23 108.827 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -58.37 -38.66 77.73 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.823 0.849 . . . . 72.31 111.276 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.46 -47.99 78.02 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.554 0.534 . . . . 63.44 111.115 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 34.6 mm-40 -70.33 -38.31 74.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.196 -0.457 . . . . 73.33 111.178 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.27 -46.35 88.76 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.613 0.571 . . . . 54.14 110.763 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.46 -47.6 80.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.633 -0.427 . . . . 71.23 110.699 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 31.9 mmmt -63.46 -47.1 83.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.163 0.431 . . . . 73.12 112.163 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.9 mmtt -63.6 -45.51 90.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 71.14 110.578 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.14 -32.48 72.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.61 0.596 . . . . 64.0 112.61 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.7 m -66.25 -38.74 88.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.558 -0.534 . . . . 75.0 109.558 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.64 67.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.953 -0.567 . . . . 72.52 110.628 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.29 -13.55 59.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 63.51 110.63 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.62 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 120.227 -0.987 . . . . 50.12 113.743 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.44 132.97 47.18 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 117.705 0.753 . . . . 63.35 110.917 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.98 16.04 4.76 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.592 -0.813 . . . . 71.43 112.395 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 32.3 mmt180 -125.43 111.96 15.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.513 -1.292 . . . . 72.42 107.513 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.91 152.21 49.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.085 0.469 . . . . 75.14 111.118 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -146.05 123.26 11.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.989 -1.486 . . . . 71.22 106.989 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -91.27 134.81 34.27 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.241 -0.584 . . . . 50.02 110.31 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -129.78 145.67 51.55 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.217 -1.031 . . . . 64.34 108.217 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -118.7 139.08 52.11 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.088 -0.708 . . . . 53.2 109.088 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.7 m -132.39 136.21 27.62 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.717 -0.475 . . . . 72.12 109.717 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.61 120.99 8.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.875 2.383 . . . . 72.44 112.184 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 43.9 m -124.85 172.51 9.29 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.71 -0.677 . . . . 74.33 110.098 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.8 p -67.29 151.09 97.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 O-C-N 123.794 0.684 . . . . 53.44 109.972 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.544 ' O ' HG12 ' A' ' 464' ' ' VAL . 71.8 Cg_exo -53.51 -27.18 39.53 Favored 'Trans proline' 0 CA--C 1.55 1.281 0 C-N-CA 122.839 2.36 . . . . 74.23 113.422 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.18 -23.89 54.73 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.73 -0.606 . . . . 74.53 112.226 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 37.4 tp -107.41 -9.39 16.01 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.069 0.461 . . . . 62.52 110.505 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.3 p -59.44 133.57 24.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.793 -0.639 . . . . 73.14 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.52 -14.09 59.41 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.613 -0.803 . . . . 64.03 112.168 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.75 158.04 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.382 0.61 . . . . 54.52 110.563 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 87.7 t -84.28 137.5 20.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.71 -1.589 . . . . 71.51 106.71 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.74 -13.79 8.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.342 -0.943 . . . . 74.32 110.563 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.88 -173.6 29.57 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 109.952 -1.259 . . . . 63.3 109.952 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.2 p -116.3 151.37 35.99 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.39 -1.337 . . . . 63.42 107.39 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -59.37 -51.46 81.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.732 -0.47 . . . . 75.31 109.732 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.01 133.94 22.47 Favored 'Trans proline' 0 C--N 1.378 2.086 0 N-CA-C 108.59 -1.35 . . . . 74.23 108.59 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.48 150.54 86.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.752 2.301 . . . . 72.24 114.534 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.31 8.49 38.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.311 1.053 . . . . 41.24 110.948 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -109.04 3.4 22.04 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.307 -0.871 . . . . 53.55 109.975 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -141.77 159.54 42.01 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-O 121.807 0.813 . . . . 73.1 111.591 -172.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -76.68 133.97 39.38 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.608 -1.633 . . . . 65.24 111.411 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 38.4 m -131.52 149.31 52.57 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.653 -1.24 . . . . 72.25 107.653 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -78.61 153.33 31.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.927 0.785 . . . . 73.14 111.683 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 47.4 mm -69.28 -8.23 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 122.163 0.982 . . . . 71.34 110.624 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 8.9 t -105.44 1.25 27.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.712 -0.676 . . . . 53.33 109.692 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 9.1 m120 -87.05 147.49 25.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.816 -0.809 . . . . 74.14 108.816 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.54 121.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.244 -1.021 . . . . 61.31 108.244 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.4 t -91.89 118.97 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.903 -0.777 . . . . 63.43 108.903 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.99 113.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.183 -1.414 . . . . 70.11 107.183 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.52 119.92 48.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.949 -1.13 . . . . 71.11 107.949 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 48.2 mt -103.23 114.96 44.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.434 0.635 . . . . 63.35 110.86 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.32 131.23 45.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.909 -0.775 . . . . 72.54 108.909 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.0 100.4 1.87 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.279 -1.129 . . . . 73.31 110.279 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 30.7 t -136.71 103.98 5.38 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.765 -0.828 . . . . 74.31 108.765 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.533 0 N-CA-C 108.471 -1.851 . . . . 72.04 108.471 176.436 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.301 0 N-CA-C 110.412 -1.075 . . . . 43.05 110.412 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.31 152.87 37.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.981 0.39 . . . . 63.04 111.214 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 22.8 m -92.1 147.13 23.18 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.554 -1.276 . . . . 72.43 107.554 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.11 74.52 4.69 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 108.475 -0.935 . . . . 74.42 108.475 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.74 137.86 32.09 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-N 113.914 -1.493 . . . . 71.42 110.637 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.07 139.91 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.17 -0.923 . . . . 75.15 108.955 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.56 137.16 36.91 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.468 -1.679 . . . . 73.43 106.468 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 363' ' ' PRO . 14.8 p -96.99 124.26 50.42 Favored Pre-proline 0 C--N 1.294 -1.838 0 C-N-CA 119.757 -0.777 . . . . 63.22 111.446 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 362' ' ' VAL . 1.5 Cg_endo -44.87 146.31 2.46 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.814 3.676 . . . . 74.3 115.681 -175.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -71.16 144.96 50.02 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.929 -1.032 . . . . 62.13 110.138 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -108.08 29.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.218 -1.401 . . . . 63.34 107.218 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -58.85 135.41 57.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.176 -1.375 . . . . 73.11 111.398 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 94.84 -15.35 63.57 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.97 -0.559 . . . . 65.23 112.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -107.19 175.26 5.56 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.588 -0.36 . . . . 73.32 110.724 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.6 p -75.57 158.12 32.93 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.825 0.345 . . . . 71.45 111.771 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 374' ' ' ILE . 44.6 t -63.25 -36.12 82.59 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.812 -0.81 . . . . 63.32 108.812 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.66 94.01 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 115.638 -0.71 . . . . 65.43 111.209 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.35 -41.38 98.55 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.127 -0.488 . . . . 73.51 109.89 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.43 83.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.461 -0.791 . . . . 63.4 110.934 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.36 -47.02 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.375 . . . . 54.22 110.301 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.95 79.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.969 -0.56 . . . . 43.23 111.855 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.7 m -62.72 -46.33 88.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.427 -0.352 . . . . 64.31 111.912 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -38.43 91.0 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.173 -0.211 . . . . 55.33 111.184 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.43 -47.2 86.38 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.922 0.889 . . . . 71.51 109.138 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.41 -20.16 62.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.129 -0.941 . . . . 73.31 111.706 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -86.79 -15.44 39.28 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.268 -0.641 . . . . 64.33 109.268 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.49 5.0 57.06 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.487 -0.863 . . . . 74.24 111.446 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -90.47 158.59 16.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.158 0.504 . . . . 74.32 110.479 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 22.6 mmtp -106.05 138.55 42.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.757 -1.571 . . . . 62.22 106.757 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.87 147.45 21.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 119.676 -0.81 . . . . 71.54 112.964 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 417' ' ' THR . 21.6 ttt180 -116.95 130.09 56.47 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.842 -1.54 . . . . 75.4 106.842 174.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.7 p -98.6 117.73 33.7 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 119.978 -0.689 . . . . 74.03 109.415 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -114.74 119.78 37.84 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.341 -1.355 . . . . 74.03 107.341 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 11.9 pm0 -112.81 126.14 55.11 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.722 -0.844 . . . . 74.42 108.722 176.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -122.42 133.65 24.5 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 120.257 -0.577 . . . . 73.11 111.033 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.19 140.32 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.091 2.527 . . . . 65.41 110.708 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.4 t70 179.75 -166.48 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.575 -1.269 . . . . 73.3 107.575 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 70.9 m -119.66 -11.15 9.46 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.422 0.63 . . . . 71.52 109.592 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -95.25 27.03 3.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.425 1.107 . . . . 73.45 108.234 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.4 pp -97.4 141.03 22.4 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 115.254 -0.884 . . . . 61.33 113.375 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.91 -179.99 4.4 Favored 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 123.239 2.626 . . . . 74.34 110.794 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.65 163.08 9.44 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.522 2.815 . . . . 72.02 112.563 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.14 -8.79 0.75 Allowed 'General case' 0 N--CA 1.522 3.149 0 C-N-CA 124.441 1.096 . . . . 71.53 112.25 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -83.75 157.12 22.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.657 -0.868 . . . . 74.15 108.657 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.26 116.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 N-CA-C 105.414 -2.069 . . . . 64.43 105.414 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.8 tt -89.99 -29.22 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 122.342 1.068 . . . . 72.43 109.036 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.57 170.59 38.18 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 104.623 -3.391 . . . . 54.21 104.623 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -176.26 2.87 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 107.249 -1.389 . . . . 74.52 107.249 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.78 145.7 30.59 Favored Pre-proline 0 C--N 1.253 -3.623 0 N-CA-C 107.93 -1.137 . . . . 74.42 107.93 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.04 -36.03 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.879 3.719 . . . . 41.05 114.047 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.63 -37.07 65.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.127 0.571 . . . . 64.03 111.701 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.64 -28.98 30.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.435 0.636 . . . . 71.24 110.496 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -83.73 -8.02 59.35 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.203 -0.908 . . . . 73.14 110.754 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 59.1 m -91.58 140.59 29.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.571 -1.27 . . . . 64.15 107.571 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 36.4 m -76.73 112.49 13.36 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.359 -0.978 . . . . 71.33 108.359 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.25 169.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.138 -0.937 . . . . 74.02 109.828 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 m -65.65 152.96 42.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.458 -0.942 . . . . 73.11 108.458 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.02 109.16 0.89 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.141 0.496 . . . . 75.13 111.293 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.16 1.27 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 115.596 -0.729 . . . . 73.53 111.78 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -134.96 -169.53 2.38 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.352 -1.721 . . . . 73.43 106.352 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 12.4 pt-20 -95.04 132.9 39.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.989 0.813 . . . . 74.33 111.617 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.97 119.4 61.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.576 -1.268 . . . . 72.44 107.576 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 385' ' ' ARG . 40.2 p -87.31 119.19 27.31 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.333 0.587 . . . . 73.23 109.849 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.99 121.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.161 -1.422 . . . . 75.34 107.161 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 7.9 p30 -107.95 125.78 51.91 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.446 0.641 . . . . 62.43 111.891 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 11.3 p -120.28 151.47 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.908 -1.042 . . . . 63.42 108.41 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.2 p -91.55 123.49 35.0 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 111.862 0.319 . . . . 64.31 111.862 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.9 t -119.04 106.13 12.11 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.806 -0.758 . . . . 75.53 111.667 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 66.29 161.23 0.98 Allowed Glycine 0 CA--C 1.552 2.401 0 N-CA-C 115.912 1.125 . . . . 71.42 115.912 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.2 Cg_endo -94.36 139.71 1.24 Allowed 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 122.708 2.272 . . . . 63.4 112.311 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 8.0 mm-40 -78.61 142.26 37.4 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.094 0.473 . . . . 73.13 111.735 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.6 mt-30 -122.54 147.14 46.73 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.243 -0.89 . . . . 72.01 108.636 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -135.44 163.73 29.39 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.523 -0.917 . . . . 73.44 108.523 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.63 135.7 33.86 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.856 -0.338 . . . . 74.23 110.592 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -80.83 119.29 75.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.068 -0.716 . . . . 61.45 109.068 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 444' ' ' LEU . 70.6 Cg_exo -56.05 141.17 87.12 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.94 2.427 . . . . 72.05 112.16 176.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -88.01 10.77 17.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 62.13 111.526 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.21 -5.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.275 0.559 . . . . 63.21 110.279 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -58.86 -40.71 85.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.01 -0.996 . . . . 75.41 110.932 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.493 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 0.6 OUTLIER -68.58 -16.95 64.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.812 0.845 . . . . 72.42 112.381 -179.003 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.26 -34.91 14.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.801 -0.636 . . . . 73.34 111.75 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 83.9 m -153.85 133.2 12.73 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.953 -0.467 . . . . 70.55 110.645 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.99 -41.63 97.44 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.074 0.55 . . . . 64.2 110.365 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 65.13 110.626 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.66 -40.83 97.82 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 116.094 -0.503 . . . . 73.33 110.948 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.67 -51.15 70.61 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 123.56 0.538 . . . . 72.33 110.217 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.33 -50.36 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.481 -0.488 . . . . 32.24 112.033 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.94 -47.97 67.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.625 0.602 . . . . 73.14 112.625 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -67.14 -38.49 85.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.011 0.374 . . . . 71.14 112.011 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.2 mp -67.89 -36.15 79.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.599 -0.44 . . . . 51.41 111.271 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.0 m -64.91 -39.2 93.16 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.309 -0.626 . . . . 73.54 109.309 176.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.57 71.07 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.97 -0.559 . . . . 72.3 110.788 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.47 -13.18 59.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 61.32 110.666 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.48 -20.63 8.29 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.425 -0.893 . . . . 42.2 113.561 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 445' ' ' THR . 98.1 m-85 -66.86 135.32 53.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 117.485 0.642 . . . . 63.31 111.369 -175.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.55 12.22 4.59 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 110.926 -0.87 . . . . 64.12 110.926 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -114.48 111.45 21.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.453 -1.314 . . . . 74.43 107.453 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.7 152.12 50.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.659 0.266 . . . . 74.21 110.72 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.45 124.22 14.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.151 -1.055 . . . . 64.02 108.151 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.93 127.11 33.63 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 110.188 -0.301 . . . . 72.13 110.188 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.61 158.12 44.02 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.612 -0.884 . . . . 62.44 108.612 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -125.14 150.31 47.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.794 0.331 . . . . 70.42 110.593 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 30.6 t -137.48 133.19 17.97 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 107.88 -1.156 . . . . 65.25 107.88 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.04 127.6 21.75 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.514 2.143 . . . . 71.12 109.599 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.6 m -148.26 174.74 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 122.118 -0.364 . . . . 71.13 111.277 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 463' ' ' LEU . 3.3 m -56.31 132.36 75.89 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.703 0.801 . . . . 62.0 110.102 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.523 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -48.79 -31.73 20.33 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.056 3.171 . . . . 52.21 114.861 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -18.55 65.41 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.24 0.543 . . . . 74.4 111.264 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 6.6 mp -106.93 6.04 28.85 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.074 -0.512 . . . . 75.32 111.508 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.6 p -60.41 126.98 19.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.258 0.552 . . . . 64.53 110.989 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.81 0.36 83.79 Favored Glycine 0 C--N 1.309 -0.94 0 CA-C-N 115.83 -0.623 . . . . 62.14 111.934 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 89.0 mttt -112.52 159.14 19.1 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.921 -1.14 . . . . 73.21 107.921 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 57.3 t -83.99 132.71 30.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.564 -0.532 . . . . 74.33 109.564 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -98.59 -16.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.222 -0.591 . . . . 70.32 111.402 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.81 174.08 37.79 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.653 -0.703 . . . . 35.42 111.704 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.7 p -124.06 149.69 45.83 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.444 -0.947 . . . . 54.12 108.444 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.6 t-20 -62.48 -51.96 69.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 120.561 -0.456 . . . . 74.02 110.921 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 11.2 Cg_exo -73.62 133.84 19.42 Favored 'Trans proline' 0 C--N 1.377 2.059 0 N-CA-C 108.304 -1.46 . . . . 73.32 108.304 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 475' ' ' ASN . 40.4 Cg_endo -65.35 130.73 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.377 2.052 . . . . 75.33 113.216 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.58 17.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.531 1.157 . . . . 44.31 109.714 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 473' ' ' PRO . 62.0 m-20 -108.6 -10.11 15.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.383 -1.281 . . . . 73.44 108.462 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -140.82 164.83 29.18 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-O 121.734 0.778 . . . . 63.34 111.368 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.7 m -84.45 124.89 31.84 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.182 -1.372 . . . . 64.42 109.431 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.2 m -125.62 149.46 48.38 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.373 -0.603 . . . . 75.31 109.373 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.66 146.74 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.537 0.208 . . . . 63.13 111.156 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.58 -22.09 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 121.755 0.788 . . . . 73.14 110.9 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 11.1 t -87.71 0.89 55.1 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.509 -0.768 . . . . 74.41 110.294 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -85.01 131.11 34.51 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.389 -0.967 . . . . 64.54 108.389 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.46 119.06 28.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.66 -0.867 . . . . 75.21 108.66 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.15 118.22 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.49 0 N-CA-C 108.115 -1.069 . . . . 72.03 108.115 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.83 112.75 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 106.341 -1.725 . . . . 75.42 106.341 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.89 119.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 108.54 -0.911 . . . . 74.25 108.54 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 23.2 mt -101.18 109.3 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 108.94 -0.763 . . . . 73.43 108.94 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 36.3 t -97.92 137.77 24.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.462 -0.79 . . . . 73.45 109.958 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -74.84 95.76 0.92 Allowed Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.488 -0.778 . . . . 61.01 111.212 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 38.1 m -142.88 112.84 7.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.775 -0.824 . . . . 74.53 108.775 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.012 0 N-CA-C 110.75 -0.94 . . . . 51.22 110.75 179.254 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.529 0 N-CA-C 110.138 -1.185 . . . . 43.05 110.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.13 141.63 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.371 -0.974 . . . . 73.15 108.371 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 12.4 m -101.56 138.94 37.9 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 120.983 0.42 . . . . 75.53 110.095 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -98.8 81.78 2.7 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.794 -1.558 . . . . 73.45 106.794 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.95 134.12 35.08 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 113.221 -1.809 . . . . 75.53 111.963 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.02 144.01 35.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.844 -1.071 . . . . 73.43 108.9 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -96.42 137.43 35.5 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.402 -1.703 . . . . 65.22 106.402 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.7 p -98.14 127.31 37.09 Favored Pre-proline 0 C--N 1.29 -1.989 0 C-N-CA 119.097 -1.041 . . . . 51.2 110.004 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.68 143.53 79.36 Favored 'Trans proline' 0 C--O 1.244 0.789 0 C-N-CA 123.031 2.487 . . . . 73.0 112.7 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -68.95 127.01 31.62 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.599 -0.728 . . . . 73.4 110.0 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 26.7 m -81.83 5.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.911 -0.586 . . . . 63.11 112.11 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -61.1 142.97 56.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.912 -0.585 . . . . 70.43 111.761 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.31 -9.78 53.92 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.884 -0.598 . . . . 54.32 111.868 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -119.38 -173.69 2.57 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.354 -0.61 . . . . 65.14 109.354 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 94.7 p -86.98 162.16 17.81 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 119.637 -0.825 . . . . 73.23 109.317 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.452 ' O ' HG13 ' A' ' 374' ' ' ILE . 74.1 p -61.93 -33.23 73.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.986 0.422 . . . . 63.14 110.065 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.67 97.45 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.878 -0.601 . . . . 73.31 110.862 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -62.31 -42.7 99.58 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.093 0.473 . . . . 73.32 109.817 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.42 77.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.89 -1.05 . . . . 64.13 110.734 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.6 -47.26 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 75.33 110.477 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.44 78.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.271 -0.422 . . . . 73.32 111.937 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.7 m -61.55 -48.59 80.31 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.137 0.494 . . . . 70.13 110.635 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 74.6 mt -65.74 -38.19 88.46 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 62.43 111.739 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -61.05 -43.53 98.74 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.565 -0.531 . . . . 75.22 109.565 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -62.78 -34.67 77.75 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.031 0.443 . . . . 62.11 111.017 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -78.27 -15.12 59.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.126 -0.488 . . . . 70.22 111.233 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.99 16.47 41.27 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.595 -1.288 . . . . 52.32 112.269 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.12 152.2 18.93 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.237 -0.653 . . . . 74.12 109.237 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 35.0 mmtp -94.31 141.2 28.84 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.529 -0.915 . . . . 73.12 108.529 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 133.96 67.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.331 0.586 . . . . 51.2 111.607 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -110.51 130.85 55.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.79 -1.189 . . . . 64.12 107.79 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 p -98.9 119.29 37.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 120.429 -0.509 . . . . 73.24 109.884 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.6 tt -111.43 119.13 37.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.459 -1.682 . . . . 63.14 106.459 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 14.0 pm0 -106.36 122.57 46.52 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.325 0.583 . . . . 75.52 110.324 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.03 131.31 24.44 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.326 -0.852 . . . . 63.41 111.119 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -91.12 130.73 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.916 2.411 . . . . 73.15 111.34 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 174.95 -170.36 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.733 -1.58 . . . . 74.31 106.733 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.1 m -113.36 -27.94 7.76 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.439 -1.319 . . . . 75.53 107.439 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 m -91.72 58.82 3.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.982 -1.488 . . . . 74.55 106.982 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 391' ' ' ASP . 1.5 pp -115.9 151.58 46.58 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 114.009 -1.45 . . . . 44.44 113.005 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 394' ' ' ILE . 7.3 Cg_exo -74.9 119.53 5.71 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.217 1.945 . . . . 64.33 108.267 169.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.55 161.88 16.49 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 C-N-CA 123.386 2.724 . . . . 71.41 113.165 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.64 -8.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.947 0.899 . . . . 74.53 112.119 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 45.1 m170 -106.18 109.49 21.44 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 104.202 -2.518 . . . . 55.03 104.202 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.76 118.0 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 122.045 0.926 . . . . 61.4 111.986 -170.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -96.29 -27.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.776 -1.102 . . . . 72.13 112.105 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -146.65 156.96 27.24 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 110.257 -1.137 . . . . 73.12 110.257 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.4 p -125.37 -178.58 4.27 Favored 'General case' 0 C--N 1.275 -2.645 0 C-N-CA 122.989 0.516 . . . . 73.11 109.799 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.95 133.57 20.96 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.509 -1.293 . . . . 63.23 107.509 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.15 -17.94 9.19 Favored 'Trans proline' 0 C--O 1.26 1.585 0 C-N-CA 123.875 3.05 . . . . 65.51 115.194 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.84 64.27 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 122.115 -0.365 . . . . 71.31 110.744 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.71 65.36 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 121.038 0.447 . . . . 53.4 110.836 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -76.06 -13.39 60.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.082 0.468 . . . . 75.24 110.957 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 61.2 m -73.33 138.06 45.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.599 -0.889 . . . . 73.11 108.599 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.94 113.3 12.09 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.417 0.627 . . . . 64.11 110.066 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.36 170.08 8.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.169 -0.923 . . . . 65.14 109.56 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 27.6 m -70.12 132.35 45.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.021 -0.733 . . . . 34.14 109.021 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -51.91 113.99 1.17 Allowed 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.862 0.726 . . . . 61.21 112.301 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.04 57.87 1.28 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.816 -0.629 . . . . 63.04 112.675 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -114.31 -166.79 1.13 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.868 -1.531 . . . . 73.12 106.868 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.8 pt-20 -113.08 134.59 54.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 119.327 0.967 . . . . 75.21 112.596 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.95 135.9 54.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.29 -1.004 . . . . 73.33 108.29 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -94.73 125.96 39.72 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.401 0.62 . . . . 60.21 109.615 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.36 116.33 47.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.82 -1.178 . . . . 73.35 107.82 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.86 128.0 35.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.097 -0.705 . . . . 71.5 109.097 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.48 145.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.295 -0.411 . . . . 71.01 110.054 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 24.1 p -84.9 123.72 30.81 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.066 0.547 . . . . 63.45 112.117 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.8 t -118.38 106.58 12.88 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 120.022 -0.671 . . . . 54.41 109.352 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.0 109.5 0.05 OUTLIER Glycine 0 C--O 1.262 1.893 0 N-CA-C 115.028 0.771 . . . . 33.42 115.028 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 30.1 Cg_exo -64.75 127.69 19.31 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.3 1.333 . . . . 62.43 109.53 172.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 6.9 mm-40 -73.38 131.55 42.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 113.255 0.835 . . . . 74.34 113.255 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.5 mt-30 -123.22 133.72 54.19 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 106.891 -1.522 . . . . 72.32 106.891 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.676 -0.861 . . . . 55.5 108.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -83.43 138.21 33.57 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.782 -0.645 . . . . 72.33 109.311 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.3 mt -89.9 125.11 61.84 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.886 -0.413 . . . . 61.34 109.886 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HB2' HG12 ' A' ' 432' ' ' VAL . 48.7 Cg_endo -69.7 141.79 46.41 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.355 2.037 . . . . 72.12 112.745 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.22 6.87 30.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.104 -0.498 . . . . 73.15 111.676 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 430' ' ' PRO . 10.3 p -76.89 -14.3 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.679 0.752 . . . . 62.14 109.673 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.9 m -53.21 -37.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.785 1.234 . . . . 61.12 112.754 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.553 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 4.3 p -69.54 -14.16 62.71 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 113.84 1.052 . . . . 73.41 113.84 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.75 -38.26 17.09 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 122.136 -0.352 . . . . 71.01 111.877 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 73.8 m -153.83 131.72 11.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.769 -0.456 . . . . 60.3 109.769 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -62.09 -43.52 98.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.094 0.557 . . . . 72.23 112.048 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.2 83.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.212 0.53 . . . . 50.33 110.374 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.26 -44.38 95.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.888 -1.051 . . . . 73.4 109.51 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.18 66.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 74.24 111.524 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.24 -38.86 81.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.668 0.618 . . . . 62.43 112.668 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -67.54 -46.71 72.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.508 -0.477 . . . . 70.22 111.071 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -64.83 -40.72 95.64 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 112.364 0.505 . . . . 61.2 112.364 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.5 mp -65.85 -41.4 91.74 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.583 -0.447 . . . . 72.42 111.498 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.7 m -62.09 -43.36 98.99 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.801 -0.444 . . . . 54.3 109.801 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.15 -16.87 62.56 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.095 -0.502 . . . . 70.41 111.757 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -89.73 -7.19 55.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.106 0.479 . . . . 45.12 110.363 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 110.9 -8.73 29.6 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.1 -0.571 . . . . 55.42 112.851 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -85.01 92.7 8.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.262 0.553 . . . . 73.53 110.151 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -100.16 -2.03 55.85 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.462 -1.055 . . . . 42.34 110.462 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -94.97 110.78 22.64 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.48 -0.933 . . . . 75.33 108.48 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -123.46 157.69 32.92 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.623 0.725 . . . . 74.14 111.477 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 485' ' ' ILE . 59.1 tptt -149.54 131.41 15.14 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 103.934 -2.617 . . . . 72.22 103.934 173.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -111.0 135.07 52.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.961 -0.695 . . . . 73.31 111.394 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.36 135.69 37.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.802 -0.814 . . . . 75.54 108.802 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -114.9 129.21 56.66 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.399 -1.334 . . . . 75.34 107.399 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 45.3 p -121.11 150.32 53.31 Favored Pre-proline 0 C--N 1.284 -2.267 0 C-N-CA 120.597 -0.441 . . . . 64.24 110.503 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.9 Cg_exo -61.58 120.61 8.34 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.207 1.938 . . . . 54.52 110.431 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.9 t -127.38 -178.53 4.49 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.472 -1.677 . . . . 72.32 106.472 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 m -74.05 142.54 79.44 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 107.844 -1.169 . . . . 74.2 107.844 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 99.1 Cg_exo -49.67 -23.29 7.89 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.593 2.862 . . . . 61.13 113.931 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.92 -11.82 60.04 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.227 0.536 . . . . 65.11 112.118 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.4 3.12 15.7 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.923 -0.486 . . . . 74.21 111.641 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.9 p -59.92 127.45 19.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.326 0.584 . . . . 71.34 111.662 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.88 -15.6 63.04 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 120.769 -0.729 . . . . 52.11 112.176 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -100.66 149.59 23.62 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.112 -0.699 . . . . 74.35 109.112 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 91.5 t -76.93 130.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.708 -1.219 . . . . 62.11 107.708 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.04 -22.6 4.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.939 -0.704 . . . . 72.45 111.949 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.49 -177.58 45.79 Favored Glycine 0 N--CA 1.423 -2.177 0 C-N-CA 120.778 -0.725 . . . . 51.24 111.373 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 486' ' ' ILE . 6.7 p -136.01 154.88 50.93 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.449 -0.945 . . . . 72.42 108.449 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.531 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.5 t-20 -56.97 -51.85 78.54 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-O 119.151 -0.452 . . . . 75.12 111.435 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.6 Cg_endo -86.34 119.01 1.68 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 N-CA-C 107.15 -1.904 . . . . 74.12 107.15 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.47 162.21 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.197 1.932 . . . . 61.35 113.704 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.39 4.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.135 0.969 . . . . 53.33 111.104 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.86 -0.55 19.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.103 -0.953 . . . . 42.24 109.3 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -108.07 153.4 23.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.905 0.859 . . . . 64.42 112.031 -174.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.1 m -112.09 93.66 4.56 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.655 -1.611 . . . . 74.11 107.358 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -100.91 148.58 24.83 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.23 -0.441 . . . . 61.33 111.278 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.16 152.83 36.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.995 0.426 . . . . 34.42 111.48 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 448' ' ' GLY . 1.7 mp -63.83 -21.41 28.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.641 0.734 . . . . 72.25 111.429 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.82 1.2 56.44 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.102 -0.499 . . . . 63.11 111.808 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -85.99 140.24 30.48 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.819 -0.438 . . . . 71.42 109.819 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 36.6 t -85.21 123.19 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.73 -0.668 . . . . 71.43 109.415 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.85 119.81 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 108.526 -0.916 . . . . 72.25 108.526 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 1.7 mp -91.89 112.76 26.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.652 -1.981 . . . . 72.02 105.652 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -92.75 119.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.591 -1.263 . . . . 60.52 107.591 -177.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 38.8 mt -106.1 116.32 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.702 0.763 . . . . 72.24 110.57 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.13 142.85 13.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.502 -0.772 . . . . 70.23 108.959 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.63 117.53 4.59 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 111.183 -0.767 . . . . 62.51 111.183 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.4 m -116.34 106.99 14.26 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.163 -0.68 . . . . 75.45 109.163 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.086 0 N-CA-C 109.981 -1.248 . . . . 70.42 109.981 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.386 0 N-CA-C 110.043 -1.223 . . . . 43.05 110.043 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -92.78 149.85 4.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 117.487 0.643 . . . . 42.33 111.481 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 57.4 m -147.12 156.75 43.25 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.187 -1.783 . . . . 73.44 106.187 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -94.26 77.23 3.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.122 -1.436 . . . . 75.32 107.122 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.28 148.28 45.2 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.432 -1.713 . . . . 74.13 110.4 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.71 152.11 13.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 123.917 0.887 . . . . 62.22 108.987 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -95.92 136.32 36.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.873 -1.899 . . . . 65.51 105.873 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.5 127.01 32.53 Favored Pre-proline 0 C--N 1.284 -2.272 0 C-N-CA 119.89 -0.724 . . . . 71.01 111.122 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.36 133.71 57.51 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.986 2.457 . . . . 71.51 112.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -59.44 134.49 57.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.012 -0.995 . . . . 75.33 111.168 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 5.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.377 -0.829 . . . . 72.41 112.476 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.5 ptt-85 -65.69 137.72 57.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.657 -0.868 . . . . 74.21 108.657 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.37 0.37 50.39 Favored Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.687 -0.965 . . . . 53.42 110.687 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 48.9 mt-30 -130.15 176.76 7.83 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.483 -0.932 . . . . 60.41 108.483 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 88.4 p -87.94 167.8 13.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.736 -0.839 . . . . 75.03 108.736 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -61.29 -34.22 74.86 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.993 0.425 . . . . 73.42 110.346 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.06 -44.84 87.68 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.704 -0.68 . . . . 70.2 110.407 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 48.8 m-20 -60.03 -44.98 94.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.528 -0.545 . . . . 64.41 109.528 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.08 67.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.226 -0.897 . . . . 73.22 111.018 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.5 -44.33 92.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.169 -0.469 . . . . 72.35 110.888 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.08 77.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.147 -0.479 . . . . 61.34 111.645 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.601 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 36.7 m -64.08 -47.52 79.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.547 -0.297 . . . . 73.3 111.199 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.13 -39.46 93.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.768 0.285 . . . . 72.43 111.768 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -60.04 -45.35 93.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.1 -0.704 . . . . 74.24 109.1 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -69.58 -27.65 65.29 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.169 -0.923 . . . . 75.33 112.025 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.601 ' HD3' ' O ' ' A' ' 376' ' ' THR . 8.5 mpt_? -85.62 -8.22 58.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.678 0.275 . . . . 71.43 110.999 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.27 14.35 54.21 Favored Glycine 0 CA--C 1.505 -0.594 0 C-N-CA 120.287 -0.959 . . . . 72.01 112.753 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -94.14 154.06 17.78 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.048 -0.723 . . . . 64.14 109.048 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.0 mmtp -104.79 133.6 49.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.263 -1.014 . . . . 62.31 108.263 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -117.82 144.86 24.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-O 121.524 0.678 . . . . 74.53 111.905 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -110.9 127.75 55.56 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 107.093 -1.447 . . . . 72.35 107.093 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.4 m -99.58 120.0 38.97 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.505 -1.665 . . . . 75.41 106.505 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.93 118.72 34.26 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.426 -1.324 . . . . 52.45 107.426 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.44 121.57 36.12 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.278 -1.378 . . . . 74.0 107.278 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.36 127.73 25.75 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 111.856 0.317 . . . . 70.42 111.856 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -87.99 131.59 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.522 2.148 . . . . 60.32 110.731 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.4 t70 174.06 -164.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.716 -1.587 . . . . 70.42 106.716 -178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 50.1 m -142.34 -0.53 1.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.343 0.657 . . . . 64.3 110.481 173.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -105.7 25.19 11.11 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 106.571 -1.64 . . . . 74.33 106.571 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 15.8 pt -115.13 151.41 45.66 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 113.708 -1.587 . . . . 72.55 110.212 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 63.2 Cg_endo -74.45 147.58 36.72 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.035 1.823 . . . . 75.13 111.465 176.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 54.0 Cg_exo -56.47 163.9 6.17 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.408 3.406 . . . . 73.11 112.288 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -56.28 -8.56 0.52 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 123.315 0.646 . . . . 73.14 112.006 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.1 m170 -91.63 113.37 25.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.213 -2.514 . . . . 74.53 104.213 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.18 118.32 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.358 0.599 . . . . 63.21 111.047 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.78 -29.49 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.206 -0.907 . . . . 74.34 109.049 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.18 157.12 27.28 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 110.432 -1.067 . . . . 71.14 110.432 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -126.03 -179.44 4.71 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 123.545 0.738 . . . . 52.35 110.418 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.33 140.29 21.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 61.3 108.639 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.39 -26.02 0.89 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 124.948 3.766 . . . . 62.43 115.53 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.34 -24.9 61.13 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 112.045 0.387 . . . . 74.45 112.045 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.74 69.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.475 0.655 . . . . 74.32 110.357 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -78.26 -11.99 59.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.59 -0.732 . . . . 63.22 111.65 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -78.82 137.46 37.71 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.063 -1.458 . . . . 70.41 107.063 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 m -82.54 112.27 19.3 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 71.41 107.712 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.6 167.42 18.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.566 -1.272 . . . . 74.33 107.566 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.2 p -61.01 147.66 42.83 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 123.46 0.704 . . . . 60.51 111.345 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.8 116.66 3.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.002 -0.544 . . . . 63.23 111.513 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.95 51.48 2.26 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.793 -0.64 . . . . 73.44 113.053 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.71 -170.14 1.69 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.803 -1.184 . . . . 74.33 107.803 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -99.05 135.27 40.7 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.494 0.664 . . . . 73.21 112.577 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.9 mm -125.17 138.76 53.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 124.796 1.239 . . . . 73.43 108.159 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 12.3 t -99.82 131.89 45.51 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.77 0.795 . . . . 65.1 111.701 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.3 t -108.15 120.71 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.459 -1.312 . . . . 73.52 107.459 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.74 129.04 41.83 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.341 -0.39 . . . . 74.5 111.458 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.75 131.3 73.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.835 -1.172 . . . . 64.12 107.835 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 49.6 p -85.96 121.85 29.18 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.099 -0.704 . . . . 72.41 109.099 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -119.45 106.7 12.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.197 -0.601 . . . . 73.15 111.1 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 71.03 125.89 0.06 OUTLIER Glycine 0 CA--C 1.544 1.874 0 N-CA-C 114.801 0.681 . . . . 65.02 114.801 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.1 Cg_exo -70.52 128.2 15.01 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.255 1.303 . . . . 64.4 109.44 173.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 15.2 mm-40 -72.3 144.78 48.21 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 112.463 0.542 . . . . 63.34 112.463 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.4 mt-30 -116.01 149.01 39.54 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.811 -1.086 . . . . 63.12 108.562 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -136.78 144.87 43.98 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.523 -0.917 . . . . 70.4 108.523 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 37.1 tt0 -81.74 119.25 23.62 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.122 -1.807 . . . . 71.04 106.122 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 62.1 mt -80.88 127.83 73.52 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.471 -0.937 . . . . 74.51 108.471 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 141.79 38.89 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.928 1.752 . . . . 62.01 110.627 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.84 73.89 10.28 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.373 1.083 . . . . 72.15 108.269 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.19 -4.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 113.668 -1.605 . . . . 74.13 107.34 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.609 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.7 m -67.13 -38.88 86.32 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 113.583 -1.644 . . . . 44.23 111.767 -176.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 16.3 p -69.84 -16.75 63.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 112.86 0.689 . . . . 54.4 112.86 -169.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.28 -48.99 11.29 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.545 -0.752 . . . . 61.23 111.656 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.2 m -157.59 130.19 7.39 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.03 -0.419 . . . . 63.43 110.116 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -55.88 -47.07 78.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.477 0.711 . . . . 72.41 112.218 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.76 84.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 64.12 111.306 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 35.4 mm-40 -67.5 -38.95 85.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.164 -0.471 . . . . 75.31 111.214 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.4 -50.85 72.37 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.614 0.572 . . . . 62.12 111.043 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.3 -45.34 98.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.516 -0.765 . . . . 75.21 110.624 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.11 -40.67 86.91 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 112.952 0.723 . . . . 52.34 112.952 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.8 mmtt -66.21 -47.18 74.7 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 110.084 -0.339 . . . . 72.53 110.084 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.647 0.61 . . . . 71.52 112.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.9 m -63.98 -39.04 93.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.907 -0.405 . . . . 71.23 109.907 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -27.02 63.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.551 . . . . 65.13 110.832 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 -13.65 59.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.336 -0.393 . . . . 54.54 111.249 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 129.96 -26.18 4.27 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.196 -1.002 . . . . 50.44 113.26 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -80.84 91.57 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.312 . . . . 72.52 110.17 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.48 26.86 16.93 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 120.512 -0.851 . . . . 70.41 111.71 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -124.77 111.84 16.01 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.587 -1.264 . . . . 71.24 107.587 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 158.97 37.2 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.777 0.799 . . . . 74.14 111.982 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.52 123.25 21.15 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.872 -1.899 . . . . 61.43 105.872 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.62 126.96 35.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.145 0.278 . . . . 72.43 110.49 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.72 48.93 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.829 -0.804 . . . . 74.42 108.829 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -129.74 148.84 51.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.505 -0.554 . . . . 75.25 109.505 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 66.4 m -135.86 133.3 19.85 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 116.488 -0.324 . . . . 73.22 110.969 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.3 Cg_endo -61.79 121.57 9.73 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.715 2.277 . . . . 71.44 110.028 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.8 p -146.39 -178.36 6.11 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.878 -1.156 . . . . 64.34 107.878 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.514 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.3 m -52.2 122.98 26.11 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.17 -0.678 . . . . 64.44 109.17 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.02 -23.63 9.51 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.314 3.342 . . . . 73.54 115.197 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -75.4 -6.43 49.98 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.81 -0.556 . . . . 44.3 111.966 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 460' ' ' THR . 4.4 mm? -98.69 5.02 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.099 -0.375 . . . . 73.11 110.955 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -59.67 126.7 17.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 CA-C-O 121.545 0.688 . . . . 71.52 111.489 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.84 -1.14 85.05 Favored Glycine 0 C--O 1.243 0.657 0 CA-C-N 115.748 -0.66 . . . . 32.44 111.772 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -111.1 144.42 40.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.148 -1.427 . . . . 71.21 107.148 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 61.8 t -83.82 134.9 25.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 109.496 -0.557 . . . . 55.24 109.496 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.37 -14.88 7.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.404 -0.518 . . . . 74.04 110.803 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.98 167.75 23.87 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 115.719 -0.673 . . . . 52.42 111.811 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 486' ' ' ILE . 14.7 p -124.28 146.17 48.94 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.417 -1.327 . . . . 62.21 107.417 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.5 t-20 -56.54 -50.72 86.14 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 63.21 110.497 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.9 Cg_exo -81.4 104.95 1.54 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 105.41 -2.573 . . . . 73.21 105.41 163.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.0 Cg_endo -63.04 149.82 90.44 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.395 2.063 . . . . 60.31 114.248 -169.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.8 16.51 0.86 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.264 1.03 . . . . 74.34 110.106 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 473' ' ' PRO . 3.9 m-20 -111.3 -3.64 15.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 124.918 1.287 . . . . 65.43 108.718 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -120.9 163.32 18.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.921 -1.036 . . . . 72.23 112.162 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 10.6 m -101.48 104.88 15.82 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.728 -1.582 . . . . 71.42 106.728 175.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.8 t -116.89 148.84 40.96 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.583 -0.525 . . . . 51.24 109.583 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.14 140.71 58.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.236 -0.438 . . . . 54.13 110.622 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.9 mm -60.58 -16.46 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 125.159 1.384 . . . . 63.13 111.776 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 10.4 t -87.93 3.62 47.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.264 -0.426 . . . . 75.05 111.185 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 46.5 m-80 -91.12 140.61 29.65 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.751 0.31 . . . . 64.12 110.634 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.64 122.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.851 -1.166 . . . . 41.21 107.851 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.05 119.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 N-CA-C 108.605 -0.887 . . . . 71.32 108.605 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 47.0 mt -91.82 112.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 104.799 -2.297 . . . . 63.41 104.799 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.84 120.45 52.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 108.685 -0.857 . . . . 74.33 108.685 -173.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.78 118.73 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 121.559 0.695 . . . . 75.41 109.333 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.45 139.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.351 -0.981 . . . . 75.02 108.351 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.27 121.66 6.22 Favored Glycine 0 N--CA 1.42 -2.43 0 N-CA-C 108.471 -1.852 . . . . 61.11 108.471 175.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 7.1 t -140.45 103.88 4.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.15 -0.685 . . . . 54.44 109.15 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.609 0 N-CA-C 109.478 -1.449 . . . . 74.53 109.478 178.18 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.309 0 N-CA-C 110.563 -1.015 . . . . 75.34 110.563 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.81 144.9 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 121.261 0.553 . . . . 53.24 111.93 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.7 m -86.03 151.5 23.66 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.825 -1.176 . . . . 75.13 107.825 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -83.23 77.2 9.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.434 0.635 . . . . 73.54 110.062 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -78.65 125.55 29.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.242 -1.392 . . . . 74.12 107.242 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.82 156.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-O 120.972 0.415 . . . . 71.11 110.506 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -98.41 136.85 37.96 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.604 -1.628 . . . . 74.11 106.604 174.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.45 129.03 27.71 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 119.437 -0.905 . . . . 73.4 109.889 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 139.79 70.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.33 2.686 . . . . 74.31 113.21 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.66 137.49 55.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.839 -1.073 . . . . 65.11 109.107 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.0 m -103.43 14.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.986 0.422 . . . . 64.41 111.96 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 0.9 OUTLIER -65.29 138.82 58.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.23 -0.441 . . . . 72.43 111.558 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 -2.08 76.35 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 115.603 -0.726 . . . . 45.31 111.449 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -116.67 162.67 17.29 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.473 -0.566 . . . . 53.22 109.473 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 79.3 p -74.75 163.16 28.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 122.764 0.426 . . . . 74.33 111.774 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 21.5 p -60.91 -45.4 94.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.165 -0.47 . . . . 73.34 110.874 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.37 95.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.992 -0.549 . . . . 62.34 111.55 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.91 -39.73 83.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.056 -0.657 . . . . 73.31 109.905 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.99 -51.84 67.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.056 -0.52 . . . . 53.41 110.099 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.517 . . . . 62.51 110.7 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.39 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.462 -0.336 . . . . 73.45 111.673 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 98.3 m -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.689 -0.232 . . . . 53.32 111.18 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.5 mm? -64.87 -42.44 94.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.811 0.339 . . . . 74.43 111.002 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -61.81 -48.43 80.64 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.854 0.861 . . . . 74.25 109.721 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -70.5 -25.35 63.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.506 -0.77 . . . . 70.22 111.584 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.4 -15.83 57.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.453 -0.573 . . . . 72.33 109.453 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.4 6.09 53.57 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 119.807 -1.187 . . . . 51.41 111.683 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.4 169.08 11.7 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.233 0.54 . . . . 74.51 109.88 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 74.9 mmtt -113.73 157.9 21.62 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.508 -1.293 . . . . 34.22 107.508 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.42 142.68 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 121.093 0.473 . . . . 73.32 111.126 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -116.81 138.63 51.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.552 -1.647 . . . . 63.13 106.552 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 3.3 p -101.81 127.06 48.78 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.386 -0.525 . . . . 72.44 110.151 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.45 119.54 39.15 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.04 -1.467 . . . . 75.13 107.04 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 15.2 pm0 -114.85 134.12 55.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.416 -0.514 . . . . 75.03 111.252 -175.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -137.02 141.77 35.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.853 -0.612 . . . . 75.43 110.192 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.5 Cg_endo -97.04 143.57 0.76 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.155 2.57 . . . . 73.3 113.234 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.656 ' HB3' HG23 ' A' ' 394' ' ' ILE . 7.7 t70 163.55 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.996 -1.853 . . . . 71.3 105.996 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 m -122.18 -12.7 8.25 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.996 -0.742 . . . . 64.22 108.996 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.3 m -98.03 14.65 26.69 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 122.457 1.123 . . . . 54.22 108.769 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.656 HG23 ' HB3' ' A' ' 391' ' ' ASP . 9.9 pt -88.64 151.83 48.41 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 115.068 -0.969 . . . . 64.22 111.601 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.06 126.78 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.921 1.747 . . . . 71.31 110.78 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.85 161.99 9.52 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.718 2.945 . . . . 73.32 112.265 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 370' ' ' SER . 4.4 p-10 -57.03 -9.93 0.99 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.477 0.711 . . . . 74.52 112.399 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -91.89 113.84 26.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.536 -2.024 . . . . 53.12 105.536 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.88 119.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 124.362 1.039 . . . . 75.34 112.29 -167.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.8 mt -95.41 -31.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 65.54 109.928 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.57 157.96 27.56 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.518 -0.849 . . . . 74.31 111.472 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.9 p -129.04 -179.1 4.92 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.588 0.755 . . . . 73.4 109.599 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -101.74 142.35 24.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.02 -1.104 . . . . 73.54 108.02 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.65 -26.45 9.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.848 3.032 . . . . 74.4 114.075 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.69 46.41 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.366 0.666 . . . . 75.44 111.168 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.42 95.28 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.723 -0.671 . . . . 35.14 111.434 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -87.54 -5.95 58.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.413 0.523 . . . . 53.55 112.413 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 37.0 m -85.95 153.01 22.48 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.96 -1.496 . . . . 72.45 106.96 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.69 112.76 11.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.761 -0.776 . . . . 61.52 110.142 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.6 m -117.94 153.04 19.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 62.34 109.542 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -67.62 141.73 56.66 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.565 -0.531 . . . . 51.51 109.565 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.26 134.6 44.9 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.529 0.732 . . . . 72.1 112.594 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 84.09 37.48 11.27 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.455 -0.793 . . . . 24.2 113.991 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -95.91 176.22 6.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.192 -1.04 . . . . 74.25 108.192 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 6.2 pt-20 -111.07 120.0 40.89 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.189 0.811 . . . . 71.24 113.189 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.79 137.85 25.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 114.951 -1.022 . . . . 60.42 108.535 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.4 t -96.02 128.67 43.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.816 0.817 . . . . 72.44 110.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.48 129.03 59.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.538 -0.912 . . . . 64.24 108.538 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -85.01 127.99 34.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.385 -0.598 . . . . 65.42 109.385 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.95 135.09 64.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.502 -0.925 . . . . 64.43 108.502 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.8 p -84.24 122.08 28.38 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.246 -0.649 . . . . 55.41 109.246 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 39.9 m -120.3 104.96 10.47 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 120.049 -0.66 . . . . 52.3 112.443 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 70.62 131.07 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 N-CA-C 115.766 1.066 . . . . 31.15 115.766 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.4 Cg_exo -75.06 134.65 17.96 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.943 1.762 . . . . 73.43 109.491 173.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.2 mm-40 -72.84 148.8 44.12 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.249 0.547 . . . . 72.11 112.266 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.8 mt-30 -124.08 139.03 54.34 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.682 -1.144 . . . . 73.55 108.015 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 14.9 mmt-85 -130.45 154.64 47.53 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 116.163 -0.471 . . . . 72.35 109.771 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.64 138.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.579 -0.897 . . . . 74.3 108.579 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -94.28 109.64 43.74 Favored Pre-proline 0 C--O 1.203 -1.352 0 N-CA-C 109.005 -0.739 . . . . 75.11 109.005 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.01 140.56 34.94 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 121.549 1.5 . . . . 73.14 111.716 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -92.5 95.17 9.48 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 118.465 -1.294 . . . . 75.12 112.172 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.63 9.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 104.502 -2.407 . . . . 64.23 104.502 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 22.6 t -78.89 -48.11 15.24 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.058 -1.883 . . . . 74.23 109.188 -172.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 40.3 p -63.85 -19.97 65.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.631 0.729 . . . . 71.44 110.829 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.29 -49.27 6.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.05 -0.977 . . . . 74.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 4.7 p -151.03 125.59 9.56 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.105 0.479 . . . . 75.4 112.117 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -61.64 -47.12 86.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 73.02 110.927 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.26 -47.84 80.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.824 . . . . 72.21 112.134 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.97 -34.75 73.79 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.995 -0.548 . . . . 72.53 112.059 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.82 -44.75 96.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.571 -0.286 . . . . 64.13 110.357 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.29 -39.84 82.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.594 0.559 . . . . 74.15 110.157 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -60.82 -48.14 83.14 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.878 -0.601 . . . . 72.43 110.504 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.8 -47.53 71.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 73.12 111.068 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.94 -43.07 84.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.046 -0.979 . . . . 75.21 111.384 -173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.3 m -69.17 -39.57 78.66 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.967 0.413 . . . . 73.33 110.224 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -16.14 62.55 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.374 -0.375 . . . . 53.01 111.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.78 -13.79 59.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.215 0.531 . . . . 62.44 109.969 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.46 -25.26 7.39 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.737 -0.744 . . . . 12.01 112.14 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -57.43 127.1 30.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.972 0.415 . . . . 65.24 111.504 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -133.55 27.72 3.35 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 109.673 -1.371 . . . . 62.21 109.673 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -128.04 111.4 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.824 -1.547 . . . . 62.12 106.824 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -135.88 154.18 51.23 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.977 0.418 . . . . 64.24 110.782 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -146.13 123.25 11.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.624 -1.25 . . . . 73.3 107.624 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -108.84 132.19 54.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.942 -0.303 . . . . 51.22 110.697 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -147.68 166.3 27.87 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.898 -0.592 . . . . 65.23 109.518 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -112.74 143.65 43.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.303 -0.629 . . . . 72.22 109.303 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.6 t -127.17 141.48 40.86 Favored Pre-proline 0 C--N 1.288 -2.107 0 N-CA-C 107.739 -1.208 . . . . 74.21 107.739 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_endo -63.37 135.18 48.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.862 2.375 . . . . 75.53 112.427 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.3 p -148.13 -178.88 6.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 105.648 -1.982 . . . . 63.23 105.648 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD13 ' A' ' 463' ' ' LEU . 31.6 m -63.69 128.2 92.45 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.076 -1.453 . . . . 70.13 107.076 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.33 -28.24 14.97 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.272 3.315 . . . . 74.43 114.576 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.31 -9.88 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 111.911 0.337 . . . . 61.24 111.911 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.6 mp -103.3 11.97 36.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.458 -0.201 . . . . 61.22 110.458 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 13.0 p -59.0 127.32 18.03 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-O 121.611 0.719 . . . . 64.44 110.969 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.57 57.81 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.408 -0.815 . . . . 34.12 111.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.16 144.8 29.6 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.271 -1.011 . . . . 74.43 108.271 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 433' ' ' SER . 65.6 t -83.43 138.24 19.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 72.43 108.503 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -98.08 -11.37 8.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.22 -0.592 . . . . 55.14 111.615 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 150.68 -177.71 28.56 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 111.121 -0.792 . . . . 61.23 111.121 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 5.4 p -116.75 161.38 19.34 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.69 -0.856 . . . . 64.05 108.69 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.15 -55.37 44.75 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.259 -0.4 . . . . 74.53 111.323 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 133.67 18.69 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 N-CA-C 108.226 -1.49 . . . . 75.32 108.226 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 134.56 47.18 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.013 1.809 . . . . 75.14 111.598 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.92 19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.852 0.861 . . . . 73.23 113.045 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -110.54 -8.23 14.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.428 -0.953 . . . . 70.14 108.428 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -99.52 156.75 16.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.068 -0.969 . . . . 74.51 113.178 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 m -106.6 110.23 22.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.422 -1.717 . . . . 63.35 106.877 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -117.61 148.46 41.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.464 -0.198 . . . . 64.23 110.464 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.12 149.41 50.57 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.269 0.356 . . . . 74.14 111.018 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.95 -14.43 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 125.083 1.353 . . . . 72.42 111.837 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.17 4.01 44.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.7 0.8 . . . . 64.13 111.701 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -97.73 134.74 40.49 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.003 -0.544 . . . . 72.3 110.607 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.99 114.93 24.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.677 -0.86 . . . . 73.3 108.677 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.44 119.85 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.378 0.609 . . . . 72.15 109.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.72 120.24 41.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.43 -1.322 . . . . 74.43 107.43 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.29 118.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 107.836 -1.172 . . . . 75.22 107.836 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -111.46 122.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.173 0.987 . . . . 74.32 112.361 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 35.5 t -97.53 141.2 16.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.713 -1.13 . . . . 64.1 108.053 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.43 121.75 5.92 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 111.657 -0.577 . . . . 21.14 111.657 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.6 m -142.06 120.89 12.72 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.153 -0.684 . . . . 60.41 109.153 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.578 0 N-CA-C 109.665 -1.374 . . . . 74.44 109.665 178.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.31 0 N-CA-C 109.923 -1.271 . . . . 72.13 109.923 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.38 145.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 117.782 0.791 . . . . 63.44 112.121 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 6.8 m -104.41 159.34 15.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.621 -1.622 . . . . 73.14 106.621 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.87 60.15 3.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.786 0.803 . . . . 74.33 112.688 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -114.53 136.4 53.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.606 -1.627 . . . . 63.45 106.606 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.65 154.14 37.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 122.528 0.331 . . . . 73.33 110.176 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -95.0 136.65 35.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.489 -0.93 . . . . 74.25 108.489 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.96 142.04 23.94 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 116.148 -0.478 . . . . 72.4 111.814 -170.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.14 142.77 20.19 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 124.015 3.143 . . . . 74.1 113.414 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.21 125.69 29.73 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.471 -0.786 . . . . 75.01 109.651 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.28 27.05 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.569 1.176 . . . . 73.01 110.669 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 145.66 55.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.09 -0.959 . . . . 74.21 111.498 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 1.0 45.49 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.998 -0.62 . . . . 65.03 114.36 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 373' ' ' ALA . 7.7 pt20 -134.6 162.5 32.11 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 117.293 0.546 . . . . 44.45 110.883 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.4 p -66.93 159.89 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.227 0.329 . . . . 61.21 110.298 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 21.2 p -56.76 -40.5 75.92 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.586 0.231 . . . . 71.02 111.62 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.36 77.85 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 111.563 0.209 . . . . 74.35 111.563 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.71 -36.76 76.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.51 -0.552 . . . . 72.42 109.51 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.4 ' HA ' ' OE1' ' A' ' 368' ' ' GLN . . . -60.5 -51.7 68.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.019 -0.537 . . . . 70.12 110.812 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.46 -38.0 76.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.764 -0.653 . . . . 73.21 110.607 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.07 99.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.964 -0.562 . . . . 74.01 110.338 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 50.6 m -61.21 -47.2 87.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.353 -0.385 . . . . 71.3 110.755 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.8 -38.64 91.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.433 0.158 . . . . 74.14 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -61.16 -46.78 89.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.366 -0.605 . . . . 72.35 109.366 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.27 -28.0 68.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.805 -0.634 . . . . 73.12 111.507 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -80.98 -14.57 57.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.365 -0.38 . . . . 70.44 111.42 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.09 48.11 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.858 -0.686 . . . . 65.23 113.667 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.91 161.97 14.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.491 0.646 . . . . 75.1 111.353 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -97.01 140.13 31.99 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.221 -1.77 . . . . 63.13 106.221 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.3 152.31 21.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.296 0.57 . . . . 54.42 112.316 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -136.16 128.99 31.04 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.934 -1.136 . . . . 64.53 107.934 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -100.58 132.83 45.77 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.187 -0.671 . . . . 73.04 109.187 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.55 119.14 35.79 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.666 -1.976 . . . . 71.31 105.666 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 12.7 pm0 -108.37 122.19 46.49 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.974 -0.75 . . . . 53.4 108.974 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.54 133.3 21.33 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.023 -0.535 . . . . 74.04 111.9 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -81.63 129.56 6.5 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.073 1.849 . . . . 73.31 108.288 169.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.4 -170.29 3.19 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.905 -1.518 . . . . 74.51 112.145 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.7 t -104.66 -40.63 5.94 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.318 -1.734 . . . . 42.02 106.318 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 395' ' ' PRO . 32.2 m -93.0 71.51 4.65 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.543 -1.651 . . . . 44.02 106.543 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 16.6 pt -89.58 112.96 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 113.241 -1.8 . . . . 65.32 113.587 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 393' ' ' THR . 6.3 Cg_exo -79.1 119.61 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 105.81 -2.419 . . . . 73.34 105.81 167.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.12 150.48 39.16 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 C-N-CA 122.631 2.221 . . . . 63.22 114.24 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.531 ' HA ' HG13 ' A' ' 420' ' ' VAL . 29.8 t70 -60.06 -9.65 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.626 1.203 . . . . 51.1 111.722 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -109.51 115.51 30.06 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 103.292 -2.855 . . . . 74.2 103.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.17 117.98 4.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 123.695 0.622 . . . . 72.11 109.53 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.57 -29.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.987 -1.116 . . . . 71.35 107.987 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.37 168.47 27.81 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 109.387 -1.485 . . . . 62.23 109.387 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 81.2 p -113.93 -176.36 2.88 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.827 0.823 . . . . 71.23 111.365 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.31 142.89 25.48 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 105.654 -1.98 . . . . 61.4 105.654 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.62 -31.67 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.286 3.324 . . . . 63.45 114.441 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.08 67.42 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 112.381 0.512 . . . . 74.03 112.381 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.25 81.95 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 121.5 0.667 . . . . 74.31 110.125 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -90.83 -0.39 57.7 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.842 0.83 . . . . 73.12 110.604 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 93.8 m -85.55 143.99 28.17 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.008 -1.479 . . . . 74.14 107.008 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.0 m -74.84 114.61 13.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.867 -0.733 . . . . 63.02 109.381 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.96 170.17 8.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 124.823 1.249 . . . . 52.34 108.921 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 23.2 t -69.67 156.98 38.13 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.535 -0.543 . . . . 75.32 109.535 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -73.38 109.6 7.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.124 -1.065 . . . . 52.43 108.124 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.53 26.51 11.87 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.673 -0.971 . . . . 52.35 110.673 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.8 t0 -76.99 -171.57 2.03 Favored 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.807 -0.812 . . . . 63.15 108.807 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.68 127.46 53.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.463 0.649 . . . . 61.11 111.129 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.63 120.1 61.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.202 -1.036 . . . . 74.11 108.202 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -97.88 128.23 44.34 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.642 -0.873 . . . . 43.34 108.642 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.57 119.58 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.717 -0.475 . . . . 63.11 109.717 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.7 121.88 33.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.459 -0.941 . . . . 61.11 108.459 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 397' ' ' ASP . 23.6 t -128.83 144.72 37.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.426 -0.953 . . . . 75.32 108.426 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 71.9 p -98.03 128.92 44.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.306 -0.958 . . . . 54.03 110.9 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 60.6 m -118.73 105.56 11.69 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.069 -1.456 . . . . 74.32 107.069 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 80.53 145.1 3.97 Favored Glycine 0 CA--C 1.546 2.011 0 C-N-CA 120.973 -0.632 . . . . 34.22 113.445 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -87.95 153.2 7.16 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 121.903 1.735 . . . . 63.23 110.38 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 146.17 47.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.177 -0.675 . . . . 73.44 109.177 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 42.0 mt-30 -128.74 124.13 34.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.632 -0.877 . . . . 73.45 108.632 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.14 159.51 34.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.469 -1.308 . . . . 72.23 107.469 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.65 139.87 30.12 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 110.209 -0.293 . . . . 71.13 110.209 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.61 131.89 63.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.631 -0.877 . . . . 74.4 108.631 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.438 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.24 151.07 60.25 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.466 2.111 . . . . 44.21 111.905 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.19 -6.55 44.49 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.485 -0.325 . . . . 71.21 110.702 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 430' ' ' PRO . 11.9 p -65.84 -15.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 122.123 0.964 . . . . 62.33 109.69 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 14.0 m -52.73 -32.95 45.77 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.889 1.676 . . . . 73.23 112.084 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 85.5 m -59.8 -34.33 72.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.53 0.732 . . . . 74.43 112.585 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.45 -37.69 83.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.307 0.854 . . . . 71.32 113.307 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.8 m -158.3 133.53 8.66 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.723 -0.473 . . . . 72.32 109.723 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.61 -49.35 75.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.559 . . . . 73.35 111.724 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.44 85.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.943 -0.571 . . . . 72.3 110.449 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.25 -41.96 99.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.933 -1.03 . . . . 64.3 109.834 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.47 69.23 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.355 -0.839 . . . . 74.42 110.582 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.34 -40.0 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.584 -0.735 . . . . 74.52 110.405 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -60.8 -46.34 90.88 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.607 -0.27 . . . . 74.22 111.064 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -47.6 83.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.268 0.355 . . . . 65.33 111.86 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.36 -40.55 85.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.946 0.721 . . . . 42.51 112.946 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 57.2 m -61.8 -43.44 98.83 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.065 0.46 . . . . 73.41 110.158 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.53 -22.33 61.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.696 -0.684 . . . . 73.31 111.553 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.21 -13.09 57.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.005 0.431 . . . . 73.22 111.061 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -19.12 8.91 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.443 -0.884 . . . . 61.44 112.715 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 445' ' ' THR . 91.0 m-85 -71.27 110.86 6.17 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.017 -0.734 . . . . 60.02 109.017 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -120.08 17.08 9.97 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.457 -0.878 . . . . 53.2 111.602 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -119.4 111.4 18.1 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.872 -1.159 . . . . 61.13 107.872 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.25 152.37 50.58 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.082 0.468 . . . . 74.44 111.892 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -138.69 126.22 21.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.756 -1.572 . . . . 74.41 106.756 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -93.4 126.25 38.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 121.229 -0.189 . . . . 64.23 111.001 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.82 161.16 38.22 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.114 0.483 . . . . 63.13 110.111 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -124.06 133.29 53.67 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.059 0.457 . . . . 61.42 110.179 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 5.1 p -116.97 133.43 23.1 Favored Pre-proline 0 N--CA 1.413 -2.28 0 CA-C-N 115.583 -0.735 . . . . 35.31 109.482 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 36.1 Cg_exo -61.8 123.66 13.06 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.435 2.09 . . . . 71.44 110.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 8.7 t -148.16 -177.99 6.05 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.557 -1.275 . . . . 63.43 107.557 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 463' ' ' LEU . 20.5 m -51.65 116.45 7.92 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.139 0.976 . . . . 73.2 110.492 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.92 -28.75 19.21 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 124.329 3.353 . . . . 73.51 116.065 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.19 -25.93 58.63 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.746 -0.596 . . . . 73.03 112.366 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 460' ' ' THR . 3.2 pp -92.8 12.04 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.695 -0.402 . . . . 71.21 112.038 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.6 p -53.29 130.85 15.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.428 0.632 . . . . 70.01 111.228 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.84 -13.32 59.21 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.819 -0.912 . . . . 61.32 110.819 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.01 147.25 26.41 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.305 0.574 . . . . 34.42 109.773 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 434' ' ' THR . 52.7 t -83.68 129.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.478 -0.783 . . . . 62.21 110.004 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -15.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 118.571 -1.251 . . . . 62.14 110.724 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.51 37.95 Favored Glycine 0 N--CA 1.418 -2.516 0 CA-C-N 115.331 -0.849 . . . . 44.42 111.146 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 486' ' ' ILE . 2.9 p -136.15 161.87 34.53 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.915 -1.143 . . . . 73.24 107.915 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.423 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.7 t30 -62.97 -49.76 80.12 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 120.75 -0.38 . . . . 71.22 110.87 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 13.5 Cg_exo -69.44 141.71 47.3 Favored 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 106.586 -2.121 . . . . 43.41 106.586 167.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.48 127.24 21.24 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.771 1.648 . . . . 41.14 112.699 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 -1.69 21.07 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.885 0.874 . . . . 53.31 113.162 -174.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -110.02 -4.27 15.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.028 -0.42 . . . . 72.42 110.136 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 13.9 mp0 -121.3 176.51 5.6 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 114.626 1.343 . . . . 75.4 114.626 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -80.48 132.65 35.73 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.708 -1.587 . . . . 54.21 110.334 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.7 p -137.26 149.54 47.2 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.605 -0.887 . . . . 64.44 108.605 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.23 148.55 45.41 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 120.206 -0.598 . . . . 61.34 111.262 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.76 -28.24 44.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.865 0.84 . . . . 75.51 110.878 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 p -88.0 5.48 40.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.954 -1.021 . . . . 63.45 111.434 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.0 135.83 33.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.111 -1.44 . . . . 63.01 107.111 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 53.0 t -79.83 112.91 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.351 -1.351 . . . . 64.55 107.351 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.25 118.81 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 109.083 -0.71 . . . . 62.13 109.083 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 60.8 mt -92.6 113.39 27.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 106.469 -1.678 . . . . 73.11 106.469 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -97.18 116.46 39.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 108.545 -0.909 . . . . 74.14 108.545 -175.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 12.3 pt -102.9 117.06 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.491 1.139 . . . . 55.04 111.571 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.67 132.88 40.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.557 -1.275 . . . . 63.3 107.557 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -68.92 113.58 5.31 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.773 -1.331 . . . . 74.31 109.773 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 8.7 m -135.01 103.72 5.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.759 -0.46 . . . . 72.02 109.759 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 108.399 -1.88 . . . . 65.31 108.399 178.837 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.36 0 N-CA-C 110.169 -1.172 . . . . 74.11 110.169 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.8 pp -98.28 133.18 41.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.372 0.606 . . . . 65.22 111.856 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 7.2 t -132.33 146.07 51.72 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.628 -0.715 . . . . 64.31 109.879 -177.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -83.21 77.48 9.76 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.752 0.787 . . . . 75.34 111.95 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.35 148.07 44.85 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.679 -2.341 . . . . 73.2 104.679 172.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.74 152.92 19.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 119.522 -0.871 . . . . 71.23 113.149 -167.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -95.28 137.07 34.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.417 -1.697 . . . . 74.41 106.417 172.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.93 131.56 27.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 C-N-CA 119.27 -0.972 . . . . 73.22 109.711 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.65 150.74 51.04 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.7 2.933 . . . . 53.12 114.026 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -72.76 -30.13 63.88 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.077 -0.965 . . . . 74.45 110.459 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 368' ' ' GLN . 42.5 t 66.77 27.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 124.193 1.949 . . . . 73.32 107.097 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 28.0 ptt180 -58.17 125.08 21.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 112.464 -2.153 . . . . 70.14 113.362 -176.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.52 -16.78 54.63 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.863 -1.062 . . . . 45.51 111.719 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.491 ' HB2' HG12 ' A' ' 365' ' ' VAL . 41.7 mt-30 -103.89 170.23 8.04 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.796 0.439 . . . . 72.5 110.006 -176.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.9 p -71.75 160.86 31.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.185 0.517 . . . . 61.13 111.998 -175.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 11.3 p -62.05 -33.85 75.17 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.637 -0.711 . . . . 55.41 110.245 174.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.5 98.58 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.011 -0.54 . . . . 52.21 110.688 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.91 -39.83 79.44 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.847 -0.341 . . . . 63.25 110.249 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.3 72.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.187 -0.46 . . . . 43.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.77 -45.26 91.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.661 178.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.55 83.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.169 -0.469 . . . . 70.02 111.769 -179.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.3 m -61.62 -47.44 85.39 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.585 0.354 . . . . 73.42 111.229 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.84 -38.67 91.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.619 0.229 . . . . 31.11 111.619 178.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -59.83 -46.16 90.12 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.501 0.72 . . . . 41.23 109.496 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -70.9 -16.62 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.32 -0.854 . . . . 61.4 112.484 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -87.31 -14.09 41.81 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.583 -0.895 . . . . 64.04 108.583 176.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.627 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.75 -2.67 55.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-N 115.089 -0.96 . . . . 74.12 111.976 178.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.72 150.6 34.42 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.162 0.506 . . . . 72.04 111.271 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 145.03 25.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.26 -1.756 . . . . 63.2 106.26 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.61 135.72 60.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.887 1.069 . . . . 73.53 113.887 -174.108 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -111.03 132.07 54.54 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.647 -1.983 . . . . 50.13 105.647 172.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.1 m -119.52 122.73 42.31 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.236 -0.586 . . . . 71.45 110.378 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.23 127.45 55.61 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.872 -1.159 . . . . 72.14 107.872 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 13.4 pm0 -108.82 122.48 47.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.2 OUTLIER -122.0 132.77 24.18 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.283 -0.417 . . . . 64.14 110.76 -177.865 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -97.56 137.6 0.44 Allowed 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 122.3 2.0 . . . . 74.51 113.152 176.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 13.8 t70 164.85 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 126.645 1.978 . . . . 74.21 106.277 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.9 m -138.27 -8.48 1.52 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 118.901 0.773 . . . . 51.33 111.909 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.79 -3.32 57.5 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 122.156 0.979 . . . . 73.22 109.601 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 391' ' ' ASP . 7.4 pt -99.69 151.7 37.55 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 113.982 -1.463 . . . . 71.31 110.368 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 51.2 Cg_exo -56.43 131.91 48.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.302 2.668 . . . . 51.02 113.932 -178.44 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 70.0 Cg_exo -55.3 164.54 3.78 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 124.913 3.742 . . . . 61.23 113.511 177.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.438 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 17.1 t70 -55.25 -9.9 0.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.493 1.517 . . . . 73.34 113.457 -174.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -87.58 124.31 33.37 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.921 -1.14 . . . . 70.04 107.921 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 44.8 t -63.16 119.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.607 -0.724 . . . . 75.33 109.845 -173.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.6 tp -90.5 -32.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.587 -0.733 . . . . 74.12 109.48 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -174.88 169.11 41.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.842 -0.903 . . . . 53.1 110.842 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.8 p -114.48 -176.69 2.96 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.066 0.947 . . . . 75.13 108.696 176.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.49 143.49 26.52 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 108.563 -0.903 . . . . 71.34 108.563 -176.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -37.23 -30.7 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.8 1 C-N-CA 125.394 4.063 . . . . 75.2 115.593 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.76 -32.15 70.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.126 0.489 . . . . 71.12 110.972 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.52 25.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.619 -0.718 . . . . 33.44 110.373 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -88.57 -7.09 57.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.393 -0.822 . . . . 74.0 111.661 -173.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.3 m -95.39 162.22 13.75 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.144 -1.428 . . . . 71.25 107.144 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 28.8 m -74.26 113.34 11.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 120.059 -0.656 . . . . 41.25 110.16 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.48 165.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.304 -0.862 . . . . 71.11 109.761 178.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.8 m -75.51 141.64 42.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.555 -0.535 . . . . 74.33 109.555 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.96 129.93 42.01 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.294 0.569 . . . . 45.25 110.226 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 103.01 11.14 35.14 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.524 -0.846 . . . . 44.42 111.896 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.17 173.74 10.97 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.68 -1.23 . . . . 75.42 107.68 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -110.63 122.62 48.23 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.644 0.735 . . . . 70.02 111.366 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.8 mm -113.05 133.42 58.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.181 -0.918 . . . . 74.41 109.779 -175.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -102.69 124.87 49.02 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.479 -0.934 . . . . 72.0 108.479 177.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.48 134.39 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.596 -0.52 . . . . 72.4 109.596 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -110.05 129.23 55.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.186 -0.672 . . . . 65.14 109.186 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -128.59 141.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.838 -1.074 . . . . 74.31 108.211 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 10.6 m -95.9 122.62 38.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.546 -0.862 . . . . 72.45 110.102 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 59.8 p -117.82 107.48 14.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.758 -0.655 . . . . 75.12 110.985 -177.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.32 136.62 2.02 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.809 -0.632 . . . . 53.24 113.486 177.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 71.1 Cg_endo -75.67 155.02 39.82 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.33 2.02 . . . . 72.05 111.634 178.037 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.21 143.86 30.17 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 74.52 108.918 174.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.7 mt-30 -127.51 135.53 50.49 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.719 -1.215 . . . . 74.21 107.719 175.056 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -131.99 157.1 44.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.873 -0.788 . . . . 73.12 108.873 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.13 138.94 31.0 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.206 -1.405 . . . . 73.21 107.206 174.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -80.21 113.67 40.67 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.332 -0.618 . . . . 73.3 109.332 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.65 140.61 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.792 1.661 . . . . 53.52 109.878 176.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -107.47 97.58 7.3 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.375 1.083 . . . . 62.24 113.603 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.27 5.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 105.349 -2.093 . . . . 75.14 105.349 169.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.715 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 12.8 m -72.07 -46.42 56.95 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 113.447 -1.706 . . . . 53.25 110.393 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 23.1 p -65.37 -23.29 66.94 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.208 -0.906 . . . . 45.33 110.962 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.42 -48.07 7.34 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.461 -0.79 . . . . 73.44 111.326 -179.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.3 m -143.79 113.41 7.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.098 0.475 . . . . 72.31 111.251 -178.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -55.48 -51.83 65.64 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.371 1.068 . . . . 72.43 112.608 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.46 -43.65 96.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.401 . . . . 63.2 111.212 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.66 -35.06 79.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.822 -0.627 . . . . 73.22 110.47 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.715 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.72 -48.52 81.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 116.012 -0.54 . . . . 55.22 110.666 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.43 -43.3 90.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-N 115.17 -0.923 . . . . 64.4 109.834 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 71.5 mmtt -66.43 -47.53 72.9 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.865 -0.607 . . . . 74.44 110.524 -177.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.57 -41.46 88.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.751 -0.659 . . . . 74.24 112.123 -177.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.31 -32.98 73.5 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.574 0.583 . . . . 75.42 112.574 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.4 m -66.96 -43.26 83.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.842 -0.799 . . . . 75.22 108.842 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.16 62.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.976 -0.556 . . . . 65.02 111.042 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.81 -13.11 59.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.413 0.625 . . . . 75.45 110.005 177.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.36 -6.31 45.79 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-O 119.223 -0.765 . . . . 53.11 114.016 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.17 130.71 44.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.118 0.959 . . . . 75.05 110.562 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.6 2.82 10.22 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.061 -1.066 . . . . 73.53 113.478 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.44 114.29 19.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.895 -0.779 . . . . 72.42 108.895 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -131.96 161.95 31.88 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.11 0.481 . . . . 74.24 110.731 -176.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 1.4 tpmt? -149.23 122.94 9.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 71.22 105.53 172.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -107.74 134.87 50.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.042 0.449 . . . . 72.13 111.193 -176.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.4 145.35 47.22 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.369 -0.832 . . . . 70.51 109.12 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 31.2 m-80 -117.65 129.51 55.79 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.372 -1.344 . . . . 63.42 107.372 175.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.8 t -130.23 147.37 65.46 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.853 -0.795 . . . . 65.23 108.853 -176.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -61.51 130.99 33.8 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 122.632 2.222 . . . . 71.14 111.489 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 55.1 p -136.23 -177.93 4.93 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.782 -1.192 . . . . 65.34 107.782 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.1 m -66.12 136.73 95.49 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 106.17 -1.789 . . . . 75.45 106.17 172.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.15 -28.16 19.06 Favored 'Trans proline' 0 C--O 1.207 -1.058 0 C-N-CA 123.583 2.855 . . . . 62.53 113.334 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -62.24 -16.76 55.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.496 0.554 . . . . 65.34 112.496 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.432 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.0 mm? -107.59 6.0 27.49 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.108 -0.37 . . . . 71.03 110.866 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.76 127.44 19.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.446 0.641 . . . . 64.32 111.807 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.56 -3.37 85.14 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.495 -0.775 . . . . 71.15 112.692 175.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -112.1 160.79 17.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.499 -0.926 . . . . 64.13 108.499 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.49 131.34 34.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.588 -0.893 . . . . 64.45 108.588 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.48 -20.75 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.239 0.543 . . . . 74.12 111.437 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.35 166.73 30.59 Favored Glycine 0 N--CA 1.418 -2.559 0 C-N-CA 120.46 -0.876 . . . . 34.11 111.891 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 486' ' ' ILE . 11.0 p -125.01 144.2 50.51 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.194 -1.41 . . . . 75.24 107.194 177.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.456 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.7 t-20 -57.41 -48.19 97.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 120.604 -0.438 . . . . 63.12 110.899 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -78.25 121.04 5.12 Favored 'Trans proline' 0 C--N 1.37 1.66 0 N-CA-C 107.952 -1.595 . . . . 72.23 107.952 168.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.13 140.79 80.11 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.377 2.052 . . . . 74.25 112.401 -176.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.17 11.59 0.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.675 0.79 . . . . 62.12 112.754 -176.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -109.81 -0.16 18.52 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.882 -0.414 . . . . 45.12 109.882 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -124.65 160.99 27.24 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.645 0.735 . . . . 71.4 111.473 -173.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 4.1 m -91.16 132.69 35.91 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.961 -1.472 . . . . 63.54 109.732 -177.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.2 m -132.11 148.4 52.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.949 -0.76 . . . . 63.34 108.949 177.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.75 159.67 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.261 0.553 . . . . 44.1 111.848 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.0 -27.2 31.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.545 0.688 . . . . 73.31 109.835 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.1 t -88.11 5.12 42.73 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.255 -0.884 . . . . 61.31 109.905 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.76 136.83 35.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.989 -1.486 . . . . 72.53 106.989 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 65.0 t -82.57 116.36 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.942 0.401 . . . . 72.34 109.99 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.81 118.57 33.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.355 -0.98 . . . . 74.33 108.355 177.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.78 112.95 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.017 -1.475 . . . . 73.44 107.017 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.477 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -102.65 118.3 49.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.164 -1.051 . . . . 73.54 108.164 -177.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 28.8 mt -107.45 119.5 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 121.472 0.654 . . . . 74.44 109.986 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.442 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 22.1 t -97.99 139.26 20.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.446 -0.946 . . . . 71.25 108.446 -178.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.87 124.5 7.01 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.193 -0.763 . . . . 61.41 111.193 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 20.1 t -131.87 103.64 6.43 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.821 -1.177 . . . . 75.25 107.821 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.249 0 N-CA-C 109.756 -1.338 . . . . 41.45 109.756 179.222 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.867 0 N-CA-C 110.136 -1.186 . . . . 61.11 110.136 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.46 157.47 43.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 122.535 0.334 . . . . 71.32 111.104 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.6 t -66.9 131.02 45.02 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 108.577 -0.897 . . . . 63.44 108.577 173.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -90.29 84.51 6.06 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.461 -0.79 . . . . 74.3 111.202 -173.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -94.19 131.91 39.28 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.32 -0.993 . . . . 75.24 108.32 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.41 161.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 116.54 -0.3 . . . . 43.44 110.832 -173.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -97.71 137.08 37.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.388 -0.967 . . . . 73.25 108.388 175.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.0 135.14 21.54 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.695 -0.483 . . . . 70.52 109.695 -176.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.6 150.92 86.13 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.256 1.97 . . . . 71.31 112.012 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.579 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 3.2 p30 -79.09 179.75 7.17 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.384 -0.825 . . . . 74.35 110.674 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.67 26.4 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 N-CA-C 107.433 -1.321 . . . . 73.44 107.433 176.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.579 ' HG3' ' OD1' ' A' ' 364' ' ' ASP . 0.9 OUTLIER -66.25 139.47 58.08 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.563 0.579 . . . . 74.23 112.563 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.65 0.24 59.28 Favored Glycine 0 C--N 1.307 -1.081 0 N-CA-C 111.577 -0.609 . . . . 44.42 111.577 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -122.57 -168.12 1.68 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.907 0.483 . . . . 70.1 109.718 -178.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -89.1 158.18 18.04 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.757 0.313 . . . . 63.4 110.548 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 31.1 t -63.37 -33.73 76.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.831 -0.803 . . . . 70.31 108.831 173.265 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.1 88.56 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.556 -0.747 . . . . 72.32 110.83 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.73 -43.92 87.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.491 -0.559 . . . . 72.44 109.491 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.5 -45.85 80.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.563 -0.744 . . . . 72.44 111.788 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.17 -48.06 89.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 123.382 0.426 . . . . 72.53 110.853 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.51 70.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.374 0.509 . . . . 71.24 112.374 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.0 m -61.35 -48.07 82.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.252 -0.431 . . . . 55.12 111.492 -177.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.92 -37.84 88.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.703 0.287 . . . . 64.31 111.398 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 65.7 tp60 -60.59 -44.62 96.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.402 0.681 . . . . 73.25 109.879 177.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.08 -22.64 64.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.729 -0.668 . . . . 74.34 111.284 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.2 mmt180 -84.13 -14.27 50.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.088 0.47 . . . . 74.35 109.843 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 99.54 4.68 55.95 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.707 -0.679 . . . . 63.45 112.554 176.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.88 160.54 17.16 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 120.84 0.353 . . . . 71.35 110.487 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.37 142.82 32.21 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.69 -1.596 . . . . 74.22 106.69 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.09 132.61 67.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.996 -0.681 . . . . 72.2 111.384 -178.492 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -109.11 126.51 53.27 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 105.751 -1.944 . . . . 70.42 105.751 176.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 m -116.05 118.19 32.2 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 120.305 -0.558 . . . . 73.52 110.302 -173.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.06 119.18 34.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.097 -1.446 . . . . 65.41 107.097 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 17.5 pm0 -118.1 133.53 55.82 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.956 -0.757 . . . . 73.31 108.956 178.177 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -139.47 148.85 58.01 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 109.432 -0.581 . . . . 63.44 109.432 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.07 136.61 16.51 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 108.158 -1.516 . . . . 74.41 108.158 167.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t0 -173.15 164.73 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.032 -2.21 . . . . 63.02 105.032 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.3 t -115.96 -9.39 11.78 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 118.89 0.768 . . . . 75.13 110.664 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.8 m -79.5 -18.01 52.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.925 0.869 . . . . 75.32 109.386 -176.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 421' ' ' SER . 9.7 pt -103.48 150.87 38.47 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 65.54 110.333 -178.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 46.8 Cg_endo -78.74 -166.74 0.43 Allowed 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 124.425 3.416 . . . . 73.32 113.123 -174.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 396' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 9.3 Cg_endo -55.74 163.91 5.03 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.292 2.661 . . . . 71.24 112.011 168.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.44 -7.89 0.46 Allowed 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.886 1.674 . . . . 51.2 113.631 -174.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -73.28 116.63 14.05 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.309 -0.997 . . . . 63.54 108.309 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.87 119.2 11.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.384 -0.825 . . . . 75.33 110.817 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.422 HD13 ' HG3' ' A' ' 395' ' ' PRO . 41.2 pt -91.93 -27.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.695 -0.684 . . . . 70.42 111.682 -177.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.08 158.33 27.65 Favored Glycine 0 N--CA 1.423 -2.19 0 C-N-CA 120.021 -1.085 . . . . 73.33 110.652 -178.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -113.22 -178.21 3.32 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.758 -0.46 . . . . 75.52 109.758 -178.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.93 131.99 22.65 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 108.338 -0.986 . . . . 65.11 108.338 -177.068 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -44.32 -32.52 5.29 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 124.521 3.481 . . . . 63.13 115.158 -176.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.89 68.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.371 -0.377 . . . . 61.13 111.581 -177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.54 79.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.11 110.579 178.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -88.81 1.07 55.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.202 -0.599 . . . . 70.14 111.118 -178.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.7 m -86.35 150.04 24.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.715 -1.217 . . . . 52.54 107.715 172.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.58 112.43 10.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.53 169.98 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.859 -0.609 . . . . 72.54 110.77 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -63.19 142.99 58.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.754 -0.657 . . . . 54.53 109.967 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.96 109.74 2.65 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.562 -0.533 . . . . 74.42 109.562 177.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 106.01 33.56 3.46 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.578 -0.82 . . . . 72.33 112.079 -178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -90.4 177.26 6.44 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.084 -1.08 . . . . 63.45 108.084 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.04 120.17 36.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.22 0.533 . . . . 72.51 111.158 -177.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.84 126.03 59.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.126 -1.435 . . . . 73.5 107.126 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.1 t -93.62 125.21 38.1 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.275 1.036 . . . . 72.03 111.556 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.02 120.01 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 60.31 107.655 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.82 119.11 32.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.813 -0.63 . . . . 51.54 109.301 178.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 21.5 t -117.22 142.12 32.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.617 -0.72 . . . . 75.44 109.809 -175.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 394' ' ' ILE . 1.9 p -102.27 121.55 42.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 116.071 -0.513 . . . . 44.12 110.309 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.1 p -119.75 105.46 11.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.236 -0.585 . . . . 61.1 110.861 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.93 120.74 0.18 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 121.143 -0.551 . . . . 53.13 113.639 178.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 55.7 Cg_endo -75.22 128.95 11.71 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.239 1.959 . . . . 54.14 111.654 176.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -73.33 135.1 44.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.351 0.871 . . . . 74.42 113.351 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.5 mt-30 -128.04 142.44 51.22 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.28 -1.378 . . . . 42.12 107.28 172.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -129.56 151.78 49.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.642 -0.873 . . . . 65.01 108.642 -178.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 39.9 mt-10 -83.45 133.91 34.89 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.886 -0.413 . . . . 74.12 109.886 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 61.2 mt -81.96 128.53 68.06 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.507 -1.294 . . . . 55.43 107.507 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.87 140.37 35.03 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 121.141 1.228 . . . . 72.22 111.122 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.29 72.62 5.33 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.057 0.932 . . . . 73.13 110.813 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.1 16.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.953 -1.476 . . . . 44.35 108.454 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -81.26 -24.85 37.04 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.991 -1.004 . . . . 71.04 110.586 -175.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 3.1 p -69.26 -13.73 62.56 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 113.103 0.779 . . . . 72.21 113.103 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.61 -47.63 72.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.642 0.608 . . . . 72.44 112.642 -177.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.1 m -162.37 137.94 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.394 -0.965 . . . . 75.13 108.394 -178.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -53.77 -50.12 66.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.8 0.44 . . . . 72.44 111.826 178.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -58.84 -42.98 90.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.361 0.413 . . . . 72.12 111.076 -179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 72.9 mm-40 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 65.12 111.17 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.09 92.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.82 0.7 . . . . 74.44 110.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.84 -42.51 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 64.51 109.975 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.3 mmtp -67.08 -44.99 78.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.288 -0.414 . . . . 70.32 111.036 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 32.9 mmmt -61.97 -46.28 89.95 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.009 0.193 . . . . 74.15 110.887 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.18 81.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.486 0.551 . . . . 72.52 112.486 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 64.0 m -62.44 -40.85 97.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.807 -0.442 . . . . 63.54 109.807 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.45 -29.75 68.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.04 111.206 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -6.75 57.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 73.42 111.198 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.2 -2.82 33.14 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.06 -0.59 . . . . 73.31 113.412 175.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -93.63 96.0 9.56 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.665 -0.495 . . . . 74.11 109.665 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -104.38 -3.91 43.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.115 -0.794 . . . . 52.14 111.115 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -93.92 112.08 23.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.514 -0.921 . . . . 72.12 108.514 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.67 150.99 48.68 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.469 0.652 . . . . 72.34 112.011 -175.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -134.28 122.41 22.67 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 105.067 -2.197 . . . . 73.34 105.067 172.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -97.9 129.81 44.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.07 -0.652 . . . . 53.14 112.435 -174.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.69 150.97 50.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.142 -1.429 . . . . 65.52 107.142 175.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.554 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 35.9 m-80 -129.44 149.5 51.19 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.634 -0.506 . . . . 73.13 109.634 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.2 t -128.97 133.61 25.4 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 107.438 -1.319 . . . . 73.23 107.438 177.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.5 Cg_exo -61.9 118.73 5.63 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.493 1.462 . . . . 72.15 108.622 176.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.9 m -128.07 168.27 15.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.188 0.518 . . . . 62.23 111.852 -172.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 21.0 p -69.55 151.89 96.49 Favored Pre-proline 0 N--CA 1.417 -2.095 0 CA-C-N 114.705 -1.134 . . . . 55.21 110.452 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.2 Cg_endo -52.13 -24.48 20.26 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.827 3.018 . . . . 65.52 114.937 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.44 -30.56 57.42 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.721 -0.612 . . . . 74.12 112.282 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.71 -3.26 49.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.178 0.436 . . . . 63.31 112.178 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.2 p -60.2 127.16 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.116 0.484 . . . . 71.53 110.636 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.57 82.58 Favored Glycine 0 C--O 1.248 1.009 0 CA-C-N 115.773 -0.649 . . . . 53.1 111.746 177.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -110.66 154.37 23.92 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.019 -0.734 . . . . 40.15 109.019 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 486' ' ' ILE . 57.5 t -84.61 135.06 25.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 N-CA-C 106.644 -1.613 . . . . 54.03 106.644 175.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -100.43 -27.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.042 -1.463 . . . . 73.43 110.687 178.112 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.01 163.7 34.0 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.797 -0.921 . . . . 74.11 110.797 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 486' ' ' ILE . 12.6 p -119.02 154.49 33.01 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.941 -1.133 . . . . 73.0 107.941 177.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HB ' ' A' ' 485' ' ' ILE . 24.4 t-20 -69.38 -51.26 17.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 119.619 -0.833 . . . . 64.1 110.627 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.442 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 22.5 Cg_exo -68.35 141.32 51.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 107.443 -1.791 . . . . 64.42 107.443 168.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.19 126.85 19.56 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 122.168 1.912 . . . . 71.41 112.984 -175.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.19 4.47 26.57 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.144 -0.934 . . . . 72.01 111.785 -175.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -109.67 -11.62 14.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.473 0.654 . . . . 75.43 109.351 175.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -114.08 -179.73 3.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.606 1.706 . . . . 72.03 115.606 -168.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.8 m -88.2 116.18 26.22 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.866 -1.97 . . . . 72.34 110.676 -174.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.8 m -121.36 148.18 44.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.19 -0.67 . . . . 73.51 109.19 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.9 149.18 50.06 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 122.392 0.277 . . . . 72.1 111.122 -177.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 43.2 mm -68.9 -26.02 31.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.195 0.521 . . . . 64.5 111.019 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -88.83 -0.5 57.41 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.501 -0.75 . . . . 52.01 110.049 177.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -70.42 130.94 43.24 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.473 -0.566 . . . . 74.31 109.473 -176.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.87 113.18 18.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.564 -1.273 . . . . 74.21 107.564 177.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 60.1 t -87.16 120.06 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-O 121.321 0.581 . . . . 74.54 109.871 -176.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 45.4 mt -91.2 112.28 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.605 -1.998 . . . . 73.44 105.605 177.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.2 121.45 60.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.667 0 CA-C-N 115.016 -0.993 . . . . 71.15 108.404 -174.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.455 HG22 HD11 ' A' ' 468' ' ' ILE . 2.4 mp -99.22 117.87 44.97 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.767 0.794 . . . . 74.22 109.049 -177.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.554 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 26.7 t -97.66 141.36 16.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.809 -1.087 . . . . 53.41 108.54 -176.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -89.4 116.81 4.79 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.49 -1.444 . . . . 72.14 109.49 175.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.0 t -136.6 138.93 41.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.006 -1.109 . . . . 75.53 108.006 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.562 0 N-CA-C 108.555 -1.818 . . . . 55.42 108.555 179.675 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.928 0 N-CA-C 110.261 -1.136 . . . . 53.23 110.261 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -104.22 157.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.977 0.388 . . . . 73.44 111.842 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.0 t -145.39 166.21 26.25 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.618 -1.623 . . . . 72.14 106.618 176.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -87.23 45.36 1.26 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.896 0.855 . . . . 63.21 111.11 -175.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 411' ' ' SER . 28.1 m-20 -131.67 133.07 44.5 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.491 -1.67 . . . . 71.31 106.491 178.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.97 165.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 114.682 1.364 . . . . 53.44 114.682 -166.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -93.11 137.03 32.83 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.507 -1.664 . . . . 73.2 106.507 174.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.66 141.61 23.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.109 -0.636 . . . . 74.2 111.078 -171.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.63 129.92 16.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.569 1.513 . . . . 62.25 111.435 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 8.1 p-10 -80.12 133.78 36.11 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.355 -0.839 . . . . 63.01 110.372 -179.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.9 t -87.74 47.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.443 1.116 . . . . 72.44 110.513 -172.074 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.3 ptm180 -66.88 139.97 57.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.134 -0.939 . . . . 75.25 111.544 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.05 0.18 60.15 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 116.117 -0.492 . . . . 70.04 112.906 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -120.35 175.35 6.01 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 122.509 -0.406 . . . . 74.15 110.154 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.3 p -72.98 157.24 37.8 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.218 -0.29 . . . . 43.34 110.218 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.2 p -59.78 -39.05 83.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.848 -0.427 . . . . 72.11 109.848 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.77 93.25 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.412 -0.813 . . . . 63.12 111.993 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -67.13 -41.99 85.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.807 -0.812 . . . . 74.32 108.807 -178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.3 78.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.421 -0.809 . . . . 64.21 111.189 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 370' ' ' SER . 98.7 mt -58.63 -44.83 90.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.577 -0.527 . . . . 74.32 109.577 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.66 74.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.25 -0.886 . . . . 52.31 112.063 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 29.1 m -66.12 -48.66 70.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.415 0.626 . . . . 73.1 109.872 -179.016 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.89 -39.83 91.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.782 -0.645 . . . . 52.34 110.581 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -61.6 -44.9 96.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 74.14 110.668 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -70.08 -21.31 63.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.153 0.501 . . . . 44.1 111.261 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -86.98 -14.65 41.08 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.158 -0.474 . . . . 72.3 111.458 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.26 8.05 66.89 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.261 -0.971 . . . . 75.0 112.657 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -75.36 163.75 27.12 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.158 -0.682 . . . . 64.52 109.158 178.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.8 mmtm -103.29 132.85 49.22 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.349 -0.982 . . . . 63.31 108.349 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.17 153.87 39.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 121.742 0.782 . . . . 62.21 112.823 -175.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -123.33 128.23 49.64 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.529 -1.669 . . . . 64.33 106.78 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.6 m -106.25 117.75 34.85 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.114 -1.069 . . . . 71.44 108.114 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 387' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.4 tm? -111.66 118.93 37.0 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 107.741 -1.207 . . . . 74.05 107.741 -176.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.9 pm0 -108.41 122.2 46.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.32 -0.993 . . . . 64.32 108.32 174.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -125.87 136.29 28.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 C-N-CA 120.446 -0.502 . . . . 72.34 111.706 -176.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.431 ' C ' ' HG3' ' A' ' 425' ' ' GLU . 2.4 Cg_endo -85.51 131.43 4.04 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 122.197 1.932 . . . . 72.52 108.163 167.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -175.3 -173.67 0.67 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.431 -2.063 . . . . 73.5 105.431 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.603 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 49.7 m -117.36 -6.6 11.24 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.943 0.877 . . . . 62.21 109.116 175.032 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.9 m -98.36 35.45 1.78 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.717 -1.586 . . . . 75.34 106.717 175.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.4 pp -88.33 146.43 37.86 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.893 -1.049 . . . . 73.23 112.131 -176.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.09 178.44 5.89 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.148 1.899 . . . . 51.13 109.399 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.28 161.37 45.95 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 121.609 1.539 . . . . 75.05 110.648 172.78 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -9.0 3.52 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.418 1.104 . . . . 75.24 111.095 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -110.42 137.07 48.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 105.379 -2.082 . . . . 74.4 105.379 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.54 118.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 123.453 0.471 . . . . 45.15 109.748 -173.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.31 -29.32 4.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.769 -1.567 . . . . 55.31 106.769 178.643 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.66 168.6 41.67 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 108.995 -1.642 . . . . 61.25 108.995 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 402' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 403' ' ' ASP . 10.9 m -114.33 -177.07 3.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.583 -1.636 . . . . 72.31 106.583 178.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 402' ' ' THR . 13.9 t70 -97.53 140.06 21.77 Favored Pre-proline 0 C--N 1.26 -3.307 0 N-CA-C 106.852 -1.536 . . . . 71.3 106.852 -175.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -33.81 -30.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 1 C-N-CA 126.209 4.606 . . . . 71.53 115.53 -177.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.82 47.16 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 123.611 0.765 . . . . 74.23 112.014 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.87 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 62.22 111.612 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -81.56 -0.6 42.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.837 0.68 . . . . 74.42 112.837 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 58.8 m -88.37 155.68 19.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.12 -1.437 . . . . 54.1 107.12 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.7 m -73.12 114.02 10.82 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.492 0.663 . . . . 74.31 109.273 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.74 170.29 5.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.305 -0.861 . . . . 63.42 109.537 -178.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 411' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 8.5 t -71.01 149.14 46.92 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 109.219 -0.66 . . . . 74.44 109.219 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.22 109.66 2.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.442 -0.948 . . . . 73.22 108.442 177.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.36 32.62 9.36 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.923 -0.871 . . . . 50.31 110.923 -176.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.6 t0 -87.05 -174.9 5.13 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 107.831 -1.174 . . . . 62.43 107.831 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 7.9 pt-20 -97.45 138.11 35.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.049 0.452 . . . . 74.42 111.51 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -125.01 124.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.933 -1.136 . . . . 51.41 107.933 175.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -90.86 125.95 35.89 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.846 0.831 . . . . 71.35 110.533 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.99 117.71 56.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.15 -1.055 . . . . 70.3 108.15 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 419' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 5.3 p30 -106.33 129.44 54.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.308 0.575 . . . . 74.24 112.468 -177.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.8 152.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.763 -1.108 . . . . 54.21 108.588 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 31.1 p -88.56 123.29 32.91 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.672 0.619 . . . . 70.44 112.672 -174.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 p -119.87 103.46 9.36 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.13 -1.028 . . . . 62.41 110.067 169.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.13 0.12 Allowed Glycine 0 CA--C 1.553 2.428 0 N-CA-C 115.473 0.949 . . . . 51.13 115.473 177.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.8 Cg_endo -85.47 133.65 4.61 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.202 1.935 . . . . 64.01 110.652 173.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 390' ' ' PRO . 10.0 mt-10 -76.44 145.19 39.45 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 113.167 0.803 . . . . 64.34 113.167 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.9 mt-30 -120.66 157.23 30.04 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.183 -1.371 . . . . 74.42 108.748 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -143.17 156.62 44.81 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.413 -1.329 . . . . 73.44 107.413 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.8 138.86 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.132 -1.062 . . . . 72.42 108.132 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 68.6 mt -79.52 132.14 62.84 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 73.54 108.687 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -53.19 141.53 58.64 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.607 2.205 . . . . 74.14 113.224 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.13 -17.72 48.91 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.505 -1.225 . . . . 73.01 112.19 -175.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.5 m -75.47 5.41 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.448 0.907 . . . . 64.23 113.448 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 48.3 m -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.264 0.839 . . . . 71.32 113.264 -175.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 52.5 m -68.92 -13.91 62.72 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.973 0.509 . . . . 62.42 112.365 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.16 -45.51 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.61 0.596 . . . . 73.04 112.61 -175.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 436' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 439' ' ' GLU . 48.1 m -162.73 145.22 10.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.525 -1.287 . . . . 51.22 107.525 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -56.84 -42.93 80.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.329 . . . . 64.33 111.102 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 438' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -62.62 -36.76 83.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 55.11 111.048 179.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 436' ' ' THR . 6.5 tp10 -67.8 -44.77 76.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.07 -0.715 . . . . 64.34 109.07 -178.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.92 -51.18 70.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.545 -1.207 . . . . 72.23 110.773 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.43 -38.29 80.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 113.439 0.903 . . . . 74.11 113.439 -177.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.8 mmtt -65.3 -49.02 71.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.9 -0.72 . . . . 74.32 110.166 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.01 -42.57 84.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.116 0.784 . . . . 74.3 113.116 -177.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.37 -43.69 76.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.231 0.456 . . . . 71.5 112.231 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -63.31 -41.86 98.97 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.951 0.405 . . . . 72.3 110.628 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.0 -24.64 62.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.96 -0.564 . . . . 61.3 111.602 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.56 -5.83 59.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 70.21 111.453 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.59 -17.73 25.47 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.473 -0.87 . . . . 63.03 112.204 178.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.04 67.89 7.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.201 0.524 . . . . 65.25 109.921 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -96.2 32.49 6.38 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.67 -0.972 . . . . 73.44 110.67 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -118.7 110.42 17.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.023 -1.843 . . . . 65.12 106.023 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.89 154.15 47.6 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.339 1.066 . . . . 74.3 113.084 -176.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.58 123.11 12.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 104.998 -2.223 . . . . 74.43 104.998 168.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -98.11 135.34 39.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.207 0.527 . . . . 74.33 111.469 -172.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.421 ' HB3' HG12 ' A' ' 487' ' ' ILE . . . -127.09 148.01 50.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.425 -1.324 . . . . 65.42 107.425 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -124.44 141.42 52.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.088 -1.078 . . . . 63.52 108.088 178.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.2 m -140.36 147.14 48.51 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 108.862 -0.792 . . . . 51.44 108.862 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 490' ' ' SER . 33.8 Cg_exo -61.45 129.66 28.95 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.708 2.272 . . . . 74.45 111.678 -176.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -145.83 164.68 31.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.154 -0.476 . . . . 73.13 111.035 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -61.37 144.6 91.75 Favored Pre-proline 0 N--CA 1.442 -0.864 0 O-C-N 124.27 0.981 . . . . 74.12 110.463 178.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.37 -34.28 31.93 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.996 3.131 . . . . 74.22 113.832 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.77 -15.3 62.66 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.381 0.511 . . . . 75.53 112.381 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 -8.52 14.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.504 -0.316 . . . . 71.44 111.775 176.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 81.3 t -60.35 126.94 19.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 120.953 0.406 . . . . 74.32 110.546 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.87 -3.16 70.36 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 110.962 -0.855 . . . . 75.1 110.962 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -116.38 155.44 28.48 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.086 -1.079 . . . . 75.31 108.086 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 486' ' ' ILE . 45.5 t -84.57 127.36 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.511 -0.551 . . . . 62.42 109.511 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.85 -18.14 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.929 -0.708 . . . . 74.12 111.405 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.19 161.7 28.04 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.574 -0.822 . . . . 53.51 111.708 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 486' ' ' ILE . 15.9 p -132.92 155.47 49.01 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.366 -1.346 . . . . 71.53 107.366 177.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -59.53 -57.85 23.87 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 120.516 -0.474 . . . . 73.33 110.103 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.19 125.21 5.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 109.09 -1.158 . . . . 74.52 109.09 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -62.36 144.17 94.7 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.057 1.838 . . . . 72.11 112.044 -177.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.29 5.98 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.159 0.984 . . . . 65.32 112.674 -174.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -109.0 -14.51 14.54 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.176 -0.466 . . . . 71.25 110.029 176.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.97 150.64 20.18 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.156 0.979 . . . . 74.24 111.717 -172.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 426' ' ' GLN . 19.4 m -85.23 111.42 19.82 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 113.588 -1.642 . . . . 63.35 107.769 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.0 m -118.19 148.56 42.25 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.917 -0.583 . . . . 73.12 110.036 -175.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.58 146.72 52.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 122.587 0.355 . . . . 70.43 110.781 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.603 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 48.3 mm -67.21 -14.68 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 CA-C-O 122.171 0.986 . . . . 71.13 110.306 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.0 t -92.16 5.52 50.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.603 -0.726 . . . . 63.41 110.358 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -89.66 133.76 34.49 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 110.062 -0.347 . . . . 72.33 110.062 178.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 122.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.855 -1.165 . . . . 71.21 107.855 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.77 119.79 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 120.19 -0.604 . . . . 75.32 109.49 -178.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.35 112.51 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.596 -2.372 . . . . 75.51 104.596 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.73 118.93 56.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 114.959 -1.018 . . . . 62.54 108.754 -173.528 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' A' ' 455' ' ' ALA . 41.2 mt -100.16 116.49 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.994 -0.743 . . . . 73.23 108.994 -177.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.6 138.14 23.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.692 -1.225 . . . . 73.52 107.692 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.48 114.69 3.93 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.285 -1.526 . . . . 44.21 109.285 177.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.7 m -142.9 143.93 32.23 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 122.009 -0.7 . . . . 62.02 109.667 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.364 0 N-CA-C 108.693 -1.763 . . . . 51.0 108.693 178.252 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.86 0 N-CA-C 111.171 -0.771 . . . . 43.32 111.171 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.47 157.75 23.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.829 0.314 . . . . 70.14 111.075 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.4 t -132.47 162.86 30.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.457 -0.571 . . . . 64.34 109.457 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 358' ' ' ARG . 3.5 mmp_? -114.21 92.96 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.608 0.718 . . . . 70.04 110.046 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -117.88 145.15 44.83 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.675 -1.602 . . . . 70.51 106.675 177.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.94 149.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.585 0.231 . . . . 74.42 110.45 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -95.8 136.48 36.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.637 -0.875 . . . . 74.11 108.637 177.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 8.6 p -97.86 127.49 37.04 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 120.329 -0.548 . . . . 74.01 110.389 -175.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 74.4 Cg_exo -56.05 148.83 56.34 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.086 2.524 . . . . 33.45 113.388 179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 146.3 53.03 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.392 -0.822 . . . . 73.44 111.493 -178.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 24.2 m -96.37 25.31 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 122.337 1.065 . . . . 72.04 109.659 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -65.32 137.17 57.35 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.778 -1.101 . . . . 75.44 111.995 -177.276 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.43 0.91 47.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.451 -0.88 . . . . 63.04 114.001 176.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 1.8 pt20 -125.83 -172.16 2.54 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.193 -0.669 . . . . 55.22 109.193 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 80.3 p -90.11 164.48 14.45 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.81 -0.756 . . . . 62.31 109.701 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 374' ' ' ILE . 3.8 p -62.09 -33.61 74.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.798 0.332 . . . . 74.24 110.305 175.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.66 98.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.794 -0.639 . . . . 63.12 109.962 176.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.321 -0.4 . . . . 72.25 110.108 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.29 70.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.763 0.665 . . . . 72.22 110.47 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 370' ' ' SER . 91.0 mt -60.25 -46.51 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.646 -0.706 . . . . 71.54 110.046 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.29 -46.99 84.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.105 -0.498 . . . . 74.2 111.905 -178.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.83 -47.84 76.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.516 -0.311 . . . . 72.05 110.431 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.17 -38.01 89.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.561 -0.29 . . . . 73.12 111.695 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -59.77 -46.92 87.67 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.601 0.76 . . . . 71.21 109.11 177.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -67.97 -30.73 70.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.558 -0.746 . . . . 72.35 111.193 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -80.09 -11.29 59.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.839 -0.619 . . . . 63.43 111.917 178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.72 12.46 58.04 Favored Glycine 0 CA--C 1.497 -1.034 0 C-N-CA 120.284 -0.96 . . . . 40.11 112.953 174.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.21 146.46 24.74 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.972 0.415 . . . . 72.32 109.954 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 34.0 mmtp -88.3 132.82 34.25 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.832 -1.914 . . . . 70.22 105.832 -178.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 141.45 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 119.899 -0.72 . . . . 73.31 111.674 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -115.99 127.98 55.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.175 -1.417 . . . . 73.32 107.175 177.179 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.6 m -101.06 119.27 38.5 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.597 -0.841 . . . . 71.12 109.709 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -111.73 119.65 39.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.64 -1.244 . . . . 73.44 107.64 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 12.4 pm0 -96.27 122.6 39.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.648 -0.706 . . . . 63.42 109.25 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -123.79 115.89 27.87 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 115.737 -0.665 . . . . 73.44 111.883 -177.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.59 134.7 6.62 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.18 1.92 . . . . 33.44 110.569 174.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.5 t70 175.71 -168.42 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 105.396 -2.076 . . . . 74.04 105.396 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.6 m -132.43 -11.0 3.2 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 118.38 0.537 . . . . 74.25 111.42 176.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 44.9 p -99.13 14.35 29.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.357 1.075 . . . . 61.4 109.5 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.401 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 1.5 pp -88.59 152.6 49.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 CA-C-N 113.877 -1.511 . . . . 71.52 112.583 -176.277 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.66 138.65 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.152 1.901 . . . . 72.31 109.921 174.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.25 154.5 40.05 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.796 2.33 . . . . 64.12 111.893 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.32 -8.48 3.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.506 0.67 . . . . 74.53 111.866 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 35.6 m170 -95.66 109.19 21.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.143 -2.169 . . . . 74.21 105.143 172.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.8 119.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.232 1.015 . . . . 61.35 112.85 -169.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.46 -29.02 3.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.063 -1.426 . . . . 73.5 110.504 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.54 28.88 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.029 -1.228 . . . . 63.41 110.029 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 -175.23 2.63 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.874 -0.787 . . . . 61.33 108.874 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.31 140.93 21.83 Favored Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 115.777 -0.647 . . . . 75.32 109.795 -172.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.27 -24.77 6.24 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 125.077 3.852 . . . . 43.35 115.059 -177.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.01 -29.34 69.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.591 0.234 . . . . 53.42 110.981 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.33 57.96 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 121.673 0.749 . . . . 44.21 110.13 178.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -79.4 -9.68 59.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.359 -0.837 . . . . 70.21 110.733 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.2 m -87.53 151.08 23.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.613 -0.884 . . . . 73.43 108.613 177.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 66.3 m -74.17 116.81 15.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.412 0.625 . . . . 54.3 109.636 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.09 169.97 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.444 -0.798 . . . . 73.15 109.501 -177.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.0 t -79.02 155.4 28.85 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.746 -1.205 . . . . 73.52 107.746 176.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.3 110.74 4.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.056 0.455 . . . . 74.33 110.244 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.07 37.7 1.63 Allowed Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.585 -0.734 . . . . 34.22 111.707 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.31 178.57 5.93 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.722 -1.214 . . . . 65.24 107.722 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.0 mt-10 -100.19 108.97 21.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.253 0.549 . . . . 74.13 111.525 -176.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.01 126.78 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.377 -1.342 . . . . 70.13 107.377 177.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 72.5 p -90.71 123.49 34.34 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.296 -0.562 . . . . 52.12 109.763 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.34 121.07 47.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.18 -1.045 . . . . 74.14 108.18 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -92.24 124.6 36.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.313 -0.625 . . . . 71.51 109.313 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.7 p -126.26 131.03 71.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.89 -1.152 . . . . 72.15 107.89 175.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 39.9 m -94.4 122.13 36.65 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.413 -0.915 . . . . 74.04 108.945 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 19.8 m -119.36 107.07 12.92 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.527 -0.761 . . . . 74.54 110.623 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 80.02 147.5 4.65 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 121.244 -0.503 . . . . 54.41 113.482 177.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.4 Cg_endo -85.01 154.48 11.22 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.186 1.924 . . . . 74.34 110.762 174.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 4.5 mm-40 -83.43 126.64 32.96 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 119.97 -0.692 . . . . 72.01 111.347 176.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 48.3 mt-30 -100.7 127.69 47.01 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.616 -1.253 . . . . 73.54 107.616 175.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 449' ' ' PHE . 10.1 tpt180 -122.2 149.41 43.7 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.941 -1.133 . . . . 70.41 107.941 -173.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -83.11 138.61 33.61 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 122.83 0.452 . . . . 75.32 111.423 -176.511 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.9 mt -89.6 131.38 40.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 109.849 -0.426 . . . . 75.21 109.849 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.6 Cg_exo -70.36 141.73 43.54 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.152 2.568 . . . . 53.05 113.443 176.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.01 -22.25 31.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.913 0.885 . . . . 42.43 110.061 -178.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.21 -3.55 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 121.877 0.846 . . . . 62.11 111.223 -175.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 8.7 p -61.03 -31.87 71.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.222 1.009 . . . . 74.32 111.409 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.4 m -67.38 -26.58 66.53 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.707 0.803 . . . . 72.11 112.537 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.34 -41.67 47.56 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.583 0.586 . . . . 72.44 112.583 -172.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.5 m -148.01 139.72 23.84 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.135 -0.691 . . . . 64.13 109.135 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -61.19 -38.86 88.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.669 -0.493 . . . . 74.51 109.669 176.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.13 -47.74 84.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.773 -0.649 . . . . 74.42 110.336 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -36.61 84.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.192 0.307 . . . . 64.24 111.649 177.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.43 -51.35 69.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.086 -0.338 . . . . 45.31 110.086 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.85 -45.76 90.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.278 -0.419 . . . . 54.44 110.657 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -63.45 -47.41 81.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.477 0.547 . . . . 73.43 112.477 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -66.28 -40.87 90.35 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.837 0.31 . . . . 72.41 111.837 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.62 -43.44 89.57 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.552 -0.459 . . . . 74.42 110.908 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 75.5 m -62.68 -40.49 97.28 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 110.015 -0.365 . . . . 72.42 110.015 178.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.2 -26.52 64.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.265 -0.425 . . . . 62.34 111.965 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.96 -13.65 50.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.749 -0.205 . . . . 73.24 111.25 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.48 -0.03 26.33 Favored Glycine 0 C--N 1.319 -0.409 0 C-N-CA 120.267 -0.968 . . . . 63.42 113.023 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 81.5 m-85 -83.62 106.91 15.72 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 122.527 -0.396 . . . . 75.22 110.016 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.4 19.3 13.08 Favored Glycine 0 C--N 1.297 -1.606 0 N-CA-C 110.009 -1.236 . . . . 24.35 110.009 176.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -113.12 111.02 21.4 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.172 -1.788 . . . . 63.1 106.172 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -131.46 148.66 52.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 72.45 111.63 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -142.16 123.04 14.41 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.935 -1.505 . . . . 73.42 106.935 172.2 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -104.1 135.76 45.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.916 0.339 . . . . 74.1 111.916 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.66 156.15 47.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.71 -0.478 . . . . 33.31 109.71 175.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -120.78 137.96 54.26 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.799 -0.815 . . . . 74.44 108.799 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 47.6 m -141.55 147.66 46.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 120.482 -0.487 . . . . 70.31 111.14 178.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_endo -65.98 125.49 14.26 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.973 2.449 . . . . 65.31 111.328 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 16.5 t -138.88 -176.49 4.51 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.318 -1.364 . . . . 61.43 107.318 -176.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.6 m -56.64 129.79 76.81 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.898 -0.778 . . . . 52.11 108.898 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.01 -25.64 12.93 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 124.023 3.149 . . . . 52.43 114.262 -178.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.41 -24.36 57.12 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.801 0.334 . . . . 72.32 111.683 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.64 12.18 34.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.639 -0.255 . . . . 45.32 111.51 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.55 126.39 17.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.849 0.833 . . . . 63.1 110.787 177.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.17 -6.86 72.51 Favored Glycine 0 C--N 1.306 -1.106 0 CA-C-N 115.194 -0.912 . . . . 72.03 111.74 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -100.88 152.21 20.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.627 -0.508 . . . . 73.3 109.627 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 58.4 t -84.6 136.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.828 -0.805 . . . . 71.31 108.828 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.04 -16.59 7.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.179 -1.008 . . . . 71.44 110.734 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.91 -179.27 26.81 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.38 -0.827 . . . . 74.32 111.714 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.9 p -116.82 161.87 18.6 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.286 -1.376 . . . . 75.11 107.286 178.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.17 -54.58 32.12 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.801 -1.16 . . . . 74.03 110.602 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.43 120.39 6.92 Favored 'Trans proline' 0 C--N 1.372 1.811 0 N-CA-C 105.963 -2.36 . . . . 60.23 105.963 166.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.7 Cg_endo -62.68 158.76 40.26 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 122.173 1.915 . . . . 62.44 113.798 -171.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.6 11.82 0.44 Allowed 'General case' 0 C--O 1.21 -0.975 0 CA-C-O 122.377 1.084 . . . . 51.11 111.6 178.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 475' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 473' ' ' PRO . 2.6 m-20 -109.13 -8.09 15.21 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.725 -1.213 . . . . 64.32 107.725 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -100.39 159.66 14.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.072 -0.967 . . . . 71.01 111.99 -171.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.1 m -114.66 108.12 16.39 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.428 -1.693 . . . . 74.1 106.428 177.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.8 p -112.24 143.19 43.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 122.128 -0.358 . . . . 64.54 111.954 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -63.99 144.37 57.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 72.42 110.34 176.051 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.17 -4.57 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.424 1.089 . . . . 42.41 111.758 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.7 p -87.17 -5.88 58.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.321 -0.862 . . . . 75.11 110.377 178.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -92.46 139.05 30.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.795 -0.639 . . . . 75.24 109.405 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.42 122.2 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.496 -1.668 . . . . 72.43 106.496 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.52 120.35 36.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.875 -0.787 . . . . 74.43 108.875 -175.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 121.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 108.056 -1.09 . . . . 71.52 108.056 -177.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -110.25 118.04 56.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.171 -0.922 . . . . 70.11 108.78 -177.069 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.29 119.24 48.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-N 115.414 -0.812 . . . . 71.32 109.482 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.6 t -97.63 133.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.246 -1.39 . . . . 64.23 107.246 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.02 125.25 7.11 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 111.425 -0.67 . . . . 72.53 111.425 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -129.52 107.01 9.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.553 -1.647 . . . . 71.45 106.553 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 491' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.416 -2.638 0 CA-C-O 118.478 -1.179 . . . . 74.15 111.45 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.247 -1.141 . . . . 51.05 110.247 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -106.82 156.99 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.871 0.336 . . . . 71.24 110.925 -179.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.7 m -114.75 132.26 56.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.934 -0.765 . . . . 71.42 108.934 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -102.17 28.1 6.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.341 1.067 . . . . 74.13 110.626 -177.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -114.03 146.41 40.22 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 106.374 -1.713 . . . . 53.22 106.374 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.5 162.24 15.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 120.893 0.378 . . . . 72.23 110.992 -172.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -95.01 136.31 35.48 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.856 -1.164 . . . . 60.35 107.856 178.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 130.9 27.84 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.077 -0.712 . . . . 64.11 109.077 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -62.39 117.61 4.48 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.335 1.356 . . . . 72.11 109.023 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.28 166.81 22.26 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.454 -0.794 . . . . 74.54 109.965 -176.039 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.72 40.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 122.954 1.359 . . . . 52.14 111.859 -168.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -66.3 145.81 55.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.929 -1.032 . . . . 74.24 110.449 172.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.71 0.51 39.68 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 114.33 0.492 . . . . 74.11 114.33 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . 0.285 0.5 OUTLIER -145.71 172.1 13.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.68 0.74 . . . . 70.1 112.804 175.592 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.3 p -54.12 154.7 4.09 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.811 1.244 . . . . 74.32 113.261 -175.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 9.1 p -57.69 -38.86 75.91 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.439 -0.8 . . . . 73.14 111.267 177.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.75 84.38 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 45.31 111.052 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.43 -37.03 77.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.103 0.478 . . . . 53.13 109.74 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.89 67.92 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.446 -0.797 . . . . 62.2 111.48 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.24 -43.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.79 -0.641 . . . . 55.45 111.367 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.38 -36.27 83.16 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.917 0.339 . . . . 71.12 111.917 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.9 m -65.89 -47.61 74.24 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.011 0.434 . . . . 75.13 110.629 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.98 -38.51 91.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.011 -0.541 . . . . 72.15 110.802 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -59.35 -42.73 92.22 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.138 0.975 . . . . 71.01 109.601 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.02 -30.68 69.97 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.965 -0.561 . . . . 73.43 112.29 178.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -80.97 -9.81 59.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.833 0.349 . . . . 65.31 111.397 176.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.15 12.64 54.6 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.864 -0.607 . . . . 73.34 113.526 173.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -91.29 149.18 21.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.12 0.486 . . . . 75.33 110.514 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 24.4 mmtp -90.5 137.06 32.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.167 -1.79 . . . . 73.24 106.167 -176.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -119.21 139.56 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 C-N-CA 118.969 -1.092 . . . . 75.13 113.526 -175.459 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -111.31 144.76 39.98 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.638 -1.616 . . . . 73.11 106.638 172.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.2 m -132.43 124.65 29.03 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.412 -0.958 . . . . 73.44 108.412 178.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -115.1 119.81 37.67 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.106 -1.442 . . . . 71.22 107.106 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 16.7 pm0 -111.36 135.5 51.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.343 -0.614 . . . . 72.31 109.343 -178.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 391' ' ' ASP . 19.6 ptmt -139.81 132.93 15.25 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.237 -0.585 . . . . 74.2 111.797 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.6 Cg_exo -78.64 140.15 16.47 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.371 2.047 . . . . 74.15 109.018 167.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 394' ' ' ILE . 9.1 t70 -170.42 -174.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.716 -1.587 . . . . 73.14 106.716 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 t -108.53 -34.84 6.63 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.714 -1.217 . . . . 74.24 107.714 177.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.1 p -87.62 40.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.911 0.862 . . . . 71.13 110.033 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 391' ' ' ASP . 23.2 pt -88.23 141.89 31.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.139 -0.937 . . . . 44.41 111.85 -176.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 172.79 15.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 106.983 -1.968 . . . . 64.41 106.983 167.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.15 147.42 66.73 Favored 'Trans proline' 0 C--O 1.209 -0.941 0 C-N-CA 121.373 1.382 . . . . 73.34 110.778 176.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.0 -7.16 10.58 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.158 0.98 . . . . 61.41 111.816 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -84.28 121.22 27.19 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.691 -2.707 . . . . 74.53 103.691 173.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.61 117.1 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.512 0.672 . . . . 71.01 110.372 -170.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.35 -28.18 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 114.893 -1.049 . . . . 71.12 109.39 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.68 157.82 27.48 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.374 -1.49 . . . . 54.15 109.374 -178.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -128.11 -174.8 3.31 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 123.679 0.792 . . . . 72.12 110.663 -173.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.65 129.13 29.51 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.648 -1.241 . . . . 60.43 107.648 -176.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -50.62 -27.75 20.33 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.202 3.268 . . . . 61.33 115.193 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.07 -26.0 67.34 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 111.926 0.343 . . . . 54.43 111.926 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.73 -36.03 81.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.756 0.788 . . . . 72.2 109.925 176.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -90.26 -2.25 58.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.543 -0.753 . . . . 73.21 111.216 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -91.31 165.14 13.59 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.061 -1.459 . . . . 71.14 107.061 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 56.9 p -74.36 113.63 11.81 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.177 0.513 . . . . 74.45 111.297 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.84 163.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.73 -0.668 . . . . 65.34 109.466 177.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.7 m -77.7 157.99 29.86 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.514 -0.55 . . . . 41.22 109.514 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.27 109.74 3.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.385 -0.598 . . . . 61.41 109.385 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 97.29 25.49 11.03 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.804 -0.712 . . . . 64.51 112.492 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.6 -172.16 3.7 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.261 -1.015 . . . . 72.31 108.261 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.0 pt-20 -107.77 139.41 42.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 118.665 0.666 . . . . 74.14 112.169 -176.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.06 136.52 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.753 -1.203 . . . . 65.42 107.753 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 10.8 t -108.37 130.93 55.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.611 0.719 . . . . 71.45 110.675 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 67.5 t -113.79 127.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.182 -0.917 . . . . 65.25 108.555 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -97.6 127.9 43.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.337 -0.616 . . . . 64.2 109.337 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 64.0 t -120.96 143.74 32.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.275 -1.009 . . . . 72.33 108.275 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.6 p -100.79 122.6 43.67 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.176 -0.675 . . . . 63.2 109.176 178.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 21.1 p -118.64 105.12 11.27 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.662 -0.815 . . . . 72.2 111.522 -178.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 72.65 152.22 1.66 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.936 0.735 . . . . 74.43 114.936 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.2 Cg_exo -80.76 148.32 17.66 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.296 1.998 . . . . 70.43 110.506 173.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.65 150.61 42.84 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.861 -0.609 . . . . 75.51 111.934 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.9 mt-30 -125.78 145.59 50.14 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.439 -0.949 . . . . 72.13 108.439 174.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 480' ' ' ILE . 4.7 tpt180 -148.15 156.92 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.013 -1.106 . . . . 71.43 108.013 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 44.5 tt0 -83.45 136.56 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.923 -0.399 . . . . 74.2 109.923 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.06 131.08 52.28 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 106.762 -1.57 . . . . 75.1 106.762 176.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 443' ' ' LYS . 32.1 Cg_endo -70.11 141.3 43.45 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.119 1.212 . . . . 65.43 110.656 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.36 -5.63 56.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.219 0.533 . . . . 75.04 111.743 -175.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 430' ' ' PRO . 34.2 m -76.7 -3.83 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 75.31 111.019 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.9 m -59.98 -27.58 66.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 41.32 110.786 178.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 37.6 p -69.15 -12.54 61.76 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.516 -0.766 . . . . 75.02 112.324 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.99 -47.66 17.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.795 0.665 . . . . 74.44 112.795 -177.153 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 27.0 m -153.77 141.06 19.6 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.662 -0.649 . . . . 62.33 109.921 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -56.18 -50.78 70.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.995 0.518 . . . . 72.22 112.208 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.32 -45.21 76.35 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.247 0.546 . . . . 63.1 111.22 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.38 -38.51 78.06 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.001 -0.999 . . . . 74.35 110.337 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -47.26 86.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.382 0.426 . . . . 64.34 110.328 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.47 -45.73 93.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.102 -0.499 . . . . 65.21 110.585 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.59 -41.63 88.2 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.753 0.279 . . . . 53.34 111.753 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.455 ' HB3' ' CG ' ' A' ' 430' ' ' PRO . 72.1 mmtt -62.77 -42.1 99.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.767 0.318 . . . . 54.53 111.616 178.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.31 -39.53 82.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.275 -0.421 . . . . 64.51 111.248 176.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 63.5 m -62.54 -39.58 94.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.573 -0.528 . . . . 73.04 109.573 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.63 65.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.628 . . . . 65.35 111.076 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -13.48 56.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.954 0.407 . . . . 44.4 110.154 177.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.32 -17.09 14.59 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.082 -0.58 . . . . 54.14 113.225 176.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.59 117.59 13.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.976 0.388 . . . . 71.12 111.062 -175.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.41 10.74 16.81 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 110.552 -1.019 . . . . 55.44 110.552 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -105.89 111.72 24.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.416 -1.327 . . . . 62.42 107.416 -177.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -132.77 146.87 52.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.375 0.607 . . . . 62.34 112.21 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -143.01 122.96 13.52 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.771 -1.566 . . . . 65.12 106.771 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -99.59 134.93 41.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.785 0.326 . . . . 64.4 110.581 -176.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -134.18 150.79 51.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.217 -1.031 . . . . 53.33 108.217 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -120.43 140.47 51.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.781 -0.452 . . . . 62.14 109.781 178.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 457' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 8.5 t -127.03 137.37 30.47 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.424 -1.324 . . . . 72.3 107.424 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.9 Cg_exo -61.23 119.5 6.68 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.338 2.025 . . . . 75.44 111.189 -177.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.2 m -131.34 -179.84 5.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.527 -0.76 . . . . 61.1 109.174 -176.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.467 ' HB ' HD13 ' A' ' 463' ' ' LEU . 62.7 m -68.45 136.78 90.9 Favored Pre-proline 0 N--CA 1.428 -1.568 0 N-CA-C 107.848 -1.168 . . . . 73.12 107.848 174.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.8 -22.88 7.69 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.846 3.697 . . . . 73.23 114.707 -176.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.58 -17.56 60.0 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.002 0.43 . . . . 74.14 111.356 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 463' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.3 mp -99.67 11.49 39.07 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.959 0.355 . . . . 73.14 111.959 -178.061 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 31.0 m -59.61 127.72 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.217 0.532 . . . . 61.32 111.629 176.092 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.49 -1.42 88.36 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 115.539 -0.755 . . . . 71.21 111.839 178.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 463' ' ' LEU . 62.8 tttp -101.54 138.94 37.87 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.122 -1.066 . . . . 62.33 108.122 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 486' ' ' ILE . 60.0 t -84.11 128.08 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.987 0.423 . . . . 63.24 110.38 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.98 -16.9 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 112.165 0.432 . . . . 63.11 112.165 -177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.43 166.01 33.5 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.795 -0.717 . . . . 74.42 111.769 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.8 p -135.77 155.55 50.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.45 -0.945 . . . . 75.0 108.45 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.88 -55.62 42.92 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.421 -0.323 . . . . 71.41 111.847 176.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.6 Cg_exo -76.8 142.71 22.85 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 108.162 -1.514 . . . . 74.42 108.162 172.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 30.8 Cg_endo -61.92 127.46 21.46 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.287 1.992 . . . . 72.52 111.761 -177.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.83 2.58 22.6 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.065 -0.971 . . . . 65.24 112.013 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -111.32 3.48 18.33 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.328 -0.396 . . . . 75.21 110.668 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.526 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 59.1 tp60 -129.57 166.07 20.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.493 0.663 . . . . 60.45 111.539 -170.049 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 62.6 m -81.85 124.18 29.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.644 -1.162 . . . . 55.23 109.799 176.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -127.37 149.47 50.05 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.761 0.424 . . . . 74.41 110.008 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.16 135.71 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.629 0.252 . . . . 73.14 110.63 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 427' ' ' ARG . 42.1 mm -62.94 -14.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.88 1.272 . . . . 71.14 112.282 -174.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -87.51 -2.55 58.69 Favored 'General case' 0 C--N 1.313 -1.003 0 O-C-N 121.6 -0.688 . . . . 62.24 110.635 -177.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 44.4 m-80 -84.61 136.98 33.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.473 -0.565 . . . . 73.3 109.473 178.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.85 124.45 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.278 -1.008 . . . . 62.23 108.278 176.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.96 119.09 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 C-N-CA 119.239 -0.984 . . . . 74.45 109.005 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.9 mp -91.7 112.66 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 N-CA-C 104.557 -2.386 . . . . 75.31 104.557 173.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.03 118.55 52.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.09 -1.078 . . . . 64.2 108.09 -175.844 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.63 118.35 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.578 0.704 . . . . 71.23 109.356 -176.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.81 141.3 16.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 107.798 -1.186 . . . . 72.54 107.798 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.9 124.29 6.52 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.002 -1.239 . . . . 64.25 110.002 177.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.1 t -141.52 136.49 31.22 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.613 -0.884 . . . . 71.44 108.613 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.665 0 N-CA-C 109.395 -1.482 . . . . 74.44 109.395 -179.577 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.893 0 N-CA-C 110.616 -0.994 . . . . 73.04 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 356' ' ' ILE 0.278 2.6 pp -111.59 117.74 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.282 1.039 . . . . 62.22 113.281 -179.666 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 25.5 m -161.44 135.27 6.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 104.036 -2.579 . . . . 60.51 104.036 176.394 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -81.21 86.1 6.26 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.603 -1.239 . . . . 73.44 112.963 -177.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.91 135.59 48.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 105.817 -1.92 . . . . 74.23 105.817 172.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.88 149.34 21.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 C-N-CA 120.146 -0.622 . . . . 54.44 110.822 -175.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -94.28 137.22 33.7 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 105.756 -1.942 . . . . 74.42 105.756 173.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.09 124.79 52.91 Favored Pre-proline 0 C--N 1.279 -2.487 0 C-N-CA 118.342 -1.343 . . . . 72.24 110.536 -169.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -51.06 129.25 27.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.57 2.847 . . . . 61.33 113.006 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.3 140.4 43.09 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.492 -1.231 . . . . 61.15 111.285 -175.458 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.41 20.28 5.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.635 -1.246 . . . . 41.11 107.635 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -64.64 133.38 52.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.961 -1.018 . . . . 72.32 111.457 -178.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 0.19 46.58 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.071 -0.968 . . . . 51.1 110.905 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -125.22 -179.81 4.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.991 -0.744 . . . . 73.02 108.991 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 93.9 p -72.48 143.04 48.55 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.485 0.584 . . . . 63.2 111.389 -176.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 374' ' ' ILE . 27.9 m -62.34 -33.65 75.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.221 -0.445 . . . . 51.13 110.971 178.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.67 94.44 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-N 116.299 -0.409 . . . . 72.04 111.062 178.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.99 -35.07 76.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 75.31 109.889 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.69 92.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.84 -0.618 . . . . 74.42 110.516 176.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 384' ' ' ILE . 82.6 mt -57.79 -46.91 87.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 122.644 0.377 . . . . 75.4 110.078 178.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.6 94.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.972 -0.558 . . . . 53.12 111.288 179.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 57.0 m -61.66 -47.64 84.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.894 -0.594 . . . . 72.21 110.952 -179.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.3 -38.45 91.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.388 -0.369 . . . . 75.04 111.465 178.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -59.87 -42.89 94.71 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.65 0.594 . . . . 73.02 109.6 178.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.356 0.873 . . . . 53.13 113.356 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.96 -14.71 53.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.127 0.489 . . . . 52.01 110.022 173.097 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.43 53.51 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.941 -0.572 . . . . 52.22 112.874 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 43.3 m-85 -84.19 152.96 23.93 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.427 0.632 . . . . 73.12 111.938 -177.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.64 134.54 34.6 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.008 -1.479 . . . . 74.01 107.008 177.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -117.47 136.64 53.97 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 C-N-CA 119.197 -1.001 . . . . 72.32 111.874 -179.14 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -111.69 128.38 56.05 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.003 -1.908 . . . . 74.51 105.976 178.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.0 m -111.41 136.65 50.26 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 119.403 -0.919 . . . . 42.12 109.444 -178.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -120.18 117.89 29.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.513 -1.662 . . . . 74.11 106.513 176.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 122.05 46.11 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.484 -1.673 . . . . 62.41 106.484 177.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -139.61 148.38 55.75 Favored Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 118.893 -1.123 . . . . 75.41 110.746 178.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 85.1 Cg_endo -85.48 163.74 10.96 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.274 1.983 . . . . 61.2 109.584 170.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.2 t70 165.22 -173.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.754 -2.313 . . . . 71.11 104.754 176.023 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.4 t -115.84 -25.39 7.77 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.566 -1.642 . . . . 72.51 106.566 174.251 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 9.9 m -98.47 69.2 1.9 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.621 -2.363 . . . . 75.44 104.621 171.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 421' ' ' SER . 4.4 pt -95.97 138.56 21.66 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 113.673 -1.603 . . . . 51.24 112.921 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 421' ' ' SER . 16.7 Cg_exo -70.4 114.35 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 106.224 -2.26 . . . . 72.24 106.224 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.11 160.34 13.12 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.514 2.809 . . . . 52.42 115.54 -169.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.06 -6.86 2.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.107 0.963 . . . . 74.32 112.003 176.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.9 m170 -107.47 120.15 41.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 103.662 -2.718 . . . . 72.1 103.662 171.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.97 117.97 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.088 0.947 . . . . 71.03 109.822 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.91 -28.87 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.947 -1.024 . . . . 44.4 110.441 -174.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.44 157.98 27.56 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.973 -1.251 . . . . 73.25 109.973 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.7 p -118.28 -178.76 3.59 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 123.194 0.598 . . . . 72.55 109.97 -177.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -102.08 155.2 36.74 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.374 -0.602 . . . . 64.11 109.374 -176.125 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.4 -30.66 64.44 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.085 2.523 . . . . 75.54 113.902 -176.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.15 -30.7 65.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.895 0.378 . . . . 65.33 110.244 -175.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.54 65.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.594 0.711 . . . . 50.42 110.05 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 407' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 407' ' ' ASN . 0.9 OUTLIER -95.8 -4.64 43.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.577 -0.738 . . . . 71.14 111.876 -177.937 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.1 m -100.16 155.39 17.77 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.244 -1.391 . . . . 54.14 107.244 176.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 55.2 p -74.77 113.17 11.74 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.191 -0.604 . . . . 75.02 109.584 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.09 169.93 15.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 116.043 -0.526 . . . . 44.22 110.772 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.0 p -62.36 133.13 54.64 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.702 -0.681 . . . . 73.11 109.396 175.241 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.46 109.33 4.73 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.956 -0.387 . . . . 73.23 109.956 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.91 10.08 5.43 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 120.137 -1.03 . . . . 45.53 112.339 -178.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.1 -174.02 4.49 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.785 -0.82 . . . . 74.41 108.785 -177.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.01 132.16 34.12 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 118.955 0.798 . . . . 72.14 112.589 -175.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.67 135.24 59.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 106.474 -1.676 . . . . 73.32 106.474 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.9 t -96.84 130.94 44.04 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 122.086 0.946 . . . . 71.41 111.764 -177.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.33 122.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 114.577 -1.192 . . . . 65.24 108.453 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -95.89 129.01 43.27 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.745 -0.661 . . . . 71.5 111.447 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.83 130.81 52.93 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 108.14 -1.059 . . . . 75.34 108.14 177.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.49 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 36.6 p -88.09 121.45 30.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.491 -0.559 . . . . 74.33 109.491 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 m -120.89 104.82 10.14 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 119.767 -0.773 . . . . 63.31 110.645 177.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.69 125.39 1.59 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 120.546 -0.835 . . . . 71.54 113.93 176.446 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 56.2 Cg_endo -86.49 130.31 3.28 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.33 2.02 . . . . 61.12 112.562 176.17 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.461 ' OE1' ' HA ' ' A' ' 391' ' ' ASP . 47.6 mt-10 -89.4 137.5 32.27 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.465 0.65 . . . . 75.33 112.12 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.47 150.45 48.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.546 -1.65 . . . . 74.22 106.546 173.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 480' ' ' ILE . 3.4 tpt180 -136.27 148.46 48.02 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.307 -0.998 . . . . 73.42 108.307 -174.049 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.9 136.5 34.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.513 -0.921 . . . . 65.33 108.513 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 70.8 mt -81.8 131.54 57.11 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.834 -0.802 . . . . 71.34 108.834 -178.623 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.65 140.6 87.36 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.583 1.522 . . . . 72.14 111.876 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.32 0.77 55.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.124 0.488 . . . . 72.24 111.191 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -76.12 -7.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.446 0.641 . . . . 41.12 109.464 176.229 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.9 p -54.96 -49.68 70.78 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.361 -0.836 . . . . 63.45 111.687 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 2.1 m -63.79 -22.28 66.83 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.361 1.065 . . . . 70.0 111.761 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.27 -42.47 13.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.263 0.468 . . . . 74.23 112.263 -173.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.4 m -145.21 124.12 12.71 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.542 -0.724 . . . . 73.11 110.905 -178.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.24 -53.52 55.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.724 0.639 . . . . 75.42 112.724 -178.156 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.43 94.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.737 0.303 . . . . 73.02 111.495 -176.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.53 -37.68 88.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.652 -0.704 . . . . 73.11 109.407 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.32 -47.18 87.15 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.922 -0.581 . . . . 54.23 110.76 -179.079 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.35 -45.71 93.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 61.11 110.414 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 9.9 mmpt? -64.46 -47.27 79.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 65.32 110.967 -178.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.14 -38.88 89.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.329 -0.396 . . . . 73.35 111.476 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.2 -43.41 86.83 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.338 0.399 . . . . 64.04 110.366 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 24.3 m -66.84 -46.01 76.45 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.404 0.621 . . . . 61.44 109.785 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.31 -15.97 63.45 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.374 -0.83 . . . . 73.1 112.053 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.56 59.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.464 . . . . 64.12 109.985 178.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.08 -16.4 11.97 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.748 -0.739 . . . . 23.35 112.036 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 449' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 93.6 m-85 -77.49 108.66 10.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.782 0.325 . . . . 64.35 110.503 -179.053 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.37 20.64 15.83 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.554 -1.019 . . . . 74.21 110.554 176.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -114.17 111.91 22.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 106.507 -1.664 . . . . 65.42 106.507 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.49 153.22 45.42 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.438 0.532 . . . . 72.13 112.438 -170.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 56.4 tptt -150.9 123.41 8.46 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 105.451 -2.055 . . . . 73.51 105.451 172.441 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -121.96 134.82 54.83 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.315 -0.554 . . . . 65.32 111.584 -173.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -142.38 165.02 28.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.1 -0.5 . . . . 62.42 110.514 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -116.44 142.07 47.35 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.719 -0.845 . . . . 62.33 108.719 176.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 19.1 t -131.04 138.55 33.22 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 108.749 -0.834 . . . . 73.01 108.749 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_exo -61.56 121.1 9.07 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.303 2.002 . . . . 72.33 110.558 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.3 m -134.26 -178.55 5.09 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 63.13 107.62 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 16.5 p -68.24 150.24 97.8 Favored Pre-proline 0 N--CA 1.427 -1.586 0 C-N-CA 120.563 -0.455 . . . . 73.53 109.822 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 461' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 464' ' ' VAL . 15.0 Cg_endo -55.69 -23.59 41.71 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.488 2.792 . . . . 71.42 113.137 -177.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -75.36 -18.45 59.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.869 0.366 . . . . 72.23 111.871 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.72 -4.45 40.7 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.992 -0.443 . . . . 73.04 112.102 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.8 p -59.51 136.58 22.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-O 120.717 0.294 . . . . 70.43 110.935 -178.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.32 84.04 Favored Glycine 0 C--N 1.311 -0.831 0 C-N-CA 120.777 -0.725 . . . . 72.03 112.389 177.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -124.19 158.87 31.38 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 109.668 -0.493 . . . . 72.12 109.668 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 434' ' ' THR . 58.1 t -83.93 137.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.8 -1.556 . . . . 45.44 106.8 178.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -96.54 -10.66 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.013 -1.475 . . . . 72.11 110.267 178.133 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 146.56 174.54 18.76 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 115.424 -0.807 . . . . 44.55 111.524 175.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.0 p -116.58 152.22 34.61 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.97 -1.122 . . . . 74.21 107.97 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -66.79 -46.06 55.53 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 118.74 -1.184 . . . . 65.24 111.874 178.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.39 110.15 3.0 Favored 'Trans proline' 0 C--N 1.362 1.261 0 N-CA-C 106.887 -2.005 . . . . 54.12 106.887 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.02 162.31 32.04 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.292 1.995 . . . . 75.14 114.286 -171.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.73 -5.15 35.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.753 1.221 . . . . 75.13 110.348 177.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.49 6.05 49.99 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.421 -1.263 . . . . 71.52 109.616 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -135.62 162.48 32.59 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.109 -0.701 . . . . 74.11 109.109 -177.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.7 m -104.47 111.73 24.51 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.235 -1.765 . . . . 70.02 106.235 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 14.9 t -106.55 148.3 28.4 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.332 -0.547 . . . . 74.54 109.874 -175.379 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.25 141.03 58.92 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.283 -0.417 . . . . 35.43 110.41 178.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 28.9 mm -60.92 -22.61 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.467 0.707 . . . . 61.13 112.876 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.0 t -91.55 4.43 52.62 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.692 0.758 . . . . 64.32 110.123 -178.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.67 138.55 34.1 Favored 'General case' 0 CA--C 1.481 -1.687 0 O-C-N 122.015 -0.428 . . . . 74.0 110.47 177.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.54 116.32 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 108.887 -0.783 . . . . 71.33 108.887 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.08 120.22 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 108.189 -1.041 . . . . 71.13 108.189 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 0.2 OUTLIER -92.73 117.07 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 106.93 -1.507 . . . . 61.41 106.93 -178.939 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 112.4 39.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.948 -1.024 . . . . 42.32 108.347 -177.335 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 485' ' ' ILE . 3.3 mp -102.75 124.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.588 -0.733 . . . . 75.53 109.275 -177.255 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 28.0 t -97.59 134.45 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.248 -1.39 . . . . 65.3 107.248 178.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -84.07 131.85 10.68 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 110.992 -0.843 . . . . 50.11 110.992 -178.368 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.3 t -141.04 132.39 26.71 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.82 -0.808 . . . . 53.25 108.82 178.318 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.07 0 N-CA-C 109.244 -1.542 . . . . 65.51 109.244 174.575 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.691 0 N-CA-C 110.49 -1.044 . . . . 62.12 110.49 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -87.2 145.75 7.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 117.582 0.691 . . . . 64.23 110.9 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 18.9 m -152.53 137.48 17.19 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.152 -1.425 . . . . 64.32 107.152 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.42 70.48 4.32 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.551 0.691 . . . . 74.22 110.936 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -106.7 138.85 42.12 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.972 -1.122 . . . . 64.14 107.972 176.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.2 150.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 112.398 0.518 . . . . 72.11 112.398 -170.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -96.4 136.55 36.75 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.538 -1.282 . . . . 53.25 107.538 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.68 131.3 27.22 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.916 -0.713 . . . . 52.15 110.079 -175.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.14 142.13 78.46 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.392 2.728 . . . . 70.4 113.946 -178.046 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.44 139.39 36.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.698 -1.137 . . . . 73.33 109.985 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 373' ' ' ALA . 12.6 t -113.24 30.98 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 122.51 1.147 . . . . 73.14 109.794 -175.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 366' ' ' ARG . 1.7 ppt_? -65.39 144.58 56.99 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.582 -0.736 . . . . 74.41 112.525 178.28 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 93.4 -5.81 74.61 Favored Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.94 -0.573 . . . . 75.33 111.699 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -117.34 176.01 5.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.294 -0.632 . . . . 74.32 109.294 -175.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.8 p -73.92 154.11 39.53 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.742 0.306 . . . . 72.43 111.139 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.2 -36.1 82.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.752 0.311 . . . . 64.03 110.619 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.97 93.62 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.104 -0.498 . . . . 53.34 111.033 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.77 -43.55 92.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.747 -0.464 . . . . 73.21 109.747 177.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -58.77 -51.53 69.6 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.964 -0.562 . . . . 73.55 111.084 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.62 -42.47 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.347 -0.388 . . . . 73.41 111.157 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.39 93.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.433 -0.348 . . . . 74.31 110.993 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 376' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 61.9 m -61.88 -47.24 85.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.551 -0.295 . . . . 60.43 110.882 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.89 -38.81 92.46 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.621 -0.263 . . . . 73.11 110.941 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -59.88 -46.92 87.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.908 0.755 . . . . 73.4 109.647 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -66.43 -27.41 67.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.78 -0.646 . . . . 62.01 111.774 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 376' ' ' THR . 11.8 mmt180 -81.21 -14.94 57.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.402 -0.363 . . . . 64.51 110.797 178.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.73 53.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.439 -0.886 . . . . 73.22 112.029 178.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.16 158.65 15.37 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.385 -0.598 . . . . 54.44 109.385 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.53 161.43 13.64 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.232 -1.025 . . . . 61.31 108.232 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 154.98 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.872 0.844 . . . . 71.53 112.79 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 417' ' ' THR . 6.7 ttp180 -141.99 129.74 21.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.885 -1.154 . . . . 72.0 107.885 175.445 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.3 m -100.51 130.38 46.58 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.7 -0.481 . . . . 71.0 109.7 -177.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.94 119.11 36.79 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.708 -1.59 . . . . 73.23 106.708 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -95.66 123.84 39.41 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 72.23 108.724 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -114.57 118.13 41.73 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 116.268 -0.424 . . . . 74.54 111.747 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 3.0 Cg_endo -88.31 128.43 2.2 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 N-CA-C 107.456 -1.786 . . . . 61.15 107.456 167.249 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 -163.88 -178.09 5.47 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.665 -1.214 . . . . 73.14 110.731 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.2 m -88.87 -42.18 12.01 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.195 -1.78 . . . . 64.1 106.195 175.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.4 m -88.69 63.43 6.91 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.458 -1.246 . . . . 61.11 108.636 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 394' ' ' ILE . 2.3 pp -98.77 112.97 63.93 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 114.156 1.169 . . . . 63.05 114.156 179.465 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 73.8 Cg_endo -80.44 170.37 16.04 Favored 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.09 1.86 . . . . 70.34 110.369 171.391 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.72 162.65 17.8 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.391 2.727 . . . . 63.24 112.691 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.66 -8.7 0.95 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 124.218 1.007 . . . . 64.1 113.135 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -79.78 159.72 26.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.783 -1.192 . . . . 74.23 107.783 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.56 117.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 105.942 -1.873 . . . . 73.2 105.942 175.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 400' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.6 pp -92.91 -28.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.408 0.623 . . . . 74.32 111.79 -178.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -160.99 158.1 29.67 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.717 -1.753 . . . . 42.2 108.717 178.702 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -114.43 -179.85 3.75 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 109.189 -0.671 . . . . 75.53 109.189 179.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.12 140.94 21.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.225 -1.028 . . . . 72.52 108.225 178.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.69 -29.46 2.34 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.0 3.134 . . . . 44.53 114.536 177.576 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.63 60.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.209 0.603 . . . . 64.42 111.98 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.16 65.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 61.51 109.857 177.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 4.7 52.32 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.328 -0.851 . . . . 72.55 110.735 -174.122 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -92.64 146.39 23.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 105.118 -2.178 . . . . 73.1 105.118 171.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.5 m -74.37 123.44 24.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 118.797 0.726 . . . . 74.12 110.171 -178.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.8 169.67 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.772 -1.196 . . . . 60.41 107.772 -177.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.8 m -66.7 138.86 57.71 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.266 -1.013 . . . . 55.43 108.266 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.18 111.36 3.89 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.079 -0.341 . . . . 73.23 110.079 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.63 43.33 0.97 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.752 -0.737 . . . . 51.22 112.162 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.65 -179.36 3.79 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.354 -1.721 . . . . 62.32 106.354 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -102.65 135.29 44.55 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.505 0.669 . . . . 75.11 111.725 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.7 mm -110.28 128.47 66.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.372 -1.344 . . . . 63.21 107.372 176.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 385' ' ' ARG . 69.4 p -100.42 130.71 46.55 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.577 -0.527 . . . . 70.42 109.577 -177.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.48 122.63 69.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.013 -0.54 . . . . 74.32 110.177 -176.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -91.17 129.46 37.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.141 0.496 . . . . 44.41 110.998 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.44 146.95 30.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.286 -1.376 . . . . 64.24 107.286 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.423 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 13.5 m -90.57 122.65 33.56 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.822 -0.751 . . . . 72.43 111.815 -176.417 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 32.8 m -120.37 106.16 11.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 109.539 -0.541 . . . . 64.12 109.539 174.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 77.32 130.57 0.47 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 120.889 -0.672 . . . . 63.24 114.772 176.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.4 Cg_exo -78.6 144.18 19.63 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.702 1.601 . . . . 63.42 109.425 171.595 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 146.06 47.96 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 116.292 -0.413 . . . . 71.45 109.906 -178.261 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.5 mt-30 -121.52 141.29 51.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.168 -0.924 . . . . 74.4 108.65 -176.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -143.45 158.68 43.45 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.954 -1.498 . . . . 73.52 106.954 -177.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.6 OUTLIER -90.1 139.62 30.45 Favored 'General case' 0 C--N 1.28 -2.419 0 O-C-N 123.088 0.242 . . . . 71.54 110.854 179.512 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -80.03 119.86 77.95 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.788 -1.56 . . . . 72.25 106.788 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.82 140.74 67.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.702 2.268 . . . . 74.34 113.589 -178.461 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.61 -22.58 62.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.771 -1.104 . . . . 73.31 112.364 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.18 2.98 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.679 -0.692 . . . . 71.35 111.748 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.9 t -62.75 -27.14 69.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.309 0.644 . . . . 74.44 110.597 179.163 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 28.0 p -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 112.851 0.685 . . . . 72.22 112.851 -177.42 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 82.6 mt -67.26 -49.01 66.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.912 1.079 . . . . 43.41 113.912 -171.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.6 m -160.43 148.8 16.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.592 -0.892 . . . . 74.02 108.592 -175.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.51 -49.83 75.98 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.873 0.694 . . . . 73.13 112.873 -177.769 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.01 89.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.714 0.293 . . . . 74.41 110.942 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.22 -46.32 90.9 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.639 -0.874 . . . . 72.21 108.639 177.195 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.66 76.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.948 -1.024 . . . . 63.31 110.409 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.82 -48.08 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.362 -0.381 . . . . 72.44 111.089 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.868 0.322 . . . . 73.44 111.868 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -66.33 -42.12 88.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 111.902 0.334 . . . . 72.05 111.902 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.43 -38.63 81.38 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.975 -0.29 . . . . 74.21 111.741 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 86.4 m -62.31 -40.46 96.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.736 -0.468 . . . . 74.21 109.736 177.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.46 -26.61 66.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.916 -0.584 . . . . 44.22 111.042 178.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 -13.01 56.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.211 0.529 . . . . 44.14 110.47 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.55 29.74 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.944 -0.646 . . . . 73.03 113.267 178.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -78.29 102.65 7.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 117.362 0.581 . . . . 74.22 109.597 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.73 15.83 34.24 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.694 -0.765 . . . . 44.53 111.301 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -118.21 110.63 17.8 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.733 -1.21 . . . . 75.13 107.733 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.35 150.26 45.7 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.028 0.442 . . . . 74.12 110.589 -176.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.522 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.4 OUTLIER -141.88 122.87 14.55 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.454 -2.054 . . . . 73.22 105.454 171.239 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -96.57 134.62 39.56 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.008 -0.677 . . . . 73.32 109.61 -178.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.19 141.47 49.09 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.938 -1.134 . . . . 74.3 107.938 176.287 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 456' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.5 m-80 -116.57 140.12 49.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.598 -1.26 . . . . 74.21 107.598 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -138.62 150.35 65.66 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 109.846 -0.427 . . . . 75.34 109.846 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_endo -60.71 120.22 7.83 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.496 2.131 . . . . 73.22 112.184 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -127.27 -178.45 4.45 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.027 -1.471 . . . . 63.14 107.027 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.0 t -68.88 137.95 90.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.968 -0.752 . . . . 70.43 108.968 176.571 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.15 -23.74 23.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.741 2.961 . . . . 70.43 113.98 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.7 -23.95 58.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.797 0.332 . . . . 75.32 111.677 -177.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.33 12.57 31.54 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.334 0.494 . . . . 72.42 112.334 -177.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.6 p -59.31 126.74 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.388 0.613 . . . . 71.34 111.143 179.311 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.55 0.07 61.11 Favored Glycine 0 C--N 1.309 -0.968 0 CA-C-N 115.987 -0.551 . . . . 51.44 112.266 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.63 144.84 30.51 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.668 -1.234 . . . . 75.34 107.668 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 84.3 t -82.28 126.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.86 -1.163 . . . . 73.24 107.86 177.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.46 -15.13 7.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.34 -0.544 . . . . 74.35 112.01 -175.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.02 177.24 33.95 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 120.451 -0.88 . . . . 74.14 111.576 178.001 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 470' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 486' ' ' ILE . 8.7 p -125.23 158.81 33.12 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.226 -1.027 . . . . 72.01 108.226 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 4.5 m-20 -63.14 -54.35 46.47 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 120.338 -0.545 . . . . 73.1 110.52 176.103 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 7.6 Cg_exo -78.14 108.6 2.53 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 106.037 -2.332 . . . . 64.13 106.037 164.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 149.87 89.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.601 2.201 . . . . 71.32 114.798 -169.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.46 7.65 2.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.742 1.217 . . . . 70.42 111.987 -177.468 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.1 -3.05 16.63 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.474 -0.784 . . . . 63.12 110.605 177.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -129.06 169.65 14.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.036 0.446 . . . . 72.13 111.335 -171.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 15.7 m -102.43 135.54 43.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.265 1.026 . . . . 74.52 108.789 -179.025 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.8 t -137.46 148.07 45.81 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.425 -0.583 . . . . 71.2 109.425 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.91 145.6 53.53 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.964 -0.384 . . . . 63.14 109.964 175.056 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.9 mm -70.17 -3.33 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.125 0.964 . . . . 72.15 111.396 -177.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -86.81 5.37 36.91 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.762 0.792 . . . . 65.44 110.325 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -110.45 138.09 47.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.358 -0.837 . . . . 65.3 109.473 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.86 124.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.281 -1.007 . . . . 75.4 108.281 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.0 t -87.36 118.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 C-N-CA 119.074 -1.051 . . . . 61.04 108.486 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 56.2 mt -93.95 112.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.081 -1.451 . . . . 70.43 107.081 176.831 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -98.62 122.28 50.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.33 -0.989 . . . . 64.53 108.33 -176.504 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 487' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 26.9 mt -100.87 119.92 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.318 0.58 . . . . 74.32 110.499 -174.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.534 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 88.9 t -97.99 128.77 49.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.959 -1.126 . . . . 61.3 107.959 178.675 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.31 115.42 6.03 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.184 -0.766 . . . . 75.13 111.184 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 37.5 m -120.35 109.88 15.88 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.334 -0.617 . . . . 61.23 109.334 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.356 0 N-CA-C 109.478 -1.449 . . . . 75.42 109.478 -179.211 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.814 0 N-CA-C 109.921 -1.272 . . . . 43.05 109.921 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.404 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.6 pp -139.98 148.06 23.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 117.195 0.498 . . . . 73.0 111.029 179.019 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.0 m -109.08 146.79 33.42 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.504 -1.665 . . . . 54.21 106.504 172.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -82.52 78.7 9.12 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.516 0.674 . . . . 75.5 109.318 178.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 409' ' ' SER . 4.3 p-10 -107.89 131.34 54.61 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.844 -1.071 . . . . 72.25 109.1 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.6 m -134.32 153.89 36.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.722 -0.473 . . . . 63.02 109.722 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -100.86 137.07 39.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.851 -1.166 . . . . 72.01 107.851 175.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.87 124.5 47.68 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 119.556 -0.858 . . . . 64.14 110.804 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.1 145.05 98.99 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.89 2.393 . . . . 75.33 112.355 177.29 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.98 166.1 16.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.872 -0.603 . . . . 74.2 110.451 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.4 HG12 ' HB2' ' A' ' 368' ' ' GLN . 15.7 t -117.47 41.68 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.495 1.14 . . . . 53.21 108.488 -175.041 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -52.57 128.66 26.78 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.344 -1.298 . . . . 75.51 113.79 -175.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.76 -18.65 57.02 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 115.503 -0.771 . . . . 72.32 113.228 173.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.4 ' HB2' HG12 ' A' ' 365' ' ' VAL . 95.4 mt-30 -97.73 166.7 11.36 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.613 0.245 . . . . 62.34 111.198 -176.673 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 81.2 p -63.3 145.04 56.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.511 . . . . 33.42 110.684 -175.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.9 p -63.66 -34.08 77.05 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.951 -0.3 . . . . 63.05 110.275 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.32 88.73 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.193 -0.458 . . . . 60.21 110.358 176.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -35.08 79.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.054 -0.521 . . . . 74.52 110.23 178.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -50.44 71.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 72.21 110.797 178.134 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.27 -43.96 87.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 123.416 0.448 . . . . 63.21 110.407 178.504 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.36 90.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 73.42 110.74 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -46.94 86.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.736 -0.211 . . . . 54.41 110.831 178.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.98 -39.3 93.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.198 -0.201 . . . . 53.3 110.753 177.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -61.2 -44.34 97.45 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.223 0.609 . . . . 64.33 110.272 179.132 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.43 -26.27 64.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.779 -0.646 . . . . 60.34 111.805 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -81.56 -13.5 57.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.226 -0.443 . . . . 63.05 110.96 175.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 94.59 16.58 42.13 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.272 -0.965 . . . . 71.12 112.368 177.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.56 159.79 14.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.034 -0.728 . . . . 43.05 109.034 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 33.5 mmtp -104.9 157.51 17.17 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.263 -1.384 . . . . 64.04 107.263 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -136.9 157.48 35.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.451 0.643 . . . . 73.15 112.04 -175.598 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 417' ' ' THR . 37.8 ttm105 -127.41 133.11 50.01 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.612 -1.996 . . . . 71.04 105.612 171.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.7 m -122.32 121.28 36.36 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.204 -0.665 . . . . 54.12 109.204 -175.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.35 119.2 35.49 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.59 -1.263 . . . . 74.43 107.59 178.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 11.7 pm0 -113.5 124.1 51.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.642 -0.503 . . . . 73.52 109.642 178.283 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -132.76 144.28 52.22 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 120.604 -0.439 . . . . 72.45 110.777 -177.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.82 144.15 13.6 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 N-CA-C 107.662 -1.707 . . . . 75.24 107.662 166.326 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.474 ' HB3' HG23 ' A' ' 394' ' ' ILE . 8.2 t70 -153.42 172.69 16.71 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 118.62 -1.232 . . . . 75.21 110.227 -176.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.8 m -87.38 -34.72 18.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.731 -1.581 . . . . 43.21 106.731 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.0 p -108.02 70.24 0.76 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 113.905 -1.498 . . . . 54.14 109.426 177.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.0 pp -90.0 121.74 68.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.35 1.241 . . . . 73.0 114.35 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.42 172.88 10.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.557 2.171 . . . . 74.42 108.516 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.73 153.54 61.59 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 122.157 1.905 . . . . 73.33 111.594 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -6.87 11.62 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.623 0.725 . . . . 63.23 111.935 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -82.26 143.53 31.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.917 -1.038 . . . . 75.02 108.858 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.92 118.01 22.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.938 -1.105 . . . . 64.3 108.889 -178.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.47 -47.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.014 -1.106 . . . . 70.11 108.014 -178.283 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.55 170.48 35.8 Favored Glycine 0 N--CA 1.403 -3.543 0 N-CA-C 109.6 -1.4 . . . . 52.11 109.6 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -119.05 -178.7 3.62 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 108.482 -0.933 . . . . 75.3 108.482 179.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.74 154.71 37.01 Favored Pre-proline 0 C--N 1.282 -2.342 0 N-CA-C 108.326 -0.99 . . . . 75.2 108.326 176.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -31.9 -32.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.856 1 C-N-CA 125.861 4.374 . . . . 71.33 116.159 -176.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -47.26 -35.0 7.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.321 1.048 . . . . 71.24 112.925 -178.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.27 -49.76 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.068 0.461 . . . . 64.5 112.023 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -86.68 -0.4 56.19 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.806 0.669 . . . . 71.21 112.806 -176.012 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.9 m -87.73 164.24 16.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.44 107.723 175.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 409' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 359' ' ' ASP . 2.5 p -74.23 113.57 11.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.87 0.843 . . . . 64.4 112.336 -176.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.62 170.13 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.951 -1.022 . . . . 73.22 108.856 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.3 t -90.26 151.73 21.38 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.792 -1.188 . . . . 73.43 107.792 176.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.12 130.92 45.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.328 -0.619 . . . . 71.11 109.328 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 91.28 25.78 22.95 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.575 -0.822 . . . . 72.2 112.399 -179.175 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.01 -175.63 3.93 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.833 -0.803 . . . . 62.31 108.833 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 29.3 mt-10 -105.43 126.78 52.51 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 118.517 0.598 . . . . 73.33 111.448 -175.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.59 124.97 60.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.031 -0.729 . . . . 65.41 109.031 175.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 385' ' ' ARG . 24.8 p -92.25 127.81 37.87 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.155 -0.475 . . . . 73.21 109.871 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 82.4 t -124.22 130.85 73.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.427 -176.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -96.87 128.59 43.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.717 -0.674 . . . . 75.25 109.414 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 42.5 t -124.57 140.36 48.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.737 -0.838 . . . . 73.11 108.737 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.2 p -103.3 122.76 45.46 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.995 0.426 . . . . 54.53 110.921 179.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 25.7 p -118.61 104.93 11.1 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.619 -0.264 . . . . 73.25 110.468 177.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.01 156.11 0.74 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 114.823 0.689 . . . . 52.43 114.823 177.513 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 2.4 Cg_endo -84.27 149.4 11.86 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.249 1.966 . . . . 51.13 110.795 173.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.72 149.41 31.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.776 -0.647 . . . . 72.3 112.678 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.6 mt-30 -107.01 151.88 24.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.579 -1.267 . . . . 75.05 107.579 176.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 480' ' ' ILE . 0.9 OUTLIER -143.88 164.38 30.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.325 -0.991 . . . . 63.45 108.325 -179.116 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.01 138.3 33.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.56 -0.533 . . . . 65.43 109.56 -178.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.2 mt -83.79 123.66 75.81 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 105.932 -1.877 . . . . 74.03 105.932 174.099 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.4 141.23 82.31 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.687 2.258 . . . . 72.31 113.306 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.46 -22.26 25.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.395 -0.821 . . . . 71.2 110.539 -177.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.49 -12.59 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.695 0.759 . . . . 75.33 110.507 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 17.6 m -53.9 -36.7 62.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.287 1.035 . . . . 71.21 112.012 -179.063 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 8.9 p -69.48 -12.99 62.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.463 0.912 . . . . 75.35 113.463 -178.162 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 435' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.4 mt -89.97 -41.07 11.96 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.753 0.649 . . . . 55.11 112.753 -178.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 91.6 m -149.24 125.82 11.0 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.979 -0.378 . . . . 74.22 109.979 -176.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.75 -48.17 80.4 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.735 . . . . 75.54 112.983 -178.514 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.23 90.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.026 0.441 . . . . 74.42 110.95 -178.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 13.8 mm-40 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.953 -0.567 . . . . 71.45 109.923 179.294 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.87 -51.08 71.25 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.766 -0.652 . . . . 71.11 109.736 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.76 -43.8 96.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.743 -0.662 . . . . 74.33 110.742 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.46 -48.57 74.74 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.167 0.432 . . . . 75.43 112.167 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 443' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 74.4 mmtt -67.62 -39.71 84.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.831 0.348 . . . . 74.41 111.415 -178.055 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.05 -39.77 93.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.562 -0.532 . . . . 54.54 109.562 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 94.3 m -67.45 -41.25 85.02 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.864 -0.607 . . . . 62.43 110.2 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.24 -16.78 63.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.199 -0.455 . . . . 72.5 111.774 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.9 -3.37 59.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.305 -0.407 . . . . 74.3 110.807 177.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.11 33.84 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.968 -0.634 . . . . 21.33 113.178 176.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -67.43 139.21 57.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.694 0.283 . . . . 74.04 110.828 -177.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -142.3 1.08 1.6 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.779 -0.725 . . . . 70.14 112.615 -179.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -104.0 111.3 23.8 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.535 -1.283 . . . . 71.31 107.535 178.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -127.28 144.67 51.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.309 -0.405 . . . . 71.2 110.29 -174.037 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -134.8 123.49 23.63 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.64 -1.985 . . . . 72.42 105.64 171.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -107.63 132.11 53.66 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 118.099 0.409 . . . . 75.45 111.139 -174.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.0 163.22 30.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.1 -0.5 . . . . 71.31 109.719 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.58 131.81 54.33 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 120.865 0.364 . . . . 74.51 110.34 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -123.27 144.56 44.02 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 106.799 -1.556 . . . . 72.22 106.799 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.67 133.5 24.03 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 121.866 1.711 . . . . 41.22 111.057 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.1 m -143.75 174.97 10.34 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.583 -0.895 . . . . 54.45 108.583 -178.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 27.2 p -65.35 149.63 96.81 Favored Pre-proline 0 C--N 1.311 -1.09 0 O-C-N 123.463 0.477 . . . . 75.54 109.842 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.47 -36.26 38.83 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 72.42 112.365 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -69.26 -22.02 63.86 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.976 0.732 . . . . 72.53 112.976 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.34 -9.77 21.94 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.778 -0.369 . . . . 74.01 111.637 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -59.9 126.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 CA-C-O 121.089 0.471 . . . . 71.44 110.372 177.014 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.24 -7.19 58.32 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.1 -0.8 . . . . 62.1 111.1 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.8 mptp? -107.34 156.27 19.08 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.792 -0.818 . . . . 54.31 108.792 177.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HD11 ' A' ' 486' ' ' ILE . 59.1 t -84.15 127.58 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.654 -1.239 . . . . 71.4 107.654 175.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.9 -19.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.138 0.792 . . . . 72.4 113.138 -175.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.36 167.96 31.51 Favored Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.422 -0.894 . . . . 73.52 111.325 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.6 p -136.96 154.18 50.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.043 -1.465 . . . . 55.14 107.043 179.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -69.31 -48.68 25.46 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 118.984 -1.086 . . . . 74.22 109.369 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.85 106.72 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 N-CA-C 106.937 -1.986 . . . . 75.44 106.937 165.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.06 151.62 85.1 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.879 2.386 . . . . 64.24 115.084 -169.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.0 12.68 0.81 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.76 1.224 . . . . 74.4 111.35 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -110.3 -15.59 13.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.577 -0.738 . . . . 74.52 110.493 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.08 154.68 22.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.848 0.832 . . . . 72.23 111.499 -171.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -87.74 110.61 20.58 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.014 -1.476 . . . . 65.35 107.014 178.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.5 m -112.83 148.52 34.68 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.772 -0.194 . . . . 74.12 111.134 -174.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.18 142.44 58.41 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.175 0.59 . . . . 64.32 110.66 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 427' ' ' ARG . 48.0 mm -64.7 -21.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.495 0.664 . . . . 71.14 111.147 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.6 p -87.14 1.83 51.79 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 116.006 -0.543 . . . . 74.24 111.412 -177.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -89.75 145.45 25.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.107 178.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.34 122.75 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.719 -0.845 . . . . 71.11 108.719 176.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.08 120.74 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 108.66 -0.867 . . . . 63.3 108.66 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -92.21 112.74 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.711 -1.218 . . . . 73.15 107.711 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.56 105.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.693 -1.225 . . . . 61.54 107.693 -177.379 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.43 118.29 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.034 -0.985 . . . . 73.3 109.338 -176.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.7 t -97.32 138.54 21.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.568 -1.271 . . . . 54.43 107.568 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -81.55 108.48 2.88 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 109.424 -1.471 . . . . 74.32 109.424 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.452 ' HA ' HG13 ' A' ' 464' ' ' VAL . 13.3 t -142.67 118.02 10.23 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 62.11 108.566 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.316 0 N-CA-C 108.834 -1.706 . . . . 75.42 108.834 179.34 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.268 0 N-CA-C 109.773 -1.331 . . . . 54.45 109.773 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.25 157.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 117.071 0.436 . . . . 70.12 110.981 178.281 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 12.8 t -125.62 169.21 12.73 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.107 -1.071 . . . . 63.32 108.107 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 358' ' ' ARG . 36.1 mmt180 -107.89 92.32 4.02 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 122.204 1.002 . . . . 73.14 110.012 177.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -117.21 148.68 41.41 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.054 -1.885 . . . . 52.14 107.623 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.62 161.5 32.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.033 0.444 . . . . 42.43 111.208 -173.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -100.69 136.32 40.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.644 -1.243 . . . . 72.45 107.644 173.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -98.49 133.2 22.92 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.149 -1.056 . . . . 64.32 108.149 -177.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.83 164.27 36.22 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 121.966 1.777 . . . . 70.21 113.67 -176.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 366' ' ' ARG . 4.1 m-20 -67.51 120.89 14.69 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.844 -1.071 . . . . 53.1 108.244 176.381 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.83 30.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.582 0 CA-C-O 123.067 1.413 . . . . 75.34 110.146 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 15.1 ptt85 -62.49 144.09 56.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.716 -1.584 . . . . 72.24 113.041 -177.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.01 0.47 48.29 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.303 -0.862 . . . . 61.21 114.164 173.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -132.77 175.88 8.95 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.824 0.812 . . . . 71.05 111.569 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 97.3 p -74.77 171.45 13.94 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.636 0.374 . . . . 75.54 111.028 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 14.6 m -61.85 -45.66 92.84 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.99 0.424 . . . . 75.21 110.09 178.346 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.83 80.4 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.106 -0.497 . . . . 74.25 111.195 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.47 -42.23 79.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.23 -0.441 . . . . 75.45 110.701 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.77 81.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 75.01 110.287 178.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.6 mt -58.71 -42.58 85.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 61.14 110.715 178.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.23 -47.17 77.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.295 -0.412 . . . . 64.24 110.985 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 43.7 m -60.77 -45.57 93.81 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 116.511 -0.313 . . . . 72.23 111.401 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.64 -38.93 92.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.737 0.303 . . . . 54.05 111.01 176.061 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -62.24 -43.3 99.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.704 -0.68 . . . . 74.21 109.839 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -64.37 -29.03 70.11 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.885 -0.598 . . . . 74.34 110.691 178.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -83.85 -12.12 56.0 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.872 -0.604 . . . . 73.05 109.709 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 381' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 96.92 0.85 60.04 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.997 -0.62 . . . . 71.31 112.416 177.256 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 43.9 m-85 -79.18 157.15 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.034 0.445 . . . . 73.34 111.851 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.8 137.83 40.5 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 106.711 -1.589 . . . . 64.45 106.711 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.63 140.26 46.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 113.96 1.096 . . . . 72.43 113.96 -177.053 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -110.69 130.89 55.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.03 -1.841 . . . . 75.32 106.03 173.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.9 m -112.64 118.09 34.08 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.782 -0.822 . . . . 53.02 108.782 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.44 118.33 32.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.943 -1.502 . . . . 75.51 106.943 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 4.6 pm0 -109.67 122.44 47.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.072 -0.714 . . . . 51.43 109.072 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.38 133.45 25.09 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.009 -0.541 . . . . 74.32 110.068 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.408 ' N ' ' HB ' ' A' ' 422' ' ' THR . 57.8 Cg_endo -76.19 139.67 21.55 Favored 'Trans proline' 0 C--O 1.257 1.431 0 C-N-CA 122.371 2.047 . . . . 62.11 109.326 172.092 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 172.78 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.491 -1.299 . . . . 62.52 107.491 -176.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 57.4 m -141.68 -14.38 0.84 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.876 -0.515 . . . . 71.4 111.928 176.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.5 p -91.37 19.35 6.13 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.364 1.078 . . . . 61.21 109.847 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.8 pt -104.57 150.95 39.11 Favored Pre-proline 0 C--N 1.296 -1.735 0 CA-C-N 114.571 -1.195 . . . . 71.34 111.839 -173.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 145.23 38.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.494 2.129 . . . . 72.44 111.291 177.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.48 162.84 7.51 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.26 3.307 . . . . 73.03 113.362 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.91 -11.78 1.15 Allowed 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 124.257 1.023 . . . . 62.21 112.451 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -101.97 109.15 20.81 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.082 -2.192 . . . . 73.31 105.082 176.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.3 p -62.14 120.64 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.079 0.942 . . . . 65.23 112.302 -170.255 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.03 -27.9 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.546 -1.206 . . . . 53.24 110.318 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.62 158.09 27.56 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 119.817 -1.182 . . . . 35.23 111.97 -177.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.1 p -114.6 -175.58 2.71 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.253 0.621 . . . . 72.51 110.249 -177.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -100.05 134.77 20.66 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.805 -1.554 . . . . 73.1 106.805 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.72 -27.94 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 1 C-N-CA 125.395 4.063 . . . . 64.33 115.939 -175.583 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.85 -24.16 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.76 0.314 . . . . 51.52 111.055 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.87 40.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.018 -0.537 . . . . 71.53 110.816 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -79.26 -2.32 40.66 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.291 0.567 . . . . 64.1 112.249 -179.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 84.2 m -84.86 146.84 27.1 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.391 -1.337 . . . . 73.03 107.391 172.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -75.43 119.6 19.73 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.903 -0.719 . . . . 51.15 110.001 -179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.02 169.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 123.898 0.879 . . . . 63.11 109.225 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.0 t -75.61 142.05 42.73 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.439 -0.949 . . . . 73.31 108.439 178.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -64.27 109.76 2.0 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.215 -0.661 . . . . 74.12 109.215 178.092 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 122.96 25.88 1.8 Allowed Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.765 -0.934 . . . . 73.03 110.765 -175.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.02 -178.29 4.02 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.047 -1.094 . . . . 51.32 108.047 -178.169 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.33 120.92 35.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.903 0.859 . . . . 63.13 112.918 -176.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.1 mm -110.96 121.35 63.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.501 -0.926 . . . . 73.4 108.501 176.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.9 t -93.81 121.39 35.2 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.549 0.69 . . . . 70.03 110.037 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.3 t -107.05 126.85 63.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.387 -0.968 . . . . 55.32 108.387 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -99.75 120.19 39.33 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.244 -0.65 . . . . 62.04 109.244 -179.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.0 t -113.07 142.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.764 -0.828 . . . . 75.44 108.764 -178.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.0 p -84.87 127.38 34.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.898 1.332 . . . . 74.33 113.792 -178.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.408 ' HB ' ' N ' ' A' ' 390' ' ' PRO . 8.8 m -101.46 156.84 17.23 Favored 'General case' 1 N--CA 1.376 -4.156 0 N-CA-C 104.092 -2.558 . . . . 74.01 104.092 170.238 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -34.84 150.64 0.01 OUTLIER Glycine 0 C--N 1.284 -2.357 0 N-CA-C 117.435 1.734 . . . . 74.15 117.435 -176.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 50.9 Cg_exo -54.71 132.2 50.27 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.128 2.552 . . . . 73.2 112.918 179.007 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -72.25 140.6 48.73 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.142 -0.935 . . . . 65.34 109.933 176.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.2 mt-30 -120.3 148.11 44.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.251 -1.018 . . . . 61.43 108.251 176.325 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -144.56 164.64 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.615 -1.254 . . . . 75.12 107.615 -176.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.39 138.84 34.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.993 -1.114 . . . . 53.3 107.993 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 429' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.5 mt -80.8 120.47 79.05 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.168 -1.049 . . . . 62.21 108.168 178.298 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.46 141.55 51.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.96 2.44 . . . . 64.41 113.69 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.44 -15.65 56.27 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.733 -1.121 . . . . 75.15 111.253 -176.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.31 -14.62 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.396 -0.82 . . . . 75.33 110.838 -178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.0 m -53.74 -40.04 65.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.922 0.889 . . . . 73.31 112.388 -178.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.8 p -69.08 -12.84 62.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 113.384 0.883 . . . . 75.3 113.384 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -82.7 -48.35 10.97 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.362 -0.535 . . . . 65.43 110.716 -178.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 75.1 m -157.29 141.74 16.49 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 110.285 -0.265 . . . . 72.51 110.285 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -56.7 -44.19 81.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.695 1.198 . . . . 74.53 111.486 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.61 78.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.915 0.388 . . . . 70.03 110.482 177.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.11 -42.0 94.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.836 -0.62 . . . . 65.52 110.935 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 440' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.79 -51.69 68.27 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.599 0.562 . . . . 73.41 110.662 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.57 -49.18 81.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.948 -0.301 . . . . 74.2 111.515 -177.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.06 -47.58 70.86 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.569 0.581 . . . . 70.22 112.569 -178.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -67.05 -38.03 85.12 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.255 0.835 . . . . 71.21 113.255 -178.566 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 444' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.42 -36.46 84.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.269 -0.572 . . . . 52.33 111.115 174.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 44.9 m -67.35 -39.95 85.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.169 -0.678 . . . . 64.41 109.169 177.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.95 68.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.157 0.503 . . . . 74.24 110.605 177.331 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.64 59.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.302 -0.408 . . . . 51.02 110.34 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.92 -21.3 8.99 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 119.163 -0.799 . . . . 43.34 114.697 174.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -55.88 128.33 34.56 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.408 0.892 . . . . 55.22 113.408 -172.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.46 -1.18 23.31 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.251 -0.886 . . . . 33.21 114.293 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 451' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 10.7 mmm180 -124.12 111.66 16.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 117.699 0.749 . . . . 63.14 110.549 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -119.07 150.99 39.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.635 . . . . 71.44 110.271 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -145.56 136.1 24.21 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.399 -1.704 . . . . 72.31 106.399 172.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -106.64 134.12 50.28 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.809 0.338 . . . . 73.15 110.148 -176.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.93 159.14 42.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.231 -0.655 . . . . 62.03 109.231 177.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -129.35 134.54 47.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.43 -0.952 . . . . 64.41 108.43 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 t -125.14 146.13 52.82 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 108.997 -0.742 . . . . 42.42 108.997 -177.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 458' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 490' ' ' SER . 40.4 Cg_exo -61.57 123.6 13.04 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.332 2.021 . . . . 75.32 109.244 173.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.5 m -139.26 -179.78 6.07 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 110.211 -0.292 . . . . 71.53 110.211 -176.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.6 m -56.18 133.5 75.11 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 108.384 -0.969 . . . . 60.25 108.384 175.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.01 -31.16 33.58 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.828 3.018 . . . . 72.21 114.173 -175.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.73 -11.23 59.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 111.962 0.356 . . . . 75.43 111.962 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.69 2.29 38.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.498 -0.319 . . . . 74.42 111.16 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.7 p -59.62 126.96 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 120.277 -0.569 . . . . 73.53 110.689 178.032 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.79 78.24 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.161 -1.019 . . . . 72.44 111.963 178.407 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -125.42 147.21 49.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.584 -0.895 . . . . 71.15 108.584 177.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.65 128.64 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.193 -0.669 . . . . 74.45 109.193 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.66 -5.39 9.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.126 -1.03 . . . . 75.22 111.226 -178.608 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.73 29.39 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.534 -0.841 . . . . 74.01 111.805 176.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.2 p -116.34 153.34 32.17 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.896 -1.15 . . . . 71.23 107.896 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 28.4 t-20 -60.75 -50.35 85.56 Favored Pre-proline 0 C--N 1.317 -0.838 0 O-C-N 123.35 0.406 . . . . 75.33 111.285 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_exo -77.98 131.28 10.92 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 N-CA-C 107.413 -1.803 . . . . 51.51 107.413 168.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.5 Cg_endo -62.46 142.14 89.34 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.373 2.049 . . . . 75.53 113.552 -175.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.99 4.18 15.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.976 0.893 . . . . 54.14 110.827 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -108.56 3.24 22.79 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.763 -1.108 . . . . 71.11 108.652 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 476' ' ' GLN . . . . . 0.406 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 36.1 tt0 -121.83 165.21 16.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.106 -1.072 . . . . 74.53 108.106 -178.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 477' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.8 m -98.77 129.64 45.2 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.029 -1.1 . . . . 61.34 108.029 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 47.5 m -124.42 148.59 47.5 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 -178.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.25 153.75 40.49 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.388 0.514 . . . . 75.52 112.388 -178.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.7 mp -66.26 -29.46 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.359 0.6 . . . . 62.11 110.694 177.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 14.6 t -90.18 2.82 54.94 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.541 0.686 . . . . 72.31 109.949 177.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 482' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 46.1 t30 -86.08 141.55 29.35 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.037 -1.097 . . . . 73.33 108.037 -178.055 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.47 112.71 17.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 120.051 -0.66 . . . . 72.4 109.22 -178.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.1 119.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 N-CA-C 107.514 -1.291 . . . . 61.04 107.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 41.0 mt -98.22 121.03 48.33 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.451 -1.314 . . . . 61.3 107.451 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.93 120.22 51.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.809 -1.182 . . . . 63.55 107.809 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.59 123.63 60.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-O 121.527 0.679 . . . . 72.32 110.048 -176.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.98 137.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.946 -1.131 . . . . 70.3 107.946 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 489' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.57 127.98 8.97 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.424 -1.07 . . . . 54.53 110.424 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.3 t -133.94 103.89 6.02 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.179 -1.045 . . . . 72.23 108.179 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.193 0 N-CA-C 108.877 -1.689 . . . . 54.41 108.877 -178.007 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.293 0 N-CA-C 109.82 -1.312 . . . . 63.53 109.82 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.71 141.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 C-N-CA 119.866 -0.734 . . . . 63.13 109.241 174.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 357' ' ' THR . . . . . 0.403 ' HB ' ' OD1' ' A' ' 359' ' ' ASP . 8.9 m -117.23 160.04 21.71 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 108.398 -0.964 . . . . 71.11 108.398 -175.024 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -97.17 56.93 1.42 Allowed 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.519 -1.289 . . . . 64.43 107.519 171.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.403 ' OD1' ' HB ' ' A' ' 357' ' ' THR . 12.6 p-10 -85.65 127.14 34.4 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.589 -1.641 . . . . 75.45 109.892 -178.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.98 152.23 20.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.474 -0.785 . . . . 74.23 110.931 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -104.54 136.7 43.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.151 -0.477 . . . . 71.11 109.941 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.95 133.77 20.18 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 109.301 -0.629 . . . . 32.23 109.301 -176.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.65 159.51 53.21 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.604 2.202 . . . . 71.14 114.635 -175.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.37 142.96 50.36 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.28 -0.873 . . . . 72.2 109.166 176.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 6.7 t -107.08 21.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.044 -1.095 . . . . 71.4 108.044 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 6.0 ptp180 -58.57 145.37 39.61 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.08 -0.964 . . . . 71.44 112.379 -177.432 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.4 1.06 43.92 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.729 -0.748 . . . . 72.34 113.317 178.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 368' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 7.6 pt20 -138.58 -175.45 4.13 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.263 -1.014 . . . . 73.31 108.263 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.1 p -76.48 163.82 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 119.609 1.095 . . . . 74.24 112.316 -172.576 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.7 p -61.85 -34.09 75.34 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.758 -0.655 . . . . 71.03 109.335 173.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.77 91.73 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.143 -0.935 . . . . 72.24 109.781 176.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.06 -42.11 89.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.58 -0.736 . . . . 75.33 110.619 177.206 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 373' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 399' ' ' VAL . . . -59.93 -47.39 85.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.722 -0.672 . . . . 50.1 111.224 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.45 -46.12 89.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.087 -0.506 . . . . 75.01 110.013 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.15 93.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.63 . . . . 54.15 111.477 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 64.9 m -66.24 -48.25 71.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.145 -0.48 . . . . 61.13 111.088 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.27 -38.7 91.1 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.325 -0.234 . . . . 74.21 111.225 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -59.71 -48.17 82.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.823 -0.806 . . . . 63.12 108.823 178.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -70.33 -17.31 63.07 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.684 1.364 . . . . 64.02 114.684 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -89.61 -14.19 35.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.353 -0.539 . . . . 71.2 111.113 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.11 16.25 30.79 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.345 -0.931 . . . . 44.11 113.25 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -96.72 154.67 17.15 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.857 -0.423 . . . . 74.23 109.857 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 383' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.1 mmtp -95.61 143.44 26.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.091 -1.448 . . . . 74.13 107.091 178.325 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -132.75 148.21 31.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.363 0.601 . . . . 65.01 112.398 -178.802 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 385' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 417' ' ' THR . 19.5 ttm-85 -118.28 144.88 45.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.705 -1.591 . . . . 73.43 106.705 174.004 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.3 m -98.46 121.58 40.58 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.008 -1.478 . . . . 73.34 107.008 176.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.34 119.47 38.96 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.872 -1.899 . . . . 74.44 105.872 -179.068 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HB2' HG22 ' A' ' 422' ' ' THR . 14.7 pm0 -110.91 122.06 46.93 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.368 0.604 . . . . 73.1 110.892 -174.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 389' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.3 OUTLIER -116.15 119.32 36.88 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 115.402 -0.817 . . . . 64.5 111.48 -177.791 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 390' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 5.8 Cg_endo -93.25 145.53 2.26 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.031 2.487 . . . . 44.22 111.662 173.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 391' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 12.0 t70 160.82 -164.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 104.861 -2.274 . . . . 64.23 104.861 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 392' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 14.8 m -132.8 1.68 3.65 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 119.533 1.06 . . . . 71.05 110.316 175.031 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -97.32 24.39 6.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 106.385 -1.709 . . . . 74.52 106.385 174.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 394' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 421' ' ' SER . 19.8 pt -89.64 151.57 45.97 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 112.527 -2.124 . . . . 65.13 110.304 -178.274 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.55 173.01 15.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 121.837 1.691 . . . . 73.42 108.652 170.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.01 160.92 14.28 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.161 1.907 . . . . 52.0 112.598 174.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.01 -8.07 0.94 Allowed 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.923 1.689 . . . . 63.32 112.781 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.423 ' HB3' ' O ' ' A' ' 368' ' ' GLN . 42.9 m80 -82.42 175.47 10.2 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.452 1.101 . . . . 70.44 108.467 179.404 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 373' ' ' ALA . 7.6 p -91.8 117.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 118.457 -1.297 . . . . 73.32 109.592 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.81 -28.76 2.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.672 -1.149 . . . . 71.44 109.808 177.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.34 160.8 27.92 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 119.79 -1.195 . . . . 52.14 112.192 -173.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 52.4 p -122.43 -174.46 2.91 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.282 1.033 . . . . 71.22 111.225 -172.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.437 ' HB3' HG23 ' A' ' 416' ' ' ILE . 6.5 t70 -98.17 142.07 23.98 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 105.896 -1.89 . . . . 71.02 105.896 -175.303 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.31 -36.14 6.08 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.795 2.996 . . . . 74.12 113.647 178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -68.54 -8.21 39.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.962 -0.563 . . . . 52.15 112.496 -178.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -81.75 -51.45 8.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.548 -0.461 . . . . 71.24 110.64 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.35 -5.12 59.24 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 120.646 -0.421 . . . . 61.41 112.043 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.5 m -97.06 142.25 29.23 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 72.42 106.624 174.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.7 p -74.24 113.74 11.8 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.763 0.792 . . . . 72.43 111.771 -177.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.25 170.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.887 -1.051 . . . . 73.2 109.462 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 48.1 m -67.02 138.56 57.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.561 -0.903 . . . . 73.11 108.561 175.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.81 109.92 0.81 Allowed 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.007 0.523 . . . . 73.24 111.483 -177.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.93 43.64 1.62 Allowed Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.582 -0.735 . . . . 65.13 111.997 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -94.39 -167.62 1.7 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.406 -1.331 . . . . 63.31 107.406 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.2 pt-20 -111.36 124.4 52.17 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.695 0.759 . . . . 64.01 111.612 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 416' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 403' ' ' ASP . 43.7 mm -114.44 135.53 53.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.012 -0.994 . . . . 65.42 108.554 -176.063 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 385' ' ' ARG . 71.1 p -94.32 127.07 39.96 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.34 -0.944 . . . . 73.14 109.689 175.462 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.28 130.13 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.242 -1.021 . . . . 72.13 108.242 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -96.69 128.81 43.99 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 116.401 -0.363 . . . . 71.42 110.595 -175.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 12.6 p -134.33 141.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.391 -0.966 . . . . 75.02 108.391 176.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 421' ' ' SER . . . . . 0.576 ' HB2' HD12 ' A' ' 394' ' ' ILE . 73.2 p -94.1 122.53 36.71 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.474 -0.565 . . . . 52.01 109.474 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 422' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 388' ' ' GLN . 12.2 t -120.14 107.5 13.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.857 -0.737 . . . . 74.23 111.992 177.36 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.04 120.65 1.59 Allowed Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.839 -1.172 . . . . 64.11 114.431 174.229 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 424' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.2 Cg_exo -75.94 128.56 10.84 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.898 1.732 . . . . 62.21 110.207 173.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 480' ' ' ILE . 6.4 mm-40 -74.99 125.75 29.57 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.687 -0.486 . . . . 54.34 109.687 177.275 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 49.1 mt-30 -110.29 139.08 45.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.083 -0.71 . . . . 71.51 109.083 177.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 427' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 1.1 tpt180 -132.64 165.45 24.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.995 0.426 . . . . 73.3 111.579 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.76 139.24 34.96 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.158 0.983 . . . . 75.34 111.2 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.67 119.82 76.36 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.278 -1.749 . . . . 60.52 106.278 172.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.25 141.35 81.87 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.651 2.234 . . . . 61.22 113.368 -178.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 -20.96 23.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.069 -0.969 . . . . 54.32 110.426 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.39 -11.73 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.407 0.623 . . . . 63.41 110.624 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.2 m -53.0 -41.03 64.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.486 1.114 . . . . 62.42 112.485 -178.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.1 p -68.2 -13.63 62.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.557 0.947 . . . . 74.23 113.557 -176.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 76.3 mt -86.86 -36.92 18.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.651 0.263 . . . . 64.11 111.306 -178.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.9 m -158.37 134.15 9.0 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 122.222 -0.299 . . . . 72.21 110.415 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.05 -46.42 89.21 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.703 0.631 . . . . 73.33 112.703 -178.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.14 -41.23 87.82 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.704 0.287 . . . . 60.45 110.468 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -63.71 -39.45 94.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.725 -0.671 . . . . 54.43 110.41 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.87 -50.92 71.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.47 0.481 . . . . 24.54 109.837 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.44 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 43.34 110.467 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 6.3 mmpt? -61.04 -46.05 92.26 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.996 -0.547 . . . . 73.15 111.267 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.43 -41.98 96.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.246 0.462 . . . . 74.24 112.246 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -43.43 96.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.936 0.398 . . . . 71.11 111.024 176.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.9 m -68.08 -39.63 82.88 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.787 -0.642 . . . . 74.13 110.333 -178.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.3 62.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 63.02 111.184 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.76 -12.84 59.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.156 0.503 . . . . 62.4 109.728 176.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.53 0.7 40.26 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-O 119.168 -0.795 . . . . 74.41 114.469 174.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.96 137.38 57.1 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.099 0.95 . . . . 74.14 112.106 -178.079 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -125.08 13.57 7.53 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.204 -0.759 . . . . 73.3 111.204 178.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.23 111.37 13.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.504 -0.924 . . . . 63.11 108.504 -178.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.08 152.74 47.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.89 -0.595 . . . . 74.45 109.94 -175.041 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 453' ' ' LYS . . . . . 0.414 ' HD3' HG13 ' A' ' 485' ' ' ILE . 64.0 tttp -150.09 122.71 8.58 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.927 -1.138 . . . . 70.3 107.927 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.73 131.98 45.36 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.796 -0.446 . . . . 65.11 109.796 -177.296 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -123.57 141.17 52.27 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.315 -1.365 . . . . 73.41 107.315 175.554 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -119.28 129.59 54.98 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.219 0.533 . . . . 72.11 110.288 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.2 t -119.94 130.84 24.64 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 108.506 -0.924 . . . . 74.21 108.506 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.73 121.81 10.09 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.45 2.1 . . . . 52.32 109.699 177.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.4 m -133.95 160.28 38.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.916 -0.314 . . . . 63.31 110.417 -176.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 460' ' ' THR . . . . . 0.525 ' HB ' ' OE1' ' A' ' 462' ' ' GLU . 14.2 p -64.65 159.06 64.47 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 124.856 1.262 . . . . 73.43 111.81 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.77 -31.13 24.89 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.789 2.992 . . . . 64.03 113.285 177.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 462' ' ' GLU . . . . . 0.525 ' OE1' ' HB ' ' A' ' 460' ' ' THR . 1.5 pm0 -75.36 -24.54 57.31 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.193 0.812 . . . . 73.31 113.193 178.115 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.17 -18.67 14.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.211 0.448 . . . . 71.0 112.211 -179.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 464' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.9 p -59.5 130.44 23.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.413 0.625 . . . . 64.31 111.29 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -4.61 64.01 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.743 -0.662 . . . . 61.13 111.971 178.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 157.05 28.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.227 0.537 . . . . 64.54 109.95 177.295 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.79 136.51 22.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.496 -1.298 . . . . 65.13 107.496 176.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.31 -16.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.543 -0.863 . . . . 55.31 111.301 -177.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.1 175.62 32.32 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.561 -0.745 . . . . 43.04 111.629 178.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.0 p -122.01 158.99 27.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.385 -0.969 . . . . 75.03 108.385 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -64.97 -57.0 17.19 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 119.086 -0.483 . . . . 74.12 110.666 175.374 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.0 Cg_endo -79.63 121.14 4.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 N-CA-C 107.951 -1.596 . . . . 71.22 107.951 170.176 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 161.29 46.5 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.537 2.158 . . . . 75.13 113.969 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -69.6 6.59 1.06 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.887 1.275 . . . . 73.32 113.283 -177.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -108.15 -4.49 17.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.158 -0.682 . . . . 74.13 109.158 179.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -99.92 161.44 13.61 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.604 -0.726 . . . . 74.41 109.936 -177.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.0 m -128.92 101.03 5.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.996 -1.483 . . . . 55.3 106.996 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.9 p -104.41 149.05 25.75 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.139 -0.482 . . . . 54.13 111.576 -174.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.8 153.53 24.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 52.0 111.015 177.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 480' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 48.2 mm -61.0 -15.1 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 C-N-CA 123.924 0.89 . . . . 65.53 112.074 -179.153 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 15.0 t -94.99 -4.09 47.26 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.8 -0.563 . . . . 72.44 110.238 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -77.25 130.89 37.83 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.98 -0.748 . . . . 54.14 108.98 179.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.31 113.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.68 -0.859 . . . . 75.54 108.68 -179.023 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.45 120.04 36.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 109.081 -0.711 . . . . 60.2 109.081 179.24 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 485' ' ' ILE . . . . . 0.414 HG13 ' HD3' ' A' ' 453' ' ' LYS . 3.8 mp -92.34 113.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 61.45 107.122 177.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.92 121.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.124 -1.065 . . . . 74.14 108.124 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 39.7 mt -101.16 116.32 44.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.566 0.698 . . . . 71.22 110.474 -175.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.5 t -98.1 132.72 42.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.245 -0.889 . . . . 65.33 109.045 -176.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.7 98.68 1.93 Allowed Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 109.207 -1.557 . . . . 63.42 109.207 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 464' ' ' VAL . 18.0 t -140.85 111.89 7.17 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.902 -0.777 . . . . 70.44 108.902 -176.041 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.92 0 N-CA-C 109.636 -1.386 . . . . 73.04 109.636 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 108.425 -0.954 . . . . 73.239999999999995 108.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 22.7 m -131.27 158.48 43.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 123.102 0.561 . . . . 74.319999999999993 109.53 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.71 137.25 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.726 -0.842 . . . . 63.420000000000002 108.726 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.36 124.52 36.97 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-O 120.828 0.347 . . . . 70.25 110.519 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.01 142.64 96.85 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.16 2.573 . . . . 64.129999999999995 113.304 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.71 149.96 34.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.742 -1.117 . . . . 54.140000000000001 110.167 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.83 31.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.987 1.375 . . . . 63.0 108.006 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -64.44 133.97 53.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.057 -1.429 . . . . 74.319999999999993 110.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.18 -0.13 47.49 Favored Glycine 0 C--N 1.317 -0.495 0 C-N-CA 121.407 -0.425 . . . . 71.239999999999995 112.326 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.23 -176.88 3.94 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.615 -0.883 . . . . 72.430000000000007 108.615 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 91.6 p -81.3 168.41 18.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 118.407 0.548 . . . . 71.439999999999998 110.266 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 374' ' ' ILE . 1.8 p -63.15 -34.83 78.46 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 116.166 -0.47 . . . . 64.340000000000003 110.637 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.91 -39.25 93.98 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.731 0.412 . . . . 71.519999999999996 110.548 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -59.57 -42.83 93.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.106 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.89 81.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.745 . . . . 73.310000000000002 110.343 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 370' ' ' SER . 80.9 mt -58.4 -46.34 89.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.654 -0.703 . . . . 53.409999999999997 110.546 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -46.98 78.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.317 -0.401 . . . . 73.040000000000006 111.705 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 74.0 m -60.9 -47.53 85.98 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.727 0.298 . . . . 71.230000000000004 111.291 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.57 -39.51 93.88 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.045 -0.262 . . . . 75.239999999999995 110.998 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.07 -42.92 99.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.459 0.703 . . . . 71.540000000000006 109.727 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -33.71 76.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.778 -0.646 . . . . 75.409999999999997 111.323 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -83.84 -10.2 58.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.057 -0.52 . . . . 75.540000000000006 111.743 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.98 0.28 56.19 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.249 -0.977 . . . . 63.229999999999997 112.497 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 53.6 m-85 -78.07 151.11 33.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.675 -0.491 . . . . 70.430000000000007 109.675 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 383' ' ' LYS . 3.0 mptp? -102.06 147.19 26.89 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.867 -1.531 . . . . 73.430000000000007 106.867 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.69 141.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-O 121.378 0.609 . . . . 72.109999999999999 111.623 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -118.65 127.97 54.08 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.334 -1.358 . . . . 73.040000000000006 107.334 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.4 m -99.71 123.95 44.48 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 109.277 -0.638 . . . . 73.510000000000005 109.277 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.63 119.57 39.14 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.302 -1.74 . . . . 73.040000000000006 106.302 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -119.18 141.29 48.99 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 110.155 -0.313 . . . . 75.510000000000005 110.155 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 11.0 ptpt -139.4 134.89 16.69 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 116.057 -0.52 . . . . 73.549999999999997 111.109 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 6.1 Cg_exo -82.7 134.24 7.33 Favored 'Trans proline' 0 C--O 1.246 0.893 0 N-CA-C 106.737 -2.063 . . . . 64.450000000000003 106.737 165.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.429 ' HB2' ' HD3' ' A' ' 389' ' ' LYS . 5.0 t70 -154.38 -176.73 6.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.182 -1.407 . . . . 55.030000000000001 112.239 -171.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.9 t -92.44 -41.09 10.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.017 -1.845 . . . . 71.420000000000002 106.017 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -101.83 74.52 1.49 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.92 -1.511 . . . . 75.510000000000005 106.92 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 421' ' ' SER . 2.1 pp -88.64 121.02 70.31 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 115.435 1.643 . . . . 71.129999999999995 115.435 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.588 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 16.5 Cg_exo -75.48 157.37 40.8 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.78 2.32 . . . . 45.539999999999999 109.519 164.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.64 160.91 47.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.33 2.02 . . . . 74.109999999999999 111.864 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.59 -6.91 5.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.041 0.756 . . . . 71.540000000000006 113.041 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -90.59 166.74 13.03 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.409 -0.814 . . . . 61.530000000000001 108.938 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.07 117.76 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.076 -0.713 . . . . 71.540000000000006 109.076 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -106.43 -28.63 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.346 -0.613 . . . . 75.030000000000001 109.346 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 168.16 28.09 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.957 -1.657 . . . . 70.209999999999994 108.957 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 p -132.58 -177.76 4.62 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-O 120.96 0.41 . . . . 63.140000000000001 110.698 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -100.94 138.78 20.11 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.947 -1.131 . . . . 65.030000000000001 107.947 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.9 -29.54 3.76 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 124.573 3.515 . . . . 75.140000000000001 114.703 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.58 -28.39 54.79 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.236 0.614 . . . . 61.340000000000003 112.0 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.66 54.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.944 0.402 . . . . 23.530000000000001 111.203 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -6.76 59.25 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.557 0.577 . . . . 71.329999999999998 112.557 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.5 m -86.02 147.69 26.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.649 -1.612 . . . . 71.530000000000001 106.649 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.0 m -74.45 112.83 11.01 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.417 -0.957 . . . . 65.120000000000005 108.417 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.67 165.06 29.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.047 -0.723 . . . . 71.340000000000003 109.047 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 50.3 m -69.23 134.13 48.81 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 120.6 -0.44 . . . . 72.340000000000003 110.242 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.89 112.01 2.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 63.240000000000002 110.218 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.53 24.21 5.1 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.537 -1.025 . . . . 74.239999999999995 110.537 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.99 -169.12 2.43 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.409 -1.33 . . . . 72.109999999999999 107.409 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.1 125.05 53.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.814 -0.554 . . . . 75.530000000000001 110.209 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -111.42 125.65 68.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.926 -0.579 . . . . 61.509999999999998 109.442 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.2 t -89.59 130.74 35.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.086 -0.709 . . . . 72.450000000000003 109.086 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 65.9 t -108.67 118.78 56.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.083 -1.08 . . . . 74.109999999999999 108.083 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.4 121.65 34.09 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.164 -0.68 . . . . 72.340000000000003 109.164 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 13.8 p -133.96 152.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.432 -1.321 . . . . 64.450000000000003 107.432 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.588 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 43.7 m -126.74 130.82 51.09 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 121.574 -0.703 . . . . 72.25 110.224 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -118.05 106.66 13.13 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.522 0.677 . . . . 65.510000000000005 110.995 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 79.33 141.24 2.19 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.205 -0.907 . . . . 43.039999999999999 114.204 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 24.0 Cg_endo -74.28 147.56 37.49 Favored 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 121.09 1.193 . . . . 74.099999999999994 109.465 172.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -72.77 164.91 25.83 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 109.628 -177.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -125.48 154.23 42.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.934 -1.136 . . . . 75.540000000000006 107.934 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.2 OUTLIER -141.9 153.48 44.44 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.318 -0.993 . . . . 71.219999999999999 108.318 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -83.06 138.86 33.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.962 -1.866 . . . . 73.120000000000005 105.962 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.2 mt -80.3 115.55 55.52 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 120.587 -0.445 . . . . 73.310000000000002 110.332 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.16 141.08 38.81 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.31 1.34 . . . . 70.430000000000007 109.969 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.6 78.77 9.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.619 1.2 . . . . 54.409999999999997 110.393 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.47 -10.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.531 -1.668 . . . . 71.349999999999994 107.588 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.6 m -59.9 -50.02 75.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.224 -1.353 . . . . 74.109999999999999 110.486 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 21.4 m -57.95 -13.56 4.76 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 125.598 1.559 . . . . 72.439999999999998 113.063 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.23 -47.08 11.18 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.731 -0.606 . . . . 73.109999999999999 110.681 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 26.6 m -160.82 145.68 14.14 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.652 -0.87 . . . . 73.200000000000003 108.652 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.57 -44.36 89.72 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 122.995 0.518 . . . . 53.310000000000002 111.085 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.76 84.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.815 -0.63 . . . . 73.549999999999997 110.748 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.451 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.5 mm-40 -61.89 -43.46 98.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.47 -0.786 . . . . 74.019999999999996 111.262 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -52.15 66.61 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 123.543 0.527 . . . . 55.420000000000002 110.729 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.76 -51.05 49.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.06 -0.518 . . . . 70.310000000000002 112.057 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -69.28 -44.94 70.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 114.04 1.126 . . . . 71.129999999999995 114.04 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.33 -38.39 84.82 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.978 -0.289 . . . . 73.329999999999998 111.312 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.15 -32.62 73.01 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.213 -0.595 . . . . 71.310000000000002 111.499 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.7 m -64.24 -40.38 95.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.999 -0.741 . . . . 75.219999999999999 108.999 174.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.65 66.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.711 -0.677 . . . . 75.200000000000003 110.798 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -12.4 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.164 0.507 . . . . 61.020000000000003 110.303 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.15 -27.57 5.56 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.886 -0.673 . . . . 73.150000000000006 113.713 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 445' ' ' THR . 88.8 m-85 -62.09 142.14 57.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.236 0.518 . . . . 71.420000000000002 111.392 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.89 13.71 4.42 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.59 -1.291 . . . . 53.210000000000001 113.278 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -128.35 113.82 16.08 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.321 -0.517 . . . . 73.239999999999995 110.049 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.1 152.36 47.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.199 0.523 . . . . 72.420000000000002 111.515 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -143.17 123.81 14.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.74 -1.578 . . . . 72.420000000000002 106.74 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -94.72 134.71 37.02 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.73 159.69 41.28 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.741 -1.207 . . . . 75.239999999999995 107.741 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.663 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.1 m-80 -128.32 140.64 51.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.535 -0.913 . . . . 74.109999999999999 108.535 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.0 m -125.17 137.58 30.02 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 109.164 -0.68 . . . . 73.010000000000005 109.164 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 15.9 Cg_endo -61.55 121.39 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.414 2.076 . . . . 71.040000000000006 111.265 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.7 m -133.44 171.41 14.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.288 -0.634 . . . . 54.140000000000001 109.288 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.4 m -58.67 143.28 82.28 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 123.823 0.849 . . . . 64.019999999999996 108.867 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.1 Cg_endo -50.6 -25.91 15.76 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.553 2.835 . . . . 63.25 113.027 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.41 -18.71 65.51 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.215 0.45 . . . . 71.140000000000001 112.215 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.22 5.17 18.26 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.281 -0.262 . . . . 74.340000000000003 111.126 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.6 p -60.25 127.3 19.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.006 0.432 . . . . 74.109999999999999 110.895 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.03 82.06 Favored Glycine 0 C--N 1.308 -0.978 0 C-N-CA 120.469 -0.872 . . . . 75.329999999999998 112.453 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -111.28 153.41 25.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.568 -0.901 . . . . 64.349999999999994 108.568 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 434' ' ' THR . 86.5 t -84.03 135.55 24.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.814 -1.55 . . . . 54.229999999999997 106.814 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.75 -5.15 9.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 118.804 -1.158 . . . . 75.540000000000006 111.527 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 145.23 -153.67 25.42 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 111.066 -0.814 . . . . 61.240000000000002 111.066 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.1 p -116.79 160.38 20.9 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.489 -0.93 . . . . 52.119999999999997 108.489 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.4 t30 -74.08 -51.4 4.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 119.491 -0.884 . . . . 53.119999999999997 110.188 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.1 Cg_exo -71.03 152.39 62.71 Favored 'Trans proline' 0 C--N 1.381 2.288 0 N-CA-C 108.122 -1.53 . . . . 64.239999999999995 108.122 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.28 127.04 19.93 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.908 1.738 . . . . 75.25 111.775 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.79 -23.26 61.54 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.822 0.82 . . . . 45.530000000000001 110.753 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.54 0.18 47.64 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.592 -0.731 . . . . 74.120000000000005 110.422 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.46 150.57 20.46 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 109.182 -0.673 . . . . 73.420000000000002 109.182 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -88.23 106.95 18.54 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -106.51 148.27 28.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.618 -0.265 . . . . 50.350000000000001 110.921 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.14 157.83 36.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.395 0.517 . . . . 72.25 112.395 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 425' ' ' GLU . 40.5 mm -60.15 -35.61 62.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.684 0.754 . . . . 74.129999999999995 110.79 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.6 p -91.62 5.19 50.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.141 -0.936 . . . . 60.119999999999997 112.278 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -83.22 141.27 32.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.44 113.44 22.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.048 0.451 . . . . 71.030000000000001 110.618 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.06 119.81 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 108.898 -0.778 . . . . 71.340000000000003 108.898 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 60.6 mt -92.9 113.36 27.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.663 -1.236 . . . . 72.0 107.663 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.52 123.3 48.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 107.953 -1.128 . . . . 63.240000000000002 107.953 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 17.6 pt -107.24 122.77 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.713 0.768 . . . . 71.319999999999993 111.798 -176.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.663 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 60.2 t -98.67 139.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.164 -0.925 . . . . 61.450000000000003 108.988 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.87 118.47 4.69 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.744 -0.942 . . . . 63.329999999999998 110.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 52.9 m -141.09 129.78 22.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.59 -0.359 . . . . 72.109999999999999 110.216 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 106.411 -2.676 . . . . 45.539999999999999 106.411 177.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 409' ' ' SER . 17.3 m-20 . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 107.653 -1.239 . . . . 73.329999999999998 107.653 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.81 155.14 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 116.476 -0.329 . . . . 62.549999999999997 110.486 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.2 136.97 34.89 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.556 -1.646 . . . . 74.230000000000004 106.556 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.62 138.27 19.59 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 116.265 -0.425 . . . . 72.530000000000001 110.27 -172.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.12 126.69 17.76 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.961 2.441 . . . . 65.109999999999999 112.814 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.21 153.77 42.7 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 114.482 -1.235 . . . . 75.340000000000003 110.457 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.463 ' HA ' HE21 ' A' ' 368' ' ' GLN . 17.1 m -109.75 3.59 9.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 114.239 1.2 . . . . 32.420000000000002 114.239 -174.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -62.94 130.29 44.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.077 0.465 . . . . 74.329999999999998 110.229 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.05 -2.9 47.8 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.815 -0.707 . . . . 75.120000000000005 111.723 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' A' ' 365' ' ' VAL . 48.7 mt-30 -115.5 167.92 10.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.868 -0.79 . . . . 73.420000000000002 108.868 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 87.6 p -78.1 164.53 24.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.416 -0.587 . . . . 73.329999999999998 109.416 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 30.1 p -58.18 -45.53 87.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.155 0.503 . . . . 41.539999999999999 110.21 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.75 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.47 -0.787 . . . . 63.210000000000001 111.77 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.22 -34.74 76.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.465 0.65 . . . . 52.299999999999997 109.56 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.21 69.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 61.219999999999999 110.158 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.2 mt -58.75 -45.45 91.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.941 -0.572 . . . . 62.109999999999999 110.07 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.1 92.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.623 -0.717 . . . . 64.030000000000001 111.721 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 78.5 m -63.29 -48.66 77.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.243 -0.435 . . . . 75.25 111.816 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.86 -41.53 91.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.653 -0.249 . . . . 64.340000000000003 111.532 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -59.68 -41.59 91.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.905 0.753 . . . . 75.430000000000007 110.09 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -69.34 -31.34 69.71 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.249 -0.432 . . . . 70.219999999999999 111.184 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -79.13 -14.79 58.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.375 -0.375 . . . . 70.430000000000007 110.799 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.4 15.24 51.53 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.651 -0.785 . . . . 73.129999999999995 111.827 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -93.52 160.32 14.84 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.928 -0.397 . . . . 74.450000000000003 109.928 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.9 mmtp -104.66 135.35 46.22 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.025 -0.731 . . . . 74.409999999999997 109.025 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.38 138.59 49.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-O 121.256 0.55 . . . . 64.409999999999997 111.584 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -110.88 128.55 55.84 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.539 -1.282 . . . . 74.219999999999999 107.539 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.8 m -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 108.028 -1.101 . . . . 71.340000000000003 108.028 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 125.3 53.79 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 103.636 -2.727 . . . . 72.140000000000001 103.636 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -125.75 142.78 51.35 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 120.001 -0.68 . . . . 43.030000000000001 110.594 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -134.01 131.84 21.08 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 120.724 -0.39 . . . . 74.129999999999995 110.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.35 134.74 6.87 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.97 1.78 . . . . 44.509999999999998 109.2 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 -171.95 -176.04 1.62 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.467 -1.679 . . . . 62.229999999999997 106.467 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 68.3 m -129.53 -8.49 4.62 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.422 0.629 . . . . 64.129999999999995 111.084 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -94.29 3.45 55.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.815 -1.18 . . . . 52.109999999999999 107.815 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.2 pp -88.52 151.05 47.65 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.513 -1.222 . . . . 72.340000000000003 113.4 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.65 172.03 11.58 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 122.538 2.159 . . . . 73.439999999999998 110.13 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.69 161.57 9.83 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.149 2.566 . . . . 63.399999999999999 112.255 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.471 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 p-10 -57.14 -9.05 0.8 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 124.711 1.204 . . . . 63.340000000000003 113.04 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 30.6 m170 -67.66 136.74 54.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.745 -1.576 . . . . 65.230000000000004 106.745 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.63 118.31 11.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.766 -0.374 . . . . 75.239999999999995 110.541 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.2 tp -93.16 -41.18 12.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.038 -0.727 . . . . 63.509999999999998 109.038 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.39 157.61 27.44 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.08 -1.208 . . . . 72.400000000000006 110.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -124.34 -178.49 4.12 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.964 0.906 . . . . 44.25 109.716 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 155.14 36.77 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 107.458 -1.312 . . . . 65.140000000000001 107.458 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.66 -15.06 5.95 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.977 3.118 . . . . 64.450000000000003 115.805 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.12 -21.91 64.17 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 112.741 0.645 . . . . 74.230000000000004 112.741 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.79 -50.84 31.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.607 . . . . 43.539999999999999 111.076 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -85.05 -7.9 58.91 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.613 0.597 . . . . 74.099999999999994 112.613 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 56.5 m -91.51 139.34 30.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.48 -1.304 . . . . 73.420000000000002 107.48 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 359' ' ' ASP . 40.1 m -75.0 113.54 12.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.211 0.529 . . . . 55.32 109.954 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 411' ' ' SER . 2.4 t -124.75 169.48 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 107.271 -1.381 . . . . 74.439999999999998 107.271 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 410' ' ' VAL . 21.9 m -68.27 148.52 50.67 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.104 0.478 . . . . 43.340000000000003 111.409 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.36 111.03 3.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.941 -0.572 . . . . 64.430000000000007 110.338 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.16 20.39 8.35 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.656 -0.783 . . . . 64.319999999999993 112.338 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -89.49 -170.73 2.95 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.628 -0.879 . . . . 62.219999999999999 108.628 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.5 pt-20 -112.45 124.54 52.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.118 1.155 . . . . 73.340000000000003 114.118 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.02 138.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.269 -1.382 . . . . 74.409999999999997 107.269 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -103.01 121.43 42.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.324 -0.95 . . . . 50.310000000000002 111.578 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.62 119.95 46.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.085 -1.08 . . . . 53.299999999999997 108.085 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 419' ' ' ASN . 0.8 OUTLIER -93.89 118.01 30.88 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.587 -0.523 . . . . 64.349999999999994 109.587 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.4 t -122.06 140.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.593 -0.73 . . . . 72.099999999999994 109.859 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.7 m -94.66 121.68 36.48 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.769 -1.197 . . . . 70.430000000000007 107.769 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.3 p -119.15 106.29 12.22 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.905 -0.318 . . . . 54.210000000000001 111.647 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.81 147.34 2.39 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 115.069 0.788 . . . . 63.119999999999997 115.069 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.7 Cg_endo -81.04 147.4 16.56 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.011 1.807 . . . . 72.439999999999998 111.161 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.58 149.19 26.05 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.788 -0.449 . . . . 65.310000000000002 109.788 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.8 mt-30 -129.1 155.67 45.08 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.935 -0.765 . . . . 73.400000000000006 108.935 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -146.76 164.24 33.4 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.448 -1.315 . . . . 72.120000000000005 107.448 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 138.86 31.52 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 110.441 -0.207 . . . . 75.329999999999998 110.441 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -83.07 119.26 73.89 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.729 -0.841 . . . . 75.019999999999996 108.729 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.43 141.27 89.8 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.584 2.189 . . . . 74.140000000000001 112.331 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -79.78 -7.04 58.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.904 -0.589 . . . . 52.219999999999999 111.499 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.446 HG23 HD12 ' A' ' 435' ' ' LEU . 13.3 p -66.58 -16.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.685 0.794 . . . . 72.219999999999999 110.74 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 23.6 m -49.89 -47.04 52.25 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.475 1.11 . . . . 72.430000000000007 113.155 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 m -59.04 -22.04 60.06 Favored 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 124.553 1.141 . . . . 61.409999999999997 112.467 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 432' ' ' VAL . 75.8 mt -78.1 -44.16 26.97 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 112.529 0.566 . . . . 62.549999999999997 112.529 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.3 m -160.63 136.2 8.09 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.245 -0.65 . . . . 73.0 109.245 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -60.78 -45.42 94.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.238 0.458 . . . . 73.340000000000003 112.238 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.15 80.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.49 0.662 . . . . 74.109999999999999 110.749 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.47 -43.72 69.21 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.953 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.16 -51.72 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.431 -0.804 . . . . 55.420000000000002 111.453 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.4 -41.19 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.886 -0.597 . . . . 64.430000000000007 111.369 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -67.69 -47.03 70.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.783 -0.367 . . . . 52.229999999999997 111.847 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.18 -38.55 88.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.971 0.36 . . . . 74.519999999999996 111.971 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.854 -0.338 . . . . 62.299999999999997 111.576 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 98.6 m -65.78 -38.77 89.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.363 0.125 . . . . 72.209999999999994 111.243 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.36 70.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.17 0.509 . . . . 72.450000000000003 110.467 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.17 -13.79 58.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.947 -0.569 . . . . 60.240000000000002 111.027 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.81 8.82 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.038 -1.077 . . . . 50.009999999999998 114.113 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' THR . 93.2 m-85 -78.89 111.52 15.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 117.91 0.855 . . . . 72.439999999999998 110.189 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -112.14 -21.64 6.2 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.426 -0.892 . . . . 62.0 112.495 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -95.15 111.47 23.3 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.491 -0.559 . . . . 72.239999999999995 109.491 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.03 159.03 25.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.444 0.64 . . . . 72.109999999999999 110.885 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -137.93 123.19 19.35 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 103.813 -2.662 . . . . 64.099999999999994 103.813 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -101.28 125.93 47.96 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.459 -0.496 . . . . 72.120000000000005 110.845 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.84 35.1 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.168 -0.679 . . . . 72.319999999999993 109.168 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.01 139.49 47.25 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.736 -0.468 . . . . 71.209999999999994 109.736 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 32.4 p -117.86 136.16 23.64 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 109.49 -0.559 . . . . 71.019999999999996 109.49 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.5 Cg_exo -61.43 120.53 8.24 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.428 2.085 . . . . 52.340000000000003 109.977 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.6 m -133.11 167.55 20.12 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.108 -0.496 . . . . 21.23 111.149 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 464' ' ' VAL . 4.6 p -76.89 156.24 82.56 Favored Pre-proline 0 N--CA 1.432 -1.369 0 C-N-CA 123.66 0.784 . . . . 73.430000000000007 109.377 174.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -49.71 -27.75 15.87 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 124.225 3.283 . . . . 74.129999999999995 114.157 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.37 -18.33 59.99 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.139 -0.482 . . . . 73.129999999999995 112.05 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.93 -18.29 13.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.642 0.258 . . . . 61.119999999999997 110.563 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 91.3 t -59.5 127.0 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.976 -0.557 . . . . 72.420000000000002 111.366 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.52 -4.46 58.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.033 -0.603 . . . . 51.299999999999997 111.813 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -122.87 161.05 24.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.103 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.95 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.909 -0.775 . . . . 71.239999999999995 108.909 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.61 -25.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.559 -0.857 . . . . 72.049999999999997 111.31 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 174.21 38.18 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.208 -0.757 . . . . 64.230000000000004 111.208 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -126.3 154.84 42.88 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.967 -0.753 . . . . 74.319999999999993 108.967 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.9 t30 -65.08 -53.28 42.41 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.248 -0.581 . . . . 62.32 110.982 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.8 Cg_exo -71.95 123.44 9.31 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 107.744 -1.675 . . . . 75.540000000000006 107.744 170.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 33.7 Cg_endo -62.7 137.45 63.72 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 122.885 2.39 . . . . 64.319999999999993 114.4 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.518 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.42 7.92 8.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.145 -0.934 . . . . 71.25 110.613 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -108.37 -4.66 17.21 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.302 -0.863 . . . . 60.119999999999997 109.548 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 28.9 mt-30 -137.24 175.67 9.4 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.268 1.032 . . . . 65.099999999999994 113.401 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 426' ' ' GLN . 29.5 m -94.3 130.5 40.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.157 -1.838 . . . . 72.230000000000004 109.449 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 429' ' ' ILE . 20.1 m -131.49 149.59 52.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.144 -0.687 . . . . 64.409999999999997 109.144 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.05 154.76 29.75 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.96 0.726 . . . . 71.340000000000003 112.96 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.08 -15.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.208 1.004 . . . . 71.549999999999997 108.37 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.64 -5.29 59.17 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.039 -0.982 . . . . 65.430000000000007 108.899 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -87.7 128.84 35.3 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.122 -1.436 . . . . 71.200000000000003 107.122 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.36 124.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.195 -1.039 . . . . 73.219999999999999 108.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.33 118.69 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 C-N-CA 120.194 -0.602 . . . . 71.230000000000004 109.65 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.16 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 105.034 -2.21 . . . . 74.420000000000002 105.034 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 121.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 107.588 -1.264 . . . . 70.219999999999999 107.588 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.78 119.11 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 121.322 0.582 . . . . 73.040000000000006 110.455 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.14 134.92 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.508 -0.923 . . . . 73.329999999999998 108.508 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.06 115.24 4.16 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.222 -1.151 . . . . 52.119999999999997 110.222 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 39.8 p -142.39 145.93 34.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.986 0.393 . . . . 71.019999999999996 110.39 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.912 0 N-CA-C 108.004 -2.038 . . . . 61.420000000000002 108.004 177.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 CA--C 1.485 -1.542 0 N-CA-C 107.417 -1.327 . . . . 62.43 107.417 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.24 142.25 32.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.153 0.501 . . . . 73.140000000000001 111.242 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.25 136.05 36.07 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.51 -1.663 . . . . 62.409999999999997 106.51 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.9 p -97.17 135.4 21.93 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 119.742 -0.783 . . . . 71.329999999999998 110.611 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.0 129.85 32.39 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.767 2.311 . . . . 70.129999999999995 111.282 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.63 147.83 52.18 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.041 . . . . 72.310000000000002 109.519 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.8 m -109.19 5.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 116.424 -0.353 . . . . 75.430000000000007 111.413 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -52.74 135.32 35.57 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.788 0.835 . . . . 70.25 111.758 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.48 1.56 59.06 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.469 -0.872 . . . . 64.010000000000005 112.946 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -121.21 179.8 4.29 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.185 -0.597 . . . . 74.340000000000003 110.639 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.2 p -73.25 149.65 42.62 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.962 -0.755 . . . . 72.299999999999997 108.962 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.0 p -63.43 -33.34 75.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.082 0.468 . . . . 75.209999999999994 110.39 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.62 86.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.412 -0.813 . . . . 70.230000000000004 111.594 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.98 -38.36 85.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.854 0.359 . . . . 42.420000000000002 110.167 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.92 78.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.968 -1.015 . . . . 71.239999999999995 110.174 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 85.0 mt -69.05 -46.21 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.804 -0.635 . . . . 71.019999999999996 110.644 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.07 -47.07 88.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.641 0.608 . . . . 63.240000000000002 112.641 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.5 m -65.49 -44.25 87.64 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 75.150000000000006 109.878 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 416' ' ' ILE . 13.3 tp -64.78 -37.75 88.65 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.924 -1.035 . . . . 73.439999999999998 110.351 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -60.51 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.984 1.313 . . . . 75.239999999999995 110.369 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -67.37 -22.64 65.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.994 -0.548 . . . . 64.409999999999997 110.805 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -85.36 -8.67 58.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.885 -0.598 . . . . 71.409999999999997 111.72 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 86.24 9.89 75.54 Favored Glycine 0 C--O 1.253 1.315 0 C-N-CA 120.912 -0.661 . . . . 52.329999999999998 113.915 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 54.8 m-85 -77.85 151.8 33.71 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.102 0.477 . . . . 64.409999999999997 110.217 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -88.26 132.74 34.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.199 -1.778 . . . . 74.540000000000006 106.199 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.29 134.98 59.18 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.804 0 CA-C-O 121.759 0.79 . . . . 53.539999999999999 110.956 -173.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -110.36 126.51 54.33 Favored 'General case' 0 C--N 1.268 -2.961 0 N-CA-C 104.743 -2.318 . . . . 73.120000000000005 104.743 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.5 m -112.73 118.86 36.16 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 108.242 -1.021 . . . . 51.210000000000001 108.242 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.52 118.89 36.98 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.45 -1.315 . . . . 72.010000000000005 107.45 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.84 124.72 53.23 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.992 -1.114 . . . . 72.310000000000002 107.992 176.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -125.45 137.07 29.16 Favored Pre-proline 0 C--N 1.284 -2.24 0 C-N-CA 119.577 -0.849 . . . . 74.219999999999999 111.131 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -88.54 128.34 2.09 Favored 'Trans proline' 0 N--CA 1.426 -2.454 0 N-CA-C 107.972 -1.588 . . . . 54.229999999999997 107.972 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 48.4 t0 -174.47 170.42 3.55 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.364 -1.347 . . . . 62.340000000000003 107.364 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 24.0 m -106.61 -18.69 13.89 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.536 0.684 . . . . 51.240000000000002 109.219 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.7 m -90.61 36.91 0.9 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 123.191 1.472 . . . . 74.319999999999993 107.71 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 391' ' ' ASP . 28.1 pt -88.8 141.69 30.05 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 114.285 -1.325 . . . . 73.409999999999997 110.72 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -73.66 173.86 13.2 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.129 1.886 . . . . 60.399999999999999 108.39 166.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.72 161.59 35.21 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.958 1.772 . . . . 65.120000000000005 111.772 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.89 -13.28 2.5 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 124.071 0.948 . . . . 62.210000000000001 111.969 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -99.61 122.55 42.82 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.696 -2.335 . . . . 64.340000000000003 104.696 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.0 117.88 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.88 0.847 . . . . 72.430000000000007 109.808 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.7 tp -90.97 -29.28 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.38 -0.827 . . . . 72.219999999999999 110.294 -174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.46 157.82 27.8 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 120.516 -0.849 . . . . 62.109999999999999 111.408 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 65.1 p -125.58 -176.91 3.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.165 -1.05 . . . . 64.219999999999999 108.165 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -101.71 139.92 20.77 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.649 -0.871 . . . . 53.549999999999997 108.649 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -48.64 -14.46 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 124.396 3.397 . . . . 51.140000000000001 115.414 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.15 64.79 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.244 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.3 -27.68 63.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.534 0.683 . . . . 73.200000000000003 110.678 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -90.32 -3.72 57.58 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.609 -0.723 . . . . 74.349999999999994 109.554 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 41.4 m -91.32 156.94 17.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.634 -1.247 . . . . 33.210000000000001 107.634 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 p -74.37 112.57 10.66 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.698 0.761 . . . . 54.409999999999997 111.056 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.48 170.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.037 -0.983 . . . . 71.549999999999997 108.903 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 75.4 p -75.8 158.73 31.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.813 -0.755 . . . . 73.420000000000002 110.835 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.54 109.94 2.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.375 -0.972 . . . . 73.340000000000003 108.375 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 92.23 29.2 11.63 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.279 -0.728 . . . . 44.509999999999998 111.279 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.3 t70 -76.79 -174.51 3.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.964 0.505 . . . . 74.299999999999997 109.655 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.53 126.97 42.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.161 0.505 . . . . 62.130000000000003 112.178 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.493 ' HB ' HD21 ' A' ' 377' ' ' LEU . 51.0 mm -121.16 127.22 75.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.472 -0.936 . . . . 75.049999999999997 108.472 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -94.38 119.13 32.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.134 0.969 . . . . 72.010000000000005 110.813 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.06 131.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.991 -1.114 . . . . 70.109999999999999 107.991 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -101.57 128.7 47.72 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.818 -0.438 . . . . 62.520000000000003 109.818 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 38.9 t -132.07 131.74 61.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.205 -1.035 . . . . 54.32 108.205 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 19.0 m -91.89 122.28 34.27 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.408 -0.59 . . . . 72.040000000000006 109.408 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.4 m -120.6 106.04 11.38 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.995 -0.372 . . . . 72.409999999999997 109.995 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 73.72 118.12 0.08 OUTLIER Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.88 0.712 . . . . 52.140000000000001 114.88 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.8 Cg_exo -71.34 138.25 32.56 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 121.919 1.746 . . . . 63.350000000000001 109.391 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 2.8 mm-40 -78.44 142.8 37.27 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 114.597 1.332 . . . . 75.439999999999998 114.597 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.82 133.56 55.31 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 113.435 -1.711 . . . . 70.319999999999993 108.674 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.14 157.8 35.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.203 -1.777 . . . . 75.519999999999996 106.203 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.81 137.41 33.72 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.609 -0.436 . . . . 75.540000000000006 110.409 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 67.4 mt -86.16 128.66 56.83 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.056 -1.461 . . . . 75.420000000000002 107.056 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.36 141.4 38.83 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.503 1.469 . . . . 62.229999999999997 112.683 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.147 0.499 . . . . 65.129999999999995 111.171 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 430' ' ' PRO . 8.9 p -65.9 -14.84 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.841 0.829 . . . . 73.519999999999996 109.851 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.7 m -52.75 -41.53 64.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.751 1.22 . . . . 71.510000000000005 111.953 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.8 m -64.15 -13.62 49.51 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.024 0.93 . . . . 60.450000000000003 112.083 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.73 -45.44 14.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.3 0.482 . . . . 52.399999999999999 112.3 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 86.9 m -156.05 135.68 12.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.65 -0.5 . . . . 74.010000000000005 109.65 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 441' ' ' VAL . 62.7 t80 -57.43 -53.57 56.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.153 0.797 . . . . 74.519999999999996 113.153 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.04 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.004 0.43 . . . . 73.439999999999998 111.248 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -62.02 -43.21 99.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.013 -0.994 . . . . 71.340000000000003 108.862 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.26 -48.88 79.85 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.364 -0.834 . . . . 72.239999999999995 110.619 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.9 t -58.93 -47.07 90.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.794 -0.639 . . . . 71.120000000000005 111.275 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.6 mmpt? -64.95 -46.51 81.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.704 -0.226 . . . . 65.439999999999998 111.213 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.69 -38.77 92.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.396 -0.365 . . . . 51.409999999999997 111.472 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.533 HD23 ' CE2' ' A' ' 452' ' ' PHE . 30.5 tp -67.29 -39.94 86.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.267 -0.424 . . . . 60.149999999999999 109.871 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.8 m -65.76 -38.86 90.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.261 -0.644 . . . . 72.109999999999999 109.261 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.59 73.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.55 -0.75 . . . . 62.439999999999998 111.138 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.24 31.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.795 -0.639 . . . . 74.409999999999997 110.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.7 -17.61 49.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.341 -0.457 . . . . 55.030000000000001 112.575 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.454 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 70.7 m-85 -83.11 83.83 7.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.381 0.61 . . . . 63.450000000000003 110.558 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -98.04 17.02 59.35 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.769 -0.932 . . . . 75.329999999999998 110.769 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -103.86 110.56 22.73 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.814 -1.551 . . . . 64.439999999999998 106.814 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . 0.533 ' CE2' HD23 ' A' ' 444' ' ' LEU . 93.4 m-85 -119.41 152.45 36.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.522 0.677 . . . . 65.150000000000006 112.073 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.1 OUTLIER -147.1 121.0 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.231 -2.137 . . . . 74.25 105.231 170.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -91.0 130.37 36.92 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.601 0.715 . . . . 73.430000000000007 111.584 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.19 152.84 46.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.4 -1.333 . . . . 75.310000000000002 107.4 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.12 149.8 52.31 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.151 0.501 . . . . 63.43 110.726 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.5 m -132.78 131.72 22.19 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 115.603 -0.726 . . . . 73.540000000000006 109.204 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 490' ' ' SER . 31.6 Cg_exo -61.51 120.01 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.004 1.802 . . . . 73.209999999999994 108.274 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.572 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 17.0 m -130.0 177.24 7.43 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.992 -0.549 . . . . 71.340000000000003 109.762 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 43.1 m -67.15 139.27 95.07 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.637 -1.246 . . . . 71.140000000000001 107.637 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.72 -23.62 8.56 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.806 3.004 . . . . 70.409999999999997 114.168 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -61.4 -32.29 72.22 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.347 0.659 . . . . 55.329999999999998 111.155 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.07 0.73 56.08 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.386 0.513 . . . . 70.510000000000005 112.386 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 461' ' ' PRO . 10.4 p -59.89 126.95 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.247 0.546 . . . . 71.439999999999998 111.114 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.47 78.31 Favored Glycine 0 C--O 1.244 0.767 0 C-N-CA 120.686 -0.769 . . . . 70.510000000000005 112.191 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.79 148.3 33.85 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.986 -0.746 . . . . 62.399999999999999 108.986 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 486' ' ' ILE . 58.7 t -84.14 132.74 30.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.061 -1.088 . . . . 74.049999999999997 108.061 175.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.68 -26.81 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.422 -0.911 . . . . 54.030000000000001 111.134 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.75 169.65 40.34 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.626 -0.797 . . . . 65.219999999999999 111.39 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.2 p -127.46 149.07 50.27 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.507 -0.924 . . . . 72.409999999999997 108.507 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.506 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.7 t30 -62.35 -52.78 63.7 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 119.327 -0.368 . . . . 73.129999999999995 110.725 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.1 Cg_exo -73.7 142.73 32.71 Favored 'Trans proline' 0 C--N 1.374 1.871 0 N-CA-C 108.178 -1.508 . . . . 75.120000000000005 108.178 171.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 126.79 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.262 1.975 . . . . 71.109999999999999 112.786 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.33 3.64 26.99 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.169 0.985 . . . . 53.420000000000002 110.253 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -111.66 4.24 18.45 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.842 -1.072 . . . . 65.239999999999995 110.922 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.458 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -137.08 164.81 27.54 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.067 0.937 . . . . 75.519999999999996 111.939 -172.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.84 125.54 29.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.299 -1.773 . . . . 71.430000000000007 108.94 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -130.82 148.32 52.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.186 -0.672 . . . . 61.310000000000002 109.186 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -69.97 140.93 53.06 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.292 0.091 . . . . 51.219999999999999 111.039 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.453 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 1.9 mp -60.76 -18.81 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.954 1.302 . . . . 75.219999999999999 111.931 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.23 5.11 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 72.340000000000003 112.063 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.97 132.29 33.84 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.672 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.3 t -79.89 114.77 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.936 -1.876 . . . . 63.32 105.936 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.04 120.54 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-O 121.255 0.55 . . . . 73.439999999999998 109.829 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 68.4 mt -91.23 112.25 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.287 -1.746 . . . . 73.420000000000002 106.287 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.39 119.39 51.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 114.658 -1.156 . . . . 72.099999999999994 108.064 -175.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 25.7 mt -99.83 115.97 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-O 121.508 0.671 . . . . 71.450000000000003 109.559 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.65 140.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.353 -0.98 . . . . 63.219999999999999 108.353 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 121.95 5.59 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 109.062 -1.615 . . . . 75.540000000000006 109.062 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.8 m -140.08 125.2 18.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 122.035 -0.685 . . . . 63.43 110.212 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.413 -2.837 0 N-CA-C 107.818 -2.113 . . . . 75.310000000000002 107.818 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.442 -0.863 0 N-CA-C 108.169 -1.049 . . . . 74.420000000000002 108.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.11 145.05 29.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.885 -0.413 . . . . 73.340000000000003 109.885 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.71 137.39 34.84 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.172 -1.047 . . . . 73.519999999999996 108.172 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.09 136.08 21.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 C-N-CA 120.57 -0.452 . . . . 34.219999999999999 109.991 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 154.6 12.18 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.711 2.941 . . . . 72.439999999999998 115.165 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.59 101.64 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 73.340000000000003 110.308 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.85 -3.65 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.25 0.548 . . . . 74.329999999999998 111.712 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.486 -0.779 . . . . 74.010000000000005 109.903 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.2 58.97 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.655 -0.978 . . . . 64.510000000000005 110.655 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -124.44 170.17 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.587 -1.264 . . . . 71.310000000000002 107.587 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.8 p -74.98 157.1 35.51 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.684 -0.487 . . . . 73.5 109.684 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.4 p -62.17 -37.86 86.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.016 0.436 . . . . 54.119999999999997 110.461 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.28 94.74 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.872 -0.604 . . . . 65.439999999999998 110.897 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.65 -37.46 76.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.505 -0.316 . . . . 73.25 110.952 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.33 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.66 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -42.62 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.258 0.348 . . . . 70.219999999999999 111.173 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.61 88.22 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.388 -0.369 . . . . 65.340000000000003 111.09 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.1 m -63.58 -46.63 84.98 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.599 -0.273 . . . . 64.530000000000001 110.743 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.18 -41.86 96.92 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.986 -0.375 . . . . 73.109999999999999 109.986 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -59.82 -46.6 88.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 70.030000000000001 110.439 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.37 -33.91 76.93 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 112.657 0.614 . . . . 74.319999999999993 112.657 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -84.83 -4.23 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.09 -0.505 . . . . 63.43 112.159 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.46 7.85 64.74 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 119.88 -1.152 . . . . 53.530000000000001 113.146 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -83.76 167.65 16.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.516 -0.55 . . . . 60.25 109.516 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 30.6 mmtp -105.79 161.58 14.3 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.293 -1.373 . . . . 54.43 107.293 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 151.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-O 121.881 0.848 . . . . 74.129999999999995 112.576 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 417' ' ' THR . 29.5 ttm-85 -137.05 141.07 42.43 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.567 -2.012 . . . . 71.120000000000005 105.567 172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -135.24 133.08 38.6 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.331 -0.618 . . . . 73.409999999999997 109.331 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.71 119.94 36.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.335 -0.987 . . . . 74.329999999999998 108.335 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -95.58 122.43 38.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.099 -1.075 . . . . 54.119999999999997 108.099 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 122.71 21.87 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 113.067 0.766 . . . . 74.340000000000003 113.067 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.52 129.07 4.19 Favored 'Trans proline' 0 C--O 1.247 0.933 0 N-CA-C 106.719 -2.07 . . . . 73.439999999999998 106.719 165.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.4 t70 -163.68 -176.03 4.44 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 63.409999999999997 109.042 -171.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 p -100.77 -23.72 14.55 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.34 -0.985 . . . . 64.299999999999997 108.34 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.2 m -89.3 35.45 0.81 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.279 -1.328 . . . . 71.5 108.983 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.8 pt -88.18 123.5 68.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 114.37 1.248 . . . . 73.230000000000004 114.37 -171.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 2.5 Cg_endo -85.15 174.89 6.86 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.861 2.374 . . . . 72.319999999999993 108.126 165.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.16 160.94 35.93 Favored 'Trans proline' 0 C--O 1.212 -0.817 0 C-N-CA 122.475 2.117 . . . . 71.209999999999994 111.261 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.22 -7.47 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.906 0.706 . . . . 74.519999999999996 112.906 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.87 147.77 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.033 -1.839 . . . . 74.450000000000003 106.033 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.37 116.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.186 -1.413 . . . . 42.409999999999997 107.186 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.5 mm -90.54 -39.77 12.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.299 -0.63 . . . . 70.329999999999998 109.299 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 157.67 27.48 Favored Glycine 0 N--CA 1.411 -3.013 0 CA-C-N 115.214 -0.903 . . . . 64.510000000000005 111.01 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -122.32 -179.68 4.26 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.49 -0.929 . . . . 62.299999999999997 108.49 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.33 139.92 20.67 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 108.948 -0.76 . . . . 71.450000000000003 108.948 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.37 -24.47 1.03 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 124.618 3.546 . . . . 73.030000000000001 114.84 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.5 63.37 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 123.133 0.573 . . . . 62.409999999999997 111.456 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.97 94.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.64 0.734 . . . . 74.109999999999999 110.464 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -4.75 57.62 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.531 -0.759 . . . . 72.239999999999995 111.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.9 m -88.83 152.85 21.51 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.938 -1.505 . . . . 63.539999999999999 106.938 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.5 m -74.12 113.53 11.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.953 0.882 . . . . 24.43 110.688 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.6 170.71 5.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.342 -1.299 . . . . 73.409999999999997 110.061 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 136.36 57.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.765 -0.652 . . . . 71.219999999999999 111.61 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.45 119.95 13.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.508 -0.553 . . . . 73.299999999999997 109.508 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 87.3 32.12 14.81 Favored Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 121.1 -0.572 . . . . 40.409999999999997 112.133 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.53 174.99 6.84 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.939 -0.763 . . . . 65.019999999999996 108.939 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 12.3 pt-20 -100.35 121.22 41.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.831 0.824 . . . . 71.329999999999998 112.782 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.76 124.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.667 -1.235 . . . . 73.230000000000004 107.667 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 13.4 t -91.85 130.29 37.65 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.532 0.682 . . . . 61.030000000000001 109.891 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 130.74 64.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.021 -0.991 . . . . 63.119999999999997 108.422 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -97.53 127.9 43.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.406 -0.961 . . . . 65.540000000000006 108.406 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.02 135.11 62.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.609 -0.886 . . . . 72.349999999999994 108.609 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 47.0 m -106.51 123.94 48.85 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.833 -0.542 . . . . 75.319999999999993 111.7 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.5 p -118.2 105.54 11.9 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 110.69 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.09 146.03 2.19 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.059 0.784 . . . . 33.219999999999999 115.059 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 76.7 Cg_endo -81.74 149.65 16.25 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.344 2.029 . . . . 75.329999999999998 111.753 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.05 144.76 40.6 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.52 -0.764 . . . . 72.310000000000002 110.849 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.537 ' HB3' HG22 ' A' ' 477' ' ' THR . 45.5 mt-30 -118.85 156.88 28.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 71.219999999999999 110.675 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.494 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 6.1 tpm_? -153.51 154.66 34.76 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.848 -1.538 . . . . 64.209999999999994 106.848 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.1 OUTLIER -93.8 140.17 29.98 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.02 -0.733 . . . . 65.030000000000001 109.02 176.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.8 mp -78.98 126.47 82.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.851 -1.166 . . . . 74.099999999999994 107.851 -175.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.97 140.32 79.53 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.203 1.936 . . . . 70.430000000000007 112.176 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.77 12.9 28.37 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.789 0.804 . . . . 73.019999999999996 110.08 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.2 -12.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.919 -1.037 . . . . 73.010000000000005 108.965 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.0 m -52.76 -40.51 63.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.503 -1.226 . . . . 72.310000000000002 112.624 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -63.01 -17.91 62.73 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.365 1.246 . . . . 71.230000000000004 114.365 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.36 -44.91 15.56 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.086 0.47 . . . . 61.409999999999997 111.689 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 65.6 m -150.2 133.22 16.16 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.896 -0.503 . . . . 74.430000000000007 109.969 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -58.37 -45.31 88.47 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.467 0.479 . . . . 75.010000000000005 111.163 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.16 -42.37 80.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.042 -0.526 . . . . 55.520000000000003 110.694 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.75 -39.39 94.15 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 116.064 -0.516 . . . . 71.099999999999994 111.398 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.49 -50.53 73.18 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.526 0.516 . . . . 53.450000000000003 109.768 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.03 -45.9 95.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.102 -0.499 . . . . 61.340000000000003 110.673 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.47 -47.72 75.13 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.813 0.301 . . . . 74.549999999999997 111.813 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -66.32 -40.24 89.81 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.109999999999999 111.688 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.1 mp -67.0 -38.43 85.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.619 -0.432 . . . . 72.400000000000006 111.608 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 68.9 m -64.81 -38.8 92.19 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.478 -0.564 . . . . 54.130000000000003 109.478 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.85 65.24 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.395 0.616 . . . . 74.409999999999997 110.455 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.494 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.44 -13.22 59.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.482 0.658 . . . . 73.239999999999995 110.296 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.22 -13.32 26.14 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.691 -0.766 . . . . 51.119999999999997 113.651 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -71.62 114.96 10.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.525 -0.546 . . . . 73.329999999999998 109.525 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.97 17.38 8.67 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.45 -0.881 . . . . 71.439999999999998 111.58 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -120.58 111.25 17.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.478 -1.675 . . . . 75.209999999999994 106.478 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.3 155.01 39.42 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.772 0.796 . . . . 74.409999999999997 112.882 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 4.5 tppp? -145.17 125.08 13.47 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.598 -1.63 . . . . 74.319999999999993 106.598 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.518 HE21 HG21 ' A' ' 488' ' ' VAL . 65.0 tt0 -100.44 126.08 46.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.169 0.509 . . . . 64.019999999999996 110.888 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.64 156.43 37.51 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.431 -0.952 . . . . 70.310000000000002 108.431 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.302 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.4 m -133.94 144.57 52.21 Favored Pre-proline 0 C--N 1.286 -2.183 0 N-CA-C 109.171 -0.677 . . . . 72.310000000000002 109.171 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_endo -62.54 122.82 11.35 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 123.257 2.638 . . . . 72.430000000000007 113.21 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.7 m -132.87 170.73 14.9 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.537 -0.912 . . . . 71.209999999999994 108.537 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.7 m -69.72 145.61 94.95 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 107.678 -1.23 . . . . 74.219999999999999 107.678 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.558 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.8 Cg_endo -49.36 -23.76 7.67 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 124.129 3.219 . . . . 63.350000000000001 114.255 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.84 -30.11 71.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.368 0.604 . . . . 64.319999999999993 110.43 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.35 1.35 35.42 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.821 -0.627 . . . . 72.129999999999995 112.581 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.6 p -60.18 126.29 17.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 119.415 -0.914 . . . . 64.230000000000004 110.72 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.92 -5.94 72.83 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.598 -0.81 . . . . 65.409999999999997 112.169 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.88 155.61 17.85 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.927 -0.768 . . . . 72.340000000000003 108.927 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 486' ' ' ILE . 66.3 t -84.67 131.59 33.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.923 -0.769 . . . . 72.340000000000003 108.923 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.13 -14.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.838 -0.745 . . . . 64.349999999999994 110.903 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.53 -177.65 41.87 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 115.567 -0.742 . . . . 74.230000000000004 111.441 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.9 p -130.44 150.03 51.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.682 -1.229 . . . . 72.420000000000002 107.682 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.9 t30 -63.87 -51.36 64.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 120.262 -0.575 . . . . 23.329999999999998 110.307 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.3 Cg_exo -75.41 130.48 12.91 Favored 'Trans proline' 0 C--N 1.375 1.955 0 N-CA-C 108.376 -1.432 . . . . 71.450000000000003 108.376 170.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.429 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 37.5 Cg_endo -62.94 136.53 57.46 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.697 2.264 . . . . 64.209999999999994 113.399 -175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.62 6.84 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.066 0.936 . . . . 53.310000000000002 109.845 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.463 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -104.61 2.59 30.81 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.857 -1.065 . . . . 61.539999999999999 109.664 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 7.7 tp-100 -145.97 173.71 11.91 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.975 -0.69 . . . . 74.310000000000002 110.923 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 426' ' ' GLN . 18.2 m -102.26 140.62 36.3 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 124.308 1.043 . . . . 74.340000000000003 110.948 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 429' ' ' ILE . 77.8 p -137.84 150.38 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.373 -0.602 . . . . 74.510000000000005 109.373 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.5 146.68 51.7 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.885 -0.326 . . . . 73.329999999999998 110.38 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.76 -11.13 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 124.052 0.941 . . . . 54.420000000000002 111.629 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 5.5 p -87.04 5.79 35.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.412 0.625 . . . . 70.430000000000007 111.065 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -93.01 142.12 27.64 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.656 -0.702 . . . . 61.310000000000002 110.362 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 52.4 t -85.79 115.18 26.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.946 -1.501 . . . . 74.329999999999998 106.946 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 81.9 t -86.58 119.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-O 121.467 0.651 . . . . 55.310000000000002 109.998 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 49.0 mt -92.36 112.9 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 107.302 -1.37 . . . . 72.400000000000006 107.302 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.38 127.13 49.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.451 -1.315 . . . . 73.349999999999994 107.451 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 15.6 mm -102.27 113.13 37.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.132 0.491 . . . . 72.109999999999999 109.943 -173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.518 HG21 HE21 ' A' ' 454' ' ' GLN . 32.9 t -98.3 141.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.673 -0.862 . . . . 62.299999999999997 108.673 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.52 121.12 6.1 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 111.035 -0.826 . . . . 72.209999999999994 111.035 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.5 m -141.39 143.76 34.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.582 -0.896 . . . . 64.230000000000004 108.582 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.562 0 CA-C-O 118.229 -1.317 . . . . 74.200000000000003 110.538 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 108.419 -0.956 . . . . 74.140000000000001 108.419 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.41 151.77 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.362 -0.607 . . . . 64.219999999999999 109.362 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -95.15 136.99 34.8 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.289 -1.374 . . . . 72.319999999999993 107.289 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.0 p -100.04 121.8 52.72 Favored Pre-proline 0 C--N 1.287 -2.122 0 N-CA-C 108.914 -0.772 . . . . 51.109999999999999 108.914 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.94 136.8 63.53 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.602 2.201 . . . . 74.519999999999996 113.046 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.545 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 7.5 p-10 -72.61 137.23 46.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.254 -0.885 . . . . 73.099999999999994 110.004 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 368' ' ' GLN . 5.8 t -89.82 45.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 122.585 1.183 . . . . 71.299999999999997 110.482 -170.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.545 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.8 ptm85 -65.51 136.29 56.23 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.418 -1.265 . . . . 64.25 110.921 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.48 0.55 62.79 Favored Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.79 -0.719 . . . . 50.310000000000002 113.024 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.417 ' HB2' HG12 ' A' ' 365' ' ' VAL . 44.9 mt-30 -125.95 172.12 10.19 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 122.586 -0.361 . . . . 72.230000000000004 110.13 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.1 p -77.14 167.14 22.27 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.626 0.251 . . . . 74.549999999999997 110.604 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.7 p -63.04 -33.96 76.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.078 0.465 . . . . 72.200000000000003 110.03 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.5 97.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.719 -0.673 . . . . 34.210000000000001 110.258 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.83 -41.43 95.75 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.539 -0.541 . . . . 55.420000000000002 109.539 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.74 80.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.108 -0.497 . . . . 71.219999999999999 110.784 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.15 -46.02 88.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.701 -0.681 . . . . 72.219999999999999 110.079 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.42 86.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.819 -0.628 . . . . 52.520000000000003 111.61 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.2 m -60.58 -47.11 87.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.326 0.25 . . . . 55.219999999999999 111.552 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.55 -42.02 95.97 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.533 -0.467 . . . . 60.210000000000001 110.593 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -41.56 91.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 109.806 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -29.27 67.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.384 -0.825 . . . . 53.329999999999998 111.12 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -82.68 -14.4 54.72 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.458 -0.571 . . . . 51.229999999999997 109.458 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.564 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.45 -2.63 56.19 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.822 -0.626 . . . . 53.310000000000002 111.692 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 46.5 m-85 -81.5 156.71 25.15 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.937 0.398 . . . . 74.510000000000005 110.075 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -105.16 147.78 27.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.371 -1.344 . . . . 62.530000000000001 107.371 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.75 142.73 30.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 121.957 0.884 . . . . 73.530000000000001 112.748 -175.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 417' ' ' THR . 58.2 ttt180 -119.06 133.39 55.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.014 -1.847 . . . . 61.229999999999997 106.014 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.9 m -104.94 125.66 51.18 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.499 -0.88 . . . . 74.299999999999997 111.36 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.2 tm? -111.51 119.33 38.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.234 -2.135 . . . . 74.400000000000006 105.234 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.576 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -112.85 122.63 48.23 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 109.292 -0.633 . . . . 73.540000000000006 109.292 -178.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -115.78 127.38 26.83 Favored Pre-proline 0 C--N 1.289 -2.034 0 C-N-CA 119.939 -0.705 . . . . 63.130000000000003 111.287 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -87.39 128.9 2.64 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 N-CA-C 107.234 -1.871 . . . . 61.420000000000002 107.234 167.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 394' ' ' ILE . 6.9 t70 -142.66 -179.4 6.29 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.639 -1.225 . . . . 61.32 110.199 -173.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.4 m -98.15 -33.47 11.12 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.365 -1.346 . . . . 60.530000000000001 107.365 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 34.5 m -101.57 71.13 1.31 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.178 -1.415 . . . . 74.409999999999997 107.178 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 391' ' ' ASP . 18.8 pt -100.85 125.32 38.92 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.867 -1.06 . . . . 74.219999999999999 111.97 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.57 175.86 3.68 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 N-CA-C 107.66 -1.708 . . . . 72.400000000000006 107.66 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 162.45 16.07 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.083 1.855 . . . . 74.450000000000003 109.992 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -56.81 -8.42 0.6 Allowed 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.254 1.022 . . . . 64.450000000000003 113.034 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.9 m80 -62.7 131.74 49.95 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.075 -0.713 . . . . 64.340000000000003 109.075 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.61 118.43 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 CA-C-N 115.645 -0.707 . . . . 73.099999999999994 109.159 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.2 pp -91.13 -28.03 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.105 -0.952 . . . . 72.349999999999994 110.359 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.435 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -169.42 157.31 29.04 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.515 -1.434 . . . . 72.400000000000006 109.515 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 403' ' ' ASP . 8.9 m -114.42 -177.18 3.07 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 106.332 -1.729 . . . . 62.43 106.332 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.604 ' H ' HG22 ' A' ' 402' ' ' THR . 10.5 t70 -97.96 138.72 20.99 Favored Pre-proline 0 C--N 1.267 -2.996 0 N-CA-C 109.092 -0.707 . . . . 73.209999999999994 109.092 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.48 -25.7 0.88 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 125.098 3.865 . . . . 72.340000000000003 115.463 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.73 68.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.954 0.407 . . . . 54.229999999999997 110.72 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.8 -38.57 62.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.775 0.798 . . . . 71.030000000000001 109.79 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.26 -5.08 48.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.903 -1.044 . . . . 63.210000000000001 110.704 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.4 m -86.8 147.87 25.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.044 -1.095 . . . . 72.519999999999996 108.044 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.9 p -74.52 112.97 11.24 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.329 -0.619 . . . . 65.310000000000002 109.329 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.28 169.22 22.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.349 -0.982 . . . . 74.219999999999999 108.349 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.1 p -80.14 137.75 36.78 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.003 -1.079 . . . . 65.530000000000001 110.432 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -60.36 138.61 57.94 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.218 -0.446 . . . . 55.25 110.655 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 100.92 15.63 28.13 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.192 -1.004 . . . . 70.349999999999994 110.779 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.51 -174.32 4.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.952 -1.499 . . . . 43.130000000000003 106.952 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 126.49 55.33 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.431 0.634 . . . . 65.230000000000004 110.926 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.01 119.44 61.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 4.9 t -85.13 118.93 24.99 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.899 0.857 . . . . 73.120000000000005 109.728 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.84 122.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.01 -0.995 . . . . 72.230000000000004 108.387 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 9.6 p30 -90.66 128.71 36.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.448 0.642 . . . . 74.439999999999998 110.461 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.0 143.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.333 -1.358 . . . . 63.310000000000002 107.333 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 2.1 p -88.04 120.02 28.98 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 119.143 -1.023 . . . . 73.340000000000003 108.898 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.0 m -120.2 105.31 10.84 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.962 -0.755 . . . . 74.349999999999994 108.962 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 75.73 166.13 19.57 Favored Glycine 0 C--O 1.259 1.677 0 CA-C-O 122.118 0.843 . . . . 43.32 114.293 177.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -96.0 157.32 1.42 Allowed 'Trans proline' 0 N--CA 1.429 -2.265 0 C-N-CA 122.998 2.466 . . . . 73.239999999999995 112.866 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.59 20.22 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.524 -2.028 . . . . 74.209999999999994 105.524 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -120.1 152.73 37.17 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.746 -0.465 . . . . 75.540000000000006 109.746 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.0 OUTLIER -146.84 156.68 43.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.067 -1.086 . . . . 75.450000000000003 108.067 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 49.2 mt-10 -83.93 140.15 32.13 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.348 -0.982 . . . . 73.120000000000005 108.348 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -79.59 119.24 76.2 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 106.634 -1.617 . . . . 71.129999999999995 106.634 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.49 140.36 94.34 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 121.675 1.584 . . . . 70.319999999999993 111.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.44 -0.68 56.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.441 0.638 . . . . 74.109999999999999 110.88 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.29 -6.54 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.887 0.851 . . . . 74.549999999999997 109.562 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 10.6 p -63.72 -28.17 69.71 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.148 -0.933 . . . . 63.329999999999998 112.105 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 20.6 p -65.32 -13.92 59.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 113.453 0.909 . . . . 64.209999999999994 113.453 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.7 -48.55 68.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.694 0.257 . . . . 63.409999999999997 111.694 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 12.3 t -174.32 165.49 4.01 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 121.234 -0.186 . . . . 75.219999999999999 110.545 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.47 -52.54 65.2 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.319 1.048 . . . . 61.399999999999999 112.666 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.83 84.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.396 -0.366 . . . . 61.350000000000001 111.593 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.67 -45.96 90.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 63.310000000000002 109.956 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.22 78.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 52.5 111.129 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.62 -46.81 95.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 116.275 -0.42 . . . . 75.129999999999995 110.907 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.48 -47.69 82.88 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.079 0.4 . . . . 75.120000000000005 112.079 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.08 -46.3 84.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.202 0.445 . . . . 62.039999999999999 112.202 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.91 -36.72 80.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.562 0.578 . . . . 65.409999999999997 112.562 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.1 m -64.44 -40.85 96.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.044 0.449 . . . . 55.420000000000002 110.075 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.59 63.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.461 0.648 . . . . 65.230000000000004 110.42 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.32 -12.89 59.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.628 -0.714 . . . . 72.439999999999998 110.049 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.84 -19.66 10.23 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.639 -0.709 . . . . 64.120000000000005 113.173 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.28 102.93 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.071 0.463 . . . . 75.530000000000001 110.489 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.22 19.85 33.93 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.744 -0.741 . . . . 64.219999999999999 111.914 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -123.63 111.48 16.27 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.411 -0.588 . . . . 70.209999999999994 109.411 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.14 158.28 39.42 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.437 0.636 . . . . 74.109999999999999 111.656 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.65 126.85 16.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.476 -1.676 . . . . 64.549999999999997 106.476 170.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -87.52 132.54 34.0 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.037 -0.357 . . . . 71.519999999999996 110.037 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.72 161.5 37.4 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.285 -1.006 . . . . 45.450000000000003 108.285 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.415 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 23.5 m-80 -133.93 149.84 51.29 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 122.537 0.335 . . . . 71.340000000000003 110.305 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 31.1 t -128.52 131.46 23.78 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 107.246 -1.39 . . . . 72.510000000000005 107.246 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.7 Cg_endo -61.8 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.764 1.642 . . . . 72.310000000000002 109.209 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 19.4 m -126.97 175.46 8.06 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 109.98 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.6 m -63.92 133.17 95.49 Favored Pre-proline 0 N--CA 1.424 -1.746 0 N-CA-C 106.289 -1.745 . . . . 54.229999999999997 106.289 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.54 -23.91 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.367 2.712 . . . . 73.5 114.027 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -67.04 -21.36 65.92 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.185 0.439 . . . . 71.030000000000001 112.185 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.2 7.84 40.74 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 121.904 -0.497 . . . . 63.299999999999997 111.622 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.2 p -59.25 127.36 18.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 CA-C-O 121.321 0.581 . . . . 73.329999999999998 110.843 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.76 -6.72 70.33 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 115.543 -0.753 . . . . 44.450000000000003 112.104 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -100.64 151.12 22.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.875 -0.787 . . . . 75.450000000000003 108.875 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.2 t -84.19 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.773 -0.825 . . . . 75.420000000000002 108.773 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.49 -16.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 120.168 -0.613 . . . . 53.299999999999997 112.38 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.19 160.23 12.34 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.019 -0.832 . . . . 52.130000000000003 111.019 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 486' ' ' ILE . 7.9 p -119.32 149.65 41.45 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.631 -1.248 . . . . 51.140000000000001 107.631 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.6 t30 -59.28 -49.7 91.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 119.797 -0.761 . . . . 62.229999999999997 110.731 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -76.07 117.6 4.72 Favored 'Trans proline' 0 C--N 1.372 1.812 0 N-CA-C 107.642 -1.715 . . . . 54.5 107.642 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.484 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.2 Cg_endo -62.9 142.95 90.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.888 2.392 . . . . 60.229999999999997 114.744 -173.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.419 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.27 0.12 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.814 -1.084 . . . . 64.150000000000006 113.24 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.467 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -109.14 0.12 19.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.29 -0.881 . . . . 73.030000000000001 109.517 175.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.484 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 6.5 tp-100 -117.74 162.11 18.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.725 0.774 . . . . 65.219999999999999 111.926 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 9.3 m -97.34 132.22 43.27 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.255 -1.338 . . . . 74.299999999999997 108.6 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.1 m -136.47 149.0 47.98 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.985 -0.376 . . . . 50.039999999999999 109.985 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.3 141.85 52.31 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 74.109999999999999 109.942 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.9 -17.0 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 114.454 1.279 . . . . 70.340000000000003 114.454 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.0 p -88.9 5.29 44.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.676 -0.64 . . . . 71.140000000000001 112.022 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -90.3 147.63 23.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.311 -0.625 . . . . 62.020000000000003 109.311 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.4 t -83.25 119.55 32.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.629 -0.878 . . . . 63.140000000000001 108.629 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.93 119.18 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 108.507 -0.923 . . . . 73.299999999999997 108.507 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.5 112.73 26.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.182 -1.784 . . . . 63.350000000000001 106.182 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.69 113.37 36.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.478 -1.304 . . . . 73.299999999999997 107.478 -177.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 22.4 mt -101.95 121.13 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.693 -0.685 . . . . 73.329999999999998 109.84 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.415 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 38.2 t -97.36 143.68 12.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.41 -0.959 . . . . 72.349999999999994 108.41 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -89.82 118.09 5.16 Favored Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 110.177 -1.169 . . . . 64.439999999999998 110.177 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 50.9 m -134.93 136.85 42.6 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.68 -0.859 . . . . 70.0 108.68 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.42 -2.373 0 N-CA-C 109.065 -1.614 . . . . 73.129999999999995 109.065 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 109.327 -0.62 . . . . 75.219999999999999 109.327 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.34 157.71 29.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.373 -0.376 . . . . 74.230000000000004 110.104 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.98 136.88 34.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.108 -1.442 . . . . 63.030000000000001 107.108 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.9 137.47 20.93 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 120.194 -0.602 . . . . 22.140000000000001 110.644 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -43.63 124.21 4.2 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 124.068 3.178 . . . . 72.420000000000002 114.67 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.4 ' CG ' ' HE ' ' A' ' 366' ' ' ARG . 9.8 t70 -76.29 138.07 40.3 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.244 -1.391 . . . . 74.219999999999999 107.244 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.569 HG23 HG11 ' A' ' 399' ' ' VAL . 31.0 m -102.16 23.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 113.545 0.943 . . . . 71.340000000000003 113.545 -170.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 401' ' ' GLY . 20.6 ptp180 -62.73 135.04 57.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.314 0.578 . . . . 71.0 111.82 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.88 -3.78 77.9 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.139 -0.784 . . . . 54.25 111.139 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -114.96 160.19 19.85 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.624 -0.51 . . . . 72.120000000000005 109.624 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 67.9 p -75.65 158.34 32.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 110.37 -0.233 . . . . 55.219999999999999 110.37 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.477 ' O ' HD13 ' A' ' 374' ' ' ILE . 17.9 p -63.13 -37.13 86.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 120.771 0.32 . . . . 53.32 110.449 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.08 90.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.249 -0.432 . . . . 64.420000000000002 110.584 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.89 -34.94 79.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.125 0.488 . . . . 61.409999999999997 110.487 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.526 -0.761 . . . . 30.420000000000002 110.371 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 384' ' ' ILE . 1.4 mp -58.55 -44.37 89.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.748 -0.66 . . . . 63.210000000000001 110.213 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.79 84.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.219 -0.446 . . . . 62.439999999999998 112.133 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 85.5 m -60.83 -47.17 87.58 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.647 0.24 . . . . 72.409999999999997 111.647 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.51 -39.02 93.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.779 0.323 . . . . 71.530000000000001 110.921 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.12 -46.0 89.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.345 -0.843 . . . . 71.120000000000005 109.601 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -70.57 -24.43 62.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 112.238 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -81.14 -15.3 56.26 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.144 -0.622 . . . . 72.150000000000006 111.584 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 98.98 14.84 35.24 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.679 -1.248 . . . . 73.049999999999997 111.888 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 48.6 m-85 -97.26 168.86 10.16 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.548 -0.908 . . . . 72.230000000000004 108.548 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.5 mmtp -113.49 157.25 22.23 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.514 -1.291 . . . . 65.299999999999997 107.514 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -135.0 142.37 40.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 121.293 0.568 . . . . 74.400000000000006 111.802 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -112.18 128.02 56.11 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.6 m -100.44 123.68 44.98 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 119.329 -0.948 . . . . 63.420000000000002 108.522 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.98 119.41 38.97 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 105.421 -2.066 . . . . 60.210000000000001 105.421 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.573 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -107.99 122.05 46.05 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.529 -0.915 . . . . 72.319999999999993 108.529 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 137.82 31.09 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.566 -0.454 . . . . 63.450000000000003 111.143 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.3 Cg_endo -93.1 148.88 2.52 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.735 2.29 . . . . 71.409999999999997 111.487 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 394' ' ' ILE . 4.9 t70 170.06 174.75 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.758 -1.571 . . . . 74.209999999999994 106.758 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.686 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 22.0 m -99.3 -33.97 10.51 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.823 -0.806 . . . . 73.239999999999995 108.823 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.8 p -94.71 63.19 2.81 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 122.538 1.161 . . . . 64.109999999999999 108.255 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.592 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -95.6 151.57 38.6 Favored Pre-proline 0 N--CA 1.424 -1.742 0 CA-C-N 113.644 -1.617 . . . . 71.519999999999996 112.51 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.42 143.73 58.88 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 N-CA-C 107.24 -1.869 . . . . 73.030000000000001 107.24 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.92 148.67 66.05 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.242 1.962 . . . . 64.540000000000006 111.461 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.91 -9.68 10.68 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.019 0.914 . . . . 52.420000000000002 110.734 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -96.52 125.99 41.39 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 103.708 -2.701 . . . . 74.409999999999997 103.708 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 365' ' ' VAL . 31.2 t -62.37 119.25 5.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.576 0.703 . . . . 75.200000000000003 111.969 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.6 tp -84.97 -29.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.369 -0.832 . . . . 70.099999999999994 109.367 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 366' ' ' ARG . . . -170.07 160.32 33.18 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 403' ' ' ASP . 0.7 OUTLIER -113.14 -175.66 2.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 105.825 -1.917 . . . . 72.239999999999995 105.825 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.439 ' H ' HG22 ' A' ' 402' ' ' THR . 17.3 t70 -99.38 136.58 20.38 Favored Pre-proline 0 C--N 1.265 -3.089 0 N-CA-C 109.71 -0.478 . . . . 74.239999999999995 109.71 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -33.73 -31.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 1 C-N-CA 126.069 4.513 . . . . 74.439999999999998 115.88 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.56 -31.92 66.6 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 122.652 0.381 . . . . 73.510000000000005 111.0 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -35.3 64.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.364 0.602 . . . . 75.209999999999994 110.58 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.93 -15.08 59.29 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.01 -0.541 . . . . 74.340000000000003 110.183 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 70.8 m -86.35 147.09 26.2 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.241 -1.022 . . . . 73.540000000000006 108.241 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.7 m -74.81 112.9 11.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.008 -1.108 . . . . 63.329999999999998 108.008 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.05 170.22 18.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.663 -0.699 . . . . 74.040000000000006 110.845 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.1 p -65.91 131.52 46.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.403 -0.817 . . . . 53.229999999999997 110.628 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.94 113.46 4.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.077 0.465 . . . . 64.409999999999997 110.114 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.29 -2.07 9.66 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.393 -0.908 . . . . 60.219999999999999 112.342 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.78 158.87 32.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.057 -0.349 . . . . 75.329999999999998 110.057 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.9 pt-20 -87.29 121.4 29.68 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.371 0.605 . . . . 53.210000000000001 111.273 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.82 131.15 45.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.851 -1.166 . . . . 70.439999999999998 107.851 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -91.55 130.0 37.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.506 0.67 . . . . 51.530000000000001 110.301 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.8 t -117.57 125.46 74.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.591 -1.263 . . . . 73.219999999999999 107.591 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.9 129.2 43.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.008 -0.367 . . . . 64.510000000000005 110.008 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.5 p -125.58 147.95 30.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.98 -1.119 . . . . 65.530000000000001 107.98 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 5.8 p -96.51 123.34 40.14 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.056 0.455 . . . . 65.230000000000004 112.197 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 t -117.61 106.08 12.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.168 -0.613 . . . . 73.140000000000001 111.393 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 74.48 130.19 0.21 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.517 0.967 . . . . 65.530000000000001 115.517 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 22.8 Cg_exo -68.43 145.99 66.95 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.943 1.762 . . . . 44.219999999999999 109.294 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.31 147.24 31.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.084 0.772 . . . . 65.549999999999997 113.084 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.4 mt-30 -123.21 137.43 54.88 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.409999999999997 107.732 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -137.15 164.4 28.54 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.451 -0.574 . . . . 75.219999999999999 109.451 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -82.49 137.8 34.53 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.277 -1.008 . . . . 72.120000000000005 108.277 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.4 mt -80.85 114.35 47.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.543 -0.91 . . . . 64.030000000000001 108.543 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 140.74 37.27 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.343 1.362 . . . . 52.450000000000003 110.296 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.76 96.57 5.55 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.133 1.161 . . . . 73.400000000000006 114.133 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.3 6.76 3.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.112 -2.921 . . . . 70.340000000000003 103.112 165.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 4.6 m -71.05 -46.37 62.13 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 112.176 -2.284 . . . . 73.129999999999995 110.86 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 466' ' ' LYS . 21.6 m -57.01 -31.77 65.46 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.529 0.681 . . . . 75.120000000000005 110.031 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.82 -48.19 8.42 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.728 -0.669 . . . . 73.049999999999997 111.723 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 57.7 m -132.38 122.95 25.81 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 121.991 -0.443 . . . . 53.420000000000002 112.145 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -60.91 -40.57 93.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.98 0.912 . . . . 73.040000000000006 111.531 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.14 93.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 44.43 110.302 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -65.39 -35.62 81.5 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.446 -0.797 . . . . 60.450000000000003 111.384 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.22 94.1 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.632 0.583 . . . . 62.340000000000003 109.487 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.23 -49.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.769 -0.651 . . . . 74.349999999999994 110.691 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -65.09 -49.23 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.434 0.531 . . . . 72.510000000000005 112.434 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 30.6 mmtp -68.02 -38.66 82.84 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.912 0.708 . . . . 64.230000000000004 112.912 -174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.44 -37.1 79.92 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.291 -0.564 . . . . 72.439999999999998 111.462 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.7 m -64.41 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.274 -0.639 . . . . 73.540000000000006 109.274 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.31 77.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.763 -0.653 . . . . 74.310000000000002 111.03 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -14.66 58.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.092 0.472 . . . . 73.519999999999996 110.225 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.41 -23.46 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-O 119.531 -0.594 . . . . 32.509999999999998 113.86 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 480' ' ' ILE . 99.0 m-85 -55.66 122.97 12.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.003 0.521 . . . . 75.129999999999995 111.962 -174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.01 8.66 5.73 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.48 -0.782 . . . . 74.420000000000002 111.62 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -110.23 110.62 21.52 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.735 -1.58 . . . . 75.340000000000003 106.735 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.37 150.29 52.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.918 0.866 . . . . 75.319999999999993 112.418 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 27.6 tptp -139.07 122.93 17.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.272 -1.751 . . . . 64.430000000000007 106.272 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -93.32 135.75 34.25 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 110.053 -0.351 . . . . 75.120000000000005 110.053 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.09 152.22 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.556 -0.535 . . . . 54.229999999999997 109.556 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.66 129.4 55.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.585 -0.895 . . . . 51.439999999999998 108.585 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.9 t -126.6 137.88 31.31 Favored Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.788 -1.19 . . . . 52.350000000000001 107.788 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.82 135.16 46.96 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.679 2.253 . . . . 64.129999999999995 110.427 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -148.18 169.86 19.11 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.465 -0.939 . . . . 73.140000000000001 108.465 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.6 m -65.46 144.12 98.87 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.785 0.834 . . . . 64.439999999999998 109.214 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.612 ' O ' HG12 ' A' ' 464' ' ' VAL . 93.3 Cg_exo -49.29 -23.47 7.04 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.915 3.076 . . . . 71.430000000000007 114.745 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -68.86 -31.98 71.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 71.209999999999994 111.142 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.39 -12.24 21.62 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.907 -0.588 . . . . 64.109999999999999 111.305 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.3 p -60.19 126.95 18.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-O 121.464 0.65 . . . . 73.420000000000002 110.448 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 98.6 -13.35 62.7 Favored Glycine 0 C--N 1.301 -1.383 0 N-CA-C 111.284 -0.726 . . . . 20.239999999999998 111.284 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 434' ' ' THR . 11.7 mptt -103.02 163.47 12.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.775 -0.824 . . . . 72.409999999999997 108.775 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.2 135.71 24.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.07 -1.085 . . . . 72.129999999999995 108.07 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.02 -12.06 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.399 -0.92 . . . . 70.510000000000005 110.546 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 151.93 176.46 24.66 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 115.198 -0.91 . . . . 35.030000000000001 112.082 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.4 p -116.41 149.46 39.38 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.607 -1.257 . . . . 64.239999999999995 107.607 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.9 t-20 -64.68 -49.38 70.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 120.201 -0.599 . . . . 74.5 111.489 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.2 Cg_exo -68.6 146.18 66.5 Favored 'Trans proline' 0 C--N 1.372 1.8 0 N-CA-C 108.724 -1.298 . . . . 74.230000000000004 108.724 170.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.69 126.52 18.41 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.522 2.148 . . . . 61.149999999999999 112.886 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.86 2.06 36.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.654 0.74 . . . . 70.109999999999999 111.608 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -109.9 -1.56 17.7 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.069 -0.514 . . . . 75.439999999999998 110.903 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -131.94 159.01 39.94 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.704 0.764 . . . . 71.209999999999994 111.39 -173.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -67.19 106.93 2.16 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.656 -1.611 . . . . 63.030000000000001 109.874 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.6 m -108.52 150.03 28.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.83 -0.804 . . . . 75.310000000000002 108.83 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.72 144.66 47.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.183 -0.673 . . . . 71.109999999999999 109.183 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.686 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 50.2 mm -70.7 -13.78 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.185 0.993 . . . . 70.530000000000001 109.16 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 392' ' ' SER . 1.3 p -87.8 -11.02 49.22 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.703 -1.135 . . . . 63.450000000000003 109.78 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.34 138.56 47.39 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.456 -0.942 . . . . 63.030000000000001 108.456 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.52 113.86 19.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.374 -1.343 . . . . 64.049999999999997 107.374 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.54 118.37 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 C-N-CA 119.526 -0.87 . . . . 72.140000000000001 108.825 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.1 mp -92.35 112.14 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 105.783 -1.932 . . . . 71.340000000000003 105.783 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 114.3 33.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.545 -1.65 . . . . 61.219999999999999 106.545 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 18.9 mt -104.27 116.93 48.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.633 -0.712 . . . . 74.120000000000005 110.216 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.74 137.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.243 -1.021 . . . . 74.129999999999995 108.243 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.62 99.33 1.0 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 109.633 -1.387 . . . . 74.329999999999998 109.633 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.2 m -142.79 105.73 4.54 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 122.742 0.417 . . . . 74.030000000000001 109.971 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.165 0 N-CA-C 109.398 -1.481 . . . . 62.329999999999998 109.398 178.153 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 . . . . . 0 CA--C 1.502 -0.893 0 N-CA-C 107.695 -1.224 . . . . 63.210000000000001 107.695 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 19.9 m -136.09 156.6 37.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.511 -0.552 . . . . 64.450000000000003 109.511 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -94.7 136.25 35.23 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.803 -1.925 . . . . 74.519999999999996 105.803 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.5 m -97.71 141.11 22.49 Favored Pre-proline 0 C--N 1.282 -2.341 0 C-N-CA 119.128 -1.029 . . . . 74.430000000000007 110.948 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.95 133.19 56.55 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.124 2.549 . . . . 73.099999999999994 113.146 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.16 126.2 28.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.032 -0.985 . . . . 72.340000000000003 110.39 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.6 m -91.79 10.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 73.519999999999996 112.109 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.94 141.37 58.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 64.0 109.838 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.65 -0.14 45.94 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.489 -0.644 . . . . 74.510000000000005 111.489 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 49.3 mt-30 -120.7 -179.22 3.93 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.315 -0.624 . . . . 72.150000000000006 109.315 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.7 p -86.04 169.96 12.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.727 -0.789 . . . . 71.109999999999999 109.342 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.3 p -61.81 -38.98 90.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.739 0.304 . . . . 51.310000000000002 111.118 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.14 87.57 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.247 -0.433 . . . . 65.109999999999999 110.93 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 62.4 m-20 -60.94 -43.66 98.35 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.199 -0.297 . . . . 74.420000000000002 110.199 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.91 75.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.524 -0.762 . . . . 63.210000000000001 110.198 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -58.28 -46.14 88.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.745 -0.661 . . . . 73.420000000000002 110.651 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.13 89.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.064 -0.517 . . . . 51.240000000000002 111.448 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 94.3 m -64.77 -48.25 75.2 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 120.575 0.226 . . . . 74.219999999999999 111.275 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.21 -38.71 91.29 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.436 -0.506 . . . . 72.230000000000004 110.892 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.02 -46.71 88.62 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.654 0.596 . . . . 61.409999999999997 109.908 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.4 -36.88 85.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.907 -0.588 . . . . 71.5 111.833 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 376' ' ' THR . 4.8 mpt_? -79.5 -14.45 58.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.540000000000006 111.652 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.3 16.35 32.57 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.387 -0.911 . . . . 72.340000000000003 113.523 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.19 166.96 12.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.912 0.387 . . . . 53.549999999999997 110.432 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 29.0 mmmt -99.93 153.14 19.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.193 -1.41 . . . . 73.109999999999999 107.193 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.469 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -130.19 138.47 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.432 0.634 . . . . 71.120000000000005 112.593 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 417' ' ' THR . 14.0 ttm180 -115.46 135.93 53.6 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.05 -1.463 . . . . 74.310000000000002 107.05 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.6 m -99.6 128.11 45.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 119.351 -0.94 . . . . 64.430000000000007 110.525 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.77 119.54 38.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.928 -1.879 . . . . 73.400000000000006 105.928 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.547 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.02 128.4 56.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 120.883 0.373 . . . . 62.520000000000003 110.142 -178.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 0.6 OUTLIER -121.53 115.7 30.97 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 112.11 0.411 . . . . 64.209999999999994 112.11 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 1.9 Cg_endo -87.94 134.4 3.15 Favored 'Trans proline' 0 C--O 1.256 1.386 0 C-N-CA 123.306 2.67 . . . . 63.43 111.825 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t70 172.2 -169.32 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 106.374 -1.713 . . . . 71.200000000000003 106.374 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 21.3 m -120.52 -12.86 8.87 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.473 0.654 . . . . 63.530000000000001 109.399 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -90.84 14.41 13.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.567 1.175 . . . . 74.319999999999993 108.291 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -88.54 151.08 47.65 Favored Pre-proline 0 N--CA 1.424 -1.763 0 CA-C-N 114.739 -1.119 . . . . 44.329999999999998 110.931 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.73 171.29 18.28 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.104 1.87 . . . . 73.200000000000003 111.35 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.53 163.03 7.34 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.504 2.803 . . . . 72.129999999999995 111.752 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.68 -7.26 0.64 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.214 1.006 . . . . 64.120000000000005 112.973 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 42.5 m170 -83.38 142.15 31.23 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.826 -0.805 . . . . 64.420000000000002 108.826 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.47 117.92 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-O 121.864 0.84 . . . . 62.409999999999997 109.544 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.76 -27.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.933 -1.03 . . . . 74.310000000000002 110.471 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.87 161.15 28.08 Favored Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 109.515 -1.434 . . . . 71.519999999999996 109.515 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.2 p -113.58 -178.48 3.39 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 121.035 0.445 . . . . 71.120000000000005 111.328 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.55 132.09 22.2 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.026 -1.472 . . . . 51.32 107.026 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.55 -30.04 11.42 Favored 'Trans proline' 0 N--CA 1.481 0.769 0 C-N-CA 124.137 3.225 . . . . 72.019999999999996 114.92 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.9 67.12 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 111.57 0.211 . . . . 71.349999999999994 111.57 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.68 -33.45 60.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.451 0.643 . . . . 73.5 110.28 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -86.17 -10.36 54.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.6 -0.727 . . . . 74.239999999999995 110.474 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 46.3 m -83.48 153.19 24.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.131 -1.433 . . . . 72.409999999999997 107.131 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.4 m -74.39 113.24 11.39 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.686 -0.806 . . . . 74.200000000000003 109.858 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.89 169.4 15.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 123.947 0.899 . . . . 75.099999999999994 109.075 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.3 t -78.96 146.96 33.14 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.913 -0.773 . . . . 74.25 108.913 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -70.87 113.22 7.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.061 -0.718 . . . . 75.109999999999999 109.061 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.71 9.1 11.45 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.384 -0.826 . . . . 53.350000000000001 111.722 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.0 -173.53 4.77 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.297 -1.371 . . . . 72.299999999999997 107.297 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 9.4 pt-20 -106.36 141.36 37.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.741 -0.784 . . . . 75.200000000000003 111.632 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -118.89 137.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.897 -1.149 . . . . 75.540000000000006 107.897 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 385' ' ' ARG . 68.4 p -92.64 130.53 38.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 120.988 0.423 . . . . 62.329999999999998 110.264 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.6 128.14 55.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.195 -1.039 . . . . 74.329999999999998 108.195 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.67 128.87 45.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.973 -0.38 . . . . 74.140000000000001 109.973 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 10.1 p -137.53 142.43 36.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.085 -0.709 . . . . 73.400000000000006 109.085 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 14.6 m -88.1 122.26 31.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.53 -0.544 . . . . 74.25 109.53 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 41.2 p -119.62 107.45 13.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.628 -0.26 . . . . 63.43 111.435 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 86.35 131.41 2.92 Favored Glycine 0 C--N 1.299 -1.522 0 C-N-CA 120.437 -0.887 . . . . 50.329999999999998 114.004 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 97.1 Cg_endo -82.3 157.83 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.635 2.223 . . . . 74.400000000000006 111.378 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 2.9 mm-40 -85.67 124.19 31.92 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.568 -0.53 . . . . 70.519999999999996 109.568 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 15.4 mt-30 -120.51 130.91 54.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.039 -1.097 . . . . 62.329999999999998 108.039 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -131.18 152.06 50.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 74.510000000000005 108.51 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -89.81 138.49 31.44 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 109.821 -0.437 . . . . 73.310000000000002 109.821 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -80.3 119.38 76.26 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.085 -0.709 . . . . 62.520000000000003 109.085 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.51 141.4 97.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.765 2.31 . . . . 75.319999999999993 111.864 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.58 8.98 25.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.33 0.492 . . . . 73.510000000000005 112.33 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.43 -7.86 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.998 0.904 . . . . 74.340000000000003 108.767 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 p -59.2 -42.85 91.91 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.982 -1.008 . . . . 72.140000000000001 111.845 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 6.5 p -69.4 -16.72 63.57 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.543 0.737 . . . . 74.25 112.367 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.25 -32.82 19.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.383 -0.371 . . . . 63.329999999999998 111.94 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.4 m -151.72 123.99 8.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.448 -0.575 . . . . 73.209999999999994 109.448 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.86 -45.42 92.66 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.275 0.472 . . . . 73.129999999999995 112.275 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.25 -43.89 95.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 75.299999999999997 110.135 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.11 -37.65 88.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.138 -0.937 . . . . 74.230000000000004 109.949 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.093 -0.503 . . . . 73.420000000000002 110.51 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.27 -43.42 98.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.697 -0.683 . . . . 55.25 110.033 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 30.8 mmmt -64.67 -47.43 78.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.398 -0.364 . . . . 72.109999999999999 111.368 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -63.83 -38.85 92.63 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 111.982 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.0 -39.41 90.27 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.01 -0.737 . . . . 60.439999999999998 109.01 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.7 m -66.75 -45.91 77.07 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.335 -0.848 . . . . 72.530000000000001 110.163 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.83 -22.93 65.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.862 0.865 . . . . 64.109999999999999 112.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.68 -11.04 59.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.413 0.625 . . . . 34.039999999999999 110.628 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.38 -15.89 19.96 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.679 -0.772 . . . . 61.119999999999997 112.986 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HA ' HG23 ' A' ' 480' ' ' ILE . 98.3 m-85 -67.54 124.7 23.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.928 0.394 . . . . 35.210000000000001 111.182 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.78 13.17 9.28 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.028 -0.829 . . . . 21.210000000000001 111.028 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -111.95 111.26 22.06 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 70.400000000000006 107.458 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -126.0 146.41 49.89 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 121.097 -0.241 . . . . 74.329999999999998 110.921 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 25.3 ttmm -153.17 122.66 6.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.353 -1.351 . . . . 63.210000000000001 107.353 171.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.46 135.3 43.19 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.247 0.546 . . . . 64.340000000000003 111.825 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.73 158.04 28.36 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.044 -1.095 . . . . 71.319999999999993 108.044 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.41 134.48 51.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.844 -0.799 . . . . 61.229999999999997 108.844 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.2 t -138.79 131.16 15.73 Favored Pre-proline 0 C--N 1.287 -2.137 0 N-CA-C 108.655 -0.868 . . . . 21.34 108.655 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 128.56 21.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.994 1.796 . . . . 65.439999999999998 109.151 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.7 t -137.13 -178.75 5.34 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.541 -0.911 . . . . 54.409999999999997 108.541 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 12.0 m -51.1 131.06 31.27 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.925 1.29 . . . . 74.430000000000007 109.484 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.79 -33.05 31.3 Favored 'Trans proline' 0 C--N 1.364 1.371 0 C-N-CA 123.815 3.01 . . . . 62.25 114.065 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -67.44 -32.24 72.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 72.109999999999999 111.668 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.33 -9.7 40.94 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.165 -0.334 . . . . 72.299999999999997 111.51 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 42.1 t -59.17 129.97 22.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 CA-C-N 115.749 -0.66 . . . . 61.219999999999999 111.861 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.34 1.28 56.8 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.841 -1.072 . . . . 52.210000000000001 110.937 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -131.22 166.33 21.41 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 109.128 -0.693 . . . . 72.430000000000007 109.128 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 486' ' ' ILE . 49.3 t -80.95 136.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.927 -0.768 . . . . 54.530000000000001 108.927 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.29 -16.54 7.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.13 -0.628 . . . . 74.409999999999997 111.564 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.61 163.79 22.14 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.26 -0.882 . . . . 50.329999999999998 110.999 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 486' ' ' ILE . 9.5 p -122.37 157.57 31.54 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.006 -1.479 . . . . 65.319999999999993 107.006 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.449 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.3 m120 -62.23 -54.51 48.85 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 119.058 -1.057 . . . . 73.299999999999997 111.298 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 13.9 Cg_exo -74.83 112.82 3.65 Favored 'Trans proline' 0 C--N 1.371 1.757 0 N-CA-C 107.801 -1.654 . . . . 65.5 107.801 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.36 162.07 43.36 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.391 2.061 . . . . 74.200000000000003 114.523 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.9 -4.01 32.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.864 -1.062 . . . . 63.439999999999998 111.553 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -108.23 12.24 26.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.098 -0.501 . . . . 51.340000000000003 109.814 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.63 151.77 46.06 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.461 0.648 . . . . 72.439999999999998 110.675 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.7 m -104.44 101.95 11.62 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.053 -1.462 . . . . 70.109999999999999 107.053 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.7 m -106.73 145.34 32.16 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.503 -0.317 . . . . 50.549999999999997 111.272 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.74 145.99 54.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.066 -0.516 . . . . 74.530000000000001 110.665 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 48.3 mm -67.25 -9.1 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 124.375 1.07 . . . . 75.040000000000006 111.42 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.8 p -86.88 -2.91 58.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.665 0.745 . . . . 74.120000000000005 110.71 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -95.82 133.93 39.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.544 -0.753 . . . . 72.230000000000004 109.382 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.28 119.37 28.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.932 -1.136 . . . . 74.200000000000003 107.932 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.18 119.15 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.628 -0.879 . . . . 64.310000000000002 108.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.3 mt -93.85 112.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.133 -1.432 . . . . 65.340000000000003 107.133 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.98 117.19 46.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.659 -1.155 . . . . 70.200000000000003 108.823 -175.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 35.0 mt -99.93 119.8 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.374 0.606 . . . . 73.540000000000006 110.09 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.43 124.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 63.530000000000001 108.851 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.7 96.38 1.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.45 -1.86 . . . . 75.150000000000006 108.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.491 ' HA ' HG13 ' A' ' 464' ' ' VAL . 5.1 p -142.79 131.51 22.66 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 110.071 -0.344 . . . . 72.25 110.071 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.0 0 N-CA-C 106.851 -2.499 . . . . 64.129999999999995 106.851 176.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 . . . . . 0 CA--C 1.499 -0.999 0 N-CA-C 108.28 -1.008 . . . . 62.439999999999998 108.28 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.46 153.65 39.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.514 -0.55 . . . . 73.319999999999993 109.514 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 407' ' ' ASN . 0.0 OUTLIER -95.43 138.59 32.91 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.04 -1.096 . . . . 63.240000000000002 108.04 176.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.59 126.62 42.65 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.335 -0.617 . . . . 65.109999999999999 109.335 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.1 141.75 89.76 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.413 2.742 . . . . 63.43 114.995 -174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.15 138.28 31.63 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.683 -1.228 . . . . 74.430000000000007 107.683 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 373' ' ' ALA . 15.7 m -116.05 27.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-O 121.936 0.874 . . . . 64.319999999999993 109.073 174.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -55.45 144.23 26.44 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.823 -1.535 . . . . 71.099999999999994 111.694 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.92 44.65 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.961 -0.856 . . . . 40.119999999999997 110.961 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -127.18 -173.3 2.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.963 -0.384 . . . . 73.219999999999999 109.963 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.9 p -70.82 151.37 44.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.755 0.312 . . . . 73.049999999999997 111.385 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 p -63.43 -36.46 83.81 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.346 -0.388 . . . . 54.240000000000002 111.411 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.76 88.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.192 -0.458 . . . . 74.209999999999994 110.546 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.41 -36.52 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 110.637 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -59.78 -51.16 70.93 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.122 -0.49 . . . . 74.150000000000006 110.99 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.34 -43.58 98.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.831 -0.622 . . . . 74.019999999999996 110.774 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.33 94.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.448 -0.342 . . . . 74.040000000000006 111.829 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.2 m -63.93 -47.07 81.95 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.961 0.41 . . . . 53.210000000000001 110.105 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.49 -38.1 89.84 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -59.89 -45.24 93.14 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.174 0.989 . . . . 75.439999999999998 109.846 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -70.17 -16.55 63.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 74.219999999999999 111.991 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -86.86 -14.14 42.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.639 -0.874 . . . . 74.519999999999996 108.639 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.86 5.2 62.91 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.53 -0.843 . . . . 61.299999999999997 111.668 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 35.6 m-85 -86.15 149.72 24.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.212 0.529 . . . . 73.120000000000005 110.291 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 13.9 mmmm -91.41 153.22 20.02 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.216 -1.401 . . . . 63.329999999999998 107.216 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.03 147.46 25.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 C-N-CA 120.3 -0.56 . . . . 74.209999999999994 111.421 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -111.07 132.22 54.43 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.012 -1.848 . . . . 73.129999999999995 106.012 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.5 m -115.72 118.2 32.37 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.372 -0.973 . . . . 71.150000000000006 108.372 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.59 119.02 36.71 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.817 -1.179 . . . . 72.530000000000001 107.817 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -104.36 131.79 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.23 0.538 . . . . 73.409999999999997 110.187 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -136.76 130.61 17.82 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.707 -0.678 . . . . 74.129999999999995 110.836 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.36 135.55 4.46 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.494 2.129 . . . . 73.150000000000006 111.616 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 34.4 t70 168.56 166.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.168 1.387 . . . . 52.219999999999999 107.305 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.602 ' O ' ' HB ' ' A' ' 481' ' ' THR . 9.4 p -123.25 8.19 9.12 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 113.096 0.776 . . . . 74.109999999999999 113.096 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -82.34 -24.51 34.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.132 -1.803 . . . . 51.32 106.132 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.432 ' H ' HG12 ' A' ' 394' ' ' ILE . 6.7 pt -88.91 148.65 41.76 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.721 -2.036 . . . . 73.129999999999995 109.718 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.63 173.01 14.01 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.098 2.532 . . . . 75.040000000000006 112.268 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.14 162.78 6.98 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 123.558 2.838 . . . . 70.25 112.69 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.46 -8.21 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.631 1.172 . . . . 74.409999999999997 113.993 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -75.47 115.69 15.4 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.396 -1.705 . . . . 75.219999999999999 106.396 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.48 117.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.018 0.437 . . . . 43.439999999999998 110.456 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.57 -27.21 3.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.641 -0.709 . . . . 64.340000000000003 110.137 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.29 157.02 27.04 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.072 -1.211 . . . . 62.039999999999999 110.072 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.9 p -128.12 -176.52 3.82 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 124.493 1.117 . . . . 63.140000000000001 111.076 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.83 132.92 22.15 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.524 -1.287 . . . . 74.099999999999994 107.524 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.59 -20.34 12.05 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.786 2.991 . . . . 71.430000000000007 114.175 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.63 61.29 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 122.453 0.301 . . . . 72.109999999999999 110.922 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.67 -41.15 84.19 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.539999999999999 110.337 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.416 ' HA ' HE21 ' A' ' 361' ' ' GLN . 47.9 m-80 -87.16 -3.87 59.09 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 120.261 -0.575 . . . . 72.239999999999995 111.534 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.4 m -80.13 131.54 35.76 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.671 -1.603 . . . . 54.409999999999997 106.671 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.8 m -74.61 113.3 11.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.032 -0.667 . . . . 75.299999999999997 110.086 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.25 167.73 24.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.246 -0.888 . . . . 54.109999999999999 109.335 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.17 50.35 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 109.459 -0.571 . . . . 64.120000000000005 109.459 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -62.51 130.8 46.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.369 0.668 . . . . 45.439999999999998 111.981 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 109.35 16.48 11.08 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.604 -0.808 . . . . 54.509999999999998 113.809 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.18 175.57 7.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.346 -1.353 . . . . 72.239999999999995 107.346 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 10.7 pt-20 -109.4 140.2 43.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 112.026 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.0 133.24 65.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.259 -1.015 . . . . 52.549999999999997 108.259 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -89.78 118.67 29.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.93 0.871 . . . . 62.439999999999998 110.038 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.3 133.58 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.91 -1.041 . . . . 72.400000000000006 109.176 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -96.97 128.74 44.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.813 -0.63 . . . . 74.209999999999994 110.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.3 p -130.25 131.9 65.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.304 -0.628 . . . . 52.240000000000002 109.304 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -91.9 122.55 34.53 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.326 -0.62 . . . . 64.120000000000005 109.326 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 16.5 p -118.92 106.66 12.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.756 0.312 . . . . 32.409999999999997 111.7 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.48 104.95 0.69 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.581 -0.819 . . . . 74.099999999999994 113.042 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 18.8 Cg_exo -66.99 128.93 19.59 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.53 2.154 . . . . 74.0 110.478 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.44 143.48 32.07 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.826 -0.35 . . . . 74.140000000000001 111.703 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -131.97 157.12 44.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.307 -0.997 . . . . 72.540000000000006 108.307 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -142.59 154.82 44.77 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.557 -0.534 . . . . 74.310000000000002 109.557 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.68 139.64 30.36 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.849 -0.426 . . . . 63.329999999999998 109.849 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.6 mp -78.7 116.15 57.4 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.844 -0.799 . . . . 62.520000000000003 108.844 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.55 140.91 40.77 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.868 1.712 . . . . 64.099999999999994 110.156 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -107.19 87.4 2.5 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.453 -1.299 . . . . 72.439999999999998 113.671 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.0 0.69 7.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 104.261 -2.496 . . . . 70.409999999999997 104.261 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.9 m -68.78 -50.11 53.02 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.972 -1.922 . . . . 72.140000000000001 110.236 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.408 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 15.7 m -64.88 -16.45 63.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 121.791 0.805 . . . . 74.519999999999996 109.908 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -48.42 7.01 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.482 -0.781 . . . . 74.010000000000005 110.241 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 66.0 m -147.71 123.91 10.84 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.085 0.469 . . . . 43.340000000000003 111.19 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -42.42 97.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.996 0.739 . . . . 71.120000000000005 112.996 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.22 -40.26 81.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 54.340000000000003 110.573 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -67.03 -35.3 79.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.485 -0.779 . . . . 74.530000000000001 111.815 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.67 -48.39 81.84 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.964 0.412 . . . . 65.349999999999994 110.26 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.57 -47.93 90.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.645 -0.707 . . . . 62.219999999999999 110.501 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -66.6 -45.7 78.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.02 -0.536 . . . . 73.129999999999995 112.119 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -66.28 -47.12 74.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 111.813 0.301 . . . . 71.010000000000005 111.813 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.11 -39.07 89.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.517 0.562 . . . . 73.0 112.517 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.0 m -61.81 -42.21 98.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.715 0.293 . . . . 65.140000000000001 110.483 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.66 66.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 62.020000000000003 111.06 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.08 59.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.958 -0.565 . . . . 64.129999999999995 111.038 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 116.52 -7.43 18.03 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.339 -0.934 . . . . 62.439999999999998 113.594 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.09 105.2 8.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.48 0.64 . . . . 65.340000000000003 109.717 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -111.74 5.16 27.67 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.723 -0.671 . . . . 72.439999999999998 111.629 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 23.1 mmt180 -113.8 111.45 21.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 64.439999999999998 108.343 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.61 156.54 43.21 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.297 0.57 . . . . 75.420000000000002 111.655 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -135.79 123.21 21.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.314 -2.106 . . . . 75.109999999999999 105.314 170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.97 122.36 36.38 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.9 155.19 35.96 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.063 -0.717 . . . . 60.439999999999998 109.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -128.08 138.45 52.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.847 0.356 . . . . 71.310000000000002 110.674 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.8 t -123.19 131.22 24.34 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.151 -1.425 . . . . 64.109999999999999 107.151 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.01 124.48 14.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.524 2.15 . . . . 62.25 110.139 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 24.8 m -134.98 160.85 36.99 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.64 -0.504 . . . . 62.5 109.64 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 461' ' ' PRO . 0.2 OUTLIER -60.81 146.22 87.09 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.482 -1.303 . . . . 74.310000000000002 107.482 175.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 464' ' ' VAL . 79.1 Cg_exo -52.26 -24.02 19.66 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 123.372 2.715 . . . . 75.230000000000004 114.306 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.51 -31.86 73.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.116 0.484 . . . . 74.430000000000007 110.857 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.37 5.08 44.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.02 0.378 . . . . 73.420000000000002 112.02 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.1 p -60.43 128.85 22.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 C-N-CA 120.087 -0.645 . . . . 65.230000000000004 110.779 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.1 83.14 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.888 -0.596 . . . . 54.119999999999997 112.584 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 434' ' ' THR . 85.9 tttt -116.38 148.22 40.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.165 -1.421 . . . . 75.230000000000004 107.165 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 433' ' ' SER . 62.0 t -84.05 136.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.038 -0.727 . . . . 71.400000000000006 109.038 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.557 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -109.44 -14.62 10.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.781 -0.768 . . . . 75.340000000000003 111.233 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.12 173.56 41.01 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.948 -0.861 . . . . 73.420000000000002 110.948 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.2 p -137.22 158.87 43.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.276 -1.009 . . . . 62.030000000000001 108.276 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.9 t-20 -69.54 -54.62 10.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 119.809 -0.756 . . . . 71.040000000000006 109.863 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.55 118.07 4.76 Favored 'Trans proline' 0 C--N 1.376 2.024 0 N-CA-C 107.574 -1.741 . . . . 72.340000000000003 107.574 172.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 475' ' ' ASN . 43.0 Cg_endo -69.17 139.71 42.97 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.732 1.621 . . . . 62.450000000000003 112.277 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.17 24.74 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.424 1.09 . . . . 52.020000000000003 112.466 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 473' ' ' PRO . 38.6 m-80 -108.32 -22.28 12.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.385 1.074 . . . . 75.299999999999997 109.822 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -131.67 160.09 36.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 C-N-CA 119.292 -0.963 . . . . 61.140000000000001 111.498 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.69 141.9 49.86 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 126.12 1.768 . . . . 64.420000000000002 110.54 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 56.3 m -133.76 149.7 51.46 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.12 -1.067 . . . . 74.530000000000001 108.12 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -76.61 157.95 31.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-O 120.803 0.335 . . . . 72.209999999999994 110.338 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 448' ' ' GLY . 50.8 mm -66.83 -16.34 20.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.112 0.958 . . . . 33.119999999999997 110.004 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 392' ' ' SER . 12.4 t -99.35 2.59 45.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.37 -0.832 . . . . 73.219999999999999 110.009 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 10.1 m120 -83.32 146.07 28.71 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.515 -0.55 . . . . 55.420000000000002 109.515 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.47 114.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 71.299999999999997 107.271 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.49 119.47 35.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.109 -0.7 . . . . 75.209999999999994 109.109 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 3.4 mp -92.06 112.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 106.608 -1.627 . . . . 60.210000000000001 106.608 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.33 121.93 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.664 -1.236 . . . . 73.019999999999996 107.664 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.41 111.58 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 121.418 0.627 . . . . 71.120000000000005 110.015 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.2 140.83 17.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.361 -0.977 . . . . 74.239999999999995 108.361 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.93 100.37 1.22 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.504 -1.038 . . . . 53.149999999999999 110.504 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 50.2 m -141.97 130.07 22.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.595 -0.52 . . . . 61.229999999999997 109.595 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.224 0 N-CA-C 107.871 -2.092 . . . . 73.319999999999993 107.871 -178.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 . . . . . 0 CA--C 1.492 -1.262 0 N-CA-C 108.751 -0.833 . . . . 65.409999999999997 108.751 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 150.68 31.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.274 -0.639 . . . . 64.219999999999999 109.274 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.31 136.6 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.659 -1.978 . . . . 72.439999999999998 105.659 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.5 p -97.46 128.48 34.52 Favored Pre-proline 0 C--N 1.282 -2.331 0 C-N-CA 119.117 -1.033 . . . . 70.409999999999997 109.627 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.97 128.07 23.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.841 2.361 . . . . 75.409999999999997 112.425 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -68.81 119.62 13.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.75 -1.113 . . . . 73.209999999999994 110.765 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 30.5 m -82.95 25.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.983 -1.008 . . . . 64.299999999999997 112.817 -174.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 400' ' ' ILE . 11.2 ptt-85 -67.85 144.04 55.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 122.044 -0.41 . . . . 74.0 111.941 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.83 0.5 45.61 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.875 -0.679 . . . . 53.530000000000001 113.647 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 0.9 OUTLIER -126.45 -172.85 2.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.336 0.568 . . . . 74.329999999999998 110.338 -177.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.8 p -79.44 164.2 24.16 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 118.266 0.484 . . . . 65.319999999999993 110.513 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 61.4 p -63.67 -33.66 76.13 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.368 -0.604 . . . . 50.009999999999998 109.368 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.14 90.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.143 -0.935 . . . . 42.450000000000003 110.339 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 368' ' ' GLN . 40.0 m-20 -60.14 -42.82 95.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.648 -0.251 . . . . 64.209999999999994 110.984 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -51.51 69.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.691 0.62 . . . . 64.310000000000002 110.438 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 384' ' ' ILE . 78.3 mt -60.73 -46.19 96.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.644 -0.707 . . . . 55.310000000000002 110.517 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.11 98.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.69 -0.686 . . . . 71.140000000000001 112.177 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.9 m -60.77 -47.69 85.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.844 0.354 . . . . 70.209999999999994 110.835 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.05 -38.82 92.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.779 0.323 . . . . 74.409999999999997 111.295 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.85 -47.62 85.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.557 -0.747 . . . . 52.240000000000002 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -68.9 -27.96 66.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.968 -0.56 . . . . 72.340000000000003 111.559 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -81.61 -13.63 57.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 111.977 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.14 14.55 48.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.561 -0.828 . . . . 63.310000000000002 112.895 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -88.61 170.57 10.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.636 -0.505 . . . . 61.530000000000001 109.636 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 14.2 mmmm -100.47 159.25 15.3 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.501 -1.296 . . . . 75.5 107.501 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.402 HG13 HG23 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -130.36 146.38 34.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.406 0.622 . . . . 73.310000000000002 110.996 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -123.59 147.43 47.33 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 105.495 -2.039 . . . . 73.129999999999995 105.495 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.4 m -116.5 129.19 56.06 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 109.072 -0.714 . . . . 74.140000000000001 109.072 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.32 118.8 36.85 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.19 -2.152 . . . . 65.040000000000006 105.19 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.48 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -115.92 129.5 56.43 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.45 -0.574 . . . . 61.350000000000001 109.45 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -138.45 134.54 17.54 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 116.351 -0.386 . . . . 70.040000000000006 110.614 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -93.38 132.68 0.88 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.92 2.413 . . . . 74.129999999999995 110.85 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.0 t70 -175.22 171.39 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.124 -1.436 . . . . 73.340000000000003 107.124 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.8 m -114.39 -5.48 12.9 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.356 0.598 . . . . 74.420000000000002 110.323 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -87.9 -12.82 43.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.104 0.954 . . . . 62.100000000000001 108.94 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 394' ' ' ILE . 12.5 pt -88.58 144.12 33.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.001 -1.0 . . . . 65.140000000000001 110.861 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.4 177.22 8.79 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.343 2.695 . . . . 75.239999999999995 110.76 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.53 160.75 10.85 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.002 2.468 . . . . 64.329999999999998 112.357 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.463 ' HB2' HG23 ' A' ' 420' ' ' VAL . 2.5 p-10 -57.74 -9.5 1.25 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 124.987 1.315 . . . . 63.539999999999999 113.631 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.89 114.46 11.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.839 -1.911 . . . . 70.540000000000006 105.839 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.52 118.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.171 0.986 . . . . 61.43 111.408 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 366' ' ' ARG . 7.8 tp -90.53 -32.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.895 -1.048 . . . . 75.519999999999996 109.86 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -157.87 157.38 28.17 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 109.592 -1.403 . . . . 73.329999999999998 109.592 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.0 p -116.47 -179.75 3.77 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.063 -0.717 . . . . 73.049999999999997 109.063 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.64 147.55 34.0 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 120.174 -0.611 . . . . 75.230000000000004 109.416 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.65 -7.38 2.15 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.373 3.382 . . . . 71.549999999999997 115.501 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.28 72.8 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.058 -0.349 . . . . 72.420000000000002 110.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.73 68.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.695 0.759 . . . . 61.409999999999997 110.107 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.7 -10.83 59.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.278 -0.874 . . . . 70.349999999999994 111.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 83.0 m -81.01 151.81 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.794 -1.187 . . . . 73.099999999999994 107.794 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.5 m -74.06 112.86 10.6 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.303 0.573 . . . . 72.530000000000001 109.7 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.42 159.69 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.081 -0.963 . . . . 61.340000000000003 109.47 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 36.6 m -74.16 146.82 43.17 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.202 -0.666 . . . . 51.420000000000002 109.202 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.3 35.5 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.874 0.369 . . . . 73.209999999999994 110.423 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.46 25.86 24.7 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.724 -0.671 . . . . 53.240000000000002 112.006 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 411' ' ' SER . 4.4 t70 -85.89 -175.68 5.68 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.792 -1.188 . . . . 72.439999999999998 107.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.7 pt-20 -114.06 133.76 55.32 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.672 -0.811 . . . . 62.43 111.357 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.37 129.74 62.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 109.315 -0.624 . . . . 61.32 109.315 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.9 t -88.18 123.17 32.55 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 122.085 0.945 . . . . 71.010000000000005 109.994 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.81 114.61 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 107.506 -1.294 . . . . 73.25 107.506 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.08 -1.082 . . . . 62.100000000000001 108.08 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 397' ' ' ASP . 14.8 p -121.41 135.96 59.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.253 0.549 . . . . 75.450000000000003 110.558 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 19.9 m -84.63 121.11 27.18 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.663 -0.866 . . . . 73.129999999999995 108.663 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -119.87 104.9 10.59 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.657 -0.247 . . . . 73.340000000000003 111.449 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.02 145.72 0.12 Allowed Glycine 0 CA--C 1.542 1.729 0 N-CA-C 115.962 1.145 . . . . 65.230000000000004 115.962 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 57.9 Cg_endo -82.07 128.47 5.74 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.565 1.51 . . . . 74.099999999999994 109.964 172.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 0.1 OUTLIER -73.55 156.9 37.65 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.608 -0.516 . . . . 62.130000000000003 109.608 -177.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.4 mt-30 -121.71 157.48 30.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.032 0.444 . . . . 65.439999999999998 110.779 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.495 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 22.2 tpt180 -145.59 145.02 30.82 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.857 -0.794 . . . . 62.409999999999997 108.857 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.29 138.93 32.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.668 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -84.09 124.76 73.96 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.859 -0.61 . . . . 74.239999999999995 110.18 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 74.7 Cg_exo -61.85 141.6 90.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.435 2.09 . . . . 51.509999999999998 111.032 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.81 20.41 2.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.334 0.494 . . . . 64.129999999999995 112.334 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.418 HG21 ' HG3' ' A' ' 443' ' ' LYS . 23.7 m -84.18 -6.37 10.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.34 -0.391 . . . . 64.140000000000001 111.902 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.0 m -51.44 -51.09 57.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.909 0.883 . . . . 65.230000000000004 112.435 -177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.3 m -61.12 -27.18 68.2 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.765 0.826 . . . . 74.409999999999997 111.716 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.15 -48.32 8.69 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.687 0.279 . . . . 51.520000000000003 111.702 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 439' ' ' GLU . 48.0 m -146.47 115.84 7.08 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.814 -0.354 . . . . 51.020000000000003 111.083 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -59.23 -44.01 92.34 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.682 -0.69 . . . . 72.450000000000003 110.937 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.65 -46.6 83.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 71.329999999999998 111.258 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 436' ' ' THR . 36.5 tt0 -68.02 -35.46 78.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.498 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.98 -43.58 95.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.314 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.84 -42.65 95.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.956 -0.565 . . . . 65.340000000000003 110.179 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.6 mmtt -66.22 -43.23 87.27 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.159 0.504 . . . . 73.549999999999997 110.352 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 39.3 mmtm -62.93 -47.74 81.92 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.521 -0.763 . . . . 74.450000000000003 111.246 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.97 -32.7 73.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.597 0.592 . . . . 73.420000000000002 112.597 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 52.3 m -67.54 -41.21 84.67 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.611 -0.514 . . . . 74.319999999999993 109.611 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.17 -22.83 61.99 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.83 0.824 . . . . 72.420000000000002 110.587 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.495 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.85 -8.89 59.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.326 -0.852 . . . . 70.5 110.423 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.13 -20.41 45.37 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.992 -0.549 . . . . 72.0 113.178 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -57.84 127.42 31.99 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.117 0.484 . . . . 75.329999999999998 111.874 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -129.12 12.92 6.05 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.389 -0.823 . . . . 53.350000000000001 111.208 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -115.75 111.04 19.96 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.332 -0.988 . . . . 75.430000000000007 108.332 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -132.93 148.59 52.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.106 0.479 . . . . 75.310000000000002 110.756 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -140.53 122.24 15.31 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 105.578 -2.008 . . . . 73.140000000000001 105.578 170.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.89 128.83 45.18 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.566 -0.531 . . . . 72.25 109.566 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.0 161.41 26.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.037 -0.727 . . . . 74.519999999999996 109.037 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -129.31 129.17 44.51 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.594 -0.891 . . . . 71.420000000000002 108.594 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -123.42 137.64 28.81 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 109.555 -0.535 . . . . 64.140000000000001 109.555 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.5 Cg_exo -61.87 134.01 47.77 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.303 2.002 . . . . 63.130000000000003 110.594 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.1 m -148.15 161.83 40.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.48 -0.563 . . . . 73.129999999999995 109.48 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 20.8 m -57.75 142.99 77.43 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 124.335 1.022 . . . . 55.140000000000001 108.261 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.613 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.13 -23.27 6.28 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.673 2.916 . . . . 70.200000000000003 114.579 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.34 -33.11 74.06 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.709 -0.62 . . . . 74.530000000000001 110.305 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.44 -9.86 28.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 112.482 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 461' ' ' PRO . 8.9 p -60.22 127.25 19.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 119.836 -0.746 . . . . 74.340000000000003 110.21 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.99 71.82 Favored Glycine 0 C--N 1.307 -1.043 0 C-N-CA 120.629 -0.796 . . . . 51.439999999999998 112.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -107.97 161.74 14.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.658 -0.867 . . . . 75.049999999999997 108.658 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 486' ' ' ILE . 98.0 t -83.98 129.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.591 -0.892 . . . . 75.519999999999996 108.591 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.08 -13.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.964 -0.695 . . . . 75.140000000000001 111.471 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 160.3 12.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.661 -0.699 . . . . 63.109999999999999 111.637 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.8 p -119.34 149.39 41.89 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.696 -1.224 . . . . 54.43 107.696 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.498 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.91 -51.46 79.19 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.34 -0.544 . . . . 62.350000000000001 110.707 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.2 Cg_exo -82.44 115.81 2.58 Favored 'Trans proline' 0 C--N 1.368 1.595 0 N-CA-C 107.841 -1.638 . . . . 74.430000000000007 107.841 169.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 39.5 Cg_endo -67.56 159.51 52.2 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.326 2.017 . . . . 73.519999999999996 113.657 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.63 -4.14 35.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.145 0.974 . . . . 35.450000000000003 111.706 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -105.34 11.12 33.17 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 109.072 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.406 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 35.0 tt0 -127.75 156.4 42.5 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.669 0.747 . . . . 60.020000000000003 110.7 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 426' ' ' GLN . 14.8 m -102.76 115.7 31.12 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.403 -1.271 . . . . 73.519999999999996 107.625 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.4 m -117.68 148.32 42.09 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 110.237 -0.283 . . . . 74.019999999999996 110.237 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.51 156.95 38.08 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.386 -0.228 . . . . 35.140000000000001 110.386 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.3 -22.78 19.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.57 0.7 . . . . 72.530000000000001 110.215 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -87.4 1.98 51.79 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.893 0.854 . . . . 70.439999999999998 109.861 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.46 130.17 34.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.478 -1.675 . . . . 70.209999999999994 106.478 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.19 113.99 19.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.602 -0.518 . . . . 75.439999999999998 109.602 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.37 118.7 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 N-CA-C 108.68 -0.859 . . . . 60.340000000000003 108.68 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.403 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.0 mt -94.45 112.89 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 107.176 -1.416 . . . . 73.230000000000004 107.176 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.61 115.44 46.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 N-CA-C 107.49 -1.3 . . . . 73.439999999999998 107.49 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.6 mt -103.61 119.82 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 115.982 -0.554 . . . . 74.099999999999994 110.148 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.16 136.24 29.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.566 -0.902 . . . . 73.329999999999998 108.566 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -71.88 113.34 4.51 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.129 -1.188 . . . . 65.25 110.129 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.2 m -131.73 104.89 7.16 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.453 -0.573 . . . . 74.239999999999995 109.453 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.096 0 N-CA-C 108.812 -1.715 . . . . 42.450000000000003 108.812 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.75 -1.204 . . . . 71.140000000000001 107.75 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.54 162.34 38.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.009 0.433 . . . . 74.340000000000003 111.664 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.23 137.33 37.9 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.233 -1.025 . . . . 52.210000000000001 108.233 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.98 133.68 20.22 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 109.343 -0.614 . . . . 63.140000000000001 109.343 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 147.03 87.54 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.89 2.394 . . . . 73.310000000000002 113.666 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.06 145.4 31.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.653 -0.703 . . . . 72.439999999999998 109.175 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.1 t -107.43 31.63 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.602 -1.629 . . . . 43.539999999999999 106.602 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.36 134.12 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.388 -1.733 . . . . 75.430000000000007 111.149 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.88 -5.19 57.96 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 111.373 -0.691 . . . . 43.240000000000002 111.373 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -119.25 -176.94 3.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 120.705 0.288 . . . . 63.219999999999999 110.225 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.6 p -72.02 158.7 35.5 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 111.531 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.5 t -63.1 -33.8 76.23 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.372 -0.603 . . . . 72.519999999999996 109.372 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.23 90.36 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.535 0.522 . . . . 72.219999999999999 110.356 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 116.332 -0.394 . . . . 73.019999999999996 110.648 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.65 -51.4 69.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.577 -0.738 . . . . 60.200000000000003 111.035 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.95 -43.18 97.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.433 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.64 98.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 52.210000000000001 112.349 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 58.7 m -64.03 -47.34 80.6 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.355 0.598 . . . . 73.230000000000004 110.264 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.4 mm? -64.34 -38.45 91.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 72.430000000000007 110.768 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.2 -45.95 91.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.653 -0.703 . . . . 64.010000000000005 110.072 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -66.22 -30.71 71.21 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.187 -0.461 . . . . 71.310000000000002 111.389 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.7 mmt-85 -78.95 -13.83 59.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.479 . . . . 75.209999999999994 111.012 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.9 13.5 56.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.889 -0.672 . . . . 74.299999999999997 113.228 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.427 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 59.4 m-85 -85.33 166.24 16.62 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.487 0.66 . . . . 75.299999999999997 111.755 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 55.8 mtmt -109.02 132.61 53.94 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.605 -1.257 . . . . 74.109999999999999 107.605 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.76 146.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.462 0.649 . . . . 71.150000000000006 112.651 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -109.5 127.73 54.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.887 -1.894 . . . . 65.319999999999993 105.887 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.4 m -107.34 117.65 34.64 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 106.663 -1.606 . . . . 73.329999999999998 106.663 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.23 118.52 36.15 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.116 -1.809 . . . . 60.210000000000001 106.116 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.476 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -113.03 128.0 56.38 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 109.164 -0.68 . . . . 75.329999999999998 109.164 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.21 138.71 33.48 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.938 -0.574 . . . . 63.439999999999998 110.364 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -82.63 146.04 13.27 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.92 1.746 . . . . 64.230000000000004 108.716 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.8 t0 -179.62 -175.0 0.32 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.349 -1.722 . . . . 71.209999999999994 106.349 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 51.4 m -135.11 0.26 2.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.158 0.504 . . . . 71.129999999999995 110.441 174.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 -14.95 49.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.221 -1.399 . . . . 61.219999999999999 107.221 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 421' ' ' SER . 14.2 pt -91.86 145.47 31.1 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.086 -1.416 . . . . 73.329999999999998 111.189 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.41 -172.88 1.47 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 123.18 2.587 . . . . 53.109999999999999 108.838 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.58 161.7 7.36 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.35 2.033 . . . . 63.0 112.608 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.2 p-10 -57.03 -8.12 0.6 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 125.228 1.411 . . . . 73.329999999999998 114.463 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -71.66 122.36 20.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.577 -1.268 . . . . 72.040000000000006 107.577 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.04 118.42 7.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 123.589 0.756 . . . . 73.129999999999995 111.645 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 400' ' ' ILE . 0.2 OUTLIER -96.4 -28.83 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.857 -0.61 . . . . 74.120000000000005 111.031 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.47 157.73 27.48 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 110.76 -0.936 . . . . 63.350000000000001 110.76 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.3 p -126.98 -177.88 4.2 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 123.283 0.633 . . . . 74.219999999999999 110.268 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.69 136.15 19.63 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.537 -1.653 . . . . 75.030000000000001 106.537 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.72 -16.67 2.48 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.406 3.404 . . . . 71.409999999999997 115.282 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.83 32.93 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 123.622 0.769 . . . . 74.200000000000003 111.854 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.44 -44.49 82.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.125 0.488 . . . . 71.430000000000007 111.034 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -86.09 -2.32 58.21 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.19 0.519 . . . . 73.040000000000006 111.662 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 67.1 m -81.55 146.79 29.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.846 -1.538 . . . . 61.350000000000001 106.846 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.2 m -74.66 112.74 11.17 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.168 -1.049 . . . . 72.540000000000006 108.168 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.23 166.81 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.519 -0.764 . . . . 71.140000000000001 111.064 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.2 t -74.51 144.66 44.01 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.108 -1.071 . . . . 33.119999999999997 108.108 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.43 114.67 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 71.310000000000002 110.521 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.34 40.68 4.16 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.668 -0.777 . . . . 35.039999999999999 111.767 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -93.2 -177.38 4.44 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.607 -1.257 . . . . 74.040000000000006 107.607 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 41.2 mt-10 -107.19 119.9 40.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.207 0.527 . . . . 65.150000000000006 111.957 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.21 130.59 61.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.538 -0.912 . . . . 71.319999999999993 108.538 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.4 t -95.05 130.76 41.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.355 0.598 . . . . 70.219999999999999 110.015 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.39 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.711 -0.848 . . . . 73.329999999999998 108.711 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -91.33 128.82 37.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.489 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 397' ' ' ASP . 46.8 t -125.16 138.59 53.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.229 -0.896 . . . . 61.219999999999999 109.428 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.481 ' HB3' HD12 ' A' ' 394' ' ' ILE . 16.0 m -89.08 121.47 31.44 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.449 -0.575 . . . . 60.020000000000003 109.449 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.2 t -120.83 104.82 10.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 119.144 -1.022 . . . . 71.5 111.005 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 64.19 172.23 2.61 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.907 0.723 . . . . 63.420000000000002 114.907 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 72.9 Cg_endo -97.18 155.09 1.06 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 122.73 2.287 . . . . 62.420000000000002 113.322 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 4.5 mm-40 -84.87 141.37 30.48 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.78 -0.645 . . . . 70.340000000000003 110.247 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -117.26 147.37 42.6 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.458 -0.942 . . . . 73.310000000000002 108.458 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.29 155.39 39.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.561 -1.274 . . . . 64.230000000000004 107.561 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -88.81 138.16 31.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.79 -0.448 . . . . 74.25 109.79 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -83.09 129.14 62.34 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.385 -0.968 . . . . 75.25 108.385 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.55 140.51 89.83 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.362 2.041 . . . . 51.409999999999997 112.356 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.03 -5.73 56.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.558 0.694 . . . . 73.239999999999995 110.18 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.36 -7.57 10.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.986 -1.006 . . . . 61.439999999999998 110.936 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 20.7 m -56.48 -41.76 77.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.304 -0.862 . . . . 64.450000000000003 111.228 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -61.74 -23.13 65.95 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.23 1.012 . . . . 64.340000000000003 111.77 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.12 -35.79 15.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.512 . . . . 74.230000000000004 111.888 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 439' ' ' GLU . 50.4 m -148.68 119.48 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.08 -0.387 . . . . 53.240000000000002 110.849 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -58.13 -51.17 70.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 111.77 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.98 -43.6 98.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 64.120000000000005 111.605 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 436' ' ' THR . 35.3 tt0 -65.67 -35.28 80.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.666 -0.697 . . . . 73.430000000000007 110.166 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.03 -51.39 69.83 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 123.775 0.672 . . . . 55.030000000000001 109.627 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.0 t -58.89 -44.12 90.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 50.32 110.48 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 73.5 mmtt -66.21 -46.64 76.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 52.240000000000002 111.762 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 33.1 mmtp -66.0 -37.95 87.23 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.876 0.324 . . . . 52.200000000000003 111.876 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 440' ' ' ALA . 10.4 mp -65.21 -40.48 94.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.932 0.145 . . . . 74.439999999999998 111.286 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.2 m -61.25 -47.06 87.8 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.33 -0.619 . . . . 64.129999999999995 109.33 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.12 -24.96 65.98 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.851 -0.613 . . . . 70.299999999999997 111.696 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.2 -8.86 59.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 65.209999999999994 111.354 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.28 48.7 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.639 -0.791 . . . . 42.200000000000003 113.187 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.25 99.34 6.23 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.266 -0.549 . . . . 73.439999999999998 109.687 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.43 23.1 27.45 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.238 -0.745 . . . . 73.219999999999999 111.238 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -118.58 111.72 18.95 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.671 -1.233 . . . . 72.140000000000001 107.671 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -131.31 144.1 51.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.012 0.91 . . . . 72.510000000000005 113.06 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 18.4 tptm -140.3 123.4 16.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.548 -1.66 . . . . 64.430000000000007 106.525 170.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -95.99 135.16 38.13 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.555 -0.535 . . . . 74.510000000000005 109.555 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.0 153.02 51.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.025 -0.732 . . . . 73.450000000000003 109.025 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -121.8 129.37 52.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.886 0.374 . . . . 74.010000000000005 110.481 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.2 t -117.2 142.46 30.14 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 107.869 -1.16 . . . . 62.329999999999998 107.869 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.98 126.96 19.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.266 1.977 . . . . 71.409999999999997 109.968 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.6 t -137.96 -178.21 5.16 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.749 -0.834 . . . . 60.229999999999997 108.749 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.462 ' HB ' HD13 ' A' ' 463' ' ' LEU . 21.0 m -63.94 138.02 97.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.41 -1.33 . . . . 75.340000000000003 107.41 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.47 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.81 -29.31 33.82 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.629 2.886 . . . . 71.420000000000002 113.965 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -76.23 -19.06 58.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.921 0.711 . . . . 63.439999999999998 112.921 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 460' ' ' THR . 10.4 mp -95.17 4.62 53.4 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.808 0.299 . . . . 65.239999999999995 111.808 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -60.15 126.35 17.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-O 121.335 0.588 . . . . 73.109999999999999 110.54 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.11 -0.16 66.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.748 -0.66 . . . . 54.310000000000002 112.09 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.57 152.29 24.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.985 -1.117 . . . . 73.349999999999994 107.985 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 486' ' ' ILE . 56.4 t -84.07 141.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.06 -0.718 . . . . 72.120000000000005 109.06 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.22 -14.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.127 -0.629 . . . . 55.119999999999997 111.456 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.08 168.28 20.91 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.733 -0.947 . . . . 63.140000000000001 110.733 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.0 p -116.95 159.3 22.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -63.52 -54.69 41.27 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 119.96 -0.696 . . . . 62.409999999999997 111.132 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 18.3 Cg_exo -72.87 112.98 3.64 Favored 'Trans proline' 0 C--N 1.373 1.834 0 N-CA-C 107.465 -1.783 . . . . 71.120000000000005 107.465 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 49.5 Cg_endo -65.65 149.03 87.62 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.917 2.412 . . . . 72.420000000000002 114.938 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.8 -0.88 28.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 70.329999999999998 110.03 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -104.41 7.33 35.52 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.439 -1.255 . . . . 75.430000000000007 110.252 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 34.9 tt0 -159.01 165.48 33.92 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.906 -0.717 . . . . 65.530000000000001 109.593 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.2 m -92.52 126.4 37.59 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.633 -0.877 . . . . 71.430000000000007 108.633 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.9 m -125.96 148.85 49.15 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.939 -0.393 . . . . 75.319999999999993 109.939 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.9 148.19 50.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.632 0.253 . . . . 75.519999999999996 111.636 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.4 mm -66.41 -12.58 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.442 0 C-N-CA 124.388 1.075 . . . . 62.009999999999998 110.818 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.3 t -87.91 5.0 42.64 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.868 0.842 . . . . 75.409999999999997 110.328 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -90.96 135.43 33.74 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.382 -0.599 . . . . 72.530000000000001 109.382 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.69 122.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.964 -1.495 . . . . 64.140000000000001 106.964 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.23 118.59 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 C-N-CA 119.618 -0.833 . . . . 61.420000000000002 108.882 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 63.8 mt -92.93 112.24 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 105.935 -1.876 . . . . 75.319999999999993 105.935 174.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -94.4 109.13 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 106.688 -1.597 . . . . 73.340000000000003 106.688 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.0 mt -97.2 116.9 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 115.513 -0.767 . . . . 65.329999999999998 109.867 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 t -97.52 141.04 16.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.961 -1.125 . . . . 62.439999999999998 107.961 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -91.31 127.11 8.72 Favored Glycine 0 N--CA 1.407 -3.276 0 N-CA-C 109.849 -1.3 . . . . 71.430000000000007 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.7 m -136.39 128.83 30.28 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.348 -0.612 . . . . 72.409999999999997 109.348 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.287 0 N-CA-C 108.569 -1.812 . . . . 64.409999999999997 108.569 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 . . . . . 0 CA--C 1.492 -1.272 0 N-CA-C 107.706 -1.22 . . . . 73.299999999999997 107.706 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.14 149.72 20.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.803 -0.443 . . . . 72.030000000000001 109.803 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.298 -1.371 . . . . 63.539999999999999 107.298 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 406' ' ' ALA . 3.6 p -97.82 118.66 63.71 Favored Pre-proline 0 C--N 1.282 -2.351 0 N-CA-C 108.637 -0.875 . . . . 71.150000000000006 108.637 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.7 160.68 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.77 2.313 . . . . 75.319999999999993 113.823 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 366' ' ' ARG . 14.6 p-10 -72.33 119.58 16.74 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.243 -0.89 . . . . 44.310000000000002 109.976 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.64 35.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 125.564 1.546 . . . . 72.530000000000001 110.728 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 364' ' ' ASP . 15.0 ptt180 -63.87 144.55 56.98 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.622 -1.627 . . . . 72.329999999999998 112.859 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.56 0.74 59.2 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.724 -0.75 . . . . 41.030000000000001 114.685 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.49 171.69 12.73 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.375 1.088 . . . . 73.340000000000003 110.995 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -71.59 156.77 39.02 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.261 -0.427 . . . . 45.32 110.547 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 374' ' ' ILE . 8.4 p -59.78 -37.12 78.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.945 0.403 . . . . 72.400000000000006 110.574 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.0 91.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.993 -0.548 . . . . 62.240000000000002 111.335 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.67 -41.88 74.92 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.487 -0.485 . . . . 74.329999999999998 110.406 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.99 -51.32 69.7 Favored 'General case' 0 C--O 1.239 0.532 0 O-C-N 123.809 0.693 . . . . 72.409999999999997 111.94 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -60.64 -46.07 96.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.281 -0.418 . . . . 72.040000000000006 110.951 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.36 87.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.035 0.383 . . . . 73.209999999999994 112.035 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 79.1 m -60.83 -45.56 93.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.742 0.306 . . . . 53.43 111.197 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.62 -38.13 89.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.363 -0.38 . . . . 72.400000000000006 110.688 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.13 -46.15 90.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.125 0.97 . . . . 74.519999999999996 110.485 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -70.36 -18.66 63.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.757 -0.656 . . . . 71.239999999999995 111.263 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 380' ' ' ARG . 25.1 mmt180 -88.49 -8.26 55.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.972 -0.558 . . . . 74.140000000000001 111.13 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.2 56.15 Favored Glycine 0 CA--C 1.504 -0.655 0 C-N-CA 120.986 -0.626 . . . . 61.350000000000001 113.353 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -80.83 150.27 29.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.226 0.536 . . . . 71.310000000000002 110.41 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -100.06 144.74 28.74 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.066 -1.457 . . . . 73.219999999999999 107.066 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -135.67 139.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-O 121.152 0.501 . . . . 74.120000000000005 111.498 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -116.19 127.75 55.04 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 62.329999999999998 107.246 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.7 m -104.7 123.75 48.17 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.265 -0.574 . . . . 63.549999999999997 110.086 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.53 119.71 39.67 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.55 -0.907 . . . . 62.439999999999998 108.55 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.426 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -104.41 127.52 52.11 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.913 -0.585 . . . . 64.540000000000006 109.635 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -134.97 139.59 32.55 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 111.773 0.286 . . . . 64.450000000000003 111.773 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 60.3 Cg_endo -89.19 145.23 5.13 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.424 2.082 . . . . 73.25 110.215 170.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.9 t70 -171.09 -176.64 1.99 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.502 -0.925 . . . . 73.109999999999999 108.502 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.544 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 3.5 m -98.65 -39.61 8.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.743 -1.577 . . . . 74.549999999999997 106.743 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -101.86 73.47 1.41 Allowed 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.406 -1.331 . . . . 72.010000000000005 107.406 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 14.5 pt -93.83 127.45 45.47 Favored Pre-proline 0 N--CA 1.419 -1.978 0 CA-C-N 113.016 -1.902 . . . . 73.25 111.593 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -69.86 124.33 10.93 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 N-CA-C 106.105 -2.306 . . . . 75.420000000000002 106.105 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.23 159.98 11.69 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.049 2.499 . . . . 75.109999999999999 113.749 -173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.9 -8.81 3.4 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.375 1.07 . . . . 74.329999999999998 111.696 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -103.82 106.86 17.49 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.073 -2.195 . . . . 72.319999999999993 105.073 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.0 m -62.63 119.72 7.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 O-C-N 124.585 1.178 . . . . 71.329999999999998 113.378 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.59 -28.22 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 113.865 -1.516 . . . . 63.420000000000002 109.89 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.47 170.4 32.88 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 110.598 -1.001 . . . . 23.41 110.598 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 403' ' ' ASP . 5.9 m -120.02 -178.21 3.6 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.389 -2.078 . . . . 54.420000000000002 105.389 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.492 ' H ' HG22 ' A' ' 402' ' ' THR . 26.9 t70 -100.02 141.14 22.21 Favored Pre-proline 0 C--N 1.266 -3.024 0 N-CA-C 108.995 -0.742 . . . . 75.230000000000004 108.995 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -41.98 -26.32 0.47 Allowed 'Trans proline' 0 C--N 1.371 1.731 1 C-N-CA 125.555 4.17 . . . . 75.109999999999999 115.248 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.55 62.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.981 0.512 . . . . 74.049999999999997 110.683 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 362' ' ' VAL . . . -77.06 -44.47 30.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.678 -0.692 . . . . 61.409999999999997 110.856 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -7.62 54.54 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.69 -0.686 . . . . 72.230000000000004 111.936 -174.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.3 m -85.17 146.02 27.32 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.421 -0.955 . . . . 73.540000000000006 108.421 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.4 p -73.49 113.87 11.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 109.795 -0.446 . . . . 73.510000000000005 109.795 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 168.84 20.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.525 -0.546 . . . . 73.329999999999998 109.525 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.8 m -72.84 133.25 44.37 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.369 -0.974 . . . . 71.120000000000005 108.369 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -55.86 135.78 51.81 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 112.442 0.534 . . . . 53.119999999999997 112.442 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.86 47.04 4.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.082 -0.963 . . . . 62.509999999999998 111.094 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -108.68 178.88 4.35 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.981 -1.118 . . . . 75.409999999999997 107.981 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.79 122.13 40.53 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.801 0.44 . . . . 52.119999999999997 111.388 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -111.18 128.88 67.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.723 -0.843 . . . . 61.439999999999998 108.723 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -87.39 128.0 35.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.138 -0.69 . . . . 53.329999999999998 109.138 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.21 128.85 73.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.532 -0.914 . . . . 75.109999999999999 108.532 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -100.96 128.34 47.03 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.395 -0.366 . . . . 72.209999999999994 110.694 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.28 146.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.558 -1.275 . . . . 73.540000000000006 107.558 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 8.8 p -98.93 123.29 43.11 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.059 -0.657 . . . . 45.450000000000003 112.531 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -118.28 105.32 11.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.888 -0.596 . . . . 75.349999999999994 110.145 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 72.94 161.2 6.01 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 121.898 0.721 . . . . 24.239999999999998 114.497 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.0 Cg_endo -92.33 157.62 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.496 2.13 . . . . 75.010000000000005 110.871 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.8 131.63 42.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 120.092 -0.643 . . . . 52.030000000000001 110.219 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -121.08 138.96 53.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.681 -0.69 . . . . 74.140000000000001 109.611 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.1 OUTLIER -131.8 150.19 52.23 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 108.566 -0.902 . . . . 64.439999999999998 108.566 -175.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.7 OUTLIER -85.98 131.65 34.23 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.064 -1.087 . . . . 72.230000000000004 108.064 176.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.08 125.23 82.11 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.372 -0.603 . . . . 72.140000000000001 109.372 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.37 141.25 73.86 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.255 1.97 . . . . 62.450000000000003 110.951 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.5 -5.26 59.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.466 0.651 . . . . 61.409999999999997 110.199 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.47 -1.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 74.420000000000002 111.165 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.2 p -65.6 -41.53 92.66 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.921 0.867 . . . . 71.25 109.708 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.4 m -65.84 -13.24 59.18 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 125.271 1.429 . . . . 71.219999999999999 111.213 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.18 -35.75 17.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.315 0.487 . . . . 64.239999999999995 112.315 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.0 m -157.94 125.21 5.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.909 -0.494 . . . . 44.450000000000003 110.522 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -57.58 -48.79 78.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.437 0.532 . . . . 73.019999999999996 112.437 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.0 76.71 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.439 -0.346 . . . . 45.229999999999997 111.888 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.88 -34.7 71.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.962 -0.563 . . . . 53.009999999999998 111.176 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.18 -47.01 86.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.477 -0.329 . . . . 75.200000000000003 110.459 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.28 -42.33 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.822 -0.627 . . . . 74.019999999999996 109.935 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -61.62 -47.59 84.75 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 111.922 0.342 . . . . 64.439999999999998 111.922 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.55 -45.54 92.46 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.55 0.34 . . . . 64.329999999999998 111.54 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.28 -40.79 81.7 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.469 -0.492 . . . . 45.100000000000001 112.175 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.2 m -63.82 -39.33 93.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.956 0.407 . . . . 61.439999999999998 110.402 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.65 -25.96 65.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 54.539999999999999 110.946 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -86.88 -8.59 57.14 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.857 -0.61 . . . . 70.439999999999998 110.938 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.3 -15.98 13.01 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.558 -0.829 . . . . 34.539999999999999 114.08 176.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.36 113.15 3.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.995 0.898 . . . . 74.540000000000006 111.54 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.86 -12.57 11.17 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.823 -0.703 . . . . 42.340000000000003 111.422 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -91.06 111.19 22.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.1 -0.704 . . . . 75.230000000000004 109.1 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -136.07 154.49 51.01 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.54 0.685 . . . . 52.219999999999999 111.864 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -137.03 122.3 19.3 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 104.841 -2.281 . . . . 63.310000000000002 104.841 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -113.57 127.89 56.24 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.023 0.439 . . . . 72.420000000000002 110.625 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.06 165.29 27.96 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.701 -0.682 . . . . 63.329999999999998 110.034 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.96 141.15 47.12 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.771 -1.196 . . . . 63.210000000000001 107.771 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.6 t -116.93 129.57 25.22 Favored Pre-proline 0 N--CA 1.407 -2.607 0 N-CA-C 107.008 -1.479 . . . . 74.409999999999997 107.008 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.55 119.97 7.15 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 122.227 1.952 . . . . 61.009999999999998 109.791 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 2.9 p -148.24 -178.35 6.26 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 115.045 -0.98 . . . . 64.239999999999995 108.84 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.3 m -61.32 128.72 90.14 Favored Pre-proline 0 C--N 1.291 -1.941 0 N-CA-C 108.48 -0.933 . . . . 75.109999999999999 108.48 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.68 -22.94 10.29 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.646 2.898 . . . . 65.209999999999994 112.899 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.11 -30.17 69.09 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.34 0.656 . . . . 72.099999999999994 110.918 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.63 5.16 44.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.362 -0.381 . . . . 73.439999999999998 111.427 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.5 p -59.58 132.26 24.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 CA-C-O 121.15 0.5 . . . . 43.310000000000002 111.247 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.81 -10.79 73.82 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.689 -0.767 . . . . 41.310000000000002 112.748 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.67 147.01 30.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.38 -0.6 . . . . 73.430000000000007 109.38 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -83.86 135.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.125 -1.065 . . . . 61.219999999999999 108.125 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.97 -16.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.516 -0.874 . . . . 71.239999999999995 111.542 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.37 167.28 32.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.641 -0.79 . . . . 74.400000000000006 111.693 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.2 p -131.78 145.62 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.309 -0.996 . . . . 74.019999999999996 108.309 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -58.97 -53.8 62.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 120.337 -0.545 . . . . 75.530000000000001 110.532 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -70.84 118.39 5.67 Favored 'Trans proline' 0 C--N 1.376 2.011 0 N-CA-C 107.338 -1.831 . . . . 71.430000000000007 107.338 169.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.12 151.93 30.8 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.028 1.819 . . . . 75.150000000000006 113.685 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -68.74 -0.93 5.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.005 -0.998 . . . . 70.150000000000006 112.244 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -107.81 -3.02 19.43 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.497 -0.32 . . . . 75.140000000000001 110.69 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -118.19 157.0 27.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.442 0.639 . . . . 71.510000000000005 110.601 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 10.3 m -102.69 97.75 7.88 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 61.340000000000003 107.404 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 40.4 m -100.88 147.99 25.48 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.986 -0.552 . . . . 73.209999999999994 110.082 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.77 148.22 51.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.107 -0.497 . . . . 61.219999999999999 110.861 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 33.0 mm -69.81 -5.04 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 122.464 1.126 . . . . 73.209999999999994 109.996 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.4 p -87.49 0.9 54.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.598 0.714 . . . . 60.119999999999997 109.736 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 482' ' ' ASN . 0.8 OUTLIER -93.07 139.42 30.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.425 -0.807 . . . . 74.219999999999999 109.08 -179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.93 123.42 36.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.911 -1.144 . . . . 75.209999999999994 107.911 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.36 118.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 108.679 -0.86 . . . . 73.510000000000005 108.679 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.461 HD13 HD22 ' A' ' 471' ' ' ASN . 2.6 mp -92.4 113.65 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.204 -1.776 . . . . 73.200000000000003 106.204 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -112.43 114.64 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 N-CA-C 108.297 -1.001 . . . . 72.239999999999995 108.297 -176.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -106.9 123.07 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.358 -0.837 . . . . 53.219999999999999 111.214 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.36 144.0 11.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.75 -1.114 . . . . 74.040000000000006 108.486 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.58 113.42 4.61 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 108.904 -1.678 . . . . 70.299999999999997 108.904 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.9 m -139.63 113.11 8.4 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 109.178 -0.675 . . . . 65.409999999999997 109.178 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.417 -2.633 0 N-CA-C 108.499 -1.84 . . . . 62.0 108.499 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 106.594 -1.632 . . . . 72.400000000000006 106.594 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.51 154.25 23.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 110.177 -0.305 . . . . 74.450000000000003 110.177 -175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -98.97 132.12 44.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.805 -1.183 . . . . 65.319999999999993 107.805 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.1 118.33 61.67 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.832 -0.747 . . . . 72.329999999999998 111.461 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.89 143.08 71.78 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.439 2.093 . . . . 64.010000000000005 112.189 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.623 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 4.0 p30 -82.68 177.9 8.46 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.225 -0.898 . . . . 73.209999999999994 111.239 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 17.1 m -138.67 29.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.478 -1.237 . . . . 74.420000000000002 108.537 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.623 ' HG3' ' OD1' ' A' ' 364' ' ' ASP 0.264 0.1 OUTLIER -64.15 146.74 53.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.438 0.903 . . . . 73.450000000000003 113.438 -174.049 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.2 0.2 41.04 Favored Glycine 0 C--N 1.308 -0.989 0 N-CA-C 110.368 -1.093 . . . . 54.409999999999997 110.368 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.535 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 46.7 mt-30 -116.44 -170.68 1.86 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.899 -0.778 . . . . 72.439999999999998 108.899 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.0 p -69.91 150.99 46.17 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.471 0.309 . . . . 63.32 111.132 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 374' ' ' ILE . 38.1 t -57.98 -36.15 72.19 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.443 -0.947 . . . . 61.530000000000001 108.443 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.3 94.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.308 -0.86 . . . . 75.010000000000005 112.237 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.88 -40.24 91.43 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.75 0.309 . . . . 75.310000000000002 110.199 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.18 88.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 72.319999999999993 110.637 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 370' ' ' SER . 76.5 mt -62.59 -46.39 96.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.68 -0.691 . . . . 70.049999999999997 110.202 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.34 79.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.997 -0.547 . . . . 51.140000000000001 112.087 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 85.5 m -60.73 -47.83 84.54 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.659 -0.246 . . . . 70.519999999999996 111.128 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.52 -38.04 89.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.71 0.263 . . . . 64.140000000000001 111.71 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -41.98 97.8 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 109.414 -0.587 . . . . 72.0 109.414 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -69.82 -22.93 63.26 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.473 -0.785 . . . . 74.140000000000001 112.107 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.2 mmt180 -84.96 -14.27 48.1 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.504 -0.554 . . . . 72.319999999999993 109.504 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.84 56.68 Favored Glycine 0 C--O 1.239 0.421 0 C-N-CA 120.895 -0.669 . . . . 53.520000000000003 112.201 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.33 149.26 25.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.966 -0.383 . . . . 74.530000000000001 109.966 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -100.18 132.35 45.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.782 -0.822 . . . . 74.040000000000006 108.782 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -121.88 137.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 113.232 0.827 . . . . 61.229999999999997 113.232 -174.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -110.56 127.87 55.4 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 107.309 -1.367 . . . . 71.219999999999999 107.309 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.0 m -99.33 121.82 41.62 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.136 -1.061 . . . . 51.530000000000001 108.136 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -111.49 119.5 38.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.251 -1.388 . . . . 73.140000000000001 107.251 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.46 128.69 55.34 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 109.431 -0.581 . . . . 71.109999999999999 109.431 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -133.04 146.25 60.42 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.904 -0.406 . . . . 73.239999999999995 109.904 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -93.08 128.87 0.74 Allowed 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.221 1.947 . . . . 74.450000000000003 109.81 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.0 t70 -173.14 -175.12 1.14 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.732 -1.21 . . . . 70.040000000000006 107.732 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.8 m -130.63 -0.68 4.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.753 0.787 . . . . 54.140000000000001 109.975 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -91.11 -0.63 57.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.881 1.324 . . . . 71.409999999999997 107.473 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.481 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.63 151.75 48.33 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.076 -1.42 . . . . 70.310000000000002 112.641 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.16 178.32 6.44 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.425 2.084 . . . . 73.450000000000003 109.698 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.96 158.13 18.24 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 121.923 1.749 . . . . 74.109999999999999 111.786 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.81 -7.21 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.842 0.829 . . . . 70.409999999999997 113.119 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -86.83 122.66 31.01 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.216 -2.513 . . . . 51.229999999999997 104.216 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 118.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.626 0.727 . . . . 75.109999999999999 111.811 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.8 mm -97.87 -28.37 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.533 -0.758 . . . . 72.409999999999997 111.004 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.94 157.99 27.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.039 -1.077 . . . . 52.399999999999999 111.794 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.8 p -114.16 -177.53 3.15 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 123.577 0.751 . . . . 72.329999999999998 111.123 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.06 143.73 27.04 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.109999999999999 107.705 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -40.25 -32.63 0.72 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 124.807 3.672 . . . . 74.099999999999994 114.715 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.09 -30.01 61.41 Favored 'General case' 0 C--O 1.208 -1.103 0 O-C-N 123.437 0.46 . . . . 72.420000000000002 111.608 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.72 -35.56 75.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.109 0.48 . . . . 73.040000000000006 111.021 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -95.66 -0.85 51.2 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.944 0.402 . . . . 72.530000000000001 111.939 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -98.29 155.94 16.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.322 -1.362 . . . . 71.150000000000006 107.322 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 11.3 p -74.31 112.7 10.73 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.723 -0.843 . . . . 73.329999999999998 108.723 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.51 169.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.439 -0.578 . . . . 73.310000000000002 109.439 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 20.3 m -69.65 146.9 51.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.298 -0.631 . . . . 63.439999999999998 109.298 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.81 108.17 2.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.821 -1.177 . . . . 53.409999999999997 107.821 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.61 59.68 1.26 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.444 -1.462 . . . . 71.209999999999994 109.444 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.3 t0 -109.94 -173.51 2.27 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.039 -1.097 . . . . 74.230000000000004 108.039 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -93.62 121.96 35.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.815 0.846 . . . . 74.230000000000004 110.079 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.8 mm -124.23 137.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.112 -1.44 . . . . 63.43 107.112 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.1 t -113.2 131.25 55.95 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 61.219999999999999 110.833 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 76.4 t -102.18 128.28 54.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.112 -0.949 . . . . 71.230000000000004 108.748 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -99.0 129.83 45.3 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.131 -0.486 . . . . 41.109999999999999 110.044 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 9.0 p -136.16 136.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.271 0.558 . . . . 64.340000000000003 109.705 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.481 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 8.2 m -89.59 123.75 33.94 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.942 -0.572 . . . . 42.32 110.982 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -119.18 105.83 11.76 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.193 -0.603 . . . . 60.109999999999999 110.015 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.08 129.32 0.5 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 120.649 -0.786 . . . . 71.319999999999993 114.792 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 17.0 Cg_exo -70.75 157.92 57.11 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.685 2.257 . . . . 75.430000000000007 110.582 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.01 155.52 19.78 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.361 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.7 mt-30 -127.84 138.78 52.82 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.827 -0.805 . . . . 63.43 108.827 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -135.52 157.68 46.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.093 -0.706 . . . . 73.219999999999999 109.093 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.64 139.35 32.86 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.653 -0.499 . . . . 75.530000000000001 109.653 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -80.47 127.34 76.21 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 108.66 -0.866 . . . . 64.530000000000001 108.66 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.53 141.57 62.3 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.842 2.361 . . . . 72.409999999999997 111.805 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.76 -15.5 48.28 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.511 0.672 . . . . 63.130000000000003 111.785 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.3 -10.55 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 121.399 0.619 . . . . 64.409999999999997 110.824 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.1 m -55.73 -45.4 77.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.583 0.753 . . . . 65.150000000000006 112.533 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.5 p -69.84 -15.67 63.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.345 0.593 . . . . 62.140000000000001 112.562 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.01 -37.99 13.92 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.215 -0.448 . . . . 64.200000000000003 111.003 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.9 m -146.98 122.22 10.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.062 0.458 . . . . 53.399999999999999 111.043 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -60.59 -42.27 96.38 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.789 0.835 . . . . 64.129999999999995 112.276 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.94 78.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.489 . . . . 73.420000000000002 110.822 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.75 -39.8 73.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.06 -0.518 . . . . 75.310000000000002 110.96 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.61 68.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.854 -0.612 . . . . 64.420000000000002 111.031 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.52 -43.83 90.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.785 0.661 . . . . 63.530000000000001 112.785 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.34 -48.53 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.801 -0.36 . . . . 71.299999999999997 111.774 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.84 -40.18 87.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 113.897 1.073 . . . . 74.549999999999997 113.897 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.39 -43.17 77.87 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.977 -0.689 . . . . 72.319999999999993 112.215 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.7 m -61.6 -43.98 97.85 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.024 0.44 . . . . 72.400000000000006 110.364 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.09 -25.1 62.47 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.795 -0.639 . . . . 60.130000000000003 111.765 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -12.69 59.77 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.172 0.51 . . . . 61.530000000000001 110.631 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.62 -19.01 8.58 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.337 -0.935 . . . . 35.409999999999997 112.791 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.2 103.82 1.67 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.008 -0.738 . . . . 54.140000000000001 109.008 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.68 11.59 18.48 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 111.029 -0.829 . . . . 75.340000000000003 111.029 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -108.87 111.05 22.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 106.68 -1.6 . . . . 72.299999999999997 106.68 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.98 155.82 49.68 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.268 0.556 . . . . 62.310000000000002 111.425 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 122.3 20.33 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 102.843 -3.021 . . . . 72.430000000000007 102.843 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -93.91 135.14 35.55 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.867 -0.42 . . . . 74.400000000000006 109.867 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 141.09 37.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.161 0.505 . . . . 72.510000000000005 110.741 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -118.96 129.36 55.12 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.058 -1.46 . . . . 75.230000000000004 107.058 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -125.36 145.35 50.62 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.448 -0.575 . . . . 74.450000000000003 109.448 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 491' ' ' GLY . 13.4 Cg_exo -68.54 126.77 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.773 1.649 . . . . 51.439999999999998 110.378 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.6 m -135.71 172.92 12.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.984 -0.747 . . . . 75.150000000000006 108.984 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 463' ' ' LEU . 25.6 m -62.81 140.09 97.26 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.402 -0.962 . . . . 74.519999999999996 108.402 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -49.32 -31.24 22.19 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.792 2.995 . . . . 62.329999999999998 113.782 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.69 -21.88 64.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.236 0.541 . . . . 64.129999999999995 111.434 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.2 mm? -105.72 -8.52 17.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.218 -0.446 . . . . 73.439999999999998 110.937 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 76.3 t -60.09 127.21 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 120.977 0.417 . . . . 61.049999999999997 110.641 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.54 59.08 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.881 -0.888 . . . . 71.329999999999998 110.881 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.22 162.42 13.21 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.663 -0.865 . . . . 72.219999999999999 108.663 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 93.1 t -83.83 128.59 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.773 -1.566 . . . . 75.329999999999998 106.773 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.42 -16.87 7.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.381 -0.928 . . . . 74.340000000000003 111.526 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.11 159.0 16.13 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 111.113 -0.795 . . . . 62.43 111.113 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.4 p -119.94 154.29 34.68 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.425 -1.694 . . . . 74.420000000000002 106.425 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 7.2 t30 -64.19 -49.94 70.72 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 119.43 -0.908 . . . . 72.209999999999994 110.349 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.4 Cg_exo -78.2 115.9 3.81 Favored 'Trans proline' 0 C--N 1.371 1.731 0 N-CA-C 108.051 -1.557 . . . . 65.519999999999996 108.051 168.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.54 149.93 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.077 1.852 . . . . 72.439999999999998 112.488 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.04 4.24 4.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.445 0.641 . . . . 63.25 112.596 -176.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -108.35 2.15 22.32 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.994 -0.548 . . . . 62.219999999999999 110.67 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -117.65 155.42 29.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.752 0.787 . . . . 64.430000000000007 111.556 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 17.4 m -95.62 111.83 23.68 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.987 -1.486 . . . . 64.319999999999993 106.987 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.6 m -115.14 149.25 37.92 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.731 -0.47 . . . . 72.430000000000007 109.731 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -62.29 150.84 38.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.156 0.503 . . . . 55.340000000000003 111.226 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.26 -26.51 27.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.035 0.921 . . . . 73.019999999999996 109.353 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 m -89.87 5.14 47.57 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.967 -1.015 . . . . 34.100000000000001 110.117 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 43.7 t-20 -83.62 135.3 34.66 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 107.609 -1.256 . . . . 64.239999999999995 107.609 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 58.8 t -79.01 114.5 19.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.249 -0.649 . . . . 73.239999999999995 109.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.77 119.52 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.082 -0.71 . . . . 72.319999999999993 109.082 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 3.0 mp -92.23 114.25 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.357 -1.72 . . . . 75.310000000000002 106.357 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.29 118.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.676 -1.231 . . . . 74.510000000000005 107.676 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.1 mt -110.32 117.33 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.587 0.708 . . . . 74.450000000000003 110.27 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.23 138.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.581 -0.736 . . . . 73.340000000000003 109.122 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.09 107.76 3.2 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.975 -0.85 . . . . 74.409999999999997 110.975 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.478 ' HA ' HG13 ' A' ' 464' ' ' VAL . 36.6 m -143.37 113.94 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.105 -0.702 . . . . 72.209999999999994 109.105 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 458' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.311 0 N-CA-C 110.183 -1.167 . . . . 74.109999999999999 110.183 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.424 -1.765 0 N-CA-C 105.486 -2.042 . . . . 73.010000000000005 105.486 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.86 164.2 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 120.88 0.372 . . . . 74.040000000000006 111.13 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -94.29 137.14 33.8 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.8 -1.926 . . . . 75.319999999999993 105.8 173.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.57 139.72 21.55 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 108.294 -1.002 . . . . 63.509999999999998 108.294 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -37.99 135.79 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.8 3.0 . . . . 63.409999999999997 113.835 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.78 88.96 1.33 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.791 -1.188 . . . . 71.400000000000006 107.791 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.42 -0.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 116.888 2.181 . . . . 55.119999999999997 116.888 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 145.25 56.5 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.032 -0.667 . . . . 74.129999999999995 112.231 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 0.48 45.29 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.802 -0.919 . . . . 42.340000000000003 110.802 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -117.3 172.51 7.26 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.608 -1.627 . . . . 71.209999999999994 106.608 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 91.0 p -81.3 153.67 26.95 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 118.482 -1.287 . . . . 62.310000000000002 107.865 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.5 m -56.65 -40.47 75.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.535 0.207 . . . . 74.140000000000001 110.897 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.67 -36.99 79.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.015 0.436 . . . . 71.310000000000002 111.395 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -67.5 -36.69 81.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.537 0.684 . . . . 72.329999999999998 109.508 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.44 90.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.495 -0.775 . . . . 65.329999999999998 110.134 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 370' ' ' SER . 70.5 mt -57.72 -46.42 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.696 0.398 . . . . 71.209999999999994 110.134 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.69 91.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.932 -0.576 . . . . 72.230000000000004 110.684 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.7 m -64.73 -47.59 77.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.412 -0.358 . . . . 71.450000000000003 111.095 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.29 -38.79 91.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 111.655 0.243 . . . . 44.350000000000001 111.655 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.11 -48.88 79.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.254 -0.647 . . . . 70.019999999999996 109.254 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -72.07 -16.47 62.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.2 -0.909 . . . . 72.5 111.935 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.91 -15.07 49.37 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.034 -1.098 . . . . 63.409999999999997 108.034 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.4 5.6 61.78 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.59 -0.732 . . . . 33.350000000000001 111.786 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 26.2 m-85 -91.83 158.95 16.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.198 0.523 . . . . 61.229999999999997 111.745 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 75.1 mmtt -95.62 146.31 24.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.052 -1.092 . . . . 73.439999999999998 108.052 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.72 144.04 38.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 121.209 0.528 . . . . 74.209999999999994 111.56 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -110.46 139.92 45.22 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.019 -2.215 . . . . 71.200000000000003 105.019 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -112.68 121.0 43.47 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 119.174 -1.01 . . . . 55.340000000000003 110.015 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.64 119.27 38.11 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.572 -1.64 . . . . 73.530000000000001 106.572 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.465 ' HB2' HG22 ' A' ' 422' ' ' THR . 0.0 OUTLIER -107.04 122.37 46.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.927 -0.768 . . . . 75.349999999999994 108.927 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.445 ' HE3' ' OD1' ' A' ' 419' ' ' ASN . 17.6 ptpt -121.15 116.97 30.87 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 113.12 0.785 . . . . 74.439999999999998 113.12 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.3 Cg_exo -83.53 140.24 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.445 2.097 . . . . 70.219999999999999 109.205 168.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 175.18 -166.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.136 -2.542 . . . . 31.02 104.136 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 15.1 m -132.67 -4.03 3.28 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 118.907 0.776 . . . . 43.219999999999999 109.982 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.1 m -106.49 38.03 2.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.204 -2.147 . . . . 53.439999999999998 105.204 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.55 HG23 ' HB3' ' A' ' 391' ' ' ASP . 16.3 pt -87.1 151.16 51.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 113.176 -1.829 . . . . 72.540000000000006 113.078 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.07 137.33 34.31 Favored 'Trans proline' 0 N--CA 1.429 -2.306 0 N-CA-C 105.974 -2.356 . . . . 65.230000000000004 105.974 165.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.66 160.69 11.27 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.332 2.021 . . . . 64.450000000000003 111.787 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.67 -8.52 2.06 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.947 0.879 . . . . 75.120000000000005 111.722 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.0 m170 -103.45 111.05 23.31 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.778 -2.675 . . . . 74.430000000000007 103.778 171.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.52 119.34 6.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.962 0.887 . . . . 73.109999999999999 112.426 -166.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.4 -27.84 4.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.958 0 CA-C-N 114.528 -1.215 . . . . 73.219999999999999 112.14 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.48 27.31 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.65 -0.98 . . . . 72.049999999999997 110.65 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.5 p -114.69 -178.0 3.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.639 0.733 . . . . 52.130000000000003 112.375 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -104.18 136.48 19.18 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 107.437 -1.32 . . . . 73.530000000000001 107.437 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -48.91 -25.37 8.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.155 3.236 . . . . 73.310000000000002 115.327 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.96 -36.04 69.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.471 0.309 . . . . 75.209999999999994 110.976 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.94 83.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 74.109999999999999 110.769 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.45 -11.4 58.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.296 -0.865 . . . . 63.439999999999998 110.953 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.1 m -93.62 155.25 17.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.143 -1.058 . . . . 74.340000000000003 108.143 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 9.7 p -74.5 114.51 12.98 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 121.543 0.687 . . . . 74.019999999999996 110.154 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.1 m -123.87 169.23 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.333 -0.849 . . . . 72.420000000000002 109.574 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 65.6 m -62.41 149.34 42.79 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.978 0.418 . . . . 74.400000000000006 111.499 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.68 112.04 3.98 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.156 -1.053 . . . . 71.209999999999994 108.156 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.45 25.54 13.65 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.346 -0.931 . . . . 23.109999999999999 112.091 -177.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.73 -173.88 4.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.0 pt-20 -108.72 132.87 53.52 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.472 0.653 . . . . 64.439999999999998 112.435 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 47.7 mm -119.86 131.48 72.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.221 -1.029 . . . . 74.299999999999997 108.221 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.3 t -89.45 131.35 35.55 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.379 0.609 . . . . 64.310000000000002 109.999 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.15 134.67 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 109.268 -0.641 . . . . 73.209999999999994 109.268 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.445 ' OD1' ' HE3' ' A' ' 389' ' ' LYS . 41.6 m-80 -103.6 129.8 50.93 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 111.655 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.8 p -134.29 142.09 41.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.13 -1.063 . . . . 75.430000000000007 108.13 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 12.9 p -101.72 123.12 45.18 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.338 -0.545 . . . . 62.009999999999998 111.761 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 388' ' ' GLN . 9.3 t -120.14 107.01 12.51 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.423 -0.511 . . . . 73.430000000000007 111.546 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.89 142.61 6.59 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.714 -0.755 . . . . 61.109999999999999 114.342 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.5 Cg_endo -87.92 133.47 3.0 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.295 1.997 . . . . 75.299999999999997 111.625 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.458 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 8.7 mm-40 -72.83 134.05 44.72 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 122.211 -0.305 . . . . 72.109999999999999 110.537 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HB3' HG22 ' A' ' 477' ' ' THR . 47.2 mt-30 -123.27 134.01 54.12 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.776 -0.824 . . . . 61.149999999999999 108.776 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -131.99 150.94 52.02 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.893 -1.151 . . . . 74.120000000000005 107.893 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 1.5 pm0 -82.33 138.95 34.38 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.403 -0.962 . . . . 75.120000000000005 108.403 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.9 mt -82.35 117.24 67.73 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.7 -0.852 . . . . 70.230000000000004 108.7 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.55 140.24 39.26 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.303 1.335 . . . . 72.5 110.884 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.46 84.37 5.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.333 1.063 . . . . 64.420000000000002 112.282 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.65 -5.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 113.645 -1.616 . . . . 63.200000000000003 106.726 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.7 m -62.74 -43.14 99.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.727 -1.579 . . . . 63.43 111.498 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.3 m -58.55 -21.31 52.19 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 122.957 0.503 . . . . 74.319999999999993 111.733 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.68 -48.08 64.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 122.289 -0.257 . . . . 62.520000000000003 110.59 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.1 t 178.45 161.85 0.66 Allowed 'General case' 0 C--O 1.249 1.054 0 N-CA-C 108.748 -0.834 . . . . 71.409999999999997 108.748 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -57.75 -42.65 84.39 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.987 0.915 . . . . 75.200000000000003 111.998 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.25 81.41 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.885 0.328 . . . . 61.439999999999998 111.885 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.78 -38.88 92.76 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.246 -0.434 . . . . 63.409999999999997 110.645 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -51.09 71.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.301 -0.863 . . . . 73.299999999999997 110.238 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.27 -43.12 98.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.536 -0.756 . . . . 74.040000000000006 111.364 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -63.25 -49.37 74.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.247 0.462 . . . . 70.019999999999996 112.247 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -68.03 -41.3 82.35 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 113.099 0.777 . . . . 73.430000000000007 113.099 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 -41.04 90.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.678 -0.409 . . . . 55.140000000000001 112.044 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -66.39 -38.8 88.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.932 -0.396 . . . . 64.200000000000003 109.932 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.26 73.79 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.253 -0.43 . . . . 74.519999999999996 110.879 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.92 58.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.368 -0.378 . . . . 72.219999999999999 110.892 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.31 -20.34 9.67 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.865 -0.683 . . . . 54.149999999999999 113.97 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 105.68 1.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.37 . . . . 74.099999999999994 110.315 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.53 22.22 15.5 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 120.563 -0.827 . . . . 71.040000000000006 111.13 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.55 111.07 18.13 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.163 -1.051 . . . . 75.530000000000001 108.163 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.4 147.1 52.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.281 0.562 . . . . 75.420000000000002 111.26 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 8.1 tmtm? -138.67 123.45 18.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.768 -1.938 . . . . 72.450000000000003 105.768 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -98.53 135.47 40.02 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.612 -0.435 . . . . 62.130000000000003 111.072 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.01 148.48 50.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.506 -1.294 . . . . 53.25 107.506 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.25 130.34 46.12 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.788 -0.819 . . . . 51.399999999999999 108.788 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 36.9 p -130.93 143.93 51.42 Favored Pre-proline 0 C--N 1.291 -1.964 0 C-N-CA 120.463 -0.495 . . . . 62.020000000000003 110.888 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_exo -63.71 122.87 11.12 Favored 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.622 2.215 . . . . 72.25 110.281 175.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.8 m -130.06 162.63 28.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.495 -0.321 . . . . 73.420000000000002 111.203 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.4 m -60.26 142.65 89.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.638 1.175 . . . . 74.420000000000002 108.782 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.561 ' O ' HG22 ' A' ' 464' ' ' VAL . 90.9 Cg_exo -49.25 -24.06 7.72 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.108 3.205 . . . . 75.349999999999994 114.498 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.19 -19.21 64.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 111.886 0.328 . . . . 75.420000000000002 111.886 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.33 -11.45 12.55 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.841 0.682 . . . . 64.299999999999997 112.841 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 461' ' ' PRO . 22.4 m -59.93 134.71 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 112.672 0.619 . . . . 65.450000000000003 112.672 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.12 74.44 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.348 -0.842 . . . . 74.219999999999999 111.189 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -119.9 165.19 14.95 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-O 121.252 0.549 . . . . 74.120000000000005 109.646 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 92.6 t -84.02 134.96 25.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.767 -1.198 . . . . 74.340000000000003 107.767 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.71 -12.0 8.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 119.863 -0.735 . . . . 75.230000000000004 110.952 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.25 169.96 20.3 Favored Glycine 0 N--CA 1.414 -2.805 0 CA-C-N 115.346 -0.843 . . . . 71.430000000000007 111.263 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -116.62 150.63 37.77 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.136 -1.061 . . . . 72.019999999999996 108.136 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.3 t30 -64.12 -47.4 79.37 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.537 -0.465 . . . . 52.25 109.924 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 10.4 Cg_exo -76.23 117.29 4.59 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 107.6 -1.731 . . . . 65.519999999999996 107.6 167.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.74 144.18 88.43 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.082 1.855 . . . . 63.009999999999998 113.037 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.41 12.94 3.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.166 0.984 . . . . 71.230000000000004 110.394 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -109.18 1.58 20.4 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.967 -1.015 . . . . 62.229999999999997 108.619 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -125.17 159.39 31.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.174 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -93.6 115.77 28.26 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.358 -1.292 . . . . 74.25 108.822 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.1 m -116.02 148.54 40.05 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.965 -0.383 . . . . 72.510000000000005 109.965 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.51 152.24 46.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.449 0.3 . . . . 63.219999999999999 111.203 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 46.1 mm -62.83 -26.21 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 121.315 0.578 . . . . 71.310000000000002 111.961 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 13.0 t -96.28 5.03 51.86 Favored 'General case' 0 C--O 1.241 0.658 0 O-C-N 122.01 -0.431 . . . . 75.340000000000003 110.467 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -74.2 129.73 38.39 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.996 -1.113 . . . . 63.530000000000001 107.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 113.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.765 -0.828 . . . . 73.109999999999999 108.765 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.33 120.02 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.567 -0.742 . . . . 72.329999999999998 109.855 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 66.8 mt -91.54 112.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.895 -1.52 . . . . 64.420000000000002 106.895 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 120.4 53.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 107.937 -1.134 . . . . 55.119999999999997 107.937 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 24.0 mt -105.2 118.82 53.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.088 0.47 . . . . 75.310000000000002 110.111 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.08 134.92 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 115.79 -0.641 . . . . 73.430000000000007 109.339 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.64 106.23 3.09 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.516 -1.034 . . . . 64.040000000000006 110.516 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -122.07 119.11 30.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.925 -0.769 . . . . 53.149999999999999 108.925 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 CA-C-O 118.009 -1.44 . . . . 54.219999999999999 109.764 -177.282 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.431 -1.399 0 N-CA-C 108.203 -1.036 . . . . 63.539999999999999 108.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.2 154.75 37.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 120.985 0.421 . . . . 75.150000000000006 110.875 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.25 139.03 32.15 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.857 -2.275 . . . . 74.230000000000004 104.857 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.2 130.86 32.82 Favored Pre-proline 0 C--N 1.283 -2.325 0 C-N-CA 119.072 -1.051 . . . . 54.310000000000002 109.367 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -41.03 125.65 2.36 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.847 3.031 . . . . 73.349999999999994 112.069 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.86 157.16 38.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.26 -1.336 . . . . 42.43 109.471 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.82 -0.24 9.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.612 -0.435 . . . . 62.409999999999997 110.973 -173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.4 ptp180 -54.91 131.05 43.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.547 0.689 . . . . 72.450000000000003 112.612 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 101.74 -1.29 52.39 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.359 -0.837 . . . . 65.319999999999993 111.146 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -118.42 -178.06 3.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.502 -0.555 . . . . 73.140000000000001 109.502 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 82.9 p -87.87 171.23 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.619 0.6 . . . . 54.009999999999998 112.619 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 8.7 p -63.89 -39.09 93.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.03 -0.532 . . . . 54.450000000000003 109.989 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.38 87.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.593 -0.73 . . . . 74.420000000000002 110.033 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.83 -44.07 90.83 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 123.209 0.318 . . . . 31.329999999999998 111.533 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.98 -51.18 67.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.866 0.365 . . . . 73.040000000000006 111.099 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 378' ' ' GLN . 1.8 mp -68.32 -46.28 81.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.139 -0.482 . . . . 64.430000000000007 111.71 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.42 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.622 0.601 . . . . 61.450000000000003 112.622 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.545 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 22.9 m -66.94 -48.29 69.05 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.629 -0.429 . . . . 74.420000000000002 110.44 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.98 -37.47 87.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.091 -0.504 . . . . 73.329999999999998 112.209 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . 0.502 ' NE2' HD11 ' A' ' 384' ' ' ILE . 5.7 tp-100 -59.21 -47.65 84.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.446 -0.946 . . . . 74.409999999999997 108.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.01 -28.13 67.15 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.161 -0.927 . . . . 63.149999999999999 112.486 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 376' ' ' THR . 10.6 mpt_? -84.47 -8.81 58.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 111.051 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 88.81 16.78 57.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.212 -0.994 . . . . 73.129999999999995 113.232 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -80.2 156.12 27.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.108 0.48 . . . . 53.039999999999999 110.323 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 31.5 mmmt -90.32 132.9 35.31 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.614 -1.625 . . . . 72.420000000000002 106.614 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.502 HD11 ' NE2' ' A' ' 378' ' ' GLN . 0.2 OUTLIER -129.53 134.73 63.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 121.541 0.686 . . . . 71.510000000000005 112.086 -177.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -112.35 127.9 56.14 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.3 m -117.67 121.16 40.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.328 -0.619 . . . . 73.230000000000004 109.328 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.21 119.25 37.71 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.399 -1.704 . . . . 74.140000000000001 106.399 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -101.54 131.22 47.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.621 -0.881 . . . . 62.299999999999997 108.621 179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.9 122.06 15.11 Favored Pre-proline 0 C--N 1.287 -2.132 0 CA-C-N 116.277 -0.419 . . . . 54.210000000000001 111.775 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 425' ' ' GLU . 6.0 Cg_exo -81.41 132.4 7.99 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.959 1.772 . . . . 74.409999999999997 107.78 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 15.1 t70 -159.46 -162.26 1.02 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.548 -1.278 . . . . 64.409999999999997 107.548 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 67.3 m -145.14 1.58 0.97 Allowed 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 119.392 0.996 . . . . 64.109999999999999 112.789 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -131.12 22.12 4.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 122.609 1.195 . . . . 75.430000000000007 108.206 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 391' ' ' ASP . 1.9 pp -88.91 152.47 48.59 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 113.625 -1.625 . . . . 41.210000000000001 112.996 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.51 157.18 53.27 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.791 1.661 . . . . 41.420000000000002 109.236 170.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.11 160.54 41.34 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 122.294 1.996 . . . . 72.340000000000003 111.104 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.537 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.6 p30 -60.4 -9.69 3.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.517 0.675 . . . . 75.140000000000001 111.943 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -84.53 111.06 19.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.456 -2.424 . . . . 50.409999999999997 104.456 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.18 118.52 4.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 122.07 0.938 . . . . 75.0 112.704 -167.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.3 tp -98.1 -31.1 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 74.030000000000001 109.386 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.98 156.77 27.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 108.894 -1.682 . . . . 54.219999999999999 108.894 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 22.2 p -114.5 -175.72 2.75 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 123.307 0.643 . . . . 60.409999999999997 111.306 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -99.58 137.84 20.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 106.464 -1.68 . . . . 74.209999999999994 106.464 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -42.97 -30.75 1.98 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.418 3.412 . . . . 55.43 114.64 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -38.3 64.62 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.931 0.492 . . . . 74.340000000000003 111.432 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.99 -27.87 62.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.729 0.776 . . . . 74.0 111.153 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.23 -8.06 49.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 110.665 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.6 m -92.54 156.53 17.07 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.947 -0.761 . . . . 63.329999999999998 108.947 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.1 m -74.15 112.79 10.64 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.606 -1.257 . . . . 74.329999999999998 107.606 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.28 170.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.932 -0.576 . . . . 73.109999999999999 109.749 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -83.96 140.07 32.15 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.404 -1.332 . . . . 61.43 107.404 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.1 2.14 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.135 0.493 . . . . 75.030000000000001 110.184 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.29 21.38 6.61 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.596 -0.812 . . . . 63.25 111.751 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -85.94 -171.33 3.53 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.474 -1.306 . . . . 61.009999999999998 107.474 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.9 pt-20 -107.91 138.87 43.4 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 118.831 0.741 . . . . 72.439999999999998 111.895 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.6 122.68 67.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.743 -1.206 . . . . 53.329999999999998 107.743 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -96.19 119.39 34.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.039 0.923 . . . . 73.530000000000001 110.249 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.72 126.66 68.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.053 -0.976 . . . . 71.420000000000002 109.33 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.7 128.87 44.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.437 -0.949 . . . . 61.520000000000003 108.437 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 397' ' ' ASP . 78.0 t -121.73 130.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.382 -0.969 . . . . 73.030000000000001 108.382 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 122.91 37.99 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.776 -0.453 . . . . 75.129999999999995 109.776 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.5 t -117.16 105.28 12.08 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.84 0.829 . . . . 73.319999999999993 110.981 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 60.99 178.69 2.39 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.983 -1.008 . . . . 74.239999999999995 115.136 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 10.1 Cg_endo -90.82 131.93 1.58 Allowed 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.038 2.492 . . . . 73.230000000000004 111.757 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.4 tp10 -72.87 151.59 41.89 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.754 -0.462 . . . . 74.120000000000005 109.754 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.5 mt-30 -123.78 150.88 43.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.477 -0.783 . . . . 72.420000000000002 110.359 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 427' ' ' ARG . 26.1 tpt180 -150.33 153.95 36.98 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.403 -1.332 . . . . 74.230000000000004 107.403 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.55 138.88 34.13 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.348 -0.982 . . . . 73.200000000000003 108.348 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 71.4 mt -80.43 124.32 82.37 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.608 -0.886 . . . . 71.319999999999993 108.608 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.86 140.06 59.55 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.069 1.179 . . . . 65.0 110.697 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.72 82.12 2.76 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 122.232 1.015 . . . . 65.319999999999993 111.94 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.86 1.43 6.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.197 -1.779 . . . . 44.329999999999998 106.197 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.0 m -67.8 -53.49 26.61 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 113.094 -1.866 . . . . 73.420000000000002 110.301 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 24.5 p -64.73 -19.12 65.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.431 0.9 . . . . 73.319999999999993 113.431 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.95 -38.21 13.01 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.711 1.004 . . . . 63.039999999999999 113.711 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 90.4 m -157.32 135.08 10.75 Favored 'General case' 0 CA--C 1.554 1.11 0 O-C-N 121.911 -0.493 . . . . 71.319999999999993 110.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -65.09 -47.28 77.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.543 0.737 . . . . 75.450000000000003 112.671 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.51 87.47 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.515 0.674 . . . . 63.020000000000003 110.865 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.54 -40.6 95.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.75 -1.114 . . . . 63.149999999999999 108.813 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.83 -51.67 68.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.784 -1.098 . . . . 65.430000000000007 111.705 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.72 -38.55 82.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.515 0.931 . . . . 61.25 113.515 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -66.53 -50.71 62.29 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 119.113 -1.035 . . . . 70.409999999999997 110.144 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.313 85.4 mttt -68.62 -39.73 80.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 115.58 1.696 . . . . 72.230000000000004 115.58 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.64 -43.38 89.65 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.745 -0.382 . . . . 52.100000000000001 111.795 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.1 m -69.24 -38.28 78.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.824 -0.35 . . . . 71.329999999999998 111.853 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.1 71.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.698 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.08 59.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 72.439999999999998 111.034 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.39 -19.98 7.07 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.688 -0.767 . . . . 64.230000000000004 113.442 176.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -78.86 101.26 7.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.364 0.602 . . . . 74.120000000000005 111.0 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -119.99 17.47 9.96 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.013 -0.835 . . . . 73.430000000000007 111.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -107.57 111.16 23.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.791 -1.559 . . . . 74.510000000000005 106.791 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.39 160.25 34.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.145 0.794 . . . . 75.519999999999996 113.145 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 23.6 ttmm -151.91 127.39 10.02 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.715 -1.957 . . . . 73.329999999999998 105.715 170.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.72 134.92 39.38 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 120.67 0.271 . . . . 70.310000000000002 110.304 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.02 156.28 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.717 -0.475 . . . . 65.200000000000003 109.717 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.16 132.35 54.03 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.253 -0.647 . . . . 70.109999999999999 109.253 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.0 t -119.25 137.12 24.93 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.749 -0.834 . . . . 71.230000000000004 108.749 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.4 Cg_exo -61.56 119.78 7.08 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.061 1.841 . . . . 75.510000000000005 109.102 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.8 m -138.74 -178.46 5.32 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.066 -0.716 . . . . 71.0 109.066 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.8 m -58.95 131.44 86.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.361 -0.977 . . . . 75.150000000000006 108.361 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.9 -34.1 35.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.832 3.021 . . . . 73.310000000000002 114.538 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.71 -14.71 61.19 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 122.687 0.395 . . . . 72.319999999999993 112.006 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.39 7.58 45.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.769 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -59.49 125.93 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.781 0.8 . . . . 70.420000000000002 111.645 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.65 -5.01 79.86 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.882 -0.599 . . . . 70.109999999999999 112.427 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -102.77 145.59 29.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.093 -1.077 . . . . 74.340000000000003 108.093 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 54.4 t -83.89 129.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.721 -0.474 . . . . 75.010000000000005 109.721 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.94 -19.68 5.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.582 -0.447 . . . . 64.310000000000002 111.449 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.6 174.23 41.16 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.634 -0.986 . . . . 62.539999999999999 110.634 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -130.93 155.07 47.39 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.696 -0.853 . . . . 72.140000000000001 108.696 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -61.2 -53.43 63.22 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 120.795 -0.362 . . . . 65.040000000000006 110.854 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.1 Cg_exo -82.6 119.34 2.97 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 107.38 -1.815 . . . . 74.530000000000001 107.38 168.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.94 147.77 94.22 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.532 2.154 . . . . 72.519999999999996 113.848 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.65 2.92 20.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.473 -0.785 . . . . 74.329999999999998 112.524 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.7 -3.09 17.02 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.813 -0.554 . . . . 71.319999999999993 109.614 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -108.46 151.73 25.66 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.191 0.996 . . . . 73.310000000000002 112.201 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 426' ' ' GLN . 26.6 m -84.24 114.01 21.52 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.625 -1.625 . . . . 70.019999999999996 108.668 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.2 m -120.42 150.13 41.28 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.506 0.722 . . . . 74.329999999999998 109.424 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.07 147.22 45.2 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.4 -0.592 . . . . 73.099999999999994 109.4 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.9 mp -66.27 -11.68 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 122.246 1.022 . . . . 71.430000000000007 110.317 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 6.4 t -98.45 -0.66 43.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.279 -0.873 . . . . 51.32 109.379 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -78.61 142.19 37.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.63 -0.507 . . . . 64.25 109.63 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.05 113.52 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.263 -1.014 . . . . 35.409999999999997 108.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.0 t -87.81 118.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 108.606 -0.887 . . . . 72.510000000000005 108.606 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.4 mt -92.7 112.54 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 106.791 -1.559 . . . . 45.310000000000002 106.791 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -93.61 107.62 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 107.374 -1.343 . . . . 74.430000000000007 107.374 -177.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.4 113.99 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 115.11 -0.95 . . . . 72.239999999999995 110.123 -174.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.32 138.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 114.959 -1.018 . . . . 65.120000000000005 108.335 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.09 130.64 11.06 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 110.254 -1.139 . . . . 32.439999999999998 110.254 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 26.6 m -140.78 120.07 13.0 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.293 -0.632 . . . . 74.0 109.293 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 107.807 -2.117 . . . . 42.299999999999997 107.807 178.68 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 106.515 -1.661 . . . . 54.329999999999998 106.515 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.64 159.73 37.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 120.794 0.33 . . . . 74.109999999999999 111.132 -174.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -94.88 137.35 34.07 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.053 -1.091 . . . . 72.540000000000006 108.053 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.35 141.3 22.82 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.277 -0.638 . . . . 74.409999999999997 109.277 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.59 123.83 4.96 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 123.456 2.771 . . . . 71.319999999999993 113.699 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.536 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 21.5 t70 -74.59 134.84 42.08 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.218 -1.355 . . . . 61.030000000000001 108.838 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 35.0 m -91.41 29.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.732 1.012 . . . . 73.140000000000001 113.732 -169.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 364' ' ' ASP . 35.2 ptt-85 -65.73 127.05 30.38 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.159 -0.473 . . . . 72.310000000000002 110.916 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.58 57.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.276 -0.964 . . . . 44.350000000000001 114.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 2.0 pt20 -120.97 169.66 10.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 117.491 0.646 . . . . 74.120000000000005 110.724 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 98.8 p -80.46 173.96 12.08 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.713 -0.395 . . . . 54.439999999999998 111.475 -174.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.4 p -63.0 -33.87 76.35 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.275 -0.42 . . . . 54.140000000000001 110.617 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.547 -0.297 . . . . 54.119999999999997 110.505 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -62.03 -41.65 98.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.382 -0.372 . . . . 64.329999999999998 110.832 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.426 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -58.62 -51.54 69.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 71.109999999999999 110.602 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.43 -42.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 110.898 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.05 -46.06 92.22 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 112.036 0.384 . . . . 74.420000000000002 112.036 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.7 m -61.92 -47.92 82.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.297 . . . . 52.200000000000003 110.916 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.3 mm? -65.42 -38.38 89.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.379 -0.373 . . . . 73.030000000000001 111.66 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.88 -48.49 81.56 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.57 0.748 . . . . 70.340000000000003 109.442 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.43 -25.31 63.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 74.530000000000001 111.203 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -78.53 -15.29 58.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.97 -0.752 . . . . 75.409999999999997 108.97 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.17 56.88 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.357 -0.925 . . . . 73.319999999999993 111.829 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 22.6 m-85 -89.7 160.66 16.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.979 0.419 . . . . 75.239999999999995 110.613 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 53.8 mtmt -105.02 132.76 50.85 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.678 -1.23 . . . . 73.140000000000001 107.678 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 141.33 43.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.328 0.585 . . . . 64.420000000000002 112.373 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -118.49 136.64 53.7 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.046 -1.464 . . . . 74.109999999999999 107.046 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 m -99.64 125.33 45.46 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.752 -0.833 . . . . 71.310000000000002 108.752 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.82 120.33 41.61 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.584 -1.265 . . . . 61.32 107.584 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.13 121.88 31.89 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.288 -0.414 . . . . 65.439999999999998 109.911 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -123.77 125.23 25.98 Favored Pre-proline 0 C--N 1.312 -1.028 0 C-N-CA 119.564 -0.854 . . . . 63.539999999999999 110.208 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -89.11 147.11 5.46 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.735 2.29 . . . . 73.510000000000005 111.306 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.4 t70 177.13 -168.37 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.233 -1.766 . . . . 63.25 106.233 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 50.2 m -143.25 -1.29 1.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.585 0.63 . . . . 74.040000000000006 111.429 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.0 m -82.93 -10.65 58.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.099 -1.445 . . . . 74.340000000000003 107.099 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 421' ' ' SER . 11.2 pt -104.74 151.61 39.35 Favored Pre-proline 0 N--CA 1.427 -1.624 0 CA-C-N 114.042 -1.435 . . . . 71.439999999999998 109.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -86.25 -176.51 2.12 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.708 2.272 . . . . 63.409999999999997 111.521 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.65 163.32 3.95 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.515 2.81 . . . . 54.149999999999999 112.737 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.442 ' HB2' ' CG2' ' A' ' 420' ' ' VAL . 4.4 p-10 -55.87 -7.93 0.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.374 1.47 . . . . 63.25 114.33 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.5 m80 -63.51 115.4 4.63 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.087 -1.819 . . . . 70.219999999999999 106.087 174.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 365' ' ' VAL . 21.3 t -64.88 118.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.778 0.799 . . . . 53.030000000000001 110.499 -172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.69 -29.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.041 -0.981 . . . . 74.109999999999999 109.91 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -171.57 160.58 32.6 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.43 -1.068 . . . . 24.329999999999998 110.43 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 -174.54 2.48 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.695 -1.224 . . . . 72.409999999999997 107.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.36 144.3 27.85 Favored Pre-proline 0 C--N 1.279 -2.474 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.98 -29.05 1.41 Allowed 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 124.676 3.584 . . . . 61.509999999999998 114.413 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.09 68.58 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.543 0.337 . . . . 63.039999999999999 111.162 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.66 58.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 64.400000000000006 110.96 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.29 0.14 53.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.472 0.654 . . . . 75.140000000000001 110.943 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.1 m -92.79 157.3 16.49 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.66 -1.608 . . . . 61.329999999999998 106.66 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.26 112.39 10.37 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.054 -1.091 . . . . 53.240000000000002 108.054 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.51 169.4 18.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.202 -0.908 . . . . 71.530000000000001 109.334 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 18.0 m -74.33 133.79 42.54 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.661 -0.496 . . . . 61.229999999999997 109.661 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.69 134.89 54.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.309 -0.405 . . . . 71.030000000000001 110.405 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.29 24.22 32.11 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.879 -0.677 . . . . 63.43 112.499 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.56 179.76 4.74 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.867 -0.79 . . . . 65.25 108.867 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.4 mt-10 -94.21 123.7 37.77 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 111.996 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.07 126.27 74.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.643 -1.244 . . . . 43.420000000000002 107.643 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -90.49 118.77 30.22 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.477 -0.934 . . . . 71.239999999999995 108.477 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.53 113.18 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.189 -1.041 . . . . 70.140000000000001 108.189 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -88.51 129.85 35.36 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.49 -0.929 . . . . 74.349999999999994 108.49 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 397' ' ' ASP . 12.4 p -123.5 146.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.163 -1.051 . . . . 55.350000000000001 108.163 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.512 ' HB3' HD12 ' A' ' 394' ' ' ILE . 3.5 p -84.59 119.71 25.52 Favored 'General case' 0 N--CA 1.411 -2.418 0 C-N-CA 119.372 -0.931 . . . . 71.099999999999994 108.79 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.8 m -121.8 106.69 11.52 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.968 -0.56 . . . . 71.209999999999994 110.916 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 84.99 129.35 2.01 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.649 -0.786 . . . . 64.329999999999998 114.183 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 52.3 Cg_endo -76.37 133.04 14.18 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 121.735 1.623 . . . . 53.409999999999997 109.536 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.31 137.15 46.47 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.475 0.655 . . . . 51.119999999999997 112.35 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 38.4 mt-30 -120.37 140.85 50.7 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.872 -1.058 . . . . 75.230000000000004 108.48 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.41 145.41 51.2 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.59 -1.263 . . . . 72.430000000000007 107.59 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 14.8 pt-20 -83.7 138.99 33.04 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.905 -0.718 . . . . 73.5 109.082 177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 80.8 mt -80.3 124.29 82.62 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.017 -1.105 . . . . 55.009999999999998 108.017 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.89 141.94 41.8 Favored 'Trans proline' 0 C--O 1.252 1.193 0 C-N-CA 122.164 1.909 . . . . 62.439999999999998 112.677 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -78.22 77.08 4.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.217 1.008 . . . . 63.530000000000001 109.414 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.25 -7.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.131 -1.395 . . . . 73.409999999999997 110.281 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 3.3 p -68.94 -31.93 71.16 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.854 -0.612 . . . . 71.140000000000001 111.116 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 1.2 p -62.26 -24.59 67.35 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 125.285 1.434 . . . . 74.400000000000006 113.18 -177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.64 -47.75 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 75.129999999999995 112.037 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.0 t -177.21 153.04 0.92 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.827 -0.805 . . . . 74.230000000000004 108.827 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -58.37 -38.66 77.73 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.823 0.849 . . . . 72.310000000000002 111.276 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.46 -47.99 78.02 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.554 0.534 . . . . 63.439999999999998 111.115 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 34.6 mm-40 -70.33 -38.31 74.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 111.178 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.27 -46.35 88.76 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.613 0.571 . . . . 54.140000000000001 110.763 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.46 -47.6 80.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.633 -0.427 . . . . 71.230000000000004 110.699 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 31.9 mmmt -63.46 -47.1 83.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.163 0.431 . . . . 73.120000000000005 112.163 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.9 mmtt -63.6 -45.51 90.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 71.140000000000001 110.578 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.14 -32.48 72.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.61 0.596 . . . . 64.0 112.61 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.7 m -66.25 -38.74 88.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.558 -0.534 . . . . 75.0 109.558 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.64 67.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.953 -0.567 . . . . 72.519999999999996 110.628 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.29 -13.55 59.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 63.509999999999998 110.63 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.62 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 120.227 -0.987 . . . . 50.119999999999997 113.743 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.44 132.97 47.18 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 117.705 0.753 . . . . 63.350000000000001 110.917 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.98 16.04 4.76 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.592 -0.813 . . . . 71.430000000000007 112.395 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 32.3 mmt180 -125.43 111.96 15.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.513 -1.292 . . . . 72.420000000000002 107.513 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.91 152.21 49.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.085 0.469 . . . . 75.140000000000001 111.118 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -146.05 123.26 11.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.989 -1.486 . . . . 71.219999999999999 106.989 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -91.27 134.81 34.27 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.241 -0.584 . . . . 50.020000000000003 110.31 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -129.78 145.67 51.55 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.217 -1.031 . . . . 64.340000000000003 108.217 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -118.7 139.08 52.11 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.088 -0.708 . . . . 53.200000000000003 109.088 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.7 m -132.39 136.21 27.62 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.717 -0.475 . . . . 72.120000000000005 109.717 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.61 120.99 8.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.875 2.383 . . . . 72.439999999999998 112.184 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 43.9 m -124.85 172.51 9.29 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.71 -0.677 . . . . 74.329999999999998 110.098 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.8 p -67.29 151.09 97.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 O-C-N 123.794 0.684 . . . . 53.439999999999998 109.972 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.544 ' O ' HG12 ' A' ' 464' ' ' VAL . 71.8 Cg_exo -53.51 -27.18 39.53 Favored 'Trans proline' 0 CA--C 1.55 1.281 0 C-N-CA 122.839 2.36 . . . . 74.230000000000004 113.422 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.18 -23.89 54.73 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.73 -0.606 . . . . 74.530000000000001 112.226 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 37.4 tp -107.41 -9.39 16.01 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.069 0.461 . . . . 62.520000000000003 110.505 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.3 p -59.44 133.57 24.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.793 -0.639 . . . . 73.140000000000001 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.52 -14.09 59.41 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.613 -0.803 . . . . 64.030000000000001 112.168 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.75 158.04 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.382 0.61 . . . . 54.520000000000003 110.563 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 87.7 t -84.28 137.5 20.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.71 -1.589 . . . . 71.510000000000005 106.71 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.74 -13.79 8.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.342 -0.943 . . . . 74.319999999999993 110.563 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.88 -173.6 29.57 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 109.952 -1.259 . . . . 63.299999999999997 109.952 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.2 p -116.3 151.37 35.99 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.39 -1.337 . . . . 63.420000000000002 107.39 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -59.37 -51.46 81.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.732 -0.47 . . . . 75.310000000000002 109.732 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.01 133.94 22.47 Favored 'Trans proline' 0 C--N 1.378 2.086 0 N-CA-C 108.59 -1.35 . . . . 74.230000000000004 108.59 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.48 150.54 86.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.752 2.301 . . . . 72.239999999999995 114.534 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.31 8.49 38.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.311 1.053 . . . . 41.240000000000002 110.948 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -109.04 3.4 22.04 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.307 -0.871 . . . . 53.549999999999997 109.975 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -141.77 159.54 42.01 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-O 121.807 0.813 . . . . 73.099999999999994 111.591 -172.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -76.68 133.97 39.38 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.608 -1.633 . . . . 65.239999999999995 111.411 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 38.4 m -131.52 149.31 52.57 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.653 -1.24 . . . . 72.25 107.653 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -78.61 153.33 31.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.927 0.785 . . . . 73.140000000000001 111.683 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 47.4 mm -69.28 -8.23 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 122.163 0.982 . . . . 71.340000000000003 110.624 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 8.9 t -105.44 1.25 27.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.712 -0.676 . . . . 53.329999999999998 109.692 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 9.1 m120 -87.05 147.49 25.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.816 -0.809 . . . . 74.140000000000001 108.816 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.54 121.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.244 -1.021 . . . . 61.310000000000002 108.244 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.4 t -91.89 118.97 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.903 -0.777 . . . . 63.43 108.903 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.99 113.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.183 -1.414 . . . . 70.109999999999999 107.183 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.52 119.92 48.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.949 -1.13 . . . . 71.109999999999999 107.949 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 48.2 mt -103.23 114.96 44.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.434 0.635 . . . . 63.350000000000001 110.86 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.32 131.23 45.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.909 -0.775 . . . . 72.540000000000006 108.909 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.0 100.4 1.87 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.279 -1.129 . . . . 73.310000000000002 110.279 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 30.7 t -136.71 103.98 5.38 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.765 -0.828 . . . . 74.310000000000002 108.765 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.533 0 N-CA-C 108.471 -1.851 . . . . 72.040000000000006 108.471 176.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 121.23 0.538 . . . . 71.420000000000002 110.637 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.07 139.91 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.17 -0.923 . . . . 75.150000000000006 108.955 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.56 137.16 36.91 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.468 -1.679 . . . . 73.430000000000007 106.468 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 363' ' ' PRO . 14.8 p -96.99 124.26 50.42 Favored Pre-proline 0 C--N 1.294 -1.838 0 C-N-CA 119.757 -0.777 . . . . 63.219999999999999 111.446 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 362' ' ' VAL . 1.5 Cg_endo -44.87 146.31 2.46 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.814 3.676 . . . . 74.299999999999997 115.681 -175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -71.16 144.96 50.02 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.929 -1.032 . . . . 62.130000000000003 110.138 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -108.08 29.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.218 -1.401 . . . . 63.340000000000003 107.218 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -58.85 135.41 57.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.176 -1.375 . . . . 73.109999999999999 111.398 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 94.84 -15.35 63.57 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.97 -0.559 . . . . 65.230000000000004 112.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -107.19 175.26 5.56 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.588 -0.36 . . . . 73.319999999999993 110.724 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.6 p -75.57 158.12 32.93 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.825 0.345 . . . . 71.450000000000003 111.771 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 374' ' ' ILE . 44.6 t -63.25 -36.12 82.59 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.812 -0.81 . . . . 63.32 108.812 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.66 94.01 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 115.638 -0.71 . . . . 65.430000000000007 111.209 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.35 -41.38 98.55 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.127 -0.488 . . . . 73.510000000000005 109.89 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.43 83.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.461 -0.791 . . . . 63.399999999999999 110.934 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.36 -47.02 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.375 . . . . 54.219999999999999 110.301 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.95 79.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.969 -0.56 . . . . 43.229999999999997 111.855 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.7 m -62.72 -46.33 88.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.427 -0.352 . . . . 64.310000000000002 111.912 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -38.43 91.0 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.173 -0.211 . . . . 55.329999999999998 111.184 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.43 -47.2 86.38 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.922 0.889 . . . . 71.510000000000005 109.138 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.41 -20.16 62.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.129 -0.941 . . . . 73.310000000000002 111.706 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -86.79 -15.44 39.28 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.268 -0.641 . . . . 64.329999999999998 109.268 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.49 5.0 57.06 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.487 -0.863 . . . . 74.239999999999995 111.446 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -90.47 158.59 16.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.158 0.504 . . . . 74.319999999999993 110.479 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 22.6 mmtp -106.05 138.55 42.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.757 -1.571 . . . . 62.219999999999999 106.757 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.87 147.45 21.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 119.676 -0.81 . . . . 71.540000000000006 112.964 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 417' ' ' THR . 21.6 ttt180 -116.95 130.09 56.47 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.842 -1.54 . . . . 75.400000000000006 106.842 174.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.7 p -98.6 117.73 33.7 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 119.978 -0.689 . . . . 74.030000000000001 109.415 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -114.74 119.78 37.84 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.341 -1.355 . . . . 74.030000000000001 107.341 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.81 126.14 55.11 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.722 -0.844 . . . . 74.420000000000002 108.722 176.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -122.42 133.65 24.5 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 120.257 -0.577 . . . . 73.109999999999999 111.033 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.19 140.32 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.091 2.527 . . . . 65.409999999999997 110.708 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.4 t70 179.75 -166.48 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.575 -1.269 . . . . 73.299999999999997 107.575 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 70.9 m -119.66 -11.15 9.46 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.422 0.63 . . . . 71.519999999999996 109.592 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -95.25 27.03 3.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.425 1.107 . . . . 73.450000000000003 108.234 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.4 pp -97.4 141.03 22.4 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 115.254 -0.884 . . . . 61.329999999999998 113.375 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.91 -179.99 4.4 Favored 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 123.239 2.626 . . . . 74.340000000000003 110.794 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.65 163.08 9.44 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.522 2.815 . . . . 72.019999999999996 112.563 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.14 -8.79 0.75 Allowed 'General case' 0 N--CA 1.522 3.149 0 C-N-CA 124.441 1.096 . . . . 71.530000000000001 112.25 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -83.75 157.12 22.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.657 -0.868 . . . . 74.150000000000006 108.657 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.26 116.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 N-CA-C 105.414 -2.069 . . . . 64.430000000000007 105.414 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.8 tt -89.99 -29.22 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 122.342 1.068 . . . . 72.430000000000007 109.036 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.57 170.59 38.18 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 104.623 -3.391 . . . . 54.210000000000001 104.623 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -176.26 2.87 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 107.249 -1.389 . . . . 74.519999999999996 107.249 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.78 145.7 30.59 Favored Pre-proline 0 C--N 1.253 -3.623 0 N-CA-C 107.93 -1.137 . . . . 74.420000000000002 107.93 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.04 -36.03 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.879 3.719 . . . . 41.049999999999997 114.047 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.63 -37.07 65.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.127 0.571 . . . . 64.030000000000001 111.701 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.64 -28.98 30.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 110.496 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -83.73 -8.02 59.35 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.203 -0.908 . . . . 73.140000000000001 110.754 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 59.1 m -91.58 140.59 29.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.571 -1.27 . . . . 64.150000000000006 107.571 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 36.4 m -76.73 112.49 13.36 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.359 -0.978 . . . . 71.329999999999998 108.359 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.25 169.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.138 -0.937 . . . . 74.019999999999996 109.828 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 m -65.65 152.96 42.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.458 -0.942 . . . . 73.109999999999999 108.458 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.02 109.16 0.89 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.141 0.496 . . . . 75.129999999999995 111.293 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.16 1.27 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 115.596 -0.729 . . . . 73.530000000000001 111.78 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -134.96 -169.53 2.38 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.352 -1.721 . . . . 73.430000000000007 106.352 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 12.4 pt-20 -95.04 132.9 39.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.989 0.813 . . . . 74.329999999999998 111.617 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.97 119.4 61.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.576 -1.268 . . . . 72.439999999999998 107.576 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 385' ' ' ARG . 40.2 p -87.31 119.19 27.31 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.333 0.587 . . . . 73.230000000000004 109.849 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.99 121.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.161 -1.422 . . . . 75.340000000000003 107.161 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 7.9 p30 -107.95 125.78 51.91 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.446 0.641 . . . . 62.43 111.891 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 11.3 p -120.28 151.47 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.908 -1.042 . . . . 63.420000000000002 108.41 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.2 p -91.55 123.49 35.0 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 111.862 0.319 . . . . 64.310000000000002 111.862 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.9 t -119.04 106.13 12.11 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.806 -0.758 . . . . 75.530000000000001 111.667 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 66.29 161.23 0.98 Allowed Glycine 0 CA--C 1.552 2.401 0 N-CA-C 115.912 1.125 . . . . 71.420000000000002 115.912 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.2 Cg_endo -94.36 139.71 1.24 Allowed 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 122.708 2.272 . . . . 63.399999999999999 112.311 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 8.0 mm-40 -78.61 142.26 37.4 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.094 0.473 . . . . 73.129999999999995 111.735 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.6 mt-30 -122.54 147.14 46.73 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.243 -0.89 . . . . 72.010000000000005 108.636 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -135.44 163.73 29.39 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.523 -0.917 . . . . 73.439999999999998 108.523 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.63 135.7 33.86 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.856 -0.338 . . . . 74.230000000000004 110.592 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -80.83 119.29 75.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.068 -0.716 . . . . 61.450000000000003 109.068 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 444' ' ' LEU . 70.6 Cg_exo -56.05 141.17 87.12 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.94 2.427 . . . . 72.049999999999997 112.16 176.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -88.01 10.77 17.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 62.130000000000003 111.526 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.21 -5.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.275 0.559 . . . . 63.210000000000001 110.279 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -58.86 -40.71 85.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.01 -0.996 . . . . 75.409999999999997 110.932 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.493 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 0.6 OUTLIER -68.58 -16.95 64.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.812 0.845 . . . . 72.420000000000002 112.381 -179.003 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.26 -34.91 14.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.801 -0.636 . . . . 73.340000000000003 111.75 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 83.9 m -153.85 133.2 12.73 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.953 -0.467 . . . . 70.549999999999997 110.645 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.99 -41.63 97.44 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.074 0.55 . . . . 64.200000000000003 110.365 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 65.129999999999995 110.626 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.66 -40.83 97.82 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.948 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.67 -51.15 70.61 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 123.56 0.538 . . . . 72.329999999999998 110.217 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.33 -50.36 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.481 -0.488 . . . . 32.240000000000002 112.033 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.94 -47.97 67.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.625 0.602 . . . . 73.140000000000001 112.625 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -67.14 -38.49 85.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.011 0.374 . . . . 71.140000000000001 112.011 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.2 mp -67.89 -36.15 79.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.599 -0.44 . . . . 51.409999999999997 111.271 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.0 m -64.91 -39.2 93.16 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.309 -0.626 . . . . 73.540000000000006 109.309 176.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.57 71.07 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.97 -0.559 . . . . 72.299999999999997 110.788 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.47 -13.18 59.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 61.32 110.666 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.48 -20.63 8.29 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.425 -0.893 . . . . 42.200000000000003 113.561 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 445' ' ' THR . 98.1 m-85 -66.86 135.32 53.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 117.485 0.642 . . . . 63.310000000000002 111.369 -175.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.55 12.22 4.59 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 110.926 -0.87 . . . . 64.120000000000005 110.926 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -114.48 111.45 21.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.453 -1.314 . . . . 74.430000000000007 107.453 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.7 152.12 50.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.659 0.266 . . . . 74.209999999999994 110.72 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.45 124.22 14.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.151 -1.055 . . . . 64.019999999999996 108.151 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.93 127.11 33.63 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 110.188 -0.301 . . . . 72.129999999999995 110.188 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.61 158.12 44.02 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.612 -0.884 . . . . 62.439999999999998 108.612 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -125.14 150.31 47.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.794 0.331 . . . . 70.420000000000002 110.593 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 30.6 t -137.48 133.19 17.97 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 107.88 -1.156 . . . . 65.25 107.88 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.04 127.6 21.75 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.514 2.143 . . . . 71.120000000000005 109.599 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.6 m -148.26 174.74 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 122.118 -0.364 . . . . 71.129999999999995 111.277 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 463' ' ' LEU . 3.3 m -56.31 132.36 75.89 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.703 0.801 . . . . 62.0 110.102 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.523 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -48.79 -31.73 20.33 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.056 3.171 . . . . 52.210000000000001 114.861 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -18.55 65.41 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.24 0.543 . . . . 74.400000000000006 111.264 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 6.6 mp -106.93 6.04 28.85 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.074 -0.512 . . . . 75.319999999999993 111.508 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.6 p -60.41 126.98 19.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.258 0.552 . . . . 64.530000000000001 110.989 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.81 0.36 83.79 Favored Glycine 0 C--N 1.309 -0.94 0 CA-C-N 115.83 -0.623 . . . . 62.140000000000001 111.934 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 89.0 mttt -112.52 159.14 19.1 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.921 -1.14 . . . . 73.209999999999994 107.921 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 57.3 t -83.99 132.71 30.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.564 -0.532 . . . . 74.329999999999998 109.564 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -98.59 -16.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.222 -0.591 . . . . 70.319999999999993 111.402 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.81 174.08 37.79 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.653 -0.703 . . . . 35.420000000000002 111.704 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.7 p -124.06 149.69 45.83 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.444 -0.947 . . . . 54.119999999999997 108.444 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.6 t-20 -62.48 -51.96 69.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 120.561 -0.456 . . . . 74.019999999999996 110.921 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 11.2 Cg_exo -73.62 133.84 19.42 Favored 'Trans proline' 0 C--N 1.377 2.059 0 N-CA-C 108.304 -1.46 . . . . 73.319999999999993 108.304 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 475' ' ' ASN . 40.4 Cg_endo -65.35 130.73 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.377 2.052 . . . . 75.329999999999998 113.216 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.58 17.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.531 1.157 . . . . 44.310000000000002 109.714 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 473' ' ' PRO . 11.4 m120 -108.6 -10.11 15.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.383 -1.281 . . . . 73.439999999999998 108.462 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -140.82 164.83 29.18 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-O 121.734 0.778 . . . . 63.340000000000003 111.368 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.7 m -84.45 124.89 31.84 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.182 -1.372 . . . . 64.420000000000002 109.431 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.2 m -125.62 149.46 48.38 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.373 -0.603 . . . . 75.310000000000002 109.373 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.66 146.74 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.537 0.208 . . . . 63.130000000000003 111.156 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.58 -22.09 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 121.755 0.788 . . . . 73.140000000000001 110.9 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 11.1 t -87.71 0.89 55.1 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.509 -0.768 . . . . 74.409999999999997 110.294 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.01 131.11 34.51 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.389 -0.967 . . . . 64.540000000000006 108.389 177.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.46 119.06 28.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.66 -0.867 . . . . 75.209999999999994 108.66 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.15 118.22 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.49 0 N-CA-C 108.115 -1.069 . . . . 72.030000000000001 108.115 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.83 112.75 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 106.341 -1.725 . . . . 75.420000000000002 106.341 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.89 119.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 108.54 -0.911 . . . . 74.25 108.54 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 23.2 mt -101.18 109.3 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 108.94 -0.763 . . . . 73.430000000000007 108.94 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 36.3 t -97.92 137.77 24.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.462 -0.79 . . . . 73.450000000000003 109.958 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -74.84 95.76 0.92 Allowed Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.488 -0.778 . . . . 61.009999999999998 111.212 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 38.1 m -142.88 112.84 7.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.775 -0.824 . . . . 74.530000000000001 108.775 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.012 0 N-CA-C 110.75 -0.94 . . . . 51.219999999999999 110.75 179.254 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 121.596 0.712 . . . . 75.530000000000001 111.963 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.02 144.01 35.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.844 -1.071 . . . . 73.430000000000007 108.9 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.42 137.43 35.5 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.402 -1.703 . . . . 65.219999999999999 106.402 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.7 p -98.14 127.31 37.09 Favored Pre-proline 0 C--N 1.29 -1.989 0 C-N-CA 119.097 -1.041 . . . . 51.200000000000003 110.004 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.68 143.53 79.36 Favored 'Trans proline' 0 C--O 1.244 0.789 0 C-N-CA 123.031 2.487 . . . . 73.0 112.7 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -68.95 127.01 31.62 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.599 -0.728 . . . . 73.400000000000006 110.0 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 26.7 m -81.83 5.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.911 -0.586 . . . . 63.109999999999999 112.11 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -61.1 142.97 56.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.912 -0.585 . . . . 70.430000000000007 111.761 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.31 -9.78 53.92 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.884 -0.598 . . . . 54.32 111.868 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -119.38 -173.69 2.57 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.354 -0.61 . . . . 65.140000000000001 109.354 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 94.7 p -86.98 162.16 17.81 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 119.637 -0.825 . . . . 73.230000000000004 109.317 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.452 ' O ' HG13 ' A' ' 374' ' ' ILE . 74.1 p -61.93 -33.23 73.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.986 0.422 . . . . 63.140000000000001 110.065 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.67 97.45 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.878 -0.601 . . . . 73.310000000000002 110.862 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -62.31 -42.7 99.58 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 109.817 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.42 77.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.89 -1.05 . . . . 64.129999999999995 110.734 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.6 -47.26 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 75.329999999999998 110.477 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.44 78.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.271 -0.422 . . . . 73.319999999999993 111.937 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.7 m -61.55 -48.59 80.31 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.137 0.494 . . . . 70.129999999999995 110.635 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 74.6 mt -65.74 -38.19 88.46 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 62.43 111.739 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -61.05 -43.53 98.74 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.565 -0.531 . . . . 75.219999999999999 109.565 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.67 77.75 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.031 0.443 . . . . 62.109999999999999 111.017 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -78.27 -15.12 59.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.126 -0.488 . . . . 70.219999999999999 111.233 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.99 16.47 41.27 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.595 -1.288 . . . . 52.32 112.269 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.12 152.2 18.93 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.237 -0.653 . . . . 74.120000000000005 109.237 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 35.0 mmtp -94.31 141.2 28.84 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.529 -0.915 . . . . 73.120000000000005 108.529 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 133.96 67.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.331 0.586 . . . . 51.200000000000003 111.607 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -110.51 130.85 55.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.79 -1.189 . . . . 64.120000000000005 107.79 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 p -98.9 119.29 37.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 120.429 -0.509 . . . . 73.239999999999995 109.884 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.6 tt -111.43 119.13 37.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.459 -1.682 . . . . 63.140000000000001 106.459 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.586 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -106.36 122.57 46.52 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.325 0.583 . . . . 75.519999999999996 110.324 -177.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.03 131.31 24.44 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.326 -0.852 . . . . 63.409999999999997 111.119 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -91.12 130.73 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.916 2.411 . . . . 73.150000000000006 111.34 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 174.95 -170.36 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.733 -1.58 . . . . 74.310000000000002 106.733 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.1 m -113.36 -27.94 7.76 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.439 -1.319 . . . . 75.530000000000001 107.439 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 m -91.72 58.82 3.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.982 -1.488 . . . . 74.549999999999997 106.982 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 391' ' ' ASP . 1.5 pp -115.9 151.58 46.58 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 114.009 -1.45 . . . . 44.439999999999998 113.005 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 394' ' ' ILE . 7.3 Cg_exo -74.9 119.53 5.71 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.217 1.945 . . . . 64.329999999999998 108.267 169.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.55 161.88 16.49 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 C-N-CA 123.386 2.724 . . . . 71.409999999999997 113.165 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.64 -8.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.947 0.899 . . . . 74.530000000000001 112.119 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 45.1 m170 -106.18 109.49 21.44 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 104.202 -2.518 . . . . 55.030000000000001 104.202 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.76 118.0 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 122.045 0.926 . . . . 61.399999999999999 111.986 -170.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -96.29 -27.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.776 -1.102 . . . . 72.129999999999995 112.105 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -146.65 156.96 27.24 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 110.257 -1.137 . . . . 73.120000000000005 110.257 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.4 p -125.37 -178.58 4.27 Favored 'General case' 0 C--N 1.275 -2.645 0 C-N-CA 122.989 0.516 . . . . 73.109999999999999 109.799 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.95 133.57 20.96 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.509 -1.293 . . . . 63.229999999999997 107.509 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.15 -17.94 9.19 Favored 'Trans proline' 0 C--O 1.26 1.585 0 C-N-CA 123.875 3.05 . . . . 65.510000000000005 115.194 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.84 64.27 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 122.115 -0.365 . . . . 71.310000000000002 110.744 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.71 65.36 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 121.038 0.447 . . . . 53.399999999999999 110.836 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -13.39 60.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.082 0.468 . . . . 75.239999999999995 110.957 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 61.2 m -73.33 138.06 45.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.94 113.3 12.09 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.417 0.627 . . . . 64.109999999999999 110.066 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.36 170.08 8.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.169 -0.923 . . . . 65.140000000000001 109.56 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 27.6 m -70.12 132.35 45.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.021 -0.733 . . . . 34.140000000000001 109.021 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -51.91 113.99 1.17 Allowed 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.862 0.726 . . . . 61.210000000000001 112.301 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.04 57.87 1.28 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.816 -0.629 . . . . 63.039999999999999 112.675 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -114.31 -166.79 1.13 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.868 -1.531 . . . . 73.120000000000005 106.868 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.8 pt-20 -113.08 134.59 54.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 119.327 0.967 . . . . 75.209999999999994 112.596 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.95 135.9 54.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.29 -1.004 . . . . 73.329999999999998 108.29 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -94.73 125.96 39.72 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.401 0.62 . . . . 60.210000000000001 109.615 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.36 116.33 47.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.82 -1.178 . . . . 73.349999999999994 107.82 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.86 128.0 35.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.097 -0.705 . . . . 71.5 109.097 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.48 145.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.295 -0.411 . . . . 71.010000000000005 110.054 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 24.1 p -84.9 123.72 30.81 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.066 0.547 . . . . 63.450000000000003 112.117 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.8 t -118.38 106.58 12.88 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 120.022 -0.671 . . . . 54.409999999999997 109.352 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.0 109.5 0.05 OUTLIER Glycine 0 C--O 1.262 1.893 0 N-CA-C 115.028 0.771 . . . . 33.420000000000002 115.028 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 30.1 Cg_exo -64.75 127.69 19.31 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.3 1.333 . . . . 62.43 109.53 172.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 6.9 mm-40 -73.38 131.55 42.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 113.255 0.835 . . . . 74.340000000000003 113.255 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.5 mt-30 -123.22 133.72 54.19 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 106.891 -1.522 . . . . 72.319999999999993 106.891 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.676 -0.861 . . . . 55.5 108.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -83.43 138.21 33.57 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.782 -0.645 . . . . 72.329999999999998 109.311 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.3 mt -89.9 125.11 61.84 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.886 -0.413 . . . . 61.340000000000003 109.886 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HB2' HG12 ' A' ' 432' ' ' VAL . 48.7 Cg_endo -69.7 141.79 46.41 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.355 2.037 . . . . 72.120000000000005 112.745 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.22 6.87 30.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.104 -0.498 . . . . 73.150000000000006 111.676 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 430' ' ' PRO . 10.3 p -76.89 -14.3 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.679 0.752 . . . . 62.140000000000001 109.673 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.9 m -53.21 -37.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.785 1.234 . . . . 61.119999999999997 112.754 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.553 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 4.3 p -69.54 -14.16 62.71 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 113.84 1.052 . . . . 73.409999999999997 113.84 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.75 -38.26 17.09 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 122.136 -0.352 . . . . 71.010000000000005 111.877 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 73.8 m -153.83 131.72 11.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.769 -0.456 . . . . 60.299999999999997 109.769 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -62.09 -43.52 98.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.094 0.557 . . . . 72.230000000000004 112.048 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.2 83.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.212 0.53 . . . . 50.329999999999998 110.374 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.26 -44.38 95.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.888 -1.051 . . . . 73.400000000000006 109.51 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.18 66.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 74.239999999999995 111.524 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.24 -38.86 81.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.668 0.618 . . . . 62.43 112.668 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -67.54 -46.71 72.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.508 -0.477 . . . . 70.219999999999999 111.071 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -64.83 -40.72 95.64 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 112.364 0.505 . . . . 61.200000000000003 112.364 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.5 mp -65.85 -41.4 91.74 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.583 -0.447 . . . . 72.420000000000002 111.498 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.7 m -62.09 -43.36 98.99 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.801 -0.444 . . . . 54.299999999999997 109.801 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.15 -16.87 62.56 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.095 -0.502 . . . . 70.409999999999997 111.757 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -89.73 -7.19 55.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.106 0.479 . . . . 45.119999999999997 110.363 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 110.9 -8.73 29.6 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.1 -0.571 . . . . 55.420000000000002 112.851 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -85.01 92.7 8.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.262 0.553 . . . . 73.530000000000001 110.151 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -100.16 -2.03 55.85 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.462 -1.055 . . . . 42.340000000000003 110.462 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -94.97 110.78 22.64 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.48 -0.933 . . . . 75.329999999999998 108.48 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -123.46 157.69 32.92 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.623 0.725 . . . . 74.140000000000001 111.477 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 485' ' ' ILE . 59.1 tptt -149.54 131.41 15.14 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 103.934 -2.617 . . . . 72.219999999999999 103.934 173.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -111.0 135.07 52.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.961 -0.695 . . . . 73.310000000000002 111.394 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.36 135.69 37.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.802 -0.814 . . . . 75.540000000000006 108.802 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.9 129.21 56.66 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.399 -1.334 . . . . 75.340000000000003 107.399 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 45.3 p -121.11 150.32 53.31 Favored Pre-proline 0 C--N 1.284 -2.267 0 C-N-CA 120.597 -0.441 . . . . 64.239999999999995 110.503 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.9 Cg_exo -61.58 120.61 8.34 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.207 1.938 . . . . 54.520000000000003 110.431 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.9 t -127.38 -178.53 4.49 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.472 -1.677 . . . . 72.319999999999993 106.472 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 m -74.05 142.54 79.44 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 107.844 -1.169 . . . . 74.200000000000003 107.844 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 99.1 Cg_exo -49.67 -23.29 7.89 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.593 2.862 . . . . 61.130000000000003 113.931 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.92 -11.82 60.04 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.227 0.536 . . . . 65.109999999999999 112.118 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.4 3.12 15.7 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.923 -0.486 . . . . 74.209999999999994 111.641 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.9 p -59.92 127.45 19.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.326 0.584 . . . . 71.340000000000003 111.662 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.88 -15.6 63.04 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 120.769 -0.729 . . . . 52.109999999999999 112.176 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -100.66 149.59 23.62 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.112 -0.699 . . . . 74.349999999999994 109.112 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 91.5 t -76.93 130.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.708 -1.219 . . . . 62.109999999999999 107.708 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.04 -22.6 4.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.939 -0.704 . . . . 72.450000000000003 111.949 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.49 -177.58 45.79 Favored Glycine 0 N--CA 1.423 -2.177 0 C-N-CA 120.778 -0.725 . . . . 51.240000000000002 111.373 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 486' ' ' ILE . 6.7 p -136.01 154.88 50.93 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.449 -0.945 . . . . 72.420000000000002 108.449 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.531 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.5 t-20 -56.97 -51.85 78.54 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-O 119.151 -0.452 . . . . 75.120000000000005 111.435 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.6 Cg_endo -86.34 119.01 1.68 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 N-CA-C 107.15 -1.904 . . . . 74.120000000000005 107.15 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.47 162.21 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.197 1.932 . . . . 61.350000000000001 113.704 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.39 4.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.135 0.969 . . . . 53.329999999999998 111.104 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.86 -0.55 19.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.103 -0.953 . . . . 42.240000000000002 109.3 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -108.07 153.4 23.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.905 0.859 . . . . 64.420000000000002 112.031 -174.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.1 m -112.09 93.66 4.56 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.655 -1.611 . . . . 74.109999999999999 107.358 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -100.91 148.58 24.83 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.23 -0.441 . . . . 61.329999999999998 111.278 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.16 152.83 36.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.995 0.426 . . . . 34.420000000000002 111.48 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 448' ' ' GLY . 1.7 mp -63.83 -21.41 28.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.641 0.734 . . . . 72.25 111.429 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.82 1.2 56.44 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.102 -0.499 . . . . 63.109999999999999 111.808 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.99 140.24 30.48 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.819 -0.438 . . . . 71.420000000000002 109.819 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 36.6 t -85.21 123.19 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.73 -0.668 . . . . 71.430000000000007 109.415 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.85 119.81 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 108.526 -0.916 . . . . 72.25 108.526 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 1.7 mp -91.89 112.76 26.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.652 -1.981 . . . . 72.019999999999996 105.652 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -92.75 119.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.591 -1.263 . . . . 60.520000000000003 107.591 -177.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 38.8 mt -106.1 116.32 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.702 0.763 . . . . 72.239999999999995 110.57 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.13 142.85 13.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.502 -0.772 . . . . 70.230000000000004 108.959 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.63 117.53 4.59 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 111.183 -0.767 . . . . 62.509999999999998 111.183 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.4 m -116.34 106.99 14.26 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.163 -0.68 . . . . 75.450000000000003 109.163 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.086 0 N-CA-C 109.981 -1.248 . . . . 70.420000000000002 109.981 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.432 -1.337 0 CA-C-O 120.928 0.394 . . . . 74.129999999999995 110.4 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.71 152.11 13.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 123.917 0.887 . . . . 62.219999999999999 108.987 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.92 136.32 36.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.873 -1.899 . . . . 65.510000000000005 105.873 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.5 127.01 32.53 Favored Pre-proline 0 C--N 1.284 -2.272 0 C-N-CA 119.89 -0.724 . . . . 71.010000000000005 111.122 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.36 133.71 57.51 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.986 2.457 . . . . 71.510000000000005 112.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -59.44 134.49 57.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.012 -0.995 . . . . 75.329999999999998 111.168 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 5.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.377 -0.829 . . . . 72.409999999999997 112.476 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.5 ptt-85 -65.69 137.72 57.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.657 -0.868 . . . . 74.209999999999994 108.657 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.37 0.37 50.39 Favored Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.687 -0.965 . . . . 53.420000000000002 110.687 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 48.9 mt-30 -130.15 176.76 7.83 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.483 -0.932 . . . . 60.409999999999997 108.483 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 88.4 p -87.94 167.8 13.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.736 -0.839 . . . . 75.030000000000001 108.736 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -61.29 -34.22 74.86 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.993 0.425 . . . . 73.420000000000002 110.346 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.06 -44.84 87.68 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.704 -0.68 . . . . 70.200000000000003 110.407 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 48.8 m-20 -60.03 -44.98 94.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.528 -0.545 . . . . 64.409999999999997 109.528 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.08 67.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.226 -0.897 . . . . 73.219999999999999 111.018 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.5 -44.33 92.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.169 -0.469 . . . . 72.349999999999994 110.888 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.08 77.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.147 -0.479 . . . . 61.340000000000003 111.645 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.601 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 36.7 m -64.08 -47.52 79.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.547 -0.297 . . . . 73.299999999999997 111.199 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.13 -39.46 93.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.768 0.285 . . . . 72.430000000000007 111.768 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -60.04 -45.35 93.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.1 -0.704 . . . . 74.239999999999995 109.1 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -69.58 -27.65 65.29 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.169 -0.923 . . . . 75.329999999999998 112.025 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.601 ' HD3' ' O ' ' A' ' 376' ' ' THR . 8.5 mpt_? -85.62 -8.22 58.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.678 0.275 . . . . 71.430000000000007 110.999 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.27 14.35 54.21 Favored Glycine 0 CA--C 1.505 -0.594 0 C-N-CA 120.287 -0.959 . . . . 72.010000000000005 112.753 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -94.14 154.06 17.78 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.048 -0.723 . . . . 64.140000000000001 109.048 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.0 mmtp -104.79 133.6 49.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.263 -1.014 . . . . 62.310000000000002 108.263 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -117.82 144.86 24.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-O 121.524 0.678 . . . . 74.530000000000001 111.905 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -110.9 127.75 55.56 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 107.093 -1.447 . . . . 72.349999999999994 107.093 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.4 m -99.58 120.0 38.97 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.505 -1.665 . . . . 75.409999999999997 106.505 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.93 118.72 34.26 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.426 -1.324 . . . . 52.450000000000003 107.426 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.44 121.57 36.12 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.278 -1.378 . . . . 74.0 107.278 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.36 127.73 25.75 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 111.856 0.317 . . . . 70.420000000000002 111.856 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -87.99 131.59 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.522 2.148 . . . . 60.32 110.731 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.4 t70 174.06 -164.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.716 -1.587 . . . . 70.420000000000002 106.716 -178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 50.1 m -142.34 -0.53 1.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.343 0.657 . . . . 64.299999999999997 110.481 173.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -105.7 25.19 11.11 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 106.571 -1.64 . . . . 74.329999999999998 106.571 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 15.8 pt -115.13 151.41 45.66 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 113.708 -1.587 . . . . 72.549999999999997 110.212 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 63.2 Cg_endo -74.45 147.58 36.72 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.035 1.823 . . . . 75.129999999999995 111.465 176.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 54.0 Cg_exo -56.47 163.9 6.17 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.408 3.406 . . . . 73.109999999999999 112.288 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -56.28 -8.56 0.52 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 123.315 0.646 . . . . 73.140000000000001 112.006 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.1 m170 -91.63 113.37 25.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.213 -2.514 . . . . 74.530000000000001 104.213 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.18 118.32 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.358 0.599 . . . . 63.210000000000001 111.047 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.78 -29.49 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.206 -0.907 . . . . 74.340000000000003 109.049 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.18 157.12 27.28 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 110.432 -1.067 . . . . 71.140000000000001 110.432 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -126.03 -179.44 4.71 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 123.545 0.738 . . . . 52.350000000000001 110.418 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.33 140.29 21.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 61.299999999999997 108.639 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.39 -26.02 0.89 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 124.948 3.766 . . . . 62.43 115.53 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.34 -24.9 61.13 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 112.045 0.387 . . . . 74.450000000000003 112.045 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.74 69.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.475 0.655 . . . . 74.319999999999993 110.357 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -78.26 -11.99 59.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.59 -0.732 . . . . 63.219999999999999 111.65 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -78.82 137.46 37.71 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.063 -1.458 . . . . 70.409999999999997 107.063 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 m -82.54 112.27 19.3 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 71.409999999999997 107.712 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.6 167.42 18.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.566 -1.272 . . . . 74.329999999999998 107.566 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.2 p -61.01 147.66 42.83 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 123.46 0.704 . . . . 60.509999999999998 111.345 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.8 116.66 3.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.002 -0.544 . . . . 63.229999999999997 111.513 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.95 51.48 2.26 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.793 -0.64 . . . . 73.439999999999998 113.053 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.71 -170.14 1.69 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.803 -1.184 . . . . 74.329999999999998 107.803 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -99.05 135.27 40.7 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.494 0.664 . . . . 73.209999999999994 112.577 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.9 mm -125.17 138.76 53.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 124.796 1.239 . . . . 73.430000000000007 108.159 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 12.3 t -99.82 131.89 45.51 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.77 0.795 . . . . 65.099999999999994 111.701 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.3 t -108.15 120.71 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.459 -1.312 . . . . 73.519999999999996 107.459 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.74 129.04 41.83 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.341 -0.39 . . . . 74.5 111.458 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.75 131.3 73.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.835 -1.172 . . . . 64.120000000000005 107.835 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 49.6 p -85.96 121.85 29.18 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.099 -0.704 . . . . 72.409999999999997 109.099 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -119.45 106.7 12.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.197 -0.601 . . . . 73.150000000000006 111.1 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 71.03 125.89 0.06 OUTLIER Glycine 0 CA--C 1.544 1.874 0 N-CA-C 114.801 0.681 . . . . 65.019999999999996 114.801 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.1 Cg_exo -70.52 128.2 15.01 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.255 1.303 . . . . 64.400000000000006 109.44 173.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 15.2 mm-40 -72.3 144.78 48.21 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 112.463 0.542 . . . . 63.340000000000003 112.463 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.4 mt-30 -116.01 149.01 39.54 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.811 -1.086 . . . . 63.119999999999997 108.562 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -136.78 144.87 43.98 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.523 -0.917 . . . . 70.400000000000006 108.523 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 37.1 tt0 -81.74 119.25 23.62 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.122 -1.807 . . . . 71.040000000000006 106.122 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 62.1 mt -80.88 127.83 73.52 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.471 -0.937 . . . . 74.510000000000005 108.471 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 141.79 38.89 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.928 1.752 . . . . 62.009999999999998 110.627 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.84 73.89 10.28 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.373 1.083 . . . . 72.150000000000006 108.269 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.19 -4.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 113.668 -1.605 . . . . 74.129999999999995 107.34 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.609 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.7 m -67.13 -38.88 86.32 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 113.583 -1.644 . . . . 44.229999999999997 111.767 -176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 16.3 p -69.84 -16.75 63.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 112.86 0.689 . . . . 54.399999999999999 112.86 -169.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.28 -48.99 11.29 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.545 -0.752 . . . . 61.229999999999997 111.656 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.2 m -157.59 130.19 7.39 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.03 -0.419 . . . . 63.43 110.116 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -55.88 -47.07 78.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.477 0.711 . . . . 72.409999999999997 112.218 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.76 84.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 111.306 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 35.4 mm-40 -67.5 -38.95 85.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 111.214 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.4 -50.85 72.37 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.614 0.572 . . . . 62.119999999999997 111.043 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.3 -45.34 98.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.516 -0.765 . . . . 75.209999999999994 110.624 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.11 -40.67 86.91 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 112.952 0.723 . . . . 52.340000000000003 112.952 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.8 mmtt -66.21 -47.18 74.7 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 110.084 -0.339 . . . . 72.530000000000001 110.084 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.647 0.61 . . . . 71.519999999999996 112.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.9 m -63.98 -39.04 93.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.907 -0.405 . . . . 71.230000000000004 109.907 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -27.02 63.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.551 . . . . 65.129999999999995 110.832 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 -13.65 59.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.336 -0.393 . . . . 54.539999999999999 111.249 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 129.96 -26.18 4.27 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.196 -1.002 . . . . 50.439999999999998 113.26 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -80.84 91.57 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.312 . . . . 72.519999999999996 110.17 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.48 26.86 16.93 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 120.512 -0.851 . . . . 70.409999999999997 111.71 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -124.77 111.84 16.01 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.587 -1.264 . . . . 71.239999999999995 107.587 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 158.97 37.2 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.777 0.799 . . . . 74.140000000000001 111.982 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.52 123.25 21.15 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.872 -1.899 . . . . 61.43 105.872 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.62 126.96 35.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.145 0.278 . . . . 72.430000000000007 110.49 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.44 ' C ' HD22 ' A' ' 456' ' ' ASN . . . -136.39 150.72 48.93 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -129.74 148.84 51.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.505 -0.554 . . . . 75.25 109.505 178.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 66.4 m -135.86 133.3 19.85 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 116.488 -0.324 . . . . 73.219999999999999 110.969 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.3 Cg_endo -61.79 121.57 9.73 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.715 2.277 . . . . 71.439999999999998 110.028 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.8 p -146.39 -178.36 6.11 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.878 -1.156 . . . . 64.340000000000003 107.878 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.514 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.3 m -52.2 122.98 26.11 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.17 -0.678 . . . . 64.439999999999998 109.17 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.02 -23.63 9.51 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.314 3.342 . . . . 73.540000000000006 115.197 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -75.4 -6.43 49.98 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.81 -0.556 . . . . 44.299999999999997 111.966 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 460' ' ' THR . 4.4 mm? -98.69 5.02 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.099 -0.375 . . . . 73.109999999999999 110.955 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -59.67 126.7 17.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 CA-C-O 121.545 0.688 . . . . 71.519999999999996 111.489 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.84 -1.14 85.05 Favored Glycine 0 C--O 1.243 0.657 0 CA-C-N 115.748 -0.66 . . . . 32.439999999999998 111.772 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -111.1 144.42 40.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.148 -1.427 . . . . 71.209999999999994 107.148 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 61.8 t -83.82 134.9 25.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 109.496 -0.557 . . . . 55.240000000000002 109.496 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.37 -14.88 7.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.404 -0.518 . . . . 74.040000000000006 110.803 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.98 167.75 23.87 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 115.719 -0.673 . . . . 52.420000000000002 111.811 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 486' ' ' ILE . 14.7 p -124.28 146.17 48.94 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.417 -1.327 . . . . 62.210000000000001 107.417 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.5 t-20 -56.54 -50.72 86.14 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 63.210000000000001 110.497 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.9 Cg_exo -81.4 104.95 1.54 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 105.41 -2.573 . . . . 73.209999999999994 105.41 163.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.0 Cg_endo -63.04 149.82 90.44 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.395 2.063 . . . . 60.310000000000002 114.248 -169.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.8 16.51 0.86 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.264 1.03 . . . . 74.340000000000003 110.106 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.495 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -111.3 -3.64 15.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 124.918 1.287 . . . . 65.430000000000007 108.718 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -120.9 163.32 18.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.921 -1.036 . . . . 72.230000000000004 112.162 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 10.6 m -101.48 104.88 15.82 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.728 -1.582 . . . . 71.420000000000002 106.728 175.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.8 t -116.89 148.84 40.96 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.583 -0.525 . . . . 51.240000000000002 109.583 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.14 140.71 58.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.236 -0.438 . . . . 54.130000000000003 110.622 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.9 mm -60.58 -16.46 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 125.159 1.384 . . . . 63.130000000000003 111.776 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 10.4 t -87.93 3.62 47.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.264 -0.426 . . . . 75.049999999999997 111.185 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 46.5 m-80 -91.12 140.61 29.65 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.751 0.31 . . . . 64.120000000000005 110.634 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.64 122.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.851 -1.166 . . . . 41.210000000000001 107.851 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.05 119.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 N-CA-C 108.605 -0.887 . . . . 71.319999999999993 108.605 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 47.0 mt -91.82 112.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 104.799 -2.297 . . . . 63.409999999999997 104.799 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.84 120.45 52.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 108.685 -0.857 . . . . 74.329999999999998 108.685 -173.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.78 118.73 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 121.559 0.695 . . . . 75.409999999999997 109.333 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.45 139.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.351 -0.981 . . . . 75.019999999999996 108.351 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.27 121.66 6.22 Favored Glycine 0 N--CA 1.42 -2.43 0 N-CA-C 108.471 -1.852 . . . . 61.109999999999999 108.471 175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 7.1 t -140.45 103.88 4.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.15 -0.685 . . . . 54.439999999999998 109.15 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.609 0 N-CA-C 109.478 -1.449 . . . . 74.530000000000001 109.478 178.18 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 107.242 -1.392 . . . . 74.120000000000005 107.242 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.82 156.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-O 120.972 0.415 . . . . 71.109999999999999 110.506 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.41 136.85 37.96 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.604 -1.628 . . . . 74.109999999999999 106.604 174.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.45 129.03 27.71 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 119.437 -0.905 . . . . 73.400000000000006 109.889 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 139.79 70.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.33 2.686 . . . . 74.310000000000002 113.21 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.66 137.49 55.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.839 -1.073 . . . . 65.109999999999999 109.107 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.0 m -103.43 14.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.986 0.422 . . . . 64.409999999999997 111.96 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 0.9 OUTLIER -65.29 138.82 58.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.23 -0.441 . . . . 72.430000000000007 111.558 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 -2.08 76.35 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 115.603 -0.726 . . . . 45.310000000000002 111.449 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -116.67 162.67 17.29 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.473 -0.566 . . . . 53.219999999999999 109.473 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 79.3 p -74.75 163.16 28.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 122.764 0.426 . . . . 74.329999999999998 111.774 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 21.5 p -60.91 -45.4 94.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.165 -0.47 . . . . 73.340000000000003 110.874 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.37 95.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.992 -0.549 . . . . 62.340000000000003 111.55 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.91 -39.73 83.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.056 -0.657 . . . . 73.310000000000002 109.905 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.99 -51.84 67.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.056 -0.52 . . . . 53.409999999999997 110.099 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.517 . . . . 62.509999999999998 110.7 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.39 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.462 -0.336 . . . . 73.450000000000003 111.673 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 98.3 m -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.689 -0.232 . . . . 53.32 111.18 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.5 mm? -64.87 -42.44 94.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.811 0.339 . . . . 74.430000000000007 111.002 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.81 -48.43 80.64 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.854 0.861 . . . . 74.25 109.721 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -70.5 -25.35 63.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.506 -0.77 . . . . 70.219999999999999 111.584 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.4 -15.83 57.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.453 -0.573 . . . . 72.329999999999998 109.453 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.4 6.09 53.57 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 119.807 -1.187 . . . . 51.409999999999997 111.683 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.4 169.08 11.7 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.233 0.54 . . . . 74.510000000000005 109.88 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 74.9 mmtt -113.73 157.9 21.62 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.508 -1.293 . . . . 34.219999999999999 107.508 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.42 142.68 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 111.126 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -116.81 138.63 51.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.552 -1.647 . . . . 63.130000000000003 106.552 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 3.3 p -101.81 127.06 48.78 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.386 -0.525 . . . . 72.439999999999998 110.151 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.45 119.54 39.15 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.04 -1.467 . . . . 75.129999999999995 107.04 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 0.0 OUTLIER -114.85 134.12 55.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.416 -0.514 . . . . 75.030000000000001 111.252 -175.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -137.02 141.77 35.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.853 -0.612 . . . . 75.430000000000007 110.192 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.5 Cg_endo -97.04 143.57 0.76 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.155 2.57 . . . . 73.299999999999997 113.234 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.656 ' HB3' HG23 ' A' ' 394' ' ' ILE . 7.7 t70 163.55 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.996 -1.853 . . . . 71.299999999999997 105.996 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 m -122.18 -12.7 8.25 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.996 -0.742 . . . . 64.219999999999999 108.996 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.3 m -98.03 14.65 26.69 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 122.457 1.123 . . . . 54.219999999999999 108.769 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.656 HG23 ' HB3' ' A' ' 391' ' ' ASP . 9.9 pt -88.64 151.83 48.41 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 115.068 -0.969 . . . . 64.219999999999999 111.601 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.06 126.78 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.921 1.747 . . . . 71.310000000000002 110.78 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.85 161.99 9.52 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.718 2.945 . . . . 73.319999999999993 112.265 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 370' ' ' SER . 4.4 p-10 -57.03 -9.93 0.99 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.477 0.711 . . . . 74.519999999999996 112.399 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -91.89 113.84 26.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.536 -2.024 . . . . 53.119999999999997 105.536 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.88 119.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 124.362 1.039 . . . . 75.340000000000003 112.29 -167.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.8 mt -95.41 -31.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 65.540000000000006 109.928 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.57 157.96 27.56 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.518 -0.849 . . . . 74.310000000000002 111.472 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.9 p -129.04 -179.1 4.92 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.588 0.755 . . . . 73.400000000000006 109.599 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -101.74 142.35 24.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.02 -1.104 . . . . 73.540000000000006 108.02 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.65 -26.45 9.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.848 3.032 . . . . 74.400000000000006 114.075 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.69 46.41 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.366 0.666 . . . . 75.439999999999998 111.168 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.42 95.28 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.723 -0.671 . . . . 35.140000000000001 111.434 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.54 -5.95 58.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.413 0.523 . . . . 53.549999999999997 112.413 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 37.0 m -85.95 153.01 22.48 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.96 -1.496 . . . . 72.450000000000003 106.96 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.69 112.76 11.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.761 -0.776 . . . . 61.520000000000003 110.142 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.6 m -117.94 153.04 19.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 62.340000000000003 109.542 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -67.62 141.73 56.66 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.565 -0.531 . . . . 51.509999999999998 109.565 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.26 134.6 44.9 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.529 0.732 . . . . 72.099999999999994 112.594 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 84.09 37.48 11.27 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.455 -0.793 . . . . 24.199999999999999 113.991 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -95.91 176.22 6.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.192 -1.04 . . . . 74.25 108.192 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 6.2 pt-20 -111.07 120.0 40.89 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.189 0.811 . . . . 71.239999999999995 113.189 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.79 137.85 25.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 114.951 -1.022 . . . . 60.420000000000002 108.535 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.4 t -96.02 128.67 43.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.816 0.817 . . . . 72.439999999999998 110.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.48 129.03 59.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.538 -0.912 . . . . 64.239999999999995 108.538 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -85.01 127.99 34.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.385 -0.598 . . . . 65.420000000000002 109.385 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.95 135.09 64.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.502 -0.925 . . . . 64.430000000000007 108.502 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.8 p -84.24 122.08 28.38 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.246 -0.649 . . . . 55.409999999999997 109.246 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 39.9 m -120.3 104.96 10.47 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 120.049 -0.66 . . . . 52.299999999999997 112.443 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 70.62 131.07 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 N-CA-C 115.766 1.066 . . . . 31.149999999999999 115.766 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.4 Cg_exo -75.06 134.65 17.96 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.943 1.762 . . . . 73.430000000000007 109.491 173.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.2 mm-40 -72.84 148.8 44.12 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.249 0.547 . . . . 72.109999999999999 112.266 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.8 mt-30 -124.08 139.03 54.34 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.682 -1.144 . . . . 73.549999999999997 108.015 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 14.9 mmt-85 -130.45 154.64 47.53 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 116.163 -0.471 . . . . 72.349999999999994 109.771 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.64 138.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.579 -0.897 . . . . 74.299999999999997 108.579 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -94.28 109.64 43.74 Favored Pre-proline 0 C--O 1.203 -1.352 0 N-CA-C 109.005 -0.739 . . . . 75.109999999999999 109.005 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.01 140.56 34.94 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 121.549 1.5 . . . . 73.140000000000001 111.716 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -92.5 95.17 9.48 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 118.465 -1.294 . . . . 75.120000000000005 112.172 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.63 9.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 104.502 -2.407 . . . . 64.230000000000004 104.502 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 22.6 t -78.89 -48.11 15.24 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.058 -1.883 . . . . 74.230000000000004 109.188 -172.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 40.3 p -63.85 -19.97 65.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.631 0.729 . . . . 71.439999999999998 110.829 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.29 -49.27 6.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.05 -0.977 . . . . 74.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 4.7 p -151.03 125.59 9.56 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.105 0.479 . . . . 75.400000000000006 112.117 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -61.64 -47.12 86.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 73.019999999999996 110.927 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.26 -47.84 80.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.824 . . . . 72.209999999999994 112.134 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.97 -34.75 73.79 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.995 -0.548 . . . . 72.530000000000001 112.059 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.82 -44.75 96.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.571 -0.286 . . . . 64.129999999999995 110.357 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.29 -39.84 82.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.594 0.559 . . . . 74.150000000000006 110.157 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -60.82 -48.14 83.14 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.878 -0.601 . . . . 72.430000000000007 110.504 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.8 -47.53 71.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 111.068 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.94 -43.07 84.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.046 -0.979 . . . . 75.209999999999994 111.384 -173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.3 m -69.17 -39.57 78.66 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.967 0.413 . . . . 73.329999999999998 110.224 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -16.14 62.55 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.374 -0.375 . . . . 53.009999999999998 111.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.78 -13.79 59.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.215 0.531 . . . . 62.439999999999998 109.969 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.46 -25.26 7.39 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.737 -0.744 . . . . 12.01 112.14 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -57.43 127.1 30.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.972 0.415 . . . . 65.239999999999995 111.504 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -133.55 27.72 3.35 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 109.673 -1.371 . . . . 62.210000000000001 109.673 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -128.04 111.4 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.824 -1.547 . . . . 62.119999999999997 106.824 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -135.88 154.18 51.23 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.977 0.418 . . . . 64.239999999999995 110.782 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -146.13 123.25 11.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.624 -1.25 . . . . 73.299999999999997 107.624 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -108.84 132.19 54.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.942 -0.303 . . . . 51.219999999999999 110.697 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -147.68 166.3 27.87 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.898 -0.592 . . . . 65.230000000000004 109.518 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.51 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.8 m120 -112.74 143.65 43.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.303 -0.629 . . . . 72.219999999999999 109.303 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.6 t -127.17 141.48 40.86 Favored Pre-proline 0 C--N 1.288 -2.107 0 N-CA-C 107.739 -1.208 . . . . 74.209999999999994 107.739 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_endo -63.37 135.18 48.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.862 2.375 . . . . 75.530000000000001 112.427 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.3 p -148.13 -178.88 6.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 105.648 -1.982 . . . . 63.229999999999997 105.648 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD13 ' A' ' 463' ' ' LEU . 31.6 m -63.69 128.2 92.45 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.076 -1.453 . . . . 70.129999999999995 107.076 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.33 -28.24 14.97 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.272 3.315 . . . . 74.430000000000007 114.576 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.31 -9.88 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 111.911 0.337 . . . . 61.240000000000002 111.911 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.6 mp -103.3 11.97 36.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.458 -0.201 . . . . 61.219999999999999 110.458 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 13.0 p -59.0 127.32 18.03 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-O 121.611 0.719 . . . . 64.439999999999998 110.969 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.57 57.81 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.408 -0.815 . . . . 34.119999999999997 111.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.16 144.8 29.6 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.271 -1.011 . . . . 74.430000000000007 108.271 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 433' ' ' SER . 65.6 t -83.43 138.24 19.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 72.430000000000007 108.503 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -98.08 -11.37 8.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.22 -0.592 . . . . 55.140000000000001 111.615 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 150.68 -177.71 28.56 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 111.121 -0.792 . . . . 61.229999999999997 111.121 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 5.4 p -116.75 161.38 19.34 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.69 -0.856 . . . . 64.049999999999997 108.69 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.15 -55.37 44.75 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.259 -0.4 . . . . 74.530000000000001 111.323 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 133.67 18.69 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 N-CA-C 108.226 -1.49 . . . . 75.319999999999993 108.226 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 134.56 47.18 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.013 1.809 . . . . 75.140000000000001 111.598 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.92 19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.852 0.861 . . . . 73.230000000000004 113.045 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -110.54 -8.23 14.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.428 -0.953 . . . . 70.140000000000001 108.428 174.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -99.52 156.75 16.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.068 -0.969 . . . . 74.510000000000005 113.178 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 m -106.6 110.23 22.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.422 -1.717 . . . . 63.350000000000001 106.877 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -117.61 148.46 41.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.464 -0.198 . . . . 64.230000000000004 110.464 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.12 149.41 50.57 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.269 0.356 . . . . 74.140000000000001 111.018 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.95 -14.43 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 125.083 1.353 . . . . 72.420000000000002 111.837 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.17 4.01 44.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.7 0.8 . . . . 64.129999999999995 111.701 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -97.73 134.74 40.49 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.003 -0.544 . . . . 72.299999999999997 110.607 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.99 114.93 24.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.677 -0.86 . . . . 73.299999999999997 108.677 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.44 119.85 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.378 0.609 . . . . 72.150000000000006 109.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.72 120.24 41.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.43 -1.322 . . . . 74.430000000000007 107.43 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.29 118.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 107.836 -1.172 . . . . 75.219999999999999 107.836 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -111.46 122.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.173 0.987 . . . . 74.319999999999993 112.361 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.51 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 35.5 t -97.53 141.2 16.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.713 -1.13 . . . . 64.099999999999994 108.053 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.43 121.75 5.92 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 111.657 -0.577 . . . . 21.140000000000001 111.657 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.6 m -142.06 120.89 12.72 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.153 -0.684 . . . . 60.409999999999997 109.153 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.578 0 N-CA-C 109.665 -1.374 . . . . 74.439999999999998 109.665 178.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 . . . . . 0 N--CA 1.437 -1.083 0 N-CA-C 106.606 -1.627 . . . . 63.450000000000003 106.606 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.65 154.14 37.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 122.528 0.331 . . . . 73.329999999999998 110.176 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -95.0 136.65 35.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.489 -0.93 . . . . 74.25 108.489 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.96 142.04 23.94 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 116.148 -0.478 . . . . 72.400000000000006 111.814 -170.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.14 142.77 20.19 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 124.015 3.143 . . . . 74.099999999999994 113.414 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.21 125.69 29.73 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.471 -0.786 . . . . 75.010000000000005 109.651 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.28 27.05 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.569 1.176 . . . . 73.010000000000005 110.669 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 145.66 55.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.09 -0.959 . . . . 74.209999999999994 111.498 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 1.0 45.49 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.998 -0.62 . . . . 65.030000000000001 114.36 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 373' ' ' ALA . 7.7 pt20 -134.6 162.5 32.11 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 117.293 0.546 . . . . 44.450000000000003 110.883 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.4 p -66.93 159.89 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.227 0.329 . . . . 61.210000000000001 110.298 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 21.2 p -56.76 -40.5 75.92 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.586 0.231 . . . . 71.019999999999996 111.62 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.36 77.85 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 111.563 0.209 . . . . 74.349999999999994 111.563 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.71 -36.76 76.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.51 -0.552 . . . . 72.420000000000002 109.51 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.4 ' HA ' ' OE1' ' A' ' 368' ' ' GLN . . . -60.5 -51.7 68.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.019 -0.537 . . . . 70.120000000000005 110.812 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.46 -38.0 76.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.764 -0.653 . . . . 73.209999999999994 110.607 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.07 99.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.964 -0.562 . . . . 74.010000000000005 110.338 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 50.6 m -61.21 -47.2 87.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.353 -0.385 . . . . 71.299999999999997 110.755 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.8 -38.64 91.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.433 0.158 . . . . 74.140000000000001 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.16 -46.78 89.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.366 -0.605 . . . . 72.349999999999994 109.366 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.27 -28.0 68.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.805 -0.634 . . . . 73.120000000000005 111.507 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -80.98 -14.57 57.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.365 -0.38 . . . . 70.439999999999998 111.42 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.09 48.11 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.858 -0.686 . . . . 65.230000000000004 113.667 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.91 161.97 14.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.491 0.646 . . . . 75.099999999999994 111.353 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -97.01 140.13 31.99 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.221 -1.77 . . . . 63.130000000000003 106.221 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.3 152.31 21.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.296 0.57 . . . . 54.420000000000002 112.316 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -136.16 128.99 31.04 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.934 -1.136 . . . . 64.530000000000001 107.934 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -100.58 132.83 45.77 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.187 -0.671 . . . . 73.040000000000006 109.187 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.55 119.14 35.79 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.666 -1.976 . . . . 71.310000000000002 105.666 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.37 122.19 46.49 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.974 -0.75 . . . . 53.399999999999999 108.974 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.54 133.3 21.33 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.023 -0.535 . . . . 74.040000000000006 111.9 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -81.63 129.56 6.5 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.073 1.849 . . . . 73.310000000000002 108.288 169.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.4 -170.29 3.19 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.905 -1.518 . . . . 74.510000000000005 112.145 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.7 t -104.66 -40.63 5.94 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.318 -1.734 . . . . 42.020000000000003 106.318 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 395' ' ' PRO . 32.2 m -93.0 71.51 4.65 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.543 -1.651 . . . . 44.020000000000003 106.543 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 16.6 pt -89.58 112.96 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 113.241 -1.8 . . . . 65.319999999999993 113.587 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 393' ' ' THR . 6.3 Cg_exo -79.1 119.61 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 105.81 -2.419 . . . . 73.340000000000003 105.81 167.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.12 150.48 39.16 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 C-N-CA 122.631 2.221 . . . . 63.219999999999999 114.24 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.531 ' HA ' HG13 ' A' ' 420' ' ' VAL . 29.8 t70 -60.06 -9.65 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.626 1.203 . . . . 51.100000000000001 111.722 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -109.51 115.51 30.06 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 103.292 -2.855 . . . . 74.200000000000003 103.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.17 117.98 4.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 123.695 0.622 . . . . 72.109999999999999 109.53 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.41 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.57 -29.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.987 -1.116 . . . . 71.349999999999994 107.987 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.37 168.47 27.81 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 109.387 -1.485 . . . . 62.229999999999997 109.387 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 81.2 p -113.93 -176.36 2.88 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.827 0.823 . . . . 71.230000000000004 111.365 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.31 142.89 25.48 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 105.654 -1.98 . . . . 61.399999999999999 105.654 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.62 -31.67 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.286 3.324 . . . . 63.450000000000003 114.441 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.08 67.42 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 112.381 0.512 . . . . 74.030000000000001 112.381 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.25 81.95 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 121.5 0.667 . . . . 74.310000000000002 110.125 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.83 -0.39 57.7 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.842 0.83 . . . . 73.120000000000005 110.604 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 93.8 m -85.55 143.99 28.17 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.008 -1.479 . . . . 74.140000000000001 107.008 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.0 m -74.84 114.61 13.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.867 -0.733 . . . . 63.020000000000003 109.381 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.96 170.17 8.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 124.823 1.249 . . . . 52.340000000000003 108.921 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 23.2 t -69.67 156.98 38.13 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.535 -0.543 . . . . 75.319999999999993 109.535 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -73.38 109.6 7.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.124 -1.065 . . . . 52.43 108.124 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.53 26.51 11.87 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.673 -0.971 . . . . 52.350000000000001 110.673 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.8 t0 -76.99 -171.57 2.03 Favored 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.807 -0.812 . . . . 63.149999999999999 108.807 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.68 127.46 53.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.463 0.649 . . . . 61.109999999999999 111.129 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.63 120.1 61.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.202 -1.036 . . . . 74.109999999999999 108.202 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -97.88 128.23 44.34 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.642 -0.873 . . . . 43.340000000000003 108.642 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.57 119.58 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.717 -0.475 . . . . 63.109999999999999 109.717 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.7 121.88 33.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.459 -0.941 . . . . 61.109999999999999 108.459 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 397' ' ' ASP . 23.6 t -128.83 144.72 37.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.426 -0.953 . . . . 75.319999999999993 108.426 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 71.9 p -98.03 128.92 44.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.306 -0.958 . . . . 54.030000000000001 110.9 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 60.6 m -118.73 105.56 11.69 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.069 -1.456 . . . . 74.319999999999993 107.069 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 80.53 145.1 3.97 Favored Glycine 0 CA--C 1.546 2.011 0 C-N-CA 120.973 -0.632 . . . . 34.219999999999999 113.445 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -87.95 153.2 7.16 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 121.903 1.735 . . . . 63.229999999999997 110.38 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 146.17 47.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.177 -0.675 . . . . 73.439999999999998 109.177 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 42.0 mt-30 -128.74 124.13 34.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.632 -0.877 . . . . 73.450000000000003 108.632 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.14 159.51 34.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.469 -1.308 . . . . 72.230000000000004 107.469 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.65 139.87 30.12 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 110.209 -0.293 . . . . 71.129999999999995 110.209 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.61 131.89 63.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.631 -0.877 . . . . 74.400000000000006 108.631 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.438 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.24 151.07 60.25 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.466 2.111 . . . . 44.210000000000001 111.905 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.19 -6.55 44.49 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.485 -0.325 . . . . 71.209999999999994 110.702 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 430' ' ' PRO . 11.9 p -65.84 -15.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 122.123 0.964 . . . . 62.329999999999998 109.69 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 14.0 m -52.73 -32.95 45.77 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.889 1.676 . . . . 73.230000000000004 112.084 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 85.5 m -59.8 -34.33 72.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.53 0.732 . . . . 74.430000000000007 112.585 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.45 -37.69 83.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.307 0.854 . . . . 71.319999999999993 113.307 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.8 m -158.3 133.53 8.66 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.723 -0.473 . . . . 72.319999999999993 109.723 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.61 -49.35 75.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.559 . . . . 73.349999999999994 111.724 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.44 85.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.943 -0.571 . . . . 72.299999999999997 110.449 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.25 -41.96 99.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.933 -1.03 . . . . 64.299999999999997 109.834 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.47 69.23 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.355 -0.839 . . . . 74.420000000000002 110.582 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.34 -40.0 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.584 -0.735 . . . . 74.519999999999996 110.405 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -60.8 -46.34 90.88 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.607 -0.27 . . . . 74.219999999999999 111.064 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -47.6 83.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.268 0.355 . . . . 65.329999999999998 111.86 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.36 -40.55 85.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.946 0.721 . . . . 42.509999999999998 112.946 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 57.2 m -61.8 -43.44 98.83 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.065 0.46 . . . . 73.409999999999997 110.158 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.53 -22.33 61.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.696 -0.684 . . . . 73.310000000000002 111.553 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.21 -13.09 57.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.005 0.431 . . . . 73.219999999999999 111.061 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -19.12 8.91 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.443 -0.884 . . . . 61.439999999999998 112.715 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 445' ' ' THR . 91.0 m-85 -71.27 110.86 6.17 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.017 -0.734 . . . . 60.020000000000003 109.017 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -120.08 17.08 9.97 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.457 -0.878 . . . . 53.200000000000003 111.602 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -119.4 111.4 18.1 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.872 -1.159 . . . . 61.130000000000003 107.872 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.25 152.37 50.58 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.082 0.468 . . . . 74.439999999999998 111.892 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -138.69 126.22 21.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.756 -1.572 . . . . 74.409999999999997 106.756 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -93.4 126.25 38.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 121.229 -0.189 . . . . 64.230000000000004 111.001 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.82 161.16 38.22 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.114 0.483 . . . . 63.130000000000003 110.111 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.06 133.29 53.67 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.059 0.457 . . . . 61.420000000000002 110.179 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 5.1 p -116.97 133.43 23.1 Favored Pre-proline 0 N--CA 1.413 -2.28 0 CA-C-N 115.583 -0.735 . . . . 35.310000000000002 109.482 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 36.1 Cg_exo -61.8 123.66 13.06 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.435 2.09 . . . . 71.439999999999998 110.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 8.7 t -148.16 -177.99 6.05 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.557 -1.275 . . . . 63.43 107.557 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 463' ' ' LEU . 20.5 m -51.65 116.45 7.92 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.139 0.976 . . . . 73.200000000000003 110.492 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.92 -28.75 19.21 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 124.329 3.353 . . . . 73.510000000000005 116.065 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.19 -25.93 58.63 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.746 -0.596 . . . . 73.030000000000001 112.366 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 460' ' ' THR . 3.2 pp -92.8 12.04 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.695 -0.402 . . . . 71.209999999999994 112.038 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.6 p -53.29 130.85 15.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.428 0.632 . . . . 70.010000000000005 111.228 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.84 -13.32 59.21 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.819 -0.912 . . . . 61.32 110.819 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.01 147.25 26.41 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.305 0.574 . . . . 34.420000000000002 109.773 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 434' ' ' THR . 52.7 t -83.68 129.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.478 -0.783 . . . . 62.210000000000001 110.004 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -15.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 118.571 -1.251 . . . . 62.140000000000001 110.724 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.51 37.95 Favored Glycine 0 N--CA 1.418 -2.516 0 CA-C-N 115.331 -0.849 . . . . 44.420000000000002 111.146 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 486' ' ' ILE . 2.9 p -136.15 161.87 34.53 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.423 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 7.7 t30 -62.97 -49.76 80.12 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 120.75 -0.38 . . . . 71.219999999999999 110.87 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 13.5 Cg_exo -69.44 141.71 47.3 Favored 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 106.586 -2.121 . . . . 43.409999999999997 106.586 167.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.458 ' HB2' HE21 ' A' ' 476' ' ' GLN . 18.4 Cg_endo -61.48 127.24 21.24 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.771 1.648 . . . . 41.140000000000001 112.699 -174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 -1.69 21.07 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.885 0.874 . . . . 53.310000000000002 113.162 -174.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -110.02 -4.27 15.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.028 -0.42 . . . . 72.420000000000002 110.136 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.458 HE21 ' HB2' ' A' ' 473' ' ' PRO . 1.4 mp0 -121.3 176.51 5.6 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 114.626 1.343 . . . . 75.400000000000006 114.626 -171.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -80.48 132.65 35.73 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.708 -1.587 . . . . 54.210000000000001 110.334 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.7 p -137.26 149.54 47.2 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.605 -0.887 . . . . 64.439999999999998 108.605 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.23 148.55 45.41 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 120.206 -0.598 . . . . 61.340000000000003 111.262 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.76 -28.24 44.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.865 0.84 . . . . 75.510000000000005 110.878 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 p -88.0 5.48 40.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.954 -1.021 . . . . 63.450000000000003 111.434 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.0 135.83 33.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.111 -1.44 . . . . 63.009999999999998 107.111 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 53.0 t -79.83 112.91 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.351 -1.351 . . . . 64.549999999999997 107.351 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.25 118.81 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 109.083 -0.71 . . . . 62.130000000000003 109.083 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 60.8 mt -92.6 113.39 27.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 106.469 -1.678 . . . . 73.109999999999999 106.469 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -97.18 116.46 39.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 108.545 -0.909 . . . . 74.140000000000001 108.545 -175.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 12.3 pt -102.9 117.06 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.491 1.139 . . . . 55.039999999999999 111.571 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.67 132.88 40.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.557 -1.275 . . . . 63.299999999999997 107.557 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -68.92 113.58 5.31 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.773 -1.331 . . . . 74.310000000000002 109.773 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 8.7 m -135.01 103.72 5.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.759 -0.46 . . . . 72.019999999999996 109.759 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 108.399 -1.88 . . . . 65.310000000000002 108.399 178.837 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 CA--C 1.492 -1.274 0 N-CA-C 104.679 -2.341 . . . . 73.200000000000003 104.679 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.74 152.92 19.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 119.522 -0.871 . . . . 71.230000000000004 113.149 -167.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.28 137.07 34.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.417 -1.697 . . . . 74.409999999999997 106.417 172.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.93 131.56 27.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 C-N-CA 119.27 -0.972 . . . . 73.219999999999999 109.711 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.65 150.74 51.04 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.7 2.933 . . . . 53.119999999999997 114.026 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -72.76 -30.13 63.88 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 110.459 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 368' ' ' GLN . 42.5 t 66.77 27.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 124.193 1.949 . . . . 73.319999999999993 107.097 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 28.0 ptt180 -58.17 125.08 21.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 112.464 -2.153 . . . . 70.140000000000001 113.362 -176.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.52 -16.78 54.63 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.863 -1.062 . . . . 45.509999999999998 111.719 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.491 ' HB2' HG12 ' A' ' 365' ' ' VAL . 41.7 mt-30 -103.89 170.23 8.04 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.796 0.439 . . . . 72.5 110.006 -176.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.9 p -71.75 160.86 31.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.185 0.517 . . . . 61.130000000000003 111.998 -175.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 11.3 p -62.05 -33.85 75.17 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.637 -0.711 . . . . 55.409999999999997 110.245 174.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.5 98.58 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.011 -0.54 . . . . 52.210000000000001 110.688 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.91 -39.83 79.44 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.847 -0.341 . . . . 63.25 110.249 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.3 72.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.187 -0.46 . . . . 43.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.77 -45.26 91.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 110.661 178.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.55 83.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.169 -0.469 . . . . 70.019999999999996 111.769 -179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.3 m -61.62 -47.44 85.39 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.585 0.354 . . . . 73.420000000000002 111.229 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.84 -38.67 91.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.619 0.229 . . . . 31.109999999999999 111.619 178.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -46.16 90.12 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.501 0.72 . . . . 41.229999999999997 109.496 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -70.9 -16.62 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.32 -0.854 . . . . 61.399999999999999 112.484 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -87.31 -14.09 41.81 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.583 -0.895 . . . . 64.040000000000006 108.583 176.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.627 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.75 -2.67 55.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-N 115.089 -0.96 . . . . 74.120000000000005 111.976 178.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.72 150.6 34.42 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.162 0.506 . . . . 72.040000000000006 111.271 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 145.03 25.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.26 -1.756 . . . . 63.200000000000003 106.26 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.61 135.72 60.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.887 1.069 . . . . 73.530000000000001 113.887 -174.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -111.03 132.07 54.54 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.647 -1.983 . . . . 50.130000000000003 105.647 172.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.1 m -119.52 122.73 42.31 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.236 -0.586 . . . . 71.450000000000003 110.378 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.23 127.45 55.61 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.872 -1.159 . . . . 72.140000000000001 107.872 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.57 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -108.82 122.48 47.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.084 -0.71 . . . . 63.130000000000003 109.084 -179.257 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.2 OUTLIER -122.0 132.77 24.18 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.283 -0.417 . . . . 64.140000000000001 110.76 -177.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -97.56 137.6 0.44 Allowed 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 122.3 2.0 . . . . 74.510000000000005 113.152 176.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 13.8 t70 164.85 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 126.645 1.978 . . . . 74.209999999999994 106.277 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.9 m -138.27 -8.48 1.52 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 118.901 0.773 . . . . 51.329999999999998 111.909 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.79 -3.32 57.5 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 122.156 0.979 . . . . 73.219999999999999 109.601 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 391' ' ' ASP . 7.4 pt -99.69 151.7 37.55 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 113.982 -1.463 . . . . 71.310000000000002 110.368 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 51.2 Cg_exo -56.43 131.91 48.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.302 2.668 . . . . 51.020000000000003 113.932 -178.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 70.0 Cg_exo -55.3 164.54 3.78 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 124.913 3.742 . . . . 61.229999999999997 113.511 177.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.438 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 17.1 t70 -55.25 -9.9 0.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.493 1.517 . . . . 73.340000000000003 113.457 -174.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -87.58 124.31 33.37 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.921 -1.14 . . . . 70.040000000000006 107.921 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 44.8 t -63.16 119.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.607 -0.724 . . . . 75.329999999999998 109.845 -173.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.6 tp -90.5 -32.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.587 -0.733 . . . . 74.120000000000005 109.48 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -174.88 169.11 41.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.842 -0.903 . . . . 53.100000000000001 110.842 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.8 p -114.48 -176.69 2.96 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.066 0.947 . . . . 75.129999999999995 108.696 176.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.49 143.49 26.52 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 108.563 -0.903 . . . . 71.340000000000003 108.563 -176.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -37.23 -30.7 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.8 1 C-N-CA 125.394 4.063 . . . . 75.200000000000003 115.593 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.76 -32.15 70.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.126 0.489 . . . . 71.120000000000005 110.972 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.52 25.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.619 -0.718 . . . . 33.439999999999998 110.373 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -88.57 -7.09 57.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.393 -0.822 . . . . 74.0 111.661 -173.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.3 m -95.39 162.22 13.75 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.144 -1.428 . . . . 71.25 107.144 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 28.8 m -74.26 113.34 11.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 120.059 -0.656 . . . . 41.25 110.16 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.48 165.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.304 -0.862 . . . . 71.109999999999999 109.761 178.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.8 m -75.51 141.64 42.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.96 129.93 42.01 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.294 0.569 . . . . 45.25 110.226 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 103.01 11.14 35.14 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.524 -0.846 . . . . 44.420000000000002 111.896 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.17 173.74 10.97 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.68 -1.23 . . . . 75.420000000000002 107.68 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -110.63 122.62 48.23 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.644 0.735 . . . . 70.019999999999996 111.366 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.8 mm -113.05 133.42 58.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.181 -0.918 . . . . 74.409999999999997 109.779 -175.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -102.69 124.87 49.02 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.479 -0.934 . . . . 72.0 108.479 177.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.48 134.39 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.596 -0.52 . . . . 72.400000000000006 109.596 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -110.05 129.23 55.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.186 -0.672 . . . . 65.140000000000001 109.186 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -128.59 141.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.838 -1.074 . . . . 74.310000000000002 108.211 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 10.6 m -95.9 122.62 38.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.546 -0.862 . . . . 72.450000000000003 110.102 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 59.8 p -117.82 107.48 14.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.758 -0.655 . . . . 75.120000000000005 110.985 -177.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.32 136.62 2.02 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.809 -0.632 . . . . 53.240000000000002 113.486 177.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 71.1 Cg_endo -75.67 155.02 39.82 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.33 2.02 . . . . 72.049999999999997 111.634 178.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.21 143.86 30.17 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 74.519999999999996 108.918 174.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.7 mt-30 -127.51 135.53 50.49 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.719 -1.215 . . . . 74.209999999999994 107.719 175.056 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -131.99 157.1 44.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.873 -0.788 . . . . 73.120000000000005 108.873 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.13 138.94 31.0 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.206 -1.405 . . . . 73.209999999999994 107.206 174.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -80.21 113.67 40.67 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.332 -0.618 . . . . 73.299999999999997 109.332 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.65 140.61 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.792 1.661 . . . . 53.520000000000003 109.878 176.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -107.47 97.58 7.3 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.375 1.083 . . . . 62.240000000000002 113.603 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.27 5.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 105.349 -2.093 . . . . 75.140000000000001 105.349 169.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.715 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 12.8 m -72.07 -46.42 56.95 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 113.447 -1.706 . . . . 53.25 110.393 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 23.1 p -65.37 -23.29 66.94 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.208 -0.906 . . . . 45.329999999999998 110.962 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.42 -48.07 7.34 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.461 -0.79 . . . . 73.439999999999998 111.326 -179.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.3 m -143.79 113.41 7.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.251 -178.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -55.48 -51.83 65.64 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.371 1.068 . . . . 72.430000000000007 112.608 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.46 -43.65 96.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.401 . . . . 63.200000000000003 111.212 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.66 -35.06 79.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.822 -0.627 . . . . 73.219999999999999 110.47 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.715 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.72 -48.52 81.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 116.012 -0.54 . . . . 55.219999999999999 110.666 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.43 -43.3 90.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-N 115.17 -0.923 . . . . 64.400000000000006 109.834 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 71.5 mmtt -66.43 -47.53 72.9 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 110.524 -177.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.57 -41.46 88.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 112.123 -177.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.31 -32.98 73.5 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.574 0.583 . . . . 75.420000000000002 112.574 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.4 m -66.96 -43.26 83.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.842 -0.799 . . . . 75.219999999999999 108.842 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.16 62.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.976 -0.556 . . . . 65.019999999999996 111.042 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.81 -13.11 59.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.413 0.625 . . . . 75.450000000000003 110.005 177.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.36 -6.31 45.79 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-O 119.223 -0.765 . . . . 53.109999999999999 114.016 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.17 130.71 44.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.118 0.959 . . . . 75.049999999999997 110.562 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.6 2.82 10.22 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.061 -1.066 . . . . 73.530000000000001 113.478 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.44 114.29 19.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.895 -0.779 . . . . 72.420000000000002 108.895 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -131.96 161.95 31.88 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.11 0.481 . . . . 74.239999999999995 110.731 -176.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 1.4 tpmt? -149.23 122.94 9.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 71.219999999999999 105.53 172.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -107.74 134.87 50.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.042 0.449 . . . . 72.129999999999995 111.193 -176.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.4 145.35 47.22 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.369 -0.832 . . . . 70.510000000000005 109.12 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 31.2 m-80 -117.65 129.51 55.79 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.372 -1.344 . . . . 63.420000000000002 107.372 175.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.8 t -130.23 147.37 65.46 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.853 -0.795 . . . . 65.230000000000004 108.853 -176.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -61.51 130.99 33.8 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 122.632 2.222 . . . . 71.140000000000001 111.489 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 55.1 p -136.23 -177.93 4.93 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.782 -1.192 . . . . 65.340000000000003 107.782 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.1 m -66.12 136.73 95.49 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 106.17 -1.789 . . . . 75.450000000000003 106.17 172.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.15 -28.16 19.06 Favored 'Trans proline' 0 C--O 1.207 -1.058 0 C-N-CA 123.583 2.855 . . . . 62.530000000000001 113.334 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -62.24 -16.76 55.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.496 0.554 . . . . 65.340000000000003 112.496 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.432 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.0 mm? -107.59 6.0 27.49 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.108 -0.37 . . . . 71.030000000000001 110.866 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.76 127.44 19.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.446 0.641 . . . . 64.319999999999993 111.807 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.56 -3.37 85.14 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.495 -0.775 . . . . 71.150000000000006 112.692 175.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -112.1 160.79 17.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.499 -0.926 . . . . 64.129999999999995 108.499 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.49 131.34 34.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.588 -0.893 . . . . 64.450000000000003 108.588 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.48 -20.75 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.239 0.543 . . . . 74.120000000000005 111.437 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.35 166.73 30.59 Favored Glycine 0 N--CA 1.418 -2.559 0 C-N-CA 120.46 -0.876 . . . . 34.109999999999999 111.891 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 486' ' ' ILE . 11.0 p -125.01 144.2 50.51 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.194 -1.41 . . . . 75.239999999999995 107.194 177.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.456 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.7 t-20 -57.41 -48.19 97.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 120.604 -0.438 . . . . 63.119999999999997 110.899 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -78.25 121.04 5.12 Favored 'Trans proline' 0 C--N 1.37 1.66 0 N-CA-C 107.952 -1.595 . . . . 72.230000000000004 107.952 168.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.13 140.79 80.11 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.377 2.052 . . . . 74.25 112.401 -176.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.17 11.59 0.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.675 0.79 . . . . 62.119999999999997 112.754 -176.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -109.81 -0.16 18.52 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.882 -0.414 . . . . 45.119999999999997 109.882 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.1 OUTLIER -124.65 160.99 27.24 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.645 0.735 . . . . 71.400000000000006 111.473 -173.279 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 4.1 m -91.16 132.69 35.91 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.961 -1.472 . . . . 63.539999999999999 109.732 -177.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.2 m -132.11 148.4 52.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.949 -0.76 . . . . 63.340000000000003 108.949 177.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.75 159.67 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.261 0.553 . . . . 44.100000000000001 111.848 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.0 -27.2 31.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.545 0.688 . . . . 73.310000000000002 109.835 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.1 t -88.11 5.12 42.73 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.255 -0.884 . . . . 61.310000000000002 109.905 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.76 136.83 35.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.989 -1.486 . . . . 72.530000000000001 106.989 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 65.0 t -82.57 116.36 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.942 0.401 . . . . 72.340000000000003 109.99 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.81 118.57 33.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.355 -0.98 . . . . 74.329999999999998 108.355 177.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.78 112.95 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.017 -1.475 . . . . 73.439999999999998 107.017 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.477 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -102.65 118.3 49.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.164 -1.051 . . . . 73.540000000000006 108.164 -177.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 28.8 mt -107.45 119.5 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 121.472 0.654 . . . . 74.439999999999998 109.986 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.442 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 22.1 t -97.99 139.26 20.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.446 -0.946 . . . . 71.25 108.446 -178.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.87 124.5 7.01 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.193 -0.763 . . . . 61.409999999999997 111.193 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 20.1 t -131.87 103.64 6.43 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.821 -1.177 . . . . 75.25 107.821 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.249 0 N-CA-C 109.756 -1.338 . . . . 41.450000000000003 109.756 179.222 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 108.32 -0.993 . . . . 75.239999999999995 108.32 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.41 161.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 116.54 -0.3 . . . . 43.439999999999998 110.832 -173.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 137.08 37.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.388 -0.967 . . . . 73.25 108.388 175.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.0 135.14 21.54 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.695 -0.483 . . . . 70.519999999999996 109.695 -176.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.6 150.92 86.13 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.256 1.97 . . . . 71.310000000000002 112.012 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.579 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 3.2 p30 -79.09 179.75 7.17 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.384 -0.825 . . . . 74.349999999999994 110.674 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.67 26.4 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 N-CA-C 107.433 -1.321 . . . . 73.439999999999998 107.433 176.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.579 ' HG3' ' OD1' ' A' ' 364' ' ' ASP . 0.9 OUTLIER -66.25 139.47 58.08 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.563 0.579 . . . . 74.230000000000004 112.563 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.65 0.24 59.28 Favored Glycine 0 C--N 1.307 -1.081 0 N-CA-C 111.577 -0.609 . . . . 44.420000000000002 111.577 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -122.57 -168.12 1.68 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.907 0.483 . . . . 70.099999999999994 109.718 -178.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -89.1 158.18 18.04 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.757 0.313 . . . . 63.399999999999999 110.548 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 31.1 t -63.37 -33.73 76.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.831 -0.803 . . . . 70.310000000000002 108.831 173.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.1 88.56 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.556 -0.747 . . . . 72.319999999999993 110.83 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.73 -43.92 87.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.491 -0.559 . . . . 72.439999999999998 109.491 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.5 -45.85 80.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.563 -0.744 . . . . 72.439999999999998 111.788 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.17 -48.06 89.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 123.382 0.426 . . . . 72.530000000000001 110.853 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.51 70.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.374 0.509 . . . . 71.239999999999995 112.374 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.0 m -61.35 -48.07 82.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.252 -0.431 . . . . 55.119999999999997 111.492 -177.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.92 -37.84 88.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.703 0.287 . . . . 64.310000000000002 111.398 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -60.59 -44.62 96.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.402 0.681 . . . . 73.25 109.879 177.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.08 -22.64 64.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.729 -0.668 . . . . 74.340000000000003 111.284 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.2 mmt180 -84.13 -14.27 50.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.088 0.47 . . . . 74.349999999999994 109.843 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 99.54 4.68 55.95 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.707 -0.679 . . . . 63.450000000000003 112.554 176.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.88 160.54 17.16 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 120.84 0.353 . . . . 71.349999999999994 110.487 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.37 142.82 32.21 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.69 -1.596 . . . . 74.219999999999999 106.69 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.09 132.61 67.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.996 -0.681 . . . . 72.200000000000003 111.384 -178.492 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -109.11 126.51 53.27 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 105.751 -1.944 . . . . 70.420000000000002 105.751 176.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 m -116.05 118.19 32.2 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 120.305 -0.558 . . . . 73.519999999999996 110.302 -173.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.06 119.18 34.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.097 -1.446 . . . . 65.409999999999997 107.097 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -118.1 133.53 55.82 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.956 -0.757 . . . . 73.310000000000002 108.956 178.177 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -139.47 148.85 58.01 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 109.432 -0.581 . . . . 63.439999999999998 109.432 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.07 136.61 16.51 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 108.158 -1.516 . . . . 74.409999999999997 108.158 167.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t0 -173.15 164.73 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.032 -2.21 . . . . 63.020000000000003 105.032 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.3 t -115.96 -9.39 11.78 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 118.89 0.768 . . . . 75.129999999999995 110.664 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.8 m -79.5 -18.01 52.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.925 0.869 . . . . 75.319999999999993 109.386 -176.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 421' ' ' SER . 9.7 pt -103.48 150.87 38.47 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 65.540000000000006 110.333 -178.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 46.8 Cg_endo -78.74 -166.74 0.43 Allowed 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 124.425 3.416 . . . . 73.319999999999993 113.123 -174.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 9.3 Cg_endo -55.74 163.91 5.03 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.292 2.661 . . . . 71.239999999999995 112.011 168.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.44 -7.89 0.46 Allowed 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.886 1.674 . . . . 51.200000000000003 113.631 -174.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -73.28 116.63 14.05 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.309 -0.997 . . . . 63.539999999999999 108.309 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.87 119.2 11.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.384 -0.825 . . . . 75.329999999999998 110.817 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.422 HD13 ' HG3' ' A' ' 395' ' ' PRO . 41.2 pt -91.93 -27.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.695 -0.684 . . . . 70.420000000000002 111.682 -177.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.08 158.33 27.65 Favored Glycine 0 N--CA 1.423 -2.19 0 C-N-CA 120.021 -1.085 . . . . 73.329999999999998 110.652 -178.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -113.22 -178.21 3.32 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.758 -0.46 . . . . 75.519999999999996 109.758 -178.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.93 131.99 22.65 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 108.338 -0.986 . . . . 65.109999999999999 108.338 -177.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -44.32 -32.52 5.29 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 124.521 3.481 . . . . 63.130000000000003 115.158 -176.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.89 68.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.371 -0.377 . . . . 61.130000000000003 111.581 -177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.54 79.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.109999999999999 110.579 178.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -88.81 1.07 55.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.202 -0.599 . . . . 70.140000000000001 111.118 -178.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.7 m -86.35 150.04 24.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.715 -1.217 . . . . 52.539999999999999 107.715 172.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.58 112.43 10.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.53 169.98 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.859 -0.609 . . . . 72.540000000000006 110.77 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -63.19 142.99 58.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.754 -0.657 . . . . 54.530000000000001 109.967 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.96 109.74 2.65 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.562 -0.533 . . . . 74.420000000000002 109.562 177.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 106.01 33.56 3.46 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.578 -0.82 . . . . 72.329999999999998 112.079 -178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -90.4 177.26 6.44 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.084 -1.08 . . . . 63.450000000000003 108.084 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.04 120.17 36.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.22 0.533 . . . . 72.510000000000005 111.158 -177.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.84 126.03 59.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.126 -1.435 . . . . 73.5 107.126 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.1 t -93.62 125.21 38.1 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.275 1.036 . . . . 72.030000000000001 111.556 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.02 120.01 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 60.310000000000002 107.655 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.82 119.11 32.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.813 -0.63 . . . . 51.539999999999999 109.301 178.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 21.5 t -117.22 142.12 32.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.617 -0.72 . . . . 75.439999999999998 109.809 -175.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 394' ' ' ILE . 1.9 p -102.27 121.55 42.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 116.071 -0.513 . . . . 44.119999999999997 110.309 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.1 p -119.75 105.46 11.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.236 -0.585 . . . . 61.100000000000001 110.861 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.93 120.74 0.18 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 121.143 -0.551 . . . . 53.130000000000003 113.639 178.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 55.7 Cg_endo -75.22 128.95 11.71 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.239 1.959 . . . . 54.140000000000001 111.654 176.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -73.33 135.1 44.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.351 0.871 . . . . 74.420000000000002 113.351 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.5 mt-30 -128.04 142.44 51.22 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.28 -1.378 . . . . 42.119999999999997 107.28 172.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -129.56 151.78 49.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.642 -0.873 . . . . 65.010000000000005 108.642 -178.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 39.9 mt-10 -83.45 133.91 34.89 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.886 -0.413 . . . . 74.120000000000005 109.886 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 61.2 mt -81.96 128.53 68.06 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.507 -1.294 . . . . 55.43 107.507 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.87 140.37 35.03 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 121.141 1.228 . . . . 72.219999999999999 111.122 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.29 72.62 5.33 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.057 0.932 . . . . 73.129999999999995 110.813 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.1 16.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.953 -1.476 . . . . 44.350000000000001 108.454 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -81.26 -24.85 37.04 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.991 -1.004 . . . . 71.040000000000006 110.586 -175.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 3.1 p -69.26 -13.73 62.56 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 113.103 0.779 . . . . 72.209999999999994 113.103 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.61 -47.63 72.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.642 0.608 . . . . 72.439999999999998 112.642 -177.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.1 m -162.37 137.94 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.394 -0.965 . . . . 75.129999999999995 108.394 -178.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -53.77 -50.12 66.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.8 0.44 . . . . 72.439999999999998 111.826 178.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -58.84 -42.98 90.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.361 0.413 . . . . 72.120000000000005 111.076 -179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 72.9 mm-40 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 65.120000000000005 111.17 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.09 92.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.82 0.7 . . . . 74.439999999999998 110.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.84 -42.51 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 64.510000000000005 109.975 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.3 mmtp -67.08 -44.99 78.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.288 -0.414 . . . . 70.319999999999993 111.036 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 32.9 mmmt -61.97 -46.28 89.95 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.009 0.193 . . . . 74.150000000000006 110.887 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.18 81.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.486 0.551 . . . . 72.519999999999996 112.486 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 64.0 m -62.44 -40.85 97.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.807 -0.442 . . . . 63.539999999999999 109.807 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.45 -29.75 68.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.040000000000006 111.206 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -6.75 57.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 73.420000000000002 111.198 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.2 -2.82 33.14 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.06 -0.59 . . . . 73.310000000000002 113.412 175.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -93.63 96.0 9.56 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.665 -0.495 . . . . 74.109999999999999 109.665 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -104.38 -3.91 43.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.115 -0.794 . . . . 52.140000000000001 111.115 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -93.92 112.08 23.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.514 -0.921 . . . . 72.120000000000005 108.514 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.67 150.99 48.68 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.469 0.652 . . . . 72.340000000000003 112.011 -175.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -134.28 122.41 22.67 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 105.067 -2.197 . . . . 73.340000000000003 105.067 172.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . 0.45 HE21 HG21 ' A' ' 488' ' ' VAL . 60.5 tt0 -97.9 129.81 44.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.07 -0.652 . . . . 53.140000000000001 112.435 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.69 150.97 50.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.142 -1.429 . . . . 65.519999999999996 107.142 175.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.554 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 35.9 m-80 -129.44 149.5 51.19 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.634 -0.506 . . . . 73.129999999999995 109.634 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.2 t -128.97 133.61 25.4 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 107.438 -1.319 . . . . 73.230000000000004 107.438 177.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.5 Cg_exo -61.9 118.73 5.63 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.493 1.462 . . . . 72.150000000000006 108.622 176.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.9 m -128.07 168.27 15.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.188 0.518 . . . . 62.229999999999997 111.852 -172.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 21.0 p -69.55 151.89 96.49 Favored Pre-proline 0 N--CA 1.417 -2.095 0 CA-C-N 114.705 -1.134 . . . . 55.210000000000001 110.452 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.2 Cg_endo -52.13 -24.48 20.26 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.827 3.018 . . . . 65.519999999999996 114.937 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.44 -30.56 57.42 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.721 -0.612 . . . . 74.120000000000005 112.282 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.71 -3.26 49.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.178 0.436 . . . . 63.310000000000002 112.178 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.2 p -60.2 127.16 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.116 0.484 . . . . 71.530000000000001 110.636 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.57 82.58 Favored Glycine 0 C--O 1.248 1.009 0 CA-C-N 115.773 -0.649 . . . . 53.100000000000001 111.746 177.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -110.66 154.37 23.92 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.019 -0.734 . . . . 40.149999999999999 109.019 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 486' ' ' ILE . 57.5 t -84.61 135.06 25.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 N-CA-C 106.644 -1.613 . . . . 54.030000000000001 106.644 175.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.556 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -100.43 -27.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.042 -1.463 . . . . 73.430000000000007 110.687 178.112 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.01 163.7 34.0 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.797 -0.921 . . . . 74.109999999999999 110.797 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 486' ' ' ILE . 12.6 p -119.02 154.49 33.01 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.941 -1.133 . . . . 73.0 107.941 177.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HB ' ' A' ' 485' ' ' ILE . 24.4 t-20 -69.38 -51.26 17.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 119.619 -0.833 . . . . 64.099999999999994 110.627 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.442 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 22.5 Cg_exo -68.35 141.32 51.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 107.443 -1.791 . . . . 64.420000000000002 107.443 168.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.19 126.85 19.56 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 122.168 1.912 . . . . 71.409999999999997 112.984 -175.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.19 4.47 26.57 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.144 -0.934 . . . . 72.010000000000005 111.785 -175.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.537 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.6 OUTLIER -109.67 -11.62 14.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.351 175.537 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -114.08 -179.73 3.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.606 1.706 . . . . 72.030000000000001 115.606 -168.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.8 m -88.2 116.18 26.22 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.866 -1.97 . . . . 72.340000000000003 110.676 -174.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.8 m -121.36 148.18 44.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.19 -0.67 . . . . 73.510000000000005 109.19 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.9 149.18 50.06 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 122.392 0.277 . . . . 72.099999999999994 111.122 -177.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 43.2 mm -68.9 -26.02 31.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.195 0.521 . . . . 64.5 111.019 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -88.83 -0.5 57.41 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.501 -0.75 . . . . 52.009999999999998 110.049 177.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -70.42 130.94 43.24 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.473 -0.566 . . . . 74.310000000000002 109.473 -176.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.87 113.18 18.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.564 -1.273 . . . . 74.209999999999994 107.564 177.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 60.1 t -87.16 120.06 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-O 121.321 0.581 . . . . 74.540000000000006 109.871 -176.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 45.4 mt -91.2 112.28 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.605 -1.998 . . . . 73.439999999999998 105.605 177.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.2 121.45 60.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.667 0 CA-C-N 115.016 -0.993 . . . . 71.150000000000006 108.404 -174.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.455 HG22 HD11 ' A' ' 468' ' ' ILE . 2.4 mp -99.22 117.87 44.97 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.767 0.794 . . . . 74.219999999999999 109.049 -177.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.554 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 26.7 t -97.66 141.36 16.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.809 -1.087 . . . . 53.409999999999997 108.54 -176.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -89.4 116.81 4.79 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.49 -1.444 . . . . 72.140000000000001 109.49 175.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.0 t -136.6 138.93 41.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.006 -1.109 . . . . 75.530000000000001 108.006 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.562 0 N-CA-C 108.555 -1.818 . . . . 55.420000000000002 108.555 179.675 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 411' ' ' SER . 28.1 m-20 . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 106.491 -1.67 . . . . 71.310000000000002 106.491 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.97 165.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 114.682 1.364 . . . . 53.439999999999998 114.682 -166.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -93.11 137.03 32.83 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.507 -1.664 . . . . 73.200000000000003 106.507 174.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.66 141.61 23.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.109 -0.636 . . . . 74.200000000000003 111.078 -171.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.63 129.92 16.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.569 1.513 . . . . 62.25 111.435 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 8.1 p-10 -80.12 133.78 36.11 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.355 -0.839 . . . . 63.009999999999998 110.372 -179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.9 t -87.74 47.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.443 1.116 . . . . 72.439999999999998 110.513 -172.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.3 ptm180 -66.88 139.97 57.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.134 -0.939 . . . . 75.25 111.544 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.05 0.18 60.15 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 116.117 -0.492 . . . . 70.040000000000006 112.906 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -120.35 175.35 6.01 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 122.509 -0.406 . . . . 74.150000000000006 110.154 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.3 p -72.98 157.24 37.8 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.218 -0.29 . . . . 43.340000000000003 110.218 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.2 p -59.78 -39.05 83.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.848 -0.427 . . . . 72.109999999999999 109.848 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.77 93.25 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.412 -0.813 . . . . 63.119999999999997 111.993 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -67.13 -41.99 85.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 -178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.3 78.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.421 -0.809 . . . . 64.209999999999994 111.189 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 370' ' ' SER . 98.7 mt -58.63 -44.83 90.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.577 -0.527 . . . . 74.319999999999993 109.577 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.66 74.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.25 -0.886 . . . . 52.310000000000002 112.063 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 29.1 m -66.12 -48.66 70.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.415 0.626 . . . . 73.099999999999994 109.872 -179.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.89 -39.83 91.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.782 -0.645 . . . . 52.340000000000003 110.581 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.6 -44.9 96.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 74.140000000000001 110.668 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -70.08 -21.31 63.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.153 0.501 . . . . 44.100000000000001 111.261 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -86.98 -14.65 41.08 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.158 -0.474 . . . . 72.299999999999997 111.458 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.26 8.05 66.89 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.261 -0.971 . . . . 75.0 112.657 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -75.36 163.75 27.12 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.158 -0.682 . . . . 64.519999999999996 109.158 178.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.8 mmtm -103.29 132.85 49.22 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.349 -0.982 . . . . 63.310000000000002 108.349 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.17 153.87 39.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 121.742 0.782 . . . . 62.210000000000001 112.823 -175.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -123.33 128.23 49.64 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.529 -1.669 . . . . 64.329999999999998 106.78 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.6 m -106.25 117.75 34.85 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.114 -1.069 . . . . 71.439999999999998 108.114 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.4 tm? -111.66 118.93 37.0 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 107.741 -1.207 . . . . 74.049999999999997 107.741 -176.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.41 122.2 46.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.32 -0.993 . . . . 64.319999999999993 108.32 174.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -125.87 136.29 28.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 C-N-CA 120.446 -0.502 . . . . 72.340000000000003 111.706 -176.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.431 ' C ' ' HG3' ' A' ' 425' ' ' GLU . 2.4 Cg_endo -85.51 131.43 4.04 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 122.197 1.932 . . . . 72.519999999999996 108.163 167.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -175.3 -173.67 0.67 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.431 -2.063 . . . . 73.5 105.431 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.603 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 49.7 m -117.36 -6.6 11.24 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.943 0.877 . . . . 62.210000000000001 109.116 175.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.9 m -98.36 35.45 1.78 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.717 -1.586 . . . . 75.340000000000003 106.717 175.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.4 pp -88.33 146.43 37.86 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.893 -1.049 . . . . 73.230000000000004 112.131 -176.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.09 178.44 5.89 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.148 1.899 . . . . 51.130000000000003 109.399 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.28 161.37 45.95 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 121.609 1.539 . . . . 75.049999999999997 110.648 172.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -9.0 3.52 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.418 1.104 . . . . 75.239999999999995 111.095 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -110.42 137.07 48.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 105.379 -2.082 . . . . 74.400000000000006 105.379 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.54 118.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 123.453 0.471 . . . . 45.149999999999999 109.748 -173.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.434 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.31 -29.32 4.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.769 -1.567 . . . . 55.310000000000002 106.769 178.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.66 168.6 41.67 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 108.995 -1.642 . . . . 61.25 108.995 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 403' ' ' ASP . 10.9 m -114.33 -177.07 3.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.583 -1.636 . . . . 72.310000000000002 106.583 178.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 402' ' ' THR . 13.9 t70 -97.53 140.06 21.77 Favored Pre-proline 0 C--N 1.26 -3.307 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 -175.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -33.81 -30.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 1 C-N-CA 126.209 4.606 . . . . 71.530000000000001 115.53 -177.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.82 47.16 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 123.611 0.765 . . . . 74.230000000000004 112.014 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.87 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 62.219999999999999 111.612 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -81.56 -0.6 42.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.837 0.68 . . . . 74.420000000000002 112.837 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 58.8 m -88.37 155.68 19.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.12 -1.437 . . . . 54.100000000000001 107.12 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.7 m -73.12 114.02 10.82 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.492 0.663 . . . . 74.310000000000002 109.273 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.74 170.29 5.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.305 -0.861 . . . . 63.420000000000002 109.537 -178.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 8.5 t -71.01 149.14 46.92 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 109.219 -0.66 . . . . 74.439999999999998 109.219 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.22 109.66 2.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.442 -0.948 . . . . 73.219999999999999 108.442 177.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.36 32.62 9.36 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.923 -0.871 . . . . 50.310000000000002 110.923 -176.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.6 t0 -87.05 -174.9 5.13 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 107.831 -1.174 . . . . 62.43 107.831 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 7.9 pt-20 -97.45 138.11 35.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.51 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -125.01 124.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.933 -1.136 . . . . 51.409999999999997 107.933 175.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -90.86 125.95 35.89 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.846 0.831 . . . . 71.349999999999994 110.533 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.99 117.71 56.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.15 -1.055 . . . . 70.299999999999997 108.15 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 5.3 p30 -106.33 129.44 54.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.308 0.575 . . . . 74.239999999999995 112.468 -177.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.8 152.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.763 -1.108 . . . . 54.210000000000001 108.588 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 31.1 p -88.56 123.29 32.91 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.672 0.619 . . . . 70.439999999999998 112.672 -174.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 p -119.87 103.46 9.36 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.13 -1.028 . . . . 62.409999999999997 110.067 169.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.13 0.12 Allowed Glycine 0 CA--C 1.553 2.428 0 N-CA-C 115.473 0.949 . . . . 51.130000000000003 115.473 177.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.8 Cg_endo -85.47 133.65 4.61 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.202 1.935 . . . . 64.010000000000005 110.652 173.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 390' ' ' PRO . 10.0 mt-10 -76.44 145.19 39.45 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 113.167 0.803 . . . . 64.340000000000003 113.167 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.9 mt-30 -120.66 157.23 30.04 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.183 -1.371 . . . . 74.420000000000002 108.748 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -143.17 156.62 44.81 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.413 -1.329 . . . . 73.439999999999998 107.413 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.8 138.86 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.132 -1.062 . . . . 72.420000000000002 108.132 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 68.6 mt -79.52 132.14 62.84 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 73.540000000000006 108.687 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -53.19 141.53 58.64 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.607 2.205 . . . . 74.140000000000001 113.224 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.13 -17.72 48.91 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.505 -1.225 . . . . 73.010000000000005 112.19 -175.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.5 m -75.47 5.41 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.448 0.907 . . . . 64.230000000000004 113.448 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 48.3 m -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.264 0.839 . . . . 71.319999999999993 113.264 -175.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 52.5 m -68.92 -13.91 62.72 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.973 0.509 . . . . 62.420000000000002 112.365 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.16 -45.51 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.61 0.596 . . . . 73.040000000000006 112.61 -175.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 439' ' ' GLU . 48.1 m -162.73 145.22 10.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.525 -1.287 . . . . 51.219999999999999 107.525 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -56.84 -42.93 80.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.329 . . . . 64.329999999999998 111.102 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -62.62 -36.76 83.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 55.109999999999999 111.048 179.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 436' ' ' THR . 6.5 tp10 -67.8 -44.77 76.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.07 -0.715 . . . . 64.340000000000003 109.07 -178.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.92 -51.18 70.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.545 -1.207 . . . . 72.230000000000004 110.773 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.43 -38.29 80.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 -177.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.8 mmtt -65.3 -49.02 71.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.9 -0.72 . . . . 74.319999999999993 110.166 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.01 -42.57 84.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.116 0.784 . . . . 74.299999999999997 113.116 -177.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.37 -43.69 76.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.231 0.456 . . . . 71.5 112.231 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -63.31 -41.86 98.97 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.951 0.405 . . . . 72.299999999999997 110.628 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.0 -24.64 62.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.96 -0.564 . . . . 61.299999999999997 111.602 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.56 -5.83 59.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 70.209999999999994 111.453 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.59 -17.73 25.47 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.473 -0.87 . . . . 63.030000000000001 112.204 178.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.04 67.89 7.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.201 0.524 . . . . 65.25 109.921 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -96.2 32.49 6.38 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.67 -0.972 . . . . 73.439999999999998 110.67 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -118.7 110.42 17.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.023 -1.843 . . . . 65.120000000000005 106.023 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.89 154.15 47.6 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.339 1.066 . . . . 74.299999999999997 113.084 -176.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.58 123.11 12.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 104.998 -2.223 . . . . 74.430000000000007 104.998 168.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -98.11 135.34 39.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.207 0.527 . . . . 74.329999999999998 111.469 -172.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.448 ' C ' HD22 ' A' ' 456' ' ' ASN . . . -127.09 148.01 50.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.425 -1.324 . . . . 65.420000000000002 107.425 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -124.44 141.42 52.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.088 -1.078 . . . . 63.520000000000003 108.088 178.253 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.2 m -140.36 147.14 48.51 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 108.862 -0.792 . . . . 51.439999999999998 108.862 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 490' ' ' SER . 33.8 Cg_exo -61.45 129.66 28.95 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.708 2.272 . . . . 74.450000000000003 111.678 -176.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -145.83 164.68 31.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 111.035 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -61.37 144.6 91.75 Favored Pre-proline 0 N--CA 1.442 -0.864 0 O-C-N 124.27 0.981 . . . . 74.120000000000005 110.463 178.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.37 -34.28 31.93 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.996 3.131 . . . . 74.219999999999999 113.832 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.77 -15.3 62.66 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.381 0.511 . . . . 75.530000000000001 112.381 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 -8.52 14.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.504 -0.316 . . . . 71.439999999999998 111.775 176.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 81.3 t -60.35 126.94 19.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 120.953 0.406 . . . . 74.319999999999993 110.546 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.87 -3.16 70.36 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 110.962 -0.855 . . . . 75.099999999999994 110.962 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -116.38 155.44 28.48 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.086 -1.079 . . . . 75.310000000000002 108.086 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 486' ' ' ILE . 45.5 t -84.57 127.36 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.511 -0.551 . . . . 62.420000000000002 109.511 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.85 -18.14 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.929 -0.708 . . . . 74.120000000000005 111.405 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.19 161.7 28.04 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.574 -0.822 . . . . 53.509999999999998 111.708 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 486' ' ' ILE . 15.9 p -132.92 155.47 49.01 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.366 -1.346 . . . . 71.530000000000001 107.366 177.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -59.53 -57.85 23.87 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 120.516 -0.474 . . . . 73.329999999999998 110.103 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.19 125.21 5.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 109.09 -1.158 . . . . 74.519999999999996 109.09 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -62.36 144.17 94.7 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.057 1.838 . . . . 72.109999999999999 112.044 -177.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.29 5.98 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.159 0.984 . . . . 65.319999999999993 112.674 -174.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -109.0 -14.51 14.54 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.176 -0.466 . . . . 71.25 110.029 176.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.97 150.64 20.18 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.156 0.979 . . . . 74.239999999999995 111.717 -172.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 426' ' ' GLN . 19.4 m -85.23 111.42 19.82 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 113.588 -1.642 . . . . 63.350000000000001 107.769 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.0 m -118.19 148.56 42.25 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.917 -0.583 . . . . 73.120000000000005 110.036 -175.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.58 146.72 52.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 122.587 0.355 . . . . 70.430000000000007 110.781 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.603 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 48.3 mm -67.21 -14.68 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 CA-C-O 122.171 0.986 . . . . 71.129999999999995 110.306 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.0 t -92.16 5.52 50.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.603 -0.726 . . . . 63.409999999999997 110.358 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -89.66 133.76 34.49 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 110.062 -0.347 . . . . 72.329999999999998 110.062 178.399 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 122.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.855 -1.165 . . . . 71.209999999999994 107.855 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.77 119.79 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 120.19 -0.604 . . . . 75.319999999999993 109.49 -178.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.35 112.51 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.596 -2.372 . . . . 75.510000000000005 104.596 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.73 118.93 56.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 114.959 -1.018 . . . . 62.539999999999999 108.754 -173.528 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' A' ' 455' ' ' ALA . 41.2 mt -100.16 116.49 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 -177.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.6 138.14 23.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.692 -1.225 . . . . 73.519999999999996 107.692 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.48 114.69 3.93 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.285 -1.526 . . . . 44.210000000000001 109.285 177.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.7 m -142.9 143.93 32.23 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 122.009 -0.7 . . . . 62.020000000000003 109.667 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.364 0 N-CA-C 108.693 -1.763 . . . . 51.0 108.693 178.252 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.502 -0.897 0 N-CA-C 106.675 -1.602 . . . . 70.510000000000005 106.675 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.94 149.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.585 0.231 . . . . 74.420000000000002 110.45 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.8 136.48 36.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.637 -0.875 . . . . 74.109999999999999 108.637 177.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 8.6 p -97.86 127.49 37.04 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 120.329 -0.548 . . . . 74.010000000000005 110.389 -175.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 74.4 Cg_exo -56.05 148.83 56.34 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.086 2.524 . . . . 33.450000000000003 113.388 179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 146.3 53.03 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 111.493 -178.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 24.2 m -96.37 25.31 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 122.337 1.065 . . . . 72.040000000000006 109.659 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -65.32 137.17 57.35 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.778 -1.101 . . . . 75.439999999999998 111.995 -177.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.43 0.91 47.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.451 -0.88 . . . . 63.039999999999999 114.001 176.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 1.8 pt20 -125.83 -172.16 2.54 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.193 -0.669 . . . . 55.219999999999999 109.193 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 80.3 p -90.11 164.48 14.45 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.81 -0.756 . . . . 62.310000000000002 109.701 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 374' ' ' ILE . 3.8 p -62.09 -33.61 74.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.798 0.332 . . . . 74.239999999999995 110.305 175.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.66 98.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.794 -0.639 . . . . 63.119999999999997 109.962 176.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.321 -0.4 . . . . 72.25 110.108 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.29 70.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.763 0.665 . . . . 72.219999999999999 110.47 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 370' ' ' SER . 91.0 mt -60.25 -46.51 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.646 -0.706 . . . . 71.540000000000006 110.046 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.29 -46.99 84.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.105 -0.498 . . . . 74.200000000000003 111.905 -178.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.83 -47.84 76.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.516 -0.311 . . . . 72.049999999999997 110.431 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.17 -38.01 89.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.561 -0.29 . . . . 73.120000000000005 111.695 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -59.77 -46.92 87.67 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.601 0.76 . . . . 71.209999999999994 109.11 177.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -67.97 -30.73 70.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.558 -0.746 . . . . 72.349999999999994 111.193 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -80.09 -11.29 59.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.839 -0.619 . . . . 63.43 111.917 178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.72 12.46 58.04 Favored Glycine 0 CA--C 1.497 -1.034 0 C-N-CA 120.284 -0.96 . . . . 40.109999999999999 112.953 174.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.21 146.46 24.74 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.972 0.415 . . . . 72.319999999999993 109.954 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 34.0 mmtp -88.3 132.82 34.25 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.832 -1.914 . . . . 70.219999999999999 105.832 -178.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 141.45 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 119.899 -0.72 . . . . 73.310000000000002 111.674 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -115.99 127.98 55.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.175 -1.417 . . . . 73.319999999999993 107.175 177.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.6 m -101.06 119.27 38.5 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.597 -0.841 . . . . 71.120000000000005 109.709 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -111.73 119.65 39.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.64 -1.244 . . . . 73.439999999999998 107.64 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.482 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -96.27 122.6 39.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.648 -0.706 . . . . 63.420000000000002 109.25 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -123.79 115.89 27.87 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 115.737 -0.665 . . . . 73.439999999999998 111.883 -177.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.59 134.7 6.62 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.18 1.92 . . . . 33.439999999999998 110.569 174.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.5 t70 175.71 -168.42 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 105.396 -2.076 . . . . 74.040000000000006 105.396 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.6 m -132.43 -11.0 3.2 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 118.38 0.537 . . . . 74.25 111.42 176.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 44.9 p -99.13 14.35 29.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.357 1.075 . . . . 61.399999999999999 109.5 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.401 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 1.5 pp -88.59 152.6 49.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 CA-C-N 113.877 -1.511 . . . . 71.519999999999996 112.583 -176.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.66 138.65 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.152 1.901 . . . . 72.310000000000002 109.921 174.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.25 154.5 40.05 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.796 2.33 . . . . 64.120000000000005 111.893 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.32 -8.48 3.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.506 0.67 . . . . 74.530000000000001 111.866 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 35.6 m170 -95.66 109.19 21.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.143 -2.169 . . . . 74.209999999999994 105.143 172.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.8 119.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.232 1.015 . . . . 61.350000000000001 112.85 -169.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.46 -29.02 3.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.063 -1.426 . . . . 73.5 110.504 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.54 28.88 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.029 -1.228 . . . . 63.409999999999997 110.029 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 -175.23 2.63 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.874 -0.787 . . . . 61.329999999999998 108.874 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.31 140.93 21.83 Favored Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 115.777 -0.647 . . . . 75.319999999999993 109.795 -172.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.27 -24.77 6.24 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 125.077 3.852 . . . . 43.350000000000001 115.059 -177.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.01 -29.34 69.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.591 0.234 . . . . 53.420000000000002 110.981 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.33 57.96 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 121.673 0.749 . . . . 44.210000000000001 110.13 178.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.4 -9.68 59.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.359 -0.837 . . . . 70.209999999999994 110.733 -178.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.2 m -87.53 151.08 23.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.613 -0.884 . . . . 73.430000000000007 108.613 177.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 66.3 m -74.17 116.81 15.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.412 0.625 . . . . 54.299999999999997 109.636 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.09 169.97 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.444 -0.798 . . . . 73.150000000000006 109.501 -177.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.0 t -79.02 155.4 28.85 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.746 -1.205 . . . . 73.519999999999996 107.746 176.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.3 110.74 4.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.244 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.07 37.7 1.63 Allowed Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.585 -0.734 . . . . 34.219999999999999 111.707 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.31 178.57 5.93 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.722 -1.214 . . . . 65.239999999999995 107.722 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.0 mt-10 -100.19 108.97 21.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 111.525 -176.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.01 126.78 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.377 -1.342 . . . . 70.129999999999995 107.377 177.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 72.5 p -90.71 123.49 34.34 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.296 -0.562 . . . . 52.119999999999997 109.763 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.34 121.07 47.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.18 -1.045 . . . . 74.140000000000001 108.18 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -92.24 124.6 36.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.313 -0.625 . . . . 71.510000000000005 109.313 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.7 p -126.26 131.03 71.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.89 -1.152 . . . . 72.150000000000006 107.89 175.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 39.9 m -94.4 122.13 36.65 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.413 -0.915 . . . . 74.040000000000006 108.945 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 19.8 m -119.36 107.07 12.92 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.527 -0.761 . . . . 74.540000000000006 110.623 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 80.02 147.5 4.65 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 121.244 -0.503 . . . . 54.409999999999997 113.482 177.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.4 Cg_endo -85.01 154.48 11.22 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.186 1.924 . . . . 74.340000000000003 110.762 174.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 4.5 mm-40 -83.43 126.64 32.96 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 119.97 -0.692 . . . . 72.010000000000005 111.347 176.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 48.3 mt-30 -100.7 127.69 47.01 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.616 -1.253 . . . . 73.540000000000006 107.616 175.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 449' ' ' PHE . 10.1 tpt180 -122.2 149.41 43.7 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.941 -1.133 . . . . 70.409999999999997 107.941 -173.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -83.11 138.61 33.61 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 122.83 0.452 . . . . 75.319999999999993 111.423 -176.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.9 mt -89.6 131.38 40.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 109.849 -0.426 . . . . 75.209999999999994 109.849 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.6 Cg_exo -70.36 141.73 43.54 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.152 2.568 . . . . 53.049999999999997 113.443 176.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.01 -22.25 31.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.913 0.885 . . . . 42.43 110.061 -178.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.21 -3.55 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 121.877 0.846 . . . . 62.109999999999999 111.223 -175.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 8.7 p -61.03 -31.87 71.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.222 1.009 . . . . 74.319999999999993 111.409 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.4 m -67.38 -26.58 66.53 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.707 0.803 . . . . 72.109999999999999 112.537 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.34 -41.67 47.56 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.583 0.586 . . . . 72.439999999999998 112.583 -172.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.5 m -148.01 139.72 23.84 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.135 -0.691 . . . . 64.129999999999995 109.135 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -61.19 -38.86 88.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.669 -0.493 . . . . 74.510000000000005 109.669 176.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.13 -47.74 84.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.773 -0.649 . . . . 74.420000000000002 110.336 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -36.61 84.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.192 0.307 . . . . 64.239999999999995 111.649 177.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.43 -51.35 69.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.086 -0.338 . . . . 45.310000000000002 110.086 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.85 -45.76 90.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.278 -0.419 . . . . 54.439999999999998 110.657 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -63.45 -47.41 81.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.477 0.547 . . . . 73.430000000000007 112.477 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -66.28 -40.87 90.35 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.837 0.31 . . . . 72.409999999999997 111.837 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.62 -43.44 89.57 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.552 -0.459 . . . . 74.420000000000002 110.908 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 75.5 m -62.68 -40.49 97.28 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 110.015 -0.365 . . . . 72.420000000000002 110.015 178.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.2 -26.52 64.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.265 -0.425 . . . . 62.340000000000003 111.965 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.96 -13.65 50.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.749 -0.205 . . . . 73.239999999999995 111.25 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.48 -0.03 26.33 Favored Glycine 0 C--N 1.319 -0.409 0 C-N-CA 120.267 -0.968 . . . . 63.420000000000002 113.023 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 81.5 m-85 -83.62 106.91 15.72 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 122.527 -0.396 . . . . 75.219999999999999 110.016 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.4 19.3 13.08 Favored Glycine 0 C--N 1.297 -1.606 0 N-CA-C 110.009 -1.236 . . . . 24.350000000000001 110.009 176.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -113.12 111.02 21.4 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.172 -1.788 . . . . 63.100000000000001 106.172 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -131.46 148.66 52.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 72.450000000000003 111.63 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -142.16 123.04 14.41 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.935 -1.505 . . . . 73.420000000000002 106.935 172.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -104.1 135.76 45.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.916 0.339 . . . . 74.099999999999994 111.916 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.66 156.15 47.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.71 -0.478 . . . . 33.310000000000002 109.71 175.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.78 137.96 54.26 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.799 -0.815 . . . . 74.439999999999998 108.799 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 47.6 m -141.55 147.66 46.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 120.482 -0.487 . . . . 70.310000000000002 111.14 178.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_endo -65.98 125.49 14.26 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.973 2.449 . . . . 65.310000000000002 111.328 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 16.5 t -138.88 -176.49 4.51 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.318 -1.364 . . . . 61.43 107.318 -176.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.6 m -56.64 129.79 76.81 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.898 -0.778 . . . . 52.109999999999999 108.898 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.01 -25.64 12.93 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 124.023 3.149 . . . . 52.43 114.262 -178.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.41 -24.36 57.12 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.801 0.334 . . . . 72.319999999999993 111.683 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.64 12.18 34.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.639 -0.255 . . . . 45.32 111.51 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.55 126.39 17.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.849 0.833 . . . . 63.100000000000001 110.787 177.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.17 -6.86 72.51 Favored Glycine 0 C--N 1.306 -1.106 0 CA-C-N 115.194 -0.912 . . . . 72.030000000000001 111.74 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -100.88 152.21 20.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.627 -0.508 . . . . 73.299999999999997 109.627 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 58.4 t -84.6 136.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.828 -0.805 . . . . 71.310000000000002 108.828 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.04 -16.59 7.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.179 -1.008 . . . . 71.439999999999998 110.734 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.91 -179.27 26.81 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.38 -0.827 . . . . 74.319999999999993 111.714 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.9 p -116.82 161.87 18.6 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.286 -1.376 . . . . 75.109999999999999 107.286 178.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.17 -54.58 32.12 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.801 -1.16 . . . . 74.030000000000001 110.602 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.43 120.39 6.92 Favored 'Trans proline' 0 C--N 1.372 1.811 0 N-CA-C 105.963 -2.36 . . . . 60.229999999999997 105.963 166.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.7 Cg_endo -62.68 158.76 40.26 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 122.173 1.915 . . . . 62.439999999999998 113.798 -171.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.6 11.82 0.44 Allowed 'General case' 0 C--O 1.21 -0.975 0 CA-C-O 122.377 1.084 . . . . 51.109999999999999 111.6 178.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 475' ' ' ASN . 0.7 OUTLIER -109.13 -8.09 15.21 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.725 -1.213 . . . . 64.319999999999993 107.725 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -100.39 159.66 14.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.072 -0.967 . . . . 71.010000000000005 111.99 -171.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.1 m -114.66 108.12 16.39 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.428 -1.693 . . . . 74.099999999999994 106.428 177.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.8 p -112.24 143.19 43.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 122.128 -0.358 . . . . 64.540000000000006 111.954 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -63.99 144.37 57.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 72.420000000000002 110.34 176.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.17 -4.57 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.424 1.089 . . . . 42.409999999999997 111.758 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.7 p -87.17 -5.88 58.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.321 -0.862 . . . . 75.109999999999999 110.377 178.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -92.46 139.05 30.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.795 -0.639 . . . . 75.239999999999995 109.405 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.42 122.2 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.496 -1.668 . . . . 72.430000000000007 106.496 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.52 120.35 36.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.875 -0.787 . . . . 74.430000000000007 108.875 -175.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 121.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 108.056 -1.09 . . . . 71.519999999999996 108.056 -177.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -110.25 118.04 56.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.171 -0.922 . . . . 70.109999999999999 108.78 -177.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.29 119.24 48.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-N 115.414 -0.812 . . . . 71.319999999999993 109.482 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.6 t -97.63 133.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.246 -1.39 . . . . 64.230000000000004 107.246 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.02 125.25 7.11 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 111.425 -0.67 . . . . 72.530000000000001 111.425 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -129.52 107.01 9.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.553 -1.647 . . . . 71.450000000000003 106.553 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.416 -2.638 0 CA-C-O 118.478 -1.179 . . . . 74.150000000000006 111.45 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 . . . . . 0 N--CA 1.433 -1.279 0 N-CA-C 106.374 -1.713 . . . . 53.219999999999999 106.374 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.5 162.24 15.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 120.893 0.378 . . . . 72.230000000000004 110.992 -172.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -95.01 136.31 35.48 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.856 -1.164 . . . . 60.350000000000001 107.856 178.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 130.9 27.84 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.077 -0.712 . . . . 64.109999999999999 109.077 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -62.39 117.61 4.48 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.335 1.356 . . . . 72.109999999999999 109.023 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.28 166.81 22.26 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.454 -0.794 . . . . 74.540000000000006 109.965 -176.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.72 40.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 122.954 1.359 . . . . 52.140000000000001 111.859 -168.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -66.3 145.81 55.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.929 -1.032 . . . . 74.239999999999995 110.449 172.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.71 0.51 39.68 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 114.33 0.492 . . . . 74.109999999999999 114.33 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . 0.285 0.5 OUTLIER -145.71 172.1 13.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.68 0.74 . . . . 70.099999999999994 112.804 175.592 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.3 p -54.12 154.7 4.09 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.811 1.244 . . . . 74.319999999999993 113.261 -175.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 9.1 p -57.69 -38.86 75.91 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.439 -0.8 . . . . 73.140000000000001 111.267 177.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.75 84.38 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 45.310000000000002 111.052 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.43 -37.03 77.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.103 0.478 . . . . 53.130000000000003 109.74 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.89 67.92 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.446 -0.797 . . . . 62.200000000000003 111.48 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.24 -43.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.79 -0.641 . . . . 55.450000000000003 111.367 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.38 -36.27 83.16 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.917 0.339 . . . . 71.120000000000005 111.917 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.9 m -65.89 -47.61 74.24 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.011 0.434 . . . . 75.129999999999995 110.629 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.98 -38.51 91.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.011 -0.541 . . . . 72.150000000000006 110.802 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -59.35 -42.73 92.22 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.138 0.975 . . . . 71.010000000000005 109.601 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.02 -30.68 69.97 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.965 -0.561 . . . . 73.430000000000007 112.29 178.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -80.97 -9.81 59.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.833 0.349 . . . . 65.310000000000002 111.397 176.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.15 12.64 54.6 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.864 -0.607 . . . . 73.340000000000003 113.526 173.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -91.29 149.18 21.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.12 0.486 . . . . 75.329999999999998 110.514 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 24.4 mmtp -90.5 137.06 32.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.167 -1.79 . . . . 73.239999999999995 106.167 -176.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -119.21 139.56 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 C-N-CA 118.969 -1.092 . . . . 75.129999999999995 113.526 -175.459 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -111.31 144.76 39.98 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.638 -1.616 . . . . 73.109999999999999 106.638 172.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.2 m -132.43 124.65 29.03 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.412 -0.958 . . . . 73.439999999999998 108.412 178.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -115.1 119.81 37.67 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.106 -1.442 . . . . 71.219999999999999 107.106 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.585 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -111.36 135.5 51.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.343 -0.614 . . . . 72.310000000000002 109.343 -178.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 391' ' ' ASP . 19.6 ptmt -139.81 132.93 15.25 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.237 -0.585 . . . . 74.200000000000003 111.797 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.6 Cg_exo -78.64 140.15 16.47 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.371 2.047 . . . . 74.150000000000006 109.018 167.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 394' ' ' ILE . 9.1 t70 -170.42 -174.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.716 -1.587 . . . . 73.140000000000001 106.716 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 t -108.53 -34.84 6.63 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.714 -1.217 . . . . 74.239999999999995 107.714 177.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.1 p -87.62 40.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.911 0.862 . . . . 71.129999999999995 110.033 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 391' ' ' ASP . 23.2 pt -88.23 141.89 31.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.139 -0.937 . . . . 44.409999999999997 111.85 -176.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 172.79 15.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 106.983 -1.968 . . . . 64.409999999999997 106.983 167.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.15 147.42 66.73 Favored 'Trans proline' 0 C--O 1.209 -0.941 0 C-N-CA 121.373 1.382 . . . . 73.340000000000003 110.778 176.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.0 -7.16 10.58 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.158 0.98 . . . . 61.409999999999997 111.816 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -84.28 121.22 27.19 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.691 -2.707 . . . . 74.530000000000001 103.691 173.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.61 117.1 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.512 0.672 . . . . 71.010000000000005 110.372 -170.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.35 -28.18 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 114.893 -1.049 . . . . 71.120000000000005 109.39 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.68 157.82 27.48 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.374 -1.49 . . . . 54.149999999999999 109.374 -178.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -128.11 -174.8 3.31 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 123.679 0.792 . . . . 72.120000000000005 110.663 -173.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.65 129.13 29.51 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.648 -1.241 . . . . 60.43 107.648 -176.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -50.62 -27.75 20.33 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.202 3.268 . . . . 61.329999999999998 115.193 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.07 -26.0 67.34 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 111.926 0.343 . . . . 54.43 111.926 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.73 -36.03 81.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.756 0.788 . . . . 72.200000000000003 109.925 176.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -90.26 -2.25 58.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.543 -0.753 . . . . 73.209999999999994 111.216 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -91.31 165.14 13.59 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.061 -1.459 . . . . 71.140000000000001 107.061 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 56.9 p -74.36 113.63 11.81 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.177 0.513 . . . . 74.450000000000003 111.297 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.84 163.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.73 -0.668 . . . . 65.340000000000003 109.466 177.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.7 m -77.7 157.99 29.86 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.514 -0.55 . . . . 41.219999999999999 109.514 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.27 109.74 3.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.385 -0.598 . . . . 61.409999999999997 109.385 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 97.29 25.49 11.03 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.804 -0.712 . . . . 64.510000000000005 112.492 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.6 -172.16 3.7 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.261 -1.015 . . . . 72.310000000000002 108.261 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.0 pt-20 -107.77 139.41 42.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 118.665 0.666 . . . . 74.140000000000001 112.169 -176.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.06 136.52 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.753 -1.203 . . . . 65.420000000000002 107.753 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 10.8 t -108.37 130.93 55.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.611 0.719 . . . . 71.450000000000003 110.675 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 67.5 t -113.79 127.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.182 -0.917 . . . . 65.25 108.555 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -97.6 127.9 43.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.337 -0.616 . . . . 64.200000000000003 109.337 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 64.0 t -120.96 143.74 32.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.275 -1.009 . . . . 72.329999999999998 108.275 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.6 p -100.79 122.6 43.67 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.176 -0.675 . . . . 63.200000000000003 109.176 178.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 21.1 p -118.64 105.12 11.27 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.662 -0.815 . . . . 72.200000000000003 111.522 -178.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 72.65 152.22 1.66 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.936 0.735 . . . . 74.430000000000007 114.936 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.2 Cg_exo -80.76 148.32 17.66 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.296 1.998 . . . . 70.430000000000007 110.506 173.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.65 150.61 42.84 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.861 -0.609 . . . . 75.510000000000005 111.934 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.9 mt-30 -125.78 145.59 50.14 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.439 -0.949 . . . . 72.129999999999995 108.439 174.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 480' ' ' ILE . 4.7 tpt180 -148.15 156.92 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.013 -1.106 . . . . 71.430000000000007 108.013 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 44.5 tt0 -83.45 136.56 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.923 -0.399 . . . . 74.200000000000003 109.923 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.06 131.08 52.28 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 106.762 -1.57 . . . . 75.099999999999994 106.762 176.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 443' ' ' LYS . 32.1 Cg_endo -70.11 141.3 43.45 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.119 1.212 . . . . 65.430000000000007 110.656 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.36 -5.63 56.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.219 0.533 . . . . 75.040000000000006 111.743 -175.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 430' ' ' PRO . 34.2 m -76.7 -3.83 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 75.310000000000002 111.019 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.9 m -59.98 -27.58 66.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 41.32 110.786 178.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 37.6 p -69.15 -12.54 61.76 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.516 -0.766 . . . . 75.019999999999996 112.324 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.99 -47.66 17.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.795 0.665 . . . . 74.439999999999998 112.795 -177.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 27.0 m -153.77 141.06 19.6 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.662 -0.649 . . . . 62.329999999999998 109.921 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -56.18 -50.78 70.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.995 0.518 . . . . 72.219999999999999 112.208 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.32 -45.21 76.35 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.247 0.546 . . . . 63.100000000000001 111.22 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.38 -38.51 78.06 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.001 -0.999 . . . . 74.349999999999994 110.337 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -47.26 86.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.382 0.426 . . . . 64.340000000000003 110.328 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.47 -45.73 93.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.102 -0.499 . . . . 65.209999999999994 110.585 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.59 -41.63 88.2 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.753 0.279 . . . . 53.340000000000003 111.753 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.455 ' HB3' ' CG ' ' A' ' 430' ' ' PRO . 72.1 mmtt -62.77 -42.1 99.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.767 0.318 . . . . 54.530000000000001 111.616 178.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.31 -39.53 82.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.275 -0.421 . . . . 64.510000000000005 111.248 176.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 63.5 m -62.54 -39.58 94.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.573 -0.528 . . . . 73.040000000000006 109.573 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.63 65.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.628 . . . . 65.349999999999994 111.076 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -13.48 56.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.954 0.407 . . . . 44.399999999999999 110.154 177.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.32 -17.09 14.59 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.082 -0.58 . . . . 54.140000000000001 113.225 176.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.59 117.59 13.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.976 0.388 . . . . 71.120000000000005 111.062 -175.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.41 10.74 16.81 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 110.552 -1.019 . . . . 55.439999999999998 110.552 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -105.89 111.72 24.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.416 -1.327 . . . . 62.420000000000002 107.416 -177.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -132.77 146.87 52.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.375 0.607 . . . . 62.340000000000003 112.21 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -143.01 122.96 13.52 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.771 -1.566 . . . . 65.120000000000005 106.771 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -99.59 134.93 41.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.785 0.326 . . . . 64.400000000000006 110.581 -176.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -134.18 150.79 51.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.217 -1.031 . . . . 53.329999999999998 108.217 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.43 140.47 51.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.781 -0.452 . . . . 62.140000000000001 109.781 178.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 8.5 t -127.03 137.37 30.47 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.424 -1.324 . . . . 72.299999999999997 107.424 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.9 Cg_exo -61.23 119.5 6.68 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.338 2.025 . . . . 75.439999999999998 111.189 -177.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.2 m -131.34 -179.84 5.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.527 -0.76 . . . . 61.100000000000001 109.174 -176.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.467 ' HB ' HD13 ' A' ' 463' ' ' LEU . 62.7 m -68.45 136.78 90.9 Favored Pre-proline 0 N--CA 1.428 -1.568 0 N-CA-C 107.848 -1.168 . . . . 73.120000000000005 107.848 174.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.8 -22.88 7.69 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.846 3.697 . . . . 73.230000000000004 114.707 -176.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.58 -17.56 60.0 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.002 0.43 . . . . 74.140000000000001 111.356 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.3 mp -99.67 11.49 39.07 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.959 0.355 . . . . 73.140000000000001 111.959 -178.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 31.0 m -59.61 127.72 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.217 0.532 . . . . 61.32 111.629 176.092 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.49 -1.42 88.36 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 115.539 -0.755 . . . . 71.209999999999994 111.839 178.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 463' ' ' LEU . 62.8 tttp -101.54 138.94 37.87 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.122 -1.066 . . . . 62.329999999999998 108.122 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 486' ' ' ILE . 60.0 t -84.11 128.08 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.987 0.423 . . . . 63.240000000000002 110.38 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.98 -16.9 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 112.165 0.432 . . . . 63.109999999999999 112.165 -177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.43 166.01 33.5 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.795 -0.717 . . . . 74.420000000000002 111.769 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.8 p -135.77 155.55 50.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.45 -0.945 . . . . 75.0 108.45 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.88 -55.62 42.92 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.421 -0.323 . . . . 71.409999999999997 111.847 176.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.6 Cg_exo -76.8 142.71 22.85 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 108.162 -1.514 . . . . 74.420000000000002 108.162 172.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 30.8 Cg_endo -61.92 127.46 21.46 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.287 1.992 . . . . 72.519999999999996 111.761 -177.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.83 2.58 22.6 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.065 -0.971 . . . . 65.239999999999995 112.013 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . 0.454 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -111.32 3.48 18.33 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.328 -0.396 . . . . 75.209999999999994 110.668 177.32 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.526 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 8.7 tp-100 -129.57 166.07 20.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.493 0.663 . . . . 60.450000000000003 111.539 -170.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 62.6 m -81.85 124.18 29.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.644 -1.162 . . . . 55.229999999999997 109.799 176.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -127.37 149.47 50.05 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.761 0.424 . . . . 74.409999999999997 110.008 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.16 135.71 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.629 0.252 . . . . 73.140000000000001 110.63 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 427' ' ' ARG . 42.1 mm -62.94 -14.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.88 1.272 . . . . 71.140000000000001 112.282 -174.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -87.51 -2.55 58.69 Favored 'General case' 0 C--N 1.313 -1.003 0 O-C-N 121.6 -0.688 . . . . 62.240000000000002 110.635 -177.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 44.4 m-80 -84.61 136.98 33.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.473 -0.565 . . . . 73.299999999999997 109.473 178.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.85 124.45 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.278 -1.008 . . . . 62.229999999999997 108.278 176.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.96 119.09 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 C-N-CA 119.239 -0.984 . . . . 74.450000000000003 109.005 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.9 mp -91.7 112.66 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 N-CA-C 104.557 -2.386 . . . . 75.310000000000002 104.557 173.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.03 118.55 52.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.09 -1.078 . . . . 64.200000000000003 108.09 -175.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.63 118.35 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.578 0.704 . . . . 71.230000000000004 109.356 -176.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.81 141.3 16.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 107.798 -1.186 . . . . 72.540000000000006 107.798 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.9 124.29 6.52 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.002 -1.239 . . . . 64.25 110.002 177.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.1 t -141.52 136.49 31.22 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.613 -0.884 . . . . 71.439999999999998 108.613 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.665 0 N-CA-C 109.395 -1.482 . . . . 74.439999999999998 109.395 -179.577 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 . . . . . 0 N--CA 1.436 -1.139 0 N-CA-C 105.817 -1.92 . . . . 74.230000000000004 105.817 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.88 149.34 21.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 C-N-CA 120.146 -0.622 . . . . 54.439999999999998 110.822 -175.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -94.28 137.22 33.7 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 105.756 -1.942 . . . . 74.420000000000002 105.756 173.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.09 124.79 52.91 Favored Pre-proline 0 C--N 1.279 -2.487 0 C-N-CA 118.342 -1.343 . . . . 72.239999999999995 110.536 -169.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -51.06 129.25 27.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.57 2.847 . . . . 61.329999999999998 113.006 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.3 140.4 43.09 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.492 -1.231 . . . . 61.149999999999999 111.285 -175.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.41 20.28 5.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.635 -1.246 . . . . 41.109999999999999 107.635 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -64.64 133.38 52.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.961 -1.018 . . . . 72.319999999999993 111.457 -178.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 0.19 46.58 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.071 -0.968 . . . . 51.100000000000001 110.905 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -125.22 -179.81 4.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.991 -0.744 . . . . 73.019999999999996 108.991 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 93.9 p -72.48 143.04 48.55 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.485 0.584 . . . . 63.200000000000003 111.389 -176.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 374' ' ' ILE . 27.9 m -62.34 -33.65 75.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.971 178.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.67 94.44 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-N 116.299 -0.409 . . . . 72.040000000000006 111.062 178.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.99 -35.07 76.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 109.889 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.69 92.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.84 -0.618 . . . . 74.420000000000002 110.516 176.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 384' ' ' ILE . 82.6 mt -57.79 -46.91 87.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 122.644 0.377 . . . . 75.400000000000006 110.078 178.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.6 94.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.972 -0.558 . . . . 53.119999999999997 111.288 179.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 57.0 m -61.66 -47.64 84.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.894 -0.594 . . . . 72.209999999999994 110.952 -179.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.3 -38.45 91.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.388 -0.369 . . . . 75.040000000000006 111.465 178.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.87 -42.89 94.71 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.65 0.594 . . . . 73.019999999999996 109.6 178.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.356 0.873 . . . . 53.130000000000003 113.356 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.96 -14.71 53.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.127 0.489 . . . . 52.009999999999998 110.022 173.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.43 53.51 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.941 -0.572 . . . . 52.219999999999999 112.874 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 43.3 m-85 -84.19 152.96 23.93 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.427 0.632 . . . . 73.120000000000005 111.938 -177.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.64 134.54 34.6 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.008 -1.479 . . . . 74.010000000000005 107.008 177.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -117.47 136.64 53.97 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 C-N-CA 119.197 -1.001 . . . . 72.319999999999993 111.874 -179.14 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -111.69 128.38 56.05 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.003 -1.908 . . . . 74.510000000000005 105.976 178.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.0 m -111.41 136.65 50.26 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 119.403 -0.919 . . . . 42.119999999999997 109.444 -178.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -120.18 117.89 29.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.513 -1.662 . . . . 74.109999999999999 106.513 176.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 122.05 46.11 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.484 -1.673 . . . . 62.409999999999997 106.484 177.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -139.61 148.38 55.75 Favored Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 118.893 -1.123 . . . . 75.409999999999997 110.746 178.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 85.1 Cg_endo -85.48 163.74 10.96 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.274 1.983 . . . . 61.200000000000003 109.584 170.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.2 t70 165.22 -173.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.754 -2.313 . . . . 71.109999999999999 104.754 176.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.4 t -115.84 -25.39 7.77 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.566 -1.642 . . . . 72.510000000000005 106.566 174.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 9.9 m -98.47 69.2 1.9 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.621 -2.363 . . . . 75.439999999999998 104.621 171.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 421' ' ' SER . 4.4 pt -95.97 138.56 21.66 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 113.673 -1.603 . . . . 51.240000000000002 112.921 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 421' ' ' SER . 16.7 Cg_exo -70.4 114.35 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 106.224 -2.26 . . . . 72.239999999999995 106.224 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.11 160.34 13.12 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.514 2.809 . . . . 52.420000000000002 115.54 -169.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.06 -6.86 2.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.107 0.963 . . . . 74.319999999999993 112.003 176.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.9 m170 -107.47 120.15 41.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 103.662 -2.718 . . . . 72.099999999999994 103.662 171.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.97 117.97 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.088 0.947 . . . . 71.030000000000001 109.822 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.91 -28.87 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.947 -1.024 . . . . 44.399999999999999 110.441 -174.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.44 157.98 27.56 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.973 -1.251 . . . . 73.25 109.973 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.7 p -118.28 -178.76 3.59 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 123.194 0.598 . . . . 72.549999999999997 109.97 -177.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -102.08 155.2 36.74 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.374 -0.602 . . . . 64.109999999999999 109.374 -176.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.4 -30.66 64.44 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.085 2.523 . . . . 75.540000000000006 113.902 -176.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.15 -30.7 65.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.895 0.378 . . . . 65.329999999999998 110.244 -175.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.54 65.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.594 0.711 . . . . 50.420000000000002 110.05 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . 0.439 ' N ' HD22 ' A' ' 407' ' ' ASN . 0.9 OUTLIER -95.8 -4.64 43.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 111.876 -177.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.1 m -100.16 155.39 17.77 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.244 -1.391 . . . . 54.140000000000001 107.244 176.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 55.2 p -74.77 113.17 11.74 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.191 -0.604 . . . . 75.019999999999996 109.584 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.09 169.93 15.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 116.043 -0.526 . . . . 44.219999999999999 110.772 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.0 p -62.36 133.13 54.64 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.702 -0.681 . . . . 73.109999999999999 109.396 175.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.46 109.33 4.73 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.956 -0.387 . . . . 73.230000000000004 109.956 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.91 10.08 5.43 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 120.137 -1.03 . . . . 45.530000000000001 112.339 -178.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.1 -174.02 4.49 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.785 -0.82 . . . . 74.409999999999997 108.785 -177.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.01 132.16 34.12 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 118.955 0.798 . . . . 72.140000000000001 112.589 -175.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.67 135.24 59.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 106.474 -1.676 . . . . 73.319999999999993 106.474 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.9 t -96.84 130.94 44.04 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 122.086 0.946 . . . . 71.409999999999997 111.764 -177.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.33 122.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 114.577 -1.192 . . . . 65.239999999999995 108.453 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -95.89 129.01 43.27 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.745 -0.661 . . . . 71.5 111.447 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.83 130.81 52.93 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 108.14 -1.059 . . . . 75.340000000000003 108.14 177.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.49 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 36.6 p -88.09 121.45 30.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.491 -0.559 . . . . 74.329999999999998 109.491 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 m -120.89 104.82 10.14 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 119.767 -0.773 . . . . 63.310000000000002 110.645 177.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.69 125.39 1.59 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 120.546 -0.835 . . . . 71.540000000000006 113.93 176.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 56.2 Cg_endo -86.49 130.31 3.28 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.33 2.02 . . . . 61.119999999999997 112.562 176.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.461 ' OE1' ' HA ' ' A' ' 391' ' ' ASP . 47.6 mt-10 -89.4 137.5 32.27 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.465 0.65 . . . . 75.329999999999998 112.12 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.47 150.45 48.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.546 -1.65 . . . . 74.219999999999999 106.546 173.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 480' ' ' ILE . 3.4 tpt180 -136.27 148.46 48.02 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.307 -0.998 . . . . 73.420000000000002 108.307 -174.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.9 136.5 34.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.513 -0.921 . . . . 65.329999999999998 108.513 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 70.8 mt -81.8 131.54 57.11 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.834 -0.802 . . . . 71.340000000000003 108.834 -178.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.65 140.6 87.36 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.583 1.522 . . . . 72.140000000000001 111.876 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.32 0.77 55.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 111.191 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -76.12 -7.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.446 0.641 . . . . 41.119999999999997 109.464 176.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.9 p -54.96 -49.68 70.78 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.361 -0.836 . . . . 63.450000000000003 111.687 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 2.1 m -63.79 -22.28 66.83 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.361 1.065 . . . . 70.0 111.761 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.27 -42.47 13.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.263 0.468 . . . . 74.230000000000004 112.263 -173.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.4 m -145.21 124.12 12.71 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.542 -0.724 . . . . 73.109999999999999 110.905 -178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.24 -53.52 55.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.724 0.639 . . . . 75.420000000000002 112.724 -178.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.43 94.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.737 0.303 . . . . 73.019999999999996 111.495 -176.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.53 -37.68 88.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.652 -0.704 . . . . 73.109999999999999 109.407 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.32 -47.18 87.15 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.922 -0.581 . . . . 54.229999999999997 110.76 -179.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.35 -45.71 93.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 61.109999999999999 110.414 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 9.9 mmpt? -64.46 -47.27 79.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 65.319999999999993 110.967 -178.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.14 -38.88 89.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.329 -0.396 . . . . 73.349999999999994 111.476 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.2 -43.41 86.83 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.338 0.399 . . . . 64.040000000000006 110.366 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 24.3 m -66.84 -46.01 76.45 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.404 0.621 . . . . 61.439999999999998 109.785 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.31 -15.97 63.45 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.374 -0.83 . . . . 73.099999999999994 112.053 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.56 59.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.464 . . . . 64.120000000000005 109.985 178.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.08 -16.4 11.97 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.748 -0.739 . . . . 23.350000000000001 112.036 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 93.6 m-85 -77.49 108.66 10.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.782 0.325 . . . . 64.349999999999994 110.503 -179.053 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.37 20.64 15.83 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.554 -1.019 . . . . 74.209999999999994 110.554 176.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -114.17 111.91 22.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 106.507 -1.664 . . . . 65.420000000000002 106.507 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.49 153.22 45.42 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.438 0.532 . . . . 72.129999999999995 112.438 -170.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 56.4 tptt -150.9 123.41 8.46 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 105.451 -2.055 . . . . 73.510000000000005 105.451 172.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -121.96 134.82 54.83 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.315 -0.554 . . . . 65.319999999999993 111.584 -173.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -142.38 165.02 28.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.1 -0.5 . . . . 62.420000000000002 110.514 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.458 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.7 m120 -116.44 142.07 47.35 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.719 -0.845 . . . . 62.329999999999998 108.719 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 19.1 t -131.04 138.55 33.22 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 108.749 -0.834 . . . . 73.010000000000005 108.749 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_exo -61.56 121.1 9.07 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.303 2.002 . . . . 72.329999999999998 110.558 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.3 m -134.26 -178.55 5.09 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 63.130000000000003 107.62 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 16.5 p -68.24 150.24 97.8 Favored Pre-proline 0 N--CA 1.427 -1.586 0 C-N-CA 120.563 -0.455 . . . . 73.530000000000001 109.822 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 464' ' ' VAL . 15.0 Cg_endo -55.69 -23.59 41.71 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.488 2.792 . . . . 71.420000000000002 113.137 -177.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -75.36 -18.45 59.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.869 0.366 . . . . 72.230000000000004 111.871 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.72 -4.45 40.7 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.992 -0.443 . . . . 73.040000000000006 112.102 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.8 p -59.51 136.58 22.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-O 120.717 0.294 . . . . 70.430000000000007 110.935 -178.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.32 84.04 Favored Glycine 0 C--N 1.311 -0.831 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.389 177.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -124.19 158.87 31.38 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 109.668 -0.493 . . . . 72.120000000000005 109.668 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 434' ' ' THR . 58.1 t -83.93 137.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.8 -1.556 . . . . 45.439999999999998 106.8 178.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.544 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -96.54 -10.66 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.013 -1.475 . . . . 72.109999999999999 110.267 178.133 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 146.56 174.54 18.76 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 115.424 -0.807 . . . . 44.549999999999997 111.524 175.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.0 p -116.58 152.22 34.61 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.97 -1.122 . . . . 74.209999999999994 107.97 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -66.79 -46.06 55.53 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 118.74 -1.184 . . . . 65.239999999999995 111.874 178.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.39 110.15 3.0 Favored 'Trans proline' 0 C--N 1.362 1.261 0 N-CA-C 106.887 -2.005 . . . . 54.119999999999997 106.887 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.02 162.31 32.04 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.292 1.995 . . . . 75.140000000000001 114.286 -171.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.73 -5.15 35.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.348 177.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.49 6.05 49.99 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.421 -1.263 . . . . 71.519999999999996 109.616 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -135.62 162.48 32.59 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.109 -0.701 . . . . 74.109999999999999 109.109 -177.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.7 m -104.47 111.73 24.51 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.235 -1.765 . . . . 70.019999999999996 106.235 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 14.9 t -106.55 148.3 28.4 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.332 -0.547 . . . . 74.540000000000006 109.874 -175.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.25 141.03 58.92 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.283 -0.417 . . . . 35.43 110.41 178.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 28.9 mm -60.92 -22.61 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.467 0.707 . . . . 61.130000000000003 112.876 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.0 t -91.55 4.43 52.62 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.692 0.758 . . . . 64.319999999999993 110.123 -178.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.67 138.55 34.1 Favored 'General case' 0 CA--C 1.481 -1.687 0 O-C-N 122.015 -0.428 . . . . 74.0 110.47 177.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.54 116.32 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 108.887 -0.783 . . . . 71.329999999999998 108.887 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.08 120.22 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 108.189 -1.041 . . . . 71.129999999999995 108.189 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 0.2 OUTLIER -92.73 117.07 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 106.93 -1.507 . . . . 61.409999999999997 106.93 -178.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 112.4 39.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.948 -1.024 . . . . 42.32 108.347 -177.335 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 485' ' ' ILE . 3.3 mp -102.75 124.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.588 -0.733 . . . . 75.530000000000001 109.275 -177.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.458 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 28.0 t -97.59 134.45 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.248 -1.39 . . . . 65.299999999999997 107.248 178.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -84.07 131.85 10.68 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 110.992 -0.843 . . . . 50.109999999999999 110.992 -178.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.3 t -141.04 132.39 26.71 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.82 -0.808 . . . . 53.25 108.82 178.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.07 0 N-CA-C 109.244 -1.542 . . . . 65.510000000000005 109.244 174.575 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 107.972 -1.122 . . . . 64.140000000000001 107.972 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.2 150.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 112.398 0.518 . . . . 72.109999999999999 112.398 -170.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -96.4 136.55 36.75 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.538 -1.282 . . . . 53.25 107.538 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.68 131.3 27.22 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.916 -0.713 . . . . 52.149999999999999 110.079 -175.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.14 142.13 78.46 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.392 2.728 . . . . 70.400000000000006 113.946 -178.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.44 139.39 36.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.698 -1.137 . . . . 73.329999999999998 109.985 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 373' ' ' ALA . 12.6 t -113.24 30.98 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 122.51 1.147 . . . . 73.140000000000001 109.794 -175.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 1.7 ppt_? -65.39 144.58 56.99 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.582 -0.736 . . . . 74.409999999999997 112.525 178.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 93.4 -5.81 74.61 Favored Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.94 -0.573 . . . . 75.329999999999998 111.699 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -117.34 176.01 5.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.294 -0.632 . . . . 74.319999999999993 109.294 -175.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.8 p -73.92 154.11 39.53 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.742 0.306 . . . . 72.430000000000007 111.139 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.2 -36.1 82.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.752 0.311 . . . . 64.030000000000001 110.619 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.97 93.62 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.104 -0.498 . . . . 53.340000000000003 111.033 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.77 -43.55 92.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.747 -0.464 . . . . 73.209999999999994 109.747 177.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -58.77 -51.53 69.6 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.964 -0.562 . . . . 73.549999999999997 111.084 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.62 -42.47 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.347 -0.388 . . . . 73.409999999999997 111.157 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.39 93.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.433 -0.348 . . . . 74.310000000000002 110.993 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 61.9 m -61.88 -47.24 85.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.551 -0.295 . . . . 60.43 110.882 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.89 -38.81 92.46 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.621 -0.263 . . . . 73.109999999999999 110.941 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -59.88 -46.92 87.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.908 0.755 . . . . 73.400000000000006 109.647 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -66.43 -27.41 67.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.78 -0.646 . . . . 62.009999999999998 111.774 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 376' ' ' THR . 11.8 mmt180 -81.21 -14.94 57.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.402 -0.363 . . . . 64.510000000000005 110.797 178.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.73 53.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.439 -0.886 . . . . 73.219999999999999 112.029 178.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.16 158.65 15.37 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.385 -0.598 . . . . 54.439999999999998 109.385 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.53 161.43 13.64 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.232 -1.025 . . . . 61.310000000000002 108.232 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 154.98 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.872 0.844 . . . . 71.530000000000001 112.79 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 417' ' ' THR . 6.7 ttp180 -141.99 129.74 21.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.885 -1.154 . . . . 72.0 107.885 175.445 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.3 m -100.51 130.38 46.58 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.7 -0.481 . . . . 71.0 109.7 -177.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.94 119.11 36.79 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.708 -1.59 . . . . 73.230000000000004 106.708 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 123.84 39.41 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 72.230000000000004 108.724 177.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -114.57 118.13 41.73 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.747 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 3.0 Cg_endo -88.31 128.43 2.2 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 N-CA-C 107.456 -1.786 . . . . 61.149999999999999 107.456 167.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 -163.88 -178.09 5.47 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.665 -1.214 . . . . 73.140000000000001 110.731 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.2 m -88.87 -42.18 12.01 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.195 -1.78 . . . . 64.099999999999994 106.195 175.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.4 m -88.69 63.43 6.91 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.458 -1.246 . . . . 61.109999999999999 108.636 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 394' ' ' ILE . 2.3 pp -98.77 112.97 63.93 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 114.156 1.169 . . . . 63.049999999999997 114.156 179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 73.8 Cg_endo -80.44 170.37 16.04 Favored 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.09 1.86 . . . . 70.340000000000003 110.369 171.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.72 162.65 17.8 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.391 2.727 . . . . 63.240000000000002 112.691 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.66 -8.7 0.95 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 124.218 1.007 . . . . 64.099999999999994 113.135 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -79.78 159.72 26.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.783 -1.192 . . . . 74.230000000000004 107.783 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.56 117.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 105.942 -1.873 . . . . 73.200000000000003 105.942 175.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.6 pp -92.91 -28.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.408 0.623 . . . . 74.319999999999993 111.79 -178.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -160.99 158.1 29.67 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.717 -1.753 . . . . 42.200000000000003 108.717 178.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -114.43 -179.85 3.75 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 109.189 -0.671 . . . . 75.530000000000001 109.189 179.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.12 140.94 21.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.225 -1.028 . . . . 72.519999999999996 108.225 178.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.69 -29.46 2.34 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.0 3.134 . . . . 44.530000000000001 114.536 177.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.63 60.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.209 0.603 . . . . 64.420000000000002 111.98 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.16 65.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 61.509999999999998 109.857 177.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 4.7 52.32 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.328 -0.851 . . . . 72.549999999999997 110.735 -174.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -92.64 146.39 23.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 105.118 -2.178 . . . . 73.099999999999994 105.118 171.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.5 m -74.37 123.44 24.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 118.797 0.726 . . . . 74.120000000000005 110.171 -178.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.8 169.67 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.772 -1.196 . . . . 60.409999999999997 107.772 -177.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.8 m -66.7 138.86 57.71 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.266 -1.013 . . . . 55.43 108.266 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.18 111.36 3.89 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.079 -0.341 . . . . 73.230000000000004 110.079 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.63 43.33 0.97 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.752 -0.737 . . . . 51.219999999999999 112.162 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.65 -179.36 3.79 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.354 -1.721 . . . . 62.32 106.354 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -102.65 135.29 44.55 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.505 0.669 . . . . 75.109999999999999 111.725 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.7 mm -110.28 128.47 66.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.372 -1.344 . . . . 63.210000000000001 107.372 176.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 385' ' ' ARG . 69.4 p -100.42 130.71 46.55 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.577 -0.527 . . . . 70.420000000000002 109.577 -177.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.48 122.63 69.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.013 -0.54 . . . . 74.319999999999993 110.177 -176.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -91.17 129.46 37.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.141 0.496 . . . . 44.409999999999997 110.998 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.44 146.95 30.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.286 -1.376 . . . . 64.239999999999995 107.286 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.423 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 13.5 m -90.57 122.65 33.56 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.822 -0.751 . . . . 72.430000000000007 111.815 -176.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 32.8 m -120.37 106.16 11.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 109.539 -0.541 . . . . 64.120000000000005 109.539 174.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 77.32 130.57 0.47 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 120.889 -0.672 . . . . 63.240000000000002 114.772 176.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.4 Cg_exo -78.6 144.18 19.63 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.702 1.601 . . . . 63.420000000000002 109.425 171.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 146.06 47.96 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 116.292 -0.413 . . . . 71.450000000000003 109.906 -178.261 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.5 mt-30 -121.52 141.29 51.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.168 -0.924 . . . . 74.400000000000006 108.65 -176.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -143.45 158.68 43.45 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.954 -1.498 . . . . 73.519999999999996 106.954 -177.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.6 OUTLIER -90.1 139.62 30.45 Favored 'General case' 0 C--N 1.28 -2.419 0 O-C-N 123.088 0.242 . . . . 71.540000000000006 110.854 179.512 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -80.03 119.86 77.95 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.788 -1.56 . . . . 72.25 106.788 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.82 140.74 67.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.702 2.268 . . . . 74.340000000000003 113.589 -178.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.61 -22.58 62.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.771 -1.104 . . . . 73.310000000000002 112.364 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.18 2.98 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.679 -0.692 . . . . 71.349999999999994 111.748 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.9 t -62.75 -27.14 69.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.309 0.644 . . . . 74.439999999999998 110.597 179.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 28.0 p -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 112.851 0.685 . . . . 72.219999999999999 112.851 -177.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 82.6 mt -67.26 -49.01 66.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.912 1.079 . . . . 43.409999999999997 113.912 -171.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.6 m -160.43 148.8 16.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.592 -0.892 . . . . 74.019999999999996 108.592 -175.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.51 -49.83 75.98 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.873 0.694 . . . . 73.129999999999995 112.873 -177.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.01 89.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.714 0.293 . . . . 74.409999999999997 110.942 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.22 -46.32 90.9 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.639 -0.874 . . . . 72.209999999999994 108.639 177.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.66 76.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.948 -1.024 . . . . 63.310000000000002 110.409 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.82 -48.08 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.362 -0.381 . . . . 72.439999999999998 111.089 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.868 0.322 . . . . 73.439999999999998 111.868 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -66.33 -42.12 88.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 111.902 0.334 . . . . 72.049999999999997 111.902 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.43 -38.63 81.38 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.975 -0.29 . . . . 74.209999999999994 111.741 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 86.4 m -62.31 -40.46 96.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.736 -0.468 . . . . 74.209999999999994 109.736 177.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.46 -26.61 66.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.916 -0.584 . . . . 44.219999999999999 111.042 178.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 -13.01 56.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.211 0.529 . . . . 44.140000000000001 110.47 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.55 29.74 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.944 -0.646 . . . . 73.030000000000001 113.267 178.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -78.29 102.65 7.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 117.362 0.581 . . . . 74.219999999999999 109.597 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.73 15.83 34.24 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.694 -0.765 . . . . 44.530000000000001 111.301 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -118.21 110.63 17.8 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.733 -1.21 . . . . 75.129999999999995 107.733 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.35 150.26 45.7 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.589 -176.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.522 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.4 OUTLIER -141.88 122.87 14.55 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.454 -2.054 . . . . 73.219999999999999 105.454 171.239 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.57 134.62 39.56 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.008 -0.677 . . . . 73.319999999999993 109.61 -178.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.19 141.47 49.09 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.938 -1.134 . . . . 74.299999999999997 107.938 176.287 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.5 m-80 -116.57 140.12 49.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.598 -1.26 . . . . 74.209999999999994 107.598 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -138.62 150.35 65.66 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 109.846 -0.427 . . . . 75.340000000000003 109.846 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_endo -60.71 120.22 7.83 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.496 2.131 . . . . 73.219999999999999 112.184 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -127.27 -178.45 4.45 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.027 -1.471 . . . . 63.140000000000001 107.027 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.0 t -68.88 137.95 90.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.968 -0.752 . . . . 70.430000000000007 108.968 176.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.15 -23.74 23.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.741 2.961 . . . . 70.430000000000007 113.98 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.7 -23.95 58.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.797 0.332 . . . . 75.319999999999993 111.677 -177.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.33 12.57 31.54 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.334 0.494 . . . . 72.420000000000002 112.334 -177.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.6 p -59.31 126.74 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.388 0.613 . . . . 71.340000000000003 111.143 179.311 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.55 0.07 61.11 Favored Glycine 0 C--N 1.309 -0.968 0 CA-C-N 115.987 -0.551 . . . . 51.439999999999998 112.266 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.63 144.84 30.51 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.668 -1.234 . . . . 75.340000000000003 107.668 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 84.3 t -82.28 126.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.86 -1.163 . . . . 73.239999999999995 107.86 177.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.46 -15.13 7.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.34 -0.544 . . . . 74.349999999999994 112.01 -175.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.02 177.24 33.95 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 120.451 -0.88 . . . . 74.140000000000001 111.576 178.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 486' ' ' ILE . 8.7 p -125.23 158.81 33.12 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.226 -1.027 . . . . 72.010000000000005 108.226 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 0.9 OUTLIER -63.14 -54.35 46.47 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 120.338 -0.545 . . . . 73.099999999999994 110.52 176.103 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 7.6 Cg_exo -78.14 108.6 2.53 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 106.037 -2.332 . . . . 64.129999999999995 106.037 164.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 149.87 89.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.601 2.201 . . . . 71.319999999999993 114.798 -169.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.46 7.65 2.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.742 1.217 . . . . 70.420000000000002 111.987 -177.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.1 -3.05 16.63 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.474 -0.784 . . . . 63.119999999999997 110.605 177.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -129.06 169.65 14.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.036 0.446 . . . . 72.129999999999995 111.335 -171.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 15.7 m -102.43 135.54 43.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.265 1.026 . . . . 74.519999999999996 108.789 -179.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.8 t -137.46 148.07 45.81 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.425 -0.583 . . . . 71.200000000000003 109.425 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.91 145.6 53.53 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.964 -0.384 . . . . 63.140000000000001 109.964 175.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.9 mm -70.17 -3.33 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.125 0.964 . . . . 72.150000000000006 111.396 -177.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -86.81 5.37 36.91 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.762 0.792 . . . . 65.439999999999998 110.325 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -110.45 138.09 47.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.358 -0.837 . . . . 65.299999999999997 109.473 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.86 124.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.281 -1.007 . . . . 75.400000000000006 108.281 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.0 t -87.36 118.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 C-N-CA 119.074 -1.051 . . . . 61.039999999999999 108.486 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 56.2 mt -93.95 112.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.081 -1.451 . . . . 70.430000000000007 107.081 176.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -98.62 122.28 50.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.33 -0.989 . . . . 64.530000000000001 108.33 -176.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 26.9 mt -100.87 119.92 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.318 0.58 . . . . 74.319999999999993 110.499 -174.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.534 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 88.9 t -97.99 128.77 49.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.959 -1.126 . . . . 61.299999999999997 107.959 178.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.31 115.42 6.03 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.184 -0.766 . . . . 75.129999999999995 111.184 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 37.5 m -120.35 109.88 15.88 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.334 -0.617 . . . . 61.229999999999997 109.334 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.356 0 N-CA-C 109.478 -1.449 . . . . 75.420000000000002 109.478 -179.211 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 409' ' ' SER . 4.3 p-10 . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 109.1 -0.704 . . . . 72.25 109.1 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.6 m -134.32 153.89 36.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.722 -0.473 . . . . 63.020000000000003 109.722 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -100.86 137.07 39.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.851 -1.166 . . . . 72.010000000000005 107.851 175.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.87 124.5 47.68 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 119.556 -0.858 . . . . 64.140000000000001 110.804 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.1 145.05 98.99 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.89 2.393 . . . . 75.329999999999998 112.355 177.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.98 166.1 16.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.872 -0.603 . . . . 74.200000000000003 110.451 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.4 HG12 ' HB2' ' A' ' 368' ' ' GLN . 15.7 t -117.47 41.68 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.495 1.14 . . . . 53.210000000000001 108.488 -175.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -52.57 128.66 26.78 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.344 -1.298 . . . . 75.510000000000005 113.79 -175.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.76 -18.65 57.02 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 115.503 -0.771 . . . . 72.319999999999993 113.228 173.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.4 ' HB2' HG12 ' A' ' 365' ' ' VAL . 25.3 mt-30 -97.73 166.7 11.36 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.613 0.245 . . . . 62.340000000000003 111.198 -176.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 81.2 p -63.3 145.04 56.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.511 . . . . 33.420000000000002 110.684 -175.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.9 p -63.66 -34.08 77.05 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.951 -0.3 . . . . 63.049999999999997 110.275 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.32 88.73 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.193 -0.458 . . . . 60.210000000000001 110.358 176.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -35.08 79.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 110.23 178.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -50.44 71.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 72.209999999999994 110.797 178.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.27 -43.96 87.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 123.416 0.448 . . . . 63.210000000000001 110.407 178.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.36 90.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 110.74 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -46.94 86.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.736 -0.211 . . . . 54.409999999999997 110.831 178.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.98 -39.3 93.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.198 -0.201 . . . . 53.299999999999997 110.753 177.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.2 -44.34 97.45 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.223 0.609 . . . . 64.329999999999998 110.272 179.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.43 -26.27 64.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.779 -0.646 . . . . 60.340000000000003 111.805 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -81.56 -13.5 57.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.226 -0.443 . . . . 63.049999999999997 110.96 175.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 94.59 16.58 42.13 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.272 -0.965 . . . . 71.120000000000005 112.368 177.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.56 159.79 14.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.034 -0.728 . . . . 43.049999999999997 109.034 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 33.5 mmtp -104.9 157.51 17.17 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.263 -1.384 . . . . 64.040000000000006 107.263 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -136.9 157.48 35.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.451 0.643 . . . . 73.150000000000006 112.04 -175.598 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 417' ' ' THR . 37.8 ttm105 -127.41 133.11 50.01 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.612 -1.996 . . . . 71.040000000000006 105.612 171.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.7 m -122.32 121.28 36.36 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.204 -0.665 . . . . 54.119999999999997 109.204 -175.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.35 119.2 35.49 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.59 -1.263 . . . . 74.430000000000007 107.59 178.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -113.5 124.1 51.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.642 -0.503 . . . . 73.519999999999996 109.642 178.283 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -132.76 144.28 52.22 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 120.604 -0.439 . . . . 72.450000000000003 110.777 -177.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.82 144.15 13.6 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 N-CA-C 107.662 -1.707 . . . . 75.239999999999995 107.662 166.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.474 ' HB3' HG23 ' A' ' 394' ' ' ILE . 8.2 t70 -153.42 172.69 16.71 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 118.62 -1.232 . . . . 75.209999999999994 110.227 -176.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.8 m -87.38 -34.72 18.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.731 -1.581 . . . . 43.210000000000001 106.731 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.0 p -108.02 70.24 0.76 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 113.905 -1.498 . . . . 54.140000000000001 109.426 177.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.0 pp -90.0 121.74 68.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.35 1.241 . . . . 73.0 114.35 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.42 172.88 10.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.557 2.171 . . . . 74.420000000000002 108.516 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.73 153.54 61.59 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 122.157 1.905 . . . . 73.329999999999998 111.594 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -6.87 11.62 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.623 0.725 . . . . 63.229999999999997 111.935 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -82.26 143.53 31.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.917 -1.038 . . . . 75.019999999999996 108.858 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.92 118.01 22.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.938 -1.105 . . . . 64.299999999999997 108.889 -178.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.47 -47.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.014 -1.106 . . . . 70.109999999999999 108.014 -178.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.55 170.48 35.8 Favored Glycine 0 N--CA 1.403 -3.543 0 N-CA-C 109.6 -1.4 . . . . 52.109999999999999 109.6 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -119.05 -178.7 3.62 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 108.482 -0.933 . . . . 75.299999999999997 108.482 179.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.74 154.71 37.01 Favored Pre-proline 0 C--N 1.282 -2.342 0 N-CA-C 108.326 -0.99 . . . . 75.200000000000003 108.326 176.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -31.9 -32.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.856 1 C-N-CA 125.861 4.374 . . . . 71.329999999999998 116.159 -176.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -47.26 -35.0 7.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.321 1.048 . . . . 71.239999999999995 112.925 -178.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.27 -49.76 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.068 0.461 . . . . 64.5 112.023 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.68 -0.4 56.19 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.806 0.669 . . . . 71.209999999999994 112.806 -176.012 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.9 m -87.73 164.24 16.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.439999999999998 107.723 175.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 359' ' ' ASP . 2.5 p -74.23 113.57 11.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.87 0.843 . . . . 64.400000000000006 112.336 -176.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.62 170.13 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.951 -1.022 . . . . 73.219999999999999 108.856 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.3 t -90.26 151.73 21.38 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.792 -1.188 . . . . 73.430000000000007 107.792 176.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.12 130.92 45.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.328 -0.619 . . . . 71.109999999999999 109.328 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 91.28 25.78 22.95 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.575 -0.822 . . . . 72.200000000000003 112.399 -179.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.01 -175.63 3.93 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.833 -0.803 . . . . 62.310000000000002 108.833 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 29.3 mt-10 -105.43 126.78 52.51 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 118.517 0.598 . . . . 73.329999999999998 111.448 -175.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.59 124.97 60.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.031 -0.729 . . . . 65.409999999999997 109.031 175.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 385' ' ' ARG . 24.8 p -92.25 127.81 37.87 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 109.871 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 82.4 t -124.22 130.85 73.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.427 -176.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -96.87 128.59 43.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.717 -0.674 . . . . 75.25 109.414 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 42.5 t -124.57 140.36 48.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.737 -0.838 . . . . 73.109999999999999 108.737 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.2 p -103.3 122.76 45.46 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.995 0.426 . . . . 54.530000000000001 110.921 179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 25.7 p -118.61 104.93 11.1 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.619 -0.264 . . . . 73.25 110.468 177.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.01 156.11 0.74 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 114.823 0.689 . . . . 52.43 114.823 177.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 2.4 Cg_endo -84.27 149.4 11.86 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.249 1.966 . . . . 51.130000000000003 110.795 173.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.72 149.41 31.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.776 -0.647 . . . . 72.299999999999997 112.678 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.6 mt-30 -107.01 151.88 24.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.579 -1.267 . . . . 75.049999999999997 107.579 176.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 480' ' ' ILE . 0.9 OUTLIER -143.88 164.38 30.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.325 -0.991 . . . . 63.450000000000003 108.325 -179.116 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.01 138.3 33.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.56 -0.533 . . . . 65.430000000000007 109.56 -178.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.2 mt -83.79 123.66 75.81 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 105.932 -1.877 . . . . 74.030000000000001 105.932 174.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.4 141.23 82.31 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.687 2.258 . . . . 72.310000000000002 113.306 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.46 -22.26 25.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.395 -0.821 . . . . 71.200000000000003 110.539 -177.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.49 -12.59 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.695 0.759 . . . . 75.329999999999998 110.507 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 17.6 m -53.9 -36.7 62.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.287 1.035 . . . . 71.209999999999994 112.012 -179.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 8.9 p -69.48 -12.99 62.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.463 0.912 . . . . 75.349999999999994 113.463 -178.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.4 mt -89.97 -41.07 11.96 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.753 0.649 . . . . 55.109999999999999 112.753 -178.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 91.6 m -149.24 125.82 11.0 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.979 -0.378 . . . . 74.219999999999999 109.979 -176.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.75 -48.17 80.4 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.735 . . . . 75.540000000000006 112.983 -178.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.23 90.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 110.95 -178.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 13.8 mm-40 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.953 -0.567 . . . . 71.450000000000003 109.923 179.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.87 -51.08 71.25 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.766 -0.652 . . . . 71.109999999999999 109.736 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.76 -43.8 96.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.743 -0.662 . . . . 74.329999999999998 110.742 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.46 -48.57 74.74 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.167 0.432 . . . . 75.430000000000007 112.167 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 74.4 mmtt -67.62 -39.71 84.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.831 0.348 . . . . 74.409999999999997 111.415 -178.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.05 -39.77 93.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.562 -0.532 . . . . 54.539999999999999 109.562 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 94.3 m -67.45 -41.25 85.02 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.864 -0.607 . . . . 62.43 110.2 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.24 -16.78 63.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.199 -0.455 . . . . 72.5 111.774 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.9 -3.37 59.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.305 -0.407 . . . . 74.299999999999997 110.807 177.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.11 33.84 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.968 -0.634 . . . . 21.329999999999998 113.178 176.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -67.43 139.21 57.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.694 0.283 . . . . 74.040000000000006 110.828 -177.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -142.3 1.08 1.6 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.779 -0.725 . . . . 70.140000000000001 112.615 -179.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -104.0 111.3 23.8 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.535 -1.283 . . . . 71.310000000000002 107.535 178.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -127.28 144.67 51.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.309 -0.405 . . . . 71.200000000000003 110.29 -174.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -134.8 123.49 23.63 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.64 -1.985 . . . . 72.420000000000002 105.64 171.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -107.63 132.11 53.66 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 118.099 0.409 . . . . 75.450000000000003 111.139 -174.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.0 163.22 30.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.1 -0.5 . . . . 71.310000000000002 109.719 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -121.58 131.81 54.33 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.34 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -123.27 144.56 44.02 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 106.799 -1.556 . . . . 72.219999999999999 106.799 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.67 133.5 24.03 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 121.866 1.711 . . . . 41.219999999999999 111.057 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.1 m -143.75 174.97 10.34 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.583 -0.895 . . . . 54.450000000000003 108.583 -178.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 27.2 p -65.35 149.63 96.81 Favored Pre-proline 0 C--N 1.311 -1.09 0 O-C-N 123.463 0.477 . . . . 75.540000000000006 109.842 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.47 -36.26 38.83 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 72.420000000000002 112.365 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -69.26 -22.02 63.86 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.976 0.732 . . . . 72.530000000000001 112.976 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.34 -9.77 21.94 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.778 -0.369 . . . . 74.010000000000005 111.637 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -59.9 126.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 CA-C-O 121.089 0.471 . . . . 71.439999999999998 110.372 177.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.24 -7.19 58.32 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.1 -0.8 . . . . 62.100000000000001 111.1 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.8 mptp? -107.34 156.27 19.08 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.792 -0.818 . . . . 54.310000000000002 108.792 177.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HD11 ' A' ' 486' ' ' ILE . 59.1 t -84.15 127.58 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.654 -1.239 . . . . 71.400000000000006 107.654 175.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.9 -19.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.138 0.792 . . . . 72.400000000000006 113.138 -175.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.36 167.96 31.51 Favored Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.422 -0.894 . . . . 73.519999999999996 111.325 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.6 p -136.96 154.18 50.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.043 -1.465 . . . . 55.140000000000001 107.043 179.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -69.31 -48.68 25.46 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 118.984 -1.086 . . . . 74.219999999999999 109.369 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.85 106.72 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 N-CA-C 106.937 -1.986 . . . . 75.439999999999998 106.937 165.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.06 151.62 85.1 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.879 2.386 . . . . 64.239999999999995 115.084 -169.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.0 12.68 0.81 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.76 1.224 . . . . 74.400000000000006 111.35 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -110.3 -15.59 13.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.577 -0.738 . . . . 74.519999999999996 110.493 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.08 154.68 22.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.848 0.832 . . . . 72.230000000000004 111.499 -171.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -87.74 110.61 20.58 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.014 -1.476 . . . . 65.349999999999994 107.014 178.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.5 m -112.83 148.52 34.68 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.772 -0.194 . . . . 74.120000000000005 111.134 -174.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.18 142.44 58.41 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.175 0.59 . . . . 64.319999999999993 110.66 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 427' ' ' ARG . 48.0 mm -64.7 -21.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.495 0.664 . . . . 71.140000000000001 111.147 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.6 p -87.14 1.83 51.79 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 116.006 -0.543 . . . . 74.239999999999995 111.412 -177.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -89.75 145.45 25.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 111.107 178.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.34 122.75 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.719 -0.845 . . . . 71.109999999999999 108.719 176.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.08 120.74 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 108.66 -0.867 . . . . 63.299999999999997 108.66 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -92.21 112.74 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.711 -1.218 . . . . 73.150000000000006 107.711 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.56 105.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.693 -1.225 . . . . 61.539999999999999 107.693 -177.379 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.43 118.29 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.034 -0.985 . . . . 73.299999999999997 109.338 -176.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.7 t -97.32 138.54 21.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.568 -1.271 . . . . 54.43 107.568 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -81.55 108.48 2.88 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 109.424 -1.471 . . . . 74.319999999999993 109.424 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.452 ' HA ' HG13 ' A' ' 464' ' ' VAL . 13.3 t -142.67 118.02 10.23 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 62.109999999999999 108.566 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.316 0 N-CA-C 108.834 -1.706 . . . . 75.420000000000002 108.834 179.34 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 107.623 -1.251 . . . . 52.140000000000001 107.623 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.62 161.5 32.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.033 0.444 . . . . 42.43 111.208 -173.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -100.69 136.32 40.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.644 -1.243 . . . . 72.450000000000003 107.644 173.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -98.49 133.2 22.92 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.149 -1.056 . . . . 64.319999999999993 108.149 -177.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.83 164.27 36.22 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 121.966 1.777 . . . . 70.209999999999994 113.67 -176.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 366' ' ' ARG . 4.1 m-20 -67.51 120.89 14.69 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.844 -1.071 . . . . 53.100000000000001 108.244 176.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.83 30.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.582 0 CA-C-O 123.067 1.413 . . . . 75.340000000000003 110.146 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 15.1 ptt85 -62.49 144.09 56.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.716 -1.584 . . . . 72.239999999999995 113.041 -177.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.01 0.47 48.29 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.303 -0.862 . . . . 61.210000000000001 114.164 173.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -132.77 175.88 8.95 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.824 0.812 . . . . 71.049999999999997 111.569 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 97.3 p -74.77 171.45 13.94 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.636 0.374 . . . . 75.540000000000006 111.028 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 14.6 m -61.85 -45.66 92.84 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.99 0.424 . . . . 75.209999999999994 110.09 178.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.83 80.4 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.106 -0.497 . . . . 74.25 111.195 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.47 -42.23 79.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.23 -0.441 . . . . 75.450000000000003 110.701 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.77 81.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 75.010000000000005 110.287 178.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.6 mt -58.71 -42.58 85.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 61.140000000000001 110.715 178.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.23 -47.17 77.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.295 -0.412 . . . . 64.239999999999995 110.985 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 43.7 m -60.77 -45.57 93.81 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 116.511 -0.313 . . . . 72.230000000000004 111.401 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.64 -38.93 92.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.737 0.303 . . . . 54.049999999999997 111.01 176.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.24 -43.3 99.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.704 -0.68 . . . . 74.209999999999994 109.839 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -29.03 70.11 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.885 -0.598 . . . . 74.340000000000003 110.691 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -83.85 -12.12 56.0 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.872 -0.604 . . . . 73.049999999999997 109.709 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 96.92 0.85 60.04 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.997 -0.62 . . . . 71.310000000000002 112.416 177.256 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 43.9 m-85 -79.18 157.15 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.034 0.445 . . . . 73.340000000000003 111.851 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.8 137.83 40.5 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 106.711 -1.589 . . . . 64.450000000000003 106.711 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.63 140.26 46.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 113.96 1.096 . . . . 72.430000000000007 113.96 -177.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -110.69 130.89 55.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.03 -1.841 . . . . 75.319999999999993 106.03 173.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.9 m -112.64 118.09 34.08 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.782 -0.822 . . . . 53.020000000000003 108.782 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.44 118.33 32.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.943 -1.502 . . . . 75.510000000000005 106.943 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.67 122.44 47.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.072 -0.714 . . . . 51.43 109.072 177.536 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.38 133.45 25.09 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.009 -0.541 . . . . 74.319999999999993 110.068 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.408 ' N ' ' HB ' ' A' ' 422' ' ' THR . 57.8 Cg_endo -76.19 139.67 21.55 Favored 'Trans proline' 0 C--O 1.257 1.431 0 C-N-CA 122.371 2.047 . . . . 62.109999999999999 109.326 172.092 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 172.78 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.491 -1.299 . . . . 62.520000000000003 107.491 -176.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 57.4 m -141.68 -14.38 0.84 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.876 -0.515 . . . . 71.400000000000006 111.928 176.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.5 p -91.37 19.35 6.13 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.364 1.078 . . . . 61.210000000000001 109.847 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.8 pt -104.57 150.95 39.11 Favored Pre-proline 0 C--N 1.296 -1.735 0 CA-C-N 114.571 -1.195 . . . . 71.340000000000003 111.839 -173.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 145.23 38.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.494 2.129 . . . . 72.439999999999998 111.291 177.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.48 162.84 7.51 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.26 3.307 . . . . 73.030000000000001 113.362 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.91 -11.78 1.15 Allowed 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 124.257 1.023 . . . . 62.210000000000001 112.451 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -101.97 109.15 20.81 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.082 -2.192 . . . . 73.310000000000002 105.082 176.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.3 p -62.14 120.64 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.079 0.942 . . . . 65.230000000000004 112.302 -170.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.03 -27.9 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.546 -1.206 . . . . 53.240000000000002 110.318 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.62 158.09 27.56 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 119.817 -1.182 . . . . 35.229999999999997 111.97 -177.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.1 p -114.6 -175.58 2.71 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.253 0.621 . . . . 72.510000000000005 110.249 -177.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -100.05 134.77 20.66 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.805 -1.554 . . . . 73.099999999999994 106.805 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.72 -27.94 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 1 C-N-CA 125.395 4.063 . . . . 64.329999999999998 115.939 -175.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.85 -24.16 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.76 0.314 . . . . 51.520000000000003 111.055 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.87 40.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.018 -0.537 . . . . 71.530000000000001 110.816 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -79.26 -2.32 40.66 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.291 0.567 . . . . 64.099999999999994 112.249 -179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 84.2 m -84.86 146.84 27.1 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.391 -1.337 . . . . 73.030000000000001 107.391 172.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -75.43 119.6 19.73 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.903 -0.719 . . . . 51.149999999999999 110.001 -179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.02 169.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 123.898 0.879 . . . . 63.109999999999999 109.225 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.0 t -75.61 142.05 42.73 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.439 -0.949 . . . . 73.310000000000002 108.439 178.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -64.27 109.76 2.0 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.215 -0.661 . . . . 74.120000000000005 109.215 178.092 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 122.96 25.88 1.8 Allowed Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.765 -0.934 . . . . 73.030000000000001 110.765 -175.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.02 -178.29 4.02 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.047 -1.094 . . . . 51.32 108.047 -178.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.33 120.92 35.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.903 0.859 . . . . 63.130000000000003 112.918 -176.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.1 mm -110.96 121.35 63.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.501 -0.926 . . . . 73.400000000000006 108.501 176.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.9 t -93.81 121.39 35.2 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.549 0.69 . . . . 70.030000000000001 110.037 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.3 t -107.05 126.85 63.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.387 -0.968 . . . . 55.32 108.387 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -99.75 120.19 39.33 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.244 -0.65 . . . . 62.039999999999999 109.244 -179.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.0 t -113.07 142.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.764 -0.828 . . . . 75.439999999999998 108.764 -178.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.0 p -84.87 127.38 34.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.898 1.332 . . . . 74.329999999999998 113.792 -178.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.408 ' HB ' ' N ' ' A' ' 390' ' ' PRO . 8.8 m -101.46 156.84 17.23 Favored 'General case' 1 N--CA 1.376 -4.156 0 N-CA-C 104.092 -2.558 . . . . 74.010000000000005 104.092 170.238 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -34.84 150.64 0.01 OUTLIER Glycine 0 C--N 1.284 -2.357 0 N-CA-C 117.435 1.734 . . . . 74.150000000000006 117.435 -176.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 50.9 Cg_exo -54.71 132.2 50.27 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.128 2.552 . . . . 73.200000000000003 112.918 179.007 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -72.25 140.6 48.73 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.142 -0.935 . . . . 65.340000000000003 109.933 176.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.2 mt-30 -120.3 148.11 44.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.251 -1.018 . . . . 61.43 108.251 176.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -144.56 164.64 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.615 -1.254 . . . . 75.120000000000005 107.615 -176.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.39 138.84 34.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.993 -1.114 . . . . 53.299999999999997 107.993 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.5 mt -80.8 120.47 79.05 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.168 -1.049 . . . . 62.210000000000001 108.168 178.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.46 141.55 51.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.96 2.44 . . . . 64.409999999999997 113.69 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.44 -15.65 56.27 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.733 -1.121 . . . . 75.150000000000006 111.253 -176.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.31 -14.62 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.396 -0.82 . . . . 75.329999999999998 110.838 -178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.0 m -53.74 -40.04 65.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.922 0.889 . . . . 73.310000000000002 112.388 -178.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.8 p -69.08 -12.84 62.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 113.384 0.883 . . . . 75.299999999999997 113.384 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -82.7 -48.35 10.97 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.362 -0.535 . . . . 65.430000000000007 110.716 -178.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 75.1 m -157.29 141.74 16.49 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 110.285 -0.265 . . . . 72.510000000000005 110.285 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -56.7 -44.19 81.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.695 1.198 . . . . 74.530000000000001 111.486 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.61 78.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.915 0.388 . . . . 70.030000000000001 110.482 177.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.11 -42.0 94.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.836 -0.62 . . . . 65.519999999999996 110.935 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.79 -51.69 68.27 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.599 0.562 . . . . 73.409999999999997 110.662 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.57 -49.18 81.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.948 -0.301 . . . . 74.200000000000003 111.515 -177.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.06 -47.58 70.86 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.569 0.581 . . . . 70.219999999999999 112.569 -178.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -67.05 -38.03 85.12 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.255 0.835 . . . . 71.209999999999994 113.255 -178.566 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.42 -36.46 84.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.269 -0.572 . . . . 52.329999999999998 111.115 174.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 44.9 m -67.35 -39.95 85.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 177.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.95 68.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.157 0.503 . . . . 74.239999999999995 110.605 177.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.64 59.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.302 -0.408 . . . . 51.020000000000003 110.34 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.92 -21.3 8.99 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 119.163 -0.799 . . . . 43.340000000000003 114.697 174.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -55.88 128.33 34.56 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.408 0.892 . . . . 55.219999999999999 113.408 -172.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.46 -1.18 23.31 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.251 -0.886 . . . . 33.210000000000001 114.293 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 10.7 mmm180 -124.12 111.66 16.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 117.699 0.749 . . . . 63.140000000000001 110.549 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -119.07 150.99 39.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.271 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -145.56 136.1 24.21 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.399 -1.704 . . . . 72.310000000000002 106.399 172.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -106.64 134.12 50.28 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.809 0.338 . . . . 73.150000000000006 110.148 -176.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.93 159.14 42.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.231 -0.655 . . . . 62.030000000000001 109.231 177.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -129.35 134.54 47.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.43 -0.952 . . . . 64.409999999999997 108.43 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 t -125.14 146.13 52.82 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 108.997 -0.742 . . . . 42.420000000000002 108.997 -177.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 490' ' ' SER . 40.4 Cg_exo -61.57 123.6 13.04 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.332 2.021 . . . . 75.319999999999993 109.244 173.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.5 m -139.26 -179.78 6.07 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 110.211 -0.292 . . . . 71.530000000000001 110.211 -176.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.6 m -56.18 133.5 75.11 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 108.384 -0.969 . . . . 60.25 108.384 175.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.01 -31.16 33.58 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.828 3.018 . . . . 72.209999999999994 114.173 -175.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.73 -11.23 59.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 111.962 0.356 . . . . 75.430000000000007 111.962 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.69 2.29 38.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.498 -0.319 . . . . 74.420000000000002 111.16 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.7 p -59.62 126.96 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 120.277 -0.569 . . . . 73.530000000000001 110.689 178.032 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.79 78.24 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.161 -1.019 . . . . 72.439999999999998 111.963 178.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -125.42 147.21 49.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.584 -0.895 . . . . 71.150000000000006 108.584 177.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.65 128.64 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.193 -0.669 . . . . 74.450000000000003 109.193 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.553 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.66 -5.39 9.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.126 -1.03 . . . . 75.219999999999999 111.226 -178.608 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.73 29.39 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.534 -0.841 . . . . 74.010000000000005 111.805 176.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.2 p -116.34 153.34 32.17 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.896 -1.15 . . . . 71.230000000000004 107.896 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 28.4 t-20 -60.75 -50.35 85.56 Favored Pre-proline 0 C--N 1.317 -0.838 0 O-C-N 123.35 0.406 . . . . 75.329999999999998 111.285 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_exo -77.98 131.28 10.92 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 N-CA-C 107.413 -1.803 . . . . 51.509999999999998 107.413 168.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.5 Cg_endo -62.46 142.14 89.34 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.373 2.049 . . . . 75.530000000000001 113.552 -175.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.99 4.18 15.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.976 0.893 . . . . 54.140000000000001 110.827 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -108.56 3.24 22.79 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.763 -1.108 . . . . 71.109999999999999 108.652 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . 0.406 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 36.1 tt0 -121.83 165.21 16.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.106 -1.072 . . . . 74.530000000000001 108.106 -178.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.8 m -98.77 129.64 45.2 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.029 -1.1 . . . . 61.340000000000003 108.029 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 47.5 m -124.42 148.59 47.5 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 -178.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.25 153.75 40.49 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.388 0.514 . . . . 75.519999999999996 112.388 -178.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.7 mp -66.26 -29.46 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.359 0.6 . . . . 62.109999999999999 110.694 177.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 14.6 t -90.18 2.82 54.94 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.541 0.686 . . . . 72.310000000000002 109.949 177.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 46.1 t30 -86.08 141.55 29.35 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.037 -1.097 . . . . 73.329999999999998 108.037 -178.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.47 112.71 17.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 120.051 -0.66 . . . . 72.400000000000006 109.22 -178.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.1 119.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 N-CA-C 107.514 -1.291 . . . . 61.039999999999999 107.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 41.0 mt -98.22 121.03 48.33 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.451 -1.314 . . . . 61.299999999999997 107.451 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.93 120.22 51.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.809 -1.182 . . . . 63.549999999999997 107.809 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.59 123.63 60.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-O 121.527 0.679 . . . . 72.319999999999993 110.048 -176.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.98 137.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.946 -1.131 . . . . 70.299999999999997 107.946 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.57 127.98 8.97 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.424 -1.07 . . . . 54.530000000000001 110.424 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.3 t -133.94 103.89 6.02 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.179 -1.045 . . . . 72.230000000000004 108.179 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.193 0 N-CA-C 108.877 -1.689 . . . . 54.409999999999997 108.877 -178.007 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-O 121.314 0.578 . . . . 75.450000000000003 109.892 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.98 152.23 20.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 110.931 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.54 136.7 43.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.151 -0.477 . . . . 71.109999999999999 109.941 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.95 133.77 20.18 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 109.301 -0.629 . . . . 32.229999999999997 109.301 -176.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.65 159.51 53.21 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.604 2.202 . . . . 71.140000000000001 114.635 -175.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.37 142.96 50.36 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.28 -0.873 . . . . 72.200000000000003 109.166 176.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 6.7 t -107.08 21.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.044 -1.095 . . . . 71.400000000000006 108.044 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 6.0 ptp180 -58.57 145.37 39.61 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.08 -0.964 . . . . 71.439999999999998 112.379 -177.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.4 1.06 43.92 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 113.317 178.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 368' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 7.6 pt20 -138.58 -175.45 4.13 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.263 -1.014 . . . . 73.310000000000002 108.263 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.1 p -76.48 163.82 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 119.609 1.095 . . . . 74.239999999999995 112.316 -172.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.7 p -61.85 -34.09 75.34 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.758 -0.655 . . . . 71.030000000000001 109.335 173.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.77 91.73 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.143 -0.935 . . . . 72.239999999999995 109.781 176.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.06 -42.11 89.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.58 -0.736 . . . . 75.329999999999998 110.619 177.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 373' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 399' ' ' VAL . . . -59.93 -47.39 85.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.722 -0.672 . . . . 50.100000000000001 111.224 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.45 -46.12 89.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.087 -0.506 . . . . 75.010000000000005 110.013 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.15 93.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.63 . . . . 54.149999999999999 111.477 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 64.9 m -66.24 -48.25 71.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.145 -0.48 . . . . 61.130000000000003 111.088 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.27 -38.7 91.1 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.325 -0.234 . . . . 74.209999999999994 111.225 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.71 -48.17 82.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.823 -0.806 . . . . 63.119999999999997 108.823 178.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -70.33 -17.31 63.07 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.684 1.364 . . . . 64.019999999999996 114.684 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -89.61 -14.19 35.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.353 -0.539 . . . . 71.200000000000003 111.113 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.11 16.25 30.79 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.345 -0.931 . . . . 44.109999999999999 113.25 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -96.72 154.67 17.15 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.857 -0.423 . . . . 74.230000000000004 109.857 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 383' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.1 mmtp -95.61 143.44 26.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.091 -1.448 . . . . 74.129999999999995 107.091 178.325 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -132.75 148.21 31.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.363 0.601 . . . . 65.010000000000005 112.398 -178.802 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 385' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 417' ' ' THR . 19.5 ttm-85 -118.28 144.88 45.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.705 -1.591 . . . . 73.430000000000007 106.705 174.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.3 m -98.46 121.58 40.58 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.008 -1.478 . . . . 73.340000000000003 107.008 176.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.34 119.47 38.96 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.872 -1.899 . . . . 74.439999999999998 105.872 -179.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HB2' HG22 ' A' ' 422' ' ' THR . 0.0 OUTLIER -110.91 122.06 46.93 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.368 0.604 . . . . 73.099999999999994 110.892 -174.619 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 389' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.3 OUTLIER -116.15 119.32 36.88 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 115.402 -0.817 . . . . 64.5 111.48 -177.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 5.8 Cg_endo -93.25 145.53 2.26 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.031 2.487 . . . . 44.219999999999999 111.662 173.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 391' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 12.0 t70 160.82 -164.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 104.861 -2.274 . . . . 64.230000000000004 104.861 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 14.8 m -132.8 1.68 3.65 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 119.533 1.06 . . . . 71.049999999999997 110.316 175.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -97.32 24.39 6.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 106.385 -1.709 . . . . 74.519999999999996 106.385 174.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 394' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 421' ' ' SER . 19.8 pt -89.64 151.57 45.97 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 112.527 -2.124 . . . . 65.129999999999995 110.304 -178.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.55 173.01 15.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 121.837 1.691 . . . . 73.420000000000002 108.652 170.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.01 160.92 14.28 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.161 1.907 . . . . 52.0 112.598 174.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.01 -8.07 0.94 Allowed 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.923 1.689 . . . . 63.32 112.781 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.423 ' HB3' ' O ' ' A' ' 368' ' ' GLN . 42.9 m80 -82.42 175.47 10.2 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.452 1.101 . . . . 70.439999999999998 108.467 179.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 373' ' ' ALA . 7.6 p -91.8 117.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 118.457 -1.297 . . . . 73.319999999999993 109.592 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.81 -28.76 2.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.672 -1.149 . . . . 71.439999999999998 109.808 177.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.34 160.8 27.92 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 119.79 -1.195 . . . . 52.140000000000001 112.192 -173.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 52.4 p -122.43 -174.46 2.91 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.282 1.033 . . . . 71.219999999999999 111.225 -172.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.437 ' HB3' HG23 ' A' ' 416' ' ' ILE . 6.5 t70 -98.17 142.07 23.98 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 105.896 -1.89 . . . . 71.019999999999996 105.896 -175.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.31 -36.14 6.08 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.795 2.996 . . . . 74.120000000000005 113.647 178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -68.54 -8.21 39.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.962 -0.563 . . . . 52.149999999999999 112.496 -178.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -81.75 -51.45 8.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.548 -0.461 . . . . 71.239999999999995 110.64 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.35 -5.12 59.24 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 120.646 -0.421 . . . . 61.409999999999997 112.043 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.5 m -97.06 142.25 29.23 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 72.420000000000002 106.624 174.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.7 p -74.24 113.74 11.8 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.763 0.792 . . . . 72.430000000000007 111.771 -177.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.25 170.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.887 -1.051 . . . . 73.200000000000003 109.462 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 48.1 m -67.02 138.56 57.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.561 -0.903 . . . . 73.109999999999999 108.561 175.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.81 109.92 0.81 Allowed 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.007 0.523 . . . . 73.239999999999995 111.483 -177.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.93 43.64 1.62 Allowed Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.582 -0.735 . . . . 65.129999999999995 111.997 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -94.39 -167.62 1.7 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.406 -1.331 . . . . 63.310000000000002 107.406 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 415' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.2 pt-20 -111.36 124.4 52.17 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.695 0.759 . . . . 64.010000000000005 111.612 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 416' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 403' ' ' ASP . 43.7 mm -114.44 135.53 53.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.012 -0.994 . . . . 65.420000000000002 108.554 -176.063 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 385' ' ' ARG . 71.1 p -94.32 127.07 39.96 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.34 -0.944 . . . . 73.140000000000001 109.689 175.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.28 130.13 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.242 -1.021 . . . . 72.129999999999995 108.242 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -96.69 128.81 43.99 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 116.401 -0.363 . . . . 71.420000000000002 110.595 -175.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 12.6 p -134.33 141.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.391 -0.966 . . . . 75.019999999999996 108.391 176.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 421' ' ' SER . . . . . 0.576 ' HB2' HD12 ' A' ' 394' ' ' ILE . 73.2 p -94.1 122.53 36.71 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.474 -0.565 . . . . 52.009999999999998 109.474 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 422' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 388' ' ' GLN . 12.2 t -120.14 107.5 13.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.857 -0.737 . . . . 74.230000000000004 111.992 177.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.04 120.65 1.59 Allowed Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.839 -1.172 . . . . 64.109999999999999 114.431 174.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 424' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.2 Cg_exo -75.94 128.56 10.84 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.898 1.732 . . . . 62.210000000000001 110.207 173.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 480' ' ' ILE . 6.4 mm-40 -74.99 125.75 29.57 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.687 -0.486 . . . . 54.340000000000003 109.687 177.275 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 49.1 mt-30 -110.29 139.08 45.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.083 -0.71 . . . . 71.510000000000005 109.083 177.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 427' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 1.1 tpt180 -132.64 165.45 24.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.995 0.426 . . . . 73.299999999999997 111.579 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.76 139.24 34.96 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.158 0.983 . . . . 75.340000000000003 111.2 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.67 119.82 76.36 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.278 -1.749 . . . . 60.520000000000003 106.278 172.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.25 141.35 81.87 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.651 2.234 . . . . 61.219999999999999 113.368 -178.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 -20.96 23.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.069 -0.969 . . . . 54.32 110.426 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.39 -11.73 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.407 0.623 . . . . 63.409999999999997 110.624 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.2 m -53.0 -41.03 64.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.486 1.114 . . . . 62.420000000000002 112.485 -178.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.1 p -68.2 -13.63 62.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.557 0.947 . . . . 74.230000000000004 113.557 -176.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 76.3 mt -86.86 -36.92 18.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.651 0.263 . . . . 64.109999999999999 111.306 -178.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.9 m -158.37 134.15 9.0 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 122.222 -0.299 . . . . 72.209999999999994 110.415 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.05 -46.42 89.21 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.703 0.631 . . . . 73.329999999999998 112.703 -178.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.14 -41.23 87.82 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.704 0.287 . . . . 60.450000000000003 110.468 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -63.71 -39.45 94.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.725 -0.671 . . . . 54.43 110.41 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.87 -50.92 71.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.47 0.481 . . . . 24.539999999999999 109.837 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.44 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 43.340000000000003 110.467 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 6.3 mmpt? -61.04 -46.05 92.26 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.996 -0.547 . . . . 73.150000000000006 111.267 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.43 -41.98 96.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.246 0.462 . . . . 74.239999999999995 112.246 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -43.43 96.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.936 0.398 . . . . 71.109999999999999 111.024 176.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.9 m -68.08 -39.63 82.88 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.787 -0.642 . . . . 74.129999999999995 110.333 -178.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.3 62.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 63.020000000000003 111.184 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.76 -12.84 59.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.156 0.503 . . . . 62.399999999999999 109.728 176.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.53 0.7 40.26 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-O 119.168 -0.795 . . . . 74.409999999999997 114.469 174.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.96 137.38 57.1 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.099 0.95 . . . . 74.140000000000001 112.106 -178.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -125.08 13.57 7.53 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.204 -0.759 . . . . 73.299999999999997 111.204 178.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.23 111.37 13.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.504 -0.924 . . . . 63.109999999999999 108.504 -178.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.08 152.74 47.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.89 -0.595 . . . . 74.450000000000003 109.94 -175.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . 0.414 ' HD3' HG13 ' A' ' 485' ' ' ILE . 64.0 tttp -150.09 122.71 8.58 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.927 -1.138 . . . . 70.299999999999997 107.927 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.73 131.98 45.36 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.796 -0.446 . . . . 65.109999999999999 109.796 -177.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -123.57 141.17 52.27 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.315 -1.365 . . . . 73.409999999999997 107.315 175.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -119.28 129.59 54.98 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.219 0.533 . . . . 72.109999999999999 110.288 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.2 t -119.94 130.84 24.64 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 108.506 -0.924 . . . . 74.209999999999994 108.506 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.73 121.81 10.09 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.45 2.1 . . . . 52.32 109.699 177.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.4 m -133.95 160.28 38.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.916 -0.314 . . . . 63.310000000000002 110.417 -176.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 460' ' ' THR . . . . . 0.525 ' HB ' ' OE1' ' A' ' 462' ' ' GLU . 14.2 p -64.65 159.06 64.47 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 124.856 1.262 . . . . 73.430000000000007 111.81 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.77 -31.13 24.89 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.789 2.992 . . . . 64.030000000000001 113.285 177.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 462' ' ' GLU . . . . . 0.525 ' OE1' ' HB ' ' A' ' 460' ' ' THR . 1.5 pm0 -75.36 -24.54 57.31 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.193 0.812 . . . . 73.310000000000002 113.193 178.115 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.17 -18.67 14.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.211 0.448 . . . . 71.0 112.211 -179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 464' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.9 p -59.5 130.44 23.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.413 0.625 . . . . 64.310000000000002 111.29 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -4.61 64.01 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.743 -0.662 . . . . 61.130000000000003 111.971 178.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 157.05 28.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.227 0.537 . . . . 64.540000000000006 109.95 177.295 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.79 136.51 22.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.496 -1.298 . . . . 65.129999999999995 107.496 176.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.31 -16.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.543 -0.863 . . . . 55.310000000000002 111.301 -177.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.1 175.62 32.32 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.561 -0.745 . . . . 43.039999999999999 111.629 178.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.0 p -122.01 158.99 27.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.385 -0.969 . . . . 75.030000000000001 108.385 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -64.97 -57.0 17.19 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 119.086 -0.483 . . . . 74.120000000000005 110.666 175.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.0 Cg_endo -79.63 121.14 4.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 N-CA-C 107.951 -1.596 . . . . 71.219999999999999 107.951 170.176 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 161.29 46.5 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.537 2.158 . . . . 75.129999999999995 113.969 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -69.6 6.59 1.06 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.887 1.275 . . . . 73.319999999999993 113.283 -177.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -108.15 -4.49 17.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.158 -0.682 . . . . 74.129999999999995 109.158 179.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -99.92 161.44 13.61 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.604 -0.726 . . . . 74.409999999999997 109.936 -177.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.0 m -128.92 101.03 5.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.996 -1.483 . . . . 55.299999999999997 106.996 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.9 p -104.41 149.05 25.75 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.139 -0.482 . . . . 54.130000000000003 111.576 -174.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.8 153.53 24.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 52.0 111.015 177.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 480' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 48.2 mm -61.0 -15.1 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 C-N-CA 123.924 0.89 . . . . 65.530000000000001 112.074 -179.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 481' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 15.0 t -94.99 -4.09 47.26 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.8 -0.563 . . . . 72.439999999999998 110.238 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 130.89 37.83 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.98 -0.748 . . . . 54.140000000000001 108.98 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.31 113.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.68 -0.859 . . . . 75.540000000000006 108.68 -179.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.45 120.04 36.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 109.081 -0.711 . . . . 60.200000000000003 109.081 179.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . 0.414 HG13 ' HD3' ' A' ' 453' ' ' LYS . 3.8 mp -92.34 113.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 61.450000000000003 107.122 177.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.92 121.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.124 -1.065 . . . . 74.140000000000001 108.124 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 39.7 mt -101.16 116.32 44.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.566 0.698 . . . . 71.219999999999999 110.474 -175.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.5 t -98.1 132.72 42.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.245 -0.889 . . . . 65.329999999999998 109.045 -176.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.7 98.68 1.93 Allowed Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 109.207 -1.557 . . . . 63.420000000000002 109.207 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 464' ' ' VAL . 18.0 t -140.85 111.89 7.17 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.902 -0.777 . . . . 70.439999999999998 108.902 -176.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.92 0 N-CA-C 109.636 -1.386 . . . . 73.040000000000006 109.636 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 110.691 -0.964 . . . . 54.549999999999997 110.691 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.68 153.14 25.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 117.174 0.487 . . . . 53.140000000000001 110.478 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.8 t -123.62 -173.38 2.73 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 107.338 -1.356 . . . . 75.349999999999994 107.338 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -92.82 100.64 13.08 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.986 -0.686 . . . . 74.099999999999994 109.715 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -115.67 127.79 55.43 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.425 -0.954 . . . . 73.239999999999995 108.425 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 22.7 m -131.27 158.48 43.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 123.102 0.561 . . . . 74.319999999999993 109.53 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.71 137.25 35.03 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.726 -0.842 . . . . 63.420000000000002 108.726 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.7 p -104.36 124.52 36.97 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-O 120.828 0.347 . . . . 70.25 110.519 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.01 142.64 96.85 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.16 2.573 . . . . 64.129999999999995 113.304 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -77.71 149.96 34.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.742 -1.117 . . . . 54.140000000000001 110.167 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.8 t -106.83 31.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 122.987 1.375 . . . . 63.0 108.006 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -64.44 133.97 53.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.057 -1.429 . . . . 74.319999999999993 110.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.18 -0.13 47.49 Favored Glycine 0 C--N 1.317 -0.495 0 C-N-CA 121.407 -0.425 . . . . 71.239999999999995 112.326 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -128.23 -176.88 3.94 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.615 -0.883 . . . . 72.430000000000007 108.615 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 91.6 p -81.3 168.41 18.47 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 118.407 0.548 . . . . 71.439999999999998 110.266 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 374' ' ' ILE . 1.8 p -63.15 -34.83 78.46 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 116.166 -0.47 . . . . 64.340000000000003 110.637 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.91 -39.25 93.98 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.731 0.412 . . . . 71.519999999999996 110.548 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -59.57 -42.83 93.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.019 0.438 . . . . 74.319999999999993 110.106 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.89 81.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.562 -0.745 . . . . 73.310000000000002 110.343 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 370' ' ' SER . 80.9 mt -58.4 -46.34 89.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.654 -0.703 . . . . 53.409999999999997 110.546 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.36 -46.98 78.01 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.317 -0.401 . . . . 73.040000000000006 111.705 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 74.0 m -60.9 -47.53 85.98 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-O 120.727 0.298 . . . . 71.230000000000004 111.291 -177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.57 -39.51 93.88 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.045 -0.262 . . . . 75.239999999999995 110.998 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -61.07 -42.92 99.4 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.459 0.703 . . . . 71.540000000000006 109.727 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -33.71 76.0 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.778 -0.646 . . . . 75.409999999999997 111.323 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -83.84 -10.2 58.21 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.057 -0.52 . . . . 75.540000000000006 111.743 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.98 0.28 56.19 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.249 -0.977 . . . . 63.229999999999997 112.497 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 53.6 m-85 -78.07 151.11 33.62 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.675 -0.491 . . . . 70.430000000000007 109.675 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 383' ' ' LYS . 3.0 mptp? -102.06 147.19 26.89 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.867 -1.531 . . . . 73.430000000000007 106.867 178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.69 141.66 46.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 CA-C-O 121.378 0.609 . . . . 72.109999999999999 111.623 -176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -118.65 127.97 54.08 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.334 -1.358 . . . . 73.040000000000006 107.334 174.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.4 m -99.71 123.95 44.48 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 109.277 -0.638 . . . . 73.510000000000005 109.277 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.63 119.57 39.14 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 106.302 -1.74 . . . . 73.040000000000006 106.302 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -119.18 141.29 48.99 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 110.155 -0.313 . . . . 75.510000000000005 110.155 -179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 391' ' ' ASP . 11.0 ptpt -139.4 134.89 16.69 Favored Pre-proline 0 C--N 1.294 -1.836 0 CA-C-N 116.057 -0.52 . . . . 73.549999999999997 111.109 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 6.1 Cg_exo -82.7 134.24 7.33 Favored 'Trans proline' 0 C--O 1.246 0.893 0 N-CA-C 106.737 -2.063 . . . . 64.450000000000003 106.737 165.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.429 ' HB2' ' HD3' ' A' ' 389' ' ' LYS . 5.0 t70 -154.38 -176.73 6.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.182 -1.407 . . . . 55.030000000000001 112.239 -171.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 41.9 t -92.44 -41.09 10.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.017 -1.845 . . . . 71.420000000000002 106.017 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -101.83 74.52 1.49 Allowed 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.92 -1.511 . . . . 75.510000000000005 106.92 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 421' ' ' SER . 2.1 pp -88.64 121.02 70.31 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 115.435 1.643 . . . . 71.129999999999995 115.435 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.588 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 16.5 Cg_exo -75.48 157.37 40.8 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 122.78 2.32 . . . . 45.539999999999999 109.519 164.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.64 160.91 47.44 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.33 2.02 . . . . 74.109999999999999 111.864 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.59 -6.91 5.92 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.041 0.756 . . . . 71.540000000000006 113.041 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -90.59 166.74 13.03 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.409 -0.814 . . . . 61.530000000000001 108.938 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.07 117.76 31.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 109.076 -0.713 . . . . 71.540000000000006 109.076 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 43.6 pt -106.43 -28.63 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.346 -0.613 . . . . 75.030000000000001 109.346 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.75 168.16 28.09 Favored Glycine 0 N--CA 1.415 -2.715 0 N-CA-C 108.957 -1.657 . . . . 70.209999999999994 108.957 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.7 p -132.58 -177.76 4.62 Favored 'General case' 0 C--N 1.272 -2.792 0 CA-C-O 120.96 0.41 . . . . 63.140000000000001 110.698 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -100.94 138.78 20.11 Favored Pre-proline 0 C--N 1.303 -1.417 0 N-CA-C 107.947 -1.131 . . . . 65.030000000000001 107.947 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -44.9 -29.54 3.76 Favored 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 124.573 3.515 . . . . 75.140000000000001 114.703 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.58 -28.39 54.79 Favored 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.236 0.614 . . . . 61.340000000000003 112.0 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.66 54.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.944 0.402 . . . . 23.530000000000001 111.203 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.35 -6.76 59.25 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.557 0.577 . . . . 71.329999999999998 112.557 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.5 m -86.02 147.69 26.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 106.649 -1.612 . . . . 71.530000000000001 106.649 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 38.0 m -74.45 112.83 11.01 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.417 -0.957 . . . . 65.120000000000005 108.417 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.5 m -128.67 165.06 29.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.047 -0.723 . . . . 71.340000000000003 109.047 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 50.3 m -69.23 134.13 48.81 Favored 'General case' 0 C--N 1.288 -2.069 0 C-N-CA 120.6 -0.44 . . . . 72.340000000000003 110.242 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -61.89 112.01 2.13 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.366 0.603 . . . . 63.240000000000002 110.218 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 112.53 24.21 5.1 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 110.537 -1.025 . . . . 74.239999999999995 110.537 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.99 -169.12 2.43 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.409 -1.33 . . . . 72.109999999999999 107.409 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.1 125.05 53.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.814 -0.554 . . . . 75.530000000000001 110.209 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -111.42 125.65 68.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.926 -0.579 . . . . 61.509999999999998 109.442 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.2 t -89.59 130.74 35.86 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.086 -0.709 . . . . 72.450000000000003 109.086 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 65.9 t -108.67 118.78 56.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.083 -1.08 . . . . 74.109999999999999 108.083 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -92.4 121.65 34.09 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.164 -0.68 . . . . 72.340000000000003 109.164 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 13.8 p -133.96 152.61 34.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 107.432 -1.321 . . . . 64.450000000000003 107.432 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.588 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 43.7 m -126.74 130.82 51.09 Favored 'General case' 0 C--N 1.282 -2.331 0 O-C-N 121.574 -0.703 . . . . 72.25 110.224 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.3 t -118.05 106.66 13.13 Favored 'General case' 0 N--CA 1.413 -2.279 0 CA-C-O 121.522 0.677 . . . . 65.510000000000005 110.995 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 79.33 141.24 2.19 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 115.205 -0.907 . . . . 43.039999999999999 114.204 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 24.0 Cg_endo -74.28 147.56 37.49 Favored 'Trans proline' 0 N--CA 1.428 -2.368 0 C-N-CA 121.09 1.193 . . . . 74.099999999999994 109.465 172.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.54 ' O ' HG12 ' A' ' 480' ' ' ILE . 0.0 OUTLIER -72.77 164.91 25.83 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.887 -0.597 . . . . 73.319999999999993 109.628 -177.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -125.48 154.23 42.37 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.934 -1.136 . . . . 75.540000000000006 107.934 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 0.2 OUTLIER -141.9 153.48 44.44 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.318 -0.993 . . . . 71.219999999999999 108.318 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -83.06 138.86 33.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.962 -1.866 . . . . 73.120000000000005 105.962 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.444 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.2 mt -80.3 115.55 55.52 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 120.587 -0.445 . . . . 73.310000000000002 110.332 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.16 141.08 38.81 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.31 1.34 . . . . 70.430000000000007 109.969 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.6 78.77 9.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 122.619 1.2 . . . . 54.409999999999997 110.393 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.47 -10.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 113.531 -1.668 . . . . 71.349999999999994 107.588 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.6 m -59.9 -50.02 75.43 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.224 -1.353 . . . . 74.109999999999999 110.486 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 21.4 m -57.95 -13.56 4.76 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 125.598 1.559 . . . . 72.439999999999998 113.063 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 65.7 mt -84.23 -47.08 11.18 Favored 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.731 -0.606 . . . . 73.109999999999999 110.681 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' A' ' 439' ' ' GLU . 26.6 m -160.82 145.68 14.14 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.652 -0.87 . . . . 73.200000000000003 108.652 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -58.57 -44.36 89.72 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 122.995 0.518 . . . . 53.310000000000002 111.085 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.76 84.66 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.815 -0.63 . . . . 73.549999999999997 110.748 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.451 ' HG2' ' HB ' ' A' ' 436' ' ' THR . 23.5 mm-40 -61.89 -43.46 98.8 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-N 115.47 -0.786 . . . . 74.019999999999996 111.262 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.02 -52.15 66.61 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 123.543 0.527 . . . . 55.420000000000002 110.729 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.4 t -68.76 -51.05 49.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 116.06 -0.518 . . . . 70.310000000000002 112.057 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -69.28 -44.94 70.82 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 114.04 1.126 . . . . 71.129999999999995 114.04 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.33 -38.39 84.82 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.978 -0.289 . . . . 73.329999999999998 111.312 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -68.15 -32.62 73.01 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.213 -0.595 . . . . 71.310000000000002 111.499 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.7 m -64.24 -40.38 95.9 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.999 -0.741 . . . . 75.219999999999999 108.999 174.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.97 -26.65 66.03 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.711 -0.677 . . . . 75.200000000000003 110.798 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.85 -12.4 59.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.164 0.507 . . . . 61.020000000000003 110.303 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.15 -27.57 5.56 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 120.886 -0.673 . . . . 73.150000000000006 113.713 176.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 445' ' ' THR . 88.8 m-85 -62.09 142.14 57.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.236 0.518 . . . . 71.420000000000002 111.392 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.89 13.71 4.42 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.59 -1.291 . . . . 53.210000000000001 113.278 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 45.2 mmt-85 -128.35 113.82 16.08 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 122.321 -0.517 . . . . 73.239999999999995 110.049 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.1 152.36 47.41 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.199 0.523 . . . . 72.420000000000002 111.515 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -143.17 123.81 14.09 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.74 -1.578 . . . . 72.420000000000002 106.74 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -94.72 134.71 37.02 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.008 0.432 . . . . 73.439999999999998 111.745 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.73 159.69 41.28 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 107.741 -1.207 . . . . 75.239999999999995 107.741 175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.663 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.1 m-80 -128.32 140.64 51.76 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.535 -0.913 . . . . 74.109999999999999 108.535 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.0 m -125.17 137.58 30.02 Favored Pre-proline 0 C--N 1.29 -1.979 0 N-CA-C 109.164 -0.68 . . . . 73.010000000000005 109.164 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 490' ' ' SER . 15.9 Cg_endo -61.55 121.39 9.51 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.414 2.076 . . . . 71.040000000000006 111.265 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 45.7 m -133.44 171.41 14.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.288 -0.634 . . . . 54.140000000000001 109.288 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.4 m -58.67 143.28 82.28 Favored Pre-proline 0 N--CA 1.44 -0.967 0 C-N-CA 123.823 0.849 . . . . 64.019999999999996 108.867 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.1 Cg_endo -50.6 -25.91 15.76 Favored 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 123.553 2.835 . . . . 63.25 113.027 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.41 -18.71 65.51 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.215 0.45 . . . . 71.140000000000001 112.215 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -112.22 5.17 18.26 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 122.281 -0.262 . . . . 74.340000000000003 111.126 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.6 p -60.25 127.3 19.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.006 0.432 . . . . 74.109999999999999 110.895 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.26 1.03 82.06 Favored Glycine 0 C--N 1.308 -0.978 0 C-N-CA 120.469 -0.872 . . . . 75.329999999999998 112.453 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -111.28 153.41 25.94 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.568 -0.901 . . . . 64.349999999999994 108.568 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 434' ' ' THR . 86.5 t -84.03 135.55 24.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 106.814 -1.55 . . . . 54.229999999999997 106.814 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.511 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.75 -5.15 9.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 118.804 -1.158 . . . . 75.540000000000006 111.527 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.468 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 145.23 -153.67 25.42 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 111.066 -0.814 . . . . 61.240000000000002 111.066 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.1 p -116.79 160.38 20.9 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.489 -0.93 . . . . 52.119999999999997 108.489 176.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.4 t30 -74.08 -51.4 4.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 119.491 -0.884 . . . . 53.119999999999997 110.188 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.1 Cg_exo -71.03 152.39 62.71 Favored 'Trans proline' 0 C--N 1.381 2.288 0 N-CA-C 108.122 -1.53 . . . . 64.239999999999995 108.122 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.28 127.04 19.93 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 121.908 1.738 . . . . 75.25 111.775 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.444 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.79 -23.26 61.54 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.822 0.82 . . . . 45.530000000000001 110.753 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -83.54 0.18 47.64 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.592 -0.731 . . . . 74.120000000000005 110.422 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -96.46 150.57 20.46 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 109.182 -0.673 . . . . 73.420000000000002 109.182 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -88.23 106.95 18.54 Favored 'General case' 0 C--N 1.272 -2.798 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -106.51 148.27 28.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.618 -0.265 . . . . 50.350000000000001 110.921 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.14 157.83 36.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.395 0.517 . . . . 72.25 112.395 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 425' ' ' GLU . 40.5 mm -60.15 -35.61 62.76 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.684 0.754 . . . . 74.129999999999995 110.79 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.6 p -91.62 5.19 50.61 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.141 -0.936 . . . . 60.119999999999997 112.278 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -83.22 141.27 32.01 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.744 -1.206 . . . . 75.109999999999999 107.744 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.44 113.44 22.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.048 0.451 . . . . 71.030000000000001 110.618 -176.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.06 119.81 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 108.898 -0.778 . . . . 71.340000000000003 108.898 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 60.6 mt -92.9 113.36 27.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.663 -1.236 . . . . 72.0 107.663 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.52 123.3 48.73 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 107.953 -1.128 . . . . 63.240000000000002 107.953 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 17.6 pt -107.24 122.77 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.713 0.768 . . . . 71.319999999999993 111.798 -176.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.663 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 60.2 t -98.67 139.92 19.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.164 -0.925 . . . . 61.450000000000003 108.988 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -83.87 118.47 4.69 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.744 -0.942 . . . . 63.329999999999998 110.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.716 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 52.9 m -141.09 129.78 22.84 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 122.59 -0.359 . . . . 72.109999999999999 110.216 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 106.411 -2.676 . . . . 45.539999999999999 106.411 177.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.3 0 N-CA-C 109.935 -1.266 . . . . 53.350000000000001 109.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.4 pp -112.13 142.65 23.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.388 0.614 . . . . 75.219999999999999 112.603 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.5 m -96.88 142.4 28.91 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 106.972 -1.492 . . . . 73.540000000000006 106.972 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -122.57 127.63 49.7 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 107.658 -1.238 . . . . 63.509999999999998 107.658 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 409' ' ' SER . 17.3 m-20 -101.67 126.7 48.56 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 107.653 -1.239 . . . . 73.329999999999998 107.653 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.81 155.14 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 CA-C-N 116.476 -0.329 . . . . 62.549999999999997 110.486 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.2 136.97 34.89 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.556 -1.646 . . . . 74.230000000000004 106.556 176.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.62 138.27 19.59 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 116.265 -0.425 . . . . 72.530000000000001 110.27 -172.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -50.12 126.69 17.76 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.961 2.441 . . . . 65.109999999999999 112.814 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.21 153.77 42.7 Favored 'General case' 0 C--O 1.252 1.215 0 CA-C-N 114.482 -1.235 . . . . 75.340000000000003 110.457 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.463 ' HA ' HE21 ' A' ' 368' ' ' GLN . 17.1 m -109.75 3.59 9.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 114.239 1.2 . . . . 32.420000000000002 114.239 -174.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -62.94 130.29 44.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.077 0.465 . . . . 74.329999999999998 110.229 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.05 -2.9 47.8 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.815 -0.707 . . . . 75.120000000000005 111.723 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' A' ' 365' ' ' VAL . 48.7 mt-30 -115.5 167.92 10.46 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.868 -0.79 . . . . 73.420000000000002 108.868 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 87.6 p -78.1 164.53 24.92 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.416 -0.587 . . . . 73.329999999999998 109.416 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 30.1 p -58.18 -45.53 87.36 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 121.155 0.503 . . . . 41.539999999999999 110.21 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.75 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.47 -0.787 . . . . 63.210000000000001 111.77 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.22 -34.74 76.8 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.465 0.65 . . . . 52.299999999999997 109.56 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -61.39 -51.21 69.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.63 -0.714 . . . . 61.219999999999999 110.158 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 78.2 mt -58.75 -45.45 91.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.941 -0.572 . . . . 62.109999999999999 110.07 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.24 -44.1 92.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.623 -0.717 . . . . 64.030000000000001 111.721 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 78.5 m -63.29 -48.66 77.19 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.243 -0.435 . . . . 75.25 111.816 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.86 -41.53 91.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.653 -0.249 . . . . 64.340000000000003 111.532 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -59.68 -41.59 91.02 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.905 0.753 . . . . 75.430000000000007 110.09 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -69.34 -31.34 69.71 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.249 -0.432 . . . . 70.219999999999999 111.184 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -79.13 -14.79 58.9 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.375 -0.375 . . . . 70.430000000000007 110.799 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.4 15.24 51.53 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.651 -0.785 . . . . 73.129999999999995 111.827 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -93.52 160.32 14.84 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.928 -0.397 . . . . 74.450000000000003 109.928 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 32.9 mmtp -104.66 135.35 46.22 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.025 -0.731 . . . . 74.409999999999997 109.025 -176.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.38 138.59 49.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 CA-C-O 121.256 0.55 . . . . 64.409999999999997 111.584 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -110.88 128.55 55.84 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.539 -1.282 . . . . 74.219999999999999 107.539 176.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.8 m -98.73 120.5 39.27 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 108.028 -1.101 . . . . 71.340000000000003 108.028 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.61 125.3 53.79 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 103.636 -2.727 . . . . 72.140000000000001 103.636 177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -125.75 142.78 51.35 Favored 'General case' 0 N--CA 1.425 -1.724 0 C-N-CA 120.001 -0.68 . . . . 43.030000000000001 110.594 -176.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -134.01 131.84 21.08 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 120.724 -0.39 . . . . 74.129999999999995 110.791 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.35 134.74 6.87 Favored 'Trans proline' 0 N--CA 1.444 -1.405 0 C-N-CA 121.97 1.78 . . . . 44.509999999999998 109.2 170.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 -171.95 -176.04 1.62 Allowed 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.467 -1.679 . . . . 62.229999999999997 106.467 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 68.3 m -129.53 -8.49 4.62 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.422 0.629 . . . . 64.129999999999995 111.084 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -94.29 3.45 55.21 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.815 -1.18 . . . . 52.109999999999999 107.815 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.2 pp -88.52 151.05 47.65 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 114.513 -1.222 . . . . 72.340000000000003 113.4 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.65 172.03 11.58 Favored 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 122.538 2.159 . . . . 73.439999999999998 110.13 173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -56.69 161.57 9.83 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.149 2.566 . . . . 63.399999999999999 112.255 176.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.471 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.7 p-10 -57.14 -9.05 0.8 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 124.711 1.204 . . . . 63.340000000000003 113.04 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 30.6 m170 -67.66 136.74 54.84 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.745 -1.576 . . . . 65.230000000000004 106.745 177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 37.1 t -67.63 118.31 11.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.766 -0.374 . . . . 75.239999999999995 110.541 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.2 tp -93.16 -41.18 12.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.038 -0.727 . . . . 63.509999999999998 109.038 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -147.39 157.61 27.44 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.08 -1.208 . . . . 72.400000000000006 110.08 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -124.34 -178.49 4.12 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.964 0.906 . . . . 44.25 109.716 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.78 155.14 36.77 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 107.458 -1.312 . . . . 65.140000000000001 107.458 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.66 -15.06 5.95 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.977 3.118 . . . . 64.450000000000003 115.805 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.12 -21.91 64.17 Favored 'General case' 0 C--O 1.215 -0.721 0 N-CA-C 112.741 0.645 . . . . 74.230000000000004 112.741 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.79 -50.84 31.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.607 . . . . 43.539999999999999 111.076 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -85.05 -7.9 58.91 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 112.613 0.597 . . . . 74.099999999999994 112.613 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 56.5 m -91.51 139.34 30.8 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.48 -1.304 . . . . 73.420000000000002 107.48 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 359' ' ' ASP . 40.1 m -75.0 113.54 12.43 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-O 121.211 0.529 . . . . 55.32 109.954 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 411' ' ' SER . 2.4 t -124.75 169.48 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 107.271 -1.381 . . . . 74.439999999999998 107.271 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.41 ' H ' HG12 ' A' ' 410' ' ' VAL . 21.9 m -68.27 148.52 50.67 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.104 0.478 . . . . 43.340000000000003 111.409 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.36 111.03 3.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.941 -0.572 . . . . 64.430000000000007 110.338 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 108.16 20.39 8.35 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.656 -0.783 . . . . 64.319999999999993 112.338 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -89.49 -170.73 2.95 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.628 -0.879 . . . . 62.219999999999999 108.628 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 6.5 pt-20 -112.45 124.54 52.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.118 1.155 . . . . 73.340000000000003 114.118 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 37.6 mm -107.02 138.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.269 -1.382 . . . . 74.409999999999997 107.269 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -103.01 121.43 42.55 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 119.324 -0.95 . . . . 50.310000000000002 111.578 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.62 119.95 46.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.085 -1.08 . . . . 53.299999999999997 108.085 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 419' ' ' ASN . 0.8 OUTLIER -93.89 118.01 30.88 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.587 -0.523 . . . . 64.349999999999994 109.587 -179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.4 t -122.06 140.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.593 -0.73 . . . . 72.099999999999994 109.859 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.7 m -94.66 121.68 36.48 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.769 -1.197 . . . . 70.430000000000007 107.769 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 20.3 p -119.15 106.29 12.22 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.905 -0.318 . . . . 54.210000000000001 111.647 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.81 147.34 2.39 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 115.069 0.788 . . . . 63.119999999999997 115.069 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.7 Cg_endo -81.04 147.4 16.56 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 122.011 1.807 . . . . 72.439999999999998 111.161 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.58 149.19 26.05 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.788 -0.449 . . . . 65.310000000000002 109.788 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.8 mt-30 -129.1 155.67 45.08 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 108.935 -0.765 . . . . 73.400000000000006 108.935 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -146.76 164.24 33.4 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.448 -1.315 . . . . 72.120000000000005 107.448 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.78 138.86 31.52 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 110.441 -0.207 . . . . 75.329999999999998 110.441 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.518 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -83.07 119.26 73.89 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 108.729 -0.841 . . . . 75.019999999999996 108.729 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.43 141.27 89.8 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.584 2.189 . . . . 74.140000000000001 112.331 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -79.78 -7.04 58.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.904 -0.589 . . . . 52.219999999999999 111.499 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.446 HG23 HD12 ' A' ' 435' ' ' LEU . 13.3 p -66.58 -16.29 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.685 0.794 . . . . 72.219999999999999 110.74 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 23.6 m -49.89 -47.04 52.25 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.475 1.11 . . . . 72.430000000000007 113.155 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 11.0 m -59.04 -22.04 60.06 Favored 'General case' 0 CA--C 1.565 1.529 0 C-N-CA 124.553 1.141 . . . . 61.409999999999997 112.467 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 432' ' ' VAL . 75.8 mt -78.1 -44.16 26.97 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 112.529 0.566 . . . . 62.549999999999997 112.529 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 60.3 m -160.63 136.2 8.09 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.245 -0.65 . . . . 73.0 109.245 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -60.78 -45.42 94.43 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.238 0.458 . . . . 73.340000000000003 112.238 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.15 80.04 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.49 0.662 . . . . 74.109999999999999 110.749 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -70.47 -43.72 69.21 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.63 -0.714 . . . . 73.109999999999999 109.953 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.16 -51.72 68.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.431 -0.804 . . . . 55.420000000000002 111.453 -178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.4 -41.19 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 115.886 -0.597 . . . . 64.430000000000007 111.369 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.454 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -67.69 -47.03 70.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.783 -0.367 . . . . 52.229999999999997 111.847 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.18 -38.55 88.32 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.971 0.36 . . . . 74.519999999999996 111.971 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.26 -39.39 92.58 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.854 -0.338 . . . . 62.299999999999997 111.576 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 98.6 m -65.78 -38.77 89.95 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.363 0.125 . . . . 72.209999999999994 111.243 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -65.31 -29.36 70.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.17 0.509 . . . . 72.450000000000003 110.467 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -81.17 -13.79 58.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.947 -0.569 . . . . 60.240000000000002 111.027 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.42 -13.81 8.82 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.038 -1.077 . . . . 50.009999999999998 114.113 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 445' ' ' THR . 93.2 m-85 -78.89 111.52 15.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 117.91 0.855 . . . . 72.439999999999998 110.189 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -112.14 -21.64 6.2 Favored Glycine 0 N--CA 1.436 -1.301 0 C-N-CA 120.426 -0.892 . . . . 62.0 112.495 -177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -95.15 111.47 23.3 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.491 -0.559 . . . . 72.239999999999995 109.491 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.03 159.03 25.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.444 0.64 . . . . 72.109999999999999 110.885 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -137.93 123.19 19.35 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 103.813 -2.662 . . . . 64.099999999999994 103.813 172.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -101.28 125.93 47.96 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.459 -0.496 . . . . 72.120000000000005 110.845 -172.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -126.52 158.84 35.1 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.168 -0.679 . . . . 72.319999999999993 109.168 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -133.01 139.49 47.25 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.736 -0.468 . . . . 71.209999999999994 109.736 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 32.4 p -117.86 136.16 23.64 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 109.49 -0.559 . . . . 71.019999999999996 109.49 177.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.5 Cg_exo -61.43 120.53 8.24 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.428 2.085 . . . . 52.340000000000003 109.977 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 14.6 m -133.11 167.55 20.12 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.108 -0.496 . . . . 21.23 111.149 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 464' ' ' VAL . 4.6 p -76.89 156.24 82.56 Favored Pre-proline 0 N--CA 1.432 -1.369 0 C-N-CA 123.66 0.784 . . . . 73.430000000000007 109.377 174.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -49.71 -27.75 15.87 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 124.225 3.283 . . . . 74.129999999999995 114.157 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -75.37 -18.33 59.99 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.139 -0.482 . . . . 73.129999999999995 112.05 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 7.2 mp -106.93 -18.29 13.96 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.642 0.258 . . . . 61.119999999999997 110.563 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 91.3 t -59.5 127.0 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.976 -0.557 . . . . 72.420000000000002 111.366 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.52 -4.46 58.21 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 121.033 -0.603 . . . . 51.299999999999997 111.813 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -122.87 161.05 24.82 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.878 0.37 . . . . 74.219999999999999 110.103 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 90.7 t -83.95 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.909 -0.775 . . . . 71.239999999999995 108.909 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.61 -25.11 4.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.559 -0.857 . . . . 72.049999999999997 111.31 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.25 174.21 38.18 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.208 -0.757 . . . . 64.230000000000004 111.208 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 16.6 p -126.3 154.84 42.88 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.967 -0.753 . . . . 74.319999999999993 108.967 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 9.9 t30 -65.08 -53.28 42.41 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 120.248 -0.581 . . . . 62.32 110.982 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.8 Cg_exo -71.95 123.44 9.31 Favored 'Trans proline' 0 C--N 1.373 1.844 0 N-CA-C 107.744 -1.675 . . . . 75.540000000000006 107.744 170.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 33.7 Cg_endo -62.7 137.45 63.72 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 122.885 2.39 . . . . 64.319999999999993 114.4 -174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.518 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -80.42 7.92 8.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.145 -0.934 . . . . 71.25 110.613 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -108.37 -4.66 17.21 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.302 -0.863 . . . . 60.119999999999997 109.548 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.47 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 28.9 mt-30 -137.24 175.67 9.4 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 122.268 1.032 . . . . 65.099999999999994 113.401 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 426' ' ' GLN . 29.5 m -94.3 130.5 40.56 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 113.157 -1.838 . . . . 72.230000000000004 109.449 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 429' ' ' ILE . 20.1 m -131.49 149.59 52.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.144 -0.687 . . . . 64.409999999999997 109.144 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.05 154.76 29.75 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.96 0.726 . . . . 71.340000000000003 112.96 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 49.3 mm -77.08 -15.33 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 122.208 1.004 . . . . 71.549999999999997 108.37 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.64 -5.29 59.17 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.039 -0.982 . . . . 65.430000000000007 108.899 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -87.7 128.84 35.3 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.122 -1.436 . . . . 71.200000000000003 107.122 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.36 124.04 38.88 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.195 -1.039 . . . . 73.219999999999999 108.195 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.7 t -87.33 118.69 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 C-N-CA 120.194 -0.602 . . . . 71.230000000000004 109.65 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.16 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 N-CA-C 105.034 -2.21 . . . . 74.420000000000002 105.034 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.6 121.87 56.92 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 107.588 -1.264 . . . . 70.219999999999999 107.588 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.78 119.11 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-O 121.322 0.582 . . . . 73.040000000000006 110.455 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.9 t -98.14 134.92 34.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.508 -0.923 . . . . 73.329999999999998 108.508 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.06 115.24 4.16 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 110.222 -1.151 . . . . 52.119999999999997 110.222 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 39.8 p -142.39 145.93 34.36 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 116.986 0.393 . . . . 71.019999999999996 110.39 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.912 0 N-CA-C 108.004 -2.038 . . . . 61.420000000000002 108.004 177.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.667 0 N-CA-C 111.224 -0.75 . . . . 43.049999999999997 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.8 pp -75.77 133.22 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 121.547 0.689 . . . . 74.230000000000004 110.942 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.2 t -136.96 157.49 46.62 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 23.420000000000002 109.769 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 358' ' ' ARG . 23.7 mmt180 -107.35 84.8 2.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.756 0.788 . . . . 72.420000000000002 109.879 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -115.36 144.22 44.11 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.417 -1.327 . . . . 62.43 107.417 176.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.24 142.25 32.08 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.153 0.501 . . . . 73.140000000000001 111.242 -172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -95.25 136.05 36.07 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 106.51 -1.663 . . . . 62.409999999999997 106.51 173.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.9 p -97.17 135.4 21.93 Favored Pre-proline 0 C--N 1.288 -2.075 0 C-N-CA 119.742 -0.783 . . . . 71.329999999999998 110.611 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.0 129.85 32.39 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.767 2.311 . . . . 70.129999999999995 111.282 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.63 147.83 52.18 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.911 -1.041 . . . . 72.310000000000002 109.519 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.8 m -109.19 5.9 9.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 116.424 -0.353 . . . . 75.430000000000007 111.413 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -52.74 135.32 35.57 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.788 0.835 . . . . 70.25 111.758 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.48 1.56 59.06 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.469 -0.872 . . . . 64.010000000000005 112.946 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -121.21 179.8 4.29 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 122.185 -0.597 . . . . 74.340000000000003 110.639 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.2 p -73.25 149.65 42.62 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 108.962 -0.755 . . . . 72.299999999999997 108.962 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 5.0 p -63.43 -33.34 75.35 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.082 0.468 . . . . 75.209999999999994 110.39 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.62 86.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.412 -0.813 . . . . 70.230000000000004 111.594 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.98 -38.36 85.91 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.854 0.359 . . . . 42.420000000000002 110.167 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.46 -47.92 78.16 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 114.968 -1.015 . . . . 71.239999999999995 110.174 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 85.0 mt -69.05 -46.21 78.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.804 -0.635 . . . . 71.019999999999996 110.644 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.07 -47.07 88.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.641 0.608 . . . . 63.240000000000002 112.641 -176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.5 m -65.49 -44.25 87.64 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 75.150000000000006 109.878 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.493 HD21 ' HB ' ' A' ' 416' ' ' ILE . 13.3 tp -64.78 -37.75 88.65 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.924 -1.035 . . . . 73.439999999999998 110.351 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -60.51 -45.45 93.77 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.984 1.313 . . . . 75.239999999999995 110.369 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -67.37 -22.64 65.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.994 -0.548 . . . . 64.409999999999997 110.805 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -85.36 -8.67 58.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.885 -0.598 . . . . 71.409999999999997 111.72 175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 86.24 9.89 75.54 Favored Glycine 0 C--O 1.253 1.315 0 C-N-CA 120.912 -0.661 . . . . 52.329999999999998 113.915 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.445 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 54.8 m-85 -77.85 151.8 33.71 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.102 0.477 . . . . 64.409999999999997 110.217 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -88.26 132.74 34.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 106.199 -1.778 . . . . 74.540000000000006 106.199 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.533 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -117.29 134.98 59.18 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.804 0 CA-C-O 121.759 0.79 . . . . 53.539999999999999 110.956 -173.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 34.6 ttm105 -110.36 126.51 54.33 Favored 'General case' 0 C--N 1.268 -2.961 0 N-CA-C 104.743 -2.318 . . . . 73.120000000000005 104.743 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 20.5 m -112.73 118.86 36.16 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 108.242 -1.021 . . . . 51.210000000000001 108.242 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.52 118.89 36.98 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 107.45 -1.315 . . . . 72.010000000000005 107.45 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.84 124.72 53.23 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 107.992 -1.114 . . . . 72.310000000000002 107.992 176.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -125.45 137.07 29.16 Favored Pre-proline 0 C--N 1.284 -2.24 0 C-N-CA 119.577 -0.849 . . . . 74.219999999999999 111.131 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -88.54 128.34 2.09 Favored 'Trans proline' 0 N--CA 1.426 -2.454 0 N-CA-C 107.972 -1.588 . . . . 54.229999999999997 107.972 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 48.4 t0 -174.47 170.42 3.55 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.364 -1.347 . . . . 62.340000000000003 107.364 -172.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 24.0 m -106.61 -18.69 13.89 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.536 0.684 . . . . 51.240000000000002 109.219 177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 18.7 m -90.61 36.91 0.9 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 123.191 1.472 . . . . 74.319999999999993 107.71 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 391' ' ' ASP . 28.1 pt -88.8 141.69 30.05 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-N 114.285 -1.325 . . . . 73.409999999999997 110.72 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -73.66 173.86 13.2 Favored 'Trans proline' 0 CA--C 1.553 1.448 0 C-N-CA 122.129 1.886 . . . . 60.399999999999999 108.39 166.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.72 161.59 35.21 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.958 1.772 . . . . 65.120000000000005 111.772 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -56.89 -13.28 2.5 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 124.071 0.948 . . . . 62.210000000000001 111.969 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -99.61 122.55 42.82 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 104.696 -2.335 . . . . 64.340000000000003 104.696 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.0 117.88 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 CA-C-O 121.88 0.847 . . . . 72.430000000000007 109.808 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.7 tp -90.97 -29.28 4.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.38 -0.827 . . . . 72.219999999999999 110.294 -174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.46 157.82 27.8 Favored Glycine 0 N--CA 1.411 -3.001 0 C-N-CA 120.516 -0.849 . . . . 62.109999999999999 111.408 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 65.1 p -125.58 -176.91 3.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.165 -1.05 . . . . 64.219999999999999 108.165 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -101.71 139.92 20.77 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.649 -0.871 . . . . 53.549999999999997 108.649 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -48.64 -14.46 0.37 Allowed 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 124.396 3.397 . . . . 51.140000000000001 115.414 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.15 64.79 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.244 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.3 -27.68 63.58 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.534 0.683 . . . . 73.200000000000003 110.678 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -90.32 -3.72 57.58 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.609 -0.723 . . . . 74.349999999999994 109.554 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 41.4 m -91.32 156.94 17.42 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.634 -1.247 . . . . 33.210000000000001 107.634 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 5.7 p -74.37 112.57 10.66 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.698 0.761 . . . . 54.409999999999997 111.056 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.8 m -115.48 170.05 5.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.037 -0.983 . . . . 71.549999999999997 108.903 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 75.4 p -75.8 158.73 31.82 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.813 -0.755 . . . . 73.420000000000002 110.835 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.54 109.94 2.97 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.375 -0.972 . . . . 73.340000000000003 108.375 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 92.23 29.2 11.63 Favored Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.279 -0.728 . . . . 44.509999999999998 111.279 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.3 t70 -76.79 -174.51 3.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.964 0.505 . . . . 74.299999999999997 109.655 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -96.53 126.97 42.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.161 0.505 . . . . 62.130000000000003 112.178 -177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.493 ' HB ' HD21 ' A' ' 377' ' ' LEU . 51.0 mm -121.16 127.22 75.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 108.472 -0.936 . . . . 75.049999999999997 108.472 176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -94.38 119.13 32.65 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.134 0.969 . . . . 72.010000000000005 110.813 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.7 t -99.06 131.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.991 -1.114 . . . . 70.109999999999999 107.991 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -101.57 128.7 47.72 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.818 -0.438 . . . . 62.520000000000003 109.818 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 38.9 t -132.07 131.74 61.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 N-CA-C 108.205 -1.035 . . . . 54.32 108.205 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 19.0 m -91.89 122.28 34.27 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.408 -0.59 . . . . 72.040000000000006 109.408 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 24.4 m -120.6 106.04 11.38 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.995 -0.372 . . . . 72.409999999999997 109.995 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 73.72 118.12 0.08 OUTLIER Glycine 0 CA--C 1.548 2.155 0 N-CA-C 114.88 0.712 . . . . 52.140000000000001 114.88 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.8 Cg_exo -71.34 138.25 32.56 Favored 'Trans proline' 0 C--O 1.242 0.693 0 C-N-CA 121.919 1.746 . . . . 63.350000000000001 109.391 172.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 2.8 mm-40 -78.44 142.8 37.27 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 114.597 1.332 . . . . 75.439999999999998 114.597 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -120.82 133.56 55.31 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 113.435 -1.711 . . . . 70.319999999999993 108.674 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.14 157.8 35.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.203 -1.777 . . . . 75.519999999999996 106.203 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.5 OUTLIER -83.81 137.41 33.72 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 120.609 -0.436 . . . . 75.540000000000006 110.409 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.432 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 67.4 mt -86.16 128.66 56.83 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.056 -1.461 . . . . 75.420000000000002 107.056 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.36 141.4 38.83 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.503 1.469 . . . . 62.229999999999997 112.683 177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.147 0.499 . . . . 65.129999999999995 111.171 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.547 HG12 ' HB2' ' A' ' 430' ' ' PRO . 8.9 p -65.9 -14.84 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.841 0.829 . . . . 73.519999999999996 109.851 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 18.7 m -52.75 -41.53 64.12 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.751 1.22 . . . . 71.510000000000005 111.953 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 10.8 m -64.15 -13.62 49.51 Favored 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 124.024 0.93 . . . . 60.450000000000003 112.083 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 44.5 mt -82.73 -45.44 14.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.3 0.482 . . . . 52.399999999999999 112.3 -176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 86.9 m -156.05 135.68 12.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.65 -0.5 . . . . 74.010000000000005 109.65 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 441' ' ' VAL . 62.7 t80 -57.43 -53.57 56.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.153 0.797 . . . . 74.519999999999996 113.153 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -62.96 -40.88 99.04 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.004 0.43 . . . . 73.439999999999998 111.248 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -62.02 -43.21 99.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.013 -0.994 . . . . 71.340000000000003 108.862 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.26 -48.88 79.85 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.364 -0.834 . . . . 72.239999999999995 110.619 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 437' ' ' TYR . 88.9 t -58.93 -47.07 90.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.794 -0.639 . . . . 71.120000000000005 111.275 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 10.6 mmpt? -64.95 -46.51 81.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.704 -0.226 . . . . 65.439999999999998 111.213 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.69 -38.77 92.13 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.396 -0.365 . . . . 51.409999999999997 111.472 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.533 HD23 ' CE2' ' A' ' 452' ' ' PHE . 30.5 tp -67.29 -39.94 86.05 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.267 -0.424 . . . . 60.149999999999999 109.871 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 25.8 m -65.76 -38.86 90.25 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.261 -0.644 . . . . 72.109999999999999 109.261 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.59 73.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.55 -0.75 . . . . 62.439999999999998 111.138 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 0.24 31.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.795 -0.639 . . . . 74.409999999999997 110.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.7 -17.61 49.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 121.341 -0.457 . . . . 55.030000000000001 112.575 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.454 ' HB2' ' HG ' ' A' ' 444' ' ' LEU . 70.7 m-85 -83.11 83.83 7.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.381 0.61 . . . . 63.450000000000003 110.558 -175.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -98.04 17.02 59.35 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.769 -0.932 . . . . 75.329999999999998 110.769 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -103.86 110.56 22.73 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 106.814 -1.551 . . . . 64.439999999999998 106.814 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . 0.533 ' CE2' HD23 ' A' ' 444' ' ' LEU . 93.4 m-85 -119.41 152.45 36.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.522 0.677 . . . . 65.150000000000006 112.073 -174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.46 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.1 OUTLIER -147.1 121.0 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 105.231 -2.137 . . . . 74.25 105.231 170.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -91.0 130.37 36.92 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.601 0.715 . . . . 73.430000000000007 111.584 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -127.19 152.84 46.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.4 -1.333 . . . . 75.310000000000002 107.4 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.12 149.8 52.31 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-O 121.151 0.501 . . . . 63.43 110.726 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 49.5 m -132.78 131.72 22.19 Favored Pre-proline 0 C--N 1.286 -2.195 0 CA-C-N 115.603 -0.726 . . . . 73.540000000000006 109.204 173.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 490' ' ' SER . 31.6 Cg_exo -61.51 120.01 7.44 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.004 1.802 . . . . 73.209999999999994 108.274 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.572 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 17.0 m -130.0 177.24 7.43 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.992 -0.549 . . . . 71.340000000000003 109.762 -174.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 43.1 m -67.15 139.27 95.07 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.637 -1.246 . . . . 71.140000000000001 107.637 174.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.476 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.72 -23.62 8.56 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.806 3.004 . . . . 70.409999999999997 114.168 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -61.4 -32.29 72.22 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.347 0.659 . . . . 55.329999999999998 111.155 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 79.7 mt -94.07 0.73 56.08 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.386 0.513 . . . . 70.510000000000005 112.386 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 461' ' ' PRO . 10.4 p -59.89 126.95 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.247 0.546 . . . . 71.439999999999998 111.114 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.47 78.31 Favored Glycine 0 C--O 1.244 0.767 0 C-N-CA 120.686 -0.769 . . . . 70.510000000000005 112.191 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.79 148.3 33.85 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.986 -0.746 . . . . 62.399999999999999 108.986 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 486' ' ' ILE . 58.7 t -84.14 132.74 30.83 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 108.061 -1.088 . . . . 74.049999999999997 108.061 175.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.68 -26.81 4.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.422 -0.911 . . . . 54.030000000000001 111.134 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 179.75 169.65 40.34 Favored Glycine 0 N--CA 1.431 -1.7 0 C-N-CA 120.626 -0.797 . . . . 65.219999999999999 111.39 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.2 p -127.46 149.07 50.27 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.507 -0.924 . . . . 72.409999999999997 108.507 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.506 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.7 t30 -62.35 -52.78 63.7 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 119.327 -0.368 . . . . 73.129999999999995 110.725 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.1 Cg_exo -73.7 142.73 32.71 Favored 'Trans proline' 0 C--N 1.374 1.871 0 N-CA-C 108.178 -1.508 . . . . 75.120000000000005 108.178 171.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.2 126.79 19.43 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.262 1.975 . . . . 71.109999999999999 112.786 -176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.432 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.33 3.64 26.99 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-O 122.169 0.985 . . . . 53.420000000000002 110.253 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -111.66 4.24 18.45 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.842 -1.072 . . . . 65.239999999999995 110.922 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.458 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -137.08 164.81 27.54 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 122.067 0.937 . . . . 75.519999999999996 111.939 -172.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.84 125.54 29.02 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 113.299 -1.773 . . . . 71.430000000000007 108.94 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -130.82 148.32 52.58 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.186 -0.672 . . . . 61.310000000000002 109.186 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -69.97 140.93 53.06 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.292 0.091 . . . . 51.219999999999999 111.039 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.453 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 1.9 mp -60.76 -18.81 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.954 1.302 . . . . 75.219999999999999 111.931 -177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.23 5.11 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.233 0.539 . . . . 72.340000000000003 112.063 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -86.97 132.29 33.84 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.672 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.3 t -79.89 114.77 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.519 0 N-CA-C 105.936 -1.876 . . . . 63.32 105.936 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.04 120.54 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 CA-C-O 121.255 0.55 . . . . 73.439999999999998 109.829 -174.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 68.4 mt -91.23 112.25 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 106.287 -1.746 . . . . 73.420000000000002 106.287 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -103.39 119.39 51.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 114.658 -1.156 . . . . 72.099999999999994 108.064 -175.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 25.7 mt -99.83 115.97 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 CA-C-O 121.508 0.671 . . . . 71.450000000000003 109.559 -175.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.65 140.11 18.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.353 -0.98 . . . . 63.219999999999999 108.353 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -82.45 121.95 5.59 Favored Glycine 0 N--CA 1.416 -2.649 0 N-CA-C 109.062 -1.615 . . . . 75.540000000000006 109.062 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.8 m -140.08 125.2 18.66 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 122.035 -0.685 . . . . 63.43 110.212 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.413 -2.837 0 N-CA-C 107.818 -2.113 . . . . 75.310000000000002 107.818 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.949 0 N-CA-C 111.142 -0.783 . . . . 71.129999999999995 111.142 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.6 pp -121.22 132.72 69.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.777 0.799 . . . . 73.530000000000001 112.466 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 11.3 m -103.84 128.78 51.28 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.545 -1.65 . . . . 63.299999999999997 106.545 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -90.59 87.01 6.56 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.711 0.767 . . . . 73.420000000000002 111.486 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.41 146.1 34.75 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.396 -1.274 . . . . 74.420000000000002 108.169 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.11 145.05 29.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 109.885 -0.413 . . . . 73.340000000000003 109.885 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.71 137.39 34.84 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.172 -1.047 . . . . 73.519999999999996 108.172 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.09 136.08 21.15 Favored Pre-proline 0 C--N 1.293 -1.853 0 C-N-CA 120.57 -0.452 . . . . 34.219999999999999 109.991 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.76 154.6 12.18 Favored 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 123.711 2.941 . . . . 72.439999999999998 115.165 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.59 101.64 1.04 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.64 -1.164 . . . . 73.340000000000003 110.308 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.85 -3.65 8.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.25 0.548 . . . . 74.329999999999998 111.712 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -65.91 144.27 56.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.486 -0.779 . . . . 74.010000000000005 109.903 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.2 58.97 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.655 -0.978 . . . . 64.510000000000005 110.655 -179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -124.44 170.17 11.12 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.587 -1.264 . . . . 71.310000000000002 107.587 -176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.8 p -74.98 157.1 35.51 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.684 -0.487 . . . . 73.5 109.684 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.4 p -62.17 -37.86 86.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.016 0.436 . . . . 54.119999999999997 110.461 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.28 94.74 Favored 'General case' 0 C--O 1.246 0.919 0 CA-C-N 115.872 -0.604 . . . . 65.439999999999998 110.897 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -69.65 -37.46 76.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 116.505 -0.316 . . . . 73.25 110.952 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.33 69.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.66 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.72 -42.62 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 123.258 0.348 . . . . 70.219999999999999 111.173 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.61 88.22 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 116.388 -0.369 . . . . 65.340000000000003 111.09 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.1 m -63.58 -46.63 84.98 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.599 -0.273 . . . . 64.530000000000001 110.743 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.18 -41.86 96.92 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.986 -0.375 . . . . 73.109999999999999 109.986 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -59.82 -46.6 88.73 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.273 -0.876 . . . . 70.030000000000001 110.439 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.37 -33.91 76.93 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 112.657 0.614 . . . . 74.319999999999993 112.657 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -84.83 -4.23 58.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.09 -0.505 . . . . 63.43 112.159 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 91.46 7.85 64.74 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 119.88 -1.152 . . . . 53.530000000000001 113.146 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -83.76 167.65 16.94 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.516 -0.55 . . . . 60.25 109.516 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 30.6 mmtp -105.79 161.58 14.3 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.293 -1.373 . . . . 54.43 107.293 -178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.05 151.37 30.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 CA-C-O 121.881 0.848 . . . . 74.129999999999995 112.576 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 417' ' ' THR . 29.5 ttm-85 -137.05 141.07 42.43 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.567 -2.012 . . . . 71.120000000000005 105.567 172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 26.8 m -135.24 133.08 38.6 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 109.331 -0.618 . . . . 73.409999999999997 109.331 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.71 119.94 36.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.335 -0.987 . . . . 74.329999999999998 108.335 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -95.58 122.43 38.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.099 -1.075 . . . . 54.119999999999997 108.099 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 122.71 21.87 Favored Pre-proline 0 C--N 1.295 -1.769 0 N-CA-C 113.067 0.766 . . . . 74.340000000000003 113.067 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.52 129.07 4.19 Favored 'Trans proline' 0 C--O 1.247 0.933 0 N-CA-C 106.719 -2.07 . . . . 73.439999999999998 106.719 165.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.4 t70 -163.68 -176.03 4.44 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.347 -0.941 . . . . 63.409999999999997 109.042 -171.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 p -100.77 -23.72 14.55 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.34 -0.985 . . . . 64.299999999999997 108.34 176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.2 m -89.3 35.45 0.81 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.279 -1.328 . . . . 71.5 108.983 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.422 HG22 ' HB3' ' A' ' 421' ' ' SER . 45.8 pt -88.18 123.5 68.48 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 114.37 1.248 . . . . 73.230000000000004 114.37 -171.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.463 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 2.5 Cg_endo -85.15 174.89 6.86 Favored 'Trans proline' 0 CA--C 1.559 1.751 0 C-N-CA 122.861 2.374 . . . . 72.319999999999993 108.126 165.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.16 160.94 35.93 Favored 'Trans proline' 0 C--O 1.212 -0.817 0 C-N-CA 122.475 2.117 . . . . 71.209999999999994 111.261 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.22 -7.47 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.906 0.706 . . . . 74.519999999999996 112.906 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.87 147.77 28.11 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.033 -1.839 . . . . 74.450000000000003 106.033 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 38.9 t -77.37 116.91 21.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.186 -1.413 . . . . 42.409999999999997 107.186 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.5 mm -90.54 -39.77 12.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.299 -0.63 . . . . 70.329999999999998 109.299 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.88 157.67 27.48 Favored Glycine 0 N--CA 1.411 -3.013 0 CA-C-N 115.214 -0.903 . . . . 64.510000000000005 111.01 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -122.32 -179.68 4.26 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 108.49 -0.929 . . . . 62.299999999999997 108.49 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -102.33 139.92 20.67 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 108.948 -0.76 . . . . 71.450000000000003 108.948 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.37 -24.47 1.03 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 124.618 3.546 . . . . 73.030000000000001 114.84 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.57 -35.5 63.37 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 123.133 0.573 . . . . 62.409999999999997 111.456 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -65.28 -40.97 94.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.64 0.734 . . . . 74.109999999999999 110.464 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -4.75 57.62 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 115.531 -0.759 . . . . 72.239999999999995 111.755 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.9 m -88.83 152.85 21.51 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.938 -1.505 . . . . 63.539999999999999 106.938 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 48.5 m -74.12 113.53 11.42 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.953 0.882 . . . . 24.43 110.688 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.6 170.71 5.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 114.342 -1.299 . . . . 73.409999999999997 110.061 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 136.36 57.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.765 -0.652 . . . . 71.219999999999999 111.61 178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.45 119.95 13.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.508 -0.553 . . . . 73.299999999999997 109.508 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 87.3 32.12 14.81 Favored Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 121.1 -0.572 . . . . 40.409999999999997 112.133 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -94.53 174.99 6.84 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.939 -0.763 . . . . 65.019999999999996 108.939 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 12.3 pt-20 -100.35 121.22 41.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.831 0.824 . . . . 71.329999999999998 112.782 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.3 mm -97.76 124.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.667 -1.235 . . . . 73.230000000000004 107.667 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 13.4 t -91.85 130.29 37.65 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.532 0.682 . . . . 61.030000000000001 109.891 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 58.8 t -111.37 130.74 64.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 115.021 -0.991 . . . . 63.119999999999997 108.422 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -97.53 127.9 43.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.406 -0.961 . . . . 65.540000000000006 108.406 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.02 135.11 62.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.609 -0.886 . . . . 72.349999999999994 108.609 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 47.0 m -106.51 123.94 48.85 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.833 -0.542 . . . . 75.319999999999993 111.7 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 45.5 p -118.2 105.54 11.9 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.737 -0.665 . . . . 74.329999999999998 110.69 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 77.09 146.03 2.19 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.059 0.784 . . . . 33.219999999999999 115.059 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 76.7 Cg_endo -81.74 149.65 16.25 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.344 2.029 . . . . 75.329999999999998 111.753 176.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.05 144.76 40.6 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.52 -0.764 . . . . 72.310000000000002 110.849 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.537 ' HB3' HG22 ' A' ' 477' ' ' THR . 45.5 mt-30 -118.85 156.88 28.67 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 71.219999999999999 110.675 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.494 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 6.1 tpm_? -153.51 154.66 34.76 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.848 -1.538 . . . . 64.209999999999994 106.848 -178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.1 OUTLIER -93.8 140.17 29.98 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.02 -0.733 . . . . 65.030000000000001 109.02 176.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.8 mp -78.98 126.47 82.07 Favored Pre-proline 0 C--N 1.311 -1.082 0 N-CA-C 107.851 -1.166 . . . . 74.099999999999994 107.851 -175.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.97 140.32 79.53 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.203 1.936 . . . . 70.430000000000007 112.176 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.77 12.9 28.37 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.789 0.804 . . . . 73.019999999999996 110.08 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 21.1 t -87.2 -12.79 10.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.919 -1.037 . . . . 73.010000000000005 108.965 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.0 m -52.76 -40.51 63.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.503 -1.226 . . . . 72.310000000000002 112.624 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.2 p -63.01 -17.91 62.73 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.365 1.246 . . . . 71.230000000000004 114.365 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 90.4 mt -82.36 -44.91 15.56 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.086 0.47 . . . . 61.409999999999997 111.689 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 65.6 m -150.2 133.22 16.16 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.896 -0.503 . . . . 74.430000000000007 109.969 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -58.37 -45.31 88.47 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.467 0.479 . . . . 75.010000000000005 111.163 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.16 -42.37 80.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.042 -0.526 . . . . 55.520000000000003 110.694 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -63.75 -39.39 94.15 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 116.064 -0.516 . . . . 71.099999999999994 111.398 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.407 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.49 -50.53 73.18 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 123.526 0.516 . . . . 53.450000000000003 109.768 178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.03 -45.9 95.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 116.102 -0.499 . . . . 61.340000000000003 110.673 -178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -65.47 -47.72 75.13 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 111.813 0.301 . . . . 74.549999999999997 111.813 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -66.32 -40.24 89.81 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 111.688 0.255 . . . . 74.109999999999999 111.688 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.407 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.1 mp -67.0 -38.43 85.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.619 -0.432 . . . . 72.400000000000006 111.608 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 68.9 m -64.81 -38.8 92.19 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.478 -0.564 . . . . 54.130000000000003 109.478 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.85 65.24 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.395 0.616 . . . . 74.409999999999997 110.455 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.494 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.44 -13.22 59.73 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.482 0.658 . . . . 73.239999999999995 110.296 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.22 -13.32 26.14 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 120.691 -0.766 . . . . 51.119999999999997 113.651 175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -71.62 114.96 10.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.525 -0.546 . . . . 73.329999999999998 109.525 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.97 17.38 8.67 Favored Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 120.45 -0.881 . . . . 71.439999999999998 111.58 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -120.58 111.25 17.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.478 -1.675 . . . . 75.209999999999994 106.478 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -124.3 155.01 39.42 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.772 0.796 . . . . 74.409999999999997 112.882 -174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 4.5 tppp? -145.17 125.08 13.47 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.598 -1.63 . . . . 74.319999999999993 106.598 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.518 HE21 HG21 ' A' ' 488' ' ' VAL . 65.0 tt0 -100.44 126.08 46.81 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.169 0.509 . . . . 64.019999999999996 110.888 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -124.64 156.43 37.51 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.431 -0.952 . . . . 70.310000000000002 108.431 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -126.97 145.18 50.79 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.302 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 52.4 m -133.94 144.57 52.21 Favored Pre-proline 0 C--N 1.286 -2.183 0 N-CA-C 109.171 -0.677 . . . . 72.310000000000002 109.171 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 490' ' ' SER . 23.8 Cg_endo -62.54 122.82 11.35 Favored 'Trans proline' 0 C--O 1.243 0.773 0 C-N-CA 123.257 2.638 . . . . 72.430000000000007 113.21 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 18.7 m -132.87 170.73 14.9 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.537 -0.912 . . . . 71.209999999999994 108.537 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.7 m -69.72 145.61 94.95 Favored Pre-proline 0 CA--C 1.559 1.326 0 N-CA-C 107.678 -1.23 . . . . 74.219999999999999 107.678 175.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.558 ' O ' HG12 ' A' ' 464' ' ' VAL . 6.8 Cg_endo -49.36 -23.76 7.67 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 124.129 3.219 . . . . 63.350000000000001 114.255 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -62.84 -30.11 71.25 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.368 0.604 . . . . 64.319999999999993 110.43 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.35 1.35 35.42 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.821 -0.627 . . . . 72.129999999999995 112.581 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.6 p -60.18 126.29 17.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 119.415 -0.914 . . . . 64.230000000000004 110.72 -178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.92 -5.94 72.83 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.598 -0.81 . . . . 65.409999999999997 112.169 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.88 155.61 17.85 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.927 -0.768 . . . . 72.340000000000003 108.927 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 486' ' ' ILE . 66.3 t -84.67 131.59 33.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.923 -0.769 . . . . 72.340000000000003 108.923 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.13 -14.2 7.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 119.838 -0.745 . . . . 64.349999999999994 110.903 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.53 -177.65 41.87 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 115.567 -0.742 . . . . 74.230000000000004 111.441 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.9 p -130.44 150.03 51.84 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.682 -1.229 . . . . 72.420000000000002 107.682 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 50.9 t30 -63.87 -51.36 64.96 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 120.262 -0.575 . . . . 23.329999999999998 110.307 177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.3 Cg_exo -75.41 130.48 12.91 Favored 'Trans proline' 0 C--N 1.375 1.955 0 N-CA-C 108.376 -1.432 . . . . 71.450000000000003 108.376 170.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.429 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 37.5 Cg_endo -62.94 136.53 57.46 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.697 2.264 . . . . 64.209999999999994 113.399 -175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.62 6.84 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.066 0.936 . . . . 53.310000000000002 109.845 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.463 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -104.61 2.59 30.81 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.857 -1.065 . . . . 61.539999999999999 109.664 178.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 7.7 tp-100 -145.97 173.71 11.91 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.975 -0.69 . . . . 74.310000000000002 110.923 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 426' ' ' GLN . 18.2 m -102.26 140.62 36.3 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 124.308 1.043 . . . . 74.340000000000003 110.948 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . 0.412 ' OG ' HD11 ' A' ' 429' ' ' ILE . 77.8 p -137.84 150.38 47.12 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.373 -0.602 . . . . 74.510000000000005 109.373 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.5 146.68 51.7 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.885 -0.326 . . . . 73.329999999999998 110.38 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.76 -11.13 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 C-N-CA 124.052 0.941 . . . . 54.420000000000002 111.629 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 5.5 p -87.04 5.79 35.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.412 0.625 . . . . 70.430000000000007 111.065 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -93.01 142.12 27.64 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 115.656 -0.702 . . . . 61.310000000000002 110.362 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 52.4 t -85.79 115.18 26.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.946 -1.501 . . . . 74.329999999999998 106.946 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 81.9 t -86.58 119.88 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 CA-C-O 121.467 0.651 . . . . 55.310000000000002 109.998 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 49.0 mt -92.36 112.9 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 107.302 -1.37 . . . . 72.400000000000006 107.302 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.38 127.13 49.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 107.451 -1.315 . . . . 73.349999999999994 107.451 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 15.6 mm -102.27 113.13 37.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.132 0.491 . . . . 72.109999999999999 109.943 -173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.518 HG21 HE21 ' A' ' 454' ' ' GLN . 32.9 t -98.3 141.54 16.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.673 -0.862 . . . . 62.299999999999997 108.673 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -90.52 121.12 6.1 Favored Glycine 0 N--CA 1.418 -2.527 0 N-CA-C 111.035 -0.826 . . . . 72.209999999999994 111.035 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 49.5 m -141.39 143.76 34.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.582 -0.896 . . . . 64.230000000000004 108.582 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.562 0 CA-C-O 118.229 -1.317 . . . . 74.200000000000003 110.538 -179.486 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.568 0 N-CA-C 109.484 -1.446 . . . . 43.049999999999997 109.484 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.01 144.73 29.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 118.017 0.908 . . . . 74.439999999999998 113.037 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -86.17 174.28 9.24 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 107.451 -1.314 . . . . 74.510000000000005 107.451 171.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -87.62 78.43 8.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.115 -1.034 . . . . 72.209999999999994 109.794 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.05 117.2 25.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.636 -1.166 . . . . 74.140000000000001 108.419 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.41 151.77 34.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 109.362 -0.607 . . . . 64.219999999999999 109.362 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -95.15 136.99 34.8 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.289 -1.374 . . . . 72.319999999999993 107.289 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.0 p -100.04 121.8 52.72 Favored Pre-proline 0 C--N 1.287 -2.122 0 N-CA-C 108.914 -0.772 . . . . 51.109999999999999 108.914 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.94 136.8 63.53 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.602 2.201 . . . . 74.519999999999996 113.046 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.545 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 7.5 p-10 -72.61 137.23 46.0 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.254 -0.885 . . . . 73.099999999999994 110.004 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 368' ' ' GLN . 5.8 t -89.82 45.56 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-O 122.585 1.183 . . . . 71.299999999999997 110.482 -170.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.545 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.8 ptm85 -65.51 136.29 56.23 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.418 -1.265 . . . . 64.25 110.921 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.48 0.55 62.79 Favored Glycine 0 C--N 1.316 -0.542 0 C-N-CA 120.79 -0.719 . . . . 50.310000000000002 113.024 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.417 ' HB2' HG12 ' A' ' 365' ' ' VAL . 44.9 mt-30 -125.95 172.12 10.19 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 122.586 -0.361 . . . . 72.230000000000004 110.13 -178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.1 p -77.14 167.14 22.27 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-O 120.626 0.251 . . . . 74.549999999999997 110.604 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 16.7 p -63.04 -33.96 76.55 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.078 0.465 . . . . 72.200000000000003 110.03 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.5 97.33 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.719 -0.673 . . . . 34.210000000000001 110.258 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -64.83 -41.43 95.75 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.539 -0.541 . . . . 55.420000000000002 109.539 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.84 -48.74 80.27 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.108 -0.497 . . . . 71.219999999999999 110.784 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 91.6 mt -58.15 -46.02 88.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.701 -0.681 . . . . 72.219999999999999 110.079 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.42 86.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.819 -0.628 . . . . 52.520000000000003 111.61 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.2 m -60.58 -47.11 87.67 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 122.326 0.25 . . . . 55.219999999999999 111.552 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.55 -42.02 95.97 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.533 -0.467 . . . . 60.210000000000001 110.593 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -41.56 91.61 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.597 0.759 . . . . 74.519999999999996 109.806 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -29.27 67.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.384 -0.825 . . . . 53.329999999999998 111.12 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -82.68 -14.4 54.72 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.458 -0.571 . . . . 51.229999999999997 109.458 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.564 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.45 -2.63 56.19 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.822 -0.626 . . . . 53.310000000000002 111.692 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.579 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 46.5 m-85 -81.5 156.71 25.15 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.937 0.398 . . . . 74.510000000000005 110.075 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -105.16 147.78 27.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.371 -1.344 . . . . 62.530000000000001 107.371 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.75 142.73 30.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 CA-C-O 121.957 0.884 . . . . 73.530000000000001 112.748 -175.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 417' ' ' THR . 58.2 ttt180 -119.06 133.39 55.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.014 -1.847 . . . . 61.229999999999997 106.014 175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.9 m -104.94 125.66 51.18 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.499 -0.88 . . . . 74.299999999999997 111.36 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.2 tm? -111.51 119.33 38.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.234 -2.135 . . . . 74.400000000000006 105.234 175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.576 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -112.85 122.63 48.23 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 109.292 -0.633 . . . . 73.540000000000006 109.292 -178.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -115.78 127.38 26.83 Favored Pre-proline 0 C--N 1.289 -2.034 0 C-N-CA 119.939 -0.705 . . . . 63.130000000000003 111.287 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -87.39 128.9 2.64 Favored 'Trans proline' 0 N--CA 1.428 -2.327 0 N-CA-C 107.234 -1.871 . . . . 61.420000000000002 107.234 167.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.459 ' HB3' HG23 ' A' ' 394' ' ' ILE . 6.9 t70 -142.66 -179.4 6.29 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.639 -1.225 . . . . 61.32 110.199 -173.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 23.4 m -98.15 -33.47 11.12 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.365 -1.346 . . . . 60.530000000000001 107.365 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 34.5 m -101.57 71.13 1.31 Allowed 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.178 -1.415 . . . . 74.409999999999997 107.178 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.459 HG23 ' HB3' ' A' ' 391' ' ' ASP . 18.8 pt -100.85 125.32 38.92 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 114.867 -1.06 . . . . 74.219999999999999 111.97 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.57 175.86 3.68 Favored 'Trans proline' 0 N--CA 1.432 -2.123 0 N-CA-C 107.66 -1.708 . . . . 72.400000000000006 107.66 168.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.9 162.45 16.07 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.083 1.855 . . . . 74.450000000000003 109.992 171.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -56.81 -8.42 0.6 Allowed 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.254 1.022 . . . . 64.450000000000003 113.034 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.9 m80 -62.7 131.74 49.95 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.075 -0.713 . . . . 64.340000000000003 109.075 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.61 118.43 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.211 0 CA-C-N 115.645 -0.707 . . . . 73.099999999999994 109.159 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.2 pp -91.13 -28.03 4.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.105 -0.952 . . . . 72.349999999999994 110.359 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.435 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -169.42 157.31 29.04 Favored Glycine 0 N--CA 1.413 -2.835 0 N-CA-C 109.515 -1.434 . . . . 72.400000000000006 109.515 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.604 HG22 ' H ' ' A' ' 403' ' ' ASP . 8.9 m -114.42 -177.18 3.07 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 106.332 -1.729 . . . . 62.43 106.332 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.604 ' H ' HG22 ' A' ' 402' ' ' THR . 10.5 t70 -97.96 138.72 20.99 Favored Pre-proline 0 C--N 1.267 -2.996 0 N-CA-C 109.092 -0.707 . . . . 73.209999999999994 109.092 -172.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.48 -25.7 0.88 Allowed 'Trans proline' 0 C--N 1.366 1.463 0 C-N-CA 125.098 3.865 . . . . 72.340000000000003 115.463 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.73 68.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.954 0.407 . . . . 54.229999999999997 110.72 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -74.8 -38.57 62.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.775 0.798 . . . . 71.030000000000001 109.79 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.26 -5.08 48.04 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.903 -1.044 . . . . 63.210000000000001 110.704 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 91.4 m -86.8 147.87 25.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.044 -1.095 . . . . 72.519999999999996 108.044 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 34.9 p -74.52 112.97 11.24 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 109.329 -0.619 . . . . 65.310000000000002 109.329 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.28 169.22 22.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.349 -0.982 . . . . 74.219999999999999 108.349 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 26.1 p -80.14 137.75 36.78 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.003 -1.079 . . . . 65.530000000000001 110.432 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -60.36 138.61 57.94 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 116.218 -0.446 . . . . 55.25 110.655 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 100.92 15.63 28.13 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.192 -1.004 . . . . 70.349999999999994 110.779 -176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.51 -174.32 4.53 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.952 -1.499 . . . . 43.130000000000003 106.952 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -113.62 126.49 55.33 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.431 0.634 . . . . 65.230000000000004 110.926 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.01 119.44 61.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 109.748 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 385' ' ' ARG . 4.9 t -85.13 118.93 24.99 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.899 0.857 . . . . 73.120000000000005 109.728 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.84 122.04 60.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.01 -0.995 . . . . 72.230000000000004 108.387 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 9.6 p30 -90.66 128.71 36.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.448 0.642 . . . . 74.439999999999998 110.461 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.0 143.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 107.333 -1.358 . . . . 63.310000000000002 107.333 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 2.1 p -88.04 120.02 28.98 Favored 'General case' 0 N--CA 1.407 -2.596 0 C-N-CA 119.143 -1.023 . . . . 73.340000000000003 108.898 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 40.0 m -120.2 105.31 10.84 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 108.962 -0.755 . . . . 74.349999999999994 108.962 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 75.73 166.13 19.57 Favored Glycine 0 C--O 1.259 1.677 0 CA-C-O 122.118 0.843 . . . . 43.32 114.293 177.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -96.0 157.32 1.42 Allowed 'Trans proline' 0 N--CA 1.429 -2.265 0 C-N-CA 122.998 2.466 . . . . 73.239999999999995 112.866 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.59 20.22 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 105.524 -2.028 . . . . 74.209999999999994 105.524 173.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -120.1 152.73 37.17 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.746 -0.465 . . . . 75.540000000000006 109.746 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.0 OUTLIER -146.84 156.68 43.3 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.067 -1.086 . . . . 75.450000000000003 108.067 -178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 49.2 mt-10 -83.93 140.15 32.13 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.348 -0.982 . . . . 73.120000000000005 108.348 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.9 mp -79.59 119.24 76.2 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 106.634 -1.617 . . . . 71.129999999999995 106.634 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.49 140.36 94.34 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 121.675 1.584 . . . . 70.319999999999993 111.627 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.44 -0.68 56.51 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.441 0.638 . . . . 74.109999999999999 110.88 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.3 p -76.29 -6.54 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 CA-C-O 121.887 0.851 . . . . 74.549999999999997 109.562 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 10.6 p -63.72 -28.17 69.71 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.148 -0.933 . . . . 63.329999999999998 112.105 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 20.6 p -65.32 -13.92 59.61 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 113.453 0.909 . . . . 64.209999999999994 113.453 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.7 -48.55 68.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 111.694 0.257 . . . . 63.409999999999997 111.694 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 12.3 t -174.32 165.49 4.01 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 121.234 -0.186 . . . . 75.219999999999999 110.545 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -58.47 -52.54 65.2 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.319 1.048 . . . . 61.399999999999999 112.666 -175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.83 84.61 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.396 -0.366 . . . . 61.350000000000001 111.593 -178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.67 -45.96 90.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 63.310000000000002 109.956 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.54 -49.22 78.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.484 -0.78 . . . . 52.5 111.129 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.62 -46.81 95.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 116.275 -0.42 . . . . 75.129999999999995 110.907 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -62.48 -47.69 82.88 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 112.079 0.4 . . . . 75.120000000000005 112.079 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.08 -46.3 84.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.202 0.445 . . . . 62.039999999999999 112.202 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.91 -36.72 80.66 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 112.562 0.578 . . . . 65.409999999999997 112.562 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.1 m -64.44 -40.85 96.52 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.044 0.449 . . . . 55.420000000000002 110.075 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.59 63.06 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.461 0.648 . . . . 65.230000000000004 110.42 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.32 -12.89 59.93 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.628 -0.714 . . . . 72.439999999999998 110.049 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.84 -19.66 10.23 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.639 -0.709 . . . . 64.120000000000005 113.173 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.28 102.93 3.81 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.071 0.463 . . . . 75.530000000000001 110.489 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.22 19.85 33.93 Favored Glycine 0 N--CA 1.436 -1.331 0 C-N-CA 120.744 -0.741 . . . . 64.219999999999999 111.914 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -123.63 111.48 16.27 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.411 -0.588 . . . . 70.209999999999994 109.411 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -129.14 158.28 39.42 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.437 0.636 . . . . 74.109999999999999 111.656 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.65 126.85 16.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.476 -1.676 . . . . 64.549999999999997 106.476 170.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -87.52 132.54 34.0 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 110.037 -0.357 . . . . 71.519999999999996 110.037 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.72 161.5 37.4 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.285 -1.006 . . . . 45.450000000000003 108.285 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.415 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 23.5 m-80 -133.93 149.84 51.29 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 122.537 0.335 . . . . 71.340000000000003 110.305 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 31.1 t -128.52 131.46 23.78 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 107.246 -1.39 . . . . 72.510000000000005 107.246 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.7 Cg_endo -61.8 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.764 1.642 . . . . 72.310000000000002 109.209 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 19.4 m -126.97 175.46 8.06 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 116.157 -0.474 . . . . 65.319999999999993 109.98 -174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 10.6 m -63.92 133.17 95.49 Favored Pre-proline 0 N--CA 1.424 -1.746 0 N-CA-C 106.289 -1.745 . . . . 54.229999999999997 106.289 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.54 -23.91 8.44 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.367 2.712 . . . . 73.5 114.027 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -67.04 -21.36 65.92 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.185 0.439 . . . . 71.030000000000001 112.185 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.2 7.84 40.74 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 121.904 -0.497 . . . . 63.299999999999997 111.622 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.2 p -59.25 127.36 18.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 CA-C-O 121.321 0.581 . . . . 73.329999999999998 110.843 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.76 -6.72 70.33 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 115.543 -0.753 . . . . 44.450000000000003 112.104 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -100.64 151.12 22.0 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.875 -0.787 . . . . 75.450000000000003 108.875 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.2 t -84.19 130.47 35.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.773 -0.825 . . . . 75.420000000000002 108.773 177.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.49 -16.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 120.168 -0.613 . . . . 53.299999999999997 112.38 -175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.19 160.23 12.34 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 111.019 -0.832 . . . . 52.130000000000003 111.019 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 486' ' ' ILE . 7.9 p -119.32 149.65 41.45 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.631 -1.248 . . . . 51.140000000000001 107.631 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.445 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 7.6 t30 -59.28 -49.7 91.38 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 119.797 -0.761 . . . . 62.229999999999997 110.731 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 12.2 Cg_exo -76.07 117.6 4.72 Favored 'Trans proline' 0 C--N 1.372 1.812 0 N-CA-C 107.642 -1.715 . . . . 54.5 107.642 167.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.484 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.2 Cg_endo -62.9 142.95 90.37 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.888 2.392 . . . . 60.229999999999997 114.744 -173.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.419 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.27 0.12 15.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.814 -1.084 . . . . 64.150000000000006 113.24 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.467 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -109.14 0.12 19.64 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.29 -0.881 . . . . 73.030000000000001 109.517 175.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.484 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 6.5 tp-100 -117.74 162.11 18.6 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.725 0.774 . . . . 65.219999999999999 111.926 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 9.3 m -97.34 132.22 43.27 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.255 -1.338 . . . . 74.299999999999997 108.6 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.1 m -136.47 149.0 47.98 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.985 -0.376 . . . . 50.039999999999999 109.985 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -70.3 141.85 52.31 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.942 -0.392 . . . . 74.109999999999999 109.942 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.9 -17.0 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 114.454 1.279 . . . . 70.340000000000003 114.454 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.0 p -88.9 5.29 44.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.676 -0.64 . . . . 71.140000000000001 112.022 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -90.3 147.63 23.38 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 109.311 -0.625 . . . . 62.020000000000003 109.311 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.4 t -83.25 119.55 32.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.629 -0.878 . . . . 63.140000000000001 108.629 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.93 119.18 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 N-CA-C 108.507 -0.923 . . . . 73.299999999999997 108.507 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.5 112.73 26.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.182 -1.784 . . . . 63.350000000000001 106.182 174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -100.69 113.37 36.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.478 -1.304 . . . . 73.299999999999997 107.478 -177.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 22.4 mt -101.95 121.13 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.693 -0.685 . . . . 73.329999999999998 109.84 -175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.415 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 38.2 t -97.36 143.68 12.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.41 -0.959 . . . . 72.349999999999994 108.41 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -89.82 118.09 5.16 Favored Glycine 0 N--CA 1.415 -2.727 0 N-CA-C 110.177 -1.169 . . . . 64.439999999999998 110.177 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 50.9 m -134.93 136.85 42.6 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.68 -0.859 . . . . 70.0 108.68 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.42 -2.373 0 N-CA-C 109.065 -1.614 . . . . 73.129999999999995 109.065 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.43 0 N-CA-C 109.216 -1.554 . . . . 43.049999999999997 109.216 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.69 140.54 15.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 117.911 0.855 . . . . 70.200000000000003 112.437 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.2 t -107.5 137.9 44.69 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.331 -0.849 . . . . 74.310000000000002 109.495 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -99.73 73.76 1.81 Allowed 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.559 -0.904 . . . . 72.25 108.559 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -89.17 144.35 26.18 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.992 -1.004 . . . . 75.219999999999999 109.327 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.34 157.71 29.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.373 -0.376 . . . . 74.230000000000004 110.104 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -94.98 136.88 34.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.108 -1.442 . . . . 63.030000000000001 107.108 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.9 137.47 20.93 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 120.194 -0.602 . . . . 22.140000000000001 110.644 -171.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -43.63 124.21 4.2 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 124.068 3.178 . . . . 72.420000000000002 114.67 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.4 ' CG ' ' HE ' ' A' ' 366' ' ' ARG . 9.8 t70 -76.29 138.07 40.3 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.244 -1.391 . . . . 74.219999999999999 107.244 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.569 HG23 HG11 ' A' ' 399' ' ' VAL . 31.0 m -102.16 23.85 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 113.545 0.943 . . . . 71.340000000000003 113.545 -170.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.402 ' HB3' ' HA2' ' A' ' 401' ' ' GLY . 20.6 ptp180 -62.73 135.04 57.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.314 0.578 . . . . 71.0 111.82 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.88 -3.78 77.9 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.139 -0.784 . . . . 54.25 111.139 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -114.96 160.19 19.85 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 109.624 -0.51 . . . . 72.120000000000005 109.624 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 67.9 p -75.65 158.34 32.5 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 110.37 -0.233 . . . . 55.219999999999999 110.37 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.477 ' O ' HD13 ' A' ' 374' ' ' ILE . 17.9 p -63.13 -37.13 86.0 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 120.771 0.32 . . . . 53.32 110.449 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.08 90.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.249 -0.432 . . . . 64.420000000000002 110.584 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.89 -34.94 79.29 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.125 0.488 . . . . 61.409999999999997 110.487 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.526 -0.761 . . . . 30.420000000000002 110.371 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 384' ' ' ILE . 1.4 mp -58.55 -44.37 89.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.748 -0.66 . . . . 63.210000000000001 110.213 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.79 84.27 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.219 -0.446 . . . . 62.439999999999998 112.133 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 85.5 m -60.83 -47.17 87.58 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.647 0.24 . . . . 72.409999999999997 111.647 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.51 -39.02 93.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.779 0.323 . . . . 71.530000000000001 110.921 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -63.12 -46.0 89.35 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.345 -0.843 . . . . 71.120000000000005 109.601 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -70.57 -24.43 62.78 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.901 -0.59 . . . . 74.319999999999993 112.238 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -81.14 -15.3 56.26 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 120.144 -0.622 . . . . 72.150000000000006 111.584 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.424 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 98.98 14.84 35.24 Favored Glycine 0 CA--C 1.503 -0.701 0 C-N-CA 119.679 -1.248 . . . . 73.049999999999997 111.888 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 48.6 m-85 -97.26 168.86 10.16 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 108.548 -0.908 . . . . 72.230000000000004 108.548 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.5 mmtp -113.49 157.25 22.23 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.514 -1.291 . . . . 65.299999999999997 107.514 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -135.0 142.37 40.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-O 121.293 0.568 . . . . 74.400000000000006 111.802 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -112.18 128.02 56.11 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 24.6 m -100.44 123.68 44.98 Favored 'General case' 0 N--CA 1.402 -2.851 0 C-N-CA 119.329 -0.948 . . . . 63.420000000000002 108.522 176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.98 119.41 38.97 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 105.421 -2.066 . . . . 60.210000000000001 105.421 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.573 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -107.99 122.05 46.05 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.529 -0.915 . . . . 72.319999999999993 108.529 -177.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 137.82 31.09 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.566 -0.454 . . . . 63.450000000000003 111.143 -178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.3 Cg_endo -93.1 148.88 2.52 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.735 2.29 . . . . 71.409999999999997 111.487 175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 394' ' ' ILE . 4.9 t70 170.06 174.75 0.06 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.758 -1.571 . . . . 74.209999999999994 106.758 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.686 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 22.0 m -99.3 -33.97 10.51 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 108.823 -0.806 . . . . 73.239999999999995 108.823 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.8 p -94.71 63.19 2.81 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-O 122.538 1.161 . . . . 64.109999999999999 108.255 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.592 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -95.6 151.57 38.6 Favored Pre-proline 0 N--CA 1.424 -1.742 0 CA-C-N 113.644 -1.617 . . . . 71.519999999999996 112.51 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.42 143.73 58.88 Favored 'Trans proline' 0 N--CA 1.439 -1.706 0 N-CA-C 107.24 -1.869 . . . . 73.030000000000001 107.24 167.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.92 148.67 66.05 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.242 1.962 . . . . 64.540000000000006 111.461 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.91 -9.68 10.68 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 122.019 0.914 . . . . 52.420000000000002 110.734 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -96.52 125.99 41.39 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 103.708 -2.701 . . . . 74.409999999999997 103.708 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 365' ' ' VAL . 31.2 t -62.37 119.25 5.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.576 0.703 . . . . 75.200000000000003 111.969 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 8.6 tp -84.97 -29.0 6.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.369 -0.832 . . . . 70.099999999999994 109.367 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 366' ' ' ARG . . . -170.07 160.32 33.18 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 403' ' ' ASP . 0.7 OUTLIER -113.14 -175.66 2.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 105.825 -1.917 . . . . 72.239999999999995 105.825 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.439 ' H ' HG22 ' A' ' 402' ' ' THR . 17.3 t70 -99.38 136.58 20.38 Favored Pre-proline 0 C--N 1.265 -3.089 0 N-CA-C 109.71 -0.478 . . . . 74.239999999999995 109.71 -171.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -33.73 -31.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 1 C-N-CA 126.069 4.513 . . . . 74.439999999999998 115.88 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -57.56 -31.92 66.6 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 122.652 0.381 . . . . 73.510000000000005 111.0 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.96 -35.3 64.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.364 0.602 . . . . 75.209999999999994 110.58 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -77.93 -15.08 59.29 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.01 -0.541 . . . . 74.340000000000003 110.183 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 70.8 m -86.35 147.09 26.2 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.241 -1.022 . . . . 73.540000000000006 108.241 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.7 m -74.81 112.9 11.5 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.008 -1.108 . . . . 63.329999999999998 108.008 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.05 170.22 18.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.663 -0.699 . . . . 74.040000000000006 110.845 -173.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.1 p -65.91 131.52 46.44 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.403 -0.817 . . . . 53.229999999999997 110.628 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.401 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.94 113.46 4.42 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.077 0.465 . . . . 64.409999999999997 110.114 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.29 -2.07 9.66 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.393 -0.908 . . . . 60.219999999999999 112.342 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.78 158.87 32.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 110.057 -0.349 . . . . 75.329999999999998 110.057 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.9 pt-20 -87.29 121.4 29.68 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.371 0.605 . . . . 53.210000000000001 111.273 -177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.9 mm -97.82 131.15 45.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 N-CA-C 107.851 -1.166 . . . . 70.439999999999998 107.851 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.5 t -91.55 130.0 37.44 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.506 0.67 . . . . 51.530000000000001 110.301 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.8 t -117.57 125.46 74.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.591 -1.263 . . . . 73.219999999999999 107.591 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.9 129.2 43.21 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 110.008 -0.367 . . . . 64.510000000000005 110.008 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.5 p -125.58 147.95 30.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.98 -1.119 . . . . 65.530000000000001 107.98 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 5.8 p -96.51 123.34 40.14 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.056 0.455 . . . . 65.230000000000004 112.197 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 t -117.61 106.08 12.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.168 -0.613 . . . . 73.140000000000001 111.393 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 74.48 130.19 0.21 Allowed Glycine 0 CA--C 1.532 1.134 0 N-CA-C 115.517 0.967 . . . . 65.530000000000001 115.517 174.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 22.8 Cg_exo -68.43 145.99 66.95 Favored 'Trans proline' 0 C--O 1.249 1.052 0 C-N-CA 121.943 1.762 . . . . 44.219999999999999 109.294 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -80.31 147.24 31.21 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.084 0.772 . . . . 65.549999999999997 113.084 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 41.4 mt-30 -123.21 137.43 54.88 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 107.732 -1.21 . . . . 74.409999999999997 107.732 174.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 427' ' ' ARG . 2.9 mmp_? -137.15 164.4 28.54 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.451 -0.574 . . . . 75.219999999999999 109.451 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -82.49 137.8 34.53 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.277 -1.008 . . . . 72.120000000000005 108.277 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 65.4 mt -80.85 114.35 47.62 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 108.543 -0.91 . . . . 64.030000000000001 108.543 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 140.74 37.27 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.343 1.362 . . . . 52.450000000000003 110.296 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -116.76 96.57 5.55 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 114.133 1.161 . . . . 73.400000000000006 114.133 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 17.3 t -126.3 6.76 3.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.112 -2.921 . . . . 70.340000000000003 103.112 165.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 4.6 m -71.05 -46.37 62.13 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 112.176 -2.284 . . . . 73.129999999999995 110.86 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 466' ' ' LYS . 21.6 m -57.01 -31.77 65.46 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.529 0.681 . . . . 75.120000000000005 110.031 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 96.9 mt -86.82 -48.19 8.42 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.728 -0.669 . . . . 73.049999999999997 111.723 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 57.7 m -132.38 122.95 25.81 Favored 'General case' 0 CA--C 1.551 0.981 0 O-C-N 121.991 -0.443 . . . . 53.420000000000002 112.145 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -60.91 -40.57 93.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.98 0.912 . . . . 73.040000000000006 111.531 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.14 93.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.25 0.548 . . . . 44.43 110.302 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -65.39 -35.62 81.5 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.446 -0.797 . . . . 60.450000000000003 111.384 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -45.22 94.1 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.632 0.583 . . . . 62.340000000000003 109.487 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.23 -49.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.769 -0.651 . . . . 74.349999999999994 110.691 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -65.09 -49.23 70.81 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.434 0.531 . . . . 72.510000000000005 112.434 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 30.6 mmtp -68.02 -38.66 82.84 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.912 0.708 . . . . 64.230000000000004 112.912 -174.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.44 -37.1 79.92 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 120.291 -0.564 . . . . 72.439999999999998 111.462 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 51.7 m -64.41 -38.13 89.95 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.274 -0.639 . . . . 73.540000000000006 109.274 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -63.4 -34.31 77.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.763 -0.653 . . . . 74.310000000000002 111.03 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -14.66 58.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.092 0.472 . . . . 73.519999999999996 110.225 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.41 -23.46 8.01 Favored Glycine 0 N--CA 1.435 -1.428 0 CA-C-O 119.531 -0.594 . . . . 32.509999999999998 113.86 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 480' ' ' ILE . 99.0 m-85 -55.66 122.97 12.58 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.003 0.521 . . . . 75.129999999999995 111.962 -174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -131.01 8.66 5.73 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.48 -0.782 . . . . 74.420000000000002 111.62 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.0 mmm180 -110.23 110.62 21.52 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.735 -1.58 . . . . 75.340000000000003 106.735 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.37 150.29 52.18 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.918 0.866 . . . . 75.319999999999993 112.418 -175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 27.6 tptp -139.07 122.93 17.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.272 -1.751 . . . . 64.430000000000007 106.272 172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -93.32 135.75 34.25 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 110.053 -0.351 . . . . 75.120000000000005 110.053 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.09 152.22 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.556 -0.535 . . . . 54.229999999999997 109.556 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -118.66 129.4 55.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.585 -0.895 . . . . 51.439999999999998 108.585 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 6.9 t -126.6 137.88 31.31 Favored Pre-proline 0 C--N 1.287 -2.12 0 N-CA-C 107.788 -1.19 . . . . 52.350000000000001 107.788 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.82 135.16 46.96 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.679 2.253 . . . . 64.129999999999995 110.427 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.1 t -148.18 169.86 19.11 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.465 -0.939 . . . . 73.140000000000001 108.465 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.6 m -65.46 144.12 98.87 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.785 0.834 . . . . 64.439999999999998 109.214 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.612 ' O ' HG12 ' A' ' 464' ' ' VAL . 93.3 Cg_exo -49.29 -23.47 7.04 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.915 3.076 . . . . 71.430000000000007 114.745 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -68.86 -31.98 71.33 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.116 0.484 . . . . 71.209999999999994 111.142 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.39 -12.24 21.62 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.907 -0.588 . . . . 64.109999999999999 111.305 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.3 p -60.19 126.95 18.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-O 121.464 0.65 . . . . 73.420000000000002 110.448 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 98.6 -13.35 62.7 Favored Glycine 0 C--N 1.301 -1.383 0 N-CA-C 111.284 -0.726 . . . . 20.239999999999998 111.284 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 434' ' ' THR . 11.7 mptt -103.02 163.47 12.19 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.775 -0.824 . . . . 72.409999999999997 108.775 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 89.8 t -84.2 135.71 24.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.07 -1.085 . . . . 72.129999999999995 108.07 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.02 -12.06 8.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 119.399 -0.92 . . . . 70.510000000000005 110.546 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 151.93 176.46 24.66 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 115.198 -0.91 . . . . 35.030000000000001 112.082 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 24.4 p -116.41 149.46 39.38 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.607 -1.257 . . . . 64.239999999999995 107.607 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.407 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 2.9 t-20 -64.68 -49.38 70.25 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 120.201 -0.599 . . . . 74.5 111.489 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 24.2 Cg_exo -68.6 146.18 66.5 Favored 'Trans proline' 0 C--N 1.372 1.8 0 N-CA-C 108.724 -1.298 . . . . 74.230000000000004 108.724 170.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.69 126.52 18.41 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.522 2.148 . . . . 61.149999999999999 112.886 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.86 2.06 36.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.654 0.74 . . . . 70.109999999999999 111.608 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -109.9 -1.56 17.7 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.069 -0.514 . . . . 75.439999999999998 110.903 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.0 OUTLIER -131.94 159.01 39.94 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-O 121.704 0.764 . . . . 71.209999999999994 111.39 -173.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.472 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -67.19 106.93 2.16 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 113.656 -1.611 . . . . 63.030000000000001 109.874 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 50.6 m -108.52 150.03 28.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.83 -0.804 . . . . 75.310000000000002 108.83 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.72 144.66 47.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.183 -0.673 . . . . 71.109999999999999 109.183 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.686 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 50.2 mm -70.7 -13.78 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 122.185 0.993 . . . . 70.530000000000001 109.16 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 392' ' ' SER . 1.3 p -87.8 -11.02 49.22 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.703 -1.135 . . . . 63.450000000000003 109.78 177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -72.34 138.56 47.39 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.456 -0.942 . . . . 63.030000000000001 108.456 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.52 113.86 19.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 107.374 -1.343 . . . . 64.049999999999997 107.374 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.2 t -87.54 118.37 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.471 0 C-N-CA 119.526 -0.87 . . . . 72.140000000000001 108.825 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 3.1 mp -92.35 112.14 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 105.783 -1.932 . . . . 71.340000000000003 105.783 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.16 114.3 33.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.545 -1.65 . . . . 61.219999999999999 106.545 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 18.9 mt -104.27 116.93 48.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.633 -0.712 . . . . 74.120000000000005 110.216 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.74 137.54 25.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.243 -1.021 . . . . 74.129999999999995 108.243 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -73.62 99.33 1.0 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 109.633 -1.387 . . . . 74.329999999999998 109.633 177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.2 m -142.79 105.73 4.54 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 122.742 0.417 . . . . 74.030000000000001 109.971 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.165 0 N-CA-C 109.398 -1.481 . . . . 62.329999999999998 109.398 178.153 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.329 0 N-CA-C 109.418 -1.473 . . . . 73.439999999999998 109.418 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.6 pp -92.11 132.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 117.768 0.784 . . . . 64.140000000000001 111.707 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 29.8 m -150.05 149.91 31.0 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.045 -1.835 . . . . 74.549999999999997 106.045 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.73 90.41 3.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 C-N-CA 119.505 -0.878 . . . . 72.329999999999998 111.41 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -113.9 138.98 49.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.695 -1.224 . . . . 63.210000000000001 107.695 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 19.9 m -136.09 156.6 37.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 109.511 -0.552 . . . . 64.450000000000003 109.511 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -94.7 136.25 35.23 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.803 -1.925 . . . . 74.519999999999996 105.803 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.5 m -97.71 141.11 22.49 Favored Pre-proline 0 C--N 1.282 -2.341 0 C-N-CA 119.128 -1.029 . . . . 74.430000000000007 110.948 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.95 133.19 56.55 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.124 2.549 . . . . 73.099999999999994 113.146 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -67.16 126.2 28.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.032 -0.985 . . . . 72.340000000000003 110.39 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.6 m -91.79 10.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 CA-C-N 115.053 -0.976 . . . . 73.519999999999996 112.109 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -63.94 141.37 58.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 64.0 109.838 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.65 -0.14 45.94 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.489 -0.644 . . . . 74.510000000000005 111.489 -177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.445 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 49.3 mt-30 -120.7 -179.22 3.93 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.315 -0.624 . . . . 72.150000000000006 109.315 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 90.7 p -86.04 169.96 12.7 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.727 -0.789 . . . . 71.109999999999999 109.342 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.3 p -61.81 -38.98 90.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.739 0.304 . . . . 51.310000000000002 111.118 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.83 -39.14 87.57 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.247 -0.433 . . . . 65.109999999999999 110.93 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 62.4 m-20 -60.94 -43.66 98.35 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 110.199 -0.297 . . . . 74.420000000000002 110.199 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.91 75.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.524 -0.762 . . . . 63.210000000000001 110.198 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.469 HG23 HG13 ' A' ' 384' ' ' ILE . 82.3 mt -58.28 -46.14 88.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.745 -0.661 . . . . 73.420000000000002 110.651 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.13 89.84 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.064 -0.517 . . . . 51.240000000000002 111.448 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 94.3 m -64.77 -48.25 75.2 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 120.575 0.226 . . . . 74.219999999999999 111.275 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.21 -38.71 91.29 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.436 -0.506 . . . . 72.230000000000004 110.892 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.02 -46.71 88.62 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.654 0.596 . . . . 61.409999999999997 109.908 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.4 -36.88 85.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.907 -0.588 . . . . 71.5 111.833 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 376' ' ' THR . 4.8 mpt_? -79.5 -14.45 58.88 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.226 -0.443 . . . . 71.540000000000006 111.652 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.3 16.35 32.57 Favored Glycine 0 C--N 1.317 -0.481 0 C-N-CA 120.387 -0.911 . . . . 72.340000000000003 113.523 176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -93.19 166.96 12.07 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.912 0.387 . . . . 53.549999999999997 110.432 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 29.0 mmmt -99.93 153.14 19.41 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.193 -1.41 . . . . 73.109999999999999 107.193 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.469 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -130.19 138.47 53.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.432 0.634 . . . . 71.120000000000005 112.593 -179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 417' ' ' THR . 14.0 ttm180 -115.46 135.93 53.6 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.05 -1.463 . . . . 74.310000000000002 107.05 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 28.6 m -99.6 128.11 45.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 119.351 -0.94 . . . . 64.430000000000007 110.525 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.77 119.54 38.98 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 105.928 -1.879 . . . . 73.400000000000006 105.928 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.547 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -114.02 128.4 56.37 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 120.883 0.373 . . . . 62.520000000000003 110.142 -178.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 390' ' ' PRO . 0.6 OUTLIER -121.53 115.7 30.97 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 112.11 0.411 . . . . 64.209999999999994 112.11 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 1.9 Cg_endo -87.94 134.4 3.15 Favored 'Trans proline' 0 C--O 1.256 1.386 0 C-N-CA 123.306 2.67 . . . . 63.43 111.825 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t70 172.2 -169.32 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 106.374 -1.713 . . . . 71.200000000000003 106.374 179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.535 ' CB ' ' HB ' ' A' ' 480' ' ' ILE . 21.3 m -120.52 -12.86 8.87 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.473 0.654 . . . . 63.530000000000001 109.399 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -90.84 14.41 13.74 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 122.567 1.175 . . . . 74.319999999999993 108.291 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.1 pp -88.54 151.08 47.65 Favored Pre-proline 0 N--CA 1.424 -1.763 0 CA-C-N 114.739 -1.119 . . . . 44.329999999999998 110.931 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.73 171.29 18.28 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.104 1.87 . . . . 73.200000000000003 111.35 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.53 163.03 7.34 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.504 2.803 . . . . 72.129999999999995 111.752 172.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.68 -7.26 0.64 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.214 1.006 . . . . 64.120000000000005 112.973 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 42.5 m170 -83.38 142.15 31.23 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.826 -0.805 . . . . 64.420000000000002 108.826 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.47 117.92 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-O 121.864 0.84 . . . . 62.409999999999997 109.544 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.76 -27.75 3.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.933 -1.03 . . . . 74.310000000000002 110.471 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.87 161.15 28.08 Favored Glycine 0 N--CA 1.421 -2.331 0 N-CA-C 109.515 -1.434 . . . . 71.519999999999996 109.515 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.2 p -113.58 -178.48 3.39 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 121.035 0.445 . . . . 71.120000000000005 111.328 -174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -101.55 132.09 22.2 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 107.026 -1.472 . . . . 51.32 107.026 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.55 -30.04 11.42 Favored 'Trans proline' 0 N--CA 1.481 0.769 0 C-N-CA 124.137 3.225 . . . . 72.019999999999996 114.92 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -64.11 -22.9 67.12 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 111.57 0.211 . . . . 71.349999999999994 111.57 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.68 -33.45 60.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.451 0.643 . . . . 73.5 110.28 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -86.17 -10.36 54.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.6 -0.727 . . . . 74.239999999999995 110.474 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 46.3 m -83.48 153.19 24.57 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.131 -1.433 . . . . 72.409999999999997 107.131 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 30.4 m -74.39 113.24 11.39 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.686 -0.806 . . . . 74.200000000000003 109.858 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.89 169.4 15.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 123.947 0.899 . . . . 75.099999999999994 109.075 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.3 t -78.96 146.96 33.14 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.913 -0.773 . . . . 74.25 108.913 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -70.87 113.22 7.71 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 109.061 -0.718 . . . . 75.109999999999999 109.061 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 116.71 9.1 11.45 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 115.384 -0.826 . . . . 53.350000000000001 111.722 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -84.0 -173.53 4.77 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.297 -1.371 . . . . 72.299999999999997 107.297 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 9.4 pt-20 -106.36 141.36 37.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.741 -0.784 . . . . 75.200000000000003 111.632 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.0 mm -118.89 137.48 52.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.897 -1.149 . . . . 75.540000000000006 107.897 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 385' ' ' ARG . 68.4 p -92.64 130.53 38.25 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 120.988 0.423 . . . . 62.329999999999998 110.264 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.6 128.14 55.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 108.195 -1.039 . . . . 74.329999999999998 108.195 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.67 128.87 45.09 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.973 -0.38 . . . . 74.140000000000001 109.973 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 10.1 p -137.53 142.43 36.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 109.085 -0.709 . . . . 73.400000000000006 109.085 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 14.6 m -88.1 122.26 31.47 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.53 -0.544 . . . . 74.25 109.53 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 41.2 p -119.62 107.45 13.27 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.628 -0.26 . . . . 63.43 111.435 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 86.35 131.41 2.92 Favored Glycine 0 C--N 1.299 -1.522 0 C-N-CA 120.437 -0.887 . . . . 50.329999999999998 114.004 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 97.1 Cg_endo -82.3 157.83 17.24 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.635 2.223 . . . . 74.400000000000006 111.378 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.529 ' HG2' ' HA ' ' A' ' 391' ' ' ASP . 2.9 mm-40 -85.67 124.19 31.92 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.568 -0.53 . . . . 70.519999999999996 109.568 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 15.4 mt-30 -120.51 130.91 54.47 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.039 -1.097 . . . . 62.329999999999998 108.039 177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -131.18 152.06 50.85 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.51 -0.922 . . . . 74.510000000000005 108.51 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -89.81 138.49 31.44 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 109.821 -0.437 . . . . 73.310000000000002 109.821 -178.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.417 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.0 mp -80.3 119.38 76.26 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 109.085 -0.709 . . . . 62.520000000000003 109.085 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -59.51 141.4 97.29 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.765 2.31 . . . . 75.319999999999993 111.864 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.58 8.98 25.63 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.33 0.492 . . . . 73.510000000000005 112.33 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.9 p -81.43 -7.86 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.998 0.904 . . . . 74.340000000000003 108.767 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 5.7 p -59.2 -42.85 91.91 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 114.982 -1.008 . . . . 72.140000000000001 111.845 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.427 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 6.5 p -69.4 -16.72 63.57 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 123.543 0.737 . . . . 74.25 112.367 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -87.25 -32.82 19.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.383 -0.371 . . . . 63.329999999999998 111.94 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.4 m -151.72 123.99 8.24 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.448 -0.575 . . . . 73.209999999999994 109.448 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.86 -45.42 92.66 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 112.275 0.472 . . . . 73.129999999999995 112.275 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.25 -43.89 95.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.883 0.373 . . . . 75.299999999999997 110.135 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -65.11 -37.65 88.15 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.138 -0.937 . . . . 74.230000000000004 109.949 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 116.093 -0.503 . . . . 73.420000000000002 110.51 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.27 -43.42 98.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.697 -0.683 . . . . 55.25 110.033 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 30.8 mmmt -64.67 -47.43 78.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.398 -0.364 . . . . 72.109999999999999 111.368 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -63.83 -38.85 92.63 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 111.982 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 22.6 tp -66.0 -39.41 90.27 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.01 -0.737 . . . . 60.439999999999998 109.01 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.7 m -66.75 -45.91 77.07 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.335 -0.848 . . . . 72.530000000000001 110.163 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.83 -22.93 65.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.862 0.865 . . . . 64.109999999999999 112.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.68 -11.04 59.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.413 0.625 . . . . 34.039999999999999 110.628 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 114.38 -15.89 19.96 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 120.679 -0.772 . . . . 61.119999999999997 112.986 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.411 ' HA ' HG23 ' A' ' 480' ' ' ILE . 98.3 m-85 -67.54 124.7 23.96 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 120.928 0.394 . . . . 35.210000000000001 111.182 -177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -121.78 13.17 9.28 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.028 -0.829 . . . . 21.210000000000001 111.028 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -111.95 111.26 22.06 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.458 -1.312 . . . . 70.400000000000006 107.458 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -126.0 146.41 49.89 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 121.097 -0.241 . . . . 74.329999999999998 110.921 -173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 25.3 ttmm -153.17 122.66 6.72 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.353 -1.351 . . . . 63.210000000000001 107.353 171.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -101.46 135.3 43.19 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.247 0.546 . . . . 64.340000000000003 111.825 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -120.73 158.04 28.36 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.044 -1.095 . . . . 71.319999999999993 108.044 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.41 134.48 51.0 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.844 -0.799 . . . . 61.229999999999997 108.844 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 33.2 t -138.79 131.16 15.73 Favored Pre-proline 0 C--N 1.287 -2.137 0 N-CA-C 108.655 -0.868 . . . . 21.34 108.655 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -64.37 128.56 21.7 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.994 1.796 . . . . 65.439999999999998 109.151 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 23.7 t -137.13 -178.75 5.34 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.541 -0.911 . . . . 54.409999999999997 108.541 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 12.0 m -51.1 131.06 31.27 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.925 1.29 . . . . 74.430000000000007 109.484 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.79 -33.05 31.3 Favored 'Trans proline' 0 C--N 1.364 1.371 0 C-N-CA 123.815 3.01 . . . . 62.25 114.065 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -67.44 -32.24 72.97 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.032 0.444 . . . . 72.109999999999999 111.668 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 8.2 mp -92.33 -9.7 40.94 Favored 'General case' 0 C--N 1.313 -1.0 0 O-C-N 122.165 -0.334 . . . . 72.299999999999997 111.51 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 42.1 t -59.17 129.97 22.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 CA-C-N 115.749 -0.66 . . . . 61.219999999999999 111.861 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 99.34 1.28 56.8 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.841 -1.072 . . . . 52.210000000000001 110.937 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -131.22 166.33 21.41 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 109.128 -0.693 . . . . 72.430000000000007 109.128 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 486' ' ' ILE . 49.3 t -80.95 136.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.927 -0.768 . . . . 54.530000000000001 108.927 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -102.29 -16.54 7.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 120.13 -0.628 . . . . 74.409999999999997 111.564 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 167.61 163.79 22.14 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 115.26 -0.882 . . . . 50.329999999999998 110.999 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 486' ' ' ILE . 9.5 p -122.37 157.57 31.54 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.006 -1.479 . . . . 65.319999999999993 107.006 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.449 HD22 ' HA ' ' A' ' 471' ' ' ASN . 9.3 m120 -62.23 -54.51 48.85 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 119.058 -1.057 . . . . 73.299999999999997 111.298 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 13.9 Cg_exo -74.83 112.82 3.65 Favored 'Trans proline' 0 C--N 1.371 1.757 0 N-CA-C 107.801 -1.654 . . . . 65.5 107.801 169.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.36 162.07 43.36 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.391 2.061 . . . . 74.200000000000003 114.523 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.9 -4.01 32.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.864 -1.062 . . . . 63.439999999999998 111.553 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -108.23 12.24 26.73 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.098 -0.501 . . . . 51.340000000000003 109.814 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -125.63 151.77 46.06 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 121.461 0.648 . . . . 72.439999999999998 110.675 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.7 m -104.44 101.95 11.62 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.053 -1.462 . . . . 70.109999999999999 107.053 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.7 m -106.73 145.34 32.16 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.503 -0.317 . . . . 50.549999999999997 111.272 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.74 145.99 54.2 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.066 -0.516 . . . . 74.530000000000001 110.665 176.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.535 ' HB ' ' CB ' ' A' ' 392' ' ' SER . 48.3 mm -67.25 -9.1 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 C-N-CA 124.375 1.07 . . . . 75.040000000000006 111.42 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 2.8 p -86.88 -2.91 58.96 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.665 0.745 . . . . 74.120000000000005 110.71 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -95.82 133.93 39.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.544 -0.753 . . . . 72.230000000000004 109.382 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.28 119.37 28.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 107.932 -1.136 . . . . 74.200000000000003 107.932 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.18 119.15 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.628 -0.879 . . . . 64.310000000000002 108.628 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.3 mt -93.85 112.64 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.133 -1.432 . . . . 65.340000000000003 107.133 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -101.98 117.19 46.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.659 -1.155 . . . . 70.200000000000003 108.823 -175.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 35.0 mt -99.93 119.8 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-O 121.374 0.606 . . . . 73.540000000000006 110.09 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.6 t -97.43 124.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.851 -0.796 . . . . 63.530000000000001 108.851 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.7 96.38 1.41 Allowed Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 108.45 -1.86 . . . . 75.150000000000006 108.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.491 ' HA ' HG13 ' A' ' 464' ' ' VAL . 5.1 p -142.79 131.51 22.66 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 110.071 -0.344 . . . . 72.25 110.071 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.0 0 N-CA-C 106.851 -2.499 . . . . 64.129999999999995 106.851 176.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.171 0 N-CA-C 110.379 -1.088 . . . . 65.099999999999994 110.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.7 pp -82.4 127.15 39.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.16 0.505 . . . . 74.019999999999996 110.535 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 11.8 m -104.07 148.26 26.45 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.331 -0.988 . . . . 73.040000000000006 108.331 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.5 83.42 6.31 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 121.256 0.551 . . . . 75.219999999999999 109.749 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -89.33 129.51 35.86 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.28 -1.008 . . . . 62.439999999999998 108.28 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.46 153.65 39.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.514 -0.55 . . . . 73.319999999999993 109.514 -178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' A' ' 407' ' ' ASN . 0.0 OUTLIER -95.43 138.59 32.91 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.04 -1.096 . . . . 63.240000000000002 108.04 176.26 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.0 p -96.59 126.62 42.65 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 109.335 -0.617 . . . . 65.109999999999999 109.335 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.1 141.75 89.76 Favored 'Trans proline' 0 C--O 1.24 0.608 0 C-N-CA 123.413 2.742 . . . . 63.43 114.995 -174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.15 138.28 31.63 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 107.683 -1.228 . . . . 74.430000000000007 107.683 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 373' ' ' ALA . 15.7 m -116.05 27.63 3.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-O 121.936 0.874 . . . . 64.319999999999993 109.073 174.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -55.45 144.23 26.44 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.823 -1.535 . . . . 71.099999999999994 111.694 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.92 44.65 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.961 -0.856 . . . . 40.119999999999997 110.961 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -127.18 -173.3 2.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.963 -0.384 . . . . 73.219999999999999 109.963 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.9 p -70.82 151.37 44.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.755 0.312 . . . . 73.049999999999997 111.385 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.1 p -63.43 -36.46 83.81 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.346 -0.388 . . . . 54.240000000000002 111.411 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.76 88.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.192 -0.458 . . . . 74.209999999999994 110.546 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.41 -36.52 76.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 110.637 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 365' ' ' VAL . . . -59.78 -51.16 70.93 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.122 -0.49 . . . . 74.150000000000006 110.99 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.34 -43.58 98.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.831 -0.622 . . . . 74.019999999999996 110.774 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.33 94.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.448 -0.342 . . . . 74.040000000000006 111.829 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 31.2 m -63.93 -47.07 81.95 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.961 0.41 . . . . 53.210000000000001 110.105 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.49 -38.1 89.84 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.777 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -59.89 -45.24 93.14 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 124.174 0.989 . . . . 75.439999999999998 109.846 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -70.17 -16.55 63.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 74.219999999999999 111.991 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -86.86 -14.14 42.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.639 -0.874 . . . . 74.519999999999996 108.639 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.86 5.2 62.91 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.53 -0.843 . . . . 61.299999999999997 111.668 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 35.6 m-85 -86.15 149.72 24.92 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.212 0.529 . . . . 73.120000000000005 110.291 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 13.9 mmmm -91.41 153.22 20.02 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.216 -1.401 . . . . 63.329999999999998 107.216 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.03 147.46 25.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 C-N-CA 120.3 -0.56 . . . . 74.209999999999994 111.421 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -111.07 132.22 54.43 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 106.012 -1.848 . . . . 73.129999999999995 106.012 169.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.5 m -115.72 118.2 32.37 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 108.372 -0.973 . . . . 71.150000000000006 108.372 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.59 119.02 36.71 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.817 -1.179 . . . . 72.530000000000001 107.817 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -104.36 131.79 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.23 0.538 . . . . 73.409999999999997 110.187 178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -136.76 130.61 17.82 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.707 -0.678 . . . . 74.129999999999995 110.836 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -86.36 135.55 4.46 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.494 2.129 . . . . 73.150000000000006 111.616 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 34.4 t70 168.56 166.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.168 1.387 . . . . 52.219999999999999 107.305 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.602 ' O ' ' HB ' ' A' ' 481' ' ' THR . 9.4 p -123.25 8.19 9.12 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 113.096 0.776 . . . . 74.109999999999999 113.096 -179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 3.1 m -82.34 -24.51 34.51 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.132 -1.803 . . . . 51.32 106.132 174.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.432 ' H ' HG12 ' A' ' 394' ' ' ILE . 6.7 pt -88.91 148.65 41.76 Favored Pre-proline 0 N--CA 1.429 -1.505 0 CA-C-N 112.721 -2.036 . . . . 73.129999999999995 109.718 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.63 173.01 14.01 Favored 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.098 2.532 . . . . 75.040000000000006 112.268 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.14 162.78 6.98 Favored 'Trans proline' 0 C--N 1.365 1.419 0 C-N-CA 123.558 2.838 . . . . 70.25 112.69 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.46 -8.21 0.5 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.631 1.172 . . . . 74.409999999999997 113.993 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -75.47 115.69 15.4 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.396 -1.705 . . . . 75.219999999999999 106.396 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.48 117.99 5.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.018 0.437 . . . . 43.439999999999998 110.456 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.57 -27.21 3.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.641 -0.709 . . . . 64.340000000000003 110.137 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.29 157.02 27.04 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.072 -1.211 . . . . 62.039999999999999 110.072 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.9 p -128.12 -176.52 3.82 Favored 'General case' 0 C--N 1.278 -2.536 0 C-N-CA 124.493 1.117 . . . . 63.140000000000001 111.076 -170.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -99.83 132.92 22.15 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 107.524 -1.287 . . . . 74.099999999999994 107.524 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.59 -20.34 12.05 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.786 2.991 . . . . 71.430000000000007 114.175 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.63 61.29 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 122.453 0.301 . . . . 72.109999999999999 110.922 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.67 -41.15 84.19 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.539999999999999 110.337 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.416 ' HA ' HE21 ' A' ' 361' ' ' GLN . 47.9 m-80 -87.16 -3.87 59.09 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 120.261 -0.575 . . . . 72.239999999999995 111.534 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.4 m -80.13 131.54 35.76 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 106.671 -1.603 . . . . 54.409999999999997 106.671 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 44.8 m -74.61 113.3 11.72 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 120.032 -0.667 . . . . 75.299999999999997 110.086 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -130.25 167.73 24.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.246 -0.888 . . . . 54.109999999999999 109.335 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.17 50.35 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 109.459 -0.571 . . . . 64.120000000000005 109.459 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -62.51 130.8 46.76 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 123.369 0.668 . . . . 45.439999999999998 111.981 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 109.35 16.48 11.08 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.604 -0.808 . . . . 54.509999999999998 113.809 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.18 175.57 7.09 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.346 -1.353 . . . . 72.239999999999995 107.346 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 10.7 pt-20 -109.4 140.2 43.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 112.026 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -118.0 133.24 65.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.259 -1.015 . . . . 52.549999999999997 108.259 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -89.78 118.67 29.54 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.93 0.871 . . . . 62.439999999999998 110.038 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.3 133.58 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.91 -1.041 . . . . 72.400000000000006 109.176 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -96.97 128.74 44.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.813 -0.63 . . . . 74.209999999999994 110.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.3 p -130.25 131.9 65.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.304 -0.628 . . . . 52.240000000000002 109.304 176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 4.1 m -91.9 122.55 34.53 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.326 -0.62 . . . . 64.120000000000005 109.326 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 16.5 p -118.92 106.66 12.7 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-O 120.756 0.312 . . . . 32.409999999999997 111.7 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.48 104.95 0.69 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.581 -0.819 . . . . 74.099999999999994 113.042 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 18.8 Cg_exo -66.99 128.93 19.59 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.53 2.154 . . . . 74.0 110.478 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.44 143.48 32.07 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 120.826 -0.35 . . . . 74.140000000000001 111.703 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.0 mt-30 -131.97 157.12 44.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.307 -0.997 . . . . 72.540000000000006 108.307 176.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -142.59 154.82 44.77 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.557 -0.534 . . . . 74.310000000000002 109.557 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.68 139.64 30.36 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.849 -0.426 . . . . 63.329999999999998 109.849 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.6 mp -78.7 116.15 57.4 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.844 -0.799 . . . . 62.520000000000003 108.844 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -70.55 140.91 40.77 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 121.868 1.712 . . . . 64.099999999999994 110.156 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -107.19 87.4 2.5 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.453 -1.299 . . . . 72.439999999999998 113.671 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.0 0.69 7.84 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 104.261 -2.496 . . . . 70.409999999999997 104.261 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.9 m -68.78 -50.11 53.02 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.972 -1.922 . . . . 72.140000000000001 110.236 -174.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.408 ' O ' ' HE2' ' A' ' 466' ' ' LYS . 15.7 m -64.88 -16.45 63.23 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-O 121.791 0.805 . . . . 74.519999999999996 109.908 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.94 -48.42 7.01 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.482 -0.781 . . . . 74.010000000000005 110.241 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 66.0 m -147.71 123.91 10.84 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 121.085 0.469 . . . . 43.340000000000003 111.19 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -63.89 -42.42 97.46 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.996 0.739 . . . . 71.120000000000005 112.996 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -58.22 -40.26 81.18 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.245 0.545 . . . . 54.340000000000003 110.573 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -67.03 -35.3 79.6 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.485 -0.779 . . . . 74.530000000000001 111.815 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.67 -48.39 81.84 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.964 0.412 . . . . 65.349999999999994 110.26 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 48.9 t -62.57 -47.93 90.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.645 -0.707 . . . . 62.219999999999999 110.501 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -66.6 -45.7 78.34 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.02 -0.536 . . . . 73.129999999999995 112.119 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -66.28 -47.12 74.66 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 111.813 0.301 . . . . 71.010000000000005 111.813 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.11 -39.07 89.63 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.517 0.562 . . . . 73.0 112.517 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.0 m -61.81 -42.21 98.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.715 0.293 . . . . 65.140000000000001 110.483 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.66 66.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.341 . . . . 62.020000000000003 111.06 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.2 -13.08 59.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.958 -0.565 . . . . 64.129999999999995 111.038 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 116.52 -7.43 18.03 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.339 -0.934 . . . . 62.439999999999998 113.594 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.09 105.2 8.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.48 0.64 . . . . 65.340000000000003 109.717 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -111.74 5.16 27.67 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 115.723 -0.671 . . . . 72.439999999999998 111.629 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 23.1 mmt180 -113.8 111.45 21.77 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.343 -0.984 . . . . 64.439999999999998 108.343 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -128.61 156.54 43.21 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.297 0.57 . . . . 75.420000000000002 111.655 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -135.79 123.21 21.99 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.314 -2.106 . . . . 75.109999999999999 105.314 170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -93.97 122.36 36.38 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -121.9 155.19 35.96 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.063 -0.717 . . . . 60.439999999999998 109.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -128.08 138.45 52.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 120.847 0.356 . . . . 71.310000000000002 110.674 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 28.8 t -123.19 131.22 24.34 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.151 -1.425 . . . . 64.109999999999999 107.151 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.01 124.48 14.98 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.524 2.15 . . . . 62.25 110.139 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 24.8 m -134.98 160.85 36.99 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 109.64 -0.504 . . . . 62.5 109.64 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.408 HG22 ' HD2' ' A' ' 461' ' ' PRO . 0.2 OUTLIER -60.81 146.22 87.09 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.482 -1.303 . . . . 74.310000000000002 107.482 175.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.484 ' O ' HG12 ' A' ' 464' ' ' VAL . 79.1 Cg_exo -52.26 -24.02 19.66 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 123.372 2.715 . . . . 75.230000000000004 114.306 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.51 -31.86 73.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.116 0.484 . . . . 74.430000000000007 110.857 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.37 5.08 44.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.02 0.378 . . . . 73.420000000000002 112.02 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 461' ' ' PRO . 9.1 p -60.43 128.85 22.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 C-N-CA 120.087 -0.645 . . . . 65.230000000000004 110.779 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.1 83.14 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.888 -0.596 . . . . 54.119999999999997 112.584 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 434' ' ' THR . 85.9 tttt -116.38 148.22 40.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.165 -1.421 . . . . 75.230000000000004 107.165 178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 433' ' ' SER . 62.0 t -84.05 136.52 22.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 109.038 -0.727 . . . . 71.400000000000006 109.038 -178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.557 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -109.44 -14.62 10.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.781 -0.768 . . . . 75.340000000000003 111.233 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 175.12 173.56 41.01 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.948 -0.861 . . . . 73.420000000000002 110.948 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.2 p -137.22 158.87 43.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.276 -1.009 . . . . 62.030000000000001 108.276 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.9 t-20 -69.54 -54.62 10.61 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 119.809 -0.756 . . . . 71.040000000000006 109.863 175.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -76.55 118.07 4.76 Favored 'Trans proline' 0 C--N 1.376 2.024 0 N-CA-C 107.574 -1.741 . . . . 72.340000000000003 107.574 172.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.458 ' C ' ' H ' ' A' ' 475' ' ' ASN . 43.0 Cg_endo -69.17 139.71 42.97 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.732 1.621 . . . . 62.450000000000003 112.277 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -71.17 24.74 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.424 1.09 . . . . 52.020000000000003 112.466 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 473' ' ' PRO . 38.6 m-80 -108.32 -22.28 12.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.385 1.074 . . . . 75.299999999999997 109.822 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -131.67 160.09 36.42 Favored 'General case' 0 N--CA 1.426 -1.625 0 C-N-CA 119.292 -0.963 . . . . 61.140000000000001 111.498 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.69 141.9 49.86 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 126.12 1.768 . . . . 64.420000000000002 110.54 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 56.3 m -133.76 149.7 51.46 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.12 -1.067 . . . . 74.530000000000001 108.12 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -76.61 157.95 31.5 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-O 120.803 0.335 . . . . 72.209999999999994 110.338 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 448' ' ' GLY . 50.8 mm -66.83 -16.34 20.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 122.112 0.958 . . . . 33.119999999999997 110.004 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 392' ' ' SER . 12.4 t -99.35 2.59 45.45 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.37 -0.832 . . . . 73.219999999999999 110.009 -178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 10.1 m120 -83.32 146.07 28.71 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.515 -0.55 . . . . 55.420000000000002 109.515 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.47 114.4 26.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 107.271 -1.381 . . . . 71.299999999999997 107.271 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 57.9 t -87.49 119.47 35.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.109 -0.7 . . . . 75.209999999999994 109.109 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 3.4 mp -92.06 112.56 25.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 106.608 -1.627 . . . . 60.210000000000001 106.608 177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.33 121.93 58.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.664 -1.236 . . . . 73.019999999999996 107.664 -176.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.41 111.58 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 121.418 0.627 . . . . 71.120000000000005 110.015 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.2 140.83 17.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.361 -0.977 . . . . 74.239999999999995 108.361 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -74.93 100.37 1.22 Allowed Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 110.504 -1.038 . . . . 53.149999999999999 110.504 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 50.2 m -141.97 130.07 22.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.595 -0.52 . . . . 61.229999999999997 109.595 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.224 0 N-CA-C 107.871 -2.092 . . . . 73.319999999999993 107.871 -178.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.502 0 N-CA-C 109.714 -1.354 . . . . 72.349999999999994 109.714 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -87.27 151.76 3.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 117.124 0.462 . . . . 74.340000000000003 111.376 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 16.8 m -88.39 146.92 24.99 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.551 -1.277 . . . . 52.210000000000001 107.551 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -89.26 75.85 7.71 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.715 . . . . 74.150000000000006 110.483 -178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -100.87 148.66 24.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.688 -1.142 . . . . 65.409999999999997 108.751 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.91 150.68 31.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.274 -0.639 . . . . 64.219999999999999 109.274 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.31 136.6 35.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.659 -1.978 . . . . 72.439999999999998 105.659 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.5 p -97.46 128.48 34.52 Favored Pre-proline 0 C--N 1.282 -2.331 0 C-N-CA 119.117 -1.033 . . . . 70.409999999999997 109.627 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.97 128.07 23.6 Favored 'Trans proline' 0 C--O 1.249 1.036 0 C-N-CA 122.841 2.361 . . . . 75.409999999999997 112.425 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -68.81 119.62 13.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.75 -1.113 . . . . 73.209999999999994 110.765 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 30.5 m -82.95 25.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.983 -1.008 . . . . 64.299999999999997 112.817 -174.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 400' ' ' ILE . 11.2 ptt-85 -67.85 144.04 55.48 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 122.044 -0.41 . . . . 74.0 111.941 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.83 0.5 45.61 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.875 -0.679 . . . . 53.530000000000001 113.647 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 0.9 OUTLIER -126.45 -172.85 2.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 117.336 0.568 . . . . 74.329999999999998 110.338 -177.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 90.8 p -79.44 164.2 24.16 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 118.266 0.484 . . . . 65.319999999999993 110.513 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 61.4 p -63.67 -33.66 76.13 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 109.368 -0.604 . . . . 50.009999999999998 109.368 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.14 90.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.143 -0.935 . . . . 42.450000000000003 110.339 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.412 ' HB2' ' HG3' ' A' ' 368' ' ' GLN . 40.0 m-20 -60.14 -42.82 95.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 116.648 -0.251 . . . . 64.209999999999994 110.984 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.14 -51.51 69.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 123.691 0.62 . . . . 64.310000000000002 110.438 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.402 HG23 HG13 ' A' ' 384' ' ' ILE . 78.3 mt -60.73 -46.19 96.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 CA-C-N 115.644 -0.707 . . . . 55.310000000000002 110.517 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.11 98.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.69 -0.686 . . . . 71.140000000000001 112.177 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 56.9 m -60.77 -47.69 85.18 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.844 0.354 . . . . 70.209999999999994 110.835 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.05 -38.82 92.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.779 0.323 . . . . 74.409999999999997 111.295 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -59.85 -47.62 85.0 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.557 -0.747 . . . . 52.240000000000002 110.493 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -68.9 -27.96 66.25 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.968 -0.56 . . . . 72.340000000000003 111.559 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -81.61 -13.63 57.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 111.977 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.14 14.55 48.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.561 -0.828 . . . . 63.310000000000002 112.895 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -88.61 170.57 10.73 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.636 -0.505 . . . . 61.530000000000001 109.636 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 14.2 mmmm -100.47 159.25 15.3 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.501 -1.296 . . . . 75.5 107.501 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.402 HG13 HG23 ' A' ' 374' ' ' ILE . 0.1 OUTLIER -130.36 146.38 34.14 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.406 0.622 . . . . 73.310000000000002 110.996 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -123.59 147.43 47.33 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 105.495 -2.039 . . . . 73.129999999999995 105.495 173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.4 m -116.5 129.19 56.06 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 109.072 -0.714 . . . . 74.140000000000001 109.072 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.32 118.8 36.85 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.19 -2.152 . . . . 65.040000000000006 105.19 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.48 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -115.92 129.5 56.43 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.45 -0.574 . . . . 61.350000000000001 109.45 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -138.45 134.54 17.54 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 116.351 -0.386 . . . . 70.040000000000006 110.614 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -93.38 132.68 0.88 Allowed 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.92 2.413 . . . . 74.129999999999995 110.85 172.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.0 t70 -175.22 171.39 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.124 -1.436 . . . . 73.340000000000003 107.124 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.8 m -114.39 -5.48 12.9 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 121.356 0.598 . . . . 74.420000000000002 110.323 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -87.9 -12.82 43.63 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 122.104 0.954 . . . . 62.100000000000001 108.94 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 394' ' ' ILE . 12.5 pt -88.58 144.12 33.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.001 -1.0 . . . . 65.140000000000001 110.861 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -79.4 177.22 8.79 Favored 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 123.343 2.695 . . . . 75.239999999999995 110.76 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.53 160.75 10.85 Favored 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 123.002 2.468 . . . . 64.329999999999998 112.357 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.463 ' HB2' HG23 ' A' ' 420' ' ' VAL . 2.5 p-10 -57.74 -9.5 1.25 Allowed 'General case' 0 N--CA 1.502 2.138 0 C-N-CA 124.987 1.315 . . . . 63.539999999999999 113.631 -174.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -72.89 114.46 11.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.839 -1.911 . . . . 70.540000000000006 105.839 177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.52 118.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 122.171 0.986 . . . . 61.43 111.408 -171.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' A' ' 366' ' ' ARG . 7.8 tp -90.53 -32.8 5.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 114.895 -1.048 . . . . 75.519999999999996 109.86 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -157.87 157.38 28.17 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 109.592 -1.403 . . . . 73.329999999999998 109.592 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.0 p -116.47 -179.75 3.77 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.063 -0.717 . . . . 73.049999999999997 109.063 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -101.64 147.55 34.0 Favored Pre-proline 0 C--N 1.294 -1.811 0 C-N-CA 120.174 -0.611 . . . . 75.230000000000004 109.416 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.65 -7.38 2.15 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 124.373 3.382 . . . . 71.549999999999997 115.501 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.28 72.8 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.058 -0.349 . . . . 72.420000000000002 110.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.73 68.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.695 0.759 . . . . 61.409999999999997 110.107 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -79.7 -10.83 59.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.278 -0.874 . . . . 70.349999999999994 111.038 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 83.0 m -81.01 151.81 28.25 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.794 -1.187 . . . . 73.099999999999994 107.794 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.5 m -74.06 112.86 10.6 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 121.303 0.573 . . . . 72.530000000000001 109.7 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.42 159.69 16.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.081 -0.963 . . . . 61.340000000000003 109.47 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 36.6 m -74.16 146.82 43.17 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.202 -0.666 . . . . 51.420000000000002 109.202 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -61.93 128.3 35.5 Favored 'General case' 0 C--O 1.244 0.812 0 CA-C-O 120.874 0.369 . . . . 73.209999999999994 110.423 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.46 25.86 24.7 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.724 -0.671 . . . . 53.240000000000002 112.006 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 411' ' ' SER . 4.4 t70 -85.89 -175.68 5.68 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.792 -1.188 . . . . 72.439999999999998 107.792 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.7 pt-20 -114.06 133.76 55.32 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.672 -0.811 . . . . 62.43 111.357 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 42.5 mm -108.37 129.74 62.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 109.315 -0.624 . . . . 61.32 109.315 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.9 t -88.18 123.17 32.55 Favored 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 122.085 0.945 . . . . 71.010000000000005 109.994 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.81 114.61 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 107.506 -1.294 . . . . 73.25 107.506 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -84.85 114.62 22.23 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.08 -1.082 . . . . 62.100000000000001 108.08 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.463 HG23 ' HB2' ' A' ' 397' ' ' ASP . 14.8 p -121.41 135.96 59.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.253 0.549 . . . . 75.450000000000003 110.558 -177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 19.9 m -84.63 121.11 27.18 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 108.663 -0.866 . . . . 73.129999999999995 108.663 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -119.87 104.9 10.59 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 116.657 -0.247 . . . . 73.340000000000003 111.449 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.02 145.72 0.12 Allowed Glycine 0 CA--C 1.542 1.729 0 N-CA-C 115.962 1.145 . . . . 65.230000000000004 115.962 175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 57.9 Cg_endo -82.07 128.47 5.74 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.565 1.51 . . . . 74.099999999999994 109.964 172.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 0.1 OUTLIER -73.55 156.9 37.65 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 109.608 -0.516 . . . . 62.130000000000003 109.608 -177.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.4 mt-30 -121.71 157.48 30.84 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.032 0.444 . . . . 65.439999999999998 110.779 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.495 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 22.2 tpt180 -145.59 145.02 30.82 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 108.857 -0.794 . . . . 62.409999999999997 108.857 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -84.29 138.93 32.65 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.668 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.465 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -84.09 124.76 73.96 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.859 -0.61 . . . . 74.239999999999995 110.18 -175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 443' ' ' LYS . 74.7 Cg_exo -61.85 141.6 90.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.435 2.09 . . . . 51.509999999999998 111.032 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -86.81 20.41 2.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 112.334 0.494 . . . . 64.129999999999995 112.334 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.418 HG21 ' HG3' ' A' ' 443' ' ' LYS . 23.7 m -84.18 -6.37 10.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.34 -0.391 . . . . 64.140000000000001 111.902 -175.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.0 m -51.44 -51.09 57.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.909 0.883 . . . . 65.230000000000004 112.435 -177.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 5.3 m -61.12 -27.18 68.2 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.765 0.826 . . . . 74.409999999999997 111.716 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -86.15 -48.32 8.69 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 120.687 0.279 . . . . 51.520000000000003 111.702 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 439' ' ' GLU . 48.0 m -146.47 115.84 7.08 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.814 -0.354 . . . . 51.020000000000003 111.083 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -59.23 -44.01 92.34 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.682 -0.69 . . . . 72.450000000000003 110.937 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.507 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -57.65 -46.6 83.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 71.329999999999998 111.258 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.409 ' H ' HG22 ' A' ' 436' ' ' THR . 36.5 tt0 -68.02 -35.46 78.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.498 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.98 -43.58 95.02 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.314 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 66.2 t -61.84 -42.65 95.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.956 -0.565 . . . . 65.340000000000003 110.179 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.6 mmtt -66.22 -43.23 87.27 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.159 0.504 . . . . 73.549999999999997 110.352 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.505 ' HB3' ' HG2' ' A' ' 430' ' ' PRO . 39.3 mmtm -62.93 -47.74 81.92 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.521 -0.763 . . . . 74.450000000000003 111.246 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.97 -32.7 73.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.597 0.592 . . . . 73.420000000000002 112.597 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 52.3 m -67.54 -41.21 84.67 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.611 -0.514 . . . . 74.319999999999993 109.611 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.17 -22.83 61.99 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.83 0.824 . . . . 72.420000000000002 110.587 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.495 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -79.85 -8.89 59.55 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.326 -0.852 . . . . 70.5 110.423 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 102.13 -20.41 45.37 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 115.992 -0.549 . . . . 72.0 113.178 175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -57.84 127.42 31.99 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.117 0.484 . . . . 75.329999999999998 111.874 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -129.12 12.92 6.05 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 115.389 -0.823 . . . . 53.350000000000001 111.208 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -115.75 111.04 19.96 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.332 -0.988 . . . . 75.430000000000007 108.332 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -132.93 148.59 52.28 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.106 0.479 . . . . 75.310000000000002 110.756 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -140.53 122.24 15.31 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 105.578 -2.008 . . . . 73.140000000000001 105.578 170.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.89 128.83 45.18 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.566 -0.531 . . . . 72.25 109.566 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -125.0 161.41 26.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.037 -0.727 . . . . 74.519999999999996 109.037 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -129.31 129.17 44.51 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.594 -0.891 . . . . 71.420000000000002 108.594 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 67.3 m -123.42 137.64 28.81 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 109.555 -0.535 . . . . 64.140000000000001 109.555 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.5 Cg_exo -61.87 134.01 47.77 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.303 2.002 . . . . 63.130000000000003 110.594 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 51.1 m -148.15 161.83 40.64 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.48 -0.563 . . . . 73.129999999999995 109.48 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 20.8 m -57.75 142.99 77.43 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 124.335 1.022 . . . . 55.140000000000001 108.261 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.613 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -49.13 -23.27 6.28 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.673 2.916 . . . . 70.200000000000003 114.579 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.34 -33.11 74.06 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.709 -0.62 . . . . 74.530000000000001 110.305 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.44 -9.86 28.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.818 -0.628 . . . . 72.540000000000006 112.482 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 461' ' ' PRO . 8.9 p -60.22 127.25 19.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 119.836 -0.746 . . . . 74.340000000000003 110.21 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.99 71.82 Favored Glycine 0 C--N 1.307 -1.043 0 C-N-CA 120.629 -0.796 . . . . 51.439999999999998 112.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -107.97 161.74 14.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.658 -0.867 . . . . 75.049999999999997 108.658 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.437 HG22 HD11 ' A' ' 486' ' ' ILE . 98.0 t -83.98 129.87 36.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.591 -0.892 . . . . 75.519999999999996 108.591 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.08 -13.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.964 -0.695 . . . . 75.140000000000001 111.471 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 160.3 12.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.661 -0.699 . . . . 63.109999999999999 111.637 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 19.8 p -119.34 149.39 41.89 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.696 -1.224 . . . . 54.43 107.696 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.498 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.91 -51.46 79.19 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 120.34 -0.544 . . . . 62.350000000000001 110.707 177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 4.2 Cg_exo -82.44 115.81 2.58 Favored 'Trans proline' 0 C--N 1.368 1.595 0 N-CA-C 107.841 -1.638 . . . . 74.430000000000007 107.841 169.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 476' ' ' GLN . 39.5 Cg_endo -67.56 159.51 52.2 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.326 2.017 . . . . 73.519999999999996 113.657 -175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.465 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.63 -4.14 35.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 122.145 0.974 . . . . 35.450000000000003 111.706 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -105.34 11.12 33.17 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 109.072 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.406 ' HB2' ' HG2' ' A' ' 473' ' ' PRO . 35.0 tt0 -127.75 156.4 42.5 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.669 0.747 . . . . 60.020000000000003 110.7 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.401 HG22 ' HB3' ' A' ' 426' ' ' GLN . 14.8 m -102.76 115.7 31.12 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.403 -1.271 . . . . 73.519999999999996 107.625 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 16.4 m -117.68 148.32 42.09 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 110.237 -0.283 . . . . 74.019999999999996 110.237 -175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -69.51 156.95 38.08 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.386 -0.228 . . . . 35.140000000000001 110.386 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.3 -22.78 19.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.57 0.7 . . . . 72.530000000000001 110.215 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.8 t -87.4 1.98 51.79 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-O 121.893 0.854 . . . . 70.439999999999998 109.861 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -85.46 130.17 34.65 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.478 -1.675 . . . . 70.209999999999994 106.478 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.19 113.99 19.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.602 -0.518 . . . . 75.439999999999998 109.602 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.37 118.7 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 N-CA-C 108.68 -0.859 . . . . 60.340000000000003 108.68 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.403 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 77.0 mt -94.45 112.89 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 107.176 -1.416 . . . . 73.230000000000004 107.176 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -104.61 115.44 46.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.353 0 N-CA-C 107.49 -1.3 . . . . 73.439999999999998 107.49 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.6 mt -103.61 119.82 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 115.982 -0.554 . . . . 74.099999999999994 110.148 -175.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -98.16 136.24 29.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.566 -0.902 . . . . 73.329999999999998 108.566 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -71.88 113.34 4.51 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.129 -1.188 . . . . 65.25 110.129 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 15.2 m -131.73 104.89 7.16 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.453 -0.573 . . . . 74.239999999999995 109.453 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.096 0 N-CA-C 108.812 -1.715 . . . . 42.450000000000003 108.812 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.436 0 N-CA-C 109.75 -1.34 . . . . 73.420000000000002 109.75 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -92.24 137.84 21.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 117.906 0.853 . . . . 75.439999999999998 109.599 176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 1.1 p -109.16 154.39 22.4 Favored 'General case' 0 N--CA 1.39 -3.475 0 CA-C-N 116.134 -0.484 . . . . 74.109999999999999 110.303 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -96.8 38.07 1.25 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.874 0.845 . . . . 74.340000000000003 109.305 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -76.01 132.87 40.43 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.535 -1.211 . . . . 71.140000000000001 107.75 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.54 162.34 38.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-O 121.009 0.433 . . . . 74.340000000000003 111.664 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.23 137.33 37.9 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.233 -1.025 . . . . 52.210000000000001 108.233 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.98 133.68 20.22 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 109.343 -0.614 . . . . 63.140000000000001 109.343 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 147.03 87.54 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.89 2.394 . . . . 73.310000000000002 113.666 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -81.06 145.4 31.14 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.653 -0.703 . . . . 72.439999999999998 109.175 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.1 t -107.43 31.63 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.602 -1.629 . . . . 43.539999999999999 106.602 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -65.36 134.12 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 113.388 -1.733 . . . . 75.430000000000007 111.149 -177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 99.88 -5.19 57.96 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 111.373 -0.691 . . . . 43.240000000000002 111.373 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -119.25 -176.94 3.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 120.705 0.288 . . . . 63.219999999999999 110.225 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 71.6 p -72.02 158.7 35.5 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 111.531 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 42.5 t -63.1 -33.8 76.23 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.372 -0.603 . . . . 72.519999999999996 109.372 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.23 90.36 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.535 0.522 . . . . 72.219999999999999 110.356 178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 116.332 -0.394 . . . . 73.019999999999996 110.648 177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.428 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.65 -51.4 69.55 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.577 -0.738 . . . . 60.200000000000003 111.035 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.95 -43.18 97.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.984 -0.553 . . . . 62.32 110.433 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.51 -42.64 98.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 52.210000000000001 112.349 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 58.7 m -64.03 -47.34 80.6 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.355 0.598 . . . . 73.230000000000004 110.264 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.4 mm? -64.34 -38.45 91.08 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.711 -0.677 . . . . 72.430000000000007 110.768 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.2 -45.95 91.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.653 -0.703 . . . . 64.010000000000005 110.072 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -66.22 -30.71 71.21 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.187 -0.461 . . . . 71.310000000000002 111.389 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 34.7 mmt-85 -78.95 -13.83 59.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.147 -0.479 . . . . 75.209999999999994 111.012 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.9 13.5 56.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.889 -0.672 . . . . 74.299999999999997 113.228 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.427 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 59.4 m-85 -85.33 166.24 16.62 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.487 0.66 . . . . 75.299999999999997 111.755 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 55.8 mtmt -109.02 132.61 53.94 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 107.605 -1.257 . . . . 74.109999999999999 107.605 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.76 146.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 CA-C-O 121.462 0.649 . . . . 71.150000000000006 112.651 -176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 20.8 ttm-85 -109.5 127.73 54.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 105.887 -1.894 . . . . 65.319999999999993 105.887 173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 8.4 m -107.34 117.65 34.64 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 106.663 -1.606 . . . . 73.329999999999998 106.663 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.23 118.52 36.15 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.116 -1.809 . . . . 60.210000000000001 106.116 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.476 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -113.03 128.0 56.38 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 109.164 -0.68 . . . . 75.329999999999998 109.164 -179.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -131.21 138.71 33.48 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.938 -0.574 . . . . 63.439999999999998 110.364 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -82.63 146.04 13.27 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 121.92 1.746 . . . . 64.230000000000004 108.716 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.8 t0 -179.62 -175.0 0.32 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 106.349 -1.722 . . . . 71.209999999999994 106.349 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 51.4 m -135.11 0.26 2.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.158 0.504 . . . . 71.129999999999995 110.441 174.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 -14.95 49.66 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.221 -1.399 . . . . 61.219999999999999 107.221 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 421' ' ' SER . 14.2 pt -91.86 145.47 31.1 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.086 -1.416 . . . . 73.329999999999998 111.189 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -83.41 -172.88 1.47 Allowed 'Trans proline' 0 CA--C 1.559 1.743 0 C-N-CA 123.18 2.587 . . . . 53.109999999999999 108.838 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.58 161.7 7.36 Favored 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.35 2.033 . . . . 63.0 112.608 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 420' ' ' VAL . 4.2 p-10 -57.03 -8.12 0.6 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 125.228 1.411 . . . . 73.329999999999998 114.463 -174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -71.66 122.36 20.45 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.577 -1.268 . . . . 72.040000000000006 107.577 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 49.9 t -65.04 118.42 7.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 123.589 0.756 . . . . 73.129999999999995 111.645 -170.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 400' ' ' ILE . 0.2 OUTLIER -96.4 -28.83 3.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.857 -0.61 . . . . 74.120000000000005 111.031 179.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.47 157.73 27.48 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 110.76 -0.936 . . . . 63.350000000000001 110.76 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 10.3 p -126.98 -177.88 4.2 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 123.283 0.633 . . . . 74.219999999999999 110.268 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -101.69 136.15 19.63 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 106.537 -1.653 . . . . 75.030000000000001 106.537 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.72 -16.67 2.48 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.406 3.404 . . . . 71.409999999999997 115.282 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.83 32.93 Favored 'General case' 0 C--O 1.221 -0.432 0 C-N-CA 123.622 0.769 . . . . 74.200000000000003 111.854 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.44 -44.49 82.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.125 0.488 . . . . 71.430000000000007 111.034 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -86.09 -2.32 58.21 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 121.19 0.519 . . . . 73.040000000000006 111.662 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 67.1 m -81.55 146.79 29.97 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.846 -1.538 . . . . 61.350000000000001 106.846 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 47.2 m -74.66 112.74 11.17 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.168 -1.049 . . . . 72.540000000000006 108.168 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.6 m -119.23 166.81 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-N 115.519 -0.764 . . . . 71.140000000000001 111.064 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.2 t -74.51 144.66 44.01 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.108 -1.071 . . . . 33.119999999999997 108.108 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.43 114.67 3.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.949 0.404 . . . . 71.310000000000002 110.521 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.34 40.68 4.16 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 120.668 -0.777 . . . . 35.039999999999999 111.767 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -93.2 -177.38 4.44 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.607 -1.257 . . . . 74.040000000000006 107.607 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 41.2 mt-10 -107.19 119.9 40.66 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.207 0.527 . . . . 65.150000000000006 111.957 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -109.21 130.59 61.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.538 -0.912 . . . . 71.319999999999993 108.538 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.4 t -95.05 130.76 41.6 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.355 0.598 . . . . 70.219999999999999 110.015 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 62.3 t -118.39 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.711 -0.848 . . . . 73.329999999999998 108.711 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -91.33 128.82 37.3 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.059 0.457 . . . . 74.439999999999998 110.489 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 397' ' ' ASP . 46.8 t -125.16 138.59 53.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.229 -0.896 . . . . 61.219999999999999 109.428 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.481 ' HB3' HD12 ' A' ' 394' ' ' ILE . 16.0 m -89.08 121.47 31.44 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.449 -0.575 . . . . 60.020000000000003 109.449 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 11.2 t -120.83 104.82 10.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 119.144 -1.022 . . . . 71.5 111.005 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 64.19 172.23 2.61 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 114.907 0.723 . . . . 63.420000000000002 114.907 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 72.9 Cg_endo -97.18 155.09 1.06 Allowed 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 122.73 2.287 . . . . 62.420000000000002 113.322 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.437 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 4.5 mm-40 -84.87 141.37 30.48 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.78 -0.645 . . . . 70.340000000000003 110.247 176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -117.26 147.37 42.6 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.458 -0.942 . . . . 73.310000000000002 108.458 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.29 155.39 39.59 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.561 -1.274 . . . . 64.230000000000004 107.561 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -88.81 138.16 31.67 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.79 -0.448 . . . . 74.25 109.79 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.8 mp -83.09 129.14 62.34 Favored Pre-proline 0 C--N 1.308 -1.239 0 N-CA-C 108.385 -0.968 . . . . 75.25 108.385 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.55 140.51 89.83 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.362 2.041 . . . . 51.409999999999997 112.356 177.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.03 -5.73 56.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.558 0.694 . . . . 73.239999999999995 110.18 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.36 -7.57 10.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.986 -1.006 . . . . 61.439999999999998 110.936 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 20.7 m -56.48 -41.76 77.14 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.304 -0.862 . . . . 64.450000000000003 111.228 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 23.0 m -61.74 -23.13 65.95 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.23 1.012 . . . . 64.340000000000003 111.77 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.12 -35.79 15.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.512 . . . . 74.230000000000004 111.888 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 439' ' ' GLU . 50.4 m -148.68 119.48 7.57 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 122.08 -0.387 . . . . 53.240000000000002 110.849 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -58.13 -51.17 70.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.639 0.776 . . . . 73.329999999999998 111.77 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.98 -43.6 98.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.107 -0.497 . . . . 64.120000000000005 111.605 -178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 436' ' ' THR . 35.3 tt0 -65.67 -35.28 80.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.666 -0.697 . . . . 73.430000000000007 110.166 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.03 -51.39 69.83 Favored 'General case' 0 CA--C 1.506 -0.717 0 O-C-N 123.775 0.672 . . . . 55.030000000000001 109.627 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 50.0 t -58.89 -44.12 90.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.39 -0.823 . . . . 50.32 110.48 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 73.5 mmtt -66.21 -46.64 76.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.513 -0.312 . . . . 52.240000000000002 111.762 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 443' ' ' LYS . 33.1 mmtp -66.0 -37.95 87.23 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.876 0.324 . . . . 52.200000000000003 111.876 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 440' ' ' ALA . 10.4 mp -65.21 -40.48 94.2 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.932 0.145 . . . . 74.439999999999998 111.286 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 59.2 m -61.25 -47.06 87.8 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.33 -0.619 . . . . 64.129999999999995 109.33 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.12 -24.96 65.98 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 115.851 -0.613 . . . . 70.299999999999997 111.696 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.2 -8.86 59.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.327 -0.397 . . . . 65.209999999999994 111.354 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.28 48.7 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.639 -0.791 . . . . 42.200000000000003 113.187 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.25 99.34 6.23 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 122.266 -0.549 . . . . 73.439999999999998 109.687 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.43 23.1 27.45 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.238 -0.745 . . . . 73.219999999999999 111.238 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -118.58 111.72 18.95 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.671 -1.233 . . . . 72.140000000000001 107.671 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -131.31 144.1 51.02 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 122.012 0.91 . . . . 72.510000000000005 113.06 -174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 18.4 tptm -140.3 123.4 16.69 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.548 -1.66 . . . . 64.430000000000007 106.525 170.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -95.99 135.16 38.13 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.555 -0.535 . . . . 74.510000000000005 109.555 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.0 153.02 51.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.025 -0.732 . . . . 73.450000000000003 109.025 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -121.8 129.37 52.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.886 0.374 . . . . 74.010000000000005 110.481 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 22.2 t -117.2 142.46 30.14 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 107.869 -1.16 . . . . 62.329999999999998 107.869 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.98 126.96 19.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.266 1.977 . . . . 71.409999999999997 109.968 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 21.6 t -137.96 -178.21 5.16 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.749 -0.834 . . . . 60.229999999999997 108.749 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.462 ' HB ' HD13 ' A' ' 463' ' ' LEU . 21.0 m -63.94 138.02 97.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 N-CA-C 107.41 -1.33 . . . . 75.340000000000003 107.41 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.47 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.3 Cg_endo -51.81 -29.31 33.82 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.629 2.886 . . . . 71.420000000000002 113.965 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -76.23 -19.06 58.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.921 0.711 . . . . 63.439999999999998 112.921 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.462 HD13 ' HB ' ' A' ' 460' ' ' THR . 10.4 mp -95.17 4.62 53.4 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 111.808 0.299 . . . . 65.239999999999995 111.808 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -60.15 126.35 17.8 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-O 121.335 0.588 . . . . 73.109999999999999 110.54 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.11 -0.16 66.32 Favored Glycine 0 N--CA 1.439 -1.125 0 CA-C-N 115.748 -0.66 . . . . 54.310000000000002 112.09 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.57 152.29 24.96 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.985 -1.117 . . . . 73.349999999999994 107.985 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 486' ' ' ILE . 56.4 t -84.07 141.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.06 -0.718 . . . . 72.120000000000005 109.06 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.22 -14.94 8.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.127 -0.629 . . . . 55.119999999999997 111.456 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 159.08 168.28 20.91 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.733 -0.947 . . . . 63.140000000000001 110.733 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.0 p -116.95 159.3 22.68 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.012 -0.736 . . . . 73.25 109.012 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.501 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.2 t-20 -63.52 -54.69 41.27 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 119.96 -0.696 . . . . 62.409999999999997 111.132 176.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 18.3 Cg_exo -72.87 112.98 3.64 Favored 'Trans proline' 0 C--N 1.373 1.834 0 N-CA-C 107.465 -1.783 . . . . 71.120000000000005 107.465 166.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 49.5 Cg_endo -65.65 149.03 87.62 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.917 2.412 . . . . 72.420000000000002 114.938 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -77.8 -0.88 28.83 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.542 -1.208 . . . . 70.329999999999998 110.03 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -104.41 7.33 35.52 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.439 -1.255 . . . . 75.430000000000007 110.252 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.49 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 34.9 tt0 -159.01 165.48 33.92 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.906 -0.717 . . . . 65.530000000000001 109.593 -172.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.2 m -92.52 126.4 37.59 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.633 -0.877 . . . . 71.430000000000007 108.633 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.9 m -125.96 148.85 49.15 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.939 -0.393 . . . . 75.319999999999993 109.939 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.9 148.19 50.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.632 0.253 . . . . 75.519999999999996 111.636 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 46.4 mm -66.41 -12.58 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.442 0 C-N-CA 124.388 1.075 . . . . 62.009999999999998 110.818 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.3 t -87.91 5.0 42.64 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.868 0.842 . . . . 75.409999999999997 110.328 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -90.96 135.43 33.74 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.382 -0.599 . . . . 72.530000000000001 109.382 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.69 122.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 106.964 -1.495 . . . . 64.140000000000001 106.964 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.23 118.59 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.315 0 C-N-CA 119.618 -0.833 . . . . 61.420000000000002 108.882 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 63.8 mt -92.93 112.24 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 105.935 -1.876 . . . . 75.319999999999993 105.935 174.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -94.4 109.13 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 106.688 -1.597 . . . . 73.340000000000003 106.688 -178.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 27.0 mt -97.2 116.9 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 115.513 -0.767 . . . . 65.329999999999998 109.867 -174.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 34.6 t -97.52 141.04 16.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 107.961 -1.125 . . . . 62.439999999999998 107.961 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -91.31 127.11 8.72 Favored Glycine 0 N--CA 1.407 -3.276 0 N-CA-C 109.849 -1.3 . . . . 71.430000000000007 109.849 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.7 m -136.39 128.83 30.28 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.348 -0.612 . . . . 72.409999999999997 109.348 177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.287 0 N-CA-C 108.569 -1.812 . . . . 64.409999999999997 108.569 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.47 0 N-CA-C 109.392 -1.483 . . . . 54.340000000000003 109.392 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.8 pp -93.45 135.41 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.094 -0.706 . . . . 55.25 109.094 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 23.6 p -78.99 143.1 36.04 Favored 'General case' 0 N--CA 1.385 -3.718 0 CA-C-N 116.251 -0.431 . . . . 65.540000000000006 110.712 -177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -97.74 77.89 2.57 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.683 -0.858 . . . . 75.310000000000002 108.683 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -100.71 135.53 42.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.706 -1.22 . . . . 73.299999999999997 107.706 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.14 149.72 20.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.803 -0.443 . . . . 72.030000000000001 109.803 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -96.85 135.47 38.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 107.298 -1.371 . . . . 63.539999999999999 107.298 174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 406' ' ' ALA . 3.6 p -97.82 118.66 63.71 Favored Pre-proline 0 C--N 1.282 -2.351 0 N-CA-C 108.637 -0.875 . . . . 71.150000000000006 108.637 177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.7 160.68 27.66 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.77 2.313 . . . . 75.319999999999993 113.823 -173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 366' ' ' ARG . 14.6 p-10 -72.33 119.58 16.74 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.243 -0.89 . . . . 44.310000000000002 109.976 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.64 35.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 125.564 1.546 . . . . 72.530000000000001 110.728 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 364' ' ' ASP . 15.0 ptt180 -63.87 144.55 56.98 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 113.622 -1.627 . . . . 72.329999999999998 112.859 -176.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.56 0.74 59.2 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.724 -0.75 . . . . 41.030000000000001 114.685 171.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.49 171.69 12.73 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 118.375 1.088 . . . . 73.340000000000003 110.995 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 59.9 p -71.59 156.77 39.02 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.261 -0.427 . . . . 45.32 110.547 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 374' ' ' ILE . 8.4 p -59.78 -37.12 78.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 120.945 0.403 . . . . 72.400000000000006 110.574 176.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.76 -46.0 91.49 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.993 -0.548 . . . . 62.240000000000002 111.335 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.67 -41.88 74.92 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.487 -0.485 . . . . 74.329999999999998 110.406 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.99 -51.32 69.7 Favored 'General case' 0 C--O 1.239 0.532 0 O-C-N 123.809 0.693 . . . . 72.409999999999997 111.94 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -60.64 -46.07 96.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 CA-C-N 116.281 -0.418 . . . . 72.040000000000006 110.951 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.36 87.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.035 0.383 . . . . 73.209999999999994 112.035 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 79.1 m -60.83 -45.56 93.98 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 120.742 0.306 . . . . 53.43 111.197 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.62 -38.13 89.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.363 -0.38 . . . . 72.400000000000006 110.688 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.13 -46.15 90.62 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.125 0.97 . . . . 74.519999999999996 110.485 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -70.36 -18.66 63.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.757 -0.656 . . . . 71.239999999999995 111.263 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 380' ' ' ARG . 25.1 mmt180 -88.49 -8.26 55.16 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.972 -0.558 . . . . 74.140000000000001 111.13 175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.6 -3.2 56.15 Favored Glycine 0 CA--C 1.504 -0.655 0 C-N-CA 120.986 -0.626 . . . . 61.350000000000001 113.353 174.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -80.83 150.27 29.21 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.226 0.536 . . . . 71.310000000000002 110.41 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -100.06 144.74 28.74 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.066 -1.457 . . . . 73.219999999999999 107.066 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.443 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -135.67 139.68 45.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-O 121.152 0.501 . . . . 74.120000000000005 111.498 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -116.19 127.75 55.04 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 107.246 -1.39 . . . . 62.329999999999998 107.246 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 14.7 m -104.7 123.75 48.17 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.265 -0.574 . . . . 63.549999999999997 110.086 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 64.2 tp -111.53 119.71 39.67 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.55 -0.907 . . . . 62.439999999999998 108.55 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.426 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -104.41 127.52 52.11 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.913 -0.585 . . . . 64.540000000000006 109.635 179.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -134.97 139.59 32.55 Favored Pre-proline 0 C--N 1.298 -1.659 0 N-CA-C 111.773 0.286 . . . . 64.450000000000003 111.773 -176.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 60.3 Cg_endo -89.19 145.23 5.13 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.424 2.082 . . . . 73.25 110.215 170.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.9 t70 -171.09 -176.64 1.99 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.502 -0.925 . . . . 73.109999999999999 108.502 178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.544 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 3.5 m -98.65 -39.61 8.6 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.743 -1.577 . . . . 74.549999999999997 106.743 177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 33.1 m -101.86 73.47 1.41 Allowed 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.406 -1.331 . . . . 72.010000000000005 107.406 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 421' ' ' SER . 14.5 pt -93.83 127.45 45.47 Favored Pre-proline 0 N--CA 1.419 -1.978 0 CA-C-N 113.016 -1.902 . . . . 73.25 111.593 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -69.86 124.33 10.93 Favored 'Trans proline' 0 N--CA 1.445 -1.363 0 N-CA-C 106.105 -2.306 . . . . 75.420000000000002 106.105 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.23 159.98 11.69 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.049 2.499 . . . . 75.109999999999999 113.749 -173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -60.9 -8.81 3.4 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 124.375 1.07 . . . . 74.329999999999998 111.696 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -103.82 106.86 17.49 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 105.073 -2.195 . . . . 72.319999999999993 105.073 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.0 m -62.63 119.72 7.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 O-C-N 124.585 1.178 . . . . 71.329999999999998 113.378 -169.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.59 -28.22 6.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 113.865 -1.516 . . . . 63.420000000000002 109.89 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -154.47 170.4 32.88 Favored Glycine 0 N--CA 1.417 -2.61 0 N-CA-C 110.598 -1.001 . . . . 23.41 110.598 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 403' ' ' ASP . 5.9 m -120.02 -178.21 3.6 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.389 -2.078 . . . . 54.420000000000002 105.389 177.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.492 ' H ' HG22 ' A' ' 402' ' ' THR . 26.9 t70 -100.02 141.14 22.21 Favored Pre-proline 0 C--N 1.266 -3.024 0 N-CA-C 108.995 -0.742 . . . . 75.230000000000004 108.995 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -41.98 -26.32 0.47 Allowed 'Trans proline' 0 C--N 1.371 1.731 1 C-N-CA 125.555 4.17 . . . . 75.109999999999999 115.248 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -55.23 -32.55 62.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.981 0.512 . . . . 74.049999999999997 110.683 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 362' ' ' VAL . . . -77.06 -44.47 30.54 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.678 -0.692 . . . . 61.409999999999997 110.856 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -7.62 54.54 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.69 -0.686 . . . . 72.230000000000004 111.936 -174.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.3 m -85.17 146.02 27.32 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.421 -0.955 . . . . 73.540000000000006 108.421 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 35.4 p -73.49 113.87 11.08 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 109.795 -0.446 . . . . 73.510000000000005 109.795 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.7 m -128.44 168.84 20.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.525 -0.546 . . . . 73.329999999999998 109.525 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 40.8 m -72.84 133.25 44.37 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.369 -0.974 . . . . 71.120000000000005 108.369 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -55.86 135.78 51.81 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 112.442 0.534 . . . . 53.119999999999997 112.442 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 86.86 47.04 4.92 Favored Glycine 0 N--CA 1.436 -1.349 0 CA-C-N 115.082 -0.963 . . . . 62.509999999999998 111.094 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -108.68 178.88 4.35 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.981 -1.118 . . . . 75.409999999999997 107.981 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -97.79 122.13 40.53 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.801 0.44 . . . . 52.119999999999997 111.388 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 44.9 mm -111.18 128.88 67.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.723 -0.843 . . . . 61.439999999999998 108.723 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.1 t -87.39 128.0 35.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.138 -0.69 . . . . 53.329999999999998 109.138 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 57.7 t -116.21 128.85 73.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.532 -0.914 . . . . 75.109999999999999 108.532 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -100.96 128.34 47.03 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.395 -0.366 . . . . 72.209999999999994 110.694 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 12.1 p -126.28 146.39 32.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.558 -1.275 . . . . 73.540000000000006 107.558 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.453 ' CB ' ' HB ' ' A' ' 394' ' ' ILE . 8.8 p -98.93 123.29 43.11 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.059 -0.657 . . . . 45.450000000000003 112.531 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.3 p -118.28 105.32 11.64 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.888 -0.596 . . . . 75.349999999999994 110.145 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 72.94 161.2 6.01 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 121.898 0.721 . . . . 24.239999999999998 114.497 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.0 Cg_endo -92.33 157.62 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.072 0 C-N-CA 122.496 2.13 . . . . 75.010000000000005 110.871 175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.8 131.63 42.56 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 120.092 -0.643 . . . . 52.030000000000001 110.219 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.1 mt-30 -121.08 138.96 53.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.681 -0.69 . . . . 74.140000000000001 109.611 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.543 ' HG2' ' HB1' ' A' ' 447' ' ' ALA . 0.1 OUTLIER -131.8 150.19 52.23 Favored 'General case' 0 N--CA 1.413 -2.287 0 N-CA-C 108.566 -0.902 . . . . 64.439999999999998 108.566 -175.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 428' ' ' GLU . 0.7 OUTLIER -85.98 131.65 34.23 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 108.064 -1.087 . . . . 72.230000000000004 108.064 176.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.7 mp -80.08 125.23 82.11 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.372 -0.603 . . . . 72.140000000000001 109.372 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.37 141.25 73.86 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.255 1.97 . . . . 62.450000000000003 110.951 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -86.5 -5.26 59.2 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.466 0.651 . . . . 61.409999999999997 110.199 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.47 -1.4 3.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.694 -0.685 . . . . 74.420000000000002 111.165 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.2 p -65.6 -41.53 92.66 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.921 0.867 . . . . 71.25 109.708 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 1.4 m -65.84 -13.24 59.18 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 125.271 1.429 . . . . 71.219999999999999 111.213 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.18 -35.75 17.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 112.315 0.487 . . . . 64.239999999999995 112.315 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.0 m -157.94 125.21 5.08 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.909 -0.494 . . . . 44.450000000000003 110.522 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -57.58 -48.79 78.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.437 0.532 . . . . 73.019999999999996 112.437 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.0 76.71 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.439 -0.346 . . . . 45.229999999999997 111.888 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.88 -34.7 71.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.962 -0.563 . . . . 53.009999999999998 111.176 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.18 -47.01 86.9 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 116.477 -0.329 . . . . 75.200000000000003 110.459 -178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.28 -42.33 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.822 -0.627 . . . . 74.019999999999996 109.935 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -61.62 -47.59 84.75 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 111.922 0.342 . . . . 64.439999999999998 111.922 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.55 -45.54 92.46 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 122.55 0.34 . . . . 64.329999999999998 111.54 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.2 mp -68.28 -40.79 81.7 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.469 -0.492 . . . . 45.100000000000001 112.175 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 88.2 m -63.82 -39.33 93.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.956 0.407 . . . . 61.439999999999998 110.402 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.65 -25.96 65.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.0 -0.545 . . . . 54.539999999999999 110.946 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.543 ' HB1' ' HG2' ' A' ' 427' ' ' ARG . . . -86.88 -8.59 57.14 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.857 -0.61 . . . . 70.439999999999998 110.938 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 117.3 -15.98 13.01 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.558 -0.829 . . . . 34.539999999999999 114.08 176.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -65.36 113.15 3.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.995 0.898 . . . . 74.540000000000006 111.54 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.86 -12.57 11.17 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.823 -0.703 . . . . 42.340000000000003 111.422 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -91.06 111.19 22.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.1 -0.704 . . . . 75.230000000000004 109.1 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -136.07 154.49 51.01 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.54 0.685 . . . . 52.219999999999999 111.864 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -137.03 122.3 19.3 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 104.841 -2.281 . . . . 63.310000000000002 104.841 170.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -113.57 127.89 56.24 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.023 0.439 . . . . 72.420000000000002 110.625 -173.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -141.06 165.29 27.96 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.701 -0.682 . . . . 63.329999999999998 110.034 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -112.96 141.15 47.12 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.771 -1.196 . . . . 63.210000000000001 107.771 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 11.6 t -116.93 129.57 25.22 Favored Pre-proline 0 N--CA 1.407 -2.607 0 N-CA-C 107.008 -1.479 . . . . 74.409999999999997 107.008 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.55 119.97 7.15 Favored 'Trans proline' 0 CA--C 1.503 -1.061 0 C-N-CA 122.227 1.952 . . . . 61.009999999999998 109.791 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 2.9 p -148.24 -178.35 6.26 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 115.045 -0.98 . . . . 64.239999999999995 108.84 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 19.3 m -61.32 128.72 90.14 Favored Pre-proline 0 C--N 1.291 -1.941 0 N-CA-C 108.48 -0.933 . . . . 75.109999999999999 108.48 176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.68 -22.94 10.29 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.646 2.898 . . . . 65.209999999999994 112.899 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -60.11 -30.17 69.09 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.34 0.656 . . . . 72.099999999999994 110.918 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.63 5.16 44.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.362 -0.381 . . . . 73.439999999999998 111.427 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.5 p -59.58 132.26 24.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 CA-C-O 121.15 0.5 . . . . 43.310000000000002 111.247 -178.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 90.81 -10.79 73.82 Favored Glycine 0 C--N 1.31 -0.872 0 C-N-CA 120.689 -0.767 . . . . 41.310000000000002 112.748 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.67 147.01 30.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 109.38 -0.6 . . . . 73.430000000000007 109.38 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 486' ' ' ILE . 60.8 t -83.86 135.54 24.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 108.125 -1.065 . . . . 61.219999999999999 108.125 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.97 -16.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 119.516 -0.874 . . . . 71.239999999999995 111.542 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.37 167.28 32.95 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.641 -0.79 . . . . 74.400000000000006 111.693 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 11.2 p -131.78 145.62 51.69 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.309 -0.996 . . . . 74.019999999999996 108.309 177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.512 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 49.0 t30 -58.97 -53.8 62.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 120.337 -0.545 . . . . 75.530000000000001 110.532 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 17.2 Cg_exo -70.84 118.39 5.67 Favored 'Trans proline' 0 C--N 1.376 2.011 0 N-CA-C 107.338 -1.831 . . . . 71.430000000000007 107.338 169.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.12 151.93 30.8 Favored 'Trans proline' 0 N--CA 1.438 -1.782 0 C-N-CA 122.028 1.819 . . . . 75.150000000000006 113.685 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.402 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -68.74 -0.93 5.93 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.005 -0.998 . . . . 70.150000000000006 112.244 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -107.81 -3.02 19.43 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.497 -0.32 . . . . 75.140000000000001 110.69 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -118.19 157.0 27.77 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.442 0.639 . . . . 71.510000000000005 110.601 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 10.3 m -102.69 97.75 7.88 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.404 -1.332 . . . . 61.340000000000003 107.404 176.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 40.4 m -100.88 147.99 25.48 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.986 -0.552 . . . . 73.209999999999994 110.082 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.77 148.22 51.55 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.107 -0.497 . . . . 61.219999999999999 110.861 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 33.0 mm -69.81 -5.04 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 122.464 1.126 . . . . 73.209999999999994 109.996 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 22.4 p -87.49 0.9 54.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.598 0.714 . . . . 60.119999999999997 109.736 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 482' ' ' ASN . 0.8 OUTLIER -93.07 139.42 30.57 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.425 -0.807 . . . . 74.219999999999999 109.08 -179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.93 123.42 36.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.911 -1.144 . . . . 75.209999999999994 107.911 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.36 118.85 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 108.679 -0.86 . . . . 73.510000000000005 108.679 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.461 HD13 HD22 ' A' ' 471' ' ' ASN . 2.6 mp -92.4 113.65 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.204 -1.776 . . . . 73.200000000000003 106.204 175.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -112.43 114.64 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.602 0 N-CA-C 108.297 -1.001 . . . . 72.239999999999995 108.297 -176.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -106.9 123.07 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.358 -0.837 . . . . 53.219999999999999 111.214 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.36 144.0 11.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.75 -1.114 . . . . 74.040000000000006 108.486 -175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -71.58 113.42 4.61 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 108.904 -1.678 . . . . 70.299999999999997 108.904 175.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.9 m -139.63 113.11 8.4 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 109.178 -0.675 . . . . 65.409999999999997 109.178 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.417 -2.633 0 N-CA-C 108.499 -1.84 . . . . 62.0 108.499 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.272 0 N-CA-C 110.243 -1.143 . . . . 43.049999999999997 110.243 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.17 145.79 16.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.39 0.614 . . . . 50.5 112.554 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.1 m -114.6 160.68 19.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.447 -1.686 . . . . 65.150000000000006 106.447 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.435 ' HD3' ' HA ' ' A' ' 358' ' ' ARG . 38.2 mmt180 -87.99 89.35 7.96 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.082 0.944 . . . . 73.030000000000001 111.823 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.72 126.24 51.93 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.594 -1.632 . . . . 72.400000000000006 106.594 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.51 154.25 23.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 110.177 -0.305 . . . . 74.450000000000003 110.177 -175.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -98.97 132.12 44.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.805 -1.183 . . . . 65.319999999999993 107.805 174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.1 118.33 61.67 Favored Pre-proline 0 C--N 1.3 -1.576 0 C-N-CA 119.832 -0.747 . . . . 72.329999999999998 111.461 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.89 143.08 71.78 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 122.439 2.093 . . . . 64.010000000000005 112.189 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.623 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 4.0 p30 -82.68 177.9 8.46 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.225 -0.898 . . . . 73.209999999999994 111.239 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 368' ' ' GLN . 17.1 m -138.67 29.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.478 -1.237 . . . . 74.420000000000002 108.537 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.623 ' HG3' ' OD1' ' A' ' 364' ' ' ASP 0.264 0.1 OUTLIER -64.15 146.74 53.73 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 113.438 0.903 . . . . 73.450000000000003 113.438 -174.049 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.2 0.2 41.04 Favored Glycine 0 C--N 1.308 -0.989 0 N-CA-C 110.368 -1.093 . . . . 54.409999999999997 110.368 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.535 ' NE2' ' HB ' ' A' ' 365' ' ' VAL . 46.7 mt-30 -116.44 -170.68 1.86 Allowed 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.899 -0.778 . . . . 72.439999999999998 108.899 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.0 p -69.91 150.99 46.17 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.471 0.309 . . . . 63.32 111.132 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 374' ' ' ILE . 38.1 t -57.98 -36.15 72.19 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.443 -0.947 . . . . 61.530000000000001 108.443 173.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.3 94.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.308 -0.86 . . . . 75.010000000000005 112.237 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.88 -40.24 91.43 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.75 0.309 . . . . 75.310000000000002 110.199 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.18 88.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.805 -0.634 . . . . 72.319999999999993 110.637 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 370' ' ' SER . 76.5 mt -62.59 -46.39 96.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.68 -0.691 . . . . 70.049999999999997 110.202 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.34 79.95 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.997 -0.547 . . . . 51.140000000000001 112.087 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.551 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 85.5 m -60.73 -47.83 84.54 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.659 -0.246 . . . . 70.519999999999996 111.128 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.52 -38.04 89.62 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.71 0.263 . . . . 64.140000000000001 111.71 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.21 -41.98 97.8 Favored 'General case' 0 C--O 1.222 -0.368 0 N-CA-C 109.414 -0.587 . . . . 72.0 109.414 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -69.82 -22.93 63.26 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 115.473 -0.785 . . . . 74.140000000000001 112.107 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 376' ' ' THR . 27.2 mmt180 -84.96 -14.27 48.1 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.504 -0.554 . . . . 72.319999999999993 109.504 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.49 0.84 56.68 Favored Glycine 0 C--O 1.239 0.421 0 C-N-CA 120.895 -0.669 . . . . 53.520000000000003 112.201 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.33 149.26 25.58 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.966 -0.383 . . . . 74.530000000000001 109.966 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -100.18 132.35 45.6 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.782 -0.822 . . . . 74.040000000000006 108.782 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -121.88 137.16 56.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 113.232 0.827 . . . . 61.229999999999997 113.232 -174.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -110.56 127.87 55.4 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 107.309 -1.367 . . . . 71.219999999999999 107.309 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 11.0 m -99.33 121.82 41.62 Favored 'General case' 0 N--CA 1.405 -2.71 0 N-CA-C 108.136 -1.061 . . . . 51.530000000000001 108.136 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -111.49 119.5 38.99 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.251 -1.388 . . . . 73.140000000000001 107.251 -177.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.581 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.46 128.69 55.34 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 109.431 -0.581 . . . . 71.109999999999999 109.431 178.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -133.04 146.25 60.42 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 109.904 -0.406 . . . . 73.239999999999995 109.904 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -93.08 128.87 0.74 Allowed 'Trans proline' 0 C--O 1.251 1.141 0 C-N-CA 122.221 1.947 . . . . 74.450000000000003 109.81 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 6.0 t70 -173.14 -175.12 1.14 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.732 -1.21 . . . . 70.040000000000006 107.732 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 14.8 m -130.63 -0.68 4.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.753 0.787 . . . . 54.140000000000001 109.975 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.1 m -91.11 -0.63 57.76 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.881 1.324 . . . . 71.409999999999997 107.473 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.481 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 2.1 pp -88.63 151.75 48.33 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 114.076 -1.42 . . . . 70.310000000000002 112.641 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.16 178.32 6.44 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 122.425 2.084 . . . . 73.450000000000003 109.698 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.96 158.13 18.24 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 121.923 1.749 . . . . 74.109999999999999 111.786 174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.81 -7.21 3.34 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.842 0.829 . . . . 70.409999999999997 113.119 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -86.83 122.66 31.01 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.216 -2.513 . . . . 51.229999999999997 104.216 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 118.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.626 0.727 . . . . 75.109999999999999 111.811 -169.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 47.8 mm -97.87 -28.37 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.533 -0.758 . . . . 72.409999999999997 111.004 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.94 157.99 27.54 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.039 -1.077 . . . . 52.399999999999999 111.794 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 11.8 p -114.16 -177.53 3.15 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 123.577 0.751 . . . . 72.329999999999998 111.123 -176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -100.06 143.73 27.04 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.705 -1.22 . . . . 64.109999999999999 107.705 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -40.25 -32.63 0.72 Allowed 'Trans proline' 0 C--N 1.367 1.55 0 C-N-CA 124.807 3.672 . . . . 74.099999999999994 114.715 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.09 -30.01 61.41 Favored 'General case' 0 C--O 1.208 -1.103 0 O-C-N 123.437 0.46 . . . . 72.420000000000002 111.608 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.72 -35.56 75.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.109 0.48 . . . . 73.040000000000006 111.021 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -95.66 -0.85 51.2 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 120.944 0.402 . . . . 72.530000000000001 111.939 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 31.9 m -98.29 155.94 16.96 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.322 -1.362 . . . . 71.150000000000006 107.322 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 11.3 p -74.31 112.7 10.73 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.723 -0.843 . . . . 73.329999999999998 108.723 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.51 169.49 12.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 N-CA-C 109.439 -0.578 . . . . 73.310000000000002 109.439 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 20.3 m -69.65 146.9 51.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.298 -0.631 . . . . 63.439999999999998 109.298 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.81 108.17 2.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.821 -1.177 . . . . 53.409999999999997 107.821 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.61 59.68 1.26 Allowed Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 109.444 -1.462 . . . . 71.209999999999994 109.444 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.3 t0 -109.94 -173.51 2.27 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.039 -1.097 . . . . 74.230000000000004 108.039 -177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -93.62 121.96 35.57 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 123.815 0.846 . . . . 74.230000000000004 110.079 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 49.8 mm -124.23 137.62 56.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.112 -1.44 . . . . 63.43 107.112 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.1 t -113.2 131.25 55.95 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 61.219999999999999 110.833 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 76.4 t -102.18 128.28 54.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.112 -0.949 . . . . 71.230000000000004 108.748 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -99.0 129.83 45.3 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 116.131 -0.486 . . . . 41.109999999999999 110.044 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 9.0 p -136.16 136.56 49.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.271 0.558 . . . . 64.340000000000003 109.705 177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.481 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 8.2 m -89.59 123.75 33.94 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.942 -0.572 . . . . 42.32 110.982 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.2 t -119.18 105.83 11.76 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.193 -0.603 . . . . 60.109999999999999 110.015 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 78.08 129.32 0.5 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 120.649 -0.786 . . . . 71.319999999999993 114.792 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.438 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 17.0 Cg_exo -70.75 157.92 57.11 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.685 2.257 . . . . 75.430000000000007 110.582 172.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.01 155.52 19.78 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 120.974 0.416 . . . . 73.439999999999998 110.361 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.7 mt-30 -127.84 138.78 52.82 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.827 -0.805 . . . . 63.43 108.827 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -135.52 157.68 46.27 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.093 -0.706 . . . . 73.219999999999999 109.093 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -83.64 139.35 32.86 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.653 -0.499 . . . . 75.530000000000001 109.653 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.458 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 2.3 mp -80.47 127.34 76.21 Favored Pre-proline 0 C--N 1.297 -1.706 0 N-CA-C 108.66 -0.866 . . . . 64.530000000000001 108.66 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.53 141.57 62.3 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.842 2.361 . . . . 72.409999999999997 111.805 176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -83.76 -15.5 48.28 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.511 0.672 . . . . 63.130000000000003 111.785 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.3 -10.55 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 CA-C-O 121.399 0.619 . . . . 64.409999999999997 110.824 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.1 m -55.73 -45.4 77.96 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.583 0.753 . . . . 65.150000000000006 112.533 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.5 p -69.84 -15.67 63.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.345 0.593 . . . . 62.140000000000001 112.562 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.1 mt -90.01 -37.99 13.92 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.215 -0.448 . . . . 64.200000000000003 111.003 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 62.9 m -146.98 122.22 10.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.062 0.458 . . . . 53.399999999999999 111.043 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -60.59 -42.27 96.38 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.789 0.835 . . . . 64.129999999999995 112.276 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.15 -36.94 78.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.489 . . . . 73.420000000000002 110.822 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -70.75 -39.8 73.07 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.06 -0.518 . . . . 75.310000000000002 110.96 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.53 -51.61 68.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.854 -0.612 . . . . 64.420000000000002 111.031 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.52 -43.83 90.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 112.785 0.661 . . . . 63.530000000000001 112.785 -177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -67.34 -48.53 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.801 -0.36 . . . . 71.299999999999997 111.774 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -66.84 -40.18 87.85 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 113.897 1.073 . . . . 74.549999999999997 113.897 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.39 -43.17 77.87 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.977 -0.689 . . . . 72.319999999999993 112.215 177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 57.7 m -61.6 -43.98 97.85 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.024 0.44 . . . . 72.400000000000006 110.364 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.09 -25.1 62.47 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.795 -0.639 . . . . 60.130000000000003 111.765 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -12.69 59.77 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.172 0.51 . . . . 61.530000000000001 110.631 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.62 -19.01 8.58 Favored Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.337 -0.935 . . . . 35.409999999999997 112.791 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.2 103.82 1.67 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.008 -0.738 . . . . 54.140000000000001 109.008 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -115.68 11.59 18.48 Favored Glycine 0 N--CA 1.43 -1.762 0 N-CA-C 111.029 -0.829 . . . . 75.340000000000003 111.029 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -108.87 111.05 22.55 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 106.68 -1.6 . . . . 72.299999999999997 106.68 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.98 155.82 49.68 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.268 0.556 . . . . 62.310000000000002 111.425 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 122.3 20.33 Favored 'General case' 0 N--CA 1.415 -2.201 0 N-CA-C 102.843 -3.021 . . . . 72.430000000000007 102.843 170.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -93.91 135.14 35.55 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.867 -0.42 . . . . 74.400000000000006 109.867 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.67 141.09 37.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.161 0.505 . . . . 72.510000000000005 110.741 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -118.96 129.36 55.12 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.058 -1.46 . . . . 75.230000000000004 107.058 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 78.0 p -125.36 145.35 50.62 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 109.448 -0.575 . . . . 74.450000000000003 109.448 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.451 ' HA ' ' HA2' ' A' ' 491' ' ' GLY . 13.4 Cg_exo -68.54 126.77 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 121.773 1.649 . . . . 51.439999999999998 110.378 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 33.6 m -135.71 172.92 12.32 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.984 -0.747 . . . . 75.150000000000006 108.984 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.404 ' HB ' HD23 ' A' ' 463' ' ' LEU . 25.6 m -62.81 140.09 97.26 Favored Pre-proline 0 CA--C 1.554 1.127 0 N-CA-C 108.402 -0.962 . . . . 74.519999999999996 108.402 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -49.32 -31.24 22.19 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 123.792 2.995 . . . . 62.329999999999998 113.782 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -68.69 -21.88 64.4 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.236 0.541 . . . . 64.129999999999995 111.434 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.404 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.2 mm? -105.72 -8.52 17.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.218 -0.446 . . . . 73.439999999999998 110.937 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 76.3 t -60.09 127.21 19.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-O 120.977 0.417 . . . . 61.049999999999997 110.641 177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.54 59.08 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.881 -0.888 . . . . 71.329999999999998 110.881 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -104.22 162.42 13.21 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.663 -0.865 . . . . 72.219999999999999 108.663 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 93.1 t -83.83 128.59 38.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 106.773 -1.566 . . . . 75.329999999999998 106.773 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.42 -16.87 7.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 119.381 -0.928 . . . . 74.340000000000003 111.526 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.11 159.0 16.13 Favored Glycine 0 N--CA 1.41 -3.043 0 N-CA-C 111.113 -0.795 . . . . 62.43 111.113 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.4 p -119.94 154.29 34.68 Favored 'General case' 0 C--N 1.269 -2.9 0 N-CA-C 106.425 -1.694 . . . . 74.420000000000002 106.425 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.488 ' HB2' ' HB ' ' A' ' 485' ' ' ILE . 7.2 t30 -64.19 -49.94 70.72 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 119.43 -0.908 . . . . 72.209999999999994 110.349 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 7.4 Cg_exo -78.2 115.9 3.81 Favored 'Trans proline' 0 C--N 1.371 1.731 0 N-CA-C 108.051 -1.557 . . . . 65.519999999999996 108.051 168.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.54 149.93 89.78 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.077 1.852 . . . . 72.439999999999998 112.488 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.458 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.04 4.24 4.53 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.445 0.641 . . . . 63.25 112.596 -176.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -108.35 2.15 22.32 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.994 -0.548 . . . . 62.219999999999999 110.67 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -117.65 155.42 29.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 121.752 0.787 . . . . 64.430000000000007 111.556 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.466 HG22 ' HB3' ' A' ' 426' ' ' GLN . 17.4 m -95.62 111.83 23.68 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.987 -1.486 . . . . 64.319999999999993 106.987 178.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 39.6 m -115.14 149.25 37.92 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.731 -0.47 . . . . 72.430000000000007 109.731 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -62.29 150.84 38.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.156 0.503 . . . . 55.340000000000003 111.226 -178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.26 -26.51 27.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 122.035 0.921 . . . . 73.019999999999996 109.353 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 15.3 m -89.87 5.14 47.57 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 114.967 -1.015 . . . . 34.100000000000001 110.117 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 43.7 t-20 -83.62 135.3 34.66 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 107.609 -1.256 . . . . 64.239999999999995 107.609 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 58.8 t -79.01 114.5 19.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.249 -0.649 . . . . 73.239999999999995 109.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.4 t -87.77 119.52 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 109.082 -0.71 . . . . 72.319999999999993 109.082 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 471' ' ' ASN . 3.0 mp -92.23 114.25 28.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 106.357 -1.72 . . . . 75.310000000000002 106.357 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.29 118.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.676 -1.231 . . . . 74.510000000000005 107.676 -177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 21.1 mt -110.32 117.33 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 CA-C-O 121.587 0.708 . . . . 74.450000000000003 110.27 -174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.23 138.44 22.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.581 -0.736 . . . . 73.340000000000003 109.122 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.09 107.76 3.2 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.975 -0.85 . . . . 74.409999999999997 110.975 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.478 ' HA ' HG13 ' A' ' 464' ' ' VAL . 36.6 m -143.37 113.94 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.105 -0.702 . . . . 72.209999999999994 109.105 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 458' ' ' PRO . . . . . . . . 0 N--CA 1.436 -1.311 0 N-CA-C 110.183 -1.167 . . . . 74.109999999999999 110.183 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.031 0 N-CA-C 110.684 -0.966 . . . . 72.420000000000002 110.684 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 21.5 pt -126.47 158.83 36.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 117.167 0.483 . . . . 72.140000000000001 109.856 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 14.1 t -128.44 -173.37 2.94 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.625 -1.62 . . . . 73.340000000000003 106.625 174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.83 65.41 8.98 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 122.255 1.026 . . . . 65.0 111.153 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -109.92 135.8 50.22 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.486 -2.042 . . . . 73.010000000000005 105.486 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 18.6 m -136.86 164.2 31.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 CA-C-O 120.88 0.372 . . . . 74.040000000000006 111.13 -171.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -94.29 137.14 33.8 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 105.8 -1.926 . . . . 75.319999999999993 105.8 173.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.57 139.72 21.55 Favored Pre-proline 0 C--N 1.274 -2.684 0 N-CA-C 108.294 -1.002 . . . . 63.509999999999998 108.294 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -37.99 135.79 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 123.8 3.0 . . . . 63.409999999999997 113.835 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.78 88.96 1.33 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.791 -1.188 . . . . 71.400000000000006 107.791 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.42 -0.34 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 116.888 2.181 . . . . 55.119999999999997 116.888 -169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.18 145.25 56.5 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 120.032 -0.667 . . . . 74.129999999999995 112.231 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 0.48 45.29 Favored Glycine 0 N--CA 1.436 -1.308 0 N-CA-C 110.802 -0.919 . . . . 42.340000000000003 110.802 -174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -117.3 172.51 7.26 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 106.608 -1.627 . . . . 71.209999999999994 106.608 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 91.0 p -81.3 153.67 26.95 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 118.482 -1.287 . . . . 62.310000000000002 107.865 176.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.464 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.5 m -56.65 -40.47 75.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.535 0.207 . . . . 74.140000000000001 110.897 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -68.67 -36.99 79.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.015 0.436 . . . . 71.310000000000002 111.395 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -67.5 -36.69 81.58 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.537 0.684 . . . . 72.329999999999998 109.508 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.44 90.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.495 -0.775 . . . . 65.329999999999998 110.134 175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 370' ' ' SER . 70.5 mt -57.72 -46.42 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.696 0.398 . . . . 71.209999999999994 110.134 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.69 91.87 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.932 -0.576 . . . . 72.230000000000004 110.684 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 87.7 m -64.73 -47.59 77.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.412 -0.358 . . . . 71.450000000000003 111.095 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.29 -38.79 91.32 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 111.655 0.243 . . . . 44.350000000000001 111.655 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -60.11 -48.88 79.87 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.254 -0.647 . . . . 70.019999999999996 109.254 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -72.07 -16.47 62.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.2 -0.909 . . . . 72.5 111.935 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.91 -15.07 49.37 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.034 -1.098 . . . . 63.409999999999997 108.034 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.4 5.6 61.78 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.59 -0.732 . . . . 33.350000000000001 111.786 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 26.2 m-85 -91.83 158.95 16.04 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.198 0.523 . . . . 61.229999999999997 111.745 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 75.1 mmtt -95.62 146.31 24.58 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.052 -1.092 . . . . 73.439999999999998 108.052 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.72 144.04 38.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 121.209 0.528 . . . . 74.209999999999994 111.56 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -110.46 139.92 45.22 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.019 -2.215 . . . . 71.200000000000003 105.019 174.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 21.0 m -112.68 121.0 43.47 Favored 'General case' 0 C--N 1.274 -2.675 0 C-N-CA 119.174 -1.01 . . . . 55.340000000000003 110.015 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -111.64 119.27 38.11 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.572 -1.64 . . . . 73.530000000000001 106.572 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.465 ' HB2' HG22 ' A' ' 422' ' ' THR . 0.0 OUTLIER -107.04 122.37 46.33 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.927 -0.768 . . . . 75.349999999999994 108.927 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.445 ' HE3' ' OD1' ' A' ' 419' ' ' ASN . 17.6 ptpt -121.15 116.97 30.87 Favored Pre-proline 0 C--N 1.286 -2.171 0 N-CA-C 113.12 0.785 . . . . 74.439999999999998 113.12 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.3 Cg_exo -83.53 140.24 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.445 2.097 . . . . 70.219999999999999 109.205 168.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 175.18 -166.85 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 104.136 -2.542 . . . . 31.02 104.136 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 15.1 m -132.67 -4.03 3.28 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 118.907 0.776 . . . . 43.219999999999999 109.982 173.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.1 m -106.49 38.03 2.16 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 105.204 -2.147 . . . . 53.439999999999998 105.204 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.55 HG23 ' HB3' ' A' ' 391' ' ' ASP . 16.3 pt -87.1 151.16 51.23 Favored Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 113.176 -1.829 . . . . 72.540000000000006 113.078 -170.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.07 137.33 34.31 Favored 'Trans proline' 0 N--CA 1.429 -2.306 0 N-CA-C 105.974 -2.356 . . . . 65.230000000000004 105.974 165.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.66 160.69 11.27 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.332 2.021 . . . . 64.450000000000003 111.787 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -59.67 -8.52 2.06 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.947 0.879 . . . . 75.120000000000005 111.722 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.0 m170 -103.45 111.05 23.31 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 103.778 -2.675 . . . . 74.430000000000007 103.778 171.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.52 119.34 6.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.962 0.887 . . . . 73.109999999999999 112.426 -166.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.7 tt -91.4 -27.84 4.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.958 0 CA-C-N 114.528 -1.215 . . . . 73.219999999999999 112.14 -173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.48 27.31 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.65 -0.98 . . . . 72.049999999999997 110.65 -177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 8.5 p -114.69 -178.0 3.26 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.639 0.733 . . . . 52.130000000000003 112.375 -173.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -104.18 136.48 19.18 Favored Pre-proline 0 C--N 1.296 -1.751 0 N-CA-C 107.437 -1.32 . . . . 73.530000000000001 107.437 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -48.91 -25.37 8.49 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 124.155 3.236 . . . . 73.310000000000002 115.327 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.96 -36.04 69.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.471 0.309 . . . . 75.209999999999994 110.976 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.97 -38.94 83.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.566 0.698 . . . . 74.109999999999999 110.769 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -82.45 -11.4 58.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.296 -0.865 . . . . 63.439999999999998 110.953 -175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 26.1 m -93.62 155.25 17.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.143 -1.058 . . . . 74.340000000000003 108.143 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 9.7 p -74.5 114.51 12.98 Favored 'General case' 0 N--CA 1.421 -1.915 0 CA-C-O 121.543 0.687 . . . . 74.019999999999996 110.154 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.1 m -123.87 169.23 15.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.333 -0.849 . . . . 72.420000000000002 109.574 -179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 65.6 m -62.41 149.34 42.79 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.978 0.418 . . . . 74.400000000000006 111.499 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.68 112.04 3.98 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.156 -1.053 . . . . 71.209999999999994 108.156 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 95.45 25.54 13.65 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 120.346 -0.931 . . . . 23.109999999999999 112.091 -177.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -80.73 -173.88 4.43 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.379 -0.971 . . . . 63.409999999999997 108.379 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.0 pt-20 -108.72 132.87 53.52 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.472 0.653 . . . . 64.439999999999998 112.435 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 47.7 mm -119.86 131.48 72.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.221 -1.029 . . . . 74.299999999999997 108.221 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.3 t -89.45 131.35 35.55 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.379 0.609 . . . . 64.310000000000002 109.999 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 11.7 p -110.15 134.67 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 109.268 -0.641 . . . . 73.209999999999994 109.268 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.445 ' OD1' ' HE3' ' A' ' 389' ' ' LYS . 41.6 m-80 -103.6 129.8 50.93 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 111.655 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.8 p -134.29 142.09 41.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.13 -1.063 . . . . 75.430000000000007 108.13 175.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 12.9 p -101.72 123.12 45.18 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.338 -0.545 . . . . 62.009999999999998 111.761 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 388' ' ' GLN . 9.3 t -120.14 107.01 12.51 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.423 -0.511 . . . . 73.430000000000007 111.546 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.89 142.61 6.59 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.714 -0.755 . . . . 61.109999999999999 114.342 174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.5 Cg_endo -87.92 133.47 3.0 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.295 1.997 . . . . 75.299999999999997 111.625 175.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.458 ' CG ' ' HA ' ' A' ' 391' ' ' ASP . 8.7 mm-40 -72.83 134.05 44.72 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 122.211 -0.305 . . . . 72.109999999999999 110.537 176.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.477 ' HB3' HG22 ' A' ' 477' ' ' THR . 47.2 mt-30 -123.27 134.01 54.12 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 108.776 -0.824 . . . . 61.149999999999999 108.776 177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -131.99 150.94 52.02 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.893 -1.151 . . . . 74.120000000000005 107.893 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 428' ' ' GLU . 1.5 pm0 -82.33 138.95 34.38 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.403 -0.962 . . . . 75.120000000000005 108.403 177.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.9 mt -82.35 117.24 67.73 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.7 -0.852 . . . . 70.230000000000004 108.7 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.55 140.24 39.26 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 121.303 1.335 . . . . 72.5 110.884 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.46 84.37 5.54 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.333 1.063 . . . . 64.420000000000002 112.282 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.65 -5.36 11.38 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 113.645 -1.616 . . . . 63.200000000000003 106.726 171.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 7.7 m -62.74 -43.14 99.56 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.727 -1.579 . . . . 63.43 111.498 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.3 m -58.55 -21.31 52.19 Favored 'General case' 0 CA--C 1.558 1.256 0 C-N-CA 122.957 0.503 . . . . 74.319999999999993 111.733 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.68 -48.08 64.84 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 122.289 -0.257 . . . . 62.520000000000003 110.59 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 15.1 t 178.45 161.85 0.66 Allowed 'General case' 0 C--O 1.249 1.054 0 N-CA-C 108.748 -0.834 . . . . 71.409999999999997 108.748 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -57.75 -42.65 84.39 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.987 0.915 . . . . 75.200000000000003 111.998 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.05 -47.25 81.41 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.885 0.328 . . . . 61.439999999999998 111.885 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.78 -38.88 92.76 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.246 -0.434 . . . . 63.409999999999997 110.645 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.31 -51.09 71.0 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.301 -0.863 . . . . 73.299999999999997 110.238 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.27 -43.12 98.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.536 -0.756 . . . . 74.040000000000006 111.364 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -63.25 -49.37 74.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.247 0.462 . . . . 70.019999999999996 112.247 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -68.03 -41.3 82.35 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 113.099 0.777 . . . . 73.430000000000007 113.099 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.31 -41.04 90.29 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.678 -0.409 . . . . 55.140000000000001 112.044 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 54.8 m -66.39 -38.8 88.33 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 109.932 -0.396 . . . . 64.200000000000003 109.932 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.31 -32.26 73.79 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 116.253 -0.43 . . . . 74.519999999999996 110.879 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -80.46 -13.92 58.71 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.368 -0.378 . . . . 72.219999999999999 110.892 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.31 -20.34 9.67 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.865 -0.683 . . . . 54.149999999999999 113.97 176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.34 105.68 1.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.876 0.37 . . . . 74.099999999999994 110.315 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -113.53 22.22 15.5 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 120.563 -0.827 . . . . 71.040000000000006 111.13 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.55 111.07 18.13 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.163 -1.051 . . . . 75.530000000000001 108.163 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.4 147.1 52.53 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.281 0.562 . . . . 75.420000000000002 111.26 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 8.1 tmtm? -138.67 123.45 18.73 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.768 -1.938 . . . . 72.450000000000003 105.768 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -98.53 135.47 40.02 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 120.612 -0.435 . . . . 62.130000000000003 111.072 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -128.01 148.48 50.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.506 -1.294 . . . . 53.25 107.506 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.25 130.34 46.12 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.788 -0.819 . . . . 51.399999999999999 108.788 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 36.9 p -130.93 143.93 51.42 Favored Pre-proline 0 C--N 1.291 -1.964 0 C-N-CA 120.463 -0.495 . . . . 62.020000000000003 110.888 178.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.613 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.7 Cg_exo -63.71 122.87 11.12 Favored 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.622 2.215 . . . . 72.25 110.281 175.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.8 m -130.06 162.63 28.31 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.495 -0.321 . . . . 73.420000000000002 111.203 -177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 31.4 m -60.26 142.65 89.89 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.638 1.175 . . . . 74.420000000000002 108.782 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.561 ' O ' HG22 ' A' ' 464' ' ' VAL . 90.9 Cg_exo -49.25 -24.06 7.72 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 124.108 3.205 . . . . 75.349999999999994 114.498 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -68.19 -19.21 64.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 111.886 0.328 . . . . 75.420000000000002 111.886 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 95.8 mt -114.33 -11.45 12.55 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.841 0.682 . . . . 64.299999999999997 112.841 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 461' ' ' PRO . 22.4 m -59.93 134.71 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 112.672 0.619 . . . . 65.450000000000003 112.672 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.12 74.44 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.348 -0.842 . . . . 74.219999999999999 111.189 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -119.9 165.19 14.95 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-O 121.252 0.549 . . . . 74.120000000000005 109.646 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 92.6 t -84.02 134.96 25.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.767 -1.198 . . . . 74.340000000000003 107.767 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -95.71 -12.0 8.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 C-N-CA 119.863 -0.735 . . . . 75.230000000000004 110.952 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 155.25 169.96 20.3 Favored Glycine 0 N--CA 1.414 -2.805 0 CA-C-N 115.346 -0.843 . . . . 71.430000000000007 111.263 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -116.62 150.63 37.77 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 108.136 -1.061 . . . . 72.019999999999996 108.136 177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.457 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 6.3 t30 -64.12 -47.4 79.37 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 120.537 -0.465 . . . . 52.25 109.924 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 10.4 Cg_exo -76.23 117.29 4.59 Favored 'Trans proline' 0 C--N 1.38 2.196 0 N-CA-C 107.6 -1.731 . . . . 65.519999999999996 107.6 167.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.74 144.18 88.43 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.082 1.855 . . . . 63.009999999999998 113.037 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.44 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.41 12.94 3.95 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.166 0.984 . . . . 71.230000000000004 110.394 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -109.18 1.58 20.4 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.967 -1.015 . . . . 62.229999999999997 108.619 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -125.17 159.39 31.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.629 0.728 . . . . 74.120000000000005 111.174 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 7.4 m -93.6 115.77 28.26 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.358 -1.292 . . . . 74.25 108.822 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 19.1 m -116.02 148.54 40.05 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.965 -0.383 . . . . 72.510000000000005 109.965 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -67.51 152.24 46.0 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 122.449 0.3 . . . . 63.219999999999999 111.203 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 46.1 mm -62.83 -26.21 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 CA-C-O 121.315 0.578 . . . . 71.310000000000002 111.961 -178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 13.0 t -96.28 5.03 51.86 Favored 'General case' 0 C--O 1.241 0.658 0 O-C-N 122.01 -0.431 . . . . 75.340000000000003 110.467 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -74.2 129.73 38.39 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.996 -1.113 . . . . 63.530000000000001 107.996 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 113.3 18.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.765 -0.828 . . . . 73.109999999999999 108.765 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.4 t -87.33 120.02 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-N 115.567 -0.742 . . . . 72.329999999999998 109.855 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 66.8 mt -91.54 112.7 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 106.895 -1.52 . . . . 64.420000000000002 106.895 176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 120.4 53.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 107.937 -1.134 . . . . 55.119999999999997 107.937 -177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 24.0 mt -105.2 118.82 53.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.088 0.47 . . . . 75.310000000000002 110.111 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 46.1 t -98.08 134.92 34.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-N 115.79 -0.641 . . . . 73.430000000000007 109.339 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -86.64 106.23 3.09 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.516 -1.034 . . . . 64.040000000000006 110.516 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 19.5 m -122.07 119.11 30.41 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.925 -0.769 . . . . 53.149999999999999 108.925 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 CA-C-O 118.009 -1.44 . . . . 54.219999999999999 109.764 -177.282 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.465 0 N-CA-C 109.345 -1.502 . . . . 43.049999999999997 109.345 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.7 pp -75.29 136.33 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 122.18 0.991 . . . . 73.329999999999998 111.847 -176.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.5 m -131.85 -173.62 3.19 Favored 'General case' 0 C--N 1.27 -2.855 0 N-CA-C 104.154 -2.536 . . . . 51.340000000000003 104.154 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -78.62 62.52 3.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 119.834 1.197 . . . . 65.209999999999994 109.85 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.58 134.25 38.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 113.518 -1.674 . . . . 63.539999999999999 108.203 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.2 154.75 37.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-O 120.985 0.421 . . . . 75.150000000000006 110.875 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -95.25 139.03 32.15 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.857 -2.275 . . . . 74.230000000000004 104.857 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.2 130.86 32.82 Favored Pre-proline 0 C--N 1.283 -2.325 0 C-N-CA 119.072 -1.051 . . . . 54.310000000000002 109.367 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -41.03 125.65 2.36 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.847 3.031 . . . . 73.349999999999994 112.069 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.86 157.16 38.0 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.26 -1.336 . . . . 42.43 109.471 -172.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.82 -0.24 9.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 120.612 -0.435 . . . . 62.409999999999997 110.973 -173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 21.4 ptp180 -54.91 131.05 43.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.547 0.689 . . . . 72.450000000000003 112.612 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 101.74 -1.29 52.39 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.359 -0.837 . . . . 65.319999999999993 111.146 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -118.42 -178.06 3.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.502 -0.555 . . . . 73.140000000000001 109.502 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 82.9 p -87.87 171.23 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 112.619 0.6 . . . . 54.009999999999998 112.619 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 8.7 p -63.89 -39.09 93.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 116.03 -0.532 . . . . 54.450000000000003 109.989 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.39 -39.38 87.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.593 -0.73 . . . . 74.420000000000002 110.033 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.83 -44.07 90.83 Favored 'General case' 0 CA--C 1.503 -0.837 0 O-C-N 123.209 0.318 . . . . 31.329999999999998 111.533 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.98 -51.18 67.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.866 0.365 . . . . 73.040000000000006 111.099 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.451 ' O ' ' HB2' ' A' ' 378' ' ' GLN . 1.8 mp -68.32 -46.28 81.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.139 -0.482 . . . . 64.430000000000007 111.71 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.38 -44.8 86.42 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 112.622 0.601 . . . . 61.450000000000003 112.622 -175.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.545 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 22.9 m -66.94 -48.29 69.05 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.629 -0.429 . . . . 74.420000000000002 110.44 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 9.8 mp -64.98 -37.47 87.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.091 -0.504 . . . . 73.329999999999998 112.209 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . 0.502 ' NE2' HD11 ' A' ' 384' ' ' ILE . 5.7 tp-100 -59.21 -47.65 84.54 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.446 -0.946 . . . . 74.409999999999997 108.446 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.01 -28.13 67.15 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.161 -0.927 . . . . 63.149999999999999 112.486 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 376' ' ' THR . 10.6 mpt_? -84.47 -8.81 58.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 111.051 177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 88.81 16.78 57.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.212 -0.994 . . . . 73.129999999999995 113.232 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -80.2 156.12 27.07 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.108 0.48 . . . . 53.039999999999999 110.323 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 31.5 mmmt -90.32 132.9 35.31 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.614 -1.625 . . . . 72.420000000000002 106.614 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.502 HD11 ' NE2' ' A' ' 378' ' ' GLN . 0.2 OUTLIER -129.53 134.73 63.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-O 121.541 0.686 . . . . 71.510000000000005 112.086 -177.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -112.35 127.9 56.14 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.3 m -117.67 121.16 40.13 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 109.328 -0.619 . . . . 73.230000000000004 109.328 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.21 119.25 37.71 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.399 -1.704 . . . . 74.140000000000001 106.399 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -101.54 131.22 47.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.621 -0.881 . . . . 62.299999999999997 108.621 179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -134.9 122.06 15.11 Favored Pre-proline 0 C--N 1.287 -2.132 0 CA-C-N 116.277 -0.419 . . . . 54.210000000000001 111.775 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 425' ' ' GLU . 6.0 Cg_exo -81.41 132.4 7.99 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.959 1.772 . . . . 74.409999999999997 107.78 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.667 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 15.1 t70 -159.46 -162.26 1.02 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.548 -1.278 . . . . 64.409999999999997 107.548 -176.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 67.3 m -145.14 1.58 0.97 Allowed 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 119.392 0.996 . . . . 64.109999999999999 112.789 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 14.6 t -131.12 22.12 4.87 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 122.609 1.195 . . . . 75.430000000000007 108.206 176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 391' ' ' ASP . 1.9 pp -88.91 152.47 48.59 Favored Pre-proline 0 C--N 1.304 -1.381 0 CA-C-N 113.625 -1.625 . . . . 41.210000000000001 112.996 -177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -72.51 157.18 53.27 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.791 1.661 . . . . 41.420000000000002 109.236 170.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.11 160.54 41.34 Favored 'Trans proline' 0 C--O 1.218 -0.515 0 C-N-CA 122.294 1.996 . . . . 72.340000000000003 111.104 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.537 ' HB2' HG13 ' A' ' 420' ' ' VAL . 3.6 p30 -60.4 -9.69 3.9 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 121.517 0.675 . . . . 75.140000000000001 111.943 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -84.53 111.06 19.17 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 104.456 -2.424 . . . . 50.409999999999997 104.456 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.9 p -62.18 118.52 4.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 122.07 0.938 . . . . 75.0 112.704 -167.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 9.3 tp -98.1 -31.1 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 74.030000000000001 109.386 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.98 156.77 27.17 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 108.894 -1.682 . . . . 54.219999999999999 108.894 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 22.2 p -114.5 -175.72 2.75 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 123.307 0.643 . . . . 60.409999999999997 111.306 -173.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -99.58 137.84 20.34 Favored Pre-proline 0 C--N 1.295 -1.787 0 N-CA-C 106.464 -1.68 . . . . 74.209999999999994 106.464 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -42.97 -30.75 1.98 Allowed 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 124.418 3.412 . . . . 55.43 114.64 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -53.88 -38.3 64.62 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.931 0.492 . . . . 74.340000000000003 111.432 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.99 -27.87 62.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.729 0.776 . . . . 74.0 111.153 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -91.23 -8.06 49.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 110.665 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 39.6 m -92.54 156.53 17.07 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.947 -0.761 . . . . 63.329999999999998 108.947 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 10.1 m -74.15 112.79 10.64 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 107.606 -1.257 . . . . 74.329999999999998 107.606 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.1 m -126.28 170.04 16.85 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.932 -0.576 . . . . 73.109999999999999 109.749 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 21.9 m -83.96 140.07 32.15 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.404 -1.332 . . . . 61.43 107.404 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -59.96 113.1 2.14 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.135 0.493 . . . . 75.030000000000001 110.184 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.29 21.38 6.61 Favored Glycine 0 C--N 1.302 -1.321 0 C-N-CA 120.596 -0.812 . . . . 63.25 111.751 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -85.94 -171.33 3.53 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.474 -1.306 . . . . 61.009999999999998 107.474 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.9 pt-20 -107.91 138.87 43.4 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 118.831 0.741 . . . . 72.439999999999998 111.895 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.6 122.68 67.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.743 -1.206 . . . . 53.329999999999998 107.743 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -96.19 119.39 34.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 122.039 0.923 . . . . 73.530000000000001 110.249 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.72 126.66 68.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.053 -0.976 . . . . 71.420000000000002 109.33 -176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.7 128.87 44.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.437 -0.949 . . . . 61.520000000000003 108.437 177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 397' ' ' ASP . 78.0 t -121.73 130.63 74.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.382 -0.969 . . . . 73.030000000000001 108.382 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 14.3 m -94.87 122.91 37.99 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 109.776 -0.453 . . . . 75.129999999999995 109.776 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.5 t -117.16 105.28 12.08 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-O 121.84 0.829 . . . . 73.319999999999993 110.981 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 60.99 178.69 2.39 Favored Glycine 0 CA--C 1.543 1.793 0 CA-C-N 114.983 -1.008 . . . . 74.239999999999995 115.136 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 10.1 Cg_endo -90.82 131.93 1.58 Allowed 'Trans proline' 0 N--CA 1.438 -1.78 0 C-N-CA 123.038 2.492 . . . . 73.230000000000004 111.757 177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 390' ' ' PRO . 6.4 tp10 -72.87 151.59 41.89 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 109.754 -0.462 . . . . 74.120000000000005 109.754 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.5 mt-30 -123.78 150.88 43.92 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 115.477 -0.783 . . . . 72.420000000000002 110.359 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 427' ' ' ARG . 26.1 tpt180 -150.33 153.95 36.98 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.403 -1.332 . . . . 74.230000000000004 107.403 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.55 138.88 34.13 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.348 -0.982 . . . . 73.200000000000003 108.348 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 71.4 mt -80.43 124.32 82.37 Favored Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.608 -0.886 . . . . 71.319999999999993 108.608 -175.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.86 140.06 59.55 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.069 1.179 . . . . 65.0 110.697 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.72 82.12 2.76 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-O 122.232 1.015 . . . . 65.319999999999993 111.94 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.86 1.43 6.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 106.197 -1.779 . . . . 44.329999999999998 106.197 169.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.741 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 5.0 m -67.8 -53.49 26.61 Favored 'General case' 0 N--CA 1.411 -2.391 0 CA-C-N 113.094 -1.866 . . . . 73.420000000000002 110.301 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 24.5 p -64.73 -19.12 65.6 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 113.431 0.9 . . . . 73.319999999999993 113.431 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.5 pp -90.95 -38.21 13.01 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.711 1.004 . . . . 63.039999999999999 113.711 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 90.4 m -157.32 135.08 10.75 Favored 'General case' 0 CA--C 1.554 1.11 0 O-C-N 121.911 -0.493 . . . . 71.319999999999993 110.714 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -65.09 -47.28 77.81 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.543 0.737 . . . . 75.450000000000003 112.671 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.51 87.47 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.515 0.674 . . . . 63.020000000000003 110.865 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.54 -40.6 95.89 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.75 -1.114 . . . . 63.149999999999999 108.813 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.83 -51.67 68.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.784 -1.098 . . . . 65.430000000000007 111.705 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.72 -38.55 82.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.515 0.931 . . . . 61.25 113.515 -175.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -66.53 -50.71 62.29 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 119.113 -1.035 . . . . 70.409999999999997 110.144 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.313 85.4 mttt -68.62 -39.73 80.68 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 115.58 1.696 . . . . 72.230000000000004 115.58 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.64 -43.38 89.65 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.745 -0.382 . . . . 52.100000000000001 111.795 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.1 m -69.24 -38.28 78.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 120.824 -0.35 . . . . 71.329999999999998 111.853 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -64.17 -30.1 71.18 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.698 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.08 59.67 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.247 -0.433 . . . . 72.439999999999998 111.034 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 124.39 -19.98 7.07 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.688 -0.767 . . . . 64.230000000000004 113.442 176.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -78.86 101.26 7.58 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.364 0.602 . . . . 74.120000000000005 111.0 -175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -119.99 17.47 9.96 Favored Glycine 0 N--CA 1.44 -1.066 0 N-CA-C 111.013 -0.835 . . . . 73.430000000000007 111.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -107.57 111.16 23.28 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 106.791 -1.559 . . . . 74.510000000000005 106.791 177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -130.39 160.25 34.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.145 0.794 . . . . 75.519999999999996 113.145 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 23.6 ttmm -151.91 127.39 10.02 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 105.715 -1.957 . . . . 73.329999999999998 105.715 170.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -96.72 134.92 39.38 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 120.67 0.271 . . . . 70.310000000000002 110.304 -177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -131.02 156.28 45.42 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.717 -0.475 . . . . 65.200000000000003 109.717 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -123.16 132.35 54.03 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.253 -0.647 . . . . 70.109999999999999 109.253 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 36.0 t -119.25 137.12 24.93 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 108.749 -0.834 . . . . 71.230000000000004 108.749 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 490' ' ' SER . 35.4 Cg_exo -61.56 119.78 7.08 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.061 1.841 . . . . 75.510000000000005 109.102 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 13.8 m -138.74 -178.46 5.32 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.066 -0.716 . . . . 71.0 109.066 -174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 1.8 m -58.95 131.44 86.76 Favored Pre-proline 0 N--CA 1.431 -1.419 0 N-CA-C 108.361 -0.977 . . . . 75.150000000000006 108.361 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.9 -34.1 35.8 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.832 3.021 . . . . 73.310000000000002 114.538 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.71 -14.71 61.19 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 122.687 0.395 . . . . 72.319999999999993 112.006 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.39 7.58 45.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.204 -0.453 . . . . 71.049999999999997 110.769 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 14.8 p -59.49 125.93 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 CA-C-O 121.781 0.8 . . . . 70.420000000000002 111.645 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 91.65 -5.01 79.86 Favored Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.882 -0.599 . . . . 70.109999999999999 112.427 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -102.77 145.59 29.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.093 -1.077 . . . . 74.340000000000003 108.093 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 54.4 t -83.89 129.32 37.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 109.721 -0.474 . . . . 75.010000000000005 109.721 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.94 -19.68 5.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 120.582 -0.447 . . . . 64.310000000000002 111.449 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 174.6 174.23 41.16 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.634 -0.986 . . . . 62.539999999999999 110.634 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 12.2 p -130.93 155.07 47.39 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 108.696 -0.853 . . . . 72.140000000000001 108.696 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.0 t-20 -61.2 -53.43 63.22 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 120.795 -0.362 . . . . 65.040000000000006 110.854 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.1 Cg_exo -82.6 119.34 2.97 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 N-CA-C 107.38 -1.815 . . . . 74.530000000000001 107.38 168.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -62.94 147.77 94.22 Favored 'Trans proline' 0 C--O 1.241 0.645 0 C-N-CA 122.532 2.154 . . . . 72.519999999999996 113.848 -174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.65 2.92 20.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.473 -0.785 . . . . 74.329999999999998 112.524 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.7 -3.09 17.02 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.813 -0.554 . . . . 71.319999999999993 109.614 174.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -108.46 151.73 25.66 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.191 0.996 . . . . 73.310000000000002 112.201 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 426' ' ' GLN . 26.6 m -84.24 114.01 21.52 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.625 -1.625 . . . . 70.019999999999996 108.668 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 23.2 m -120.42 150.13 41.28 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 123.506 0.722 . . . . 74.329999999999998 109.424 -175.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.07 147.22 45.2 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.4 -0.592 . . . . 73.099999999999994 109.4 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.9 mp -66.27 -11.68 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 CA-C-O 122.246 1.022 . . . . 71.430000000000007 110.317 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 6.4 t -98.45 -0.66 43.08 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.279 -0.873 . . . . 51.32 109.379 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -78.61 142.19 37.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.63 -0.507 . . . . 64.25 109.63 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.05 113.52 19.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.263 -1.014 . . . . 35.409999999999997 108.263 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 49.0 t -87.81 118.73 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.156 0 N-CA-C 108.606 -0.887 . . . . 72.510000000000005 108.606 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 58.4 mt -92.7 112.54 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 N-CA-C 106.791 -1.559 . . . . 45.310000000000002 106.791 175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -93.61 107.62 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 N-CA-C 107.374 -1.343 . . . . 74.430000000000007 107.374 -177.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 36.9 mt -95.4 113.99 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-N 115.11 -0.95 . . . . 72.239999999999995 110.123 -174.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.2 t -97.32 138.36 22.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 114.959 -1.018 . . . . 65.120000000000005 108.335 -176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.09 130.64 11.06 Favored Glycine 0 N--CA 1.414 -2.815 0 N-CA-C 110.254 -1.139 . . . . 32.439999999999998 110.254 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 26.6 m -140.78 120.07 13.0 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.293 -0.632 . . . . 74.0 109.293 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 107.807 -2.117 . . . . 42.299999999999997 107.807 178.68 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.28 0 N-CA-C 110.221 -1.151 . . . . 43.049999999999997 110.221 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.58 144.5 29.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 112.842 0.682 . . . . 73.340000000000003 112.842 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.3 m -132.04 143.23 49.9 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.605 -1.628 . . . . 72.409999999999997 106.605 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -77.52 86.03 3.87 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 122.038 0.923 . . . . 63.520000000000003 111.408 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -106.22 140.22 39.51 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.515 -1.661 . . . . 54.329999999999998 106.515 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.3 m -127.64 159.73 37.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 120.794 0.33 . . . . 74.109999999999999 111.132 -174.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -94.88 137.35 34.07 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.053 -1.091 . . . . 72.540000000000006 108.053 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.35 141.3 22.82 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.277 -0.638 . . . . 74.409999999999997 109.277 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -44.59 123.83 4.96 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 123.456 2.771 . . . . 71.319999999999993 113.699 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.536 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 21.5 t70 -74.59 134.84 42.08 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.218 -1.355 . . . . 61.030000000000001 108.838 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.485 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 35.0 m -91.41 29.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 113.732 1.012 . . . . 73.140000000000001 113.732 -169.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.536 ' NH1' ' HB3' ' A' ' 364' ' ' ASP . 35.2 ptt-85 -65.73 127.05 30.38 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.159 -0.473 . . . . 72.310000000000002 110.916 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.58 57.37 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.276 -0.964 . . . . 44.350000000000001 114.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 2.0 pt20 -120.97 169.66 10.26 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 117.491 0.646 . . . . 74.120000000000005 110.724 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 98.8 p -80.46 173.96 12.08 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.713 -0.395 . . . . 54.439999999999998 111.475 -174.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 20.4 p -63.0 -33.87 76.35 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 116.275 -0.42 . . . . 54.140000000000001 110.617 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.75 -44.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.547 -0.297 . . . . 54.119999999999997 110.505 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -62.03 -41.65 98.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.382 -0.372 . . . . 64.329999999999998 110.832 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.426 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -58.62 -51.54 69.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 71.109999999999999 110.602 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.43 -42.87 94.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 110.898 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.05 -46.06 92.22 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 112.036 0.384 . . . . 74.420000000000002 112.036 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.7 m -61.92 -47.92 82.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.297 . . . . 52.200000000000003 110.916 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.3 mm? -65.42 -38.38 89.76 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.379 -0.373 . . . . 73.030000000000001 111.66 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -60.88 -48.49 81.56 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.57 0.748 . . . . 70.340000000000003 109.442 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -70.43 -25.31 63.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.602 -0.726 . . . . 74.530000000000001 111.203 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -78.53 -15.29 58.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.97 -0.752 . . . . 75.409999999999997 108.97 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.96 13.17 56.88 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.357 -0.925 . . . . 73.319999999999993 111.829 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 22.6 m-85 -89.7 160.66 16.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.979 0.419 . . . . 75.239999999999995 110.613 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 53.8 mtmt -105.02 132.76 50.85 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 107.678 -1.23 . . . . 73.140000000000001 107.678 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 141.33 43.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-O 121.328 0.585 . . . . 64.420000000000002 112.373 -176.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -118.49 136.64 53.7 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.046 -1.464 . . . . 74.109999999999999 107.046 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.9 m -99.64 125.33 45.46 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.752 -0.833 . . . . 71.310000000000002 108.752 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -111.82 120.33 41.61 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.584 -1.265 . . . . 61.32 107.584 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -89.13 121.88 31.89 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.288 -0.414 . . . . 65.439999999999998 109.911 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -123.77 125.23 25.98 Favored Pre-proline 0 C--N 1.312 -1.028 0 C-N-CA 119.564 -0.854 . . . . 63.539999999999999 110.208 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -89.11 147.11 5.46 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.735 2.29 . . . . 73.510000000000005 111.306 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.4 t70 177.13 -168.37 0.06 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.233 -1.766 . . . . 63.25 106.233 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 50.2 m -143.25 -1.29 1.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 118.585 0.63 . . . . 74.040000000000006 111.429 175.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.0 m -82.93 -10.65 58.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 107.099 -1.445 . . . . 74.340000000000003 107.099 175.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 421' ' ' SER . 11.2 pt -104.74 151.61 39.35 Favored Pre-proline 0 N--CA 1.427 -1.624 0 CA-C-N 114.042 -1.435 . . . . 71.439999999999998 109.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -86.25 -176.51 2.12 Favored 'Trans proline' 0 CA--C 1.563 1.967 0 C-N-CA 122.708 2.272 . . . . 63.409999999999997 111.521 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.65 163.32 3.95 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 123.515 2.81 . . . . 54.149999999999999 112.737 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.442 ' HB2' ' CG2' ' A' ' 420' ' ' VAL . 4.4 p-10 -55.87 -7.93 0.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 125.374 1.47 . . . . 63.25 114.33 -172.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 31.5 m80 -63.51 115.4 4.63 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 106.087 -1.819 . . . . 70.219999999999999 106.087 174.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 365' ' ' VAL . 21.3 t -64.88 118.74 7.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.778 0.799 . . . . 53.030000000000001 110.499 -172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 12.2 tt -84.69 -29.21 6.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 115.041 -0.981 . . . . 74.109999999999999 109.91 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -171.57 160.58 32.6 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.43 -1.068 . . . . 24.329999999999998 110.43 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 -174.54 2.48 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.695 -1.224 . . . . 72.409999999999997 107.695 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.36 144.3 27.85 Favored Pre-proline 0 C--N 1.279 -2.474 0 N-CA-C 108.688 -0.856 . . . . 70.329999999999998 108.688 -172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -42.98 -29.05 1.41 Allowed 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 124.676 3.584 . . . . 61.509999999999998 114.413 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.62 -40.09 68.58 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.543 0.337 . . . . 63.039999999999999 111.162 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.12 -24.66 58.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.545 0.688 . . . . 64.400000000000006 110.96 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.29 0.14 53.45 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.472 0.654 . . . . 75.140000000000001 110.943 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 94.1 m -92.79 157.3 16.49 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.66 -1.608 . . . . 61.329999999999998 106.66 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.26 112.39 10.37 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 108.054 -1.091 . . . . 53.240000000000002 108.054 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.51 169.4 18.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.202 -0.908 . . . . 71.530000000000001 109.334 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 18.0 m -74.33 133.79 42.54 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 109.661 -0.496 . . . . 61.229999999999997 109.661 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -65.69 134.89 54.17 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.309 -0.405 . . . . 71.030000000000001 110.405 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 89.29 24.22 32.11 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.879 -0.677 . . . . 63.43 112.499 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.56 179.76 4.74 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.867 -0.79 . . . . 65.25 108.867 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 43.4 mt-10 -94.21 123.7 37.77 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.162 0.506 . . . . 73.340000000000003 111.996 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 67.8 mt -117.07 126.27 74.36 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.643 -1.244 . . . . 43.420000000000002 107.643 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.0 t -90.49 118.77 30.22 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.477 -0.934 . . . . 71.239999999999995 108.477 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.53 113.18 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 108.189 -1.041 . . . . 70.140000000000001 108.189 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -88.51 129.85 35.36 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.49 -0.929 . . . . 74.349999999999994 108.49 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 397' ' ' ASP . 12.4 p -123.5 146.87 28.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 108.163 -1.051 . . . . 55.350000000000001 108.163 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.512 ' HB3' HD12 ' A' ' 394' ' ' ILE . 3.5 p -84.59 119.71 25.52 Favored 'General case' 0 N--CA 1.411 -2.418 0 C-N-CA 119.372 -0.931 . . . . 71.099999999999994 108.79 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 23.8 m -121.8 106.69 11.52 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.968 -0.56 . . . . 71.209999999999994 110.916 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 84.99 129.35 2.01 Favored Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 120.649 -0.786 . . . . 64.329999999999998 114.183 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 52.3 Cg_endo -76.37 133.04 14.18 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 121.735 1.623 . . . . 53.409999999999997 109.536 174.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -72.31 137.15 46.47 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.475 0.655 . . . . 51.119999999999997 112.35 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 38.4 mt-30 -120.37 140.85 50.7 Favored 'General case' 0 N--CA 1.41 -2.461 0 CA-C-N 114.872 -1.058 . . . . 75.230000000000004 108.48 176.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -132.41 145.41 51.2 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 107.59 -1.263 . . . . 72.430000000000007 107.59 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 14.8 pt-20 -83.7 138.99 33.04 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 119.905 -0.718 . . . . 73.5 109.082 177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 80.8 mt -80.3 124.29 82.62 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 108.017 -1.105 . . . . 55.009999999999998 108.017 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.89 141.94 41.8 Favored 'Trans proline' 0 C--O 1.252 1.193 0 C-N-CA 122.164 1.909 . . . . 62.439999999999998 112.677 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -78.22 77.08 4.73 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 122.217 1.008 . . . . 63.530000000000001 109.414 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 13.1 p -146.25 -7.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 114.131 -1.395 . . . . 73.409999999999997 110.281 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 3.3 p -68.94 -31.93 71.16 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.854 -0.612 . . . . 71.140000000000001 111.116 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.463 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 1.2 p -62.26 -24.59 67.35 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 125.285 1.434 . . . . 74.400000000000006 113.18 -177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 86.1 mt -62.64 -47.75 82.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 75.129999999999995 112.037 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 9.0 t -177.21 153.04 0.92 Allowed 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.827 -0.805 . . . . 74.230000000000004 108.827 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -58.37 -38.66 77.73 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.823 0.849 . . . . 72.310000000000002 111.276 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -56.46 -47.99 78.02 Favored 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.554 0.534 . . . . 63.439999999999998 111.115 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 34.6 mm-40 -70.33 -38.31 74.86 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 111.178 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.27 -46.35 88.76 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.613 0.571 . . . . 54.140000000000001 110.763 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 52.9 t -67.46 -47.6 80.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 C-N-CA 120.633 -0.427 . . . . 71.230000000000004 110.699 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 31.9 mmmt -63.46 -47.1 83.22 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.163 0.431 . . . . 73.120000000000005 112.163 -175.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.9 mmtt -63.6 -45.51 90.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 71.140000000000001 110.578 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.14 -32.48 72.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.61 0.596 . . . . 64.0 112.61 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 55.7 m -66.25 -38.74 88.56 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.558 -0.534 . . . . 75.0 109.558 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.64 67.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.953 -0.567 . . . . 72.519999999999996 110.628 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.29 -13.55 59.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 63.509999999999998 110.63 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.27 -12.25 16.62 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 120.227 -0.987 . . . . 50.119999999999997 113.743 176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.44 132.97 47.18 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 117.705 0.753 . . . . 63.350000000000001 110.917 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -132.98 16.04 4.76 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.592 -0.813 . . . . 71.430000000000007 112.395 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 32.3 mmt180 -125.43 111.96 15.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.513 -1.292 . . . . 72.420000000000002 107.513 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -129.91 152.21 49.63 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.085 0.469 . . . . 75.140000000000001 111.118 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -146.05 123.26 11.53 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 106.989 -1.486 . . . . 71.219999999999999 106.989 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -91.27 134.81 34.27 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.241 -0.584 . . . . 50.020000000000003 110.31 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -129.78 145.67 51.55 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.217 -1.031 . . . . 64.340000000000003 108.217 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -118.7 139.08 52.11 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.088 -0.708 . . . . 53.200000000000003 109.088 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 61.7 m -132.39 136.21 27.62 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.717 -0.475 . . . . 72.120000000000005 109.717 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.61 120.99 8.75 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.875 2.383 . . . . 72.439999999999998 112.184 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 43.9 m -124.85 172.51 9.29 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.71 -0.677 . . . . 74.329999999999998 110.098 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 41.8 p -67.29 151.09 97.5 Favored Pre-proline 0 N--CA 1.434 -1.25 0 O-C-N 123.794 0.684 . . . . 53.439999999999998 109.972 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.544 ' O ' HG12 ' A' ' 464' ' ' VAL . 71.8 Cg_exo -53.51 -27.18 39.53 Favored 'Trans proline' 0 CA--C 1.55 1.281 0 C-N-CA 122.839 2.36 . . . . 74.230000000000004 113.422 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -76.18 -23.89 54.73 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.73 -0.606 . . . . 74.530000000000001 112.226 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 37.4 tp -107.41 -9.39 16.01 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.069 0.461 . . . . 62.520000000000003 110.505 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 461' ' ' PRO . 7.3 p -59.44 133.57 24.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 115.793 -0.639 . . . . 73.140000000000001 110.293 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.52 -14.09 59.41 Favored Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.613 -0.803 . . . . 64.030000000000001 112.168 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.75 158.04 16.26 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.382 0.61 . . . . 54.520000000000003 110.563 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 87.7 t -84.28 137.5 20.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.71 -1.589 . . . . 71.510000000000005 106.71 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.5 pp -95.74 -13.79 8.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.342 -0.943 . . . . 74.319999999999993 110.563 -176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.88 -173.6 29.57 Favored Glycine 0 N--CA 1.411 -2.997 0 N-CA-C 109.952 -1.259 . . . . 63.299999999999997 109.952 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.2 p -116.3 151.37 35.99 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 107.39 -1.337 . . . . 63.420000000000002 107.39 176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -59.37 -51.46 81.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 109.732 -0.47 . . . . 75.310000000000002 109.732 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.01 133.94 22.47 Favored 'Trans proline' 0 C--N 1.378 2.086 0 N-CA-C 108.59 -1.35 . . . . 74.230000000000004 108.59 168.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -65.48 150.54 86.7 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.752 2.301 . . . . 72.239999999999995 114.534 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -92.31 8.49 38.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.311 1.053 . . . . 41.240000000000002 110.948 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -109.04 3.4 22.04 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.307 -0.871 . . . . 53.549999999999997 109.975 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -141.77 159.54 42.01 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-O 121.807 0.813 . . . . 73.099999999999994 111.591 -172.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 0.2 OUTLIER -76.68 133.97 39.38 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.608 -1.633 . . . . 65.239999999999995 111.411 -175.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 38.4 m -131.52 149.31 52.57 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.653 -1.24 . . . . 72.25 107.653 177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -78.61 153.33 31.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 118.927 0.785 . . . . 73.140000000000001 111.683 -175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 47.4 mm -69.28 -8.23 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 CA-C-O 122.163 0.982 . . . . 71.340000000000003 110.624 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 8.9 t -105.44 1.25 27.55 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.712 -0.676 . . . . 53.329999999999998 109.692 179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 451' ' ' ARG . 9.1 m120 -87.05 147.49 25.67 Favored 'General case' 0 CA--C 1.495 -1.159 0 N-CA-C 108.816 -0.809 . . . . 74.140000000000001 108.816 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -84.54 121.39 36.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.244 -1.021 . . . . 61.310000000000002 108.244 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.4 t -91.89 118.97 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.903 -0.777 . . . . 63.43 108.903 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.99 113.16 27.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 107.183 -1.414 . . . . 70.109999999999999 107.183 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.52 119.92 48.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.949 -1.13 . . . . 71.109999999999999 107.949 -177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 48.2 mt -103.23 114.96 44.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.434 0.635 . . . . 63.350000000000001 110.86 -173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.2 t -98.32 131.23 45.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.909 -0.775 . . . . 72.540000000000006 108.909 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -80.0 100.4 1.87 Allowed Glycine 0 N--CA 1.424 -2.136 0 N-CA-C 110.279 -1.129 . . . . 73.310000000000002 110.279 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 464' ' ' VAL . 30.7 t -136.71 103.98 5.38 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 108.765 -0.828 . . . . 74.310000000000002 108.765 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.533 0 N-CA-C 108.471 -1.851 . . . . 72.040000000000006 108.471 176.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.301 0 N-CA-C 110.412 -1.075 . . . . 43.049999999999997 110.412 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.31 152.87 37.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 116.981 0.39 . . . . 63.039999999999999 111.214 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 22.8 m -92.1 147.13 23.18 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.554 -1.276 . . . . 72.430000000000007 107.554 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.11 74.52 4.69 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 108.475 -0.935 . . . . 74.420000000000002 108.475 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -86.74 137.86 32.09 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-N 113.914 -1.493 . . . . 71.420000000000002 110.637 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.07 139.91 30.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.17 -0.923 . . . . 75.150000000000006 108.955 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.56 137.16 36.91 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.468 -1.679 . . . . 73.430000000000007 106.468 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 363' ' ' PRO . 14.8 p -96.99 124.26 50.42 Favored Pre-proline 0 C--N 1.294 -1.838 0 C-N-CA 119.757 -0.777 . . . . 63.219999999999999 111.446 -170.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 362' ' ' VAL . 1.5 Cg_endo -44.87 146.31 2.46 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.814 3.676 . . . . 74.299999999999997 115.681 -175.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -71.16 144.96 50.02 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 114.929 -1.032 . . . . 62.130000000000003 110.138 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -108.08 29.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.218 -1.401 . . . . 63.340000000000003 107.218 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -58.85 135.41 57.51 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.176 -1.375 . . . . 73.109999999999999 111.398 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 94.84 -15.35 63.57 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.97 -0.559 . . . . 65.230000000000004 112.627 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -107.19 175.26 5.56 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.588 -0.36 . . . . 73.319999999999993 110.724 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.6 p -75.57 158.12 32.93 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.825 0.345 . . . . 71.450000000000003 111.771 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.416 ' O ' HG13 ' A' ' 374' ' ' ILE . 44.6 t -63.25 -36.12 82.59 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.812 -0.81 . . . . 63.32 108.812 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.66 94.01 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 115.638 -0.71 . . . . 65.430000000000007 111.209 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.35 -41.38 98.55 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.127 -0.488 . . . . 73.510000000000005 109.89 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.43 83.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.461 -0.791 . . . . 63.399999999999999 110.934 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.36 -47.02 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.374 -0.375 . . . . 54.219999999999999 110.301 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.95 79.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.969 -0.56 . . . . 43.229999999999997 111.855 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.7 m -62.72 -46.33 88.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.427 -0.352 . . . . 64.310000000000002 111.912 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -38.43 91.0 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.173 -0.211 . . . . 55.329999999999998 111.184 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.43 -47.2 86.38 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.922 0.889 . . . . 71.510000000000005 109.138 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -70.41 -20.16 62.94 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.129 -0.941 . . . . 73.310000000000002 111.706 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -86.79 -15.44 39.28 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.268 -0.641 . . . . 64.329999999999998 109.268 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 98.49 5.0 57.06 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.487 -0.863 . . . . 74.239999999999995 111.446 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -90.47 158.59 16.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.158 0.504 . . . . 74.319999999999993 110.479 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 22.6 mmtp -106.05 138.55 42.04 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.757 -1.571 . . . . 62.219999999999999 106.757 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.87 147.45 21.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 119.676 -0.81 . . . . 71.540000000000006 112.964 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 417' ' ' THR . 21.6 ttt180 -116.95 130.09 56.47 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.842 -1.54 . . . . 75.400000000000006 106.842 174.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 27.7 p -98.6 117.73 33.7 Favored 'General case' 0 N--CA 1.411 -2.399 0 C-N-CA 119.978 -0.689 . . . . 74.030000000000001 109.415 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 2.9 tm? -114.74 119.78 37.84 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.341 -1.355 . . . . 74.030000000000001 107.341 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -112.81 126.14 55.11 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.722 -0.844 . . . . 74.420000000000002 108.722 176.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -122.42 133.65 24.5 Favored Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 120.257 -0.577 . . . . 73.109999999999999 111.033 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.19 140.32 2.67 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.091 2.527 . . . . 65.409999999999997 110.708 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.4 t70 179.75 -166.48 0.07 Allowed 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.575 -1.269 . . . . 73.299999999999997 107.575 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 70.9 m -119.66 -11.15 9.46 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-O 121.422 0.63 . . . . 71.519999999999996 109.592 176.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 5.3 m -95.25 27.03 3.45 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.425 1.107 . . . . 73.450000000000003 108.234 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 2.4 pp -97.4 141.03 22.4 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 115.254 -0.884 . . . . 61.329999999999998 113.375 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -83.91 -179.99 4.4 Favored 'Trans proline' 0 CA--C 1.554 1.49 0 C-N-CA 123.239 2.626 . . . . 74.340000000000003 110.794 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -57.65 163.08 9.44 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.522 2.815 . . . . 72.019999999999996 112.563 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -57.14 -8.79 0.75 Allowed 'General case' 0 N--CA 1.522 3.149 0 C-N-CA 124.441 1.096 . . . . 71.530000000000001 112.25 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -83.75 157.12 22.23 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.657 -0.868 . . . . 74.150000000000006 108.657 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.26 116.86 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 N-CA-C 105.414 -2.069 . . . . 64.430000000000007 105.414 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 18.8 tt -89.99 -29.22 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 122.342 1.068 . . . . 72.430000000000007 109.036 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -162.57 170.59 38.18 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 104.623 -3.391 . . . . 54.210000000000001 104.623 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.57 -176.26 2.87 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 107.249 -1.389 . . . . 74.519999999999996 107.249 -177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -99.78 145.7 30.59 Favored Pre-proline 0 C--N 1.253 -3.623 0 N-CA-C 107.93 -1.137 . . . . 74.420000000000002 107.93 -170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -37.04 -36.03 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 124.879 3.719 . . . . 41.049999999999997 114.047 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.63 -37.07 65.21 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.127 0.571 . . . . 64.030000000000001 111.701 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -82.64 -28.98 30.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.435 0.636 . . . . 71.239999999999995 110.496 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -83.73 -8.02 59.35 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.203 -0.908 . . . . 73.140000000000001 110.754 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 59.1 m -91.58 140.59 29.59 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 107.571 -1.27 . . . . 64.150000000000006 107.571 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 36.4 m -76.73 112.49 13.36 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 108.359 -0.978 . . . . 71.329999999999998 108.359 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 35.0 m -116.25 169.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.138 -0.937 . . . . 74.019999999999996 109.828 -175.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 41.1 m -65.65 152.96 42.97 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.458 -0.942 . . . . 73.109999999999999 108.458 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -60.02 109.16 0.89 Allowed 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.141 0.496 . . . . 75.129999999999995 111.293 -177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 88.99 85.16 1.27 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-N 115.596 -0.729 . . . . 73.530000000000001 111.78 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -134.96 -169.53 2.38 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.352 -1.721 . . . . 73.430000000000007 106.352 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 12.4 pt-20 -95.04 132.9 39.41 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 118.989 0.813 . . . . 74.329999999999998 111.617 -177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.4 mm -117.97 119.4 61.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 107.576 -1.268 . . . . 72.439999999999998 107.576 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 385' ' ' ARG . 40.2 p -87.31 119.19 27.31 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.333 0.587 . . . . 73.230000000000004 109.849 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.99 121.07 55.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.161 -1.422 . . . . 75.340000000000003 107.161 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 7.9 p30 -107.95 125.78 51.91 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.446 0.641 . . . . 62.43 111.891 -176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 11.3 p -120.28 151.47 23.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.908 -1.042 . . . . 63.420000000000002 108.41 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 7.2 p -91.55 123.49 35.0 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 111.862 0.319 . . . . 64.310000000000002 111.862 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 10.9 t -119.04 106.13 12.11 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 119.806 -0.758 . . . . 75.530000000000001 111.667 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 66.29 161.23 0.98 Allowed Glycine 0 CA--C 1.552 2.401 0 N-CA-C 115.912 1.125 . . . . 71.420000000000002 115.912 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.2 Cg_endo -94.36 139.71 1.24 Allowed 'Trans proline' 0 N--CA 1.441 -1.6 0 C-N-CA 122.708 2.272 . . . . 63.399999999999999 112.311 176.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 8.0 mm-40 -78.61 142.26 37.4 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.094 0.473 . . . . 73.129999999999995 111.735 176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.6 mt-30 -122.54 147.14 46.73 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.243 -0.89 . . . . 72.010000000000005 108.636 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 0.7 OUTLIER -135.44 163.73 29.39 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.523 -0.917 . . . . 73.439999999999998 108.523 178.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -92.63 135.7 33.86 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.856 -0.338 . . . . 74.230000000000004 110.592 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.1 mp -80.83 119.29 75.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 109.068 -0.716 . . . . 61.450000000000003 109.068 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 444' ' ' LEU . 70.6 Cg_exo -56.05 141.17 87.12 Favored 'Trans proline' 0 C--O 1.241 0.644 0 C-N-CA 122.94 2.427 . . . . 72.049999999999997 112.16 176.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -88.01 10.77 17.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.599 -0.728 . . . . 62.130000000000003 111.526 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 27.0 m -88.21 -5.25 10.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.275 0.559 . . . . 63.210000000000001 110.279 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -58.86 -40.71 85.12 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.01 -0.996 . . . . 75.409999999999997 110.932 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.493 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 0.6 OUTLIER -68.58 -16.95 64.03 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 123.812 0.845 . . . . 72.420000000000002 112.381 -179.003 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.26 -34.91 14.77 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.801 -0.636 . . . . 73.340000000000003 111.75 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 83.9 m -153.85 133.2 12.73 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.953 -0.467 . . . . 70.549999999999997 110.645 -176.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -63.99 -41.63 97.44 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.074 0.55 . . . . 64.200000000000003 110.365 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.27 93.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 65.129999999999995 110.626 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -63.66 -40.83 97.82 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 116.094 -0.503 . . . . 73.329999999999998 110.948 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.67 -51.15 70.61 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 123.56 0.538 . . . . 72.329999999999998 110.217 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.33 -50.36 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 120.481 -0.488 . . . . 32.240000000000002 112.033 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -67.94 -47.97 67.21 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.625 0.602 . . . . 73.140000000000001 112.625 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -67.14 -38.49 85.61 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.011 0.374 . . . . 71.140000000000001 112.011 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.2 mp -67.89 -36.15 79.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.599 -0.44 . . . . 51.409999999999997 111.271 176.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 88.0 m -64.91 -39.2 93.16 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 109.309 -0.626 . . . . 73.540000000000006 109.309 176.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.16 -30.57 71.07 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.97 -0.559 . . . . 72.299999999999997 110.788 177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.47 -13.18 59.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 61.32 110.666 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 121.48 -20.63 8.29 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 120.425 -0.893 . . . . 42.200000000000003 113.561 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 445' ' ' THR . 98.1 m-85 -66.86 135.32 53.7 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 117.485 0.642 . . . . 63.310000000000002 111.369 -175.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -134.55 12.22 4.59 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 110.926 -0.87 . . . . 64.120000000000005 110.926 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -114.48 111.45 21.43 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 107.453 -1.314 . . . . 74.430000000000007 107.453 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -136.7 152.12 50.01 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.659 0.266 . . . . 74.209999999999994 110.72 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -143.45 124.22 14.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.151 -1.055 . . . . 64.019999999999996 108.151 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -83.93 127.11 33.63 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 110.188 -0.301 . . . . 72.129999999999995 110.188 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -133.61 158.12 44.02 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.612 -0.884 . . . . 62.439999999999998 108.612 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -125.14 150.31 47.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.794 0.331 . . . . 70.420000000000002 110.593 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 30.6 t -137.48 133.19 17.97 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 107.88 -1.156 . . . . 65.25 107.88 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.04 127.6 21.75 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.514 2.143 . . . . 71.120000000000005 109.599 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 70.6 m -148.26 174.74 11.7 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 122.118 -0.364 . . . . 71.129999999999995 111.277 -175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.418 ' HB ' HD13 ' A' ' 463' ' ' LEU . 3.3 m -56.31 132.36 75.89 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.703 0.801 . . . . 62.0 110.102 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.523 ' O ' HG12 ' A' ' 464' ' ' VAL . 85.0 Cg_exo -48.79 -31.73 20.33 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.056 3.171 . . . . 52.210000000000001 114.861 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -65.97 -18.55 65.41 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.24 0.543 . . . . 74.400000000000006 111.264 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 466' ' ' LYS . 6.6 mp -106.93 6.04 28.85 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.074 -0.512 . . . . 75.319999999999993 111.508 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.6 p -60.41 126.98 19.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-O 121.258 0.552 . . . . 64.530000000000001 110.989 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.81 0.36 83.79 Favored Glycine 0 C--N 1.309 -0.94 0 CA-C-N 115.83 -0.623 . . . . 62.140000000000001 111.934 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.487 ' HD2' ' HA ' ' A' ' 463' ' ' LEU . 89.0 mttt -112.52 159.14 19.1 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.921 -1.14 . . . . 73.209999999999994 107.921 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 57.3 t -83.99 132.71 30.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 109.564 -0.532 . . . . 74.329999999999998 109.564 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -98.59 -16.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.222 -0.591 . . . . 70.319999999999993 111.402 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 169.81 174.08 37.79 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 115.653 -0.703 . . . . 35.420000000000002 111.704 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.7 p -124.06 149.69 45.83 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.444 -0.947 . . . . 54.119999999999997 108.444 177.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.467 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 26.6 t-20 -62.48 -51.96 69.15 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 120.561 -0.456 . . . . 74.019999999999996 110.921 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 11.2 Cg_exo -73.62 133.84 19.42 Favored 'Trans proline' 0 C--N 1.377 2.059 0 N-CA-C 108.304 -1.46 . . . . 73.319999999999993 108.304 171.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 475' ' ' ASN . 40.4 Cg_endo -65.35 130.73 26.1 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.377 2.052 . . . . 75.329999999999998 113.216 -175.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -82.58 17.56 1.76 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.531 1.157 . . . . 44.310000000000002 109.714 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 473' ' ' PRO . 11.4 m120 -108.6 -10.11 15.25 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.383 -1.281 . . . . 73.439999999999998 108.462 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -140.82 164.83 29.18 Favored 'General case' 0 N--CA 1.408 -2.567 0 CA-C-O 121.734 0.778 . . . . 63.340000000000003 111.368 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 1.7 m -84.45 124.89 31.84 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.182 -1.372 . . . . 64.420000000000002 109.431 -177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 20.2 m -125.62 149.46 48.38 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.373 -0.603 . . . . 75.310000000000002 109.373 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.66 146.74 54.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.537 0.208 . . . . 63.130000000000003 111.156 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.58 -22.09 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 121.755 0.788 . . . . 73.140000000000001 110.9 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 11.1 t -87.71 0.89 55.1 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.509 -0.768 . . . . 74.409999999999997 110.294 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.01 131.11 34.51 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.389 -0.967 . . . . 64.540000000000006 108.389 177.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 59.4 t -79.46 119.06 28.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.66 -0.867 . . . . 75.209999999999994 108.66 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.2 t -87.15 118.22 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.49 0 N-CA-C 108.115 -1.069 . . . . 72.030000000000001 108.115 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.83 112.75 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 106.341 -1.725 . . . . 75.420000000000002 106.341 177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 9.6 tt -92.89 119.88 41.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 108.54 -0.911 . . . . 74.25 108.54 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 23.2 mt -101.18 109.3 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 108.94 -0.763 . . . . 73.430000000000007 108.94 -175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 467' ' ' VAL . 36.3 t -97.92 137.77 24.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.462 -0.79 . . . . 73.450000000000003 109.958 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -74.84 95.76 0.92 Allowed Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.488 -0.778 . . . . 61.009999999999998 111.212 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 38.1 m -142.88 112.84 7.04 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.775 -0.824 . . . . 74.530000000000001 108.775 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.012 0 N-CA-C 110.75 -0.94 . . . . 51.219999999999999 110.75 179.254 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.529 0 N-CA-C 110.138 -1.185 . . . . 43.049999999999997 110.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.13 141.63 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 108.371 -0.974 . . . . 73.150000000000006 108.371 175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 12.4 m -101.56 138.94 37.9 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-O 120.983 0.42 . . . . 75.530000000000001 110.095 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -98.8 81.78 2.7 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.794 -1.558 . . . . 73.450000000000003 106.794 172.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.95 134.12 35.08 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 113.221 -1.809 . . . . 75.530000000000001 111.963 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 26.6 m -135.02 144.01 35.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.844 -1.071 . . . . 73.430000000000007 108.9 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -96.42 137.43 35.5 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.402 -1.703 . . . . 65.219999999999999 106.402 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.7 p -98.14 127.31 37.09 Favored Pre-proline 0 C--N 1.29 -1.989 0 C-N-CA 119.097 -1.041 . . . . 51.200000000000003 110.004 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.68 143.53 79.36 Favored 'Trans proline' 0 C--O 1.244 0.789 0 C-N-CA 123.031 2.487 . . . . 73.0 112.7 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -68.95 127.01 31.62 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 115.599 -0.728 . . . . 73.400000000000006 110.0 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 26.7 m -81.83 5.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.911 -0.586 . . . . 63.109999999999999 112.11 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -61.1 142.97 56.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.912 -0.585 . . . . 70.430000000000007 111.761 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.31 -9.78 53.92 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.884 -0.598 . . . . 54.32 111.868 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -119.38 -173.69 2.57 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.354 -0.61 . . . . 65.140000000000001 109.354 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 94.7 p -86.98 162.16 17.81 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 119.637 -0.825 . . . . 73.230000000000004 109.317 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.452 ' O ' HG13 ' A' ' 374' ' ' ILE . 74.1 p -61.93 -33.23 73.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.986 0.422 . . . . 63.140000000000001 110.065 177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.67 97.45 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.878 -0.601 . . . . 73.310000000000002 110.862 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -62.31 -42.7 99.58 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 109.817 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.42 77.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.89 -1.05 . . . . 64.129999999999995 110.734 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 370' ' ' SER . 90.3 mt -58.6 -47.26 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 75.329999999999998 110.477 -178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.71 -46.44 78.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.271 -0.422 . . . . 73.319999999999993 111.937 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.7 m -61.55 -48.59 80.31 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.137 0.494 . . . . 70.129999999999995 110.635 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 74.6 mt -65.74 -38.19 88.46 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 62.43 111.739 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -61.05 -43.53 98.74 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 109.565 -0.531 . . . . 75.219999999999999 109.565 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -34.67 77.75 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.031 0.443 . . . . 62.109999999999999 111.017 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -78.27 -15.12 59.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.126 -0.488 . . . . 70.219999999999999 111.233 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 94.99 16.47 41.27 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 119.595 -1.288 . . . . 52.32 112.269 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -94.12 152.2 18.93 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 109.237 -0.653 . . . . 74.120000000000005 109.237 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 35.0 mmtp -94.31 141.2 28.84 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.529 -0.915 . . . . 73.120000000000005 108.529 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.1 133.96 67.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.331 0.586 . . . . 51.200000000000003 111.607 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -110.51 130.85 55.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.79 -1.189 . . . . 64.120000000000005 107.79 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 p -98.9 119.29 37.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 C-N-CA 120.429 -0.509 . . . . 73.239999999999995 109.884 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.6 tt -111.43 119.13 37.77 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.459 -1.682 . . . . 63.140000000000001 106.459 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.586 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -106.36 122.57 46.52 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.325 0.583 . . . . 75.519999999999996 110.324 -177.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.03 131.31 24.44 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 115.326 -0.852 . . . . 63.409999999999997 111.119 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -91.12 130.73 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.916 2.411 . . . . 73.150000000000006 111.34 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 174.95 -170.36 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.733 -1.58 . . . . 74.310000000000002 106.733 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 16.1 m -113.36 -27.94 7.76 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.439 -1.319 . . . . 75.530000000000001 107.439 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 7.5 m -91.72 58.82 3.57 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.982 -1.488 . . . . 74.549999999999997 106.982 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 391' ' ' ASP . 1.5 pp -115.9 151.58 46.58 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 114.009 -1.45 . . . . 44.439999999999998 113.005 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 394' ' ' ILE . 7.3 Cg_exo -74.9 119.53 5.71 Favored 'Trans proline' 0 N--CA 1.441 -1.599 0 C-N-CA 122.217 1.945 . . . . 64.329999999999998 108.267 169.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.55 161.88 16.49 Favored 'Trans proline' 0 C--O 1.219 -0.451 0 C-N-CA 123.386 2.724 . . . . 71.409999999999997 113.165 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -57.64 -8.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.947 0.899 . . . . 74.530000000000001 112.119 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 45.1 m170 -106.18 109.49 21.44 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 104.202 -2.518 . . . . 55.030000000000001 104.202 169.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.76 118.0 10.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-O 122.045 0.926 . . . . 61.399999999999999 111.986 -170.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.7 pp -96.29 -27.99 3.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 114.776 -1.102 . . . . 72.129999999999995 112.105 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.445 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -146.65 156.96 27.24 Favored Glycine 0 N--CA 1.419 -2.44 0 N-CA-C 110.257 -1.137 . . . . 73.120000000000005 110.257 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 2.4 p -125.37 -178.58 4.27 Favored 'General case' 0 C--N 1.275 -2.645 0 C-N-CA 122.989 0.516 . . . . 73.109999999999999 109.799 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.95 133.57 20.96 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 107.509 -1.293 . . . . 63.229999999999997 107.509 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.15 -17.94 9.19 Favored 'Trans proline' 0 C--O 1.26 1.585 0 C-N-CA 123.875 3.05 . . . . 65.510000000000005 115.194 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.69 -19.84 64.27 Favored 'General case' 0 C--O 1.214 -0.769 0 O-C-N 122.115 -0.365 . . . . 71.310000000000002 110.744 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.83 -47.71 65.36 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 121.038 0.447 . . . . 53.399999999999999 110.836 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.06 -13.39 60.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.082 0.468 . . . . 75.239999999999995 110.957 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 61.2 m -73.33 138.06 45.17 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.599 -0.889 . . . . 73.109999999999999 108.599 175.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -74.94 113.3 12.09 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.417 0.627 . . . . 64.109999999999999 110.066 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.36 170.08 8.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.169 -0.923 . . . . 65.140000000000001 109.56 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 27.6 m -70.12 132.35 45.68 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.021 -0.733 . . . . 34.140000000000001 109.021 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -51.91 113.99 1.17 Allowed 'General case' 0 C--O 1.24 0.584 0 O-C-N 123.862 0.726 . . . . 61.210000000000001 112.301 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 94.04 57.87 1.28 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.816 -0.629 . . . . 63.039999999999999 112.675 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -114.31 -166.79 1.13 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.868 -1.531 . . . . 73.120000000000005 106.868 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.8 pt-20 -113.08 134.59 54.46 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 119.327 0.967 . . . . 75.209999999999994 112.596 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.95 135.9 54.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.29 -1.004 . . . . 73.329999999999998 108.29 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.8 t -94.73 125.96 39.72 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.401 0.62 . . . . 60.210000000000001 109.615 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.36 116.33 47.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.82 -1.178 . . . . 73.349999999999994 107.82 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.86 128.0 35.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.097 -0.705 . . . . 71.5 109.097 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.48 145.01 36.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.295 -0.411 . . . . 71.010000000000005 110.054 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 24.1 p -84.9 123.72 30.81 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.066 0.547 . . . . 63.450000000000003 112.117 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 8.8 t -118.38 106.58 12.88 Favored 'General case' 0 N--CA 1.422 -1.837 0 C-N-CA 120.022 -0.671 . . . . 54.409999999999997 109.352 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 72.0 109.5 0.05 OUTLIER Glycine 0 C--O 1.262 1.893 0 N-CA-C 115.028 0.771 . . . . 33.420000000000002 115.028 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.655 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 30.1 Cg_exo -64.75 127.69 19.31 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.3 1.333 . . . . 62.43 109.53 172.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 6.9 mm-40 -73.38 131.55 42.0 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 113.255 0.835 . . . . 74.340000000000003 113.255 -178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 47.5 mt-30 -123.22 133.72 54.19 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 106.891 -1.522 . . . . 72.319999999999993 106.891 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.676 -0.861 . . . . 55.5 108.676 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -83.43 138.21 33.57 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.782 -0.645 . . . . 72.329999999999998 109.311 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 70.3 mt -89.9 125.11 61.84 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.886 -0.413 . . . . 61.340000000000003 109.886 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HB2' HG12 ' A' ' 432' ' ' VAL . 48.7 Cg_endo -69.7 141.79 46.41 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.355 2.037 . . . . 72.120000000000005 112.745 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.22 6.87 30.92 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.104 -0.498 . . . . 73.150000000000006 111.676 -176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.411 HG12 ' HB2' ' A' ' 430' ' ' PRO . 10.3 p -76.89 -14.3 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.679 0.752 . . . . 62.140000000000001 109.673 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.9 m -53.21 -37.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.785 1.234 . . . . 61.119999999999997 112.754 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.553 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 4.3 p -69.54 -14.16 62.71 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 113.84 1.052 . . . . 73.409999999999997 113.84 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 88.3 mt -86.75 -38.26 17.09 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 122.136 -0.352 . . . . 71.010000000000005 111.877 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 73.8 m -153.83 131.72 11.65 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.769 -0.456 . . . . 60.299999999999997 109.769 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -62.09 -43.52 98.65 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.094 0.557 . . . . 72.230000000000004 112.048 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.2 83.96 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.212 0.53 . . . . 50.329999999999998 110.374 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.26 -44.38 95.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.888 -1.051 . . . . 73.400000000000006 109.51 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.18 66.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.557 -0.747 . . . . 74.239999999999995 111.524 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.24 -38.86 81.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.668 0.618 . . . . 62.43 112.668 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -67.54 -46.71 72.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 120.508 -0.477 . . . . 70.219999999999999 111.071 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -64.83 -40.72 95.64 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 112.364 0.505 . . . . 61.200000000000003 112.364 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 10.5 mp -65.85 -41.4 91.74 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.583 -0.447 . . . . 72.420000000000002 111.498 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 87.7 m -62.09 -43.36 98.99 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.801 -0.444 . . . . 54.299999999999997 109.801 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.15 -16.87 62.56 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.095 -0.502 . . . . 70.409999999999997 111.757 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -89.73 -7.19 55.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.106 0.479 . . . . 45.119999999999997 110.363 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 480' ' ' ILE . . . 110.9 -8.73 29.6 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.1 -0.571 . . . . 55.420000000000002 112.851 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -85.01 92.7 8.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.262 0.553 . . . . 73.530000000000001 110.151 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -100.16 -2.03 55.85 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 110.462 -1.055 . . . . 42.340000000000003 110.462 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -94.97 110.78 22.64 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.48 -0.933 . . . . 75.329999999999998 108.48 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -123.46 157.69 32.92 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.623 0.725 . . . . 74.140000000000001 111.477 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.514 ' HB3' HG13 ' A' ' 485' ' ' ILE . 59.1 tptt -149.54 131.41 15.14 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 103.934 -2.617 . . . . 72.219999999999999 103.934 173.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -111.0 135.07 52.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 119.961 -0.695 . . . . 73.310000000000002 111.394 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -137.36 135.69 37.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.802 -0.814 . . . . 75.540000000000006 108.802 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.9 129.21 56.66 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.399 -1.334 . . . . 75.340000000000003 107.399 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 45.3 p -121.11 150.32 53.31 Favored Pre-proline 0 C--N 1.284 -2.267 0 C-N-CA 120.597 -0.441 . . . . 64.239999999999995 110.503 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 490' ' ' SER . 37.9 Cg_exo -61.58 120.61 8.34 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.207 1.938 . . . . 54.520000000000003 110.431 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 22.9 t -127.38 -178.53 4.49 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 106.472 -1.677 . . . . 72.319999999999993 106.472 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 7.2 m -74.05 142.54 79.44 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 107.844 -1.169 . . . . 74.200000000000003 107.844 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.449 ' O ' HG12 ' A' ' 464' ' ' VAL . 99.1 Cg_exo -49.67 -23.29 7.89 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 123.593 2.862 . . . . 61.130000000000003 113.931 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -75.92 -11.82 60.04 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-O 121.227 0.536 . . . . 65.109999999999999 112.118 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.4 3.12 15.7 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.923 -0.486 . . . . 74.209999999999994 111.641 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 461' ' ' PRO . 14.9 p -59.92 127.45 19.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.326 0.584 . . . . 71.340000000000003 111.662 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.88 -15.6 63.04 Favored Glycine 0 CA--C 1.496 -1.133 0 C-N-CA 120.769 -0.729 . . . . 52.109999999999999 112.176 177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -100.66 149.59 23.62 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 109.112 -0.699 . . . . 74.349999999999994 109.112 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 91.5 t -76.93 130.12 36.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.708 -1.219 . . . . 62.109999999999999 107.708 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.04 -22.6 4.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.939 -0.704 . . . . 72.450000000000003 111.949 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 173.49 -177.58 45.79 Favored Glycine 0 N--CA 1.423 -2.177 0 C-N-CA 120.778 -0.725 . . . . 51.240000000000002 111.373 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 486' ' ' ILE . 6.7 p -136.01 154.88 50.93 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 108.449 -0.945 . . . . 72.420000000000002 108.449 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.531 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 22.5 t-20 -56.97 -51.85 78.54 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-O 119.151 -0.452 . . . . 75.120000000000005 111.435 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 1.6 Cg_endo -86.34 119.01 1.68 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 N-CA-C 107.15 -1.904 . . . . 74.120000000000005 107.15 167.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.47 162.21 34.85 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.197 1.932 . . . . 61.350000000000001 113.704 -174.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -76.06 7.39 4.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 122.135 0.969 . . . . 53.329999999999998 111.104 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.86 -0.55 19.74 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 115.103 -0.953 . . . . 42.240000000000002 109.3 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -108.07 153.4 23.18 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.905 0.859 . . . . 64.420000000000002 112.031 -174.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 7.1 m -112.09 93.66 4.56 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.655 -1.611 . . . . 74.109999999999999 107.358 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 6.3 p -100.91 148.58 24.83 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.23 -0.441 . . . . 61.329999999999998 111.278 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -63.16 152.83 36.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.995 0.426 . . . . 34.420000000000002 111.48 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 448' ' ' GLY . 1.7 mp -63.83 -21.41 28.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.641 0.734 . . . . 72.25 111.429 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.82 1.2 56.44 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.102 -0.499 . . . . 63.109999999999999 111.808 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -85.99 140.24 30.48 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.819 -0.438 . . . . 71.420000000000002 109.819 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 36.6 t -85.21 123.19 39.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.73 -0.668 . . . . 71.430000000000007 109.415 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 48.6 t -93.85 119.81 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 108.526 -0.916 . . . . 72.25 108.526 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.531 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 1.7 mp -91.89 112.76 26.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.652 -1.981 . . . . 72.019999999999996 105.652 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -92.75 119.47 40.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.591 -1.263 . . . . 60.520000000000003 107.591 -177.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 38.8 mt -106.1 116.32 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.702 0.763 . . . . 72.239999999999995 110.57 -174.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 41.5 t -98.13 142.85 13.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.502 -0.772 . . . . 70.230000000000004 108.959 -177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -85.63 117.53 4.59 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 111.183 -0.767 . . . . 62.509999999999998 111.183 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.4 m -116.34 106.99 14.26 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.163 -0.68 . . . . 75.450000000000003 109.163 177.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.086 0 N-CA-C 109.981 -1.248 . . . . 70.420000000000002 109.981 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.386 0 N-CA-C 110.043 -1.223 . . . . 43.049999999999997 110.043 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -92.78 149.85 4.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 117.487 0.643 . . . . 42.329999999999998 111.481 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 57.4 m -147.12 156.75 43.25 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.187 -1.783 . . . . 73.439999999999998 106.187 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -94.26 77.23 3.97 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.122 -1.436 . . . . 75.319999999999993 107.122 172.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -122.28 148.28 45.2 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.432 -1.713 . . . . 74.129999999999995 110.4 -172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.71 152.11 13.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 123.917 0.887 . . . . 62.219999999999999 108.987 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -95.92 136.32 36.5 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.873 -1.899 . . . . 65.510000000000005 105.873 170.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.5 127.01 32.53 Favored Pre-proline 0 C--N 1.284 -2.272 0 C-N-CA 119.89 -0.724 . . . . 71.010000000000005 111.122 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.36 133.71 57.51 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.986 2.457 . . . . 71.510000000000005 112.549 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -59.44 134.49 57.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.012 -0.995 . . . . 75.329999999999998 111.168 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 30.7 m -87.06 5.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.377 -0.829 . . . . 72.409999999999997 112.476 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.5 ptt-85 -65.69 137.72 57.5 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.657 -0.868 . . . . 74.209999999999994 108.657 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.37 0.37 50.39 Favored Glycine 0 C--N 1.299 -1.505 0 N-CA-C 110.687 -0.965 . . . . 53.420000000000002 110.687 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 372' ' ' ASP . 48.9 mt-30 -130.15 176.76 7.83 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.483 -0.932 . . . . 60.409999999999997 108.483 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 88.4 p -87.94 167.8 13.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.736 -0.839 . . . . 75.030000000000001 108.736 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -61.29 -34.22 74.86 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.993 0.425 . . . . 73.420000000000002 110.346 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -65.06 -44.84 87.68 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 115.704 -0.68 . . . . 70.200000000000003 110.407 179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 368' ' ' GLN . 48.8 m-20 -60.03 -44.98 94.27 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.528 -0.545 . . . . 64.409999999999997 109.528 177.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.37 -52.08 67.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.226 -0.897 . . . . 73.219999999999999 111.018 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 83.7 mt -59.5 -44.33 92.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.169 -0.469 . . . . 72.349999999999994 110.888 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.33 -47.08 77.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.147 -0.479 . . . . 61.340000000000003 111.645 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.601 ' O ' ' HD3' ' A' ' 380' ' ' ARG . 36.7 m -64.08 -47.52 79.76 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.547 -0.297 . . . . 73.299999999999997 111.199 -176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.13 -39.46 93.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.768 0.285 . . . . 72.430000000000007 111.768 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -60.04 -45.35 93.1 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.1 -0.704 . . . . 74.239999999999995 109.1 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -69.58 -27.65 65.29 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.169 -0.923 . . . . 75.329999999999998 112.025 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.601 ' HD3' ' O ' ' A' ' 376' ' ' THR . 8.5 mpt_? -85.62 -8.22 58.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.678 0.275 . . . . 71.430000000000007 110.999 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 93.27 14.35 54.21 Favored Glycine 0 CA--C 1.505 -0.594 0 C-N-CA 120.287 -0.959 . . . . 72.010000000000005 112.753 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -94.14 154.06 17.78 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 109.048 -0.723 . . . . 64.140000000000001 109.048 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.0 mmtp -104.79 133.6 49.34 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.263 -1.014 . . . . 62.310000000000002 108.263 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -117.82 144.86 24.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-O 121.524 0.678 . . . . 74.530000000000001 111.905 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -110.9 127.75 55.56 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 107.093 -1.447 . . . . 72.349999999999994 107.093 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 5.4 m -99.58 120.0 38.97 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.505 -1.665 . . . . 75.409999999999997 106.505 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -114.93 118.72 34.26 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.426 -1.324 . . . . 52.450000000000003 107.426 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.44 121.57 36.12 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.278 -1.378 . . . . 74.0 107.278 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.36 127.73 25.75 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 111.856 0.317 . . . . 70.420000000000002 111.856 -178.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -87.99 131.59 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.522 2.148 . . . . 60.32 110.731 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.4 t70 174.06 -164.71 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.716 -1.587 . . . . 70.420000000000002 106.716 -178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 50.1 m -142.34 -0.53 1.25 Allowed 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 123.343 0.657 . . . . 64.299999999999997 110.481 173.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 1.4 m -105.7 25.19 11.11 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 106.571 -1.64 . . . . 74.329999999999998 106.571 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 15.8 pt -115.13 151.41 45.66 Favored Pre-proline 0 C--N 1.298 -1.648 0 CA-C-N 113.708 -1.587 . . . . 72.549999999999997 110.212 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 63.2 Cg_endo -74.45 147.58 36.72 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.035 1.823 . . . . 75.129999999999995 111.465 176.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 54.0 Cg_exo -56.47 163.9 6.17 Favored 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.408 3.406 . . . . 73.109999999999999 112.288 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -56.28 -8.56 0.52 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 123.315 0.646 . . . . 73.140000000000001 112.006 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 36.1 m170 -91.63 113.37 25.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.213 -2.514 . . . . 74.530000000000001 104.213 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 43.2 t -62.18 118.32 4.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-O 121.358 0.599 . . . . 63.210000000000001 111.047 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.78 -29.49 3.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.206 -0.907 . . . . 74.340000000000003 109.049 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.18 157.12 27.28 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 110.432 -1.067 . . . . 71.140000000000001 110.432 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 1.8 p -126.03 -179.44 4.71 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 123.545 0.738 . . . . 52.350000000000001 110.418 -176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -102.33 140.29 21.0 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.639 -0.874 . . . . 61.299999999999997 108.639 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -43.39 -26.02 0.89 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 124.948 3.766 . . . . 62.43 115.53 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.34 -24.9 61.13 Favored 'General case' 0 C--O 1.217 -0.623 0 N-CA-C 112.045 0.387 . . . . 74.450000000000003 112.045 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -70.36 -43.74 69.56 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.475 0.655 . . . . 74.319999999999993 110.357 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -78.26 -11.99 59.97 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.59 -0.732 . . . . 63.219999999999999 111.65 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -78.82 137.46 37.71 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.063 -1.458 . . . . 70.409999999999997 107.063 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 15.3 m -82.54 112.27 19.3 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 107.712 -1.218 . . . . 71.409999999999997 107.712 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.6 167.42 18.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 107.566 -1.272 . . . . 74.329999999999998 107.566 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 10.2 p -61.01 147.66 42.83 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 123.46 0.704 . . . . 60.509999999999998 111.345 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.8 116.66 3.59 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.002 -0.544 . . . . 63.229999999999997 111.513 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 92.95 51.48 2.26 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.793 -0.64 . . . . 73.439999999999998 113.053 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.71 -170.14 1.69 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.803 -1.184 . . . . 74.329999999999998 107.803 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 9.7 pt-20 -99.05 135.27 40.7 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.494 0.664 . . . . 73.209999999999994 112.577 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 384' ' ' ILE . 48.9 mm -125.17 138.76 53.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 124.796 1.239 . . . . 73.430000000000007 108.159 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 12.3 t -99.82 131.89 45.51 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.77 0.795 . . . . 65.099999999999994 111.701 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 64.3 t -108.15 120.71 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 N-CA-C 107.459 -1.312 . . . . 73.519999999999996 107.459 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -94.74 129.04 41.83 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.341 -0.39 . . . . 74.5 111.458 -177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 93.9 t -123.75 131.3 73.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.835 -1.172 . . . . 64.120000000000005 107.835 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 49.6 p -85.96 121.85 29.18 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 109.099 -0.704 . . . . 72.409999999999997 109.099 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 15.0 t -119.45 106.7 12.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 120.197 -0.601 . . . . 73.150000000000006 111.1 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 71.03 125.89 0.06 OUTLIER Glycine 0 CA--C 1.544 1.874 0 N-CA-C 114.801 0.681 . . . . 65.019999999999996 114.801 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 12.1 Cg_exo -70.52 128.2 15.01 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.255 1.303 . . . . 64.400000000000006 109.44 173.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 391' ' ' ASP . 15.2 mm-40 -72.3 144.78 48.21 Favored 'General case' 0 CA--C 1.475 -1.932 0 N-CA-C 112.463 0.542 . . . . 63.340000000000003 112.463 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 43.4 mt-30 -116.01 149.01 39.54 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.811 -1.086 . . . . 63.119999999999997 108.562 177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -136.78 144.87 43.98 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 108.523 -0.917 . . . . 70.400000000000006 108.523 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 37.1 tt0 -81.74 119.25 23.62 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.122 -1.807 . . . . 71.040000000000006 106.122 177.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 62.1 mt -80.88 127.83 73.52 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 108.471 -0.937 . . . . 74.510000000000005 108.471 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 141.79 38.89 Favored 'Trans proline' 0 C--O 1.245 0.866 0 C-N-CA 121.928 1.752 . . . . 62.009999999999998 110.627 174.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.84 73.89 10.28 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 122.373 1.083 . . . . 72.150000000000006 108.269 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 12.5 p -110.19 -4.31 10.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 113.668 -1.605 . . . . 74.129999999999995 107.34 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.609 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 8.7 m -67.13 -38.88 86.32 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-N 113.583 -1.644 . . . . 44.229999999999997 111.767 -176.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 16.3 p -69.84 -16.75 63.32 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 112.86 0.689 . . . . 54.399999999999999 112.86 -169.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.28 -48.99 11.29 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.545 -0.752 . . . . 61.229999999999997 111.656 -175.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.2 m -157.59 130.19 7.39 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.03 -0.419 . . . . 63.43 110.116 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -55.88 -47.07 78.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.477 0.711 . . . . 72.409999999999997 112.218 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.82 -46.76 84.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.134 -0.484 . . . . 64.120000000000005 111.306 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 35.4 mm-40 -67.5 -38.95 85.09 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.164 -0.471 . . . . 75.310000000000002 111.214 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.4 -50.85 72.37 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 123.614 0.572 . . . . 62.119999999999997 111.043 -176.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.3 -45.34 98.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.516 -0.765 . . . . 75.209999999999994 110.624 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -67.11 -40.67 86.91 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 112.952 0.723 . . . . 52.340000000000003 112.952 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 73.8 mmtt -66.21 -47.18 74.7 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 110.084 -0.339 . . . . 72.530000000000001 110.084 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.03 -38.76 91.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.647 0.61 . . . . 71.519999999999996 112.647 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 43.9 m -63.98 -39.04 93.23 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.907 -0.405 . . . . 71.230000000000004 109.907 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -27.02 63.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.989 -0.551 . . . . 65.129999999999995 110.832 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.83 -13.65 59.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.336 -0.393 . . . . 54.539999999999999 111.249 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 129.96 -26.18 4.27 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.196 -1.002 . . . . 50.439999999999998 113.26 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -80.84 91.57 5.98 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.756 0.312 . . . . 72.519999999999996 110.17 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -107.48 26.86 16.93 Favored Glycine 0 C--N 1.307 -1.029 0 C-N-CA 120.512 -0.851 . . . . 70.409999999999997 111.71 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -124.77 111.84 16.01 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.587 -1.264 . . . . 71.239999999999995 107.587 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.81 158.97 37.2 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.777 0.799 . . . . 74.140000000000001 111.982 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -136.52 123.25 21.15 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.872 -1.899 . . . . 61.43 105.872 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -89.62 126.96 35.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.145 0.278 . . . . 72.430000000000007 110.49 -172.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.44 ' C ' HD22 ' A' ' 456' ' ' ASN . . . -136.39 150.72 48.93 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -129.74 148.84 51.66 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.505 -0.554 . . . . 75.25 109.505 178.172 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 66.4 m -135.86 133.3 19.85 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 116.488 -0.324 . . . . 73.219999999999999 110.969 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.3 Cg_endo -61.79 121.57 9.73 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.715 2.277 . . . . 71.439999999999998 110.028 176.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 2.8 p -146.39 -178.36 6.11 Favored 'General case' 0 C--N 1.275 -2.638 0 N-CA-C 107.878 -1.156 . . . . 64.340000000000003 107.878 -176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.514 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.3 m -52.2 122.98 26.11 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.17 -0.678 . . . . 64.439999999999998 109.17 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -50.02 -23.63 9.51 Favored 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.314 3.342 . . . . 73.540000000000006 115.197 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -75.4 -6.43 49.98 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 121.81 -0.556 . . . . 44.299999999999997 111.966 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.514 HD23 ' HB ' ' A' ' 460' ' ' THR . 4.4 mm? -98.69 5.02 47.94 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 122.099 -0.375 . . . . 73.109999999999999 110.955 176.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 11.8 p -59.67 126.7 17.83 Favored 'Isoleucine or valine' 0 C--O 1.252 1.2 0 CA-C-O 121.545 0.688 . . . . 71.519999999999996 111.489 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 87.84 -1.14 85.05 Favored Glycine 0 C--O 1.243 0.657 0 CA-C-N 115.748 -0.66 . . . . 32.439999999999998 111.772 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -111.1 144.42 40.26 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.148 -1.427 . . . . 71.209999999999994 107.148 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.583 HG22 HD11 ' A' ' 486' ' ' ILE . 61.8 t -83.82 134.9 25.92 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 109.496 -0.557 . . . . 55.240000000000002 109.496 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.37 -14.88 7.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.404 -0.518 . . . . 74.040000000000006 110.803 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 162.98 167.75 23.87 Favored Glycine 0 N--CA 1.431 -1.664 0 CA-C-N 115.719 -0.673 . . . . 52.420000000000002 111.811 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 486' ' ' ILE . 14.7 p -124.28 146.17 48.94 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.417 -1.327 . . . . 62.210000000000001 107.417 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.521 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 4.5 t-20 -56.54 -50.72 86.14 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 118.579 0.627 . . . . 63.210000000000001 110.497 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 2.9 Cg_exo -81.4 104.95 1.54 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 105.41 -2.573 . . . . 73.209999999999994 105.41 163.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 475' ' ' ASN . 35.0 Cg_endo -63.04 149.82 90.44 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.395 2.063 . . . . 60.310000000000002 114.248 -169.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.8 16.51 0.86 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.264 1.03 . . . . 74.340000000000003 110.106 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.495 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -111.3 -3.64 15.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 124.918 1.287 . . . . 65.430000000000007 108.718 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -120.9 163.32 18.39 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.921 -1.036 . . . . 72.230000000000004 112.162 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 10.6 m -101.48 104.88 15.82 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.728 -1.582 . . . . 71.420000000000002 106.728 175.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 28.8 t -116.89 148.84 40.96 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.583 -0.525 . . . . 51.240000000000002 109.583 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -66.14 140.71 58.23 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 116.236 -0.438 . . . . 54.130000000000003 110.622 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 48.9 mm -60.58 -16.46 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 125.159 1.384 . . . . 63.130000000000003 111.776 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 10.4 t -87.93 3.62 47.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.264 -0.426 . . . . 75.049999999999997 111.185 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 46.5 m-80 -91.12 140.61 29.65 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.751 0.31 . . . . 64.120000000000005 110.634 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 81.5 t -82.64 122.13 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.851 -1.166 . . . . 41.210000000000001 107.851 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 54.4 t -87.05 119.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.643 0 N-CA-C 108.605 -0.887 . . . . 71.319999999999993 108.605 -178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 47.0 mt -91.82 112.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.182 0 N-CA-C 104.799 -2.297 . . . . 63.409999999999997 104.799 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.583 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -102.84 120.45 52.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 108.685 -0.857 . . . . 74.329999999999998 108.685 -173.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.78 118.73 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 121.559 0.695 . . . . 75.409999999999997 109.333 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 18.3 t -97.45 139.83 19.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.351 -0.981 . . . . 75.019999999999996 108.351 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.27 121.66 6.22 Favored Glycine 0 N--CA 1.42 -2.43 0 N-CA-C 108.471 -1.852 . . . . 61.109999999999999 108.471 175.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 7.1 t -140.45 103.88 4.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.15 -0.685 . . . . 54.439999999999998 109.15 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.609 0 N-CA-C 109.478 -1.449 . . . . 74.530000000000001 109.478 178.18 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.309 0 N-CA-C 110.563 -1.015 . . . . 75.340000000000003 110.563 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.81 144.9 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-O 121.261 0.553 . . . . 53.240000000000002 111.93 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 32.7 m -86.03 151.5 23.66 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.825 -1.176 . . . . 75.129999999999995 107.825 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -83.23 77.2 9.81 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.434 0.635 . . . . 73.540000000000006 110.062 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -78.65 125.55 29.52 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 107.242 -1.392 . . . . 74.120000000000005 107.242 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 32.3 m -117.82 156.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-O 120.972 0.415 . . . . 71.109999999999999 110.506 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.41 136.85 37.96 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.604 -1.628 . . . . 74.109999999999999 106.604 174.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.45 129.03 27.71 Favored Pre-proline 0 C--N 1.283 -2.318 0 C-N-CA 119.437 -0.905 . . . . 73.400000000000006 109.889 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.08 139.79 70.94 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.33 2.686 . . . . 74.310000000000002 113.21 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -67.66 137.49 55.61 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.839 -1.073 . . . . 65.109999999999999 109.107 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 24.0 m -103.43 14.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-O 120.986 0.422 . . . . 64.409999999999997 111.96 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.468 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 0.9 OUTLIER -65.29 138.82 58.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.23 -0.441 . . . . 72.430000000000007 111.558 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 91.68 -2.08 76.35 Favored Glycine 0 C--N 1.306 -1.092 0 CA-C-N 115.603 -0.726 . . . . 45.310000000000002 111.449 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -116.67 162.67 17.29 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.473 -0.566 . . . . 53.219999999999999 109.473 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 79.3 p -74.75 163.16 28.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 122.764 0.426 . . . . 74.329999999999998 111.774 -175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 397' ' ' ASP . 21.5 p -60.91 -45.4 94.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 116.165 -0.47 . . . . 73.340000000000003 110.874 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.37 95.7 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.992 -0.549 . . . . 62.340000000000003 111.55 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.91 -39.73 83.54 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 120.056 -0.657 . . . . 73.310000000000002 109.905 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 377' ' ' LEU . . . -60.99 -51.84 67.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.056 -0.52 . . . . 53.409999999999997 110.099 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 74.8 mt -58.9 -46.12 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.064 -0.517 . . . . 62.509999999999998 110.7 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -60.82 -44.39 96.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.462 -0.336 . . . . 73.450000000000003 111.673 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 98.3 m -61.0 -47.51 86.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.689 -0.232 . . . . 53.32 111.18 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 373' ' ' ALA . 4.5 mm? -64.87 -42.44 94.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.811 0.339 . . . . 74.430000000000007 111.002 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.81 -48.43 80.64 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.854 0.861 . . . . 74.25 109.721 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -70.5 -25.35 63.1 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 115.506 -0.77 . . . . 70.219999999999999 111.584 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.4 -15.83 57.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.453 -0.573 . . . . 72.329999999999998 109.453 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.4 6.09 53.57 Favored Glycine 0 CA--C 1.486 -1.731 0 C-N-CA 119.807 -1.187 . . . . 51.409999999999997 111.683 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -89.4 169.08 11.7 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 121.233 0.54 . . . . 74.510000000000005 109.88 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 415' ' ' GLU . 74.9 mmtt -113.73 157.9 21.62 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.508 -1.293 . . . . 34.219999999999999 107.508 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.42 142.68 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 121.093 0.473 . . . . 73.319999999999993 111.126 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -116.81 138.63 51.36 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.552 -1.647 . . . . 63.130000000000003 106.552 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 3.3 p -101.81 127.06 48.78 Favored 'General case' 0 C--N 1.276 -2.606 0 C-N-CA 120.386 -0.525 . . . . 72.439999999999998 110.151 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 33.9 tp -111.45 119.54 39.15 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.04 -1.467 . . . . 75.129999999999995 107.04 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 422' ' ' THR . 0.0 OUTLIER -114.85 134.12 55.4 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 120.416 -0.514 . . . . 75.030000000000001 111.252 -175.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -137.02 141.77 35.91 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.853 -0.612 . . . . 75.430000000000007 110.192 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 66.5 Cg_endo -97.04 143.57 0.76 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 123.155 2.57 . . . . 73.299999999999997 113.234 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.656 ' HB3' HG23 ' A' ' 394' ' ' ILE . 7.7 t70 163.55 -167.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.996 -1.853 . . . . 71.299999999999997 105.996 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 m -122.18 -12.7 8.25 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.996 -0.742 . . . . 64.219999999999999 108.996 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.3 m -98.03 14.65 26.69 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 122.457 1.123 . . . . 54.219999999999999 108.769 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.656 HG23 ' HB3' ' A' ' 391' ' ' ASP . 9.9 pt -88.64 151.83 48.41 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 115.068 -0.969 . . . . 64.219999999999999 111.601 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.06 126.78 12.78 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 121.921 1.747 . . . . 71.310000000000002 110.78 175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.85 161.99 9.52 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.718 2.945 . . . . 73.319999999999993 112.265 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 370' ' ' SER . 4.4 p-10 -57.03 -9.93 0.99 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.477 0.711 . . . . 74.519999999999996 112.399 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -91.89 113.84 26.21 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 105.536 -2.024 . . . . 53.119999999999997 105.536 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.88 119.37 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 124.362 1.039 . . . . 75.340000000000003 112.29 -167.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.8 mt -95.41 -31.26 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.275 0.56 . . . . 65.540000000000006 109.928 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.57 157.96 27.56 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.518 -0.849 . . . . 74.310000000000002 111.472 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.9 p -129.04 -179.1 4.92 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 123.588 0.755 . . . . 73.400000000000006 109.599 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -101.74 142.35 24.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.02 -1.104 . . . . 73.540000000000006 108.02 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -48.65 -26.45 9.33 Favored 'Trans proline' 0 C--N 1.36 1.166 0 C-N-CA 123.848 3.032 . . . . 74.400000000000006 114.075 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -52.19 -34.69 46.41 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.366 0.666 . . . . 75.439999999999998 111.168 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.23 -44.42 95.28 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.723 -0.671 . . . . 35.140000000000001 111.434 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.54 -5.95 58.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.413 0.523 . . . . 53.549999999999997 112.413 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 37.0 m -85.95 153.01 22.48 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.96 -1.496 . . . . 72.450000000000003 106.96 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.69 112.76 11.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 119.761 -0.776 . . . . 61.520000000000003 110.142 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.6 m -117.94 153.04 19.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.638 -0.71 . . . . 62.340000000000003 109.542 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.7 m -67.62 141.73 56.66 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.565 -0.531 . . . . 51.509999999999998 109.565 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -54.26 134.6 44.9 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.529 0.732 . . . . 72.099999999999994 112.594 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 84.09 37.48 11.27 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.455 -0.793 . . . . 24.199999999999999 113.991 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -95.91 176.22 6.2 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.192 -1.04 . . . . 74.25 108.192 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 383' ' ' LYS . 6.2 pt-20 -111.07 120.0 40.89 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 113.189 0.811 . . . . 71.239999999999995 113.189 -175.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -98.79 137.85 25.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 114.951 -1.022 . . . . 60.420000000000002 108.535 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 13.4 t -96.02 128.67 43.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.816 0.817 . . . . 72.439999999999998 110.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.5 t -105.48 129.03 59.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.538 -0.912 . . . . 64.239999999999995 108.538 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -85.01 127.99 34.44 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.385 -0.598 . . . . 65.420000000000002 109.385 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.95 135.09 64.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.502 -0.925 . . . . 64.430000000000007 108.502 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 10.8 p -84.24 122.08 28.38 Favored 'General case' 0 N--CA 1.424 -1.729 0 N-CA-C 109.246 -0.649 . . . . 55.409999999999997 109.246 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 388' ' ' GLN . 39.9 m -120.3 104.96 10.47 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 120.049 -0.66 . . . . 52.299999999999997 112.443 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 70.62 131.07 0.08 OUTLIER Glycine 0 CA--C 1.541 1.67 0 N-CA-C 115.766 1.066 . . . . 31.149999999999999 115.766 172.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.4 Cg_exo -75.06 134.65 17.96 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.943 1.762 . . . . 73.430000000000007 109.491 173.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 12.2 mm-40 -72.84 148.8 44.12 Favored 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 121.249 0.547 . . . . 72.109999999999999 112.266 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.8 mt-30 -124.08 139.03 54.34 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.682 -1.144 . . . . 73.549999999999997 108.015 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 14.9 mmt-85 -130.45 154.64 47.53 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 116.163 -0.471 . . . . 72.349999999999994 109.771 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.64 138.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.579 -0.897 . . . . 74.299999999999997 108.579 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.6 mt -94.28 109.64 43.74 Favored Pre-proline 0 C--O 1.203 -1.352 0 N-CA-C 109.005 -0.739 . . . . 75.109999999999999 109.005 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.01 140.56 34.94 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 121.549 1.5 . . . . 73.140000000000001 111.716 178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -92.5 95.17 9.48 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 118.465 -1.294 . . . . 75.120000000000005 112.172 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.63 9.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 104.502 -2.407 . . . . 64.230000000000004 104.502 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 22.6 t -78.89 -48.11 15.24 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.058 -1.883 . . . . 74.230000000000004 109.188 -172.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 40.3 p -63.85 -19.97 65.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.631 0.729 . . . . 71.439999999999998 110.829 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 79.7 mt -90.29 -49.27 6.64 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.05 -0.977 . . . . 74.0 110.083 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 4.7 p -151.03 125.59 9.56 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.105 0.479 . . . . 75.400000000000006 112.117 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -61.64 -47.12 86.85 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 73.019999999999996 110.927 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.26 -47.84 80.38 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.824 . . . . 72.209999999999994 112.134 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -69.97 -34.75 73.79 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.995 -0.548 . . . . 72.530000000000001 112.059 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.82 -44.75 96.5 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 116.571 -0.286 . . . . 64.129999999999995 110.357 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 76.9 t -60.29 -39.84 82.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 O-C-N 123.594 0.559 . . . . 74.150000000000006 110.157 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -60.82 -48.14 83.14 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.878 -0.601 . . . . 72.430000000000007 110.504 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.8 -47.53 71.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 111.068 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.94 -43.07 84.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.046 -0.979 . . . . 75.209999999999994 111.384 -173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.3 m -69.17 -39.57 78.66 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 120.967 0.413 . . . . 73.329999999999998 110.224 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.11 -16.14 62.55 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.374 -0.375 . . . . 53.009999999999998 111.346 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.78 -13.79 59.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.215 0.531 . . . . 62.439999999999998 109.969 177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.46 -25.26 7.39 Favored Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 120.737 -0.744 . . . . 12.01 112.14 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -57.43 127.1 30.28 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 120.972 0.415 . . . . 65.239999999999995 111.504 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -133.55 27.72 3.35 Favored Glycine 0 C--N 1.299 -1.485 0 N-CA-C 109.673 -1.371 . . . . 62.210000000000001 109.673 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -128.04 111.4 13.47 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.824 -1.547 . . . . 62.119999999999997 106.824 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -135.88 154.18 51.23 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.977 0.418 . . . . 64.239999999999995 110.782 -173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -146.13 123.25 11.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.624 -1.25 . . . . 73.299999999999997 107.624 172.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -108.84 132.19 54.26 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.942 -0.303 . . . . 51.219999999999999 110.697 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -147.68 166.3 27.87 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.898 -0.592 . . . . 65.230000000000004 109.518 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.51 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.8 m120 -112.74 143.65 43.59 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.303 -0.629 . . . . 72.219999999999999 109.303 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 23.6 t -127.17 141.48 40.86 Favored Pre-proline 0 C--N 1.288 -2.107 0 N-CA-C 107.739 -1.208 . . . . 74.209999999999994 107.739 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 490' ' ' SER . 27.3 Cg_endo -63.37 135.18 48.68 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.862 2.375 . . . . 75.530000000000001 112.427 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 53.3 p -148.13 -178.88 6.54 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 105.648 -1.982 . . . . 63.229999999999997 105.648 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD13 ' A' ' 463' ' ' LEU . 31.6 m -63.69 128.2 92.45 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 107.076 -1.453 . . . . 70.129999999999995 107.076 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -49.33 -28.24 14.97 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.272 3.315 . . . . 74.430000000000007 114.576 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -71.31 -9.88 58.85 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 111.911 0.337 . . . . 61.240000000000002 111.911 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.6 mp -103.3 11.97 36.07 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 110.458 -0.201 . . . . 61.219999999999999 110.458 177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 13.0 p -59.0 127.32 18.03 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 CA-C-O 121.611 0.719 . . . . 64.439999999999998 110.969 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.57 57.81 Favored Glycine 0 C--N 1.311 -0.813 0 CA-C-N 115.408 -0.815 . . . . 34.119999999999997 111.785 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.16 144.8 29.6 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.271 -1.011 . . . . 74.430000000000007 108.271 175.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.493 ' HB ' ' O ' ' A' ' 433' ' ' SER . 65.6 t -83.43 138.24 19.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 72.430000000000007 108.503 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -98.08 -11.37 8.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.22 -0.592 . . . . 55.140000000000001 111.615 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 150.68 -177.71 28.56 Favored Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 111.121 -0.792 . . . . 61.229999999999997 111.121 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 5.4 p -116.75 161.38 19.34 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.69 -0.856 . . . . 64.049999999999997 108.69 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -61.15 -55.37 44.75 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 119.259 -0.4 . . . . 74.530000000000001 111.323 177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 133.67 18.69 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 N-CA-C 108.226 -1.49 . . . . 75.319999999999993 108.226 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 134.56 47.18 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.013 1.809 . . . . 75.140000000000001 111.598 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -68.92 19.19 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.852 0.861 . . . . 73.230000000000004 113.045 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -110.54 -8.23 14.65 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.428 -0.953 . . . . 70.140000000000001 108.428 174.07 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -99.52 156.75 16.88 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.068 -0.969 . . . . 74.510000000000005 113.178 -170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 17.2 m -106.6 110.23 22.37 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.422 -1.717 . . . . 63.350000000000001 106.877 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 32.7 m -117.61 148.46 41.91 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 110.464 -0.198 . . . . 64.230000000000004 110.464 -176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -67.12 149.41 50.57 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.269 0.356 . . . . 74.140000000000001 111.018 177.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.5 mm -60.95 -14.43 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.307 0 C-N-CA 125.083 1.353 . . . . 72.420000000000002 111.837 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.17 4.01 44.11 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.7 0.8 . . . . 64.129999999999995 111.701 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -97.73 134.74 40.49 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.003 -0.544 . . . . 72.299999999999997 110.607 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.99 114.93 24.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 108.677 -0.86 . . . . 73.299999999999997 108.677 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.44 119.85 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.378 0.609 . . . . 72.150000000000006 109.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 45.6 mt -92.72 120.24 41.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.43 -1.322 . . . . 74.430000000000007 107.43 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.29 118.92 56.93 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 107.836 -1.172 . . . . 75.219999999999999 107.836 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 0.1 OUTLIER -111.46 122.64 66.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-O 122.173 0.987 . . . . 74.319999999999993 112.361 -178.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.51 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 35.5 t -97.53 141.2 16.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 114.713 -1.13 . . . . 64.099999999999994 108.053 -177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -77.43 121.75 5.92 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 111.657 -0.577 . . . . 21.140000000000001 111.657 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.6 m -142.06 120.89 12.72 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 109.153 -0.684 . . . . 60.409999999999997 109.153 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.578 0 N-CA-C 109.665 -1.374 . . . . 74.439999999999998 109.665 178.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.31 0 N-CA-C 109.923 -1.271 . . . . 72.129999999999995 109.923 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.38 145.04 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 117.782 0.791 . . . . 63.439999999999998 112.121 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 6.8 m -104.41 159.34 15.81 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.621 -1.622 . . . . 73.140000000000001 106.621 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -79.87 60.15 3.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.786 0.803 . . . . 74.329999999999998 112.688 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -114.53 136.4 53.06 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.606 -1.627 . . . . 63.450000000000003 106.606 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.65 154.14 37.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 122.528 0.331 . . . . 73.329999999999998 110.176 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -95.0 136.65 35.06 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.489 -0.93 . . . . 74.25 108.489 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.96 142.04 23.94 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 116.148 -0.478 . . . . 72.400000000000006 111.814 -170.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -49.14 142.77 20.19 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 124.015 3.143 . . . . 74.099999999999994 113.414 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.21 125.69 29.73 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.471 -0.786 . . . . 75.010000000000005 109.651 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.28 27.05 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 CA-C-O 122.569 1.176 . . . . 73.010000000000005 110.669 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.9 145.66 55.66 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.09 -0.959 . . . . 74.209999999999994 111.498 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.92 1.0 45.49 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.998 -0.62 . . . . 65.030000000000001 114.36 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 373' ' ' ALA . 7.7 pt20 -134.6 162.5 32.11 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 117.293 0.546 . . . . 44.450000000000003 110.883 -177.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 61.4 p -66.93 159.89 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.227 0.329 . . . . 61.210000000000001 110.298 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 21.2 p -56.76 -40.5 75.92 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 120.586 0.231 . . . . 71.019999999999996 111.62 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.36 77.85 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 111.563 0.209 . . . . 74.349999999999994 111.563 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.71 -36.76 76.19 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.51 -0.552 . . . . 72.420000000000002 109.51 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.4 ' HA ' ' OE1' ' A' ' 368' ' ' GLN . . . -60.5 -51.7 68.34 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.019 -0.537 . . . . 70.120000000000005 110.812 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.46 -38.0 76.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.764 -0.653 . . . . 73.209999999999994 110.607 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.07 99.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.964 -0.562 . . . . 74.010000000000005 110.338 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 50.6 m -61.21 -47.2 87.22 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.353 -0.385 . . . . 71.299999999999997 110.755 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -63.8 -38.64 91.86 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.433 0.158 . . . . 74.140000000000001 111.304 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -61.16 -46.78 89.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.366 -0.605 . . . . 72.349999999999994 109.366 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -66.27 -28.0 68.37 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.805 -0.634 . . . . 73.120000000000005 111.507 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -80.98 -14.57 57.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.365 -0.38 . . . . 70.439999999999998 111.42 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.71 14.09 48.11 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.858 -0.686 . . . . 65.230000000000004 113.667 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.91 161.97 14.6 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.491 0.646 . . . . 75.099999999999994 111.353 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -97.01 140.13 31.99 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.221 -1.77 . . . . 63.130000000000003 106.221 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.3 152.31 21.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 121.296 0.57 . . . . 54.420000000000002 112.316 -176.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -136.16 128.99 31.04 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.934 -1.136 . . . . 64.530000000000001 107.934 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 42.9 m -100.58 132.83 45.77 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 109.187 -0.671 . . . . 73.040000000000006 109.187 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -114.55 119.14 35.79 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 105.666 -1.976 . . . . 71.310000000000002 105.666 174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.37 122.19 46.49 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.974 -0.75 . . . . 53.399999999999999 108.974 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.54 133.3 21.33 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.023 -0.535 . . . . 74.040000000000006 111.9 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 38.2 Cg_endo -81.63 129.56 6.5 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.073 1.849 . . . . 73.310000000000002 108.288 169.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.4 -170.29 3.19 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 117.905 -1.518 . . . . 74.510000000000005 112.145 -173.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 36.7 t -104.66 -40.63 5.94 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.318 -1.734 . . . . 42.020000000000003 106.318 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 395' ' ' PRO . 32.2 m -93.0 71.51 4.65 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.543 -1.651 . . . . 44.020000000000003 106.543 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 16.6 pt -89.58 112.96 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 113.241 -1.8 . . . . 65.319999999999993 113.587 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 393' ' ' THR . 6.3 Cg_exo -79.1 119.61 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 N-CA-C 105.81 -2.419 . . . . 73.340000000000003 105.81 167.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.12 150.48 39.16 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 C-N-CA 122.631 2.221 . . . . 63.219999999999999 114.24 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.531 ' HA ' HG13 ' A' ' 420' ' ' VAL . 29.8 t70 -60.06 -9.65 3.41 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.626 1.203 . . . . 51.100000000000001 111.722 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -109.51 115.51 30.06 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 103.292 -2.855 . . . . 74.200000000000003 103.292 176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.17 117.98 4.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 O-C-N 123.695 0.622 . . . . 72.109999999999999 109.53 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.41 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -106.57 -29.89 2.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.987 -1.116 . . . . 71.349999999999994 107.987 179.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.37 168.47 27.81 Favored Glycine 0 N--CA 1.422 -2.271 0 N-CA-C 109.387 -1.485 . . . . 62.229999999999997 109.387 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 81.2 p -113.93 -176.36 2.88 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.827 0.823 . . . . 71.230000000000004 111.365 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -100.31 142.89 25.48 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 105.654 -1.98 . . . . 61.399999999999999 105.654 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -41.62 -31.67 1.28 Allowed 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 124.286 3.324 . . . . 63.450000000000003 114.441 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -58.84 -30.08 67.42 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 112.381 0.512 . . . . 74.030000000000001 112.381 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.14 -38.25 81.95 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 121.5 0.667 . . . . 74.310000000000002 110.125 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.83 -0.39 57.7 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.842 0.83 . . . . 73.120000000000005 110.604 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 93.8 m -85.55 143.99 28.17 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.008 -1.479 . . . . 74.140000000000001 107.008 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.0 m -74.84 114.61 13.49 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.867 -0.733 . . . . 63.020000000000003 109.381 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 30.8 m -118.96 170.17 8.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 124.823 1.249 . . . . 52.340000000000003 108.921 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 23.2 t -69.67 156.98 38.13 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.535 -0.543 . . . . 75.319999999999993 109.535 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -73.38 109.6 7.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.124 -1.065 . . . . 52.43 108.124 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 95.53 26.51 11.87 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.673 -0.971 . . . . 52.350000000000001 110.673 -175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 411' ' ' SER . 3.8 t0 -76.99 -171.57 2.03 Favored 'General case' 0 C--O 1.249 1.055 0 N-CA-C 108.807 -0.812 . . . . 63.149999999999999 108.807 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.68 127.46 53.38 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.463 0.649 . . . . 61.109999999999999 111.129 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.8 mm -112.63 120.1 61.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.202 -1.036 . . . . 74.109999999999999 108.202 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 69.3 p -97.88 128.23 44.34 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.642 -0.873 . . . . 43.340000000000003 108.642 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.57 119.58 59.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 109.717 -0.475 . . . . 63.109999999999999 109.717 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -91.7 121.88 33.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.459 -0.941 . . . . 61.109999999999999 108.459 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.531 HG13 ' HA ' ' A' ' 397' ' ' ASP . 23.6 t -128.83 144.72 37.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.426 -0.953 . . . . 75.319999999999993 108.426 -175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 71.9 p -98.03 128.92 44.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 119.306 -0.958 . . . . 54.030000000000001 110.9 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 60.6 m -118.73 105.56 11.69 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.069 -1.456 . . . . 74.319999999999993 107.069 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 80.53 145.1 3.97 Favored Glycine 0 CA--C 1.546 2.011 0 C-N-CA 120.973 -0.632 . . . . 34.219999999999999 113.445 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -87.95 153.2 7.16 Favored 'Trans proline' 0 N--CA 1.438 -1.779 0 C-N-CA 121.903 1.735 . . . . 63.229999999999997 110.38 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.5 146.17 47.0 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 109.177 -0.675 . . . . 73.439999999999998 109.177 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 479' ' ' ALA . 42.0 mt-30 -128.74 124.13 34.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.632 -0.877 . . . . 73.450000000000003 108.632 -179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.14 159.51 34.02 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.469 -1.308 . . . . 72.230000000000004 107.469 -171.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -89.65 139.87 30.12 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 110.209 -0.293 . . . . 71.129999999999995 110.209 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.61 131.89 63.25 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.631 -0.877 . . . . 74.400000000000006 108.631 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.438 ' HB2' HG12 ' A' ' 432' ' ' VAL . 55.2 Cg_endo -71.24 151.07 60.25 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 122.466 2.111 . . . . 44.210000000000001 111.905 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -94.19 -6.55 44.49 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.485 -0.325 . . . . 71.209999999999994 110.702 -177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 430' ' ' PRO . 11.9 p -65.84 -15.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-O 122.123 0.964 . . . . 62.329999999999998 109.69 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 14.0 m -52.73 -32.95 45.77 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.889 1.676 . . . . 73.230000000000004 112.084 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 85.5 m -59.8 -34.33 72.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.53 0.732 . . . . 74.430000000000007 112.585 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.1 mt -67.45 -37.69 83.33 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.307 0.854 . . . . 71.319999999999993 113.307 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.8 m -158.3 133.53 8.66 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.723 -0.473 . . . . 72.319999999999993 109.723 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -56.61 -49.35 75.21 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.099 0.559 . . . . 73.349999999999994 111.724 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.44 85.86 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.943 -0.571 . . . . 72.299999999999997 110.449 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.25 -41.96 99.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.933 -1.03 . . . . 64.299999999999997 109.834 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.47 69.23 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.355 -0.839 . . . . 74.420000000000002 110.582 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.34 -40.0 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.584 -0.735 . . . . 74.519999999999996 110.405 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.593 ' HA ' ' HE3' ' A' ' 442' ' ' LYS . 0.0 OUTLIER -60.8 -46.34 90.88 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 116.607 -0.27 . . . . 74.219999999999999 111.064 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -47.6 83.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.268 0.355 . . . . 65.329999999999998 111.86 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.36 -40.55 85.78 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.946 0.721 . . . . 42.509999999999998 112.946 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 449' ' ' PHE . 57.2 m -61.8 -43.44 98.83 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.065 0.46 . . . . 73.409999999999997 110.158 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.53 -22.33 61.78 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.696 -0.684 . . . . 73.310000000000002 111.553 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.21 -13.09 57.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.005 0.431 . . . . 73.219999999999999 111.061 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.95 -19.12 8.91 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.443 -0.884 . . . . 61.439999999999998 112.715 177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 445' ' ' THR . 91.0 m-85 -71.27 110.86 6.17 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.017 -0.734 . . . . 60.020000000000003 109.017 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -120.08 17.08 9.97 Favored Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.457 -0.878 . . . . 53.200000000000003 111.602 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -119.4 111.4 18.1 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 107.872 -1.159 . . . . 61.130000000000003 107.872 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.25 152.37 50.58 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.082 0.468 . . . . 74.439999999999998 111.892 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -138.69 126.22 21.9 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.756 -1.572 . . . . 74.409999999999997 106.756 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -93.4 126.25 38.43 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 121.229 -0.189 . . . . 64.230000000000004 111.001 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -139.82 161.16 38.22 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.114 0.483 . . . . 63.130000000000003 110.111 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.06 133.29 53.67 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 121.059 0.457 . . . . 61.420000000000002 110.179 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 5.1 p -116.97 133.43 23.1 Favored Pre-proline 0 N--CA 1.413 -2.28 0 CA-C-N 115.583 -0.735 . . . . 35.310000000000002 109.482 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 457' ' ' SER . 36.1 Cg_exo -61.8 123.66 13.06 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.435 2.09 . . . . 71.439999999999998 110.609 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 8.7 t -148.16 -177.99 6.05 Favored 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 107.557 -1.275 . . . . 63.43 107.557 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 463' ' ' LEU . 20.5 m -51.65 116.45 7.92 Favored Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 124.139 0.976 . . . . 73.200000000000003 110.492 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -49.92 -28.75 19.21 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 C-N-CA 124.329 3.353 . . . . 73.510000000000005 116.065 -172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -75.19 -25.93 58.63 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 121.746 -0.596 . . . . 73.030000000000001 112.366 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 460' ' ' THR . 3.2 pp -92.8 12.04 24.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.695 -0.402 . . . . 71.209999999999994 112.038 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 7.6 p -53.29 130.85 15.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.428 0.632 . . . . 70.010000000000005 111.228 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.84 -13.32 59.21 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.819 -0.912 . . . . 61.32 110.819 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.01 147.25 26.41 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.305 0.574 . . . . 34.420000000000002 109.773 177.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 434' ' ' THR . 52.7 t -83.68 129.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 115.478 -0.783 . . . . 62.210000000000001 110.004 -173.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -15.84 7.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 C-N-CA 118.571 -1.251 . . . . 62.140000000000001 110.724 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.51 37.95 Favored Glycine 0 N--CA 1.418 -2.516 0 CA-C-N 115.331 -0.849 . . . . 44.420000000000002 111.146 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 486' ' ' ILE . 2.9 p -136.15 161.87 34.53 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.915 -1.143 . . . . 73.239999999999995 107.915 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.423 ' CB ' ' HB ' ' A' ' 485' ' ' ILE . 7.7 t30 -62.97 -49.76 80.12 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 120.75 -0.38 . . . . 71.219999999999999 110.87 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 13.5 Cg_exo -69.44 141.71 47.3 Favored 'Trans proline' 0 C--N 1.375 1.942 0 N-CA-C 106.586 -2.121 . . . . 43.409999999999997 106.586 167.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.458 ' HB2' HE21 ' A' ' 476' ' ' GLN . 18.4 Cg_endo -61.48 127.24 21.24 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.771 1.648 . . . . 41.140000000000001 112.699 -174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -74.03 -1.69 21.07 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.885 0.874 . . . . 53.310000000000002 113.162 -174.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -110.02 -4.27 15.98 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 122.028 -0.42 . . . . 72.420000000000002 110.136 175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.458 HE21 ' HB2' ' A' ' 473' ' ' PRO . 1.4 mp0 -121.3 176.51 5.6 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 114.626 1.343 . . . . 75.400000000000006 114.626 -171.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.3 m -80.48 132.65 35.73 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.708 -1.587 . . . . 54.210000000000001 110.334 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 13.7 p -137.26 149.54 47.2 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.605 -0.887 . . . . 64.439999999999998 108.605 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.454 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.23 148.55 45.41 Favored 'General case' 0 C--O 1.211 -0.951 0 C-N-CA 120.206 -0.598 . . . . 61.340000000000003 111.262 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.76 -28.24 44.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.865 0.84 . . . . 75.510000000000005 110.878 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 p -88.0 5.48 40.61 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 114.954 -1.021 . . . . 63.450000000000003 111.434 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -85.0 135.83 33.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.111 -1.44 . . . . 63.009999999999998 107.111 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 53.0 t -79.83 112.91 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.351 -1.351 . . . . 64.549999999999997 107.351 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 61.6 t -87.25 118.81 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 109.083 -0.71 . . . . 62.130000000000003 109.083 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.423 ' HB ' ' CB ' ' A' ' 471' ' ' ASN . 60.8 mt -92.6 113.39 27.61 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 106.469 -1.678 . . . . 73.109999999999999 106.469 177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -97.18 116.46 39.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 108.545 -0.909 . . . . 74.140000000000001 108.545 -175.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 12.3 pt -102.9 117.06 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-O 122.491 1.139 . . . . 55.039999999999999 111.571 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 38.3 t -96.67 132.88 40.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 107.557 -1.275 . . . . 63.299999999999997 107.557 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -68.92 113.58 5.31 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.773 -1.331 . . . . 74.310000000000002 109.773 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 8.7 m -135.01 103.72 5.68 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 109.759 -0.46 . . . . 72.019999999999996 109.759 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.516 0 N-CA-C 108.399 -1.88 . . . . 65.310000000000002 108.399 178.837 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.36 0 N-CA-C 110.169 -1.172 . . . . 74.109999999999999 110.169 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.422 HD12 ' O ' ' A' ' 356' ' ' ILE . 2.8 pp -98.28 133.18 41.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.372 0.606 . . . . 65.219999999999999 111.856 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 7.2 t -132.33 146.07 51.72 Favored 'General case' 0 N--CA 1.418 -2.032 0 CA-C-N 115.628 -0.715 . . . . 64.310000000000002 109.879 -177.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -83.21 77.48 9.76 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.752 0.787 . . . . 75.340000000000003 111.95 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.35 148.07 44.85 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 104.679 -2.341 . . . . 73.200000000000003 104.679 172.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.74 152.92 19.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 119.522 -0.871 . . . . 71.230000000000004 113.149 -167.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -95.28 137.07 34.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.417 -1.697 . . . . 74.409999999999997 106.417 172.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.3 p -96.93 131.56 27.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 C-N-CA 119.27 -0.972 . . . . 73.219999999999999 109.711 -174.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.65 150.74 51.04 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.7 2.933 . . . . 53.119999999999997 114.026 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -72.76 -30.13 63.88 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 110.459 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 368' ' ' GLN . 42.5 t 66.77 27.35 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-O 124.193 1.949 . . . . 73.319999999999993 107.097 -174.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 28.0 ptt180 -58.17 125.08 21.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 112.464 -2.153 . . . . 70.140000000000001 113.362 -176.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 102.52 -16.78 54.63 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 114.863 -1.062 . . . . 45.509999999999998 111.719 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.491 ' HB2' HG12 ' A' ' 365' ' ' VAL . 41.7 mt-30 -103.89 170.23 8.04 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 122.796 0.439 . . . . 72.5 110.006 -176.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 87.9 p -71.75 160.86 31.88 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.185 0.517 . . . . 61.130000000000003 111.998 -175.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 11.3 p -62.05 -33.85 75.17 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.637 -0.711 . . . . 55.409999999999997 110.245 174.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.5 98.58 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 116.011 -0.54 . . . . 52.210000000000001 110.688 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.91 -39.83 79.44 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 120.847 -0.341 . . . . 63.25 110.249 179.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.3 72.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.187 -0.46 . . . . 43.0 111.466 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.77 -45.26 91.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 110.661 178.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.55 83.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.169 -0.469 . . . . 70.019999999999996 111.769 -179.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 86.3 m -61.62 -47.44 85.39 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 122.585 0.354 . . . . 73.420000000000002 111.229 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.84 -38.67 91.74 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.619 0.229 . . . . 31.109999999999999 111.619 178.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -59.83 -46.16 90.12 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.501 0.72 . . . . 41.229999999999997 109.496 177.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -70.9 -16.62 62.69 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.32 -0.854 . . . . 61.399999999999999 112.484 178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -87.31 -14.09 41.81 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.583 -0.895 . . . . 64.040000000000006 108.583 176.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.627 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 100.75 -2.67 55.79 Favored Glycine 0 N--CA 1.425 -2.046 0 CA-C-N 115.089 -0.96 . . . . 74.120000000000005 111.976 178.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -77.72 150.6 34.42 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.162 0.506 . . . . 72.040000000000006 111.271 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -96.05 145.03 25.8 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.26 -1.756 . . . . 63.200000000000003 106.26 -179.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.4 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -129.61 135.72 60.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.887 1.069 . . . . 73.530000000000001 113.887 -174.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -111.03 132.07 54.54 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 105.647 -1.983 . . . . 50.130000000000003 105.647 172.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 19.1 m -119.52 122.73 42.31 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 120.236 -0.586 . . . . 71.450000000000003 110.378 -177.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.23 127.45 55.61 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.872 -1.159 . . . . 72.140000000000001 107.872 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.57 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -108.82 122.48 47.27 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.084 -0.71 . . . . 63.130000000000003 109.084 -179.257 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.2 OUTLIER -122.0 132.77 24.18 Favored Pre-proline 0 C--N 1.3 -1.555 0 CA-C-N 116.283 -0.417 . . . . 64.140000000000001 110.76 -177.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -97.56 137.6 0.44 Allowed 'Trans proline' 0 CA--C 1.554 1.5 0 C-N-CA 122.3 2.0 . . . . 74.510000000000005 113.152 176.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 13.8 t70 164.85 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 126.645 1.978 . . . . 74.209999999999994 106.277 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 25.9 m -138.27 -8.48 1.52 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 118.901 0.773 . . . . 51.329999999999998 111.909 -179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 41.4 p -90.79 -3.32 57.5 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 122.156 0.979 . . . . 73.219999999999999 109.601 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 391' ' ' ASP . 7.4 pt -99.69 151.7 37.55 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 113.982 -1.463 . . . . 71.310000000000002 110.368 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 396' ' ' PRO . 51.2 Cg_exo -56.43 131.91 48.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.302 2.668 . . . . 51.020000000000003 113.932 -178.44 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 395' ' ' PRO . 70.0 Cg_exo -55.3 164.54 3.78 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 C-N-CA 124.913 3.742 . . . . 61.229999999999997 113.511 177.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.438 ' HA ' ' CG2' ' A' ' 420' ' ' VAL . 17.1 t70 -55.25 -9.9 0.5 Allowed 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.493 1.517 . . . . 73.340000000000003 113.457 -174.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -87.58 124.31 33.37 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.921 -1.14 . . . . 70.040000000000006 107.921 171.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 44.8 t -63.16 119.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.607 -0.724 . . . . 75.329999999999998 109.845 -173.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 10.6 tp -90.5 -32.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.587 -0.733 . . . . 74.120000000000005 109.48 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -174.88 169.11 41.98 Favored Glycine 0 N--CA 1.415 -2.741 0 N-CA-C 110.842 -0.903 . . . . 53.100000000000001 110.842 -179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 32.8 p -114.48 -176.69 2.96 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.066 0.947 . . . . 75.129999999999995 108.696 176.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.49 143.49 26.52 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 108.563 -0.903 . . . . 71.340000000000003 108.563 -176.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -37.23 -30.7 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.8 1 C-N-CA 125.394 4.063 . . . . 75.200000000000003 115.593 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.76 -32.15 70.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.126 0.489 . . . . 71.120000000000005 110.972 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -86.55 -24.52 25.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.619 -0.718 . . . . 33.439999999999998 110.373 178.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -88.57 -7.09 57.04 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.393 -0.822 . . . . 74.0 111.661 -173.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 25.3 m -95.39 162.22 13.75 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.144 -1.428 . . . . 71.25 107.144 178.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 28.8 m -74.26 113.34 11.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 120.059 -0.656 . . . . 41.25 110.16 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 20.8 m -122.48 165.47 18.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.304 -0.862 . . . . 71.109999999999999 109.761 178.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 15.8 m -75.51 141.64 42.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -63.96 129.93 42.01 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.294 0.569 . . . . 45.25 110.226 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 103.01 11.14 35.14 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.524 -0.846 . . . . 44.420000000000002 111.896 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.17 173.74 10.97 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.68 -1.23 . . . . 75.420000000000002 107.68 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -110.63 122.62 48.23 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.644 0.735 . . . . 70.019999999999996 111.366 -176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 46.8 mm -113.05 133.42 58.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.181 -0.918 . . . . 74.409999999999997 109.779 -175.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -102.69 124.87 49.02 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 108.479 -0.934 . . . . 72.0 108.479 177.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 12.6 p -114.48 134.39 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 N-CA-C 109.596 -0.52 . . . . 72.400000000000006 109.596 -177.405 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -110.05 129.23 55.71 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 109.186 -0.672 . . . . 65.140000000000001 109.186 177.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 397' ' ' ASP . 8.6 p -128.59 141.02 47.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-N 114.838 -1.074 . . . . 74.310000000000002 108.211 -178.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 389' ' ' LYS . 10.6 m -95.9 122.62 38.9 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.546 -0.862 . . . . 72.450000000000003 110.102 -178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 59.8 p -117.82 107.48 14.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.758 -0.655 . . . . 75.120000000000005 110.985 -177.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 81.32 136.62 2.02 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.809 -0.632 . . . . 53.240000000000002 113.486 177.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 71.1 Cg_endo -75.67 155.02 39.82 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.33 2.02 . . . . 72.049999999999997 111.634 178.037 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -83.21 143.86 30.17 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 74.519999999999996 108.918 174.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.7 mt-30 -127.51 135.53 50.49 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.719 -1.215 . . . . 74.209999999999994 107.719 175.056 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -131.99 157.1 44.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.873 -0.788 . . . . 73.120000000000005 108.873 -178.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.13 138.94 31.0 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 107.206 -1.405 . . . . 73.209999999999994 107.206 174.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.2 mp -80.21 113.67 40.67 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 109.332 -0.618 . . . . 73.299999999999997 109.332 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.65 140.61 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.792 1.661 . . . . 53.520000000000003 109.878 176.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -107.47 97.58 7.3 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.375 1.083 . . . . 62.240000000000002 113.603 -178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.27 5.99 5.72 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 105.349 -2.093 . . . . 75.140000000000001 105.349 169.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.715 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 12.8 m -72.07 -46.42 56.95 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 113.447 -1.706 . . . . 53.25 110.393 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 23.1 p -65.37 -23.29 66.94 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.208 -0.906 . . . . 45.329999999999998 110.962 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 81.1 mt -90.42 -48.07 7.34 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.461 -0.79 . . . . 73.439999999999998 111.326 -179.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 29.3 m -143.79 113.41 7.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.251 -178.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -55.48 -51.83 65.64 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.371 1.068 . . . . 72.430000000000007 112.608 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -60.46 -43.65 96.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.317 -0.401 . . . . 63.200000000000003 111.212 -177.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.66 -35.06 79.81 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.822 -0.627 . . . . 73.219999999999999 110.47 -178.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.715 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -59.72 -48.52 81.35 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 116.012 -0.54 . . . . 55.219999999999999 110.666 -178.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.43 -43.3 90.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 CA-C-N 115.17 -0.923 . . . . 64.400000000000006 109.834 178.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 71.5 mmtt -66.43 -47.53 72.9 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 110.524 -177.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -66.57 -41.46 88.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 115.751 -0.659 . . . . 74.239999999999995 112.123 -177.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.31 -32.98 73.5 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 112.574 0.583 . . . . 75.420000000000002 112.574 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.4 m -66.96 -43.26 83.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.842 -0.799 . . . . 75.219999999999999 108.842 175.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.16 62.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.976 -0.556 . . . . 65.019999999999996 111.042 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.81 -13.11 59.66 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.413 0.625 . . . . 75.450000000000003 110.005 177.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 104.36 -6.31 45.79 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-O 119.223 -0.765 . . . . 53.109999999999999 114.016 175.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -65.17 130.71 44.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.118 0.959 . . . . 75.049999999999997 110.562 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -122.6 2.82 10.22 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.061 -1.066 . . . . 73.530000000000001 113.478 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -123.44 114.29 19.91 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.895 -0.779 . . . . 72.420000000000002 108.895 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -131.96 161.95 31.88 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.11 0.481 . . . . 74.239999999999995 110.731 -176.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 1.4 tpmt? -149.23 122.94 9.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 105.53 -2.026 . . . . 71.219999999999999 105.53 172.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -107.74 134.87 50.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.042 0.449 . . . . 72.129999999999995 111.193 -176.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.4 145.35 47.22 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.369 -0.832 . . . . 70.510000000000005 109.12 179.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 31.2 m-80 -117.65 129.51 55.79 Favored 'General case' 0 CA--C 1.485 -1.541 0 N-CA-C 107.372 -1.344 . . . . 63.420000000000002 107.372 175.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 8.8 t -130.23 147.37 65.46 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.853 -0.795 . . . . 65.230000000000004 108.853 -176.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 490' ' ' SER . 18.1 Cg_endo -61.51 130.99 33.8 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 122.632 2.222 . . . . 71.140000000000001 111.489 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 55.1 p -136.23 -177.93 4.93 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 107.782 -1.192 . . . . 65.340000000000003 107.782 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.432 ' HB ' HD23 ' A' ' 463' ' ' LEU . 9.1 m -66.12 136.73 95.49 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 106.17 -1.789 . . . . 75.450000000000003 106.17 172.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.15 -28.16 19.06 Favored 'Trans proline' 0 C--O 1.207 -1.058 0 C-N-CA 123.583 2.855 . . . . 62.530000000000001 113.334 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -62.24 -16.76 55.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.496 0.554 . . . . 65.340000000000003 112.496 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.432 HD23 ' HB ' ' A' ' 460' ' ' THR . 3.0 mm? -107.59 6.0 27.49 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.108 -0.37 . . . . 71.030000000000001 110.866 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 9.4 p -59.76 127.44 19.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-O 121.446 0.641 . . . . 64.319999999999993 111.807 -177.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.56 -3.37 85.14 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.495 -0.775 . . . . 71.150000000000006 112.692 175.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -112.1 160.79 17.19 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.499 -0.926 . . . . 64.129999999999995 108.499 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.49 131.34 34.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.588 -0.893 . . . . 64.450000000000003 108.588 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.48 -20.75 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.239 0.543 . . . . 74.120000000000005 111.437 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 171.35 166.73 30.59 Favored Glycine 0 N--CA 1.418 -2.559 0 C-N-CA 120.46 -0.876 . . . . 34.109999999999999 111.891 178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 486' ' ' ILE . 11.0 p -125.01 144.2 50.51 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.194 -1.41 . . . . 75.239999999999995 107.194 177.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.456 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 3.7 t-20 -57.41 -48.19 97.73 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 120.604 -0.438 . . . . 63.119999999999997 110.899 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 6.7 Cg_exo -78.25 121.04 5.12 Favored 'Trans proline' 0 C--N 1.37 1.66 0 N-CA-C 107.952 -1.595 . . . . 72.230000000000004 107.952 168.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.13 140.79 80.11 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.377 2.052 . . . . 74.25 112.401 -176.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.17 11.59 0.9 Allowed 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.675 0.79 . . . . 62.119999999999997 112.754 -176.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -109.81 -0.16 18.52 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.882 -0.414 . . . . 45.119999999999997 109.882 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' A' ' 476' ' ' GLN . 0.1 OUTLIER -124.65 160.99 27.24 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.645 0.735 . . . . 71.400000000000006 111.473 -173.279 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 426' ' ' GLN . 4.1 m -91.16 132.69 35.91 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.961 -1.472 . . . . 63.539999999999999 109.732 -177.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 27.2 m -132.11 148.4 52.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.949 -0.76 . . . . 63.340000000000003 108.949 177.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -72.75 159.67 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.261 0.553 . . . . 44.100000000000001 111.848 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.0 -27.2 31.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.545 0.688 . . . . 73.310000000000002 109.835 177.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.1 t -88.11 5.12 42.73 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 115.255 -0.884 . . . . 61.310000000000002 109.905 178.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -95.76 136.83 35.66 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.989 -1.486 . . . . 72.530000000000001 106.989 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 65.0 t -82.57 116.36 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 120.942 0.401 . . . . 72.340000000000003 109.99 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.81 118.57 33.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.355 -0.98 . . . . 74.329999999999998 108.355 177.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.78 112.95 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.017 -1.475 . . . . 73.439999999999998 107.017 176.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.477 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -102.65 118.3 49.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.164 -1.051 . . . . 73.540000000000006 108.164 -177.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 28.8 mt -107.45 119.5 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 121.472 0.654 . . . . 74.439999999999998 109.986 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.442 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 22.1 t -97.99 139.26 20.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.446 -0.946 . . . . 71.25 108.446 -178.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -86.87 124.5 7.01 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 111.193 -0.763 . . . . 61.409999999999997 111.193 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.657 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 20.1 t -131.87 103.64 6.43 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.821 -1.177 . . . . 75.25 107.821 177.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.249 0 N-CA-C 109.756 -1.338 . . . . 41.450000000000003 109.756 179.222 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.867 0 N-CA-C 110.136 -1.186 . . . . 61.109999999999999 110.136 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.46 157.47 43.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 122.535 0.334 . . . . 71.319999999999993 111.104 -179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 5.6 t -66.9 131.02 45.02 Favored 'General case' 0 C--O 1.25 1.091 0 N-CA-C 108.577 -0.897 . . . . 63.439999999999998 108.577 173.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -90.29 84.51 6.06 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.461 -0.79 . . . . 74.299999999999997 111.202 -173.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -94.19 131.91 39.28 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.32 -0.993 . . . . 75.239999999999995 108.32 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.41 161.43 27.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 116.54 -0.3 . . . . 43.439999999999998 110.832 -173.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.71 137.08 37.14 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.388 -0.967 . . . . 73.25 108.388 175.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.6 p -98.0 135.14 21.54 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 109.695 -0.483 . . . . 70.519999999999996 109.695 -176.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.6 150.92 86.13 Favored 'Trans proline' 0 C--O 1.25 1.078 0 C-N-CA 122.256 1.97 . . . . 71.310000000000002 112.012 177.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.579 ' OD1' ' HG3' ' A' ' 366' ' ' ARG . 3.2 p30 -79.09 179.75 7.17 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.384 -0.825 . . . . 74.349999999999994 110.674 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.67 26.4 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.294 0 N-CA-C 107.433 -1.321 . . . . 73.439999999999998 107.433 176.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.579 ' HG3' ' OD1' ' A' ' 364' ' ' ASP . 0.9 OUTLIER -66.25 139.47 58.08 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 112.563 0.579 . . . . 74.230000000000004 112.563 -177.272 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.65 0.24 59.28 Favored Glycine 0 C--N 1.307 -1.081 0 N-CA-C 111.577 -0.609 . . . . 44.420000000000002 111.577 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -122.57 -168.12 1.68 Allowed 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 122.907 0.483 . . . . 70.099999999999994 109.718 -178.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 80.6 p -89.1 158.18 18.04 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.757 0.313 . . . . 63.399999999999999 110.548 -176.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 31.1 t -63.37 -33.73 76.18 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.831 -0.803 . . . . 70.310000000000002 108.831 173.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -58.86 -46.1 88.56 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.556 -0.747 . . . . 72.319999999999993 110.83 179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.73 -43.92 87.56 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.491 -0.559 . . . . 72.439999999999998 109.491 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -56.5 -45.85 80.81 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.563 -0.744 . . . . 72.439999999999998 111.788 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.7 mt -60.17 -48.06 89.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 123.382 0.426 . . . . 72.530000000000001 110.853 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -67.35 -47.51 70.24 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.374 0.509 . . . . 71.239999999999995 112.374 -179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.626 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 90.0 m -61.35 -48.07 82.96 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.252 -0.431 . . . . 55.119999999999997 111.492 -177.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.92 -37.84 88.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.703 0.287 . . . . 64.310000000000002 111.398 178.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -60.59 -44.62 96.05 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.402 0.681 . . . . 73.25 109.879 177.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -68.08 -22.64 64.91 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.729 -0.668 . . . . 74.340000000000003 111.284 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 376' ' ' THR . 13.2 mmt180 -84.13 -14.27 50.72 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.088 0.47 . . . . 74.349999999999994 109.843 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.429 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 99.54 4.68 55.95 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.707 -0.679 . . . . 63.450000000000003 112.554 176.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.88 160.54 17.16 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-O 120.84 0.353 . . . . 71.349999999999994 110.487 179.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -101.37 142.82 32.21 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.69 -1.596 . . . . 74.219999999999999 106.69 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.46 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -118.09 132.61 67.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 C-N-CA 119.996 -0.681 . . . . 72.200000000000003 111.384 -178.492 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -109.11 126.51 53.27 Favored 'General case' 0 N--CA 1.407 -2.585 0 N-CA-C 105.751 -1.944 . . . . 70.420000000000002 105.751 176.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.0 m -116.05 118.19 32.2 Favored 'General case' 0 C--N 1.28 -2.415 0 C-N-CA 120.305 -0.558 . . . . 73.519999999999996 110.302 -173.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -118.06 119.18 34.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.097 -1.446 . . . . 65.409999999999997 107.097 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -118.1 133.53 55.82 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 108.956 -0.757 . . . . 73.310000000000002 108.956 178.177 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -139.47 148.85 58.01 Favored Pre-proline 0 C--N 1.283 -2.29 0 N-CA-C 109.432 -0.581 . . . . 63.439999999999998 109.432 178.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.07 136.61 16.51 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 108.158 -1.516 . . . . 74.409999999999997 108.158 167.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.9 t0 -173.15 164.73 4.86 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.032 -2.21 . . . . 63.020000000000003 105.032 -178.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.3 t -115.96 -9.39 11.78 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 118.89 0.768 . . . . 75.129999999999995 110.664 -177.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 2.8 m -79.5 -18.01 52.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.925 0.869 . . . . 75.319999999999993 109.386 -176.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 421' ' ' SER . 9.7 pt -103.48 150.87 38.47 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 114.857 -1.065 . . . . 65.540000000000006 110.333 -178.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 396' ' ' PRO . 46.8 Cg_endo -78.74 -166.74 0.43 Allowed 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 124.425 3.416 . . . . 73.319999999999993 113.123 -174.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 395' ' ' PRO . 9.3 Cg_endo -55.74 163.91 5.03 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.292 2.661 . . . . 71.239999999999995 112.011 168.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.44 -7.89 0.46 Allowed 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.886 1.674 . . . . 51.200000000000003 113.631 -174.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -73.28 116.63 14.05 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.309 -0.997 . . . . 63.539999999999999 108.309 175.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.87 119.2 11.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 115.384 -0.825 . . . . 75.329999999999998 110.817 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.422 HD13 ' HG3' ' A' ' 395' ' ' PRO . 41.2 pt -91.93 -27.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.695 -0.684 . . . . 70.420000000000002 111.682 -177.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.08 158.33 27.65 Favored Glycine 0 N--CA 1.423 -2.19 0 C-N-CA 120.021 -1.085 . . . . 73.329999999999998 110.652 -178.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 19.5 p -113.22 -178.21 3.32 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 109.758 -0.46 . . . . 75.519999999999996 109.758 -178.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.93 131.99 22.65 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 108.338 -0.986 . . . . 65.109999999999999 108.338 -177.068 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -44.32 -32.52 5.29 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 124.521 3.481 . . . . 63.130000000000003 115.158 -176.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -62.0 -26.89 68.49 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-N 116.371 -0.377 . . . . 61.130000000000003 111.581 -177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.54 79.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.44 0.638 . . . . 60.109999999999999 110.579 178.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -88.81 1.07 55.89 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.202 -0.599 . . . . 70.140000000000001 111.118 -178.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.7 m -86.35 150.04 24.61 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.715 -1.217 . . . . 52.539999999999999 107.715 172.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.1 m -74.58 112.43 10.77 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.992 -0.744 . . . . 72.5 108.992 178.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.53 169.98 19.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.859 -0.609 . . . . 72.540000000000006 110.77 -175.208 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.6 t -63.19 142.99 58.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 115.754 -0.657 . . . . 54.530000000000001 109.967 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.96 109.74 2.65 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 109.562 -0.533 . . . . 74.420000000000002 109.562 177.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 106.01 33.56 3.46 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.578 -0.82 . . . . 72.329999999999998 112.079 -178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -90.4 177.26 6.44 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.084 -1.08 . . . . 63.450000000000003 108.084 -179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.04 120.17 36.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.22 0.533 . . . . 72.510000000000005 111.158 -177.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 43.3 mm -104.84 126.03 59.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 107.126 -1.435 . . . . 73.5 107.126 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 15.1 t -93.62 125.21 38.1 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.275 1.036 . . . . 72.030000000000001 111.556 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.6 t -104.02 120.01 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.655 -1.239 . . . . 60.310000000000002 107.655 176.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -94.82 119.11 32.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.813 -0.63 . . . . 51.539999999999999 109.301 178.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 21.5 t -117.22 142.12 32.62 Favored 'Isoleucine or valine' 0 C--O 1.249 1.067 0 CA-C-N 115.617 -0.72 . . . . 75.439999999999998 109.809 -175.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.421 ' HB3' HD12 ' A' ' 394' ' ' ILE . 1.9 p -102.27 121.55 42.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-N 116.071 -0.513 . . . . 44.119999999999997 110.309 177.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 17.1 p -119.75 105.46 11.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 120.236 -0.585 . . . . 61.100000000000001 110.861 175.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 76.93 120.74 0.18 Allowed Glycine 0 CA--C 1.542 1.743 0 C-N-CA 121.143 -0.551 . . . . 53.130000000000003 113.639 178.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 55.7 Cg_endo -75.22 128.95 11.71 Favored 'Trans proline' 0 C--O 1.241 0.675 0 C-N-CA 122.239 1.959 . . . . 54.140000000000001 111.654 176.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -73.33 135.1 44.31 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 113.351 0.871 . . . . 74.420000000000002 113.351 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.5 mt-30 -128.04 142.44 51.22 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.28 -1.378 . . . . 42.119999999999997 107.28 172.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -129.56 151.78 49.8 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.642 -0.873 . . . . 65.010000000000005 108.642 -178.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 39.9 mt-10 -83.45 133.91 34.89 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.886 -0.413 . . . . 74.120000000000005 109.886 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 61.2 mt -81.96 128.53 68.06 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.507 -1.294 . . . . 55.43 107.507 178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.87 140.37 35.03 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 121.141 1.228 . . . . 72.219999999999999 111.122 174.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -92.29 72.62 5.33 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.057 0.932 . . . . 73.129999999999995 110.813 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.1 16.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 113.953 -1.476 . . . . 44.350000000000001 108.454 177.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 19.8 m -81.26 -24.85 37.04 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.991 -1.004 . . . . 71.040000000000006 110.586 -175.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 3.1 p -69.26 -13.73 62.56 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 113.103 0.779 . . . . 72.209999999999994 113.103 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.61 -47.63 72.03 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.642 0.608 . . . . 72.439999999999998 112.642 -177.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.1 m -162.37 137.94 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.394 -0.965 . . . . 75.129999999999995 108.394 -178.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -53.77 -50.12 66.75 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.8 0.44 . . . . 72.439999999999998 111.826 178.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -58.84 -42.98 90.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.361 0.413 . . . . 72.120000000000005 111.076 -179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 72.9 mm-40 -65.41 -41.17 93.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 65.120000000000005 111.17 179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.09 92.15 Favored 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 123.82 0.7 . . . . 74.439999999999998 110.846 -179.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.84 -42.51 85.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.102 -0.499 . . . . 64.510000000000005 109.975 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 34.3 mmtp -67.08 -44.99 78.65 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.288 -0.414 . . . . 70.319999999999993 111.036 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 32.9 mmmt -61.97 -46.28 89.95 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.009 0.193 . . . . 74.150000000000006 110.887 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.99 -42.18 81.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.486 0.551 . . . . 72.519999999999996 112.486 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 64.0 m -62.44 -40.85 97.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.807 -0.442 . . . . 63.539999999999999 109.807 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.45 -29.75 68.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.040000000000006 111.206 178.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.75 -6.75 57.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.144 -0.48 . . . . 73.420000000000002 111.198 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.2 -2.82 33.14 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.06 -0.59 . . . . 73.310000000000002 113.412 175.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -93.63 96.0 9.56 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.665 -0.495 . . . . 74.109999999999999 109.665 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -104.38 -3.91 43.94 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 111.115 -0.794 . . . . 52.140000000000001 111.115 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -93.92 112.08 23.87 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.514 -0.921 . . . . 72.120000000000005 108.514 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.67 150.99 48.68 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 121.469 0.652 . . . . 72.340000000000003 112.011 -175.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 59.1 tptt -134.28 122.41 22.67 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 105.067 -2.197 . . . . 73.340000000000003 105.067 172.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . 0.45 HE21 HG21 ' A' ' 488' ' ' VAL . 60.5 tt0 -97.9 129.81 44.81 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.07 -0.652 . . . . 53.140000000000001 112.435 -174.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -128.69 150.97 50.03 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.142 -1.429 . . . . 65.519999999999996 107.142 175.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.554 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 35.9 m-80 -129.44 149.5 51.19 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.634 -0.506 . . . . 73.129999999999995 109.634 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 29.2 t -128.97 133.61 25.4 Favored Pre-proline 0 C--N 1.283 -2.318 0 N-CA-C 107.438 -1.319 . . . . 73.230000000000004 107.438 177.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 490' ' ' SER . 34.5 Cg_exo -61.9 118.73 5.63 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.493 1.462 . . . . 72.150000000000006 108.622 176.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 26.9 m -128.07 168.27 15.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.188 0.518 . . . . 62.229999999999997 111.852 -172.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 21.0 p -69.55 151.89 96.49 Favored Pre-proline 0 N--CA 1.417 -2.095 0 CA-C-N 114.705 -1.134 . . . . 55.210000000000001 110.452 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 464' ' ' VAL . 9.2 Cg_endo -52.13 -24.48 20.26 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.827 3.018 . . . . 65.519999999999996 114.937 -177.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.44 -30.56 57.42 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 121.721 -0.612 . . . . 74.120000000000005 112.282 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.71 -3.26 49.62 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.178 0.436 . . . . 63.310000000000002 112.178 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 461' ' ' PRO . 11.2 p -60.2 127.16 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.116 0.484 . . . . 71.530000000000001 110.636 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 89.71 -2.57 82.58 Favored Glycine 0 C--O 1.248 1.009 0 CA-C-N 115.773 -0.649 . . . . 53.100000000000001 111.746 177.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -110.66 154.37 23.92 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.019 -0.734 . . . . 40.149999999999999 109.019 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.548 HG22 HD11 ' A' ' 486' ' ' ILE . 57.5 t -84.61 135.06 25.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 N-CA-C 106.644 -1.613 . . . . 54.030000000000001 106.644 175.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.556 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -100.43 -27.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.042 -1.463 . . . . 73.430000000000007 110.687 178.112 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -175.01 163.7 34.0 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.797 -0.921 . . . . 74.109999999999999 110.797 179.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.401 HG22 ' HA ' ' A' ' 486' ' ' ILE . 12.6 p -119.02 154.49 33.01 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.941 -1.133 . . . . 73.0 107.941 177.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.508 ' HB3' ' HB ' ' A' ' 485' ' ' ILE . 24.4 t-20 -69.38 -51.26 17.39 Favored Pre-proline 0 C--N 1.321 -0.67 0 C-N-CA 119.619 -0.833 . . . . 64.099999999999994 110.627 178.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.442 ' HG2' ' HA ' ' A' ' 484' ' ' VAL . 22.5 Cg_exo -68.35 141.32 51.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 107.443 -1.791 . . . . 64.420000000000002 107.443 168.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.19 126.85 19.56 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 122.168 1.912 . . . . 71.409999999999997 112.984 -175.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -83.19 4.47 26.57 Favored 'General case' 0 C--O 1.204 -1.3 0 CA-C-N 115.144 -0.934 . . . . 72.010000000000005 111.785 -175.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.537 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.6 OUTLIER -109.67 -11.62 14.73 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 121.473 0.654 . . . . 75.430000000000007 109.351 175.537 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -114.08 -179.73 3.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.606 1.706 . . . . 72.030000000000001 115.606 -168.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 3.8 m -88.2 116.18 26.22 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 112.866 -1.97 . . . . 72.340000000000003 110.676 -174.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 49.8 m -121.36 148.18 44.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.19 -0.67 . . . . 73.510000000000005 109.19 179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.9 149.18 50.06 Favored 'General case' 0 C--O 1.214 -0.793 0 C-N-CA 122.392 0.277 . . . . 72.099999999999994 111.122 -177.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 43.2 mm -68.9 -26.02 31.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.195 0.521 . . . . 64.5 111.019 -179.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -88.83 -0.5 57.41 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.501 -0.75 . . . . 52.009999999999998 110.049 177.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -70.42 130.94 43.24 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.473 -0.566 . . . . 74.310000000000002 109.473 -176.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.87 113.18 18.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.564 -1.273 . . . . 74.209999999999994 107.564 177.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.442 ' HA ' ' HG2' ' A' ' 472' ' ' PRO . 60.1 t -87.16 120.06 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.128 0 CA-C-O 121.321 0.581 . . . . 74.540000000000006 109.871 -176.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 471' ' ' ASN . 45.4 mt -91.2 112.28 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 105.605 -1.998 . . . . 73.439999999999998 105.605 177.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.2 121.45 60.08 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.667 0 CA-C-N 115.016 -0.993 . . . . 71.150000000000006 108.404 -174.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.455 HG22 HD11 ' A' ' 468' ' ' ILE . 2.4 mp -99.22 117.87 44.97 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 121.767 0.794 . . . . 74.219999999999999 109.049 -177.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.554 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 26.7 t -97.66 141.36 16.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 114.809 -1.087 . . . . 53.409999999999997 108.54 -176.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -89.4 116.81 4.79 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 109.49 -1.444 . . . . 72.140000000000001 109.49 175.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 11.0 t -136.6 138.93 41.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.006 -1.109 . . . . 75.530000000000001 108.006 -179.094 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.562 0 N-CA-C 108.555 -1.818 . . . . 55.420000000000002 108.555 179.675 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.928 0 N-CA-C 110.261 -1.136 . . . . 53.229999999999997 110.261 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -104.22 157.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.977 0.388 . . . . 73.439999999999998 111.842 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 15.0 t -145.39 166.21 26.25 Favored 'General case' 0 N--CA 1.41 -2.458 0 N-CA-C 106.618 -1.623 . . . . 72.140000000000001 106.618 176.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 -87.23 45.36 1.26 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.896 0.855 . . . . 63.210000000000001 111.11 -175.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 411' ' ' SER . 28.1 m-20 -131.67 133.07 44.5 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.491 -1.67 . . . . 71.310000000000002 106.491 178.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 30.4 m -121.97 165.47 17.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 114.682 1.364 . . . . 53.439999999999998 114.682 -166.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -93.11 137.03 32.83 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 106.507 -1.664 . . . . 73.200000000000003 106.507 174.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.66 141.61 23.0 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.109 -0.636 . . . . 74.200000000000003 111.078 -171.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -71.63 129.92 16.34 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.569 1.513 . . . . 62.25 111.435 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 366' ' ' ARG . 8.1 p-10 -80.12 133.78 36.11 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.355 -0.839 . . . . 63.009999999999998 110.372 -179.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.9 t -87.74 47.91 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.443 1.116 . . . . 72.439999999999998 110.513 -172.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 364' ' ' ASP . 10.3 ptm180 -66.88 139.97 57.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.134 -0.939 . . . . 75.25 111.544 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 97.05 0.18 60.15 Favored Glycine 0 N--CA 1.44 -1.073 0 CA-C-N 116.117 -0.492 . . . . 70.040000000000006 112.906 177.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -120.35 175.35 6.01 Favored 'General case' 0 C--N 1.313 -0.983 0 O-C-N 122.509 -0.406 . . . . 74.150000000000006 110.154 -177.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 54.3 p -72.98 157.24 37.8 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 110.218 -0.29 . . . . 43.340000000000003 110.218 -178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.485 ' O ' HG13 ' A' ' 374' ' ' ILE . 14.2 p -59.78 -39.05 83.63 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.848 -0.427 . . . . 72.109999999999999 109.848 177.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.77 93.25 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.412 -0.813 . . . . 63.119999999999997 111.993 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -67.13 -41.99 85.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.807 -0.812 . . . . 74.319999999999993 108.807 -178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.3 78.08 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.421 -0.809 . . . . 64.209999999999994 111.189 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 370' ' ' SER . 98.7 mt -58.63 -44.83 90.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.577 -0.527 . . . . 74.319999999999993 109.577 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -64.0 -32.66 74.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.25 -0.886 . . . . 52.310000000000002 112.063 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 29.1 m -66.12 -48.66 70.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.415 0.626 . . . . 73.099999999999994 109.872 -179.016 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.89 -39.83 91.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.782 -0.645 . . . . 52.340000000000003 110.581 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.6 -44.9 96.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.551 -0.75 . . . . 74.140000000000001 110.668 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -70.08 -21.31 63.15 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.153 0.501 . . . . 44.100000000000001 111.261 179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -86.98 -14.65 41.08 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.158 -0.474 . . . . 72.299999999999997 111.458 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 90.26 8.05 66.89 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.261 -0.971 . . . . 75.0 112.657 178.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -75.36 163.75 27.12 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 109.158 -0.682 . . . . 64.519999999999996 109.158 178.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 46.8 mmtm -103.29 132.85 49.22 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.349 -0.982 . . . . 63.310000000000002 108.349 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.17 153.87 39.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 121.742 0.782 . . . . 62.210000000000001 112.823 -175.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -123.33 128.23 49.64 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.529 -1.669 . . . . 64.329999999999998 106.78 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 22.6 m -106.25 117.75 34.85 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.114 -1.069 . . . . 71.439999999999998 108.114 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 419' ' ' ASN . 3.4 tm? -111.66 118.93 37.0 Favored 'General case' 0 N--CA 1.409 -2.507 0 N-CA-C 107.741 -1.207 . . . . 74.049999999999997 107.741 -176.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.41 122.2 46.52 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.32 -0.993 . . . . 64.319999999999993 108.32 174.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -125.87 136.29 28.23 Favored Pre-proline 0 C--N 1.297 -1.691 0 C-N-CA 120.446 -0.502 . . . . 72.340000000000003 111.706 -176.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.431 ' C ' ' HG3' ' A' ' 425' ' ' GLU . 2.4 Cg_endo -85.51 131.43 4.04 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 122.197 1.932 . . . . 72.519999999999996 108.163 167.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.1 t70 -175.3 -173.67 0.67 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 105.431 -2.063 . . . . 73.5 105.431 -176.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.603 ' OG ' ' HB ' ' A' ' 480' ' ' ILE . 49.7 m -117.36 -6.6 11.24 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-O 121.943 0.877 . . . . 62.210000000000001 109.116 175.032 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.9 m -98.36 35.45 1.78 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.717 -1.586 . . . . 75.340000000000003 106.717 175.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.554 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.4 pp -88.33 146.43 37.86 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 114.893 -1.049 . . . . 73.230000000000004 112.131 -176.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.09 178.44 5.89 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.148 1.899 . . . . 51.130000000000003 109.399 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -71.28 161.37 45.95 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 121.609 1.539 . . . . 75.049999999999997 110.648 172.78 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -9.0 3.52 Favored 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 122.418 1.104 . . . . 75.239999999999995 111.095 175.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -110.42 137.07 48.62 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 105.379 -2.082 . . . . 74.400000000000006 105.379 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.54 118.17 9.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 123.453 0.471 . . . . 45.149999999999999 109.748 -173.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.434 ' O ' HD13 ' A' ' 400' ' ' ILE . 0.0 OUTLIER -92.31 -29.32 4.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 106.769 -1.567 . . . . 55.310000000000002 106.769 178.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -170.66 168.6 41.67 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 108.995 -1.642 . . . . 61.25 108.995 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 403' ' ' ASP . 10.9 m -114.33 -177.07 3.04 Favored 'General case' 0 C--N 1.265 -3.073 0 N-CA-C 106.583 -1.636 . . . . 72.310000000000002 106.583 178.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 402' ' ' THR . 13.9 t70 -97.53 140.06 21.77 Favored Pre-proline 0 C--N 1.26 -3.307 0 N-CA-C 106.852 -1.536 . . . . 71.299999999999997 106.852 -175.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -33.81 -30.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.267 1 C-N-CA 126.209 4.606 . . . . 71.530000000000001 115.53 -177.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -54.18 -29.82 47.16 Favored 'General case' 0 C--O 1.209 -1.056 0 C-N-CA 123.611 0.765 . . . . 74.230000000000004 112.014 178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.87 49.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.917 0.389 . . . . 62.219999999999999 111.612 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -81.56 -0.6 42.9 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 112.837 0.68 . . . . 74.420000000000002 112.837 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 58.8 m -88.37 155.68 19.57 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.12 -1.437 . . . . 54.100000000000001 107.12 172.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.7 m -73.12 114.02 10.82 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.492 0.663 . . . . 74.310000000000002 109.273 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.74 170.29 5.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.305 -0.861 . . . . 63.420000000000002 109.537 -178.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 414' ' ' ASP . 8.5 t -71.01 149.14 46.92 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 109.219 -0.66 . . . . 74.439999999999998 109.219 179.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -66.22 109.66 2.73 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.442 -0.948 . . . . 73.219999999999999 108.442 177.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 90.36 32.62 9.36 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.923 -0.871 . . . . 50.310000000000002 110.923 -176.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 411' ' ' SER . 5.6 t0 -87.05 -174.9 5.13 Favored 'General case' 0 C--O 1.246 0.916 0 N-CA-C 107.831 -1.174 . . . . 62.43 107.831 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 7.9 pt-20 -97.45 138.11 35.39 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.049 0.452 . . . . 74.420000000000002 111.51 -179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 50.9 mm -125.01 124.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 107.933 -1.136 . . . . 51.409999999999997 107.933 175.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 9.7 t -90.86 125.95 35.89 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.846 0.831 . . . . 71.349999999999994 110.533 178.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 60.9 t -114.99 117.71 56.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.15 -1.055 . . . . 70.299999999999997 108.15 -179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 387' ' ' LEU . 5.3 p30 -106.33 129.44 54.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.308 0.575 . . . . 74.239999999999995 112.468 -177.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -121.8 152.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.763 -1.108 . . . . 54.210000000000001 108.588 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 31.1 p -88.56 123.29 32.91 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.672 0.619 . . . . 70.439999999999998 112.672 -174.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 7.0 p -119.87 103.46 9.36 Favored 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.13 -1.028 . . . . 62.409999999999997 110.067 169.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 69.4 141.13 0.12 Allowed Glycine 0 CA--C 1.553 2.428 0 N-CA-C 115.473 0.949 . . . . 51.130000000000003 115.473 177.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 73.8 Cg_endo -85.47 133.65 4.61 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.202 1.935 . . . . 64.010000000000005 110.652 173.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 390' ' ' PRO . 10.0 mt-10 -76.44 145.19 39.45 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 113.167 0.803 . . . . 64.340000000000003 113.167 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.57 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 40.9 mt-30 -120.66 157.23 30.04 Favored 'General case' 0 N--CA 1.408 -2.551 0 CA-C-N 114.183 -1.371 . . . . 74.420000000000002 108.748 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -143.17 156.62 44.81 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.413 -1.329 . . . . 73.439999999999998 107.413 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.8 138.86 33.84 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.132 -1.062 . . . . 72.420000000000002 108.132 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 68.6 mt -79.52 132.14 62.84 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 108.687 -0.857 . . . . 73.540000000000006 108.687 -177.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -53.19 141.53 58.64 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.607 2.205 . . . . 74.140000000000001 113.224 177.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.13 -17.72 48.91 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.505 -1.225 . . . . 73.010000000000005 112.19 -175.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 31.5 m -75.47 5.41 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.448 0.907 . . . . 64.230000000000004 113.448 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 48.3 m -57.29 -48.86 77.84 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.264 0.839 . . . . 71.319999999999993 113.264 -175.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 52.5 m -68.92 -13.91 62.72 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 122.973 0.509 . . . . 62.420000000000002 112.365 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 87.1 mt -70.16 -45.51 66.61 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.61 0.596 . . . . 73.040000000000006 112.61 -175.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 439' ' ' GLU . 48.1 m -162.73 145.22 10.72 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.525 -1.287 . . . . 51.219999999999999 107.525 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -56.84 -42.93 80.56 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.792 0.329 . . . . 64.329999999999998 111.102 177.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . 0.539 ' O ' ' HG2' ' A' ' 442' ' ' LYS . . . -62.62 -36.76 83.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 55.109999999999999 111.048 179.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 436' ' ' THR . 6.5 tp10 -67.8 -44.77 76.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.07 -0.715 . . . . 64.340000000000003 109.07 -178.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.92 -51.18 70.36 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.545 -1.207 . . . . 72.230000000000004 110.773 -179.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.43 -38.29 80.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 113.439 0.903 . . . . 74.109999999999999 113.439 -177.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 438' ' ' ALA . 74.8 mmtt -65.3 -49.02 71.11 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 119.9 -0.72 . . . . 74.319999999999993 110.166 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.01 -42.57 84.74 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.116 0.784 . . . . 74.299999999999997 113.116 -177.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.37 -43.69 76.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.231 0.456 . . . . 71.5 112.231 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 90.5 m -63.31 -41.86 98.97 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 120.951 0.405 . . . . 72.299999999999997 110.628 -179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.0 -24.64 62.42 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.96 -0.564 . . . . 61.299999999999997 111.602 -179.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.56 -5.83 59.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 70.209999999999994 111.453 -179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 111.59 -17.73 25.47 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.473 -0.87 . . . . 63.030000000000001 112.204 178.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -81.04 67.89 7.12 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.201 0.524 . . . . 65.25 109.921 -179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -96.2 32.49 6.38 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.67 -0.972 . . . . 73.439999999999998 110.67 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.1 mmm-85 -118.7 110.42 17.26 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.023 -1.843 . . . . 65.120000000000005 106.023 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.89 154.15 47.6 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.339 1.066 . . . . 74.299999999999997 113.084 -176.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.58 123.11 12.44 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 104.998 -2.223 . . . . 74.430000000000007 104.998 168.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -98.11 135.34 39.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.207 0.527 . . . . 74.329999999999998 111.469 -172.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.448 ' C ' HD22 ' A' ' 456' ' ' ASN . . . -127.09 148.01 50.15 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.425 -1.324 . . . . 65.420000000000002 107.425 174.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 455' ' ' ALA . 0.9 OUTLIER -124.44 141.42 52.09 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.088 -1.078 . . . . 63.520000000000003 108.088 178.253 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 49.2 m -140.36 147.14 48.51 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 108.862 -0.792 . . . . 51.439999999999998 108.862 176.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.652 ' HA ' ' O ' ' A' ' 490' ' ' SER . 33.8 Cg_exo -61.45 129.66 28.95 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.708 2.272 . . . . 74.450000000000003 111.678 -176.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 49.6 m -145.83 164.68 31.16 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 111.035 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.5 t -61.37 144.6 91.75 Favored Pre-proline 0 N--CA 1.442 -0.864 0 O-C-N 124.27 0.981 . . . . 74.120000000000005 110.463 178.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.37 -34.28 31.93 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.996 3.131 . . . . 74.219999999999999 113.832 -178.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.77 -15.3 62.66 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.381 0.511 . . . . 75.530000000000001 112.381 -177.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 -8.52 14.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.504 -0.316 . . . . 71.439999999999998 111.775 176.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 81.3 t -60.35 126.94 19.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 120.953 0.406 . . . . 74.319999999999993 110.546 176.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 93.87 -3.16 70.36 Favored Glycine 0 C--O 1.247 0.953 0 N-CA-C 110.962 -0.855 . . . . 75.099999999999994 110.962 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -116.38 155.44 28.48 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 108.086 -1.079 . . . . 75.310000000000002 108.086 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 486' ' ' ILE . 45.5 t -84.57 127.36 39.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.511 -0.551 . . . . 62.420000000000002 109.511 -178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.85 -18.14 6.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.929 -0.708 . . . . 74.120000000000005 111.405 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -179.19 161.7 28.04 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.574 -0.822 . . . . 53.509999999999998 111.708 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 486' ' ' ILE . 15.9 p -132.92 155.47 49.01 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.366 -1.346 . . . . 71.530000000000001 107.366 177.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -59.53 -57.85 23.87 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 120.516 -0.474 . . . . 73.329999999999998 110.103 176.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -81.19 125.21 5.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 N-CA-C 109.09 -1.158 . . . . 74.519999999999996 109.09 171.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -62.36 144.17 94.7 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.057 1.838 . . . . 72.109999999999999 112.044 -177.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -73.29 5.98 3.21 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.159 0.984 . . . . 65.319999999999993 112.674 -174.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -109.0 -14.51 14.54 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 116.176 -0.466 . . . . 71.25 110.029 176.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.97 150.64 20.18 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.156 0.979 . . . . 74.239999999999995 111.717 -172.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 426' ' ' GLN . 19.4 m -85.23 111.42 19.82 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 113.588 -1.642 . . . . 63.350000000000001 107.769 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 21.0 m -118.19 148.56 42.25 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.917 -0.583 . . . . 73.120000000000005 110.036 -175.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.58 146.72 52.82 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 122.587 0.355 . . . . 70.430000000000007 110.781 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.603 ' HB ' ' OG ' ' A' ' 392' ' ' SER . 48.3 mm -67.21 -14.68 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 CA-C-O 122.171 0.986 . . . . 71.129999999999995 110.306 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 9.0 t -92.16 5.52 50.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.603 -0.726 . . . . 63.409999999999997 110.358 178.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 0.9 OUTLIER -89.66 133.76 34.49 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 110.062 -0.347 . . . . 72.329999999999998 110.062 178.399 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.4 t -85.56 122.32 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.855 -1.165 . . . . 71.209999999999994 107.855 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.77 119.79 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 C-N-CA 120.19 -0.604 . . . . 75.319999999999993 109.49 -178.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.35 112.51 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.596 -2.372 . . . . 75.510000000000005 104.596 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -107.73 118.93 56.43 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 114.959 -1.018 . . . . 62.539999999999999 108.754 -173.528 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' A' ' 455' ' ' ALA . 41.2 mt -100.16 116.49 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 108.994 -0.743 . . . . 73.230000000000004 108.994 -177.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.9 t -97.6 138.14 23.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.692 -1.225 . . . . 73.519999999999996 107.692 -177.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -79.48 114.69 3.93 Favored Glycine 0 N--CA 1.418 -2.519 0 N-CA-C 109.285 -1.526 . . . . 44.210000000000001 109.285 177.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.652 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 43.7 m -142.9 143.93 32.23 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 122.009 -0.7 . . . . 62.020000000000003 109.667 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.364 0 N-CA-C 108.693 -1.763 . . . . 51.0 108.693 178.252 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.86 0 N-CA-C 111.171 -0.771 . . . . 43.32 111.171 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.47 157.75 23.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 116.829 0.314 . . . . 70.140000000000001 111.075 178.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 8.4 t -132.47 162.86 30.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.457 -0.571 . . . . 64.340000000000003 109.457 -178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 358' ' ' ARG . 3.5 mmp_? -114.21 92.96 4.14 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.608 0.718 . . . . 70.040000000000006 110.046 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -117.88 145.15 44.83 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 106.675 -1.602 . . . . 70.510000000000005 106.675 177.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.94 149.38 30.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.585 0.231 . . . . 74.420000000000002 110.45 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -95.8 136.48 36.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.637 -0.875 . . . . 74.109999999999999 108.637 177.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 363' ' ' PRO . 8.6 p -97.86 127.49 37.04 Favored Pre-proline 0 C--N 1.299 -1.611 0 C-N-CA 120.329 -0.548 . . . . 74.010000000000005 110.389 -175.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 362' ' ' VAL . 74.4 Cg_exo -56.05 148.83 56.34 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 123.086 2.524 . . . . 33.450000000000003 113.388 179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 146.3 53.03 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 115.392 -0.822 . . . . 73.439999999999998 111.493 -178.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.53 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 24.2 m -96.37 25.31 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 122.337 1.065 . . . . 72.040000000000006 109.659 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -65.32 137.17 57.35 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.778 -1.101 . . . . 75.439999999999998 111.995 -177.276 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.43 0.91 47.06 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.451 -0.88 . . . . 63.039999999999999 114.001 176.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 1.8 pt20 -125.83 -172.16 2.54 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.193 -0.669 . . . . 55.219999999999999 109.193 -178.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 80.3 p -90.11 164.48 14.45 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.81 -0.756 . . . . 62.310000000000002 109.701 179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 374' ' ' ILE . 3.8 p -62.09 -33.61 74.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.798 0.332 . . . . 74.239999999999995 110.305 175.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.66 98.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.794 -0.639 . . . . 63.119999999999997 109.962 176.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -65.56 -41.9 92.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.321 -0.4 . . . . 72.25 110.108 178.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.54 -51.29 70.07 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.763 0.665 . . . . 72.219999999999999 110.47 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 370' ' ' SER . 91.0 mt -60.25 -46.51 94.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.646 -0.706 . . . . 71.540000000000006 110.046 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.29 -46.99 84.18 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.105 -0.498 . . . . 74.200000000000003 111.905 -178.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 32.7 m -64.83 -47.84 76.5 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.516 -0.311 . . . . 72.049999999999997 110.431 -177.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.17 -38.01 89.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.561 -0.29 . . . . 73.120000000000005 111.695 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -59.77 -46.92 87.67 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.601 0.76 . . . . 71.209999999999994 109.11 177.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -67.97 -30.73 70.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.558 -0.746 . . . . 72.349999999999994 111.193 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -80.09 -11.29 59.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.839 -0.619 . . . . 63.43 111.917 178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 92.72 12.46 58.04 Favored Glycine 0 CA--C 1.497 -1.034 0 C-N-CA 120.284 -0.96 . . . . 40.109999999999999 112.953 174.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -89.21 146.46 24.74 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.972 0.415 . . . . 72.319999999999993 109.954 179.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 34.0 mmtp -88.3 132.82 34.25 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 105.832 -1.914 . . . . 70.219999999999999 105.832 -178.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 141.45 45.32 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 119.899 -0.72 . . . . 73.310000000000002 111.674 -177.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -115.99 127.98 55.37 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.175 -1.417 . . . . 73.319999999999993 107.175 177.179 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.6 m -101.06 119.27 38.5 Favored 'General case' 0 N--CA 1.415 -2.201 0 C-N-CA 119.597 -0.841 . . . . 71.120000000000005 109.709 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -111.73 119.65 39.36 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.64 -1.244 . . . . 73.439999999999998 107.64 -179.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.482 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -96.27 122.6 39.31 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.648 -0.706 . . . . 63.420000000000002 109.25 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -123.79 115.89 27.87 Favored Pre-proline 0 C--N 1.291 -1.976 0 CA-C-N 115.737 -0.665 . . . . 73.439999999999998 111.883 -177.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.59 134.7 6.62 Favored 'Trans proline' 0 C--O 1.253 1.24 0 C-N-CA 122.18 1.92 . . . . 33.439999999999998 110.569 174.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 8.5 t70 175.71 -168.42 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 105.396 -2.076 . . . . 74.040000000000006 105.396 179.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 49.6 m -132.43 -11.0 3.2 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 118.38 0.537 . . . . 74.25 111.42 176.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 44.9 p -99.13 14.35 29.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.357 1.075 . . . . 61.399999999999999 109.5 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.401 ' HB ' ' OG ' ' A' ' 421' ' ' SER . 1.5 pp -88.59 152.6 49.59 Favored Pre-proline 0 C--N 1.294 -1.834 0 CA-C-N 113.877 -1.511 . . . . 71.519999999999996 112.583 -176.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.66 138.65 70.93 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.152 1.901 . . . . 72.310000000000002 109.921 174.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.25 154.5 40.05 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.796 2.33 . . . . 64.120000000000005 111.893 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -61.32 -8.48 3.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.506 0.67 . . . . 74.530000000000001 111.866 -178.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 35.6 m170 -95.66 109.19 21.5 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 105.143 -2.169 . . . . 74.209999999999994 105.143 172.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 6.1 p -62.8 119.11 5.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 122.232 1.015 . . . . 61.350000000000001 112.85 -169.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 23.9 pt -95.46 -29.02 3.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 114.063 -1.426 . . . . 73.5 110.504 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.54 28.88 Favored Glycine 0 N--CA 1.419 -2.45 0 N-CA-C 110.029 -1.228 . . . . 63.409999999999997 110.029 -178.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 -175.23 2.63 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.874 -0.787 . . . . 61.329999999999998 108.874 -177.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -100.31 140.93 21.83 Favored Pre-proline 0 C--N 1.283 -2.307 0 CA-C-N 115.777 -0.647 . . . . 75.319999999999993 109.795 -172.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -48.27 -24.77 6.24 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 125.077 3.852 . . . . 43.350000000000001 115.059 -177.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.01 -29.34 69.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.591 0.234 . . . . 53.420000000000002 110.981 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.33 57.96 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 121.673 0.749 . . . . 44.210000000000001 110.13 178.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.4 -9.68 59.65 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.359 -0.837 . . . . 70.209999999999994 110.733 -178.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 52.2 m -87.53 151.08 23.29 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.613 -0.884 . . . . 73.430000000000007 108.613 177.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 66.3 m -74.17 116.81 15.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.412 0.625 . . . . 54.299999999999997 109.636 177.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.09 169.97 19.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.444 -0.798 . . . . 73.150000000000006 109.501 -177.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 23.0 t -79.02 155.4 28.85 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.746 -1.205 . . . . 73.519999999999996 107.746 176.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -69.3 110.74 4.79 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 110.244 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.07 37.7 1.63 Allowed Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.585 -0.734 . . . . 34.219999999999999 111.707 -178.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -91.31 178.57 5.93 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 107.722 -1.214 . . . . 65.239999999999995 107.722 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 44.0 mt-10 -100.19 108.97 21.22 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.253 0.549 . . . . 74.129999999999995 111.525 -176.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.01 126.78 55.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.377 -1.342 . . . . 70.129999999999995 107.377 177.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 72.5 p -90.71 123.49 34.34 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 120.296 -0.562 . . . . 52.119999999999997 109.763 -178.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 96.1 t -97.34 121.07 47.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.18 -1.045 . . . . 74.140000000000001 108.18 -179.45 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -92.24 124.6 36.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.313 -0.625 . . . . 71.510000000000005 109.313 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 7.7 p -126.26 131.03 71.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 107.89 -1.152 . . . . 72.150000000000006 107.89 175.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 394' ' ' ILE . 39.9 m -94.4 122.13 36.65 Favored 'General case' 0 C--N 1.284 -2.255 0 C-N-CA 119.413 -0.915 . . . . 74.040000000000006 108.945 179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 19.8 m -119.36 107.07 12.92 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 115.527 -0.761 . . . . 74.540000000000006 110.623 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 80.02 147.5 4.65 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 121.244 -0.503 . . . . 54.409999999999997 113.482 177.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 86.4 Cg_endo -85.01 154.48 11.22 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 122.186 1.924 . . . . 74.340000000000003 110.762 174.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 479' ' ' ALA . 4.5 mm-40 -83.43 126.64 32.96 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 119.97 -0.692 . . . . 72.010000000000005 111.347 176.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 48.3 mt-30 -100.7 127.69 47.01 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.616 -1.253 . . . . 73.540000000000006 107.616 175.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 449' ' ' PHE . 10.1 tpt180 -122.2 149.41 43.7 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.941 -1.133 . . . . 70.409999999999997 107.941 -173.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -83.11 138.61 33.61 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 122.83 0.452 . . . . 75.319999999999993 111.423 -176.511 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.425 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.9 mt -89.6 131.38 40.13 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 109.849 -0.426 . . . . 75.209999999999994 109.849 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 429' ' ' ILE . 16.6 Cg_exo -70.36 141.73 43.54 Favored 'Trans proline' 0 CA--C 1.55 1.31 0 C-N-CA 123.152 2.568 . . . . 53.049999999999997 113.443 176.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.01 -22.25 31.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.913 0.885 . . . . 42.43 110.061 -178.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.21 -3.55 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 121.877 0.846 . . . . 62.109999999999999 111.223 -175.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 8.7 p -61.03 -31.87 71.49 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.222 1.009 . . . . 74.319999999999993 111.409 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 66.4 m -67.38 -26.58 66.53 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.707 0.803 . . . . 72.109999999999999 112.537 -178.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 85.7 mt -76.34 -41.67 47.56 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.583 0.586 . . . . 72.439999999999998 112.583 -172.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 2.5 m -148.01 139.72 23.84 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.135 -0.691 . . . . 64.129999999999995 109.135 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -61.19 -38.86 88.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.669 -0.493 . . . . 74.510000000000005 109.669 176.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -61.13 -47.74 84.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.773 -0.649 . . . . 74.420000000000002 110.336 178.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.38 -36.61 84.28 Favored 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 123.192 0.307 . . . . 64.239999999999995 111.649 177.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.42 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.43 -51.35 69.85 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 110.086 -0.338 . . . . 45.310000000000002 110.086 178.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.85 -45.76 90.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.278 -0.419 . . . . 54.439999999999998 110.657 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -63.45 -47.41 81.98 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 112.477 0.547 . . . . 73.430000000000007 112.477 -177.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -66.28 -40.87 90.35 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 111.837 0.31 . . . . 72.409999999999997 111.837 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.62 -43.44 89.57 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.552 -0.459 . . . . 74.420000000000002 110.908 177.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 75.5 m -62.68 -40.49 97.28 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 110.015 -0.365 . . . . 72.420000000000002 110.015 178.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.2 -26.52 64.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.265 -0.425 . . . . 62.340000000000003 111.965 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -84.96 -13.65 50.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.749 -0.205 . . . . 73.239999999999995 111.25 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 112.48 -0.03 26.33 Favored Glycine 0 C--N 1.319 -0.409 0 C-N-CA 120.267 -0.968 . . . . 63.420000000000002 113.023 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 427' ' ' ARG . 81.5 m-85 -83.62 106.91 15.72 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 122.527 -0.396 . . . . 75.219999999999999 110.016 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.4 19.3 13.08 Favored Glycine 0 C--N 1.297 -1.606 0 N-CA-C 110.009 -1.236 . . . . 24.350000000000001 110.009 176.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -113.12 111.02 21.4 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.172 -1.788 . . . . 63.100000000000001 106.172 -178.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -131.46 148.66 52.66 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.398 0.618 . . . . 72.450000000000003 111.63 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -142.16 123.04 14.41 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.935 -1.505 . . . . 73.420000000000002 106.935 172.2 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -104.1 135.76 45.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.916 0.339 . . . . 74.099999999999994 111.916 -173.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -138.66 156.15 47.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.71 -0.478 . . . . 33.310000000000002 109.71 175.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -120.78 137.96 54.26 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.799 -0.815 . . . . 74.439999999999998 108.799 -179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 47.6 m -141.55 147.66 46.96 Favored Pre-proline 0 C--N 1.295 -1.77 0 C-N-CA 120.482 -0.487 . . . . 70.310000000000002 111.14 178.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_endo -65.98 125.49 14.26 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.973 2.449 . . . . 65.310000000000002 111.328 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 491' ' ' GLY . 16.5 t -138.88 -176.49 4.51 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.318 -1.364 . . . . 61.43 107.318 -176.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 14.6 m -56.64 129.79 76.81 Favored Pre-proline 0 N--CA 1.438 -1.07 0 N-CA-C 108.898 -0.778 . . . . 52.109999999999999 108.898 177.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -50.01 -25.64 12.93 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 C-N-CA 124.023 3.149 . . . . 52.43 114.262 -178.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.41 -24.36 57.12 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.801 0.334 . . . . 72.319999999999993 111.683 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.4 mp -97.64 12.18 34.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.639 -0.255 . . . . 45.32 111.51 -175.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . . . . . . . . . 7.5 p -59.55 126.39 17.18 Favored 'Isoleucine or valine' 0 C--O 1.253 1.256 0 CA-C-O 121.849 0.833 . . . . 63.100000000000001 110.787 177.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 94.17 -6.86 72.51 Favored Glycine 0 C--N 1.306 -1.106 0 CA-C-N 115.194 -0.912 . . . . 72.030000000000001 111.74 -179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -100.88 152.21 20.8 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.627 -0.508 . . . . 73.299999999999997 109.627 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.482 HG22 HD11 ' A' ' 486' ' ' ILE . 58.4 t -84.6 136.64 22.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.828 -0.805 . . . . 71.310000000000002 108.828 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.04 -16.59 7.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.179 -1.008 . . . . 71.439999999999998 110.734 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 149.91 -179.27 26.81 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 115.38 -0.827 . . . . 74.319999999999993 111.714 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 6.9 p -116.82 161.87 18.6 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.286 -1.376 . . . . 75.109999999999999 107.286 178.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.17 -54.58 32.12 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.801 -1.16 . . . . 74.030000000000001 110.602 179.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -71.43 120.39 6.92 Favored 'Trans proline' 0 C--N 1.372 1.811 0 N-CA-C 105.963 -2.36 . . . . 60.229999999999997 105.963 166.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 475' ' ' ASN . 32.7 Cg_endo -62.68 158.76 40.26 Favored 'Trans proline' 0 C--N 1.329 -0.45 0 C-N-CA 122.173 1.915 . . . . 62.439999999999998 113.798 -171.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.425 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -71.6 11.82 0.44 Allowed 'General case' 0 C--O 1.21 -0.975 0 CA-C-O 122.377 1.084 . . . . 51.109999999999999 111.6 178.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.51 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.7 OUTLIER -109.13 -8.09 15.21 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.725 -1.213 . . . . 64.319999999999993 107.725 179.354 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -100.39 159.66 14.96 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.072 -0.967 . . . . 71.010000000000005 111.99 -171.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 9.1 m -114.66 108.12 16.39 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.428 -1.693 . . . . 74.099999999999994 106.428 177.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.8 p -112.24 143.19 43.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 122.128 -0.358 . . . . 64.540000000000006 111.954 -175.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 425' ' ' GLU . . . -63.99 144.37 57.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.034 -0.53 . . . . 72.420000000000002 110.34 176.051 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 50.0 mm -65.17 -4.57 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.424 1.089 . . . . 42.409999999999997 111.758 -178.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.7 p -87.17 -5.88 58.83 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 121.321 -0.862 . . . . 75.109999999999999 110.377 178.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -92.46 139.05 30.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.795 -0.639 . . . . 75.239999999999995 109.405 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.42 122.2 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.496 -1.668 . . . . 72.430000000000007 106.496 176.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 45.7 t -86.52 120.35 36.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.875 -0.787 . . . . 74.430000000000007 108.875 -175.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 121.08 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.87 0 N-CA-C 108.056 -1.09 . . . . 71.519999999999996 108.056 -177.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -110.25 118.04 56.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 115.171 -0.922 . . . . 70.109999999999999 108.78 -177.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.29 119.24 48.11 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-N 115.414 -0.812 . . . . 71.319999999999993 109.482 -177.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 35.6 t -97.63 133.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.246 -1.39 . . . . 64.230000000000004 107.246 179.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -78.02 125.25 7.11 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 111.425 -0.67 . . . . 72.530000000000001 111.425 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 23.2 t -129.52 107.01 9.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.553 -1.647 . . . . 71.450000000000003 106.553 177.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 459' ' ' SER . . . . . . . . 0 N--CA 1.416 -2.638 0 CA-C-O 118.478 -1.179 . . . . 74.150000000000006 111.45 -174.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.247 -1.141 . . . . 51.049999999999997 110.247 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -106.82 156.99 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 116.871 0.336 . . . . 71.239999999999995 110.925 -179.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 17.7 m -114.75 132.26 56.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.934 -0.765 . . . . 71.420000000000002 108.934 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 56.2 mtp85 -102.17 28.1 6.12 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.341 1.067 . . . . 74.129999999999995 110.626 -177.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -114.03 146.41 40.22 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 106.374 -1.713 . . . . 53.219999999999999 106.374 178.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 31.2 m -117.5 162.24 15.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-O 120.893 0.378 . . . . 72.230000000000004 110.992 -172.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -95.01 136.31 35.48 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.856 -1.164 . . . . 60.350000000000001 107.856 178.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.83 130.9 27.84 Favored Pre-proline 0 C--N 1.287 -2.143 0 N-CA-C 109.077 -0.712 . . . . 64.109999999999999 109.077 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -62.39 117.61 4.48 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 121.335 1.356 . . . . 72.109999999999999 109.023 175.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.28 166.81 22.26 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.454 -0.794 . . . . 74.540000000000006 109.965 -176.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.72 40.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 CA-C-O 122.954 1.359 . . . . 52.140000000000001 111.859 -168.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -66.3 145.81 55.31 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.929 -1.032 . . . . 74.239999999999995 110.449 172.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 105.71 0.51 39.68 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 114.33 0.492 . . . . 74.109999999999999 114.33 179.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . 0.285 0.5 OUTLIER -145.71 172.1 13.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 117.68 0.74 . . . . 70.099999999999994 112.804 175.592 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 88.3 p -54.12 154.7 4.09 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.811 1.244 . . . . 74.319999999999993 113.261 -175.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 9.1 p -57.69 -38.86 75.91 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.439 -0.8 . . . . 73.140000000000001 111.267 177.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -63.59 -46.75 84.38 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.428 -0.351 . . . . 45.310000000000002 111.052 -179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -69.43 -37.03 77.22 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.103 0.478 . . . . 53.130000000000003 109.74 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.89 67.92 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.446 -0.797 . . . . 62.200000000000003 111.48 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.24 -43.95 97.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.79 -0.641 . . . . 55.450000000000003 111.367 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.38 -36.27 83.16 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.917 0.339 . . . . 71.120000000000005 111.917 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 60.9 m -65.89 -47.61 74.24 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.011 0.434 . . . . 75.129999999999995 110.629 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.98 -38.51 91.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.011 -0.541 . . . . 72.150000000000006 110.802 178.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -59.35 -42.73 92.22 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.138 0.975 . . . . 71.010000000000005 109.601 176.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -68.02 -30.68 69.97 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.965 -0.561 . . . . 73.430000000000007 112.29 178.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -80.97 -9.81 59.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 120.833 0.349 . . . . 65.310000000000002 111.397 176.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 95.15 12.64 54.6 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.864 -0.607 . . . . 73.340000000000003 113.526 173.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -91.29 149.18 21.86 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.12 0.486 . . . . 75.329999999999998 110.514 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 24.4 mmtp -90.5 137.06 32.65 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.167 -1.79 . . . . 73.239999999999995 106.167 -176.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 384' ' ' ILE . 0.2 OUTLIER -119.21 139.56 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 C-N-CA 118.969 -1.092 . . . . 75.129999999999995 113.526 -175.459 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -111.31 144.76 39.98 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.638 -1.616 . . . . 73.109999999999999 106.638 172.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 18.2 m -132.43 124.65 29.03 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.412 -0.958 . . . . 73.439999999999998 108.412 178.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -115.1 119.81 37.67 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.106 -1.442 . . . . 71.219999999999999 107.106 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.585 ' N ' HE21 ' A' ' 388' ' ' GLN . 0.0 OUTLIER -111.36 135.5 51.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.343 -0.614 . . . . 72.310000000000002 109.343 -178.971 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 391' ' ' ASP . 19.6 ptmt -139.81 132.93 15.25 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.237 -0.585 . . . . 74.200000000000003 111.797 176.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 389' ' ' LYS . 6.6 Cg_exo -78.64 140.15 16.47 Favored 'Trans proline' 0 C--O 1.242 0.703 0 C-N-CA 122.371 2.047 . . . . 74.150000000000006 109.018 167.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 394' ' ' ILE . 9.1 t70 -170.42 -174.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.716 -1.587 . . . . 73.140000000000001 106.716 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 t -108.53 -34.84 6.63 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.714 -1.217 . . . . 74.239999999999995 107.714 177.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.1 p -87.62 40.19 0.92 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.911 0.862 . . . . 71.129999999999995 110.033 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.631 HG23 ' HB3' ' A' ' 391' ' ' ASP . 23.2 pt -88.23 141.89 31.27 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.139 -0.937 . . . . 44.409999999999997 111.85 -176.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 172.79 15.56 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 N-CA-C 106.983 -1.968 . . . . 64.409999999999997 106.983 167.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.15 147.42 66.73 Favored 'Trans proline' 0 C--O 1.209 -0.941 0 C-N-CA 121.373 1.382 . . . . 73.340000000000003 110.778 176.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.0 -7.16 10.58 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 122.158 0.98 . . . . 61.409999999999997 111.816 178.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -84.28 121.22 27.19 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 103.691 -2.707 . . . . 74.530000000000001 103.691 173.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.61 117.1 3.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.512 0.672 . . . . 71.010000000000005 110.372 -170.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.35 -28.18 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-N 114.893 -1.049 . . . . 71.120000000000005 109.39 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.68 157.82 27.48 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 109.374 -1.49 . . . . 54.149999999999999 109.374 -178.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.8 p -128.11 -174.8 3.31 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 123.679 0.792 . . . . 72.120000000000005 110.663 -173.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -99.65 129.13 29.51 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.648 -1.241 . . . . 60.43 107.648 -176.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -50.62 -27.75 20.33 Favored 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 124.202 3.268 . . . . 61.329999999999998 115.193 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -61.07 -26.0 67.34 Favored 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 111.926 0.343 . . . . 54.43 111.926 -178.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.73 -36.03 81.5 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.756 0.788 . . . . 72.200000000000003 109.925 176.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -90.26 -2.25 58.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.543 -0.753 . . . . 73.209999999999994 111.216 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 34.7 m -91.31 165.14 13.59 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.061 -1.459 . . . . 71.140000000000001 107.061 174.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 56.9 p -74.36 113.63 11.81 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.177 0.513 . . . . 74.450000000000003 111.297 -178.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 24.3 m -121.84 163.84 19.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.73 -0.668 . . . . 65.340000000000003 109.466 177.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.7 m -77.7 157.99 29.86 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.514 -0.55 . . . . 41.219999999999999 109.514 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -68.27 109.74 3.74 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.385 -0.598 . . . . 61.409999999999997 109.385 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 97.29 25.49 11.03 Favored Glycine 0 N--CA 1.435 -1.41 0 C-N-CA 120.804 -0.712 . . . . 64.510000000000005 112.492 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.6 -172.16 3.7 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.261 -1.015 . . . . 72.310000000000002 108.261 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 13.0 pt-20 -107.77 139.41 42.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 118.665 0.666 . . . . 74.140000000000001 112.169 -176.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.9 mm -123.06 136.52 59.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.753 -1.203 . . . . 65.420000000000002 107.753 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 10.8 t -108.37 130.93 55.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.611 0.719 . . . . 71.450000000000003 110.675 -179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 67.5 t -113.79 127.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.182 -0.917 . . . . 65.25 108.555 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -97.6 127.9 43.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.337 -0.616 . . . . 64.200000000000003 109.337 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 64.0 t -120.96 143.74 32.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.275 -1.009 . . . . 72.329999999999998 108.275 -177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 5.6 p -100.79 122.6 43.67 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 109.176 -0.675 . . . . 63.200000000000003 109.176 178.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 21.1 p -118.64 105.12 11.27 Favored 'General case' 0 N--CA 1.422 -1.871 0 C-N-CA 119.662 -0.815 . . . . 72.200000000000003 111.522 -178.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 424' ' ' PRO . . . 72.65 152.22 1.66 Allowed Glycine 0 CA--C 1.546 1.999 0 N-CA-C 114.936 0.735 . . . . 74.430000000000007 114.936 177.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 6.2 Cg_exo -80.76 148.32 17.66 Favored 'Trans proline' 0 N--CA 1.441 -1.562 0 C-N-CA 122.296 1.998 . . . . 70.430000000000007 110.506 173.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.65 150.61 42.84 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.861 -0.609 . . . . 75.510000000000005 111.934 179.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.5 ' HB3' HG22 ' A' ' 477' ' ' THR . 43.9 mt-30 -125.78 145.59 50.14 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.439 -0.949 . . . . 72.129999999999995 108.439 174.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.471 ' HB2' HD11 ' A' ' 480' ' ' ILE . 4.7 tpt180 -148.15 156.92 43.16 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.013 -1.106 . . . . 71.430000000000007 108.013 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 44.5 tt0 -83.45 136.56 34.26 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.923 -0.399 . . . . 74.200000000000003 109.923 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.06 131.08 52.28 Favored Pre-proline 0 N--CA 1.431 -1.423 0 N-CA-C 106.762 -1.57 . . . . 75.099999999999994 106.762 176.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.455 ' CG ' ' HB3' ' A' ' 443' ' ' LYS . 32.1 Cg_endo -70.11 141.3 43.45 Favored 'Trans proline' 0 N--CA 1.437 -1.81 0 C-N-CA 121.119 1.212 . . . . 65.430000000000007 110.656 175.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.36 -5.63 56.72 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.219 0.533 . . . . 75.040000000000006 111.743 -175.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 430' ' ' PRO . 34.2 m -76.7 -3.83 5.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.063 -0.517 . . . . 75.310000000000002 111.019 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.9 m -59.98 -27.58 66.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.337 0.589 . . . . 41.32 110.786 178.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 37.6 p -69.15 -12.54 61.76 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.516 -0.766 . . . . 75.019999999999996 112.324 179.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 89.2 mt -77.99 -47.66 17.99 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 112.795 0.665 . . . . 74.439999999999998 112.795 -177.153 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 27.0 m -153.77 141.06 19.6 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.662 -0.649 . . . . 62.329999999999998 109.921 -177.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -56.18 -50.78 70.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.995 0.518 . . . . 72.219999999999999 112.208 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.32 -45.21 76.35 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.247 0.546 . . . . 63.100000000000001 111.22 179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -69.38 -38.51 78.06 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 115.001 -0.999 . . . . 74.349999999999994 110.337 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.28 -47.26 86.78 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.382 0.426 . . . . 64.340000000000003 110.328 179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.47 -45.73 93.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.102 -0.499 . . . . 65.209999999999994 110.585 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.59 -41.63 88.2 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.753 0.279 . . . . 53.340000000000003 111.753 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.455 ' HB3' ' CG ' ' A' ' 430' ' ' PRO . 72.1 mmtt -62.77 -42.1 99.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.767 0.318 . . . . 54.530000000000001 111.616 178.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.31 -39.53 82.0 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.275 -0.421 . . . . 64.510000000000005 111.248 176.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 63.5 m -62.54 -39.58 94.05 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 109.573 -0.528 . . . . 73.040000000000006 109.573 177.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -68.81 -26.63 65.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.628 . . . . 65.349999999999994 111.076 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -13.48 56.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.954 0.407 . . . . 44.399999999999999 110.154 177.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 116.32 -17.09 14.59 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 121.082 -0.58 . . . . 54.140000000000001 113.225 176.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.59 117.59 13.34 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.976 0.388 . . . . 71.120000000000005 111.062 -175.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -116.41 10.74 16.81 Favored Glycine 0 C--N 1.311 -0.831 0 N-CA-C 110.552 -1.019 . . . . 55.439999999999998 110.552 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -105.89 111.72 24.48 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.416 -1.327 . . . . 62.420000000000002 107.416 -177.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -132.77 146.87 52.2 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.375 0.607 . . . . 62.340000000000003 112.21 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -143.01 122.96 13.52 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.771 -1.566 . . . . 65.120000000000005 106.771 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -99.59 134.93 41.76 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.785 0.326 . . . . 64.400000000000006 110.581 -176.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -134.18 150.79 51.11 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.217 -1.031 . . . . 53.329999999999998 108.217 176.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.43 140.47 51.33 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.781 -0.452 . . . . 62.140000000000001 109.781 178.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 458' ' ' PRO . 8.5 t -127.03 137.37 30.47 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.424 -1.324 . . . . 72.299999999999997 107.424 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 490' ' ' SER . 36.9 Cg_exo -61.23 119.5 6.68 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 122.338 2.025 . . . . 75.439999999999998 111.189 -177.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 17.2 m -131.34 -179.84 5.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.527 -0.76 . . . . 61.100000000000001 109.174 -176.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.467 ' HB ' HD13 ' A' ' 463' ' ' LEU . 62.7 m -68.45 136.78 90.9 Favored Pre-proline 0 N--CA 1.428 -1.568 0 N-CA-C 107.848 -1.168 . . . . 73.120000000000005 107.848 174.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.8 -22.88 7.69 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 C-N-CA 124.846 3.697 . . . . 73.230000000000004 114.707 -176.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.58 -17.56 60.0 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.002 0.43 . . . . 74.140000000000001 111.356 -179.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 460' ' ' THR . 7.3 mp -99.67 11.49 39.07 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 111.959 0.355 . . . . 73.140000000000001 111.959 -178.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 31.0 m -59.61 127.72 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-O 121.217 0.532 . . . . 61.32 111.629 176.092 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 85.49 -1.42 88.36 Favored Glycine 0 C--O 1.241 0.564 0 CA-C-N 115.539 -0.755 . . . . 71.209999999999994 111.839 178.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 463' ' ' LEU . 62.8 tttp -101.54 138.94 37.87 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.122 -1.066 . . . . 62.329999999999998 108.122 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 486' ' ' ILE . 60.0 t -84.11 128.08 39.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-O 120.987 0.423 . . . . 63.240000000000002 110.38 -178.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -101.98 -16.9 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 112.165 0.432 . . . . 63.109999999999999 112.165 -177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 177.43 166.01 33.5 Favored Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 120.795 -0.717 . . . . 74.420000000000002 111.769 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 22.8 p -135.77 155.55 50.2 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.45 -0.945 . . . . 75.0 108.45 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 8.1 t30 -60.88 -55.62 42.92 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.421 -0.323 . . . . 71.409999999999997 111.847 176.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 5.6 Cg_exo -76.8 142.71 22.85 Favored 'Trans proline' 0 C--N 1.365 1.397 0 N-CA-C 108.162 -1.514 . . . . 74.420000000000002 108.162 172.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.526 ' HG2' ' HB3' ' A' ' 476' ' ' GLN . 30.8 Cg_endo -61.92 127.46 21.46 Favored 'Trans proline' 0 C--O 1.24 0.61 0 C-N-CA 122.287 1.992 . . . . 72.519999999999996 111.761 -177.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -79.83 2.58 22.6 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.065 -0.971 . . . . 65.239999999999995 112.013 -174.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . 0.454 ' N ' HD22 ' A' ' 475' ' ' ASN . 0.8 OUTLIER -111.32 3.48 18.33 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.328 -0.396 . . . . 75.209999999999994 110.668 177.32 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.526 ' HB3' ' HG2' ' A' ' 473' ' ' PRO . 8.7 tp-100 -129.57 166.07 20.45 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.493 0.663 . . . . 60.450000000000003 111.539 -170.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 62.6 m -81.85 124.18 29.46 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.644 -1.162 . . . . 55.229999999999997 109.799 176.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 24.4 m -127.37 149.47 50.05 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.761 0.424 . . . . 74.409999999999997 110.008 -178.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 426' ' ' GLN . . . -72.16 135.71 46.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.629 0.252 . . . . 73.140000000000001 110.63 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.471 HD11 ' HB2' ' A' ' 427' ' ' ARG . 42.1 mm -62.94 -14.48 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 124.88 1.272 . . . . 71.140000000000001 112.282 -174.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.7 t -87.51 -2.55 58.69 Favored 'General case' 0 C--N 1.313 -1.003 0 O-C-N 121.6 -0.688 . . . . 62.240000000000002 110.635 -177.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 479' ' ' ALA . 44.4 m-80 -84.61 136.98 33.54 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 109.473 -0.565 . . . . 73.299999999999997 109.473 178.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.85 124.45 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 108.278 -1.008 . . . . 62.229999999999997 108.278 176.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 44.7 t -87.96 119.09 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.572 0 C-N-CA 119.239 -0.984 . . . . 74.450000000000003 109.005 -178.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 2.9 mp -91.7 112.66 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.903 0 N-CA-C 104.557 -2.386 . . . . 75.310000000000002 104.557 173.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -105.03 118.55 52.62 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.09 -1.078 . . . . 64.200000000000003 108.09 -175.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.63 118.35 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 121.578 0.704 . . . . 71.230000000000004 109.356 -176.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.81 141.3 16.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 107.798 -1.186 . . . . 72.540000000000006 107.798 -178.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -78.9 124.29 6.52 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.002 -1.239 . . . . 64.25 110.002 177.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 18.1 t -141.52 136.49 31.22 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.613 -0.884 . . . . 71.439999999999998 108.613 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.665 0 N-CA-C 109.395 -1.482 . . . . 74.439999999999998 109.395 -179.577 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.893 0 N-CA-C 110.616 -0.994 . . . . 73.040000000000006 110.616 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 356' ' ' ILE 0.278 2.6 pp -111.59 117.74 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-O 122.282 1.039 . . . . 62.219999999999999 113.281 -179.666 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 25.5 m -161.44 135.27 6.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 104.036 -2.579 . . . . 60.509999999999998 104.036 176.394 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -81.21 86.1 6.26 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.603 -1.239 . . . . 73.439999999999998 112.963 -177.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.91 135.59 48.06 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 105.817 -1.92 . . . . 74.230000000000004 105.817 172.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.88 149.34 21.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 C-N-CA 120.146 -0.622 . . . . 54.439999999999998 110.822 -175.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -94.28 137.22 33.7 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 105.756 -1.942 . . . . 74.420000000000002 105.756 173.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -95.09 124.79 52.91 Favored Pre-proline 0 C--N 1.279 -2.487 0 C-N-CA 118.342 -1.343 . . . . 72.239999999999995 110.536 -169.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -51.06 129.25 27.66 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 123.57 2.847 . . . . 61.329999999999998 113.006 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.3 140.4 43.09 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.492 -1.231 . . . . 61.149999999999999 111.285 -175.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.6 t -107.41 20.28 5.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.635 -1.246 . . . . 41.109999999999999 107.635 178.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -64.64 133.38 52.1 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.961 -1.018 . . . . 72.319999999999993 111.457 -178.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.5 0.19 46.58 Favored Glycine 0 N--CA 1.433 -1.564 0 CA-C-N 115.071 -0.968 . . . . 51.100000000000001 110.905 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -125.22 -179.81 4.75 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.991 -0.744 . . . . 73.019999999999996 108.991 179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 93.9 p -72.48 143.04 48.55 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 118.485 0.584 . . . . 63.200000000000003 111.389 -176.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 374' ' ' ILE . 27.9 m -62.34 -33.65 75.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 116.221 -0.445 . . . . 51.130000000000003 110.971 178.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.67 94.44 Favored 'General case' 0 C--O 1.253 1.267 0 CA-C-N 116.299 -0.409 . . . . 72.040000000000006 111.062 178.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.99 -35.07 76.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 109.889 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -59.27 -43.69 92.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.84 -0.618 . . . . 74.420000000000002 110.516 176.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.543 HG23 HG13 ' A' ' 384' ' ' ILE . 82.6 mt -57.79 -46.91 87.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 122.644 0.377 . . . . 75.400000000000006 110.078 178.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.6 94.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.972 -0.558 . . . . 53.119999999999997 111.288 179.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 57.0 m -61.66 -47.64 84.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.894 -0.594 . . . . 72.209999999999994 110.952 -179.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.3 -38.45 91.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.388 -0.369 . . . . 75.040000000000006 111.465 178.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.87 -42.89 94.71 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.65 0.594 . . . . 73.019999999999996 109.6 178.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.356 0.873 . . . . 53.130000000000003 113.356 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -82.96 -14.71 53.56 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.127 0.489 . . . . 52.009999999999998 110.022 173.097 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 100.25 6.43 53.51 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.941 -0.572 . . . . 52.219999999999999 112.874 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.513 ' HA ' ' HA2' ' A' ' 413' ' ' GLY . 43.3 m-85 -84.19 152.96 23.93 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.427 0.632 . . . . 73.120000000000005 111.938 -177.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.64 134.54 34.6 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.008 -1.479 . . . . 74.010000000000005 107.008 177.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.543 HG13 HG23 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -117.47 136.64 53.97 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 C-N-CA 119.197 -1.001 . . . . 72.319999999999993 111.874 -179.14 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -111.69 128.38 56.05 Favored 'General case' 0 C--N 1.264 -3.119 0 CA-C-N 113.003 -1.908 . . . . 74.510000000000005 105.976 178.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 31.0 m -111.41 136.65 50.26 Favored 'General case' 0 C--N 1.278 -2.537 0 C-N-CA 119.403 -0.919 . . . . 42.119999999999997 109.444 -178.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -120.18 117.89 29.08 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.513 -1.662 . . . . 74.109999999999999 106.513 176.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 122.05 46.11 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.484 -1.673 . . . . 62.409999999999997 106.484 177.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -139.61 148.38 55.75 Favored Pre-proline 0 C--N 1.291 -1.951 0 C-N-CA 118.893 -1.123 . . . . 75.409999999999997 110.746 178.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 85.1 Cg_endo -85.48 163.74 10.96 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.274 1.983 . . . . 61.200000000000003 109.584 170.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 7.2 t70 165.22 -173.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.754 -2.313 . . . . 71.109999999999999 104.754 176.023 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 480' ' ' ILE . 8.4 t -115.84 -25.39 7.77 Favored 'General case' 0 C--N 1.272 -2.786 0 N-CA-C 106.566 -1.642 . . . . 72.510000000000005 106.566 174.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 9.9 m -98.47 69.2 1.9 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 104.621 -2.363 . . . . 75.439999999999998 104.621 171.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 421' ' ' SER . 4.4 pt -95.97 138.56 21.66 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 113.673 -1.603 . . . . 51.240000000000002 112.921 -173.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 421' ' ' SER . 16.7 Cg_exo -70.4 114.35 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 106.224 -2.26 . . . . 72.239999999999995 106.224 166.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.11 160.34 13.12 Favored 'Trans proline' 0 C--O 1.212 -0.816 0 C-N-CA 123.514 2.809 . . . . 52.420000000000002 115.54 -169.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.06 -6.86 2.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.107 0.963 . . . . 74.319999999999993 112.003 176.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 369' ' ' SER . 63.9 m170 -107.47 120.15 41.4 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 103.662 -2.718 . . . . 72.099999999999994 103.662 171.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 4.7 p -62.97 117.97 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-O 122.088 0.947 . . . . 71.030000000000001 109.822 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 11.1 tp -99.91 -28.87 3.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.947 -1.024 . . . . 44.399999999999999 110.441 -174.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -146.44 157.98 27.56 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.973 -1.251 . . . . 73.25 109.973 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 3.7 p -118.28 -178.76 3.59 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 123.194 0.598 . . . . 72.549999999999997 109.97 -177.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -102.08 155.2 36.74 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.374 -0.602 . . . . 64.109999999999999 109.374 -176.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.4 -30.66 64.44 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 123.085 2.523 . . . . 75.540000000000006 113.902 -176.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -72.15 -30.7 65.27 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.895 0.378 . . . . 65.329999999999998 110.244 -175.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -69.94 -28.54 65.66 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.594 0.711 . . . . 50.420000000000002 110.05 177.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . 0.439 ' N ' HD22 ' A' ' 407' ' ' ASN . 0.9 OUTLIER -95.8 -4.64 43.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.577 -0.738 . . . . 71.140000000000001 111.876 -177.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 57.1 m -100.16 155.39 17.77 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.244 -1.391 . . . . 54.140000000000001 107.244 176.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 55.2 p -74.77 113.17 11.74 Favored 'General case' 0 N--CA 1.42 -1.941 0 C-N-CA 120.191 -0.604 . . . . 75.019999999999996 109.584 179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.09 169.93 15.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 116.043 -0.526 . . . . 44.219999999999999 110.772 -178.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 6.0 p -62.36 133.13 54.64 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.702 -0.681 . . . . 73.109999999999999 109.396 175.241 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -70.46 109.33 4.73 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.956 -0.387 . . . . 73.230000000000004 109.956 -177.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 382' ' ' PHE . . . 123.91 10.08 5.43 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 120.137 -1.03 . . . . 45.530000000000001 112.339 -178.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.1 -174.02 4.49 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.785 -0.82 . . . . 74.409999999999997 108.785 -177.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -86.01 132.16 34.12 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 118.955 0.798 . . . . 72.140000000000001 112.589 -175.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.2 mm -118.67 135.24 59.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 106.474 -1.676 . . . . 73.319999999999993 106.474 174.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 14.9 t -96.84 130.94 44.04 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 122.086 0.946 . . . . 71.409999999999997 111.764 -177.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.9 t -107.33 122.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 CA-C-N 114.577 -1.192 . . . . 65.239999999999995 108.453 179.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -95.89 129.01 43.27 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.745 -0.661 . . . . 71.5 111.447 -178.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.4 t -134.83 130.81 52.93 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 108.14 -1.059 . . . . 75.340000000000003 108.14 177.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.49 ' HB3' ' HB ' ' A' ' 394' ' ' ILE . 36.6 p -88.09 121.45 30.51 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.491 -0.559 . . . . 74.329999999999998 109.491 178.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 9.0 m -120.89 104.82 10.14 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 119.767 -0.773 . . . . 63.310000000000002 110.645 177.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 85.69 125.39 1.59 Allowed Glycine 0 CA--C 1.538 1.528 0 C-N-CA 120.546 -0.835 . . . . 71.540000000000006 113.93 176.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 56.2 Cg_endo -86.49 130.31 3.28 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.33 2.02 . . . . 61.119999999999997 112.562 176.17 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.461 ' OE1' ' HA ' ' A' ' 391' ' ' ASP . 47.6 mt-10 -89.4 137.5 32.27 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.465 0.65 . . . . 75.329999999999998 112.12 179.416 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.47 150.45 48.69 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.546 -1.65 . . . . 74.219999999999999 106.546 173.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.49 ' HB2' HD11 ' A' ' 480' ' ' ILE . 3.4 tpt180 -136.27 148.46 48.02 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.307 -0.998 . . . . 73.420000000000002 108.307 -174.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -83.9 136.5 34.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.513 -0.921 . . . . 65.329999999999998 108.513 175.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 70.8 mt -81.8 131.54 57.11 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.834 -0.802 . . . . 71.340000000000003 108.834 -178.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.65 140.6 87.36 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 121.583 1.522 . . . . 72.140000000000001 111.876 179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -88.32 0.77 55.79 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.124 0.488 . . . . 72.239999999999995 111.191 -177.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -76.12 -7.3 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 121.446 0.641 . . . . 41.119999999999997 109.464 176.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 440' ' ' ALA . 4.9 p -54.96 -49.68 70.78 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.361 -0.836 . . . . 63.450000000000003 111.687 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 467' ' ' VAL . 2.1 m -63.79 -22.28 66.83 Favored 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 124.361 1.065 . . . . 70.0 111.761 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 84.7 mt -86.27 -42.47 13.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.263 0.468 . . . . 74.230000000000004 112.263 -173.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 85.4 m -145.21 124.12 12.71 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 121.542 -0.724 . . . . 73.109999999999999 110.905 -178.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.24 -53.52 55.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.724 0.639 . . . . 75.420000000000002 112.724 -178.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.43 94.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.737 0.303 . . . . 73.019999999999996 111.495 -176.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.53 -37.68 88.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.652 -0.704 . . . . 73.109999999999999 109.407 -179.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 433' ' ' SER . . . -60.32 -47.18 87.15 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.922 -0.581 . . . . 54.229999999999997 110.76 -179.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 91.8 t -59.35 -45.71 93.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.615 -0.72 . . . . 61.109999999999999 110.414 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 9.9 mmpt? -64.46 -47.27 79.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.095 -0.502 . . . . 65.319999999999993 110.967 -178.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.14 -38.88 89.22 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.329 -0.396 . . . . 73.349999999999994 111.476 -178.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.2 -43.41 86.83 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.338 0.399 . . . . 64.040000000000006 110.366 -178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 24.3 m -66.84 -46.01 76.45 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-O 121.404 0.621 . . . . 61.439999999999998 109.785 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.31 -15.97 63.45 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.374 -0.83 . . . . 73.099999999999994 112.053 -178.496 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.84 -13.56 59.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.073 0.464 . . . . 64.120000000000005 109.985 178.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 118.08 -16.4 11.97 Favored Glycine 0 N--CA 1.431 -1.638 0 C-N-CA 120.748 -0.739 . . . . 23.350000000000001 112.036 179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 427' ' ' ARG . 93.6 m-85 -77.49 108.66 10.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.782 0.325 . . . . 64.349999999999994 110.503 -179.053 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.37 20.64 15.83 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 110.554 -1.019 . . . . 74.209999999999994 110.554 176.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -114.17 111.91 22.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 106.507 -1.664 . . . . 65.420000000000002 106.507 -179.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.49 153.22 45.42 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 112.438 0.532 . . . . 72.129999999999995 112.438 -170.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 485' ' ' ILE . 56.4 tptt -150.9 123.41 8.46 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 105.451 -2.055 . . . . 73.510000000000005 105.451 172.441 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -121.96 134.82 54.83 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.315 -0.554 . . . . 65.319999999999993 111.584 -173.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -142.38 165.02 28.57 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.1 -0.5 . . . . 62.420000000000002 110.514 -178.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.458 ' ND2' ' HB ' ' A' ' 488' ' ' VAL . 12.7 m120 -116.44 142.07 47.35 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.719 -0.845 . . . . 62.329999999999998 108.719 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 19.1 t -131.04 138.55 33.22 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 108.749 -0.834 . . . . 73.010000000000005 108.749 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 490' ' ' SER . 32.5 Cg_exo -61.56 121.1 9.07 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.303 2.002 . . . . 72.329999999999998 110.558 176.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.3 m -134.26 -178.55 5.09 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.62 -1.252 . . . . 63.130000000000003 107.62 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 16.5 p -68.24 150.24 97.8 Favored Pre-proline 0 N--CA 1.427 -1.586 0 C-N-CA 120.563 -0.455 . . . . 73.530000000000001 109.822 176.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 464' ' ' VAL . 15.0 Cg_endo -55.69 -23.59 41.71 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.488 2.792 . . . . 71.420000000000002 113.137 -177.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -75.36 -18.45 59.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.869 0.366 . . . . 72.230000000000004 111.871 -179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 91.7 mt -96.72 -4.45 40.7 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.992 -0.443 . . . . 73.040000000000006 112.102 -177.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 9.8 p -59.51 136.58 22.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-O 120.717 0.294 . . . . 70.430000000000007 110.935 -178.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.32 84.04 Favored Glycine 0 C--N 1.311 -0.831 0 C-N-CA 120.777 -0.725 . . . . 72.030000000000001 112.389 177.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -124.19 158.87 31.38 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 109.668 -0.493 . . . . 72.120000000000005 109.668 179.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 434' ' ' THR . 58.1 t -83.93 137.54 20.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 106.8 -1.556 . . . . 45.439999999999998 106.8 178.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.544 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -96.54 -10.66 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.013 -1.475 . . . . 72.109999999999999 110.267 178.133 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 467' ' ' VAL . . . 146.56 174.54 18.76 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 115.424 -0.807 . . . . 44.549999999999997 111.524 175.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 14.0 p -116.58 152.22 34.61 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.97 -1.122 . . . . 74.209999999999994 107.97 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -66.79 -46.06 55.53 Favored Pre-proline 0 N--CA 1.483 1.189 0 C-N-CA 118.74 -1.184 . . . . 65.239999999999995 111.874 178.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -73.39 110.15 3.0 Favored 'Trans proline' 0 C--N 1.362 1.261 0 N-CA-C 106.887 -2.005 . . . . 54.119999999999997 106.887 163.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -77.02 162.31 32.04 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.292 1.995 . . . . 75.140000000000001 114.286 -171.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -72.73 -5.15 35.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 124.753 1.221 . . . . 75.129999999999995 110.348 177.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -95.49 6.05 49.99 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.421 -1.263 . . . . 71.519999999999996 109.616 -178.191 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -135.62 162.48 32.59 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.109 -0.701 . . . . 74.109999999999999 109.109 -177.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 4.7 m -104.47 111.73 24.51 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 106.235 -1.765 . . . . 70.019999999999996 106.235 178.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 14.9 t -106.55 148.3 28.4 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.332 -0.547 . . . . 74.540000000000006 109.874 -175.379 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . . . . . . . . . . . -64.25 141.03 58.92 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.283 -0.417 . . . . 35.43 110.41 178.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 28.9 mm -60.92 -22.61 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.467 0.707 . . . . 61.130000000000003 112.876 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 13.0 t -91.55 4.43 52.62 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-O 121.692 0.758 . . . . 64.319999999999993 110.123 -178.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.67 138.55 34.1 Favored 'General case' 0 CA--C 1.481 -1.687 0 O-C-N 122.015 -0.428 . . . . 74.0 110.47 177.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 86.0 t -79.54 116.32 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 108.887 -0.783 . . . . 71.329999999999998 108.887 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.08 120.22 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.938 0 N-CA-C 108.189 -1.041 . . . . 71.129999999999995 108.189 -178.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 0.2 OUTLIER -92.73 117.07 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.283 0 N-CA-C 106.93 -1.507 . . . . 61.409999999999997 106.93 -178.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.33 112.4 39.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 CA-C-N 114.948 -1.024 . . . . 42.32 108.347 -177.335 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 485' ' ' ILE . 3.3 mp -102.75 124.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.588 -0.733 . . . . 75.530000000000001 109.275 -177.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.458 ' HB ' ' ND2' ' A' ' 456' ' ' ASN . 28.0 t -97.59 134.45 35.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.248 -1.39 . . . . 65.299999999999997 107.248 178.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -84.07 131.85 10.68 Favored Glycine 0 N--CA 1.421 -2.341 0 N-CA-C 110.992 -0.843 . . . . 50.109999999999999 110.992 -178.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 36.3 t -141.04 132.39 26.71 Favored 'General case' 0 N--CA 1.417 -2.096 0 N-CA-C 108.82 -0.808 . . . . 53.25 108.82 178.318 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.07 0 N-CA-C 109.244 -1.542 . . . . 65.510000000000005 109.244 174.575 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.691 0 N-CA-C 110.49 -1.044 . . . . 62.119999999999997 110.49 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -87.2 145.75 7.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 117.582 0.691 . . . . 64.230000000000004 110.9 178.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 18.9 m -152.53 137.48 17.19 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.152 -1.425 . . . . 64.319999999999993 107.152 178.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.42 70.48 4.32 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.551 0.691 . . . . 74.219999999999999 110.936 -179.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -106.7 138.85 42.12 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.972 -1.122 . . . . 64.140000000000001 107.972 176.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.2 150.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 112.398 0.518 . . . . 72.109999999999999 112.398 -170.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -96.4 136.55 36.75 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.538 -1.282 . . . . 53.25 107.538 177.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 8.1 p -97.68 131.3 27.22 Favored Pre-proline 0 C--N 1.288 -2.087 0 C-N-CA 119.916 -0.713 . . . . 52.149999999999999 110.079 -175.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.14 142.13 78.46 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.392 2.728 . . . . 70.400000000000006 113.946 -178.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.44 139.39 36.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.698 -1.137 . . . . 73.329999999999998 109.985 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 373' ' ' ALA . 12.6 t -113.24 30.98 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-O 122.51 1.147 . . . . 73.140000000000001 109.794 -175.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 366' ' ' ARG . 1.7 ppt_? -65.39 144.58 56.99 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.582 -0.736 . . . . 74.409999999999997 112.525 178.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 93.4 -5.81 74.61 Favored Glycine 0 C--N 1.311 -0.815 0 CA-C-N 115.94 -0.573 . . . . 75.329999999999998 111.699 178.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -117.34 176.01 5.35 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.294 -0.632 . . . . 74.319999999999993 109.294 -175.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.8 p -73.92 154.11 39.53 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 120.742 0.306 . . . . 72.430000000000007 111.139 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 4.5 p -63.2 -36.1 82.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.752 0.311 . . . . 64.030000000000001 110.619 176.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -60.57 -40.97 93.62 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 116.104 -0.498 . . . . 53.340000000000003 111.033 177.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -64.77 -43.55 92.9 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.747 -0.464 . . . . 73.209999999999994 109.747 177.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' A' ' 365' ' ' VAL . . . -58.77 -51.53 69.6 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.964 -0.562 . . . . 73.549999999999997 111.084 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.62 -42.47 84.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.347 -0.388 . . . . 73.409999999999997 111.157 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.32 -40.39 93.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.433 -0.348 . . . . 74.310000000000002 110.993 178.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 380' ' ' ARG . 61.9 m -61.88 -47.24 85.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.551 -0.295 . . . . 60.43 110.882 179.663 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.89 -38.81 92.46 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.621 -0.263 . . . . 73.109999999999999 110.941 179.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -59.88 -46.92 87.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.908 0.755 . . . . 73.400000000000006 109.647 178.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -66.43 -27.41 67.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.78 -0.646 . . . . 62.009999999999998 111.774 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 376' ' ' THR . 11.8 mmt180 -81.21 -14.94 57.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.402 -0.363 . . . . 64.510000000000005 110.797 178.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.73 53.62 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.439 -0.886 . . . . 73.219999999999999 112.029 178.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.16 158.65 15.37 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.385 -0.598 . . . . 54.439999999999998 109.385 178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.53 161.43 13.64 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.232 -1.025 . . . . 61.310000000000002 108.232 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.08 154.98 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.872 0.844 . . . . 71.530000000000001 112.79 -175.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 417' ' ' THR . 6.7 ttp180 -141.99 129.74 21.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.885 -1.154 . . . . 72.0 107.885 175.445 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 23.3 m -100.51 130.38 46.58 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 109.7 -0.481 . . . . 71.0 109.7 -177.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -112.94 119.11 36.79 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.708 -1.59 . . . . 73.230000000000004 106.708 177.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 123.84 39.41 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 72.230000000000004 108.724 177.507 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -114.57 118.13 41.73 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 111.747 -177.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 3.0 Cg_endo -88.31 128.43 2.2 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 N-CA-C 107.456 -1.786 . . . . 61.149999999999999 107.456 167.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 5.6 t70 -163.88 -178.09 5.47 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 118.665 -1.214 . . . . 73.140000000000001 110.731 -173.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.2 m -88.87 -42.18 12.01 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.195 -1.78 . . . . 64.099999999999994 106.195 175.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 6.4 m -88.69 63.43 6.91 Favored 'General case' 0 N--CA 1.417 -2.08 0 CA-C-N 114.458 -1.246 . . . . 61.109999999999999 108.636 -179.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.448 ' O ' HD12 ' A' ' 394' ' ' ILE . 2.3 pp -98.77 112.97 63.93 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 114.156 1.169 . . . . 63.049999999999997 114.156 179.465 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . 0.423 ' HD2' ' OG ' ' A' ' 421' ' ' SER . 73.8 Cg_endo -80.44 170.37 16.04 Favored 'Trans proline' 0 CA--C 1.552 1.414 0 C-N-CA 122.09 1.86 . . . . 70.340000000000003 110.369 171.391 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.72 162.65 17.8 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.391 2.727 . . . . 63.240000000000002 112.691 178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.66 -8.7 0.95 Allowed 'General case' 0 N--CA 1.507 2.42 0 C-N-CA 124.218 1.007 . . . . 64.099999999999994 113.135 178.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -79.78 159.72 26.44 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.783 -1.192 . . . . 74.230000000000004 107.783 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.56 117.03 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.793 0 N-CA-C 105.942 -1.873 . . . . 73.200000000000003 105.942 175.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 401' ' ' GLY . 2.6 pp -92.91 -28.42 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.408 0.623 . . . . 74.319999999999993 111.79 -178.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 400' ' ' ILE . . . -160.99 158.1 29.67 Favored Glycine 0 N--CA 1.41 -3.097 0 N-CA-C 108.717 -1.753 . . . . 42.200000000000003 108.717 178.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -114.43 -179.85 3.75 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 109.189 -0.671 . . . . 75.530000000000001 109.189 179.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -102.12 140.94 21.6 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.225 -1.028 . . . . 72.519999999999996 108.225 178.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.69 -29.46 2.34 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.0 3.134 . . . . 44.530000000000001 114.536 177.576 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.63 60.79 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.209 0.603 . . . . 64.420000000000002 111.98 -179.144 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.86 -40.16 65.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.597 0.713 . . . . 61.509999999999998 109.857 177.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.86 4.7 52.32 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.328 -0.851 . . . . 72.549999999999997 110.735 -174.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 40.6 m -92.64 146.39 23.7 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 105.118 -2.178 . . . . 73.099999999999994 105.118 171.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 17.5 m -74.37 123.44 24.64 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 118.797 0.726 . . . . 74.120000000000005 110.171 -178.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.8 169.67 18.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.772 -1.196 . . . . 60.409999999999997 107.772 -177.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 19.8 m -66.7 138.86 57.71 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.266 -1.013 . . . . 55.43 108.266 175.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -67.18 111.36 3.89 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.079 -0.341 . . . . 73.230000000000004 110.079 -178.357 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 111.63 43.33 0.97 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.752 -0.737 . . . . 51.219999999999999 112.162 179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.65 -179.36 3.79 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 106.354 -1.721 . . . . 62.32 106.354 178.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -102.65 135.29 44.55 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.505 0.669 . . . . 75.109999999999999 111.725 -179.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 49.7 mm -110.28 128.47 66.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.372 -1.344 . . . . 63.210000000000001 107.372 176.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 385' ' ' ARG . 69.4 p -100.42 130.71 46.55 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 109.577 -0.527 . . . . 70.420000000000002 109.577 -177.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 69.1 t -118.48 122.63 69.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.013 -0.54 . . . . 74.319999999999993 110.177 -176.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -91.17 129.46 37.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.141 0.496 . . . . 44.409999999999997 110.998 177.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.44 146.95 30.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.286 -1.376 . . . . 64.239999999999995 107.286 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.423 ' OG ' ' HD2' ' A' ' 395' ' ' PRO . 13.5 m -90.57 122.65 33.56 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.822 -0.751 . . . . 72.430000000000007 111.815 -176.417 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 32.8 m -120.37 106.16 11.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 109.539 -0.541 . . . . 64.120000000000005 109.539 174.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 390' ' ' PRO . . . 77.32 130.57 0.47 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 120.889 -0.672 . . . . 63.240000000000002 114.772 176.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.4 Cg_exo -78.6 144.18 19.63 Favored 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 121.702 1.601 . . . . 63.420000000000002 109.425 171.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 146.06 47.96 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 116.292 -0.413 . . . . 71.450000000000003 109.906 -178.261 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.5 mt-30 -121.52 141.29 51.2 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.168 -0.924 . . . . 74.400000000000006 108.65 -176.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -143.45 158.68 43.45 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.954 -1.498 . . . . 73.519999999999996 106.954 -177.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 477' ' ' THR . 0.6 OUTLIER -90.1 139.62 30.45 Favored 'General case' 0 C--N 1.28 -2.419 0 O-C-N 123.088 0.242 . . . . 71.540000000000006 110.854 179.512 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 3.4 mp -80.03 119.86 77.95 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 106.788 -1.56 . . . . 72.25 106.788 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.82 140.74 67.47 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.702 2.268 . . . . 74.340000000000003 113.589 -178.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.61 -22.58 62.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.771 -1.104 . . . . 73.310000000000002 112.364 -177.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 30.4 m -76.18 2.98 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.679 -0.692 . . . . 71.349999999999994 111.748 -177.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 35.9 t -62.75 -27.14 69.08 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.309 0.644 . . . . 74.439999999999998 110.597 179.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 28.0 p -69.35 -26.09 64.51 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 112.851 0.685 . . . . 72.219999999999999 112.851 -177.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 82.6 mt -67.26 -49.01 66.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.912 1.079 . . . . 43.409999999999997 113.912 -171.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 46.6 m -160.43 148.8 16.63 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.592 -0.892 . . . . 74.019999999999996 108.592 -175.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.51 -49.83 75.98 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.873 0.694 . . . . 73.129999999999995 112.873 -177.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -63.45 -38.01 89.48 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.714 0.293 . . . . 74.409999999999997 110.942 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -61.22 -46.32 90.9 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.639 -0.874 . . . . 72.209999999999994 108.639 177.195 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.32 -49.66 76.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.948 -1.024 . . . . 63.310000000000002 110.409 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.82 -48.08 87.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.362 -0.381 . . . . 72.439999999999998 111.089 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -64.45 -42.97 95.66 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.868 0.322 . . . . 73.439999999999998 111.868 -179.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -66.33 -42.12 88.63 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 111.902 0.334 . . . . 72.049999999999997 111.902 179.014 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.43 -38.63 81.38 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.975 -0.29 . . . . 74.209999999999994 111.741 177.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 86.4 m -62.31 -40.46 96.39 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.736 -0.468 . . . . 74.209999999999994 109.736 177.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -67.46 -26.61 66.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.916 -0.584 . . . . 44.219999999999999 111.042 178.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.84 -13.01 56.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.211 0.529 . . . . 44.140000000000001 110.47 177.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.55 29.74 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.944 -0.646 . . . . 73.030000000000001 113.267 178.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -78.29 102.65 7.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 117.362 0.581 . . . . 74.219999999999999 109.597 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -108.73 15.83 34.24 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.694 -0.765 . . . . 44.530000000000001 111.301 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -118.21 110.63 17.8 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.733 -1.21 . . . . 75.129999999999995 107.733 179.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.35 150.26 45.7 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.589 -176.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.522 ' HA ' ' HE3' ' A' ' 453' ' ' LYS . 0.4 OUTLIER -141.88 122.87 14.55 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.454 -2.054 . . . . 73.219999999999999 105.454 171.239 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -96.57 134.62 39.56 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.008 -0.677 . . . . 73.319999999999993 109.61 -178.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 487' ' ' ILE . . . -132.19 141.47 49.09 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.938 -1.134 . . . . 74.299999999999997 107.938 176.287 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 488' ' ' VAL . 37.5 m-80 -116.57 140.12 49.74 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.598 -1.26 . . . . 74.209999999999994 107.598 177.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 50.9 m -138.62 150.35 65.66 Favored Pre-proline 0 C--N 1.288 -2.066 0 N-CA-C 109.846 -0.427 . . . . 75.340000000000003 109.846 -178.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 490' ' ' SER . 19.2 Cg_endo -60.71 120.22 7.83 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.496 2.131 . . . . 73.219999999999999 112.184 -179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 15.3 m -127.27 -178.45 4.45 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.027 -1.471 . . . . 63.140000000000001 107.027 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 8.0 t -68.88 137.95 90.17 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 108.968 -0.752 . . . . 70.430000000000007 108.968 176.571 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -53.15 -23.74 23.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 123.741 2.961 . . . . 70.430000000000007 113.98 -178.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.7 -23.95 58.69 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.797 0.332 . . . . 75.319999999999993 111.677 -177.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 11.1 mp -105.33 12.57 31.54 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.334 0.494 . . . . 72.420000000000002 112.334 -177.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.6 p -59.31 126.74 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.388 0.613 . . . . 71.340000000000003 111.143 179.311 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.55 0.07 61.11 Favored Glycine 0 C--N 1.309 -0.968 0 CA-C-N 115.987 -0.551 . . . . 51.439999999999998 112.266 179.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -102.63 144.84 30.51 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.668 -1.234 . . . . 75.340000000000003 107.668 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 84.3 t -82.28 126.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.86 -1.163 . . . . 73.239999999999995 107.86 177.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.46 -15.13 7.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.34 -0.544 . . . . 74.349999999999994 112.01 -175.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.02 177.24 33.95 Favored Glycine 0 N--CA 1.422 -2.26 0 C-N-CA 120.451 -0.88 . . . . 74.140000000000001 111.576 178.001 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 486' ' ' ILE . 8.7 p -125.23 158.81 33.12 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.226 -1.027 . . . . 72.010000000000005 108.226 179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 472' ' ' PRO . 0.9 OUTLIER -63.14 -54.35 46.47 Favored Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 120.338 -0.545 . . . . 73.099999999999994 110.52 176.103 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 471' ' ' ASN . 7.6 Cg_exo -78.14 108.6 2.53 Favored 'Trans proline' 0 C--N 1.367 1.551 0 N-CA-C 106.037 -2.332 . . . . 64.129999999999995 106.037 164.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.45 149.87 89.38 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.601 2.201 . . . . 71.319999999999993 114.798 -169.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -74.46 7.65 2.77 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.742 1.217 . . . . 70.420000000000002 111.987 -177.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -110.1 -3.05 16.63 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.474 -0.784 . . . . 63.119999999999997 110.605 177.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -129.06 169.65 14.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.036 0.446 . . . . 72.129999999999995 111.335 -171.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 428' ' ' GLU . 15.7 m -102.43 135.54 43.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 124.265 1.026 . . . . 74.519999999999996 108.789 -179.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 30.8 t -137.46 148.07 45.81 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.425 -0.583 . . . . 71.200000000000003 109.425 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -68.91 145.6 53.53 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 109.964 -0.384 . . . . 63.140000000000001 109.964 175.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . . . . . . . . . 25.9 mm -70.17 -3.33 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.311 0 CA-C-O 122.125 0.964 . . . . 72.150000000000006 111.396 -177.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 1.3 p -86.81 5.37 36.91 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.762 0.792 . . . . 65.439999999999998 110.325 179.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -110.45 138.09 47.3 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.358 -0.837 . . . . 65.299999999999997 109.473 179.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.86 124.72 38.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.281 -1.007 . . . . 75.400000000000006 108.281 178.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 55.0 t -87.36 118.22 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 C-N-CA 119.074 -1.051 . . . . 61.039999999999999 108.486 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 453' ' ' LYS . 56.2 mt -93.95 112.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 N-CA-C 107.081 -1.451 . . . . 70.430000000000007 107.081 176.831 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 470' ' ' THR . 0.0 OUTLIER -98.62 122.28 50.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.33 -0.989 . . . . 64.530000000000001 108.33 -176.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 455' ' ' ALA . 26.9 mt -100.87 119.92 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.318 0.58 . . . . 74.319999999999993 110.499 -174.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.534 ' HB ' ' OD1' ' A' ' 456' ' ' ASN . 88.9 t -97.99 128.77 49.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.959 -1.126 . . . . 61.299999999999997 107.959 178.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -70.31 115.42 6.03 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 111.184 -0.766 . . . . 75.129999999999995 111.184 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 37.5 m -120.35 109.88 15.88 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.334 -0.617 . . . . 61.229999999999997 109.334 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.356 0 N-CA-C 109.478 -1.449 . . . . 75.420000000000002 109.478 -179.211 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.814 0 N-CA-C 109.921 -1.272 . . . . 43.049999999999997 109.921 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.404 ' O ' HD12 ' A' ' 356' ' ' ILE . 2.6 pp -139.98 148.06 23.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 117.195 0.498 . . . . 73.0 111.029 179.019 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 35.0 m -109.08 146.79 33.42 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 106.504 -1.665 . . . . 54.210000000000001 106.504 172.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -82.52 78.7 9.12 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.516 0.674 . . . . 75.5 109.318 178.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 409' ' ' SER . 4.3 p-10 -107.89 131.34 54.61 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.844 -1.071 . . . . 72.25 109.1 -179.419 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 24.6 m -134.32 153.89 36.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.722 -0.473 . . . . 63.020000000000003 109.722 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -100.86 137.07 39.73 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.851 -1.166 . . . . 72.010000000000005 107.851 175.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 14.5 p -97.87 124.5 47.68 Favored Pre-proline 0 C--N 1.295 -1.779 0 C-N-CA 119.556 -0.858 . . . . 64.140000000000001 110.804 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.1 145.05 98.99 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.89 2.393 . . . . 75.329999999999998 112.355 177.29 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -85.98 166.1 16.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.872 -0.603 . . . . 74.200000000000003 110.451 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.4 HG12 ' HB2' ' A' ' 368' ' ' GLN . 15.7 t -117.47 41.68 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 CA-C-O 122.495 1.14 . . . . 53.210000000000001 108.488 -175.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -52.57 128.66 26.78 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 114.344 -1.298 . . . . 75.510000000000005 113.79 -175.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 95.76 -18.65 57.02 Favored Glycine 0 C--N 1.312 -0.798 0 CA-C-N 115.503 -0.771 . . . . 72.319999999999993 113.228 173.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.4 ' HB2' HG12 ' A' ' 365' ' ' VAL . 25.3 mt-30 -97.73 166.7 11.36 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 120.613 0.245 . . . . 62.340000000000003 111.198 -176.673 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 81.2 p -63.3 145.04 56.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.077 -0.511 . . . . 33.420000000000002 110.684 -175.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 17.9 p -63.66 -34.08 77.05 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.951 -0.3 . . . . 63.049999999999997 110.275 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -59.19 -46.32 88.73 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 116.193 -0.458 . . . . 60.210000000000001 110.358 176.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.11 -35.08 79.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.054 -0.521 . . . . 74.519999999999996 110.23 178.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.17 -50.44 71.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 72.209999999999994 110.797 178.134 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 384' ' ' ILE . 1.7 mp -58.27 -43.96 87.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 O-C-N 123.416 0.448 . . . . 63.210000000000001 110.407 178.504 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.91 -38.36 90.79 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.067 -0.515 . . . . 73.420000000000002 110.74 178.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 88.2 m -62.43 -46.94 86.29 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.736 -0.211 . . . . 54.409999999999997 110.831 178.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.98 -39.3 93.82 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 121.198 -0.201 . . . . 53.299999999999997 110.753 177.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -61.2 -44.34 97.45 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.223 0.609 . . . . 64.329999999999998 110.272 179.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -69.43 -26.27 64.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.779 -0.646 . . . . 60.340000000000003 111.805 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -81.56 -13.5 57.98 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.226 -0.443 . . . . 63.049999999999997 110.96 175.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.515 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 94.59 16.58 42.13 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.272 -0.965 . . . . 71.120000000000005 112.368 177.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -97.56 159.79 14.71 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.034 -0.728 . . . . 43.049999999999997 109.034 177.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.491 ' HB2' ' HG2' ' A' ' 415' ' ' GLU . 33.5 mmtp -104.9 157.51 17.17 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.263 -1.384 . . . . 64.040000000000006 107.263 -179.749 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.446 HG13 HG13 ' A' ' 374' ' ' ILE . 0.2 OUTLIER -136.9 157.48 35.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.451 0.643 . . . . 73.150000000000006 112.04 -175.598 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 417' ' ' THR . 37.8 ttm105 -127.41 133.11 50.01 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 105.612 -1.996 . . . . 71.040000000000006 105.612 171.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 4.7 m -122.32 121.28 36.36 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 109.204 -0.665 . . . . 54.119999999999997 109.204 -175.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -115.35 119.2 35.49 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.59 -1.263 . . . . 74.430000000000007 107.59 178.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -113.5 124.1 51.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.642 -0.503 . . . . 73.519999999999996 109.642 178.283 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -132.76 144.28 52.22 Favored Pre-proline 0 C--N 1.292 -1.913 0 C-N-CA 120.604 -0.439 . . . . 72.450000000000003 110.777 -177.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -81.82 144.15 13.6 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 N-CA-C 107.662 -1.707 . . . . 75.239999999999995 107.662 166.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.474 ' HB3' HG23 ' A' ' 394' ' ' ILE . 8.2 t70 -153.42 172.69 16.71 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 118.62 -1.232 . . . . 75.209999999999994 110.227 -176.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 11.8 m -87.38 -34.72 18.68 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.731 -1.581 . . . . 43.210000000000001 106.731 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 8.0 p -108.02 70.24 0.76 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-N 113.905 -1.498 . . . . 54.140000000000001 109.426 177.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.474 HG23 ' HB3' ' A' ' 391' ' ' ASP . 2.0 pp -90.0 121.74 68.5 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.35 1.241 . . . . 73.0 114.35 179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.42 172.88 10.1 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.557 2.171 . . . . 74.420000000000002 108.516 170.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.73 153.54 61.59 Favored 'Trans proline' 0 CA--C 1.549 1.241 0 C-N-CA 122.157 1.905 . . . . 73.329999999999998 111.594 174.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -65.44 -6.87 11.62 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 121.623 0.725 . . . . 63.229999999999997 111.935 -179.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -82.26 143.53 31.27 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.917 -1.038 . . . . 75.019999999999996 108.858 179.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.92 118.01 22.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 C-N-CA 118.938 -1.105 . . . . 64.299999999999997 108.889 -178.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 62.4 mt -84.47 -47.1 17.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.014 -1.106 . . . . 70.109999999999999 108.014 -178.283 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -159.55 170.48 35.8 Favored Glycine 0 N--CA 1.403 -3.543 0 N-CA-C 109.6 -1.4 . . . . 52.109999999999999 109.6 178.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 17.3 p -119.05 -178.7 3.62 Favored 'General case' 0 C--N 1.27 -2.85 0 N-CA-C 108.482 -0.933 . . . . 75.299999999999997 108.482 179.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.74 154.71 37.01 Favored Pre-proline 0 C--N 1.282 -2.342 0 N-CA-C 108.326 -0.99 . . . . 75.200000000000003 108.326 176.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -31.9 -32.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.856 1 C-N-CA 125.861 4.374 . . . . 71.329999999999998 116.159 -176.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -47.26 -35.0 7.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.321 1.048 . . . . 71.239999999999995 112.925 -178.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -73.27 -49.76 25.98 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.068 0.461 . . . . 64.5 112.023 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.68 -0.4 56.19 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.806 0.669 . . . . 71.209999999999994 112.806 -176.012 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 88.9 m -87.73 164.24 16.09 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.723 -1.214 . . . . 74.439999999999998 107.723 175.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 359' ' ' ASP . 2.5 p -74.23 113.57 11.59 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.87 0.843 . . . . 64.400000000000006 112.336 -176.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.62 170.13 16.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.951 -1.022 . . . . 73.219999999999999 108.856 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 17.3 t -90.26 151.73 21.38 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.792 -1.188 . . . . 73.430000000000007 107.792 176.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -65.12 130.92 45.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 109.328 -0.619 . . . . 71.109999999999999 109.328 178.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 91.28 25.78 22.95 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.575 -0.822 . . . . 72.200000000000003 112.399 -179.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.01 -175.63 3.93 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.833 -0.803 . . . . 62.310000000000002 108.833 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.491 ' HG2' ' HB2' ' A' ' 383' ' ' LYS . 29.3 mt-10 -105.43 126.78 52.51 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-N 118.517 0.598 . . . . 73.329999999999998 111.448 -175.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.59 124.97 60.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.031 -0.729 . . . . 65.409999999999997 109.031 175.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 385' ' ' ARG . 24.8 p -92.25 127.81 37.87 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 109.871 -179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 82.4 t -124.22 130.85 73.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 110.427 -176.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -96.87 128.59 43.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.717 -0.674 . . . . 75.25 109.414 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 42.5 t -124.57 140.36 48.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.737 -0.838 . . . . 73.109999999999999 108.737 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.2 p -103.3 122.76 45.46 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 120.995 0.426 . . . . 54.530000000000001 110.921 179.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . . . . . . . . . 25.7 p -118.61 104.93 11.1 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.619 -0.264 . . . . 73.25 110.468 177.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 68.01 156.11 0.74 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 114.823 0.689 . . . . 52.43 114.823 177.513 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 2.4 Cg_endo -84.27 149.4 11.86 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.249 1.966 . . . . 51.130000000000003 110.795 173.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -79.72 149.41 31.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.776 -0.647 . . . . 72.299999999999997 112.678 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 44.6 mt-30 -107.01 151.88 24.73 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.579 -1.267 . . . . 75.049999999999997 107.579 176.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 480' ' ' ILE . 0.9 OUTLIER -143.88 164.38 30.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.325 -0.991 . . . . 63.450000000000003 108.325 -179.116 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.01 138.3 33.8 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.56 -0.533 . . . . 65.430000000000007 109.56 -178.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 74.2 mt -83.79 123.66 75.81 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 105.932 -1.877 . . . . 74.030000000000001 105.932 174.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.4 141.23 82.31 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.687 2.258 . . . . 72.310000000000002 113.306 -176.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.46 -22.26 25.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.395 -0.821 . . . . 71.200000000000003 110.539 -177.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.49 -12.59 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.695 0.759 . . . . 75.329999999999998 110.507 -179.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 17.6 m -53.9 -36.7 62.99 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.287 1.035 . . . . 71.209999999999994 112.012 -179.063 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 8.9 p -69.48 -12.99 62.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.463 0.912 . . . . 75.349999999999994 113.463 -178.162 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 466' ' ' LYS . 93.4 mt -89.97 -41.07 11.96 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 112.753 0.649 . . . . 55.109999999999999 112.753 -178.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 91.6 m -149.24 125.82 11.0 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.979 -0.378 . . . . 74.219999999999999 109.979 -176.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -57.75 -48.17 80.4 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.983 0.735 . . . . 75.540000000000006 112.983 -178.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.23 90.52 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 110.95 -178.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 443' ' ' LYS . 13.8 mm-40 -69.68 -35.9 75.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.953 -0.567 . . . . 71.450000000000003 109.923 179.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -59.87 -51.08 71.25 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.766 -0.652 . . . . 71.109999999999999 109.736 179.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.76 -43.8 96.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.743 -0.662 . . . . 74.329999999999998 110.742 -179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -64.46 -48.57 74.74 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.167 0.432 . . . . 75.430000000000007 112.167 -179.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 439' ' ' GLU . 74.4 mmtt -67.62 -39.71 84.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.831 0.348 . . . . 74.409999999999997 111.415 -178.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 29.4 tp -65.05 -39.77 93.79 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.562 -0.532 . . . . 54.539999999999999 109.562 -179.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 94.3 m -67.45 -41.25 85.02 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.864 -0.607 . . . . 62.43 110.2 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -69.24 -16.78 63.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.199 -0.455 . . . . 72.5 111.774 -178.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -86.9 -3.37 59.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.305 -0.407 . . . . 74.299999999999997 110.807 177.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.11 33.84 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.968 -0.634 . . . . 21.329999999999998 113.178 176.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -67.43 139.21 57.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.694 0.283 . . . . 74.040000000000006 110.828 -177.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -142.3 1.08 1.6 Allowed Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.779 -0.725 . . . . 70.140000000000001 112.615 -179.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -104.0 111.3 23.8 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.535 -1.283 . . . . 71.310000000000002 107.535 178.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -127.28 144.67 51.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.309 -0.405 . . . . 71.200000000000003 110.29 -174.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -134.8 123.49 23.63 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.64 -1.985 . . . . 72.420000000000002 105.64 171.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -107.63 132.11 53.66 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 118.099 0.409 . . . . 75.450000000000003 111.139 -174.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -135.0 163.22 30.36 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.1 -0.5 . . . . 71.310000000000002 109.719 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -121.58 131.81 54.33 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 120.865 0.364 . . . . 74.510000000000005 110.34 -179.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 9.6 t -123.27 144.56 44.02 Favored Pre-proline 0 C--N 1.293 -1.881 0 N-CA-C 106.799 -1.556 . . . . 72.219999999999999 106.799 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.67 133.5 24.03 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 121.866 1.711 . . . . 41.219999999999999 111.057 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 27.1 m -143.75 174.97 10.34 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.583 -0.895 . . . . 54.450000000000003 108.583 -178.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 27.2 p -65.35 149.63 96.81 Favored Pre-proline 0 C--N 1.311 -1.09 0 O-C-N 123.463 0.477 . . . . 75.540000000000006 109.842 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.47 -36.26 38.83 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.095 2.53 . . . . 72.420000000000002 112.365 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -69.26 -22.02 63.86 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.976 0.732 . . . . 72.530000000000001 112.976 179.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.34 -9.77 21.94 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.778 -0.369 . . . . 74.010000000000005 111.637 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 90.7 t -59.9 126.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.767 0 CA-C-O 121.089 0.471 . . . . 71.439999999999998 110.372 177.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 100.24 -7.19 58.32 Favored Glycine 0 C--N 1.311 -0.839 0 N-CA-C 111.1 -0.8 . . . . 62.100000000000001 111.1 -178.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 435' ' ' LEU . 3.8 mptp? -107.34 156.27 19.08 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.792 -0.818 . . . . 54.310000000000002 108.792 177.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.44 HG22 HD11 ' A' ' 486' ' ' ILE . 59.1 t -84.15 127.58 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.654 -1.239 . . . . 71.400000000000006 107.654 175.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.9 -19.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.138 0.792 . . . . 72.400000000000006 113.138 -175.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 170.36 167.96 31.51 Favored Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.422 -0.894 . . . . 73.519999999999996 111.325 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 20.6 p -136.96 154.18 50.5 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.043 -1.465 . . . . 55.140000000000001 107.043 179.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -69.31 -48.68 25.46 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 118.984 -1.086 . . . . 74.219999999999999 109.369 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -79.85 106.72 1.99 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 N-CA-C 106.937 -1.986 . . . . 75.439999999999998 106.937 165.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.06 151.62 85.1 Favored 'Trans proline' 0 C--O 1.242 0.679 0 C-N-CA 122.879 2.386 . . . . 64.239999999999995 115.084 -169.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -75.0 12.68 0.81 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.76 1.224 . . . . 74.400000000000006 111.35 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -110.3 -15.59 13.92 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.577 -0.738 . . . . 74.519999999999996 110.493 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -110.08 154.68 22.92 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.848 0.832 . . . . 72.230000000000004 111.499 -171.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 6.4 m -87.74 110.61 20.58 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.014 -1.476 . . . . 65.349999999999994 107.014 178.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 41.5 m -112.83 148.52 34.68 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.772 -0.194 . . . . 74.120000000000005 111.134 -174.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -64.18 142.44 58.41 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.175 0.59 . . . . 64.319999999999993 110.66 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 427' ' ' ARG . 48.0 mm -64.7 -21.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.495 0.664 . . . . 71.140000000000001 111.147 -179.529 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.6 p -87.14 1.83 51.79 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-N 116.006 -0.543 . . . . 74.239999999999995 111.412 -177.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -89.75 145.45 25.19 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 111.107 178.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.34 122.75 37.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.719 -0.845 . . . . 71.109999999999999 108.719 176.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 47.8 t -95.08 120.74 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 108.66 -0.867 . . . . 63.299999999999997 108.66 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 15.6 tt -92.21 112.74 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.655 0 N-CA-C 107.711 -1.218 . . . . 73.150000000000006 107.711 177.487 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 467' ' ' VAL . 0.0 OUTLIER -97.56 105.96 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.693 -1.225 . . . . 61.539999999999999 107.693 -177.379 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.43 118.29 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.034 -0.985 . . . . 73.299999999999997 109.338 -176.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 25.7 t -97.32 138.54 21.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.568 -1.271 . . . . 54.43 107.568 -176.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -81.55 108.48 2.88 Favored Glycine 0 N--CA 1.417 -2.596 0 N-CA-C 109.424 -1.471 . . . . 74.319999999999993 109.424 177.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.452 ' HA ' HG13 ' A' ' 464' ' ' VAL . 13.3 t -142.67 118.02 10.23 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 62.109999999999999 108.566 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.316 0 N-CA-C 108.834 -1.706 . . . . 75.420000000000002 108.834 179.34 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.268 0 N-CA-C 109.773 -1.331 . . . . 54.450000000000003 109.773 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.25 157.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 117.071 0.436 . . . . 70.120000000000005 110.981 178.281 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . . . . . . . . . 12.8 t -125.62 169.21 12.73 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.107 -1.071 . . . . 63.32 108.107 178.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 358' ' ' ARG . 36.1 mmt180 -107.89 92.32 4.02 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-O 122.204 1.002 . . . . 73.140000000000001 110.012 177.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -117.21 148.68 41.41 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.054 -1.885 . . . . 52.140000000000001 107.623 179.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.62 161.5 32.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.033 0.444 . . . . 42.43 111.208 -173.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -100.69 136.32 40.74 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.644 -1.243 . . . . 72.450000000000003 107.644 173.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 10.8 p -98.49 133.2 22.92 Favored Pre-proline 0 C--N 1.292 -1.918 0 N-CA-C 108.149 -1.056 . . . . 64.319999999999993 108.149 -177.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -71.83 164.27 36.22 Favored 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 121.966 1.777 . . . . 70.209999999999994 113.67 -176.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 366' ' ' ARG . 4.1 m-20 -67.51 120.89 14.69 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.844 -1.071 . . . . 53.100000000000001 108.244 176.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 11.3 p -81.83 30.72 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.582 0 CA-C-O 123.067 1.413 . . . . 75.340000000000003 110.146 -178.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 15.1 ptt85 -62.49 144.09 56.39 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 113.716 -1.584 . . . . 72.239999999999995 113.041 -177.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 103.01 0.47 48.29 Favored Glycine 0 N--CA 1.436 -1.365 0 CA-C-N 115.303 -0.862 . . . . 61.210000000000001 114.164 173.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -132.77 175.88 8.95 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.824 0.812 . . . . 71.049999999999997 111.569 -177.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 97.3 p -74.77 171.45 13.94 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 122.636 0.374 . . . . 75.540000000000006 111.028 -176.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 14.6 m -61.85 -45.66 92.84 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.99 0.424 . . . . 75.209999999999994 110.09 178.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -67.22 -35.83 80.4 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.106 -0.497 . . . . 74.25 111.195 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.47 -42.23 79.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.23 -0.441 . . . . 75.450000000000003 110.701 176.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.77 81.79 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 75.010000000000005 110.287 178.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 77.6 mt -58.71 -42.58 85.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.031 -0.986 . . . . 61.140000000000001 110.715 178.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -65.23 -47.17 77.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.295 -0.412 . . . . 64.239999999999995 110.985 179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 43.7 m -60.77 -45.57 93.81 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 116.511 -0.313 . . . . 72.230000000000004 111.401 -178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.64 -38.93 92.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.737 0.303 . . . . 54.049999999999997 111.01 176.061 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -62.24 -43.3 99.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.704 -0.68 . . . . 74.209999999999994 109.839 179.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -29.03 70.11 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.885 -0.598 . . . . 74.340000000000003 110.691 178.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -83.85 -12.12 56.0 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.872 -0.604 . . . . 73.049999999999997 109.709 -179.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . 0.569 ' O ' ' HA2' ' A' ' 413' ' ' GLY . . . 96.92 0.85 60.04 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.997 -0.62 . . . . 71.310000000000002 112.416 177.256 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.452 ' CZ ' ' HA ' ' A' ' 412' ' ' ALA . 43.9 m-85 -79.18 157.15 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.034 0.445 . . . . 73.340000000000003 111.851 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -102.8 137.83 40.5 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 106.711 -1.589 . . . . 64.450000000000003 106.711 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.63 140.26 46.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 113.96 1.096 . . . . 72.430000000000007 113.96 -177.053 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -110.69 130.89 55.45 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 106.03 -1.841 . . . . 75.319999999999993 106.03 173.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 7.9 m -112.64 118.09 34.08 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.782 -0.822 . . . . 53.020000000000003 108.782 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -115.44 118.33 32.9 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.943 -1.502 . . . . 75.510000000000005 106.943 179.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 420' ' ' VAL . 0.0 OUTLIER -109.67 122.44 47.48 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.072 -0.714 . . . . 51.43 109.072 177.536 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.38 133.45 25.09 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.009 -0.541 . . . . 74.319999999999993 110.068 -179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.408 ' N ' ' HB ' ' A' ' 422' ' ' THR . 57.8 Cg_endo -76.19 139.67 21.55 Favored 'Trans proline' 0 C--O 1.257 1.431 0 C-N-CA 122.371 2.047 . . . . 62.109999999999999 109.326 172.092 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 9.6 t70 172.78 -157.29 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.491 -1.299 . . . . 62.520000000000003 107.491 -176.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 481' ' ' THR . 57.4 m -141.68 -14.38 0.84 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.876 -0.515 . . . . 71.400000000000006 111.928 176.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 40.5 p -91.37 19.35 6.13 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.364 1.078 . . . . 61.210000000000001 109.847 179.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . . . . . . . . . 9.8 pt -104.57 150.95 39.11 Favored Pre-proline 0 C--N 1.296 -1.735 0 CA-C-N 114.571 -1.195 . . . . 71.340000000000003 111.839 -173.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.32 145.23 38.16 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.494 2.129 . . . . 72.439999999999998 111.291 177.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.48 162.84 7.51 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.26 3.307 . . . . 73.030000000000001 113.362 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.91 -11.78 1.15 Allowed 'General case' 0 N--CA 1.515 2.788 0 C-N-CA 124.257 1.023 . . . . 62.210000000000001 112.451 -178.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -101.97 109.15 20.81 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.082 -2.192 . . . . 73.310000000000002 105.082 176.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 366' ' ' ARG . 7.3 p -62.14 120.64 8.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 122.079 0.942 . . . . 65.230000000000004 112.302 -170.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 14.1 tt -104.03 -27.9 3.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.546 -1.206 . . . . 53.240000000000002 110.318 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -145.62 158.09 27.56 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 119.817 -1.182 . . . . 35.229999999999997 111.97 -177.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 77.1 p -114.6 -175.58 2.71 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 123.253 0.621 . . . . 72.510000000000005 110.249 -177.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -100.05 134.77 20.66 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 106.805 -1.554 . . . . 73.099999999999994 106.805 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -39.72 -27.94 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.015 1 C-N-CA 125.395 4.063 . . . . 64.329999999999998 115.939 -175.583 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -59.85 -24.16 63.99 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.76 0.314 . . . . 51.520000000000003 111.055 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.0 -49.87 40.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.018 -0.537 . . . . 71.530000000000001 110.816 178.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -79.26 -2.32 40.66 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.291 0.567 . . . . 64.099999999999994 112.249 -179.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 84.2 m -84.86 146.84 27.1 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.391 -1.337 . . . . 73.030000000000001 107.391 172.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 19.2 m -75.43 119.6 19.73 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.903 -0.719 . . . . 51.149999999999999 110.001 -179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 16.7 m -137.02 169.2 20.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 123.898 0.879 . . . . 63.109999999999999 109.225 -179.524 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 22.0 t -75.61 142.05 42.73 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.439 -0.949 . . . . 73.310000000000002 108.439 178.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 382' ' ' PHE . . . -64.27 109.76 2.0 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.215 -0.661 . . . . 74.120000000000005 109.215 178.092 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 381' ' ' GLY . . . 122.96 25.88 1.8 Allowed Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 110.765 -0.934 . . . . 73.030000000000001 110.765 -175.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.02 -178.29 4.02 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.047 -1.094 . . . . 51.32 108.047 -178.169 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -94.33 120.92 35.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.903 0.859 . . . . 63.130000000000003 112.918 -176.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . . . . . . . . . 51.1 mm -110.96 121.35 63.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.501 -0.926 . . . . 73.400000000000006 108.501 176.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.9 t -93.81 121.39 35.2 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.549 0.69 . . . . 70.030000000000001 110.037 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 61.3 t -107.05 126.85 63.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.387 -0.968 . . . . 55.32 108.387 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -99.75 120.19 39.33 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.244 -0.65 . . . . 62.039999999999999 109.244 -179.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 59.0 t -113.07 142.89 24.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.764 -0.828 . . . . 75.439999999999998 108.764 -178.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . . . . . . . . . 3.0 p -84.87 127.38 34.13 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.898 1.332 . . . . 74.329999999999998 113.792 -178.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.408 ' HB ' ' N ' ' A' ' 390' ' ' PRO . 8.8 m -101.46 156.84 17.23 Favored 'General case' 1 N--CA 1.376 -4.156 0 N-CA-C 104.092 -2.558 . . . . 74.010000000000005 104.092 170.238 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -34.84 150.64 0.01 OUTLIER Glycine 0 C--N 1.284 -2.357 0 N-CA-C 117.435 1.734 . . . . 74.150000000000006 117.435 -176.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 50.9 Cg_exo -54.71 132.2 50.27 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.128 2.552 . . . . 73.200000000000003 112.918 179.007 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -72.25 140.6 48.73 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.142 -0.935 . . . . 65.340000000000003 109.933 176.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 45.2 mt-30 -120.3 148.11 44.14 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 108.251 -1.018 . . . . 61.43 108.251 176.325 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -144.56 164.64 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.615 -1.254 . . . . 75.120000000000005 107.615 -176.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.39 138.84 34.34 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.993 -1.114 . . . . 53.299999999999997 107.993 177.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . 0.523 ' HB ' ' HA ' ' A' ' 474' ' ' ALA . 69.5 mt -80.8 120.47 79.05 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 108.168 -1.049 . . . . 62.210000000000001 108.168 178.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.46 141.55 51.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.96 2.44 . . . . 64.409999999999997 113.69 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -80.44 -15.65 56.27 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.733 -1.121 . . . . 75.150000000000006 111.253 -176.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 14.4 p -67.31 -14.62 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.396 -0.82 . . . . 75.329999999999998 110.838 -178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 20.0 m -53.74 -40.04 65.81 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.922 0.889 . . . . 73.310000000000002 112.388 -178.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . . . . . . . . . 20.8 p -69.08 -12.84 62.04 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 113.384 0.883 . . . . 75.299999999999997 113.384 -176.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 74.7 mt -82.7 -48.35 10.97 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.362 -0.535 . . . . 65.430000000000007 110.716 -178.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 75.1 m -157.29 141.74 16.49 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 110.285 -0.265 . . . . 72.510000000000005 110.285 -176.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -56.7 -44.19 81.28 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.695 1.198 . . . . 74.530000000000001 111.486 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -55.88 -44.61 78.31 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.915 0.388 . . . . 70.030000000000001 110.482 177.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -65.11 -42.0 94.37 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 115.836 -0.62 . . . . 65.519999999999996 110.935 178.369 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . 0.437 ' O ' HD13 ' A' ' 444' ' ' LEU . . . -60.79 -51.69 68.27 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.599 0.562 . . . . 73.409999999999997 110.662 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 86.3 t -64.57 -49.18 81.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 C-N-CA 120.948 -0.301 . . . . 74.200000000000003 111.515 -177.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.06 -47.58 70.86 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.569 0.581 . . . . 70.219999999999999 112.569 -178.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . 0.265 0.8 OUTLIER -67.05 -38.03 85.12 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.255 0.835 . . . . 71.209999999999994 113.255 -178.566 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 440' ' ' ALA . 11.0 mp -65.42 -36.46 84.01 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.269 -0.572 . . . . 52.329999999999998 111.115 174.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 44.9 m -67.35 -39.95 85.8 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.169 -0.678 . . . . 64.409999999999997 109.169 177.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -66.57 -28.95 68.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.157 0.503 . . . . 74.239999999999995 110.605 177.331 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.87 -13.64 59.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.302 -0.408 . . . . 51.020000000000003 110.34 177.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 119.92 -21.3 8.99 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 119.163 -0.799 . . . . 43.340000000000003 114.697 174.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -55.88 128.33 34.56 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.408 0.892 . . . . 55.219999999999999 113.408 -172.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -114.46 -1.18 23.31 Favored Glycine 0 N--CA 1.432 -1.586 0 CA-C-N 115.251 -0.886 . . . . 33.210000000000001 114.293 -176.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 482' ' ' ASN . 10.7 mmm180 -124.12 111.66 16.18 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 117.699 0.749 . . . . 63.140000000000001 110.549 178.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -119.07 150.99 39.06 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.804 -0.635 . . . . 71.439999999999998 110.271 179.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -145.56 136.1 24.21 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.399 -1.704 . . . . 72.310000000000002 106.399 172.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -106.64 134.12 50.28 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 120.809 0.338 . . . . 73.150000000000006 110.148 -176.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -136.93 159.14 42.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.231 -0.655 . . . . 62.030000000000001 109.231 177.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -129.35 134.54 47.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.43 -0.952 . . . . 64.409999999999997 108.43 177.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 32.4 t -125.14 146.13 52.82 Favored Pre-proline 0 C--N 1.29 -2.021 0 N-CA-C 108.997 -0.742 . . . . 42.420000000000002 108.997 -177.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 490' ' ' SER . 40.4 Cg_exo -61.57 123.6 13.04 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 122.332 2.021 . . . . 75.319999999999993 109.244 173.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 47.5 m -139.26 -179.78 6.07 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 110.211 -0.292 . . . . 71.530000000000001 110.211 -176.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . . . . . . . . . 4.6 m -56.18 133.5 75.11 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 108.384 -0.969 . . . . 60.25 108.384 175.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.01 -31.16 33.58 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 123.828 3.018 . . . . 72.209999999999994 114.173 -175.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.73 -11.23 59.95 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 111.962 0.356 . . . . 75.430000000000007 111.962 -178.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.69 2.29 38.47 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.498 -0.319 . . . . 74.420000000000002 111.16 -176.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 489' ' ' GLY . 12.7 p -59.62 126.96 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 120.277 -0.569 . . . . 73.530000000000001 110.689 178.032 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.79 78.24 Favored Glycine 0 C--N 1.308 -0.997 0 C-N-CA 120.161 -1.019 . . . . 72.439999999999998 111.963 178.407 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -125.42 147.21 49.28 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.584 -0.895 . . . . 71.150000000000006 108.584 177.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.65 128.64 38.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.193 -0.669 . . . . 74.450000000000003 109.193 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.553 ' H ' HD13 ' A' ' 468' ' ' ILE . 0.2 OUTLIER -97.66 -5.39 9.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.126 -1.03 . . . . 75.219999999999999 111.226 -178.608 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.73 29.39 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 120.534 -0.841 . . . . 74.010000000000005 111.805 176.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 9.2 p -116.34 153.34 32.17 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 107.896 -1.15 . . . . 71.230000000000004 107.896 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 28.4 t-20 -60.75 -50.35 85.56 Favored Pre-proline 0 C--N 1.317 -0.838 0 O-C-N 123.35 0.406 . . . . 75.329999999999998 111.285 179.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 3.0 Cg_exo -77.98 131.28 10.92 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 N-CA-C 107.413 -1.803 . . . . 51.509999999999998 107.413 168.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . 0.406 ' HG2' ' CB ' ' A' ' 476' ' ' GLN . 19.5 Cg_endo -62.46 142.14 89.34 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.373 2.049 . . . . 75.530000000000001 113.552 -175.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 429' ' ' ILE . . . -78.99 4.18 15.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.976 0.893 . . . . 54.140000000000001 110.827 -178.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -108.56 3.24 22.79 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.763 -1.108 . . . . 71.109999999999999 108.652 178.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . 0.406 ' CB ' ' HG2' ' A' ' 473' ' ' PRO . 36.1 tt0 -121.83 165.21 16.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.106 -1.072 . . . . 74.530000000000001 108.106 -178.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 426' ' ' GLN . 2.8 m -98.77 129.64 45.2 Favored 'General case' 0 C--N 1.278 -2.523 0 N-CA-C 108.029 -1.1 . . . . 61.340000000000003 108.029 -179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 47.5 m -124.42 148.59 47.5 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.952 -0.388 . . . . 62.43 109.952 -178.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -73.25 153.75 40.49 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.388 0.514 . . . . 75.519999999999996 112.388 -178.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 392' ' ' SER . 1.7 mp -66.26 -29.46 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 121.359 0.6 . . . . 62.109999999999999 110.694 177.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 14.6 t -90.18 2.82 54.94 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 121.541 0.686 . . . . 72.310000000000002 109.949 177.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 479' ' ' ALA . 46.1 t30 -86.08 141.55 29.35 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 108.037 -1.097 . . . . 73.329999999999998 108.037 -178.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 60.4 t -79.47 112.71 17.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 120.051 -0.66 . . . . 72.400000000000006 109.22 -178.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 52.1 t -96.1 119.44 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 N-CA-C 107.514 -1.291 . . . . 61.039999999999999 107.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 41.0 mt -98.22 121.03 48.33 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 107.451 -1.314 . . . . 61.299999999999997 107.451 -179.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.93 120.22 51.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.809 -1.182 . . . . 63.549999999999997 107.809 -179.219 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.59 123.63 60.1 Favored 'Isoleucine or valine' 0 C--O 1.251 1.184 0 CA-C-O 121.527 0.679 . . . . 72.319999999999993 110.048 -176.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.98 137.33 25.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.946 -1.131 . . . . 70.299999999999997 107.946 179.065 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 464' ' ' VAL . . . -76.57 127.98 8.97 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.424 -1.07 . . . . 54.530000000000001 110.424 179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 458' ' ' PRO . 8.3 t -133.94 103.89 6.02 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.179 -1.045 . . . . 72.230000000000004 108.179 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.193 0 N-CA-C 108.877 -1.689 . . . . 54.409999999999997 108.877 -178.007 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.293 0 N-CA-C 109.82 -1.312 . . . . 63.530000000000001 109.82 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 2.6 pp -87.71 141.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 C-N-CA 119.866 -0.734 . . . . 63.130000000000003 109.241 174.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 357' ' ' THR . . . . . 0.403 ' HB ' ' OD1' ' A' ' 359' ' ' ASP . 8.9 m -117.23 160.04 21.71 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 108.398 -0.964 . . . . 71.109999999999999 108.398 -175.024 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -97.17 56.93 1.42 Allowed 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.519 -1.289 . . . . 64.430000000000007 107.519 171.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.403 ' OD1' ' HB ' ' A' ' 357' ' ' THR . 12.6 p-10 -85.65 127.14 34.4 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 113.589 -1.641 . . . . 75.450000000000003 109.892 -178.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 360' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.98 152.23 20.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 110.931 -174.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 361' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.54 136.7 43.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 116.151 -0.477 . . . . 71.109999999999999 109.941 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 12.0 p -102.95 133.77 20.18 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 109.301 -0.629 . . . . 32.229999999999997 109.301 -176.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.65 159.51 53.21 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.604 2.202 . . . . 71.140000000000001 114.635 -175.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.37 142.96 50.36 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 115.28 -0.873 . . . . 72.200000000000003 109.166 176.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 368' ' ' GLN . 6.7 t -107.08 21.67 4.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.044 -1.095 . . . . 71.400000000000006 108.044 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 399' ' ' VAL . 6.0 ptp180 -58.57 145.37 39.61 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.08 -0.964 . . . . 71.439999999999998 112.379 -177.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 367' ' ' GLY . . . . . . . . . . . . . . . 104.4 1.06 43.92 Favored Glycine 0 C--N 1.319 -0.412 0 C-N-CA 120.729 -0.748 . . . . 72.340000000000003 113.317 178.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 365' ' ' VAL . 7.6 pt20 -138.58 -175.45 4.13 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.263 -1.014 . . . . 73.310000000000002 108.263 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 398' ' ' HIS . 96.1 p -76.48 163.82 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 119.609 1.095 . . . . 74.239999999999995 112.316 -172.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 2.7 p -61.85 -34.09 75.34 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.758 -0.655 . . . . 71.030000000000001 109.335 173.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 371' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.77 91.73 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.143 -0.935 . . . . 72.239999999999995 109.781 176.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.06 -42.11 89.54 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.58 -0.736 . . . . 75.329999999999998 110.619 177.206 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 373' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 399' ' ' VAL . . . -59.93 -47.39 85.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.722 -0.672 . . . . 50.100000000000001 111.224 179.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 82.6 mt -58.45 -46.12 89.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.087 -0.506 . . . . 75.010000000000005 110.013 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.15 93.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.815 -0.63 . . . . 54.149999999999999 111.477 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 376' ' ' THR . . . . . . . . . . . . . 64.9 m -66.24 -48.25 71.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.145 -0.48 . . . . 61.130000000000003 111.088 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.27 -38.7 91.1 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 122.325 -0.234 . . . . 74.209999999999994 111.225 178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -59.71 -48.17 82.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.823 -0.806 . . . . 63.119999999999997 108.823 178.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 379' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -70.33 -17.31 63.07 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.684 1.364 . . . . 64.019999999999996 114.684 -179.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -89.61 -14.19 35.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.353 -0.539 . . . . 71.200000000000003 111.113 172.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . 99.11 16.25 30.79 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 120.345 -0.931 . . . . 44.109999999999999 113.25 176.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -96.72 154.67 17.15 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.857 -0.423 . . . . 74.230000000000004 109.857 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 383' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 415' ' ' GLU . 33.1 mmtp -95.61 143.44 26.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.091 -1.448 . . . . 74.129999999999995 107.091 178.325 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 384' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 416' ' ' ILE . 0.2 OUTLIER -132.75 148.21 31.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.363 0.601 . . . . 65.010000000000005 112.398 -178.802 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 385' ' ' ARG . . . . . 0.503 ' HB3' HG22 ' A' ' 417' ' ' THR . 19.5 ttm-85 -118.28 144.88 45.47 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 106.705 -1.591 . . . . 73.430000000000007 106.705 174.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 386' ' ' THR . . . . . . . . . . . . . 12.3 m -98.46 121.58 40.58 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.008 -1.478 . . . . 73.340000000000003 107.008 176.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.34 119.47 38.96 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 105.872 -1.899 . . . . 74.439999999999998 105.872 -179.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.58 ' HB2' HG22 ' A' ' 422' ' ' THR . 0.0 OUTLIER -110.91 122.06 46.93 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 121.368 0.604 . . . . 73.099999999999994 110.892 -174.619 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 389' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 421' ' ' SER . 0.3 OUTLIER -116.15 119.32 36.88 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 115.402 -0.817 . . . . 64.5 111.48 -177.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 391' ' ' ASP . 5.8 Cg_endo -93.25 145.53 2.26 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 123.031 2.487 . . . . 44.219999999999999 111.662 173.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 391' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 424' ' ' PRO . 12.0 t70 160.82 -164.56 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 104.861 -2.274 . . . . 64.230000000000004 104.861 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . 0.459 ' HB2' ' HB ' ' A' ' 480' ' ' ILE . 14.8 m -132.8 1.68 3.65 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 119.533 1.06 . . . . 71.049999999999997 110.316 175.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 393' ' ' THR . . . . . . . . . . . . . 4.1 m -97.32 24.39 6.55 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 106.385 -1.709 . . . . 74.519999999999996 106.385 174.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 394' ' ' ILE . . . . . 0.576 HD12 ' HB2' ' A' ' 421' ' ' SER . 19.8 pt -89.64 151.57 45.97 Favored Pre-proline 0 N--CA 1.427 -1.587 0 CA-C-N 112.527 -2.124 . . . . 65.129999999999995 110.304 -178.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 395' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.55 173.01 15.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 121.837 1.691 . . . . 73.420000000000002 108.652 170.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 396' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.01 160.92 14.28 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.161 1.907 . . . . 52.0 112.598 174.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.01 -8.07 0.94 Allowed 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 125.923 1.689 . . . . 63.32 112.781 -179.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.423 ' HB3' ' O ' ' A' ' 368' ' ' GLN . 42.9 m80 -82.42 175.47 10.2 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 124.452 1.101 . . . . 70.439999999999998 108.467 179.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 373' ' ' ALA . 7.6 p -91.8 117.92 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 118.457 -1.297 . . . . 73.319999999999993 109.592 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 400' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.81 -28.76 2.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 114.672 -1.149 . . . . 71.439999999999998 109.808 177.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . . . . . . . . . . . -144.34 160.8 27.92 Favored Glycine 0 N--CA 1.421 -2.345 0 C-N-CA 119.79 -1.195 . . . . 52.140000000000001 112.192 -173.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 402' ' ' THR . . . . . . . . . . . . . 52.4 p -122.43 -174.46 2.91 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.282 1.033 . . . . 71.219999999999999 111.225 -172.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.437 ' HB3' HG23 ' A' ' 416' ' ' ILE . 6.5 t70 -98.17 142.07 23.98 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 105.896 -1.89 . . . . 71.019999999999996 105.896 -175.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 404' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.31 -36.14 6.08 Favored 'Trans proline' 0 C--O 1.242 0.722 0 C-N-CA 123.795 2.996 . . . . 74.120000000000005 113.647 178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 405' ' ' ALA . . . . . . . . . . . . . . . -68.54 -8.21 39.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.962 -0.563 . . . . 52.149999999999999 112.496 -178.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -81.75 -51.45 8.15 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 120.548 -0.461 . . . . 71.239999999999995 110.64 178.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 407' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.35 -5.12 59.24 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 120.646 -0.421 . . . . 61.409999999999997 112.043 -179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 32.5 m -97.06 142.25 29.23 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 72.420000000000002 106.624 174.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 16.7 p -74.24 113.74 11.8 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-O 121.763 0.792 . . . . 72.430000000000007 111.771 -177.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.25 170.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.887 -1.051 . . . . 73.200000000000003 109.462 -179.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 411' ' ' SER . . . . . . . . . . . . . 48.1 m -67.02 138.56 57.3 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.561 -0.903 . . . . 73.109999999999999 108.561 175.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -57.81 109.92 0.81 Allowed 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.007 0.523 . . . . 73.239999999999995 111.483 -177.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . 104.93 43.64 1.62 Allowed Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.582 -0.735 . . . . 65.129999999999995 111.997 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -94.39 -167.62 1.7 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.406 -1.331 . . . . 63.310000000000002 107.406 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 415' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 383' ' ' LYS . 11.2 pt-20 -111.36 124.4 52.17 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.695 0.759 . . . . 64.010000000000005 111.612 -179.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 416' ' ' ILE . . . . . 0.437 HG23 ' HB3' ' A' ' 403' ' ' ASP . 43.7 mm -114.44 135.53 53.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.012 -0.994 . . . . 65.420000000000002 108.554 -176.063 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 385' ' ' ARG . 71.1 p -94.32 127.07 39.96 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.34 -0.944 . . . . 73.140000000000001 109.689 175.462 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.28 130.13 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 108.242 -1.021 . . . . 72.129999999999995 108.242 178.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 419' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -96.69 128.81 43.99 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 116.401 -0.363 . . . . 71.420000000000002 110.595 -175.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 388' ' ' GLN . 12.6 p -134.33 141.38 43.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.391 -0.966 . . . . 75.019999999999996 108.391 176.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 421' ' ' SER . . . . . 0.576 ' HB2' HD12 ' A' ' 394' ' ' ILE . 73.2 p -94.1 122.53 36.71 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 109.474 -0.565 . . . . 52.009999999999998 109.474 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 422' ' ' THR . . . . . 0.58 HG22 ' HB2' ' A' ' 388' ' ' GLN . 12.2 t -120.14 107.5 13.11 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.857 -0.737 . . . . 74.230000000000004 111.992 177.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . 88.04 120.65 1.59 Allowed Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.839 -1.172 . . . . 64.109999999999999 114.431 174.229 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 424' ' ' PRO . . . . . 0.656 ' HA ' ' O ' ' A' ' 391' ' ' ASP . 5.2 Cg_exo -75.94 128.56 10.84 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 121.898 1.732 . . . . 62.210000000000001 110.207 173.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.452 ' O ' HG12 ' A' ' 480' ' ' ILE . 6.4 mm-40 -74.99 125.75 29.57 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.687 -0.486 . . . . 54.340000000000003 109.687 177.275 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 479' ' ' ALA . 49.1 mt-30 -110.29 139.08 45.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.083 -0.71 . . . . 71.510000000000005 109.083 177.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 427' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 426' ' ' GLN . 1.1 tpt180 -132.64 165.45 24.41 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.995 0.426 . . . . 73.299999999999997 111.579 -177.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.76 139.24 34.96 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 124.158 0.983 . . . . 75.340000000000003 111.2 -172.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 429' ' ' ILE . . . . . . . . . . . . . 3.0 mp -81.67 119.82 76.36 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.278 -1.749 . . . . 60.520000000000003 106.278 172.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.25 141.35 81.87 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.651 2.234 . . . . 61.219999999999999 113.368 -178.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 431' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -89.06 -20.96 23.69 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.069 -0.969 . . . . 54.32 110.426 179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 10.0 p -70.39 -11.73 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-O 121.407 0.623 . . . . 63.409999999999997 110.624 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . . . . . . . . . 18.2 m -53.0 -41.03 64.26 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.486 1.114 . . . . 62.420000000000002 112.485 -178.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 434' ' ' THR . . . . . 0.451 ' HA ' ' HB ' ' A' ' 467' ' ' VAL . 3.1 p -68.2 -13.63 62.38 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.557 0.947 . . . . 74.230000000000004 113.557 -176.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 435' ' ' LEU . . . . . . . . . . . . . 76.3 mt -86.86 -36.92 18.18 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.651 0.263 . . . . 64.109999999999999 111.306 -178.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 89.9 m -158.37 134.15 9.0 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 122.222 -0.299 . . . . 72.209999999999994 110.415 -177.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 437' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -62.05 -46.42 89.21 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.703 0.631 . . . . 73.329999999999998 112.703 -178.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 438' ' ' ALA . . . . . . . . . . . . . . . -59.14 -41.23 87.82 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.704 0.287 . . . . 60.450000000000003 110.468 -179.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -63.71 -39.45 94.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.725 -0.671 . . . . 54.43 110.41 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 440' ' ' ALA . . . . . . . . . . . . . . . -60.87 -50.92 71.46 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.47 0.481 . . . . 24.539999999999999 109.837 178.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 441' ' ' VAL . . . . . . . . . . . . . 98.0 t -59.44 -46.46 92.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 43.340000000000003 110.467 -179.818 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 442' ' ' LYS . 6.3 mmpt? -61.04 -46.05 92.26 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.996 -0.547 . . . . 73.150000000000006 111.267 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 443' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -64.43 -41.98 96.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.246 0.462 . . . . 74.239999999999995 112.246 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 444' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.74 -43.43 96.5 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.936 0.398 . . . . 71.109999999999999 111.024 176.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . . . . . . . . . 27.9 m -68.08 -39.63 82.88 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.787 -0.642 . . . . 74.129999999999995 110.333 -178.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 446' ' ' ALA . . . . . . . . . . . . . . . -71.06 -25.3 62.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 63.020000000000003 111.184 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.76 -12.84 59.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.156 0.503 . . . . 62.399999999999999 109.728 176.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 105.53 0.7 40.26 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-O 119.168 -0.795 . . . . 74.409999999999997 114.469 174.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 449' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -65.96 137.38 57.1 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.099 0.95 . . . . 74.140000000000001 112.106 -178.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . -125.08 13.57 7.53 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.204 -0.759 . . . . 73.299999999999997 111.204 178.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 451' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -127.23 111.37 13.87 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.504 -0.924 . . . . 63.109999999999999 108.504 -178.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 452' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.08 152.74 47.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.89 -0.595 . . . . 74.450000000000003 109.94 -175.041 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . 0.414 ' HD3' HG13 ' A' ' 485' ' ' ILE . 64.0 tttp -150.09 122.71 8.58 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.927 -1.138 . . . . 70.299999999999997 107.927 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 454' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -99.73 131.98 45.36 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.796 -0.446 . . . . 65.109999999999999 109.796 -177.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -123.57 141.17 52.27 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.315 -1.365 . . . . 73.409999999999997 107.315 175.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 456' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -119.28 129.59 54.98 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.219 0.533 . . . . 72.109999999999999 110.288 179.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 457' ' ' SER . . . . . . . . . . . . . 16.2 t -119.94 130.84 24.64 Favored Pre-proline 0 N--CA 1.41 -2.443 0 N-CA-C 108.506 -0.924 . . . . 74.209999999999994 108.506 -178.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 458' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.73 121.81 10.09 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.45 2.1 . . . . 52.32 109.699 177.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 20.4 m -133.95 160.28 38.18 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.916 -0.314 . . . . 63.310000000000002 110.417 -176.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 460' ' ' THR . . . . . 0.525 ' HB ' ' OE1' ' A' ' 462' ' ' GLU . 14.2 p -64.65 159.06 64.47 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 124.856 1.262 . . . . 73.430000000000007 111.81 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 461' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.77 -31.13 24.89 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 123.789 2.992 . . . . 64.030000000000001 113.285 177.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 462' ' ' GLU . . . . . 0.525 ' OE1' ' HB ' ' A' ' 460' ' ' THR . 1.5 pm0 -75.36 -24.54 57.31 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.193 0.812 . . . . 73.310000000000002 113.193 178.115 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 463' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.17 -18.67 14.06 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.211 0.448 . . . . 71.0 112.211 -179.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 464' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 490' ' ' SER . 7.9 p -59.5 130.44 23.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.413 0.625 . . . . 64.310000000000002 111.29 -179.509 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 96.6 -4.61 64.01 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 115.743 -0.662 . . . . 61.130000000000003 111.971 178.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.13 157.05 28.68 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.227 0.537 . . . . 64.540000000000006 109.95 177.295 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 467' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 434' ' ' THR . 94.6 t -83.79 136.51 22.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.496 -1.298 . . . . 65.129999999999995 107.496 176.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.31 -16.02 7.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.543 -0.863 . . . . 55.310000000000002 111.301 -177.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 161.1 175.62 32.32 Favored Glycine 0 N--CA 1.427 -1.964 0 CA-C-N 115.561 -0.745 . . . . 43.039999999999999 111.629 178.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 470' ' ' THR . . . . . . . . . . . . . 17.0 p -122.01 158.99 27.92 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.385 -0.969 . . . . 75.030000000000001 108.385 177.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 471' ' ' ASN . . . . . 0.454 ' HB3' ' HD3' ' A' ' 472' ' ' PRO . 27.0 t-20 -64.97 -57.0 17.19 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 119.086 -0.483 . . . . 74.120000000000005 110.666 175.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 472' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 471' ' ' ASN . 15.0 Cg_endo -79.63 121.14 4.56 Favored 'Trans proline' 0 C--N 1.372 1.802 0 N-CA-C 107.951 -1.596 . . . . 71.219999999999999 107.951 170.176 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 161.29 46.5 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 122.537 2.158 . . . . 75.129999999999995 113.969 -174.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -69.6 6.59 1.06 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 124.887 1.275 . . . . 73.319999999999993 113.283 -177.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 475' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -108.15 -4.49 17.62 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.158 -0.682 . . . . 74.129999999999995 109.158 179.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 476' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -99.92 161.44 13.61 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.604 -0.726 . . . . 74.409999999999997 109.936 -177.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 477' ' ' THR . . . . . . . . . . . . . 24.0 m -128.92 101.03 5.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.996 -1.483 . . . . 55.299999999999997 106.996 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 478' ' ' SER . . . . . . . . . . . . . 35.9 p -104.41 149.05 25.75 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.139 -0.482 . . . . 54.130000000000003 111.576 -174.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 479' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 426' ' ' GLN . . . -60.8 153.53 24.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.007 -0.542 . . . . 52.0 111.015 177.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 480' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 392' ' ' SER . 48.2 mm -61.0 -15.1 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 C-N-CA 123.924 0.89 . . . . 65.530000000000001 112.074 -179.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 392' ' ' SER . 15.0 t -94.99 -4.09 47.26 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.8 -0.563 . . . . 72.439999999999998 110.238 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 482' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 130.89 37.83 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.98 -0.748 . . . . 54.140000000000001 108.98 179.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.31 113.84 21.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.68 -0.859 . . . . 75.540000000000006 108.68 -179.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 60.5 t -88.45 120.04 36.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 109.081 -0.711 . . . . 60.200000000000003 109.081 179.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . 0.414 HG13 ' HD3' ' A' ' 453' ' ' LYS . 3.8 mp -92.34 113.02 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.122 -1.436 . . . . 61.450000000000003 107.122 177.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.92 121.28 53.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.124 -1.065 . . . . 74.140000000000001 108.124 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 487' ' ' ILE . . . . . . . . . . . . . 39.7 mt -101.16 116.32 44.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 121.566 0.698 . . . . 71.219999999999999 110.474 -175.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 37.5 t -98.1 132.72 42.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.245 -0.889 . . . . 65.329999999999998 109.045 -176.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 489' ' ' GLY . . . . . . . . . . . . . . . -81.7 98.68 1.93 Allowed Glycine 0 N--CA 1.426 -1.975 0 N-CA-C 109.207 -1.557 . . . . 63.420000000000002 109.207 175.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 464' ' ' VAL . 18.0 t -140.85 111.89 7.17 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 108.902 -0.777 . . . . 70.439999999999998 108.902 -176.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 491' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.92 0 N-CA-C 109.636 -1.386 . . . . 73.040000000000006 109.636 179.772 . . . . . . . . 0 0 . 1 stop_ save_